,CUI1,CUI2,label
0,Anaplasia,Adenocarcinoma with squamous metaplasia,0
1,HIF1A Overexpression Positive,Adenocarcinoma with squamous metaplasia,0
2,Cauliflower-Like Mass,Occult Lung Cancer AJCC v8,0
3,Numerous Stromal Mast Cells Present,Stromal sarcoma,0
4,Congenital Abnormality,Congenital melanocytic nevus,0
5,Severe dysplasia,Mild epithelial dysplasia,0
6,Acinar Proliferation,Acinar cell cystadenocarcinoma,0
7,Vater-Pacini Corpuscles-Like Structures Present,Pseudolymphoma,0
8,Peau d'orange surface of breast,Usual ductal hyperplasia of breast,0
9,Collagenous Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
10,Schwannian Stroma Predominant Component of the Tumor Volume,Benign Mixed Tumor of the Vulva,0
11,Fibrovascular Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
12,Alopecia,Malignant neoplasm of stomach recurrent,0
13,Sheets of Interfollicular Plasma Cells Present,Recurrent tumors of the Ewing's family,0
14,Monoclonal Eosinophils Present,Monoclonal Gammopathy of Undetermined Significance,0
15,Somatostatin Positive Neoplastic Cells Present,Neoplastic Polyp,0
16,Pseudopapillary Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
17,Superficial Lesion,Pre-Malignant Skin Epithelial Lesion,0
18,Recurrent Malignant Neoplasm,Recurrent Human Papillomavirus-Related Malignant Neoplasm,0
19,Neuronal Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
20,Carcinomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
21,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,0
22,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
23,Hemorrhagic Neuroblastic Nodules Present,Neuroblastic tumors,0
24,IDH Gene Family Mutation Status Unknown,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,0
25,Entrapped Respiratory Epithelium Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
26,Confluent Sheets of Neoplastic B-Lymphocytes Present,Recurrent tumors of the Ewing's family,0
27,Multilocular Lesion,Primary Melanocytic Lesion of Meninges,0
28,Chronic Phase of Disease,Leukemic Phase of Non-Hodgkin's Lymphoma,0
29,Subcutaneous nodule,Endometrial stromal nodule,0
30,Fibroblastoma-Like Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
31,Tall Papillae Present,Malignant neoplasm of stomach recurrent,0
32,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
33,CD56-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
34,Alternative Fascicle (Bundle) Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
35,Abnormal alveolar pattern,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
36,Extraosseous Lesion,Pre-Malignant Skin Epithelial Lesion,0
37,Mild dysplasia of colon,Mild epithelial dysplasia,0
38,Nuclear Clearing,Adenocarcinoma with squamous metaplasia,0
39,Undifferentiated Lesion,Undifferentiated carcinoma of ovary,0
40,Intracellular Accumulation of Lipids,"Benign neoplasm of brain, unspecified",0
41,Perineural spread,Adenocarcinoma with squamous metaplasia,0
42,CD4-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
43,Cholesterolosis,Adenocarcinoma with squamous metaplasia,0
44,Inoperable Disease,Localized Castleman Disease,0
45,Parakeratinized Stratified Squamous Epithelium Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,0
46,Vacuolated Plasma Cells in the Bone Marrow,Breast Carcinoma Metastatic in the Bone,0
47,Ependymal Differentiation,Ventricular and Brain Stem Ependymal Tumor,0
48,Metastatic/Recurrent Disease,Chronic Bullous Disease of Childhood,0
49,Multilineage Dysplasia Present,Squamous Lung Dysplasia,0
50,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
51,Nuclear Clearing,Occult Lung Cancer AJCC v8,0
52,Endometrial Type Glands and Stroma Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
53,Multinodular and Vacuolated Pattern,Testicular Mixed Embryonal Carcinoma and Seminoma,0
54,Dermal Involvement,Benign Dermal Schwannoma,0
55,Angioinvasion,Malignant neoplasm of stomach recurrent,0
56,Unfavorable Clinical Outcome,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
57,Granulocytes Increased in Bone Marrow,Breast Carcinoma Metastatic in the Bone,0
58,Geographic Necrosis,Pseudolymphoma,0
59,Hyaline Cartilage Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
60,Sarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
61,Monomorphic Cellular Infiltrate,Cellular neurothekeoma,0
62,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Recurrent tumors of the Ewing's family,0
63,Jaw Keratocyst,Occult Lung Cancer AJCC v8,0
64,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
65,Foveolar-Type Epithelium Present,Germinative Follicular Epithelium Neoplasm,0
66,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,0
67,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Bone Marrow Transplantation Nephropathy,0
68,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
69,Cementum Formation,Pseudolymphoma,0
70,Squamous metaplasia,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
71,Cervical lymphadenopathy,Cervical Warty Carcinoma,0
72,Polymorphic Cellular Infiltrate,Cellular Blue Nevus,0
73,Human Papillomavirus Negative,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
74,Abundance of Small Lymphocytes,Small cell carcinoma of ovary,0
75,Herringbone Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
76,Bilateral Disease,Multi-centric Castleman's Disease,0
77,Glial Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
78,Ventricular Involvement Only,Ventricular and Brain Stem Ependymal Tumor,0
79,Squamous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
80,Basal Cells with Pale Cytoplasm Present,Basal cell nevus with comedones,0
81,Chronic lymphocytic inflammation,Stage B Chronic Lymphocytic Leukemia,0
82,Glomeruloid Vessels Present,Occult Lung Cancer AJCC v8,0
83,Sarcomatous or Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
84,Fibrosarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,0
85,Cold Nodule,Placental Site Nodule or Plaque,0
86,Toxic effect,Adenocarcinoma with squamous metaplasia,0
87,Metaplasia,Intestinal Metaplasia of Bladder Urothelium,0
88,Erythema,Occult Lung Cancer AJCC v8,0
89,Mediastinal mass,Mediastinal Neuroblastoma,0
90,Submucosal Tumor Growth,Malignant Gastric Granular Cell Tumor,0
91,Coughing,Malignant neoplasm of stomach recurrent,0
92,Micronodular Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
93,Aggressive Clinical Course,Non-Hodgkin Lymphoma with Variable Clinical Course,0
94,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Anemia due to membrane defect,0
95,Well Differentiated Lesion,Well Differentiated Malignant Neoplasm,0
96,Pseudopapillary Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
97,Favorable Clinical Outcome,Favorable Hodgkin Lymphoma,0
98,Pseudostratified Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
99,Wide Vessel-Like Spaces Formation,Adenocarcinoma with squamous metaplasia,0
100,Defective Mu Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
101,Sebaceous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
102,Fibrotic Stroma with Finger-Like Projections Present,Adenocarcinoma with squamous metaplasia,0
103,Endobronchial Mass,Endobronchial Hamartoma,0
104,Multihormonal Immunoreactivity Present in Two or More Cell Types,Malignant Gastric Granular Cell Tumor,0
105,bone marrow fibrosis,Secondary malignant neoplasm of bone marrow,0
106,Nuclear pleomorphism,Occult Lung Cancer AJCC v8,0
107,Therapy-Related Toxicity,Adenocarcinoma with squamous metaplasia,0
108,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
109,Cellular Changes Resembling Foveolar Epithelium Cells,Cellular neurothekeoma,0
110,Mammary Gland Type Features Present,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
111,Wide Vessel-Like Spaces Formation,Adenocarcinoma with squamous metaplasia,0
112,Pushing Tumor Margin,Childhood Carcinoid Tumor,0
113,Increased red cell mass,Squamous cell carcinoma of skin,0
114,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
115,Chronic Clinical Course,Non-Hodgkin Lymphoma with Variable Clinical Course,0
116,Human Papillomavirus Positive,Recurrent Human Papillomavirus-Related Malignant Neoplasm,0
117,Cytokeratin Positive Neoplastic Cells Present,Neoplastic Polyp,0
118,Splenomegaly,Adenocarcinoma with squamous metaplasia,0
119,Non-Invasive Lesion,Reactive Cutaneous Fibrous Lesion,0
120,Hyperchromatism,Adenocarcinoma with squamous metaplasia,0
121,Low Cellularity Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
122,Malignant Cellular Infiltrate,Cellular neurothekeoma,0
123,Moderate cytologic atypia,Adenocarcinoma with squamous metaplasia,0
124,Efferent Arteriolar Hyalinosis,Malignant neoplasm of stomach recurrent,0
125,Fibrosarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
126,Eosinophil count raised (finding),Occult Lung Cancer AJCC v8,0
127,Dysplastic Dentin Formation,Low Grade Liver Dysplastic Nodule,0
128,Fever,Adenocarcinoma with squamous metaplasia,0
129,Tubal Diverticulosis,Serous Tubal Intraepithelial Carcinoma,0
130,Mesenchymal Component Present,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0
131,Multilineage Dysplasia Present,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0
132,Precocious Puberty,Malignant neoplasm of stomach recurrent,0
133,Hyalinized Stroma Formation,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
134,Thin Bands of Collagen Present,Recurrent tumors of the Ewing's family,0
135,Intravascular Spread,Central Nervous System Intravascular Large B-Cell Lymphoma,0
136,Exanthema,Pseudolymphoma,0
137,Borderline Resectable Mass,Borderline Ovarian Endometrioid Cystadenofibroma,0
138,Mature Schwannian Stroma Present,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage,0
139,Bone Marrow Dysplasia Present,Bone Marrow Transplantation Nephropathy,0
140,Ganglioneuroblastoma Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
141,Matrical Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
142,Capsular Invasion,Malignant neoplasm of stomach recurrent,0
143,Prominent In Situ Component Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,0
144,Mixture of Morphologic Patterns,Recurrent tumors of the Ewing's family,0
145,Cutaneous plaque,Cutaneous neurofibroma,0
146,Endodermal Sinus Pattern,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,0
147,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
148,Matrical Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
149,Local disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
150,Sarcomatoid Features,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",0
151,Immunoglobulin Light Chain Deposition,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
152,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
153,Polyclonal hypergammaglobulinemia,Occult Lung Cancer AJCC v8,0
154,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
155,Microsatellite Stable,Occult Lung Cancer AJCC v8,0
156,Myofibroblastic Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
157,Lesion Less than 10mm in Diameter,Colon Carcinoma Metastatic in the Liver,0
158,Radial Growth Phase,"Polycythemia Vera, Polycythemic Phase",0
159,Infundibular-Like Structures Present,Occult Lung Cancer AJCC v8,0
160,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
161,Hot Nodule,Thyroid Nodule,0
162,Extraocular Dissemination of Disease,Paget Disease of the Scrotum,0
163,Dilated Vascular Space Formation,Benign Cutaneous Vascular Neoplasm,0
164,Schwannian Stroma More than 50 Percent of the Tumor Volume,Multinodular and Vacuolated Tumor of the Cerebrum,0
165,Angiocentric Pattern,Angiocentric lymphoma stage I,0
166,Histiocytosis haematophagic,Refractory Langerhans Cell Histiocytosis,0
167,Mucinous degeneration,Ampulla of Vater Mucinous Adenocarcinoma,0
168,Neuroectodermal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
169,Epithelioid Component Present,Breast Epithelioid Hemangioma,0
170,Lamellar Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
171,HER2/Neu Negative,Adenocarcinoma with squamous metaplasia,0
172,Trichoblastic Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
173,Diffuse Lesion,Diffuse Lipomatosis,0
174,Epithelioid Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
175,Fibroblastoma-Like Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
176,Mixed Cellular Population,Cellular neurothekeoma,0
177,Non-Contiguous Disease,Chronic Bullous Disease of Childhood,0
178,Lymphoplasmacytic Infiltrate,Malignant neoplasm of stomach recurrent,0
179,Retiform Structures Comprise 90% or More of the Tumor,Benign Mixed Tumor of the Vulva,0
180,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
181,Acral Lesion,Reactive Cutaneous Fibrous Lesion,0
182,Endometrial Type Glands and Stroma Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
183,Koilocytotic atypia,Occult Lung Cancer AJCC v8,0
184,Numerous Stromal Mast Cells Present,Stromal sarcoma,0
185,Finding related to pregnancy,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
186,Spindle Cell Metaplasia,Ciliary Body Spindle Cell Type B Melanoma,0
187,Numerous Stromal Mast Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
188,Fibromuscular Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
189,WNT Pathway Activated,Refractory Visual Pathway Glioma,0
190,Hyperplastic Epithelial Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
191,Paucicellular Stroma Present,Gastric Carcinoma with Lymphoid Stroma,0
192,Poorly Differentiated Neuroendocrine Lesion,Poorly Differentiated Neuroblastoma,0
193,Lesion with Diameter of 10mm or Less,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
194,Tumor Mass,Malignant Gastric Granular Cell Tumor,0
195,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Multinodular and Vacuolated Tumor of the Cerebrum,0
196,Tubular Structures Present,Small Intestinal Tubular Adenoma,0
197,Macule,Occult Lung Cancer AJCC v8,0
198,Acral Lesion,Pre-Malignant Skin Epithelial Lesion,0
199,Nests of Nevus Cells Resembling Nerve Bundles Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
200,Ganglion Cell-Like Elements Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
201,Numerous Stromal Mast Cells Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
202,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Ovarian Biphasic or Triphasic Teratoma,0
203,Villous Projections of the Neoplastic Epithelium Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
204,BRAF V600E Mutation Present,Myeloid Neoplasms with Germline GATA2 Mutation,0
205,Pseudorosette Formation,Occult Lung Cancer AJCC v8,0
206,Thyroglobulin Positive Neoplastic Cells Present,Neoplastic Polyp,0
207,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Colorectal Carcinoma Metastatic in the Liver,0
208,Pseudostratified Columnar Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
209,Apocrine metaplasia,Nephrogenic metaplasia,0
210,Intra or Intercytoplasmic Lumina Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
211,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,Malignant Giant Cell Tumor of Bone,0
212,Stable Disease,Localized Castleman Disease,0
213,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
214,Bone marrow depression,Unresectable Bone Sarcoma,0
215,Immature Granulocytes in Peripheral Blood Increased,Colorectal Carcinoma Metastatic in the Liver,0
216,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
217,Steatohepatitis,Malignant neoplasm of stomach recurrent,0
218,Nested Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
219,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,Acute Myeloid Leukemia with Variant MLL Translocations,0
220,Focal Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
221,High Plasma Renin Activity,DS Stage II Plasma Cell Myeloma,0
222,Increased megakaryocytes (bone marrow),Occult Lung Cancer AJCC v8,0
223,Koilocytotic atypia,Occult Lung Cancer AJCC v8,0
224,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
225,Pregnancy Complications,Non-Hodgkin Lymphoma During Pregnancy,0
226,Superficial Lesion,Pre-Malignant Skin Epithelial Lesion,0
227,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
228,Multinodular Lesion,Pre-Malignant Skin Epithelial Lesion,0
229,Lesion with Diameter of 2cm or Less,Columnar Cell Change of the Breast with Atypia,0
230,Urine phosphorous concentration above normal,Occult Lung Cancer AJCC v8,0
231,Defective Heavy Chain Present,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
232,Platinum Sensitivity,Occult Lung Cancer AJCC v8,0
233,Intravascular Fibrin Thrombus Formation,Intravascular Angioleiomyoma,0
234,Primary Lesion,Primary mediastinal large B-cell lymphoma stage III,0
235,Peribronchial Proliferation of Neoplastic Cells Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
236,Hypertensive disease,Lhermitte-Duclos disease,0
237,Tissue Differentiation Uncertain,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
238,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
239,Severe cytologic atypia,Complex endometrial hyperplasia without atypia,0
240,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
241,Cholesterolosis,Adenocarcinoma with squamous metaplasia,0
242,Unclassifiable Lesion,Reactive Cutaneous Fibrous Lesion,0
243,Finding related to pregnancy,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
244,Distortion of the Hair Follicle,Erosive Adenomatosis of the Nipple,0
245,Multiple Tumor Masses,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
246,Neoplastic Plasma Cells Present in Bone Marrow,Bone Marrow Transplantation Nephropathy,0
247,Unifocal Disease,Localized Castleman Disease,0
248,Melanin-Pigmented Dendritic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
249,effusion,Occult Lung Cancer AJCC v8,0
250,Infundibular-Like Structures Present,Occult Lung Cancer AJCC v8,0
251,Presence of a Hormonal Syndrome,Recurrent tumors of the Ewing's family,0
252,Giant Mitochondria Present,Giant cell angiofibroma,0
253,Endobronchial Lesion,Pre-Malignant Skin Epithelial Lesion,0
254,Huge Vascular Channel Formation,Radiation-Induced Vascular Disease,0
255,Polymorphic Cellular Infiltrate,Cellular Blue Nevus,0
256,Cytologic atypia,Occult Lung Cancer AJCC v8,0
257,Fried-Egg Appearance of the Bone Marrow,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
258,Thin-Walled Branching Vascular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
259,Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Sellar Region,0
260,Lesion with Diameter Less than 11mm,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
261,Acral Lesion,Acral Lentiginous Malignant Melanoma,0
262,Humoral hypercalcemia of malignancy (disorder),Malignant neoplasm of stomach recurrent,0
263,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Multinodular and Vacuolated Tumor of the Cerebrum,0
264,Malignant Primitive Cellular Infiltrate,Malignant Gastric Granular Cell Tumor,0
265,Extensive Stage Lesion,Stage IB Uterine Corpus Cancer AJCC v7,0
266,Unmethylated MGMT Gene Promoter,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
267,Venous Type Vascular Channel Formation,Intermediate Cell Type Ciliary Body Melanoma,0
268,Fibroblastoma-Like Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
269,Tubal Diverticulosis,Tubal Hyperplasia,0
270,Diffuse Immunoblastic Proliferation,Hereditary Diffuse Gastric Adenocarcinoma,0
271,Endometrial Type Glands and Stroma Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
272,PSA Failure,Malignant neoplasm of stomach recurrent,0
273,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
274,Serum phosphate concentration below normal,Adenocarcinoma with squamous metaplasia,0
275,Bilateral Disease,Multi-centric Castleman's Disease,0
276,HMB-45-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
277,Presence of a Hormonal Syndrome,"Benign neoplasm of brain, unspecified",0
278,Dyskeratosis,Malignant neoplasm of stomach recurrent,0
279,Serrated Glandular Architecture,Cervical Glandular Neoplasm,0
280,Solitary Skin Tumor,Peritoneal Solitary Fibrous Tumor,0
281,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
282,Rarely Metastasizing Lesion,Pre-Malignant Skin Epithelial Lesion,0
283,Neoplastic Growth or Spread,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
284,Unilineage Dysplasia Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
285,Desmoplastic Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
286,Concentric Perivascular Arrangement of Tumor Cells,Ampulla of Vater Neuroendocrine Tumor,0
287,Mixed Cellular Population,Cellular neurothekeoma,0
288,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
289,Abundant Intracytoplasmic Lipofuscin Present,Adenocarcinoma with squamous metaplasia,0
290,Blasts 10-19 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
291,Congenital Lesion,Reactive Cutaneous Fibrous Lesion,0
292,Desmoplastic Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
293,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
294,Efferent Arteriolar Hyalinosis,Adenocarcinoma with squamous metaplasia,0
295,Therapy-Related Toxicity,Adenocarcinoma with squamous metaplasia,0
296,Sebaceous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
297,Absence of Invasion,Malignant neoplasm of stomach recurrent,0
298,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Columnar Cell Change of the Breast with Atypia,0
299,Transformed Phase of Disease,Chronic Bullous Disease of Childhood,0
300,Melanin-Pigmented Dendritic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
301,Misplaced Exocytosis Present,Adenocarcinoma with squamous metaplasia,0
302,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
303,Muscle Invasion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0
304,Islands of Odontogenic Epithelium Present,Recurrent tumors of the Ewing's family,0
305,Increased red cell mass,Basal cell carcinoma,0
306,Vacuolated Plasma Cells in the Bone Marrow,Colorectal Carcinoma Metastatic in the Liver,0
307,Enterochromaffin Type Granules Present,Multiple Endocrine Neoplasia Type 2a,0
308,Confluent Sheets of Anaplastic T-Lymphocytes Present,Malignant neoplasm of stomach recurrent,0
309,Spindle Cell Osteo-Fibrous Component Present,Ciliary Body Spindle Cell Type B Melanoma,0
310,Polyclonal hypergammaglobulinemia,Pseudolymphoma,0
311,Pseudoalveolar Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
312,Bone Marrow Involvement,Unresectable Bone Sarcoma,0
313,Atypical Mitotic Figures,Recurrent Atypical Teratoid/Rhabdoid Tumor,0
314,Bead-Like Arrangement of Elastic Fibers,"Benign neoplasm of brain, unspecified",0
315,Localized Hydropic Villous Change,Localized Castleman Disease,0
316,Sclerotic Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
317,Slit-Like Vascular Channel Formation,Radiation-Induced Vascular Disease,0
318,Diffuse Immunoblastic Proliferation,Immunoblastic Large-Cell Lymphoma,0
319,Glomeruloid Vessels Present,Occult Lung Cancer AJCC v8,0
320,Cytopenia,Occult Lung Cancer AJCC v8,0
321,progesterone receptor negative,Adenocarcinoma with squamous metaplasia,0
322,Fibromyxoid Stroma Formation,Classical Low Grade Fibromyxoid Sarcoma,0
323,Primary Site Unspecified,Primary cutaneous diffuse large cell B-cell lymphoma,0
324,Fibrovascular Septa Present,Occult Lung Cancer AJCC v8,0
325,Epithelial hyperplasia of skin,Benign fibrohistiocytic neoplasm of skin,0
326,Slit-Like Stromal Retraction Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
327,Microcystic Change,Microcystic meningioma,0
328,Huge Vascular Channel Formation,Vascular neoplasm of skin,0
329,Unilineage Dysplasia Present,Squamous Lung Dysplasia,0
330,Skin Erosion,Transplant-Related Skin Squamous Cell Carcinoma,0
331,Well Differentiated Lesion,Well Differentiated Malignant Neoplasm,0
332,Folliculotropic Lymphocytic Infiltrate,Cutaneous Chronic Lymphocytic Leukemia,0
333,Misplaced Exocytosis Present,Pseudolymphoma,0
334,Peribronchial Proliferation of Neoplastic Cells Present,T-Cell Proliferation of Uncertain Malignant Potential,0
335,Vascular proliferation,Vascular neoplasm of skin,0
336,Locally Aggressive Lesion,Locally Advanced Head and Neck Carcinoma,0
337,Defective Gamma Heavy Chain Present,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
338,Psammoma Body Formation,Intermediate Cell Type Ciliary Body Melanoma,0
339,Perivascular Pseudorosette Formation,Adenocarcinoma with squamous metaplasia,0
340,Calcinosis,Adenocarcinoma with squamous metaplasia,0
341,Moderate cytologic atypia,Colorectal Adenoma with Moderate Dysplasia,0
342,Slow Growing Painless Mass,Occult Lung Cancer AJCC v8,0
343,Fibrotic Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
344,Multifocal Multisystem Disease,Localized Castleman Disease,0
345,Cutaneous plaque,Grade 3 Cutaneous Follicular Lymphoma,0
346,Unfavorable Clinical Outcome,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
347,Keratin Horn Pearls Formation,Malignant neoplasm of stomach recurrent,0
348,Cartilage-Like Elements Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
349,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Recurrent tumors of the Ewing's family,0
350,Vertical Growth Phase,Leukemic Phase of Non-Hodgkin's Lymphoma,0
351,Moderate dysplasia,Gastric dysplasia,0
352,Intramucosal Lesion,Reactive Cutaneous Fibrous Lesion,0
353,Defective Gamma Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
354,Erythroid hyperplasia,Atypical hyperplasia of breast,0
355,Rapidly Enlarging Mass,Occult Lung Cancer AJCC v8,0
356,Pineocytomatous Rosette Formation,Pseudolymphoma,0
357,Hypoglycemia,Malignant neoplasm of stomach recurrent,0
358,Anastomosing Cells Connected to the Basal Layer of the Epidermis Present,Recurrent tumors of the Ewing's family,0
359,Polymorphic Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
360,Thick-Walled Hyalinized Vessels Present,Adenocarcinoma with squamous metaplasia,0
361,Villous Projections of the Neoplastic Epithelium Present,Erosive Adenomatosis of the Nipple,0
362,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Columnar Cell Change of the Breast with Atypia,0
363,Therapy-Related Toxicity,Adenocarcinoma with squamous metaplasia,0
364,Aflatoxins Toxicity,Occult Lung Cancer AJCC v8,0
365,Tubular Structures Present,Colorectal Tubular Adenoma,0
366,Parakeratinized Stratified Squamous Epithelium Present,Squamous cell carcinoma of skin,0
367,Enterochromaffin Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
368,Cervical lymphadenopathy,Locally Advanced Unresectable Cervical Adenocarcinoma,0
369,Birbeck Granules Present,Malignant neoplasm of stomach recurrent,0
370,Windblown Appearance of Atypical Keratinocytes,Atypical hyperplasia of breast,0
371,Mass of body structure,Secondary malignant neoplasm of ciliary body,0
372,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
373,Myxoid Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
374,"Nodular, Reticulin-Free Zones Present",Pseudolymphoma,0
375,Antoni B Pattern,Stage B Chronic Lymphocytic Leukemia,0
376,Mature Schwannian Stroma Present,Ann Arbor Stage II Mature T- and NK-Cell Lymphoma,0
377,Fenestrated Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
378,Glucagon-Like Peptide Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
379,Intracytoplasmic Eosinophilic Inclusion,Eosinophilic Granuloma,0
380,Coughing,Malignant neoplasm of stomach recurrent,0
381,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
382,Thyroglobulin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
383,Red Papular Lesion,Primary Melanocytic Lesion of Meninges,0
384,Metastatic/Recurrent Disease,Erdheim-Chester Disease,0
385,Increased Cellularity Present,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage,0
386,New bone formation (morphologic abnormality),Benign bone neoplasm,0
387,Neoplastic Growth or Spread,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
388,Benzene Exposure,Pseudolymphoma,0
389,Hypercellular bone marrow,malignant neoplasm of bone marrow,0
390,Squamous metaplasia,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
391,Marked Bone Marrow Fibrosis,Unresectable Bone Sarcoma,0
392,Tartrate Resistant Acid Phosphatase Positive Cells Present,Tumors Derived from Langerhans Cells,0
393,Ganglion Cell-Like Elements Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
394,Keratin pearl formation,Adenocarcinoma with squamous metaplasia,0
395,Intestinal metaplasia,Intestinal Neuroendocrine Neoplasm,0
396,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
397,Lesion with Diameter Greater than 2cm,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
398,Histiocytosis,Thyroid Gland Langerhans Cell Histiocytosis,0
399,Sarcomatoid Stroma Formation,Thymic Sarcomatoid Carcinoma,0
400,Ependymal Differentiation,Supratentorial Ependymal Tumor,0
401,Monoclonal Gammapathies,Monoclonal B-Cell Lymphocytosis,0
402,Blasts 5-19 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
403,Vascular Channel Formation with Muscular Walls,Adenocarcinoma with squamous metaplasia,0
404,Respiratory distress,Malignant neoplasm of stomach recurrent,0
405,Serrated Glandular Architecture,Cervical Glandular Neoplasm,0
406,Proliferation of Small Ducts Present,Small cell carcinoma of esophagus,0
407,Chronic Inflammatory Infiltrate,Inflammatory Breast Carcinoma,0
408,Epidermal Involvement,Toxic Epidermal Necrolysis,0
409,Multinodular Pattern,Multinodular and Vacuolated Tumor of the Cerebrum,0
410,Micronodular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
411,Confluent Sheets of Anaplastic T-Lymphocytes Present,Anaplastic Sarcoma of the Kidney,0
412,Spindle Cell Component Present,Ciliary Body Spindle Cell Type B Melanoma,0
413,Monoclonal Paraproteinemia,Monoclonal Gammopathy of Undetermined Significance,0
414,Thrombocytosis,Pseudolymphoma,0
415,Fibrotic Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
416,Mixture of Morphologic Patterns,Recurrent tumors of the Ewing's family,0
417,Pregnancy Complications,Non-Hodgkin Lymphoma During Pregnancy,0
418,Intracytoplasmic Eosinophilic Inclusion,Childhood Acute Eosinophilic Leukemia,0
419,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical hyperplasia of breast,0
420,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Metastatic Malignant Neoplasm in the Sellar Region,0
421,Lymphoplasmacytic Infiltrate,Malignant neoplasm of stomach recurrent,0
422,Chemotherapeutic Agent Toxicity,Occult Lung Cancer AJCC v8,0
423,Microvascular Proliferation,B-Cell Proliferation of Uncertain Malignant Potential,0
424,Tumor Droplets Present,Malignant Gastric Granular Cell Tumor,0
425,Non-Specific Glandular Pattern,Glandular papilloma,0
426,Rhabdomyosarcomatous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
427,Multihormonal Immunoreactivity Present,Malignant neoplasm of stomach recurrent,0
428,Lipomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
429,Angiodestructive Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
430,S-100-Positive Neoplastic Cells Present,Neoplastic Polyp,0
431,Positive Axillary Lymph Node,Palisaded Lymph Node Myofibroblastoma,0
432,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
433,Capillary Sized Vascular Channel Formation,Vascular neoplasm of skin,0
434,Infundibular-Like Structures Present,Malignant neoplasm of stomach recurrent,0
435,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,0
436,Neuropil Present,Pseudolymphoma,0
437,Birbeck Granules Present,Malignant neoplasm of stomach recurrent,0
438,Architectural Distortion,Adenocarcinoma with squamous metaplasia,0
439,Multifocal Unisystem Disease,Erdheim-Chester Disease,0
440,Basophilia (finding),Malignant neoplasm of stomach recurrent,0
441,Ganglioneuroma Component Present,Ganglioneuroma of skin,0
442,Confluent Sheets of Neoplastic B-Lymphocytes Present,Malignant neoplasm of stomach recurrent,0
443,Well Developed Rough Endoplasmic Reticulum Present,Pleural Well Differentiated Papillary Mesothelioma,0
444,Squamous metaplasia,Adenocarcinoma with squamous metaplasia,0
445,Above the Diaphragm Disease,Paget Disease of the Anus,0
446,Tumor Vascular Invasion,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
447,Large Neoplastic Glands with Branching and Papillary Infolding Present,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
448,Peripheral Blood Involvement,Peripheral Intraneural Angiosarcoma,0
449,Hyalinized Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
450,Multifocal Unisystem Disease,Chronic Bullous Disease of Childhood,0
451,Squamous metaplasia of bladder,Squamous cell carcinoma of skin,0
452,Nuclear Expression of STAT6 Protein,Ampulla of Vater Mucinous Adenocarcinoma,0
453,Skin Papule,Transplant-Related Skin Squamous Cell Carcinoma,0
454,Fibrovascular Septa Present,Adenocarcinoma with squamous metaplasia,0
455,Sarcomatoid Features,Central Nervous System Embryonal Tumor with Rhabdoid Features,0
456,Tartrate Resistant Acid Phosphatase Positive Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
457,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
458,Smooth Muscle Component Present,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0
459,Poorly Cohesive Malignant Cellular Infiltrate,Malignant Gastric Granular Cell Tumor,0
460,Non-Malignant Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
461,Unifocal Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
462,Firm mass,Pseudolymphoma,0
463,Perineural spread,Occult Lung Cancer AJCC v8,0
464,Platinum Sensitivity,Pseudolymphoma,0
465,Lymphoplasmacytic Infiltrate,Malignant neoplasm of stomach recurrent,0
466,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
467,Malignant Germinomatous Cellular Infiltrate,Malignant Gastric Granular Cell Tumor,0
468,Burn injury,Adenocarcinoma with squamous metaplasia,0
469,Cellular Stratification,Ovarian Cellular Fibroma,0
470,Castration-Naive,Pseudolymphoma,0
471,Clusters and Cords of GFAP Positive Epithelioid Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
472,Intraepithelial Neoplasia,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
473,"Undifferentiated ""Fetal-Type"" Tissues Present",Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
474,Mixed Neoplastic Glandular and Squamous Cell Population,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,0
475,Microglandular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
476,Black Discoloration,Malignant neoplasm of stomach recurrent,0
477,Dystrophic calcification,Malignant neoplasm of stomach recurrent,0
478,Intermediate Filaments Present,Intermediate Atypical Prostate Carcinoma,0
479,Morphologic Overlap,Occult Lung Cancer AJCC v8,0
480,Microcystic Change,Columnar Cell Change of the Breast with Atypia,0
481,Firm mass,Occult Lung Cancer AJCC v8,0
482,Minimal Invasion Present,Adult Acute Myeloid Leukemia with Minimal Differentiation,0
483,Cellular Pseudostratification,Cellular neurothekeoma,0
484,Florid Follicular Hyperplasia,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,0
485,Submucosal Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
486,Myomatous Stroma Formation,Adenocarcinoma with squamous metaplasia,0
487,Serotonin Positive Neoplastic Cells Present,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
488,Hemosiderin pigmentation,Malignant neoplasm of stomach recurrent,0
489,Regional Disease,Erdheim-Chester Disease,0
490,Chronic Inflammatory Infiltrate,Chronic Bullous Disease of Childhood,0
491,Chronic Clinical Course,Non-Hodgkin Lymphoma by Clinical Course,0
492,Low Cellularity Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
493,Monophasic Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
494,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
495,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
496,Histiocytosis,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
497,Microglandular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
498,Multilocular Lesion,Primary Melanocytic Lesion of Meninges,0
499,Jaw Keratocyst,Malignant neoplasm of stomach recurrent,0
500,Castration-Sensitive,Adenocarcinoma with squamous metaplasia,0
501,Black Discoloration,Malignant neoplasm of stomach recurrent,0
502,Mitotic Activity,Occult Lung Cancer AJCC v8,0
503,Moderately Differentiated Lesion,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
504,Keratin Horn Pearls Formation,Pseudolymphoma,0
505,Nests of Nevus Cells Resembling Nerve Bundles Present,Nevus of Ota,0
506,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Sellar Teratoma with Malignant Transformation,0
507,Serrated Glandular Architecture,Glandular papilloma,0
508,Monoclonal Langerhans Cells Present,Tumors Derived from Langerhans Cells,0
509,Absence of Stromal Invasion,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
510,Hyaline Cartilage Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
511,Diffuse Cellular Infiltrate,Refractory Diffuse Intrinsic Pontine Glioma,0
512,Ischemia,Occult Lung Cancer AJCC v8,0
513,Philadelphia chromosome negative,"Anaplastic large cell lymphoma, ALK negative",0
514,Smooth Muscle Component Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
515,Pancytopenia,Pseudolymphoma,0
516,Florid Follicular Hyperplasia,Follicular Lymph Node Hyperplasia,0
517,Vater-Pacini Corpuscles-Like Structures Present,Adenocarcinoma with squamous metaplasia,0
518,Less than 2 Mitoses per 10HPF,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,0
519,CD56-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
520,Contiguous Disease,Chronic Bullous Disease of Childhood,0
521,Islands of Neuropil-Like Matrix Present,Malignant neoplasm of stomach recurrent,0
522,Malignant Component Present,Malignant neoplasm of nasopharynx,0
523,Nodules of Compact Keratin Present,Recurrent tumors of the Ewing's family,0
524,Radiation Sickness,Adenocarcinoma with squamous metaplasia,0
525,Increased megakaryocytes (bone marrow),Pseudolymphoma,0
526,Steatohepatitis,Occult Lung Cancer AJCC v8,0
527,Acinar Proliferation,Acinar cell cystadenocarcinoma,0
528,Distortion of the Hair Follicle,Erosive Adenomatosis of the Nipple,0
529,Alternative Fascicle (Bundle) Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
530,Lobular Pattern,"Carcinoma, Lobular",0
531,Hydropic degeneration,Occult Lung Cancer AJCC v8,0
532,Cystic Change,Columnar Cell Change of the Breast with Atypia,0
533,Marked Thickening of the Bladder Urothelium Present,Erosive Adenomatosis of the Nipple,0
534,Local disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
535,atypia morphology,Occult Lung Cancer AJCC v8,0
536,Pleural effusion disorder,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,0
537,Mesenchymal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
538,Wheezing,Malignant neoplasm of stomach recurrent,0
539,Neuropil Present,Occult Lung Cancer AJCC v8,0
540,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
541,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Giant Cell Tumor of Bone,0
542,Cigarette Smoking Toxicity,Adenocarcinoma with squamous metaplasia,0
543,Finding related to pregnancy,Metastatic malignant neoplasm to nasopharynx,0
544,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
545,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Anemia due to membrane defect,0
546,Mass of body structure,Leiomyoma of ciliary body,0
547,Blastemal Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
548,Undifferentiated Lesion,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,0
549,Endobronchial Mass,Endobronchial Hamartoma,0
550,Blue Bone Formation,Breast Carcinoma Metastatic in the Bone,0
551,Non-Contiguous Disease,Localized Castleman Disease,0
552,Focal dysplasia,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
553,Gyriform Trabecular Pattern,Thyroid Hyalinizing Trabecular Adenoma,0
554,Multilineage Dysplasia Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
555,Premalignant Lesion,Reactive Cutaneous Fibrous Lesion,0
556,Low Grade Neuroendocrine Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",0
557,Curvilinear Thin-Walled Vascular Pattern,Radiation-Induced Vascular Disease,0
558,Pagetoid Proliferation,B-Cell Proliferation of Uncertain Malignant Potential,0
559,Castration-Naive,Occult Lung Cancer AJCC v8,0
560,Pseudolobular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
561,Granulocytes Increased in Bone Marrow,Prostate Carcinoma Metastatic in the Bone,0
562,Pale Eosinophilic Stroma Formation,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
563,Monophasic Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
564,Unfavorable Clinical Outcome,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
565,Fibrotic Stroma Formation,Adenocarcinoma with squamous metaplasia,0
566,No Evidence of Radiologic Finding,Malignant neoplasm of stomach recurrent,0
567,Epithelial Component Present,Tubal Epithelial Hyperplasia,0
568,"Fully Differentiated ""Adult-Type"" Tissues Present",Poorly Differentiated Hepatocellular Carcinoma,0
569,Glandular cell atypia,Primary cutaneous diffuse large cell B-cell lymphoma,0
570,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
571,Endocervical Type Epithelium Present,"Endocervical Adenocarcinoma, Usual Type",0
572,No Identifiable Line of Differentiation,Soft Tissue Tumor of Uncertain Differentiation,0
573,Microfollicular Structures Present,Adenocarcinoma with squamous metaplasia,0
574,Morphologic Overlap,Occult Lung Cancer AJCC v8,0
575,"Nodular, Reticulin-Free Zones Present",Occult Lung Cancer AJCC v8,0
576,Platinum Sensitivity,Malignant neoplasm of stomach recurrent,0
577,Cytoplasmic Accumulation of Black Pigment,Malignant neoplasm of stomach recurrent,0
578,Pineocytomatous Rosette Formation,Pseudolymphoma,0
579,Primary Site Unspecified,Primary Malignant Liver Neoplasm,0
580,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Malignant neoplasm of stomach recurrent,0
581,Cicatrix,Malignant neoplasm of stomach recurrent,0
582,Multifocal Unisystem Disease,Erdheim-Chester Disease,0
583,Breast Implant-Related Lesion,Grade 3 Invasive Breast Carcinoma,0
584,Sarcomatous or Carcinomatous Component Present,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
585,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Ovarian Clear Cell Tumor,0
586,CD1a-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
587,Mesenchymal Metaplasia,Breast Carcinoma with Chondroid Metaplasia,0
588,Epithelioid Component Present,Breast Epithelioid Hemangioma,0
589,Non-Contiguous Disease,Chronic Bullous Disease of Childhood,0
590,Burn injury,Adenocarcinoma with squamous metaplasia,0
591,Spontaneous Regression,Malignant neoplasm of stomach recurrent,0
592,Clear Perinuclear Halo Present,Clear Cell Hepatocellular Carcinoma,0
593,Transformed Phase of Disease,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
594,Enterochromaffin Type Granules Present,Multiple Endocrine Neoplasia Type 2a,0
595,'Starry-sky' pattern,Pseudolymphoma,0
596,Spindle Cell Metaplasia,Childhood Spindle Cell Rhabdomyosarcoma,0
597,Myomatous Stroma Formation,Adenocarcinoma with squamous metaplasia,0
598,Minimal Invasion Present,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
599,Rapidly Enlarging Mass,Rapidly progressive glomerulonephritis,0
600,Ischemia,Adenocarcinoma with squamous metaplasia,0
601,Atypical Mitotic Figures,Childhood Atypical Choroid Plexus Papilloma,0
602,Neuronal Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
603,Multinodular Lesion,Primary Melanocytic Lesion of Meninges,0
604,S-100-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
605,Diffuse Cellular Infiltrate,Cellular neurothekeoma,0
606,Gastric dysplasia,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
607,Microvascular Proliferation,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
608,Mucinous degeneration,Ampulla of Vater Mucinous Adenocarcinoma,0
609,Chronic Clinical Course,Hodgkin Lymphoma by Clinical Course,0
610,Cribriform Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
611,Red Papular Lesion,Reactive Cutaneous Fibrous Lesion,0
612,Sarcomatoid Features,Central Nervous System Embryonal Tumor with Rhabdoid Features,0
613,Well Developed Rough Endoplasmic Reticulum Present,Pleural Well Differentiated Papillary Mesothelioma,0
614,Nuclei of Various Sizes and Shapes Present,Squamous cell carcinoma of head and neck metastatic,0
615,Ischemia,Occult Lung Cancer AJCC v8,0
616,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
617,Drug Exposure,Adenocarcinoma with squamous metaplasia,0
618,Dermal Involvement,Adenocarcinoma with squamous metaplasia,0
619,Dense Intercellular Reticulin Network Present,Occult Lung Cancer AJCC v8,0
620,C19MC Amplification,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21,0
621,Burn injury,Adenocarcinoma with squamous metaplasia,0
622,Solitary Skin Tumor,Pericardial Solitary Fibrous Tumor,0
623,Canalicular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
624,Dual Population of Bone Marrow Blasts Present,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
625,Acquired Lesion,Primary Melanocytic Lesion of Meninges,0
626,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Poorly Differentiated Neuroblastoma,0
627,Mesenchymal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
628,Endobronchial Lesion,Endobronchial Leiomyoma,0
629,Absence of a Hormonal Syndrome,Malignant neoplasm of stomach recurrent,0
630,Non-Invasive Lesion,Reactive Cutaneous Fibrous Lesion,0
631,Mixed Neoplastic Glandular and Squamous Cell Population,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,0
632,Metaplasia,Intestinal Metaplasia of Bladder Urachal Epithelium,0
633,Rimming of Adipose Tissue Cells Present,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
634,Clinical TNM Finding,Hodgkin Lymphoma by Clinical Course,0
635,Systemic disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
636,Pleural effusion disorder,Stage I Pleural Malignant Mesothelioma AJCC v8,0
637,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,Acute Myeloid Leukemia with Variant MLL Translocations,0
638,Intramucosal Lesion,Pre-Malignant Skin Epithelial Lesion,0
639,"Fully Differentiated ""Adult-Type"" Tissues Present","Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
640,Fascicles of Spindly Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
641,Philadelphia chromosome negative,Adenocarcinoma with squamous metaplasia,0
642,Cytoplasmic Accumulation of Black Pigment,Malignant neoplasm of stomach recurrent,0
643,Reactive Germinal Centers Present,Reactive Cutaneous Fibrous Lesion,0
644,Embryoid Bodies Present,Malignant neoplasm of stomach recurrent,0
645,Acral Lesion,Reactive Cutaneous Fibrous Lesion,0
646,Tumor Vascular Invasion,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
647,Castration Resistance,Malignant neoplasm of stomach recurrent,0
648,Jaw Keratocyst,Pseudolymphoma,0
649,Dual Population of Bone Marrow Blasts Present,Bone Marrow Transplantation Nephropathy,0
650,High Grade Lesion,Colorectal High Grade Intraepithelial Neoplasia,0
651,Ventricular Involvement Only,Ventricular and Brain Stem Ependymal Tumor,0
652,Non-Malignant Cellular Infiltrate,Cellular neurothekeoma,0
653,Blastemal Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
654,Aberrant Thyroid Tissue Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,0
655,Tissue Differentiation Uncertain,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
656,"Undifferentiated ""Fetal-Type"" Tissues Present",Endometrial Undifferentiated Carcinoma,0
657,Mallory Bodies,Pseudolymphoma,0
658,Osteosclerotic Lesion,Pre-Malignant Skin Epithelial Lesion,0
659,Pseudoglandular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
660,Nodular and Diffuse Pattern,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
661,Non-Specific Glandular Pattern,Cervical Glandular Neoplasm,0
662,More than 10 Mitoses per 10HPF,Malignant neoplasm of stomach recurrent,0
663,Epithelial hyperplasia of skin,Non-neoplastic nevus of skin,0
664,Acral Lesion,Reactive Cutaneous Fibrous Lesion,0
665,Actinic Damage,Pseudolymphoma,0
666,Cauliflower-Like Mass,Malignant neoplasm of stomach recurrent,0
667,Concentric Perivascular Arrangement of Tumor Cells,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
668,Pseudorosette Formation,Malignant neoplasm of stomach recurrent,0
669,Multinodular Mass,Malignant neoplasm of stomach recurrent,0
670,Nidus Formation,Malignant neoplasm of stomach recurrent,0
671,Multifocal Multisystem Disease,Multi-centric Castleman's Disease,0
672,Vertical Growth Phase,Leukemic Phase of Non-Hodgkin's Lymphoma,0
673,Multihormonal Immunoreactivity Present in Two or More Cell Types,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
674,Finding related to pregnancy,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0
675,Blasts 10-19 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
676,Crystal deposition,Occult Lung Cancer AJCC v8,0
677,Cysts Containing Proteinaceous Fluid Present,Pseudolymphoma,0
678,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
679,Tall Papillae Present,Malignant neoplasm of stomach recurrent,0
680,1p/19q Codeletion Status Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
681,Plasma cell inflammation,Plasma cell myeloma recurrent,0
682,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
683,Intravascular Fibrin Thrombus Formation,Intravascular Angioleiomyoma,0
684,Endobronchial Mass,Endobronchial Leiomyoma,0
685,Endocervical Type Epithelium Present,Multiple Endocrine Neoplasia Type 2a,0
686,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Colorectal Carcinoma Metastatic in the Liver,0
687,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent tumors of the Ewing's family,0
688,Annular Tubules Present,Adenocarcinoma with squamous metaplasia,0
689,Well Differentiated Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
690,Shadow Cells Present,Testicular Seminoma with Syncytiotrophoblastic Cells,0
691,Bone marrow reticulin fibrosis,Breast Carcinoma Metastatic in the Bone,0
692,Pregnancy Complications,Non-Hodgkin Lymphoma During Pregnancy,0
693,Eosinophilic inflammation,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
694,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Malignant neoplasm of stomach recurrent,0
695,Lesion with Diameter of 5cm or Less,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
696,Microsatellite Stable,Occult Lung Cancer AJCC v8,0
697,Glomeruloid Vessels Present,Leiomyosarcoma of Vessels,0
698,Single Malignant Cells Present,Malignant Gastric Granular Cell Tumor,0
699,CD30-Positive Neoplastic Cells Present,Neoplastic Polyp,0
700,Monoclonal Gammapathies,Monoclonal B-Cell Lymphocytosis,0
701,Follicular Structures Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
702,Koilocytotic atypia,Complex endometrial hyperplasia without atypia,0
703,Photosensitivity of skin,Squamous cell carcinoma of skin,0
704,Chemotherapeutic Agent Toxicity,Adenocarcinoma with squamous metaplasia,0
705,Dystrophic calcification,Adenocarcinoma with squamous metaplasia,0
706,Well Differentiated Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
707,Fascicular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
708,Foveolar-Type Epithelium Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
709,Nodular and Diffuse Pattern,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
710,Hormone Receptor Positive,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
711,Rapidly Enlarging Mass,Malignant neoplasm of stomach recurrent,0
712,Plexiform Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
713,Chronic Inflammatory Infiltrate,Stage B Chronic Lymphocytic Leukemia,0
714,Philadelphia chromosome negative,"Anaplastic large cell lymphoma, ALK negative",0
715,Fibrovascular Stalks Present,Adenocarcinoma with squamous metaplasia,0
716,Diffuse Pattern,Diffuse Lipomatosis,0
717,Fibrosis,Malignant neoplasm of stomach recurrent,0
718,Gastric-Type Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
719,Lesion with Diameter of 5cm or Less,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
720,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
721,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
722,CD56-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
723,Questionable Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
724,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
725,Polyclonal hypergammaglobulinemia,Malignant neoplasm of stomach recurrent,0
726,Ganglion Cell-Like Elements Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
727,Multilocular Lesion,Primary Melanocytic Lesion of Meninges,0
728,Obesity,Malignant neoplasm of stomach recurrent,0
729,Hyperplastic Tissue Present,Malignant Splenic Soft Tissue Neoplasm,0
730,Spindle Cell Component Present,Spindle Cell Type A Uveal Melanoma,0
731,Hormone Receptor Positive,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
732,Neuroendocrine Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
733,Mild cytologic atypia,Mild epithelial dysplasia,0
734,Fetiform Mass,Malignant neoplasm of stomach recurrent,0
735,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
736,Submucosal Tumor Growth,Childhood Carcinoid Tumor,0
737,Histiocytosis,Refractory Langerhans Cell Histiocytosis,0
738,BRAF V600E Mutation Present,Myeloid Neoplasms with Germline GATA2 Mutation,0
739,Delicate Vascular Network Formation,Radiation-Induced Vascular Disease,0
740,Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
741,Nuclear pleomorphism,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
742,Cellular Pleomorphism,Cellular neurothekeoma,0
743,Glucagon-Like Peptide Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
744,Castration-Sensitive,Adenocarcinoma with squamous metaplasia,0
745,Single Malignant Cells Present,Malignant Gastric Granular Cell Tumor,0
746,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Squamous cell carcinoma of head and neck metastatic,0
747,Multihormonal Immunoreactivity Present in Two or More Cell Types,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
748,1p/19q Codeletion Status Unknown,Adenocarcinoma of Unknown Primary,0
749,Pseudo-Psammoma Body Formation,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
750,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of nasopharynx,0
751,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
752,Spontaneous Regression,Occult Lung Cancer AJCC v8,0
753,Efferent Arteriolar Hyalinosis,Adenocarcinoma with squamous metaplasia,0
754,Extraosseous Lesion,Reactive Cutaneous Fibrous Lesion,0
755,EBV-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
756,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
757,Dystrophic calcification,Malignant neoplasm of stomach recurrent,0
758,Multifocal Unisystem Disease,Erdheim-Chester Disease,0
759,Cutaneous plaque,Grade 3 Cutaneous Follicular Lymphoma,0
760,Prominent Squamous Eddies Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,0
761,Paucicellular Stroma Present,Adenocarcinoma with squamous metaplasia,0
762,Immunoglobulin Heavy Chain Deposition,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
763,Thick-Walled Vessels Present,Occult Lung Cancer AJCC v8,0
764,Vascular Channel Formation with Muscular Walls,Adenocarcinoma with squamous metaplasia,0
765,Hyalinized Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
766,Marked Thickening of the Bladder Urothelium Present,Erosive Adenomatosis of the Nipple,0
767,Antoni A Pattern,"Spindle cell melanoma, type A",0
768,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
769,Schwannian Stroma Predominant Component of the Tumor Volume,Benign Mixed Tumor of the Vulva,0
770,Splenomegaly,Adenocarcinoma with squamous metaplasia,0
771,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Vulvar Superficial Angiomyxoma,0
772,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
773,Mucoid Stroma Formation,Adenocarcinoma with squamous metaplasia,0
774,Nests of Nevus Cells Resembling Nerve Bundles Present,Recurrent tumors of the Ewing's family,0
775,Presence of a Hormonal Syndrome,"Benign neoplasm of brain, unspecified",0
776,Pseudopapillary Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
777,Neoplastic Plasma Cells Present in Bone Marrow,Osteosarcoma Arising in Paget Disease of Bone,0
778,Peripheral Blood Involvement,Intermediate Blood Vessel Neoplasm,0
779,Multifocal Multisystem Disease,Localized Castleman Disease,0
780,Villous Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
781,Multiple Tumor Masses,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
782,Human Papillomavirus Negative,AIDS-Related Human Papillomavirus Infection,0
783,Fibrovascular Septa Present,Malignant neoplasm of stomach recurrent,0
784,Human Papillomavirus Negative,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
785,Giant Mitochondria Present,Giant Hemangioma,0
786,Glandular Differentiation,Glandular papilloma,0
787,Dermal Nodule,Benign Dermal Schwannoma,0
788,Abnormal alveolar pattern,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
789,Rosette-Like Configurations Present,Pseudolymphoma,0
790,Complete Spontaneous Regression,Malignant neoplasm of stomach recurrent,0
791,Peribronchial Proliferation of Neoplastic Cells Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
792,Moderate cytologic atypia,Colorectal Adenoma with Moderate Dysplasia,0
793,Herringbone Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
794,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent tumors of the Ewing's family,0
795,Atypical Mitotic Figures,Childhood Atypical Choroid Plexus Papilloma,0
796,Single Malignant Cells Present,Malignant Gastric Granular Cell Tumor,0
797,Mucinous degeneration,"Cervical Mucinous Adenocarcinoma, Endocervical Type",0
798,Intraluminal Necrosis,Malignant neoplasm of stomach recurrent,0
799,Cellular Stratification,Cellular neurothekeoma,0
800,Castration-Naive,Pseudolymphoma,0
801,Large Spaces Filled with Blood Present,Large B-cell lymphoma with IRF4 rearrangement,0
802,Windblown Appearance of Atypical Keratinocytes,Atypical hyperplasia of breast,0
803,Cambium Layer,Occult Lung Cancer AJCC v8,0
804,Hot Nodule,Low Grade Liver Dysplastic Nodule,0
805,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
806,Castration Resistance,Occult Lung Cancer AJCC v8,0
807,Respiratory distress,Malignant neoplasm of stomach recurrent,0
808,Platinum Sensitivity,Occult Lung Cancer AJCC v8,0
809,Macule,Pseudolymphoma,0
810,Herringbone Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
811,Nests of Nevus Cells Resembling Nerve Bundles Present,Recurrent tumors of the Ewing's family,0
812,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
813,Aberrant Thyroid Tissue Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,0
814,Abnormal Eosinophilic Granules Present,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
815,Pseudo-'onion bulb' formation,Occult Lung Cancer AJCC v8,0
816,Tumor Droplets Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
817,Nuclear Molding,Adenocarcinoma with squamous metaplasia,0
818,Angiosarcoma-Like Areas Present,Occult Lung Cancer AJCC v8,0
819,Embryoid Bodies Present,Pseudolymphoma,0
820,Bilateral Mass,Bilateral Carcinoma,0
821,Moderately Differentiated Lesion,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
822,Blasts Under 10 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
823,Cartilaginous Component Present,Glioblastoma with Primitive Neuronal Component,0
824,Huge Vascular Channel Formation,Vascular neoplasm of skin,0
825,Fetiform Mass,Adenocarcinoma with squamous metaplasia,0
826,Antoni B Pattern,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),0
827,Blastemal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
828,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Squamous cell carcinoma of head and neck metastatic,0
829,Elastophagocytosis,Occult Lung Cancer AJCC v8,0
830,Slit-Like Vascular Channel Formation,Malignant Vascular Neoplasm,0
831,Hypoglycemia,Malignant neoplasm of stomach recurrent,0
832,Dystrophic calcification,Occult Lung Cancer AJCC v8,0
833,Giant Mitochondria Present,Giant cell angiofibroma,0
834,Intra or Intercytoplasmic Lumina Present,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
835,Progressive Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
836,Delicate Arborizing Vascular Channel Formation,Benign Cutaneous Vascular Neoplasm,0
837,Clinical TNM Finding,Hodgkin Lymphoma by Clinical Course,0
838,Radial Growth Phase,"Polycythemia Vera, Polycythemic Phase",0
839,Neutral Epithelial Mucin Present,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
840,Acinar Cell Differentiation,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,0
841,Bone Marrow Dysplasia Present,Bone Marrow Transplantation Nephropathy,0
842,Pseudoencapsulated Mass,Occult Lung Cancer AJCC v8,0
843,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Glandular Intraepithelial Neoplasia,0
844,CD56-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
845,Rapidly Enlarging Mass,Rapidly progressive glomerulonephritis,0
846,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Glandular Intraepithelial Neoplasia,0
847,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Multinodular and Vacuolated Tumor of the Cerebrum,0
848,Bead-Like Arrangement of Elastic Fibers,Malignant neoplasm of stomach recurrent,0
849,Entrapped Respiratory Epithelium Present,Respiratory papilloma,0
850,Thick-Walled Vessels Present,Leiomyosarcoma of Vessels,0
851,Squamous Differentiation,Squamous cell carcinoma of skin,0
852,Absence of Basal Cell Layer,Clear Cell Sarcoma of Soft Tissue,0
853,Calcitonin Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
854,Tissue Differentiation Uncertain,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
855,Embryoid Bodies Present,Occult Lung Cancer AJCC v8,0
856,Scattered Collections of Differentiating Neuroblasts Present,Recurrent tumors of the Ewing's family,0
857,Immature Myeloid Cells Increased in Bone Marrow,Prostate Carcinoma Metastatic in the Bone,0
858,Serum IgM Monoclonal Gammopathy of Less than 30g/L,Monoclonal Gammopathy of Undetermined Significance,0
859,Mixture of Embryonal and Alveolar Features Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
860,Floret-Like Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
861,Perivascular fibrosis,"Perivascular epithelioid tumor, malignant",0
862,New bone formation (morphologic abnormality),benign fibrous histiocytoma of bone,0
863,Lesion with Diameter of 2cm or Less,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
864,Black Discoloration,Occult Lung Cancer AJCC v8,0
865,Windblown Appearance of Atypical Keratinocytes,Recurrent tumors of the Ewing's family,0
866,Serum IgM Monoclonal Gammopathy of Less than 30g/L,Monoclonal Gammopathy of Undetermined Significance,0
867,Multinodular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
868,Glandular Pattern,"Ovarian Yolk Sac Tumor, Glandular Pattern",0
869,Rhabdomyosarcomatous Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
870,Lesion with Diameter Greater than 2cm,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,0
871,Acral Lesion,Pre-Malignant Skin Epithelial Lesion,0
872,Glucagon-Like Peptide Positive Neoplastic Cells Present,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
873,S-100-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
874,Arborising Network of Cords of Basaloid Cells Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
875,Florid Follicular Hyperplasia,Follicular Lymph Node Hyperplasia,0
876,Glomeruloid Vessels Present,Leiomyosarcoma of Vessels,0
877,Pseudorosette Formation,Malignant neoplasm of stomach recurrent,0
878,Drug Exposure,Pseudolymphoma,0
879,Neoplastic Plasma Cells Present in Bone Marrow,Osteosarcoma Arising in Paget Disease of Bone,0
880,Myxoid Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
881,Dense Intercellular Reticulin Network Present,Adenocarcinoma with squamous metaplasia,0
882,Osseous Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
883,Fetal -Epithelial Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
884,Small Aggregates of Tumor Cells Present,Multinodular and Vacuolated Tumor of the Cerebrum,0
885,Neoplastic Growth or Spread,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
886,No Evidence of Metastatic Disease,Chronic Bullous Disease of Childhood,0
887,Cytoplasmic Eosinophilic Globules Present,Childhood Acute Eosinophilic Leukemia,0
888,Perivascular Pseudorosette Formation,Adenocarcinoma with squamous metaplasia,0
889,Emperipolesis,Occult Lung Cancer AJCC v8,0
890,Parakeratosis,Adenocarcinoma with squamous metaplasia,0
891,Fibrovascular Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
892,"Hyperkeratosis, Epidermolytic","Keratoderma, Palmoplantar, Epidermolytic",0
893,Epithelial Component Present,Tubal Epithelial Hyperplasia,0
894,Mediastinal mass,Mediastinal Neuroblastoma,0
895,Calcinosis,Malignant neoplasm of stomach recurrent,0
896,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
897,Multifocal Unisystem Disease,Chronic Bullous Disease of Childhood,0
898,Fibrosis,Pseudolymphoma,0
899,Dentin formation,Occult Lung Cancer AJCC v8,0
900,Monoclonal Cellular Population Present,Cellular Blue Nevus,0
901,Pale Eosinophilic Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
902,Localized Hydropic Villous Change,Columnar Cell Change of the Breast with Atypia,0
903,Thrombocytosis,Adenocarcinoma with squamous metaplasia,0
904,Vascular proliferation,Benign Cutaneous Vascular Neoplasm,0
905,Rubbery Skin Lesion,Transplant-Related Skin Squamous Cell Carcinoma,0
906,Capillary Sized Vascular Channel Formation,Radiation-Induced Vascular Disease,0
907,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Bone Marrow Transplantation Nephropathy,0
908,Gastrin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
909,Thick-Walled Vessels Present,Adenocarcinoma with squamous metaplasia,0
910,Glucagon-Like Peptide Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
911,Polyclonal hypergammaglobulinemia,Pseudolymphoma,0
912,Drug toxicity,Pseudolymphoma,0
913,Lymphoplasmacytic Infiltrate,Adenocarcinoma with squamous metaplasia,0
914,Poorly Differentiated Neuroendocrine Lesion,Poorly Differentiated Neuroblastoma,0
915,Polymorphic Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
916,Geographic Necrosis,Malignant neoplasm of stomach recurrent,0
917,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Columnar Cell Change of the Breast with Atypia,0
918,Cartilaginous metaplasia,adenocarcinoma of breast with spindle cell metaplasia,0
919,Finding related to pregnancy,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
920,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
921,Extensive Secretory Changes Present,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0
922,Prominent Intraductal Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
923,Non Lipogenic Sarcomatous Stroma Present,Non functioning pancreatic endocrine tumor,0
924,Lesion with Diameter Greater than 2cm,Renal Cell Carcinoma Associated with Neuroblastoma,0
925,Epineurial Invasion,Malignant neoplasm of stomach recurrent,0
926,Multinodular and Vacuolated Pattern,Testicular Mixed Embryonal Carcinoma and Seminoma,0
927,BCR/ABL1 Fusion Negative,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,0
928,Thyroglobulin Positive Neoplastic Cells Present,Neoplastic Polyp,0
929,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0
930,Complex Glandular Pattern,Cervical Glandular Neoplasm,0
931,Lesion with Diameter Greater than 10mm,Adenocarcinoma with squamous metaplasia,0
932,Superficial Lesion,Superficial Epithelioma with Sebaceous Differentiation,0
933,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
934,Favorable Clinical Outcome,Favorable Hodgkin Lymphoma,0
935,Fetal -Epithelial Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
936,Ionizing Radiation Toxicity,Radiation Anemia,0
937,Localized Lesion,Localized Unresectable Neuroblastoma,0
938,Two Separate Tumor Masses Present in the Same Organ,Colon Carcinoma Metastatic in the Liver,0
939,Precocious Puberty,Pseudolymphoma,0
940,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
941,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
942,Broad Fibrous Bands Formation,Intracranial Benign Fibrous Histiocytoma,0
943,Clusters and Cords of GFAP Positive Epithelioid Tumor Cells Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
944,Confluent Sheets of Anaplastic T-Lymphocytes Present,Ampulla of Vater Mucinous Adenocarcinoma,0
945,Cord-Like Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
946,Obesity,Adenocarcinoma with squamous metaplasia,0
947,Benzene Exposure,Occult Lung Cancer AJCC v8,0
948,Thin-Walled Branching Vascular Pattern,Vascular neoplasm of skin,0
949,Lobular Pattern,"Carcinoma, Lobular",0
950,Acinar Proliferation,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",0
951,Delicate Arborizing Vascular Channel Formation,Radiation-Induced Vascular Disease,0
952,BCR/ABL1 Fusion Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
953,Crystal deposition,Occult Lung Cancer AJCC v8,0
954,NRBC - Nucleated red blood cell present result,Primary cutaneous diffuse large cell B-cell lymphoma,0
955,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Recurrent tumors of the Ewing's family,0
956,Ectopic Thyroid Tissue Present,Metastatic Thyroid Gland Carcinoma,0
957,Osteogenesis,Adenocarcinoma with squamous metaplasia,0
958,Blasts Under 5 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
959,Metaplasia,Ductal Breast Carcinoma with Squamous Metaplasia,0
960,Apocrine metaplasia,Adenocarcinoma with osseous metaplasia,0
961,Non-Contiguous Disease,Erdheim-Chester Disease,0
962,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
963,Inflammation,Occult Lung Cancer AJCC v8,0
964,Calcitonin serum level increased,Malignant neoplasm of stomach recurrent,0
965,Alternative Fascicle (Bundle) Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
966,Neutral Epithelial Mucin Present,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
967,More than 10 Mitoses per 10HPF,Adenocarcinoma with squamous metaplasia,0
968,Massive Sinusoidal Histiocytic Infiltrate,Histiocytic Necrotizing Lymphadenitis,0
969,Pseudostratified Tumor Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
970,Perivascular Lymphocytic Infiltrate,Cutaneous Chronic Lymphocytic Leukemia,0
971,Widely Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
972,Mild dysplasia of colon,Pseudopolyposis of colon,0
973,Sheets of Interfollicular Plasma Cells Present,Recurrent tumors of the Ewing's family,0
974,Nuclear Molding,Adenocarcinoma with squamous metaplasia,0
975,Dysplastic Dentin Formation,Dysplastic Nevus Syndrome,0
976,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
977,Perivascular fibrosis,Occult Lung Cancer AJCC v8,0
978,Neuroendocrine Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
979,Gastric-Type Epithelial Differentiation,Tubal Epithelial Hyperplasia,0
980,Thin-Walled Branching Vascular Pattern,Vascular neoplasm of skin,0
981,Well Differentiated Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
982,Multilineage Dysplasia Present,Large Cell Dysplasia,0
983,"Amorphus, Eosinophilic, and Acellular Deposit",Testicular Mixed Embryonal Carcinoma and Seminoma,0
984,Juvenile Lesion,Pre-Malignant Skin Epithelial Lesion,0
985,Cellular Pseudostratification,Cellular Blue Nevus,0
986,Fibrosis,Pseudolymphoma,0
987,Diarrhea,Malignant neoplasm of stomach recurrent,0
988,Granuloma,Granuloma Annulare,0
989,Intermediate Filaments Present,Intermediate Lipomatous Neoplasm,0
990,Unifocal Disease at Presentation,Multi-centric Castleman's Disease,0
991,Generalized Dysplasia,Acute Generalized Exanthematous Pustulosis,0
992,Monoclonal Eosinophils Present,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
993,Staghorn Configuration,Adenocarcinoma with squamous metaplasia,0
994,Inclusion-Like Nucleoli,Occult Lung Cancer AJCC v8,0
995,Drug Exposure,Occult Lung Cancer AJCC v8,0
996,Alopecia,Adenocarcinoma with squamous metaplasia,0
997,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
998,Blasts Under 10 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
999,Herringbone Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1000,Infundibular-Like Structures Present,Pseudolymphoma,0
1001,Collagenous Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
1002,Juvenile Lesion,Pre-Malignant Skin Epithelial Lesion,0
1003,Absence of Invasion of the Muscularis Externa,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
1004,Melanosomes Present,Adenocarcinoma with squamous metaplasia,0
1005,Abundance of Small Lymphocytes,Small cell carcinoma of esophagus,0
1006,Drug toxicity,Pseudolymphoma,0
1007,Lobulated Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1008,"Amorphus, Eosinophilic, and Acellular Deposit",Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1009,VIP Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
1010,Primary Site Unspecified,Primary cutaneous diffuse large cell B-cell lymphoma,0
1011,Hypercellular bone marrow,benign fibrous histiocytoma of bone,0
1012,Pseudorosette Formation,Occult Lung Cancer AJCC v8,0
1013,Non-Specific Glandular Pattern,Glandular papilloma,0
1014,Low Grade Lesion,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
1015,Melanin Pigment Present,Occult Lung Cancer AJCC v8,0
1016,Well Differentiated Neuroendocrine Lesion,Pleural Well Differentiated Papillary Mesothelioma,0
1017,Perineural spread,Malignant neoplasm of stomach recurrent,0
1018,CD4-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
1019,Cytopenia,Adenocarcinoma with squamous metaplasia,0
1020,Early Stromal Invasion Present,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
1021,Jaw Keratocyst,Occult Lung Cancer AJCC v8,0
1022,Positive Axillary Lymph Node,Palisaded Lymph Node Myofibroblastoma,0
1023,Nuclear pleomorphism,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
1024,Desmoplastic Stroma Formation,Desmoplastic fibroma,0
1025,Hypergammaglobulinemia,Malignant neoplasm of stomach recurrent,0
1026,Skin Erosion,Transplant-Related Skin Squamous Cell Carcinoma,0
1027,Inflammatory infiltrate,Inflammatory carcinoma of breast recurrent,0
1028,Polyvesicular Vitelline Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1029,Toxic effect,Adenocarcinoma with squamous metaplasia,0
1030,Pericanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1031,Subcutaneous nodule,Subcutaneous Nodular Fasciitis,0
1032,Sarcomatous or Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,0
1033,Humoral hypercalcemia of malignancy (disorder),Recurrent tumors of the Ewing's family,0
1034,Skin Ulcer,Locally Advanced Skin Squamous Cell Carcinoma,0
1035,Diffuse Pattern,Diffuse Lipomatosis,0
1036,Pseudoangiomatoid Space Formation,Adenocarcinoma with squamous metaplasia,0
1037,Infundibular-Like Structures Present,Pseudolymphoma,0
1038,Comedo Necrosis,Adenocarcinoma with squamous metaplasia,0
1039,Immunoglobulin Light Chain Deposition,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
1040,Abundant Intracytoplasmic Lipofuscin Present,Occult Lung Cancer AJCC v8,0
1041,Edematous Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
1042,HIF1A Overexpression Positive,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
1043,Islands of Neuropil-Like Matrix Present,Recurrent tumors of the Ewing's family,0
1044,Osteoid formation,Osteoid osteoma,0
1045,Endometrial Type Glands and Stroma Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
1046,Bilateral Mass,Bilateral Optic Nerve Meningioma,0
1047,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,Bone Marrow Transplantation Nephropathy,0
1048,Preserved Nuclear Polarity,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
1049,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Erosive Adenomatosis of the Nipple,0
1050,CD30-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1051,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1052,Absence of Invasion,Ampulla of Vater Mucinous Adenocarcinoma,0
1053,Non-Malignant Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
1054,Hyperkeratosis,Pseudolymphoma,0
1055,Exanthema,Occult Lung Cancer AJCC v8,0
1056,Intracellular Accumulation of Lipids,Recurrent tumors of the Ewing's family,0
1057,Mass of pleura,Benign neoplasm of pleura,0
1058,Intraosseous Lesion,Pre-Malignant Skin Epithelial Lesion,0
1059,Monoclonal Myeloid or Lymphoid Cells Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0
1060,Unfavorable Clinical Outcome,Advanced Unfavorable Hodgkin Lymphoma,0
1061,Intravascular papillary endothelial hyperplasia,Endometrial cystic hyperplasia,0
1062,Lesion with Diameter of 2cm or Less,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
1063,Blue Bone Formation,Cellular Blue Nevus,0
1064,Primary Site Unspecified,Primary mediastinal large B-cell lymphoma stage III,0
1065,Well Differentiated Hyaline Cartilage Present,Well Differentiated Malignant Neoplasm,0
1066,Severe cytologic atypia,Severe pre-eclampsia,0
1067,Cytoplasmic Eosinophilic Globules Present,Childhood Acute Eosinophilic Leukemia,0
1068,Multiple Tumor Masses,Multiple Endocrine Neoplasia Type 2a,0
1069,Odontogenic Cysts,Odontogenic myxoma,0
1070,Multihormonal Immunoreactivity Present in a Single Cell Type,Intermediate Cell Type Iris Melanoma,0
1071,Plasma cell inflammation,Plasma cell myeloma recurrent,0
1072,Marked Bone Marrow Fibrosis,Breast Carcinoma Metastatic in the Bone,0
1073,Mild dysplasia,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
1074,Hypercellular bone marrow,Secondary malignant neoplasm of bone marrow,0
1075,Glandular Pattern,Glandular papilloma,0
1076,Gastric dysplasia,Malignant Gastric Granular Cell Tumor,0
1077,Multinodular Lesion,Primary Melanocytic Lesion of Meninges,0
1078,Lymphocyte count increased,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1079,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1080,Acinar Proliferation,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
1081,Multihormonal Immunoreactivity Present in a Single Cell Type,Intermediate Cell Type Iris Melanoma,0
1082,Exposure to asbestos,Anemia due to membrane defect,0
1083,Eosinophilic inflammation,Eosinophilic Granuloma,0
1084,Diffuse Immunoblastic Proliferation,Immunoblastic Large-Cell Lymphoma,0
1085,Ganglioneuroma Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
1086,Vascular proliferation,Benign Cutaneous Vascular Neoplasm,0
1087,Large Mass,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
1088,Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
1089,Plasma cell inflammation,Basal cell carcinoma,0
1090,Pancreatobiliary-Type Malignant Cells Present,Malignant neoplasm of nasopharynx,0
1091,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
1092,Cavernous Lymphatic Space Formation,Thyroid Gland Cavernous Hemangioma,0
1093,Moderate cytologic atypia,Colorectal Adenoma with Moderate Dysplasia,0
1094,Heterologous Elements Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",0
1095,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
1096,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1097,Painless Mass,Occult Lung Cancer AJCC v8,0
1098,Skin Erosion,Transplant-Related Skin Squamous Cell Carcinoma,0
1099,Thin-Branching Papillae Present,Malignant neoplasm of stomach recurrent,0
1100,Antoni B Pattern,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),0
1101,Tubular Pattern,Tubular breast carcinoma,0
1102,Abnormal Eosinophilic Granules Present,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
1103,Regional Disease,Chronic Bullous Disease of Childhood,0
1104,More than 5 Mitoses per 50HPF,Malignant neoplasm of stomach recurrent,0
1105,Rare Lesion,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0
1106,BCR/ABL1 Fusion Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
1107,Cartilaginous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
1108,Fibrinous Material Present,Pseudolymphoma,0
1109,Tricholemmal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1110,Mixture of Embryonal and Alveolar Features Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1111,Low Grade Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
1112,Intracytoplasmic Eosinophilic Inclusion,Childhood Acute Eosinophilic Leukemia,0
1113,Nodules of Compact Keratin Present,Malignant neoplasm of stomach recurrent,0
1114,Mucinous degeneration,Ampulla of Vater Mucinous Adenocarcinoma,0
1115,One Germ Layer Present,Adult Central Nervous System Mixed Germ Cell Tumor,0
1116,Fetal -Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1117,Bilateral Disease,Multi-centric Castleman's Disease,0
1118,Multifocal Unisystem Disease,Erdheim-Chester Disease,0
1119,Koilocytotic atypia,Malignant neoplasm of stomach recurrent,0
1120,Borderline Lesion,Reactive Cutaneous Fibrous Lesion,0
1121,"Undifferentiated ""Fetal-Type"" Tissues Present",Endometrial Undifferentiated Carcinoma,0
1122,Cysts Containing Proteinaceous Fluid Present,Adenocarcinoma with squamous metaplasia,0
1123,Tubular Structures Present,Colorectal Tubular Adenoma,0
1124,Splenomegaly,Malignant neoplasm of stomach recurrent,0
1125,Gastrin Positive Neoplastic Cells Present,Neoplastic Polyp,0
1126,Gastric dysplasia,Malignant Gastric Granular Cell Tumor,0
1127,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Vulvar Superficial Angiomyxoma,0
1128,Castration-Sensitive,Occult Lung Cancer AJCC v8,0
1129,Leukoerythroblastic Reaction,Adenocarcinoma with squamous metaplasia,0
1130,Dense Intercellular Reticulin Network Present,Malignant neoplasm of stomach recurrent,0
1131,Abnormal Eosinophilic Granules Present,Eosinophilic Granuloma,0
1132,Multinodular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1133,Pancreatobiliary-Type Malignant Cells Present,Metastatic Extracranial Malignant Solid Neoplasm,0
1134,Squamous Differentiation,Squamous cell carcinoma of skin,0
1135,Ectopic Thyroid Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
1136,Tobacco Chewing Toxicity,Malignant neoplasm of stomach recurrent,0
1137,Non-Malignant Cellular Infiltrate,Cellular Blue Nevus,0
1138,Primitive Mesenchymal Stroma Formation,"Neuroectodermal Tumor, Primitive",0
1139,Oligodendroglial Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
1140,Mediastinal mass,Mediastinal Leiomyoma,0
1141,CDKN2A-p16 Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
1142,Gastric dysplasia,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1143,Prominent Collagen Rosette Formation,Occult Lung Cancer AJCC v8,0
1144,Multicentric Lesion,Reactive Cutaneous Fibrous Lesion,0
1145,Mesenchymal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1146,Lesion with Diameter of 10mm or Less,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
1147,Congenital Abnormality,Small Congenital Melanocytic Nevus,0
1148,Cauliflower-Like Mass,Occult Lung Cancer AJCC v8,0
1149,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1150,Cytokeratin Positive Neoplastic Cells Present,Neoplastic Polyp,0
1151,Severe cytologic atypia,Complex endometrial hyperplasia without atypia,0
1152,Neonatal Lesion,Primary Melanocytic Lesion of Meninges,0
1153,Mitotic Activity,Occult Lung Cancer AJCC v8,0
1154,Syncytial Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1155,Negative Peripheral Blood,Peripheral Intraneural Angiosarcoma,0
1156,Perivascular Pseudorosette Formation,"Perivascular epithelioid tumor, benign",0
1157,Macronodular adrenal hyperplasia,Atypical hyperplasia of breast,0
1158,Pseudo-Psammoma Body Formation,Benign Carotid Body Paraganglioma,0
1159,Neutral Epithelial Mucin Present,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
1160,Minimal Invasion Present,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type",0
1161,Lipomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
1162,Refractory Disease,Steroid Refractory Graft Versus Host Disease,0
1163,Pseudostratified Neuroepithelial Tumor Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1164,Disease regression,Multi-centric Castleman's Disease,0
1165,Pineocytomatous Rosette Formation,Pseudolymphoma,0
1166,Fried-Egg Appearance of the Bone Marrow,Recurrent tumors of the Ewing's family,0
1167,Reinke Crystals Formation,Adenocarcinoma with squamous metaplasia,0
1168,Microsatellite Stable,Adenocarcinoma with squamous metaplasia,0
1169,Pseudoalveolar Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1170,Regional Disease,Chronic Bullous Disease of Childhood,0
1171,Cartilage-Like Elements Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
1172,Mesenchymal Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
1173,Bone Marrow Lymphoplasmacytic Infiltrate,Stage IB Bone Sarcoma AJCC v7,0
1174,Cartilaginous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1175,Presence of a Hormonal Syndrome,Ampulla of Vater Mucinous Adenocarcinoma,0
1176,CDKN2A-p16 Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
1177,Nodules of Compact Keratin Present,"Benign neoplasm of brain, unspecified",0
1178,Abnormal alveolar pattern,Adenocarcinoma with squamous metaplasia,0
1179,Histiocytoid Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1180,Spindle Cell Metaplasia of Malignant Cells Present,Spindle Cell Oncocytoma of the Adenohypophysis,0
1181,Crooke Hyaline Change,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,0
1182,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Erosive Adenomatosis of the Nipple,0
1183,Schwannian Stroma Predominant Component of the Tumor Volume,Benign Mixed Tumor of the Vulva,0
1184,Multifocal Multisystem Disease,Chronic Bullous Disease of Childhood,0
1185,Reactive Germinal Centers Present,Reactive Cutaneous Fibrous Lesion,0
1186,Fetal -Epithelial Differentiation,Fetal Lung Adenocarcinoma,0
1187,Congenital Abnormality,Congenital melanocytic nevus,0
1188,Dystrophic calcification,Adenocarcinoma with squamous metaplasia,0
1189,Diffuse Lesion,Diffuse Lipomatosis,0
1190,Minimally Invasive Lesion,Grade 3 Invasive Breast Carcinoma,0
1191,Pseudolobular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1192,Intraepithelial Neoplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
1193,Fried-Egg Appearance of the Bone Marrow,Erosive Adenomatosis of the Nipple,0
1194,Capsular Invasion,Pseudolymphoma,0
1195,Negative Peripheral Blood,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
1196,Pseudoencapsulated Mass,Occult Lung Cancer AJCC v8,0
1197,Antoni A Pattern,Kadish Stage A Olfactory Neuroblastoma,0
1198,Curvilinear Thin-Walled Vascular Pattern,Vascular neoplasm of skin,0
1199,Cavernous Lymphatic Space Formation,Thyroid Gland Cavernous Hemangioma,0
1200,Parakeratinized Stratified Squamous Epithelium Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,0
1201,Poorly Cohesive Malignant Cellular Infiltrate,Malignant neoplasm of stomach recurrent,0
1202,Acquired Lesion,Reactive Cutaneous Fibrous Lesion,0
1203,Tobacco Toxicity,Malignant neoplasm of stomach recurrent,0
1204,Monoclonal Paraproteinemia,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0
1205,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
1206,Emperipolesis,Malignant neoplasm of stomach recurrent,0
1207,Necrotic changes (finding),Adenocarcinoma with squamous metaplasia,0
1208,Multinodular Lesion,Reactive Cutaneous Fibrous Lesion,0
1209,Bilateral Mass,Bilateral Malignant Neoplasm,0
1210,Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1211,Dedifferentiated Malignant Infiltrate,Metastatic Extracranial Malignant Solid Neoplasm,0
1212,Retiform Structures Comprise 90% or More of the Tumor,Malignant Mixed Tumor of the Major Salivary Gland,0
1213,Polymorphic Cellular Infiltrate,Cellular Blue Nevus,0
1214,Localized Hydropic Villous Change,Columnar Cell Change of the Breast with Atypia,0
1215,Low Cellularity Present,Classical Low Grade Fibromyxoid Sarcoma,0
1216,Aggressive Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
1217,Meckel Diverticulum,Adenocarcinoma with squamous metaplasia,0
1218,Non-Invasive Lesion,Primary Melanocytic Lesion of Meninges,0
1219,Annular Tubules Present,Occult Lung Cancer AJCC v8,0
1220,Striated Muscle Component Present,Malignant Skeletal Muscle Neoplasm,0
1221,Hypergammaglobulinemia,Occult Lung Cancer AJCC v8,0
1222,Nerve palsy,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
1223,Villous Projections of the Neoplastic Epithelium Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1224,Broad Fibrous Bands Formation,Intracranial Benign Fibrous Histiocytoma,0
1225,Mass of body structure,Hemangioma of intracranial structure,0
1226,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
1227,Rimming of Adipose Tissue Cells Present,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
1228,Confluent Sheets of Neoplastic B-Lymphocytes Present,Recurrent tumors of the Ewing's family,0
1229,Monocytosis,Pseudolymphoma,0
1230,Thin Bands of Collagen Present,Recurrent tumors of the Ewing's family,0
1231,Moderate dysplasia,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
1232,Edema,Pseudolymphoma,0
1233,Unfavorable Clinical Outcome,Advanced Unfavorable Hodgkin Lymphoma,0
1234,Pseudo-'onion bulb' formation,Occult Lung Cancer AJCC v8,0
1235,Nodules of Compact Keratin Present,Recurrent tumors of the Ewing's family,0
1236,Bile Pigment Present,Bile duct cystadenocarcinoma,0
1237,Hyperplastic Epithelial Tissue Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
1238,Cytoplasmic Eosinophilic Globules Present,Childhood Acute Eosinophilic Leukemia,0
1239,Mesenchymal Metaplasia,Breast Carcinoma with Chondroid Metaplasia,0
1240,Cervical Glandular Dysplasia,Cervical Warty Carcinoma,0
1241,Syncytial Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1242,Endodermal Sinus Pattern,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,0
1243,Tumor Vascular Invasion,Childhood Carcinoid Tumor,0
1244,Polarization of Nuclei Towards the Glandular Lumen,Recurrent tumors of the Ewing's family,0
1245,Angiosarcoma-Like Areas Present,Occult Lung Cancer AJCC v8,0
1246,Cambium Layer,Pseudolymphoma,0
1247,Questionable Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
1248,Acral Lesion,Reactive Cutaneous Fibrous Lesion,0
1249,Immature Myeloid Cells Increased in Bone Marrow,Prostate Carcinoma Metastatic in the Bone,0
1250,Shadow Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1251,Defective Gamma Heavy Chain Present,Heavy Chain Deposition Disease,0
1252,Slow Growing Mass,Malignant neoplasm of stomach recurrent,0
1253,Nidus Formation,Malignant neoplasm of stomach recurrent,0
1254,Serum phosphate concentration below normal,Malignant neoplasm of stomach recurrent,0
1255,Thin Bands of Collagen Present,Malignant neoplasm of stomach recurrent,0
1256,Granuloma,Adenocarcinoma with squamous metaplasia,0
1257,Glomeruloid Vessels Present,Leiomyosarcoma of Vessels,0
1258,Confluent Sheets of Neoplastic B-Lymphocytes Present,Recurrent tumors of the Ewing's family,0
1259,Macrofollicular Structures Present,Occult Lung Cancer AJCC v8,0
1260,Cartilaginous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
1261,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
1262,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1263,Fibrovascular Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
1264,Sinusoidal Vascular Channel Formation,Benign Cutaneous Vascular Neoplasm,0
1265,Fetiform Mass,Adenocarcinoma with squamous metaplasia,0
1266,Crooke Hyaline Change,Adenocarcinoma with squamous metaplasia,0
1267,Zonal Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1268,Abnormal alveolar pattern,Occult Lung Cancer AJCC v8,0
1269,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1270,Marked Nuclear Atypia Present,Columnar Cell Change of the Breast with Atypia,0
1271,Locally Aggressive Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma,0
1272,Entrapped Respiratory Epithelium Present,Germinative Follicular Epithelium Neoplasm,0
1273,Poorly Differentiated Neuroendocrine Lesion,Poorly Differentiated Neuroblastoma,0
1274,Five or Less Mitoses per 50HPF,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
1275,Metastatic/Recurrent Disease,Multi-centric Castleman's Disease,0
1276,Decreased platelet count,Occult Lung Cancer AJCC v8,0
1277,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
1278,Nuclear pleomorphism,Occult Lung Cancer AJCC v8,0
1279,Acral Lesion,Acral Lentiginous Malignant Melanoma,0
1280,HIF1A Overexpression Positive,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
1281,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
1282,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Benign neoplasm of brain, unspecified",0
1283,Platinum Resistance,Adenocarcinoma with squamous metaplasia,0
1284,Alopecia,Occult Lung Cancer AJCC v8,0
1285,Serrated Glandular Architecture,Glandular papilloma,0
1286,Minimally Invasive Lesion,Minimally Invasive Mucinous Lung Adenocarcinoma,0
1287,Birbeck Granules Present,Pseudolymphoma,0
1288,Marked Bone Marrow Fibrosis,Unresectable Bone Sarcoma,0
1289,Pseudostratified Tumor Cells Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0
1290,Metastatic/Recurrent Disease,Localized Castleman Disease,0
1291,Gastric dysplasia,Gastric Papillary Adenocarcinoma,0
1292,Primary Site Unspecified,Primary Malignant Liver Neoplasm,0
1293,Tissues Derived from Two or Three Embryonic Layers Present,Tumors Derived from Langerhans Cells,0
1294,High Mitotic Activity,Refractory High Risk Myelodysplastic Syndrome,0
1295,Vertical Growth Phase,Leukemic Phase of Non-Hodgkin's Lymphoma,0
1296,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
1297,Endocervical Type Epithelium Present,"Endocervical Adenocarcinoma, Usual Type",0
1298,Insular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1299,Cutaneous plaque,Cutaneous sarcoidosis,0
1300,Melanin-Pigmented Dendritic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1301,Microsatellite Stable,Malignant neoplasm of stomach recurrent,0
1302,Vater-Pacini Corpuscles-Like Structures Present,Occult Lung Cancer AJCC v8,0
1303,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0
1304,Alopecia,Occult Lung Cancer AJCC v8,0
1305,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
1306,Rare Lesion,Pre-Malignant Skin Epithelial Lesion,0
1307,Submucosal Tumor Growth,Malignant Gastric Granular Cell Tumor,0
1308,Nuclear pleomorphism,Occult Lung Cancer AJCC v8,0
1309,Moderately Differentiated Lesion,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
1310,Antoni B Pattern,Stage B Chronic Lymphocytic Leukemia,0
1311,Skin Red Dot,Locally Advanced Skin Squamous Cell Carcinoma,0
1312,Bilateral Mass,Bilateral Optic Nerve Meningioma,0
1313,Pale Eosinophilic Stroma Formation,Eosinophilic Granuloma,0
1314,Plexiform Vasculature Present,Plexiform Neurofibroma,0
1315,Lipomatous Metaplasia,Intermediate Lipomatous Neoplasm,0
1316,Intravascular papillary endothelial hyperplasia,Atypical hyperplasia of breast,0
1317,Annular Tubules Present,Occult Lung Cancer AJCC v8,0
1318,Rapidly Enlarging Mass,Malignant neoplasm of stomach recurrent,0
1319,Prominent In Situ Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,0
1320,Diffuse Pattern,Hereditary Diffuse Gastric Adenocarcinoma,0
1321,Peribronchial and Lobular Septal Involvement Only,Invasive Ductal and Invasive Lobular Breast Carcinoma,0
1322,Cicatrix,Malignant neoplasm of stomach recurrent,0
1323,Refractory Disease,Steroid Refractory Graft Versus Host Disease,0
1324,Microglandular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1325,Transformed Phase of Disease,Leukemic Phase of Non-Hodgkin's Lymphoma,0
1326,Neuroectodermal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1327,Abnormal alveolar pattern,Adenocarcinoma with squamous metaplasia,0
1328,Thyroglobulin Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
1329,Acquired Lesion,Acquired cystic disease associated renal cell carcinoma,0
1330,Intravascular papillary endothelial hyperplasia,Gallbladder papillary adenocarcinoma,0
1331,Melanoma Cells Present,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,0
1332,Generalized Dysplasia,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
1333,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Metastatic Malignant Neoplasm in the Iris,0
1334,Low Cellularity Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
1335,Dense Intercellular Reticulin Network Present,Adenocarcinoma with squamous metaplasia,0
1336,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1337,VIP Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1338,Venous Type Vascular Channel Formation,Intermediate Cell Type Ciliary Body Melanoma,0
1339,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
1340,Fibrovascular Stalks Present,Adenocarcinoma with squamous metaplasia,0
1341,Misplaced Exocytosis Present,Malignant neoplasm of stomach recurrent,0
1342,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Malignant neoplasm of stomach recurrent,0
1343,Sebaceous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1344,Microvascular Proliferation,T-Cell Proliferation of Uncertain Malignant Potential,0
1345,Thin-Walled Branching Vascular Pattern,Vascular neoplasm of skin,0
1346,Pericanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1347,Intramucosal Lesion,Pre-Malignant Skin Epithelial Lesion,0
1348,Prominent Keratin Formation,Adenocarcinoma with squamous metaplasia,0
1349,Microvascular Proliferation,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
1350,Nodular lesions,Nodular fasciitis,0
1351,Acinar Pattern,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",0
1352,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
1353,Early Stromal Invasion Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1354,Matrical Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
1355,Non-Hereditary Lesion,Pre-Malignant Skin Epithelial Lesion,0
1356,Endobronchial Mass,Adenocarcinoma with squamous metaplasia,0
1357,No Evidence of Metastatic Disease,Chronic Bullous Disease of Childhood,0
1358,Small Lesion,Adult Desmoplastic Small Round Cell Tumor,0
1359,Cartilaginous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1360,Storiform Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1361,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
1362,Glucagon-Like Peptide Positive Neoplastic Cells Present,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
1363,Borderline Lesion,Reactive Cutaneous Fibrous Lesion,0
1364,Dilated Thin-Walled Vascular Space Formation,Malignant Vascular Neoplasm,0
1365,Blasts Expressing B-Lymphoid and Myeloid Markers Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
1366,Low Grade Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",0
1367,Cribriform Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1368,Wedge-Shaped Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1369,Junctional Proliferation,B-Cell Proliferation of Uncertain Malignant Potential,0
1370,Antoni B Pattern,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),0
1371,Subcutaneous Involvement,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,0
1372,Plexiform Vasculature Present,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas",0
1373,Cementum Formation,Pseudolymphoma,0
1374,Increased NFkappaB Pathway Activation,Refractory Visual Pathway Glioma,0
1375,Lymphatic Spread,Lymphatic Vessel Tumors,0
1376,Solid Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1377,Fibrovascular Septa Present,Adenocarcinoma with squamous metaplasia,0
1378,Prominent Keratin Formation,Occult Lung Cancer AJCC v8,0
1379,Urine phosphorous concentration above normal,Malignant neoplasm of stomach recurrent,0
1380,Diffuse Pattern,Diffuse Lipomatosis,0
1381,Epithelioid Component Present,Breast Epithelioid Hemangioma,0
1382,Five or Less Mitoses per 50HPF,Ovarian Biphasic or Triphasic Teratoma,0
1383,Retiform Structures Comprise 90% or More of the Tumor,Malignant Mixed Tumor of the Major Salivary Gland,0
1384,Borderline Lesion,Reactive Cutaneous Fibrous Lesion,0
1385,New bone formation (morphologic abnormality),Peripheral primitive neuroectodermal bone tumor,0
1386,Pseudoalveolar Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1387,Systemic disease,Lhermitte-Duclos disease,0
1388,Decreased platelet count,Adenocarcinoma with squamous metaplasia,0
1389,Curvilinear Thin-Walled Vascular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1390,Collagenous Stroma Formation,Adenocarcinoma with squamous metaplasia,0
1391,Two Separate Tumor Masses Present in the Same Organ,Colorectal Carcinoma Metastatic in the Liver,0
1392,Intravascular papillary endothelial hyperplasia,Atypical hyperplasia of breast,0
1393,Lesion with Diameter Greater than 15mm,Adenocarcinoma with squamous metaplasia,0
1394,Breast Implant-Related Lesion,Breast Phyllodes Tumor,0
1395,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Vulvar Superficial Angiomyxoma,0
1396,Lesion with Diameter Greater than 15mm,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1397,Prominent Intraductal Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
1398,Seminomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
1399,Intraductal Lesion,Pre-Malignant Skin Epithelial Lesion,0
1400,Inoperable Disease,Localized Castleman Disease,0
1401,Slow Growing Painless Mass,Pseudolymphoma,0
1402,Hyalinized Vessels Present,Leiomyosarcoma of Vessels,0
1403,Pancreatobiliary-Type Malignant Cells Present,Malignant neoplasm of nasopharynx,0
1404,Venous Type Vascular Channel Formation,Intermediate Cell Type Ciliary Body Melanoma,0
1405,Glomerular Hypertrophy,Occult Lung Cancer AJCC v8,0
1406,Sinusoidal Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1407,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1408,Fascicles of Spindly Tumor Cells Present,Ampulla of Vater Neuroendocrine Tumor,0
1409,MGMT Gene Promoter Methylation,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
1410,No Evidence of Metastatic Disease,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
1411,Blastemal Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1412,Chronic lymphocytic inflammation,Chronic lymphocytic leukemia stage 0,0
1413,Multinodular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1414,Glandular metaplasia,Cervical Glandular Neoplasm,0
1415,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Ovarian Biphasic or Triphasic Teratoma,0
1416,Storiform Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1417,Glomerular Hypertrophy,Occult Lung Cancer AJCC v8,0
1418,Lesion with Diameter Greater than 15mm,Renal Cell Carcinoma Associated with Neuroblastoma,0
1419,Cold Nodule,Placental Site Nodule or Plaque,0
1420,Lipomatous Differentiation,Intermediate Lipomatous Neoplasm,0
1421,Hepatomegaly,Malignant neoplasm of stomach recurrent,0
1422,Reinke Crystals Formation,Pseudolymphoma,0
1423,EBV-Positive Neoplastic Cells Present,Neoplastic Polyp,0
1424,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
1425,Ground Glass Nuclear Inclusion,Malignant neoplasm of stomach recurrent,0
1426,Fried-Egg Appearance of the Bone Marrow,Recurrent tumors of the Ewing's family,0
1427,Jaw Keratocyst,Pseudolymphoma,0
1428,Unfavorable Clinical Outcome,Advanced Unfavorable Hodgkin Lymphoma,0
1429,CDKN2A-p16 Negative,Occult Lung Cancer AJCC v8,0
1430,Plexiform Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1431,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1432,Misplaced Exocytosis Present,Occult Lung Cancer AJCC v8,0
1433,Skin Erosion,Stage IV Skin Cancer,0
1434,S-100-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
1435,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
1436,Diffuse Cellular Infiltrate,Cellular neurothekeoma,0
1437,Non-Invasive Lesion,Reactive Cutaneous Fibrous Lesion,0
1438,Fried-Egg Appearance of the Bone Marrow,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
1439,Pseudo-Psammoma Body Formation,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
1440,Swelling,Malignant neoplasm of stomach recurrent,0
1441,Spindle Cell Metaplasia,Spindle Cell Melanoma,0
1442,Complex Glandular Pattern,"Ovarian Yolk Sac Tumor, Glandular Pattern",0
1443,Acquired Lesion,Acquired cystic disease associated renal cell carcinoma,0
1444,Anaplasia,Malignant neoplasm of stomach recurrent,0
1445,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
1446,Mixture of Morphologic Patterns,Malignant neoplasm of stomach recurrent,0
1447,Platinum Sensitivity,Occult Lung Cancer AJCC v8,0
1448,Cytoplasmic Accumulation of Black Pigment,Ampulla of Vater Mucinous Adenocarcinoma,0
1449,Bilateral Mass,Bilateral Malignant Neoplasm,0
1450,Windblown Appearance of Atypical Keratinocytes,Atypical hyperplasia of breast,0
1451,Sclerotic Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1452,Hepatomegaly,Occult Lung Cancer AJCC v8,0
1453,Mucocele of appendix,Neuroendocrine carcinoma of appendix,0
1454,Above the Diaphragm Disease,Paget Disease of the Anus,0
1455,Elastin Fibers Present,Malignant neoplasm of stomach recurrent,0
1456,Focal dysplasia,Focal Segmental Glomerulosclerosis Collapsing Variant,0
1457,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1458,Serotonin Positive Neoplastic Cells Present,Neoplastic Polyp,0
1459,Unifocal Lesion,Reactive Cutaneous Fibrous Lesion,0
1460,Keratin Horn Pearls Formation,Malignant neoplasm of stomach recurrent,0
1461,Inoperable Disease,Localized Castleman Disease,0
1462,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
1463,Diffuse Lesion,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
1464,Multihormonal Immunoreactivity Present in Two or More Cell Types,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,0
1465,Lymphatic Spread,Occult Lung Cancer AJCC v8,0
1466,Nuclear Expression of STAT6 Protein,Ampulla of Vater Mucinous Adenocarcinoma,0
1467,Premalignant Lesion,Reactive Cutaneous Fibrous Lesion,0
1468,Monomorphic Cellular Infiltrate,Cellular Blue Nevus,0
1469,Giant Mitochondria Present,Giant cell angiofibroma,0
1470,Mesenchymal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1471,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
1472,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,0
1473,Vater-Pacini Corpuscles-Like Structures Present,Pseudolymphoma,0
1474,Castration-Sensitive,Occult Lung Cancer AJCC v8,0
1475,Macrocystic Change,Columnar Cell Change of the Breast with Atypia,0
1476,Hypocellular Tissue,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
1477,Peau d'orange surface of breast,malignant myoepithelioma of breast,0
1478,Spindle Cell Osteo-Fibrous Component Present,Spindle Cell Type A Uveal Melanoma,0
1479,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
1480,BCR/ABL1 Fusion Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
1481,Apocrine Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1482,Non-Malignant Cellular Infiltrate,Ovarian Cellular Fibroma,0
1483,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
1484,Subcutaneous nodule,Subcutaneous Nodular Fasciitis,0
1485,Extranodal Extension,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV,0
1486,Lymphadenopathy,Adenocarcinoma with squamous metaplasia,0
1487,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of lacrimal duct,0
1488,Multicentric Lesion,Multicentric Thyroid Gland Papillary Carcinoma,0
1489,Human Papillomavirus Negative,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,0
1490,Sonic Hedgehog/Patch Pathway Activated,Activated B-cell type diffuse large B-cell lymphoma,0
1491,VIP Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1492,"Nodular, Reticulin-Free Zones Present",Pseudolymphoma,0
1493,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
1494,Lesion with Diameter of 5cm or Less,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
1495,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1496,CDKN2A-p16 Negative,Occult Lung Cancer AJCC v8,0
1497,Nodular Pattern,Subcutaneous Nodular Fasciitis,0
1498,Ganglioneuroblastoma Component Present,Glioblastoma with Primitive Neuronal Component,0
1499,Lesion Less than 5mm in Diameter,Metastatic Malignant Neoplasm in the Sellar Region,0
1500,Acinar Cell Differentiation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1501,Perivascular Lymphocytic Infiltrate,Stage B Chronic Lymphocytic Leukemia,0
1502,Non-Contiguous Disease,Multi-centric Castleman's Disease,0
1503,Prominent Intraductal Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
1504,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1505,Hypokalemia,Adenocarcinoma with squamous metaplasia,0
1506,Vater-Pacini Corpuscles-Like Structures Present,Adenocarcinoma with squamous metaplasia,0
1507,Hemosiderin pigmentation,Malignant neoplasm of stomach recurrent,0
1508,BCR/ABL1 Fusion Negative,Occult Lung Cancer AJCC v8,0
1509,Diffuse Lesion,Diffuse Lipomatosis,0
1510,Microglandular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1511,S-100-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1512,Antoni B Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1513,Sarcomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
1514,Progressive Disease,Localized Castleman Disease,0
1515,Meckel Diverticulum,Occult Lung Cancer AJCC v8,0
1516,Pain,Pseudolymphoma,0
1517,Annular Tubules Present,Malignant neoplasm of stomach recurrent,0
1518,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
1519,Moderate cytologic atypia,Occult Lung Cancer AJCC v8,0
1520,Decreased platelet count,Occult Lung Cancer AJCC v8,0
1521,Plexiform Vasculature Present,Plexiform Neurofibroma,0
1522,Gyriform Trabecular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1523,Macronodular adrenal hyperplasia,Endometrial cystic hyperplasia,0
1524,Enterochromaffin-Like Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
1525,Thick-Walled Hyalinized Vessels Present,Malignant neoplasm of stomach recurrent,0
1526,Blasts Expressing CD56 and Immature T-Cell Markers Present,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
1527,Generalized Dysplasia,Acute Generalized Exanthematous Pustulosis,0
1528,Blasts 10-19 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
1529,No Identifiable Line of Differentiation,Recurrent tumors of the Ewing's family,0
1530,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Bone Marrow Transplantation Nephropathy,0
1531,Proliferation of Small Ducts Present,T-Cell Proliferation of Uncertain Malignant Potential,0
1532,Progressive Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
1533,Abnormal alveolar pattern,Occult Lung Cancer AJCC v8,0
1534,Below the Diaphragm Disease,Paget Disease of the Anus,0
1535,Cicatrix,Pseudolymphoma,0
1536,Large Neoplastic Glands with Branching and Papillary Infolding Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
1537,Rarely Metastasizing Lesion,Reactive Cutaneous Fibrous Lesion,0
1538,Infantile Lesion,Infantile digital fibromatosis,0
1539,Submucosal Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
1540,Schwannian Stroma More than 50 Percent of the Tumor Volume,Multinodular and Vacuolated Tumor of the Cerebrum,0
1541,Spontaneous Regression,Occult Lung Cancer AJCC v8,0
1542,Lepidic Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1543,Neuroectodermal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1544,Carcinomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
1545,Human Papillomavirus Positive,Recurrent Human Papillomavirus-Related Malignant Neoplasm,0
1546,Non-Invasive Lesion,Reactive Cutaneous Fibrous Lesion,0
1547,Seizures,Adenocarcinoma with squamous metaplasia,0
1548,Cytologic atypia,Complex endometrial hyperplasia without atypia,0
1549,Severe cytologic atypia,Severe pre-eclampsia,0
1550,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,Acute Myeloid Leukemia with Variant MLL Translocations,0
1551,Blasts of Mixed Phenotype Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,0
1552,Microcystic Change,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1553,Blasts Under 10 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
1554,Syncytial Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1555,Koilocytotic atypia,Adenocarcinoma with squamous metaplasia,0
1556,Cafe-au-Lait Spots,Adenocarcinoma with squamous metaplasia,0
1557,Melanosomes Present,Adenocarcinoma with squamous metaplasia,0
1558,Breast Microcalcification,Papillary Ductal Breast Hyperplasia,0
1559,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
1560,Borderline Lesion,Reactive Cutaneous Fibrous Lesion,0
1561,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1562,Urine phosphorous concentration above normal,Malignant neoplasm of stomach recurrent,0
1563,Blasts Under 5 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
1564,Mucocele of appendix,Carcinoid tumor of appendix,0
1565,Osseous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
1566,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1567,Broad Fibrous Bands Formation,Reactive Cutaneous Fibrous Lesion,0
1568,Sinusoidal Vascular Channel Formation,Radiation-Induced Vascular Disease,0
1569,Enterochromaffin Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
1570,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
1571,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Malignant neoplasm of stomach recurrent,0
1572,effusion,Malignant neoplasm of stomach recurrent,0
1573,Bile Pigment Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
1574,Loss of INI 1 Protein Expression,Malignant neoplasm of stomach recurrent,0
1575,Neoplastic Plasma Cells Present in Bone Marrow,Prostate Carcinoma Metastatic in the Bone,0
1576,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
1577,Multifocal Unisystem Disease,Erdheim-Chester Disease,0
1578,Absence of Invasion,Ampulla of Vater Mucinous Adenocarcinoma,0
1579,Benzene Exposure,Malignant neoplasm of stomach recurrent,0
1580,Pseudoglandular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1581,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
1582,Precocious Puberty,Occult Lung Cancer AJCC v8,0
1583,Multinodular Mass,Malignant neoplasm of stomach recurrent,0
1584,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Erosive Adenomatosis of the Nipple,0
1585,Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
1586,Tissue Differentiation Uncertain,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1587,Presence of a Hormonal Syndrome,Recurrent tumors of the Ewing's family,0
1588,Vacuolated Plasma Cells in the Bone Marrow,Breast Carcinoma Metastatic in the Bone,0
1589,Ground Glass Nuclear Inclusion,Malignant neoplasm of stomach recurrent,0
1590,Prominent Squamous Eddies Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,0
1591,Dentin formation,Pseudolymphoma,0
1592,Keratin pearl formation,Occult Lung Cancer AJCC v8,0
1593,Complete Spontaneous Regression,Occult Lung Cancer AJCC v8,0
1594,Monoclonal Paraproteinemia,Monoclonal Gammopathy of Undetermined Significance,0
1595,Cellular Pleomorphism,Cellular neurothekeoma,0
1596,Plexiform Vasculature Present,Plexiform Neurofibroma,0
1597,Blasts Expressing CD56 and Immature T-Cell Markers Present,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
1598,Castration Resistance,Pseudolymphoma,0
1599,Follicular Cell Differentiation,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,0
1600,Defective Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
1601,Cytoplasmic Accumulation of Black Pigment,Ampulla of Vater Mucinous Adenocarcinoma,0
1602,Primary Site Unknown,Primary Carcinoma Unspecified Site,0
1603,Nuclear Clearing,Malignant neoplasm of stomach recurrent,0
1604,Pautrier-Like Microabscess Present,Adenocarcinoma with squamous metaplasia,0
1605,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of nasopharynx,0
1606,Lobulated Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1607,Multilocular Lesion,Reactive Cutaneous Fibrous Lesion,0
1608,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Spindle cell nevus of Reed,0
1609,Nuclear Pseudoinclusion,Occult Lung Cancer AJCC v8,0
1610,Histiocytosis haematophagic,Pulmonary Histiocytosis X,0
1611,Well Differentiated Neuroendocrine Lesion,Pleural Well Differentiated Papillary Mesothelioma,0
1612,Rarely Metastasizing Lesion,Pre-Malignant Skin Epithelial Lesion,0
1613,Poorly Differentiated Neuroendocrine Lesion,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
1614,Retiform Structures Comprise 90% or More of the Tumor,Multinodular and Vacuolated Tumor of the Cerebrum,0
1615,Lesion Less than 10mm in Diameter,Colon Carcinoma Metastatic in the Liver,0
1616,Immunoglobulin Deposition,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
1617,Bilateral Mass,Bilateral Optic Nerve Meningioma,0
1618,Chronic Inflammatory Infiltrate,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0
1619,Nuclear Clearing,Adenocarcinoma with squamous metaplasia,0
1620,Fenestrated Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1621,Primary Lesion,Primary cutaneous diffuse large cell B-cell lymphoma,0
1622,Blue Bone Formation,Stage IB Bone Sarcoma AJCC v7,0
1623,Concentric Perivascular Arrangement of Tumor Cells,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
1624,Cutaneous plaque,Cutaneous neurofibroma,0
1625,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1626,Slit-Like Stromal Retraction Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
1627,Insular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1628,Chromogranin A Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1629,Polymorphic Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
1630,Tobacco Toxicity,Adenocarcinoma with squamous metaplasia,0
1631,Complete Spontaneous Regression,Complete hydatidiform mole,0
1632,Pancytopenia,Adenocarcinoma with squamous metaplasia,0
1633,Intramucosal Lesion,Reactive Cutaneous Fibrous Lesion,0
1634,Giant Mitochondria Present,Giant Hemangioma,0
1635,Melanin-Forming Neuroepithelial Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1636,Thrombocytosis,Malignant neoplasm of stomach recurrent,0
1637,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1638,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
1639,Immature Granulocytes in Peripheral Blood Increased,Intermediate Blood Vessel Neoplasm,0
1640,Lipomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
1641,Hyperplastic Tissue Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
1642,Peau d'orange surface of breast,malignant myoepithelioma of breast,0
1643,Extramedullary Hematopoiesis (disorder),Funisitis (disorder),0
1644,Abnormal alveolar pattern,Adenocarcinoma with squamous metaplasia,0
1645,Organoid Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1646,Beaded Anastomosing Cords Present,Occult Lung Cancer AJCC v8,0
1647,Myxoid Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
1648,Multinodular Pattern,Multinodular and Vacuolated Tumor of the Cerebrum,0
1649,Drug Exposure,Pseudolymphoma,0
1650,Monoclonal Paraproteinemia,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0
1651,Tumor Droplets Present,Malignant Gastric Granular Cell Tumor,0
1652,Rarely Metastasizing Lesion,Metastasizing Pleomorphic Adenoma of the Salivary Gland,0
1653,"Nodular, Reticulin-Free Zones Present",Pseudolymphoma,0
1654,Parakeratosis,Adenocarcinoma with squamous metaplasia,0
1655,Solar Radiation Toxicity,Solar lentigo,0
1656,HMB-45-Positive Neoplastic Cells Present,Neoplastic Polyp,0
1657,Insular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1658,Nuclei of Various Sizes and Shapes Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1659,bone marrow fibrosis,benign fibrous histiocytoma of bone,0
1660,Neoplastic Plasma Cells Present in Bone Marrow,Osteosarcoma Arising in Paget Disease of Bone,0
1661,Rare Lesion,Primary Melanocytic Lesion of Meninges,0
1662,Diarrhea,Malignant neoplasm of stomach recurrent,0
1663,Focal Pattern,Focal Segmental Glomerulosclerosis Collapsing Variant,0
1664,Lytic lesion,Proliferative dermal lesion in congenital nevus,0
1665,Monoclonal Cellular Population Present,Cellular neurothekeoma,0
1666,Absence of Basal Cell Layer,Columnar Cell Change of the Breast with Atypia,0
1667,Myomatous Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
1668,Crooke Hyaline Change,Adenocarcinoma with squamous metaplasia,0
1669,Multicentric Lesion,Pre-Malignant Skin Epithelial Lesion,0
1670,Solitary Skin Tumor,Peritoneal Solitary Fibrous Tumor,0
1671,Sarcomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
1672,Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1673,Obesity,Malignant neoplasm of stomach recurrent,0
1674,Human Papillomavirus Negative,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
1675,Lesion with Diameter Greater than 2cm,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,0
1676,Sebaceous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1677,Bone marrow reticulin fibrosis,Stage IB Bone Sarcoma AJCC v7,0
1678,Hemorrhagic,Occult Lung Cancer AJCC v8,0
1679,Anastomosing Strands of Tumor Cells Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
1680,Epithelial hyperplasia of skin,Squamous cell carcinoma of skin,0
1681,Nuclear Expression of STAT6 Protein,Malignant neoplasm of stomach recurrent,0
1682,Plexiform Vasculature Present,Chest Wall Plexiform Fibrohistiocytic Neoplasm,0
1683,Swelling,Adenocarcinoma with squamous metaplasia,0
1684,Misplaced Exocytosis Present,Adenocarcinoma with squamous metaplasia,0
1685,Monoclonal Eosinophils Present,Monoclonal Gammopathy of Renal Significance,0
1686,Massive Sinusoidal Histiocytic Infiltrate,Histiocytic sarcoma,0
1687,Blasts 5-19 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
1688,Skin Erosion,Pre-Malignant Skin Epithelial Lesion,0
1689,Retiform Structures Comprise 90% or More of the Tumor,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
1690,Epidermal Involvement,Adenocarcinoma with squamous metaplasia,0
1691,Increased Cellularity Present,Adult Mixed Cellularity Classical Hodgkin Lymphoma,0
1692,Well Developed Rough Endoplasmic Reticulum Present,Well Differentiated Adrenal Cortex Carcinoma,0
1693,Neutral Epithelial Mucin Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
1694,Blasts 10-19 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
1695,"Amorphus, Eosinophilic, and Acellular Deposit",Gastric Body Carcinoma In Situ AJCC v6 and v7,0
1696,Ectopic Thyroid Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
1697,Non-Encapsulated Neoplasm,Primary Malignant Liver Neoplasm,0
1698,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1699,Metaplasia of Malignant Cells Present,Malignant neoplasm of nasopharynx,0
1700,Schwannian Stroma More than 50 Percent of the Tumor Volume,Multinodular and Vacuolated Tumor of the Cerebrum,0
1701,Peribronchial Proliferation of Neoplastic Cells Present,B-Cell Proliferation of Uncertain Malignant Potential,0
1702,Ependymal Differentiation,Ventricular and Brain Stem Ependymal Tumor,0
1703,Photosensitivity of skin,Melanocytic nevus of skin,0
1704,Stromal Invasion,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
1705,Multilineage Dysplasia Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
1706,Fever,Pseudolymphoma,0
1707,Fibrovascular Stalks Present,Adenocarcinoma with squamous metaplasia,0
1708,Bile Pigment Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,0
1709,Beaded Anastomosing Cords Present,Occult Lung Cancer AJCC v8,0
1710,Blasts Expressing B-Lymphoid and Myeloid Markers Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1711,Necrotic changes (finding),Occult Lung Cancer AJCC v8,0
1712,Myxoid Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
1713,Non Lipogenic Sarcomatous Stroma Present,Gastric Carcinoma with Lymphoid Stroma,0
1714,Borderline Lesion,Pre-Malignant Skin Epithelial Lesion,0
1715,Cytokeratin Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
1716,Extranodal Extension,Extranodal marginal zone B-cell lymphoma (MALT type) stage II,0
1717,Tumor Mass,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1718,Vacuolated Plasma Cells in the Bone Marrow,Colorectal Carcinoma Metastatic in the Liver,0
1719,Black Discoloration,Malignant neoplasm of stomach recurrent,0
1720,Systemic disease,Crohn's disease of large bowel,0
1721,Cellular Pseudostratification,Uterine Corpus Cellular Leiomyoma,0
1722,Decreased platelet count,Adenocarcinoma with squamous metaplasia,0
1723,Generalized Dysplasia,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
1724,Platinum Resistance,Adenocarcinoma with squamous metaplasia,0
1725,Defective Gamma Heavy Chain Present,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
1726,Neuronal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1727,Diffuse Pattern,Diffuse Lipomatosis,0
1728,Chondromyxoid Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
1729,Composite Lesion,Primary Melanocytic Lesion of Meninges,0
1730,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,0
1731,Chronic lymphocytic inflammation,Chronic lymphocytic leukemia stage 2,0
1732,Finding related to pregnancy,Metastatic malignant neoplasm to nasopharynx,0
1733,Multinodular and Vacuolated Pattern,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1734,Sarcomatoid Features,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",0
1735,Proliferation of High Endothelial Venules Present,T-Cell Proliferation of Uncertain Malignant Potential,0
1736,Crooke Hyaline Change,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,0
1737,Hypertensive disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
1738,Enterochromaffin Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
1739,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Squamous cell carcinoma of head and neck metastatic,0
1740,Elastin Fibers Present,Pseudolymphoma,0
1741,Thin-Branching Papillae Present,Occult Lung Cancer AJCC v8,0
1742,Breast Implant-Related Lesion,Breast Phyllodes Tumor,0
1743,"Adenocarcinoma, intestinal type",intestinal type adenocarcinoma of gallbladder,0
1744,Extensive Stage Lesion,Stage IB Uterine Corpus Cancer AJCC v7,0
1745,Well Differentiated Neuroendocrine Lesion,Pleural Well Differentiated Papillary Mesothelioma,0
1746,Antoni B Pattern,Stage B Chronic Lymphocytic Leukemia,0
1747,Polyvesicular Vitelline Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1748,Lytic lesion,Angiocentric immunoproliferative lesion grade 2,0
1749,Spontaneous Regression,Adenocarcinoma with squamous metaplasia,0
1750,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Recurrent tumors of the Ewing's family,0
1751,Microglandular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1752,Defective Mu Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
1753,Cytokeratin Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
1754,Monoclonal Paraproteinemia,Monoclonal B-Cell Lymphocytosis,0
1755,Neuronal Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
1756,Basal Cells with Pale Cytoplasm Present,Testicular Seminoma with Syncytiotrophoblastic Cells,0
1757,Keratin pearl formation,Adenocarcinoma with squamous metaplasia,0
1758,Philadelphia chromosome negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
1759,Staghorn Configuration,Adenocarcinoma with squamous metaplasia,0
1760,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1761,Pseudoencapsulated Mass,Adenocarcinoma with squamous metaplasia,0
1762,Platinum Sensitivity,Occult Lung Cancer AJCC v8,0
1763,Minimally Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
1764,Insular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1765,Broad Fibrous Bands Formation,Broad Ligament Serous Cystadenofibroma,0
1766,Acinar Pattern,Acinar cell cystadenocarcinoma,0
1767,Hereditary Lesion,Reactive Cutaneous Fibrous Lesion,0
1768,Low Grade Neuroendocrine Lesion,Low Grade Lung Neuroendocrine Neoplasm,0
1769,Ganglioneuroma Component Present,Ganglioneuroma of skin,0
1770,Lymphoplasmacytic Infiltrate,Malignant neoplasm of stomach recurrent,0
1771,Presence of a Hormonal Syndrome,"Benign neoplasm of brain, unspecified",0
1772,Cellular Pleomorphism,Ovarian Cellular Fibroma,0
1773,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
1774,Plexiform Vasculature Present,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas",0
1775,Diarrhea,Occult Lung Cancer AJCC v8,0
1776,Lesion Less than 10mm in Diameter,Metastatic Malignant Neoplasm in the Sellar Region,0
1777,Lesion with Diameter of 5cm or Less,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
1778,Neutral Epithelial Mucin Present,Tubal Epithelial Hyperplasia,0
1779,Delicate Vascular Network Formation,Benign Cutaneous Vascular Neoplasm,0
1780,Hemorrhagic,Occult Lung Cancer AJCC v8,0
1781,Steatohepatitis,Adenocarcinoma with squamous metaplasia,0
1782,Lipomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
1783,Dedifferentiated Malignant Infiltrate,Malignant neoplasm of stomach recurrent,0
1784,Intraductal Lesion,Pre-Malignant Skin Epithelial Lesion,0
1785,"Undifferentiated ""Fetal-Type"" Tissues Present",Endometrial Undifferentiated Carcinoma,0
1786,Bilateral Mass,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
1787,Positive Axillary Lymph Node,Palisaded Lymph Node Myofibroblastoma,0
1788,Low Cellularity Present,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
1789,Tobacco Chewing Toxicity,Occult Lung Cancer AJCC v8,0
1790,Human Papillomavirus Negative,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
1791,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Ampulla of Vater Mucinous Adenocarcinoma,0
1792,Immunologic Deficiency Syndromes,Malignant neoplasm of stomach recurrent,0
1793,Hyperplastic Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
1794,Primary Site Unknown,Primary Carcinoma Unspecified Site,0
1795,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1796,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Ampulla of Vater Tubular Adenoma,0
1797,Bone marrow reticulin fibrosis,Unresectable Bone Sarcoma,0
1798,Macrotrabecular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1799,Acral Lesion,Acral Skin Nevus,0
1800,Anaplasia,Adenocarcinoma with squamous metaplasia,0
1801,Trabecular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1802,Bone Marrow Lymphoplasmacytic Infiltrate,Unresectable Bone Sarcoma,0
1803,Generalized Dysplasia,Large Cell Dysplasia,0
1804,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
1805,High Plasma Renin Activity,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
1806,Drug Exposure,Malignant neoplasm of stomach recurrent,0
1807,Entrapped Respiratory Epithelium Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
1808,Regional Disease,Erdheim-Chester Disease,0
1809,Adnexal Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
1810,Sinusoidal Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1811,Platinum Sensitivity,Malignant neoplasm of stomach recurrent,0
1812,Inoperable Disease,Chronic Bullous Disease of Childhood,0
1813,Diffuse Cellular Infiltrate,Cellular neurothekeoma,0
1814,Metastatic/Recurrent Disease,Erdheim-Chester Disease,0
1815,Steatohepatitis,Pseudolymphoma,0
1816,Bone marrow depression,Bone marrow hyperplasia,0
1817,Squamoid Corpuscle,Malignant neoplasm of stomach recurrent,0
1818,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1819,Non-Encapsulated Neoplasm,Intermediate Blood Vessel Neoplasm,0
1820,Tumor Vascular Invasion,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1821,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
1822,Sebaceous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1823,Radiation Sickness,Adenocarcinoma with squamous metaplasia,0
1824,Above the Diaphragm Disease,Paget Disease of the Scrotum,0
1825,Collagenous Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
1826,Recurrent Genetic Abnormalities Present,Recurrent Gliosarcoma,0
1827,Photosensitivity of skin,Squamous cell carcinoma of skin,0
1828,Vertical Growth Phase,Growth Hormone-Producing Pituitary Gland Neoplasm,0
1829,Fibrovascular Septa Present,Giant Fibrovascular Esophageal Polyp,0
1830,Reinke Crystals Formation,Malignant neoplasm of stomach recurrent,0
1831,bone marrow fibrosis,Secondary malignant neoplasm of bone marrow,0
1832,Glomerular Hypertrophy,Pseudolymphoma,0
1833,Cervical lymphadenopathy,Locally Advanced Unresectable Cervical Adenocarcinoma,0
1834,High Plasma Renin Activity,Refractory High Risk Myelodysplastic Syndrome,0
1835,Desmoplastic Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
1836,Dilated Cystic Spaces Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
1837,Sarcomatoid Features,Thymic Sarcomatoid Carcinoma,0
1838,IDH Gene Family Mutation Status Unknown,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,0
1839,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
1840,Intracytoplasmic Eosinophilic Spherical Inclusion,Eosinophilic Granuloma,0
1841,Mixture of Germ Cell Neoplastic Components Present,Childhood Malignant Ovarian Germ Cell Tumor,0
1842,Atypical Lymphocytes Present in Peripheral Blood,Intermediate Atypical Prostate Carcinoma,0
1843,Defective Gamma Heavy Chain Present,Heavy Chain Deposition Disease,0
1844,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Spindle Cell Oncocytoma of the Adenohypophysis,0
1845,Dermal Nodule,Benign Dermal Schwannoma,0
1846,Recurrent Genetic Abnormalities Present,Recurrent Gliosarcoma,0
1847,Cartilaginous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
1848,Rapidly Enlarging Mass,Occult Lung Cancer AJCC v8,0
1849,Infiltrative Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1850,Increased NFkappaB Pathway Activation,Adenocarcinoma with squamous metaplasia,0
1851,Lipomatous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1852,NRBC - Nucleated red blood cell present result,Atypical fibroxanthoma - spindle cell type,0
1853,Nuclear Molding,Adenocarcinoma with squamous metaplasia,0
1854,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of lacrimal duct,0
1855,VIP Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1856,Perivascular Arrangement of Tumor Cells,Ampulla of Vater Neuroendocrine Tumor,0
1857,Philadelphia chromosome negative,"Anaplastic large cell lymphoma, ALK negative",0
1858,Lymphocyte count increased,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1859,Bile Pigment Present,Bile duct cystadenocarcinoma,0
1860,Acute inflammation,Acute biphenotypic leukemia,0
1861,Curvilinear Thin-Walled Vascular Pattern,Vascular neoplasm of skin,0
1862,Large Neoplastic Glands with Branching and Papillary Infolding Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
1863,Hyperchromatism,Malignant neoplasm of stomach recurrent,0
1864,Poikilocytosis,Occult Lung Cancer AJCC v8,0
1865,Positive Axillary Lymph Node,Breast Carcinoma Metastatic in Lymph Node,0
1866,Monoclonal Cellular Population Present,Uterine Corpus Cellular Leiomyoma,0
1867,Solitary Skin Tumor,Pleural Solitary Fibrous Tumor,0
1868,Thin-Walled Branching Vascular Pattern,Vascular neoplasm of skin,0
1869,Architectural Distortion,Pseudolymphoma,0
1870,Limited Early T-Cell Differentiation,Early gastric cancer,0
1871,Chronic Clinical Course,Hodgkin Lymphoma by Clinical Course,0
1872,Mild dysplasia of colon,Adenomatous polyp of colon,0
1873,Transformed Phase of Disease,Paget Disease of the Anus,0
1874,Gyriform Trabecular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1875,Multinodular Mass,Multinodular and Vacuolated Tumor of the Cerebrum,0
1876,Ganglion Cell-Like Elements Present,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0
1877,Pagetoid Proliferation,Pagetoid reticulosis,0
1878,Immature Myeloid Cells Increased in Bone Marrow,Prostate Carcinoma Metastatic in the Bone,0
1879,Pseudoencapsulated Mass,Adenocarcinoma with squamous metaplasia,0
1880,Parakeratosis,Pseudolymphoma,0
1881,Swelling,Adenocarcinoma with squamous metaplasia,0
1882,Intravascular Fibrin Thrombus Formation,Central Nervous System Intravascular Large B-Cell Lymphoma,0
1883,Absence of Stromal Invasion,Low Grade Endometrioid Stromal Sarcoma of the Vagina,0
1884,Lepidic Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
1885,Focal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1886,Granuloma,Granuloma annulare aggravated,0
1887,Prominent Intraductal Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
1888,Venous Type Vascular Channel Formation,Intermediate Cell Type Ciliary Body Melanoma,0
1889,Nodular lesions,Nodular fasciitis,0
1890,Abnormal Eosinophilic Granules Present,Eosinophilic Granuloma,0
1891,Parakeratosis,Occult Lung Cancer AJCC v8,0
1892,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1893,Nuclear Grooves,Malignant neoplasm of stomach recurrent,0
1894,Primary Lesion,Primary cutaneous diffuse large cell B-cell lymphoma,0
1895,Mallory Bodies,Pseudolymphoma,0
1896,Melanin-Pigmented Dendritic Cells Present,Tumors Derived from Langerhans Cells,0
1897,Peripheral Blood Involvement,Peripheral Intraneural Angiosarcoma,0
1898,Pain,Occult Lung Cancer AJCC v8,0
1899,Synchronous Lesion,Reactive Cutaneous Fibrous Lesion,0
1900,Thrombocytosis,Adenocarcinoma with squamous metaplasia,0
1901,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Lung Neuroendocrine Neoplasm,0
1902,Coughing,Adenocarcinoma with squamous metaplasia,0
1903,No Identifiable Line of Differentiation,Benign Soft Tissue Tumor of Uncertain Differentiation,0
1904,Ischemia,Adenocarcinoma with squamous metaplasia,0
1905,Congenital Lesion,Pre-Malignant Skin Epithelial Lesion,0
1906,Intracytoplasmic Eosinophilic Inclusion,Childhood Acute Eosinophilic Leukemia,0
1907,Low Cellularity Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
1908,Metaplasia,Breast Carcinoma with Chondroid Metaplasia,0
1909,Lamellar Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1910,Loss of INI 1 Protein Expression,Recurrent tumors of the Ewing's family,0
1911,Absence of Basal Cell Layer,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
1912,Pseudopapillary Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1913,Trabecular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1914,White blood cell count increased (lab result),Ovarian germ cell choriocarcinoma stage I,0
1915,Seminomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
1916,Cystic Lesion,Cystic Neoplasm,0
1917,Hydropic Villous Change,Villous adenoma of colon,0
1918,Dense Intercellular Reticulin Network Present,Pseudolymphoma,0
1919,Rimming of Adipose Tissue Cells Present,Clear Cell Sarcoma of Soft Tissue,0
1920,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1921,Tall Papillae Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0
1922,Progressive Clinical Course,Non-Hodgkin Lymphoma by Clinical Course,0
1923,Hereditary Lesion,Pre-Malignant Skin Epithelial Lesion,0
1924,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1925,Less than 2 Mitoses per 10HPF,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,0
1926,Congenital Abnormality,Congenital Vena Cava Abnormality,0
1927,VIP Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1928,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Osteosarcoma Arising in Paget Disease of Bone,0
1929,Hypokalemia,Adenocarcinoma with squamous metaplasia,0
1930,Peribronchial and Lobular Septal Involvement Only,Invasive Ductal and Lobular Carcinoma,0
1931,Matrical Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
1932,Cytoplasmic Membrane-Bound Granules Present,Pseudolymphoma,0
1933,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1934,Chromogranin A Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1935,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Bone Marrow Transplantation Nephropathy,0
1936,Blue Bone Formation,Cellular Blue Nevus,0
1937,Non-Invasive Lesion,Reactive Cutaneous Fibrous Lesion,0
1938,Cellular Pleomorphism,Cellular neurothekeoma,0
1939,Severe dysplasia,Severe pre-eclampsia,0
1940,Reactive Germinal Centers Present,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0
1941,Thin-Walled Branching Vascular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1942,Nested Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1943,Cryptitis,Adenocarcinoma with squamous metaplasia,0
1944,Islands of Neuropil-Like Matrix Present,Malignant neoplasm of stomach recurrent,0
1945,Angioinvasion,Occult Lung Cancer AJCC v8,0
1946,Low Cellularity Present,Classical Low Grade Fibromyxoid Sarcoma,0
1947,Metastatic/Recurrent Disease,Multi-centric Castleman's Disease,0
1948,Intravascular Spread,Central Nervous System Intravascular Large B-Cell Lymphoma,0
1949,Peau d'orange surface of breast,Usual ductal hyperplasia of breast,0
1950,Non-Malignant Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
1951,Intracanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1952,Architectural Distortion,Adenocarcinoma with squamous metaplasia,0
1953,Cavernous Lymphatic Space Formation,Cavernous hemangioma of the face,0
1954,Neuroectodermal Differentiation,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
1955,Localized Hydropic Villous Change,Localized Unresectable Neuroblastoma,0
1956,Dysplastic Dentin Formation,Vulvar Dysplastic Melanocytic Nevus,0
1957,Marked Bone Marrow Fibrosis,Stage IB Bone Sarcoma AJCC v7,0
1958,Splenomegaly,Pseudolymphoma,0
1959,Confluent Sheets of Neoplastic B-Lymphocytes Present,Ampulla of Vater Mucinous Adenocarcinoma,0
1960,Trichoblastic Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
1961,Blastemal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1962,Proliferation of Small Ducts Present,Small cell carcinoma of esophagus,0
1963,Carcinomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
1964,Glomeruloid Vessels Present,Leiomyosarcoma of Vessels,0
1965,Fascicles of Spindly Tumor Cells Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
1966,Cystic Lesion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
1967,Multiple Tumor Masses,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
1968,Lesion with Diameter Greater than 15mm,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1969,Extraocular Dissemination of Disease,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
1970,Diffuse Immunoblastic Proliferation,Refractory Diffuse Intrinsic Pontine Glioma,0
1971,Herringbone Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
1972,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
1973,Borderline Lesion,Pre-Malignant Skin Epithelial Lesion,0
1974,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
1975,Thin Bands of Collagen Present,Recurrent tumors of the Ewing's family,0
1976,Nuclear Atypia,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
1977,Lesion with Diameter of 2cm or Less,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
1978,Slit-Like Vascular Channel Formation,Malignant Vascular Neoplasm,0
1979,CD1a-Positive Neoplastic Cells Present,Neoplastic Polyp,0
1980,Decreased platelet count,Pseudolymphoma,0
1981,Glandular metaplasia,Cervical Glandular Neoplasm,0
1982,Pseudostratified Columnar Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
1983,Blue Bone Formation,Cellular Blue Nevus,0
1984,Lymphocyte count increased,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1985,Junctional Proliferation,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
1986,Biphasic Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1987,Focal dysplasia,Focal Segmental Glomerulosclerosis Collapsing Variant,0
1988,Intraepithelial Neoplasia,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
1989,Pagetoid Proliferation,T-Cell Proliferation of Uncertain Malignant Potential,0
1990,Mature Neutrophils Present,Sellar Mature Teratoma,0
1991,Breast Implant-Related Lesion,Prognostic Stage IA Breast Cancer AJCC v8,0
1992,Lamellar Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1993,Diffuse Lesion,Diffuse Lipomatosis,0
1994,Inconspicuous Syncytiotrophoblastic Cell Component,Transplant-Related Renal Cell Carcinoma,0
1995,Mild dysplasia,Gastric dysplasia,0
1996,Cryptitis,Malignant neoplasm of stomach recurrent,0
1997,Somatostatin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1998,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
1999,Intracytoplasmic Eosinophilic Spherical Inclusion,Childhood Acute Eosinophilic Leukemia,0
2000,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2001,Mammary Gland Type Features Present,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
2002,Cystic Lesion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
2003,Dilated Cystic Spaces Present,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,0
2004,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
2005,Precocious Puberty,Malignant neoplasm of stomach recurrent,0
2006,Huge Vascular Channel Formation,Benign Cutaneous Vascular Neoplasm,0
2007,Single Malignant Cells Present,Malignant neoplasm of nasopharynx,0
2008,CDKN2A-p16 Negative,Occult Lung Cancer AJCC v8,0
2009,Epithelioid Differentiation,Breast Epithelioid Hemangioma,0
2010,Vater-Pacini Corpuscles-Like Structures Present,Adenocarcinoma with squamous metaplasia,0
2011,Varicosity,Adenocarcinoma with squamous metaplasia,0
2012,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
2013,Metaplasia of Malignant Cells Present,Malignant neoplasm of lacrimal duct,0
2014,Epithelioid Differentiation,Adult Epithelioid Hemangioendothelioma,0
2015,Poorly Differentiated Neuroendocrine Lesion,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
2016,Lipomatous Metaplasia,Intestinal Metaplasia of Bladder Urothelium,0
2017,Marked Thickening of the Bladder Urothelium Present,Intestinal Metaplasia of Bladder Urothelium,0
2018,Microcystic Change,Microcystic meningioma,0
2019,Subcutaneous nodule,Subcutaneous Nodular Fasciitis,0
2020,Immunoglobulin Light Chain Deposition,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2021,Spindle Cell Component Present,Spindle Cell Melanoma,0
2022,Slit-Like Vascular Channel Formation,Malignant Vascular Neoplasm,0
2023,Fenestrated Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2024,Perineural spread,Malignant neoplasm of stomach recurrent,0
2025,Two Separate Tumor Masses Present in the Same Organ,Lung Carcinoma Metastatic in the Liver,0
2026,Skin nodule,Pre-Malignant Skin Epithelial Lesion,0
2027,Concentric Perivascular Arrangement of Tumor Cells,Multinodular and Vacuolated Tumor of the Cerebrum,0
2028,Primary Site Unknown,Primary Carcinoma Unspecified Site,0
2029,Parakeratinized Stratified Squamous Epithelium Present,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
2030,Pseudorosette Formation,Pseudolymphoma,0
2031,Koilocytotic atypia,Malignant neoplasm of stomach recurrent,0
2032,Hypocellular Tissue,Malignant Splenic Soft Tissue Neoplasm,0
2033,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
2034,Malignant Cellular Infiltrate,Cellular neurothekeoma,0
2035,Pushing Tumor Margin,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
2036,Local disease,Crohn's disease of large bowel,0
2037,Dense Collagenized Tissue Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
2038,Endobronchial Mass,Endobronchial Hamartoma,0
2039,Dentin formation,Malignant neoplasm of stomach recurrent,0
2040,Chronic Clinical Course,Non-Hodgkin Lymphoma with Variable Clinical Course,0
2041,Mixed Cellular Population,Testicular Mixed Embryonal Carcinoma and Seminoma,0
2042,Oligodendroglial Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
2043,Slit-Like Stromal Retraction Present,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
2044,High Mitotic Activity,Refractory High Risk Myelodysplastic Syndrome,0
2045,Refractory Disease,Steroid Refractory Graft Versus Host Disease,0
2046,Arborizing Vascular Channel Formation,Malignant Vascular Neoplasm,0
2047,Photosensitivity of skin,Squamous cell carcinoma of skin,0
2048,Non-Contiguous Disease,Chronic Bullous Disease of Childhood,0
2049,Positive Axillary Lymph Node,Palisaded Lymph Node Myofibroblastoma,0
2050,Tubular Structures Present,Small Intestinal Tubular Adenoma,0
2051,Inflammatory infiltrate,Inflammatory Breast Carcinoma,0
2052,Rarely Metastasizing Lesion,Pre-Malignant Skin Epithelial Lesion,0
2053,Neutral Epithelial Mucin Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
2054,Painless Mass,Pseudolymphoma,0
2055,Slow Growing Mass,Adenocarcinoma with squamous metaplasia,0
2056,Trichoblastic Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2057,Hot Nodule,Adenocarcinoma with squamous metaplasia,0
2058,Lymphatic Spread,Occult Lung Cancer AJCC v8,0
2059,Abundance of Small Lymphocytes,Small cell carcinoma of ovary,0
2060,Epidermotropic Lymphocytic Infiltrate,Stage B Chronic Lymphocytic Leukemia,0
2061,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
2062,Koilocytotic atypia,Adenocarcinoma with squamous metaplasia,0
2063,Proliferation of Small Ducts Present,B-Cell Proliferation of Uncertain Malignant Potential,0
2064,Complex Glandular Pattern,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2065,Nuclear Pseudoinclusion,Adenocarcinoma with squamous metaplasia,0
2066,Vertical Growth Phase,"Polycythemia Vera, Polycythemic Phase",0
2067,Extramedullary Hematopoiesis (disorder),Clonal Hematopoiesis of Indeterminate Potential,0
2068,Disease regression,Chronic Bullous Disease of Childhood,0
2069,Below the Diaphragm Disease,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
2070,effusion,Adenocarcinoma with squamous metaplasia,0
2071,Black Discoloration,Adenocarcinoma with squamous metaplasia,0
2072,Canalicular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2073,Questionable Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,0
2074,"Hyperkeratosis, Epidermolytic","Keratoderma, Palmoplantar, Epidermolytic",0
2075,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Benign Mixed Tumor of the Vulva,0
2076,Undifferentiated Lesion,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
2077,Eosinophilic inflammation,Diffuse large B-cell lymphoma associated with chronic inflammation,0
2078,Epithelioid Component Present,Epithelioid glioblastoma,0
2079,Chronic Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
2080,Tumor Vascular Invasion,Childhood Carcinoid Tumor,0
2081,Minimal Invasion Present,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
2082,Meckel Diverticulum,Occult Lung Cancer AJCC v8,0
2083,Cellular Changes Resembling Foveolar Epithelium Cells,Intestinal Metaplasia of Bladder Urachal Epithelium,0
2084,Peripheral Blood Involvement,Peripheral Intraneural Angiosarcoma,0
2085,Reinke Crystals Formation,Malignant neoplasm of stomach recurrent,0
2086,Pineocytomatous Rosette Formation,Pseudolymphoma,0
2087,Large Spaces Filled with Blood Present,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
2088,Transformed Phase of Disease,Chronic Bullous Disease of Childhood,0
2089,Epithelial hyperplasia of skin,Non-neoplastic nevus of skin,0
2090,Lipomatous Differentiation,Intermediate Lipomatous Neoplasm,0
2091,Hyalinized Vessels Present,Leiomyosarcoma of Vessels,0
2092,Parakeratinized Stratified Squamous Epithelium Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,0
2093,Villous atrophy,Vaginal Villous Adenoma,0
2094,Intra or Intercytoplasmic Lumina Present,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
2095,Prominent Elastic Tissue Cores Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
2096,Histiocytosis haematophagic,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
2097,Numerous Stromal Mast Cells Present,Stromal sarcoma,0
2098,Absence of Invasion of the Muscularis Externa,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
2099,Zonal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2100,Small Lesion,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,0
2101,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Squamous cell carcinoma of head and neck metastatic,0
2102,Plexiform Vasculature Present,Plexiform fibrohistiocytic tumor,0
2103,Tumor Droplets Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2104,Hyalinized Vessels Present,Malignant neoplasm of stomach recurrent,0
2105,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2106,Breast Implant-Related Lesion,Prognostic Stage IA Breast Cancer AJCC v8,0
2107,Perivascular Pseudorosette Formation,Adenocarcinoma with squamous metaplasia,0
2108,Exophytic Polypoid Lesion,Reactive Cutaneous Fibrous Lesion,0
2109,Epithelioid Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2110,Acinar Proliferation,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",0
2111,Preserved Nuclear Polarity,Occult Lung Cancer AJCC v8,0
2112,Cord-Like Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
2113,Hyperplastic Tissue Present,Malignant Splenic Soft Tissue Neoplasm,0
2114,Pain,Malignant neoplasm of stomach recurrent,0
2115,Whorling Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2116,Urine phosphorous concentration above normal,Occult Lung Cancer AJCC v8,0
2117,Intraluminal Necrosis,Malignant neoplasm of stomach recurrent,0
2118,Large Spaces Filled with Blood Present,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
2119,Whorling Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2120,Carcinomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
2121,Matrical Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2122,Malignant Cellular Infiltrate,Cellular neurothekeoma,0
2123,Above the Diaphragm Disease,Paget Disease of the Anus,0
2124,Well Differentiated Hyaline Cartilage Present,Well Differentiated Malignant Neoplasm,0
2125,Eccrine Differentiation,Eccrine dermal cylindroma,0
2126,Dilated Cystic Spaces Present,Cervical Adenoid Cystic Carcinoma,0
2127,Syncytial Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
2128,Lymphatic Spread,Adenocarcinoma with squamous metaplasia,0
2129,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Spindle Cell Oncocytoma of the Adenohypophysis,0
2130,Nuclear Atypia,Simple Endometrial Hyperplasia with Atypia,0
2131,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,0
2132,Intravascular papillary endothelial hyperplasia,Gallbladder papillary adenocarcinoma,0
2133,Lobulated Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2134,Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2135,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
2136,Bilateral Mass,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
2137,Deep Lesion,Deep seated dermatophytosis,0
2138,Striated Muscle Component Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
2139,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2140,Elastin Fibers Present,Pseudolymphoma,0
2141,Aggressive Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
2142,HER2/Neu Negative,Occult Lung Cancer AJCC v8,0
2143,Reactive Germinal Centers Present,Reactive systemic amyloidosis,0
2144,Seizures,Malignant neoplasm of stomach recurrent,0
2145,Sinusoidal Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2146,Fibrous Septa Present,Intracranial Benign Fibrous Histiocytoma,0
2147,Fever,Pseudolymphoma,0
2148,Monomorphic Cellular Infiltrate,Cellular neurothekeoma,0
2149,Favorable Clinical Outcome,Hodgkin Lymphoma by Clinical Course,0
2150,Smooth Muscle Component Present,Glioblastoma with Primitive Neuronal Component,0
2151,Hyperplastic Epithelial Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
2152,Islands of Odontogenic Epithelium Present,Ampulla of Vater Mucinous Adenocarcinoma,0
2153,Slit-Like Stromal Retraction Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
2154,Pseudoalveolar Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2155,Mixture of Germ Cell Neoplastic Components Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
2156,Nuclear Clearing,Malignant neoplasm of stomach recurrent,0
2157,Lytic lesion,Precancerous skin lesion,0
2158,Nodular lesions,Subcutaneous Nodular Fasciitis,0
2159,Nuclear pleomorphism,Occult Lung Cancer AJCC v8,0
2160,Dedifferentiated Malignant Infiltrate,Metastatic Extracranial Malignant Solid Neoplasm,0
2161,Poikilocytosis,Adenocarcinoma with squamous metaplasia,0
2162,Cartilaginous metaplasia,Adenocarcinoma with osseous metaplasia,0
2163,Monophasic Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2164,Moderate cytologic atypia,Colorectal Adenoma with Moderate Dysplasia,0
2165,Small Lesion,Stage IV Lung Small Cell Carcinoma AJCC v7,0
2166,Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
2167,Antoni A Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2168,Lepidic Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2169,Defective Mu Heavy Chain Present,Heavy Chain Deposition Disease,0
2170,C19MC Amplification,Adenocarcinoma with squamous metaplasia,0
2171,Absence of Invasion of the Muscularis Externa,Recurrent tumors of the Ewing's family,0
2172,Glandular Pattern,Cervical Glandular Neoplasm,0
2173,Chronic Phase of Disease,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
2174,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
2175,Progressive Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
2176,Fibrosarcomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
2177,Bone Marrow Eosinophilia,Unresectable Bone Sarcoma,0
2178,Poorly Differentiated Lesion,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
2179,Pre-existing condition,Adenocarcinoma with squamous metaplasia,0
2180,Epithelioid Differentiation,Breast Epithelioid Hemangioma,0
2181,Exophytic Papillary Lesion,Gastric Papillary Adenocarcinoma,0
2182,Bilateral Mass,Bilateral Carcinoma,0
2183,Drug toxicity,Adenocarcinoma with squamous metaplasia,0
2184,Cytologic atypia,Adenocarcinoma with squamous metaplasia,0
2185,Hyperchromatism,Malignant neoplasm of stomach recurrent,0
2186,Serum IgM Monoclonal Gammopathy of Less than 30g/L,Monoclonal Gammopathy of Renal Significance,0
2187,Parakeratinized Stratified Squamous Epithelium Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,0
2188,Multifocal Multisystem Disease,Multi-centric Castleman's Disease,0
2189,Plasma cell inflammation,Primary cutaneous diffuse large cell B-cell lymphoma,0
2190,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
2191,Myofibroblastic Differentiation,Abdominal Inflammatory Myofibroblastic Tumor,0
2192,Schwannian Stroma Predominant Component of the Tumor Volume,Malignant Mixed Tumor of the Major Salivary Gland,0
2193,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,0
2194,Indolent Clinical Course,Non-Hodgkin Lymphoma by Clinical Course,0
2195,Limited Early T-Cell Differentiation,Refractory T-Cell Prolymphocytic Leukemia,0
2196,Neuronal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2197,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2198,Localized Lesion,Pre-Malignant Skin Epithelial Lesion,0
2199,Crooke Hyaline Change,Columnar Cell Change of the Breast with Atypia,0
2200,Fibrosarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,0
2201,Vacuolated Plasma Cells in the Bone Marrow,Breast Carcinoma Metastatic in the Bone,0
2202,Dilated Thin-Walled Vascular Space Formation,Malignant Vascular Neoplasm,0
2203,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Ductal Breast Carcinoma In Situ,0
2204,Mesenchymal Metaplasia,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0
2205,Thick-Walled Hyalinized Vessels Present,Occult Lung Cancer AJCC v8,0
2206,Well Differentiated Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
2207,IDH Gene Family Mutation Status Unknown,Acute Myeloid Leukemia with FLT3/ITD Mutation,0
2208,Polymorphic Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
2209,Radiation Sickness,Adenocarcinoma with squamous metaplasia,0
2210,Fibrovascular Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
2211,Histiocytosis haematophagic,Pulmonary Histiocytosis X,0
2212,Metastatic/Recurrent Disease,Chronic Bullous Disease of Childhood,0
2213,Abnormal Eosinophilic Granules Present,Eosinophilic Granuloma,0
2214,Solar Radiation Toxicity,Solar lentigo,0
2215,Pale Eosinophilic Stroma Formation,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
2216,Cartilage-Like Elements Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",0
2217,Diarrhea,Malignant neoplasm of stomach recurrent,0
2218,Elastophagocytosis,Adenocarcinoma with squamous metaplasia,0
2219,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
2220,Acinar Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2221,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
2222,Osseous Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
2223,Desmoplastic Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
2224,Apocrine Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2225,Cervical Glandular Dysplasia,Cervical Warty Carcinoma,0
2226,Foveolar-Type Epithelium Present,Malignant Germinative Follicular Epithelium Neoplasm,0
2227,Pseudoglandular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2228,Mediastinal mass,Mediastinal Neuroblastoma,0
2229,Follicular Differentiation,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
2230,Tobacco Chewing Toxicity,Malignant neoplasm of stomach recurrent,0
2231,Intravascular papillary endothelial hyperplasia,Gallbladder papillary adenocarcinoma,0
2232,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
2233,Well-Circumscribed Lesion,Reactive Cutaneous Fibrous Lesion,0
2234,Eosinophil count raised (finding),Occult Lung Cancer AJCC v8,0
2235,Unicystic Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
2236,Cartilaginous metaplasia,adenocarcinoma of breast with spindle cell metaplasia,0
2237,"Hyperkeratosis, Epidermolytic",Adenocarcinoma with squamous metaplasia,0
2238,Nidus Formation,Pseudolymphoma,0
2239,Slow Growing Mass,Malignant neoplasm of stomach recurrent,0
2240,Psammoma Body Formation,Benign Carotid Body Paraganglioma,0
2241,Borderline Lesion,Reactive Cutaneous Fibrous Lesion,0
2242,Whorling Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2243,Lesion Less than 10mm in Diameter,Metastatic Malignant Neoplasm in the Sellar Region,0
2244,Gastric-Type Epithelial Differentiation,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
2245,Osteogenesis,Occult Lung Cancer AJCC v8,0
2246,Above the Diaphragm Disease,Paget Disease of the Anus,0
2247,Hydropic degeneration,Adenocarcinoma with squamous metaplasia,0
2248,Hypocellular Tissue,Clear Cell Sarcoma of Soft Tissue,0
2249,Glandular Differentiation,Glandular papilloma,0
2250,Lytic lesion,Cervical high grade squamous intraepithelial lesion,0
2251,Skin nodule,Pre-Malignant Skin Epithelial Lesion,0
2252,Bilateral Mass,Bilateral Optic Nerve Meningioma,0
2253,Marked Thickening of the Bladder Urothelium Present,Erosive Adenomatosis of the Nipple,0
2254,Squamous metaplasia,Adenocarcinoma with squamous metaplasia,0
2255,Dermal Nodule,Placental Site Nodule or Plaque,0
2256,Nuclear Atypia,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
2257,Neoplastic Growth or Spread,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
2258,Increased NFkappaB Pathway Activation,Adenocarcinoma with squamous metaplasia,0
2259,Anastomosing Cells Connected to the Basal Layer of the Epidermis Present,Recurrent tumors of the Ewing's family,0
2260,Platinum Resistance,Adenocarcinoma with squamous metaplasia,0
2261,Endodermal Sinus Pattern,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,0
2262,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
2263,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
2264,Cartilaginous Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
2265,Diffuse Cellular Infiltrate,Refractory Diffuse Intrinsic Pontine Glioma,0
2266,Rapidly Enlarging Mass,Malignant neoplasm of stomach recurrent,0
2267,Neutrophilia (finding),Malignant neoplasm of stomach recurrent,0
2268,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Giant Cell Tumor of Bone,0
2269,Recurrent Malignant Neoplasm,Recurrent Human Papillomavirus-Related Malignant Neoplasm,0
2270,Multifocal Lesion,Pre-Malignant Skin Epithelial Lesion,0
2271,Pregnancy Complications,Non-Hodgkin Lymphoma During Pregnancy,0
2272,Hot Nodule,Low Grade Liver Dysplastic Nodule,0
2273,Presence of a Hormonal Syndrome,Malignant neoplasm of stomach recurrent,0
2274,Cellular Pseudostratification,Ovarian Cellular Fibroma,0
2275,Lipomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
2276,Malignant Component Present,Metastatic Extracranial Malignant Solid Neoplasm,0
2277,Lymphocyte count increased,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2278,Prominent In Situ Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
2279,Mild cytologic atypia,Adenocarcinoma with squamous metaplasia,0
2280,Leukoerythroblastic Reaction,Pseudolymphoma,0
2281,Confluent Sheets of Anaplastic T-Lymphocytes Present,Ampulla of Vater Mucinous Adenocarcinoma,0
2282,Hydropic degeneration,Pseudolymphoma,0
2283,Epineurial Invasion,Occult Lung Cancer AJCC v8,0
2284,Recurrent Genetic Abnormalities Present,Recurrent Ampulla of Vater Adenocarcinoma,0
2285,Pain,Adenocarcinoma with squamous metaplasia,0
2286,Histiocytoid Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2287,Coughing,Adenocarcinoma with squamous metaplasia,0
2288,Therapy-Related Toxicity,Occult Lung Cancer AJCC v8,0
2289,Pseudo-Psammoma Body Formation,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
2290,Mucoid Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
2291,Chromogranin A Positive Neoplastic Cells Present,"Spindle cell melanoma, type A",0
2292,Mixture of Germ Cell Neoplastic Components Present,Childhood Malignant Ovarian Germ Cell Tumor,0
2293,No Identifiable Line of Differentiation,Malignant neoplasm of stomach recurrent,0
2294,Negative Peripheral Blood,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,0
2295,Slow Growing Mass,Occult Lung Cancer AJCC v8,0
2296,Dome-Shaped Lesion,Reactive Cutaneous Fibrous Lesion,0
2297,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Colorectal Carcinoma Metastatic in the Liver,0
2298,Questionable Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,0
2299,Skin Erosion,Transplant-Related Skin Squamous Cell Carcinoma,0
2300,Cambium Layer,Occult Lung Cancer AJCC v8,0
2301,Pseudoencapsulated Mass,Occult Lung Cancer AJCC v8,0
2302,Hyperplastic Tissue Present,Malignant Splenic Soft Tissue Neoplasm,0
2303,Endobronchial Mass,Endobronchial Leiomyoma,0
2304,Peripheral Blood Involvement,Intermediate Blood Vessel Neoplasm,0
2305,Large Spaces Filled with Blood Present,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
2306,Tumor Droplets Present,Childhood Carcinoid Tumor,0
2307,Monoclonal Gammapathies,Monoclonal B-Cell Lymphocytosis,0
2308,Inoperable Disease,Localized Castleman Disease,0
2309,Spindle Cell Osteo-Fibrous Component Present,Spindle Cell Type A Uveal Melanoma,0
2310,Delicate Vascular Network Formation,Benign Cutaneous Vascular Neoplasm,0
2311,Generalized Hydropic Villous Change,Columnar Cell Change of the Breast with Atypia,0
2312,"Hyperkeratosis, Epidermolytic","Keratoderma, Palmoplantar, Epidermolytic",0
2313,Monoclonal Cellular Population Present,Uterine Corpus Cellular Leiomyoma,0
2314,Absence of Invasion or Limited Invasion Present,Malignant neoplasm of stomach recurrent,0
2315,Metaplasia,Breast Carcinoma with Chondroid Metaplasia,0
2316,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Benign Mixed Tumor of the Vulva,0
2317,High Plasma Renin Activity,Plasma Cell Myeloma by DS Stage,0
2318,Lipomatous Metaplasia,Intermediate Lipomatous Neoplasm,0
2319,Chemotherapeutic Agent Toxicity,Occult Lung Cancer AJCC v8,0
2320,Extraosseous Lesion,Primary Melanocytic Lesion of Meninges,0
2321,Dilated Cystic Spaces Present,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,0
2322,Acanthosis,Adenocarcinoma with squamous metaplasia,0
2323,Fibrovascular Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
2324,Positive Axillary Lymph Node,Follicular Lymph Node Hyperplasia,0
2325,Osseous Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
2326,Non-Contiguous Disease,Localized Castleman Disease,0
2327,Mild dysplasia of colon,Mild epithelial dysplasia,0
2328,Endometrial Type Glands and Stroma Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",0
2329,Extraocular Dissemination of Disease,Chronic Bullous Disease of Childhood,0
2330,Pre-existing condition,Adenocarcinoma with squamous metaplasia,0
2331,Pseudostratified Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
2332,Aflatoxins Toxicity,Occult Lung Cancer AJCC v8,0
2333,Cicatrix,Malignant neoplasm of stomach recurrent,0
2334,Stromal Invasion,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
2335,Moderate dysplasia,Mild epithelial dysplasia,0
2336,Scattered Collections of Differentiating Neuroblasts Present,"Benign neoplasm of brain, unspecified",0
2337,Neoplastic Growth or Spread,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
2338,Concentric Aggregates of Intermediate Filaments Present,Malignant neoplasm of stomach recurrent,0
2339,Lobulated Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2340,Prominent Collagen Rosette Formation,Malignant neoplasm of stomach recurrent,0
2341,Schwannian Stroma More than 50 Percent of the Tumor Volume,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
2342,S-100-Positive Neoplastic Cells Present,Neoplastic Polyp,0
2343,Intra or Intercytoplasmic Lumina Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
2344,Bone Marrow Lymphoplasmacytic Infiltrate,Unresectable Bone Sarcoma,0
2345,No Identifiable Line of Differentiation,Recurrent tumors of the Ewing's family,0
2346,No Identifiable Line of Differentiation,Malignant neoplasm of stomach recurrent,0
2347,Moderate cytologic atypia,Complex endometrial hyperplasia without atypia,0
2348,Unifocal Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
2349,Dense Intercellular Reticulin Network Present,Adenocarcinoma with squamous metaplasia,0
2350,Mixture of Morphologic Patterns,Malignant neoplasm of stomach recurrent,0
2351,Defective Alpha Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2352,Dedifferentiated Malignant Infiltrate,Malignant Gastric Granular Cell Tumor,0
2353,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
2354,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
2355,Multilayered Rosette Formation,Occult Lung Cancer AJCC v8,0
2356,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Sellar Region,0
2357,Keratin Horn Pearls Formation,Occult Lung Cancer AJCC v8,0
2358,Sarcomatoid Features,Thymic Sarcomatoid Carcinoma,0
2359,Increased red cell mass,Basal cell carcinoma,0
2360,Proliferation of Small Ducts Present,T-Cell Proliferation of Uncertain Malignant Potential,0
2361,Microglandular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2362,Keratin pearl formation,Adenocarcinoma with squamous metaplasia,0
2363,MGMT Gene Promoter Methylation,Breast Carcinoma by Gene Expression Profile,0
2364,Atypical Mitotic Figures,Childhood Atypical Choroid Plexus Papilloma,0
2365,Staghorn Configuration,Occult Lung Cancer AJCC v8,0
2366,Myomatous Stroma Formation,Adenocarcinoma with squamous metaplasia,0
2367,Subcutaneous Involvement,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,0
2368,Apocrine metaplasia,Adenocarcinoma with osseous metaplasia,0
2369,Nested Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2370,Necrotic changes (finding),Occult Lung Cancer AJCC v8,0
2371,Finding related to pregnancy,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
2372,Argentaffin Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
2373,Shadow Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
2374,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
2375,Ganglion Cell-Like Elements Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
2376,Chemotherapeutic Agent Toxicity,Pseudolymphoma,0
2377,Emperipolesis,Malignant neoplasm of stomach recurrent,0
2378,Fibrosis,Adenocarcinoma with squamous metaplasia,0
2379,CD4-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
2380,Schwannian Stroma Predominant Component of the Tumor Volume,Malignant Mixed Tumor of the Major Salivary Gland,0
2381,Seminomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
2382,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Ampulla of Vater Cancer by AJCC v7 Stage,0
2383,Intraosseous Lesion,Primary Melanocytic Lesion of Meninges,0
2384,Well Differentiated Hyaline Cartilage Present,Pleural Well Differentiated Papillary Mesothelioma,0
2385,Intraocular Lesion,Reactive Cutaneous Fibrous Lesion,0
2386,Ulcer,Adenocarcinoma with squamous metaplasia,0
2387,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
2388,Skin Erosion,Stage IV Skin Cancer,0
2389,Intracanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2390,Preserved Nuclear Polarity,Occult Lung Cancer AJCC v8,0
2391,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2392,Skin Erosion,Stage IV Skin Cancer,0
2393,Slit-Like Vascular Channel Formation,Radiation-Induced Vascular Disease,0
2394,Lipomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
2395,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
2396,Glandular metaplasia,Adenocarcinoma with squamous metaplasia,0
2397,Ectopic Thyroid Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
2398,Hemorrhagic Neuroblastic Nodules Present,Adenocarcinoma with squamous metaplasia,0
2399,Toxic effect,Adenocarcinoma with squamous metaplasia,0
2400,Pseudo-'onion bulb' formation,Adenocarcinoma with squamous metaplasia,0
2401,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Neoplastic Polyp,0
2402,Cartilaginous metaplasia,adenocarcinoma of breast with spindle cell metaplasia,0
2403,Proliferation of Follicular Dendritic Cells Present,B-Cell Proliferation of Uncertain Malignant Potential,0
2404,Defective Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2405,Extraocular Dissemination of Disease,Paget Disease of the Scrotum,0
2406,Multifocal Unisystem Disease,Multi-centric Castleman's Disease,0
2407,Deep Lesion,Primary Melanocytic Lesion of Meninges,0
2408,Pseudolobular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2409,Peripheral Blood Involvement,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,0
2410,Generalized Dysplasia,Large Cell Dysplasia,0
2411,Distortion of the Hair Follicle,Erosive Adenomatosis of the Nipple,0
2412,Bilateral Mass,Bilateral Optic Nerve Meningioma,0
2413,Decreased platelet count,Occult Lung Cancer AJCC v8,0
2414,Nuclear Pseudoinclusion,Occult Lung Cancer AJCC v8,0
2415,Spindle Cell Metaplasia,Childhood Spindle Cell Rhabdomyosarcoma,0
2416,Hypokalemia,Malignant neoplasm of stomach recurrent,0
2417,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Malignant Giant Cell Tumor of Bone,0
2418,Cystic Lesion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
2419,Juvenile Lesion,Juvenile Myelomonocytic Leukemia,0
2420,Low Grade Neuroendocrine Lesion,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",0
2421,Swelling,Malignant neoplasm of stomach recurrent,0
2422,Recurrent Genetic Abnormalities Present,Recurrent Gliosarcoma,0
2423,Neonatal Lesion,Reactive Cutaneous Fibrous Lesion,0
2424,Peripheral Nuclear Palisading,Peripheral Intraneural Angiosarcoma,0
2425,Well-Circumscribed Lesion,Pre-Malignant Skin Epithelial Lesion,0
2426,Proliferation of High Endothelial Venules Present,T-Cell Proliferation of Uncertain Malignant Potential,0
2427,NRBC - Nucleated red blood cell present result,Basal cell carcinoma - keratotic,0
2428,Philadelphia chromosome negative,Philadelphia chromosome negative chronic myelogenous leukemia,0
2429,Ectopic Thyroid Tissue Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0
2430,Pseudoalveolar Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
2431,CDKN2A-p16 Negative,Occult Lung Cancer AJCC v8,0
2432,Bile Pigment Present,Extrahepatic Bile Duct Neuroendocrine Tumor,0
2433,Infiltrative Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2434,More than 10 Mitoses per 10HPF,Occult Lung Cancer AJCC v8,0
2435,Rimming of Adipose Tissue Cells Present,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
2436,Fibrosis,Occult Lung Cancer AJCC v8,0
2437,Tobacco Chewing Toxicity,Occult Lung Cancer AJCC v8,0
2438,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2439,Lesion with Diameter of 2cm or Less,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
2440,Serum phosphate concentration below normal,Occult Lung Cancer AJCC v8,0
2441,Ground Glass Nuclear Inclusion,Occult Lung Cancer AJCC v8,0
2442,Embryoid Bodies Present,Adenocarcinoma with squamous metaplasia,0
2443,Dysplastic Dentin Formation,Low Grade Liver Dysplastic Nodule,0
2444,Beaded Anastomosing Cords Present,Anastomosing Hemangioma,0
2445,Multinodular Lesion,Pre-Malignant Skin Epithelial Lesion,0
2446,Intestinal metaplasia,Adenocarcinoma with squamous metaplasia,0
2447,Hemosiderin pigmentation,Malignant neoplasm of stomach recurrent,0
2448,Striated Muscle Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
2449,Leukoerythroblastic Reaction,Adenocarcinoma with squamous metaplasia,0
2450,Mixture of Germ Cell Neoplastic Components Present,Benign Mediastinal Germ Cell Tumor,0
2451,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2452,Follicular Structures Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
2453,Insular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2454,Prominent In Situ Component Present,Lung Adenocarcinoma In Situ,0
2455,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Squamous cell carcinoma of head and neck metastatic,0
2456,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
2457,Recurrent Genetic Abnormalities Present,Recurrent Ampulla of Vater Adenocarcinoma,0
2458,Windblown Appearance of Atypical Keratinocytes,Ampulla of Vater Mucinous Adenocarcinoma,0
2459,Malignant Germinomatous Cellular Infiltrate,Malignant Gastric Granular Cell Tumor,0
2460,Blasts Under 20 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
2461,Multiple Tumor Masses,Multiple Endocrine Neoplasia Type 2a,0
2462,Skin nodule,Transplant-Related Skin Squamous Cell Carcinoma,0
2463,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2464,Concentric Aggregates of Intermediate Filaments Present,"Benign neoplasm of brain, unspecified",0
2465,Minimal Invasion Present,Minimal Deviation Melanoma,0
2466,Spindle Cell Osteo-Fibrous Component Present,Childhood Spindle Cell Rhabdomyosarcoma,0
2467,Tissue Differentiation Uncertain,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
2468,Dilated Thin-Walled Vascular Space Formation,Radiation-Induced Vascular Disease,0
2469,Cicatrix,Occult Lung Cancer AJCC v8,0
2470,Rimming of Adipose Tissue Cells Present,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
2471,Absence of Basal Cell Layer,Clear Cell Sarcoma of Soft Tissue,0
2472,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Breast Carcinoma Metastatic in the Bone,0
2473,Nuclear Palisading,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
2474,Hemorrhagic,Adenocarcinoma with squamous metaplasia,0
2475,Positive Axillary Lymph Node,Palisaded Lymph Node Myofibroblastoma,0
2476,Encapsulated Mass,Adenocarcinoma with squamous metaplasia,0
2477,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
2478,Defective Heavy Chain Present,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2479,"Fully Differentiated ""Adult-Type"" Tissues Present","Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
2480,Cervical lymphadenopathy,Stage IA2 Cervical Cancer AJCC v8,0
2481,Extensive Stage Lesion,Recurrent Extensive Stage Lung Small Cell Carcinoma,0
2482,Adnexal Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
2483,Wheezing,Pseudolymphoma,0
2484,Focal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2485,Non Lipogenic Sarcomatous Stroma Present,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
2486,Acantholysis,Occult Lung Cancer AJCC v8,0
2487,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Anemia due to membrane defect,0
2488,Ganglioneuroblastoma Component Present,Glioblastoma with Primitive Neuronal Component,0
2489,Extracutaneous Dissemination of Disease,Chronic Bullous Disease of Childhood,0
2490,Collagen Bundles Formation,Malignant neoplasm of stomach recurrent,0
2491,Gyriform Trabecular Pattern,Thyroid Hyalinizing Trabecular Adenoma,0
2492,Hypertensive disease,Lhermitte-Duclos disease,0
2493,Cervical Glandular Dysplasia,Cervical Glandular Neoplasm,0
2494,Enterochromaffin Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
2495,Squamous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
2496,Histiocytoid Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
2497,Contiguous Disease,Chronic Bullous Disease of Childhood,0
2498,Monoclonal Paraproteinemia Present in Lower than Myeloma Levels,Colorectal Carcinoma Metastatic in the Liver,0
2499,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
2500,Endobronchial Mass,Endobronchial Leiomyoma,0
2501,Intracytoplasmic Eosinophilic Spherical Inclusion,Childhood Acute Eosinophilic Leukemia,0
2502,Cytopenia,Adenocarcinoma with squamous metaplasia,0
2503,Follicular Cell Differentiation,"Dendritic Cell Sarcoma, Follicular",0
2504,Slow Growing Painless Mass,Occult Lung Cancer AJCC v8,0
2505,Hyaline Cartilage Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2506,Human Papillomavirus Negative,AIDS-Related Human Papillomavirus Infection,0
2507,Endobronchial Lesion,Endobronchial Leiomyoma,0
2508,Bone Marrow Eosinophilia,Unresectable Bone Sarcoma,0
2509,Inclusion-Like Nucleoli,Malignant neoplasm of stomach recurrent,0
2510,Cartilaginous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2511,Firm mass,Adenocarcinoma with squamous metaplasia,0
2512,Steatohepatitis,Malignant neoplasm of stomach recurrent,0
2513,Venous Type Vascular Channel Formation,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
2514,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
2515,Whorling Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2516,Syncytial Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2517,Pericanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2518,Hypergammaglobulinemia,Malignant neoplasm of stomach recurrent,0
2519,Absence of Invasion,Ampulla of Vater Mucinous Adenocarcinoma,0
2520,Fetal -Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2521,Erythroid hyperplasia,Endometrial cystic hyperplasia,0
2522,Enterochromaffin Type Granules Present,Multiple Endocrine Neoplasia Type 2a,0
2523,Pushing Tumor Margin,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2524,Endodermal Sinus Pattern,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,0
2525,Rubbery Skin Lesion,Transplant-Related Skin Squamous Cell Carcinoma,0
2526,Lobular Pattern,"Carcinoma, Lobular",0
2527,Neutrophilia (finding),Occult Lung Cancer AJCC v8,0
2528,Generalized Dysplasia,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
2529,Single Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
2530,Premalignant Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
2531,Superficial Lesion,Reactive Cutaneous Fibrous Lesion,0
2532,Anaplasia,Occult Lung Cancer AJCC v8,0
2533,Undifferentiated Lesion,Undifferentiated carcinoma of ovary,0
2534,Plasma cell inflammation,Plasma cell myeloma recurrent,0
2535,Epithelial Differentiation,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
2536,Chemotherapeutic Agent Toxicity,Pseudolymphoma,0
2537,Apocrine Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
2538,BCR/ABL1 Fusion Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
2539,Sinusoidal Infiltration,Malignant neoplasm of stomach recurrent,0
2540,Multifocal Lesion,Pre-Malignant Skin Epithelial Lesion,0
2541,Clinical TNM Finding,Hodgkin Lymphoma by Clinical Course,0
2542,Therapy-Related Toxicity,Malignant neoplasm of stomach recurrent,0
2543,Fibrovascular Septa Present,Adenocarcinoma with squamous metaplasia,0
2544,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Columnar Cell Change of the Breast with Atypia,0
2545,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
2546,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Osteosarcoma Arising in Paget Disease of Bone,0
2547,Vacuolated Plasma Cells in the Bone Marrow,Prostate Carcinoma Metastatic in the Bone,0
2548,Lytic lesion,Angiocentric immunoproliferative lesion grade 2,0
2549,Thick-Walled Vessels Present,Adenocarcinoma with squamous metaplasia,0
2550,Angioinvasion,Adenocarcinoma with squamous metaplasia,0
2551,Philadelphia chromosome negative,"Anaplastic large cell lymphoma, ALK negative",0
2552,Shadow Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
2553,Vacuolated Plasma Cells in the Bone Marrow,Colorectal Carcinoma Metastatic in the Liver,0
2554,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
2555,Monoclonal Myeloid or Lymphoid Cells Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
2556,Monomorphic Cellular Infiltrate,Cellular Blue Nevus,0
2557,Thick-Walled Hyalinized Vessels Present,Adenocarcinoma with squamous metaplasia,0
2558,Multinodular Mass,Multinodular and Vacuolated Tumor of the Cerebrum,0
2559,Sarcomatoid Features,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",0
2560,Serrated Glandular Architecture,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2561,Hypercellular bone marrow,Benign bone neoplasm,0
2562,Increased megakaryocytes (bone marrow),Malignant neoplasm of stomach recurrent,0
2563,Submucosal Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
2564,Huge Vascular Channel Formation,Radiation-Induced Vascular Disease,0
2565,Matrical Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
2566,Pseudostratified Tumor Cells Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0
2567,Collagenous Stroma Formation,Adenocarcinoma with squamous metaplasia,0
2568,Osteosclerotic Lesion,Pre-Malignant Skin Epithelial Lesion,0
2569,Micronodular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2570,Immunoglobulin Heavy Chain Deposition,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2571,Calcitonin Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
2572,More than 10 Mitoses per 10HPF,Adenocarcinoma with squamous metaplasia,0
2573,Abundant Intracytoplasmic Lipofuscin Present,Occult Lung Cancer AJCC v8,0
2574,Lesion with Diameter of 5cm or Less,Columnar Cell Change of the Breast with Atypia,0
2575,Infundibular-Like Structures Present,Pseudolymphoma,0
2576,IDH Gene Family Mutation Status Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
2577,Non-Encapsulated Neoplasm,Intermediate Blood Vessel Neoplasm,0
2578,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Tubular adenoma of colon,0
2579,Poorly Cohesive Malignant Cellular Infiltrate,Malignant Gastric Granular Cell Tumor,0
2580,Regional Disease,Chronic Bullous Disease of Childhood,0
2581,Intracanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2582,Apocrine metaplasia,Adenocarcinoma with osseous metaplasia,0
2583,CD4-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
2584,Lobulated Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
2585,Adnexal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2586,Blasts Under 5 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
2587,Broad Fibrous Bands Formation,Reactive Cutaneous Fibrous Lesion,0
2588,Myxoid Changes Present,Adult Extraskeletal Myxoid Chondrosarcoma,0
2589,Mass of pleura,Lipoma of pleura,0
2590,Intracytoplasmic Eosinophilic Spherical Inclusion,Eosinophilic Granuloma,0
2591,Marked Bone Marrow Fibrosis,Stage IB Bone Sarcoma AJCC v7,0
2592,Pseudorosette Formation,Pseudolymphoma,0
2593,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Erosive Adenomatosis of the Nipple,0
2594,Osseous Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
2595,Mature Schwannian Stroma Present,Ann Arbor Stage II Mature T- and NK-Cell Lymphoma,0
2596,Positive Axillary Lymph Node,Breast Carcinoma Metastatic in Lymph Node,0
2597,Microvascular Proliferation,B-Cell Proliferation of Uncertain Malignant Potential,0
2598,Follicular Structures Present,Vulvar Inverted Follicular Keratosis,0
2599,1p/19q Codeletion Status Unknown,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
2600,More than 10 Mitoses per 10HPF,Occult Lung Cancer AJCC v8,0
2601,Ganglioneuroblastoma Component Present,Ganglioneuroblastoma,0
2602,Hyalinized Stroma Formation,Adenocarcinoma with squamous metaplasia,0
2603,Unifocal Lesion,Pre-Malignant Skin Epithelial Lesion,0
2604,Absence of Invasion,Ampulla of Vater Mucinous Adenocarcinoma,0
2605,Humoral hypercalcemia of malignancy (disorder),Serous papillary cystic tumor of borderline malignancy,0
2606,Intra or Intercytoplasmic Lumina Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
2607,Positive Axillary Lymph Node,Palisaded Lymph Node Myofibroblastoma,0
2608,Collagen Bundles Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,0
2609,Serum IgM Monoclonal Gammopathy of Less than 30g/L,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0
2610,Well Differentiated Hyaline Cartilage Present,Pleural Well Differentiated Papillary Mesothelioma,0
2611,Marked Nuclear Atypia Present,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
2612,Fibrotic Stroma with Finger-Like Projections Present,Adenocarcinoma with squamous metaplasia,0
2613,Follicular Structures Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
2614,Defective Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2615,Papulovesicular Lesion,Primary Melanocytic Lesion of Meninges,0
2616,Islands of Neuropil-Like Matrix Present,Ampulla of Vater Mucinous Adenocarcinoma,0
2617,Hemorrhagic Neuroblastic Nodules Present,Neuroblastic tumors,0
2618,Hereditary Lesion,Reactive Cutaneous Fibrous Lesion,0
2619,Stromal Invasion,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
2620,Pale Eosinophilic Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
2621,Breast Implant-Related Lesion,Papillary Ductal Breast Hyperplasia,0
2622,Distortion of the Hair Follicle,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
2623,Perivascular Pseudorosette Formation,"Perivascular epithelioid tumor, benign",0
2624,Unclassifiable Lesion,Reactive Cutaneous Fibrous Lesion,0
2625,Precocious Puberty,Malignant neoplasm of stomach recurrent,0
2626,Primary Site Unspecified,Primary mediastinal large B-cell lymphoma stage III,0
2627,NRBC - Nucleated red blood cell present result,Basal cell carcinoma - keratotic,0
2628,Serum phosphate concentration below normal,Cytogenetically normal acute myeloid leukemia,0
2629,Pseudoalveolar Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2630,Micronodular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2631,Melanosomes Present,Pseudolymphoma,0
2632,Primary Site Unspecified,Primary mediastinal large B-cell lymphoma stage III,0
2633,Multinodular Mass,Occult Lung Cancer AJCC v8,0
2634,Tubal Diverticulosis,Serous Tubal Intraepithelial Carcinoma,0
2635,Granuloma,Eosinophilic Granuloma,0
2636,Lesion with Diameter of 10mm or Less,Columnar Cell Change of the Breast with Atypia,0
2637,Storiform Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2638,Crooke Hyaline Change,Adenocarcinoma with squamous metaplasia,0
2639,Enterochromaffin Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
2640,Hepatomegaly,Malignant neoplasm of stomach recurrent,0
2641,Tumor Droplets Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
2642,Mass of body structure,Secondary malignant neoplasm of ciliary body,0
2643,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
2644,Blasts 5-19 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
2645,Trabecular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2646,Histiocytoid Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2647,Dentin formation,Malignant neoplasm of stomach recurrent,0
2648,Skin Papule,Transplant-Related Skin Squamous Cell Carcinoma,0
2649,Carcinomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
2650,Synchronous Lesion,Reactive Cutaneous Fibrous Lesion,0
2651,Floret-Like Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2652,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
2653,Cartilaginous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
2654,Tubular Structures Present,Small Intestinal Tubular Adenoma,0
2655,Nodules of Compact Keratin Present,Ampulla of Vater Mucinous Adenocarcinoma,0
2656,Dense Collagenized Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
2657,Limited Early T-Cell Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2658,Microcystic Change,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2659,Neuroectodermal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2660,Villous Projections of the Neoplastic Epithelium Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
2661,Exanthema,Occult Lung Cancer AJCC v8,0
2662,Cementum Formation,Adenocarcinoma with squamous metaplasia,0
2663,Hormonal resistance,Adenocarcinoma with squamous metaplasia,0
2664,Intraepithelial Neoplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
2665,Unifocal Disease,Chronic Bullous Disease of Childhood,0
2666,Poikilocytosis,Pseudolymphoma,0
2667,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
2668,High Grade Non Cartilaginous Sarcomatous Stroma Present,Colorectal High Grade Intraepithelial Neoplasia,0
2669,Lymphocyte count increased,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2670,Defective Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2671,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
2672,Drug Exposure,Malignant neoplasm of stomach recurrent,0
2673,Cartilage-Like Elements Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",0
2674,Regional Disease,Localized Castleman Disease,0
2675,Precise Histogenesis Unknown,Adenocarcinoma of Unknown Primary,0
2676,Hyperkeratosis,Pseudolymphoma,0
2677,Polyclonal hypergammaglobulinemia,Pseudolymphoma,0
2678,Pleural effusion disorder,Pleural Synovial Sarcoma,0
2679,Oligodendroglial Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
2680,Cavernous Lymphatic Space Formation,Thyroid Gland Cavernous Hemangioma,0
2681,Monoclonal Langerhans Cells Present,Tumors Derived from Langerhans Cells,0
2682,Osseous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2683,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2684,Low Cellularity Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",0
2685,Lesion Less than 5mm in Diameter,Lung Carcinoma Metastatic in the Liver,0
2686,Broad Fibrous Bands Formation,Intracranial Benign Fibrous Histiocytoma,0
2687,Exposure to asbestos,Anemia due to membrane defect,0
2688,Congenital Abnormality,Congenital melanocytic nevus,0
2689,Blasts 5-19 Percent of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
2690,Prominent Collagen Rosette Formation,Occult Lung Cancer AJCC v8,0
2691,Large Spaces Filled with Blood Present,Large cell carcinoma with rhabdoid phenotype,0
2692,Chronic lymphocytic inflammation,Chronic lymphocytic leukemia stage 0,0
2693,Desmoplastic Stroma Formation,Desmoplastic fibroma,0
2694,Low Grade Lesion,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
2695,Shadow Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
2696,Apocrine Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2697,Metastatic/Recurrent Disease,Erdheim-Chester Disease,0
2698,Polymorphic Cellular Infiltrate,Cellular Blue Nevus,0
2699,VIP Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
2700,Osseous metaplasia,Adenocarcinoma with squamous metaplasia,0
2701,Absence of Malignant Features,Malignant lymphoma of spleen,0
2702,Lesion with Diameter of 5cm or Less,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
2703,Pseudostratified Neuroepithelial Tumor Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2704,Fibrinous Material Present,Adenocarcinoma with squamous metaplasia,0
2705,Extraosseous Lesion,Reactive Cutaneous Fibrous Lesion,0
2706,Histiocytosis haematophagic,Pulmonary Histiocytosis X,0
2707,Concentric Perivascular Arrangement of Tumor Cells,Multinodular and Vacuolated Tumor of the Cerebrum,0
2708,Skin nodule,Transplant-Related Skin Squamous Cell Carcinoma,0
2709,Cafe-au-Lait Spots,Occult Lung Cancer AJCC v8,0
2710,Unfavorable Clinical Outcome,Advanced Unfavorable Hodgkin Lymphoma,0
2711,Squamous metaplasia of bladder,Squamous cell carcinoma of head and neck metastatic,0
2712,Intraepithelial Neoplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
2713,Cytologic atypia,Occult Lung Cancer AJCC v8,0
2714,Hot Nodule,Low Grade Liver Dysplastic Nodule,0
2715,Cartilaginous metaplasia,Nephrogenic metaplasia,0
2716,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Osteosarcoma Arising in Paget Disease of Bone,0
2717,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
2718,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Erosive Adenomatosis of the Nipple,0
2719,Microfollicular Structures Present,Adenocarcinoma with squamous metaplasia,0
2720,Absence of Invasion of the Muscularis Externa,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
2721,Acinar Proliferation,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",0
2722,Hemosiderin pigmentation,Pseudolymphoma,0
2723,Lymphoplasmacytic Infiltrate,Occult Lung Cancer AJCC v8,0
2724,Immunoglobulin Light Chain Deposition,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2725,Solitary Skin Tumor,Malignant Gastric Granular Cell Tumor,0
2726,Architectural Distortion,Occult Lung Cancer AJCC v8,0
2727,Small Aggregates of Tumor Cells Present,Multinodular and Vacuolated Tumor of the Cerebrum,0
2728,Polarization of Nuclei Towards the Glandular Lumen,Recurrent tumors of the Ewing's family,0
2729,C19MC Amplification,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21,0
2730,Lamellar Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2731,1p/19q Codeletion Status Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
2732,Arborizing Vascular Channel Formation,Malignant Vascular Neoplasm,0
2733,Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
2734,Gyriform Trabecular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2735,Neoplastic Cells with TFH Cell Phenotype Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0
2736,Severe cytologic atypia,Severe pre-eclampsia,0
2737,Multinodular and Vacuolated Pattern,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2738,Mixture of Germ Cell Neoplastic Components Present,Childhood Malignant Ovarian Germ Cell Tumor,0
2739,Squamous metaplasia of bladder,Squamous cell carcinoma of skin,0
2740,Neoplastic Growth or Spread,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
2741,Cartilaginous metaplasia,Adenocarcinoma with osseous metaplasia,0
2742,Poorly Differentiated Neuroendocrine Lesion,Poorly Differentiated Neuroblastoma,0
2743,Epidermal Involvement,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
2744,Ulcer,Occult Lung Cancer AJCC v8,0
2745,Rosette-Like Configurations Present,Occult Lung Cancer AJCC v8,0
2746,Sarcomatoid Stroma Formation,Thymic Sarcomatoid Carcinoma,0
2747,Carcinomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
2748,Distortion of the Hair Follicle,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
2749,Multinodular Mass,Multinodular and Vacuolated Tumor of the Cerebrum,0
2750,Lymphocyte count increased,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2751,Finding related to pregnancy,Metastatic malignant neoplasm to nasopharynx,0
2752,Hyalinized Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
2753,Mass of body structure,Hemangioma of intracranial structure,0
2754,Cribriform Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2755,Fibrotic Stroma Formation,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
2756,Scattered Collections of Differentiating Neuroblasts Present,Ampulla of Vater Mucinous Adenocarcinoma,0
2757,Precise Histogenesis Unknown,Adenocarcinoma of Unknown Primary,0
2758,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
2759,Neuropil Present,Occult Lung Cancer AJCC v8,0
2760,Intraocular Lesion,Reactive Cutaneous Fibrous Lesion,0
2761,Cytokeratin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
2762,Dense Intercellular Reticulin Network Present,Pseudolymphoma,0
2763,Thrombocytosis,Pseudolymphoma,0
2764,Clear Perinuclear Halo Present,Clear Cell Sarcoma of Soft Tissue,0
2765,Absence of Invasion,"Benign neoplasm of brain, unspecified",0
2766,Antoni B Pattern,Ciliary Body Spindle Cell Type B Melanoma,0
2767,Plexiform Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2768,No Evidence of Radiologic Finding,Malignant neoplasm of stomach recurrent,0
2769,Non-Invasive Lesion,Primary Melanocytic Lesion of Meninges,0
2770,Dilated Vascular Space Formation,Radiation-Induced Vascular Disease,0
2771,Lipomatous Metaplasia,Intestinal Metaplasia of Bladder Urothelium,0
2772,Glandular Pattern,Cervical Glandular Neoplasm,0
2773,Anastomosing Cells Connected to the Basal Layer of the Epidermis Present,Recurrent tumors of the Ewing's family,0
2774,Lymphatic Spread,Medulloblastoma with Leptomeningeal Spread,0
2775,Follicular Cell Differentiation,Thyroid Gland Signet Ring Cell Follicular Adenoma,0
2776,Diffuse Cellular Infiltrate,Diffuse Lipomatosis,0
2777,Birbeck Granules Present,Malignant neoplasm of stomach recurrent,0
2778,Duct-Like Structures Present,Occult Lung Cancer AJCC v8,0
2779,Heterologous Elements Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",0
2780,Systemic disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
2781,Follicular Differentiation,Vulvar Inverted Follicular Keratosis,0
2782,Infiltrating Tumor Margins Present,Malignant Gastric Granular Cell Tumor,0
2783,Enterochromaffin-Like Type Granules Present,Intermediate Cell Type Ciliary Body Melanoma,0
2784,Intraductal Lesion,Pre-Malignant Skin Epithelial Lesion,0
2785,Neoplastic Cells with TFH Cell Phenotype Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0
2786,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Glandular Intraepithelial Neoplasia,0
2787,Lamellar Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2788,Fascicular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2789,Hemosiderin pigmentation,Adenocarcinoma with squamous metaplasia,0
2790,Well Differentiated Hyaline Cartilage Present,Pleural Well Differentiated Papillary Mesothelioma,0
2791,Tubular Structures Present,Colorectal Tubular Adenoma,0
2792,Rubbery Skin Lesion,Transplant-Related Skin Squamous Cell Carcinoma,0
2793,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
2794,Keratin pearl formation,Pseudolymphoma,0
2795,Sonic Hedgehog/Patch Pathway Activated,Refractory Visual Pathway Glioma,0
2796,Nuclear Expression of STAT6 Protein,Ampulla of Vater Mucinous Adenocarcinoma,0
2797,Fibromuscular Stroma Formation,Adenocarcinoma with squamous metaplasia,0
2798,High Mitotic Activity,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
2799,Lesion Less than 10mm in Diameter,Colon Carcinoma Metastatic in the Liver,0
2800,CDKN2A-p16 Negative,Occult Lung Cancer AJCC v8,0
2801,Epithelial Differentiation,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
2802,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
2803,Slowly Progressive Clinical Course,Hodgkin Lymphoma by Clinical Course,0
2804,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2805,Lipomatous Component Present,Intermediate Lipomatous Neoplasm,0
2806,Delicate Vascular Network Formation,Malignant Vascular Neoplasm,0
2807,Nuclear Atypia,Simple Endometrial Hyperplasia with Atypia,0
2808,Synchronous Lesion,Primary Melanocytic Lesion of Meninges,0
2809,Monocytosis,Malignant neoplasm of stomach recurrent,0
2810,Peribronchial and Lobular Septal Involvement Only,Invasive Ductal and Lobular Carcinoma,0
2811,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Malignant Mixed Tumor of the Major Salivary Gland,0
2812,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
2813,Focal dysplasia,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
2814,Cellular Pleomorphism,Cellular neurothekeoma,0
2815,Collagen Bundles Formation,Occult Lung Cancer AJCC v8,0
2816,Locally Aggressive Lesion,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,0
2817,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,Bone Marrow Transplantation Nephropathy,0
2818,Dermal Nodule,Benign Dermal Schwannoma,0
2819,Carcinomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
2820,Myofibroblastic Differentiation,Abdominal Inflammatory Myofibroblastic Tumor,0
2821,No Evidence of Radiologic Finding,Ampulla of Vater Mucinous Adenocarcinoma,0
2822,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Squamous cell carcinoma of head and neck metastatic,0
2823,One Germ Layer Present,Childhood Malignant Ovarian Germ Cell Tumor,0
2824,Immunoglobulin Light Chain Deposition,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2825,Cervical lymphadenopathy,Locally Advanced Unresectable Cervical Adenocarcinoma,0
2826,Eosinophilic inflammation,Eosinophilic Granuloma,0
2827,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
2828,Clusters and Cords of GFAP Positive Epithelioid Tumor Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2829,More than 5 Mitoses per 50HPF,Adenocarcinoma with squamous metaplasia,0
2830,Bilateral Mass,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
2831,Neutral Epithelial Mucin Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,0
2832,Less than 2 Mitoses per 10HPF,Angiosarcoma NCI Grade 2,0
2833,Nuclear Atypia,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
2834,Lesion Less than 5mm in Diameter,Metastatic Malignant Neoplasm in the Sellar Region,0
2835,Radial Growth Phase,"Polycythemia Vera, Polycythemic Phase",0
2836,Diffuse Immunoblastic Proliferation,Hereditary Diffuse Gastric Adenocarcinoma,0
2837,Mucocele of appendix,Neuroendocrine carcinoma of appendix,0
2838,Lymphocyte count increased,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2839,Bead-Like Arrangement of Elastic Fibers,Ampulla of Vater Mucinous Adenocarcinoma,0
2840,Pineocytomatous Rosette Formation,Pseudolymphoma,0
2841,Single Malignant Cells Present,Metastatic Extracranial Malignant Solid Neoplasm,0
2842,Hypergammaglobulinemia,Malignant neoplasm of stomach recurrent,0
2843,Platinum Sensitivity,Occult Lung Cancer AJCC v8,0
2844,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
2845,Burn injury,Adenocarcinoma with squamous metaplasia,0
2846,CD4-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
2847,Actinic Damage,Pseudolymphoma,0
2848,Solitary mass,Solitary Adult Fibroma,0
2849,Multihormonal Immunoreactivity Present in a Single Cell Type,Ciliary Body Spindle Cell Type B Melanoma,0
2850,Odontogenic Cysts,Odontogenic myxoma,0
2851,Hyperkeratosis,Adenocarcinoma with squamous metaplasia,0
2852,Blue Bone Formation,"Nevus, Blue",0
2853,Delicate Arborizing Vascular Channel Formation,Vascular neoplasm of skin,0
2854,Glomeruloid Vessels Present,Occult Lung Cancer AJCC v8,0
2855,Lesion Less than 10mm in Diameter,Colon Carcinoma Metastatic in the Liver,0
2856,Mass of pleura,Malignant neoplasm of stomach recurrent,0
2857,Low Mitotic Activity,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
2858,More Than Two Separate Tumor Masses Present in the Same Organ,Lung Carcinoma Metastatic in the Liver,0
2859,Pseudostratified Columnar Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
2860,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
2861,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Metastatic Malignant Neoplasm in the Soft Tissues,0
2862,Painless Mass,Adenocarcinoma with squamous metaplasia,0
2863,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
2864,Mitotic Activity,Pseudolymphoma,0
2865,Hyperplastic Epithelial Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
2866,Increased megakaryocytes (bone marrow),Adenocarcinoma with squamous metaplasia,0
2867,Serrated Glandular Architecture,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2868,Villous Projections of the Neoplastic Epithelium Present,Erosive Adenomatosis of the Nipple,0
2869,Tall Papillae Present,Occult Lung Cancer AJCC v8,0
2870,Serum phosphate concentration below normal,Occult Lung Cancer AJCC v8,0
2871,Serum IgM Monoclonal Gammopathy of Less than 30g/L,Monoclonal Gammopathy of Renal Significance,0
2872,Hyperchromatism,Malignant neoplasm of stomach recurrent,0
2873,Acquired Lesion,Pre-Malignant Skin Epithelial Lesion,0
2874,Parakeratosis,Malignant neoplasm of stomach recurrent,0
2875,Malignant Germinomatous Cellular Infiltrate,Malignant neoplasm of stomach recurrent,0
2876,Nuclear Grooves,Adenocarcinoma with squamous metaplasia,0
2877,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
2878,Fetal -Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2879,One Germ Layer Present,Recurrent Ovarian Germ Cell Tumor,0
2880,Dentin formation,Pseudolymphoma,0
2881,Fibroblastoma-Like Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
2882,Low Cellularity Present,Classical Low Grade Fibromyxoid Sarcoma,0
2883,Geographic Necrosis,Malignant neoplasm of stomach recurrent,0
2884,Nodular and Diffuse Pattern,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
2885,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2886,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Giant Cell Tumor of Bone,0
2887,Hot Nodule,Placental Site Nodule or Plaque,0
2888,Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
2889,One Germ Layer Present,Childhood Malignant Ovarian Germ Cell Tumor,0
2890,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Colorectal Carcinoma Metastatic in the Liver,0
2891,Rosenthal Fibers Present,Malignant neoplasm of stomach recurrent,0
2892,Floret-Like Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2893,Polymorphic Cellular Infiltrate,Cellular neurothekeoma,0
2894,Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
2895,Defective Gamma Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
2896,Rimming of Adipose Tissue Cells Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
2897,Subcutaneous nodule,Subcutaneous Disorder,0
2898,Mild dysplasia of colon,Non-hodgkin lymphoma of colon,0
2899,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
2900,Koilocytotic atypia,Malignant neoplasm of stomach recurrent,0
2901,Melanin-Pigmented Dendritic Cells Present,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,0
2902,Toxic effect,Adenocarcinoma with squamous metaplasia,0
2903,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2904,Beaded Anastomosing Cords Present,Malignant neoplasm of stomach recurrent,0
2905,Desmoplastic Stroma Formation,Desmoplastic fibroma,0
2906,Bone Marrow Dysplasia Present,Breast Carcinoma Metastatic in the Bone,0
2907,Parakeratosis,Occult Lung Cancer AJCC v8,0
2908,Architectural Distortion,Pseudolymphoma,0
2909,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Multinodular and Vacuolated Tumor of the Cerebrum,0
2910,Desmoplastic Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
2911,Lymphatic Spread,Medulloblastoma with Leptomeningeal Spread,0
2912,Perivascular Lymphocytic Infiltrate,Stage B Chronic Lymphocytic Leukemia,0
2913,Lipomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
2914,Defective Alpha Heavy Chain Present,Heavy Chain Deposition Disease,0
2915,Multicentric Lesion,Reactive Cutaneous Fibrous Lesion,0
2916,Sarcomatoid Features,Thymic Sarcomatoid Carcinoma,0
2917,Follicular Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2918,Scattered Collections of Differentiating Neuroblasts Present,"Benign neoplasm of brain, unspecified",0
2919,Synchronous Lesion,Pre-Malignant Skin Epithelial Lesion,0
2920,Fascicular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
2921,Horny Masses of Keratin Present,Ampulla of Vater Mucinous Adenocarcinoma,0
2922,Tissue Differentiation Uncertain,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2923,Venous Type Vascular Channel Formation,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
2924,Vascular Channel Formation,Radiation-Induced Vascular Disease,0
2925,Monoclonal Langerhans Cells Present,Tumors Derived from Langerhans Cells,0
2926,Vascular Channel Formation,Radiation-Induced Vascular Disease,0
2927,Villous atrophy,Villous adenoma of colon,0
2928,Antoni B Pattern,Ciliary Body Spindle Cell Type B Melanoma,0
2929,Cryptitis,Malignant neoplasm of stomach recurrent,0
2930,Duct-Like Structures Present,Malignant neoplasm of stomach recurrent,0
2931,Angiodestructive Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2932,Macronodular adrenal hyperplasia,Endometrial cystic hyperplasia,0
2933,Non-Contiguous Disease,Chronic Bullous Disease of Childhood,0
2934,Composite Lesion,Primary Melanocytic Lesion of Meninges,0
2935,Neuroendocrine Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
2936,Nuclear Palisading,Adenocarcinoma with squamous metaplasia,0
2937,Cytokeratin Positive Neoplastic Cells Present,Neoplastic Polyp,0
2938,Fibrosarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
2939,Organoid Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
2940,Mixture of Germ Cell Neoplastic Components Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
2941,Lesion Less than 10mm in Diameter,Colorectal Carcinoma Metastatic in the Liver,0
2942,Large Spaces Filled with Blood Present,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
2943,Eccrine Differentiation,Eccrine dermal cylindroma,0
2944,Estrogen receptor negative,Adenocarcinoma with squamous metaplasia,0
2945,No Evidence of Metastatic Disease,Chronic Bullous Disease of Childhood,0
2946,Vater-Pacini Corpuscles-Like Structures Present,Occult Lung Cancer AJCC v8,0
2947,Villous Projections of the Neoplastic Epithelium Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
2948,Extraosseous Lesion,Reactive Cutaneous Fibrous Lesion,0
2949,Pre-existing condition,Pseudolymphoma,0
2950,Cribriform Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
2951,Malignant Component Present,Malignant Gastric Granular Cell Tumor,0
2952,Fetal -Epithelial Differentiation,Fetal Lung Adenocarcinoma,0
2953,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
2954,Infantile Lesion,Primary Melanocytic Lesion of Meninges,0
2955,Melanin Pigment Present,Occult Lung Cancer AJCC v8,0
2956,Moderate dysplasia,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
2957,Bile Pigment Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
2958,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
2959,Stable Disease,Multi-centric Castleman's Disease,0
2960,Tall Papillae Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0
2961,Mural Nodule,Placental Site Nodule or Plaque,0
2962,Micropapillary Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2963,Generalized Dysplasia,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
2964,Drug toxicity,Adenocarcinoma with squamous metaplasia,0
2965,Numerous Stromal Mast Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2966,Osseous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
2967,Curvilinear Thin-Walled Vascular Pattern,Vascular neoplasm of skin,0
2968,Xp11.2 Translocations/TFE3 Gene Fusions Present,Breast Carcinoma by Gene Expression Profile,0
2969,Fibrous Septa Present,Pericardial Solitary Fibrous Tumor,0
2970,Undifferentiated Lesion,Endometrial Undifferentiated Carcinoma,0
2971,Extraosseous Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
2972,'Starry-sky' pattern,Adenocarcinoma with squamous metaplasia,0
2973,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Recurrent tumors of the Ewing's family,0
2974,Cementum Formation,Pseudolymphoma,0
2975,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
2976,Odontogenic Cysts,"Odontogenic tumor, benign",0
2977,Hypercellular bone marrow,benign fibrous histiocytoma of bone,0
2978,Floret-Like Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
2979,Humoral hypercalcemia of malignancy (disorder),Recurrent tumors of the Ewing's family,0
2980,Negative Peripheral Blood,Intermediate Blood Vessel Neoplasm,0
2981,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
2982,Non-Hereditary Lesion,Primary Melanocytic Lesion of Meninges,0
2983,Acquired Lesion,Acquired cystic disease associated renal cell carcinoma,0
2984,Low Grade Lesion,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
2985,Cold Nodule,Adenocarcinoma with squamous metaplasia,0
2986,Fibrotic Stroma with Finger-Like Projections Present,Adenocarcinoma with squamous metaplasia,0
2987,Microfollicular Structures Present,Malignant neoplasm of stomach recurrent,0
2988,Pleural effusion disorder,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,0
2989,Well Developed Rough Endoplasmic Reticulum Present,Pleural Well Differentiated Papillary Mesothelioma,0
2990,Intracellular Accumulation of Lipids,"Benign neoplasm of brain, unspecified",0
2991,Absence of Invasion,Malignant neoplasm of stomach recurrent,0
2992,Nuclear Molding,Malignant neoplasm of stomach recurrent,0
2993,"Adenocarcinoma, intestinal type",intestinal type adenocarcinoma of gallbladder,0
2994,Intraocular Lesion,Pre-Malignant Skin Epithelial Lesion,0
2995,Histiocytoid Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
2996,High Grade Lesion,Colorectal High Grade Intraepithelial Neoplasia,0
2997,Peripheral Nuclear Palisading,Recurrent Peripheral Primitive Neuroectodermal Tumor,0
2998,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Ductal Breast Carcinoma In Situ,0
2999,effusion,Pseudolymphoma,0
3000,Lytic lesion,Precancerous skin lesion,0
3001,Vascular proliferation,Benign Cutaneous Vascular Neoplasm,0
3002,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
3003,Dermal Involvement,Adenocarcinoma with squamous metaplasia,0
3004,Trichoblastic Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3005,Plasma cell inflammation,Plasma cell myeloma recurrent,0
3006,Sarcomatoid Features,Central Nervous System Embryonal Tumor with Rhabdoid Features,0
3007,Intracanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3008,Confluent Sheets of Anaplastic T-Lymphocytes Present,Recurrent tumors of the Ewing's family,0
3009,Human Papillomavirus Negative,Recurrent Human Papillomavirus-Related Malignant Neoplasm,0
3010,Tumor Vascular Invasion,Childhood Carcinoid Tumor,0
3011,Vascular proliferation,Radiation-Induced Vascular Disease,0
3012,Toxic effect,Toxic Epidermal Necrolysis,0
3013,Focal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3014,Dense Collagenized Tissue Present,Clear Cell Sarcoma of Soft Tissue,0
3015,Focal dysplasia,Focal Segmental Glomerulosclerosis Collapsing Variant,0
3016,Entrapped Respiratory Epithelium Present,Benign Germinative Follicular Epithelium Neoplasm,0
3017,Acquired Lesion,Acquired cystic disease associated renal cell carcinoma,0
3018,Neuropil Present,Malignant neoplasm of stomach recurrent,0
3019,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3020,Tissue of Mullerian Origin Present,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
3021,Microfollicular Structures Present,Malignant neoplasm of stomach recurrent,0
3022,Single Cell Necrosis,Transplant-Related Renal Cell Carcinoma,0
3023,Seizures,Malignant neoplasm of stomach recurrent,0
3024,Aberrant Thyroid Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
3025,Calcinosis,Occult Lung Cancer AJCC v8,0
3026,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Sellar Region,0
3027,Nuclear Molding,Adenocarcinoma with squamous metaplasia,0
3028,Atypical Lymphocytes Present in Peripheral Blood,Lung Carcinoma Metastatic in the Liver,0
3029,Metaplasia,Ductal Breast Carcinoma with Squamous Metaplasia,0
3030,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Gastric Body Carcinoma In Situ AJCC v6 and v7,0
3031,Recurrent Lymphoma,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0
3032,Synchronous Lesion,Pre-Malignant Skin Epithelial Lesion,0
3033,Peripheral Blood Involvement,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
3034,Serrated Glandular Architecture,Cervical Glandular Neoplasm,0
3035,Mediastinal mass,Mediastinal Leiomyoma,0
3036,Polyvesicular Vitelline Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3037,Favorable Clinical Outcome,Hodgkin Lymphoma by Clinical Course,0
3038,Lytic lesion,Angiocentric immunoproliferative lesion grade 2,0
3039,Firm mass,Occult Lung Cancer AJCC v8,0
3040,Well Developed Rough Endoplasmic Reticulum Present,Pleural Well Differentiated Papillary Mesothelioma,0
3041,Cauliflower-Like Mass,Pseudolymphoma,0
3042,Neoplastic Plasma Cells Present in Bone Marrow,Prostate Carcinoma Metastatic in the Bone,0
3043,Pseudostratified Tumor Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3044,Sclerotic Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3045,Aberrant Thyroid Tissue Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,0
3046,Syncytial Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3047,Nuclear Molding,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
3048,Muscle Invasion,Benign Skeletal Muscle Neoplasm,0
3049,Gastrin Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
3050,Mature Neutrophils Present,Sellar Mature Teratoma,0
3051,Hemosiderin pigmentation,Pseudolymphoma,0
3052,Limited Early T-Cell Differentiation,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,0
3053,Striated Muscle Component Present,Malignant Skeletal Muscle Neoplasm,0
3054,Annular Tubules Present,Occult Lung Cancer AJCC v8,0
3055,Glandular cell atypia,Ovarian germ cell choriocarcinoma stage I,0
3056,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
3057,Therapy-Related Toxicity,Occult Lung Cancer AJCC v8,0
3058,PSA Failure,Adenocarcinoma with squamous metaplasia,0
3059,Extramedullary Hematopoiesis (disorder),Adenocarcinoma of lung (disorder),0
3060,Regional Disease,Erdheim-Chester Disease,0
3061,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
3062,CDKN2A-p16 Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
3063,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
3064,Lesion Less than 5mm in Diameter,Metastatic Malignant Neoplasm in the Sellar Region,0
3065,Well-Circumscribed Lesion,Pre-Malignant Skin Epithelial Lesion,0
3066,Serotonin Positive Neoplastic Cells Present,Neoplastic Polyp,0
3067,Metaplasia,Breast Carcinoma with Chondroid Metaplasia,0
3068,Gastric-Type Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3069,Red Papular Lesion,Pre-Malignant Skin Epithelial Lesion,0
3070,Fibromyxoid Stroma Formation,Classical Low Grade Fibromyxoid Sarcoma,0
3071,Lepidic Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3072,Nodular lesions,Subcutaneous Nodular Fasciitis,0
3073,Aflatoxins Toxicity,Malignant neoplasm of stomach recurrent,0
3074,Epithelial Component Present,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
3075,Intravascular papillary endothelial hyperplasia,Endometrial cystic hyperplasia,0
3076,Unmethylated MGMT Gene Promoter,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
3077,Desmoplastic Stroma Formation,Desmoplastic fibroma,0
3078,Cord-Like Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3079,Less than 2 Mitoses per 10HPF,Grade 2 Colon Adenocarcinoma,0
3080,Proliferation of High Endothelial Venules Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
3081,Lesion with Diameter Less than 11mm,Renal Cell Carcinoma Associated with Neuroblastoma,0
3082,Black Discoloration,Adenocarcinoma with squamous metaplasia,0
3083,Microvascular Proliferation,B-Cell Proliferation of Uncertain Malignant Potential,0
3084,Striated Muscle Component Present,Malignant Skeletal Muscle Neoplasm,0
3085,Five or Less Mitoses per 50HPF,Ovarian Biphasic or Triphasic Teratoma,0
3086,Absence of Basal Cell Layer,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3087,Cystic Change,Cervical Adenoid Cystic Carcinoma,0
3088,Folliculotropic Lymphocytic Infiltrate,Stage B Chronic Lymphocytic Leukemia,0
3089,Generalized illness,Adenocarcinoma with squamous metaplasia,0
3090,Multilocular Lesion,Primary Melanocytic Lesion of Meninges,0
3091,Hypergammaglobulinemia,Malignant neoplasm of stomach recurrent,0
3092,Prominent In Situ Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,0
3093,Somatostatin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
3094,Well Differentiated Hyaline Cartilage Present,Well Differentiated Malignant Neoplasm,0
3095,More than 5 Mitoses per 50HPF,Adenocarcinoma with squamous metaplasia,0
3096,Bile Pigment Present,Bile duct cystadenocarcinoma,0
3097,Non-Malignant Cellular Infiltrate,Ovarian Cellular Fibroma,0
3098,Pregnancy Complications,Non-Hodgkin Lymphoma During Pregnancy,0
3099,Malignant Cellular Infiltrate,Cellular neurothekeoma,0
3100,Cementum Formation,Pseudolymphoma,0
3101,Birbeck Granules Present,Occult Lung Cancer AJCC v8,0
3102,Blasts Under 5 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
3103,Blasts 10-19 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
3104,Extraosseous Lesion,Primary Melanocytic Lesion of Meninges,0
3105,Entrapped Respiratory Epithelium Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
3106,Ganglion Cell-Like Elements Present,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0
3107,Arborizing Vascular Channel Formation,Malignant Vascular Neoplasm,0
3108,Polarization of Nuclei Towards the Glandular Lumen,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
3109,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Lung Neuroendocrine Neoplasm,0
3110,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Bone Marrow Transplantation Nephropathy,0
3111,Drop Metastasis,Stage IV Major Salivary Gland Carcinoma without Metastasis,0
3112,Splenomegaly,Occult Lung Cancer AJCC v8,0
3113,MGMT Gene Promoter Methylation,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
3114,Neuroectodermal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3115,Multinodular Mass,Adenocarcinoma with squamous metaplasia,0
3116,Matrical Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
3117,Basophilia (finding),Malignant neoplasm of stomach recurrent,0
3118,Nodular Pattern,Nodular fasciitis,0
3119,Aggressive Clinical Course,Non-Hodgkin Lymphoma by Clinical Course,0
3120,Lepidic Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3121,Proliferation of Follicular Dendritic Cells Present,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,0
3122,Single Type of Tissue Derived from One Embryonic Layer Present,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
3123,Spindle Cell Osteo-Fibrous Component Present,Ciliary Body Spindle Cell Type B Melanoma,0
3124,Microcystic Change,Microcystic meningioma,0
3125,Aggressive Clinical Course,Non-Hodgkin Lymphoma with Variable Clinical Course,0
3126,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
3127,Stable Disease,Chronic Bullous Disease of Childhood,0
3128,New bone formation (morphologic abnormality),malignant neoplasm of bone marrow,0
3129,Mitotic Activity,Malignant neoplasm of stomach recurrent,0
3130,"Fully Differentiated ""Adult-Type"" Tissues Present",Differentiated Thyroid Gland Carcinoma,0
3131,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
3132,Pseudostratified Columnar Tumor Cells Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0
3133,Monoclonal Paraproteinemia,Monoclonal Gammopathy of Renal Significance,0
3134,Prominent Collagen Rosette Formation,Malignant neoplasm of stomach recurrent,0
3135,Squamous Metaplasia of Malignant Cells Present,Malignant lymphoma of spleen,0
3136,Clinical TNM Finding,Hodgkin Lymphoma by Clinical Course,0
3137,Atypical Mitotic Figures,Childhood Atypical Choroid Plexus Papilloma,0
3138,Monoclonal Myeloid or Lymphoid Cells Present,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0
3139,Peribronchial Proliferation of Neoplastic Cells Present,T-Cell Proliferation of Uncertain Malignant Potential,0
3140,Defective Alpha Heavy Chain Present,Heavy Chain Deposition Disease,0
3141,Preserved Nuclear Polarity,Malignant neoplasm of stomach recurrent,0
3142,Comedo Necrosis,Adenocarcinoma with squamous metaplasia,0
3143,Antoni A Pattern,Stage A Chronic Lymphocytic Leukemia,0
3144,Subcutaneous Involvement,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
3145,Reactive Germinal Centers Present,Reactive systemic amyloidosis,0
3146,Multinodular Pattern,Multinodular and Vacuolated Tumor of the Cerebrum,0
3147,Intermediate Grade Lesion,Intermediate Grade Ductal Breast Carcinoma In Situ,0
3148,Dermal Nodule,Placental Site Nodule or Plaque,0
3149,Non-Hereditary Lesion,Reactive Cutaneous Fibrous Lesion,0
3150,Regional Disease,Localized Castleman Disease,0
3151,Junctional Proliferation,Junctional Epidermolysis Bullosa,0
3152,Prominent In Situ Component Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,0
3153,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3154,Pseudo-Psammoma Body Formation,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,0
3155,Mesenchymal Component Present,Glioblastoma with Primitive Neuronal Component,0
3156,Epithelioid Differentiation,Epithelioid cell nevus,0
3157,Well Differentiated Hyaline Cartilage Present,Advanced Well Differentiated Neuroendocrine Neoplasm,0
3158,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Squamous cell carcinoma of head and neck metastatic,0
3159,Widely Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,0
3160,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
3161,Hypocellular Tissue,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
3162,Mesenchymal Component Present,Glioblastoma with Primitive Neuronal Component,0
3163,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
3164,Osteosclerotic Lesion,Reactive Cutaneous Fibrous Lesion,0
3165,Prominent Collagen Rosette Formation,Occult Lung Cancer AJCC v8,0
3166,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Metastatic Malignant Neoplasm in the Iris,0
3167,Hyperkeratosis,Occult Lung Cancer AJCC v8,0
3168,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
3169,Ventricular Involvement Only,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
3170,Smooth Muscle Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
3171,Micropapillary Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
3172,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
3173,Tubal Diverticulosis,Tubal Epithelial Hyperplasia,0
3174,Extensive Stage Lesion,Refractory Extensive Stage Lung Small Cell Carcinoma,0
3175,Crystal deposition,Immunoglobulin deposition disease,0
3176,Monoclonal Langerhans Cells Present,Tumors Derived from Langerhans Cells,0
3177,Malignant Germinomatous Cellular Infiltrate,Cellular neurothekeoma,0
3178,Squamous metaplasia of bladder,Squamous cell carcinoma of skin,0
3179,Lesion with Diameter of 2cm or Less,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
3180,Cavernous Lymphatic Space Formation,Thyroid Gland Cavernous Hemangioma,0
3181,Slit-Like Vascular Channel Formation,Radiation-Induced Vascular Disease,0
3182,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
3183,Absence of Muscle Invasion,Recurrent tumors of the Ewing's family,0
3184,Abnormal Eosinophilic Granules Present,Eosinophilic Granuloma,0
3185,Bone Marrow Involvement,Unresectable Bone Sarcoma,0
3186,Junctional Proliferation,Junctional Epidermolysis Bullosa,0
3187,Pautrier-Like Microabscess Present,Adenocarcinoma with squamous metaplasia,0
3188,Well Differentiated Lesion,Well Differentiated Malignant Neoplasm,0
3189,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
3190,Seizures,Malignant neoplasm of stomach recurrent,0
3191,Erythema,Adenocarcinoma with squamous metaplasia,0
3192,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3193,Tumor Mass,Malignant Gastric Granular Cell Tumor,0
3194,Matrical Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3195,Fenestrated Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3196,Tubular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3197,Small Aggregates of Tumor Cells Present,Adult Desmoplastic Small Round Cell Tumor,0
3198,Vascular Channel Formation,Radiation-Induced Vascular Disease,0
3199,Non-Contiguous Disease,Localized Castleman Disease,0
3200,Seminomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
3201,Increased NFkappaB Pathway Activation,Adenocarcinoma with squamous metaplasia,0
3202,Angioinvasion,Adenocarcinoma with squamous metaplasia,0
3203,Rimming of Adipose Tissue Cells Present,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
3204,Nuclear Expression of STAT6 Protein,Malignant neoplasm of stomach recurrent,0
3205,Drug Exposure,Malignant neoplasm of stomach recurrent,0
3206,Exophytic Papillary Lesion,Gastric Papillary Adenocarcinoma,0
3207,Villous Projections of the Neoplastic Epithelium Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
3208,More than 10 Mitoses per 10HPF,Occult Lung Cancer AJCC v8,0
3209,Ionizing Radiation Toxicity,Radiation Anemia,0
3210,Melanoma Cells Present,Nevoid Melanoma,0
3211,Odontogenic Cysts,Odontogenic myxoma,0
3212,Photosensitivity of skin,Non-neoplastic nevus of skin,0
3213,Intracellular Accumulation of Lipids,Ampulla of Vater Mucinous Adenocarcinoma,0
3214,Whorling Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3215,Dilated Cystic Spaces Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
3216,Endometrial Type Glands and Stroma Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",0
3217,Prominent Elastic Tissue Cores Present,Malignant Splenic Soft Tissue Neoplasm,0
3218,Sonic Hedgehog/Patch Pathway Activated,Recurrent Childhood Visual Pathway Astrocytoma,0
3219,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Lung Neuroendocrine Neoplasm,0
3220,Unilineage Dysplasia Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
3221,Cord-Like Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3222,Nuclear Expression of STAT6 Protein,"Benign neoplasm of brain, unspecified",0
3223,Encapsulated Mass,Adenocarcinoma with squamous metaplasia,0
3224,Rubbery Skin Lesion,Locally Advanced Skin Squamous Cell Carcinoma,0
3225,HER2/Neu Negative,Occult Lung Cancer AJCC v8,0
3226,Pre-existing condition,Pseudolymphoma,0
3227,Hereditary Lesion,Reactive Cutaneous Fibrous Lesion,0
3228,Schwannian Stroma More than 50 Percent of the Tumor Volume,Multinodular and Vacuolated Tumor of the Cerebrum,0
3229,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3230,No Evidence of Metastatic Disease,Chronic Bullous Disease of Childhood,0
3231,Pseudo-Psammoma Body Formation,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
3232,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,0
3233,Giant Mitochondria Present,Giant Hemangioma,0
3234,Indolent Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
3235,Micronodular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3236,Premalignant Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
3237,Emperipolesis,Malignant neoplasm of stomach recurrent,0
3238,Mass of pleura,Lipoma of pleura,0
3239,Finding related to pregnancy,Anemia due to membrane defect,0
3240,Positive Axillary Lymph Node,Axillary lymphadenitis,0
3241,Low Grade Cartilaginous Component Present,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
3242,Neoplastic Growth or Spread,Neoplastic Polyp,0
3243,PSA Failure,Malignant neoplasm of stomach recurrent,0
3244,Proliferation of Small Ducts Present,Small cell carcinoma of esophagus,0
3245,Monocytosis,Malignant neoplasm of stomach recurrent,0
3246,Hyalinized Vessels Present,Malignant neoplasm of stomach recurrent,0
3247,Windblown Appearance of Atypical Keratinocytes,Atypical hyperplasia of breast,0
3248,Intraluminal Tumor Growth,Childhood Carcinoid Tumor,0
3249,Ineffective hematopoiesis,Occult Lung Cancer AJCC v8,0
3250,Rapidly Enlarging Mass,Adenocarcinoma with squamous metaplasia,0
3251,Transformed Phase of Disease,Leukemic Phase of Non-Hodgkin's Lymphoma,0
3252,Chronic Clinical Course,Non-Hodgkin Lymphoma by Clinical Course,0
3253,Dual Population of Bone Marrow Blasts Present,Malignant Giant Cell Tumor of Bone,0
3254,Microfollicular Structures Present,Malignant neoplasm of stomach recurrent,0
3255,Gastrointestinal Type Epithelium Present,Multiple Endocrine Neoplasia Type 2a,0
3256,Cambium Layer,Malignant neoplasm of stomach recurrent,0
3257,Slit-Like Stromal Retraction Present,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
3258,Inflammation,Occult Lung Cancer AJCC v8,0
3259,Glandular Differentiation,Cervical Glandular Neoplasm,0
3260,Estrogen receptor negative,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
3261,Vater-Pacini Corpuscles-Like Structures Present,Adenocarcinoma with squamous metaplasia,0
3262,Osseous metaplasia,Nephrogenic metaplasia,0
3263,Recurrent Malignant Neoplasm,Childhood Recurrent Malignant Solid Neoplasm,0
3264,Aggravated Disease,Multi-centric Castleman's Disease,0
3265,Reactive Germinal Centers Present,Reactive Cutaneous Fibrous Lesion,0
3266,Epithelioid Differentiation,Breast Epithelioid Hemangioma,0
3267,CD56-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
3268,Monoclonal Paraproteinemia Present in Lower than Myeloma Levels,Colorectal Carcinoma Metastatic in the Liver,0
3269,Absence of Malignant Features,Malignant neoplasm of stomach recurrent,0
3270,Prominent Squamous Eddies Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,0
3271,Mesenchymal Metaplasia,Breast Carcinoma with Chondroid Metaplasia,0
3272,Melanoma Cells Present,Nevoid Melanoma,0
3273,Neuropil Present,Malignant neoplasm of stomach recurrent,0
3274,Multifocal Lesion,Pre-Malignant Skin Epithelial Lesion,0
3275,Neuronal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3276,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
3277,No Evidence of Metastatic Disease,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
3278,Skin Ulcer,Transplant-Related Skin Squamous Cell Carcinoma,0
3279,Dysplastic Dentin Formation,Low Grade Liver Dysplastic Nodule,0
3280,Osteosclerotic Lesion,Primary Melanocytic Lesion of Meninges,0
3281,Nuclear Molding,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
3282,Rosette-Like Configurations Present,Occult Lung Cancer AJCC v8,0
3283,Edematous Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
3284,Blasts 5-19 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
3285,Intraluminal Tumor Growth,Childhood Carcinoid Tumor,0
3286,Tobacco Toxicity,Adenocarcinoma with squamous metaplasia,0
3287,Tartrate Resistant Acid Phosphatase Positive Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
3288,Obesity,Adenocarcinoma with squamous metaplasia,0
3289,Diffuse Cellular Infiltrate,Diffuse Lipomatosis,0
3290,Chromogranin A Positive Neoplastic Cells Present,"Spindle cell melanoma, type A",0
3291,Pseudostratified Tumor Cells Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0
3292,Bone Marrow Lymphoplasmacytic Infiltrate,Breast Carcinoma Metastatic in the Bone,0
3293,Schwannian Stroma More than 50 Percent of the Tumor Volume,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
3294,Serum phosphate concentration below normal,Adenocarcinoma with squamous metaplasia,0
3295,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
3296,Neoplastic Cells with TFH Cell Phenotype Present,Renal Cell Carcinoma Associated with Neuroblastoma,0
3297,Eosinophil count raised (finding),Pseudolymphoma,0
3298,Refractory Disease,Steroid Refractory Graft Versus Host Disease,0
3299,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Squamous cell carcinoma of head and neck metastatic,0
3300,Moderate cytologic atypia,Occult Lung Cancer AJCC v8,0
3301,Lesion with Diameter of 2cm or Less,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
3302,Chromogranin A Positive Neoplastic Cells Present,Neoplastic Polyp,0
3303,Perineural spread,Pseudolymphoma,0
3304,Serum phosphate concentration below normal,Cytogenetically normal acute myeloid leukemia,0
3305,Fetal -Epithelial Differentiation,Fetal Lung Adenocarcinoma,0
3306,Pseudostratified Tumor Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3307,More than 5 Mitoses per 50HPF,Occult Lung Cancer AJCC v8,0
3308,Bone Marrow Lymphoplasmacytic Infiltrate,Stage IB Bone Sarcoma AJCC v7,0
3309,Cytoplasmic Accumulation of Black Pigment,Ampulla of Vater Mucinous Adenocarcinoma,0
3310,Lymphadenopathy,Occult Lung Cancer AJCC v8,0
3311,Multifocal Unisystem Disease,Multi-centric Castleman's Disease,0
3312,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
3313,Endodermal Sinus Pattern,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,0
3314,Arborising Network of Cords of Basaloid Cells Present,Malignant neoplasm of stomach recurrent,0
3315,Cytoplasmic Accumulation of Black Pigment,Recurrent tumors of the Ewing's family,0
3316,Unfavorable Clinical Outcome,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
3317,Lymphadenopathy,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,0
3318,Negative Bone Marrow and Peripheral Blood,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3319,"Amorphus, Eosinophilic, and Acellular Deposit",Gastric Body Carcinoma In Situ AJCC v6 and v7,0
3320,Follicular Structures Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
3321,Macrofollicular Structures Present,Adenocarcinoma with squamous metaplasia,0
3322,Cartilaginous metaplasia,Adenocarcinoma with osseous metaplasia,0
3323,Extramedullary Hematopoiesis (disorder),Extramedullary Plasmacytoma,0
3324,Prominent Stromal Reaction,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
3325,Paucicellular Stroma Present,Gastric Carcinoma with Lymphoid Stroma,0
3326,Antoni B Pattern,Stage B Chronic Lymphocytic Leukemia,0
3327,Sarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,0
3328,Lepidic Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3329,Pleural effusion disorder,Pleural Synovial Sarcoma,0
3330,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Giant Cell Tumor of Bone,0
3331,Squamous metaplasia of bladder,Carcinoma of bladder,0
3332,Marked Nuclear Atypia Present,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
3333,Thin-Branching Papillae Present,Adenocarcinoma with squamous metaplasia,0
3334,Radiation Sickness,Adenocarcinoma with squamous metaplasia,0
3335,Cambium Layer,Malignant neoplasm of stomach recurrent,0
3336,Bilateral Mass,Bilateral Carcinoma,0
3337,Plexiform Vasculature Present,Plexiform fibrohistiocytic tumor,0
3338,High Plasma Renin Activity,Plasma Cell Myeloma by DS Stage,0
3339,Fever,Adenocarcinoma with squamous metaplasia,0
3340,Folliculotropic Lymphocytic Infiltrate,Stage B Chronic Lymphocytic Leukemia,0
3341,Plexiform Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
3342,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Malignant neoplasm of stomach recurrent,0
3343,Glomeruloid Vessels Present,Occult Lung Cancer AJCC v8,0
3344,Erythema,Erythema Multiforme Major,0
3345,Jaw Keratocyst,Occult Lung Cancer AJCC v8,0
3346,Chronic Clinical Course,Non-Hodgkin Lymphoma by Clinical Course,0
3347,Lipomatous Differentiation,Intermediate Lipomatous Neoplasm,0
3348,Efferent Arteriolar Hyalinosis,Pseudolymphoma,0
3349,Pseudo-'onion bulb' formation,Occult Lung Cancer AJCC v8,0
3350,Thin Bands of Collagen Present,"Benign neoplasm of brain, unspecified",0
3351,Foveolar-Type Epithelium Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
3352,Islands of Odontogenic Epithelium Present,Recurrent tumors of the Ewing's family,0
3353,Blasts Expressing B-Lymphoid and Myeloid Markers Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
3354,Epithelial Component Present,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
3355,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Ampulla of Vater Tubular Adenoma,0
3356,Mixed Cellular Population,Cellular Blue Nevus,0
3357,Duct-Like Structures Present,Malignant neoplasm of stomach recurrent,0
3358,Tumor Vascular Invasion,Malignant Gastric Granular Cell Tumor,0
3359,Well Differentiated Hyaline Cartilage Present,Advanced Well Differentiated Neuroendocrine Neoplasm,0
3360,Fibrinous Material Present,Malignant neoplasm of stomach recurrent,0
3361,Perivascular fibrosis,"Perivascular epithelioid tumor, benign",0
3362,Nuclear Expression of STAT6 Protein,Malignant neoplasm of stomach recurrent,0
3363,Lesion with Diameter Greater than 15mm,Adenocarcinoma with squamous metaplasia,0
3364,Well Differentiated Neuroendocrine Lesion,Pleural Well Differentiated Papillary Mesothelioma,0
3365,Cellular Stratification,Uterine Corpus Cellular Leiomyoma,0
3366,Inclusion-Like Nucleoli,Adenocarcinoma with squamous metaplasia,0
3367,Mesenchymal Component Present,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
3368,Nuclear Molding,Malignant neoplasm of stomach recurrent,0
3369,VIP Positive Neoplastic Cells Present,Neoplastic Polyp,0
3370,Respiratory distress,Respiratory papilloma,0
3371,Abnormal alveolar pattern,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
3372,Neutrophilia (finding),Malignant neoplasm of stomach recurrent,0
3373,Cartilaginous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3374,Muscle Invasion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0
3375,Borderline Resectable Mass,Borderline Ovarian Endometrioid Cystadenofibroma,0
3376,Nuclear Expression of STAT6 Protein,Malignant neoplasm of stomach recurrent,0
3377,Annular Tubules Present,Malignant neoplasm of stomach recurrent,0
3378,Islands of Neuropil-Like Matrix Present,Malignant neoplasm of stomach recurrent,0
3379,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
3380,Muscle Invasion,Benign Skeletal Muscle Neoplasm,0
3381,Defective Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
3382,Mixture of Germ Cell Neoplastic Components Present,Benign Mediastinal Germ Cell Tumor,0
3383,Dysplastic Dentin Formation,Adenocarcinoma with squamous metaplasia,0
3384,Multilocular Lesion,Reactive Cutaneous Fibrous Lesion,0
3385,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3386,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Malignant Mixed Tumor of the Major Salivary Gland,0
3387,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Colorectal Carcinoma Metastatic in the Liver,0
3388,Cystic Change,Cervical Adenoid Cystic Carcinoma,0
3389,Pale Eosinophilic Stroma Formation,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
3390,Endobronchial Mass,Adenocarcinoma with squamous metaplasia,0
3391,Generalized Dysplasia,Squamous Lung Dysplasia,0
3392,Atypical Lymphocytes Present in Peripheral Blood,Colorectal Carcinoma Metastatic in the Liver,0
3393,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
3394,Infundibular-Like Structures Present,Occult Lung Cancer AJCC v8,0
3395,Monoclonal Cellular Population Present,Ovarian Cellular Fibroma,0
3396,Paucicellular Stroma Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
3397,Villous Projections of the Neoplastic Epithelium Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
3398,Glandular metaplasia,Cervical Glandular Neoplasm,0
3399,Defective Gamma Heavy Chain Present,Heavy Chain Deposition Disease,0
3400,High Grade Non Cartilaginous Sarcomatous Stroma Present,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
3401,Keratin Horn Pearls Formation,Pseudolymphoma,0
3402,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Giant Cell Tumor of Bone,0
3403,Pseudoencapsulated Mass,Adenocarcinoma with squamous metaplasia,0
3404,Nuclear pleomorphism,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
3405,Micropapillary Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3406,Acute inflammation,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0
3407,Mixture of Morphologic Patterns,Ampulla of Vater Mucinous Adenocarcinoma,0
3408,Chromogranin A Positive Neoplastic Cells Present,Kadish Stage A Olfactory Neuroblastoma,0
3409,High Plasma Renin Activity,DS Stage II Plasma Cell Myeloma,0
3410,Intravascular Spread,Medulloblastoma with Leptomeningeal Spread,0
3411,Dentin formation,Pseudolymphoma,0
3412,Hyperplastic Epithelial Tissue Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
3413,Pseudo-Psammoma Body Formation,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
3414,Oligodendroglial Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
3415,Endobronchial Mass,Endobronchial Leiomyoma,0
3416,Lipomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
3417,Bone marrow depression,Bone marrow hyperplasia,0
3418,Hormone Receptor Positive,Hormone refractory prostate cancer,0
3419,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Benign neoplasm of brain, unspecified",0
3420,Mild cytologic atypia,Complex endometrial hyperplasia without atypia,0
3421,Hypertensive disease,Lhermitte-Duclos disease,0
3422,Collagen Bundles Formation,Adenocarcinoma with squamous metaplasia,0
3423,Schwannian Stroma Predominant Component of the Tumor Volume,Multinodular and Vacuolated Tumor of the Cerebrum,0
3424,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
3425,Dyskeratosis,Adenocarcinoma with squamous metaplasia,0
3426,Peribronchial and Lobular Septal Involvement Only,Testicular Mixed Embryonal Carcinoma and Seminoma,0
3427,Immunoglobulin Deposition,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
3428,Low Grade Cartilaginous Component Present,Classical Low Grade Fibromyxoid Sarcoma,0
3429,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
3430,Glandular cell atypia,Primary cutaneous diffuse large cell B-cell lymphoma,0
3431,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Mixed Tumor of the Major Salivary Gland,0
3432,Acanthosis,Malignant neoplasm of stomach recurrent,0
3433,Glomeruloid Vessels Present,Adenocarcinoma with squamous metaplasia,0
3434,Bone Marrow Involvement,Unresectable Bone Sarcoma,0
3435,Extraosseous Lesion,Primary Melanocytic Lesion of Meninges,0
3436,Solar Radiation Toxicity,Solar lentigo,0
3437,Gyriform Trabecular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3438,Pain,Adenocarcinoma with squamous metaplasia,0
3439,Jaw Keratocyst,Occult Lung Cancer AJCC v8,0
3440,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Bone Marrow Transplantation Nephropathy,0
3441,Obesity,Malignant neoplasm of stomach recurrent,0
3442,Cambium Layer,Malignant neoplasm of stomach recurrent,0
3443,Lesion with Diameter Greater than 10mm,Adenocarcinoma with squamous metaplasia,0
3444,Large Spaces Filled with Blood Present,Large B-cell lymphoma with IRF4 rearrangement,0
3445,Locally Aggressive Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
3446,Sarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
3447,Well Differentiated Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
3448,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
3449,Defective Gamma Heavy Chain Present,Heavy Chain Disease,0
3450,Acral Lesion,Acral Lentiginous Malignant Melanoma,0
3451,Monoclonal Gammapathies,Monoclonal B-Cell Lymphocytosis,0
3452,Sheets of Interfollicular Plasma Cells Present,Malignant neoplasm of stomach recurrent,0
3453,Therapy-Related Toxicity,Adenocarcinoma with squamous metaplasia,0
3454,Huge Vascular Channel Formation,Malignant Vascular Neoplasm,0
3455,Urine phosphorous concentration above normal,Malignant neoplasm of stomach recurrent,0
3456,Plasma cell inflammation,Plasma cell myeloma recurrent,0
3457,Thyroglobulin Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
3458,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Sellar Region,0
3459,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Squamous cell carcinoma of head and neck metastatic,0
3460,Neuroendocrine Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3461,CD30-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
3462,Bone Marrow Involvement,Stage IB Bone Sarcoma AJCC v7,0
3463,Schwannian Stroma Predominant Component of the Tumor Volume,Multinodular and Vacuolated Tumor of the Cerebrum,0
3464,CD4-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
3465,Endobronchial Mass,Endobronchial lipoma,0
3466,Poikilocytosis,Malignant neoplasm of stomach recurrent,0
3467,Islands of Neuropil-Like Matrix Present,Recurrent tumors of the Ewing's family,0
3468,Diffuse Lesion,Diffuse Lipomatosis,0
3469,Melanosomes Present,Occult Lung Cancer AJCC v8,0
3470,Progressive Clinical Course,Non-Hodgkin Lymphoma with Variable Clinical Course,0
3471,Infundibular-Like Structures Present,Occult Lung Cancer AJCC v8,0
3472,Defective Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
3473,Generalized Hydropic Villous Change,Villous adenoma of rectum,0
3474,Ectopic Thyroid Tissue Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0
3475,Cellular Pleomorphism,Cellular Blue Nevus,0
3476,Monophasic Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3477,Precise Histogenesis Unknown,Adenocarcinoma of Unknown Primary,0
3478,Fried-Egg Appearance of the Bone Marrow,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
3479,Non Lipogenic Sarcomatous Stroma Present,Non functioning pancreatic endocrine tumor,0
3480,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Recurrent tumors of the Ewing's family,0
3481,Drug Exposure,Occult Lung Cancer AJCC v8,0
3482,Granuloma,Granuloma Annulare,0
3483,Human Papillomavirus Positive,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
3484,Calcitonin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
3485,Fascicles of Spindly Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3486,Immature Myeloid Cells Increased in Bone Marrow,Osteosarcoma Arising in Paget Disease of Bone,0
3487,Parakeratinized Stratified Squamous Epithelium Present,Squamous cell carcinoma of skin,0
3488,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Recurrent tumors of the Ewing's family,0
3489,Abnormal Eosinophilic Granules Present,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
3490,atypia morphology,Complex endometrial hyperplasia without atypia,0
3491,Acantholysis,Adenocarcinoma with squamous metaplasia,0
3492,Retiform Structures Comprise 90% or More of the Tumor,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
3493,Pagetoid Proliferation,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
3494,Perineural spread,Pseudolymphoma,0
3495,Hypokalemia,Malignant neoplasm of stomach recurrent,0
3496,Rapidly Enlarging Mass,Rapidly progressive glomerulonephritis,0
3497,Arborizing Vascular Channel Formation,Benign Cutaneous Vascular Neoplasm,0
3498,Distortion of the Hair Follicle,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
3499,Multihormonal Immunoreactivity Present in a Single Cell Type,Intermediate Cell Type Iris Melanoma,0
3500,Follicular Structures Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
3501,Neoplastic Cells with TFH Cell Phenotype Present,Renal Cell Carcinoma Associated with Neuroblastoma,0
3502,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Mixed Tumor of the Major Salivary Gland,0
3503,Cord-Like Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
3504,Drug Exposure,Pseudolymphoma,0
3505,Skin Ulcer,Locally Advanced Skin Squamous Cell Carcinoma,0
3506,Eccrine Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3507,Low Grade Lesion,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
3508,Antoni A Pattern,Stage A Chronic Lymphocytic Leukemia,0
3509,Intraosseous Lesion,Pre-Malignant Skin Epithelial Lesion,0
3510,"Undifferentiated ""Fetal-Type"" Tissues Present",Endometrial Undifferentiated Carcinoma,0
3511,Diffuse Pattern,Diffuse Lipomatosis,0
3512,Thin-Walled Branching Vascular Pattern,Radiation-Induced Vascular Disease,0
3513,Intramucosal Lesion,Reactive Cutaneous Fibrous Lesion,0
3514,Lymphadenopathy,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,0
3515,Two Separate Tumor Masses Present in the Same Organ,Colorectal Carcinoma Metastatic in the Liver,0
3516,Hemosiderin pigmentation,Occult Lung Cancer AJCC v8,0
3517,Precocious Puberty,Pseudolymphoma,0
3518,Folliculotropic Lymphocytic Infiltrate,Cutaneous Chronic Lymphocytic Leukemia,0
3519,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
3520,Villous Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3521,Oligodendroglial Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
3522,Bone Marrow and Blood Involvement,Testicular Mixed Embryonal Carcinoma and Seminoma,0
3523,Congenital Lesion,Pre-Malignant Skin Epithelial Lesion,0
3524,Capsular Invasion,Adenocarcinoma with squamous metaplasia,0
3525,Granuloma,Granuloma Annulare,0
3526,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Tubal Epithelial Hyperplasia,0
3527,Fibrosarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
3528,Extraosseous Lesion,Reactive Cutaneous Fibrous Lesion,0
3529,Blasts of Mixed Phenotype Present,Benign Mixed Tumor of the Vulva,0
3530,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
3531,Intracanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3532,Unmethylated MGMT Gene Promoter,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,0
3533,Nuclear pleomorphism,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
3534,Cicatrix,Adenocarcinoma with squamous metaplasia,0
3535,NRBC - Nucleated red blood cell present result,Primary cutaneous diffuse large cell B-cell lymphoma,0
3536,Low Grade Cartilaginous Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",0
3537,Actinic Damage,Malignant neoplasm of stomach recurrent,0
3538,Thick-Walled Hyalinized Vessels Present,Leiomyosarcoma of Vessels,0
3539,Lesion with Diameter Greater than 2cm,Adenocarcinoma with squamous metaplasia,0
3540,Rapidly Enlarging Mass,Adenocarcinoma with squamous metaplasia,0
3541,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of lacrimal duct,0
3542,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,Bone Marrow Transplantation Nephropathy,0
3543,Fascicles of Spindly Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3544,Seizures,Malignant neoplasm of stomach recurrent,0
3545,Neoplastic Plasma Cells Present in Bone Marrow,Bone Marrow Transplantation Nephropathy,0
3546,Efferent Arteriolar Hyalinosis,Occult Lung Cancer AJCC v8,0
3547,Mild dysplasia of colon,Pseudopolyposis of colon,0
3548,Endometrial Type Glands and Stroma Present,Type I Endometrial Adenocarcinoma,0
3549,Monoclonal Gammapathies,Monoclonal B-Cell Lymphocytosis,0
3550,Increased NFkappaB Pathway Activation,Adenocarcinoma with squamous metaplasia,0
3551,Tartrate Resistant Acid Phosphatase Positive Cells Present,Tumors Derived from Langerhans Cells,0
3552,Fetal -Epithelial Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3553,Embryoid Bodies Present,Malignant neoplasm of stomach recurrent,0
3554,Zonal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3555,Spindle Cell Metaplasia,Spindle Cell Type A Uveal Melanoma,0
3556,Cartilage-Like Elements Present,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0
3557,Endophytic Tumor Growth,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3558,Gastrointestinal Type Epithelium Present,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0
3559,Castration Resistance,Adenocarcinoma with squamous metaplasia,0
3560,MGMT Gene Promoter Methylation,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,0
3561,Dense Collagenized Tissue Present,Malignant Splenic Soft Tissue Neoplasm,0
3562,Immunoglobulin Heavy Chain Deposition,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
3563,Increased red cell mass,Primary cutaneous diffuse large cell B-cell lymphoma,0
3564,Pseudoangiomatoid Space Formation,Occult Lung Cancer AJCC v8,0
3565,Rosette-Like Configurations Present,Pseudolymphoma,0
3566,Cartilaginous Component Present,Glioblastoma with Primitive Neuronal Component,0
3567,Peribronchial and Lobular Septal Involvement Only,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
3568,Fever,Malignant neoplasm of stomach recurrent,0
3569,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
3570,Cartilaginous metaplasia,Adenocarcinoma with osseous metaplasia,0
3571,Melanin Pigment Present,Occult Lung Cancer AJCC v8,0
3572,Bone Marrow Dysplasia Present,Bone Marrow Transplantation Nephropathy,0
3573,Abundance of Small Lymphocytes,Small cell carcinoma of esophagus,0
3574,Entrapped Respiratory Epithelium Present,Germinative Follicular Epithelium Neoplasm,0
3575,One Germ Layer Present,Benign Mediastinal Germ Cell Tumor,0
3576,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
3577,Increased megakaryocytes (bone marrow),Malignant neoplasm of stomach recurrent,0
3578,Elastophagocytosis,Occult Lung Cancer AJCC v8,0
3579,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Erosive Adenomatosis of the Nipple,0
3580,Mammary Gland Type Features Present,Metastatic Thyroid Gland Carcinoma,0
3581,Mucocele of appendix,Carcinoid tumor of appendix,0
3582,Odontogenic Cysts,"Odontogenic tumor, benign",0
3583,Ectopic Thyroid Tissue Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,0
3584,Gastric-Type Epithelial Differentiation,Hepatoblastoma with Pure Fetal Epithelial Differentiation,0
3585,Basal Cells with Pale Cytoplasm Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
3586,Tall Papillae Present,Occult Lung Cancer AJCC v8,0
3587,HER2/Neu Negative,Adenocarcinoma with squamous metaplasia,0
3588,Pale Eosinophilic Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
3589,Annular Tubules Present,Adenocarcinoma with squamous metaplasia,0
3590,Extracutaneous Dissemination of Disease,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
3591,Indolent Clinical Course,Non-Hodgkin Lymphoma with Variable Clinical Course,0
3592,Dilated Thin-Walled Vascular Space Formation,Benign Cutaneous Vascular Neoplasm,0
3593,Acute inflammation,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,0
3594,Small Lesion,Stage IV Lung Small Cell Carcinoma AJCC v7,0
3595,Pseudorosette Formation,Pseudolymphoma,0
3596,Exposure to asbestos,Metastatic malignant neoplasm to nasopharynx,0
3597,Low Mitotic Activity,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
3598,Venous Type Vascular Channel Formation,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
3599,Solitary mass,Peritoneal Solitary Fibrous Tumor,0
3600,Aberrant Thyroid Tissue Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0
3601,Intracytoplasmic Eosinophilic Inclusion,Childhood Acute Eosinophilic Leukemia,0
3602,Glial Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3603,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3604,Adnexal Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
3605,Pancreatobiliary-Type Malignant Cells Present,Malignant Gastric Granular Cell Tumor,0
3606,Curvilinear Thin-Walled Vascular Pattern,Vascular neoplasm of skin,0
3607,Apocrine Differentiation,Breast Apocrine Adenoma,0
3608,Small Lesion,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,0
3609,Broad Fibrous Bands Formation,Reactive Cutaneous Fibrous Lesion,0
3610,Marked Thickening of the Bladder Urothelium Present,Recurrent tumors of the Ewing's family,0
3611,"Nodular, Reticulin-Free Zones Present",Adenocarcinoma with squamous metaplasia,0
3612,Fibrovascular Stalks Present,Adenocarcinoma with squamous metaplasia,0
3613,Fried-Egg Appearance of the Bone Marrow,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
3614,Perineural spread,Malignant neoplasm of stomach recurrent,0
3615,Cartilaginous metaplasia,adenocarcinoma of breast with spindle cell metaplasia,0
3616,Infantile Lesion,Reactive Cutaneous Fibrous Lesion,0
3617,Peripheral Nuclear Palisading,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
3618,Congenital Lesion,Reactive Cutaneous Fibrous Lesion,0
3619,Superficial Lesion,Superficial Epithelioma with Sebaceous Differentiation,0
3620,Nuclear Pseudoinclusion,Adenocarcinoma with squamous metaplasia,0
3621,Cervical lymphadenopathy,Stage IA2 Cervical Cancer AJCC v8,0
3622,Castration-Naive,Adenocarcinoma with squamous metaplasia,0
3623,Polarization of Nuclei Towards the Glandular Lumen,Erosive Adenomatosis of the Nipple,0
3624,Lesion with Diameter Greater than 2cm,Adenocarcinoma with squamous metaplasia,0
3625,Radial Growth Phase,"Polycythemia Vera, Polycythemic Phase",0
3626,Plexiform Vasculature Present,Chest Wall Plexiform Fibrohistiocytic Neoplasm,0
3627,Cytopenia,Occult Lung Cancer AJCC v8,0
3628,Mixed Cellular Population,Cellular neurothekeoma,0
3629,Endobronchial Lesion,Endobronchial Leiomyoma,0
3630,Lymphadenopathy,Occult Lung Cancer AJCC v8,0
3631,Dense Collagenized Tissue Present,Clear Cell Sarcoma of Soft Tissue,0
3632,Fascicular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3633,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent tumors of the Ewing's family,0
3634,Actinic Damage,Adenocarcinoma with squamous metaplasia,0
3635,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Prostate Carcinoma Metastatic in the Bone,0
3636,Negative Peripheral Blood,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
3637,MGMT Gene Promoter Methylation,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,0
3638,Dense Intercellular Reticulin Network Present,Occult Lung Cancer AJCC v8,0
3639,Nuclear Molding,Malignant neoplasm of stomach recurrent,0
3640,Melanoma Cells Present,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,0
3641,Multicentric Lesion,Pre-Malignant Skin Epithelial Lesion,0
3642,No Evidence of Metastatic Disease,Chronic Bullous Disease of Childhood,0
3643,Platinum Resistance,Adenocarcinoma with squamous metaplasia,0
3644,Arborizing Vascular Channel Formation,Vascular neoplasm of skin,0
3645,Mesenchymal Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
3646,Erythroid hyperplasia,Usual ductal hyperplasia of breast,0
3647,"Amorphus, Eosinophilic, and Acellular Deposit",Testicular Mixed Embryonal Carcinoma and Seminoma,0
3648,Microglandular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3649,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
3650,Dome-Shaped Lesion,Pre-Malignant Skin Epithelial Lesion,0
3651,Non-Specific Glandular Pattern,Glandular papilloma,0
3652,Submucosal Lesion,Pre-Malignant Skin Epithelial Lesion,0
3653,Edematous Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
3654,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
3655,Increased Cellularity Present,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage,0
3656,Parakeratosis,Occult Lung Cancer AJCC v8,0
3657,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Spindle Cell Oncocytoma of the Adenohypophysis,0
3658,Inoperable Disease,Multi-centric Castleman's Disease,0
3659,Multihormonal Immunoreactivity Present in a Single Cell Type,Intermediate Cell Type Iris Melanoma,0
3660,Congenital Abnormality,Congenital Vena Cava Abnormality,0
3661,Unfavorable Clinical Outcome,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
3662,Papulovesicular Lesion,Reactive Cutaneous Fibrous Lesion,0
3663,Pseudoencapsulated Mass,Adenocarcinoma with squamous metaplasia,0
3664,Pseudostratified Columnar Tumor Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3665,Squamoid Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3666,Concentric Perivascular Arrangement of Tumor Cells,Ampulla of Vater Neuroendocrine Tumor,0
3667,Biphasic Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3668,Dentin formation,Occult Lung Cancer AJCC v8,0
3669,Immature Myeloid Cells Increased in Bone Marrow,Bone Marrow Transplantation Nephropathy,0
3670,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
3671,Non-Malignant Cellular Infiltrate,Cellular Blue Nevus,0
3672,Acute inflammation,Childhood Acute Monoblastic Leukemia,0
3673,Acinar Proliferation,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",0
3674,Canalicular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3675,Bone marrow depression,Bone marrow hyperplasia,0
3676,Massive Sinusoidal Histiocytic Infiltrate,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",0
3677,Numerous Stromal Mast Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3678,Massive Sinusoidal Histiocytic Infiltrate,Histiocytic sarcoma,0
3679,Ventricular Involvement Only,Ventricular and Brain Stem Ependymal Tumor,0
3680,Juvenile Lesion,Juvenile Myelomonocytic Leukemia,0
3681,Low Grade Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
3682,More than 10 Mitoses per 10HPF,Malignant neoplasm of stomach recurrent,0
3683,Thick-Walled Hyalinized Vessels Present,Occult Lung Cancer AJCC v8,0
3684,Juvenile Lesion,Reactive Cutaneous Fibrous Lesion,0
3685,Bone Marrow Lymphoplasmacytic Infiltrate,Breast Carcinoma Metastatic in the Bone,0
3686,Insular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3687,Vascular Channel Formation with Muscular Walls,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3688,Cellular Stratification,Cellular neurothekeoma,0
3689,Defective Alpha Heavy Chain Present,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
3690,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Ovarian Biphasic or Triphasic Teratoma,0
3691,Immature Granulocytes in Peripheral Blood Increased,Colorectal Carcinoma Metastatic in the Liver,0
3692,Jaw Keratocyst,Occult Lung Cancer AJCC v8,0
3693,Nuclei of Various Sizes and Shapes Present,Squamous cell carcinoma of head and neck metastatic,0
3694,Gastric-Type Epithelial Differentiation,Hepatoblastoma with Pure Fetal Epithelial Differentiation,0
3695,Absence of a Hormonal Syndrome,Ampulla of Vater Mucinous Adenocarcinoma,0
3696,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Poorly Differentiated Hepatocellular Carcinoma,0
3697,Nodules of Compact Keratin Present,Ampulla of Vater Mucinous Adenocarcinoma,0
3698,Perineural spread,Adenocarcinoma with squamous metaplasia,0
3699,Fetiform Mass,Occult Lung Cancer AJCC v8,0
3700,Vertical Growth Phase,Leukemic Phase of Non-Hodgkin's Lymphoma,0
3701,Epithelial Differentiation,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
3702,Cold Nodule,Placental Site Nodule or Plaque,0
3703,Pseudostratified Columnar Tumor Cells Present,Malignant Gastric Granular Cell Tumor,0
3704,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Metastatic malignant neoplasm to nasopharynx,0
3705,Dense Intercellular Reticulin Network Present,Pseudolymphoma,0
3706,Lesion with Diameter Greater than 15mm,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3707,Generalized Dysplasia,Large Cell Dysplasia,0
3708,atypia morphology,Malignant neoplasm of stomach recurrent,0
3709,Two Separate Tumor Masses Present in the Same Organ,Lung Carcinoma Metastatic in the Liver,0
3710,Coughing,Occult Lung Cancer AJCC v8,0
3711,Non-Invasive Lesion,Primary Melanocytic Lesion of Meninges,0
3712,Massive Sinusoidal Histiocytic Infiltrate,Histiocytic Necrotizing Lymphadenitis,0
3713,Psammoma Body Formation,Intermediate Cell Type Ciliary Body Melanoma,0
3714,Mammary Gland Type Features Present,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0
3715,Peau d'orange surface of breast,Atypical hyperplasia of breast,0
3716,Comedo Necrosis,Malignant neoplasm of stomach recurrent,0
3717,Tartrate Resistant Acid Phosphatase Positive Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
3718,Meckel Diverticulum,Malignant neoplasm of stomach recurrent,0
3719,Pseudoangiomatoid Space Formation,Pseudolymphoma,0
3720,Sinusoidal Infiltration,Malignant neoplasm of stomach recurrent,0
3721,Multilocular Lesion,Reactive Cutaneous Fibrous Lesion,0
3722,Annular Tubules Present,Malignant neoplasm of stomach recurrent,0
3723,Cambium Layer,Occult Lung Cancer AJCC v8,0
3724,Human Papillomavirus Negative,AIDS-Related Human Papillomavirus Infection,0
3725,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3726,Confluent Sheets of Neoplastic B-Lymphocytes Present,Ampulla of Vater Mucinous Adenocarcinoma,0
3727,Blasts Under 5 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
3728,Mass of body structure,Leiomyoma of ciliary body,0
3729,Locally Aggressive Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
3730,Cryptitis,Occult Lung Cancer AJCC v8,0
3731,Peau d'orange surface of breast,malignant myoepithelioma of breast,0
3732,High Plasma Renin Activity,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
3733,Infiltrating Tumor Margins Present,Malignant Gastric Granular Cell Tumor,0
3734,Infiltrative Growth Pattern,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",0
3735,Neuropil Present,Occult Lung Cancer AJCC v8,0
3736,Unclassifiable Lesion,Primary Melanocytic Lesion of Meninges,0
3737,Mixture of Morphologic Patterns,"Benign neoplasm of brain, unspecified",0
3738,Cysts Containing Proteinaceous Fluid Present,Malignant neoplasm of stomach recurrent,0
3739,Red Papular Lesion,Primary Melanocytic Lesion of Meninges,0
3740,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3741,Atypical Mitotic Figures,Recurrent Atypical Teratoid/Rhabdoid Tumor,0
3742,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
3743,Pushing Tumor Margin,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3744,Poorly Differentiated Lesion,Poorly Differentiated Neuroblastoma,0
3745,Respiratory distress,Respiratory papilloma,0
3746,Diffuse Lesion,Hereditary Diffuse Gastric Adenocarcinoma,0
3747,Blastemal Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
3748,Peripheral Blood Involvement,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
3749,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
3750,Papulovesicular Lesion,Pre-Malignant Skin Epithelial Lesion,0
3751,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
3752,Infiltrating Tumor Margins Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3753,Tumor Mass,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3754,Islands of Odontogenic Epithelium Present,Recurrent tumors of the Ewing's family,0
3755,Bile Pigment Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,0
3756,Complete Spontaneous Regression,Malignant neoplasm of stomach recurrent,0
3757,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Malignant neoplasm of stomach recurrent,0
3758,Intermediate Grade Lesion,Intermediate Grade Ductal Breast Carcinoma In Situ,0
3759,Increased Cellularity Present,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage,0
3760,Absence of a Hormonal Syndrome,Malignant neoplasm of stomach recurrent,0
3761,Intermediate Filaments Present,Intermediate Lipomatous Neoplasm,0
3762,Blastemal Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3763,Minimally Invasive Lesion,Minimally Invasive Mucinous Lung Adenocarcinoma,0
3764,Non-Contiguous Disease,Localized Castleman Disease,0
3765,Well Differentiated Hyaline Cartilage Present,Advanced Well Differentiated Neuroendocrine Neoplasm,0
3766,Osteogenesis,Pseudolymphoma,0
3767,Neuropil Present,Malignant neoplasm of stomach recurrent,0
3768,Sarcomatoid Stroma Formation,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",0
3769,Monoclonal Gammapathies,Monoclonal B-Cell Lymphocytosis,0
3770,Pale Eosinophilic Stroma Formation,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
3771,Actinic Damage,Adenocarcinoma with squamous metaplasia,0
3772,Fetiform Mass,Malignant neoplasm of stomach recurrent,0
3773,Distortion of the Hair Follicle,Erosive Adenomatosis of the Nipple,0
3774,Cytokeratin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
3775,Non-Malignant Cellular Infiltrate,Ovarian Cellular Fibroma,0
3776,Subcutaneous Involvement,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,0
3777,Poorly Differentiated Lesion,Poorly Differentiated Neuroblastoma,0
3778,Bilateral Disease,Erdheim-Chester Disease,0
3779,Precocious Puberty,Pseudolymphoma,0
3780,Islands of Odontogenic Epithelium Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
3781,Absence of Invasion or Limited Invasion Present,Malignant neoplasm of stomach recurrent,0
3782,Fibrotic Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
3783,Thin Bands of Collagen Present,Malignant neoplasm of stomach recurrent,0
3784,Plexiform Vasculature Present,Plexiform fibrohistiocytic tumor,0
3785,Unifocal Disease,Chronic Bullous Disease of Childhood,0
3786,Morphologic Overlap,Pseudolymphoma,0
3787,Massive Sinusoidal Histiocytic Infiltrate,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",0
3788,Concentric Perivascular Arrangement of Tumor Cells,Ampulla of Vater Neuroendocrine Tumor,0
3789,Thin-Branching Papillae Present,Occult Lung Cancer AJCC v8,0
3790,Systemic disease,Lhermitte-Duclos disease,0
3791,Basal Cells with Pale Cytoplasm Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
3792,Regional Disease,Localized Castleman Disease,0
3793,Rosette-Like Configurations Present,Malignant neoplasm of stomach recurrent,0
3794,Solitary Skin Tumor,Malignant Gastric Granular Cell Tumor,0
3795,Pseudoglandular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
3796,Severe dysplasia,Gastric dysplasia,0
3797,Leukoerythroblastic Reaction,Occult Lung Cancer AJCC v8,0
3798,Polyclonal hypergammaglobulinemia,Adenocarcinoma with squamous metaplasia,0
3799,Extraosseous Lesion,Primary Melanocytic Lesion of Meninges,0
3800,Solid Growth Pattern,Advanced Extracranial Malignant Solid Neoplasm,0
3801,VIP Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
3802,Ground Glass Nuclear Inclusion,Malignant neoplasm of stomach recurrent,0
3803,Mild cytologic atypia,Adenocarcinoma with squamous metaplasia,0
3804,Estrogen receptor negative,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
3805,Pancytopenia,Occult Lung Cancer AJCC v8,0
3806,Folliculotropic Lymphocytic Infiltrate,Cutaneous Chronic Lymphocytic Leukemia,0
3807,Plexiform Vasculature Present,Plexiform Neurofibroma,0
3808,Schwannian Stroma More than 50 Percent of the Tumor Volume,Malignant Mixed Tumor of the Major Salivary Gland,0
3809,Concentric Perivascular Arrangement of Tumor Cells,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3810,NRBC - Nucleated red blood cell present result,Primary cutaneous diffuse large cell B-cell lymphoma,0
3811,Minimally Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
3812,Enterochromaffin Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
3813,Wide Vessel-Like Spaces Formation,Malignant neoplasm of stomach recurrent,0
3814,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
3815,Negative Peripheral Blood,Peripheral Intraneural Angiosarcoma,0
3816,Generalized Hydropic Villous Change,Villous adenoma of rectum,0
3817,Shadow Cells Present,Tumors Derived from Langerhans Cells,0
3818,Nodular Pattern,Nodular fasciitis,0
3819,Mixture of Germ Cell Neoplastic Components Present,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
3820,"Hyperkeratosis, Epidermolytic","Keratoderma, Palmoplantar, Epidermolytic",0
3821,Endophytic Tumor Growth,Malignant Gastric Granular Cell Tumor,0
3822,Lesion with Diameter Greater than 15mm,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,0
3823,Monophasic Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3824,Lobular Pattern,"Carcinoma, Lobular",0
3825,Serum IgM Monoclonal Gammopathy of Less than 30g/L,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0
3826,IDH Gene Family Mutation Status Unknown,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,0
3827,Osseous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3828,Paucicellular Stroma Present,Gastric Carcinoma with Lymphoid Stroma,0
3829,Multinodular Mass,Malignant neoplasm of stomach recurrent,0
3830,Lesion with Diameter Greater than 2cm,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3831,Lesion Less than 10mm in Diameter,Colon Carcinoma Metastatic in the Liver,0
3832,Endophytic Tumor Growth,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3833,Defective Gamma Heavy Chain Present,Heavy Chain Deposition Disease,0
3834,Hyperchromatism,Occult Lung Cancer AJCC v8,0
3835,Perineural spread,Adenocarcinoma with squamous metaplasia,0
3836,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
3837,Shadow Cells Present,Testicular Seminoma with Syncytiotrophoblastic Cells,0
3838,Enterochromaffin Type Granules Present,Multiple Endocrine Neoplasia Type 2a,0
3839,Hyperchromatism,Occult Lung Cancer AJCC v8,0
3840,Swelling,Occult Lung Cancer AJCC v8,0
3841,Anaplasia,Occult Lung Cancer AJCC v8,0
3842,Histiocytosis haematophagic,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
3843,Poikilocytosis,Adenocarcinoma with squamous metaplasia,0
3844,Psammoma Body Formation,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,0
3845,NRBC - Nucleated red blood cell present result,Basal cell carcinoma - keratotic,0
3846,Intermediate Grade Lesion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
3847,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3848,Windblown Appearance of Atypical Keratinocytes,Ampulla of Vater Mucinous Adenocarcinoma,0
3849,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3850,Diffuse Pattern,Hereditary Diffuse Gastric Adenocarcinoma,0
3851,Aggressive Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
3852,Adnexal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3853,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,0
3854,Basal Cells with Pale Cytoplasm Present,Testicular Seminoma with Syncytiotrophoblastic Cells,0
3855,Dentin formation,Pseudolymphoma,0
3856,Cellular Pseudostratification,Ovarian Cellular Fibroma,0
3857,Squamoid Corpuscle,Malignant neoplasm of stomach recurrent,0
3858,Immature Granulocytes in Peripheral Blood Under 10 Percent,Intermediate Blood Vessel Neoplasm,0
3859,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
3860,Massive Sinusoidal Histiocytic Infiltrate,Histiocytic Necrotizing Lymphadenitis,0
3861,Villous Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
3862,Neoplastic Cells with TFH Cell Phenotype Present,Renal Cell Carcinoma Associated with Neuroblastoma,0
3863,Fever,Malignant neoplasm of stomach recurrent,0
3864,Platinum Sensitivity,Occult Lung Cancer AJCC v8,0
3865,Alopecia,Adenocarcinoma with squamous metaplasia,0
3866,Plasma cell inflammation,Primary cutaneous diffuse large cell B-cell lymphoma,0
3867,Intravascular Spread,Medulloblastoma with Leptomeningeal Spread,0
3868,Cold Nodule,Placental Site Nodule or Plaque,0
3869,Nuclei of Various Sizes and Shapes Present,Squamous cell carcinoma of head and neck metastatic,0
3870,Mixture of Embryonal and Alveolar Features Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
3871,Deep Lesion,Pre-Malignant Skin Epithelial Lesion,0
3872,Osseous Component Present,Glioblastoma with Primitive Neuronal Component,0
3873,Psammoma Body Formation,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,0
3874,Poikilocytosis,Occult Lung Cancer AJCC v8,0
3875,Canalicular Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3876,Antoni B Pattern,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),0
3877,Extensive Stage Lesion,Recurrent Extensive Stage Lung Small Cell Carcinoma,0
3878,Glucagon-Like Peptide Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
3879,Angioinvasion,Malignant neoplasm of stomach recurrent,0
3880,Leukoerythroblastic Reaction,Adenocarcinoma with squamous metaplasia,0
3881,Nuclear Expression of STAT6 Protein,Malignant neoplasm of stomach recurrent,0
3882,Humoral hypercalcemia of malignancy (disorder),Recurrent tumors of the Ewing's family,0
3883,Skin Erosion,Pre-Malignant Skin Epithelial Lesion,0
3884,Locally Aggressive Lesion,Locally Advanced Head and Neck Carcinoma,0
3885,Multiple Tumor Masses,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3886,Diffuse Lesion,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
3887,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3888,Osseous Component Present,Benign Extraskeletal Cartilaginous and Osseous Neoplasm,0
3889,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Erosive Adenomatosis of the Nipple,0
3890,Osteogenesis,Pseudolymphoma,0
3891,Argentaffin Positive Neoplastic Cells Present,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
3892,Trichoblastic Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
3893,Small Aggregates of Tumor Cells Present,Adult Desmoplastic Small Round Cell Tumor,0
3894,Thin-Walled Branching Vascular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
3895,Fascicular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3896,Multinodular Mass,Occult Lung Cancer AJCC v8,0
3897,Pale Eosinophilic Stroma Formation,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
3898,HIF1A Overexpression Positive,Hormone Receptor Positive Breast Carcinoma,0
3899,Fibromuscular Stroma Formation,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
3900,Enterochromaffin Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
3901,Lesion with Diameter Greater than 15mm,Adenocarcinoma with squamous metaplasia,0
3902,Antoni B Pattern,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),0
3903,Eccrine Differentiation,Eccrine Poroma,0
3904,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
3905,Skin nodule,Transplant-Related Skin Squamous Cell Carcinoma,0
3906,Hyperkeratosis,Pseudolymphoma,0
3907,WNT Pathway Activated,Recurrent Childhood Visual Pathway Astrocytoma,0
3908,Mixed Cellular Population,Cellular Blue Nevus,0
3909,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
3910,Limited Early T-Cell Differentiation,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,0
3911,Systemic disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
3912,Koilocytotic atypia,Malignant neoplasm of stomach recurrent,0
3913,Concentric Perivascular Arrangement of Tumor Cells,Ampulla of Vater Neuroendocrine Tumor,0
3914,Fibrovascular Septa Present,Malignant neoplasm of stomach recurrent,0
3915,Glomeruloid Vessels Present,Adenocarcinoma with squamous metaplasia,0
3916,Increased Cellularity Present,Adult Mixed Cellularity Classical Hodgkin Lymphoma,0
3917,Immature Granulocytes in Peripheral Blood Increased,Intermediate Blood Vessel Neoplasm,0
3918,EBV-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
3919,Ischemia,Occult Lung Cancer AJCC v8,0
3920,Sebaceous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3921,Cartilaginous metaplasia,adenocarcinoma of breast with spindle cell metaplasia,0
3922,Non-Specific Glandular Pattern,"Ovarian Yolk Sac Tumor, Glandular Pattern",0
3923,Less than 2 Mitoses per 10HPF,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,0
3924,Systemic disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
3925,Sinusoidal Infiltration,Pseudolymphoma,0
3926,Dilated Cystic Spaces Present,Cervical Adenoid Cystic Carcinoma,0
3927,Tubular Pattern,Tubular breast carcinoma,0
3928,Glandular Differentiation,Glandular papilloma,0
3929,Glandular Pattern,Cervical Glandular Neoplasm,0
3930,Edema,Malignant neoplasm of stomach recurrent,0
3931,Anastomosing Cells Connected to the Basal Layer of the Epidermis Present,Recurrent tumors of the Ewing's family,0
3932,Nuclei of Various Sizes and Shapes Present,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3933,Stromal Invasion,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
3934,Hemorrhagic Neuroblastic Nodules Present,Adenocarcinoma with squamous metaplasia,0
3935,Distortion of the Hair Follicle,Erosive Adenomatosis of the Nipple,0
3936,Spindle Cell Component Present,Spindle Cell Melanoma,0
3937,Hypergammaglobulinemia,Malignant neoplasm of stomach recurrent,0
3938,Fascicular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
3939,Organoid Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3940,Non-Hereditary Lesion,Primary Melanocytic Lesion of Meninges,0
3941,Histiocytoid Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
3942,Villous atrophy,Vaginal Villous Adenoma,0
3943,Hemosiderin pigmentation,Pseudolymphoma,0
3944,Red Papular Lesion,Reactive Cutaneous Fibrous Lesion,0
3945,Juvenile Lesion,Reactive Cutaneous Fibrous Lesion,0
3946,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
3947,Osteoid formation,Malignant neoplasm of stomach recurrent,0
3948,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
3949,Hyperkeratosis,Adenocarcinoma with squamous metaplasia,0
3950,Thick-Walled Vessels Present,Adenocarcinoma with squamous metaplasia,0
3951,Microcystic Change,Microcystic meningioma,0
3952,Juvenile Lesion,Juvenile astrocytoma,0
3953,Pre-existing condition,Adenocarcinoma with squamous metaplasia,0
3954,Microvascular Proliferation,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
3955,Lytic lesion,Cervical high grade squamous intraepithelial lesion,0
3956,Firm mass,Pseudolymphoma,0
3957,Urine phosphorous concentration above normal,Occult Lung Cancer AJCC v8,0
3958,Endocervical Type Epithelium Present,Multiple Endocrine Neoplasia Type 2a,0
3959,Lobular Pattern,"Carcinoma, Lobular",0
3960,Monocytosis,Adenocarcinoma with squamous metaplasia,0
3961,No Evidence of Hormonal Immunoreactivity Present,Ampulla of Vater Mucinous Adenocarcinoma,0
3962,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Sellar Teratoma with Malignant Transformation,0
3963,Blasts Expressing CD56 and Immature T-Cell Markers Present,Stage III Immature Testicular Teratoma AJCC v6 and v7,0
3964,Follicular Structures Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
3965,Cysts Containing Proteinaceous Fluid Present,Occult Lung Cancer AJCC v8,0
3966,Atypical Mitotic Figures,Recurrent Atypical Teratoid/Rhabdoid Tumor,0
3967,Organoid Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3968,Dermal Nodule,Low Grade Liver Dysplastic Nodule,0
3969,Tumor Mass,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3970,Angioinvasion,Pseudolymphoma,0
3971,Staghorn Configuration,Adenocarcinoma with squamous metaplasia,0
3972,Sebaceous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3973,Absence of Invasion,Recurrent tumors of the Ewing's family,0
3974,Hemorrhagic,Adenocarcinoma with squamous metaplasia,0
3975,Large Spaces Filled with Blood Present,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
3976,Rhabdomyosarcomatous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
3977,Beaded Anastomosing Cords Present,Anastomosing Hemangioma,0
3978,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3979,Cartilaginous Metaplasia of Malignant Cells Present,Malignant neoplasm of nasopharynx,0
3980,Capsular Invasion,Pseudolymphoma,0
3981,Composite Lesion,Pre-Malignant Skin Epithelial Lesion,0
3982,Bone Marrow Dysplasia Present,Bone Marrow Transplantation Nephropathy,0
3983,Hormone Receptor Positive,Hormone refractory prostate cancer,0
3984,Mass of body structure,Leiomyoma of ciliary body,0
3985,One Germ Layer Present,Childhood Malignant Ovarian Germ Cell Tumor,0
3986,Solitary Skin Tumor,Pericardial Solitary Fibrous Tumor,0
3987,Lesion Less than 5mm in Diameter,Lung Carcinoma Metastatic in the Liver,0
3988,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Erosive Adenomatosis of the Nipple,0
3989,Peau d'orange surface of breast,Usual ductal hyperplasia of breast,0
3990,Pushing Tumor Margin,Malignant Gastric Granular Cell Tumor,0
3991,Villous Projections of the Neoplastic Epithelium Present,Recurrent tumors of the Ewing's family,0
3992,Drop Metastasis,Occult Lung Cancer AJCC v8,0
3993,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,0
3994,Moderately Differentiated Lesion,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
3995,Perivascular Pseudorosette Formation,Occult Lung Cancer AJCC v8,0
3996,Nuclear Grooves,Adenocarcinoma with squamous metaplasia,0
3997,Fenestrating Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
3998,Sarcomatoid Features,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",0
3999,Multiple Tumor Masses,Malignant Gastric Granular Cell Tumor,0
4000,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4001,Nests of Nevus Cells Resembling Nerve Bundles Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4002,Lytic lesion,Angiocentric immunoproliferative lesion grade 2,0
4003,Prominent Keratin Formation,Occult Lung Cancer AJCC v8,0
4004,Osteogenesis,Malignant neoplasm of stomach recurrent,0
4005,Peribronchial and Lobular Septal Involvement Only,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
4006,Abnormal alveolar pattern,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
4007,Collagen Bundles Formation,Malignant neoplasm of stomach recurrent,0
4008,Focal Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4009,Intraepithelial Neoplasia,Transitional Cell Intraepithelial Neoplasia,0
4010,Nodular Pattern,Subcutaneous Nodular Fasciitis,0
4011,Rosette-Like Configurations Present,Malignant neoplasm of stomach recurrent,0
4012,Birbeck Granules Present,Pseudolymphoma,0
4013,Aberrant Thyroid Tissue Present,Metastatic Thyroid Gland Carcinoma,0
4014,Plexiform Growth Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4015,Dentin formation,Adenocarcinoma with squamous metaplasia,0
4016,Cellular Stratification,Cellular Blue Nevus,0
4017,No Evidence of Hormonal Immunoreactivity Present,Ampulla of Vater Mucinous Adenocarcinoma,0
4018,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
4019,Osseous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
4020,Hemosiderin pigmentation,Malignant neoplasm of stomach recurrent,0
4021,Cellular Stratification,Ovarian Cellular Fibroma,0
4022,Unicystic Lesion,Pre-Malignant Skin Epithelial Lesion,0
4023,Macrotrabecular Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
4024,Tricholemmal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4025,Monoclonal Gammapathies,Monoclonal B-Cell Lymphocytosis,0
4026,Nuclei of Various Sizes and Shapes Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
4027,Estrogen receptor negative,Adenocarcinoma with squamous metaplasia,0
4028,Rubbery Skin Lesion,Pre-Malignant Skin Epithelial Lesion,0
4029,Chondromyxoid Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
4030,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
4031,Perivascular Arrangement of Tumor Cells,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4032,Cytokeratin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4033,Follicular Structures Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
4034,Intraluminal Masses of Mucin Present,Malignant neoplasm of stomach recurrent,0
4035,Negative Bone Marrow and Peripheral Blood,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4036,Hemorrhagic Neuroblastic Nodules Present,Adenocarcinoma with squamous metaplasia,0
4037,High Plasma Renin Activity,Refractory High Risk Myelodysplastic Syndrome,0
4038,Micronodular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4039,Solitary mass,Pericardial Solitary Fibrous Tumor,0
4040,Single Cell Necrosis,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4041,Nodular Pattern,Subcutaneous Nodular Fasciitis,0
4042,Oligodendroglial Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
4043,Composite Lesion,Pre-Malignant Skin Epithelial Lesion,0
4044,Gastric-Type Epithelial Differentiation,Hepatoblastoma with Pure Fetal Epithelial Differentiation,0
4045,Poorly Differentiated Neuroendocrine Lesion,Poorly Differentiated Neuroblastoma,0
4046,Rosenthal Fibers Present,Pseudolymphoma,0
4047,Adnexal Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
4048,Therapy-Related Toxicity,Malignant neoplasm of stomach recurrent,0
4049,Moderately Differentiated Lesion,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
4050,Humoral hypercalcemia of malignancy (disorder),Adenocarcinoma of lung (disorder),0
4051,Serum phosphate concentration below normal,Adenocarcinoma with squamous metaplasia,0
4052,Storiform Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4053,Parakeratinized Stratified Squamous Epithelium Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,0
4054,Widely Invasive Lesion,Grade 3 Invasive Breast Carcinoma,0
4055,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Columnar Cell Change of the Breast with Atypia,0
4056,Cholesterolosis,Occult Lung Cancer AJCC v8,0
4057,Morphologic Overlap,Adenocarcinoma with squamous metaplasia,0
4058,Squamous Differentiation,Squamous cell carcinoma of skin,0
4059,Mass of body structure,Leiomyoma of ciliary body,0
4060,Pseudoencapsulated Mass,Occult Lung Cancer AJCC v8,0
4061,Bone Marrow Dysplasia Present,Breast Carcinoma Metastatic in the Bone,0
4062,Glomeruloid Vessels Present,Leiomyosarcoma of Vessels,0
4063,Serum IgM Monoclonal Gammopathy of Less than 30g/L,Monoclonal Gammopathy of Renal Significance,0
4064,High Plasma Renin Activity,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
4065,Nested Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4066,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Multinodular and Vacuolated Tumor of the Cerebrum,0
4067,Early Stromal Invasion Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4068,Immunoglobulin Light Chain Deposition,Immunoglobulin deposition disease,0
4069,Rhabdomyosarcomatous Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4070,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
4071,Plasma cell inflammation,Plasma cell myeloma recurrent,0
4072,Junctional Proliferation,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
4073,Cambium Layer,Occult Lung Cancer AJCC v8,0
4074,Multilayered Rosette Formation,Occult Lung Cancer AJCC v8,0
4075,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
4076,Unifocal Lesion,Reactive Cutaneous Fibrous Lesion,0
4077,New bone formation (morphologic abnormality),Peripheral primitive neuroectodermal bone tumor,0
4078,Abnormal Eosinophilic Granules Present,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,0
4079,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
4080,Five or Less Mitoses per 50HPF,Ovarian Biphasic or Triphasic Teratoma,0
4081,bone marrow fibrosis,malignant neoplasm of bone marrow,0
4082,Monoclonal Cellular Population Present,Cellular Blue Nevus,0
4083,High Plasma Renin Activity,DS Stage II Plasma Cell Myeloma,0
4084,Low Mitotic Activity,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
4085,Squamoid Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4086,Tumor Droplets Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4087,Histiocytoid Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4088,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
4089,Tumor Vascular Invasion,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4090,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4091,Peripheral Blood Involvement,Peripheral Intraneural Angiosarcoma,0
4092,Ectopic Thyroid Tissue Present,Metastatic Thyroid Gland Carcinoma,0
4093,Nuclear Molding,Malignant neoplasm of stomach recurrent,0
4094,Radiation Sickness,Adenocarcinoma with squamous metaplasia,0
4095,Dense Intercellular Reticulin Network Present,Malignant neoplasm of stomach recurrent,0
4096,Compartmentalized Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
4097,Sinusoidal Vascular Channel Formation,Vascular neoplasm of skin,0
4098,Well Developed Rough Endoplasmic Reticulum Present,Well Differentiated Malignant Neoplasm,0
4099,No Evidence of Metastatic Disease,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
4100,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
4101,Cytoplasmic Eosinophilic Globules Present,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,0
4102,Diarrhea,Adenocarcinoma with squamous metaplasia,0
4103,Locally Aggressive Lesion,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,0
4104,Malignant Cellular Infiltrate,Cellular neurothekeoma,0
4105,Tubal Diverticulosis,"Pregnancy, Tubal",0
4106,"Hyperkeratosis, Epidermolytic",Occult Lung Cancer AJCC v8,0
4107,Moderately Differentiated Lesion,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
4108,Broad Fibrous Bands Formation,Intracranial Benign Fibrous Histiocytoma,0
4109,Non-Contiguous Disease,Localized Castleman Disease,0
4110,Calcinosis,Malignant neoplasm of stomach recurrent,0
4111,Multilineage Dysplasia Present,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0
4112,Pseudostratified Tumor Cells Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0
4113,Parakeratinized Stratified Squamous Epithelium Present,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
4114,Large Neoplastic Glands with Branching and Papillary Infolding Present,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
4115,Abundance of Small Lymphocytes,Small cell neuroendocrine carcinoma of bladder,0
4116,Tissues Derived from Two or Three Embryonic Layers Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
4117,Primary Lesion,Primary Malignant Liver Neoplasm,0
4118,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
4119,Rapidly Enlarging Mass,Malignant neoplasm of stomach recurrent,0
4120,Unmethylated MGMT Gene Promoter,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,0
4121,Bone Marrow Involvement,Stage IB Bone Sarcoma AJCC v7,0
4122,Biphasic Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4123,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
4124,Neuropil Present,Pseudolymphoma,0
4125,Firm mass,Occult Lung Cancer AJCC v8,0
4126,Hyperplastic Tissue Present,Malignant Splenic Soft Tissue Neoplasm,0
4127,Alcohol Toxicity,Malignant neoplasm of stomach recurrent,0
4128,Pseudo-'onion bulb' formation,Pseudolymphoma,0
4129,Generalized Hydropic Villous Change,Small Intestinal Villous Adenoma,0
4130,Lesion Less than 5mm in Diameter,Colon Carcinoma Metastatic in the Liver,0
4131,Melanoma Cells Present,Nevoid Melanoma,0
4132,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent tumors of the Ewing's family,0
4133,Xp11.2 Translocations/TFE3 Gene Fusions Present,Breast Carcinoma by Gene Expression Profile,0
4134,Elastophagocytosis,Adenocarcinoma with squamous metaplasia,0
4135,Delicate Arborizing Vascular Channel Formation,Vascular neoplasm of skin,0
4136,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
4137,Matrical Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4138,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
4139,Absence of Invasion of the Muscularis Externa,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
4140,Mesenchymal Metaplasia,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
4141,Increased NFkappaB Pathway Activation,Refractory Visual Pathway Glioma,0
4142,Lipomatous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4143,Epithelial hyperplasia of skin,Benign fibrohistiocytic neoplasm of skin,0
4144,NRBC - Nucleated red blood cell present result,Basal cell carcinoma - keratotic,0
4145,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
4146,Multiple Tumor Masses,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4147,Slowly Progressive Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
4148,Precise Histogenesis Unknown,Adenocarcinoma of Unknown Primary,0
4149,Somatostatin Positive Neoplastic Cells Present,Neoplastic Polyp,0
4150,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
4151,Thyroglobulin Positive Neoplastic Cells Present,Neoplastic Polyp,0
4152,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4153,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Prostate Carcinoma Metastatic in the Bone,0
4154,Emperipolesis,Occult Lung Cancer AJCC v8,0
4155,Low Cellularity Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",0
4156,Epidermotropic Lymphocytic Infiltrate,Cutaneous Chronic Lymphocytic Leukemia,0
4157,Infiltrative Growth Pattern,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",0
4158,Intestinal metaplasia,Intestinal Neuroendocrine Neoplasm,0
4159,Oligodendroglial Component Present,Glioblastoma with Primitive Neuronal Component,0
4160,Non-Contiguous Disease,Chronic Bullous Disease of Childhood,0
4161,Monoclonal Eosinophils Present,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
4162,Lipomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
4163,Atypical Mitotic Figures,Atypical hyperplasia of breast,0
4164,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Breast Carcinoma Metastatic in the Bone,0
4165,Slit-Like Stromal Retraction Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
4166,Congenital Abnormality,Congenital Vena Cava Abnormality,0
4167,Striated Muscle Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
4168,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
4169,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Columnar Cell Change of the Breast with Atypia,0
4170,Hot Nodule,Placental Site Nodule or Plaque,0
4171,Platinum Resistance,Pseudolymphoma,0
4172,Foveolar-Type Epithelium Present,Benign Germinative Follicular Epithelium Neoplasm,0
4173,Lytic lesion,Cervical high grade squamous intraepithelial lesion,0
4174,Bead-Like Arrangement of Elastic Fibers,Ampulla of Vater Mucinous Adenocarcinoma,0
4175,Hypertensive disease,Lhermitte-Duclos disease,0
4176,Fascicles of Spindly Tumor Cells Present,Ampulla of Vater Neuroendocrine Tumor,0
4177,Mixture of Embryonal and Alveolar Features Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
4178,Nodular and Diffuse Pattern,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
4179,Intermediate Grade Neuroendocrine Lesion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
4180,Erythema,Erythema Multiforme Major,0
4181,Dyskeratosis,Malignant neoplasm of stomach recurrent,0
4182,Pain,Occult Lung Cancer AJCC v8,0
4183,Immature Myeloid Cells Increased in Bone Marrow,Breast Carcinoma Metastatic in the Bone,0
4184,Adnexal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4185,Beaded Anastomosing Cords Present,Malignant neoplasm of stomach recurrent,0
4186,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Mixed Tumor of the Major Salivary Gland,0
4187,Pseudoglandular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4188,Non-Specific Glandular Pattern,Cervical Glandular Neoplasm,0
4189,Biphasic Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4190,Defective Alpha Heavy Chain Present,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
4191,Melanin-Forming Neuroepithelial Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
4192,Rimming of Adipose Tissue Cells Present,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
4193,Solid Growth Pattern,Unresectable Solid Neoplasm,0
4194,Human Papillomavirus Negative,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,0
4195,Hormonal resistance,Adenocarcinoma with squamous metaplasia,0
4196,Precise Histogenesis Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
4197,Foveolar-Type Epithelium Present,Malignant Germinative Follicular Epithelium Neoplasm,0
4198,Platinum Resistance,Pseudolymphoma,0
4199,Tubular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4200,Osteogenesis,Pseudolymphoma,0
4201,Lesion with Diameter Greater than 10mm,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,0
4202,"Hyperkeratosis, Epidermolytic",Occult Lung Cancer AJCC v8,0
4203,Mucinous degeneration,Ampulla of Vater Mucinous Adenocarcinoma,0
4204,Castration-Naive,Occult Lung Cancer AJCC v8,0
4205,Unifocal Disease at Presentation,Erdheim-Chester Disease,0
4206,Exophytic Papillary Lesion,Papillary Ductal Breast Hyperplasia,0
4207,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
4208,Fibrovascular Septa Present,Occult Lung Cancer AJCC v8,0
4209,Cord-Like Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
4210,Microcystic Change,Columnar Cell Change of the Breast with Atypia,0
4211,PSA Failure,Malignant neoplasm of stomach recurrent,0
4212,Hyperplastic Tissue Present,Malignant Splenic Soft Tissue Neoplasm,0
4213,Mediastinal mass,Stage II Malignant Mediastinal Germ Cell Tumor,0
4214,Estrogen receptor negative,"Anaplastic large cell lymphoma, ALK negative",0
4215,Necrotic changes (finding),Adenocarcinoma with squamous metaplasia,0
4216,Preserved Nuclear Polarity,Malignant neoplasm of stomach recurrent,0
4217,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Ampulla of Vater Cancer by AJCC v7 Stage,0
4218,Pale Eosinophilic Stroma Formation,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
4219,Venous Type Vascular Channel Formation,Intermediate Cell Type Ciliary Body Melanoma,0
4220,Vascular proliferation,Malignant Vascular Neoplasm,0
4221,Clear Perinuclear Halo Present,Clear Cell Sarcoma of Soft Tissue,0
4222,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of nasopharynx,0
4223,Favorable Clinical Outcome,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
4224,Crystal deposition,Occult Lung Cancer AJCC v8,0
4225,Clear Perinuclear Halo Present,"Adenocarcinoma, Clear Cell",0
4226,Fibrosarcomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
4227,High Mitotic Activity,Colorectal High Grade Intraepithelial Neoplasia,0
4228,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
4229,Cellular Changes Resembling Foveolar Epithelium Cells,Intestinal Metaplasia of Bladder Urachal Epithelium,0
4230,Malignant Germinomatous Cellular Infiltrate,Malignant neoplasm of stomach recurrent,0
4231,Pagetoid Proliferation,B-Cell Proliferation of Uncertain Malignant Potential,0
4232,Fibrotic Stroma with Finger-Like Projections Present,Adenocarcinoma with squamous metaplasia,0
4233,Misplaced Exocytosis Present,Occult Lung Cancer AJCC v8,0
4234,Spontaneous Regression,Occult Lung Cancer AJCC v8,0
4235,Delicate Arborizing Vascular Channel Formation,Vascular neoplasm of skin,0
4236,Matrical Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
4237,Follicular Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,0
4238,Glandular Pattern,Cervical Glandular Neoplasm,0
4239,Stable Disease,Localized Castleman Disease,0
4240,Defective Alpha Heavy Chain Present,Heavy Chain Disease,0
4241,Endobronchial Mass,Adenocarcinoma with squamous metaplasia,0
4242,Moderately Differentiated Lesion,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
4243,Monoclonal Myeloid or Lymphoid Cells Present,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
4244,Monoclonal Paraproteinemia Present in Lower than Myeloma Levels,DS Stage II Plasma Cell Myeloma,0
4245,Sarcomatous Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,0
4246,Bone marrow depression,Bone marrow hyperplasia,0
4247,Absence of a Hormonal Syndrome,"Benign neoplasm of brain, unspecified",0
4248,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Vulvar Superficial Angiomyxoma,0
4249,Lymphadenopathy,Occult Lung Cancer AJCC v8,0
4250,Pseudostratified Neuroepithelial Tumor Cells Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0
4251,Congenital Abnormality,Small Congenital Melanocytic Nevus,0
4252,Nests of Nevus Cells Resembling Nerve Bundles Present,Nevus of Ota,0
4253,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
4254,Defective Alpha Heavy Chain Present,Heavy Chain Disease,0
4255,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
4256,Skin Red Dot,Pre-Malignant Skin Epithelial Lesion,0
4257,Microsatellite Stable,Adenocarcinoma with squamous metaplasia,0
4258,"Fully Differentiated ""Adult-Type"" Tissues Present",Poorly Differentiated Hepatocellular Carcinoma,0
4259,Submucosal Tumor Growth,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4260,Prominent Collagen Rosette Formation,Malignant neoplasm of stomach recurrent,0
4261,Windblown Appearance of Atypical Keratinocytes,Recurrent tumors of the Ewing's family,0
4262,Painless Mass,Malignant neoplasm of stomach recurrent,0
4263,Hydropic degeneration,Occult Lung Cancer AJCC v8,0
4264,Unicystic Lesion,Primary Melanocytic Lesion of Meninges,0
4265,Pseudo-'onion bulb' formation,Malignant neoplasm of stomach recurrent,0
4266,Necrotic changes (finding),Adenocarcinoma with squamous metaplasia,0
4267,Congenital Abnormality,Congenital melanocytic nevus,0
4268,Therapy-Related Toxicity,Malignant neoplasm of stomach recurrent,0
4269,Multinodular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4270,Absence of Invasion or Limited Invasion Present,Ampulla of Vater Mucinous Adenocarcinoma,0
4271,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
4272,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
4273,Cambium Layer,Pseudolymphoma,0
4274,Multilayered Rosette Formation,Occult Lung Cancer AJCC v8,0
4275,Monoclonal Eosinophils Present,Monoclonal Gammopathy of Renal Significance,0
4276,Human Papillomavirus Positive,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
4277,Venous Type Vascular Channel Formation,Multiple Endocrine Neoplasia Type 2a,0
4278,Glandular cell atypia,Basal cell carcinoma,0
4279,Precocious Puberty,Pseudolymphoma,0
4280,High Plasma Renin Activity,Plasma Cell Myeloma by DS Stage,0
4281,Cribriform Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4282,Spontaneous Regression,Pseudolymphoma,0
4283,Complex Glandular Pattern,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4284,Inflammatory infiltrate,Inflammatory Breast Carcinoma,0
4285,Mucocele of appendix,Neuroendocrine carcinoma of appendix,0
4286,Granulocytes Increased in Bone Marrow,Breast Carcinoma Metastatic in the Bone,0
4287,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Sellar Teratoma with Malignant Transformation,0
4288,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of lacrimal duct,0
4289,Ganglioneuroblastoma Component Present,Ganglioneuroblastoma,0
4290,Cartilaginous Component Present,Benign Extraskeletal Cartilaginous and Osseous Neoplasm,0
4291,Anastomosing Cells Connected to the Basal Layer of the Epidermis Present,Erosive Adenomatosis of the Nipple,0
4292,Storiform Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4293,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,0
4294,Cementum Formation,Occult Lung Cancer AJCC v8,0
4295,Low Grade Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
4296,Focal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4297,Dome-Shaped Lesion,Reactive Cutaneous Fibrous Lesion,0
4298,Hydropic degeneration,Adenocarcinoma with squamous metaplasia,0
4299,Pseudostratified Columnar Tumor Cells Present,Malignant Gastric Granular Cell Tumor,0
4300,Exophytic Papillary Lesion,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0
4301,Thin Bands of Collagen Present,Malignant neoplasm of stomach recurrent,0
4302,Glomerular Hypertrophy,Pseudolymphoma,0
4303,Monophasic Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4304,Humoral hypercalcemia of malignancy (disorder),Adenocarcinoma of lung (disorder),0
4305,Endocervical Type Epithelium Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type",0
4306,Perivascular Pseudorosette Formation,"Perivascular epithelioid tumor, benign",0
4307,Recurrent Malignant Neoplasm,Recurrent Subsequent Malignant Neoplasm,0
4308,Efferent Arteriolar Hyalinosis,Adenocarcinoma with squamous metaplasia,0
4309,Extensive Secretory Changes Present,Mammary Analog Secretory Carcinoma of Salivary Gland,0
4310,progesterone receptor negative,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
4311,Splenomegaly,Malignant neoplasm of stomach recurrent,0
4312,Increased red cell mass,Primary cutaneous diffuse large cell B-cell lymphoma,0
4313,Lesion with Diameter Greater than 2cm,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4314,Castration-Sensitive,Adenocarcinoma with squamous metaplasia,0
4315,Diffuse Cellular Infiltrate,Cellular neurothekeoma,0
4316,Vascular Channel Formation,Radiation-Induced Vascular Disease,0
4317,Cytologic atypia,Occult Lung Cancer AJCC v8,0
4318,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
4319,Unifocal Disease,Localized Castleman Disease,0
4320,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
4321,Myofibroblastic Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
4322,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral Primitive Neuroectodermal Tumor of the Kidney,0
4323,Cartilaginous Metaplasia of Malignant Cells Present,Malignant neoplasm of lacrimal duct,0
4324,Histiocytoid Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4325,Benzene Exposure,Adenocarcinoma with squamous metaplasia,0
4326,Dentin formation,Malignant neoplasm of stomach recurrent,0
4327,Capillary Sized Vascular Channel Formation,Benign Cutaneous Vascular Neoplasm,0
4328,Pseudostratified Tumor Cells Present,Malignant Gastric Granular Cell Tumor,0
4329,No Identifiable Line of Differentiation,Benign Soft Tissue Tumor of Uncertain Differentiation,0
4330,NRBC - Nucleated red blood cell present result,Basal cell carcinoma - follicular,0
4331,Pale Eosinophilic Stroma Formation,Eosinophilic Granuloma,0
4332,Heterologous Elements Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",0
4333,Nodular and Diffuse Pattern,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
4334,Breast Implant-Related Lesion,Breast Phyllodes Tumor,0
4335,Cartilaginous metaplasia,Adenocarcinoma with squamous metaplasia,0
4336,Immunoglobulin Deposition,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
4337,Perineural spread,Occult Lung Cancer AJCC v8,0
4338,Chronic lymphocytic inflammation,Stage B Chronic Lymphocytic Leukemia,0
4339,Pseudostratified Columnar Tumor Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4340,Necrotic changes (finding),Adenocarcinoma with squamous metaplasia,0
4341,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
4342,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
4343,Microcystic Change,Microcystic meningioma,0
4344,Hormonal resistance,Pseudolymphoma,0
4345,Epithelial Differentiation,Tubal Epithelial Hyperplasia,0
4346,Thrombocytosis,Occult Lung Cancer AJCC v8,0
4347,Gastrin Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4348,Lesion with Diameter Greater than 10mm,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,0
4349,Polyclonal hypergammaglobulinemia,Malignant neoplasm of stomach recurrent,0
4350,Extramedullary Hematopoiesis (disorder),Extramedullary Plasmacytoma,0
4351,Rubbery Skin Lesion,Transplant-Related Skin Squamous Cell Carcinoma,0
4352,Proliferation of High Endothelial Venules Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
4353,Widely Invasive Lesion,Grade 3 Invasive Breast Carcinoma,0
4354,Elastin Fibers Present,Malignant neoplasm of stomach recurrent,0
4355,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Erosive Adenomatosis of the Nipple,0
4356,Pseudolobular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4357,progesterone receptor negative,"Anaplastic large cell lymphoma, ALK negative",0
4358,Pseudostratified Columnar Tumor Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4359,Geographic Necrosis,Malignant neoplasm of stomach recurrent,0
4360,Poorly Differentiated Lesion,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
4361,Mixture of Embryonal and Alveolar Features Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
4362,Thick-Walled Vessels Present,Leiomyosarcoma of Vessels,0
4363,Mixture of Morphologic Patterns,"Benign neoplasm of brain, unspecified",0
4364,Nuclear Pseudoinclusion,Occult Lung Cancer AJCC v8,0
4365,Mesenchymal Differentiation,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
4366,Malignant Component Present,Malignant neoplasm of stomach recurrent,0
4367,Nuclei of Various Sizes and Shapes Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
4368,Epithelioid Differentiation,Breast Epithelioid Hemangioma,0
4369,Obesity,Adenocarcinoma with squamous metaplasia,0
4370,S-100-Positive Neoplastic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
4371,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
4372,HMB-45-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4373,EBV-Positive Neoplastic Cells Present,Neoplastic Polyp,0
4374,Geographic Necrosis,Malignant neoplasm of stomach recurrent,0
4375,Storiform Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
4376,Stable Disease,Multi-centric Castleman's Disease,0
4377,Abundant Intracytoplasmic Lipofuscin Present,Pseudolymphoma,0
4378,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
4379,Bone Marrow Involvement,Bone Marrow Transplantation Nephropathy,0
4380,Mixed Cellular Population,Adult Central Nervous System Mixed Germ Cell Tumor,0
4381,Polarization of Nuclei Towards the Glandular Lumen,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
4382,Necrotic changes (finding),Occult Lung Cancer AJCC v8,0
4383,Rarely Metastasizing Lesion,Primary Melanocytic Lesion of Meninges,0
4384,Embryoid Bodies Present,Malignant neoplasm of stomach recurrent,0
4385,Intracellular Accumulation of Lipids,Ampulla of Vater Mucinous Adenocarcinoma,0
4386,Intracanalicular Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
4387,Unifocal Lesion,Primary Melanocytic Lesion of Meninges,0
4388,Swelling,Adenocarcinoma with squamous metaplasia,0
4389,Necrotic changes (finding),Adenocarcinoma with squamous metaplasia,0
4390,Increased red cell mass,Basal cell carcinoma,0
4391,Distortion of the Hair Follicle,Recurrent tumors of the Ewing's family,0
4392,Perivascular Lymphocytic Infiltrate,Stage A Chronic Lymphocytic Leukemia,0
4393,Hyaline Cartilage Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
4394,Neuropil Present,Malignant neoplasm of stomach recurrent,0
4395,Distortion of the Hair Follicle,Recurrent tumors of the Ewing's family,0
4396,Sarcomatoid Features,Thymic Sarcomatoid Carcinoma,0
4397,Castration Resistance,Pseudolymphoma,0
4398,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Squamous cell carcinoma of head and neck metastatic,0
4399,"Undifferentiated ""Fetal-Type"" Tissues Present",Undifferentiated carcinoma of ovary,0
4400,Capillary Sized Vascular Channel Formation,Benign Cutaneous Vascular Neoplasm,0
4401,Plexiform Growth Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4402,High Plasma Renin Activity,Plasma Cell Myeloma by DS Stage,0
4403,Enterochromaffin-Like Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
4404,Poorly Differentiated Neuroendocrine Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
4405,Villous atrophy,Villous adenoma of rectum,0
4406,Unclassifiable Lesion,Reactive Cutaneous Fibrous Lesion,0
4407,Serum phosphate concentration below normal,Adenocarcinoma with squamous metaplasia,0
4408,Negative Bone Marrow and Peripheral Blood,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
4409,Adulthood Lesion,Pre-Malignant Skin Epithelial Lesion,0
4410,Immunoglobulin Light Chain Deposition,Heavy Chain Deposition Disease,0
4411,Clear Perinuclear Halo Present,Clear Cell Sarcoma of Soft Tissue,0
4412,atypia morphology,Malignant neoplasm of stomach recurrent,0
4413,Peribronchial and Lobular Septal Involvement Only,Invasive Ductal and Lobular Carcinoma,0
4414,Exophytic Papillary Lesion,Papillary Ductal Breast Hyperplasia,0
4415,Infantile Lesion,Infantile digital fibromatosis,0
4416,Follicular Structures Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
4417,More Than Two Separate Tumor Masses Present in the Same Organ,Colorectal Carcinoma Metastatic in the Liver,0
4418,Mesenchymal Metaplasia,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0
4419,Prominent Collagen Rosette Formation,Occult Lung Cancer AJCC v8,0
4420,Villous Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4421,Well Differentiated Lesion,Well Differentiated Malignant Neoplasm,0
4422,Macrofollicular Structures Present,Adenocarcinoma with squamous metaplasia,0
4423,Encapsulated Mass,Adenocarcinoma with squamous metaplasia,0
4424,Black Discoloration,Adenocarcinoma with squamous metaplasia,0
4425,Wide Vessel-Like Spaces Formation,Occult Lung Cancer AJCC v8,0
4426,Multinodular and Vacuolated Pattern,Testicular Mixed Embryonal Carcinoma and Seminoma,0
4427,Peribronchial and Lobular Septal Involvement Only,Testicular Mixed Embryonal Carcinoma and Seminoma,0
4428,Basal Cells with Pale Cytoplasm Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
4429,Apocrine Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4430,Non-Malignant Cellular Infiltrate,Cellular neurothekeoma,0
4431,Positive Axillary Lymph Node,Axillary lymphadenitis,0
4432,Xp11.2 Translocations/TFE3 Gene Fusions Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
4433,Mixture of Embryonal and Alveolar Features Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
4434,Cellular Pleomorphism,Ovarian Cellular Fibroma,0
4435,Systemic disease,Lhermitte-Duclos disease,0
4436,Cryptitis,Adenocarcinoma with squamous metaplasia,0
4437,Metastatic/Recurrent Disease,Chronic Bullous Disease of Childhood,0
4438,Localized Lesion,Reactive Cutaneous Fibrous Lesion,0
4439,Enterochromaffin-Like Type Granules Present,Intermediate Cell Type Ciliary Body Melanoma,0
4440,Proliferation of Small Ducts Present,B-Cell Proliferation of Uncertain Malignant Potential,0
4441,Localized Hydropic Villous Change,Localized Unresectable Neuroblastoma,0
4442,Lytic lesion,Cervical high grade squamous intraepithelial lesion,0
4443,Mesenchymal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4444,"Amorphus, Eosinophilic, and Acellular Deposit",Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
4445,Pagetoid Proliferation,T-Cell Proliferation of Uncertain Malignant Potential,0
4446,Humoral hypercalcemia of malignancy (disorder),Serous papillary cystic tumor of borderline malignancy,0
4447,Dilated Thin-Walled Vascular Space Formation,Benign Cutaneous Vascular Neoplasm,0
4448,Absence of Muscle Invasion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0
4449,Squamous Differentiation,Squamous cell carcinoma of skin,0
4450,Hydropic Villous Change,Villous adenoma of rectum,0
4451,Inclusion-Like Nucleoli,Pseudolymphoma,0
4452,Melanin-Pigmented Dendritic Cells Present,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,0
4453,Marked Thickening of the Bladder Urothelium Present,Intestinal Metaplasia of Bladder Urothelium,0
4454,Intravascular Fibrin Thrombus Formation,Intravascular Angioleiomyoma,0
4455,Eosinophil count raised (finding),Malignant neoplasm of stomach recurrent,0
4456,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
4457,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
4458,Abnormal alveolar pattern,Occult Lung Cancer AJCC v8,0
4459,Pleural effusion disorder,Stage I Pleural Malignant Mesothelioma AJCC v8,0
4460,BCR/ABL1 Fusion Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
4461,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Malignant Giant Cell Tumor of Bone,0
4462,Microsatellite Stable,Adenocarcinoma with squamous metaplasia,0
4463,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0
4464,Mesenchymal Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4465,Duct-Like Structures Present,Malignant neoplasm of stomach recurrent,0
4466,Intraluminal Tumor Growth,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4467,Therapy-Related Toxicity,Adenocarcinoma with squamous metaplasia,0
4468,Bone marrow reticulin fibrosis,Bone marrow hyperplasia,0
4469,Myomatous Stroma Formation,Adenocarcinoma with squamous metaplasia,0
4470,Lipomatous Metaplasia,Intestinal Metaplasia of Bladder Urachal Epithelium,0
4471,Red Papular Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
4472,Clinical TNM Finding,Hodgkin Lymphoma by Clinical Course,0
4473,Multinodular Lesion,Primary Melanocytic Lesion of Meninges,0
4474,Slow Growing Mass,Malignant neoplasm of stomach recurrent,0
4475,Prominent Keratin Formation,Pseudolymphoma,0
4476,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
4477,Nested Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4478,Moderately Differentiated Lesion,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
4479,Photosensitivity of skin,Benign fibrohistiocytic neoplasm of skin,0
4480,Lesion Less than 5mm in Diameter,Colorectal Carcinoma Metastatic in the Liver,0
4481,Lesion Less than 5mm in Diameter,Colorectal Carcinoma Metastatic in the Liver,0
4482,Windblown Appearance of Atypical Keratinocytes,Atypical hyperplasia of breast,0
4483,Skin Red Dot,Pre-Malignant Skin Epithelial Lesion,0
4484,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Metastatic malignant neoplasm to nasopharynx,0
4485,Hereditary Lesion,Pre-Malignant Skin Epithelial Lesion,0
4486,Hyaline Cartilage Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4487,Giant Mitochondria Present,Giant Hemangioma,0
4488,Drug toxicity,Pseudolymphoma,0
4489,Immunoglobulin Heavy Chain Deposition,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
4490,High Plasma Renin Activity,Refractory High Risk Myelodysplastic Syndrome,0
4491,Bead-Like Arrangement of Elastic Fibers,Ampulla of Vater Mucinous Adenocarcinoma,0
4492,Eosinophilic inflammation,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
4493,Spontaneous Regression,Pseudolymphoma,0
4494,PSA Failure,Occult Lung Cancer AJCC v8,0
4495,Breast Implant-Related Lesion,Prognostic Stage IA Breast Cancer AJCC v8,0
4496,Hormone Receptor Positive,Hormone refractory prostate cancer,0
4497,Prominent Collagen Rosette Formation,Adenocarcinoma with squamous metaplasia,0
4498,Odontogenic Cysts,Ghost Cell Odontogenic Carcinoma,0
4499,Glial Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4500,Cartilaginous Component Present,Glioblastoma with Primitive Neuronal Component,0
4501,Inflammatory infiltrate,Inflammatory carcinoma of breast recurrent,0
4502,Neoplastic Growth or Spread,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
4503,Canalicular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4504,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
4505,Breast Implant-Related Lesion,Prognostic Stage IA Breast Cancer AJCC v8,0
4506,Capillary Sized Vascular Channel Formation,Radiation-Induced Vascular Disease,0
4507,Epithelial Component Present,Tubal Epithelial Hyperplasia,0
4508,Defective Mu Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
4509,Superficial Lesion,Pre-Malignant Skin Epithelial Lesion,0
4510,Non-Hereditary Lesion,Reactive Cutaneous Fibrous Lesion,0
4511,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4512,Synchronous Lesion,Primary Melanocytic Lesion of Meninges,0
4513,Black Discoloration,Adenocarcinoma with squamous metaplasia,0
4514,Adnexal Differentiation,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
4515,Two Separate Tumor Masses Present in the Same Organ,Lung Carcinoma Metastatic in the Liver,0
4516,Extraocular Dissemination of Disease,Paget Disease of the Scrotum,0
4517,Chronic lymphocytic inflammation,Stage B Chronic Lymphocytic Leukemia,0
4518,Follicular Differentiation,Vulvar Inverted Follicular Keratosis,0
4519,Perivascular fibrosis,"Perivascular epithelioid tumor, malignant",0
4520,Lymphoplasmacytic Infiltrate,Occult Lung Cancer AJCC v8,0
4521,Nuclear Clearing,Occult Lung Cancer AJCC v8,0
4522,Endophytic Tumor Growth,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4523,Islands of Odontogenic Epithelium Present,Malignant neoplasm of stomach recurrent,0
4524,Dyskeratosis,Malignant neoplasm of stomach recurrent,0
4525,Multifocal Lesion,Reactive Cutaneous Fibrous Lesion,0
4526,Lesion with Diameter of 4mm or More,Columnar Cell Change of the Breast with Atypia,0
4527,Radiation Sickness,Adenocarcinoma with squamous metaplasia,0
4528,'Starry-sky' pattern,Malignant neoplasm of stomach recurrent,0
4529,Lymphatic Spread,Medulloblastoma with Leptomeningeal Spread,0
4530,Acquired Lesion,Reactive Cutaneous Fibrous Lesion,0
4531,Huge Vascular Channel Formation,Radiation-Induced Vascular Disease,0
4532,Limited Early T-Cell Differentiation,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,0
4533,Recurrent Lymphoma,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,0
4534,Single Type of Tissue Derived from One Embryonic Layer Present,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
4535,Primitive Mesenchymal Stroma Formation,Recurrent Primitive Neuroectodermal Tumor,0
4536,Collagen Bundles Formation,Malignant neoplasm of stomach recurrent,0
4537,Elastophagocytosis,Adenocarcinoma with squamous metaplasia,0
4538,Reactive Germinal Centers Present,Reactive systemic amyloidosis,0
4539,Sebaceous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4540,Less than 2 Mitoses per 10HPF,Grade 2 Colon Adenocarcinoma,0
4541,Juvenile Lesion,Pre-Malignant Skin Epithelial Lesion,0
4542,Severe dysplasia,Mild epithelial dysplasia,0
4543,Thin-Branching Papillae Present,Pseudolymphoma,0
4544,Absence of a Hormonal Syndrome,Ampulla of Vater Mucinous Adenocarcinoma,0
4545,Vascular proliferation,Benign Cutaneous Vascular Neoplasm,0
4546,Progressive Disease,Multi-centric Castleman's Disease,0
4547,Gastrointestinal Type Epithelium Present,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0
4548,Pautrier-Like Microabscess Present,Malignant neoplasm of stomach recurrent,0
4549,Submucosal Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
4550,Chemotherapeutic Agent Toxicity,Pseudolymphoma,0
4551,Numerous Stromal Mast Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4552,PSA Failure,Pseudolymphoma,0
4553,Matrical Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
4554,Eosinophilic inflammation,Diffuse large B-cell lymphoma associated with chronic inflammation,0
4555,Bilateral Disease,Multi-centric Castleman's Disease,0
4556,Wheezing,Pseudolymphoma,0
4557,Zonal Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4558,atypia morphology,Adenocarcinoma with squamous metaplasia,0
4559,Hemosiderin pigmentation,Pseudolymphoma,0
4560,Proliferation of Small Ducts Present,T-Cell Proliferation of Uncertain Malignant Potential,0
4561,Ventricular Involvement Only,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
4562,Spindle Cell Metaplasia,Ciliary Body Spindle Cell Type B Melanoma,0
4563,Mild cytologic atypia,Mild esophageal dysplasia,0
4564,Tobacco Toxicity,Occult Lung Cancer AJCC v8,0
4565,Intracytoplasmic Eosinophilic Inclusion,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,0
4566,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4567,Angiosarcoma-Like Areas Present,Pseudolymphoma,0
4568,Sarcomatoid Stroma Formation,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",0
4569,Schwannian Stroma Predominant Component of the Tumor Volume,Malignant Mixed Tumor of the Major Salivary Gland,0
4570,Spindle Cell Component Present,Spindle Cell Melanoma,0
4571,Superficial Lesion,Reactive Cutaneous Fibrous Lesion,0
4572,Ionizing Radiation Toxicity,Radiation Pneumonitis,0
4573,Malignant Component Present,Metastatic Extracranial Malignant Solid Neoplasm,0
4574,Mass of body structure,Secondary malignant neoplasm of ciliary body,0
4575,Lamellar Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4576,Fenestrating Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4577,Peau d'orange surface of breast,Atypical hyperplasia of breast,0
4578,Cystic Change,Cervical Adenoid Cystic Carcinoma,0
4579,Pre-existing condition,Malignant neoplasm of stomach recurrent,0
4580,Poorly Cohesive Malignant Cellular Infiltrate,Malignant neoplasm of stomach recurrent,0
4581,Fibrinous Material Present,Occult Lung Cancer AJCC v8,0
4582,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
4583,Nodular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4584,Fibrinous Material Present,Malignant neoplasm of stomach recurrent,0
4585,Morphologic Overlap,Occult Lung Cancer AJCC v8,0
4586,Monocytosis,Occult Lung Cancer AJCC v8,0
4587,Marked Thickening of the Bladder Urothelium Present,Recurrent tumors of the Ewing's family,0
4588,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Sellar Region,0
4589,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,Malignant Giant Cell Tumor of Bone,0
4590,Two Separate Tumor Masses Present in the Same Organ,Colorectal Carcinoma Metastatic in the Liver,0
4591,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Benign Mixed Tumor of the Vulva,0
4592,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
4593,Dilated Terminal Duct Lobular Units Present,Extrahepatic Bile Duct Neuroendocrine Tumor,0
4594,Marked Thickening of the Bladder Urothelium Present,Intestinal Metaplasia of Bladder Urothelium,0
4595,Obesity,Malignant neoplasm of stomach recurrent,0
4596,Moderate dysplasia,Mild epithelial dysplasia,0
4597,Juvenile Lesion,Reactive Cutaneous Fibrous Lesion,0
4598,Fascicular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4599,Xp11.2 Translocations/TFE3 Gene Fusions Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
4600,Cribriform Pattern,Prostatic Cribriform Hyperplasia,0
4601,Favorable Clinical Outcome,Favorable Hodgkin Lymphoma,0
4602,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
4603,Mucocele of appendix,Neuroendocrine carcinoma of appendix,0
4604,Infundibular-Like Structures Present,Adenocarcinoma with squamous metaplasia,0
4605,Ependymal Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4606,White blood cell count increased (lab result),Primary cutaneous diffuse large cell B-cell lymphoma,0
4607,Ventricular Involvement Only,Ventricular myxoma,0
4608,Lesion with Diameter of 2cm or Less,Columnar Cell Change of the Breast with Atypia,0
4609,Slow Growing Painless Mass,Occult Lung Cancer AJCC v8,0
4610,Sclerotic Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4611,Progressive Disease,Chronic Bullous Disease of Childhood,0
4612,Muscle Invasion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0
4613,Malignant Component Present,Malignant neoplasm of stomach recurrent,0
4614,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of nasopharynx,0
4615,Superficial Lesion,Pre-Malignant Skin Epithelial Lesion,0
4616,PSA Failure,Adenocarcinoma with squamous metaplasia,0
4617,Hemorrhagic Neuroblastic Nodules Present,Neuroblastic tumors,0
4618,Blasts Expressing CD56 and Immature T-Cell Markers Present,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
4619,Vacuolated Plasma Cells in the Bone Marrow,Colorectal Carcinoma Metastatic in the Liver,0
4620,Multilocular Lesion,Primary Melanocytic Lesion of Meninges,0
4621,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
4622,Non-Encapsulated Neoplasm,Metastatic Extracranial Malignant Solid Neoplasm,0
4623,Non-Malignant Cellular Infiltrate,Cellular Blue Nevus,0
4624,Mass of pleura,Malignant tumor of pleura,0
4625,Castration-Sensitive,Occult Lung Cancer AJCC v8,0
4626,Castration-Naive,Pseudolymphoma,0
4627,Inconspicuous Syncytiotrophoblastic Cell Component,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",0
4628,Intracytoplasmic Eosinophilic Inclusion,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0
4629,Squamous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
4630,Thin Bands of Collagen Present,Malignant neoplasm of stomach recurrent,0
4631,Myxoid Stroma Formation,Gastric Carcinoma with Lymphoid Stroma,0
4632,Cervical Glandular Dysplasia,Cervical Warty Carcinoma,0
4633,Beaded Anastomosing Cords Present,Occult Lung Cancer AJCC v8,0
4634,Glucagon-Like Peptide Positive Neoplastic Cells Present,Neoplastic Polyp,0
4635,Intermediate Filaments Present,Intermediate Blood Vessel Neoplasm,0
4636,HIF1A Overexpression Positive,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
4637,Confluent Sheets of Neoplastic B-Lymphocytes Present,Malignant neoplasm of stomach recurrent,0
4638,Epithelial hyperplasia of skin,Atypical hyperplasia of breast,0
4639,Lesion with Diameter Less than 11mm,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4640,Cryptitis,Occult Lung Cancer AJCC v8,0
4641,Microsatellite Stable,Adenocarcinoma with squamous metaplasia,0
4642,Extranodal Extension,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0
4643,Exanthema,Malignant neoplasm of stomach recurrent,0
4644,Glucagon-Like Peptide Positive Neoplastic Cells Present,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
4645,Cystic Lesion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
4646,Lymphoplasmacytic Infiltrate,Pseudolymphoma,0
4647,Unclassifiable Lesion,Primary Melanocytic Lesion of Meninges,0
4648,Epithelial Component Present,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
4649,Mild cytologic atypia,Complex endometrial hyperplasia without atypia,0
4650,Infiltrating Tumor Margins Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4651,Stable Disease,Erdheim-Chester Disease,0
4652,Five or Less Mitoses per 50HPF,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
4653,Arborising Network of Cords of Basaloid Cells Present,Recurrent tumors of the Ewing's family,0
4654,Low Grade Lesion,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
4655,Fibrous Septa Present,Intracranial Benign Fibrous Histiocytoma,0
4656,No Identifiable Line of Differentiation,Malignant neoplasm of stomach recurrent,0
4657,Granulocytes Increased in Bone Marrow,Bone Marrow Transplantation Nephropathy,0
4658,Follicular Differentiation,Vulvar Inverted Follicular Keratosis,0
4659,Trabecular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4660,Chronic lymphocytic inflammation,Chronic lymphocytic leukemia stage 4,0
4661,Small Lesion,Adult Desmoplastic Small Round Cell Tumor,0
4662,Pseudo-Psammoma Body Formation,Intermediate Cell Type Ciliary Body Melanoma,0
4663,Immunoglobulin Light Chain Deposition,Immunoglobulin deposition disease,0
4664,progesterone receptor negative,Adenocarcinoma with squamous metaplasia,0
4665,Well Differentiated Neuroendocrine Lesion,Pleural Well Differentiated Papillary Mesothelioma,0
4666,Less than 2 Mitoses per 10HPF,Grade 2 Colon Adenocarcinoma,0
4667,Encapsulated Mass,Adenocarcinoma with squamous metaplasia,0
4668,Edema,Pseudolymphoma,0
4669,Unfavorable Clinical Outcome,Advanced Unfavorable Hodgkin Lymphoma,0
4670,"Fully Differentiated ""Adult-Type"" Tissues Present",Differentiated Thyroid Gland Carcinoma,0
4671,Steatohepatitis,Adenocarcinoma with squamous metaplasia,0
4672,Ischemia,Occult Lung Cancer AJCC v8,0
4673,VIP Positive Neoplastic Cells Present,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
4674,Mixture of Germ Cell Neoplastic Components Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4675,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
4676,Nests of Nevus Cells Resembling Nerve Bundles Present,Malignant neoplasm of stomach recurrent,0
4677,Mitotic Activity,Adenocarcinoma with squamous metaplasia,0
4678,Prominent Keratin Formation,Pseudolymphoma,0
4679,Exophytic Papillary Lesion,Gastric Papillary Adenocarcinoma,0
4680,Unilineage Dysplasia Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
4681,Thick-Walled Vessels Present,Adenocarcinoma with squamous metaplasia,0
4682,Recurrent Malignant Neoplasm,Recurrent Subsequent Malignant Neoplasm,0
4683,Histiocytosis,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
4684,Nuclear Atypia,"Breast Fibrocystic Change, Proliferative Type without Atypia",0
4685,Diffuse Pattern,Diffuse Lipomatosis,0
4686,Confluent Sheets of Anaplastic T-Lymphocytes Present,Ampulla of Vater Mucinous Adenocarcinoma,0
4687,Microsatellite Stable,Malignant neoplasm of stomach recurrent,0
4688,Cord-Like Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4689,Osteosclerotic Lesion,Primary Melanocytic Lesion of Meninges,0
4690,Multifocal Unisystem Disease,Erdheim-Chester Disease,0
4691,Parakeratosis,Occult Lung Cancer AJCC v8,0
4692,Lesion with Diameter of 10mm or Less,Columnar Cell Change of the Breast with Atypia,0
4693,Broad Fibrous Bands Formation,Pericardial Solitary Fibrous Tumor,0
4694,Shadow Cells Present,Testicular Seminoma with Syncytiotrophoblastic Cells,0
4695,Enterochromaffin Type Granules Present,Multiple Endocrine Neoplasia Type 2a,0
4696,Large Mass,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0
4697,Efferent Arteriolar Hyalinosis,Pseudolymphoma,0
4698,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
4699,Multinodular Lesion,Primary Melanocytic Lesion of Meninges,0
4700,Metaplasia,Intestinal Metaplasia of Bladder Urothelium,0
4701,Regional Disease,Localized Castleman Disease,0
4702,More than 5 Mitoses per 50HPF,Pseudolymphoma,0
4703,Melanin-Pigmented Dendritic Cells Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
4704,Bone Marrow Lymphoplasmacytic Infiltrate,Breast Carcinoma Metastatic in the Bone,0
4705,Moderate dysplasia,Esophageal dysplasia,0
4706,Absence of Malignant Features,Malignant neoplasm of nasopharynx,0
4707,IDH Gene Family Mutation Status Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
4708,Scattered Collections of Differentiating Neuroblasts Present,Ampulla of Vater Mucinous Adenocarcinoma,0
4709,Respiratory distress,Respiratory papilloma,0
4710,Crooke Hyaline Change,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,0
4711,Mature Neutrophils Present,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage,0
4712,Blasts Expressing B-Lymphoid and Myeloid Markers Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4713,Dentin formation,Malignant neoplasm of stomach recurrent,0
4714,bone marrow fibrosis,Secondary malignant neoplasm of bone marrow,0
4715,Follicular Structures Present,Vulvar Inverted Follicular Keratosis,0
4716,Unilineage Dysplasia Present,Large Cell Dysplasia,0
4717,Extramedullary Hematopoiesis (disorder),Funisitis (disorder),0
4718,Neuroendocrine Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4719,Myofibroblastic Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
4720,Angiosarcoma-Like Areas Present,Malignant neoplasm of stomach recurrent,0
4721,Decreased platelet count,Malignant neoplasm of stomach recurrent,0
4722,Low Grade Neuroendocrine Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
4723,Diarrhea,Malignant neoplasm of stomach recurrent,0
4724,Perivascular Lymphocytic Infiltrate,Stage B Chronic Lymphocytic Leukemia,0
4725,Meckel Diverticulum,Occult Lung Cancer AJCC v8,0
4726,Prominent Intraductal Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
4727,Gastric dysplasia,Malignant Gastric Granular Cell Tumor,0
4728,Hypergammaglobulinemia,Occult Lung Cancer AJCC v8,0
4729,Localized Hydropic Villous Change,Localized Castleman Disease,0
4730,Epithelial Differentiation,Tubal Epithelial Hyperplasia,0
4731,Rubbery Skin Lesion,Stage IV Skin Cancer,0
4732,Melanin-Forming Neuroepithelial Cells Present,Tumors Derived from Langerhans Cells,0
4733,Cervical Glandular Dysplasia,Cervical Warty Carcinoma,0
4734,Polymorphic Cellular Infiltrate,Cellular Blue Nevus,0
4735,Mediastinal mass,Benign Mediastinal Germ Cell Tumor,0
4736,Lipomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
4737,CD30-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,0
4738,Capsular Invasion,Adenocarcinoma with squamous metaplasia,0
4739,Sinusoidal Infiltration,Pseudolymphoma,0
4740,Platinum Sensitivity,Adenocarcinoma with squamous metaplasia,0
4741,Polymorphic Cellular Infiltrate,Cellular neurothekeoma,0
4742,Burn injury,Adenocarcinoma with squamous metaplasia,0
4743,Large Spaces Filled with Blood Present,Large cell carcinoma with rhabdoid phenotype,0
4744,Polarization of Nuclei Towards the Glandular Lumen,Recurrent tumors of the Ewing's family,0
4745,Estrogen receptor negative,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
4746,Superficial Lesion,Pre-Malignant Skin Epithelial Lesion,0
4747,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Prostate Carcinoma Metastatic in the Bone,0
4748,Burn injury,Adenocarcinoma with squamous metaplasia,0
4749,Extracutaneous Dissemination of Disease,Paget Disease of the Anus,0
4750,Aggravated Disease,Multi-centric Castleman's Disease,0
4751,Unicystic Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
4752,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Malignant neoplasm of stomach recurrent,0
4753,Blasts Expressing CD56 and Immature T-Cell Markers Present,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
4754,Immunoglobulin Light Chain Deposition,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
4755,Hereditary Lesion,Pre-Malignant Skin Epithelial Lesion,0
4756,No Evidence of Hormonal Immunoreactivity Present,"Benign neoplasm of brain, unspecified",0
4757,Multilayered Rosette Formation,Adenocarcinoma with squamous metaplasia,0
4758,Storiform Growth Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4759,Numerous Stromal Mast Cells Present,Stromal sarcoma,0
4760,Sarcomatous Component Present,Glioblastoma with Primitive Neuronal Component,0
4761,Small Lesion,Adult Desmoplastic Small Round Cell Tumor,0
4762,Primary Site Unknown,Primary Carcinoma Unspecified Site,0
4763,Cytoplasmic Membrane-Bound Granules Present,Pseudolymphoma,0
4764,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Erosive Adenomatosis of the Nipple,0
4765,Varicosity,Adenocarcinoma with squamous metaplasia,0
4766,Generalized Dysplasia,Squamous Lung Dysplasia,0
4767,Unclassifiable Lesion,Primary Melanocytic Lesion of Meninges,0
4768,Clinical TNM Finding,Hodgkin Lymphoma by Clinical Course,0
4769,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0
4770,Blasts Under 10 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
4771,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach recurrent,0
4772,Cutaneous plaque,Pure Cutaneous Mastocytosis,0
4773,Chronic lymphocytic inflammation,Chronic lymphocytic leukemia stage 0,0
4774,Morphologic Overlap,Pseudolymphoma,0
4775,Poorly Differentiated Neuroendocrine Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
4776,Schwannian Stroma Predominant Component of the Tumor Volume,Benign Mixed Tumor of the Vulva,0
4777,Moderate dysplasia,Esophageal dysplasia,0
4778,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
4779,Myomatous Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
4780,Osteoid formation,Adenocarcinoma with squamous metaplasia,0
4781,Drug Exposure,Adenocarcinoma with squamous metaplasia,0
4782,Reinke Crystals Formation,Malignant neoplasm of stomach recurrent,0
4783,CD8-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4784,Concentric Perivascular Arrangement of Tumor Cells,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
4785,Prominent Elastic Tissue Cores Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
4786,Hepatomegaly,Malignant neoplasm of stomach recurrent,0
4787,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Giant Cell Tumor of Bone,0
4788,Clear Perinuclear Halo Present,Bladder Papillary Clear Cell Adenocarcinoma,0
4789,Villous Projections of the Neoplastic Epithelium Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
4790,Tubal Diverticulosis,Tubal Hyperplasia,0
4791,Squamous metaplasia of bladder,Squamous cell carcinoma of skin,0
4792,Acquired Lesion,Reactive Cutaneous Fibrous Lesion,0
4793,Fenestrating Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4794,Lipomatous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4795,New bone formation (morphologic abnormality),benign fibrous histiocytoma of bone,0
4796,Adulthood Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
4797,Seizures,Occult Lung Cancer AJCC v8,0
4798,Pautrier-Like Microabscess Present,Occult Lung Cancer AJCC v8,0
4799,Architectural Distortion,Pseudolymphoma,0
4800,Oligodendroglial Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
4801,Transformed Phase of Disease,Paget Disease of the Anus,0
4802,Hyperplastic Tissue Present,Colon Hyperplastic Polyp,0
4803,Hemorrhagic,Adenocarcinoma with squamous metaplasia,0
4804,Non-Contiguous Disease,Multi-centric Castleman's Disease,0
4805,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,Bone Marrow Transplantation Nephropathy,0
4806,Borderline Resectable Mass,Borderline Ovarian Endometrioid Cystadenofibroma,0
4807,Congenital Abnormality,Congenital melanocytic nevus,0
4808,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Prostate Carcinoma Metastatic in the Bone,0
4809,Intraluminal Necrosis,Adenocarcinoma with squamous metaplasia,0
4810,Dilated Thin-Walled Vascular Space Formation,Benign Cutaneous Vascular Neoplasm,0
4811,Nuclear pleomorphism,Adenocarcinoma with squamous metaplasia,0
4812,Mixture of Embryonal and Alveolar Features Present,Testicular Mixed Embryonal Carcinoma and Seminoma,0
4813,Polarization of Nuclei Towards the Glandular Lumen,Erosive Adenomatosis of the Nipple,0
4814,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
4815,Drug Exposure,Adenocarcinoma with squamous metaplasia,0
4816,Lesion with Diameter of 2cm or Less,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
4817,Serrated Glandular Architecture,Cervical Glandular Neoplasm,0
4818,Severe dysplasia,Mild epithelial dysplasia,0
4819,Pseudostratified Neuroepithelial Tumor Cells Present,Cribriform Neuroepithelial Tumor,0
4820,Castration Resistance,Malignant neoplasm of stomach recurrent,0
4821,Paucicellular Stroma Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
4822,Endometrial Type Glands and Stroma Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",0
4823,Prominent Stromal Reaction,Stromal sarcoma,0
4824,Mucoid Stroma Formation,Adenocarcinoma with squamous metaplasia,0
4825,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Refractory T-Cell Prolymphocytic Leukemia,0
4826,Monoclonal Cellular Population Present,Ovarian Cellular Fibroma,0
4827,Glial Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
4828,Microcystic Change,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
4829,Sinusoidal Vascular Channel Formation,Malignant Vascular Neoplasm,0
4830,Dystrophic calcification,Adenocarcinoma with squamous metaplasia,0
4831,Dystrophic calcification,Occult Lung Cancer AJCC v8,0
4832,Cholesterolosis,Occult Lung Cancer AJCC v8,0
4833,Sarcomatous or Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
4834,Splenomegaly,Occult Lung Cancer AJCC v8,0
4835,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
4836,Regional Disease,Multi-centric Castleman's Disease,0
4837,Squamoid Corpuscle,Pseudolymphoma,0
4838,Fibromuscular Stroma Formation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,0
4839,Absence of Invasion of the Muscularis Externa,Erosive Adenomatosis of the Nipple,0
4840,Cytoplasmic Membrane-Bound Granules Present,Malignant neoplasm of stomach recurrent,0
4841,Lipomatous Metaplasia,Intestinal Metaplasia of Bladder Urothelium,0
4842,Rosenthal Fibers Present,Malignant neoplasm of stomach recurrent,0
4843,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Mixed Tumor of the Vulva,0
4844,Somatostatin Positive Neoplastic Cells Present,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
4845,Mild dysplasia,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
4846,Abnormal alveolar pattern,Adenocarcinoma with squamous metaplasia,0
4847,Windblown Appearance of Atypical Keratinocytes,Malignant neoplasm of stomach recurrent,0
4848,Chronic lymphocytic inflammation,Chronic lymphocytic leukemia stage 0,0
4849,Small Lesion,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,0
4850,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4851,CD30-Positive Neoplastic Cells Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4852,Increased Cellularity Present,Adenocarcinoma with squamous metaplasia,0
4853,Marked Thickening of the Bladder Urothelium Present,Erosive Adenomatosis of the Nipple,0
4854,Slit-Like Stromal Retraction Present,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
4855,Malignant Component Present,Malignant Gastric Granular Cell Tumor,0
4856,Edematous Stroma Formation,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
4857,Distortion of the Hair Follicle,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
4858,Tobacco Chewing Toxicity,Malignant neoplasm of stomach recurrent,0
4859,Intracytoplasmic Eosinophilic Spherical Inclusion,Eosinophilic Granuloma,0
4860,Loss of INI 1 Protein Expression,Ampulla of Vater Mucinous Adenocarcinoma,0
4861,Intestinal metaplasia of gastric mucosa,Squamous cell carcinoma of buccal mucosa,0
4862,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Ovarian Clear Cell Tumor,0
4863,Spindle Cell Osteo-Fibrous Component Present,Ciliary Body Spindle Cell Type B Melanoma,0
4864,Cutaneous plaque,Cutaneous sarcoidosis,0
4865,Blasts Expressing B-Lymphoid and Myeloid Markers Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
4866,Epithelial Component Present,Tubal Epithelial Hyperplasia,0
4867,Bead-Like Arrangement of Elastic Fibers,Malignant neoplasm of stomach recurrent,0
4868,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Squamous cell carcinoma of head and neck metastatic,0
4869,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4870,Lesion with Diameter Greater than 2cm,Renal Cell Carcinoma Associated with Neuroblastoma,0
4871,Histiocytosis,Pulmonary Histiocytosis X,0
4872,Skin Ulcer,Pre-Malignant Skin Epithelial Lesion,0
4873,Focal dysplasia,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
4874,Immunoglobulin Light Chain Deposition,Heavy Chain Deposition Disease,0
4875,Blasts Under 10 Percent of Bone Marrow Nucleated Cells,Osteoclastic Giant Cell-Rich Tumor of Bone,0
4876,Micronodular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4877,Tumor Mass,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4878,Intra or Intercytoplasmic Lumina Present,Ovarian Biphasic or Triphasic Teratoma,0
4879,Intestinal metaplasia of gastric mucosa,Squamous cell carcinoma of buccal mucosa,0
4880,Myxoid Changes Present,"Leiomyosarcoma, Myxoid",0
4881,Platinum Sensitivity,Malignant neoplasm of stomach recurrent,0
4882,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
4883,Single Cell Necrosis,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",0
4884,Large Spaces Filled with Blood Present,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
4885,Vascular Channel Formation with Muscular Walls,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,0
4886,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Bone Marrow Transplantation Nephropathy,0
4887,Pineocytomatous Rosette Formation,Adenocarcinoma with squamous metaplasia,0
4888,Progressive Clinical Course,Non-Hodgkin Lymphoma with Variable Clinical Course,0
4889,Neutral Epithelial Mucin Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,0
4890,Poorly Cohesive Malignant Cellular Infiltrate,Malignant Gastric Granular Cell Tumor,0
4891,Osseous Metaplasia of Malignant Cells Present,Malignant lymphoma of spleen,0
4892,Absence of a Hormonal Syndrome,Malignant neoplasm of stomach recurrent,0
4893,Solid Growth Pattern,Unresectable Solid Neoplasm,0
4894,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Refractory T-Cell Prolymphocytic Leukemia,0
4895,Antoni A Pattern,Kadish Stage A Olfactory Neuroblastoma,0
4896,Annular Tubules Present,Adenocarcinoma with squamous metaplasia,0
4897,PSA Failure,Adenocarcinoma with squamous metaplasia,0
4898,Osteoid formation,Malignant neoplasm of stomach recurrent,0
4899,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
4900,Castration Resistance,Occult Lung Cancer AJCC v8,0
4901,Encapsulated Mass,Adenocarcinoma with squamous metaplasia,0
4902,Hypocellular Tissue,Clear Cell Sarcoma of Soft Tissue,0
4903,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4904,No Evidence of Radiologic Finding,Recurrent tumors of the Ewing's family,0
4905,Tissue Differentiation Uncertain,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4906,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,0
4907,Steatohepatitis,Malignant neoplasm of stomach recurrent,0
4908,Mass of pleura,Lipoma of pleura,0
4909,Intraluminal Necrosis,Pseudolymphoma,0
4910,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0
4911,Rapidly Enlarging Mass,Occult Lung Cancer AJCC v8,0
4912,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4913,Cervical lymphadenopathy,Locally Advanced Unresectable Cervical Adenocarcinoma,0
4914,Microinvasive tumor,Wolffian tumor,0
4915,Emperipolesis,Adenocarcinoma with squamous metaplasia,0
4916,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,0
4917,Small Aggregates of Tumor Cells Present,Adult Ependymal Tumor,0
4918,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,rhabdomyosarcoma of mediastinum,0
4919,Small Aggregates of Tumor Cells Present,Small intestine carcinoma resectable,0
4920,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pharyngeal Carcinoma by AJCC v6 Stage,0
4921,Abundance of Small Lymphocytes,rhabdomyosarcoma of prostate,0
4922,Absence of Malignant Features,Malignant melanoma of rectum,0
4923,Malignant Cellular Infiltrate,Cellular fibroma,0
4924,Endobronchial Lesion,Cardiac Intramuscular Hemangioma,0
4925,Intermediate Grade Neuroendocrine Lesion,Refractory Neuroendocrine Neoplasm,0
4926,Smooth Muscle Component Present,"Leukemia, Mast-Cell",0
4927,Secondary Lesion,Colorectal Serrated Adenocarcinoma,0
4928,Endobronchial Lesion,Intramuscular Myxoma,0
4929,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
4930,Lesion with Diameter of 5cm or Less,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7,0
4931,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Urethral Carcinoma,0
4932,Mixed Neoplastic Glandular and Squamous Cell Population,Intraepithelial Squamous Cell Carcinoma,0
4933,Endobronchial Lesion,Stage IIIA Vulvar Cancer AJCC v7,0
4934,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Metastatic malignant neoplasm to nasopharynx,0
4935,Endobronchial Lesion,Ureter Carcinoma,0
4936,Extensive Stage Lesion,Stage II Nasopharyngeal Carcinoma AJCC v7,0
4937,Plexiform Vasculature Present,Plexiform Schwannoma,0
4938,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7,0
4939,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Renal Cell Cancer,0
4940,Limited Early T-Cell Differentiation,T-Cell Lymphoma,0
4941,Cavernous Lymphatic Space Formation,Liver Cavernous Hemangioma,0
4942,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,0
4943,Extensive Stage Lesion,Non-Hodgkin Lymphoma by Ann Arbor Stage,0
4944,Recurrent Malignant Neoplasm,Recurrent Malignant Urinary System Neoplasm,0
4945,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Facial Nerve Palsy Related to Birth,0
4946,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0
4947,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Locally Advanced Malignant Neoplasm,0
4948,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign neoplasm of middle ear,0
4949,Extensive Stage Lesion,Stage IB Distal Bile Duct Cancer AJCC v7,0
4950,Endobronchial Lesion,Stage IVA Lung Cancer AJCC v8,0
4951,Tumor Droplets Present,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,0
4952,Extensive Stage Lesion,Stage IIB Gastric Cancer AJCC v7,0
4953,Mixed Neoplastic Glandular and Squamous Cell Population,"Carcinoma, Large Cell",0
4954,Endobronchial Lesion,Parosteal Osteosarcoma,0
4955,Follicular Cell Differentiation,Laryngeal Giant Cell Carcinoma,0
4956,Abundance of Small Lymphocytes,adenoid cystic carcinoma of accessory sinus,0
4957,EBV-Positive Neoplastic Cells Present,Gestational Trophoblastic Neoplasms,0
4958,Secondary Lesion,Mature Ovarian Teratoma,0
4959,Abundance of Small Lymphocytes,Mucoepidermoid carcinoma of skin,0
4960,Extensive Stage Lesion,Masaoka-Koga Stage II,0
4961,Follicular Cell Differentiation,Merkel Cell Carcinoma by AJCC v8 Stage,0
4962,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Secondary malignant neoplasm of thymus,0
4963,Extensive Stage Lesion,Stage 0 Lip Carcinoma,0
4964,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4965,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Fibroid Tumor,0
4966,White blood cell count increased (lab result),Bladder transitional cell carcinoma stage II,0
4967,Intermediate Grade Lesion,Grade III Childhood Astrocytoma,0
4968,Cutaneous plaque,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,0
4969,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7,0
4970,Tumor Droplets Present,Localized Digestive System Neuroendocrine Tumor G1,0
4971,Dense Collagenized Tissue Present,Stage II Soft Tissue Sarcoma AJCC v7,0
4972,Endobronchial Lesion,Uterine Cancer,0
4973,Photosensitivity of skin,Hemangioendothelioma of skin,0
4974,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Cardiac Paraganglioma,0
4975,Tumor Droplets Present,Descending Colon Neuroendocrine Tumor G1,0
4976,Small Aggregates of Tumor Cells Present,Temporal Lobe Ependymal Tumor,0
4977,Smooth Muscle Component Present,Oropharyngeal squamous papilloma,0
4978,Extensive Stage Lesion,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,0
4979,EBV-Positive Neoplastic Cells Present,Metastatic osteosarcoma,0
4980,EBV-Positive Neoplastic Cells Present,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",0
4981,Endobronchial Lesion,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage,0
4982,Smooth Muscle Component Present,Ethmoid Sinus Schneiderian Papilloma,0
4983,Small Aggregates of Tumor Cells Present,Benign Anal Granular Cell Tumor,0
4984,Small Aggregates of Tumor Cells Present,Tumor of follicular infundibulum,0
4985,Smooth Muscle Component Present,Metaplastic thymoma,0
4986,Endobronchial Lesion,Parathyroid Adenoma,0
4987,Tumor Droplets Present,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,0
4988,Smooth Muscle Component Present,EBV-Related Lymphoma,0
4989,Absence of Malignant Features,Malignant Cardiovascular Neoplasm,0
4990,EBV-Positive Neoplastic Cells Present,Palate carcinoma,0
4991,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of subglottis,0
4992,EBV-Positive Neoplastic Cells Present,Aflatoxins-Related Hepatocellular Carcinoma,0
4993,Tumor Droplets Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4994,High Grade Lesion,Grade 3 Teratoma,0
4995,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Bladder Squamous Cell Carcinoma,0
4996,Secondary Lesion,Hemangioma acquired,0
4997,Malignant Primitive Cellular Infiltrate,Malignant Pericytic Neoplasm,0
4998,Lesion with Diameter of 10mm or Less,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease",0
4999,Intermediate Grade Neuroendocrine Lesion,Advanced Digestive System Neuroendocrine Neoplasm,0
5000,Non-Encapsulated Neoplasm,Stage IV Gestational Trophoblastic Neoplasm AJCC v8,0
5001,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary Peripheral Chondrosarcoma,0
5002,EBV-Positive Neoplastic Cells Present,Benign Lymphoproliferative Disorder,0
5003,Numerous Stromal Mast Cells Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
5004,Extensive Stage Lesion,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8,0
5005,Melanoma Cells Present,Ovarian Dermoid Cyst with Melanoma,0
5006,EBV-Positive Neoplastic Cells Present,Parotid Gland Carcinoma,0
5007,Endobronchial Lesion,Stage IV Major Salivary Gland Cancer AJCC v7,0
5008,Secondary Lesion,Ataxia Telangiectasia,0
5009,Endobronchial Lesion,"Neuroectodermal Tumor, Primitive",0
5010,Single Cell Necrosis,Chromophobe Renal Cell Carcinoma,0
5011,Secondary Lesion,B-cell lymphoma refractory,0
5012,Small Aggregates of Tumor Cells Present,Small intestine carcinoma recurrent,0
5013,Secondary Lesion,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8,0
5014,EBV-Positive Neoplastic Cells Present,Advanced Uveal Melanoma,0
5015,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Hilar Cholangiocarcinoma by AJCC v8 Stage,0
5016,Secondary Lesion,Stage III Hodgkin Lymphoma,0
5017,Blasts Under 20 Percent of Peripheral Blood White Cells,Stage IIA Ampulla of Vater Cancer AJCC v8,0
5018,Multiple Tumor Masses,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
5019,Blasts Expressing CD56 and Immature T-Cell Markers Present,Cutaneous Adult T-Cell Leukemia/Lymphoma,0
5020,EBV-Positive Neoplastic Cells Present,Periductal Breast Myoepitheliosis,0
5021,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8,0
5022,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,AIDS with Kaposi's sarcoma,0
5023,EBV-Positive Neoplastic Cells Present,Hormone refractory breast cancer,0
5024,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Alcohol-Related Carcinoma,0
5025,Smooth Muscle Component Present,Mycosis fungoides refractory,0
5026,Extensive Stage Lesion,Stage III Renal Pelvis Cancer AJCC v7,0
5027,Recurrent Genetic Abnormalities Present,Recurrent Anal Mucinous Adenocarcinoma,0
5028,Smooth Muscle Component Present,Hypopharyngeal Cancer,0
5029,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIIB Cervical Cancer AJCC v6 and v7,0
5030,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
5031,EBV-Positive Neoplastic Cells Present,Gastric Hemangioma,0
5032,EBV-Positive Neoplastic Cells Present,Lung Myoepithelioma,0
5033,Endobronchial Lesion,Lymphoid interstitial pneumonia,0
5034,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Adrenal Cortex Carcinoma,0
5035,Smooth Muscle Component Present,Pityriasis Lichenoides et Varioliformis Acuta,0
5036,Large Neoplastic Glands with Branching and Papillary Infolding Present,AIDS-Related Diffuse Large B-cell Lymphoma,0
5037,Respiratory distress,Respiratory papilloma,0
5038,Endobronchial Lesion,Stage IB Osteosarcoma AJCC v7,0
5039,Smooth Muscle Component Present,Childhood Infratentorial Ependymoma,0
5040,Absence of Malignant Features,Resectable Malignant Mesothelioma,0
5041,Endobronchial Lesion,Indolent Systemic Mastocytosis,0
5042,EBV-Positive Neoplastic Cells Present,Angioimmunoblastic T-cell lymphoma stage IV,0
5043,Non-Encapsulated Neoplasm,Stage II Gestational Trophoblastic Neoplasm AJCC v8,0
5044,Proliferation of Small Ducts Present,Stage IIB Small Intestinal Adenocarcinoma AJCC v8,0
5045,Progressive Disease,Progressive bulbar palsy,0
5046,Recurrent Genetic Abnormalities Present,Recurrent BRCA-Mutated Ovarian Carcinoma,0
5047,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Colon Carcinoma,0
5048,EBV-Positive Neoplastic Cells Present,Childhood Mature Teratoma,0
5049,Abundance of Small Lymphocytes,Small cell osteosarcoma,0
5050,Mesenchymal Metaplasia of Malignant Cells Present,Malignant melanoma of eyelid,0
5051,Secondary Lesion,Acral Fibromyxoma,0
5052,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of hilus of lung,0
5053,Smooth Muscle Component Present,Paraganglioma,0
5054,Intermediate Grade Lesion,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma,0
5055,Secondary Lesion,Stage IIB Colorectal Cancer AJCC v8,0
5056,Blasts Under 20 Percent of Peripheral Blood White Cells,benign tumor of hypopharynx,0
5057,EBV-Positive Neoplastic Cells Present,Breast Pleomorphic Adenoma,0
5058,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant tumor of mediastinum,0
5059,Endobronchial Lesion,Sympathetic paraganglioma,0
5060,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,0
5061,EBV-Positive Neoplastic Cells Present,Stage IVB Thymoma AJCC v8,0
5062,Small Aggregates of Tumor Cells Present,Childhood Testicular Germ Cell Tumor,0
5063,Abundance of Small Lymphocytes,Epithelial tumor of ovary,0
5064,Multihormonal Immunoreactivity Present in a Single Cell Type,ISS Stage II Plasma Cell Myeloma,0
5065,Confluent Sheets of Anaplastic T-Lymphocytes Present,Recurrent Childhood Anaplastic Astrocytoma,0
5066,EBV-Positive Neoplastic Cells Present,Favorable Non-Hodgkin Lymphoma,0
5067,Blasts Under 20 Percent of Peripheral Blood White Cells,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin,0
5068,Abundance of Small Lymphocytes,Polyp of vocal cord,0
5069,Follicular Differentiation,Ann Arbor Stage III Grade 1 Follicular Lymphoma,0
5070,Endobronchial Lesion,Intracranial Liposarcoma,0
5071,EBV-Positive Neoplastic Cells Present,Relapsed Hypopharynx Carcinoma,0
5072,Abundance of Small Lymphocytes,Malignant neoplasm of breast,0
5073,Endobronchial Lesion,Resectable Undifferentiated Pleomorphic Sarcoma,0
5074,Endobronchial Lesion,Postauricular lymphadenitis,0
5075,Secondary Lesion,Unresectable Liposarcoma,0
5076,Smooth Muscle Component Present,Aleukemic leukemia,0
5077,Recurrent Malignant Neoplasm,Reproductive Endocrine Neoplasm,0
5078,Follicular Differentiation,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,0
5079,Recurrent Malignant Neoplasm,Recurrent Ureter Carcinoma,0
5080,Secondary Lesion,Vulvar Alveolar Rhabdomyosarcoma,0
5081,EBV-Positive Neoplastic Cells Present,Benign Pericytic Neoplasm,0
5082,Fibrous Septa Present,Cutaneous Fibrous Histiocytoma,0
5083,Secondary Lesion,Glossopharyngeal nerve paralysis,0
5084,Proliferation of Follicular Dendritic Cells Present,Methotrexate-Associated Follicular Lymphoma,0
5085,Secondary Lesion,Common wart,0
5086,Secondary Lesion,Central Nervous System Leiomyoma,0
5087,Endobronchial Lesion,Meyerson Nevus,0
5088,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Squamous cell carcinoma of the hypopharynx recurrent,0
5089,Mixed Neoplastic Glandular and Squamous Cell Population,"Lung Squamous Cell Carcinoma, Small Cell Variant",0
5090,Large Neoplastic Glands with Branching and Papillary Infolding Present,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,0
5091,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Oral Cavity Squamous Cell Carcinoma,0
5092,Dense Collagenized Tissue Present,Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5093,Abundance of Small Lymphocytes,Small cell neuroendocrine carcinoma of bladder,0
5094,Recurrent Malignant Neoplasm,Recurrent Anaplastic Oligoastrocytoma,0
5095,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hormone Receptor Positive Breast Carcinoma,0
5096,Malignant Primitive Cellular Infiltrate,Malignant mesothelioma,0
5097,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,"Malignant lymphoma centroblastic, diffuse",0
5098,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
5099,Recurrent Genetic Abnormalities Present,Skin Abnormalities,0
5100,EBV-Positive Neoplastic Cells Present,Stage IA Uterine Corpus Cancer AJCC v7,0
5101,Endobronchial Lesion,Adult Erythroleukemia,0
5102,EBV-Positive Neoplastic Cells Present,Luteoma,0
5103,Malignant Primitive Cellular Infiltrate,"Malignant tumor, giant cell type",0
5104,Endobronchial Lesion,Testicular yolk sac tumor stage III,0
5105,Multinodular and Vacuolated Pattern,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,0
5106,Unifocal Disease,gamma-Chain Disease,0
5107,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
5108,Smooth Muscle Component Present,High-Risk Neuroblastoma,0
5109,Cervical lymphadenopathy,Cervical Adenocarcinoma,0
5110,NRBC - Nucleated red blood cell present result,Giant cell angiofibroma,0
5111,EBV-Positive Neoplastic Cells Present,Alveolar soft part sarcoma recurrent,0
5112,Smooth Muscle Component Present,Desmoplastic Medulloblastoma,0
5113,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Cutaneous Melanoma AJCC v6 and v7,0
5114,EBV-Positive Neoplastic Cells Present,Vestibular Papilloma,0
5115,Diffuse Immunoblastic Proliferation,Thyroid Immunoblastic Lymphoma,0
5116,Secondary Lesion,Gastric Schwannoma,0
5117,Extensive Stage Lesion,Stage IV Uterine Corpus Leiomyosarcoma AJCC v8,0
5118,Smooth Muscle Component Present,Genitourinary Cancer,0
5119,EBV-Positive Neoplastic Cells Present,Extramedullary Plasmacytoma,0
5120,EBV-Positive Neoplastic Cells Present,Anatomic Stage IA Breast Cancer AJCC v8,0
5121,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Adult Liver Carcinoma,0
5122,Endobronchial Lesion,Reactive Cutaneous Fibrous Lesion,0
5123,Rimming of Adipose Tissue Cells Present,Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5124,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adenocarcinoma in adenomatous polyp,0
5125,EBV-Positive Neoplastic Cells Present,Stage IVB Rectal Cancer AJCC v7,0
5126,Endobronchial Lesion,Gastric Lymphangioma,0
5127,Smooth Muscle Component Present,Ethmoid Sinus Adenocarcinoma,0
5128,"Adenocarcinoma, intestinal type","Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",0
5129,EBV-Positive Neoplastic Cells Present,Marginal zone lymphoma stage IV,0
5130,Extensive Stage Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,0
5131,Gastric dysplasia,Gastric Body Carcinoma,0
5132,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Paget's disease of vulva,0
5133,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Noninfiltrating Intraductal Carcinoma,0
5134,EBV-Positive Neoplastic Cells Present,Classical Glioblastoma,0
5135,Epithelioid Differentiation,Ciliary Body Epithelioid Cell Melanoma,0
5136,EBV-Positive Neoplastic Cells Present,Refractory T Lymphoblastic Lymphoma,0
5137,Follicular Cell Differentiation,Malignant Ovarian Germ Cell Neoplasm,0
5138,Malignant Primitive Cellular Infiltrate,Malignant Childhood Central Nervous System Neoplasm,0
5139,Smooth Muscle Component Present,Epidermolysis Bullosa,0
5140,EBV-Positive Neoplastic Cells Present,Blast Phase,0
5141,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Disorder of pregnancy,0
5142,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Gastroesophageal Junction Neuroendocrine Carcinoma,0
5143,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
5144,Granulocytes Increased in Bone Marrow,Stage IIB Bone Sarcoma AJCC v7,0
5145,Secondary Lesion,Anaplastic Oligodendroglioma,0
5146,White blood cell count increased (lab result),Papillary squamous cell carcinoma,0
5147,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,keratinizing squamous cell carcinoma of vulva,0
5148,Small Aggregates of Tumor Cells Present,Small Intestinal Carcinoid Tumor,0
5149,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage III Ampulla of Vater Cancer AJCC v7,0
5150,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,0
5151,Secondary Lesion,Refractory Uterine Corpus Carcinosarcoma,0
5152,Endobronchial Lesion,Stage 0 Testicular Cancer AJCC v8,0
5153,Endobronchial Lesion,Centroblastic lymphoma refractory,0
5154,Endobronchial Lesion,Primary Peritoneal Serous Adenocarcinoma,0
5155,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IB Gastric Cancer AJCC v8,0
5156,Secondary Lesion,Adrenal Gland Schwannoma,0
5157,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IV Pancreatic Cancer AJCC v6 and v7,0
5158,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Subglottic Squamous Cell Carcinoma,0
5159,Lesion with Diameter of 10mm or Less,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0
5160,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0
5161,Acute inflammation,Childhood Acute Basophilic Leukemia,0
5162,Secondary Lesion,Familial Hemophagocytic Lymphocytosis,0
5163,EBV-Positive Neoplastic Cells Present,Meningeal Leukemia,0
5164,Low Grade Cartilaginous Component Present,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,0
5165,Extensive Stage Lesion,Stage I Uterine Sarcoma AJCC v7,0
5166,Multiple Tumor Masses,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
5167,Multihormonal Immunoreactivity Present in a Single Cell Type,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0
5168,Endobronchial Lesion,"Hepatocellular carcinoma, scirrhous",0
5169,EBV-Positive Neoplastic Cells Present,Pancreatic carcinoma non-resectable,0
5170,Secondary Lesion,Fallopian Tube Papilloma,0
5171,Unifocal Disease at Presentation,HHV8-Positive Multicentric Castleman Disease,0
5172,Mammary Gland Type Features Present,Adult Salivary Gland Carcinoma,0
5173,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,0
5174,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,cloacogenic carcinoma of rectum,0
5175,EBV-Positive Neoplastic Cells Present,Choroid Plexus Neoplasms,0
5176,Recurrent Malignant Neoplasm,Malignant Sternal Neoplasm,0
5177,Single Cell Necrosis,Benign Basal Cell Neoplasm,0
5178,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IIB Colon Neuroendocrine Tumor AJCC v8,0
5179,Endobronchial Lesion,Fibrillary Astrocytoma,0
5180,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Polyp in nasopharynx,0
5181,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage III Lip Basal Cell Carcinoma,0
5182,Endometrial Type Glands and Stroma Present,Recurrent Endometrial Cancer,0
5183,Abundance of Small Lymphocytes,Benign neoplasm of sebaceous gland,0
5184,Multihormonal Immunoreactivity Present in a Single Cell Type,Epithelioid Type Angiomyolipoma,0
5185,Extensive Stage Lesion,Stage IIB Pancreatic Cancer AJCC v8,0
5186,EBV-Positive Neoplastic Cells Present,Refractory Glioblastoma,0
5187,EBV-Positive Neoplastic Cells Present,Fallopian Tube Adenocarcinoma,0
5188,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5189,Follicular Cell Differentiation,Giant Cell Fibroblastoma,0
5190,Recurrent Malignant Neoplasm,Recurrent Childhood Gliomatosis Cerebri,0
5191,Small Aggregates of Tumor Cells Present,Pancreatic Neuroendocrine Tumor G2,0
5192,NRBC - Nucleated red blood cell present result,Precursor cell lymphoblastic lymphoma,0
5193,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Condyloma acuminata of vagina,0
5194,Postneoadjuvant Therapy Pathologic TNM Finding,Gastric Cancer by AJCC v8 Pathologic Stage,0
5195,EBV-Positive Neoplastic Cells Present,Neuroblastic tumors,0
5196,Abundance of Small Lymphocytes,Normal Breast-Like Subtype of Breast Carcinoma,0
5197,Smooth Muscle Component Present,liposarcoma,0
5198,Cutaneous plaque,Cutaneous Melanoma by AJCC v6 Stage,0
5199,EBV-Positive Neoplastic Cells Present,"Lymphoma, Non-Hodgkin",0
5200,Glandular cell atypia,Spindle cell liposarcoma,0
5201,Nerve palsy,Bilateral Optic Nerve Meningioma,0
5202,Extensive Stage Lesion,Stage I Gallbladder Cancer AJCC v7,0
5203,EBV-Positive Neoplastic Cells Present,Stage IVC Major Salivary Gland Cancer AJCC v8,0
5204,Skin Red Dot,Skin Abnormalities,0
5205,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,leiomyosarcoma of vulva,0
5206,White blood cell count increased (lab result),Precursor cell lymphoblastic lymphoma,0
5207,Endometrial Type Glands and Stroma Present,Serous Endometrial Intraepithelial Carcinoma,0
5208,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of maxillary sinus,0
5209,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
5210,Secondary Lesion,Stage III Urethral Cancer AJCC v8,0
5211,Fibrotic Stroma with Finger-Like Projections Present,Acute myeloid leukemia with BCR-ABL1,0
5212,Multihormonal Immunoreactivity Present in a Single Cell Type,RISS Stage I Plasma Cell Myeloma,0
5213,No Evidence of Metastatic Disease,Metastatic Carcinoma,0
5214,EBV-Positive Neoplastic Cells Present,Stage I Adrenal Cortex Carcinoma AJCC v8,0
5215,EBV-Positive Neoplastic Cells Present,Thyroid Gland Oncocytic Adenoma,0
5216,Endobronchial Lesion,"Refractory Medulloblastoma, SHH-Activated",0
5217,Secondary Lesion,Infant T Acute Lymphoblastic Leukemia,0
5218,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Stage IB Distal Bile Duct Cancer AJCC v7,0
5219,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5220,Plasma cell inflammation,"Papillary renal cell carcinoma, sporadic",0
5221,Non-Encapsulated Neoplasm,Chondrogenic Neoplasm,0
5222,Abundance of Small Lymphocytes,Malignant tumor of ethmoid sinus,0
5223,Islands of Odontogenic Epithelium Present,"Odontogenic tumor, benign",0
5224,Lesion with Diameter of 4mm or More,Ocular Melanoma with Extraocular Extension,0
5225,Intermediate Grade Lesion,Angiosarcoma NCI Grade 2,0
5226,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
5227,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Retinoblastoma by AJCC v8 Clinical Stage,0
5228,Blasts Under 20 Percent of Peripheral Blood White Cells,Splenic Manifestation of T-Cell Prolymphocytic Leukemia,0
5229,Squamous Differentiation,Vulvar Squamous Neoplasm,0
5230,Extensive Stage Lesion,Stage III Nasopharyngeal Carcinoma AJCC v8,0
5231,Abundance of Small Lymphocytes,Secondary malignant neoplasm of pituitary gland,0
5232,Lesion with Diameter of 4mm or More,Ovarian Dermoid Cyst with Sebaceous Carcinoma,0
5233,Endobronchial Lesion,Stage IIIB Eyelid Carcinoma AJCC v7,0
5234,Endobronchial Lesion,Anatomic Stage IIIC Breast Cancer AJCC v8,0
5235,EBV-Positive Neoplastic Cells Present,Unresectable Leiomyosarcoma,0
5236,Blasts Under 20 Percent of Peripheral Blood White Cells,cystadenocarcinoma of salivary gland,0
5237,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,0
5238,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Lung Neuroendocrine Neoplasm,0
5239,Endobronchial Lesion,Refractory Chronic Leukemia,0
5240,Absence of Malignant Features,Malignant tumor of eye,0
5241,Gastric dysplasia,Clinical Stage IVB Gastric Cancer AJCC v8,0
5242,Endobronchial Lesion,Recurrent Childhood Cerebral Astrocytoma,0
5243,Small Aggregates of Tumor Cells Present,Ileal Neuroendocrine Tumor,0
5244,Multihormonal Immunoreactivity Present in a Single Cell Type,Cervical Squamous Cell Carcinoma,0
5245,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IB Cutaneous Melanoma AJCC v8,0
5246,Progressive Disease,Bowen's Disease,0
5247,Endobronchial Lesion,Cholangiocarcinoma,0
5248,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Childhood Salivary Gland Carcinoma,0
5249,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Lung Squamous Cell Carcinoma AJCC v7,0
5250,Epithelial hyperplasia of skin,Clear cell squamous cell carcinoma of skin,0
5251,Endobronchial Lesion,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2",0
5252,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Infiltrating Bladder Urothelial Carcinoma,0
5253,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic rejection of renal transplant,0
5254,"Adenocarcinoma, intestinal type","Salivary Gland Adenocarcinoma, Not Otherwise Specified",0
5255,Secondary Lesion,Mammary-Type Myofibroblastoma,0
5256,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,tubulopapillary adenoma of extrahepatic bile duct,0
5257,Endobronchial Lesion,Subcutaneous Disorder,0
5258,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Leiomyosarcoma of uterus,0
5259,No Evidence of Metastatic Disease,Metastatic Rectal Carcinoma,0
5260,Secondary Lesion,Stage 4S neuroblastoma,0
5261,Secondary Lesion,Suppurative lymphadenopathy,0
5262,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Prostatic Duct Urothelial Carcinoma,0
5263,NRBC - Nucleated red blood cell present result,Benign squamous cell tumor,0
5264,Generalized illness,Acute Generalized Exanthematous Pustulosis,0
5265,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Glandular Neoplasm,0
5266,Mixed Neoplastic Glandular and Squamous Cell Population,Head and neck cancer metastatic,0
5267,Tumor Droplets Present,Metastatic Malignant Germ Cell Tumor,0
5268,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,malignant neoplasm of bone marrow,0
5269,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign pheochromocytoma of adrenal gland,0
5270,Follicular Cell Differentiation,Small Intestinal Follicular Lymphoma,0
5271,Endobronchial Lesion,Medulloepithelioma,0
5272,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Anaplastic Large Cell Lymphoma,0
5273,Endobronchial Lesion,Breast Fibroepithelial Neoplasm,0
5274,Endobronchial Lesion,AIDS-Related Carcinoma,0
5275,Extensive Stage Lesion,Stage II Colon Cancer AJCC v8,0
5276,Endobronchial Lesion,Endometrial Mucinous Adenocarcinoma,0
5277,Endobronchial Lesion,Placenta Percreta,0
5278,Small Aggregates of Tumor Cells Present,Soft Palate Benign Granular Cell Tumor,0
5279,Abundance of Small Lymphocytes,Mucoepidermoid carcinoma of salivary gland,0
5280,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0
5281,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),0
5282,Cutaneous plaque,Clinical Stage 0 Cutaneous Melanoma AJCC v8,0
5283,Lesion with Diameter of 4mm or More,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0
5284,Extensive Stage Lesion,Stage IVB Lung Cancer AJCC v8,0
5285,Large Neoplastic Glands with Branching and Papillary Infolding Present,Esophageal Diffuse Large B-Cell Lymphoma,0
5286,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Tufted angioma of skin,0
5287,Abundance of Small Lymphocytes,Malignant tumor of base of tongue,0
5288,Tumor Droplets Present,Recurrent Ovarian Germ Cell Tumor,0
5289,Cervical lymphadenopathy,Stage IA Cervical Cancer AJCC v8,0
5290,Cervical lymphadenopathy,Stage I Cervical Cancer AJCC v6 and v7,0
5291,Recurrent Malignant Neoplasm,Transplant-Related Malignant Neoplasm,0
5292,EBV-Positive Neoplastic Cells Present,Lymphoma,0
5293,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Ewing's sarcoma of bone,0
5294,Absence of Malignant Features,Malignant neoplasm of kidney,0
5295,Recurrent Genetic Abnormalities Present,Recurrent Acute Leukemia,0
5296,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,cystadenocarcinoma of salivary gland,0
5297,Fibrotic Stroma with Finger-Like Projections Present,Palmoplantar keratoderma with leukoplakia,0
5298,Recurrent Malignant Neoplasm,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,0
5299,Single Cell Necrosis,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",0
5300,Endobronchial Lesion,GIANT PIGMENTED HAIRY NEVUS,0
5301,EBV-Positive Neoplastic Cells Present,B-Cell Lymphomas,0
5302,Smooth Muscle Component Present,Vaginal Endometrioid Adenocarcinoma,0
5303,Extensive Stage Lesion,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,0
5304,Non-Encapsulated Neoplasm,Oligodendroglial Neoplasm,0
5305,Extensive Stage Lesion,Pathologic Stage IIIB Gastric Cancer AJCC v8,0
5306,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor,0
5307,Endobronchial Lesion,Benign Cerebellar Neoplasms,0
5308,EBV-Positive Neoplastic Cells Present,Benign Struma Ovarii,0
5309,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Carcinoid tumor of the liver,0
5310,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ampulla of Vater Undifferentiated Carcinoma,0
5311,Secondary Lesion,tumor miofibroblástico peribronquial congénito,0
5312,Small Aggregates of Tumor Cells Present,Lung Inflammatory Myofibroblastic Tumor,0
5313,Secondary Lesion,Uterine Corpus Adenomyoma,0
5314,Secondary Lesion,Meyerson Nevus,0
5315,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Esophageal Glandular Intraepithelial Neoplasia,0
5316,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign neoplasm of hilus of lung,0
5317,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adenocarcinoma of small intestine,0
5318,Smooth Muscle Component Present,Colon Leiomyosarcoma,0
5319,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Laryngeal Acantholytic Squamous Cell Carcinoma,0
5320,EBV-Positive Neoplastic Cells Present,Radiation Anemia,0
5321,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Luminal A Breast Carcinoma,0
5322,EBV-Positive Neoplastic Cells Present,Stage IV Urethral Cancer AJCC v8,0
5323,Follicular Cell Differentiation,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
5324,Well Differentiated Neuroendocrine Lesion,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,0
5325,Endobronchial Lesion,Disseminated adenocarcinoma,0
5326,Smooth Muscle Component Present,"Carcinoma, Spindle-Cell",0
5327,Secondary Lesion,Stage IVA Thymoma AJCC v8,0
5328,Follicular Differentiation,Childhood Thyroid Gland Follicular Carcinoma,0
5329,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant tumor of eye,0
5330,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Pulmonary Vein Neoplasm,0
5331,Large Neoplastic Glands with Branching and Papillary Infolding Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,0
5332,Diffuse Immunoblastic Proliferation,Diffuse Glioma,0
5333,Secondary Lesion,Ovarian Serous Adenofibroma,0
5334,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of conjunctiva,0
5335,NRBC - Nucleated red blood cell present result,Large cell lung cancer recurrent,0
5336,Endobronchial Lesion,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",0
5337,Secondary Lesion,Stage 0is Ureter Cancer AJCC v8,0
5338,EBV-Positive Neoplastic Cells Present,"Hamartoma Syndrome, Multiple",0
5339,EBV-Positive Neoplastic Cells Present,Psoriasis,0
5340,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraepithelial Melanocytic Hyperplasia,0
5341,Mixed Neoplastic Glandular and Squamous Cell Population,Malignant Outer Hair Sheath and Infundibulum Neoplasm,0
5342,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Prostate Carcinoma,0
5343,Secondary Lesion,Conventional Cardiac Rhabdomyoma,0
5344,Blasts Under 20 Percent of Peripheral Blood White Cells,embryonal rhabdomyosarcoma of orbit,0
5345,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
5346,EBV-Positive Neoplastic Cells Present,Stage IIIC Eyelid Carcinoma AJCC v7,0
5347,EBV-Positive Neoplastic Cells Present,Serous cystadenocarcinoma ovary,0
5348,Secondary Lesion,Acute leukemia,0
5349,Endobronchial Lesion,Gastric Leiomyoma,0
5350,Small Aggregates of Tumor Cells Present,Peritoneal Solitary Fibrous Tumor,0
5351,Mesenchymal Metaplasia of Malignant Cells Present,Malignant tumor of rectosigmoid junction,0
5352,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage II Choroidal and Ciliary Body Melanoma AJCC v8,0
5353,Secondary Lesion,Acute Promyelocytic Leukemia,0
5354,Enterochromaffin-Like Type Granules Present,Refractory Neurofibromatosis Type 1,0
5355,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,non-Hodgkin's lymphoma of nasal cavity,0
5356,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Squamous cell carcinoma of the hypopharynx stage II,0
5357,Secondary Lesion,Refractory Uterine Corpus Carcinosarcoma,0
5358,Follicular Cell Differentiation,Non-Small Cell Adenocarcinoma,0
5359,Recurrent Genetic Abnormalities Present,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5360,Secondary Lesion,Masaoka-Koga Stage IIb,0
5361,Intermediate Grade Lesion,Grade 1 Colorectal Adenocarcinoma,0
5362,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adenoma of ampulla of Vater,0
5363,EBV-Positive Neoplastic Cells Present,Prognostic Stage II Breast Cancer AJCC v8,0
5364,Cervical lymphadenopathy,Cervical Adenoid Cystic Carcinoma,0
5365,Recurrent Malignant Neoplasm,Intermediate Grade Malignant Neoplasm,0
5366,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Bladder Cancer by AJCC v6 Stage,0
5367,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7,0
5368,Blue Bone Formation,Cervical Blue Nevus,0
5369,Neoplastic Plasma Cells Present in Bone Marrow,"Neoplastic Syndromes, Hereditary",0
5370,Blasts Under 20 Percent of Peripheral Blood White Cells,leiomyoma of extrahepatic bile duct,0
5371,Abundance of Small Lymphocytes,undifferentiated carcinoma of pancreas,0
5372,NRBC - Nucleated red blood cell present result,Testicular germ cell tumor mixed stage II,0
5373,Secondary Lesion,Vaginal Myofibroblastoma,0
5374,Endobronchial Lesion,Piloleiomyoma,0
5375,Abundance of Small Lymphocytes,Fibroma of lung,0
5376,EBV-Positive Neoplastic Cells Present,Plantar wart,0
5377,Endobronchial Lesion,Thymic Adenosquamous Carcinoma,0
5378,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Inflammatory pseudotumor of liver,0
5379,Endobronchial Lesion,Stage I Esophageal Cancer AJCC v7,0
5380,Blasts 5-19 Percent of Peripheral Blood White Cells,Peripheral Breast Papilloma,0
5381,Secondary Lesion,Childhood Undifferentiated Pleomorphic Sarcoma,0
5382,Aggressive Clinical Course,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
5383,EBV-Positive Neoplastic Cells Present,Prostate Adenoid Cystic Carcinoma,0
5384,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adenocarcinoma of small intestine,0
5385,EBV-Positive Neoplastic Cells Present,Maturing Ganglioneuroma,0
5386,EBV-Positive Neoplastic Cells Present,Radiation-Related Non-Neoplastic Disorder,0
5387,EBV-Positive Neoplastic Cells Present,Vulvar Ectopic Fibroadenoma,0
5388,Multinodular and Vacuolated Pattern,Stage IIIA Anal Canal Cancer AJCC v6 and v7,0
5389,Extensive Stage Lesion,Retinoblastoma by AJCC v8 Stage,0
5390,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Region 17p13 Allelic Loss Associated Medulloblastoma,0
5391,Glandular cell atypia,Acantholytic squamous cell carcinoma,0
5392,Enterochromaffin Type Granules Present,"Breast Fibrocystic Change, Non-Proliferative Type",0
5393,EBV-Positive Neoplastic Cells Present,CARCINOMA OF VULVA,0
5394,Secondary Lesion,Thymic Adenosquamous Carcinoma,0
5395,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Gastric Intraepithelial Neoplasia,0
5396,Cutaneous plaque,Pure Cutaneous Mastocytosis,0
5397,EBV-Positive Neoplastic Cells Present,Localized Non-Resectable Adult Liver Carcinoma,0
5398,EBV-Positive Neoplastic Cells Present,Stage III Prostate Cancer AJCC v7,0
5399,Mass of pleura,Secondary malignant neoplasm of pleura,0
5400,Recurrent Malignant Neoplasm,Benign Extrahepatic Bile Duct Soft Tissue Neoplasm,0
5401,EBV-Positive Neoplastic Cells Present,Mediastinal Leiomyoma,0
5402,Mammary Gland Type Features Present,Submandibular Gland Undifferentiated Carcinoma,0
5403,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Epithelial Predominant Kidney Wilms Tumor,0
5404,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Mucoepidermoid carcinoma of the oral cavity,0
5405,EBV-Positive Neoplastic Cells Present,Disseminated neuroblastoma,0
5406,Secondary Lesion,Cherubism,0
5407,Inflammatory infiltrate,Inflammatory Hepatocellular Adenoma,0
5408,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,0
5409,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,leiomyosarcoma of bone,0
5410,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Adrenal Cortex Carcinoma AJCC v8,0
5411,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0
5412,Squamous Differentiation,Anal Canal Squamous Papilloma,0
5413,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Unresectable Carcinoma,0
5414,Smooth Muscle Component Present,Dermatitis acneiform,0
5415,EBV-Positive Neoplastic Cells Present,Urethral Inverted Papilloma,0
5416,Mesenchymal Metaplasia of Malignant Cells Present,Malignant tumor of base of tongue,0
5417,Low Grade Cartilaginous Component Present,Low Grade Gastric Intraepithelial Neoplasia,0
5418,Small Aggregates of Tumor Cells Present,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,0
5419,Endobronchial Lesion,Keratoderma,0
5420,Diffuse Cellular Infiltrate,"Keratoderma, Palmoplantar, Diffuse",0
5421,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of the hypopharynx stage IV,0
5422,Smooth Muscle Component Present,Seminoma,0
5423,Multihormonal Immunoreactivity Present in a Single Cell Type,Multiple endocrine neoplasia Type 2,0
5424,Endobronchial Lesion,Metastatic Neuroblastoma,0
5425,Intermediate Grade Lesion,Grade 2 Colorectal Adenocarcinoma,0
5426,Smooth Muscle Component Present,Ichthyosis linearis circumflexa,0
5427,Diffuse Cellular Infiltrate,Diffuse Glioma,0
5428,Rimming of Adipose Tissue Cells Present,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0
5429,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Polyp of gallbladder,0
5430,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Bone marrow hyperplasia,0
5431,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Advanced Sarcoma of the Extremity,0
5432,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,0
5433,EBV-Positive Neoplastic Cells Present,Stage IV Hilar Cholangiocarcinoma AJCC v8,0
5434,Secondary Lesion,Unresectable Adrenal Cortex Carcinoma,0
5435,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,0
5436,Endobronchial Lesion,Colon Lipoma,0
5437,Nodular and Diffuse Pattern,"Adrenal Gland Ganglioneuroblastoma, Nodular",0
5438,Secondary Lesion,Ivory Exostosis,0
5439,High Grade Lesion,High grade cervical glandular intraepithelial neoplasia,0
5440,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Aortic Neoplasm,0
5441,Endobronchial Lesion,Smoldering myeloma,0
5442,Endobronchial Lesion,Colorectal Mixed Adenoneuroendocrine Carcinoma,0
5443,Mixed Neoplastic Glandular and Squamous Cell Population,"Papilloma, Squamous Cell",0
5444,Intravascular papillary endothelial hyperplasia,Intraductal papillary breast neoplasm,0
5445,Large Neoplastic Glands with Branching and Papillary Infolding Present,Nasopharyngeal Papillary Adenocarcinoma,0
5446,Blasts Expressing CD56 and Immature T-Cell Markers Present,Stage I Immature Testicular Teratoma AJCC v6 and v7,0
5447,Endobronchial Lesion,Tracheal Lymphoma,0
5448,EBV-Positive Neoplastic Cells Present,Gastric Cardia Adenocarcinoma,0
5449,Smooth Muscle Component Present,Eruptive collagenoma,0
5450,Non-Encapsulated Neoplasm,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,0
5451,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Stage III Ovarian Germ Cell Tumor AJCC v6 and v7,0
5452,Recurrent Malignant Neoplasm,Recurrent Childhood Liver Cancer,0
5453,Extensive Stage Lesion,Stage IA Uterine Corpus Adenosarcoma AJCC v8,0
5454,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,carcinoma of lacrimal gland,0
5455,Endobronchial Lesion,"Refractory Medulloblastoma, SHH-Activated",0
5456,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Aflatoxins-Related Hepatocellular Carcinoma,0
5457,Single Cell Necrosis,Prostate Basal Cell Carcinoma,0
5458,Smooth Muscle Component Present,Hobnail Hemangioma,0
5459,Venous Type Vascular Channel Formation,"Gallbladder Adenocarcinoma, Biliary Type",0
5460,Endobronchial Lesion,Cardiac hemangioma,0
5461,Single Cell Necrosis,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",0
5462,Blasts Under 5 Percent of Peripheral Blood White Cells,Secondary Peripheral Chondrosarcoma,0
5463,Lesion with Diameter of 10mm or Less,Mixed Hepatoblastoma with Teratoid Features,0
5464,EBV-Positive Neoplastic Cells Present,St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8,0
5465,Early Stromal Invasion Present,Childhood Gastrointestinal Stromal Tumor,0
5466,Mixture of Embryonal and Alveolar Features Present,Childhood Testicular Embryonal Carcinoma,0
5467,Abundance of Small Lymphocytes,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8,0
5468,Endobronchial Lesion,Ovarian Serous Adenocarcinoma,0
5469,Blasts Under 20 Percent of Peripheral Blood White Cells,Neuroendocrine neoplasm of gallbladder,0
5470,EBV-Positive Neoplastic Cells Present,B-cell lymphoma stage I,0
5471,Neoplastic Plasma Cells Present in Bone Marrow,Stage IV Bone Sarcoma AJCC v7,0
5472,Secondary Lesion,Pineal Region Choriocarcinoma,0
5473,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,0
5474,EBV-Positive Neoplastic Cells Present,Mediastinal Extraskeletal Osteosarcoma,0
5475,Secondary Lesion,Hereditary benign intraepithelial dyskeratosis,0
5476,Large Neoplastic Glands with Branching and Papillary Infolding Present,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
5477,EBV-Positive Neoplastic Cells Present,Ectopia Lentis,0
5478,Abundance of Small Lymphocytes,Stage IIIA Ampulla of Vater Cancer AJCC v8,0
5479,EBV-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X,0
5480,Abundance of Small Lymphocytes,Hemangioma of spleen,0
5481,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction,0
5482,Epithelioid Differentiation,Epithelioid Sarcoma NCI Grade 3,0
5483,Nodular Pattern,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5484,Abundance of Small Lymphocytes,atypical medullary carcinoma of breast,0
5485,Endobronchial Lesion,Mediastinal Neuroblastoma,0
5486,EBV-Positive Neoplastic Cells Present,Class 1b Uveal Melanoma,0
5487,Blasts Under 20 Percent of Peripheral Blood White Cells,Paget's disease of vulva,0
5488,Fibrotic Stroma with Finger-Like Projections Present,Myeloid Neoplasms with Germline ANKRD26 Mutation,0
5489,Lesion with Diameter of 4mm or More,Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12),0
5490,Extensive Stage Lesion,Stage IV Retroperitoneal Sarcoma AJCC v8,0
5491,Follicular Cell Differentiation,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage,0
5492,Recurrent Genetic Abnormalities Present,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
5493,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Resectable Carcinoma,0
5494,Locally Aggressive Lesion,Locally Advanced Unresectable Cervical Carcinoma,0
5495,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Choriocarcinoma of the Testis,0
5496,Endobronchial Lesion,Piloleiomyoma,0
5497,Malignant Germinomatous Cellular Infiltrate,Cellular Congenital Mesoblastic Nephroma,0
5498,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7,0
5499,Large Neoplastic Glands with Branching and Papillary Infolding Present,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,0
5500,Abundance of Small Lymphocytes,Infection of amniotic cavity,0
5501,Early Stromal Invasion Present,Ovarian Sclerosing Stromal Tumor,0
5502,Tumor Droplets Present,Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and 7,0
5503,Secondary Lesion,Granulocytic Sarcoma,0
5504,Well Differentiated Hyaline Cartilage Present,Well Differentiated Malignant Neoplasm,0
5505,Large Neoplastic Glands with Branching and Papillary Infolding Present,Diffuse Large B-Cell Lymphoma,0
5506,Multiple Tumor Masses,Extrahepatic Bile Duct Neuroendocrine Tumor G2,0
5507,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,0
5508,Gastric dysplasia,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,0
5509,Fibrotic Stroma with Finger-Like Projections Present,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214,0
5510,Endobronchial Lesion,Hereditary Kidney Oncocytoma,0
5511,Plasma cell inflammation,Basal cell carcinoma - follicular,0
5512,Follicular Cell Differentiation,ISS Stage I Plasma Cell Myeloma,0
5513,Mammary Gland Type Features Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,0
5514,Mixed Neoplastic Glandular and Squamous Cell Population,Testicular Mixed Choriocarcinoma and Teratoma,0
5515,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Cell Carcinoma of Unknown Primary,0
5516,Epithelioid Differentiation,Proximal-Type Epithelioid Sarcoma,0
5517,Unfavorable Clinical Outcome,Clinical Stage I Retinoblastoma AJCC v8,0
5518,Tumor Droplets Present,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
5519,Secondary Lesion,Cardiac Intramuscular Hemangioma,0
5520,Endobronchial Lesion,Recurrent Childhood Lymphomatoid Granulomatosis,0
5521,Gastric-Type Epithelial Differentiation,Stage III Thymus Epithelial Neoplasm AJCC v8,0
5522,EBV-Positive Neoplastic Cells Present,Adult Central Nervous System Embryonal Carcinoma,0
5523,Endobronchial Lesion,Telangiectatic Glomangioma,0
5524,Lesion with Diameter of 10mm or Less,Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10,0
5525,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,solid type ductal carcinoma in situ of breast,0
5526,EBV-Positive Neoplastic Cells Present,Exocervical Carcinoma,0
5527,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
5528,Extensive Stage Lesion,Stage IVB Hypopharyngeal Carcinoma AJCC v7,0
5529,Large Neoplastic Glands with Branching and Papillary Infolding Present,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0
5530,Endobronchial Lesion,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,0
5531,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,0
5532,Secondary Lesion,Childhood Leiomyosarcoma,0
5533,High Grade Non Cartilaginous Sarcomatous Stroma Present,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",0
5534,Tumor Droplets Present,Ventricular and Brain Stem Ependymal Tumor,0
5535,Extensive Stage Lesion,Anal Cancer by AJCC v8 Stage,0
5536,EBV-Positive Neoplastic Cells Present,Oropharyngeal cancer recurrent,0
5537,Secondary Lesion,Breast cancer recurrent,0
5538,Lymphocyte count increased,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5539,Delicate Vascular Network Formation,Vascular insufficiency of intestine,0
5540,EBV-Positive Neoplastic Cells Present,Stage IIIB Adult Liver Cancer AJCC v7,0
5541,Undifferentiated Lesion,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7,0
5542,EBV-Positive Neoplastic Cells Present,Testicular embryonal carcinoma stage II,0
5543,Endobronchial Lesion,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
5544,Mixed Neoplastic Glandular and Squamous Cell Population,Liver and Intrahepatic Bile Duct Malignant Non-Epithelial Neoplasm,0
5545,Mammary Gland Type Features Present,Major Salivary Gland Cancer by AJCC v8 Stage,0
5546,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Carcinoma of soft palate,0
5547,Secondary Lesion,Stage IIIC Prostate Cancer AJCC v8,0
5548,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Colorectal Large Cell Neuroendocrine Carcinoma,0
5549,Extensive Stage Lesion,Stage IIIC Eyelid Carcinoma AJCC v7,0
5550,Acinar Proliferation,Recurrent Prostate Acinar Adenocarcinoma,0
5551,EBV-Positive Neoplastic Cells Present,"Medulloblastoma, SHH-Activated, TP53-Mutant",0
5552,Presence of a Hormonal Syndrome,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5553,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8,0
5554,Lesion with Diameter of 4mm or More,Breast Carcinoma with Melanotic Features,0
5555,Smooth Muscle Component Present,Gingival fibroepithelial polyp,0
5556,Blasts Under 20 Percent of Peripheral Blood White Cells,Polyp of ethmoidal sinus,0
5557,Smooth Muscle Component Present,Neuronevus,0
5558,EBV-Positive Neoplastic Cells Present,Impetigo,0
5559,EBV-Positive Neoplastic Cells Present,Infant Acute Undifferentiated Leukemia,0
5560,Fibrotic Stroma with Finger-Like Projections Present,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH,0
5561,Mediastinal mass,Mature Mediastinal Teratoma,0
5562,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Palmoplantar keratoderma with leukoplakia,0
5563,Absence of Malignant Features,Malignant neoplasm of penis,0
5564,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Testicular Cancer AJCC v6 and v7,0
5565,Smooth Muscle Component Present,T-cell lymphoma recurrent,0
5566,Smooth Muscle Component Present,Lactating adenoma,0
5567,Glandular cell atypia,Adenosquamous cell lung cancer stage III,0
5568,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Atypical carcinoid tumor,0
5569,Abundance of Small Lymphocytes,Adenocarcinoma of colon,0
5570,Secondary Lesion,Sclerosing PEComa,0
5571,Mixed Neoplastic Glandular and Squamous Cell Population,Glucagon Cell Hyperplasia and Neoplasia,0
5572,EBV-Positive Neoplastic Cells Present,Pseudomyxoma Peritonei,0
5573,Smooth Muscle Component Present,Pancreatic Vipoma,0
5574,Smooth Muscle Component Present,Pityriasis Rosea,0
5575,EBV-Positive Neoplastic Cells Present,Epithelioid sarcoma recurrent,0
5576,Undifferentiated Lesion,Refractory Undifferentiated Pleomorphic Sarcoma,0
5577,Endobronchial Lesion,Hepatic Angiomyolipoma,0
5578,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Mammary Analog Secretory Carcinoma of Salivary Gland,0
5579,Endobronchial Lesion,Lung Melanoma,0
5580,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Low Grade Salivary Gland Mucoepidermoid Carcinoma,0
5581,Endobronchial Lesion,Tobacco Chewing-Related Carcinoma,0
5582,Extensive Stage Lesion,Stage IIIB Rectal Cancer AJCC v8,0
5583,Intermediate Grade Lesion,Grade 3 Colorectal Adenocarcinoma,0
5584,Abundance of Small Lymphocytes,Ganglioneuroma of skin,0
5585,Recurrent Malignant Neoplasm,Recurrent T-Cell Prolymphocytic Leukemia,0
5586,Small Lesion,Small intestine carcinoma metastatic,0
5587,Secondary Lesion,Stage IIIB Ovarian Cancer AJCC v8,0
5588,Squamous metaplasia of bladder,hepatoid adenocarcinoma of bladder,0
5589,Monoclonal Myeloid or Lymphoid Cells Present,Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5590,Epithelioid Differentiation,Ciliary Body Epithelioid Cell Melanoma,0
5591,Eccrine Differentiation,Eccrine Poroma,0
5592,Endobronchial Lesion,Metastatic Rectal Carcinoma,0
5593,Large Mass,Stage I Diffuse Large B-Cell Lymphoma,0
5594,Indolent Clinical Course,Indolent Adult Non-Hodgkin Lymphoma,0
5595,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hereditary Papillary Renal Carcinoma,0
5596,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Rete Ovarii Cystadenoma,0
5597,Recurrent Malignant Neoplasm,Recurrent Desmoid-Type Fibromatosis,0
5598,Abundance of Small Lymphocytes,Secondary malignant neoplasm of chest wall,0
5599,Recurrent Malignant Neoplasm,Environment-Related Neoplasm,0
5600,Smooth Muscle Component Present,Adult cystic teratoma,0
5601,Smooth Muscle Component Present,Neuronevus,0
5602,Extensive Stage Lesion,Stage III Adrenal Cortex Carcinoma AJCC v8,0
5603,Abundance of Small Lymphocytes,Kaposi's sarcoma of skin,0
5604,Recurrent disease,Hodgkin's disease mixed cellularity stage II subdiaphragmatic,0
5605,Endobronchial Lesion,Superficial angiomyxoma,0
5606,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Glomus Tympanicum Tumor,0
5607,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Distal 1/3 of the Common Bile Duct Adenocarcinoma,0
5608,Cervical lymphadenopathy,Locally Advanced Unresectable Cervical Carcinoma,0
5609,Malignant Primitive Cellular Infiltrate,Stage I Pleural Malignant Mesothelioma AJCC v8,0
5610,EBV-Positive Neoplastic Cells Present,Ivory Exostosis,0
5611,Recurrent Genetic Abnormalities Present,Recurrent Anal Adenocarcinoma,0
5612,Secondary Lesion,Stage IIIA Prostate Cancer AJCC v8,0
5613,EBV-Positive Neoplastic Cells Present,Refractory Central Nervous System Lymphoma,0
5614,Mesenchymal Metaplasia of Malignant Cells Present,Malignant tumor of endocardium,0
5615,Endobronchial Lesion,Stage I Cervical Cancer AJCC v8,0
5616,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Lip and Oral Cavity Cancer AJCC v8,0
5617,NRBC - Nucleated red blood cell present result,Clear cell hidradenoma,0
5618,Less than 2 Mitoses per 10HPF,Class 2 Uveal Melanoma,0
5619,EBV-Positive Neoplastic Cells Present,recurrent adult acute myeloid leukemia,0
5620,Apocrine metaplasia,Apocrine Breast Carcinoma In Situ,0
5621,Non-Encapsulated Neoplasm,Osteogenic Neoplasm,0
5622,Blasts Under 20 Percent of Peripheral Blood White Cells,Fibrous Hamartoma of Infancy,0
5623,Abundance of Small Lymphocytes,Medullary carcinoma of breast,0
5624,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Ovarian Polyembryoma AJCC v6 and v7,0
5625,EBV-Positive Neoplastic Cells Present,"Paget's Disease, Mammary",0
5626,EBV-Positive Neoplastic Cells Present,Vulvar Proximal-Type Epithelioid Sarcoma,0
5627,Endobronchial Lesion,Cutaneous Leiomyosarcoma,0
5628,White blood cell count increased (lab result),Mantle cell lymphoma stage III,0
5629,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,0
5630,Low Grade Neuroendocrine Lesion,Low Grade Sarcoma,0
5631,Mature Neutrophils Present,Childhood Mature Teratoma,0
5632,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign neoplasm of endocardium,0
5633,EBV-Positive Neoplastic Cells Present,Contralateral Breast Carcinoma,0
5634,Secondary Lesion,Sebaceoma,0
5635,Melanoma Cells Present,Stage IV Superficial Spreading Melanoma AJCC v6 and v7,0
5636,Abundance of Small Lymphocytes,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0
5637,Mixed Neoplastic Glandular and Squamous Cell Population,Early Invasive Cervical Squamous Cell Carcinoma,0
5638,Secondary Lesion,Angiocentric lymphoma stage II,0
5639,Single Cell Necrosis,Squamous Cell Bile Duct Carcinoma,0
5640,Blasts Under 20 Percent of Peripheral Blood White Cells,Primary myoepithelial carcinoma of lung,0
5641,Pleural effusion disorder,Stage I Pleural Malignant Mesothelioma AJCC v7,0
5642,EBV-Positive Neoplastic Cells Present,Immunoblastic Large-Cell Lymphoma,0
5643,Small Aggregates of Tumor Cells Present,Adult Oligodendroglial Tumor,0
5644,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Vaginal Warty Carcinoma,0
5645,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Cutaneous Melanoma by AJCC v6 Stage,0
5646,Intermediate Grade Lesion,Epithelioid Sarcoma NCI Grade 3,0
5647,Endobronchial Lesion,Choriocarcinoma,0
5648,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucoepidermoid carcinoma of the oral cavity stage I,0
5649,EBV-Positive Neoplastic Cells Present,Meningeal Gliomatosis,0
5650,Multiple Tumor Masses,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,0
5651,EBV-Positive Neoplastic Cells Present,Stage IIB Ovarian Cancer AJCC v8,0
5652,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of the nasal cavity,0
5653,EBV-Positive Neoplastic Cells Present,Vulvar Congenital Melanocytic Nevus,0
5654,Secondary Lesion,Esophageal carcinoma recurrent,0
5655,Endobronchial Lesion,Stage I Cervical Cancer AJCC v8,0
5656,Blasts Under 20 Percent of Peripheral Blood White Cells,basal cell adenocarcinoma of salivary gland,0
5657,Plasma cell inflammation,Bladder squamous cell carcinoma stage I,0
5658,Enterochromaffin Type Granules Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type",0
5659,EBV-Positive Neoplastic Cells Present,Liver Adenosquamous Carcinoma,0
5660,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5661,Malignant Cellular Infiltrate,Cellular Schwannoma,0
5662,Endobronchial Lesion,Primary Effusion Lymphoma,0
5663,Lesion with Diameter of 4mm or More,B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged,0
5664,EBV-Positive Neoplastic Cells Present,Chondroblastic osteosarcoma,0
5665,Fibrotic Stroma with Finger-Like Projections Present,Refractory cytopenia with unilineage dysplasia,0
5666,Rimming of Adipose Tissue Cells Present,Soft Tissue Sarcoma by AJCC v7 Stage,0
5667,Blasts of Mixed Phenotype Present,Mixed parotid tumor,0
5668,Ectopic Thyroid Tissue Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
5669,EBV-Positive Neoplastic Cells Present,Gastric Juvenile Polyp,0
5670,Endobronchial Lesion,Recurrent Pancreatic Cystadenocarcinoma,0
5671,Tumor Droplets Present,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,0
5672,Multihormonal Immunoreactivity Present in a Single Cell Type,DS Stage III Plasma Cell Myeloma,0
5673,Endobronchial Lesion,Intracranial cavernous hemangioma,0
5674,Extensive Stage Lesion,Stage I Lung Cancer AJCC v6,0
5675,EBV-Positive Neoplastic Cells Present,"Refractory NK-Cell Lymphoma, Unclassifiable",0
5676,EBV-Positive Neoplastic Cells Present,Dermatologic disorders,0
5677,EBV-Positive Neoplastic Cells Present,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1",0
5678,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7,0
5679,Neoplastic Plasma Cells Present in Bone Marrow,Metastatic Bone Ewing Sarcoma,0
5680,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Testicular Seminoma AJCC v6 and v7,0
5681,Secondary Lesion,Chondrosarcoma,0
5682,Abundance of Small Lymphocytes,Benign neoplasm of testis,0
5683,Mixed Neoplastic Glandular and Squamous Cell Population,Lobular Endocervical Glandular Hyperplasia,0
5684,Extensive Stage Lesion,Stage IV Adult Liver Cancer AJCC v7,0
5685,EBV-Positive Neoplastic Cells Present,Mediastinal Extraskeletal Osteosarcoma,0
5686,Multihormonal Immunoreactivity Present in a Single Cell Type,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,0
5687,Endobronchial Lesion,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,0
5688,Follicular Cell Differentiation,Clinical Stage I Merkel Cell Carcinoma AJCC v8,0
5689,Lesion with Diameter of 4mm or More,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas",0
5690,EBV-Positive Neoplastic Cells Present,"Myelodysplastic syndrome, no ICD-O subtype",0
5691,Endobronchial Lesion,Synchronous Multifocal Osteosarcoma,0
5692,Single Cell Necrosis,Stage IIB Lung Large Cell Carcinoma AJCC v7,0
5693,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Vulvar Adenocarcinoma of Mammary Gland Type,0
5694,Smooth Muscle Component Present,Hepatic lymphoma,0
5695,Smooth Muscle Component Present,"Lymphoma, AIDS-Related",0
5696,Absence of Malignant Features,Grade 3a Malignant Neoplasm,0
5697,Follicular Differentiation,Follicular thyroid carcinoma,0
5698,Follicular Cell Differentiation,Crooke Cell Adenoma,0
5699,Secondary Lesion,Stage IIIA Fallopian Tube Cancer AJCC v7,0
5700,EBV-Positive Neoplastic Cells Present,Advanced Favorable Non-Hodgkin Lymphoma,0
5701,Endobronchial Lesion,"Pheochromocytoma, malignant",0
5702,Endobronchial Lesion,Anaplastic Embryonal Rhabdomyosarcoma,0
5703,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,0
5704,Secondary Lesion,Colorectal Cribriform Comedo-Type Adenocarcinoma,0
5705,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Fibrous histiocytoma of tendon sheath,0
5706,Single Cell Necrosis,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,0
5707,Endobronchial Lesion,Stage IB Eyelid Carcinoma AJCC v8,0
5708,Defective Alpha Heavy Chain Present,Heavy Chain Deposition Disease,0
5709,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Pancreatic Cancer AJCC v6 and v7,0
5710,Low Grade Neuroendocrine Lesion,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,0
5711,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage I Oral Cavity Cancer AJCC v6 and v7,0
5712,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma in situ of cecum,0
5713,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant myoepithelioma,0
5714,Secondary Lesion,Infratentorial Glioblastoma,0
5715,Photosensitivity of skin,Digital papillary eccrine carcinoma of skin,0
5716,Abundance of Small Lymphocytes,Benign neoplasm of breast,0
5717,Secondary Lesion,Stage IVA Paranasal Sinus Cancer AJCC v7,0
5718,Endobronchial Lesion,"Vulvar Deep ""Aggressive"" Angiomyxoma",0
5719,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Secondary malignant neoplasm of larynx,0
5720,Secondary Lesion,Scrotal Infection,0
5721,Lesion with Diameter of 4mm or More,Columnar Cell Lesion of the Breast,0
5722,Endobronchial Lesion,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,0
5723,Small Aggregates of Tumor Cells Present,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
5724,Absence of Malignant Features,Recurrent Malignant Pharyngeal Neoplasm,0
5725,Multiple Tumor Masses,Temporal Lobe and Parietal Lobe Ependymal Tumor,0
5726,Secondary Lesion,Sarcoma,0
5727,EBV-Positive Neoplastic Cells Present,Stage I Ovarian Cancer AJCC v8,0
5728,Absence of Malignant Features,Childhood Malignant Liver Neoplasm,0
5729,Smooth Muscle Component Present,Mucous Membrane Hemangioma,0
5730,Peau d'orange surface of breast,adenocarcinoma of breast with spindle cell metaplasia,0
5731,Nodular Pattern,Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5732,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Cerebral Lymphoma in Immunocompetent Host,0
5733,Epithelioid Differentiation,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,0
5734,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Fallopian Tube Cancer by AJCC v8 Stage,0
5735,Tumor Droplets Present,Stage IV Gestational Trophoblastic Tumor AJCC v7,0
5736,Follicular Cell Differentiation,"Carcinoma, Transitional Cell",0
5737,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8,0
5738,Extensive Stage Lesion,Stage I Adrenal Cortex Carcinoma AJCC v8,0
5739,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,keratinizing squamous cell carcinoma of nasal cavity,0
5740,Secondary Lesion,Renal Allograft Thrombosis,0
5741,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Herpes zoster dermatitis of eyelid,0
5742,Numerous Stromal Mast Cells Present,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage,0
5743,Endobronchial Lesion,Stage IIA Uterine Sarcoma AJCC v7,0
5744,EBV-Positive Neoplastic Cells Present,Stage IIIC Colorectal Cancer AJCC v7,0
5745,Secondary Lesion,Fallopian Tube Serous Adenofibroma,0
5746,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ethmoid Sinus Squamous Cell Carcinoma,0
5747,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
5748,Tumor Droplets Present,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
5749,Endobronchial Lesion,Intestinal T-cell lymphoma stage II,0
5750,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Squamous cell carcinoma of the oral cavity stage IV,0
5751,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,0
5752,Glandular cell atypia,Stage III renal cell cancer,0
5753,Endobronchial Lesion,Hereditary retinal dystrophy,0
5754,Extensive Stage Lesion,Stage IIIA Colorectal Cancer AJCC v8,0
5755,Blasts 5-19 Percent of Peripheral Blood White Cells,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0
5756,Smooth Muscle Component Present,Histiocytoma,0
5757,Smooth Muscle Component Present,Unresectable Craniopharyngioma,0
5758,White blood cell count increased (lab result),Transitional cell carcinoma metastatic,0
5759,EBV-Positive Neoplastic Cells Present,Vulval intraepithelial neoplasia,0
5760,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5761,Photosensitivity of skin,Eccrine mixed tumor of skin,0
5762,Secondary Lesion,Choroid Plexus Neoplasms,0
5763,White blood cell count increased (lab result),Oropharyngeal squamous cell carcinoma stage I,0
5764,Single Cell Necrosis,Renal Cell Cancer by AJCC v6 Stage,0
5765,Recurrent Malignant Neoplasm,Recurrent Hepatocellular Carcinoma,0
5766,Blasts 5-19 Percent of Peripheral Blood White Cells,Peripheral neuroblastoma,0
5767,EBV-Positive Neoplastic Cells Present,Brain Stem Glioma,0
5768,Nodular Pattern,Subcutaneous Nodular Fasciitis,0
5769,Secondary Lesion,ALK positive large B-cell lymphoma,0
5770,Recurrent Genetic Abnormalities Present,Recurrent Salivary Gland Cancer,0
5771,Plasma cell inflammation,Anal canal squamous cell carcinoma,0
5772,Extensive Stage Lesion,Stage III Hypopharyngeal Carcinoma AJCC v8,0
5773,EBV-Positive Neoplastic Cells Present,Prognostic Stage IV Breast Cancer AJCC v8,0
5774,Nodular and Diffuse Pattern,"Ganglioneuroblastoma, Nodular",0
5775,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Esophageal Squamous Cell Carcinoma AJCC v7,0
5776,No Evidence of Metastatic Disease,Metastatic thymic carcinoma,0
5777,Recurrent Malignant Neoplasm,Solar Radiation-Related Malignant Neoplasm,0
5778,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage II Hypopharyngeal Carcinoma AJCC v6 and v7,0
5779,Melanoma Cells Present,Orbital Melanoma,0
5780,Single Cell Necrosis,Submandibular Gland Acinic Cell Carcinoma,0
5781,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Adult Atypical Meningioma,0
5782,Smooth Muscle Component Present,"Mesothelioma, biphasic, malignant",0
5783,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7,0
5784,Recurrent Malignant Neoplasm,Refractory Malignant Neoplasm of Multiple Primary Sites,0
5785,Secondary Lesion,childhood nasal type extranodal NK/T-cell lymphoma,0
5786,Immature Myeloid Cells Increased in Bone Marrow,Myeloid Leukemia,0
5787,Secondary Lesion,Pilosebaceous Hamartoma,0
5788,White blood cell count increased (lab result),Basaloid squamous cell carcinoma,0
5789,Fibrotic Stroma with Finger-Like Projections Present,Medulloblastoma with Leptomeningeal Spread,0
5790,Endobronchial Lesion,Stage IIIA Prostate Cancer AJCC v8,0
5791,Glandular cell atypia,Nasopharyngeal squamous cell carcinoma stage III,0
5792,EBV-Positive Neoplastic Cells Present,Anaplastic ganglioglioma,0
5793,Plasma cell inflammation,"Basal cell carcinoma, infundibulocystic",0
5794,Multinodular and Vacuolated Pattern,Stage III Lip Cancer AJCC v6 and v7,0
5795,Abundance of Small Lymphocytes,Lipomatosis of Nerve,0
5796,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
5797,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Stage IV Thymus Epithelial Neoplasm AJCC v8,0
5798,EBV-Positive Neoplastic Cells Present,"Hemangioma, Cavernous, Central Nervous System",0
5799,Secondary Lesion,FSH-Producing Gonadotroph Adenoma,0
5800,Endobronchial Lesion,"Hamartoma Syndrome, Multiple",0
5801,Cystic Lesion,Childhood Cystic Nephroma,0
5802,Extensive Stage Lesion,Stage I Pancreatic Cancer AJCC v8,0
5803,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Risk Myelodysplastic Syndrome,0
5804,Blasts Under 20 Percent of Peripheral Blood White Cells,Polyp of maxillary sinus,0
5805,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,0
5806,Recurrent Genetic Abnormalities Present,Recurrent Mixed Phenotype Acute Leukemia,0
5807,EBV-Positive Neoplastic Cells Present,Thyroid Gland Adenocarcinoma,0
5808,Breast Implant-Related Lesion,Recurrent Breast Angiosarcoma,0
5809,Endometrial Type Glands and Stroma Present,Endometrial Adenosquamous Carcinoma,0
5810,Follicular Cell Differentiation,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,0
5811,EBV-Positive Neoplastic Cells Present,Thyroid Gland Adenocarcinoma,0
5812,Secondary Lesion,Stage IIA Colorectal Cancer AJCC v7,0
5813,Secondary Lesion,Adult Undifferentiated Pleomorphic Sarcoma,0
5814,Fibrous Septa Present,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",0
5815,Abundance of Small Lymphocytes,Crohn's disease of large bowel,0
5816,Secondary Lesion,"Vulvar Deep ""Aggressive"" Angiomyxoma",0
5817,Smooth Muscle Component Present,Hyperplasia,0
5818,Small Aggregates of Tumor Cells Present,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
5819,Smooth Muscle Component Present,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),0
5820,EBV-Positive Neoplastic Cells Present,Chondrosarcoma,0
5821,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Intermediate Bone Neoplasm,0
5822,Smooth Muscle Component Present,Nasopharyngeal lymphoepithelioma stage II,0
5823,Mesenchymal Metaplasia,Adult Mesenchymal Chondrosarcoma,0
5824,Blasts Under 20 Percent of Peripheral Blood White Cells,Inflammatory carcinoma of breast recurrent,0
5825,Follicular Cell Differentiation,RISS Stage II Plasma Cell Myeloma,0
5826,Fibrotic Stroma with Finger-Like Projections Present,Adenocarcinoma with apocrine metaplasia,0
5827,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,rhabdomyosarcoma of mediastinum,0
5828,Endobronchial Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",0
5829,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,0
5830,Peau d'orange surface of breast,Fibrosclerosis of breast,0
5831,Blasts Under 20 Percent of Peripheral Blood White Cells,Congenital spondylolysis of lumbosacral region,0
5832,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Inflammatory carcinoma of breast recurrent,0
5833,Endobronchial Lesion,Bile duct adenocarcinoma resectable,0
5834,EBV-Positive Neoplastic Cells Present,Thymic Adenosquamous Carcinoma,0
5835,EBV-Positive Neoplastic Cells Present,Radiation-Related Osteosarcoma,0
5836,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Undifferentiated Carcinoma of Colon,0
5837,Multihormonal Immunoreactivity Present in a Single Cell Type,Childhood Renal Cell Carcinoma,0
5838,Abundance of Small Lymphocytes,Benign neoplasm of pharynx,0
5839,No Evidence of Metastatic Disease,Metastatic osteosarcoma,0
5840,Secondary Lesion,Ocular Cicatricial Pemphigoid,0
5841,Chronic Clinical Course,Clinical Stage IV Gastric Cancer AJCC v8,0
5842,Diffuse Immunoblastic Proliferation,Diffuse hyperplasia,0
5843,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Papillary tumor of renal pelvis,0
5844,Smooth Muscle Component Present,"Somatostatinoma, malignant",0
5845,Chronic Clinical Course,Retinoblastoma by AJCC v8 Clinical Stage,0
5846,Venous Type Vascular Channel Formation,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
5847,Extensive Stage Lesion,Stage IV Nasopharyngeal Carcinoma AJCC v6,0
5848,Endometrial Type Glands and Stroma Present,Refractory Endometrial Endometrioid Adenocarcinoma,0
5849,Recurrent disease,Polycystic liver disease,0
5850,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Osteosarcoma Arising in Paget Disease of Bone,0
5851,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,clear cell adenocarcinofibroma of ovary,0
5852,Endobronchial Lesion,Fallopian Tube Papillary Adenocarcinoma,0
5853,Smooth Muscle Component Present,"Pancreatic carcinoma, familial",0
5854,Secondary Lesion,Epidermolysis Bullosa,0
5855,Intestinal metaplasia of gastric mucosa,Refractory Small Intestinal Carcinoma,0
5856,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Borderline Ovarian Transitional Cell Tumor,0
5857,Plasma cell inflammation,Bladder squamous cell carcinoma stage III,0
5858,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVC Lip and Oral Cavity Cancer AJCC v8,0
5859,Small Aggregates of Tumor Cells Present,Malignant Intracranial Germ Cell Tumor,0
5860,Secondary Lesion,Platinum-Resistant Fallopian Tube Carcinoma,0
5861,Smooth Muscle Component Present,Benign Ovarian Luteinized Thecoma,0
5862,Sonic Hedgehog/Patch Pathway Activated,Refractory Visual Pathway Glioma,0
5863,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Prostate Carcinoma,0
5864,EBV-Positive Neoplastic Cells Present,Stage III Adult Lymphoblastic Lymphoma,0
5865,EBV-Positive Neoplastic Cells Present,"Cystadenoma, Papillary",0
5866,Mammary Gland Type Features Present,Pituitary Gland Paraganglioma,0
5867,EBV-Positive Neoplastic Cells Present,Acute myelomonocytic leukemia,0
5868,Endobronchial Lesion,Primary cerebral lymphoma,0
5869,Secondary Lesion,Acrodermatitis,0
5870,Early Stromal Invasion Present,Benign Gastric Gastrointestinal Stromal Tumor,0
5871,Abundance of Small Lymphocytes,clear cell adenocarcinoma of urethra,0
5872,EBV-Positive Neoplastic Cells Present,Burkitt Leukemia,0
5873,Lesion with Diameter of 4mm or More,Condyloma Acuminatum with Dysplasia,0
5874,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Nipple Carcinoma,0
5875,EBV-Positive Neoplastic Cells Present,"Testicular Seminoma, Cribriform Variant",0
5876,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Desmoplastic Small Round Cell Tumor,0
5877,No Evidence of Metastatic Disease,Metastatic Urethral Urothelial Carcinoma,0
5878,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,0
5879,Well Developed Rough Endoplasmic Reticulum Present,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
5880,Endobronchial Lesion,Smoldering Waldenstrom Macroglobulinemia,0
5881,Secondary Lesion,Breast Angiomatosis,0
5882,Smooth Muscle Component Present,Methotrexate-Associated Burkitt Lymphoma,0
5883,Secondary Lesion,Childhood Nasal Cavity Carcinoma,0
5884,Follicular Cell Differentiation,Primary Cutaneous Anaplastic Large Cell Lymphoma,0
5885,Single Cell Necrosis,Metastatic Sarcomatoid Renal Cell Carcinoma,0
5886,EBV-Positive Neoplastic Cells Present,Extranodal marginal zone B-cell lymphoma (MALT type) stage III,0
5887,Rubbery Skin Lesion,Stage I Skin Cancer,0
5888,Non-Encapsulated Neoplasm,Chondrogenic Neoplasm,0
5889,Blasts Under 20 Percent of Peripheral Blood White Cells,Paget disease of anal canal,0
5890,Secondary Lesion,Chondroid lipoma,0
5891,EBV-Positive Neoplastic Cells Present,Stage IIIC2 Uterine Corpus Cancer AJCC v8,0
5892,Blasts Under 20 Percent of Peripheral Blood White Cells,mucinous adenocarcinoma of rectum,0
5893,EBV-Positive Neoplastic Cells Present,Gardner Syndrome,0
5894,Smooth Muscle Component Present,"Mastocytosis, Systemic",0
5895,Follicular Cell Differentiation,Stage IIA Lung Large Cell Carcinoma AJCC v7,0
5896,Smooth Muscle Component Present,Duodenal Adenoma,0
5897,Secondary Lesion,Fallopian Tube Adenosarcoma,0
5898,Endobronchial Lesion,Endometrial Mucinous Adenocarcinoma,0
5899,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of Bartholin's gland,0
5900,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign neoplasm of vulva,0
5901,Blasts Under 20 Percent of Peripheral Blood White Cells,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",0
5902,Aggressive Clinical Course,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,0
5903,Small Aggregates of Tumor Cells Present,Benign Notochordal Cell Tumor,0
5904,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IV Ovarian Teratoma AJCC v6 and v7,0
5905,NRBC - Nucleated red blood cell present result,Adenosquamous cell lung cancer stage III,0
5906,Endobronchial Lesion,Retinoblastoma,0
5907,Melanoma Cells Present,Stage III Cutaneous Melanoma AJCC v6,0
5908,EBV-Positive Neoplastic Cells Present,Benign Anterior Tongue Neoplasm,0
5909,Endobronchial Lesion,Gastric Mixed Adenocarcinoma,0
5910,Endobronchial Lesion,Deep Hemangioma,0
5911,Secondary Lesion,Refractory Central Nervous System Lymphoma,0
5912,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Head and Neck Neoplasm,0
5913,Secondary Lesion,Diencephalic Astrocytoma,0
5914,Abundance of Small Lymphocytes,Papilloma of buccal mucosa,0
5915,Mammary Gland Type Features Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,0
5916,High Grade Lesion,High Grade Malignant Neoplasm,0
5917,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Leiomyosarcoma NCI Grade 2,0
5918,Secondary Lesion,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8,0
5919,Endobronchial Lesion,Triple-Negative Breast Carcinoma,0
5920,Chronic Clinical Course,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
5921,Endobronchial Lesion,Refractory Colorectal Carcinoma,0
5922,Smooth Muscle Component Present,Childhood Central Nervous System Teratoma,0
5923,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Infection of amniotic cavity,0
5924,Epithelioid Differentiation,Uterine Corpus Epithelioid Leiomyoma,0
5925,Blasts Under 20 Percent of Peripheral Blood White Cells,Adenocarcinoma of duodenum,0
5926,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Childhood Anaplastic Large Cell Lymphoma,0
5927,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant tumor of eye,0
5928,Slowly Progressive Clinical Course,"Leukoencephalopathy, Progressive Multifocal",0
5929,Minimally Invasive Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant",0
5930,"Adenocarcinoma, intestinal type",Pleuropulmonary blastoma type III,0
5931,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,AIDS-Related Diffuse Large B-cell Lymphoma,0
5932,Blasts Under 20 Percent of Peripheral Blood White Cells,Mucinous cystadenocarcinoma of ovary,0
5933,EBV-Positive Neoplastic Cells Present,Stage IIIA Gallbladder Cancer AJCC v8,0
5934,Recurrent Malignant Neoplasm,Malignant Adult Brain Neoplasm,0
5935,Tumor Droplets Present,Stage I Malignant Mediastinal Germ Cell Tumor,0
5936,Smooth Muscle Component Present,Intraneural perineurioma,0
5937,EBV-Positive Neoplastic Cells Present,Childhood Lymphoma,0
5938,Endobronchial Lesion,CIC-DUX Sarcoma,0
5939,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Sarcomatoid Carcinoma of the Penis,0
5940,EBV-Positive Neoplastic Cells Present,Luteoma,0
5941,Recurrent Genetic Abnormalities Present,Recurrent Glioma,0
5942,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Recurrent Peripheral Primitive Neuroectodermal Tumor,0
5943,Tumor Droplets Present,Benign Prostate Phyllodes Tumor,0
5944,Recurrent Malignant Neoplasm,Recurrent Vulvar Carcinoma,0
5945,Endobronchial Lesion,Stage IV Osteosarcoma AJCC v7,0
5946,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Ovarian Neuroendocrine Neoplasm,0
5947,Extensive Stage Lesion,Stage IA Fallopian Tube Cancer AJCC v8,0
5948,Melanoma Cells Present,Choroid Necrotic Melanoma,0
5949,Presence of a Hormonal Syndrome,Bloom Syndrome,0
5950,Blasts Under 5 Percent of Peripheral Blood White Cells,Peripheral Ganglioneuroblastoma,0
5951,Smooth Muscle Component Present,AIDS-Related Toxoplasmosis,0
5952,Extensive Stage Lesion,Stage IVA Colorectal Cancer AJCC v8,0
5953,EBV-Positive Neoplastic Cells Present,M5b Acute differentiated monocytic leukemia,0
5954,Tumor Droplets Present,Mixed Cell Type Kidney Wilms Tumor,0
5955,Endobronchial Lesion,BCLC Stage B Adult Hepatocellular Carcinoma,0
5956,EBV-Positive Neoplastic Cells Present,Hepatic cancer metastatic,0
5957,Single Cell Necrosis,Pancreatic Large Cell Neuroendocrine Carcinoma,0
5958,Serrated Glandular Architecture,Colorectal Sporadic Serrated Polyp,0
5959,Solid Growth Pattern,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",0
5960,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant tumor of epididymis,0
5961,Blasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Peripheral Primitive Neuroectodermal Tumor,0
5962,Recurrent Malignant Neoplasm,Recurrent Childhood Malignant Germ Cell Tumor,0
5963,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Uterine Corpus Carcinoma,0
5964,Secondary Lesion,Asynchronous Multifocal Osteosarcoma,0
5965,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,0
5966,Endobronchial Lesion,Stage IV Hypopharyngeal Carcinoma AJCC v6,0
5967,Smooth Muscle Component Present,B-cell lymphoma refractory,0
5968,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,0
5969,Large Neoplastic Glands with Branching and Papillary Infolding Present,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,0
5970,Epithelioid Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
5971,Follicular Cell Differentiation,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
5972,Secondary Lesion,Prostate cancer stage C,0
5973,Rimming of Adipose Tissue Cells Present,Stage I Soft Tissue Sarcoma AJCC v7,0
5974,Secondary Lesion,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0
5975,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIC Cutaneous Melanoma AJCC v6 and v7,0
5976,EBV-Positive Neoplastic Cells Present,Stage IIC Colorectal Cancer AJCC v7,0
5977,Secondary Lesion,Appendix adenoma,0
5978,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage III Lip Cancer AJCC v6 and v7,0
5979,Endobronchial Lesion,Refractory cancer,0
5980,Smooth Muscle Component Present,Esophageal Leiomyosarcoma,0
5981,Multihormonal Immunoreactivity Present in a Single Cell Type,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,0
5982,Prominent Elastic Tissue Cores Present,Stage II Adult Soft Tissue Sarcoma AJCC v7,0
5983,Smooth Muscle Component Present,Uterine Corpus Rhabdomyosarcoma,0
5984,Single Cell Necrosis,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
5985,Endobronchial Lesion,Refractory Neutropenia,0
5986,Follicular Differentiation,Recurrent Grade 3 Follicular Lymphoma,0
5987,Blasts Under 20 Percent of Peripheral Blood White Cells,large cell neuroendocrine carcinoma of extrahepatic bile duct,0
5988,Extensive Stage Lesion,Stage III Pharynx Carcinoma,0
5989,Insular Pattern,"Ovarian Yolk Sac Tumor, Glandular Pattern",0
5990,EBV-Positive Neoplastic Cells Present,Radiation-induced myelopathy,0
5991,Blasts Under 20 Percent of Peripheral Blood White Cells,Polyp of external auditory meatus,0
5992,Mixed Neoplastic Glandular and Squamous Cell Population,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage,0
5993,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Locally Advanced Bone Sarcoma,0
5994,Multinodular and Vacuolated Pattern,Stage II Nasal Cavity Cancer AJCC v6 and v7,0
5995,Endobronchial Lesion,Juxtacortical chondroma,0
5996,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma of the Floor of the Mouth,0
5997,Lesion with Diameter of 4mm or More,Burkitt-like lymphoma with 11q aberration,0
5998,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
5999,Multinodular and Vacuolated Pattern,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7,0
6000,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,large cell neuroendocrine carcinoma of gallbladder,0
6001,Secondary Lesion,Stage IIIA Prostate Cancer AJCC v8,0
6002,Endobronchial Lesion,Extracutaneous Mastocytoma,0
6003,Abundance of Small Lymphocytes,Benign tumor of endocrine gland,0
6004,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,"Adenocarcinoma of lung, stage III",0
6005,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Alkylating Agent-Related Acute Myeloid Leukemia,0
6006,Abundance of Small Lymphocytes,benign lipoma of gallbladder,0
6007,Rubbery Skin Lesion,Recurrent Skin Angiosarcoma,0
6008,EBV-Positive Neoplastic Cells Present,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,0
6009,EBV-Positive Neoplastic Cells Present,Placental Non-Neoplastic Disorder,0
6010,Endobronchial Lesion,Fibrolamellar Hepatocellular Carcinoma,0
6011,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Stromal-Leydig Cell Tumor,0
6012,Extensive Stage Lesion,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage,0
6013,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7,0
6014,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Squamous cell carcinoma of the head and neck,0
6015,Secondary Lesion,Juxta-Articular Myxoma,0
6016,Absence of Malignant Features,Malignant Gastric Soft Tissue Neoplasm,0
6017,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IA Lung Small Cell Carcinoma AJCC v7,0
6018,Glandular cell atypia,Spindle cell liposarcoma,0
6019,Absence of Malignant Features,Malignant neoplasm of trachea,0
6020,Venous Type Vascular Channel Formation,"Breast Fibrocystic Change, Proliferative Type",0
6021,Pregnancy Complications,Hodgkin Lymphoma During Pregnancy,0
6022,Tumor Droplets Present,Malignant Cutaneous Granular Cell Tumor,0
6023,Endobronchial Lesion,Stage II Uterine Corpus Cancer AJCC v8,0
6024,Secondary Lesion,Prolactin-producing pituitary tumor,0
6025,Endobronchial Lesion,Ethmoid Sinus Schneiderian Papilloma,0
6026,Tumor Droplets Present,Ovarian Dermoid Cyst with Secondary Tumor,0
6027,Lesion with Diameter of 10mm or Less,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
6028,EBV-Positive Neoplastic Cells Present,"Ichthyosis, X-Linked",0
6029,EBV-Positive Neoplastic Cells Present,Stage IVA Fallopian Tube Cancer AJCC v8,0
6030,Mucocele of appendix,Adenocarcinoma of appendix,0
6031,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
6032,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0
6033,Endobronchial Lesion,Ovarian Papillary Cystadenoma,0
6034,EBV-Positive Neoplastic Cells Present,Metastasizing Chondroblastoma,0
6035,Extensive Stage Lesion,Stage IIB Penile Cancer AJCC v8,0
6036,Endobronchial Lesion,Stage IV Renal Pelvis Cancer AJCC v7,0
6037,Absence of Malignant Features,Anterior Urethral Malignant Neoplasm,0
6038,Endobronchial Lesion,"Cystadenoma, Papillary",0
6039,Endobronchial Lesion,Prolactinoma,0
6040,Small Aggregates of Tumor Cells Present,Refractory Lung Small Cell Carcinoma,0
6041,Mixed Neoplastic Glandular and Squamous Cell Population,Pituitary Gland Mixed Gangliocytoma-Adenoma,0
6042,Secondary Lesion,Angiomatous Meningioma,0
6043,Nodular and Diffuse Pattern,Diffuse melanocytosis,0
6044,Lesion with Diameter of 10mm or Less,Colorectal Adenoma with Moderate Dysplasia,0
6045,Apocrine metaplasia,Breast Apocrine Adenosis,0
6046,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
6047,White blood cell count increased (lab result),Non-small cell lung cancer stage III,0
6048,EBV-Positive Neoplastic Cells Present,Benign Intraocular Medulloepithelioma,0
6049,High Mitotic Activity,High grade cervical glandular intraepithelial neoplasia,0
6050,Localized Hydropic Villous Change,Localized Resectable Adult Hepatocellular Carcinoma,0
6051,Secondary Lesion,Infiltrating Intramuscular Lipoma,0
6052,Smooth Muscle Component Present,Atrial Paraganglioma,0
6053,Small Aggregates of Tumor Cells Present,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,0
6054,EBV-Positive Neoplastic Cells Present,Cholangiocarcinoma resectable,0
6055,Abundance of Small Lymphocytes,Inflammatory pseudotumor of liver,0
6056,Glandular cell atypia,Spindle cell liposarcoma,0
6057,Intermediate Grade Neuroendocrine Lesion,High Grade Gastric Intraepithelial Neoplasia,0
6058,Endobronchial Lesion,Mammary-Type Myofibroblastoma,0
6059,Intraepithelial Neoplasia,High Grade Esophageal Squamous Intraepithelial Neoplasia,0
6060,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Epithelioid and spindle cell nevus,0
6061,Breast Implant-Related Lesion,Prognostic Stage IB Breast Cancer AJCC v8,0
6062,Tumor Droplets Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0
6063,Venous Type Vascular Channel Formation,Vascular Breast Neoplasm,0
6064,Endobronchial Lesion,Childhood Acute Lymphoblastic Leukemia,0
6065,Venous Type Vascular Channel Formation,Lobular Neoplasia Type A,0
6066,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7,0
6067,NRBC - Nucleated red blood cell present result,Cystic basal cell carcinoma,0
6068,Secondary Lesion,Vulvar Fibrolipoma,0
6069,Abundance of Small Lymphocytes,Secretory adenoma of pituitary,0
6070,Secondary Lesion,Colorectal Leiomyosarcoma,0
6071,Extensive Stage Lesion,Stage IVA Vulvar Cancer AJCC v8,0
6072,Extensive Stage Lesion,Stage IV Non-Hodgkin Lymphoma,0
6073,Extensive Stage Lesion,Stage I Hodgkin Lymphoma,0
6074,Abundance of Small Lymphocytes,Secondary malignant neoplasm of kidney,0
6075,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIB Lung Small Cell Carcinoma AJCC v7,0
6076,Secondary Lesion,Rete Testis Adenoma,0
6077,Endobronchial Lesion,Contact dermatitis due to solar radiation,0
6078,Endobronchial Lesion,Nasopharyngeal lymphoepithelioma recurrent,0
6079,Confluent Sheets of Anaplastic T-Lymphocytes Present,Anaplastic large B-cell lymphoma,0
6080,Endobronchial Lesion,Gastric Choriocarcinoma,0
6081,Blasts Under 20 Percent of Peripheral Blood White Cells,Undifferentiated Carcinoma of Colon,0
6082,EBV-Positive Neoplastic Cells Present,Mediastinal Synovial Sarcoma,0
6083,Secondary Lesion,St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8,0
6084,Endobronchial Lesion,Colon Serrated Adenocarcinoma,0
6085,EBV-Positive Neoplastic Cells Present,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8,0
6086,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IV Vaginal Cancer AJCC v6 and v7,0
6087,Extensive Stage Lesion,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,0
6088,Endobronchial Lesion,Benign Uveal Neoplasm,0
6089,EBV-Positive Neoplastic Cells Present,Fallopian Tube Adenocarcinoma,0
6090,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of testis,0
6091,Abundance of Small Lymphocytes,Adenocarcinoma of Skene Gland Origin,0
6092,Multihormonal Immunoreactivity Present in a Single Cell Type,Classic Type Atypical Fibroxanthoma,0
6093,Endobronchial Lesion,Desmoplastic Medulloblastoma,0
6094,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Choroidal and Ciliary Body Melanoma AJCC v8,0
6095,Malignant Primitive Cellular Infiltrate,Malignant Sebaceous Neoplasm,0
6096,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign tumor of eyelid,0
6097,Neoplastic Plasma Cells Present in Bone Marrow,Adenocarcinoma in villous adenoma,0
6098,EBV-Positive Neoplastic Cells Present,Congenital aphakia,0
6099,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Immature Testicular Teratoma AJCC v6 and v7,0
6100,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Small Congenital Melanocytic Nevus,0
6101,Non-Encapsulated Neoplasm,Stage III Gestational Trophoblastic Neoplasm AJCC v8,0
6102,EBV-Positive Neoplastic Cells Present,Ann Arbor Stage IIIB Hodgkin Lymphoma,0
6103,Glandular cell atypia,Vaginal clear cell adenocarcinoma,0
6104,Secondary Lesion,Lung Hilum Carcinoma,0
6105,EBV-Positive Neoplastic Cells Present,Endometrial Endometrioid Adenocarcinoma,0
6106,More Than Two Separate Tumor Masses Present in the Same Organ,Uveal Melanoma Metastatic in the Liver,0
6107,Epithelial hyperplasia of skin,Ganglioneuroma of skin,0
6108,Endobronchial Lesion,Metastatic Lung Adenocarcinoma,0
6109,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Cervical Yolk Sac Tumor,0
6110,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Breast Cancer AJCC v6 and v7,0
6111,Early Stromal Invasion Present,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6112,EBV-Positive Neoplastic Cells Present,Epithelioma,0
6113,Follicular Differentiation,Clear Cell Variant Thyroid Gland Follicular Carcinoma,0
6114,Secondary Lesion,Intramucosal Adenocarcinoma,0
6115,Abundance of Small Lymphocytes,Secondary malignant neoplasm of neck,0
6116,EBV-Positive Neoplastic Cells Present,Sebaceous Gland Neoplasms,0
6117,Well Differentiated Neuroendocrine Lesion,Well Differentiated Malignant Neoplasm,0
6118,Secondary Lesion,Solitary Osteochondroma,0
6119,EBV-Positive Neoplastic Cells Present,Stage IVA Osteosarcoma AJCC v7,0
6120,Blasts Under 20 Percent of Peripheral Blood White Cells,cystadenoma of intrahepatic bile duct,0
6121,Endobronchial Lesion,Solitary Adult Fibroma,0
6122,No Evidence of Metastatic Disease,Metastatic Ductal Breast Carcinoma,0
6123,Tumor Droplets Present,Temporal Lobe Ependymal Tumor,0
6124,Fibrotic Stroma with Finger-Like Projections Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0
6125,Endobronchial Lesion,Stage IV Anal Cancer AJCC v8,0
6126,Smooth Muscle Component Present,Dermatophytosis,0
6127,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Secondary malignant neoplasm of vertebral column,0
6128,Secondary Lesion,"Schneiderian papilloma, inverted",0
6129,Neoplastic Plasma Cells Present in Bone Marrow,Adenocarcinoma in situ in adenomatous polyp,0
6130,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Vaginal Cancer AJCC v6 and v7,0
6131,EBV-Positive Neoplastic Cells Present,Stage III Non-Hodgkin Lymphoma,0
6132,Secondary Lesion,Ivory Exostosis,0
6133,Endobronchial Lesion,"Adenoma, Monomorphic",0
6134,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,cystadenoma of extrahepatic bile duct,0
6135,Endobronchial Lesion,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8,0
6136,Endobronchial Lesion,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
6137,Recurrent Malignant Neoplasm,Pancreatic Serous Neoplasm,0
6138,Small Aggregates of Tumor Cells Present,Breast Carcinoid Tumor,0
6139,Mixed Neoplastic Glandular and Squamous Cell Population,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0
6140,Secondary Lesion,Esophageal carcinoma recurrent,0
6141,Intraepithelial Neoplasia,Anal Intraepithelial Neoplasia 3,0
6142,Abundance of Small Lymphocytes,adenoid cystic carcinoma of accessory sinus,0
6143,Breast Implant-Related Lesion,Anatomic Stage IA Breast Cancer AJCC v8,0
6144,EBV-Positive Neoplastic Cells Present,Hypertensive episode,0
6145,Melanoma Cells Present,Acral Lentiginous Malignant Melanoma,0
6146,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Squamous cell carcinoma of colon,0
6147,Melanoma Cells Present,Nevoid Melanoma,0
6148,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,0
6149,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Polyp of vulva,0
6150,Dilated Terminal Duct Lobular Units Present,Localized Extrahepatic Bile Duct Carcinoma,0
6151,Extensive Stage Lesion,Stage II Indolent Adult Non-Hodgkin Lymphoma,0
6152,Endobronchial Lesion,Hibernoma,0
6153,Endobronchial Lesion,Stage IIA Fallopian Tube Cancer AJCC v8,0
6154,Malignant Primitive Cellular Infiltrate,"Peripheral Nerve Neoplasms, Malignant",0
6155,EBV-Positive Neoplastic Cells Present,Stage IA1 Lung Cancer AJCC v8,0
6156,Primary Lesion,Primary amyloidosis,0
6157,Small Aggregates of Tumor Cells Present,Recurrent Digestive System Neuroendocrine Tumor G1,0
6158,Lesion with Diameter of 4mm or More,"Neoplasm, malignant, uncertain whether primary or metastatic",0
6159,Extensive Stage Lesion,Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage,0
6160,Abundance of Small Lymphocytes,Serous cystadenoma of pancreas,0
6161,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Skin Carcinoma,0
6162,Endobronchial Lesion,Localized Carcinoma,0
6163,Mammary Gland Type Features Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,0
6164,Extensive Stage Lesion,Stage IVB Osteosarcoma AJCC v7,0
6165,Fibrotic Stroma with Finger-Like Projections Present,Ovarian Dermoid Cyst with Adenocarcinoma,0
6166,EBV-Positive Neoplastic Cells Present,Alveolar soft part sarcoma non-metastatic,0
6167,Endobronchial Lesion,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
6168,Enterochromaffin-Like Type Granules Present,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,0
6169,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage,0
6170,Secondary Lesion,Cerebral Glioblastoma,0
6171,Mammary Gland Type Features Present,Stage IVC Major Salivary Gland Cancer AJCC v7,0
6172,Smooth Muscle Component Present,Non-Functioning Corticotroph Adenoma,0
6173,Smooth Muscle Component Present,Hemangioma,0
6174,Lesion with Diameter of 10mm or Less,Acute Myeloid Leukemia with t(17;17)(q21;q21),0
6175,Recurrent Malignant Neoplasm,Refractory Childhood Spinal Cord Neoplasm,0
6176,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IVA Cervical Cancer AJCC v6 and v7,0
6177,Secondary Lesion,Uterine Cancer,0
6178,Endobronchial Lesion,Rectosigmoid cancer,0
6179,Extensive Stage Lesion,Childhood Lymphoma by AJCC v8 Stage,0
6180,Secondary Lesion,Peritoneal mesothelioma malignant recurrent,0
6181,Endobronchial Lesion,Mycosis fungoides/Sezary syndrome stage II,0
6182,Endobronchial Lesion,Localized Parathyroid Gland Carcinoma,0
6183,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Vaginal Cancer AJCC v6 and v7,0
6184,Secondary Lesion,Benign Epithelioma,0
6185,Low Grade Lesion,Low grade cervical glandular intraepithelial neoplasia,0
6186,Abundance of Small Lymphocytes,Secondary malignant neoplasm of pituitary gland,0
6187,Primary Site Unknown,Prefibrotic/Early Primary Myelofibrosis,0
6188,Smooth Muscle Component Present,Schwannomatosis,0
6189,Mammary Gland Type Features Present,Benign Accessory Urethral Gland Neoplasm,0
6190,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,0
6191,Multiple Tumor Masses,Nonossifying Fibromyxoid Tumor,0
6192,Enterochromaffin Type Granules Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type",0
6193,Low Grade Cartilaginous Component Present,Low Grade Broad Ligament Serous Adenocarcinoma,0
6194,Endobronchial Lesion,Stage 0is Penile Cancer AJCC v8,0
6195,Secondary Lesion,Intracranial Benign Fibrous Histiocytoma,0
6196,Recurrent Genetic Abnormalities Present,Recurrent Childhood Pilocytic Astrocytoma,0
6197,Recurrent Malignant Neoplasm,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,0
6198,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thymic Adenosquamous Carcinoma,0
6199,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Fibroma of tendon sheath,0
6200,Chondromyxoid Stroma Formation,Sternal Chondromyxoid Fibroma,0
6201,Secondary Lesion,"Medulloblastoma, SHH-Activated, TP53-Wildtype",0
6202,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,"Hydatidiform Mole, Invasive",0
6203,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Anal Canal Cancer AJCC v6 and v7,0
6204,EBV-Positive Neoplastic Cells Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,0
6205,Endobronchial Lesion,Recurrent B-Cell Prolymphocytic Leukemia,0
6206,Secondary Lesion,St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8,0
6207,Prominent In Situ Component Present,Apocrine Breast Carcinoma In Situ,0
6208,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Renal Cell Cancer AJCC v8,0
6209,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Peritoneal Germ Cell Tumor,0
6210,Secondary Lesion,Gonadal Polyembryoma,0
6211,Nodular and Diffuse Pattern,Diffuse Large B-Cell Lymphoma,0
6212,Well Differentiated Neuroendocrine Lesion,Pleural Well Differentiated Papillary Mesothelioma,0
6213,Multihormonal Immunoreactivity Present in a Single Cell Type,Hepatocellular Small Cell Change,0
6214,NRBC - Nucleated red blood cell present result,Bladder squamous cell carcinoma recurrent,0
6215,Secondary Lesion,Childhood Brain Germinoma,0
6216,Mixed Neoplastic Glandular and Squamous Cell Population,Giant Cell Glioblastoma,0
6217,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Cutaneous Melanoma of the Extremity,0
6218,Secondary Lesion,Testicular yolk sac tumor stage I,0
6219,Photosensitivity of skin,Malignant blue nevus of skin,0
6220,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Adenoid Cystic Carcinoma,0
6221,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,0
6222,Malignant Primitive Cellular Infiltrate,"Malignant Mixed Tumor, Not Otherwise Specified",0
6223,Abundance of Small Lymphocytes,Benign neoplasm of thorax,0
6224,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Squamous cell carcinoma of the oral cavity stage II,0
6225,Early Stromal Invasion Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
6226,Proliferation of Small Ducts Present,Small intestine adenocarcinoma metastatic NOS,0
6227,Follicular Cell Differentiation,Lung Large Cell Carcinoma by AJCC v7 Stage,0
6228,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,0
6229,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Secondary Acute Myeloid Leukemia,0
6230,Mucinous degeneration,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
6231,Abundance of Small Lymphocytes,large cell neuroendocrine carcinoma of gallbladder,0
6232,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6233,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7,0
6234,Recurrent Malignant Neoplasm,Recurrent Malignant Ovarian Brenner Tumor,0
6235,Endobronchial Lesion,Broad Ligament Serous Cystadenofibroma,0
6236,Tumor Droplets Present,Adult Oligodendroglial Tumor,0
6237,Secondary Lesion,Breast Lymphoma,0
6238,Breast Implant-Related Lesion,Anatomic Stage IIIB Breast Cancer AJCC v8,0
6239,Villous Projections of the Neoplastic Epithelium Present,Colorectal Villous Adenoma,0
6240,Abundance of Small Lymphocytes,Secondary malignant neoplasm of epididymis,0
6241,Endobronchial Lesion,Uterine Ligament Mucinous Adenocarcinoma,0
6242,Regional Disease,Paget Disease,0
6243,Smooth Muscle Component Present,Colon Lipoma,0
6244,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Hodgkin's disease of intrapelvic lymph nodes,0
6245,Multinodular and Vacuolated Pattern,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,0
6246,Squamous metaplasia of bladder,Squamous cell carcinoma of mouth,0
6247,Secondary Lesion,Sporadic Retinoblastoma,0
6248,Mixed Neoplastic Glandular and Squamous Cell Population,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,0
6249,Secondary Lesion,Lentigo maligna recurrent,0
6250,Fibrotic Stroma with Finger-Like Projections Present,Myeloid Neoplasms with Germline Predisposition,0
6251,Multiple Tumor Masses,Solid Glomus Tumor,0
6252,Secondary Lesion,Thoracic NUT Carcinoma,0
6253,Absence of Malignant Features,Malignant neoplasm of respiratory system,0
6254,EBV-Positive Neoplastic Cells Present,Stage IVC Colon Cancer AJCC v8,0
6255,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,0
6256,Endobronchial Lesion,Classical Hodgkin's Lymphoma,0
6257,Endobronchial Lesion,Testicular choriocarcinoma stage II,0
6258,Secondary Lesion,B-cell small lymphocytic lymphoma stage III,0
6259,Absence of Malignant Features,Non-Resectable Malignant Liver Neoplasm,0
6260,Multihormonal Immunoreactivity Present in a Single Cell Type,Intermediate Cell Type Ciliary Body Melanoma,0
6261,Lesion with Diameter of 4mm or More,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
6262,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Benign neoplasm of the lip,0
6263,Secondary Lesion,In situ follicular neoplasia,0
6264,EBV-Positive Neoplastic Cells Present,Oropharyngeal Carcinoma,0
6265,Smooth Muscle Component Present,Brain Hemangioma,0
6266,Endobronchial Lesion,Stage I Retroperitoneal Sarcoma AJCC v8,0
6267,Skin nodule,Skin Papilloma,0
6268,Smooth Muscle Component Present,Brain Stem Glioma,0
6269,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
6270,Single Cell Necrosis,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7,0
6271,Endobronchial Lesion,Serous surface papillary carcinoma,0
6272,Endobronchial Lesion,Pulmonary Artery Angiosarcoma,0
6273,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Postcricoid Squamous Cell Carcinoma,0
6274,Locally Aggressive Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0
6275,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Lymphoproliferative Disorder of NK-Cells,0
6276,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Lymphoproliferative Disorder of the Skin,0
6277,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Oligodendroglioma-Astrocytoma,0
6278,Endobronchial Lesion,Recurrent Pancreatic Ductal Adenocarcinoma,0
6279,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of hypopharynx recurrent,0
6280,Endobronchial Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,0
6281,Absence of Malignant Features,Malignant tenosynovial giant cell tumor,0
6282,Blasts Under 20 Percent of Peripheral Blood White Cells,IgM monoclonal gammopathy of uncertain significance,0
6283,Extensive Stage Lesion,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
6284,Multihormonal Immunoreactivity Present in a Single Cell Type,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
6285,Secondary Lesion,Childhood Ependymoma,0
6286,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Polyp of esophagus,0
6287,Large Neoplastic Glands with Branching and Papillary Infolding Present,Papillary mucinous cystadenoma,0
6288,Secondary Lesion,Stage II Colorectal Cancer,0
6289,EBV-Positive Neoplastic Cells Present,Hepatic lymphoma,0
6290,Unfavorable Clinical Outcome,Unfavorable Hodgkin Lymphoma,0
6291,Extensive Stage Lesion,Stage III Laryngeal Cancer AJCC v8,0
6292,Extensive Stage Lesion,Stage I Ureter Cancer AJCC v8,0
6293,Lesion with Diameter of 4mm or More,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6294,Secondary Lesion,Nephrogenic adenofibroma,0
6295,EBV-Positive Neoplastic Cells Present,Hemangioma acquired,0
6296,EBV-Positive Neoplastic Cells Present,Colorectal Peutz-Jeghers Polyp,0
6297,Multihormonal Immunoreactivity Present in a Single Cell Type,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",0
6298,EBV-Positive Neoplastic Cells Present,Pancreatic Somatostatinoma,0
6299,Acute inflammation,Acute cellular allograft nephropathy,0
6300,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma,0
6301,EBV-Positive Neoplastic Cells Present,Central Nervous System Extraskeletal Osteosarcoma,0
6302,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Recurrent Cancer of Gallbladder,0
6303,Polarization of Nuclei Towards the Glandular Lumen,Cervical Glandular Neoplasm,0
6304,Mixed Neoplastic Glandular and Squamous Cell Population,Alcohol-Related Esophageal Squamous Cell Carcinoma,0
6305,Cutaneous plaque,Old Burn Scar-Related Cutaneous Melanoma,0
6306,EBV-Positive Neoplastic Cells Present,Vagina Carcinoma,0
6307,No Evidence of Metastatic Disease,Metastatic Digestive System Carcinoma,0
6308,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Paranasal Sinus Cancer AJCC v6 and v7,0
6309,Endobronchial Lesion,McCune-Albright Syndrome,0
6310,Extensive Stage Lesion,Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8,0
6311,EBV-Positive Neoplastic Cells Present,"Elliptocytosis, Hereditary",0
6312,Mesenchymal Metaplasia of Malignant Cells Present,Malignant mesothelioma of pericardium,0
6313,Tumor Droplets Present,Recurrent Malignant Extragonadal Germ Cell Tumor,0
6314,Secondary Lesion,Adenolymphoma,0
6315,Endobronchial Lesion,Hereditary Multiple Exostoses,0
6316,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Advanced Renal Cell Carcinoma,0
6317,Secondary Lesion,"Sarcoma, Epithelioid",0
6318,Recurrent Genetic Abnormalities Present,Recurrent Brain Neoplasm,0
6319,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,0
6320,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Glomus Tumor of Uncertain Malignant Potential,0
6321,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Intestinal Neuroendocrine Tumor,0
6322,Intravascular Spread,Recurrent Intravascular Large B-Cell Lymphoma,0
6323,EBV-Positive Neoplastic Cells Present,Multiple endocrine neoplasia type 4,0
6324,Intestinal metaplasia of gastric mucosa,Early gastric cancer,0
6325,Extensive Stage Lesion,Stage III Primary Peritoneal Cancer AJCC v8,0
6326,Mucinous degeneration,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
6327,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,BCLC Stage C Hepatocellular Carcinoma,0
6328,Solid Growth Pattern,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0
6329,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,ENSAT Stage III Adrenal Cortex Carcinoma,0
6330,Recurrent Malignant Neoplasm,Malignant Skeletal Muscle Neoplasm,0
6331,Abundance of Small Lymphocytes,Sarcoma of pelvis,0
6332,Plasma cell inflammation,Chief cell adenoma,0
6333,Well Differentiated Hyaline Cartilage Present,Pleural Well Differentiated Papillary Mesothelioma,0
6334,Single Cell Necrosis,Osteosclerotic Plasma Cell Myeloma,0
6335,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
6336,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,0
6337,Endobronchial Lesion,Oral neoplasm malignant recurrent,0
6338,EBV-Positive Neoplastic Cells Present,Suppurative lymphadenopathy,0
6339,Extensive Stage Lesion,Kadish Stage C Olfactory Neuroblastoma,0
6340,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
6341,Endobronchial Lesion,Precursor T-lymphoblastic lymphoma/leukemia recurrent,0
6342,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Sarcoma of vulva,0
6343,Malignant Primitive Cellular Infiltrate,Malignant Inferior Vena Cava Neoplasm,0
6344,Endobronchial Lesion,Testicular Dermoid Cyst,0
6345,Endobronchial Lesion,"Cancer, Supratentorial",0
6346,Local disease,Anal margin Paget's disease,0
6347,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Metastatic Lung Neuroendocrine Neoplasm,0
6348,EBV-Positive Neoplastic Cells Present,Urothelial carcinoma ureter metastatic,0
6349,EBV-Positive Neoplastic Cells Present,FIGO Stage IC1 Ovarian Cancer,0
6350,EBV-Positive Neoplastic Cells Present,Pruritus,0
6351,Secondary Lesion,Fibrolamellar Hepatocellular Carcinoma,0
6352,Fibrotic Stroma with Finger-Like Projections Present,Myeloid Neoplasms with Germline ETV6 Mutation,0
6353,Nodular and Diffuse Pattern,"Diffuse Astrocytoma, IDH-Mutant",0
6354,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,0
6355,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adult Central Nervous System Mixed Germ Cell Tumor,0
6356,Recurrent Genetic Abnormalities Present,Recurrent Childhood Hodgkin Lymphoma,0
6357,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Osteosarcoma Arising in Paget Disease of Bone,0
6358,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acantholytic squamous cell carcinoma of skin,0
6359,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,adenocarcinoma of oral cavity,0
6360,EBV-Positive Neoplastic Cells Present,Lugano Classification Advanced Stage Hodgkin Lymphoma AJCC v8,0
6361,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of trachea,0
6362,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell breast carcinoma,0
6363,Small Aggregates of Tumor Cells Present,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,0
6364,Smooth Muscle Component Present,Bladder Paraganglioma,0
6365,Mixed Neoplastic Glandular and Squamous Cell Population,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,0
6366,EBV-Positive Neoplastic Cells Present,Benign neurologic neoplasms,0
6367,Confluent Sheets of Anaplastic T-Lymphocytes Present,Childhood Anaplastic Oligodendroglioma,0
6368,Breast Implant-Related Lesion,Intracystic Papillary Breast Carcinoma,0
6369,Small Aggregates of Tumor Cells Present,Breast Phyllodes Tumor,0
6370,Local disease,Polycystic liver disease,0
6371,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of sebaceous gland,0
6372,Abundance of Small Lymphocytes,Granular cell tumor of skin,0
6373,Tumor Droplets Present,Esophageal Neuroendocrine Tumor G1,0
6374,Secondary Lesion,Stage IIA Lung Cancer AJCC v8,0
6375,No Evidence of Metastatic Disease,Metastatic Nasopharyngeal Undifferentiated Carcinoma,0
6376,Endobronchial Lesion,Stage IB Ovarian Cancer AJCC v8,0
6377,Endobronchial Lesion,Metastatic angiosarcoma,0
6378,Secondary Lesion,Acute leukemia,0
6379,Multihormonal Immunoreactivity Present in a Single Cell Type,Primary Intraosseous Squamous Cell Carcinoma,0
6380,Abundance of Small Lymphocytes,Small Intestinal Squamous Cell Carcinoma,0
6381,Chronic Clinical Course,Clinical Chorioamnionitis,0
6382,Small Lesion,Small intestine carcinoma recurrent,0
6383,Endobronchial Lesion,Pituitary Gland Double Adenomas,0
6384,Smooth Muscle Component Present,Epithelioma,0
6385,Serrated Glandular Architecture,Colon Serrated Polyposis,0
6386,Endobronchial Lesion,Stage I Testicular Cancer AJCC v8,0
6387,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7,0
6388,Cutaneous plaque,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",0
6389,Endobronchial Lesion,Luteoma,0
6390,Abundance of Small Lymphocytes,sarcoma of testis,0
6391,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Laryngeal Cancer AJCC v6 and v7,0
6392,Secondary Lesion,Lipoblastomatosis,0
6393,Melanoma Cells Present,Uveal Melanoma by AJCC v7 Stage,0
6394,Endobronchial Lesion,Stage IIA Colorectal Cancer AJCC v8,0
6395,EBV-Positive Neoplastic Cells Present,Anal Ectopic Fibroadenoma,0
6396,Endobronchial Lesion,Metastatic Pharyngeal Carcinoma,0
6397,Presence of a Hormonal Syndrome,Dysplastic Nevus Syndrome,0
6398,Pleural effusion disorder,Stage IA Pleural Malignant Mesothelioma AJCC v7,0
6399,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colloid Carcinoma of the Pancreas,0
6400,Follicular Cell Differentiation,Colorectal Signet Ring Cell Carcinoma,0
6401,Lesion with Diameter of 5cm or Less,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
6402,Locally Aggressive Lesion,Aggressive Non-Hodgkin Lymphoma,0
6403,Malignant Primitive Cellular Infiltrate,Malignant Eccrine Neoplasm,0
6404,Glandular cell atypia,Bladder squamous cell carcinoma stage II,0
6405,No Evidence of Metastatic Disease,Metastatic Adrenal Gland Pheochromocytoma,0
6406,Blasts Under 5 Percent of Peripheral Blood White Cells,Peripheral T-cell lymphoma unspecified refractory,0
6407,Recurrent Malignant Neoplasm,Recurrent Primary Effusion Lymphoma,0
6408,Blasts Under 20 Percent of Peripheral Blood White Cells,adenosquamous carcinoma of pancreas,0
6409,Islands of Odontogenic Epithelium Present,"Odontogenic tumor, benign",0
6410,Photosensitivity of skin,Hamartoma of skin appendage,0
6411,Endobronchial Lesion,Radiation-Induced Intracranial Meningioma,0
6412,EBV-Positive Neoplastic Cells Present,Gemistocytic astrocytoma,0
6413,EBV-Positive Neoplastic Cells Present,American cutaneous leishmaniasis,0
6414,EBV-Positive Neoplastic Cells Present,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
6415,Endobronchial Lesion,Stage IVA Rectal Cancer AJCC v7,0
6416,Follicular Cell Differentiation,Giant Cell Angioblastoma,0
6417,Endobronchial Lesion,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,0
6418,Abundance of Small Lymphocytes,Benign neoplasm of female breast,0
6419,Endobronchial Lesion,Stage I Thymoma AJCC v8,0
6420,Follicular Differentiation,Follicular Variant Thyroid Gland Papillary Carcinoma,0
6421,Endobronchial Lesion,Colon Burkitt Lymphoma,0
6422,Endobronchial Lesion,Endometrial Adenosquamous Carcinoma,0
6423,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Hemangioma of subcutaneous tissue,0
6424,Microinvasive tumor,Juxtaglomerular tumor,0
6425,Endobronchial Lesion,Serous surface papilloma,0
6426,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,0
6427,Multiple Tumor Masses,Stage IIA Gestational Trophoblastic Tumor AJCC v7,0
6428,Smooth Muscle Component Present,T-cell/histiocyte rich large B-cell lymphoma,0
6429,EBV-Positive Neoplastic Cells Present,Stage IIIa Penile Cancer AJCC v7,0
6430,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage,0
6431,Extensive Stage Lesion,Stage IB Uterine Corpus Adenosarcoma AJCC v8,0
6432,Ectopic Thyroid Tissue Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,0
6433,EBV-Positive Neoplastic Cells Present,Abducens Nerve Palsy,0
6434,Malignant Primitive Cellular Infiltrate,Malignant Female Reproductive System Neoplasm,0
6435,EBV-Positive Neoplastic Cells Present,Frontal Lobe Anaplastic Astrocytoma,0
6436,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,non-Hodgkin's lymphoma of small intestine,0
6437,EBV-Positive Neoplastic Cells Present,Refractory Central Nervous System Non-Hodgkin Lymphoma,0
6438,Smooth Muscle Component Present,Cloacogenic carcinoma,0
6439,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Eyelid Carcinoma by AJCC v8 Stage,0
6440,EBV-Positive Neoplastic Cells Present,Pineocytoma,0
6441,Insular Pattern,"Prostate Ductal Adenocarcinoma, Solid Pattern",0
6442,Recurrent Malignant Neoplasm,Pancreatic Serous Neoplasm,0
6443,Smooth Muscle Component Present,Chest Wall Sarcoma,0
6444,Multihormonal Immunoreactivity Present in a Single Cell Type,Rectosigmoid Signet Ring Cell Carcinoma,0
6445,EBV-Positive Neoplastic Cells Present,Lepidic Predominant Adenocarcinoma,0
6446,EBV-Positive Neoplastic Cells Present,Genitourinary Cancer,0
6447,EBV-Positive Neoplastic Cells Present,Central odontogenic fibroma,0
6448,EBV-Positive Neoplastic Cells Present,Endocrine Gland Neoplasms,0
6449,Endobronchial Lesion,Splenic Lymphoplasmacytic Lymphoma,0
6450,Secondary Lesion,Rapidly progressive glomerulonephritis,0
6451,Secondary Lesion,"Testicular Seminoma, Cribriform Variant",0
6452,Endobronchial Lesion,Stage 0 Eyelid Carcinoma AJCC v8,0
6453,Ectopic Thyroid Tissue Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,0
6454,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lung Adenocarcinoma by AJCC v7 Stage,0
6455,Endobronchial Lesion,Mediastinal Epithelioid Hemangioendothelioma,0
6456,EBV-Positive Neoplastic Cells Present,Tobacco Chewing-Related Carcinoma,0
6457,Malignant Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
6458,Secondary Lesion,Parotid Gland Carcinosarcoma,0
6459,Local disease,Chronic graft-versus-host disease,0
6460,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,malignant tumor of male genital organ,0
6461,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Squamous cell carcinoma of the oral cavity stage II,0
6462,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Dermoid cyst of ovary,0
6463,EBV-Positive Neoplastic Cells Present,Angiomyoma,0
6464,Acute inflammation,Childhood Acute Erythroid Leukemia,0
6465,Abundance of Small Lymphocytes,Adenoma of Minor Vestibular Glands,0
6466,Extensive Stage Lesion,Prognostic Stage IIIB Breast Cancer AJCC v8,0
6467,Endobronchial Lesion,Stage IV Nasopharyngeal Carcinoma AJCC v7,0
6468,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,cystadenoma of intrahepatic bile duct,0
6469,Extensive Stage Lesion,Lugano Classification Hodgkin Lymphoma by AJCC v8 Stage,0
6470,Tumor Droplets Present,Refractory Desmoplastic Small Round Cell Tumor,0
6471,Tumor Droplets Present,Advanced Pancreatic Neuroendocrine Tumor,0
6472,Acinar Proliferation,"Acinar Prostate Adenocarcinoma, Atrophic Variant",0
6473,Dense Collagenized Tissue Present,Benign Cervical Soft Tissue Neoplasm,0
6474,Mesenchymal Component Present,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm,0
6475,Endobronchial Lesion,Refractory Thymic Carcinoma,0
6476,Multihormonal Immunoreactivity Present in a Single Cell Type,"Acanthoma, Clear Cell",0
6477,Secondary Lesion,Disseminated Juvenile Xanthogranuloma,0
6478,Secondary Lesion,Childhood Ovarian Mature Teratoma,0
6479,Tumor Droplets Present,Stage IV Appendix Neuroendocrine Tumor AJCC v8,0
6480,Large Neoplastic Glands with Branching and Papillary Infolding Present,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
6481,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IB Vulvar Carcinoma AJCC v6,0
6482,Endobronchial Lesion,PRETEXT Stage 2 Hepatoblastoma,0
6483,Secondary Lesion,recurrent childhood acute myeloid leukemia,0
6484,Tumor Droplets Present,Blastema Predominant Kidney Wilms Tumor,0
6485,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,sarcoma of lung,0
6486,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Childhood Central Nervous System Mixed Germ Cell Tumor,0
6487,Extensive Stage Lesion,Stage I Cervical Cancer AJCC v8,0
6488,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIA Lung Squamous Cell Carcinoma AJCC v7,0
6489,Blasts Under 20 Percent of Peripheral Blood White Cells,Adenoma of lung,0
6490,Follicular Differentiation,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0
6491,Eosinophilic inflammation,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,0
6492,Small Aggregates of Tumor Cells Present,Stage I Digestive System Neuroendocrine Tumor AJCC v7,0
6493,Smooth Muscle Component Present,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",0
6494,Absence of Malignant Features,Malignant tumor of epididymis,0
6495,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Mucoepidermoid Breast Carcinoma,0
6496,Secondary Lesion,Sclerosing Epithelioid Fibrosarcoma,0
6497,Secondary Lesion,Trichilemmocarcinoma,0
6498,Secondary Lesion,Stage IVB Hilar Cholangiocarcinoma AJCC v7,0
6499,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Stage III Ampulla of Vater Cancer AJCC v7,0
6500,Smooth Muscle Component Present,AIDS-Related Oropharyngeal Candidiasis,0
6501,Endobronchial Lesion,Stage II Adult Burkitt Lymphoma,0
6502,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Ovarian Stromal-Leydig Cell Tumor,0
6503,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hereditary Papillary Renal Carcinoma,0
6504,Chronic Inflammatory Infiltrate,Refractory Transformed Chronic Lymphocytic Leukemia,0
6505,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Sarcoma of orbit,0
6506,Multihormonal Immunoreactivity Present in a Single Cell Type,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
6507,Follicular Cell Differentiation,Recurrent Endometrial Clear Cell Adenocarcinoma,0
6508,Early Stromal Invasion Present,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",0
6509,Endobronchial Lesion,Stage 0 Esophageal Cancer AJCC v6,0
6510,Smooth Muscle Component Present,PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,0
6511,Single Type of Tissue Derived from One Embryonic Layer Present,Clear Cell Sarcoma of Soft Tissue,0
6512,Nodular and Diffuse Pattern,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma,0
6513,Abundance of Small Lymphocytes,malignant gastrinoma of pancreas,0
6514,Unfavorable Clinical Outcome,Clinical Stage II Gastric Cancer AJCC v8,0
6515,Breast Implant-Related Lesion,Sebaceous Breast Carcinoma,0
6516,EBV-Positive Neoplastic Cells Present,Stage 0 Bladder Carcinoma,0
6517,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Advanced Digestive System Neuroendocrine Neoplasm,0
6518,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIC Fallopian Tube Cancer AJCC v6 and v7,0
6519,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0
6520,Lesion with Diameter of 10mm or Less,Acute Myeloid Leukemia with t(11;17)(q23;q21),0
6521,Endobronchial Lesion,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder,0
6522,Extensive Stage Lesion,Stage II Colorectal Cancer,0
6523,Secondary Lesion,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
6524,Squamous metaplasia of bladder,Squamous Cell Carcinoma of Unknown Primary,0
6525,Papillary Pattern,Cerebellar Papillary Meningioma,0
6526,Single Cell Necrosis,Basal Cell Ameloblastoma,0
6527,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Anaplastic Malignant Neoplasm,0
6528,Chronic Inflammatory Infiltrate,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
6529,Tumor Droplets Present,Buschke-Lowenstein Tumor,0
6530,Endobronchial Lesion,Anaplastic ganglioglioma,0
6531,Malignant Primitive Cellular Infiltrate,Malignant Sebaceous Neoplasm,0
6532,EBV-Positive Neoplastic Cells Present,Right atrial myxoma,0
6533,EBV-Positive Neoplastic Cells Present,Vaginal Myofibroblastoma,0
6534,Smooth Muscle Component Present,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0
6535,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of lacrimal duct,0
6536,Lesion with Diameter of 4mm or More,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
6537,Smooth Muscle Component Present,Gallbladder Sarcoma,0
6538,Smooth Muscle Component Present,Chest Wall Hodgkin Lymphoma,0
6539,Abundance of Small Lymphocytes,"Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",0
6540,Abundance of Small Lymphocytes,leiomyosarcoma of ovary,0
6541,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of great vessels,0
6542,EBV-Positive Neoplastic Cells Present,Kadish Stage A Olfactory Neuroblastoma,0
6543,Intermediate Grade Neuroendocrine Lesion,"Ampullary Flat Intraepithelial Neoplasia, High Grade",0
6544,Blasts Under 20 Percent of Peripheral Blood White Cells,Adult Malignant Peripheral Nerve Sheath Tumor,0
6545,Recurrent Malignant Neoplasm,Recurrent Burkitt Lymphoma,0
6546,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Foregut Carcinoid Tumor,0
6547,Chronic Clinical Course,Clinical Stage IIB Cutaneous Melanoma AJCC v8,0
6548,Endobronchial Lesion,Localized Gallbladder Carcinoma,0
6549,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Kidney Medullary Carcinoma,0
6550,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8,0
6551,Small Aggregates of Tumor Cells Present,Parietal Lobe and Occipital Lobe Ependymal Tumor,0
6552,Follicular Cell Differentiation,Childhood Pineal Parenchymal Cell Neoplasm,0
6553,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Childhood Mixed Germ Cell Tumor,0
6554,Granulocytes Increased in Bone Marrow,Malignant Chest Wall Bone Neoplasm,0
6555,EBV-Positive Neoplastic Cells Present,Epithelioid hemangioendothelioma,0
6556,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Recurrent Acute Myeloid Leukemia,0
6557,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of meninges,0
6558,Endobronchial Lesion,Prostate Cancer by AJCC v6 Stage,0
6559,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Lung Carcinoma,0
6560,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Contact dermatitis due to acid,0
6561,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Pancoast Tumor,0
6562,Lesion with Diameter of 10mm or Less,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0
6563,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Stage IVB Bone Cancer AJCC v7,0
6564,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma,0
6565,Recurrent Malignant Neoplasm,Benign Childhood Supratentorial Neoplasm,0
6566,Venous Type Vascular Channel Formation,Spindle Cell Type A Uveal Melanoma,0
6567,Chronic Inflammatory Infiltrate,Refractory Chronic Myelomonocytic Leukemia,0
6568,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Grade 1 Teratoma,0
6569,Small Aggregates of Tumor Cells Present,Stage IV Gestational Trophoblastic Tumor AJCC v7,0
6570,Small Aggregates of Tumor Cells Present,Stage IIA Small Intestinal Cancer AJCC v7,0
6571,Smooth Muscle Component Present,B-cell lymphoma refractory,0
6572,Endobronchial Lesion,Extracavitary Primary Effusion Lymphoma,0
6573,Nodular and Diffuse Pattern,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6574,Mammary Gland Type Features Present,Thyroid Gland Oncocytic Adenoma,0
6575,EBV-Positive Neoplastic Cells Present,Pineal Region Mature Teratoma,0
6576,Multiple Tumor Masses,Benign Prostate Phyllodes Tumor,0
6577,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,0
6578,Recurrent Malignant Neoplasm,Recurrent Primary Peritoneal Serous Adenocarcinoma,0
6579,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage,0
6580,EBV-Positive Neoplastic Cells Present,Esophageal Fibroma,0
6581,Secondary Lesion,Stage II Esophageal Cancer,0
6582,EBV-Positive Neoplastic Cells Present,Disseminated neuroblastoma,0
6583,Blasts Under 20 Percent of Peripheral Blood White Cells,Basal cell carcinoma of vulva,0
6584,Secondary Lesion,Frontal Lobe Anaplastic Astrocytoma,0
6585,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Recurrent Combined Thymic Epithelial Neoplasm,0
6586,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of testis,0
6587,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Abdominal Neoplasm,0
6588,Follicular Differentiation,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,0
6589,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Childhood Acute Myeloid Leukemia with Maturation,0
6590,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,carcinosarcoma of lung,0
6591,Recurrent Malignant Neoplasm,Malignant Neoplasm with Regional Lymph Node Involvement,0
6592,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Sweat Gland Tubular Carcinoma,0
6593,Venous Type Vascular Channel Formation,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
6594,Secondary Lesion,"Medulloblastoma, WNT-Activated",0
6595,"Adenocarcinoma, intestinal type","Colorectal cancer, hereditary nonpolyposis, type 1",0
6596,Intermediate Grade Neuroendocrine Lesion,High Grade Fallopian Tube Serous Adenocarcinoma,0
6597,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Ovarian Mixed Germ Cell Tumor,0
6598,Blasts Under 20 Percent of Peripheral Blood White Cells,undifferentiated carcinoma of ureter,0
6599,Endobronchial Lesion,Stage II Eyelid Carcinoma AJCC v8,0
6600,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IVB Lip and Oral Cavity Cancer AJCC v8,0
6601,EBV-Positive Neoplastic Cells Present,Stage IVA Uterine Sarcoma AJCC v7,0
6602,Endobronchial Lesion,Cartilaginous exostosis,0
6603,Extensive Stage Lesion,Stage IIA Prostate Cancer AJCC v7,0
6604,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Childhood Thyroid Gland Follicular Carcinoma,0
6605,Glandular cell atypia,Non-small cell carcinoma,0
6606,Intestinal metaplasia,Primary Intestinal Follicular Lymphoma,0
6607,EBV-Positive Neoplastic Cells Present,Gallbladder Hyperplastic Polyp,0
6608,Tumor Droplets Present,Intestinal Neuroendocrine Tumor,0
6609,Endobronchial Lesion,Pleural Carcinomatosis,0
6610,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,0
6611,Endobronchial Lesion,Nodal marginal zone B-cell lymphoma stage II,0
6612,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Resectable Digestive System Carcinoma,0
6613,Smooth Muscle Component Present,Marginal zone lymphoma stage III,0
6614,EBV-Positive Neoplastic Cells Present,Prostatic Cribriform Hyperplasia,0
6615,Smooth Muscle Component Present,Uterine Ligament Serous Adenocarcinoma,0
6616,Undifferentiated Lesion,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,0
6617,Abundance of Small Lymphocytes,Clear cell sarcoma of kidney,0
6618,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Prostate Myeloid Sarcoma,0
6619,Abundance of Small Lymphocytes,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0
6620,Smooth Muscle Component Present,Pseudomyxoma Peritonei,0
6621,Abundance of Small Lymphocytes,Small Cell Undifferentiated Hepatoblastoma,0
6622,Multiple Tumor Masses,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0
6623,Endobronchial Lesion,Cutaneous neurofibroma,0
6624,Endobronchial Lesion,Erythema Multiforme,0
6625,Abundance of Small Lymphocytes,Malignant neoplasm of gallbladder localized,0
6626,EBV-Positive Neoplastic Cells Present,Stage IVA Colon Cancer AJCC v7,0
6627,Moderately Differentiated Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0
6628,Secondary Lesion,AIDS-Related Enterocolitis,0
6629,Endobronchial Lesion,Mesonephric tumor,0
6630,Endobronchial Lesion,Undifferentiated Endocervical Sarcoma,0
6631,Endobronchial Lesion,Lentigo maligna melanoma,0
6632,Endobronchial Lesion,Intracranial Melanoma,0
6633,Mesenchymal Metaplasia of Malignant Cells Present,Malignant melanoma of vulva,0
6634,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,malignant neoplasm of epiglottis,0
6635,EBV-Positive Neoplastic Cells Present,Stage II Vaginal Cancer AJCC v8,0
6636,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Stage III Malignant Mediastinal Germ Cell Tumor,0
6637,Endobronchial Lesion,Stage IIB Lung Cancer AJCC v8,0
6638,Secondary Lesion,Alveolar soft part sarcoma non-metastatic,0
6639,Recurrent Malignant Neoplasm,Recurrent ovarian cancer,0
6640,EBV-Positive Neoplastic Cells Present,Flat Urothelial Hyperplasia,0
6641,Follicular Cell Differentiation,Stage IV Lip Basal Cell Carcinoma,0
6642,EBV-Positive Neoplastic Cells Present,Major Salivary Gland Sarcoma,0
6643,Nodular and Diffuse Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,0
6644,Abundance of Small Lymphocytes,carcinosarcoma of fallopian tube,0
6645,Absence of Malignant Features,Pleural Malignant Mesothelioma by AJCC v8 Stage,0
6646,EBV-Positive Neoplastic Cells Present,Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8,0
6647,Multiple Tumor Masses,Breast Inflammatory Myofibroblastic Tumor,0
6648,Endobronchial Lesion,Myxoid chondrosarcoma,0
6649,Secondary Lesion,Sellar Chondroid Chordoma,0
6650,Multihormonal Immunoreactivity Present in a Single Cell Type,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,0
6651,Follicular Differentiation,"Dendritic Cell Sarcoma, Follicular",0
6652,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Benign Soft Tissue Tumor of Uncertain Differentiation,0
6653,Endobronchial Lesion,Endocervical Carcinoma,0
6654,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Major Salivary Gland Adenoid Cystic Carcinoma,0
6655,Multihormonal Immunoreactivity Present in a Single Cell Type,Transplant-Related Renal Cell Carcinoma,0
6656,Nodular and Diffuse Pattern,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage,0
6657,Extensive Stage Lesion,Stage 0is Renal Pelvis Cancer AJCC v7,0
6658,EBV-Positive Neoplastic Cells Present,Adult Myelodysplastic Syndrome,0
6659,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Major Salivary Gland Acinic Cell Carcinoma,0
6660,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of mesothelial tissue of pleura,0
6661,Secondary Lesion,Lymphoplasmacytoid lymphoma/immunocytoma stage IV,0
6662,Extramedullary Hematopoiesis (disorder),Extramedullary Plasmacytoma,0
6663,Acanthosis,Acanthosis Nigricans,0
6664,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
6665,Small Aggregates of Tumor Cells Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
6666,Smooth Muscle Component Present,Fallopian tube leiomyoma,0
6667,Abundance of Small Lymphocytes,ductal papilloma of salivary gland,0
6668,Endobronchial Lesion,Stage II Colorectal Cancer AJCC v8,0
6669,Absence of Malignant Features,Unresectable Malignant Neoplasm,0
6670,EBV-Positive Neoplastic Cells Present,Acute promyelocytic leukemia - hypogranular variant,0
6671,WNT Pathway Activated,Childhood Visual Pathway Astrocytoma,0
6672,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of hard palate,0
6673,Unfavorable Clinical Outcome,Clinical Stage III Retinoblastoma AJCC v8,0
6674,Smooth Muscle Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,0
6675,Multiple Tumor Masses,Frontal Lobe and Parietal Lobe Ependymal Tumor,0
6676,Recurrent Malignant Neoplasm,Adult Central Nervous System Neoplasm,0
6677,No Evidence of Metastatic Disease,Metastatic Adrenal Cortex Carcinoma,0
6678,Endobronchial Lesion,Stage IB Fallopian Tube Cancer AJCC v8,0
6679,Endobronchial Lesion,Serous surface papillary carcinoma,0
6680,Large Neoplastic Glands with Branching and Papillary Infolding Present,"Cystadenoma, Papillary",0
6681,Follicular Cell Differentiation,Recurrent Merkel Cell Carcinoma,0
6682,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of thymus,0
6683,Intermediate Grade Neuroendocrine Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma,0
6684,Endobronchial Lesion,Stage IIIC2 Uterine Corpus Cancer AJCC v8,0
6685,EBV-Positive Neoplastic Cells Present,Pulmonary Blastoma,0
6686,Smooth Muscle Component Present,Adrenal Medullary Hyperplasia,0
6687,EBV-Positive Neoplastic Cells Present,Fetal Lung Adenocarcinoma,0
6688,Abundance of Small Lymphocytes,signet ring cell carcinoma of pancreas,0
6689,Ectopic Thyroid Tissue Present,Childhood Thyroid Gland Papillary Carcinoma,0
6690,Blasts Under 20 Percent of Peripheral Blood White Cells,leiomyosarcoma of liver,0
6691,Abundance of Small Lymphocytes,Benign neoplasm of brain stem,0
6692,Endobronchial Lesion,Pyloric Gland Adenoma,0
6693,Cutaneous plaque,Clinical Stage II Cutaneous Melanoma AJCC v8,0
6694,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Marginal Zone Lymphoma by Ann Arbor Stage,0
6695,Endobronchial Lesion,Hormone refractory breast cancer,0
6696,Smooth Muscle Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,0
6697,EBV-Positive Neoplastic Cells Present,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
6698,Epidermotropic Lymphocytic Infiltrate,Stage B Chronic Lymphocytic Leukemia,0
6699,EBV-Positive Neoplastic Cells Present,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8,0
6700,Endobronchial Lesion,Metastatic Vulvar Carcinoma,0
6701,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IA Eyelid Carcinoma AJCC v8,0
6702,Chronic Inflammatory Infiltrate,Aleukemic Chronic Lymphocytic Leukemia,0
6703,Extensive Stage Lesion,Stage II Hypopharyngeal Carcinoma AJCC v8,0
6704,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIC Merkel Cell Carcinoma AJCC v7,0
6705,EBV-Positive Neoplastic Cells Present,Ewings sarcoma,0
6706,Recurrent Genetic Abnormalities Present,Recurrent Primary Peritoneal Carcinoma,0
6707,Smooth Muscle Component Present,Endometrioid carcinoma ovary,0
6708,Secondary Lesion,Stage III Uterine Corpus Leiomyosarcoma AJCC v8,0
6709,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Colorectal Cancer by AJCC v7 Stage,0
6710,Recurrent Malignant Neoplasm,Recurrent Primary Amyloidosis,0
6711,EBV-Positive Neoplastic Cells Present,Colorectal cancer recurrent,0
6712,Numerous Stromal Mast Cells Present,Gastrointestinal Stromal Sarcoma,0
6713,Lymphocyte count increased,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6714,Recurrent Malignant Neoplasm,Recurrent Inverted Schneiderian Papilloma,0
6715,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Prostatic Atypical Adenomatous Hyperplasia,0
6716,Single Cell Necrosis,Upper Gingival Squamous Cell Carcinoma,0
6717,Secondary Lesion,Stage IV Prostate Cancer AJCC v8,0
6718,Endobronchial Lesion,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6719,EBV-Positive Neoplastic Cells Present,Hemophagocytic Syndrome,0
6720,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,0
6721,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Parotid Gland Undifferentiated Carcinoma,0
6722,Endobronchial Lesion,Stage IVB Hepatocellular Carcinoma AJCC v7,0
6723,Diffuse Cellular Infiltrate,"Diffuse Astrocytoma, IDH-Mutant",0
6724,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant hepatobiliary neoplasms,0
6725,Early Stromal Invasion Present,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage,0
6726,Endobronchial Lesion,Dermatosis Papulosa Nigra,0
6727,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Lip Carcinoma,0
6728,Proliferation of Small Ducts Present,Small intestine carcinoma stage I,0
6729,Defective Alpha Heavy Chain Present,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6730,Smooth Muscle Component Present,Biliary papillomatosis,0
6731,EBV-Positive Neoplastic Cells Present,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8,0
6732,Breast Implant-Related Lesion,Breast T-Cell Non-Hodgkin Lymphoma,0
6733,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Stromal-Leydig Cell Tumor,0
6734,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
6735,Small Aggregates of Tumor Cells Present,Leydig Cell Tumor,0
6736,Extensive Stage Lesion,Stage IB Eyelid Carcinoma AJCC v8,0
6737,Endobronchial Lesion,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,0
6738,Tumor Droplets Present,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
6739,Lesion with Diameter of 4mm or More,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,0
6740,Blasts Under 20 Percent of Peripheral Blood White Cells,Cyst of Skene's duct,0
6741,Secondary Lesion,Breast Myofibroblastoma,0
6742,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Ovarian Germ Cell Tumor AJCC v6 and v7,0
6743,Blasts Under 20 Percent of Peripheral Blood White Cells,Glioblastoma multiforme of spinal cord,0
6744,Abundance of Small Lymphocytes,Pilocytic astrocytoma of cerebellum,0
6745,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH,0
6746,Secondary Lesion,Childhood Bladder Carcinoma,0
6747,EBV-Positive Neoplastic Cells Present,Dermatosis Papulosa Nigra,0
6748,Endobronchial Lesion,Adrenal Gland Lymphoma,0
6749,EBV-Positive Neoplastic Cells Present,Extragonadal primary malignant teratoma,0
6750,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Primary Carcinoma,0
6751,Smooth Muscle Component Present,recurrent adult acute myeloid leukemia,0
6752,Monoclonal Myeloid or Lymphoid Cells Present,Secondary Acute Myeloid Leukemia,0
6753,White blood cell count increased (lab result),Juvenile granulosa cell tumor,0
6754,Tumor Droplets Present,Klatskin Tumor,0
6755,EBV-Positive Neoplastic Cells Present,Bladder Alveolar Soft Part Sarcoma,0
6756,Malignant Primitive Cellular Infiltrate,Malignant Ovarian Thecoma,0
6757,Smooth Muscle Component Present,Mycosis Fungoides,0
6758,Abundance of Small Lymphocytes,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0
6759,Extensive Stage Lesion,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,0
6760,EBV-Positive Neoplastic Cells Present,Microscopic Thymoma,0
6761,Endobronchial Lesion,Giant Fibrovascular Esophageal Polyp,0
6762,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Viscera,0
6763,Endobronchial Lesion,Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8,0
6764,Abundance of Small Lymphocytes,Secretory adenoma of pituitary,0
6765,Endobronchial Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7,0
6766,Well Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0
6767,EBV-Positive Neoplastic Cells Present,Stage I Liver Carcinoma,0
6768,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Endometrial Undifferentiated Carcinoma,0
6769,Secondary Lesion,leiomyosarcoma,0
6770,Endobronchial Lesion,Adenomyoma,0
6771,Mammary Gland Type Features Present,Adrenal Gland Sarcoma,0
6772,EBV-Positive Neoplastic Cells Present,"Hydatidiform Mole, Partial",0
6773,Endobronchial Lesion,Uterine Corpus Epithelioid Leiomyosarcoma,0
6774,Secondary Lesion,Stage III Intrahepatic Cholangiocarcinoma AJCC v7,0
6775,Endobronchial Lesion,Resectable Undifferentiated Pleomorphic Sarcoma,0
6776,EBV-Positive Neoplastic Cells Present,Metastatic Dermatofibrosarcoma Protuberans,0
6777,Tumor Droplets Present,Stage IIA Gestational Trophoblastic Tumor AJCC v7,0
6778,Squamous metaplasia of bladder,Bladder Squamous Papilloma,0
6779,Abundance of Small Lymphocytes,Malignant neoplasm of retina,0
6780,Endobronchial Lesion,Cardiac Lymphoma,0
6781,Extensive Stage Lesion,Stage IIIB Lung Cancer AJCC v8,0
6782,Well Differentiated Hyaline Cartilage Present,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
6783,Secondary Lesion,Juvenile rheumatoid arthritis,0
6784,Solitary Skin Tumor,Pericardial Solitary Fibrous Tumor,0
6785,Smooth Muscle Component Present,"Medulloblastoma, WNT-Activated",0
6786,More Than Two Separate Tumor Masses Present in the Same Organ,Rectal Carcinoma Metastatic in the Liver,0
6787,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Secondary malignant neoplasm of prostate,0
6788,Focal dysplasia,Mild epithelial dysplasia,0
6789,Extensive Stage Lesion,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8,0
6790,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical neurofibroma,0
6791,Gastric dysplasia,Gastric hyperplastic polyp,0
6792,Absence of Malignant Features,Malignant tumor of pyriform fossa,0
6793,Cervical lymphadenopathy,Stage IIA Cervical Cancer AJCC v6,0
6794,Endobronchial Lesion,Congenital Vena Cava Abnormality,0
6795,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Colon Carcinoma,0
6796,Extensive Stage Lesion,Vaginal Cancer by AJCC v8 Stage,0
6797,Limited Early T-Cell Differentiation,Central Nervous System T-Cell Non-Hodgkin Lymphoma,0
6798,Secondary Lesion,Stage IV Hilar Cholangiocarcinoma AJCC v8,0
6799,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Cervical Glandular Neoplasm,0
6800,EBV-Positive Neoplastic Cells Present,Benign melanocytic nevus,0
6801,Gastric dysplasia,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,0
6802,Single Cell Necrosis,Stage IIIB Lung Large Cell Carcinoma AJCC v7,0
6803,Tumor Droplets Present,Pancoast Tumor,0
6804,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage I Appendix Neuroendocrine Tumor AJCC v7,0
6805,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,small cell carcinoma of gallbladder,0
6806,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,cystadenoma of salivary gland,0
6807,Multihormonal Immunoreactivity Present in a Single Cell Type,"Dendritic Cell Sarcoma, Follicular",0
6808,Presence of a Hormonal Syndrome,Sezary Syndrome,0
6809,Pleural effusion disorder,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,0
6810,Extensive Stage Lesion,Prostate Cancer by AJCC v7 Stage,0
6811,Recurrent Malignant Neoplasm,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
6812,Abundance of Small Lymphocytes,sarcoma of lung,0
6813,Endobronchial Lesion,Thyroid Gland Schwannoma,0
6814,Endobronchial Lesion,Stage III Uterine Sarcoma AJCC v7,0
6815,Mixed Neoplastic Glandular and Squamous Cell Population,Systemic Anaplastic Large Cell Lymphoma,0
6816,EBV-Positive Neoplastic Cells Present,Metanephric adenoma,0
6817,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,0
6818,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIC Testicular Cancer AJCC v6 and v7,0
6819,Blasts Under 20 Percent of Peripheral Blood White Cells,undifferentiated carcinoma of gallbladder,0
6820,Endobronchial Lesion,Glomangiomatosis,0
6821,Endobronchial Lesion,Acute GVH disease,0
6822,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of sternum,0
6823,Secondary Lesion,Central Nervous System Myofibroblastoma,0
6824,Smooth Muscle Component Present,Pityriasis Rosea,0
6825,Mammary Gland Type Features Present,Adrenal Gland Pheochromocytoma,0
6826,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7,0
6827,Secondary Lesion,Stage IIA Rectal Cancer AJCC v8,0
6828,EBV-Positive Neoplastic Cells Present,Mycosis fungoides/Sezary syndrome refractory,0
6829,EBV-Positive Neoplastic Cells Present,Scrotal Liposarcoma,0
6830,Secondary Lesion,"Anemia, Hemolytic, Congenital",0
6831,Mammary Gland Type Features Present,Minor Salivary Gland Adenoid Cystic Carcinoma,0
6832,Endobronchial Lesion,Inverted urothelial papilloma,0
6833,Vacuolated Plasma Cells in the Bone Marrow,Breast Carcinoma Metastatic in the Spine,0
6834,EBV-Positive Neoplastic Cells Present,Pleural Carcinomatosis,0
6835,Smooth Muscle Component Present,Nasopharyngeal lymphoepithelioma stage III,0
6836,White blood cell count increased (lab result),Mantle cell lymphoma refractory,0
6837,Endobronchial Lesion,Localized Gastroesophageal Junction Adenocarcinoma,0
6838,Limited Early T-Cell Differentiation,T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,0
6839,Secondary Lesion,Vertebral chordoma,0
6840,Rimming of Adipose Tissue Cells Present,Mucosa-Associated Lymphoid Tissue Lymphoma,0
6841,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,0
6842,EBV-Positive Neoplastic Cells Present,Adult Erythroleukemia,0
6843,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,non-Hodgkin's lymphoma of small intestine,0
6844,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Advanced Urothelial Carcinoma,0
6845,White blood cell count increased (lab result),Precursor cell lymphoblastic lymphoma,0
6846,Blasts Expressing CD56 and Immature T-Cell Markers Present,Cutaneous Mature T-Cell and NK-Cell Neoplasm,0
6847,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,adenocarcinoma of epididymis,0
6848,NRBC - Nucleated red blood cell present result,Adenosquamous cell lung cancer,0
6849,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,0
6850,Endobronchial Lesion,Bladder Adenocarcinoma,0
6851,Tumor Droplets Present,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor",0
6852,EBV-Positive Neoplastic Cells Present,Serous cystadenocarcinoma ovary,0
6853,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIIA Merkel Cell Carcinoma AJCC v7,0
6854,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Childhood Hodgkin Lymphoma by Ann Arbor Stage,0
6855,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,0
6856,Endobronchial Lesion,Stage II Adult Burkitt Lymphoma,0
6857,Tumor Droplets Present,Adult Malignant Peripheral Nerve Sheath Tumor,0
6858,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Undifferentiated Carcinoma of Unknown Primary,0
6859,Mesenchymal Metaplasia of Malignant Cells Present,Malignant tumor of extrahepatic bile duct,0
6860,Single Cell Necrosis,Upper Gingival Squamous Cell Carcinoma,0
6861,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Epithelial Predominant Kidney Wilms Tumor,0
6862,Recurrent Genetic Abnormalities Present,Recurrent Primary Vitreoretinal Lymphoma,0
6863,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of buccal mucosa,0
6864,Smooth Muscle Component Present,Osteosarcoma localised,0
6865,Secondary Lesion,Pleuropulmonary blastoma type I,0
6866,EBV-Positive Neoplastic Cells Present,Stage IIC Testicular Cancer AJCC v8,0
6867,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Metastasizing Pleomorphic Adenoma of the Salivary Gland,0
6868,Small Aggregates of Tumor Cells Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,0
6869,EBV-Positive Neoplastic Cells Present,Embryonal Carcinoma,0
6870,Extensive Stage Lesion,Stage IIA Colon Cancer AJCC v7,0
6871,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIA Testicular Cancer AJCC v6 and v7,0
6872,EBV-Positive Neoplastic Cells Present,Stage IIB Gallbladder Cancer AJCC v8,0
6873,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Platinum-Resistant Primary Peritoneal Carcinoma,0
6874,Aggressive Clinical Course,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,0
6875,Blasts Expressing CD56 and Immature T-Cell Markers Present,Cutaneous Angioimmunoblastic T-Cell Lymphoma,0
6876,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
6877,Primary Site Unknown,Stage IIIA Primary Peritoneal Cancer AJCC v7,0
6878,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Squamous cell carcinoma of the oral cavity stage III,0
6879,Endobronchial Lesion,"Pheochromocytoma, Extra-Adrenal",0
6880,Endobronchial Lesion,Cervical Microglandular Hyperplasia,0
6881,NRBC - Nucleated red blood cell present result,In situ mantle cell neoplasia,0
6882,Photosensitivity of skin,Non-neoplastic nevus of skin,0
6883,Endobronchial Lesion,Deep Leiomyoma,0
6884,EBV-Positive Neoplastic Cells Present,Hemolymphangioma,0
6885,Endobronchial Lesion,Stage IVB Appendix Carcinoma AJCC v8,0
6886,Endobronchial Lesion,High-Grade Prostatic Intraepithelial Neoplasia,0
6887,Smooth Muscle Component Present,EBV-Related Lymphoma,0
6888,Smooth Muscle Component Present,Lymphoplasmacytoid lymphoma/immunocytoma refractory,0
6889,Malignant Primitive Cellular Infiltrate,Asbestos-Related Malignant Mesothelioma,0
6890,Multinodular and Vacuolated Pattern,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
6891,Secondary Lesion,Broad Ligament Serous Adenofibroma,0
6892,Endobronchial Lesion,Stage III Pancreatic Cancer AJCC v8,0
6893,Moderately Differentiated Lesion,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,0
6894,Intermediate Grade Lesion,Grade 3 Endometrial Endometrioid Adenocarcinoma,0
6895,Lesion with Diameter of 10mm or Less,Adenocarcinoma with metaplasia,0
6896,NRBC - Nucleated red blood cell present result,Spindle cell squamous cell carcinoma,0
6897,Follicular Cell Differentiation,Crooke Cell Adenoma,0
6898,Well Developed Rough Endoplasmic Reticulum Present,Well Differentiated Oligodendroglioma,0
6899,Abundance of Small Lymphocytes,Malignant melanoma of retina,0
6900,Extensive Stage Lesion,Stage IIA Uterine Sarcoma AJCC v7,0
6901,Smooth Muscle Component Present,Prostate carcinoma,0
6902,EBV-Positive Neoplastic Cells Present,Classical Hodgkin's Lymphoma,0
6903,Non-Encapsulated Neoplasm,Adult Spinal Cord Neoplasm,0
6904,EBV-Positive Neoplastic Cells Present,Ectopic Thyroid Gland Thymoma,0
6905,Secondary Lesion,Pediatric follicular lymphoma,0
6906,Smooth Muscle Component Present,Supratentorial Pleomorphic Xanthoastrocytoma,0
6907,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IV Oral Cavity Cancer AJCC v6 and v7,0
6908,Secondary Lesion,Subependymal Glioma,0
6909,Absence of Malignant Features,Malignant Aortic Neoplasm,0
6910,Numerous Stromal Mast Cells Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
6911,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Tobacco-Related Carcinoma,0
6912,EBV-Positive Neoplastic Cells Present,Oral neoplasm malignant recurrent,0
6913,Endobronchial Lesion,Stage IV Bladder Cancer AJCC v7,0
6914,Small Aggregates of Tumor Cells Present,Stage II Lung Small Cell Carcinoma AJCC v7,0
6915,Melanoma Cells Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6916,Endobronchial Lesion,Light chain disease,0
6917,EBV-Positive Neoplastic Cells Present,Colorectal Serrated Adenocarcinoma,0
6918,Endobronchial Lesion,Multiple polyps,0
6919,EBV-Positive Neoplastic Cells Present,Vipoma,0
6920,EBV-Positive Neoplastic Cells Present,Ovarian Papillary Cystadenoma,0
6921,Blasts Under 20 Percent of Peripheral Blood White Cells,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood,0
6922,Recurrent Genetic Abnormalities Present,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
6923,Diffuse Immunoblastic Proliferation,Diffuse Laminar Endocervical Hyperplasia,0
6924,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0
6925,EBV-Positive Neoplastic Cells Present,Gallbladder papillary adenocarcinoma,0
6926,"Adenocarcinoma, intestinal type","Salivary Gland Adenocarcinoma, Not Otherwise Specified",0
6927,EBV-Positive Neoplastic Cells Present,Mediastinal Neuroblastoma,0
6928,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,0
6929,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Anal Canal Cancer by AJCC v6 and v7 Stage,0
6930,Smooth Muscle Component Present,Sarcoma,0
6931,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Merkel Cell Carcinoma AJCC v7,0
6932,Abundance of Small Lymphocytes,Pseudopolyposis of colon,0
6933,EBV-Positive Neoplastic Cells Present,Nodular amyloidosis,0
6934,Multihormonal Immunoreactivity Present in a Single Cell Type,ISS Stage II Plasma Cell Myeloma,0
6935,Secondary Lesion,Eccrine angiomatous hamartoma,0
6936,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,papillomatosis of extrahepatic bile duct,0
6937,Chronic Clinical Course,Clinical Stage IIB Gastric Cancer AJCC v8,0
6938,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Thymic Carcinoma,0
6939,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIB Appendix Carcinoma AJCC v7,0
6940,Endobronchial Lesion,Chondrosarcoma metastatic,0
6941,Extensive Stage Lesion,Stage 0 Anal Cancer AJCC v8,0
6942,EBV-Positive Neoplastic Cells Present,Stage III Lung Cancer AJCC v8,0
6943,EBV-Positive Neoplastic Cells Present,Benign Pilar-Associated Mesenchyme Neoplasm,0
6944,Secondary Lesion,Pituitary Gland Gangliocytoma,0
6945,Extensive Stage Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,0
6946,Secondary Lesion,Hair nevus,0
6947,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVB Oral Cavity Cancer AJCC v6 and v7,0
6948,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Small Intestinal Large Cell Neuroendocrine Carcinoma,0
6949,Single Cell Necrosis,Unresectable Skin Basal Cell Carcinoma,0
6950,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Prostate cancer stage B,0
6951,EBV-Positive Neoplastic Cells Present,Stage II Uterine Corpus Cancer AJCC v8,0
6952,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Appendix Tubular Adenoma,0
6953,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Skin Squamous Cell Carcinoma,0
6954,Unifocal Disease at Presentation,Multi-centric Castleman's Disease,0
6955,Endobronchial Lesion,Stage IA Esophageal Cancer AJCC v7,0
6956,Follicular Cell Differentiation,Ann Arbor Stage I Follicular Lymphoma,0
6957,Tumor Droplets Present,Benign Extragonadal Germ Cell Tumor,0
6958,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of pericardium,0
6959,Recurrent Malignant Neoplasm,Recurrent Glioma,0
6960,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,leiomyoma of extrahepatic bile duct,0
6961,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Adenocarcinoma with cartilaginous and osseous metaplasia,0
6962,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Primary malignant neoplasm of brain,0
6963,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed epithelial-mesenchymal hepatoblastoma,0
6964,Fibrotic Stroma with Finger-Like Projections Present,Acute myeloid leukemia with mutated RUNX1,0
6965,Extensive Stage Lesion,Stage IIIB Esophageal Cancer AJCC v7,0
6966,EBV-Positive Neoplastic Cells Present,Roberts-SC phocomelia syndrome,0
6967,Extensive Stage Lesion,Stage I Hypopharyngeal Carcinoma AJCC v8,0
6968,Intestinal metaplasia,Intestinal T-cell lymphoma stage II,0
6969,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Colon Cancer by AJCC v6 Stage,0
6970,Endobronchial Lesion,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
6971,Malignant Primitive Cellular Infiltrate,Malignant Cervical Soft Tissue Neoplasm,0
6972,Plasma cell inflammation,Ovarian germ cell tumor mixed,0
6973,Intraepithelial Neoplasia,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
6974,Endobronchial Lesion,Anaplastic Brain Stem Glioma,0
6975,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Rectal Small Cell Neuroendocrine Carcinoma,0
6976,Smooth Muscle Component Present,Cerebellar Vermis Medulloblastoma,0
6977,Secondary Lesion,Intrahepatic cholangiocarcinoma recurrent,0
6978,Extensive Stage Lesion,Oropharyngeal Carcinoma by AJCC v6 Stage,0
6979,Recurrent Malignant Neoplasm,Adult Cerebellar Neoplasm,0
6980,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myxoma of the Endocardium,0
6981,Abundance of Small Lymphocytes,Secondary malignant neoplasm of ureter,0
6982,Small Aggregates of Tumor Cells Present,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage,0
6983,Secondary Lesion,Pleomorphic Lipoma,0
6984,Blasts Under 20 Percent of Peripheral Blood White Cells,Lymphoma of retina,0
6985,Extensive Stage Lesion,Stage I Burkitt Lymphoma,0
6986,Intermediate Grade Neuroendocrine Lesion,Grade III Meningioma,0
6987,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous Papilloma of the Nasopharynx,0
6988,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Temporal Lobe and Parietal Lobe Ependymal Tumor,0
6989,Follicular Differentiation,Follicular mycosis fungoides,0
6990,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Renal Pelvis Urothelial Carcinoma,0
6991,Endobronchial Lesion,Submandibular Gland Undifferentiated Carcinoma,0
6992,Endobronchial Lesion,Stage II Vulvar Cancer AJCC v7,0
6993,Extensive Stage Lesion,Stage IVA Uterine Corpus Cancer AJCC v8,0
6994,Endobronchial Lesion,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV,0
6995,EBV-Positive Neoplastic Cells Present,Multiple Endocrine Neoplasia,0
6996,Cervical lymphadenopathy,Cervical Warty Carcinoma,0
6997,Blasts Under 20 Percent of Peripheral Blood White Cells,Acute vascular insufficiency of intestine (disorder),0
6998,EBV-Positive Neoplastic Cells Present,Urothelial Carcinoma,0
6999,EBV-Positive Neoplastic Cells Present,Stage IIA Fallopian Tube Cancer AJCC v8,0
7000,Endobronchial Lesion,Periosteal Osteosarcoma,0
7001,Lesion with Diameter of 4mm or More,Refractory cytopenia with multilineage dysplasia,0
7002,Sonic Hedgehog/Patch Pathway Activated,Childhood Visual Pathway Astrocytoma,0
7003,EBV-Positive Neoplastic Cells Present,Uterine Ligament Endometrioid Adenocarcinoma,0
7004,EBV-Positive Neoplastic Cells Present,Primary amyloidosis,0
7005,Endometrial Type Glands and Stroma Present,Recurrent Endometrial Serous Adenocarcinoma,0
7006,Malignant Germinomatous Cellular Infiltrate,Cellular neurothekeoma,0
7007,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant",0
7008,Extensive Stage Lesion,Stage I Uterine Sarcoma AJCC v7,0
7009,Mammary Gland Type Features Present,Metastatic Thyroid Gland Carcinoma,0
7010,EBV-Positive Neoplastic Cells Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",0
7011,Multicentric Lesion,Multicentric Thyroid Gland Papillary Carcinoma,0
7012,Extensive Stage Lesion,Fallopian Tube Cancer by AJCC v6 Stage,0
7013,Apocrine Differentiation,Breast Apocrine Adenoma,0
7014,Smooth Muscle Component Present,Carcinomatosis,0
7015,Tumor Droplets Present,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,0
7016,Recurrent Malignant Neoplasm,Recurrent Acute Myeloid Leukemia,0
7017,Endobronchial Lesion,Colon Cancer by AJCC v8 Stage,0
7018,Abundance of Small Lymphocytes,Inflammatory pseudotumor of liver,0
7019,Extensive Stage Lesion,Stage IIB Esophageal Adenocarcinoma AJCC v7,0
7020,Extensive Stage Lesion,Stage II Penile Cancer AJCC v6,0
7021,Primary Site Unknown,Stage IV Primary Peritoneal Cancer AJCC v8,0
7022,Ectopic Thyroid Tissue Present,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,0
7023,Secondary Lesion,Syringoma,0
7024,Secondary Lesion,Fibrolamellar Hepatocellular Carcinoma,0
7025,Secondary Lesion,Prostate Angiosarcoma,0
7026,Endobronchial Lesion,"Adenocarcinoma, intestinal type",0
7027,Endobronchial Lesion,Recurrent Burkitt Leukemia,0
7028,Stromal Invasion,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
7029,Erythema,Erythema Multiforme Major,0
7030,Breast Implant-Related Lesion,Stage IIB Breast Carcinoma,0
7031,Abundance of Small Lymphocytes,Stage 0 Ampulla of Vater Cancer AJCC v8,0
7032,Large Neoplastic Glands with Branching and Papillary Infolding Present,"Carcinoma, Papillary",0
7033,EBV-Positive Neoplastic Cells Present,Rectosigmoid cancer recurrent,0
7034,Tumor Droplets Present,Stage IIA Gestational Trophoblastic Tumor AJCC v7,0
7035,Endobronchial Lesion,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7036,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Cyst of Skene's duct,0
7037,Non-Encapsulated Neoplasm,Adult Spinal Cord Neoplasm,0
7038,Endobronchial Lesion,Central Nervous System Angiosarcoma,0
7039,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8,0
7040,Secondary Lesion,Stage I Hilar Cholangiocarcinoma AJCC v8,0
7041,Secondary Lesion,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8,0
7042,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
7043,Extensive Stage Lesion,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,0
7044,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,0
7045,Endobronchial Lesion,Rectosigmoid Adenocarcinoma,0
7046,Mixed Neoplastic Glandular and Squamous Cell Population,Clear Cell Papillary Cystadenoma,0
7047,Apocrine metaplasia,Apocrine adenoma,0
7048,Diffuse Cellular Infiltrate,"Diffuse large B-cell lymphoma, unclassifiable, NOS",0
7049,Intermediate Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Microadenoma,0
7050,Tumor Droplets Present,Frontal Lobe and Parietal Lobe Ependymal Tumor,0
7051,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0
7052,Smooth Muscle Component Present,Uterine Corpus Sarcoma,0
7053,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,0
7054,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage I Choroidal and Ciliary Body Melanoma AJCC v8,0
7055,Secondary Lesion,Biliary Intraepithelial Neoplasia,0
7056,Chronic Clinical Course,Chronic Myelomonocytic Leukemia-2,0
7057,EBV-Positive Neoplastic Cells Present,Treatment related secondary malignancy,0
7058,Follicular Cell Differentiation,Recurrent Spindle Cell Sarcoma,0
7059,Extensive Stage Lesion,Stage IV Uveal Melanoma AJCC v7,0
7060,Endobronchial Lesion,"Thrombocythemia, Essential",0
7061,EBV-Positive Neoplastic Cells Present,Prognostic Stage III Breast Cancer AJCC v8,0
7062,Secondary Lesion,Superior Vena Cava Leiomyosarcoma,0
7063,Follicular Cell Differentiation,Cervical Clear Cell Adenocarcinoma,0
7064,Extensive Stage Lesion,Stage I Cutaneous Melanoma AJCC v6,0
7065,EBV-Positive Neoplastic Cells Present,Stage IB Uterine Corpus Cancer AJCC v8,0
7066,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,small cell carcinoma of breast,0
7067,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Clonal Hematopoiesis of Indeterminate Potential,0
7068,Extensive Stage Lesion,Stage IIIB Vulvar Cancer AJCC v7,0
7069,Endobronchial Lesion,Disseminated carcinoma,0
7070,Secondary Lesion,Tumorlet,0
7071,Endobronchial Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v8,0
7072,Secondary Lesion,B-cell small lymphocytic lymphoma stage II,0
7073,High Grade Lesion,FNCLCC Sarcoma Grade 3,0
7074,NRBC - Nucleated red blood cell present result,Anal squamous cell carcinoma,0
7075,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
7076,Endobronchial Lesion,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,0
7077,EBV-Positive Neoplastic Cells Present,Palisaded Lymph Node Myofibroblastoma,0
7078,Multiple Tumor Masses,Recurrent Atypical Teratoid/Rhabdoid Tumor,0
7079,Endobronchial Lesion,Stage III Intrahepatic Cholangiocarcinoma AJCC v8,0
7080,Multinodular and Vacuolated Pattern,Stage IB Ovarian Cancer AJCC v6 and v7,0
7081,Endobronchial Lesion,Urothelial Hyperplasia,0
7082,Extensive Stage Lesion,Stage IIIb Penile Cancer AJCC v7,0
7083,Absence of Malignant Features,Malignant Frontal Sinus Neoplasm,0
7084,EBV-Positive Neoplastic Cells Present,Posterior Tongue Mucoepidermoid Carcinoma,0
7085,Endobronchial Lesion,Masaoka-Koga Stage IIb,0
7086,Endobronchial Lesion,Lipoblastomatosis,0
7087,EBV-Positive Neoplastic Cells Present,Primary leiomyosarcoma,0
7088,Extensive Stage Lesion,Appendix Carcinoma by AJCC v8 Stage,0
7089,EBV-Positive Neoplastic Cells Present,Pleural Biphasic Synovial Sarcoma,0
7090,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Prostate Carcinoma,0
7091,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign Notochordal Cell Tumor,0
7092,Small Aggregates of Tumor Cells Present,Small cell carcinoma of the cervix,0
7093,EBV-Positive Neoplastic Cells Present,Hepatoerythropoietic Porphyria,0
7094,Lesion with Diameter of 4mm or More,Adenocarcinoma with cartilaginous and osseous metaplasia,0
7095,Smooth Muscle Component Present,Trichoadenoma,0
7096,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage,0
7097,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of nervous system,0
7098,Epithelial hyperplasia of skin,Bronchial Epithelial Hyperplasia,0
7099,Smooth Muscle Component Present,Benign Smooth Muscle Neoplasm,0
7100,Smooth Muscle Component Present,Iatrogenic Kaposi Sarcoma,0
7101,Mixture of Embryonal and Alveolar Features Present,Transitional cell cancer of renal pelvis and ureter metastatic,0
7102,Secondary Lesion,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,0
7103,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Secondary malignant neoplasm of pericardium,0
7104,Endobronchial Lesion,Flat Urothelial Hyperplasia,0
7105,Plasma cell inflammation,Vaginal clear cell adenocarcinoma,0
7106,Primary Site Unknown,Primary ameloblastic carcinoma,0
7107,EBV-Positive Neoplastic Cells Present,Barrett Esophagus,0
7108,Absence of Malignant Features,Malignant neoplasm of olfactory nerve,0
7109,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Villous adenoma of colon,0
7110,NRBC - Nucleated red blood cell present result,Acquired cystic disease associated renal cell carcinoma,0
7111,Tumor Droplets Present,Fallopian Tube Metaplastic Papillary Tumor,0
7112,Abundance of Small Lymphocytes,Malignant neoplasm of trachea,0
7113,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,0
7114,EBV-Positive Neoplastic Cells Present,Class 1a Uveal Melanoma,0
7115,EBV-Positive Neoplastic Cells Present,Adult T-cell lymphoma/leukemia stage II,0
7116,Enterochromaffin Type Granules Present,Intermediate Cell Type Iris Melanoma,0
7117,Endobronchial Lesion,Stage IIIA Lung Cancer AJCC v7,0
7118,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Giant Cell Glioblastoma,0
7119,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of epicardium,0
7120,Human Papillomavirus Negative,Human Papillomavirus-Related Squamous Cell Carcinoma,0
7121,Fibrotic Stroma with Finger-Like Projections Present,Acute myeloid leukemia with mutated NPM1,0
7122,Solitary Skin Tumor,Thyroid Gland Solitary Fibrous Tumor,0
7123,Endobronchial Lesion,Pancreatic carcinoma non-resectable,0
7124,Abundance of Small Lymphocytes,Leukemic Phase of Non-Hodgkin's Lymphoma,0
7125,Endobronchial Lesion,Lentigo,0
7126,Multinodular and Vacuolated Pattern,Stage 0 Gallbladder Cancer AJCC v6 and v7,0
7127,High Grade Non Cartilaginous Sarcomatous Stroma Present,Adult Grade III Meningioma,0
7128,Endobronchial Lesion,Abdominal Undifferentiated Pleomorphic Sarcoma,0
7129,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,0
7130,Secondary Lesion,Cardiac Myxofibrosarcoma,0
7131,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Sertoli cell tumor of testis,0
7132,Intermediate Grade Neuroendocrine Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",0
7133,EBV-Positive Neoplastic Cells Present,"Phyllodes tumor, borderline",0
7134,Intermediate Grade Lesion,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
7135,Endobronchial Lesion,Metastasizing Chondroblastoma,0
7136,Secondary Lesion,Waldenstrom's macroglobulinemia recurrent,0
7137,Abundance of Small Lymphocytes,histiocytic sarcoma of central nervous system,0
7138,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,AIDS-Related Diffuse Large B-cell Lymphoma,0
7139,Extensive Stage Lesion,Stage III Colon Cancer AJCC v7,0
7140,Secondary Lesion,Childhood Leiomyosarcoma,0
7141,Low Grade Lesion,Low Grade Prostatic Intraepithelial Neoplasia,0
7142,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage III Lung Small Cell Carcinoma AJCC v7,0
7143,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Anemia due to membrane defect,0
7144,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIC Appendix Carcinoma AJCC v8,0
7145,Extensive Stage Lesion,Childhood Lymphoma by AJCC v8 Stage,0
7146,Endobronchial Lesion,Vaginal Undifferentiated Sarcoma,0
7147,Insular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
7148,Extensive Stage Lesion,Clinical Stage II Retinoblastoma AJCC v8,0
7149,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
7150,Dense Collagenized Tissue Present,Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma,0
7151,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Anal Canal Squamous Intraepithelial Neoplasia,0
7152,Single Cell Necrosis,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
7153,Smooth Muscle Component Present,Bladder Leiomyoma,0
7154,Non-Encapsulated Neoplasm,Erythroid Neoplasm,0
7155,Endobronchial Lesion,Major Salivary Gland Adenoid Cystic Carcinoma,0
7156,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Temporal Lobe and Parietal Lobe Ependymal Tumor,0
7157,EBV-Positive Neoplastic Cells Present,Post-kala-azar dermal leishmaniasis,0
7158,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,0
7159,Abundance of Small Lymphocytes,Benign tumor of mediastinum,0
7160,Smooth Muscle Component Present,Vaginal adenocarcinoma,0
7161,Secondary Lesion,Lung Lymphoepithelioma-Like Carcinoma,0
7162,Hot Nodule,Thyroid Nodule,0
7163,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Primitive Germ Cell Tumor,0
7164,Generalized Hydropic Villous Change,"Adenoma, Villous",0
7165,EBV-Positive Neoplastic Cells Present,Stage IC Ovarian Cancer AJCC v8,0
7166,Abundance of Small Lymphocytes,lymphoma of spinal cord,0
7167,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of pharynx,0
7168,Skin Red Dot,Recurrent Skin Angiosarcoma,0
7169,Mammary Gland Type Features Present,Thyroid Gland Cavernous Hemangioma,0
7170,EBV-Positive Neoplastic Cells Present,Mature Ganglioneuroma,0
7171,Smooth Muscle Component Present,Adenocarcinofibroma,0
7172,Locally Aggressive Lesion,Locally Advanced Angiosarcoma,0
7173,EBV-Positive Neoplastic Cells Present,Stage IIC Rectal Cancer AJCC v8,0
7174,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Clear Cell Adenocarcinoma,0
7175,Tumor Droplets Present,Pericardial Solitary Fibrous Tumor,0
7176,Secondary Lesion,Laryngeal Paraganglioma,0
7177,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Hepatocellular Carcinoma AJCC v8,0
7178,Absence of Malignant Features,Distantly Metastatic Malignant Neoplasm,0
7179,Blasts Under 20 Percent of Peripheral Blood White Cells,Serous papillary cystic tumor of borderline malignancy,0
7180,EBV-Positive Neoplastic Cells Present,Papillary neoplasm,0
7181,Smooth Muscle Component Present,Bladder adenocarcinoma stage II,0
7182,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
7183,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Serous cystadenocarcinoma of pancreas,0
7184,Smooth Muscle Component Present,Chorioangioma,0
7185,Secondary Lesion,calcifying aponeurotic fibroma,0
7186,Early Stromal Invasion Present,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",0
7187,Plasma cell inflammation,granulosa cell tumor,0
7188,Secondary Lesion,Gastro-enteropancreatic neuroendocrine tumor,0
7189,EBV-Positive Neoplastic Cells Present,Stage IIA Cervical Cancer AJCC v8,0
7190,Absence of Malignant Features,Malignant neoplasm of maxillary sinus,0
7191,Diffuse Immunoblastic Proliferation,Recurrent Adult Immunoblastic Lymphoma,0
7192,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIB Merkel Cell Carcinoma AJCC v7,0
7193,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Pleomorphic lobular carcinoma in situ of breast,0
7194,White blood cell count increased (lab result),Anal margin basal cell carcinoma,0
7195,Smooth Muscle Component Present,Bladder adenocarcinoma stage II,0
7196,Blasts Under 20 Percent of Peripheral Blood White Cells,Leiomyoma of Gallbladder,0
7197,Mixed Neoplastic Glandular and Squamous Cell Population,Lip and Oral Cavity Squamous Cell Carcinoma,0
7198,EBV-Positive Neoplastic Cells Present,Embryonal Rhabdomyosarcoma,0
7199,Secondary Lesion,Prostate carcinoma,0
7200,Secondary Lesion,Lung Adenocarcinoma In Situ,0
7201,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Stage II Diffuse Large B-Cell Lymphoma,0
7202,NRBC - Nucleated red blood cell present result,Bladder squamous cell carcinoma stage I,0
7203,Neoplastic Cells with TFH Cell Phenotype Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7204,Abundance of Small Lymphocytes,Sertoli-Leydig cell tumor of ovary,0
7205,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Clonal Hematopoiesis of Indeterminate Potential,0
7206,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adenosarcoma of cervix uteri,0
7207,Smooth Muscle Component Present,"Trophoblastic tumor, epithelioid",0
7208,Single Cell Necrosis,Recurrent Ovarian Transitional Cell Carcinoma,0
7209,Secondary Lesion,B-cell small lymphocytic lymphoma refractory,0
7210,Rimming of Adipose Tissue Cells Present,Soft Tissue Sarcoma by AJCC v8 Stage,0
7211,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,0
7212,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Vulvar Superficial Angiomyxoma,0
7213,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
7214,Tumor Droplets Present,Benign Anal Granular Cell Tumor,0
7215,Abundance of Small Lymphocytes,undifferentiated carcinoma of cervix,0
7216,Abundance of Small Lymphocytes,Polyp of sphenoidal sinus,0
7217,Follicular Cell Differentiation,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,0
7218,Smooth Muscle Component Present,Spongiotic dermatitis,0
7219,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Resectable Malignant Mesothelioma,0
7220,Endobronchial Lesion,Villoglandular Endometrial Endometrioid Adenocarcinoma,0
7221,EBV-Positive Neoplastic Cells Present,Benign Osteogenic Neoplasm,0
7222,Single Cell Necrosis,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
7223,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,"Adenocarcinoma of lung, stage II",0
7224,Recurrent Genetic Abnormalities Present,Recurrent respiratory papillomatosis,0
7225,Low Grade Neuroendocrine Lesion,Ovarian Low Grade Endometrioid Stromal Sarcoma,0
7226,Multiple Tumor Masses,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,0
7227,Endobronchial Lesion,Stage IVA Hypopharyngeal Carcinoma AJCC v7,0
7228,EBV-Positive Neoplastic Cells Present,Remote Placental Infarction,0
7229,Extensive Stage Lesion,Stage IIA Prostate Cancer AJCC v7,0
7230,Blasts Under 20 Percent of Peripheral Blood White Cells,Stage II Ampulla of Vater Cancer AJCC v8,0
7231,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Ovarian Teratoma AJCC v6 and v7,0
7232,Endobronchial Lesion,Cytogenetically normal acute myeloid leukemia,0
7233,EBV-Positive Neoplastic Cells Present,Telangiectatic osteosarcoma,0
7234,NRBC - Nucleated red blood cell present result,Benign germ cell neoplasm,0
7235,Intermediate Grade Lesion,Sarcoma NCI Grade 3,0
7236,Endobronchial Lesion,Stage IIC Colon Cancer AJCC v7,0
7237,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,0
7238,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Uterine Corpus Cancer by AJCC v8 Stage,0
7239,Endobronchial Lesion,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
7240,Multihormonal Immunoreactivity Present in a Single Cell Type,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,0
7241,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,lipoma of mediastinum,0
7242,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,0
7243,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Malignant Neoplasm,0
7244,Secondary Lesion,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),0
7245,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Pulmonary Vein Neoplasm,0
7246,Multihormonal Immunoreactivity Present in a Single Cell Type,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,0
7247,Epithelioid Differentiation,Epithelioid sarcoma metastatic,0
7248,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Rhabdomyosarcoma with ganglionic differentiation,0
7249,Smooth Muscle Component Present,Lipoma,0
7250,Multihormonal Immunoreactivity Present in a Single Cell Type,Colorectal Squamous Cell Carcinoma,0
7251,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage III Renal Cell Cancer AJCC v8,0
7252,Abundance of Small Lymphocytes,Adenocarcinoma of Skene Gland Origin,0
7253,Extensive Stage Lesion,Stage IIB Distal Bile Duct Cancer AJCC v8,0
7254,Follicular Differentiation,Follicular Lymph Node Hyperplasia,0
7255,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Gallbladder Carcinoma,0
7256,Fibrous Septa Present,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,0
7257,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of pyriform sinus,0
7258,EBV-Positive Neoplastic Cells Present,Benign Lymphoproliferative Disorder,0
7259,Abundance of Small Lymphocytes,Malignant tumor of base of tongue,0
7260,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of Cowper Glands,0
7261,EBV-Positive Neoplastic Cells Present,Stage 0a Renal Pelvis Cancer AJCC v7,0
7262,Abundance of Small Lymphocytes,Pleomorphic adenoma of parotid gland,0
7263,Secondary Lesion,Stage III Esophageal Cancer,0
7264,Smooth Muscle Component Present,MUTYH-Associate Polyposis,0
7265,Endobronchial Lesion,Childhood Myxopapillary Ependymoma,0
7266,Secondary Lesion,Eccrine Poroma,0
7267,Abundance of Small Lymphocytes,Secondary malignant neoplasm of female breast,0
7268,EBV-Positive Neoplastic Cells Present,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0
7269,Abundance of Small Lymphocytes,Hyperplasia of Brunner glands of duodenum,0
7270,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Vulvar Neoplasm of Skin Appendage Origin,0
7271,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,0
7272,Endobronchial Lesion,AIDS-Related Gastric Kaposi Sarcoma,0
7273,Schwannian Stroma Predominant Component of the Tumor Volume,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,0
7274,EBV-Positive Neoplastic Cells Present,Advanced Lung Carcinoma,0
7275,Tumor Droplets Present,Hemosiderotic Fibrolipomatous Tumor,0
7276,Cervical lymphadenopathy,Metastatic Cervical Adenocarcinoma,0
7277,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7,0
7278,Multihormonal Immunoreactivity Present in a Single Cell Type,Cutaneous Mantle Cell Lymphoma,0
7279,Endobronchial Lesion,Adenocarcinoma Of Esophagus,0
7280,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Ovarian Polyembryoma AJCC v6 and v7,0
7281,EBV-Positive Neoplastic Cells Present,Pruritus,0
7282,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Breast Solid Neuroendocrine Carcinoma,0
7283,Rimming of Adipose Tissue Cells Present,Refractory Soft Tissue Sarcoma,0
7284,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage III Cervical Cancer AJCC v6 and v7,0
7285,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Testicular Cancer AJCC v6 and v7,0
7286,EBV-Positive Neoplastic Cells Present,Gastric Hepatoid Adenocarcinoma,0
7287,Endobronchial Lesion,Colorectal Angiosarcoma,0
7288,Absence of Invasion or Limited Invasion Present,Lugano Classification Limited Stage Adult Lymphoma AJCC v8,0
7289,EBV-Positive Neoplastic Cells Present,Solitary fibrous tumor,0
7290,EBV-Positive Neoplastic Cells Present,Stage I Lung Cancer AJCC v8,0
7291,Endobronchial Lesion,Fallopian Tube Gestational Choriocarcinoma,0
7292,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIIA Testicular Cancer AJCC v6 and v7,0
7293,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Distal 1/3 of the Common Bile Duct Adenocarcinoma,0
7294,Blasts Under 20 Percent of Peripheral Blood White Cells,Kaposi's sarcoma of lung,0
7295,Mammary Gland Type Features Present,Thyroid Gland Paraganglioma,0
7296,Smooth Muscle Component Present,Vipoma,0
7297,Secondary Lesion,Adult Pineal Gland Astrocytoma,0
7298,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Central Nervous System Germ Cell Tumor,0
7299,Extensive Stage Lesion,Stage IIA Appendix Carcinoma AJCC v7,0
7300,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
7301,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of the paranasal sinus,0
7302,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Intrahepatic Bile Duct Papillary Neoplasm,0
7303,Immature Granulocytes in Peripheral Blood Increased,Childhood Immature Teratoma,0
7304,Malignant Primitive Cellular Infiltrate,Malignant Lung Hilum Neoplasm,0
7305,EBV-Positive Neoplastic Cells Present,Stage IV Major Salivary Gland Cancer AJCC v7,0
7306,Endobronchial Lesion,Colorectal Sporadic Serrated Polyp,0
7307,Recurrent Genetic Abnormalities Present,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,0
7308,Malignant Primitive Cellular Infiltrate,Bulbomembranous Urethral Malignant Neoplasm,0
7309,Secondary Lesion,Deep Lipoma,0
7310,Endobronchial Lesion,Penile Cancer by AJCC v7 Stage,0
7311,Endobronchial Lesion,Cerebral Hodgkin Lymphoma,0
7312,Endobronchial Lesion,Third Ventricle Pilocytic Astrocytoma,0
7313,Endobronchial Lesion,Central Nervous System Kaposi Sarcoma,0
7314,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,0
7315,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
7316,Recurrent Malignant Neoplasm,Recurrent Childhood Lymphomatoid Granulomatosis,0
7317,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of middle ear,0
7318,Solid Growth Pattern,Locally Advanced Malignant Solid Neoplasm,0
7319,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Paget's disease of penis,0
7320,Endobronchial Lesion,Stage IV Vulvar Cancer AJCC v8,0
7321,Endobronchial Lesion,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,0
7322,Endobronchial Lesion,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,0
7323,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,0
7324,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Skin Metatypical Carcinoma,0
7325,Secondary Lesion,Peritoneal mesothelioma malignant recurrent,0
7326,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Lip and Oral Cavity Squamous Cell Carcinoma,0
7327,Endobronchial Lesion,Stage III Colorectal Cancer,0
7328,Local disease,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,0
7329,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of sternum,0
7330,Smooth Muscle Component Present,Placenta Accreta,0
7331,EBV-Positive Neoplastic Cells Present,Fallopian Tube Lymphoma,0
7332,Smooth Muscle Component Present,Tonsillar Lymphoma,0
7333,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade III Chondrosarcoma,0
7334,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Esophageal Moderately Differentiated Squamous Cell Carcinoma,0
7335,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Extrahepatic Bile Duct Carcinoid Tumor,0
7336,EBV-Positive Neoplastic Cells Present,Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
7337,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Resectable Pancreatic Acinar Cell Carcinoma,0
7338,Recurrent Malignant Neoplasm,Recurrent Adrenal Gland Pheochromocytoma,0
7339,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Childhood Anaplastic Large Cell Lymphoma,0
7340,Absence of Malignant Features,Malignant neoplasm of gallbladder,0
7341,Multihormonal Immunoreactivity Present in a Single Cell Type,Transitional Cell Intraepithelial Neoplasia,0
7342,Endobronchial Lesion,Angiocentric lymphoma recurrent,0
7343,Rubbery Skin Lesion,Stage III Skin Cancer,0
7344,EBV-Positive Neoplastic Cells Present,Stage III Rectosigmoid Cancer AJCC v6,0
7345,Chronic Clinical Course,Refractory Chronic Leukemia,0
7346,Well Differentiated Neuroendocrine Lesion,Prostate Neuroendocrine Neoplasm,0
7347,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Childhood Acute Myeloid Leukemia with Maturation,0
7348,Blasts Under 20 Percent of Peripheral Blood White Cells,large cell neuroendocrine carcinoma of breast,0
7349,Small Aggregates of Tumor Cells Present,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,0
7350,Primitive Mesenchymal Stroma Formation,Central Nervous System Mesenchymal Chondrosarcoma,0
7351,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasms of independent (primary) multiple sites,0
7352,Endobronchial Lesion,Unna-Thost Syndrome,0
7353,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Refractory anemia with ringed sideroblasts,0
7354,Multihormonal Immunoreactivity Present in a Single Cell Type,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",0
7355,EBV-Positive Neoplastic Cells Present,Stage IV Esophageal Adenocarcinoma,0
7356,EBV-Positive Neoplastic Cells Present,Rectal Sessile Serrated Adenoma/Polyp,0
7357,Recurrent Malignant Neoplasm,Recurrent Childhood Glioblastoma,0
7358,EBV-Positive Neoplastic Cells Present,Pancreatic Ductal Adenocarcinoma,0
7359,Unfavorable Clinical Outcome,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,0
7360,Gastric-Type Epithelial Differentiation,Stage III Thymus Epithelial Neoplasm AJCC v8,0
7361,Secondary Lesion,Vulvar adenocarcinoma,0
7362,EBV-Positive Neoplastic Cells Present,Urothelial Neoplasm,0
7363,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Parotid Gland Mixed Tumor,0
7364,Follicular Cell Differentiation,Plasma Cell Myeloma by DS Stage,0
7365,Secondary Lesion,Radiation-Induced Intracranial Meningioma,0
7366,Plasma cell inflammation,Bladder transitional cell carcinoma stage 0,0
7367,Lesion with Diameter of 4mm or More,carcinoma of pancreas with osteoclast-like giant cells,0
7368,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Cardiac Yolk Sac Tumor,0
7369,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,adenocarcinoma of renal pelvis,0
7370,Secondary Lesion,Stage IV Childhood Burkitt Lymphoma,0
7371,Endobronchial Lesion,Actinic keratosis,0
7372,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
7373,Tumor Droplets Present,Refractory Peripheral Primitive Neuroectodermal Tumor,0
7374,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of subglottis,0
7375,Extensive Stage Lesion,Stage IIIA Uterine Corpus Cancer AJCC v8,0
7376,Extensive Stage Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v7,0
7377,Recurrent Malignant Neoplasm,Recurrent Hematologic Malignancy,0
7378,EBV-Positive Neoplastic Cells Present,Tinea Favosa,0
7379,Extensive Stage Lesion,Stage II Burkitt Lymphoma,0
7380,Blasts Under 20 Percent of Peripheral Blood White Cells,mucoepidermoid carcinoma of floor of mouth,0
7381,Solid Growth Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",0
7382,EBV-Positive Neoplastic Cells Present,Locally Advanced Unresectable Prostate Carcinoma,0
7383,Mesenchymal Metaplasia of Malignant Cells Present,Malignant mesothelioma of pericardium,0
7384,Secondary Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,0
7385,Small Aggregates of Tumor Cells Present,Descending Colon Neuroendocrine Tumor G1,0
7386,Tumor Vascular Invasion,"Neoplasms, Vascular Tissue",0
7387,Smooth Muscle Component Present,Solar lentigo,0
7388,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Recurrent Salivary Duct Carcinoma,0
7389,Extensive Stage Lesion,Stage IIIA2 Ovarian Cancer AJCC v8,0
7390,Endobronchial Lesion,Stage III Ureter Cancer AJCC v7,0
7391,High Grade Lesion,Grade 1 Colorectal Adenocarcinoma,0
7392,EBV-Positive Neoplastic Cells Present,FIGO Stage IIIA2 Ovarian Cancer,0
7393,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Laryngeal Giant Cell Carcinoma,0
7394,Smooth Muscle Component Present,Ceruminous adenocarcinoma,0
7395,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,mucinous adenocarcinoma of cervix,0
7396,EBV-Positive Neoplastic Cells Present,Multiple polyps,0
7397,Secondary Lesion,Childhood Laryngeal Carcinoma,0
7398,Slowly Progressive Clinical Course,Progressive bulbar palsy,0
7399,Squamous metaplasia of bladder,Cervical Squamous Intraepithelial Neoplasia 1,0
7400,Smooth Muscle Component Present,Urethral cancer regional,0
7401,Abundance of Small Lymphocytes,Nevus of eyelid,0
7402,Endobronchial Lesion,Adult Spinal Cord Neoplasm,0
7403,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Advanced Squamous Cell Carcinoma of the Oropharynx,0
7404,EBV-Positive Neoplastic Cells Present,Distal Esophagus Adenocarcinoma,0
7405,Endobronchial Lesion,Ann Arbor Stage IV AIDS-Related Lymphoma,0
7406,Lesion with Diameter of 4mm or More,Myelodysplastic Syndrome with Gene Mutation,0
7407,Prominent In Situ Component Present,Apocrine Breast Carcinoma In Situ,0
7408,Endobronchial Lesion,EBV-Related Post-Transplant Lymphoproliferative Disorder,0
7409,Fascicular Pattern,"Testicular Yolk Sac Tumor, Solid Pattern",0
7410,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Platinum-Resistant Ovarian Carcinoma,0
7411,EBV-Positive Neoplastic Cells Present,Childhood Acute Monoblastic Leukemia,0
7412,Extensive Stage Lesion,Stage IIIB Appendix Carcinoma AJCC v8,0
7413,Multihormonal Immunoreactivity Present in a Single Cell Type,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,0
7414,Secondary Lesion,Stage II Lung Cancer AJCC v7,0
7415,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Ann Arbor Stage III Mature T- and NK-Cell Lymphoma,0
7416,Intermediate Grade Lesion,Grade 1 Rectal Adenocarcinoma,0
7417,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,mucinous adenocarcinoma of salivary gland,0
7418,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIB Appendix Carcinoma AJCC v8,0
7419,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adenoid cystic carcinoma of the oral cavity,0
7420,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Vulvar Cancer by AJCC v7 Stage,0
7421,Monoclonal Myeloid or Lymphoid Cells Present,Cardiac Myeloid Sarcoma,0
7422,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,sialadenoma papilliferum of salivary gland,0
7423,Aggressive Clinical Course,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma,0
7424,NRBC - Nucleated red blood cell present result,Benign squamous cell tumor,0
7425,Multinodular and Vacuolated Pattern,Stage I Testicular Cancer AJCC v6 and v7,0
7426,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Secondary malignant neoplasm of extrahepatic bile ducts,0
7427,Endobronchial Lesion,Oral Cavity Carcinoma,0
7428,Nodular and Diffuse Pattern,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage,0
7429,Lesion with Diameter of 10mm or Less,Adult Primary Melanocytic Lesion of Meninges,0
7430,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIB Cervical Cancer AJCC v6 and v7,0
7431,Endobronchial Lesion,Gastrointestinal lymphoma,0
7432,Abundance of Small Lymphocytes,Stage IIB Small Intestinal Adenocarcinoma AJCC v8,0
7433,Intestinal metaplasia of gastric mucosa,Intestinal Neuroendocrine Carcinoma,0
7434,Endobronchial Lesion,Appendix Leiomyoma,0
7435,Neoplastic Cells with TFH Cell Phenotype Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),0
7436,Single Cell Necrosis,Recurrent Acinic Cell Breast Carcinoma,0
7437,Mammary Gland Type Features Present,Thyroid Gland Hemangioma,0
7438,Smooth Muscle Component Present,Childhood Ovarian Teratoma,0
7439,Pleural effusion disorder,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,0
7440,Blasts Under 20 Percent of Peripheral Blood White Cells,ductal papilloma of salivary gland,0
7441,Blasts Expressing CD56 and Immature T-Cell Markers Present,Refractory Hepatosplenic T-Cell Lymphoma,0
7442,Endobronchial Lesion,Adult Oligodendroglioma,0
7443,Endobronchial Lesion,Oropharyngeal cancer recurrent,0
7444,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,"Adenocarcinoma of lung, stage I",0
7445,Multihormonal Immunoreactivity Present in a Single Cell Type,Rectosigmoid Signet Ring Cell Carcinoma,0
7446,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Early-Stage Breast Carcinoma,0
7447,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma ex pleomorphic adenoma,0
7448,Smooth Muscle Component Present,Uterine Corpus Adenofibroma,0
7449,Endobronchial Lesion,Childhood Bladder Carcinoma,0
7450,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ependymoma of spinal cord,0
7451,Extensive Stage Lesion,Bladder Cancer by AJCC v8 Stage,0
7452,EBV-Positive Neoplastic Cells Present,Aflatoxins-Related Hepatocellular Carcinoma,0
7453,Fascicular Pattern,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",0
7454,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of choroid,0
7455,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Colorectal Medullary Carcinoma,0
7456,Smooth Muscle Component Present,B-cell lymphoma refractory,0
7457,Early Stromal Invasion Present,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
7458,Endobronchial Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,0
7459,Dermal Nodule,Dermal Fibroma,0
7460,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Pleomorphic adenoma of parotid gland,0
7461,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoid tumor of the duodenum,0
7462,Blasts Under 20 Percent of Peripheral Blood White Cells,basal cell carcinoma of penis,0
7463,WNT Pathway Activated,Recurrent Childhood Visual Pathway Glioma,0
7464,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of brain stem,0
7465,Endobronchial Lesion,"Glioblastoma, IDH-Wildtype",0
7466,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Serous Tubal Intraepithelial Carcinoma,0
7467,Multiple Tumor Masses,Metastatic Digestive System Neuroendocrine Tumor G1,0
7468,Focal dysplasia,Focal Segmental Glomerulosclerosis Collapsing Variant,0
7469,Endobronchial Lesion,Chronic Active Colitis,0
7470,EBV-Positive Neoplastic Cells Present,Stage II Hepatocellular Carcinoma AJCC v8,0
7471,Endobronchial Lesion,Melanotic malignant nerve sheath tumor,0
7472,Mucinous degeneration,Acinar Prostate Mucinous Adenocarcinoma,0
7473,Endobronchial Lesion,Carcinoma ex Eccrine Spiradenoma,0
7474,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Bladder Urothelial Carcinoma,0
7475,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
7476,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Enteropathy-Associated T-Cell Lymphoma,0
7477,White blood cell count increased (lab result),Squamous cell breast carcinoma,0
7478,Absence of Malignant Features,Malignant Intracranial Neoplasm,0
7479,Positive Axillary Lymph Node,Palisaded Lymph Node Myofibroblastoma,0
7480,NRBC - Nucleated red blood cell present result,Small cell lung cancer limited stage,0
7481,Abundance of Small Lymphocytes,Inflammatory carcinoma of breast stage IV,0
7482,Endometrial Type Glands and Stroma Present,Endometrial Adenosquamous Carcinoma,0
7483,Secondary Lesion,Stage IV Urethral Cancer AJCC v8,0
7484,Blasts Under 20 Percent of Peripheral Blood White Cells,Lipoma of spermatic cord,0
7485,Secondary Lesion,Tanycytic ependymoma,0
7486,Melanoma Cells Present,Stage IIIA Cutaneous Melanoma AJCC v7,0
7487,Multihormonal Immunoreactivity Present in a Single Cell Type,Bladder Papillary Clear Cell Adenocarcinoma,0
7488,Endobronchial Lesion,Borderline cystadenoma,0
7489,Tumor Droplets Present,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
7490,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Ameloblastoma,0
7491,Smooth Muscle Component Present,Ovarian cancer stage III,0
7492,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,0
7493,EBV-Positive Neoplastic Cells Present,Stage III Hypopharyngeal Carcinoma AJCC v8,0
7494,Abundance of Small Lymphocytes,Small Intestinal Tubulovillous Adenoma,0
7495,Venous Type Vascular Channel Formation,Recurrent Neurofibromatosis Type 1,0
7496,Secondary Lesion,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified",0
7497,Aggressive Clinical Course,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
7498,EBV-Positive Neoplastic Cells Present,St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8,0
7499,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,0
7500,Smooth Muscle Component Present,Tibial adamantinoma,0
7501,Endobronchial Lesion,Stage IIA Colorectal Cancer AJCC v7,0
7502,EBV-Positive Neoplastic Cells Present,Adult Brain Stem Neoplasm,0
7503,Extensive Stage Lesion,Fallopian Tube Cancer by AJCC v8 Stage,0
7504,Secondary Lesion,Vertebral chordoma,0
7505,Endobronchial Lesion,Borderline Ovarian Endometrioid Cystadenofibroma,0
7506,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Vaginal Cancer by AJCC v7 Stage,0
7507,EBV-Positive Neoplastic Cells Present,Treatment related acute myeloid leukaemia,0
7508,Smooth Muscle Component Present,Myofibromatosis,0
7509,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7,0
7510,Endobronchial Lesion,Sympathetic paraganglioma,0
7511,Recurrent Malignant Neoplasm,Microinvasive Malignant Neoplasm,0
7512,Solid Growth Pattern,Locally Advanced Malignant Solid Neoplasm,0
7513,Microinvasive tumor,Pilar tumor,0
7514,Endobronchial Lesion,Colorectal Kaposi Sarcoma,0
7515,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,0
7516,Extensive Stage Lesion,Stage I Vulvar Cancer,0
7517,Endobronchial Lesion,Duodenal Extraskeletal Osteosarcoma,0
7518,Small Aggregates of Tumor Cells Present,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
7519,Atypical Mitotic Figures,Atypical Mesothelial Hyperplasia,0
7520,EBV-Positive Neoplastic Cells Present,Adult Ependymoma,0
7521,Cervical lymphadenopathy,Locally Advanced Unresectable Cervical Carcinoma,0
7522,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Carcinoma,0
7523,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Pustulosis of Palms and Soles,0
7524,Endobronchial Lesion,"Intracranial Embryonal Tumor, Not Otherwise Specified",0
7525,Abundance of Small Lymphocytes,teratocarcinoma of mediastinum,0
7526,EBV-Positive Neoplastic Cells Present,Stage I Major Salivary Gland Cancer AJCC v8,0
7527,Follicular Cell Differentiation,Breast Columnar Cell Mucinous Carcinoma,0
7528,Malignant Primitive Cellular Infiltrate,Malignant Head and Neck Neoplasm,0
7529,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,0
7530,Blasts Under 20 Percent of Peripheral Blood White Cells,Ampulla of Vater Neuroendocrine Neoplasm,0
7531,Extensive Stage Lesion,Stage IIIA Fallopian Tube Cancer AJCC v8,0
7532,EBV-Positive Neoplastic Cells Present,Breast Epithelioid Hemangioma,0
7533,Secondary Lesion,Mesenteric Lymphadenitis,0
7534,Small Aggregates of Tumor Cells Present,Metastatic Bladder Small Cell Carcinoma,0
7535,Small Aggregates of Tumor Cells Present,Gastric Small Cell Carcinoma,0
7536,EBV-Positive Neoplastic Cells Present,FIGO Stage IIIA2 Ovarian Cancer,0
7537,Follicular Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,0
7538,Endobronchial Lesion,Thyroid Hyalinizing Trabecular Adenoma,0
7539,Endobronchial Lesion,Colonic Polyps,0
7540,Secondary Lesion,Parasite-Related Carcinoma,0
7541,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adenocarcinoma of lung stage IIIA,0
7542,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of stomach stage I,0
7543,Endobronchial Lesion,Broad Ligament Papillary Cystadenoma,0
7544,Extensive Stage Lesion,Stage IIB Appendix Carcinoma AJCC v8,0
7545,Follicular Cell Differentiation,Childhood Pineal Parenchymal Cell Neoplasm,0
7546,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Extragonadal Germ Cell Tumor,0
7547,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,B-Cell Proliferation of Uncertain Malignant Potential,0
7548,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6,0
7549,Endobronchial Lesion,Complex Endometrial Hyperplasia,0
7550,Secondary Lesion,Unresectable Adrenal Gland Pheochromocytoma,0
7551,Smooth Muscle Component Present,Dermatofibrosarcoma Protuberans,0
7552,Endobronchial Lesion,Stage IB2 Cervical Cancer,0
7553,Smooth Muscle Component Present,Seminal Vesicle Adenocarcinoma,0
7554,Small Aggregates of Tumor Cells Present,Laryngeal Carcinoid Tumor,0
7555,EBV-Positive Neoplastic Cells Present,Oncocytic Breast Carcinoma,0
7556,Endobronchial Lesion,Thoracic Esophagus Adenocarcinoma,0
7557,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign epithelial neoplasm of skin,0
7558,EBV-Positive Neoplastic Cells Present,Congenital facial nerve palsy,0
7559,EBV-Positive Neoplastic Cells Present,Clear-Cell Myomelanocytic Tumors,0
7560,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,0
7561,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Inflammatory carcinoma of breast stage III,0
7562,Secondary Lesion,Intracortical osteosarcoma,0
7563,Smooth Muscle Component Present,Childhood Central Nervous System Neuroblastoma,0
7564,Tumor Droplets Present,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,0
7565,Ectopic Thyroid Tissue Present,Thyroid carcinoma,0
7566,Secondary Lesion,"Lymphoma, AIDS-Related",0
7567,White blood cell count increased (lab result),Bladder squamous cell carcinoma stage III,0
7568,Multiple Tumor Masses,Cerebellar and Ventricular Ependymal Tumor,0
7569,Blasts Under 20 Percent of Peripheral Blood White Cells,Kaposi's sarcoma of penis,0
7570,Secondary Lesion,Stage IIB Testicular Cancer AJCC v8,0
7571,Single Cell Necrosis,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,0
7572,Blasts Under 20 Percent of Peripheral Blood White Cells,large cell neuroendocrine carcinoma of thymus,0
7573,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign tumor of penis,0
7574,Intermediate Grade Lesion,Adult Grade II Meningioma,0
7575,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
7576,Secondary Lesion,Anaplastic Medulloblastoma,0
7577,Endobronchial Lesion,Stage I Gallbladder Cancer AJCC v8,0
7578,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Leydig Cell Tumor,0
7579,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Myeloid Leukemia,0
7580,Multiple Tumor Masses,Carcinoid Tumor,0
7581,Endobronchial Lesion,Sparsely Granulated Lactotroph Adenoma,0
7582,Tumor Droplets Present,Hemosiderotic Fibrolipomatous Tumor,0
7583,Smooth Muscle Component Present,Placental Non-Neoplastic Disorder,0
7584,Cutaneous plaque,Pathologic Stage IIB Cutaneous Melanoma AJCC v8,0
7585,Extensive Stage Lesion,Stage 0 Appendix Carcinoma AJCC v7,0
7586,EBV-Positive Neoplastic Cells Present,Metastatic Neuroblastoma,0
7587,Intermediate Grade Neuroendocrine Lesion,Refractory Digestive System Neuroendocrine Neoplasm,0
7588,Fibrous Septa Present,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",0
7589,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIB Testicular Cancer AJCC v6 and v7,0
7590,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Mixed Glioma,0
7591,Endobronchial Lesion,Stage IIIB Primary Peritoneal Cancer AJCC v8,0
7592,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign neoplasm of chest wall,0
7593,EBV-Positive Neoplastic Cells Present,Paratesticular Lipoma,0
7594,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Paranasal Sinus Cancer AJCC v6 and v7,0
7595,EBV-Positive Neoplastic Cells Present,Colon Kaposi Sarcoma,0
7596,Abundance of Small Lymphocytes,Small intestine carcinoma recurrent,0
7597,Follicular Cell Differentiation,Ann Arbor Stage II Contiguous Mantle Cell Lymphoma,0
7598,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Primary Intraosseous Squamous Cell Carcinoma,0
7599,Absence of a Hormonal Syndrome,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7,0
7600,Extensive Stage Lesion,Stage IIIC Vulvar Cancer AJCC v7,0
7601,Malignant Cellular Infiltrate,"Teratoma, Malignant",0
7602,Endobronchial Lesion,Refractory Digestive System Carcinoma,0
7603,Extensive Stage Lesion,Cervical Cancer by AJCC v8 Stage,0
7604,Glandular cell atypia,"Basal cell carcinoma, infundibulocystic",0
7605,Multihormonal Immunoreactivity Present in a Single Cell Type,Vaginal Keratinizing Squamous Cell Carcinoma,0
7606,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Invasive carcinoma of breast,0
7607,Smooth Muscle Component Present,Endobronchial Leiomyoma,0
7608,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7609,Small Aggregates of Tumor Cells Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,0
7610,Numerous Stromal Mast Cells Present,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
7611,Absence of Malignant Features,Malignant neoplasm of brain,0
7612,Blasts Under 20 Percent of Peripheral Blood White Cells,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0
7613,Multihormonal Immunoreactivity Present in a Single Cell Type,Glottic Squamous Cell Carcinoma,0
7614,Smooth Muscle Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,0
7615,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,anaplastic large cell lymphoma of central nervous system,0
7616,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIB Fallopian Tube Cancer AJCC v6 and v7,0
7617,Endobronchial Lesion,Endometrial Undifferentiated Carcinoma,0
7618,Secondary Lesion,Waldenstrom's macroglobulinemia refractory,0
7619,Endobronchial Lesion,Microscopic Thymoma,0
7620,Limited Early T-Cell Differentiation,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",0
7621,Single Cell Necrosis,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,0
7622,EBV-Positive Neoplastic Cells Present,Intraneural perineurioma,0
7623,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of glottis,0
7624,Extensive Stage Lesion,Stage IIIB Gallbladder Cancer AJCC v7,0
7625,Secondary Lesion,Stage II Gallbladder Cancer AJCC v7,0
7626,EBV-Positive Neoplastic Cells Present,Rectosigmoid Adenocarcinoma,0
7627,Endobronchial Lesion,Hard Palate Adenoid Cystic Carcinoma,0
7628,Endobronchial Lesion,Frontal Lobe Anaplastic Astrocytoma,0
7629,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Distal Bile Duct Carcinoma,0
7630,Secondary Lesion,Sclerosing PEComa,0
7631,Solitary Skin Tumor,Thyroid Gland Solitary Fibrous Tumor,0
7632,Plasma cell inflammation,Ovarian germ cell choriocarcinoma stage II,0
7633,Endobronchial Lesion,Colorectal Microvesicular Hyperplastic Polyp,0
7634,Abundance of Small Lymphocytes,Malignant neoplasm of retina,0
7635,Secondary Lesion,Pseudolymphoma,0
7636,Abundance of Small Lymphocytes,Adenocarcinoma of Unknown Primary,0
7637,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of adrenal medulla,0
7638,Endobronchial Lesion,Encapsulated Thymoma,0
7639,Endobronchial Lesion,Liver Leiomyoma,0
7640,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Germ Cell Tumor,0
7641,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage I Cutaneous Melanoma AJCC v8,0
7642,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Central Nervous System Germ Cell Tumor,0
7643,Intestinal metaplasia of gastric mucosa,Early gastric cancer,0
7644,EBV-Positive Neoplastic Cells Present,Microcystic adnexal carcinoma,0
7645,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,0
7646,Secondary Lesion,Stage IIIB Fallopian Tube Cancer AJCC v7,0
7647,Secondary Lesion,Leptomeningeal sarcoma,0
7648,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0 Pancreatic Cancer AJCC v6 and v7,0
7649,Secondary Lesion,Stage IIIB Rectal Cancer AJCC v7,0
7650,Secondary Lesion,Stage I Renal Pelvis Cancer AJCC v7,0
7651,High Grade Non Cartilaginous Sarcomatous Stroma Present,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,0
7652,Secondary Lesion,Prostate Leiomyosarcoma,0
7653,EBV-Positive Neoplastic Cells Present,Stage IV Penile Cancer AJCC v6,0
7654,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Pharynx Carcinoma,0
7655,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Early-Stage Breast Carcinoma,0
7656,Endobronchial Lesion,Adult T-cell lymphoma/leukemia refractory,0
7657,Endobronchial Lesion,Stage IIB Primary Peritoneal Cancer AJCC v8,0
7658,EBV-Positive Neoplastic Cells Present,Adult Meningeal Melanoma,0
7659,High Grade Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",0
7660,Smooth Muscle Component Present,Uterine Corpus Carcinosarcoma,0
7661,Endobronchial Lesion,B-cell small lymphocytic lymphoma stage III,0
7662,Endobronchial Lesion,Cutaneous Liposarcoma,0
7663,Smooth Muscle Component Present,Transplant-Related Kaposi Sarcoma,0
7664,EBV-Positive Neoplastic Cells Present,Blastic Granulocytic Sarcoma,0
7665,EBV-Positive Neoplastic Cells Present,Pure Erythroid Leukemia,0
7666,Abundance of Small Lymphocytes,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7667,EBV-Positive Neoplastic Cells Present,Supraglottic Verrucous Carcinoma,0
7668,EBV-Positive Neoplastic Cells Present,Stage I Cervical Cancer AJCC v8,0
7669,Lesion with Diameter of 10mm or Less,Acute myeloid leukemia with BCR-ABL1,0
7670,Follicular Cell Differentiation,"Chondrosarcoma, Clear Cell",0
7671,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Serous Tumor,0
7672,Endobronchial Lesion,AIDS-Related Anal Non-Hodgkin Lymphoma,0
7673,EBV-Positive Neoplastic Cells Present,Centroblastic lymphoma stage II,0
7674,Large Mass,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
7675,Secondary Lesion,Luteoma,0
7676,Smooth Muscle Component Present,Ethmoid Sinus Schneiderian Papilloma,0
7677,Endobronchial Lesion,Anal Extramucosal (Perianal) Adenocarcinoma,0
7678,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Invasive Ductal and Lobular Carcinoma,0
7679,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Parathyroid Gland Atypical Adenoma,0
7680,Abundance of Small Lymphocytes,Small cell carcinoma of lung,0
7681,Lesion with Diameter of 10mm or Less,adenocarcinoma of breast with squamous metaplasia,0
7682,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,0
7683,Follicular Cell Differentiation,Stage II Childhood Anaplastic Large Cell Lymphoma,0
7684,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Retinoblastoma by AJCC v8 Stage,0
7685,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
7686,Small Aggregates of Tumor Cells Present,Pancreatic Neuroendocrine Tumor G1,0
7687,Absence of Malignant Features,Refractory Malignant Male Reproductive System Neoplasm,0
7688,EBV-Positive Neoplastic Cells Present,Vulvar Superficial Angiomyxoma,0
7689,Blasts Under 20 Percent of Peripheral Blood White Cells,Peripheral T-Cell Lymphoma,0
7690,Follicular Cell Differentiation,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
7691,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Benign neoplasm of the lip,0
7692,Single Cell Necrosis,Metastatic Renal Cell Carcinoma,0
7693,No Evidence of Metastatic Disease,Metastatic Jugulotympanic Paraganglioma,0
7694,Secondary Lesion,Frontal Sinus Schneiderian Papilloma,0
7695,Mammary Gland Type Features Present,Pituitary Gland Macroadenoma,0
7696,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ameloblastic Carcinoma,0
7697,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Breast Inflammatory Myofibroblastic Tumor,0
7698,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Carcinoma in situ of cecum,0
7699,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Endometrial Clear Cell Adenocarcinoma,0
7700,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cervical Adenosquamous Carcinoma,0
7701,EBV-Positive Neoplastic Cells Present,Unresectable Gastroesophageal Junction Adenocarcinoma,0
7702,Absence of Malignant Features,Malignant neoplasm of endocrine gland,0
7703,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Squamous cell carcinoma of lip,0
7704,EBV-Positive Neoplastic Cells Present,Lung Synovial Sarcoma,0
7705,Blasts Under 20 Percent of Peripheral Blood White Cells,squamous cell carcinoma of ovary,0
7706,EBV-Positive Neoplastic Cells Present,"Acanthoma, Pilar Sheath",0
7707,Cutaneous plaque,Clinical Stage II Cutaneous Melanoma AJCC v8,0
7708,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign Ovarian Clear Cell Tumor,0
7709,Mixed Neoplastic Glandular and Squamous Cell Population,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,0
7710,Secondary Lesion,Genital rhabdomyoma,0
7711,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Gastric Soft Tissue Neoplasm,0
7712,Osseous Differentiation,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,0
7713,Smooth Muscle Component Present,Vulvar adenocarcinoma,0
7714,Follicular Cell Differentiation,Stage IIA Merkel Cell Carcinoma AJCC v7,0
7715,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,acute biphenotypic leukemia in relapse,0
7716,Neoplastic Plasma Cells Present in Bone Marrow,Stage IVB Bone Sarcoma AJCC v7,0
7717,Absence of Malignant Features,Malignant melanoma of rectum,0
7718,Smooth Muscle Component Present,Adult Extraskeletal Osteosarcoma,0
7719,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Lip and Oral Cavity Carcinoma,0
7720,Smooth Muscle Component Present,Nodal marginal zone B-cell lymphoma stage I,0
7721,Abundance of Small Lymphocytes,Pyogenic granuloma of oral mucosa,0
7722,Malignant Primitive Cellular Infiltrate,Vulvar Cellular Angiofibroma,0
7723,Humoral hypercalcemia of malignancy (disorder),"Papillary mucinous cystadenoma, borderline malignancy",0
7724,Localized Hydropic Villous Change,Localized Unresectable Adult Hepatocellular Carcinoma,0
7725,Indolent Clinical Course,Hodgkin Lymphoma by Clinical Course,0
7726,No Evidence of Metastatic Disease,Metastatic Vaginal Carcinoma,0
7727,Abundance of Small Lymphocytes,Malignant tumor of orbit,0
7728,Extensive Stage Lesion,Stage I Appendix Carcinoma AJCC v7,0
7729,Endobronchial Lesion,Stage IVB Thymoma AJCC v8,0
7730,Smooth Muscle Component Present,Acoustic Neuroma,0
7731,Secondary Lesion,Splenic marginal zone lymphoma refractory,0
7732,Secondary Lesion,Vestibular Micropapillomatosis,0
7733,Breast Implant-Related Lesion,Central Breast Papilloma,0
7734,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIC Appendix Carcinoma AJCC v8,0
7735,Endobronchial Lesion,Stage IV Primary Peritoneal Cancer AJCC v8,0
7736,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Colon Cancer by AJCC v8 Stage,0
7737,EBV-Positive Neoplastic Cells Present,Stage IIIA Lung Cancer AJCC v8,0
7738,Abundance of Small Lymphocytes,Carcinoma of sublingual gland,0
7739,Nodular and Diffuse Pattern,Nodular Sclerosis Classical Hodgkin Lymphoma,0
7740,EBV-Positive Neoplastic Cells Present,Multiple Myeloma,0
7741,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adenocarcinoma in villous adenoma,0
7742,Malignant Primitive Cellular Infiltrate,Malignant Sebaceous Neoplasm,0
7743,Cutaneous plaque,Stage II Cutaneous Melanoma AJCC v6 and v7,0
7744,Large Neoplastic Glands with Branching and Papillary Infolding Present,MCD Diffuse Large B-Cell Lymphoma,0
7745,Absence of Malignant Features,Malignant Accessory Urethral Gland Neoplasm,0
7746,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Kaposi Sarcoma Related to Immunosuppressive Treatment,0
7747,Nodular and Diffuse Pattern,Colon Diffuse Large B-Cell Lymphoma,0
7748,Secondary Lesion,Gallbladder Carcinoma,0
7749,Moderately Differentiated Lesion,Poorly Differentiated Thyroid Carcinoma,0
7750,Endobronchial Lesion,Primary Carcinoma Unspecified Site,0
7751,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Inverting papilloma of the paranasal sinus,0
7752,Endobronchial Lesion,Anal cancer metastatic,0
7753,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIB Testicular Cancer AJCC v6 and v7,0
7754,EBV-Positive Neoplastic Cells Present,Hepatosplenic T-cell lymphoma,0
7755,Secondary Lesion,Stage I Adult Hodgkin Lymphoma,0
7756,Smooth Muscle Component Present,Hyperacute allograft rejection,0
7757,Blasts Under 20 Percent of Peripheral Blood White Cells,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,0
7758,Small Aggregates of Tumor Cells Present,Ovarian Wilms Tumor,0
7759,Endobronchial Lesion,Complex Endometrial Hyperplasia,0
7760,Mucinous degeneration,Ovarian Mucinous Cystadenofibroma,0
7761,EBV-Positive Neoplastic Cells Present,Cervical Leiomyoma,0
7762,Small Aggregates of Tumor Cells Present,Dedifferentiated Solitary Fibrous Tumor,0
7763,Multihormonal Immunoreactivity Present in a Single Cell Type,Rectosigmoid Signet Ring Cell Carcinoma,0
7764,Endobronchial Lesion,Duodenal Adenoma,0
7765,Blasts Under 20 Percent of Peripheral Blood White Cells,Monoclonal Gammopathy of Renal Significance,0
7766,EBV-Positive Neoplastic Cells Present,Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8,0
7767,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Primary malignant neoplasm of brain,0
7768,Primitive Mesenchymal Stroma Formation,Adult Mesenchymal Chondrosarcoma,0
7769,Secondary Lesion,St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8,0
7770,Secondary Lesion,Choroid Plexus Carcinoma,0
7771,Abundance of Small Lymphocytes,atypical medullary carcinoma of breast,0
7772,NRBC - Nucleated red blood cell present result,"Squamous cell carcinoma, keratinizing",0
7773,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7774,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Dermoid Cyst of the Spinal Cord,0
7775,EBV-Positive Neoplastic Cells Present,Neoplastic Polyp,0
7776,Endobronchial Lesion,Infratentorial Glioblastoma,0
7777,EBV-Positive Neoplastic Cells Present,Colon Intramucosal Adenocarcinoma,0
7778,Absence of Malignant Features,Malignant neoplasm of large intestine,0
7779,EBV-Positive Neoplastic Cells Present,Orbital lymphoma,0
7780,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Inflammatory pseudotumor of liver,0
7781,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Sarcomatoid Renal Cell Carcinoma,0
7782,Low Grade Cartilaginous Component Present,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,0
7783,Secondary Lesion,Endolymphatic sac tumor,0
7784,EBV-Positive Neoplastic Cells Present,Esophageal adenocarcinoma recurrent,0
7785,Secondary Lesion,Vulvar Fibrolipoma,0
7786,Endobronchial Lesion,Digestive System Hemangioma,0
7787,Lesion with Diameter of 4mm or More,Myeloid Neoplasms with Germline ANKRD26 Mutation,0
7788,Secondary Lesion,Esophageal Leiomyosarcoma,0
7789,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma,0
7790,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Esophageal Squamous Cell Carcinoma AJCC v7,0
7791,EBV-Positive Neoplastic Cells Present,"Nevus, Blue",0
7792,EBV-Positive Neoplastic Cells Present,Stage III Retroperitoneal Sarcoma AJCC v8,0
7793,No Evidence of Metastatic Disease,Metastatic melanoma,0
7794,Secondary Lesion,Stage I Uterine Corpus Adenosarcoma AJCC v8,0
7795,Endobronchial Lesion,Lymphatic Vessel Tumors,0
7796,Malignant Primitive Cellular Infiltrate,Secondary Malignant Neoplasm,0
7797,Abundance of Small Lymphocytes,Vulvar Adenocarcinoma of Sweat Gland Type,0
7798,EBV-Positive Neoplastic Cells Present,Focal glomerulosclerosis,0
7799,Plasma cell inflammation,Basaloid squamous cell carcinoma,0
7800,Endobronchial Lesion,Circumscribed storiform collagenoma,0
7801,Epithelioid Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
7802,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Splenic Manifestation of T-Cell Prolymphocytic Leukemia,0
7803,Prominent Stromal Reaction,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
7804,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Benign Peritoneal and Retroperitoneal Neoplasm,0
7805,Blasts Under 20 Percent of Peripheral Blood White Cells,rhabdomyosarcoma of testis,0
7806,Mixed Neoplastic Glandular and Squamous Cell Population,Malignant Head and Neck Neoplasm,0
7807,Secondary Lesion,Childhood Colorectal Carcinoma,0
7808,Small Aggregates of Tumor Cells Present,Stage IVA Gestational Trophoblastic Tumor AJCC v7,0
7809,Acute inflammation,Childhood Acute Basophilic Leukemia,0
7810,Endobronchial Lesion,"Carcinoma, Cribriform",0
7811,Recurrent Malignant Neoplasm,Recurrent Malignant Female Reproductive System Neoplasm,0
7812,EBV-Positive Neoplastic Cells Present,Breast Capillary Hemangioma,0
7813,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Colon Carcinoma Metastatic in the Lung,0
7814,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Distal Urethral Carcinoma,0
7815,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Borderline Fallopian Tube Mucinous Tumor,0
7816,Mesenchymal Metaplasia of Malignant Cells Present,Malignant melanoma of vulva,0
7817,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of sternum,0
7818,Cervical lymphadenopathy,Stage IA2 Cervical Cancer,0
7819,Endobronchial Lesion,Childhood Brain Germinoma,0
7820,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Benign Peripheral Nerve Granular Cell Tumor,0
7821,Recurrent Genetic Abnormalities Present,Recurrent Testicular Lymphoma,0
7822,Endobronchial Lesion,Benign Adult Cerebellar Neoplasm,0
7823,EBV-Positive Neoplastic Cells Present,Simple Endometrial Hyperplasia without Atypia,0
7824,Secondary Lesion,"Lymphoma, AIDS-Related",0
7825,Recurrent Genetic Abnormalities Present,Recurrent Childhood Anaplastic Oligoastrocytoma,0
7826,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Childhood Anaplastic Large Cell Lymphoma,0
7827,Endobronchial Lesion,Adenoma,0
7828,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Ampulla of Vater Tubulovillous Adenoma,0
7829,Endobronchial Lesion,Extracutaneous Mastocytoma,0
7830,Primary Site Unknown,Stage IV Primary Peritoneal Cancer AJCC v7,0
7831,Acute inflammation,Acute monoblastic leukemia,0
7832,High Grade Lesion,Grade II Prostatic Intraepithelial Neoplasia,0
7833,Multihormonal Immunoreactivity Present in a Single Cell Type,Refractory Lung Small Cell Carcinoma,0
7834,Single Cell Necrosis,Cervical Large Cell Neuroendocrine Carcinoma,0
7835,Lesion with Diameter of 4mm or More,Myeloid/Lymphoid Neoplasms with PCM1-JAK2,0
7836,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Esophageal Spindle Cell Carcinoma,0
7837,Large Mass,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
7838,Endobronchial Lesion,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7839,Absence of Malignant Features,Malignant tumor of renal pelvis,0
7840,Secondary Lesion,B-cell small lymphocytic lymphoma refractory,0
7841,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Squamous Cell Carcinoma,0
7842,Endobronchial Lesion,Ossifying Fibroma,0
7843,Extensive Stage Lesion,Stage IIC Colorectal Cancer AJCC v8,0
7844,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,0
7845,Recurrent Malignant Neoplasm,Recurrent Central Nervous System Non-Hodgkin Lymphoma,0
7846,Extensive Stage Lesion,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,0
7847,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
7848,Secondary Lesion,Cervical Angiosarcoma,0
7849,Epithelioid Differentiation,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,0
7850,Mammary Gland Type Features Present,Parotid Gland Sarcoma,0
7851,Mixed Neoplastic Glandular and Squamous Cell Population,Pancreatic Mixed Adenoneuroendocrine Carcinoma,0
7852,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Recurrent tumors of the Ewing's family,0
7853,Secondary Lesion,Stage IV Gallbladder Cancer AJCC v6,0
7854,Extensive Stage Lesion,Stage IIA2 Cervical Cancer AJCC v8,0
7855,Lesion with Diameter of 4mm or More,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
7856,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Bladder Cancer AJCC v6 and v7,0
7857,Secondary Lesion,Dysgerminoma,0
7858,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,T-Cell Lymphoma,0
7859,Tumor Droplets Present,Stage III Jejunal Neuroendocrine Tumor AJCC v8,0
7860,Well Differentiated Neuroendocrine Lesion,Liver Neuroendocrine Neoplasm,0
7861,EBV-Positive Neoplastic Cells Present,Cholangiocarcinoma metastatic,0
7862,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage I Immature Testicular Teratoma AJCC v6 and v7,0
7863,Endobronchial Lesion,Stage II Non-Hodgkin Lymphoma,0
7864,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Undifferentiated carcinoma of stomach,0
7865,Smooth Muscle Component Present,Laryngeal Leiomyoma,0
7866,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Fallopian Tube Squamous Cell Carcinoma,0
7867,Blasts Under 20 Percent of Peripheral Blood White Cells,Polyp of large intestine,0
7868,No Evidence of Metastatic Disease,Metastatic Digestive System Carcinoma,0
7869,Absence of Malignant Features,Malignant Ovarian Teratoma,0
7870,Blasts Under 20 Percent of Peripheral Blood White Cells,Sarcoma of soft tissue,0
7871,White blood cell count increased (lab result),"Papillary transitional cell carcinoma, non-invasive",0
7872,Endobronchial Lesion,Stage IVA Ovarian Cancer AJCC v8,0
7873,Malignant Primitive Cellular Infiltrate,"Peripheral Nerve Neoplasms, Malignant",0
7874,Multihormonal Immunoreactivity Present in a Single Cell Type,Intraepithelial Squamous Cell Carcinoma,0
7875,Abundance of Small Lymphocytes,Secondary malignant neoplasm of axilla,0
7876,Absence of a Hormonal Syndrome,Brown-Vialetto-Van Laere Syndrome 1,0
7877,Endobronchial Lesion,Stage IIB Cervical Cancer AJCC v8,0
7878,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thymic Carcinoma,0
7879,EBV-Positive Neoplastic Cells Present,Unresectable Gastric Adenocarcinoma,0
7880,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Classic Variant of Chromophobe Renal Cell Carcinoma,0
7881,Smooth Muscle Component Present,Urothelial carcinoma ureter metastatic,0
7882,Endobronchial Lesion,Stage I Appendix Carcinoma AJCC v8,0
7883,Endobronchial Lesion,Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8,0
7884,Blasts Under 20 Percent of Peripheral Blood White Cells,Polymorphous low grade adenocarcinoma of salivary gland,0
7885,Prominent Elastic Tissue Cores Present,Stage IB Adult Soft Tissue Sarcoma AJCC v7,0
7886,High Grade Lesion,High Grade Conjunctival Intraepithelial Neoplasia,0
7887,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Metastatic Malignant Neoplasm to the Cervix,0
7888,Small Aggregates of Tumor Cells Present,Fibroid Tumor,0
7889,Finding related to pregnancy,Enteritis due to radiation,0
7890,Secondary Lesion,Serous adenofibroma,0
7891,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",0
7892,Malignant Primitive Cellular Infiltrate,Malignant mastocytosis,0
7893,Smooth Muscle Component Present,Vulvar Fibrolipoma,0
7894,Endobronchial Lesion,Colorectal Carcinoma,0
7895,EBV-Positive Neoplastic Cells Present,Refractory HIV-Associated Lymphoproliferative Disorder,0
7896,Abundance of Small Lymphocytes,Verrucous carcinoma of penis,0
7897,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7898,1p/19q Codeletion Status Unknown,"Neoplasms, Unknown Primary",0
7899,Endobronchial Lesion,B-cell lymphoma refractory,0
7900,EBV-Positive Neoplastic Cells Present,Impetigo,0
7901,Endobronchial Lesion,Sclerosing thymoma,0
7902,Secondary Lesion,Pyogenic granuloma,0
7903,Endobronchial Lesion,Left atrial myxoma,0
7904,Extensive Stage Lesion,Stage IVA Nasopharyngeal Carcinoma AJCC v7,0
7905,Endobronchial Lesion,Pigmented villonodular synovitis,0
7906,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIC Cutaneous Melanoma AJCC v6 and v7,0
7907,Folliculotropic Lymphocytic Infiltrate,Adult Acute Lymphocytic Leukemia,0
7908,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage I Testicular Cancer AJCC v6 and v7,0
7909,Microinvasive tumor,Plexiform fibrohistiocytic tumor,0
7910,EBV-Positive Neoplastic Cells Present,Mucinous adenofibroma,0
7911,Recurrent Genetic Abnormalities Present,Recurrent Ovarian Carcinosarcoma,0
7912,Smooth Muscle Component Present,Superior Vena Cava Angiosarcoma,0
7913,EBV-Positive Neoplastic Cells Present,Dedifferentiated chondrosarcoma,0
7914,Negative Peripheral Blood,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
7915,EBV-Positive Neoplastic Cells Present,Adult Meningeal Melanoma,0
7916,EBV-Positive Neoplastic Cells Present,Thymic Papillary Adenocarcinoma,0
7917,Diffuse Immunoblastic Proliferation,Stage II Adult Immunoblastic Lymphoma,0
7918,Well Differentiated Hyaline Cartilage Present,Well Differentiated Pancreatic Endocrine Tumor,0
7919,Secondary Lesion,Fundic gland polyp,0
7920,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Metastases to adrenals,0
7921,EBV-Positive Neoplastic Cells Present,Warty dyskeratoma,0
7922,EBV-Positive Neoplastic Cells Present,Stage II Colon Cancer AJCC v8,0
7923,EBV-Positive Neoplastic Cells Present,Adult Brain Stem Neoplasm,0
7924,Vacuolated Plasma Cells in the Bone Marrow,Colorectal Carcinoma Metastatic in the Lung,0
7925,Extensive Stage Lesion,Stage IVB Rectal Cancer AJCC v7,0
7926,Monoclonal Myeloid or Lymphoid Cells Present,Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7927,EBV-Positive Neoplastic Cells Present,Stage II Uterine Corpus Leiomyosarcoma AJCC v8,0
7928,Follicular Cell Differentiation,Ann Arbor Stage I Grade 2 Follicular Lymphoma,0
7929,Endobronchial Lesion,Stage III Uterine Corpus Adenosarcoma AJCC v8,0
7930,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,0
7931,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of gallbladder,0
7932,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0
7933,EBV-Positive Neoplastic Cells Present,Hormone-Resistant Prostate Carcinoma,0
7934,Secondary Lesion,alopecia congenita,0
7935,EBV-Positive Neoplastic Cells Present,Primary leiomyosarcoma,0
7936,Smooth Muscle Component Present,Classic medulloblastoma,0
7937,Atypical Mitotic Figures,Atypical Mesothelial Hyperplasia,0
7938,Blasts Under 20 Percent of Peripheral Blood White Cells,keratinizing squamous cell carcinoma of lung,0
7939,Tumor Droplets Present,Cerebellar and Fourth Ventricle Ependymal Tumor,0
7940,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Cervical Cancer AJCC v6 and v7,0
7941,Follicular Cell Differentiation,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,0
7942,EBV-Positive Neoplastic Cells Present,Posterior Tongue Adenoid Cystic Carcinoma,0
7943,EBV-Positive Neoplastic Cells Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,0
7944,Antoni A Pattern,"Spindle cell melanoma, type A",0
7945,Extensive Stage Lesion,Stage IIIC Uterine Sarcoma AJCC v7,0
7946,Endobronchial Lesion,Pineal Region Choriocarcinoma,0
7947,Recurrent Malignant Neoplasm,Recurrent Appendix Carcinoma,0
7948,Tumor Droplets Present,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7949,EBV-Positive Neoplastic Cells Present,Stage IIB Cervical Cancer AJCC v8,0
7950,Blasts Under 20 Percent of Peripheral Blood White Cells,rhabdomyosarcoma of extrahepatic bile duct,0
7951,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Anal Canal Cancer by AJCC v6 and v7 Stage,0
7952,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of testis,0
7953,Skin nodule,Stage IV Skin Cancer,0
7954,Melanoma Cells Present,Uveal Melanoma by AJCC v7 Stage,0
7955,Secondary Lesion,Fibrolamellar Hepatocellular Carcinoma,0
7956,Endobronchial Lesion,Hereditary Ovarian Carcinoma,0
7957,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,0
7958,Endobronchial Lesion,Vulvar Superficial Myofibroblastoma,0
7959,Endobronchial Lesion,Unresectable Gastroesophageal Junction Adenocarcinoma,0
7960,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
7961,Tumor Droplets Present,Ovarian Dermoid Cyst with Secondary Tumor,0
7962,Extensive Stage Lesion,Stage IB Esophageal Cancer AJCC v7,0
7963,No Evidence of Metastatic Disease,Metastatic Oropharyngeal Carcinoma,0
7964,Ganglioneuroma Component Present,Colorectal Ganglioneuroma,0
7965,Endobronchial Lesion,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,0
7966,Glandular cell atypia,Fibroblastic reticular cell tumor,0
7967,Blasts Under 20 Percent of Peripheral Blood White Cells,Scirrhous carcinoma of breast,0
7968,Secondary Lesion,Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8,0
7969,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Head and Neck Carcinoma,0
7970,Single Cell Necrosis,Myxoid/Round Cell Liposarcoma,0
7971,EBV-Positive Neoplastic Cells Present,Ependymoblastoma,0
7972,Secondary Lesion,Stage IVC Colon Cancer AJCC v8,0
7973,Blasts Under 20 Percent of Peripheral Blood White Cells,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
7974,Abundance of Small Lymphocytes,Acrokeratosis Verruciformis of Hopf,0
7975,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cholangiolocellular Carcinoma,0
7976,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Lung Cancer by AJCC v6 Stage,0
7977,Nodular and Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
7978,Endobronchial Lesion,Stage III Adult Liver Cancer AJCC v7,0
7979,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Warty Carcinoma of the Penis,0
7980,Blasts Under 20 Percent of Peripheral Blood White Cells,ganglioneuroblastoma of mediastinum,0
7981,Fibrotic Stroma with Finger-Like Projections Present,Adenocarcinoma with cartilaginous and osseous metaplasia,0
7982,Squamous metaplasia of bladder,Perianal Squamous Intraepithelial Neoplasia,0
7983,Tumor Droplets Present,Stage IIIB Gestational Trophoblastic Tumor AJCC v7,0
7984,Melanoma Cells Present,Metastatic Non-Cutaneous Melanoma,0
7985,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adenoid cystic carcinoma of parotid gland,0
7986,Small Aggregates of Tumor Cells Present,Stage II Gastric Neuroendocrine Tumor AJCC v8,0
7987,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of sublingual gland,0
7988,Smooth Muscle Component Present,Scleromyxedema,0
7989,Lesion with Diameter of 4mm or More,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0
7990,Blasts Under 20 Percent of Peripheral Blood White Cells,Polyp of vulva,0
7991,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Metastatic Squamous Cell Carcinoma of the Larynx,0
7992,Recurrent Genetic Abnormalities Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,0
7993,Endobronchial Lesion,Stage IVA Vulvar Cancer AJCC v6,0
7994,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Ampulla of Vater Adenosquamous Carcinoma,0
7995,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,0
7996,Lesion with Diameter of 10mm or Less,Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement,0
7997,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Stage I Superficial Spreading Melanoma AJCC v7,0
7998,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
7999,Blasts Under 20 Percent of Peripheral Blood White Cells,lipoma of bone,0
8000,Windblown Appearance of Atypical Keratinocytes,Atypical polypoid adenomyoma,0
8001,Well Developed Rough Endoplasmic Reticulum Present,Well Differentiated Prostate Adenocarcinoma,0
8002,EBV-Positive Neoplastic Cells Present,Childhood Conventional Osteosarcoma,0
8003,Endobronchial Lesion,Stage I Eyelid Carcinoma AJCC v8,0
8004,EBV-Positive Neoplastic Cells Present,"Carcinoma, Spindle-Cell",0
8005,Endobronchial Lesion,Regressing nevus,0
8006,Multinodular and Vacuolated Pattern,Stage IB Pancreatic Cancer AJCC v6 and v7,0
8007,EBV-Positive Neoplastic Cells Present,Chest Wall Sarcoma,0
8008,Secondary Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,0
8009,Secondary Lesion,Stage IV Colon Cancer AJCC v8,0
8010,Endobronchial Lesion,Stage IIIC Esophageal Cancer AJCC v7,0
8011,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Vaginal Cancer by AJCC v7 Stage,0
8012,Endobronchial Lesion,Pancreatic carcinoma recurrent,0
8013,Endobronchial Lesion,Refractory Melanoma,0
8014,EBV-Positive Neoplastic Cells Present,Mixed epithelial-mesenchymal hepatoblastoma,0
8015,Large Mass,Large Bowel Juvenile Polyp,0
8016,Tumor Droplets Present,Thymic Typical Carcinoid Tumor,0
8017,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,follicular lymphoma of spleen,0
8018,Mammary Gland Type Features Present,Metastatic Salivary Gland Carcinoma,0
8019,Lesion with Diameter of 4mm or More,Adenocarcinoma with apocrine metaplasia,0
8020,Extensive Stage Lesion,Stage IIIB Testicular Cancer AJCC v8,0
8021,Nodular and Diffuse Pattern,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8022,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,External Ear Squamous Cell Carcinoma,0
8023,Multinodular and Vacuolated Pattern,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,0
8024,Low Grade Cartilaginous Component Present,Low Grade Squamous Intraepithelial Neoplasia,0
8025,Smooth Muscle Component Present,Benign Meningioma,0
8026,Absence of a Hormonal Syndrome,Familial Atypical Mole Melanoma Syndrome,0
8027,Non-Encapsulated Neoplasm,Benign Childhood Supratentorial Neoplasm,0
8028,Endobronchial Lesion,Seminal Vesicle Cystadenoma,0
8029,Tissues Derived from Two or Three Embryonic Layers Present,Tumors Derived from Langerhans Cells,0
8030,No Evidence of Metastatic Disease,Metastatic Carcinoma,0
8031,Recurrent Malignant Neoplasm,Esophageal Neuroendocrine Neoplasm,0
8032,Non-Encapsulated Neoplasm,Papillary Urothelial Neoplasm,0
8033,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
8034,Recurrent Malignant Neoplasm,Malignant Uterine Ligament Neoplasm,0
8035,Endobronchial Lesion,Vulvar Alveolar Soft Part Sarcoma,0
8036,Absence of Malignant Features,Malignant neoplasm of prostate,0
8037,Primary Site Unknown,Primary Cutaneous Meningioma,0
8038,Smooth Muscle Component Present,Bronchioloalveolar Adenocarcinoma,0
8039,Islands of Odontogenic Epithelium Present,Odontogenic myxoma,0
8040,Gastrointestinal Type Epithelium Present,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0
8041,Ectopic Thyroid Tissue Present,Thyroid Gland Schwannoma,0
8042,Endobronchial Lesion,Esophageal carcinoma recurrent,0
8043,Extensive Stage Lesion,Stage IB Vulvar Carcinoma AJCC v6,0
8044,Endobronchial Lesion,Lymphadenopathic Kaposi Sarcoma,0
8045,Endobronchial Lesion,Hormone secreting pituitary neoplasms,0
8046,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Acute myeloid leukemia with BCR-ABL1,0
8047,Recurrent Malignant Neoplasm,Malignant Vulvar Sweat Gland Neoplasm,0
8048,Endobronchial Lesion,Pilosebaceous Hamartoma,0
8049,Large Neoplastic Glands with Branching and Papillary Infolding Present,Anal Papillary Hidradenoma,0
8050,Recurrent Genetic Abnormalities Present,Recurrent Childhood Visual Pathway Glioma,0
8051,Extensive Stage Lesion,Masaoka-Koga Stage IVa,0
8052,Endobronchial Lesion,Prostatic Intraepithelial Neoplasias,0
8053,EBV-Positive Neoplastic Cells Present,Stage IV Colorectal Cancer AJCC v7,0
8054,EBV-Positive Neoplastic Cells Present,"Xeroderma pigmentosum, group B",0
8055,Small Aggregates of Tumor Cells Present,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0
8056,Small Aggregates of Tumor Cells Present,Breast Phyllodes Tumor,0
8057,Secondary Lesion,Pityriasis Rosea,0
8058,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,choriocarcinoma of mediastinum,0
8059,Endobronchial Lesion,Mediastinal Extraskeletal Osteosarcoma,0
8060,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,adenoma of intrahepatic bile duct,0
8061,Blasts Under 5 Percent of Peripheral Blood White Cells,Hemangioma of Peripheral Nerve,0
8062,Secondary Lesion,Testicular yolk sac tumor stage I,0
8063,Endobronchial Lesion,Renal Vein Leiomyosarcoma,0
8064,Schwannian Stroma Predominant Component of the Tumor Volume,Stromal Predominant Kidney Wilms Tumor,0
8065,Follicular Cell Differentiation,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma,0
8066,Endobronchial Lesion,Pericanalicular fibroadenoma,0
8067,Secondary Lesion,Cerebellopontine Angle Schwannoma,0
8068,High Grade Lesion,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
8069,EBV-Positive Neoplastic Cells Present,Extra-osseous Ewing's sarcoma recurrent,0
8070,EBV-Positive Neoplastic Cells Present,Stage 0 Hilar Cholangiocarcinoma AJCC v7,0
8071,Small Aggregates of Tumor Cells Present,Stage I Jejunal Neuroendocrine Tumor AJCC v8,0
8072,Smooth Muscle Component Present,Sellar Ependymoma,0
8073,Mammary Gland Type Features Present,Major Salivary Gland Carcinoma,0
8074,Multihormonal Immunoreactivity Present in a Single Cell Type,Small Cell Undifferentiated Hepatoblastoma,0
8075,Mixed Neoplastic Glandular and Squamous Cell Population,Postcricoid Squamous Cell Carcinoma,0
8076,Limited Early T-Cell Differentiation,Acute Adult T-Cell Leukemia/Lymphoma,0
8077,EBV-Positive Neoplastic Cells Present,Locally Advanced Sarcoma,0
8078,Endobronchial Lesion,Pancreatic Intraepithelial Neoplasia-1,0
8079,Smooth Muscle Component Present,Rectosigmoid Adenocarcinoma,0
8080,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Stage IIB Distal Bile Duct Cancer AJCC v8,0
8081,Endobronchial Lesion,Pigmented villonodular synovitis,0
8082,Squamous metaplasia of bladder,Squamous odontogenic tumor,0
8083,Smooth Muscle Component Present,Adult Central Nervous System Germinoma,0
8084,Venous Type Vascular Channel Formation,"Castleman Disease, Hyaline-Vascular Type",0
8085,Endobronchial Lesion,Bladder Papillary Urothelial Carcinoma,0
8086,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,0
8087,Small Aggregates of Tumor Cells Present,Krukenberg Tumor,0
8088,Smooth Muscle Component Present,Schneiderian carcinoma,0
8089,Endobronchial Lesion,Juxtaglomerular tumor,0
8090,Secondary Lesion,Ovarian Surface Papilloma,0
8091,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,0
8092,Extensive Stage Lesion,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
8093,Endobronchial Lesion,Platinum-Resistant Primary Peritoneal Carcinoma,0
8094,Epithelial hyperplasia of skin,Ganglioneuroma of skin,0
8095,Endobronchial Lesion,Lymphohistiocytoid Mesothelioma,0
8096,Blasts Under 20 Percent of Peripheral Blood White Cells,Squamous cell carcinoma of oropharynx,0
8097,NRBC - Nucleated red blood cell present result,"Spindle cell melanoma, type A",0
8098,Endobronchial Lesion,"Thrombocythemia, Essential",0
8099,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,0
8100,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thyroid Gland Mucinous Carcinoma,0
8101,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Recurrent Ependymal Tumor,0
8102,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Stage IV Bone Sarcoma AJCC v7,0
8103,EBV-Positive Neoplastic Cells Present,Extranodal marginal zone B-cell lymphoma (MALT type) refractory,0
8104,Secondary Lesion,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
8105,Well Differentiated Neuroendocrine Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma,0
8106,Large Neoplastic Glands with Branching and Papillary Infolding Present,Papillary Lung Adenocarcinoma,0
8107,Squamous metaplasia,Squamous Lung Dysplasia,0
8108,Prominent Stromal Reaction,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
8109,Monoclonal Myeloid or Lymphoid Cells Present,Colon Mucosa-Associated Lymphoid Tissue Lymphoma,0
8110,EBV-Positive Neoplastic Cells Present,Acute humoral allograft nephropathy,0
8111,Endobronchial Lesion,Stage IC Uterine Corpus Adenosarcoma AJCC v8,0
8112,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Squamous cell carcinoma of the hypopharynx recurrent,0
8113,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0
8114,Recurrent Malignant Neoplasm,Anterior Urethral Malignant Neoplasm,0
8115,Endobronchial Lesion,Sarcomatosis,0
8116,Mild dysplasia of colon,Colorectal Adenoma with Mild Dysplasia,0
8117,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Anaplastic Large Cell Lymphoma,0
8118,Endobronchial Lesion,Recurrent Ovarian Cystadenocarcinoma,0
8119,Malignant Primitive Cellular Infiltrate,Malignant Pulmonary Vein Neoplasm,0
8120,Multiple Tumor Masses,Multiple Endocrine Neoplasia Type 2a,0
8121,Endobronchial Lesion,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,0
8122,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,0
8123,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,0
8124,Single Cell Necrosis,Adult Pineal Parenchymal Cell Neoplasm,0
8125,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Primary Peritoneal Carcinoma,0
8126,Endobronchial Lesion,Burkitt Leukemia,0
8127,Solid Growth Pattern,"Testicular Yolk Sac Tumor, Papillary Pattern",0
8128,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,0
8129,Ectopic Thyroid Tissue Present,Vulvar Ectopic Fibroadenoma,0
8130,Ganglioneuroma Component Present,Colon Ganglioneuroma,0
8131,Single Cell Necrosis,Stage II Renal Cell Cancer AJCC v8,0
8132,Extensive Stage Lesion,Stage I Acral Lentiginous Melanoma AJCC v7,0
8133,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Epithelioid hemangioma of skin,0
8134,Secondary Lesion,Lymphoepithelioid lymphoma (clinical),0
8135,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Pericytic Neoplasm,0
8136,Endobronchial Lesion,Stage IIA Uterine Sarcoma AJCC v7,0
8137,Early Stromal Invasion Present,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
8138,Secondary Lesion,Adrenal neuroblastoma,0
8139,High Grade Lesion,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,0
8140,Abundance of Small Lymphocytes,Secondary malignant neoplasm of bone,0
8141,Lesion with Diameter of 4mm or More,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,0
8142,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Tubal Epithelial Hyperplasia,0
8143,Follicular Cell Differentiation,Ann Arbor Stage I Follicular Lymphoma,0
8144,Blasts Under 20 Percent of Peripheral Blood White Cells,Ampulla of Vater Tubulovillous Adenoma,0
8145,Endobronchial Lesion,Thyroid Gland Hemangioma,0
8146,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Extraocular Cutaneous Sebaceous Carcinoma,0
8147,Secondary Lesion,Trigeminal schwannoma,0
8148,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Secondary malignant neoplasm of parathyroid gland,0
8149,White blood cell count increased (lab result),Metastatic signet ring cell carcinoma,0
8150,Recurrent Malignant Neoplasm,Childhood Hematopoietic Neoplasm,0
8151,Diffuse Cellular Infiltrate,Adult Diffuse Astrocytoma,0
8152,EBV-Positive Neoplastic Cells Present,Pure Erythroid Leukemia,0
8153,Numerous Stromal Mast Cells Present,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
8154,Abundance of Small Lymphocytes,cloacogenic carcinoma of rectum,0
8155,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,0
8156,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gastric Mixed Adenoneuroendocrine Carcinoma,0
8157,Glandular cell atypia,Bile duct clear cell adenocarcinoma,0
8158,Smooth Muscle Component Present,Gliofibroma,0
8159,Arborising Network of Cords of Basaloid Cells Present,Basaloid carcinoma,0
8160,Secondary Lesion,Childhood Liposarcoma,0
8161,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Lip and Oral Cavity Carcinoma,0
8162,Abundance of Small Lymphocytes,small cell carcinoma of appendix,0
8163,EBV-Positive Neoplastic Cells Present,Stage IIIB Uterine Sarcoma AJCC v7,0
8164,Large Mass,Central Nervous System Intravascular Large B-Cell Lymphoma,0
8165,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
8166,Plasma cell inflammation,Infiltrating basal cell carcinoma,0
8167,Secondary Lesion,Testicular Thecoma,0
8168,Endobronchial Lesion,Choriocarcinoma,0
8169,Blasts Under 20 Percent of Peripheral Blood White Cells,Hemangioma of bone,0
8170,Nodular and Diffuse Pattern,Stage IV Diffuse Large B-Cell Lymphoma,0
8171,EBV-Positive Neoplastic Cells Present,Extraskeletal Myxoid Chondrosarcoma,0
8172,Small Aggregates of Tumor Cells Present,Borderline Ovarian Transitional Cell Tumor,0
8173,Multiple Tumor Masses,Borderline Ovarian Mucinous Tumor,0
8174,Endobronchial Lesion,Stage II Adult Hodgkin Lymphoma,0
8175,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of cervical part of esophagus,0
8176,Endobronchial Lesion,Benign Ovarian Thecoma,0
8177,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Acute Lymphoblastic Leukemia by Gene Expression Profile,0
8178,Endobronchial Lesion,Stage IVA Hilar Cholangiocarcinoma AJCC v7,0
8179,Absence of Malignant Features,Malignant Head and Neck Neoplasm,0
8180,EBV-Positive Neoplastic Cells Present,Thymic Sarcomatoid Carcinoma,0
8181,NRBC - Nucleated red blood cell present result,"Transitional cell papilloma, inverted",0
8182,Endometrial Type Glands and Stroma Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,0
8183,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,fibroma of testis,0
8184,Smooth Muscle Component Present,"FANCONI ANEMIA, COMPLEMENTATION GROUP J",0
8185,Endobronchial Lesion,Mixed Congenital Mesoblastic Nephroma,0
8186,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Angiocentric immunoproliferative lesion grade 2,0
8187,Extensive Stage Lesion,Stage IIIC Rectal Cancer AJCC v7,0
8188,Multiple Tumor Masses,Malignant Proliferating Pilar Tumor,0
8189,Nodular and Diffuse Pattern,Diffuse leptomeningeal glioneuronal neoplasm,0
8190,Secondary Lesion,Stage IVA Laryngeal Cancer AJCC v7,0
8191,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Head and Neck Squamous Cell Carcinoma,0
8192,EBV-Positive Neoplastic Cells Present,Anaplastic thyroid carcinoma,0
8193,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Mucinous adenocarcinoma of colon,0
8194,Secondary Lesion,Rete Ovarii Cystadenofibroma,0
8195,Focal dysplasia,Esophageal dysplasia,0
8196,Mixed Neoplastic Glandular and Squamous Cell Population,Parathyroid Clear Cell Hyperplasia,0
8197,EBV-Positive Neoplastic Cells Present,Brain Ependymoma,0
8198,Endobronchial Lesion,Adult Spinal Cord Ependymoma,0
8199,More Than Two Separate Tumor Masses Present in the Same Organ,Breast Carcinoma Metastatic in the Liver,0
8200,Extensive Stage Lesion,Stage IA Cutaneous Melanoma AJCC v7,0
8201,Breast Implant-Related Lesion,Stage IB Breast Cancer AJCC v7,0
8202,Secondary Lesion,Stage 4S neuroblastoma,0
8203,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Testicular Germ Cell Tumor,0
8204,EBV-Positive Neoplastic Cells Present,Stage III Colorectal Cancer,0
8205,Blasts Under 20 Percent of Peripheral Blood White Cells,hepatoid adenocarcinoma of bladder,0
8206,Dilated Terminal Duct Lobular Units Present,Stage IIIB Distal Bile Duct Cancer AJCC v8,0
8207,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,rhabdomyosarcoma of mediastinum,0
8208,Intermediate Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Neoplasm,0
8209,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Tracheal Carcinoma,0
8210,Endobronchial Lesion,Salivary duct carcinoma,0
8211,EBV-Positive Neoplastic Cells Present,Philadelphia chromosome negative chronic myelogenous leukemia,0
8212,Lesion with Diameter of 4mm or More,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,0
8213,Glandular cell atypia,"Synovial sarcoma, spindle cell",0
8214,Tumor Droplets Present,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
8215,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7,0
8216,Breast Implant-Related Lesion,Benign Breast Adenomyoepithelioma,0
8217,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign neoplasm of endometrium,0
8218,Extensive Stage Lesion,Stage I Anal Cancer AJCC v8,0
8219,EBV-Positive Neoplastic Cells Present,Mesenteric Lymphadenitis,0
8220,Atypical Mitotic Figures,Atypical Lipoma,0
8221,Blasts Under 20 Percent of Peripheral Blood White Cells,Verrucous carcinoma of oral cavity,0
8222,Extensive Stage Lesion,Appendix Carcinoma by AJCC v8 Stage,0
8223,Cutaneous plaque,Cutaneous Mature T-Cell and NK-Cell Neoplasm,0
8224,Mixed Neoplastic Glandular and Squamous Cell Population,Malignant Peritoneal and Retroperitoneal Neoplasm,0
8225,Small Aggregates of Tumor Cells Present,Malignant Parotid Gland Mixed Tumor,0
8226,Cutaneous plaque,Cutaneous leiomyoma,0
8227,Multihormonal Immunoreactivity Present in a Single Cell Type,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",0
8228,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Uterine Corpus Sarcoma by AJCC v7 Stage,0
8229,Small Aggregates of Tumor Cells Present,Rectal Small Cell Neuroendocrine Carcinoma,0
8230,Endometrial Type Glands and Stroma Present,Endometrial adenocarcinoma metastatic,0
8231,Smooth Muscle Component Present,Kasabach-Merritt syndrome,0
8232,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Luminal B Prostate Carcinoma,0
8233,Multihormonal Immunoreactivity Present in a Single Cell Type,Renal Cell Cancer by AJCC v7 Stage,0
8234,Prominent In Situ Component Present,High Grade Ductal Breast Carcinoma In Situ,0
8235,Endobronchial Lesion,Stage IIIC Eyelid Carcinoma AJCC v7,0
8236,Breast Implant-Related Lesion,Intraductal Breast Papillomatosis,0
8237,Smooth Muscle Component Present,Colorectal cancer recurrent,0
8238,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,sarcoma of small intestine,0
8239,EBV-Positive Neoplastic Cells Present,Colorectal Hodgkin Lymphoma,0
8240,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant tumor of gum,0
8241,Secondary Lesion,Waldenstrom's macroglobulinemia refractory,0
8242,EBV-Positive Neoplastic Cells Present,Childhood Brain Stem Mixed Glioma,0
8243,Multiple Tumor Masses,Ascending Colon Neuroendocrine Tumor G1,0
8244,EBV-Positive Neoplastic Cells Present,Pemphigoid Gestationis,0
8245,Enterochromaffin Type Granules Present,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
8246,Intermediate Grade Neuroendocrine Lesion,Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm,0
8247,Breast Implant-Related Lesion,Inflammatory Breast Carcinoma,0
8248,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermal Fibroma,0
8249,Erythroid hyperplasia,Adrenal hyperplasia,0
8250,Smooth Muscle Component Present,Leptomeningeal sarcoma,0
8251,Deep Lesion,Deep seated dermatophytosis,0
8252,EBV-Positive Neoplastic Cells Present,Stage IIIA Fallopian Tube Cancer AJCC v8,0
8253,Endobronchial Lesion,Reactive C-Cell Hyperplasia,0
8254,EBV-Positive Neoplastic Cells Present,Nodular melanoma,0
8255,EBV-Positive Neoplastic Cells Present,Prostate cancer stage C,0
8256,Secondary Lesion,Hormone-Resistant Prostate Carcinoma,0
8257,Secondary Lesion,"Pheochromocytoma, malignant",0
8258,Tumor Droplets Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0
8259,Secondary Lesion,Atrial myxoma,0
8260,EBV-Positive Neoplastic Cells Present,Metastatic Jugulotympanic Paraganglioma,0
8261,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Oral Cavity Cancer AJCC v6 and v7,0
8262,Multinodular and Vacuolated Pattern,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7,0
8263,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of retroperitoneum,0
8264,High Grade Lesion,Grade 1 Malignant Neoplasm,0
8265,Small Aggregates of Tumor Cells Present,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0
8266,Endobronchial Lesion,Vaginal Endometrioid Adenocarcinoma,0
8267,Lesion with Diameter of 4mm or More,Chronic Myelomonocytic Leukemia with Eosinophilia,0
8268,Secondary Lesion,Stage I Uterine Corpus Cancer AJCC v8,0
8269,Small Aggregates of Tumor Cells Present,Pericardial Solitary Fibrous Tumor,0
8270,Smooth Muscle Component Present,"NK-Cell Lymphoma, Unclassifiable",0
8271,Intermediate Grade Neuroendocrine Lesion,Grade 1 Rectal Adenocarcinoma,0
8272,Endobronchial Lesion,Ureter Cancer by AJCC v7 Stage,0
8273,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Labia Minora Carcinoma,0
8274,Extensive Stage Lesion,Ann Arbor Stage IIIB Hodgkin Lymphoma,0
8275,Secondary Lesion,Cockade nevus,0
8276,Enterochromaffin Type Granules Present,"Castleman Disease, Hyaline-Vascular Type",0
8277,Secondary Lesion,Stage IIB Penile Cancer AJCC v8,0
8278,Multihormonal Immunoreactivity Present in a Single Cell Type,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,0
8279,Gastrointestinal Type Epithelium Present,"Gastrointestinal stromal tumor, uncertain malignant potential",0
8280,EBV-Positive Neoplastic Cells Present,Stage IIA Rectal Cancer AJCC v7,0
8281,Abundance of Small Lymphocytes,Malignant neoplasm of clitoris,0
8282,Secondary Lesion,"Pregnancy, Ovarian",0
8283,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Anal Canal Cancer AJCC v6 and v7,0
8284,High Grade Non Cartilaginous Sarcomatous Stroma Present,Adult Grade III Meningioma,0
8285,Endobronchial Lesion,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,0
8286,Blasts Under 20 Percent of Peripheral Blood White Cells,Ampulla of Vater Undifferentiated Carcinoma,0
8287,Blasts Under 20 Percent of Peripheral Blood White Cells,Non-Hodgkin's lymphoma of lung,0
8288,Delicate Vascular Network Formation,Vascular insufficiency of intestine,0
8289,Blasts Under 20 Percent of Peripheral Blood White Cells,histiocytic sarcoma of central nervous system,0
8290,Secondary Lesion,Meyerson Nevus,0
8291,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Leiomyosarcoma of Deep Soft Tissue,0
8292,Abundance of Small Lymphocytes,Dermoid cyst of ovary,0
8293,Lesion with Diameter of 4mm or More,Burkitt lymphoma associated with AIDS,0
8294,Endobronchial Lesion,Pancreatic Endocrine Carcinoma,0
8295,EBV-Positive Neoplastic Cells Present,Sweat gland adenocarcinoma,0
8296,EBV-Positive Neoplastic Cells Present,Papillary Urothelial Hyperplasia,0
8297,EBV-Positive Neoplastic Cells Present,"Carcinoma, diffuse type",0
8298,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Colon Cancer by AJCC v8 Stage,0
8299,Lesion with Diameter of 4mm or More,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),0
8300,Smooth Muscle Component Present,Fundic gland polyp,0
8301,Endobronchial Lesion,Exocervical Carcinoma,0
8302,White blood cell count increased (lab result),Adenosquamous cell lung cancer stage II,0
8303,Chronic Clinical Course,Chronic lymphadenitis,0
8304,Absence of Malignant Features,Childhood Recurrent Malignant Solid Neoplasm,0
8305,Endobronchial Lesion,Stage II Thymoma AJCC v8,0
8306,Smooth Muscle Component Present,Cardiac Extraskeletal Osteosarcoma,0
8307,Smooth Muscle Component Present,Lung Pleomorphic Adenoma,0
8308,Multihormonal Immunoreactivity Present in a Single Cell Type,Adult Anaplastic Large Cell Lymphoma,0
8309,Smooth Muscle Component Present,Intravenous leiomyomatosis,0
8310,Secondary Lesion,Stage I Penile Cancer AJCC v8,0
8311,EBV-Positive Neoplastic Cells Present,Acute myelomonocytic leukemia,0
8312,Dilated Terminal Duct Lobular Units Present,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8,0
8313,Endobronchial Lesion,Refractory cancer,0
8314,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lymphoproliferative disorder caused by methotrexate,0
8315,Melanoma Cells Present,Clinical Stage IA Cutaneous Melanoma AJCC v8,0
8316,Photosensitivity of skin,Ganglioneuroma of skin,0
8317,Mixed Neoplastic Glandular and Squamous Cell Population,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0
8318,Glandular cell atypia,Acantholytic squamous cell carcinoma,0
8319,EBV-Positive Neoplastic Cells Present,"Dermatitis, Allergic Contact",0
8320,Endobronchial Lesion,Colorectal Sarcoma,0
8321,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cervical Papillary Squamous Cell Carcinoma,0
8322,Non-Encapsulated Neoplasm,Benign Eccrine Neoplasm,0
8323,Endobronchial Lesion,Stage IIIC Ovarian Cancer AJCC v8,0
8324,Endobronchial Lesion,"Hemangioma, Intramuscular",0
8325,Endobronchial Lesion,Stage IIIC Lung Cancer AJCC v8,0
8326,Endobronchial Lesion,Stage IIIa Penile Cancer AJCC v7,0
8327,Intermediate Grade Neuroendocrine Lesion,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,0
8328,Smooth Muscle Component Present,Fibrosarcoma metastatic,0
8329,Absence of Malignant Features,Malignant Thymoma,0
8330,EBV-Positive Neoplastic Cells Present,Cutaneous Radiation-Related Angiosarcoma,0
8331,Secondary Lesion,Urinary Bladder Nephrogenic Adenoma,0
8332,EBV-Positive Neoplastic Cells Present,Colon Sessile Serrated Adenoma/Polyp,0
8333,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
8334,Mild dysplasia of colon,Squamous cell carcinoma of colon,0
8335,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pharyngeal Carcinoma by AJCC v7 Stage,0
8336,Smooth Muscle Component Present,Unresectable Liposarcoma,0
8337,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Uveal Melanoma by Gene Expression Profile,0
8338,Mixed Neoplastic Glandular and Squamous Cell Population,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,0
8339,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of meninges,0
8340,Plasma cell inflammation,Vaginal clear cell adenocarcinoma,0
8341,Tumor Droplets Present,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8342,Endobronchial Lesion,Therapy-related myelodysplastic syndrome,0
8343,Abundance of Small Lymphocytes,Small intestine carcinoma stage I,0
8344,Multihormonal Immunoreactivity Present in a Single Cell Type,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant",0
8345,NRBC - Nucleated red blood cell present result,Mantle cell lymphoma stage IV,0
8346,Chronic Clinical Course,Clinical Stage II Cutaneous Melanoma AJCC v8,0
8347,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,0
8348,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous cell breast carcinoma,0
8349,Tumor Droplets Present,Gastric Inflammatory Myofibroblastic Tumor,0
8350,Schwannian Stroma Predominant Component of the Tumor Volume,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
8351,Diffuse Immunoblastic Proliferation,"Diffuse Astrocytoma, IDH-Mutant",0
8352,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Bone Marrow Transplantation Nephropathy,0
8353,Endobronchial Lesion,Benign Mediastinal Psammomatous Schwannoma,0
8354,EBV-Positive Neoplastic Cells Present,AIDS-Related Human Papillomavirus Infection,0
8355,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Leuteoma of Pregnancy,0
8356,Endobronchial Lesion,Refractory Indolent Adult Non-Hodgkin Lymphoma,0
8357,Endobronchial Lesion,AIDS-Related Hodgkin Lymphoma,0
8358,Small Aggregates of Tumor Cells Present,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
8359,Lesion with Diameter of 4mm or More,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0
8360,Polarization of Nuclei Towards the Glandular Lumen,Glandular papilloma,0
8361,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Digestive System Carcinoma,0
8362,EBV-Positive Neoplastic Cells Present,Stage I Adrenal Cortex Carcinoma AJCC v8,0
8363,EBV-Positive Neoplastic Cells Present,Mediastinal Extraskeletal Osteosarcoma,0
8364,Endobronchial Lesion,Cutaneous sarcoidosis,0
8365,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Childhood Acute Myeloid Leukemia with Maturation,0
8366,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of great vessels,0
8367,EBV-Positive Neoplastic Cells Present,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
8368,Squamous metaplasia of bladder,Squamous cell carcinoma,0
8369,Secondary Lesion,Parotid Gland Non-Hodgkin Lymphoma,0
8370,Immunoglobulin Heavy Chain Deposition,Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8371,Fibrotic Stroma with Finger-Like Projections Present,Acute myeloid leukemia with abnormal marrow eosinophils,0
8372,Multiple Tumor Masses,Thymic Atypical Carcinoid Tumor,0
8373,Smooth Muscle Component Present,Gonadoblastoma,0
8374,Multinodular and Vacuolated Pattern,"Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8",0
8375,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Head and Neck Squamous Cell Carcinoma,0
8376,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Oropharyngeal Squamous Cell Carcinoma,0
8377,Follicular Cell Differentiation,Large Cell Dysplasia,0
8378,Extramedullary Hematopoiesis (disorder),"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)",0
8379,Endobronchial Lesion,Hodgkin's disease nodular sclerosis refractory,0
8380,Secondary Lesion,Acne Keloid,0
8381,Abundance of Small Lymphocytes,Benign neoplasm of retroperitoneum,0
8382,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0
8383,Blasts Under 20 Percent of Peripheral Blood White Cells,Capillary hemangioma of eyelid,0
8384,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
8385,Plasma cell inflammation,Bile duct signet-ring cell carcinoma,0
8386,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Clear cell squamous cell carcinoma of skin,0
8387,Low Grade Neuroendocrine Lesion,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
8388,Endobronchial Lesion,Broad Ligament Serous Adenocarcinoma,0
8389,Recurrent Malignant Neoplasm,Recurrent Thyroid Gland Medullary Carcinoma,0
8390,Mammary Gland Type Features Present,Thyroid Gland Leiomyoma,0
8391,Secondary Lesion,Stage IIIC Prostate Cancer AJCC v8,0
8392,Endobronchial Lesion,Locally Advanced Prostate Adenocarcinoma,0
8393,Gastric dysplasia,AIDS-Related Gastric Kaposi Sarcoma,0
8394,Non-Encapsulated Neoplasm,Recurrent Brain Neoplasm,0
8395,Endobronchial Lesion,Refractory Mature B-Cell Non-Hodgkin Lymphoma,0
8396,Secondary Lesion,Testicular yolk sac tumor stage II,0
8397,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,carcinosarcoma of gallbladder,0
8398,Blue Bone Formation,Vaginal Blue Nevus,0
8399,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,0
8400,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7,0
8401,Endobronchial Lesion,Testicular embryonal carcinoma stage I,0
8402,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Paget's disease and intraductal carcinoma of breast,0
8403,Ectopic Thyroid Tissue Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,0
8404,Small Aggregates of Tumor Cells Present,Small Intestinal Villous Adenoma,0
8405,Absence of a Hormonal Syndrome,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
8406,EBV-Positive Neoplastic Cells Present,Stage 0 Penile Cancer AJCC v8,0
8407,Absence of Malignant Features,Refractory Malignant Thyroid Gland Neoplasm,0
8408,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant lymphoma of testis,0
8409,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
8410,Endobronchial Lesion,Indolent Systemic Mastocytosis,0
8411,Fibrotic Stroma with Finger-Like Projections Present,Colorectal Adenoma with Severe Dysplasia,0
8412,Primitive Mesenchymal Stroma Formation,Central Nervous System Mesenchymal Chondrosarcoma,0
8413,Mixed Neoplastic Glandular and Squamous Cell Population,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",0
8414,EBV-Positive Neoplastic Cells Present,Fascial fibrosarcoma,0
8415,EBV-Positive Neoplastic Cells Present,Nodular amyloidosis,0
8416,Mesenchymal Metaplasia of Malignant Cells Present,Malignant vascular tumor of skin,0
8417,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Adenocarcinoma of the prostate stage III,0
8418,Follicular Cell Differentiation,Papillary Renal Cell Carcinoma,0
8419,Insular Pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",0
8420,Abundance of Small Lymphocytes,Secondary malignant neoplasm of lip,0
8421,Ectopic Thyroid Tissue Present,Ectopic Thyroid Gland Thymoma,0
8422,Generalized illness,Acute Generalized Exanthematous Pustulosis,0
8423,Single Cell Necrosis,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7,0
8424,Blue Bone Formation,Vulvar Blue Nevus,0
8425,Multinodular and Vacuolated Pattern,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
8426,Endobronchial Lesion,Pelvic Cancer,0
8427,Smooth Muscle Component Present,Benign Prostatic Hyperplasia,0
8428,Secondary Lesion,Central Nervous System B-Cell Non-Hodgkin Lymphoma,0
8429,Abundance of Small Lymphocytes,Squamous cell carcinoma of esophagus,0
8430,Low Grade Neuroendocrine Lesion,Low Grade Endometrial Stromal Sarcoma,0
8431,Postneoadjuvant Therapy Pathologic TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage,0
8432,Mixed Neoplastic Glandular and Squamous Cell Population,Renal Cell Cancer by AJCC v8 Stage,0
8433,Small Aggregates of Tumor Cells Present,Borderline Breast Phyllodes Tumor,0
8434,Extensive Stage Lesion,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8,0
8435,EBV-Positive Neoplastic Cells Present,Glomangiomatosis,0
8436,Abundance of Small Lymphocytes,embryonal rhabdomyosarcoma of prostate,0
8437,Abundance of Small Lymphocytes,Benign neoplasm of subglottis,0
8438,Secondary Lesion,Seminal Vesicle Cystadenoma,0
8439,High Grade Non Cartilaginous Sarcomatous Stroma Present,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
8440,Secondary Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,0
8441,Absence of Malignant Features,Malignant tumor of dermis,0
8442,Smooth Muscle Component Present,Benign Supratentorial Neoplasms,0
8443,Mammary Gland Type Features Present,"Adrenal Gland Ganglioneuroblastoma, Intermixed",0
8444,Secondary Lesion,Stage IIA Penile Cancer AJCC v8,0
8445,Endobronchial Lesion,Stage IV Adult Lymphoblastic Lymphoma,0
8446,Small Aggregates of Tumor Cells Present,Duodenal Neuroendocrine Tumor,0
8447,Abundance of Small Lymphocytes,malignant epithelioid hemangioendothelioma of liver,0
8448,Secondary Lesion,Childhood Central Nervous System Teratoma,0
8449,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IA Ampulla of Vater Cancer AJCC v7,0
8450,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Central Nervous System T-Cell Non-Hodgkin Lymphoma,0
8451,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign neoplasm of retroperitoneum,0
8452,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,BCLC Stage B Hepatocellular Carcinoma,0
8453,Extensive Stage Lesion,Stage II Intrahepatic Cholangiocarcinoma AJCC v8,0
8454,EBV-Positive Neoplastic Cells Present,Urethral Condyloma Acuminatum,0
8455,Endobronchial Lesion,Secondary Prostate Urothelial Carcinoma,0
8456,Single Cell Necrosis,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,0
8457,EBV-Positive Neoplastic Cells Present,Meningeal Carcinomatosis,0
8458,Smooth Muscle Component Present,Tumorlet,0
8459,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
8460,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
8461,Minimally Invasive Lesion,Invasive Mixed Breast Carcinoma,0
8462,Endobronchial Lesion,Childhood Kidney Angiomyolipoma,0
8463,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of thalamus,0
8464,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Stage IIB Bone Cancer AJCC v7,0
8465,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Atypical adenomatous hyperplasia,0
8466,Multihormonal Immunoreactivity Present in a Single Cell Type,Cervical Esophagus Squamous Cell Carcinoma,0
8467,Endobronchial Lesion,Stage II Uterine Sarcoma AJCC v7,0
8468,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,0
8469,EBV-Positive Neoplastic Cells Present,Ovarian Cystic Teratoma,0
8470,Mesenchymal Metaplasia of Malignant Cells Present,Malignant neoplasm of nasal cavity,0
8471,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8472,Single Cell Necrosis,Colorectal Mantle Cell Lymphoma,0
8473,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Adrenal Cortex Carcinoma,0
8474,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma,0
8475,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of female breast,0
8476,Ganglioneuroma Component Present,Maturing Ganglioneuroma,0
8477,Unfavorable Clinical Outcome,Clinical Stage II Esophageal Adenocarcinoma AJCC v8,0
8478,EBV-Positive Neoplastic Cells Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v8,0
8479,Follicular Cell Differentiation,Stage I Childhood Anaplastic Large Cell Lymphoma,0
8480,Recurrent Malignant Neoplasm,Metastatic Malignant Pancreatic Neoplasm,0
8481,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,verrucous carcinoma of vulva,0
8482,EBV-Positive Neoplastic Cells Present,BCLC Stage C Adult Hepatocellular Carcinoma,0
8483,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Appendix Carcinoma AJCC v8,0
8484,Smooth Muscle Component Present,Pemphigoid Gestationis,0
8485,Multiple Tumor Masses,Stage IVB Gestational Trophoblastic Tumor AJCC v7,0
8486,Extensive Stage Lesion,Stage IIA Ovarian Cancer AJCC v8,0
8487,Small Aggregates of Tumor Cells Present,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,0
8488,Endobronchial Lesion,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8,0
8489,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage 0 Gastric Cancer AJCC v8,0
8490,Endobronchial Lesion,Nipple Syringomatous Adenoma,0
8491,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Gallbladder Neuroendocrine Tumor G2,0
8492,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Hypodiploid B Acute Lymphoblastic Leukemia,0
8493,No Evidence of Metastatic Disease,Metastatic Urethral Carcinoma,0
8494,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Squamous cell carcinoma of the hypopharynx stage I,0
8495,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage,0
8496,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of pericardium,0
8497,Blasts Under 20 Percent of Peripheral Blood White Cells,Stage IV Ampulla of Vater Cancer AJCC v7,0
8498,Extensive Stage Lesion,Stage III Uterine Sarcoma AJCC v7,0
8499,Regional Disease,Erdheim-Chester Disease,0
8500,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Stage IA Bone Cancer AJCC v7,0
8501,EBV-Positive Neoplastic Cells Present,Luteoma,0
8502,Well Differentiated Neuroendocrine Lesion,Moderately Differentiated Hepatocellular Carcinoma,0
8503,Monoclonal Paraproteinemia Present in Lower than Myeloma Levels,Multiple Myeloma,0
8504,EBV-Positive Neoplastic Cells Present,Gonadotroph adenoma,0
8505,Endobronchial Lesion,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,0
8506,Abundance of Small Lymphocytes,Non-Hodgkin's lymphoma of central nervous system,0
8507,NRBC - Nucleated red blood cell present result,Basal cell carcinoma,0
8508,Endobronchial Lesion,"Carcinoma, Lobular",0
8509,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Lymphoma of colon,0
8510,EBV-Positive Neoplastic Cells Present,FIGO Stage IIIA1(ii) Ovarian Cancer,0
8511,Endobronchial Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v8,0
8512,Endobronchial Lesion,Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8,0
8513,NRBC - Nucleated red blood cell present result,"Squamous cell carcinoma, small cell, nonkeratinizing",0
8514,Peau d'orange surface of breast,Lipoma of breast,0
8515,Extensive Stage Lesion,Stage IVA Laryngeal Cancer AJCC v7,0
8516,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,acute undifferentiated leukemia in relapse,0
8517,Intermediate Grade Lesion,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
8518,Endobronchial Lesion,Chondromatosis,0
8519,Epithelial hyperplasia of skin,Mucoepidermoid carcinoma of skin,0
8520,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
8521,EBV-Positive Neoplastic Cells Present,McCune-Albright Syndrome,0
8522,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Serous Endometrial Intraepithelial Carcinoma,0
8523,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IC Fallopian Tube Cancer AJCC v6 and v7,0
8524,Breast Implant-Related Lesion,Breast cancer recurrent,0
8525,Abundance of Small Lymphocytes,Secondary malignant neoplasm of esophagus,0
8526,EBV-Positive Neoplastic Cells Present,Radial scar,0
8527,Single Cell Necrosis,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7,0
8528,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermal Fibroma,0
8529,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present","Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",0
8530,Cavernous Lymphatic Space Formation,Cavernous Angioleiomyoma,0
8531,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Contralateral Breast Carcinoma,0
8532,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Oral Cavity Cancer AJCC v6 and v7,0
8533,Monoclonal Myeloid or Lymphoid Cells Present,"Myeloid Leukemia, Chronic",0
8534,Secondary Lesion,Asynchronous Multifocal Osteosarcoma,0
8535,Smooth Muscle Component Present,Secondary carcinoma,0
8536,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign neoplasm of myocardium,0
8537,Mesenchymal Metaplasia of Malignant Cells Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
8538,Endobronchial Lesion,Transplant-Related Hematologic Malignancy,0
8539,Multihormonal Immunoreactivity Present in a Single Cell Type,Rectal Small Cell Neuroendocrine Carcinoma,0
8540,Smooth Muscle Component Present,Dermatitis acneiform,0
8541,EBV-Positive Neoplastic Cells Present,Stage I Paranasal Sinus Cancer,0
8542,Smooth Muscle Component Present,Colon Sarcoma,0
8543,Abundance of Small Lymphocytes,Benign neoplasm of sweat gland,0
8544,Venous Type Vascular Channel Formation,"Cervical Mucinous Adenocarcinoma, Endocervical Type",0
8545,EBV-Positive Neoplastic Cells Present,Maxillary Sinus Inverted Papilloma,0
8546,Breast Implant-Related Lesion,Breast Lymphoma,0
8547,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIB Merkel Cell Carcinoma AJCC v7,0
8548,Large Neoplastic Glands with Branching and Papillary Infolding Present,Papillary Eccrine Carcinoma,0
8549,Endobronchial Lesion,Bile duct carcinoma,0
8550,Multinodular and Vacuolated Pattern,Stage III Testicular Seminoma AJCC v6 and v7,0
8551,Blasts Under 20 Percent of Peripheral Blood White Cells,signet ring cell carcinoma of pancreas,0
8552,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Childhood Liver and Intrahepatic Bile Duct Neoplasm,0
8553,Endobronchial Lesion,Stage IIB Colon Cancer AJCC v8,0
8554,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Refractory Desmoplastic Small Round Cell Tumor,0
8555,Recurrent Genetic Abnormalities Present,Recurrent Thymic Carcinoma,0
8556,Endobronchial Lesion,Endometrioid adenocarcinoma recurrent,0
8557,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,0
8558,Abundance of Small Lymphocytes,eccrine adenocarcinoma of vulva,0
8559,Endobronchial Lesion,Metastatic Unresectable Carcinoma,0
8560,Lesion with Diameter of 10mm or Less,Choriocarcinoma combined with other germ cell elements,0
8561,Endobronchial Lesion,"Ganglioneuroblastoma, Nodular",0
8562,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of intestinal tract,0
8563,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Burkitt-like lymphoma with 11q aberration,0
8564,Chronic Clinical Course,Gastric Cancer by AJCC v8 Clinical Stage,0
8565,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Plasmablastic Lymphoma of Mucosa Site,0
8566,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,0
8567,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Synchronous Bilateral Breast Carcinoma,0
8568,Secondary Lesion,Stage 0a Bladder Cancer AJCC v8,0
8569,Blasts Under 20 Percent of Peripheral Blood White Cells,mucoepidermoid carcinoma of esophagus,0
8570,Absence of Malignant Features,Malignant neoplasm of upper third of esophagus,0
8571,Squamous Differentiation,Perianal Squamous Intraepithelial Neoplasia,0
8572,Secondary Lesion,Ceruminous adenocarcinoma,0
8573,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVA Vaginal Cancer AJCC v6 and v7,0
8574,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Distal Urethral Carcinoma,0
8575,Secondary Lesion,Stage IV Vulvar Cancer AJCC v6,0
8576,Absence of Malignant Features,Refractory Malignant Urinary System Neoplasm,0
8577,Endobronchial Lesion,Childhood Pleomorphic Rhabdomyosarcoma,0
8578,Endobronchial Lesion,Colorectal Intraepithelial Neoplasia,0
8579,EBV-Positive Neoplastic Cells Present,Hepatoblastoma non-resectable,0
8580,EBV-Positive Neoplastic Cells Present,Ann Arbor Stage IV AIDS-Related Lymphoma,0
8581,Mixture of Embryonal and Alveolar Features Present,Fusion-Positive Alveolar Rhabdomyosarcoma,0
8582,Cellular Pleomorphism,Cellular neurothekeoma,0
8583,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Small Intestinal VIP-Producing Neuroendocrine Tumor,0
8584,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of testis,0
8585,Absence of Malignant Features,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0
8586,Smooth Muscle Component Present,Colorectal hyperplastic polyp,0
8587,Endobronchial Lesion,Benign Intracranial Meningioma,0
8588,Endobronchial Lesion,Stage II Primary Peritoneal Cancer AJCC v8,0
8589,Secondary Lesion,Stage IIA Colorectal Cancer AJCC v8,0
8590,Endobronchial Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v8,0
8591,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,malignant epithelioid hemangioendothelioma of liver,0
8592,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,0
8593,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Squamous cell carcinoma of prostate,0
8594,Prominent Elastic Tissue Cores Present,Childhood Soft Tissue Sarcoma,0
8595,Secondary Lesion,Inverted urothelial papilloma,0
8596,Multiple Tumor Masses,Digestive System Neuroendocrine Tumor G2,0
8597,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7,0
8598,Secondary Lesion,Postsurgical Stage III Hepatoblastoma,0
8599,Tumor Droplets Present,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
8600,Secondary Lesion,Radiation sickness syndrome,0
8601,Secondary Lesion,Refractory Transformed Non-Hodgkin Lymphoma,0
8602,Smooth Muscle Component Present,Epithelioma,0
8603,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Insular Carcinoid Tumor,0
8604,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Thyroid Carcinoma,0
8605,Secondary Lesion,Pancreatic Serous Adenoma,0
8606,Endobronchial Lesion,Unresectable Digestive System Adenocarcinoma,0
8607,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,sialadenoma papilliferum of salivary gland,0
8608,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Nasopharyngeal Carcinoma by AJCC v6 Stage,0
8609,Mixed Neoplastic Glandular and Squamous Cell Population,Sellar Mixed Germ Cell Tumor,0
8610,Extensive Stage Lesion,Clinical Stage IV Retinoblastoma AJCC v8,0
8611,High Grade Non Cartilaginous Sarcomatous Stroma Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",0
8612,Extensive Stage Lesion,Penile Cancer by AJCC v8 Stage,0
8613,EBV-Positive Neoplastic Cells Present,Biliary Intraepithelial Neoplasia-1,0
8614,Tumor Droplets Present,High Grade Malignant Peripheral Nerve Sheath Tumor,0
8615,Secondary Lesion,Laryngeal Mucoepidermoid Carcinoma,0
8616,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
8617,Endobronchial Lesion,Non-Hematologic Malignancy,0
8618,Endobronchial Lesion,Infiltrating Bladder Urothelial Carcinoma,0
8619,Multihormonal Immunoreactivity Present in a Single Cell Type,Intraductal carcinoma and lobular carcinoma in situ,0
8620,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Borderline Ovarian Transitional Cell Tumor,0
8621,Endobronchial Lesion,Stage IVB Colon Cancer AJCC v7,0
8622,Abundance of Small Lymphocytes,follicular dendritic cell sarcoma of thyroid gland,0
8623,EBV-Positive Neoplastic Cells Present,"Cystadenoma, Papillary",0
8624,Extensive Stage Lesion,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,0
8625,Multinodular and Vacuolated Pattern,Testicular Mixed Choriocarcinoma and Seminoma,0
8626,EBV-Positive Neoplastic Cells Present,Stage IVC Major Salivary Gland Cancer AJCC v7,0
8627,Endobronchial Lesion,Diaper candidiasis,0
8628,Endobronchial Lesion,Intraductal Breast Papillomatosis,0
8629,Secondary Lesion,FIGO Stage IIIB Ovarian Cancer,0
8630,Well Differentiated Neuroendocrine Lesion,Neuroendocrine Tumors,0
8631,Bone Marrow Lymphoplasmacytic Infiltrate,Splenic Lymphoplasmacytic Lymphoma,0
8632,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Ann Arbor Stage III Mature T- and NK-Cell Lymphoma,0
8633,Ectopic Thyroid Tissue Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,0
8634,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,mucinous adenocarcinoma of gallbladder,0
8635,Recurrent Genetic Abnormalities Present,Recurrent Extranodal Diffuse Large B-cell Lymphoma,0
8636,Multihormonal Immunoreactivity Present in a Single Cell Type,Occult Lung Squamous Cell Carcinoma,0
8637,Intraepithelial Neoplasia,Cervical Intraepithelial Neoplasia Grade 2/3,0
8638,Recurrent Malignant Neoplasm,Benign Intracranial Neoplasm,0
8639,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Metastatic Malignant Neoplasm to the Leptomeninges,0
8640,EBV-Positive Neoplastic Cells Present,Stage IIC Prostate Cancer AJCC v8,0
8641,"Adenocarcinoma, intestinal type",Hodgkin's disease lymphocyte depletion type recurrent,0
8642,Smooth Muscle Component Present,Pediatric follicular lymphoma,0
8643,Neoplastic Plasma Cells Present in Bone Marrow,"Castleman Disease, Plasma Cell Type",0
8644,Extensive Stage Lesion,Stage IIB Distal Bile Duct Cancer AJCC v8,0
8645,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Squamous cell carcinoma of the hypopharynx stage I,0
8646,Microinvasive tumor,Mixed germ cell-sex cord-stromal tumor,0
8647,Intermediate Grade Lesion,Grade 3 Teratoma,0
8648,Epithelial hyperplasia of skin,Pyogenic granuloma of skin and subcutaneous tissue,0
8649,Endobronchial Lesion,Metastatic Adrenal Cortex Carcinoma,0
8650,Endobronchial Lesion,FIGO Stage IIIA1(ii) Ovarian Cancer,0
8651,Endobronchial Lesion,Childhood Acute Megakaryoblastic Leukemia,0
8652,Endobronchial Lesion,Prostate Lymphoma,0
8653,Follicular Cell Differentiation,Hairy Cell Leukemia,0
8654,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7,0
8655,Endobronchial Lesion,Childhood Central Nervous System Ganglioneuroblastoma,0
8656,Dysplastic Dentin Formation,Vulvar Dysplastic Melanocytic Nevus,0
8657,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant fibrous histiocytoma metastatic,0
8658,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Anal Canal Small Cell Neuroendocrine Carcinoma,0
8659,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,0
8660,EBV-Positive Neoplastic Cells Present,EBV-Related Non-Hodgkin Lymphoma,0
8661,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Secondary malignant neoplasm of ovary,0
8662,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Myeloid Leukemia,0
8663,Smooth Muscle Component Present,Conventional Cardiac Rhabdomyoma,0
8664,Secondary Lesion,Adrenal neuroblastoma,0
8665,Secondary Lesion,Colorectal Microvesicular Hyperplastic Polyp,0
8666,EBV-Positive Neoplastic Cells Present,Tendon Sheath Lipoma,0
8667,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Vulvar Cancer by AJCC v8 Stage,0
8668,Low Grade Cartilaginous Component Present,Low Grade Prostatic Intraepithelial Neoplasia,0
8669,Absence of a Hormonal Syndrome,High Risk Myelodysplastic Syndrome,0
8670,Photosensitivity of skin,Preauricular skin tag,0
8671,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Spindle cell nevus of Reed,0
8672,Gastric dysplasia,Pathologic Stage IIIA Gastric Cancer AJCC v8,0
8673,Myxoid Changes Present,Myxoid liposarcoma metastatic,0
8674,Epithelial hyperplasia of skin,Mesothelial hyperplasia,0
8675,Blasts Under 20 Percent of Peripheral Blood White Cells,Corn of toe,0
8676,Abundance of Small Lymphocytes,Kaposi's sarcoma of extrahepatic bile duct,0
8677,Secondary Lesion,Stage III Esophageal Adenocarcinoma AJCC v7,0
8678,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Carcinoma of Cowper Glands,0
8679,EBV-Positive Neoplastic Cells Present,Parathyroid Adenoma,0
8680,Secondary Lesion,Endometrioid adenocarcinoma recurrent,0
8681,EBV-Positive Neoplastic Cells Present,Hepatoid adenocarcinoma,0
8682,Enterochromaffin Type Granules Present,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,0
8683,Endobronchial Lesion,Recurrent Sarcoma,0
8684,Neoplastic Cells with TFH Cell Phenotype Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
8685,Secondary Lesion,Stage IVB Paranasal Sinus Cancer AJCC v7,0
8686,Cutaneous plaque,Cutaneous leiomyoma,0
8687,Secondary Lesion,Vulval intraepithelial neoplasia,0
8688,EBV-Positive Neoplastic Cells Present,Submandibular Gland Adenocarcinoma,0
8689,Melanoma Cells Present,Acral Lentiginous Malignant Melanoma,0
8690,Abundance of Small Lymphocytes,Secondary malignant neoplasm of spinal cord,0
8691,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Grade 3 Clear Cell Renal Cell Carcinoma,0
8692,Endobronchial Lesion,Intramuscular Myxoma,0
8693,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of thyroid gland,0
8694,Rimming of Adipose Tissue Cells Present,Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma,0
8695,Smooth Muscle Component Present,Senile cardiac amyloidosis,0
8696,Single Cell Necrosis,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
8697,Endobronchial Lesion,Anaplastic adrenocortical carcinoma,0
8698,Follicular Cell Differentiation,"Dendritic Cell Sarcoma, Interdigitating",0
8699,NRBC - Nucleated red blood cell present result,Water-clear cell adenoma,0
8700,EBV-Positive Neoplastic Cells Present,Cardiac Leiomyosarcoma,0
8701,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Stage 0 Distal Bile Duct Cancer AJCC v8,0
8702,Rimming of Adipose Tissue Cells Present,Benign Gastric Soft Tissue Neoplasm,0
8703,Secondary Lesion,"Acanthoma, Pilar Sheath",0
8704,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Childhood Anaplastic Large Cell Lymphoma,0
8705,Epithelial hyperplasia of skin,Glomangioma of skin,0
8706,Smooth Muscle Component Present,Pericardial Angiosarcoma,0
8707,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Multiple self-healing epithelioma of Ferguson-Smith,0
8708,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,0
8709,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Colon Carcinoma Metastatic in the Liver,0
8710,Extensive Stage Lesion,ENSAT Stage III Adrenal Cortex Carcinoma,0
8711,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hormone-Resistant Prostate Carcinoma,0
8712,Gastric dysplasia,Clinical Stage IVA Gastric Cancer AJCC v8,0
8713,Endobronchial Lesion,Childhood Central Nervous System Choriocarcinoma,0
8714,Secondary Lesion,Third Ventricle Pilocytic Astrocytoma,0
8715,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of cornea,0
8716,Low Grade Cartilaginous Component Present,Low Grade Broad Ligament Serous Adenocarcinoma,0
8717,NRBC - Nucleated red blood cell present result,Large cell neuroendocrine carcinoma,0
8718,Macronodular adrenal hyperplasia,Mesothelial hyperplasia,0
8719,Multihormonal Immunoreactivity Present in a Single Cell Type,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,0
8720,Early Stromal Invasion Present,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
8721,Malignant Primitive Cellular Infiltrate,Malignant Splenic Soft Tissue Neoplasm,0
8722,Mediastinal mass,Mediastinal Epithelioid Hemangioendothelioma,0
8723,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Multicentric Breast Carcinoma,0
8724,Smooth Muscle Component Present,Kidney Extraskeletal Osteosarcoma,0
8725,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
8726,EBV-Positive Neoplastic Cells Present,Extra-Adrenal Retroperitoneal Paraganglioma,0
8727,Dermal Nodule,Dermal nerve sheath myxoma,0
8728,Follicular Differentiation,Grade 2 Cutaneous Follicular Lymphoma,0
8729,Glandular cell atypia,Spindle cell liposarcoma,0
8730,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,eccrine adenocarcinoma of vulva,0
8731,Large Neoplastic Glands with Branching and Papillary Infolding Present,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0
8732,Unfavorable Clinical Outcome,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,0
8733,Endobronchial Lesion,Anatomic Stage IIB Breast Cancer AJCC v8,0
8734,Abundance of Small Lymphocytes,Benign neoplasm of adrenal cortex,0
8735,Secondary Lesion,Bartholin Gland Adenomyoma,0
8736,EBV-Positive Neoplastic Cells Present,Salivary gland carcinoma,0
8737,Papillary Pattern,Papillary glioneuronal tumor,0
8738,Low Grade Neuroendocrine Lesion,Low Grade Malignant Neoplasm,0
8739,Abundance of Small Lymphocytes,non-Hodgkin's lymphoma of accessory sinus,0
8740,Abundance of Small Lymphocytes,sarcoma of testis,0
8741,Endobronchial Lesion,Gestational Ovarian Choriocarcinoma,0
8742,Smooth Muscle Component Present,Cauda Equina Paraganglioma,0
8743,Endobronchial Lesion,Intraosseous well differentiated osteosarcoma,0
8744,Mixed Neoplastic Glandular and Squamous Cell Population,Keratinizing Head and Neck Squamous Cell Carcinoma,0
8745,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of large intestine,0
8746,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Collecting Duct Carcinoma of the Kidney,0
8747,Blasts Under 20 Percent of Peripheral Blood White Cells,Lipoma of corpus callosum,0
8748,Multihormonal Immunoreactivity Present in a Single Cell Type,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
8749,EBV-Positive Neoplastic Cells Present,Cervical Villoglandular Adenocarcinoma,0
8750,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Adrenal Cortex Carcinoma AJCC v8,0
8751,Neoplastic Plasma Cells Present in Bone Marrow,Stage I Bone Cancer AJCC v7,0
8752,EBV-Positive Neoplastic Cells Present,Carcinoma duodenum resectable,0
8753,EBV-Positive Neoplastic Cells Present,Adult Epithelioid Hemangioendothelioma,0
8754,Extensive Stage Lesion,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,0
8755,Venous Type Vascular Channel Formation,Classic Type Trichilemmoma,0
8756,Dense Collagenized Tissue Present,Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8757,EBV-Positive Neoplastic Cells Present,Vaginal Mesonephric Adenocarcinoma,0
8758,Extensive Stage Lesion,Oropharyngeal Carcinoma by AJCC v6 Stage,0
8759,Tumor Droplets Present,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7,0
8760,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Childhood Giant Cell Glioblastoma,0
8761,Abundance of Small Lymphocytes,Stage IA Lung Small Cell Carcinoma AJCC v7,0
8762,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation,0
8763,Smooth Muscle Component Present,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
8764,Smooth Muscle Component Present,Marginal zone lymphoma stage III,0
8765,Secondary Lesion,Pediatric Extraocular Retinoblastoma,0
8766,Endobronchial Lesion,Metastatic Urethral Urothelial Carcinoma,0
8767,Absence of Malignant Features,Malignant tumor of ethmoid sinus,0
8768,Extensive Stage Lesion,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,0
8769,Secondary Lesion,Pedunculated conjunctival papilloma,0
8770,Abundance of Small Lymphocytes,Carcinoma of base of tongue,0
8771,Enterochromaffin Type Granules Present,Gliomatosis Cerebri Type I,0
8772,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7,0
8773,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of anus,0
8774,Endobronchial Lesion,Stage 0a Renal Pelvis Cancer AJCC v8,0
8775,Smooth Muscle Component Present,Placenta Accreta,0
8776,Lesion with Diameter of 4mm or More,Choriocarcinoma combined with other germ cell elements,0
8777,Malignant Primitive Cellular Infiltrate,Malignant Female Reproductive System Neoplasm,0
8778,Blasts Under 20 Percent of Peripheral Blood White Cells,"Peripheral T-Cell Lymphoma, Unclassifiable",0
8779,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,0
8780,Microinvasive tumor,Hybrid nerve sheath tumor,0
8781,EBV-Positive Neoplastic Cells Present,Refractory Fibrosarcoma,0
8782,Ectopic Thyroid Tissue Present,Thyroid Gland Hemangioma,0
8783,Secondary Lesion,Abruptio Placentae,0
8784,Endobronchial Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0
8785,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
8786,Smooth Muscle Component Present,Centroblastic lymphoma recurrent,0
8787,Squamous metaplasia,Squamous Hyperplasia,0
8788,Malignant Primitive Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,0
8789,EBV-Positive Neoplastic Cells Present,Pelvic Fibromatosis,0
8790,NRBC - Nucleated red blood cell present result,In situ mantle cell neoplasia,0
8791,Secondary Lesion,bilateral breast cancer,0
8792,Abundance of Small Lymphocytes,Stage I Small Intestinal Adenocarcinoma AJCC v8,0
8793,Recurrent Genetic Abnormalities Present,Recurrent Malignant Central Nervous System Neoplasm,0
8794,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Glomus Jugulare Tumor,0
8795,EBV-Positive Neoplastic Cells Present,"Thrombocythemia, Essential",0
8796,Lesion with Diameter of 4mm or More,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction,0
8797,Intraepithelial Neoplasia,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,0
8798,Locally Aggressive Lesion,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,0
8799,Defective Heavy Chain Present,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0
8800,Absence of Malignant Features,Malignant neoplasm of endometrium,0
8801,Single Cell Necrosis,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
8802,Gastric-Type Epithelial Differentiation,"Carcinoma, Ovarian Epithelial",0
8803,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma ex pleomorphic adenoma of parotid gland,0
8804,Neoplastic Cells with TFH Cell Phenotype Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),0
8805,Smooth Muscle Component Present,"Extra-adrenal paraganglioma, malignant",0
8806,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,0
8807,Endobronchial Lesion,Philadelphia chromosome negative chronic myelogenous leukemia,0
8808,Locally Aggressive Lesion,Locally Advanced Prostate Adenocarcinoma,0
8809,Smooth Muscle Component Present,Cholangiocarcinoma metastatic,0
8810,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Childhood Germ Cell Tumor,0
8811,Abundance of Small Lymphocytes,Leiomyosarcoma of cervix uteri,0
8812,Low Grade Neuroendocrine Lesion,Low Grade Endometrial Stromal Sarcoma,0
8813,Malignant Primitive Cellular Infiltrate,Malignant Mediastinal Soft Tissue Neoplasm,0
8814,Single Cell Necrosis,Stage IIA Lung Squamous Cell Carcinoma AJCC v7,0
8815,Recurrent Malignant Neoplasm,Advanced Digestive System Neuroendocrine Neoplasm,0
8816,Endobronchial Lesion,Cutaneous Liposarcoma,0
8817,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,sarcoma of oral cavity,0
8818,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,0
8819,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Kidney Mixed Epithelial and Stromal Tumor Family,0
8820,Intermediate Grade Neuroendocrine Lesion,Epithelioid Sarcoma NCI Grade 2,0
8821,Smooth Muscle Component Present,Pancreatic adenocarcinoma metastatic,0
8822,Single Cell Necrosis,MiT Family Translocation-Associated Renal Cell Carcinoma,0
8823,Endobronchial Lesion,BRCA1 Syndrome,0
8824,Endobronchial Lesion,Psoriasiform eczema,0
8825,Mammary Gland Type Features Present,Stage IVA Major Salivary Gland Cancer AJCC v8,0
8826,Secondary Lesion,Stage IIIB Hilar Cholangiocarcinoma AJCC v8,0
8827,Endobronchial Lesion,Lymphadenitis,0
8828,Absence of Malignant Features,Recurrent Malignant Thyroid Gland Neoplasm,0
8829,Smooth Muscle Component Present,Ovarian epithelial cancer stage II,0
8830,Intermediate Grade Lesion,FNCLCC Sarcoma Grade 2,0
8831,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Resectable Digestive System Carcinoma,0
8832,EBV-Positive Neoplastic Cells Present,Upper Gingival Verrucous Carcinoma,0
8833,Endobronchial Lesion,Blepharal carcinoma,0
8834,Secondary Lesion,Stage 0 Ureter Cancer AJCC v7,0
8835,EBV-Positive Neoplastic Cells Present,Thyroid Gland Paraganglioma,0
8836,Absence of Malignant Features,Malignant neoplasm of glottis,0
8837,Blasts Under 20 Percent of Peripheral Blood White Cells,Signet-ring cell adenocarcinoma of colon,0
8838,EBV-Positive Neoplastic Cells Present,Hard Palate Pleomorphic Adenoma,0
8839,Multihormonal Immunoreactivity Present in a Single Cell Type,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant",0
8840,Endobronchial Lesion,Refractory Hemophagocytic Lymphohistiocytosis,0
8841,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
8842,Abundance of Small Lymphocytes,mucinous adenocarcinoma of gallbladder,0
8843,Ectopic Thyroid Tissue Present,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",0
8844,EBV-Positive Neoplastic Cells Present,Undifferentiated (Embryonal) Sarcoma,0
8845,EBV-Positive Neoplastic Cells Present,Colon Traditional Serrated Adenoma,0
8846,Multiple Tumor Masses,Pituitary Gland Multiple Adenomas,0
8847,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Seborrheic keratosis of eyelid,0
8848,Secondary Lesion,Adult Extracardiac Rhabdomyoma,0
8849,EBV-Positive Neoplastic Cells Present,Colorectal hyperplastic polyp,0
8850,EBV-Positive Neoplastic Cells Present,Cervical Leiomyoma,0
8851,Fascicular Pattern,"Testicular Yolk Sac Tumor, Myxomatous Pattern",0
8852,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Hodgkin's lymphoma of CNS,0
8853,Endobronchial Lesion,Childhood Central Nervous System Germinoma,0
8854,NRBC - Nucleated red blood cell present result,Benign germ cell neoplasm,0
8855,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,TSH-Producing Pituitary Gland Carcinoma,0
8856,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Paraganglioma of head and neck,0
8857,Enterochromaffin Type Granules Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",0
8858,Abundance of Small Lymphocytes,Secondary malignant neoplasm of colon,0
8859,Abundance of Small Lymphocytes,C-cell hyperplasia of thyroid,0
8860,Secondary Lesion,Unresectable Gastroesophageal Junction Adenocarcinoma,0
8861,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of gallbladder localized,0
8862,Secondary Lesion,Cecum Non-Hodgkin Lymphoma,0
8863,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Gastric Gastrin-Producing Neuroendocrine Tumor,0
8864,Secondary Lesion,Erythema multiforme minor,0
8865,Smooth Muscle Component Present,Brain Ependymoma,0
8866,Endobronchial Lesion,Sparsely Granulated Somatotroph Adenoma,0
8867,Abundance of Small Lymphocytes,Benign neoplasm of trachea,0
8868,Smooth Muscle Component Present,alopecia congenita,0
8869,Solitary Skin Tumor,Dedifferentiated Solitary Fibrous Tumor,0
8870,Blasts Under 20 Percent of Peripheral Blood White Cells,Large cell carcinoma of lung,0
8871,Endobronchial Lesion,Clivus Chondroid Chordoma,0
8872,EBV-Positive Neoplastic Cells Present,Stage 3 Neuroblastoma,0
8873,Schwannian Stroma Predominant Component of the Tumor Volume,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
8874,Plasma cell inflammation,Acquired cystic disease associated renal cell carcinoma,0
8875,Small Aggregates of Tumor Cells Present,Stage III Duodenal Neuroendocrine Tumor AJCC v8,0
8876,Smooth Muscle Component Present,Childhood Meningioma,0
8877,EBV-Positive Neoplastic Cells Present,Childhood Seminoma,0
8878,Smooth Muscle Component Present,Thymoliposarcoma,0
8879,Secondary Lesion,Stage IIB Rectal Cancer AJCC v8,0
8880,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Vaginal Papillary Carcinoma,0
8881,Mixed Neoplastic Glandular and Squamous Cell Population,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0
8882,Endobronchial Lesion,Pharyngeal cancer recurrent,0
8883,EBV-Positive Neoplastic Cells Present,Periampullary Adenocarcinoma,0
8884,Peau d'orange surface of breast,Malignant melanoma of breast,0
8885,Mixed Neoplastic Glandular and Squamous Cell Population,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",0
8886,Endobronchial Lesion,Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8,0
8887,Secondary Lesion,"Thrombocythemia, Essential",0
8888,EBV-Positive Neoplastic Cells Present,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8889,Endobronchial Lesion,Fibroblastic osteosarcoma,0
8890,Extensive Stage Lesion,Gallbladder Cancer by AJCC v6 Stage,0
8891,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Rhabdomyosarcoma of cervix uteri,0
8892,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIC Appendix Carcinoma AJCC v7,0
8893,Breast Implant-Related Lesion,Intraductal Breast Myoepitheliosis,0
8894,Endobronchial Lesion,Bullous pemphigoid,0
8895,Lesion with Diameter of 10mm or Less,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0
8896,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign Ovarian Transitional Cell Tumor,0
8897,Epithelioid Differentiation,Childhood Epithelioid Hemangioendothelioma,0
8898,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Fallopian Tube Transitional Cell Carcinoma,0
8899,Mixed Neoplastic Glandular and Squamous Cell Population,Testicular Cancer by AJCC v6 and v7 Stage,0
8900,Secondary Lesion,Iatrogenic Kaposi Sarcoma,0
8901,EBV-Positive Neoplastic Cells Present,Acanthoma,0
8902,Secondary Lesion,Refractory Cholangiocarcinoma,0
8903,EBV-Positive Neoplastic Cells Present,PRETEXT Stage 3 Hepatoblastoma,0
8904,White blood cell count increased (lab result),Infiltrating basal cell carcinoma,0
8905,Absence of Malignant Features,Malignant neoplasm of oropharynx,0
8906,Endobronchial Lesion,Stage IA Distal Bile Duct Cancer AJCC v7,0
8907,EBV-Positive Neoplastic Cells Present,"Odontogenic tumor, benign",0
8908,Smooth Muscle Component Present,Epicardial Lipoma,0
8909,Single Cell Necrosis,"Langerhans Cell Histiocytosis, Disseminated",0
8910,Smooth Muscle Component Present,Liver Leiomyoma,0
8911,Abnormal Eosinophilic Granules Present,Eosinophilic Granuloma,0
8912,EBV-Positive Neoplastic Cells Present,Maturing Ganglioneuroma,0
8913,Endobronchial Lesion,Immature Ovarian Teratoma,0
8914,EBV-Positive Neoplastic Cells Present,Cauda Equina Paraganglioma,0
8915,Secondary Lesion,Biliary Intraepithelial Neoplasia-2,0
8916,Endobronchial Lesion,Stage IIA Uveal Melanoma AJCC v7,0
8917,Endobronchial Lesion,Third Ventricle Germinoma,0
8918,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,mucoepidermoid carcinoma of accessory sinus,0
8919,Extensive Stage Lesion,Stage IV Ureter Cancer AJCC v8,0
8920,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0
8921,Secondary Lesion,"Adenoma, Monomorphic",0
8922,Recurrent Malignant Neoplasm,Recurrent Adult Acute Lymphoblastic Leukemia,0
8923,Blasts Under 20 Percent of Peripheral Blood White Cells,follicular lymphoma of thyroid gland,0
8924,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,0
8925,Endobronchial Lesion,Adult Brain Meningioma,0
8926,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of breast,0
8927,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Endometrial Undifferentiated Carcinoma,0
8928,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIC Testicular Cancer AJCC v6 and v7,0
8929,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Keratocystic Odontogenic Tumor,0
8930,EBV-Positive Neoplastic Cells Present,Glossopharyngeal nerve paralysis,0
8931,NRBC - Nucleated red blood cell present result,Metastatic basal cell carcinoma,0
8932,Endobronchial Lesion,Stage IIIB Colorectal Cancer AJCC v7,0
8933,Malignant Primitive Cellular Infiltrate,Cellular angiofibroma,0
8934,EBV-Positive Neoplastic Cells Present,Smoldering myeloma,0
8935,No Evidence of Metastatic Disease,Metastatic Lung Carcinoma,0
8936,Endobronchial Lesion,Borderline Ovarian Mucinous Adenofibroma,0
8937,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
8938,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Colloid Carcinoma of the Pancreas,0
8939,Secondary Lesion,Acanthosis Nigricans,0
8940,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Mucinous cystadenocarcinoma of ovary,0
8941,Inflammatory infiltrate,Anal Inflammatory Cloacogenic Polyp,0
8942,Secondary Lesion,"Adenocarcinoma, endocervical type",0
8943,Recurrent Malignant Neoplasm,Small Intestinal Neuroendocrine Neoplasm,0
8944,Unfavorable Clinical Outcome,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,0
8945,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Moderately Differentiated Squamous Cell Carcinoma,0
8946,Endobronchial Lesion,Adult Cerebellar Neoplasm,0
8947,Lesion with Diameter of 4mm or More,Ovarian Dermoid Cyst with Leiomyosarcoma,0
8948,EBV-Positive Neoplastic Cells Present,Glioblastoma,0
8949,Extensive Stage Lesion,Stage IV Esophageal Cancer AJCC v7,0
8950,EBV-Positive Neoplastic Cells Present,Stage III Vulvar Cancer AJCC v8,0
8951,High Grade Non Cartilaginous Sarcomatous Stroma Present,Colorectal High Grade Intraepithelial Neoplasia,0
8952,No Evidence of Metastatic Disease,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
8953,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,serous adenocarcinofibroma of ovary,0
8954,Undifferentiated Lesion,Unresectable Undifferentiated Pleomorphic Sarcoma,0
8955,Squamous metaplasia of bladder,Squamous non-small cell lung cancer,0
8956,Well Differentiated Neuroendocrine Lesion,Differentiated Thyroid Gland Carcinoma,0
8957,Absence of Malignant Features,Refractory Malignant Male Reproductive System Neoplasm,0
8958,Endobronchial Lesion,Anaplastic Embryonal Rhabdomyosarcoma,0
8959,Endobronchial Lesion,"Hemangioma, Cavernous, Central Nervous System",0
8960,Secondary Lesion,GIANT PIGMENTED HAIRY NEVUS,0
8961,Lesion with Diameter of 10mm or Less,Medulloblastoma with Leptomeningeal Spread,0
8962,Neoplastic Growth or Spread,Growth Hormone-Producing Pituitary Gland Carcinoma,0
8963,Intravascular Fibrin Thrombus Formation,Recurrent Intravascular Large B-Cell Lymphoma,0
8964,Endobronchial Lesion,Bladder Urachal Urothelial Carcinoma,0
8965,Endobronchial Lesion,Renal Pelvis Cancer by AJCC v8 Stage,0
8966,Fibrotic Stroma with Finger-Like Projections Present,Testicular Spermatocytic Seminoma with Sarcoma,0
8967,Secondary Lesion,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",0
8968,Gastric dysplasia,Metastatic Gastric Carcinoma,0
8969,Secondary Lesion,Pituitary Gland Macroadenoma,0
8970,Absence of Malignant Features,Stage III Pleural Malignant Mesothelioma AJCC v8,0
8971,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unclassified Renal Cell Carcinoma,0
8972,Secondary Lesion,Salivary Gland Pleomorphic Adenoma,0
8973,Endobronchial Lesion,Stage IIB Gastric Cancer AJCC v7,0
8974,Entrapped Respiratory Epithelium Present,Benign Germinative Follicular Epithelium Neoplasm,0
8975,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Testicular Cancer by AJCC v6 and v7 Stage,0
8976,Abundance of Small Lymphocytes,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0
8977,Low Grade Cartilaginous Component Present,Low Grade Sarcoma,0
8978,Rimming of Adipose Tissue Cells Present,Thymic Mucosa-Associated Lymphoid Tissue Lymphoma,0
8979,Multiple Tumor Masses,Stage IIB Gestational Trophoblastic Tumor AJCC v7,0
8980,Mesenchymal Metaplasia of Malignant Cells Present,Malignant tumor of minor salivary gland,0
8981,Secondary Lesion,Adult Central Nervous System Choriocarcinoma,0
8982,Angiocentric Pattern,Angiocentric lymphoma refractory,0
8983,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of lacrimal duct,0
8984,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),0
8985,Myxoid Changes Present,Metastatic Extraskeletal Myxoid Chondrosarcoma,0
8986,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IIB Pancreatic Cancer AJCC v6 and v7,0
8987,Secondary Lesion,Stage I Adult Burkitt Lymphoma,0
8988,EBV-Positive Neoplastic Cells Present,Alveolar soft part sarcoma recurrent,0
8989,Mucinous degeneration,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0
8990,EBV-Positive Neoplastic Cells Present,Thymic Hepatoid Adenocarcinoma,0
8991,EBV-Positive Neoplastic Cells Present,Vulvar Eccrine Porocarcinoma,0
8992,NRBC - Nucleated red blood cell present result,granulosa cell tumor,0
8993,Blasts Under 20 Percent of Peripheral Blood White Cells,melanoma of scrotum,0
8994,EBV-Positive Neoplastic Cells Present,Penis carcinoma,0
8995,EBV-Positive Neoplastic Cells Present,Morbidly adherent placenta (disorder),0
8996,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8997,Endobronchial Lesion,inverted follicular keratosis,0
8998,Extensive Stage Lesion,Stage IC Fallopian Tube Cancer AJCC v8,0
8999,Endobronchial Lesion,Harlequin Fetus,0
9000,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8,0
9001,Extensive Stage Lesion,Stage IIB Fallopian Tube Cancer AJCC v8,0
9002,Small Aggregates of Tumor Cells Present,Pancreatic ACTH-Producing Neuroendocrine Tumor,0
9003,Mucinous degeneration,Grade 2 Endometrial Mucinous Adenocarcinoma,0
9004,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIA Ovarian Cancer AJCC V6 and v7,0
9005,Malignant Primitive Cellular Infiltrate,Locally Advanced Unresectable Malignant Neoplasm,0
9006,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign tumor of penis,0
9007,Endobronchial Lesion,Stage IIIA Bladder Cancer AJCC v8,0
9008,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of esophagus,0
9009,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of vagina,0
9010,Absence of Malignant Features,Unresectable Malignant Solid Neoplasm,0
9011,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,AIDS-Related Malignant Neoplasm,0
9012,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage II Pancreatic Cancer AJCC v6 and v7,0
9013,EBV-Positive Neoplastic Cells Present,Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
9014,Localized Hydropic Villous Change,Villous adenocarcinoma,0
9015,Endobronchial Lesion,Postsurgical Stage III Hepatoblastoma,0
9016,Crystal deposition,Immunoglobulin deposition disease,0
9017,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0
9018,Secondary Lesion,Chondromatosis,0
9019,Endobronchial Lesion,Stage IA Cervical Cancer AJCC v8,0
9020,EBV-Positive Neoplastic Cells Present,Ovarian Solid Teratoma,0
9021,Small Aggregates of Tumor Cells Present,Benign Brenner Tumor,0
9022,Unfavorable Clinical Outcome,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,0
9023,Secondary Lesion,Stage IV Hilar Cholangiocarcinoma AJCC v8,0
9024,EBV-Positive Neoplastic Cells Present,Epulides,0
9025,Endobronchial Lesion,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0
9026,Mixed Neoplastic Glandular and Squamous Cell Population,"Adenocarcinoma, Clear Cell",0
9027,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Head and Neck Squamous Cell Carcinoma,0
9028,Blasts Under 20 Percent of Peripheral Blood White Cells,Pilocytic astrocytoma of cerebellum,0
9029,Smooth Muscle Component Present,Dermatofibrosarcoma Protuberans,0
9030,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Squamous Papilloma of the Nasopharynx,0
9031,Secondary Lesion,Transplant-Related Kaposi Sarcoma,0
9032,Secondary Lesion,Lentigo,0
9033,Prominent In Situ Component Present,Skin Squamous Cell Carcinoma In Situ,0
9034,Large Neoplastic Glands with Branching and Papillary Infolding Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,0
9035,EBV-Positive Neoplastic Cells Present,Stage IV Eyelid Carcinoma AJCC v7,0
9036,Endobronchial Lesion,Cobb's syndrome,0
9037,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Stromal Tumor with Minor Sex Cord Elements,0
9038,Secondary Lesion,Refractory Glioblastoma,0
9039,Multihormonal Immunoreactivity Present in a Single Cell Type,Ann Arbor Stage II Mantle Cell Lymphoma,0
9040,Single Cell Necrosis,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
9041,Endobronchial Lesion,Congenital Epulides,0
9042,Blasts Under 20 Percent of Peripheral Blood White Cells,Carcinoma of anal canal,0
9043,Smooth Muscle Component Present,Sphenoid Sinus Inverted Papilloma,0
9044,Pleural effusion disorder,Lymphoproliferative disorder caused by methotrexate,0
9045,Abundance of Small Lymphocytes,Carcinoma of unknown primary,0
9046,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Clear Cell Adenocarcinoma,0
9047,Secondary Lesion,Monophasic Synovial Sarcoma,0
9048,Malignant Primitive Cellular Infiltrate,Cellular leiomyoma,0
9049,Smooth Muscle Component Present,Oncocytic Schneiderian papilloma,0
9050,Non-Encapsulated Neoplasm,Stage III Gestational Trophoblastic Neoplasm AJCC v8,0
9051,Smooth Muscle Component Present,Solar lentigo,0
9052,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Undifferentiated Carcinoma of Colon,0
9053,Schwannian Stroma Predominant Component of the Tumor Volume,Lepidic Predominant Adenocarcinoma,0
9054,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Inverting papilloma of the paranasal sinus,0
9055,Undifferentiated Lesion,Refractory Undifferentiated Pleomorphic Sarcoma,0
9056,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,0
9057,Unfavorable Clinical Outcome,Clinical Stage IVA Gastric Cancer AJCC v8,0
9058,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of kidney,0
9059,Secondary Lesion,Extra-abdominal fibromatosis,0
9060,Extramedullary Hematopoiesis (disorder),"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)",0
9061,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Dermoid Cyst of the Spinal Cord,0
9062,Secondary Lesion,Ovarian Thecoma,0
9063,Endobronchial Lesion,Locally Advanced Unresectable Sarcoma,0
9064,EBV-Positive Neoplastic Cells Present,Childhood Ependymoma,0
9065,Endobronchial Lesion,"Focal Segmental Glomerulosclerosis, Not Otherwise Specified",0
9066,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Male Reproductive System Neoplasm,0
9067,Endobronchial Lesion,Endobronchial Leiomyoma,0
9068,Non-Encapsulated Neoplasm,Pancreatic Serous Neoplasm,0
9069,NRBC - Nucleated red blood cell present result,Adenosquamous cell lung cancer stage III,0
9070,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Synchronous Bilateral Breast Carcinoma,0
9071,Endobronchial Lesion,Stage IVA Prostate Cancer AJCC v8,0
9072,Small Aggregates of Tumor Cells Present,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
9073,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IA Testicular Cancer AJCC v6 and v7,0
9074,Endobronchial Lesion,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,0
9075,Endobronchial Lesion,"Recurrent NK-Cell Lymphoma, Unclassifiable",0
9076,EBV-Positive Neoplastic Cells Present,Degenerated Schwannoma,0
9077,Enterochromaffin Type Granules Present,Multiple Endocrine Neoplasia Type 1,0
9078,Endobronchial Lesion,Stage I Vulvar Carcinoma,0
9079,Small Aggregates of Tumor Cells Present,Testicular Brenner Tumor,0
9080,Well Differentiated Neuroendocrine Lesion,Breast Neuroendocrine Neoplasm,0
9081,Locally Aggressive Lesion,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma,0
9082,EBV-Positive Neoplastic Cells Present,"Optic Atrophies, Hereditary",0
9083,Endobronchial Lesion,AIDS-Related Herpes Zoster,0
9084,Small Aggregates of Tumor Cells Present,Pancreatic Small Cell Neuroendocrine Carcinoma,0
9085,Multiple Tumor Masses,Hereditary Kidney Wilms Tumor,0
9086,EBV-Positive Neoplastic Cells Present,Hodgkin's disease mixed cellularity recurrent,0
9087,Secondary Lesion,Stage IV Adult Hodgkin Lymphoma,0
9088,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Oral Cavity Adenoid Cystic Carcinoma,0
9089,Mixed Neoplastic Glandular and Squamous Cell Population,"Papilloma, Squamous Cell",0
9090,Melanoma Cells Present,Stage II Lentigo Maligna Melanoma AJCC v6 and v7,0
9091,Secondary Lesion,Childhood Ovarian Mature Teratoma,0
9092,EBV-Positive Neoplastic Cells Present,Stage II Hepatocellular Carcinoma AJCC v8,0
9093,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,0
9094,Large Neoplastic Glands with Branching and Papillary Infolding Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,0
9095,Extensive Stage Lesion,Stage IB Pancreatic Cancer AJCC v8,0
9096,Secondary Lesion,Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
9097,EBV-Positive Neoplastic Cells Present,Advanced Cervical Adenocarcinoma,0
9098,Small Aggregates of Tumor Cells Present,Benign Ovarian Transitional Cell Tumor,0
9099,Lymphocyte count increased,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9100,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Unresectable Prostate Carcinoma,0
9101,Secondary Lesion,Signet Ring Melanoma,0
9102,EBV-Positive Neoplastic Cells Present,"Kaposi's sarcoma, metastatic",0
9103,EBV-Positive Neoplastic Cells Present,Unresectable Craniopharyngioma,0
9104,Secondary Lesion,Appendix Lymphoma,0
9105,Endobronchial Lesion,Childhood Liposarcoma,0
9106,Nodular and Diffuse Pattern,Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9107,Smooth Muscle Component Present,Soft tissue chondroma,0
9108,Secondary Lesion,Stage III Vaginal Cancer AJCC v8,0
9109,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,0
9110,Multiple Tumor Masses,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,0
9111,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Pancreatic Neuroendocrine Carcinoma,0
9112,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of ethmoidal sinus,0
9113,Small Aggregates of Tumor Cells Present,Small Intestinal Carcinoid Tumor,0
9114,Extensive Stage Lesion,Stage I Distal Bile Duct Cancer AJCC v8,0
9115,Absence of Malignant Features,Malignant neoplasm of sublingual gland,0
9116,Smooth Muscle Component Present,Aortic Angiosarcoma,0
9117,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Human Papillomavirus-Related Endocervical Adenocarcinoma,0
9118,EBV-Positive Neoplastic Cells Present,Stage II Uterine Corpus Adenosarcoma AJCC v8,0
9119,Endobronchial Lesion,Prostate Undifferentiated Carcinoma,0
9120,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Adult Brain,0
9121,Blasts Under 20 Percent of Peripheral Blood White Cells,mucinous adenocarcinoma of gallbladder,0
9122,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Prostate Carcinoma,0
9123,Enterochromaffin-Like Type Granules Present,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,0
9124,Endobronchial Lesion,Benign melanocytic nevus,0
9125,Endobronchial Lesion,Adult cystic teratoma,0
9126,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",0
9127,Endobronchial Lesion,Hemangioma,0
9128,Neoplastic Plasma Cells Present in Bone Marrow,Stage I Bone Sarcoma AJCC v7,0
9129,Secondary Lesion,Stage IVB Colon Cancer AJCC v7,0
9130,Mammary Gland Type Features Present,Parotid Gland Lymphangioma,0
9131,Tumor Droplets Present,Bone Glomus Tumor,0
9132,Smooth Muscle Component Present,Pancreatic intraepithelial neoplasia,0
9133,Tubular Structures Present,Small Intestinal Tubular Adenoma,0
9134,Endobronchial Lesion,Recurrent Hematologic Malignancy,0
9135,Local disease,Hodgkin's disease lymphocyte depletion type recurrent,0
9136,Follicular Differentiation,Recurrent Follicular Lymphoma,0
9137,Single Cell Necrosis,Stage I Esophageal Squamous Cell Carcinoma AJCC v7,0
9138,Blasts Under 20 Percent of Peripheral Blood White Cells,Carcinoma of anal margin,0
9139,Endobronchial Lesion,Refractory Ewing Sarcoma,0
9140,Rimming of Adipose Tissue Cells Present,Soft Tissue Sarcoma by AJCC v7 Stage,0
9141,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Corneal Intraepithelial Neoplasia,0
9142,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Esophageal Carcinoma,0
9143,Epithelioid Differentiation,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,0
9144,EBV-Positive Neoplastic Cells Present,Lugano Classification Stage I Hodgkin Lymphoma AJCC v8,0
9145,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,0
9146,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,0
9147,Endobronchial Lesion,Endocrine Gland Neoplasms,0
9148,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Growth Hormone-Producing Pituitary Gland Carcinoma,0
9149,Endobronchial Lesion,Colorectal Hamartoma,0
9150,Locally Aggressive Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
9151,Gastric-Type Epithelial Differentiation,Papillary Epithelial Neoplasm,0
9152,Extensive Stage Lesion,Stage III Liver Cancer,0
9153,Follicular Cell Differentiation,Refractory Langerhans Cell Histiocytosis,0
9154,Primary Site Unknown,Primary Prostate Urothelial Carcinoma,0
9155,Extensive Stage Lesion,Stage IVB Appendix Carcinoma AJCC v7,0
9156,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Renal Pelvis and Ureter Cancer AJCC v8,0
9157,Enterochromaffin Type Granules Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type",0
9158,EBV-Positive Neoplastic Cells Present,Favorable Non-Hodgkin Lymphoma,0
9159,Endobronchial Lesion,Stage IV Adrenal Cortex Carcinoma AJCC v7,0
9160,Multiple Tumor Masses,Stage IV Kidney Wilms Tumor,0
9161,Endobronchial Lesion,Stage I Adult Immunoblastic Lymphoma,0
9162,Intravascular Fibrin Thrombus Formation,Primary Cutaneous Intravascular Large B-Cell Lymphoma,0
9163,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign tumor of choroid plexus,0
9164,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Carcinoma of glottis,0
9165,Intestinal metaplasia of gastric mucosa,Stage I Small Intestinal Adenocarcinoma AJCC v8,0
9166,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Choroidal and Ciliary Body Melanoma AJCC v8,0
9167,Single Cell Necrosis,Plasma Cell Myeloma by RISS Stage,0
9168,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Supratentorial Ependymal Tumor,0
9169,Blasts Under 20 Percent of Peripheral Blood White Cells,squamous cell carcinoma of renal pelvis,0
9170,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0
9171,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colloid Carcinoma of the Pancreas,0
9172,Recurrent Genetic Abnormalities Present,Recurrent Central Nervous System Non-Hodgkin Lymphoma,0
9173,Epithelioid Differentiation,Adult Epithelioid Hemangioendothelioma,0
9174,Non-Encapsulated Neoplasm,Environment-Related Neoplasm,0
9175,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Dysplastic Melanocytic Nevus,0
9176,Endobronchial Lesion,Chronic lymphadenitis,0
9177,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Small Intestinal Neuroendocrine Carcinoma,0
9178,Endobronchial Lesion,Hypertensive crisis,0
9179,EBV-Positive Neoplastic Cells Present,Contact Dermatitis,0
9180,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of the Floor of the Mouth,0
9181,EBV-Positive Neoplastic Cells Present,Stage IVB Colon Cancer AJCC v8,0
9182,Endobronchial Lesion,Stage I Hepatocellular Carcinoma AJCC v8,0
9183,Primary Site Unknown,Stage II Primary Peritoneal Cancer AJCC v8,0
9184,Tumor Droplets Present,Desmoplastic Small Round Cell Tumor,0
9185,Tumor Droplets Present,Lung Inflammatory Myofibroblastic Tumor,0
9186,Endocervical Type Epithelium Present,"Endocervical Adenocarcinoma, Usual Type",0
9187,Abundance of Small Lymphocytes,Benign neoplasm of conjunctiva,0
9188,Endobronchial Lesion,Lung Cancer by AJCC v7 Stage,0
9189,Plasma cell inflammation,Adenosquamous cell lung cancer stage IIIB,0
9190,Secondary Lesion,Verrucous keratotic hemangioma,0
9191,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Polyp of vagina,0
9192,Tubular Pattern,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",0
9193,Endobronchial Lesion,Nasopharyngeal lymphoepithelioma recurrent,0
9194,Multiple Tumor Masses,Benign Brenner Tumor,0
9195,Tumor Droplets Present,Ovarian Sex Cord Tumor with Annular Tubules,0
9196,Abundance of Small Lymphocytes,Fibroma of lung,0
9197,Glandular cell atypia,Tubulocystic renal cell carcinoma,0
9198,Recurrent Malignant Neoplasm,Recurrent Childhood Brain Stem Astrocytoma,0
9199,Blasts of Mixed Phenotype Present,Bladder Mixed Adenocarcinoma,0
9200,Endobronchial Lesion,Bile duct mucinous adenocarcinoma,0
9201,Smooth Muscle Component Present,"Medulloblastoma, Not Otherwise Specified",0
9202,Well Differentiated Hyaline Cartilage Present,Well Differentiated Pancreatic Endocrine Tumor,0
9203,Enterochromaffin Type Granules Present,Classic Type Atypical Fibroxanthoma,0
9204,EBV-Positive Neoplastic Cells Present,AIDS-Related Gastric Kaposi Sarcoma,0
9205,Numerous Stromal Mast Cells Present,Undifferentiated Stromal Sarcoma,0
9206,Multiple Tumor Masses,Borderline Ovarian Serous Tumor with Microinvasion,0
9207,Secondary Lesion,Thyroid Sarcoma,0
9208,Abundance of Small Lymphocytes,Carcinoma of Littre Glands,0
9209,Secondary Lesion,Vaginal Blue Nevus,0
9210,Abundance of Small Lymphocytes,Herpes zoster dermatitis of eyelid,0
9211,Abundance of Small Lymphocytes,Crohn's disease of small intestine,0
9212,Smooth Muscle Component Present,Advanced Sarcoma,0
9213,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colorectal Neuroendocrine Tumor G2,0
9214,Smooth Muscle Component Present,Kaposiform Hemangioendothelioma,0
9215,Smooth Muscle Component Present,Vulvar Syringoma,0
9216,EBV-Positive Neoplastic Cells Present,Histiocytic sarcoma,0
9217,Peau d'orange surface of breast,Hemangioma of breast,0
9218,Endobronchial Lesion,Deep Leiomyoma,0
9219,EBV-Positive Neoplastic Cells Present,Stage IIIC Fallopian Tube Cancer AJCC v8,0
9220,Endobronchial Lesion,Meningothelial sarcoma,0
9221,Endobronchial Lesion,Urethra Fibroepithelial Polyp,0
9222,EBV-Positive Neoplastic Cells Present,Gallbladder Papillomatosis,0
9223,Secondary Lesion,Epidermolytic acanthoma,0
9224,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Gastrointestinal melanoma,0
9225,Neoplastic Plasma Cells Present in Bone Marrow,Benign Bone Schwannoma,0
9226,Intermediate Grade Lesion,Recurrent Grade II Lymphomatoid Granulomatosis,0
9227,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Acute Myeloid Leukemia with t(5;17)(q35;q21),0
9228,Ectopic Thyroid Tissue Present,Stage IV Adult Soft Tissue Sarcoma AJCC v7,0
9229,EBV-Positive Neoplastic Cells Present,Chronic Active Colitis,0
9230,EBV-Positive Neoplastic Cells Present,Childhood Central Nervous System Neoplasm,0
9231,Single Cell Necrosis,Ann Arbor Stage II Mantle Cell Lymphoma,0
9232,Acute inflammation,Adult Acute Monoblastic Leukemia,0
9233,Epithelial hyperplasia of skin,Precancerous skin lesion,0
9234,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
9235,Multiple Tumor Masses,Recurrent Atypical Teratoid/Rhabdoid Tumor,0
9236,EBV-Positive Neoplastic Cells Present,Stage IIIB Uterine Corpus Cancer AJCC v8,0
9237,Acute inflammation,Acute humoral allograft nephropathy,0
9238,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Mediastinal Non-Seminomatous Germ Cell Tumor,0
9239,Lesion with Diameter of 10mm or Less,B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH,0
9240,Squamous metaplasia of bladder,Inverted papilloma of urinary bladder,0
9241,Endobronchial Lesion,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,0
9242,EBV-Positive Neoplastic Cells Present,Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8,0
9243,Endobronchial Lesion,Refractory Lymphoproliferative Disorder,0
9244,Smooth Muscle Component Present,Central nervous system leukemia,0
9245,Endobronchial Lesion,Stage 0 Urethral Cancer AJCC v7,0
9246,Recurrent Malignant Neoplasm,Grade 4 Malignant Neoplasm,0
9247,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,"Squamous Cell Carcinoma of the Penis, Usual Type",0
9248,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Vaginal Tubular Adenoma,0
9249,Blasts Under 20 Percent of Peripheral Blood White Cells,Intermediate Blood Vessel Neoplasm,0
9250,Endobronchial Lesion,Scrotal Liposarcoma,0
9251,EBV-Positive Neoplastic Cells Present,Cervical Adenocarcinoma In Situ,0
9252,Secondary Lesion,Ectopia Lentis,0
9253,Cutaneous plaque,"Cutaneous Fibrous Histiocytoma, Cellular Variant",0
9254,Endobronchial Lesion,Endocervical polyp,0
9255,Blasts Under 20 Percent of Peripheral Blood White Cells,non-Hodgkin's lymphoma of accessory sinus,0
9256,Blasts Expressing CD56 and Immature T-Cell Markers Present,Stage III Immature Testicular Teratoma AJCC v6 and v7,0
9257,Endobronchial Lesion,Stage IB Uterine Corpus Leiomyosarcoma AJCC v8,0
9258,Monoclonal Myeloid or Lymphoid Cells Present,Intracranial Myeloid Sarcoma,0
9259,Lesion with Diameter of 4mm or More,Acute myeloid leukemia with mutated CEBPA,0
9260,Minimally Invasive Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant",0
9261,Smooth Muscle Component Present,Infiltrating Intramuscular Lipoma,0
9262,Abundance of Small Lymphocytes,Cancer of Lip,0
9263,Abundance of Small Lymphocytes,Choriocarcinoma of ovary,0
9264,Secondary Lesion,Lung Non-Mucinous Adenocarcinoma In Situ,0
9265,Blasts Under 20 Percent of Peripheral Blood White Cells,Stage I Carcinoma of Penis,0
9266,Smooth Muscle Component Present,Bladder cancer stage IV,0
9267,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adenocarcinoma in adenomatous polyp,0
9268,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage I Cutaneous Melanoma AJCC v8,0
9269,Endobronchial Lesion,Stage III Colorectal Cancer,0
9270,EBV-Positive Neoplastic Cells Present,Benign Ovarian Neoplasm,0
9271,Recurrent Genetic Abnormalities Present,Recurrent Inverted Schneiderian Papilloma,0
9272,Endobronchial Lesion,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9273,Epithelioid Differentiation,Adult Epithelioid Hemangioendothelioma,0
9274,Small Aggregates of Tumor Cells Present,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,0
9275,Follicular Cell Differentiation,Follicular Lymphoma by Ann Arbor Stage,0
9276,Extensive Stage Lesion,Cervical Cancer by AJCC v8 Stage,0
9277,Endobronchial Lesion,Intraductal papillomatosis,0
9278,EBV-Positive Neoplastic Cells Present,Odontoameloblastoma,0
9279,Recurrent Malignant Neoplasm,Benign Neoplasm,0
9280,Endobronchial Lesion,Stage 2 Neuroblastoma,0
9281,Endobronchial Lesion,Anal cancer metastatic,0
9282,Endobronchial Lesion,Nodular Bartholin Gland Hyperplasia,0
9283,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,hepatoid adenocarcinoma of gallbladder,0
9284,Multihormonal Immunoreactivity Present in a Single Cell Type,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,0
9285,Extensive Stage Lesion,Stage I Laryngeal Cancer AJCC v8,0
9286,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,0
9287,Mixed Neoplastic Glandular and Squamous Cell Population,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified",0
9288,Endobronchial Lesion,Aplasia Cutis Congenita,0
9289,Secondary Lesion,Pancreatic carcinoma recurrent,0
9290,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Sellar Yolk Sac Tumor,0
9291,Endobronchial Lesion,Refractory Ependymoma,0
9292,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Nasopharyngeal Carcinoma by AJCC v8 Stage,0
9293,Proliferation of Follicular Dendritic Cells Present,Follicular Myxoma,0
9294,Recurrent Malignant Neoplasm,Non-Resectable Malignant Liver Neoplasm,0
9295,EBV-Positive Neoplastic Cells Present,Colorectal Undifferentiated Carcinoma,0
9296,Dilated Terminal Duct Lobular Units Present,Stage IA Distal Bile Duct Cancer AJCC v7,0
9297,Lesion with Diameter of 10mm or Less,Ovarian Dermoid Cyst with Sebaceous Carcinoma,0
9298,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ductal Breast Carcinoma with Squamous Metaplasia,0
9299,Endobronchial Lesion,Uterine Corpus Apoplectic Leiomyoma,0
9300,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Refractory Malignant Bone Neoplasm,0
9301,Endobronchial Lesion,Pityriasis Rosea,0
9302,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IVA Lip Cancer AJCC v6 and v7,0
9303,Photosensitivity of skin,Benign neoplasm of skin,0
9304,Endobronchial Lesion,Cervical intraepithelial neoplasia grade 1,0
9305,Endobronchial Lesion,Stage IIIA Ovarian Cancer AJCC v8,0
9306,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,rhabdomyosarcoma of extrahepatic bile duct,0
9307,Secondary Lesion,Stage IIA Ovarian Cancer AJCC v8,0
9308,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Bladder Cancer AJCC v6 and v7,0
9309,Secondary Lesion,Hydatidiform Mole,0
9310,EBV-Positive Neoplastic Cells Present,B-cell small lymphocytic lymphoma refractory,0
9311,Secondary Lesion,Sclerosing Epithelioid Fibrosarcoma,0
9312,Lesion with Diameter of 10mm or Less,Acute Myeloid Leukemia with t(5;17)(q35;q21),0
9313,Endobronchial Lesion,Benign Esophageal Schwannoma,0
9314,Generalized Hydropic Villous Change,Cecum Villous Adenoma,0
9315,EBV-Positive Neoplastic Cells Present,Lymphoma stage III,0
9316,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Grade 2 Invasive Breast Carcinoma,0
9317,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Ovarian Luteinized Thecoma,0
9318,EBV-Positive Neoplastic Cells Present,Stage IV Nasopharyngeal Carcinoma AJCC v6,0
9319,Diffuse Cellular Infiltrate,"Diffuse Astrocytoma, IDH-Mutant",0
9320,Recurrent Genetic Abnormalities Present,Recurrent Minor Salivary Gland Adenocarcinoma,0
9321,Islands of Odontogenic Epithelium Present,"Odontogenic tumor, benign",0
9322,Smooth Muscle Component Present,Adamantinous Craniopharyngioma,0
9323,Smooth Muscle Component Present,Extraventricular neurocytoma,0
9324,Epithelial hyperplasia of skin,Acantholytic squamous cell carcinoma of skin,0
9325,EBV-Positive Neoplastic Cells Present,Borderline Ovarian Serous Adenofibroma,0
9326,Recurrent Malignant Neoplasm,Recurrent Malignant Skin Neoplasm,0
9327,Mucinous degeneration,Uterine Ligament Mucinous Adenocarcinoma,0
9328,Endobronchial Lesion,Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8,0
9329,EBV-Positive Neoplastic Cells Present,Stage 2B Neuroblastoma,0
9330,Lesion with Diameter of 10mm or Less,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,0
9331,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Squamous Papilloma,0
9332,Secondary Lesion,EBV-Related Carcinoma,0
9333,Acute inflammation,Acute myeloid leukemia refractory,0
9334,High Grade Non Cartilaginous Sarcomatous Stroma Present,WHO Grade III Glioma,0
9335,Mixed Neoplastic Glandular and Squamous Cell Population,Glandular Cell Intraepithelial Neoplasia,0
9336,Multihormonal Immunoreactivity Present in a Single Cell Type,Minor Salivary Gland Acinic Cell Carcinoma,0
9337,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,0
9338,Single Cell Necrosis,Stage IV Esophageal Squamous Cell Carcinoma,0
9339,EBV-Positive Neoplastic Cells Present,Stage IIIA Appendix Carcinoma AJCC v8,0
9340,Endobronchial Lesion,Stage III Rectosigmoid Cancer AJCC v7,0
9341,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Vaginal Adenoid Cystic Carcinoma,0
9342,Secondary Lesion,Deep Penetrating Nevus,0
9343,Extensive Stage Lesion,Stage IB Lung Cancer AJCC v7,0
9344,Extensive Stage Lesion,Stage II Anal Cancer AJCC v8,0
9345,Endobronchial Lesion,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8,0
9346,Smooth Muscle Component Present,Syringofibroadenoma,0
9347,Malignant Germinomatous Cellular Infiltrate,Cellular Pleomorphic Adenoma,0
9348,EBV-Positive Neoplastic Cells Present,Seminal Vesicle Adenocarcinoma,0
9349,Endobronchial Lesion,Transformed Non-Hodgkin Lymphoma,0
9350,Recurrent Malignant Neoplasm,Benign Adult Cerebral Neoplasm,0
9351,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Gastric Neuroendocrine Tumor,0
9352,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adenocarcinoma in situ in a polyp,0
9353,Cutaneous plaque,Pathologic Stage IV Cutaneous Melanoma AJCC v8,0
9354,Endobronchial Lesion,Nasopharyngeal lymphoepithelioma stage II,0
9355,Small Aggregates of Tumor Cells Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
9356,Multihormonal Immunoreactivity Present in a Single Cell Type,Endometrial Clear Cell Adenocarcinoma,0
9357,Secondary Lesion,Childhood Pilomyxoid Astrocytoma,0
9358,Blasts Under 20 Percent of Peripheral Blood White Cells,tubular adenoma of extrahepatic bile duct,0
9359,Endobronchial Lesion,Childhood Embryonal Carcinoma,0
9360,Multihormonal Immunoreactivity Present in a Single Cell Type,Vaginal Keratinizing Squamous Cell Carcinoma,0
9361,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
9362,Secondary Lesion,Gastro-enteropancreatic neuroendocrine tumor,0
9363,Endobronchial Lesion,Ethmoid Sinus Adenoid Cystic Carcinoma,0
9364,Secondary Lesion,Stage I Uterine Corpus Cancer AJCC v6,0
9365,Endobronchial Lesion,Undifferentiated Fallopian Tube Carcinoma,0
9366,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,0
9367,Tumor Droplets Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
9368,Extensive Stage Lesion,Stage III Rectosigmoid Cancer AJCC v6,0
9369,Extensive Stage Lesion,Stage IIIB Primary Peritoneal Cancer AJCC v7,0
9370,Endobronchial Lesion,Metastatic leiomyosarcoma,0
9371,Secondary Lesion,Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8,0
9372,Blasts Under 20 Percent of Peripheral Blood White Cells,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid,0
9373,Small Aggregates of Tumor Cells Present,Benign Anal Granular Cell Tumor,0
9374,Small Aggregates of Tumor Cells Present,Cerebellar and Fourth Ventricle Ependymal Tumor,0
9375,Extensive Stage Lesion,Stage III Primary Peritoneal Cancer AJCC v7,0
9376,Single Cell Necrosis,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
9377,Endobronchial Lesion,Sebaceous Adenocarcinoma,0
9378,Extensive Stage Lesion,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
9379,Extensive Stage Lesion,Stage IV Hepatocellular Carcinoma AJCC v7,0
9380,Endobronchial Lesion,Peritoneal cystic mesothelioma,0
9381,Endobronchial Lesion,Undifferentiated Fallopian Tube Carcinoma,0
9382,EBV-Positive Neoplastic Cells Present,Lung Biphasic Synovial Sarcoma,0
9383,Acute inflammation,Childhood Acute Myelomonocytic Leukemia,0
9384,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Childhood Gonadal Germ Cell Tumor,0
9385,Smooth Muscle Component Present,Cardiac Intramuscular Hemangioma,0
9386,Eosinophilic inflammation,Adult Acute Eosinophilic Leukemia,0
9387,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of trachea,0
9388,Smooth Muscle Component Present,Hepatoblastoma,0
9389,Multinodular and Vacuolated Pattern,Stage I Ovarian Dysgerminoma AJCC v6 and v7,0
9390,Tumor Droplets Present,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,0
9391,Blasts Under 20 Percent of Peripheral Blood White Cells,Villous adenoma of duodenum,0
9392,Tumor Droplets Present,Pericardial Yolk Sac Tumor,0
9393,Gastric dysplasia,Gastric Non-Hodgkin's Lymphoma,0
9394,Extensive Stage Lesion,Stage IV Uterine Corpus Cancer AJCC v8,0
9395,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,yolk sac tumor of mediastinum,0
9396,Secondary Lesion,Anal cancer recurrent,0
9397,Endobronchial Lesion,Overt Primary Myelofibrosis,0
9398,Non-Encapsulated Neoplasm,Bladder Non-Invasive Urothelial Neoplasm,0
9399,Mixed Neoplastic Glandular and Squamous Cell Population,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
9400,Endobronchial Lesion,Pancreatic Intraepithelial Neoplasia-1B,0
9401,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Synchronous Bilateral Breast Carcinoma,0
9402,Ectopic Thyroid Tissue Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,0
9403,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adenocarcinoma of anus,0
9404,Endobronchial Lesion,Prostate Sarcoma,0
9405,NRBC - Nucleated red blood cell present result,"Papillary squamous cell carcinoma, non-invasive",0
9406,Secondary Lesion,Digestive System Hodgkin Lymphoma,0
9407,Mucinous degeneration,Endometrial Mucinous Adenocarcinoma,0
9408,Smooth Muscle Component Present,Mongolian Spot,0
9409,Abundance of Small Lymphocytes,Malignant neoplasm of cornea,0
9410,Recurrent Genetic Abnormalities Present,Recurrent Adenoid Cystic Carcinoma,0
9411,High Grade Non Cartilaginous Sarcomatous Stroma Present,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",0
9412,Secondary Lesion,Prostate cancer stage A,0
9413,Extensive Stage Lesion,Stage IC Ovarian Cancer AJCC v8,0
9414,EBV-Positive Neoplastic Cells Present,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8,0
9415,Extensive Stage Lesion,Stage IIIC Fallopian Tube Cancer AJCC v8,0
9416,Endobronchial Lesion,Spindle Cell/Pleomorphic Lipoma,0
9417,Dilated Terminal Duct Lobular Units Present,Adenosquamous Bile Duct Carcinoma,0
9418,Blasts Under 20 Percent of Peripheral Blood White Cells,Acinic cell carcinoma of salivary gland,0
9419,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,0
9420,White blood cell count increased (lab result),Renal cell carcinoma recurrent,0
9421,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Refractory anemia with ringed sideroblasts,0
9422,Smooth Muscle Component Present,Adult Erythroleukemia,0
9423,Endobronchial Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma,0
9424,Blasts Expressing CD56 and Immature T-Cell Markers Present,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0
9425,Schwannian Stroma Predominant Component of the Tumor Volume,Malignant Mixed Tumor of the Major Salivary Gland,0
9426,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Leukemic Phase of Non-Hodgkin's Lymphoma,0
9427,Photosensitivity of skin,Benign neoplasm of skin,0
9428,EBV-Positive Neoplastic Cells Present,Metastatic Penile Cancer,0
9429,EBV-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type A",0
9430,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Squamous cell carcinoma of the hypopharynx stage III,0
9431,EBV-Positive Neoplastic Cells Present,B-cell small lymphocytic lymphoma refractory,0
9432,Endobronchial Lesion,Stage IIIB Colon Cancer AJCC v8,0
9433,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Endometrial Carcinoma,0
9434,Secondary Lesion,Benign Parathyroid Gland Adenoma,0
9435,Melanoma Cells Present,Spinal Cord Melanoma,0
9436,Endobronchial Lesion,Hodgkin's disease nodular sclerosis refractory,0
9437,EBV-Positive Neoplastic Cells Present,Stage IIIA Vulvar Cancer AJCC v8,0
9438,Secondary Lesion,"Leukemia, Myeloid, Chronic-Phase",0
9439,Plasma cell inflammation,Acquired cystic disease associated renal cell carcinoma,0
9440,Recurrent Malignant Neoplasm,Intermediate Cutaneous Fibrohistiocytic Neoplasm,0
9441,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,hepatoid adenocarcinoma of bladder,0
9442,Endobronchial Lesion,Central Nervous System Undifferentiated Pleomorphic Sarcoma,0
9443,Small Aggregates of Tumor Cells Present,Stage III Kidney Wilms Tumor,0
9444,Secondary Lesion,Adrenal Cortical Adenoma,0
9445,Gastric dysplasia,Gastric hyperplastic polyp,0
9446,NRBC - Nucleated red blood cell present result,Mantle cell lymphoma,0
9447,Mature Neutrophils Present,Mature Ovarian Teratoma,0
9448,Malignant Primitive Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v8,0
9449,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Endometrial Clear Cell Adenocarcinoma,0
9450,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Carcinoma to the Uterine Cervix,0
9451,EBV-Positive Neoplastic Cells Present,Erythema Multiforme,0
9452,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage,0
9453,Skin nodule,Flexural Skin Nevus,0
9454,Secondary Lesion,Intimal sarcoma,0
9455,EBV-Positive Neoplastic Cells Present,Stage IVB Laryngeal Cancer AJCC v7,0
9456,Endobronchial Lesion,Pulmonary Lymphomatoid Granulomatosis,0
9457,EBV-Positive Neoplastic Cells Present,Gastric Burkitt Lymphoma,0
9458,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Uterine Corpus Atypical Polypoid Adenomyoma,0
9459,Blasts Under 20 Percent of Peripheral Blood White Cells,malignant lymphoma of mediastinum,0
9460,Tumor Droplets Present,Stage IIB Colon Neuroendocrine Tumor AJCC v8,0
9461,No Evidence of Metastatic Disease,Metastatic Neoplasm,0
9462,Secondary Lesion,Stage IVB Colon Cancer AJCC v7,0
9463,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,malignant tumor of male genital organ,0
9464,Endobronchial Lesion,Stage II Laryngeal Cancer AJCC v8,0
9465,Follicular Cell Differentiation,"Dendritic Cell Sarcoma, Interdigitating",0
9466,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Solar Radiation-Related Malignant Neoplasm,0
9467,Rubbery Skin Lesion,Skin Angiosarcoma,0
9468,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIA Breast Carcinoma,0
9469,Secondary Lesion,Stage IVB Colon Cancer AJCC v8,0
9470,Tissues Derived from Two or Three Embryonic Layers Present,Ameloblastic Carcinoma Derived From Odontogenic Cyst,0
9471,Extensive Stage Lesion,Stage IB Hepatocellular Carcinoma AJCC v8,0
9472,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Mixed Mesodermal (Mullerian) Tumor,0
9473,Smooth Muscle Component Present,Digestive System Non-Hodgkin Lymphoma,0
9474,EBV-Positive Neoplastic Cells Present,Refractory Hepatoblastoma,0
9475,EBV-Positive Neoplastic Cells Present,Stage IIA Cervical Cancer AJCC v7,0
9476,EBV-Positive Neoplastic Cells Present,Engraftment syndrome,0
9477,Tumor Droplets Present,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,0
9478,EBV-Positive Neoplastic Cells Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v7,0
9479,Abundance of Small Lymphocytes,polyembryoma of ovary,0
9480,Extensive Stage Lesion,Stage IIIA Gallbladder Cancer AJCC v8,0
9481,Abundance of Small Lymphocytes,large cell carcinoma of salivary gland,0
9482,Small Aggregates of Tumor Cells Present,Anaplastic Kidney Wilms Tumor,0
9483,Endobronchial Lesion,Childhood B Acute Lymphoblastic Leukemia,0
9484,Abundance of Small Lymphocytes,Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9485,Entrapped Respiratory Epithelium Present,Benign Germinative Follicular Epithelium Neoplasm,0
9486,Endobronchial Lesion,Cutaneous Leiomyosarcoma,0
9487,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IA Eyelid Carcinoma AJCC v7,0
9488,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Dermatophytosis of groin and perianal area,0
9489,Smooth Muscle Component Present,Dermatitis,0
9490,Extensive Stage Lesion,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,0
9491,Endobronchial Lesion,Stage IV Rectosigmoid Cancer AJCC v7,0
9492,Smooth Muscle Component Present,Syringoma,0
9493,Stromal Invasion,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
9494,Blasts Under 20 Percent of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
9495,EBV-Positive Neoplastic Cells Present,Subcutaneous Disorder,0
9496,Single Cell Necrosis,Ki-1+ Anaplastic Large Cell Lymphoma,0
9497,Endobronchial Lesion,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7,0
9498,Single Cell Necrosis,Lip and Oral Cavity Squamous Cell Carcinoma,0
9499,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Mucoepidermoid Breast Carcinoma,0
9500,Blasts Under 20 Percent of Peripheral Blood White Cells,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,0
9501,Extensive Stage Lesion,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,0
9502,EBV-Positive Neoplastic Cells Present,Familial Hemophagocytic Lymphocytosis,0
9503,Single Cell Necrosis,Refractory Lung Non-Small Cell Carcinoma,0
9504,Single Cell Necrosis,Anterior Tongue Squamous Cell Carcinoma,0
9505,Blasts 5-19 Percent of Peripheral Blood White Cells,Peripheral Breast Papilloma,0
9506,Smooth Muscle Component Present,High-Risk Neuroblastoma,0
9507,Secondary Lesion,Renal carcinoma,0
9508,Abundance of Small Lymphocytes,Peutz-Jeghers polyps of small bowel,0
9509,EBV-Positive Neoplastic Cells Present,Resectable Dedifferentiated Liposarcoma,0
9510,Endobronchial Lesion,AIDS-Related Cryptococcosis,0
9511,Smooth Muscle Component Present,Supratentorial Pleomorphic Xanthoastrocytoma,0
9512,Endobronchial Lesion,Stage IV Hepatocellular Carcinoma AJCC v8,0
9513,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
9514,Large Neoplastic Glands with Branching and Papillary Infolding Present,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,0
9515,Small Aggregates of Tumor Cells Present,Stage IV Kidney Wilms Tumor,0
9516,Secondary Lesion,Ventricular myxoma,0
9517,EBV-Positive Neoplastic Cells Present,Stage 0 Pharynx Carcinoma,0
9518,Secondary Lesion,"Leukemia, Myelocytic, Acute",0
9519,Single Cell Necrosis,Hepatocellular Small Cell Change,0
9520,Endobronchial Lesion,Stage IV Prostate Cancer AJCC v7,0
9521,Spindle Cell Component Present,Lung Spindle Cell Carcinoma,0
9522,Follicular Differentiation,Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation,0
9523,Blasts of Mixed Phenotype Present,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,0
9524,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,0
9525,Tumor Droplets Present,Mixed Cell Type Kidney Wilms Tumor,0
9526,Secondary Lesion,Adult Undifferentiated Pleomorphic Sarcoma,0
9527,Blasts Under 20 Percent of Peripheral Blood White Cells,Inflammatory fibrous hyperplasia of mouth,0
9528,EBV-Positive Neoplastic Cells Present,"Thymoma, type A",0
9529,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of pancreas,0
9530,Smooth Muscle Component Present,Fourth Ventricle Medulloblastoma,0
9531,Endobronchial Lesion,Osteochondritis juvenilis,0
9532,Secondary Lesion,Stage II Prostate Cancer AJCC v8,0
9533,Mammary Gland Type Features Present,Childhood Salivary Gland Carcinoma,0
9534,Plasma cell inflammation,Nasopharyngeal squamous cell carcinoma stage II,0
9535,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Grade 1 Ovarian Teratoma,0
9536,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Carcinoma in situ of prostate,0
9537,Absence of Malignant Features,Refractory Malignant Urinary System Neoplasm,0
9538,Unifocal Disease,Hodgkin Disease,0
9539,Abundance of Small Lymphocytes,Small intestine carcinoma recurrent,0
9540,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Ewing's sarcoma of bone,0
9541,Single Cell Necrosis,Transitional Cell Neoplasm,0
9542,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of larynx,0
9543,EBV-Positive Neoplastic Cells Present,Myoblastoma,0
9544,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Bone Cancer by AJCC v8 Stage,0
9545,Abundance of Small Lymphocytes,Neuroendocrine carcinoma of appendix,0
9546,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IA Fallopian Tube Cancer AJCC v6 and v7,0
9547,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Histiocytic and Dendritic Cell Neoplasm,0
9548,Secondary Lesion,Childhood Seminoma,0
9549,Lesion with Diameter of 4mm or More,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0
9550,Secondary Lesion,Lymphoepithelioid lymphoma (clinical),0
9551,Mixed Neoplastic Glandular and Squamous Cell Population,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,0
9552,EBV-Positive Neoplastic Cells Present,Metastatic osteosarcoma,0
9553,Endobronchial Lesion,Refractory Liver Carcinoma,0
9554,Secondary Lesion,Laryngeal Adenosquamous Carcinoma,0
9555,EBV-Positive Neoplastic Cells Present,Diencephalic Glioblastoma,0
9556,Tubular Structures Present,Rectal Tubular Adenoma,0
9557,White blood cell count increased (lab result),Clear cell odontogenic carcinoma,0
9558,Endobronchial Lesion,Enteropathy-Associated T-Cell Lymphoma,0
9559,Malignant Primitive Cellular Infiltrate,Malignant Uterine Corpus Neoplasm,0
9560,Congenital Abnormality,Congenital Mesoblastic Nephroma,0
9561,Small Aggregates of Tumor Cells Present,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
9562,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IC Ovarian Cancer AJCC v6 and v7,0
9563,Endobronchial Lesion,Pancreatic Endocrine Carcinoma,0
9564,Localized Hydropic Villous Change,Colorectal Villous Adenoma,0
9565,Secondary Lesion,Stage IIIA1 Fallopian Tube Cancer AJCC v8,0
9566,Epithelial hyperplasia of skin,Lymphangioma of skin,0
9567,Secondary Lesion,Childhood Ovarian Teratoma,0
9568,Venous Type Vascular Channel Formation,"Breast Fibrocystic Change, Proliferative Type without Atypia",0
9569,Glandular cell atypia,Adenosquamous cell lung cancer,0
9570,Plasma cell inflammation,Bladder squamous cell carcinoma recurrent,0
9571,Endobronchial Lesion,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,0
9572,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gastric Large Cell Neuroendocrine Carcinoma,0
9573,Recurrent Malignant Neoplasm,Recurrent Childhood Oligodendroglioma,0
9574,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IV Kidney Wilms Tumor,0
9575,Secondary Lesion,Stage III Renal Pelvis Cancer AJCC v7,0
9576,Breast Implant-Related Lesion,Breast Myofibroblastoma,0
9577,EBV-Positive Neoplastic Cells Present,Solid Alveolar Rhabdomyosarcoma,0
9578,Endobronchial Lesion,Mycosis fungoides stage II,0
9579,Endobronchial Lesion,Recurrent HIV-Associated Lymphoproliferative Disorder,0
9580,Fibrotic Stroma with Finger-Like Projections Present,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0
9581,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,0
9582,Ectopic Thyroid Tissue Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
9583,Blasts Under 20 Percent of Peripheral Blood White Cells,Burkitt's lymphoma of small intestine,0
9584,Absence of Malignant Features,Malignant neoplasm of muscle,0
9585,Mesenchymal Metaplasia of Malignant Cells Present,Malignant tumor of eye,0
9586,Secondary Lesion,Refractory Glioblastoma,0
9587,Secondary Lesion,Stage II Hilar Cholangiocarcinoma AJCC v8,0
9588,Blasts Under 20 Percent of Peripheral Blood White Cells,non-Hodgkin's lymphoma of accessory sinus,0
9589,Endobronchial Lesion,Chronic myeloproliferative disorder,0
9590,Large Neoplastic Glands with Branching and Papillary Infolding Present,Pancreatic Intraductal Papillary Mucinous Neoplasm,0
9591,Well Differentiated Neuroendocrine Lesion,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,0
9592,Endobronchial Lesion,Metastatic Colon Carcinoma,0
9593,Endobronchial Lesion,Refractory Breast Lymphoma,0
9594,Secondary Lesion,Desmoplastic trichilemmoma,0
9595,Secondary Lesion,Stage II Rectosigmoid Cancer AJCC v6,0
9596,Abundance of Small Lymphocytes,Epithelial neoplasm of skin,0
9597,Rubbery Skin Lesion,Skin Angiosarcoma,0
9598,Prominent Stromal Reaction,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
9599,Secondary Lesion,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9600,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Cell Neoplasms,0
9601,Recurrent Malignant Neoplasm,Recurrent Appendix Carcinoma,0
9602,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,0
9603,Endobronchial Lesion,Stage III Cervical Cancer AJCC v8,0
9604,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Localized Unresectable Adult Hepatocellular Carcinoma,0
9605,Smooth Muscle Component Present,Tumorlet,0
9606,EBV-Positive Neoplastic Cells Present,Stage 0 Esophageal Adenocarcinoma AJCC v7,0
9607,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0
9608,EBV-Positive Neoplastic Cells Present,Ann Arbor Stage IIIB Hodgkin Lymphoma,0
9609,Endobronchial Lesion,Bladder Cancer by AJCC v7 Stage,0
9610,Lesion with Diameter of 4mm or More,Testicular Teratoma with Somatic-Type Malignancy,0
9611,EBV-Positive Neoplastic Cells Present,Ovarian Myxoid Liposarcoma,0
9612,Acinar Pattern,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",0
9613,Extensive Stage Lesion,Stage IVB Hilar Cholangiocarcinoma AJCC v7,0
9614,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adenocarcinoma of lacrimal gland,0
9615,Secondary Lesion,Stage IV Non-Hodgkin Lymphoma,0
9616,Blasts Under 20 Percent of Peripheral Blood White Cells,Astrocytoma of brain stem,0
9617,Endobronchial Lesion,Stage II Rectal Cancer AJCC v8,0
9618,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,mucinous adenocarcinoma of ovary,0
9619,Endobronchial Lesion,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8,0
9620,Lesion with Diameter of 10mm or Less,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9621,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
9622,Gastric dysplasia,Locally Advanced Unresectable Gastric Adenocarcinoma,0
9623,EBV-Positive Neoplastic Cells Present,Poikiloderma,0
9624,Mucinous degeneration,Recurrent Ovarian Mucinous Adenocarcinoma,0
9625,EBV-Positive Neoplastic Cells Present,Stage II Urethral Cancer AJCC v8,0
9626,Endobronchial Lesion,Thyroid Gland Mucoepidermoid Carcinoma,0
9627,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Oral Cavity Cancer AJCC v6 and v7,0
9628,Recurrent Malignant Neoplasm,Recurrent Soft Tissue Sarcoma,0
9629,Multihormonal Immunoreactivity Present in a Single Cell Type,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,0
9630,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Posterior Tongue Squamous Cell Carcinoma,0
9631,EBV-Positive Neoplastic Cells Present,Anaplastic adrenocortical carcinoma,0
9632,High Grade Non Cartilaginous Sarcomatous Stroma Present,High grade cervical glandular intraepithelial neoplasia,0
9633,No Evidence of Metastatic Disease,Refractory Metastatic Digestive System Carcinoma,0
9634,Non-Encapsulated Neoplasm,Secondary Neoplasm,0
9635,Small Aggregates of Tumor Cells Present,Stage I Malignant Mediastinal Germ Cell Tumor,0
9636,Abundance of Small Lymphocytes,Malignant melanoma of ciliary body,0
9637,Blasts of Mixed Phenotype Present,Adult Mixed Glioma,0
9638,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Flat Ductal Epithelial Atypia of the Breast,0
9639,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Columnar Cell Lesion of the Breast,0
9640,Extensive Stage Lesion,Stage IIB Testicular Cancer AJCC v8,0
9641,Mixed Neoplastic Glandular and Squamous Cell Population,Maxillary Sinus Squamous Cell Carcinoma,0
9642,Secondary Lesion,Angiocentric lymphoma stage IV,0
9643,Endobronchial Lesion,"Recurrent NK-Cell Lymphoma, Unclassifiable",0
9644,Endobronchial Lesion,Undifferentiated (Embryonal) Sarcoma,0
9645,Enterochromaffin Type Granules Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
9646,Tumor Droplets Present,Malignant Vulvar Phyllodes Tumor,0
9647,EBV-Positive Neoplastic Cells Present,Hereditary Melanoma,0
9648,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,solid type ductal carcinoma in situ of breast,0
9649,Spindle Cell Component Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
9650,EBV-Positive Neoplastic Cells Present,Degenerated Schwannoma,0
9651,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Renal Pelvis Urothelial Carcinoma,0
9652,Progressive Disease,Hodgkin Disease,0
9653,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,0
9654,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,0
9655,Endobronchial Lesion,Metastatic Pharyngeal Carcinoma,0
9656,Tumor Droplets Present,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,0
9657,Multihormonal Immunoreactivity Present in a Single Cell Type,Kidney Epithelioid Type Angiomyolipoma,0
9658,Endobronchial Lesion,Lipoadenoma,0
9659,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Refractory Stage 0 Bladder Cancer AJCC v6 and v7,0
9660,Lesion with Diameter of 4mm or More,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0
9661,Secondary Lesion,Opisthorchis Viverrini-Related Cholangiocarcinoma,0
9662,EBV-Positive Neoplastic Cells Present,FIGO Stage IIIA1(i) Ovarian Cancer,0
9663,EBV-Positive Neoplastic Cells Present,Erythema toxicum neonatorum,0
9664,Follicular Cell Differentiation,Prostatic Basal Cell Hyperplasia,0
9665,Primary Site Unknown,Stage IIIA Primary Peritoneal Cancer AJCC v7,0
9666,EBV-Positive Neoplastic Cells Present,Pancreatic Ductal Adenocarcinoma,0
9667,Skin Erosion,Non-Neoplastic Skin Disorder,0
9668,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage II Bladder Cancer AJCC v6 and v7,0
9669,Small Aggregates of Tumor Cells Present,Malignant Ovarian Sex Cord-Stromal Tumor,0
9670,Abundance of Small Lymphocytes,Malignant neoplasm of thalamus,0
9671,Endometrial Type Glands and Stroma Present,Endometrial Carcinoma,0
9672,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Malignant Ovarian Sex Cord-Stromal Tumor,0
9673,Single Cell Necrosis,Stage III Anaplastic Large Cell Lymphoma,0
9674,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of gallbladder,0
9675,Secondary Lesion,Alcohol-Related Hepatocellular Carcinoma,0
9676,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0
9677,Absence of Malignant Features,Malignant Paraganglionic Neoplasm,0
9678,Ectopic Thyroid Tissue Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,0
9679,EBV-Positive Neoplastic Cells Present,Epicardial Lipoma,0
9680,Abundance of Small Lymphocytes,Clear cell adenocarcinoma of ovary,0
9681,Blasts Under 20 Percent of Peripheral Blood White Cells,Primary malignant neoplasm of oculomotor nerve,0
9682,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,0
9683,Large Neoplastic Glands with Branching and Papillary Infolding Present,Hereditary Papillary Renal Carcinoma,0
9684,Endobronchial Lesion,"Mesothelioma, Cystic",0
9685,Recurrent Malignant Neoplasm,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9686,Mural Nodule,Thyroid Nodule,0
9687,Smooth Muscle Component Present,Centroblastic lymphoma refractory,0
9688,Endobronchial Lesion,Congenital hemangioma,0
9689,Recurrent Malignant Neoplasm,Recurrent Skin Carcinoma,0
9690,Cutaneous plaque,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9691,Blasts Under 20 Percent of Peripheral Blood White Cells,Squamous cell carcinoma of oropharynx,0
9692,Endobronchial Lesion,Adult Intracranial Neoplasm,0
9693,Small Aggregates of Tumor Cells Present,Ovarian Sex Cord Tumor with Annular Tubules,0
9694,Secondary Lesion,Disseminated Juvenile Xanthogranuloma,0
9695,Endobronchial Lesion,Childhood Choriocarcinoma,0
9696,White blood cell count increased (lab result),Nasopharyngeal squamous cell carcinoma recurrent,0
9697,EBV-Positive Neoplastic Cells Present,Fundic gland polyp,0
9698,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of lower gum,0
9699,Dense Collagenized Tissue Present,Benign Cervical Soft Tissue Neoplasm,0
9700,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,0
9701,Extensive Stage Lesion,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,0
9702,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Childhood Hepatocellular Carcinoma AJCC v7,0
9703,NRBC - Nucleated red blood cell present result,Oropharyngeal squamous cell carcinoma recurrent,0
9704,Single Cell Necrosis,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
9705,Endobronchial Lesion,Acute lymphocytic leukemia,0
9706,Absence of Malignant Features,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,0
9707,Absence of Malignant Features,Grade 1 Malignant Neoplasm,0
9708,Secondary Lesion,Stage II Hilar Cholangiocarcinoma AJCC v8,0
9709,Tumor Droplets Present,Pancoast Tumor,0
9710,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Leiomyosarcoma of cervix uteri,0
9711,Smooth Muscle Component Present,Lymphohistiocytoid Mesothelioma,0
9712,Smooth Muscle Component Present,Kaposiform Hemangioendothelioma,0
9713,EBV-Positive Neoplastic Cells Present,Stage IA Mycosis Fungoides AJCC v7,0
9714,Multihormonal Immunoreactivity Present in a Single Cell Type,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant",0
9715,Enterochromaffin Type Granules Present,"Cervical Mucinous Adenocarcinoma, Gastric Type",0
9716,Endobronchial Lesion,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8,0
9717,Tumor Droplets Present,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
9718,EBV-Positive Neoplastic Cells Present,Thymic Lymphoma,0
9719,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
9720,Secondary Lesion,Childhood Cerebral Astrocytoma,0
9721,Extensive Stage Lesion,Anatomic Stage IA Breast Cancer AJCC v8,0
9722,Endobronchial Lesion,Stage IB Pancreatic Cancer AJCC v8,0
9723,Mucinous degeneration,Fallopian Tube Mucinous Adenocarcinoma,0
9724,Small Lesion,Small intestine carcinoma non-resectable,0
9725,Abundance of Small Lymphocytes,Leiomyoma of Gallbladder,0
9726,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,0
9727,Secondary Lesion,Mycosis fungoides stage II,0
9728,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0
9729,Endobronchial Lesion,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion",0
9730,Multihormonal Immunoreactivity Present in a Single Cell Type,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,0
9731,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage I Ovarian Polyembryoma AJCC v6 and v7,0
9732,Extensive Stage Lesion,Stage IIIB Colon Cancer AJCC v8,0
9733,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Esophageal Large Cell Neuroendocrine Carcinoma,0
9734,Recurrent Genetic Abnormalities Present,Recurrent Urinary System Carcinoma,0
9735,Endobronchial Lesion,"Lymphoma, T-Cell, Cutaneous",0
9736,NRBC - Nucleated red blood cell present result,Basal cell carcinoma - adenoid,0
9737,No Evidence of Metastatic Disease,Metastatic Chordoma,0
9738,Recurrent Genetic Abnormalities Present,Recurrent Breast Angiosarcoma,0
9739,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adenoid cystic carcinoma of parotid gland,0
9740,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Liver Carcinoma,0
9741,Secondary Lesion,Tongue Alveolar Soft Part Sarcoma',0
9742,Melanoma Cells Present,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,0
9743,Secondary Lesion,Disseminated neuroblastoma,0
9744,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9745,Blasts of Mixed Phenotype Present,Mixed germ cell-sex cord-stromal tumor,0
9746,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Ann Arbor Stage III Mature T- and NK-Cell Lymphoma,0
9747,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Posterior Urethral Malignant Neoplasm,0
9748,Endobronchial Lesion,Pilar-Associated Mesenchyme Neoplasm,0
9749,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Childhood Extragonadal Malignant Germ Cell Tumor,0
9750,EBV-Positive Neoplastic Cells Present,Plantar wart,0
9751,Follicular Cell Differentiation,Stage IB Lung Large Cell Carcinoma AJCC v7,0
9752,Primary Site Unknown,Primary Carcinoma,0
9753,Endobronchial Lesion,Brain Glioblastoma,0
9754,No Evidence of Metastatic Disease,Metastatic Oral Cavity Carcinoma,0
9755,EBV-Positive Neoplastic Cells Present,Renal carcinoma,0
9756,Abundance of Small Lymphocytes,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
9757,Absence of Malignant Features,Malignant odontogenic tumor,0
9758,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of esophagus,0
9759,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,0
9760,Erythroid hyperplasia,Pseudoangiomatous stromal hyperplasia,0
9761,Chronic Inflammatory Infiltrate,Chronic eosinophilic leukemia,0
9762,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,0
9763,Secondary Lesion,Pilomatrixoma,0
9764,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Gastric Cancer by AJCC v8 Pathologic Stage,0
9765,Perivascular fibrosis,"Perivascular epithelioid tumor, malignant",0
9766,Intermediate Grade Lesion,Sarcoma NCI Grade 2,0
9767,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta,0
9768,Absence of Malignant Features,Malignant tumor of epidermal appendage,0
9769,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Uterine Corpus Cancer by AJCC v6 Stage,0
9770,Secondary Lesion,Brain sarcoma,0
9771,Endobronchial Lesion,Hereditary Prostate Carcinoma,0
9772,Secondary Lesion,Hereditary spherocytosis,0
9773,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Luminal B Prostate Carcinoma,0
9774,EBV-Positive Neoplastic Cells Present,Colon Kaposi Sarcoma,0
9775,Secondary Lesion,Neurodermatitis,0
9776,Endobronchial Lesion,Cervical Alveolar Soft Part Sarcoma,0
9777,EBV-Positive Neoplastic Cells Present,Lipofibromatosis,0
9778,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Malignant neoplasm of stomach,0
9779,Small Aggregates of Tumor Cells Present,Stage IV Appendix Neuroendocrine Tumor AJCC v8,0
9780,EBV-Positive Neoplastic Cells Present,Thyroid Gland Adenocarcinoma,0
9781,EBV-Positive Neoplastic Cells Present,CIC-DUX Sarcoma,0
9782,Smooth Muscle Component Present,Cerebral Non-Hodgkin Lymphoma,0
9783,EBV-Positive Neoplastic Cells Present,Diaper candidiasis,0
9784,EBV-Positive Neoplastic Cells Present,Sezary Syndrome,0
9785,Neoplastic Growth or Spread,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,0
9786,Endobronchial Lesion,Childhood Oligoastrocytoma,0
9787,Multihormonal Immunoreactivity Present in a Single Cell Type,Adenocarcinoma in villous adenoma,0
9788,Malignant Primitive Cellular Infiltrate,Malignant Cardiac Paraganglioma,0
9789,Blasts Under 20 Percent of Peripheral Blood White Cells,Secondary malignant neoplasm of brain stem,0
9790,Photosensitivity of skin,Kaposi's sarcoma of skin,0
9791,Mild dysplasia of colon,Villous adenoma of colon,0
9792,Extensive Stage Lesion,Stage IIIA Anal Cancer AJCC v8,0
9793,Secondary Lesion,Hemangioendothelioma,0
9794,EBV-Positive Neoplastic Cells Present,AIDS-Related Cryptococcosis,0
9795,Secondary Lesion,Porphyria Cutanea Tarda,0
9796,Smooth Muscle Component Present,Exaggerated placental site,0
9797,Extensive Stage Lesion,Stage IIC Rectal Cancer AJCC v8,0
9798,Endobronchial Lesion,Recurrent Rhabdomyosarcoma,0
9799,Subcutaneous nodule,Subcutaneous Disorder,0
9800,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Urothelial Carcinoma,0
9801,"Adenocarcinoma, intestinal type","Thymoma, type B2, malignant",0
9802,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Thyroid Gland Follicular Carcinoma,0
9803,Smooth Muscle Component Present,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),0
9804,Absence of Malignant Features,Malignant tumor of cervix,0
9805,Multihormonal Immunoreactivity Present in a Single Cell Type,Ann Arbor Stage II Mantle Cell Lymphoma,0
9806,Erythroid hyperplasia,Adenomatous hyperplasia,0
9807,EBV-Positive Neoplastic Cells Present,Vulvar Proximal-Type Epithelioid Sarcoma,0
9808,Nodular and Diffuse Pattern,Uterine Corpus Diffuse Leiomyomatosis,0
9809,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Glomus Tumor of Uncertain Malignant Potential,0
9810,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of chest wall,0
9811,Granulocytes Increased in Bone Marrow,Breast Carcinoma Metastatic in Lymph Node,0
9812,Endobronchial Lesion,Gastric Cronkhite Canada Polyposis,0
9813,Granulocytes Increased in Bone Marrow,Recurrent Malignant Bone Neoplasm,0
9814,Nodular and Diffuse Pattern,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
9815,Abundance of Small Lymphocytes,clear cell adenocarcinoma of urethra,0
9816,EBV-Positive Neoplastic Cells Present,Masaoka-Koga Stage III,0
9817,Abundance of Small Lymphocytes,Neoplasm of scrotum,0
9818,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Testicular Large Cell Calcifying Sertoli Cell Tumor,0
9819,Tumor Droplets Present,Malignant Gastric Germ Cell Tumor,0
9820,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Undifferentiated carcinoma of nasopharynx,0
9821,Secondary Lesion,Fibrous polyp,0
9822,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
9823,Tumor Droplets Present,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,0
9824,EBV-Positive Neoplastic Cells Present,Engraftment syndrome,0
9825,Endobronchial Lesion,Right atrial myxoma,0
9826,High Grade Lesion,Recurrent Grade II Lymphomatoid Granulomatosis,0
9827,Extensive Stage Lesion,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma,0
9828,Multiple Tumor Masses,Borderline Ovarian Serous Tumor with Microinvasion,0
9829,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Pancreatic Cancer AJCC v6 and v7,0
9830,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lymphoma by Site,0
9831,EBV-Positive Neoplastic Cells Present,Vulvar Dysplastic Melanocytic Nevus,0
9832,Granulocytes Increased in Bone Marrow,Squamous cell carcinoma in situ with questionable stromal invasion,0
9833,Mucinous degeneration,Ovarian Mucinous Adenofibroma,0
9834,EBV-Positive Neoplastic Cells Present,Bronchogenic Carcinoma,0
9835,Blasts Under 20 Percent of Peripheral Blood White Cells,Benign neoplasm of sweat gland,0
9836,Secondary Lesion,Scleromyxedema,0
9837,Blasts Under 20 Percent of Peripheral Blood White Cells,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb,0
9838,Endobronchial Lesion,Infantile fibrosarcoma,0
9839,Blasts Under 20 Percent of Peripheral Blood White Cells,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract,0
9840,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Squamous cell carcinoma of the hypopharynx stage II,0
9841,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9842,EBV-Positive Neoplastic Cells Present,Stage I Pancreatic Cancer AJCC v8,0
9843,Secondary Lesion,Impetigo,0
9844,Secondary Lesion,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8,0
9845,Blasts Under 20 Percent of Peripheral Blood White Cells,keratinizing squamous cell carcinoma of lung,0
9846,Tumor Droplets Present,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
9847,Follicular Cell Differentiation,Stage IV Lip Basal Cell Carcinoma,0
9848,Endobronchial Lesion,Pancreatic Foamy Gland Adenocarcinoma,0
9849,Secondary Lesion,"Leukemia, Mast-Cell",0
9850,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,0
9851,EBV-Positive Neoplastic Cells Present,Stage III Ureter Cancer AJCC v8,0
9852,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Plasmablastic Lymphoma of Mucosa Site,0
9853,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Lung Clear Cell Tumor,0
9854,Endobronchial Lesion,Dysplastic Nevus,0
9855,Blasts Under 20 Percent of Peripheral Blood White Cells,benign fibroma of liver,0
9856,Smooth Muscle Component Present,Lymphoplasmacytoid lymphoma/immunocytoma stage III,0
9857,Endobronchial Lesion,Mucosal lentiginous melanoma,0
9858,Osseous Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
9859,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Cutaneous Melanoma of the Extremity,0
9860,EBV-Positive Neoplastic Cells Present,Stage III Cervical Cancer AJCC v8,0
9861,EBV-Positive Neoplastic Cells Present,Cardiac Intramuscular Hemangioma,0
9862,White blood cell count increased (lab result),"Papillary transitional cell carcinoma, non-invasive",0
9863,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Benign neoplasm of trachea,0
9864,Lesion with Diameter of 10mm or Less,carcinoma of pancreas with osteoclast-like giant cells,0
9865,EBV-Positive Neoplastic Cells Present,EBV-Related Carcinoma,0
9866,EBV-Positive Neoplastic Cells Present,Stage IVA Pharyngeal Carcinoma,0
9867,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Carcinoma in situ of ampulla of Vater,0
9868,Nodular and Diffuse Pattern,"Mastocytosis, Diffuse Cutaneous",0
9869,Neoplastic Growth or Spread,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,0
9870,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage II Retinoblastoma AJCC v8,0
9871,Secondary Lesion,Spermatocytic seminoma,0
9872,Windblown Appearance of Atypical Keratinocytes,Childhood Atypical Choroid Plexus Papilloma,0
9873,Abundance of Small Lymphocytes,Primary myoepithelial carcinoma of lung,0
9874,Tumor Droplets Present,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
9875,Small Aggregates of Tumor Cells Present,Recurrent Malignant Ovarian Brenner Tumor,0
9876,Smooth Muscle Component Present,Trichoadenoma,0
9877,Endobronchial Lesion,tumor miofibroblástico peribronquial congénito,0
9878,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,small cell carcinoma of breast,0
9879,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Gastric Tubular Adenocarcinoma,0
9880,EBV-Positive Neoplastic Cells Present,Oncocytic Breast Carcinoma,0
9881,Endobronchial Lesion,Stage IV Hilar Cholangiocarcinoma AJCC v8,0
9882,Absence of Malignant Features,Stage II Pleural Malignant Mesothelioma AJCC v7,0
9883,EBV-Positive Neoplastic Cells Present,Rectal Serrated Adenocarcinoma,0
9884,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present",Stage IVB Oral Cavity Cancer AJCC v6 and v7,0
9885,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Carcinoma of soft palate,0
9886,Single Cell Necrosis,Lung Basaloid Large Cell Carcinoma,0
9887,Recurrent Genetic Abnormalities Present,Recurrent Adult Hodgkin Lymphoma,0
9888,Multihormonal Immunoreactivity Present in a Single Cell Type,Lung Basaloid Large Cell Carcinoma,0
9889,Follicular Cell Differentiation,Grade 3 Cutaneous Follicular Lymphoma,0
9890,Cellular Pleomorphism,Cellular Neurofibroma,0
9891,EBV-Positive Neoplastic Cells Present,Mast-Cell Sarcoma,0
9892,Small Aggregates of Tumor Cells Present,Osteoclastic Giant Cell-Rich Tumor of Bone,0
9893,Gastric-Type Epithelial Differentiation,Stage II Thymus Epithelial Neoplasm AJCC v8,0
9894,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Acute Myeloid Leukemia with t(11;17)(q13;q21),0
9895,Abundance of Small Lymphocytes,Mucoepidermoid carcinoma of skin,0
9896,Endobronchial Lesion,Mature B-Cell Non-Hodgkin Lymphoma,0
9897,Pleural effusion disorder,Pleural Desmoplastic Mesothelioma,0
9898,Endobronchial Lesion,Sacral Chordoma,0
9899,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Parotid Gland Adenoid Cystic Carcinoma,0
9900,Endobronchial Lesion,Adrenal Medullary Hyperplasia,0
9901,Abundance of Small Lymphocytes,Acute vascular insufficiency of intestine (disorder),0
9902,Abundance of Small Lymphocytes,Squamous cell carcinoma of vulva,0
9903,Multiple Tumor Masses,Stage IIA Gestational Trophoblastic Tumor AJCC v7,0
9904,Intraepithelial Neoplasia,Biliary Intraepithelial Neoplasia-3,0
9905,EBV-Positive Neoplastic Cells Present,Hypodiploid B Acute Lymphoblastic Leukemia,0
9906,Unifocal Disease at Presentation,Maternally Derived Graft Versus Host Disease,0
9907,Multiple Tumor Masses,Stage IIA Gestational Trophoblastic Tumor AJCC v7,0
9908,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Crohn's disease of large bowel,0
9909,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Adult Acute Promyelocytic Leukemia with PML-RARA,0
9910,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Transitional cell carcinoma in situ,0
9911,Erythroid hyperplasia,Erythroid Neoplasm,0
9912,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Mixed Acinar-Ductal Carcinoma of the Pancreas,0
9913,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIB Gastric Cancer AJCC v8,0
9914,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
9915,Endobronchial Lesion,Stage IIA Prostate Cancer AJCC v7,0
9916,hemorrhage during pregnancy threatening abortion,Threatened abortion,0
9917,Threatened abortion,hemorrhage during pregnancy threatening abortion,0
9918,Threatened abortion,hemorrhage during pregnancy threatening abortion with baby delivered,0
9919,Threatened abortion,hemorrhage during pregnancy threatening abortion as antepartum condition,0
9920,hemorrhage during pregnancy threatening abortion with baby delivered,Threatened abortion,0
9921,hemorrhage during pregnancy threatening abortion as antepartum condition,Threatened abortion,0
9922,Grafting procedure,Complication of artificial skin graft,0
9923,Lupus Erythematosus,Subcutaneous nodule associated with lupus erythematosus,0
9924,Operative Surgical Procedures,Granuloma of surgical wound,0
9925,Subcutaneous nodule associated with lupus erythematosus,Lupus Erythematosus,0
9926,Complication of artificial skin graft and decellularized allodermis,Interventional procedure,0
9927,Complication of artificial skin graft and decellularized allodermis,Artificial skin,0
9928,Leakage of peritoneal dialysate into subcutaneous tissue of abdominal wall,Peritoneal Dialysis,0
9929,Leakage of peritoneal dialysate into pleural cavity,Peritoneal Dialysis,0
9930,Granuloma of surgical wound,Operative Surgical Procedures,0
9931,Complication of artificial skin graft,Grafting procedure,0
9932,Catheter related infection,Catheterization,0
9933,Encapsulating peritoneal sclerosis associated with peritoneal dialysis,Peritoneal Dialysis,0
9934,Catheterization,Catheter related infection,0
9935,Peritoneal Dialysis,Leakage of peritoneal dialysate into subcutaneous tissue of abdominal wall,0
9936,Peritoneal Dialysis,Leakage of peritoneal dialysate into pleural cavity,0
9937,Peritoneal Dialysis,Encapsulating peritoneal sclerosis associated with peritoneal dialysis,0
9938,Interventional procedure,Complication of artificial skin graft and decellularized allodermis,0
9939,Artificial skin,Complication of artificial skin graft and decellularized allodermis,0
9940,Focal Infection,Localized enamel hypomineralization associated with localized infection,0
9941,Connective Tissue Diseases,Scleroderma-associated necrotizing vasculitis,0
9942,Localized enamel hypomineralization associated with localized infection,Focal Infection,0
9943,Failure of dental post,Interventional procedure,0
9944,Blocked central line,Interventional procedure,0
9945,Miscarriage due to Leptospira,Leptospirosis,0
9946,Mechanical complication of chin prosthesis,Interventional procedure,0
9947,Mycoplasma Infections,Erythema multiforme due to mycoplasma infection,0
9948,Lymphogranuloma Venereum,Lymphedema due to lymphogranuloma venereum,0
9949,Toxoplasmosis,suspected damage to fetus from maternal toxoplasmosis,0
9950,Complication of implant,Interventional procedure,0
9951,Nervous system complication from surgically implanted device,Interventional procedure,0
9952,Mucocutaneous Lymph Node Syndrome,Fever,0
9953,Urinary calculus in schistosomiasis,Schistosoma hematobium infection,0
9954,Complete miscarriage with genital tract or pelvic infection,Communicable Diseases,0
9955,Fetus with viral damage via mother,Virus Diseases,0
9956,Fetus with viral damage via mother - delivered,Virus Diseases,0
9957,Fetus with viral damage via mother with antenatal problem,Virus Diseases,0
9958,Fetus with viral damage via mother,Virus Diseases,0
9959,"Mechanical complication of nervous system device, implant AND/OR graft",Interventional procedure,0
9960,Mechanical complication of nervous system device,Interventional procedure,0
9961,Mechanical complication of dorsal column stimulator,Interventional procedure,0
9962,Mechanical complication of electrodes implanted in brain,Interventional procedure,0
9963,"Mechanical complication of nervous system device, implant AND/OR graft",Interventional procedure,0
9964,"Mechanical complication of other specified prosthetic device, implant, and graft",Interventional procedure,0
9965,"Mechanical complication of prosthetic device, unspecified",Interventional procedure,0
9966,Mechanical complication of chin prosthesis,Interventional procedure,0
9967,Mechanical complication of eye orbit prosthesis,Interventional procedure,0
9968,Graft complications,Interventional procedure,0
9969,"Mechanical complication of other specified prosthetic device, implant, and graft",Interventional procedure,0
9970,"Other complications of internal prosthetic device, implant, and graft",Interventional procedure,0
9971,Disruption of nerve repair,Neuroplasty,0
9972,Vacuolar myelopathy,Acquired Immunodeficiency Syndrome,0
9973,Disorder of nerve repair,Neuroplasty,0
9974,Dehiscence of nerve repair,Neuroplasty,0
9975,Neuroma of nerve repair,Neuroplasty,0
9976,Toxic inhalation-induced febrile illness,Fever,0
9977,Humidifier fever,Fever,0
9978,Pulmonary mycotoxicosis,Fever,0
9979,Lymphedema due to lymphogranuloma venereum,Lymphogranuloma Venereum,0
9980,Disorder of dental prosthesis,Interventional procedure,0
9981,Dental Prosthesis Failure,Interventional procedure,0
9982,suspected damage to fetus from maternal toxoplasmosis,Toxoplasmosis,0
9983,Organ dysfunction syndrome,Systemic inflammatory response syndrome associated with organ dysfunction,0
9984,Allergic contact dermatitis caused by nickel implant,Interventional procedure,0
9985,Febrile proteinuria,Fever,0
9986,Fetus with viral damage via mother,Virus Diseases,0
9987,Intrauterine Devices,Retained intrauterine contraceptive device in pregnancy,0
9988,Mechanical complication of central nervous system device,Interventional procedure,0
9989,Mechanical complication of central nervous system device,Interventional procedure,0
9990,Breakage of prosthesis,Interventional procedure,0
9991,Disorders of prostheses and implants of the nervous system,Interventional procedure,0
9992,Disorder of dorsal column stimulator,Interventional procedure,0
9993,Disorder of electrodes implanted in brain,Interventional procedure,0
9994,Neuroplasty,Disruption of nerve repair,0
9995,Neuroplasty,Disorder of nerve repair,0
9996,Neuroplasty,Dehiscence of nerve repair,0
9997,Neuroplasty,Neuroma of nerve repair,0
9998,Fractured maxillofacial prosthesis,Interventional procedure,0
9999,Parametritis,Abortion with parametritis,0
10000,"complications; prosthetic, mechanical",Interventional procedure,0
10001,Incomplete inevitable miscarriage complicated by genital tract and pelvic infection,Communicable Diseases,0
10002,Disorder of prostheses and implants,Interventional procedure,0
10003,Postprocedural intra-abdominal sepsis,Interventional procedure,0
10004,Welders ague,Fever,0
10005,Dislocated intraocular lens,Interventional procedure,0
10006,Dislocated intraocular lens into vitreous,Interventional procedure,0
10007,Disorders of prostheses and implants of the eye,Interventional procedure,0
10008,Disorder of intraocular lens,Interventional procedure,0
10009,Deposits on intraocular lens,Interventional procedure,0
10010,YAG laser pit in intraocular lens,Interventional procedure,0
10011,Silicone oil droplets on intraocular lens,Interventional procedure,0
10012,Migration of spinal cord stimulator,Interventional procedure,0
10013,Polymer fume fever,Fever,0
10014,Mycoses,Mycotic abortion,0
10015,Female pelvic peritonitis,pelvic peritonitis following abortion,0
10016,Virus Diseases,Fetus with viral damage via mother,0
10017,Virus Diseases,Fetus with viral damage via mother - delivered,0
10018,Virus Diseases,Fetus with viral damage via mother with antenatal problem,0
10019,Virus Diseases,Fetus with viral damage via mother,0
10020,Virus Diseases,Fetus with viral damage via mother,0
10021,Migration of implant or internal device,Interventional procedure,0
10022,infection of genital tract involving pelvis following abortion,Communicable Diseases,0
10023,salpingitis following abortion,Salpingitis,0
10024,pelvic peritonitis following abortion,Female pelvic peritonitis,0
10025,Miscarriage complicated by genital-pelvic infection,Communicable Diseases,0
10026,endometritis; abortion,Endometritis,0
10027,Abortion with parametritis,Parametritis,0
10028,salpingo-oophoritis following abortion,Tubo-ovarian inflammatory disease,0
10029,Legal termination of pregnancy complicated by genital-pelvic infection,Communicable Diseases,0
10030,Illegal termination of pregnancy complicated by genital-pelvic infection,Communicable Diseases,0
10031,Fever,Mucocutaneous Lymph Node Syndrome,0
10032,Fever,Toxic inhalation-induced febrile illness,0
10033,Fever,Humidifier fever,0
10034,Fever,Pulmonary mycotoxicosis,0
10035,Fever,Febrile proteinuria,0
10036,Fever,Welders ague,0
10037,Fever,Polymer fume fever,0
10038,Fever,Sweet's disease due to drug,0
10039,Fever,Febrile Ulceronecrotic Mucha-Habermann disease,0
10040,Fever,Sweet's disease following infection,0
10041,Fever,Disorder characterized by fever,0
10042,Fever,Copper fever,0
10043,Fever,Myoclonus associated with fever,0
10044,Fever,Metal fever,0
10045,Fever,Febrile transfusion reaction,0
10046,Fever,Brass-founders' fever,0
10047,Fever,Mucocutaneous Lymph Node Syndrome,0
10048,Fever,Grain fever,0
10049,Fever,Sweet Syndrome,0
10050,Operative Surgical Procedures,Dehiscence of internal surgical wound,0
10051,Sweet's disease due to drug,Fever,0
10052,Febrile Ulceronecrotic Mucha-Habermann disease,Fever,0
10053,Erythema nodosum due to bacterial infection,Bacterial Infections,0
10054,Erythema nodosum due to streptococcal infection,Streptococcal Infections,0
10055,Erythema nodosum due to Yersinia enterocolitica,Infection by Yersinia enterocolitica,0
10056,Erythema multiforme due to mycoplasma infection,Mycoplasma Infections,0
10057,Sweet's disease following infection,Fever,0
10058,Scleroderma-associated necrotizing vasculitis,Connective Tissue Diseases,0
10059,Scleroderma-associated nail dystrophy,Dermatologic disorders,0
10060,Dental prosthesis infection,Interventional procedure,0
10061,Communicable Diseases,Complete miscarriage with genital tract or pelvic infection,0
10062,Communicable Diseases,Incomplete inevitable miscarriage complicated by genital tract and pelvic infection,0
10063,Communicable Diseases,infection of genital tract involving pelvis following abortion,0
10064,Communicable Diseases,Miscarriage complicated by genital-pelvic infection,0
10065,Communicable Diseases,Legal termination of pregnancy complicated by genital-pelvic infection,0
10066,Communicable Diseases,Illegal termination of pregnancy complicated by genital-pelvic infection,0
10067,Communicable Diseases,Fetal OR neonatal jaundice from infection,0
10068,Pharmaceutical Preparations,Myotonia due to drug,0
10069,Pharmaceutical Preparations,Dependence on unknown drug,0
10070,Disorder characterized by fever,Fever,0
10071,Opacification of intraocular lens,Interventional procedure,0
10072,"Unspecified complication of internal orthopedic prosthetic device, implant and graft",Interventional procedure,0
10073,Dislocated capsular tension ring,Interventional procedure,0
10074,Opacification of intraocular lens,Interventional procedure,0
10075,Exudative maculopathy with type 1 diabetes mellitus,Diabetes Mellitus,0
10076,Decentered intraocular lens implant,Interventional procedure,0
10077,Listeriosis,Listeria miscarriage,0
10078,Brucella abortus infection,Miscarriage due to Brucella abortus,0
10079,Infection due to Brucella canis,Abortion due to Brucella canis,0
10080,Miscarriage due to Brucella abortus,Brucella abortus infection,0
10081,Abortion due to Brucella canis,Infection due to Brucella canis,0
10082,Copper fever,Fever,0
10083,Destot sign,Fracture of pelvis,0
10084,Systemic inflammatory response syndrome associated with organ dysfunction,Organ dysfunction syndrome,0
10085,Myoclonus associated with fever,Fever,0
10086,Multiple complications due to diabetes mellitus,Diabetes Mellitus,0
10087,Myotonia due to drug,Pharmaceutical Preparations,0
10088,Hyperglycemic crisis in diabetes mellitus,Diabetes Mellitus,0
10089,Dependence on unknown drug,Pharmaceutical Preparations,0
10090,Hepatitis B associated with Human immunodeficiency virus infection,HIV Infections,0
10091,Dehiscence of internal surgical wound,Operative Surgical Procedures,0
10092,Cloudy peritoneal dialysis effluent,Peritoneal Dialysis,0
10093,Failure of osseointegration of dental implant,Interventional procedure,0
10094,Non-Hodgkin lymphoma associated with Human immunodeficiency virus infection,HIV Infections,0
10095,Tubo-ovarian inflammatory disease,salpingo-oophoritis following abortion,0
10096,Mechanical complication of eye orbit prosthesis,Interventional procedure,0
10097,Mechanical complication of bile duct prosthesis,Interventional procedure,0
10098,Listeria miscarriage,Listeriosis,0
10099,Schistosoma hematobium infection,Urinary calculus in schistosomiasis,0
10100,Mycotic abortion,Mycoses,0
10101,Acquired Immunodeficiency Syndrome,Vacuolar myelopathy,0
10102,mechanical complication due to ocular lens prosthesis,Interventional procedure,0
10103,Peritoneal Dialysis,Cloudy peritoneal dialysis effluent,0
10104,Interventional procedure,Failure of dental post,0
10105,Interventional procedure,Blocked central line,0
10106,Interventional procedure,Mechanical complication of chin prosthesis,0
10107,Interventional procedure,Complication of implant,0
10108,Interventional procedure,Nervous system complication from surgically implanted device,0
10109,Interventional procedure,"Mechanical complication of nervous system device, implant AND/OR graft",0
10110,Interventional procedure,Mechanical complication of nervous system device,0
10111,Interventional procedure,Mechanical complication of dorsal column stimulator,0
10112,Interventional procedure,Mechanical complication of electrodes implanted in brain,0
10113,Interventional procedure,"Mechanical complication of nervous system device, implant AND/OR graft",0
10114,Interventional procedure,"Mechanical complication of other specified prosthetic device, implant, and graft",0
10115,Interventional procedure,"Mechanical complication of prosthetic device, unspecified",0
10116,Interventional procedure,Mechanical complication of chin prosthesis,0
10117,Interventional procedure,Mechanical complication of eye orbit prosthesis,0
10118,Interventional procedure,Graft complications,0
10119,Interventional procedure,"Mechanical complication of other specified prosthetic device, implant, and graft",0
10120,Interventional procedure,"Other complications of internal prosthetic device, implant, and graft",0
10121,Interventional procedure,Disorder of dental prosthesis,0
10122,Interventional procedure,Dental Prosthesis Failure,0
10123,Interventional procedure,Allergic contact dermatitis caused by nickel implant,0
10124,Interventional procedure,Mechanical complication of central nervous system device,0
10125,Interventional procedure,Mechanical complication of central nervous system device,0
10126,Interventional procedure,Breakage of prosthesis,0
10127,Interventional procedure,Disorders of prostheses and implants of the nervous system,0
10128,Interventional procedure,Disorder of dorsal column stimulator,0
10129,Interventional procedure,Disorder of electrodes implanted in brain,0
10130,Interventional procedure,Fractured maxillofacial prosthesis,0
10131,Interventional procedure,"complications; prosthetic, mechanical",0
10132,Interventional procedure,Disorder of prostheses and implants,0
10133,Interventional procedure,Postprocedural intra-abdominal sepsis,0
10134,Interventional procedure,Dislocated intraocular lens,0
10135,Interventional procedure,Dislocated intraocular lens into vitreous,0
10136,Interventional procedure,Disorders of prostheses and implants of the eye,0
10137,Interventional procedure,Disorder of intraocular lens,0
10138,Interventional procedure,Deposits on intraocular lens,0
10139,Interventional procedure,YAG laser pit in intraocular lens,0
10140,Interventional procedure,Silicone oil droplets on intraocular lens,0
10141,Interventional procedure,Migration of spinal cord stimulator,0
10142,Interventional procedure,Migration of implant or internal device,0
10143,Interventional procedure,Dental prosthesis infection,0
10144,Interventional procedure,Opacification of intraocular lens,0
10145,Interventional procedure,"Unspecified complication of internal orthopedic prosthetic device, implant and graft",0
10146,Interventional procedure,Dislocated capsular tension ring,0
10147,Interventional procedure,Opacification of intraocular lens,0
10148,Interventional procedure,Decentered intraocular lens implant,0
10149,Interventional procedure,Failure of osseointegration of dental implant,0
10150,Interventional procedure,Mechanical complication of eye orbit prosthesis,0
10151,Interventional procedure,Mechanical complication of bile duct prosthesis,0
10152,Interventional procedure,mechanical complication due to ocular lens prosthesis,0
10153,Interventional procedure,Mechanical complication of aortic graft,0
10154,Interventional procedure,Implant site reaction,0
10155,Interventional procedure,Drug implant site reaction,0
10156,Interventional procedure,Drug implant site rejection,0
10157,Interventional procedure,Adverse effect of prosthetic device,0
10158,Metal fever,Fever,0
10159,Diabetes Mellitus,Exudative maculopathy with type 1 diabetes mellitus,0
10160,Diabetes Mellitus,Multiple complications due to diabetes mellitus,0
10161,Diabetes Mellitus,Hyperglycemic crisis in diabetes mellitus,0
10162,Febrile transfusion reaction,Fever,0
10163,Brass-founders' fever,Fever,0
10164,Mucocutaneous Lymph Node Syndrome,Fever,0
10165,Leptospirosis,Miscarriage due to Leptospira,0
10166,Fracture of pelvis,Destot sign,0
10167,Endometritis,endometritis; abortion,0
10168,Mechanical complication of aortic graft,Interventional procedure,0
10169,Grain fever,Fever,0
10170,Infection by Yersinia enterocolitica,Erythema nodosum due to Yersinia enterocolitica,0
10171,Sweet Syndrome,Fever,0
10172,Streptococcal Infections,Erythema nodosum due to streptococcal infection,0
10173,HIV Infections,Hepatitis B associated with Human immunodeficiency virus infection,0
10174,HIV Infections,Non-Hodgkin lymphoma associated with Human immunodeficiency virus infection,0
10175,Bacterial Infections,Erythema nodosum due to bacterial infection,0
10176,Salpingitis,salpingitis following abortion,0
10177,Fetal OR neonatal jaundice from infection,Communicable Diseases,0
10178,Retained intrauterine contraceptive device in pregnancy,Intrauterine Devices,0
10179,Dermatologic disorders,Scleroderma-associated nail dystrophy,0
10180,Implant site reaction,Interventional procedure,0
10181,Drug implant site reaction,Interventional procedure,0
10182,Drug implant site rejection,Interventional procedure,0
10183,Adverse effect of prosthetic device,Interventional procedure,0
10184,Mycobacterium tuberculosis,Exposure to Mycobacterium tuberculosis,0
10185,Neutrophil count decreased,Neutropenic sepsis,0
10186,Exposure to Bacillus anthracis,Bacillus anthracis,0
10187,Neisseria meningitidis,Exposure to Neisseria meningitidis,0
10188,HIV,Exposure to Human immunodeficiency virus,0
10189,Dementia associated with another disease,Disease,0
10190,Myopathy due to systemic sclerosis,Systemic Scleroderma,0
10191,Human herpesvirus 3,Exposure to varicella,0
10192,Human herpes simplex virus,Exposure to anogenital Herpes simplex virus,0
10193,Bacillus anthracis,Exposure to Bacillus anthracis,0
10194,Trichomonas vaginalis,Exposure to genital trichomoniasis,0
10195,Construction of conduit - right atrium to pulmonary trunk,Leakage of conduit from right atrium to pulmonary artery,0
10196,insulin resistance in diabetes,Pharmaceutical Preparations,0
10197,Insulin resistance - type A,Pharmaceutical Preparations,0
10198,Insulin resistance - type B,Pharmaceutical Preparations,0
10199,Wound hematoma,Infection of wound hematoma,0
10200,Smallpox Viruses,Exposure to Variola virus,0
10201,Leptospira,Exposure to Leptospira,0
10202,Salmonella,Exposure to Salmonella,0
10203,Pediculus humanus capitis (eukaryote),Exposure to Pediculus humanus capitus,0
10204,Complication of gastrostomy,Gastrostomy,0
10205,Drug resistance,Pharmaceutical Preparations,0
10206,Hepatitis A Virus,Exposure to Hepatitis A virus,0
10207,Osteoporosis due to corticosteroid,Pharmaceutical Preparations,0
10208,Organism,Exposure to organism,0
10209,Pharmaceutical Preparations,insulin resistance in diabetes,0
10210,Pharmaceutical Preparations,Insulin resistance - type A,0
10211,Pharmaceutical Preparations,Insulin resistance - type B,0
10212,Pharmaceutical Preparations,Drug resistance,0
10213,Pharmaceutical Preparations,Osteoporosis due to corticosteroid,0
10214,Pharmaceutical Preparations,Drug resistance to antiretroviral therapy,0
10215,Pharmaceutical Preparations,Insulin Resistance,0
10216,Pharmaceutical Preparations,Increased drug resistance,0
10217,Pharmaceutical Preparations,Drug resistance to corticoids,0
10218,SARS coronavirus,Exposure to severe acute respiratory syndrome coronavirus,0
10219,Calymmatobacterium granulomatis,Exposure to Klebsiella granulomatis,0
10220,Exposure to Mumps virus (event),Mumps virus,0
10221,Drug resistance to antiretroviral therapy,Pharmaceutical Preparations,0
10222,Malfunction of gastrostomy tube,Gastrostomy,0
10223,Abscess of gastrostomy button site,Gastrostomy,0
10224,Human poliovirus,Exposure to Human poliovirus,0
10225,"Influenza A Virus, H1N1 Subtype",Exposure to Influenza A virus subtype H1N1,0
10226,Infection of gastrostomy site,Gastrostomy,0
10227,Disorder of cornea associated with contact lens,Contact Lenses,0
10228,Leakage of conduit from right atrium to pulmonary artery,Construction of conduit - right atrium to pulmonary trunk,0
10229,Developmentally disabled (finding),Developmental Disabilities,0
10230,Infection of tick bite,Tick bite (disorder),0
10231,Neutropenic sepsis,Neutrophil count decreased,0
10232,Exposure to organism,Organism,0
10233,Infection of wound hematoma,Wound hematoma,0
10234,Erythropoietin resistance in anemia of chronic kidney disease,Erythropoietin,0
10235,Exposure to Variola virus,Smallpox Viruses,0
10236,Exposure to Human immunodeficiency virus,HIV,0
10237,Exposure to Neisseria meningitidis,Neisseria meningitidis,0
10238,Exposure to Klebsiella granulomatis,Calymmatobacterium granulomatis,0
10239,Exposure to Gardnerella vaginalis,Gardnerella vaginalis,0
10240,Exposure to Human poliovirus,Human poliovirus,0
10241,Exposure to Haemophilus ducreyi,Hemophilus ducreyi,0
10242,Exposure to Neisseria gonorrhoeae,Neisseria gonorrhoeae,0
10243,Exposure to Treponema pallidum,Treponema pallidum,0
10244,Exposure to Vibrio cholerae (event),Vibrio cholerae,0
10245,Exposure to Enterobius vermicularis,Enterobius vermicularis,0
10246,Exposure to Bordetella pertussis,Bordetella pertussis,0
10247,Exposure to anaerobic bacterial vaginosis,"Bacteria, Anaerobic",0
10248,Exposure to Legionella,Legionella,0
10249,Exposure to Leptospira,Leptospira,0
10250,Exposure to Streptococcus (event),Streptococcus,0
10251,Exposure to Chlamydia trachomatis,Chlamydia trachomatis,0
10252,Exposure to Pediculus humanus capitus,Pediculus humanus capitis (eukaryote),0
10253,Exposure to Influenza A virus subtype H1N1,"Influenza A Virus, H1N1 Subtype",0
10254,Rubeola exposure,Measles virus,0
10255,Exposure to genital trichomoniasis,Trichomonas vaginalis,0
10256,Exposure to varicella,Human herpesvirus 3,0
10257,Exposure to Rubella virus,Rubella virus,0
10258,Exposure to Rabies virus,Rabies virus,0
10259,Exposure to lymphogranuloma venereum,Chlamydia trachomatis,0
10260,Exposure to severe acute respiratory syndrome coronavirus,SARS coronavirus,0
10261,Exposure to Hepatitis B virus,Hepatitis B Virus,0
10262,Exposure to anogenital Herpes simplex virus,Human herpes simplex virus,0
10263,Exposure to Salmonella,Salmonella,0
10264,Exposure to Hepatitis A virus,Hepatitis A Virus,0
10265,Exposure to Mycobacterium tuberculosis,Mycobacterium tuberculosis,0
10266,Exposure to rubella in pregnancy,Rubella virus,0
10267,Insulin Resistance,Pharmaceutical Preparations,0
10268,Mumps virus,Exposure to Mumps virus (event),0
10269,Polyarthropathy associated with another disorder,Disease,0
10270,Rubella virus,Exposure to Rubella virus,0
10271,Rubella virus,Exposure to rubella in pregnancy,0
10272,Bordetella pertussis,Exposure to Bordetella pertussis,0
10273,Measles virus,Rubeola exposure,0
10274,Developmental Disabilities,Developmentally disabled (finding),0
10275,Gastrostomy,Complication of gastrostomy,0
10276,Gastrostomy,Malfunction of gastrostomy tube,0
10277,Gastrostomy,Abscess of gastrostomy button site,0
10278,Gastrostomy,Infection of gastrostomy site,0
10279,Enterobius vermicularis,Exposure to Enterobius vermicularis,0
10280,Contact Lenses,Disorder of cornea associated with contact lens,0
10281,Streptococcus,Exposure to Streptococcus (event),0
10282,"Bacteria, Anaerobic",Exposure to anaerobic bacterial vaginosis,0
10283,Rabies virus,Exposure to Rabies virus,0
10284,Polyarthritis associated with another disorder,Disease,0
10285,Chlamydia trachomatis,Exposure to Chlamydia trachomatis,0
10286,Chlamydia trachomatis,Exposure to lymphogranuloma venereum,0
10287,Gardnerella vaginalis,Exposure to Gardnerella vaginalis,0
10288,Disease,Dementia associated with another disease,0
10289,Disease,Polyarthropathy associated with another disorder,0
10290,Disease,Polyarthritis associated with another disorder,0
10291,Hemophilus ducreyi,Exposure to Haemophilus ducreyi,0
10292,Neisseria gonorrhoeae,Exposure to Neisseria gonorrhoeae,0
10293,Treponema pallidum,Exposure to Treponema pallidum,0
10294,Sleep Apnea Syndromes,Hypersomnia with sleep apnea,0
10295,Legionella,Exposure to Legionella,0
10296,Vibrio cholerae,Exposure to Vibrio cholerae (event),0
10297,Hypersomnia with sleep apnea,Sleep Apnea Syndromes,0
10298,Hepatitis B Virus,Exposure to Hepatitis B virus,0
10299,Erythropoietin,Erythropoietin resistance in anemia of chronic kidney disease,0
10300,Systemic Scleroderma,Myopathy due to systemic sclerosis,0
10301,Tick bite (disorder),Infection of tick bite,0
10302,Increased drug resistance,Pharmaceutical Preparations,0
10303,Drug resistance to corticoids,Pharmaceutical Preparations,0
10304,Friedreich Ataxia,Cardiomyopathy in Friedreich's ataxia,0
10305,Skeletal dysplasia,Lordosis in skeletal dysplasia,0
10306,Skeletal dysplasia,Scoliosis in skeletal dysplasia,0
10307,Cobalt poisoning,Cobalt cardiomyopathy,0
10308,Grafting procedure,Graft versus host disease in skin,0
10309,Dilated cardiomyopathy secondary to radiation,Disease,0
10310,Granulomatous disorder,Restrictive cardiomyopathy secondary to granulomas,0
10311,Complication of electronic internal device,Insertion of therapeutic device,0
10312,Restrictive cardiomyopathy secondary to infiltrations,Disease,0
10313,Peripartum cardiomyopathy,Disease,0
10314,"Mechanical complication of internal fixation device such as nail, plate AND/OR rod",Insertion of therapeutic device,0
10315,Dietary selenium deficiency,Keshan disease,0
10316,Cystic Fibrosis,Fibrosing colonopathy,0
10317,Neurofibromatoses,Scoliosis in neurofibromatosis,0
10318,Cardiomyopathy in Friedreich's ataxia,Friedreich Ataxia,0
10319,Dilated cardiomyopathy secondary to toxic reaction,Disease,0
10320,Arthropathy in Crohn's disease,Crohn Disease,0
10321,Lordosis in skeletal dysplasia,Skeletal dysplasia,0
10322,Lordosis in hip disease,Disorder of hip joint,0
10323,Scoliosis in skeletal dysplasia,Skeletal dysplasia,0
10324,Scoliosis in neurofibromatosis,Neurofibromatoses,0
10325,Secondary dilated cardiomyopathy,Disease,0
10326,Mechanical complication of internal nail fixing device,Insertion of therapeutic device,0
10327,Mechanical complication of internal rod fixation device,Insertion of therapeutic device,0
10328,Mechanical complication of internal plate fixing device,Insertion of therapeutic device,0
10329,Breakage of plate,Insertion of therapeutic device,0
10330,Loosening of plate,Insertion of therapeutic device,0
10331,Prominence of plate,Insertion of therapeutic device,0
10332,Breakage of screw,Insertion of therapeutic device,0
10333,Loosening of screw,Insertion of therapeutic device,0
10334,Prominence of screw,Insertion of therapeutic device,0
10335,Breakage of intramedullary nail,Insertion of therapeutic device,0
10336,Loosening of intramedullary nail,Insertion of therapeutic device,0
10337,Prominence of intramedullary nail,Insertion of therapeutic device,0
10338,Breakage of external fixator,Insertion of therapeutic device,0
10339,Loosening of external fixator pin,Insertion of therapeutic device,0
10340,Breakage of spinal fixation device,Insertion of therapeutic device,0
10341,Loosening of spinal fixation device,Insertion of therapeutic device,0
10342,Prominence of spinal fixation device,Insertion of therapeutic device,0
10343,Infected plate or screw,Insertion of therapeutic device,0
10344,Infected intramedullary nail,Insertion of therapeutic device,0
10345,Infected spinal fixation device,Insertion of therapeutic device,0
10346,Infected external fixator pin,Insertion of therapeutic device,0
10347,Disorder of bile duct stent,Insertion of therapeutic device,0
10348,Displacement of biliary stent,Insertion of therapeutic device,0
10349,Obstruction of biliary stent,Insertion of therapeutic device,0
10350,Infection of biliary stent,Insertion of therapeutic device,0
10351,Secondary ossification of muscle,Disease,0
10352,Bone fixation device infection,Insertion of therapeutic device,0
10353,Bone fixation device loosening,Insertion of therapeutic device,0
10354,Bone fixation device protrusion,Insertion of therapeutic device,0
10355,Bone fixation device failure,Insertion of therapeutic device,0
10356,Anovulatory (finding),Anovulatory amenorrhea,0
10357,Infection of bone wire,Insertion of therapeutic device,0
10358,Loosening of wire,Insertion of therapeutic device,0
10359,Prominence of wire,Insertion of therapeutic device,0
10360,Bending of bone fixation device,Insertion of therapeutic device,0
10361,Breakage of bone fixation device,Insertion of therapeutic device,0
10362,Breakage of wire,Insertion of therapeutic device,0
10363,Bending of spinal fixation device,Insertion of therapeutic device,0
10364,Bending of external fixator,Insertion of therapeutic device,0
10365,Bending of intramedullary nail,Insertion of therapeutic device,0
10366,Bending of screw,Insertion of therapeutic device,0
10367,Bending of plate,Insertion of therapeutic device,0
10368,Dilated cardiomyopathy secondary to sensitivity,Disease,0
10369,Glycogen Storage Disease,Restrictive cardiomyopathy secondary to glycogen storage disease,0
10370,Infection of internal Kirschner wire fixator,Insertion of therapeutic device,0
10371,Infection and inflammatory reaction due to internal orthopedic fixation device,Insertion of therapeutic device,0
10372,Cardiomyopathy in Duchenne muscular dystrophy,"Muscular Dystrophy, Duchenne",0
10373,Crohn Disease,Arthropathy in Crohn's disease,0
10374,Tachycardia,Tachycardia-induced cardiomyopathy,0
10375,Polymyositis Ossificans,Disease,0
10376,Portal Hypertension,Pulmonary arterial hypertension associated with portal hypertension,0
10377,Dilated cardiomyopathy due to systemic sclerosis,Systemic Scleroderma,0
10378,Malignant Neoplasms,Dilated cardiomyopathy secondary to malignancy,0
10379,Dilated cardiomyopathy secondary to protozoal myocarditis,Protozoan myocarditis,0
10380,Hairy leukoplakia of tongue associated with HIV disease,HIV Infections,0
10381,Leukoplakia of tongue associated with HIV disease,HIV Infections,0
10382,Secondary restrictive cardiomyopathy,Disease,0
10383,Hypertrophic cardiomyopathy secondary to neuromuscular disorder,Disease,0
10384,Oligo-ovulation,Oligoovulatory dysfunctional uterine bleeding,0
10385,Tachycardia-induced cardiomyopathy,Tachycardia,0
10386,Disorder of hip joint,Lordosis in hip disease,0
10387,Graft versus host disease in skin,Grafting procedure,0
10388,Seroma of breast as complication of procedure,Interventional procedure,0
10389,Oligoovulatory dysfunctional uterine bleeding,Oligo-ovulation,0
10390,Exposure to Hepatitis C virus,Hepatitis C virus,0
10391,Anovulatory amenorrhea,Anovulatory (finding),0
10392,Fibrosing colonopathy,Cystic Fibrosis,0
10393,Macroalbuminuric diabetic nephropathy,Systemic disease,0
10394,Macroalbuminuric diabetic nephropathy,Diabetes Mellitus,0
10395,Accidental puncture of artery during catheter insertion,Catheterization,0
10396,Pulmonary arterial hypertension associated with portal hypertension,Portal Hypertension,0
10397,Hypertrophic cardiomyopathy associated with another disorder,Disease,0
10398,Catheterization,Accidental puncture of artery during catheter insertion,0
10399,Complication of internal fixation device,Insertion of therapeutic device,0
10400,Keshan disease,Dietary selenium deficiency,0
10401,Cobalt cardiomyopathy,Cobalt poisoning,0
10402,Systemic disease,Macroalbuminuric diabetic nephropathy,0
10403,Paraplegia,Massive calcification in paraplegic,0
10404,Thyrotoxic heart disease,Thyrotoxicosis,0
10405,Hepatitis C virus,Exposure to Hepatitis C virus,0
10406,Disease,Dilated cardiomyopathy secondary to radiation,0
10407,Disease,Restrictive cardiomyopathy secondary to infiltrations,0
10408,Disease,Peripartum cardiomyopathy,0
10409,Disease,Dilated cardiomyopathy secondary to toxic reaction,0
10410,Disease,Secondary dilated cardiomyopathy,0
10411,Disease,Secondary ossification of muscle,0
10412,Disease,Dilated cardiomyopathy secondary to sensitivity,0
10413,Disease,Polymyositis Ossificans,0
10414,Disease,Secondary restrictive cardiomyopathy,0
10415,Disease,Hypertrophic cardiomyopathy secondary to neuromuscular disorder,0
10416,Disease,Hypertrophic cardiomyopathy associated with another disorder,0
10417,Disease,Dilated cardiomyopathy secondary to infiltration,0
10418,Disease,Dilated cardiomyopathy secondary to drug,0
10419,Disease,Dilated cardiomyopathy secondary to neuromuscular disorder,0
10420,Disease,"Cardiomyopathy, Alcoholic",0
10421,Restrictive cardiomyopathy secondary to glycogen storage disease,Glycogen Storage Disease,0
10422,Dilated cardiomyopathy secondary to infiltration,Disease,0
10423,Massive calcification in paraplegic,Paraplegia,0
10424,Insertion of therapeutic device,Complication of electronic internal device,0
10425,Insertion of therapeutic device,"Mechanical complication of internal fixation device such as nail, plate AND/OR rod",0
10426,Insertion of therapeutic device,Mechanical complication of internal nail fixing device,0
10427,Insertion of therapeutic device,Mechanical complication of internal rod fixation device,0
10428,Insertion of therapeutic device,Mechanical complication of internal plate fixing device,0
10429,Insertion of therapeutic device,Breakage of plate,0
10430,Insertion of therapeutic device,Loosening of plate,0
10431,Insertion of therapeutic device,Prominence of plate,0
10432,Insertion of therapeutic device,Breakage of screw,0
10433,Insertion of therapeutic device,Loosening of screw,0
10434,Insertion of therapeutic device,Prominence of screw,0
10435,Insertion of therapeutic device,Breakage of intramedullary nail,0
10436,Insertion of therapeutic device,Loosening of intramedullary nail,0
10437,Insertion of therapeutic device,Prominence of intramedullary nail,0
10438,Insertion of therapeutic device,Breakage of external fixator,0
10439,Insertion of therapeutic device,Loosening of external fixator pin,0
10440,Insertion of therapeutic device,Breakage of spinal fixation device,0
10441,Insertion of therapeutic device,Loosening of spinal fixation device,0
10442,Insertion of therapeutic device,Prominence of spinal fixation device,0
10443,Insertion of therapeutic device,Infected plate or screw,0
10444,Insertion of therapeutic device,Infected intramedullary nail,0
10445,Insertion of therapeutic device,Infected spinal fixation device,0
10446,Insertion of therapeutic device,Infected external fixator pin,0
10447,Insertion of therapeutic device,Disorder of bile duct stent,0
10448,Insertion of therapeutic device,Displacement of biliary stent,0
10449,Insertion of therapeutic device,Obstruction of biliary stent,0
10450,Insertion of therapeutic device,Infection of biliary stent,0
10451,Insertion of therapeutic device,Bone fixation device infection,0
10452,Insertion of therapeutic device,Bone fixation device loosening,0
10453,Insertion of therapeutic device,Bone fixation device protrusion,0
10454,Insertion of therapeutic device,Bone fixation device failure,0
10455,Insertion of therapeutic device,Infection of bone wire,0
10456,Insertion of therapeutic device,Loosening of wire,0
10457,Insertion of therapeutic device,Prominence of wire,0
10458,Insertion of therapeutic device,Bending of bone fixation device,0
10459,Insertion of therapeutic device,Breakage of bone fixation device,0
10460,Insertion of therapeutic device,Breakage of wire,0
10461,Insertion of therapeutic device,Bending of spinal fixation device,0
10462,Insertion of therapeutic device,Bending of external fixator,0
10463,Insertion of therapeutic device,Bending of intramedullary nail,0
10464,Insertion of therapeutic device,Bending of screw,0
10465,Insertion of therapeutic device,Bending of plate,0
10466,Insertion of therapeutic device,Infection of internal Kirschner wire fixator,0
10467,Insertion of therapeutic device,Infection and inflammatory reaction due to internal orthopedic fixation device,0
10468,Insertion of therapeutic device,Complication of internal fixation device,0
10469,Insertion of therapeutic device,Complication of internal device,0
10470,Insertion of therapeutic device,Retained intrauterine contraceptive device in pregnancy,0
10471,Interventional procedure,Seroma of breast as complication of procedure,0
10472,Dilated cardiomyopathy secondary to drug,Disease,0
10473,Diabetes Mellitus,Macroalbuminuric diabetic nephropathy,0
10474,Dilated cardiomyopathy secondary to malignancy,Malignant Neoplasms,0
10475,"Muscular Dystrophy, Duchenne",Cardiomyopathy in Duchenne muscular dystrophy,0
10476,Restrictive cardiomyopathy secondary to granulomas,Granulomatous disorder,0
10477,Dilated cardiomyopathy secondary to neuromuscular disorder,Disease,0
10478,"Cardiomyopathy, Alcoholic",Disease,0
10479,HIV Infections,Hairy leukoplakia of tongue associated with HIV disease,0
10480,HIV Infections,Leukoplakia of tongue associated with HIV disease,0
10481,Systemic Scleroderma,Dilated cardiomyopathy due to systemic sclerosis,0
10482,Protozoan myocarditis,Dilated cardiomyopathy secondary to protozoal myocarditis,0
10483,Complication of internal device,Insertion of therapeutic device,0
10484,Thyrotoxicosis,Thyrotoxic heart disease,0
10485,Retained intrauterine contraceptive device in pregnancy,Insertion of therapeutic device,0
10486,Soft-nose bullet,reported blunt trauma by round-pointed rubber bullet,0
10487,Air Bags,reported blunt trauma by car airbag,0
10488,Non-diagnostic medical procedure finding,electroencephalography: nonspecific abnormal findings,0
10489,belching accompanied by abdominal bloating,Abdominal bloating,0
10490,anal pain accompanied by bleeding,Hemorrhage,0
10491,coughing up white sputum,White sputum,0
10492,Percutaneous Transluminal Coronary Angioplasty,PTCA indications: abnormal stress test,0
10493,Cresol,intentional poisoning by cresol,0
10494,choking on foreign object,Foreign Bodies,0
10495,visit for screening exam for poison from contaminated water,Chemical/poison screening,0
10496,Abdominal bloating,belching accompanied by abdominal bloating,0
10497,Uremic neuropathy,chronic renal failure with uremic nephropathy,0
10498,Metal (material),metal splinters in skin,0
10499,mucous discharge from eye,Mucous discharge substance,0
10500,instrument failure during abdominal paracentesis,Abdominal paracentesis,0
10501,depression alternating with periods of elation,Elation,0
10502,History of allergy to insect bites or stings,Insect Sting,0
10503,exposure to drug-resistant tuberculosis,"Tuberculosis, Drug-Resistant",0
10504,reported blunt trauma by baseball bat,Baseball bat,0
10505,reported blunt trauma by hammer,Hammer,0
10506,reported blunt trauma by fist,Fist,0
10507,reported blunt trauma by sports equipment,Recreation equipment,0
10508,reported blunt trauma by golf ball,Golf ball,0
10509,reported blunt trauma by baseball,Manufactured Baseball,0
10510,reported blunt trauma by hockey puck,Hockey puck,0
10511,reported blunt trauma by car airbag,Air Bags,0
10512,reported blunt trauma by round-pointed rubber bullet,Soft-nose bullet,0
10513,Foreign Bodies,choking on foreign object,0
10514,Parathyroid Adenoma,Parathyroid Adenoma,0
10515,Hemorrhage,anal pain accompanied by bleeding,0
10516,Hemorrhage,"Thrombocythemia, Essential",0
10517,depression more in winter,Seasonal Affective Disorder,0
10518,depression more in summer,Seasonal Affective Disorder,0
10519,depression accompanied by eating more,Excessive dietary caloric intake,0
10520,depression accompanied by eating less,Loss of appetite (finding),0
10521,depression accompanied by sleeping more,Hypersomnia,0
10522,depression accompanied by sleeping less,Poor sleep pattern,0
10523,depression accompanied by persistent worry,Worried,0
10524,depression seasonal pattern with few nonseasonal occurrences,Seasonal Affective Disorder,0
10525,Symptom relieving factors,factors relieving chest pain,0
10526,serous drainage from incision of cornea,Serous discharge,0
10527,serosanguineous drainage from incision of cornea,Serosanguineous discharge,0
10528,bloody incision of cornea,Bloody discharge substance,0
10529,purulent incision of cornea,Purulent discharge substance,0
10530,pain of acromioclavicular joint elicited by motion,Pain on joint movement,0
10531,Initial cardiac assessment,acute myocardial infarction of posterior wall with initial care,0
10532,Follow-up cardiac assessment,acute myocardial infarction of posterior wall with subsequent care,0
10533,culdocentesis clear serous fluid,Clear body fluid,0
10534,culdocentesis blood,Blood,0
10535,electroencephalography: nonspecific abnormal findings,Non-diagnostic medical procedure finding,0
10536,Mite Infestations,Mite-borne hemorrhagic fever,0
10537,mucous discharge from right eye,Mucous discharge substance,0
10538,mucous discharge from left eye,Mucous discharge substance,0
10539,Dendritic ulcer,"Keratitis, Dendritic",0
10540,Basilar artery occlusion,stroke due to basilar artery occlusion,0
10541,Td vaccine up to date,Diphtheria and tetanus toxoid adsorbed,0
10542,intentional poisoning by wood alcohol,Methanol,0
10543,intentional poisoning by parasympatholytics,Anticholinergic Agents,0
10544,Accident caused by needle,accidental needlestick with exposure to hepatitis B,0
10545,Chlamydial cervicitis,Sexually Transmitted Diseases,0
10546,bronchospirochetosis,Spirochaetales Infections,0
10547,Heart Block,atrial flutter with block,0
10548,septic tenosynovitis of ankle,Sepsis,0
10549,septic tenosynovitis of extensor muscle of left ankle,Sepsis,0
10550,Manufactured Baseball,reported blunt trauma by baseball,0
10551,septic synovitis,Sepsis,0
10552,Septic tenosynovitis of foot,Sepsis,0
10553,septic synovitis of toe,Sepsis,0
10554,Hand gun,attempted suicide by handgun,0
10555,foul-smelling weeping incision of cornea,Odor symptom,0
10556,mucous discharge from both eyes,Mucous discharge substance,0
10557,Seasonal Affective Disorder,depression more in winter,0
10558,Seasonal Affective Disorder,depression more in summer,0
10559,Seasonal Affective Disorder,depression seasonal pattern with few nonseasonal occurrences,0
10560,Disruptive Behavior,Alzheimer's dementia with behavioral disturbance,0
10561,Rusty sputum,Rusty sputum,0
10562,Dirty sputum,coughing up black sputum,0
10563,Unicuspid aortic valve,aortic regurgitation with unicuspid valve,0
10564,Quadricuspid aortic valve,aortic regurgitation with quadracuspid valve,0
10565,Infection - suppurative,suppurative abdominal abscess,0
10566,aminosalicylic acid,intentional poisoning by para-aminosalicylic acid derivatives,0
10567,Hockey puck,reported blunt trauma by hockey puck,0
10568,Focal glomerulosclerosis,chronic focal sclerosing glomerulonephritis,0
10569,Methanol,intentional poisoning by wood alcohol,0
10570,Rusty sputum,Rusty sputum,0
10571,coughing up reddish brown sputum,Brown sputum,0
10572,open wound of finger with protruding bone,Protrusion of bone,0
10573,coughing up black sputum,Dirty sputum,0
10574,Ventricular hypertrophy,hypertrophied common ventricle,0
10575,Continuous ECG monitoring,2-D echocardiography with continuous ECG monitoring,0
10576,Chemical/poison screening,visit for screening exam for poison from contaminated water,0
10577,alcohol-induced mood disorder during withdrawal,Mood Disorders,0
10578,alcohol-induced anxiety disorder during withdrawal,Anxiety,0
10579,alcohol-induced psychotic disorder during withdrawal,Psychotic Disorders,0
10580,alcohol-induced sleep disorder during withdrawal,Sleep Disorders,0
10581,psychotic disorder due to intoxication with unspecified substance,Substance type unknown,0
10582,Mite-borne hemorrhagic fever,Mite Infestations,0
10583,partial complex seizure with memory disturbances,Memory impairment,0
10584,aspiration pneumonia due to food,Aspiration of food,0
10585,necrotic lung abscess,Pulmonary necrosis,0
10586,hernia secondary to colostomy,Colostomy Procedure,0
10587,hernia secondary to enterostomy,Enterostomy procedure,0
10588,carotid artery atherosclerosis with cerebral infarction,Cerebral Infarction,0
10589,Brown sputum,coughing up reddish brown sputum,0
10590,respiratory distress syndrome of newborn with cardiac component,Cardiac finding,0
10591,choking on liquid,Liquid substance,0
10592,abdominal bloating after medications,Has shown side effects from medication,0
10593,coughing up milk,Milk - dietary,0
10594,Pain on joint movement,pain of acromioclavicular joint elicited by motion,0
10595,Protrusion of bone,open wound of finger with protruding bone,0
10596,Insect Sting,History of allergy to insect bites or stings,0
10597,Multiple lesions,cafe-au-lait spots of which 6 or more were at least 15mm.,0
10598,Cardiac finding,respiratory distress syndrome of newborn with cardiac component,0
10599,Baseball bat,reported blunt trauma by baseball bat,0
10600,Parathyroid Adenoma,Parathyroid Adenoma,0
10601,estrogen-producing adrenal cortical adenoma,Estrogens,0
10602,ruptured endometrioma,Ruptured cyst of ovary,0
10603,Mucous discharge substance,mucous discharge from eye,0
10604,Mucous discharge substance,mucous discharge from right eye,0
10605,Mucous discharge substance,mucous discharge from left eye,0
10606,Mucous discharge substance,mucous discharge from both eyes,0
10607,Serous discharge,serous drainage from incision of cornea,0
10608,Purulent discharge substance,purulent incision of cornea,0
10609,Bloody discharge substance,bloody incision of cornea,0
10610,Serosanguineous discharge,serosanguineous drainage from incision of cornea,0
10611,burn with secondary Pseudomonas infection,Pseudomonas Infections,0
10612,Ventricular Septal Rupture,myocardial infarction with septal perforation,0
10613,Infected bursa,Sepsis,0
10614,intentional poisoning by para-aminosalicylic acid derivatives,aminosalicylic acid,0
10615,intentional poisoning by pertussis combination vaccine,Pertussis Vaccine,0
10616,intentional poisoning by cresol,Cresol,0
10617,"Thrombocythemia, Essential",Hemorrhage,0
10618,Alzheimer's dementia with behavioral disturbance,Disruptive Behavior,0
10619,aortic regurgitation with bicuspid valve,Bicuspid aortic valve,0
10620,aortic regurgitation with unicuspid valve,Unicuspid aortic valve,0
10621,aortic regurgitation with quadracuspid valve,Quadricuspid aortic valve,0
10622,"Amyotrophic Lateral Sclerosis, Autosomal Recessive",Autosomal recessive hereditary disorder,0
10623,acute kidney failure due to renal medullary necrosis,Kidney Papillary Necrosis,0
10624,Poor sleep pattern,depression accompanied by sleeping less,0
10625,increased pressure hydrocephalus,Increased pressure,0
10626,stroke due to basilar artery occlusion,Basilar artery occlusion,0
10627,2-D echocardiography with continuous ECG monitoring,Continuous ECG monitoring,0
10628,atrial flutter with block,Heart Block,0
10629,myocardial infarction arrhythmias,Conduction disorder of the heart,0
10630,myocardial infarction with septal perforation,Ventricular Septal Rupture,0
10631,myocardial infarction with papillary muscle dysfunction,Dysfunction of papillary muscle,0
10632,Liquid substance,choking on liquid,0
10633,factors relieving chest pain,Symptom relieving factors,0
10634,cryptosporidial cholecystitis,Cryptosporidium,0
10635,BB gun missile,intentional injury by another person with airgun,0
10636,Elation,depression alternating with periods of elation,0
10637,mood disorder of unknown (Axis III) etiology,Axis III diagnosis,0
10638,intimacy with person having hepatitis B,Sexual partners - finding,0
10639,accidental needlestick with exposure to hepatitis B,Accident caused by needle,0
10640,persistent vomiting in nonpregnant patient,Not pregnant (finding),0
10641,Communicating Hydrocephalus,Increased pressure,0
10642,delusional disorder due to unspecified substance,Substance type unknown,0
10643,acute inferoseptal myocardial infarction,Acute myocardial infarction of septum,0
10644,hypertrophied common ventricle,Ventricular hypertrophy,0
10645,maternal collagen vascular disease affecting fetus or newborn,Collagen Diseases,0
10646,Intrafamilial sexual abuse,adult sexual abuse by father,0
10647,Sexual partners - finding,intimacy with person having hepatitis B,0
10648,photodermatitis in tattoo,Decorative tattoo,0
10649,sexually active with persons at risk for HIV-related disease,HIV Infections,0
10650,Anticholinergic Agents,intentional poisoning by parasympatholytics,0
10651,attempted suicide by corrosive or caustic substances,Suicide attempt,0
10652,attempted suicide by handgun,Hand gun,0
10653,Memory impairment,partial complex seizure with memory disturbances,0
10654,adenocarcinoma of lung metastatic to bone,Secondary malignant neoplasm of bone,0
10655,basal cell carcinoma of skin with metastasis to lung from inhaled fragments,Secondary malignant neoplasm of lung,0
10656,Odor symptom,foul-smelling weeping incision of cornea,0
10657,Pertussis Vaccine,intentional poisoning by pertussis combination vaccine,0
10658,Colostomy Procedure,hernia secondary to colostomy,0
10659,Sleep Disorders,alcohol-induced sleep disorder during withdrawal,0
10660,Acquired disorder of keratinization,acquired cholesteatoma,0
10661,Has shown side effects from medication,abdominal bloating after medications,0
10662,Decorative tattoo,photodermatitis in tattoo,0
10663,Arbovirus Infections,Arbovirus encephalitis,0
10664,Communicable Diseases,infectious bronchiolitis,0
10665,Spirochaetales Infections,bronchospirochetosis,0
10666,Clear body fluid,culdocentesis clear serous fluid,0
10667,Ocular Prosthesis,anophthalmos of right eye with prosthesis,0
10668,Ocular Prosthesis,anophthalmos of left eye with prosthesis,0
10669,Estrogens,estrogen-producing adrenal cortical adenoma,0
10670,"Tuberculosis, Drug-Resistant",exposure to drug-resistant tuberculosis,0
10671,White sputum,coughing up white sputum,0
10672,Excessive dietary caloric intake,depression accompanied by eating more,0
10673,Cerebral Infarction,carotid artery atherosclerosis with cerebral infarction,0
10674,Conduction disorder of the heart,myocardial infarction arrhythmias,0
10675,Golf ball,reported blunt trauma by golf ball,0
10676,Mood Disorders,alcohol-induced mood disorder during withdrawal,0
10677,Anxiety,alcohol-induced anxiety disorder during withdrawal,0
10678,Hammer,reported blunt trauma by hammer,0
10679,Increased pressure,increased pressure hydrocephalus,0
10680,Increased pressure,Communicating Hydrocephalus,0
10681,Aspiration of food,aspiration pneumonia due to food,0
10682,Not pregnant (finding),persistent vomiting in nonpregnant patient,0
10683,anophthalmos of right eye with prosthesis,Ocular Prosthesis,0
10684,anophthalmos of left eye with prosthesis,Ocular Prosthesis,0
10685,cafe-au-lait spots of which 6 or more were at least 15mm.,Multiple lesions,0
10686,metal splinters in skin,Metal (material),0
10687,Pseudomonas Infections,burn with secondary Pseudomonas infection,0
10688,Substance type unknown,psychotic disorder due to intoxication with unspecified substance,0
10689,Substance type unknown,delusional disorder due to unspecified substance,0
10690,Fist,reported blunt trauma by fist,0
10691,Diphtheria and tetanus toxoid adsorbed,Td vaccine up to date,0
10692,Psychotic Disorders,alcohol-induced psychotic disorder during withdrawal,0
10693,Recreation equipment,reported blunt trauma by sports equipment,0
10694,Milk - dietary,coughing up milk,0
10695,Pulmonary necrosis,necrotic lung abscess,0
10696,Bicuspid aortic valve,aortic regurgitation with bicuspid valve,0
10697,PTCA indications: abnormal stress test,Percutaneous Transluminal Coronary Angioplasty,0
10698,Hypersomnia,depression accompanied by sleeping more,0
10699,Acute myocardial infarction of septum,acute inferoseptal myocardial infarction,0
10700,Worried,depression accompanied by persistent worry,0
10701,Loss of appetite (finding),depression accompanied by eating less,0
10702,Sexually Transmitted Diseases,Chlamydial cervicitis,0
10703,Collagen Diseases,maternal collagen vascular disease affecting fetus or newborn,0
10704,Suicide attempt,attempted suicide by corrosive or caustic substances,0
10705,Suicide attempt,attempted suicide by arsenic,0
10706,Cryptosporidium,cryptosporidial cholecystitis,0
10707,Autosomal recessive hereditary disorder,"Amyotrophic Lateral Sclerosis, Autosomal Recessive",0
10708,HIV Infections,sexually active with persons at risk for HIV-related disease,0
10709,Dysfunction of papillary muscle,myocardial infarction with papillary muscle dysfunction,0
10710,Enterostomy procedure,hernia secondary to enterostomy,0
10711,Blood,culdocentesis blood,0
10712,Axis III diagnosis,mood disorder of unknown (Axis III) etiology,0
10713,Abdominal paracentesis,instrument failure during abdominal paracentesis,0
10714,Kidney Papillary Necrosis,acute kidney failure due to renal medullary necrosis,0
10715,infectious bronchiolitis,Communicable Diseases,0
10716,adult sexual abuse by father,Intrafamilial sexual abuse,0
10717,acute septic laryngitis,Sepsis,0
10718,Sepsis,septic tenosynovitis of ankle,0
10719,Sepsis,septic tenosynovitis of extensor muscle of left ankle,0
10720,Sepsis,septic synovitis,0
10721,Sepsis,Septic tenosynovitis of foot,0
10722,Sepsis,septic synovitis of toe,0
10723,Sepsis,Infected bursa,0
10724,Sepsis,acute septic laryngitis,0
10725,acute myocardial infarction of posterior wall with initial care,Initial cardiac assessment,0
10726,acute myocardial infarction of posterior wall with subsequent care,Follow-up cardiac assessment,0
10727,Secondary malignant neoplasm of bone,adenocarcinoma of lung metastatic to bone,0
10728,Secondary malignant neoplasm of lung,basal cell carcinoma of skin with metastasis to lung from inhaled fragments,0
10729,acquired cholesteatoma,Acquired disorder of keratinization,0
10730,chronic renal failure with uremic nephropathy,Uremic neuropathy,0
10731,Ruptured cyst of ovary,ruptured endometrioma,0
10732,attempted suicide by arsenic,Suicide attempt,0
10733,intentional injury by another person with airgun,BB gun missile,0
10734,suppurative abdominal abscess,Infection - suppurative,0
10735,chronic focal sclerosing glomerulonephritis,Focal glomerulosclerosis,0
10736,"Keratitis, Dendritic",Dendritic ulcer,0
10737,Arbovirus encephalitis,Arbovirus Infections,0
10738,Symptoms of stress,military combat stress reaction,0
10739,Change of prescription of spectacles,worsening vision after prescription change,0
10740,Change of prescription of spectacles,worsening distance vision after prescription change,0
10741,diaphragm used for birth control,Vaginal contraceptive diaphragm (device),0
10742,Familial disease,"Creutzfeldt-Jakob Disease, Familial",0
10743,Lochia sanguinolenta,Lochia serosa,0
10744,anxiety with persistent worry about recurrent panic attacks,Panic Attacks,0
10745,Iatrogenic Disease,iatrogenic hypertension,0
10746,reported trauma with retained wood splinter,Wood splinter,0
10747,Foreign Bodies,reported trauma foreign body retained radioactive fragment,0
10748,taking medication for a long time prophylactically,Drug prophylaxis,0
10749,reported trauma foreign body retained organic fragment,Organic natural material,0
10750,reported trauma foreign body retained metal fragment magnetic,Magnet <device>,0
10751,reported trauma foreign body retained metal fragment nonmagnetic,Nonmagnetic metal,0
10752,reported trauma foreign body retained plastic fragment,Plastic object,0
10753,reported trauma foreign body retained radioactive fragment,Foreign Bodies,0
10754,reported trauma foreign body retained animal quill,Quill,0
10755,reported trauma foreign body retained tooth,Tooth finding,0
10756,a fall from a motorized wheelchair,motorized wheelchair,0
10757,a fall from a motorized mobility scooter,Motor scooter (physical object),0
10758,family doctor - last seen [use onset date],Seen by physician,0
10759,eye doctor - last seen [use onset date],Seen by medical ophthalmologist,0
10760,gynecologist - last seen [use onset date],Seen by gynecologist,0
10761,Post-exercise state,baby's (in uterus) activity after exercise,0
10762,Hemorrhage,chronic glomerulonephritis with hemorrhage,0
10763,Increased size (finding),axillary lump increasing in size,0
10764,Animal inoculation: organism - finding,Zoonotic bacterial disease,0
10765,Drug prophylaxis,taking medication for a long time prophylactically,0
10766,Vaginal contraceptive diaphragm (device),diaphragm used for birth control,0
10767,"complication due to renal dialysis device, implant, or graft",Implants,0
10768,uncontrolled type 1 diabetes mellitus with diabetic amyotrophy or mononeuritis multiplex,Type 1 diabetes mellitus uncontrolled,0
10769,Autonomic neuropathy with type 1 diabetes mellitus,"Diabetes Mellitus, Insulin-Dependent",0
10770,Blood vessel finding,intravascular complication of blood transfusion,0
10771,Motor scooter (physical object),a fall from a motorized mobility scooter,0
10772,Panic Attacks,anxiety with persistent worry about recurrent panic attacks,0
10773,Cerebrovascular accident,cerebromalacia due to cerebrovascular accident,0
10774,Pneumonia,influenza A with pneumonia,0
10775,motorized wheelchair,a fall from a motorized wheelchair,0
10776,Sore to touch,abdomen hernia epigastric tender,0
10777,Extravascular blood,extravascular complication of blood transfusion,0
10778,Infection - suppurative,suppurative abdominal abscess due to anaerobic bacteria,0
10779,Infection - suppurative,suppurative abdominal abscess due to Bacteroides fragilis,0
10780,Tube drain,incision drainage tube patent,0
10781,Tube drain,incision drainage tube displaced,0
10782,Tube drain,incision drainage tube leaking,0
10783,Wound drain,wound drainage tube patent,0
10784,Wound drain,wound drainage tube displaced,0
10785,Wound drain,wound drainage tube leaking,0
10786,Obstetrical laceration,Postnatal maternal examination,0
10787,First-degree perineal laceration during delivery,Postnatal maternal examination,0
10788,Second degree perineal laceration,Postnatal maternal examination,0
10789,Third degree perineal laceration,Postnatal maternal examination,0
10790,Fourth degree perineal laceration,Postnatal maternal examination,0
10791,Abdomen firm on palpation,Palpation of abdomen,0
10792,Nonmagnetic metal,reported trauma foreign body retained metal fragment nonmagnetic,0
10793,Gastrointestinal symptom,influenza A with gastrointestinal manifestations,0
10794,Gastrointestinal symptom,influenza a h1n1 novel 2009 with gastrointestinal manifestations,0
10795,Diabetic - poor control,uncontrolled diabetes mellitus with neurological complications,0
10796,Diabetic - poor control,uncontrolled diabetes mellitus with diabetic dermatitis,0
10797,Diabetic - poor control,uncontrolled necrobiosis lipoidica diabeticorum,0
10798,Diabetic - poor control,uncontrolled diabetes mellitus with ketoacidosis,0
10799,abdominal pregnancy with intrauterine pregnancy,Intrauterine pregnancy,0
10800,Combined intrauterine and ovarian pregnancy,Intrauterine pregnancy,0
10801,cornual pregnancy with intrauterine pregnancy,Intrauterine pregnancy,0
10802,idiopathic rhabdomyolysis,Idiopathic disease,0
10803,Axis IV problems primary support group,Axis IV diagnosis,0
10804,Abnormal histological finding in specimen from female genital organ,"tb female genital organs tb (+) histology, (-) bacteriology",0
10805,Abnormal histological finding in specimen from male genital organ,"tb male genital organs tb (+) histology, (-) bacteriology",0
10806,acute ascending bacterial myelitis,Bacterial Infections,0
10807,subacute primary traumatic iritis,Traumatic injury,0
10808,Anal sphincter tear,third-degree perineal laceration during delivery involving anal sphincter,0
10809,fibrinopurulent empyema,Fibrinopurulent pleurisy,0
10810,uncontrolled diabetes mellitus with neurological complications,Diabetic - poor control,0
10811,Type 1 diabetes mellitus with hypoglycemia,"Diabetes Mellitus, Insulin-Dependent",0
10812,Type 2 diabetes mellitus with hypoglycemia,"Diabetes Mellitus, Non-Insulin-Dependent",0
10813,uncontrolled diabetes mellitus with diabetic dermatitis,Diabetic - poor control,0
10814,Type 1 diabetes mellitus with diabetic dermatitis,"Diabetes Mellitus, Insulin-Dependent",0
10815,uncontrolled type 1 diabetes mellitus with diabetic dermatitis,Type 1 diabetes mellitus uncontrolled,0
10816,uncontrolled necrobiosis lipoidica diabeticorum,Diabetic - poor control,0
10817,type I necrobiosis lipoidica diabeticorum,"Diabetes Mellitus, Insulin-Dependent",0
10818,uncontrolled type 1 diabetes mellitus with foot ulcer,Type 1 diabetes mellitus uncontrolled,0
10819,chronic glomerulonephritis with hemorrhage,Hemorrhage,0
10820,Delayed transfusion reaction,abo incompatibility with delayed serologic transfusion reaction,0
10821,Delayed transfusion reaction,non-abo incompatibility with delayed serologic transfusion reaction,0
10822,Delayed transfusion reaction,rh incompatibility with delayed serologic transfusion reaction,0
10823,mural pregnancy with intrauterine pregnancy,Intrauterine pregnancy,0
10824,uncontrolled diabetes mellitus with ketoacidosis,Diabetic - poor control,0
10825,third-degree perineal laceration during delivery involving anal sphincter,Anal sphincter tear,0
10826,Tooth finding,reported trauma foreign body retained tooth,0
10827,brown penile discharge,Dark color,0
10828,painful axillary lump,Mass of axilla,0
10829,axillary lump increasing in size,Increased size (finding),0
10830,baby's (in uterus) activity after exercise,Post-exercise state,0
10831,Organic natural material,reported trauma foreign body retained organic fragment,0
10832,worsening vision after prescription change,Change of prescription of spectacles,0
10833,worsening distance vision after prescription change,Change of prescription of spectacles,0
10834,artificial skin on arm,Artificial skin,0
10835,artificial skin on scrotum,Artificial skin,0
10836,Lochia serosa,Lochia sanguinolenta,0
10837,assessment of bandage / dressing,Dressing change assessment,0
10838,bandage / dressing absent,Dressing change assessment,0
10839,bandage / dressing poor adherence,Dressing change assessment,0
10840,bandage / dressing poor absorption,Dressing change assessment,0
10841,bandage / dressing contaminated,Dressing change assessment,0
10842,wound drainage tube patent,Wound drain,0
10843,incision drainage tube patent,Tube drain,0
10844,incision drainage tube displaced,Tube drain,0
10845,incision drainage tube leaking,Tube drain,0
10846,wound drainage tube displaced,Wound drain,0
10847,wound drainage tube leaking,Wound drain,0
10848,functional exam medical devices,Medical Devices,0
10849,functional exam use of a blood pressure machine,Sphygmomanometers,0
10850,functional exam use of temperature measuring equipment,Temperature taking,0
10851,functional exam use of a glucose monitor,Blood glucose monitoring equipment,0
10852,abdomen hernia epigastric tender,Sore to touch,0
10853,Mass of axilla,painful axillary lump,0
10854,Banti's syndrome,Idiopathic disease,0
10855,Neurogenic claudication,spinal stenosis lumbar canal with neurogenic claudication,0
10856,extravascular complication of blood transfusion,Extravascular blood,0
10857,intravascular complication of blood transfusion,Blood vessel finding,0
10858,Seen by physician,family doctor - last seen [use onset date],0
10859,Seen by medical ophthalmologist,eye doctor - last seen [use onset date],0
10860,Seen by gynecologist,gynecologist - last seen [use onset date],0
10861,acute space motion sickness involving malaise,Malaise,0
10862,infection due to ocular lens prosthesis,Intraocular lens implant device,0
10863,acquired red blood cell aplasia with thymoma,Thymoma,0
10864,"Creutzfeldt-Jakob Disease, Familial",Familial disease,0
10865,Intraocular lens implant device,infection due to ocular lens prosthesis,0
10866,twin to twin transfusion with baby delivered,Postpartum Period,0
10867,twin to twin transfusion as antepartum condition,Antepartum fetal status,0
10868,arteriovenous malformation of duodenum with hemorrhage,Duodenal hemorrhage,0
10869,hemochromatosis due to repeated rbc transfusions,Transfusion (procedure),0
10870,influenza A with pneumonia,Pneumonia,0
10871,influenza A with bronchopneumonia,Bronchopneumonia,0
10872,influenza A with acute uri,Acute upper respiratory infection,0
10873,influenza A with laryngitis,Laryngitis,0
10874,influenza A with pharyngitis,Pharyngitis,0
10875,influenza A with encephalopathy,Brain Diseases,0
10876,influenza A with gastrointestinal manifestations,Gastrointestinal symptom,0
10877,influenza a h1n1 novel 2009 with bronchopneumonia,Bronchopneumonia,0
10878,influenza a h1n1 novel 2009 with acute uri,Acute upper respiratory infection,0
10879,influenza a h1n1 novel 2009 with laryngitis,Laryngitis,0
10880,influenza a h1n1 novel 2009 with pharyngitis,Pharyngitis,0
10881,influenza a h1n1 novel 2009 with encephalopathy,Brain Diseases,0
10882,influenza a h1n1 novel 2009 with gastrointestinal manifestations,Gastrointestinal symptom,0
10883,spinal stenosis lumbar canal with neurogenic claudication,Neurogenic claudication,0
10884,abo incompatibility with hemolytic transfusion reaction,Hemolytic Transfusion Reaction,0
10885,abo incompatibility with hemolytic transfusion reaction acute,Immediate hemolytic transfusion reaction,0
10886,abo incompatibility with hemolytic transfusion reaction delayed,Delayed Hemolytic Transfusion Reaction,0
10887,abo incompatibility with delayed serologic transfusion reaction,Delayed transfusion reaction,0
10888,transfusion complications intravascular non-abo incompatibility,Transfusion reaction due to isoantibody,0
10889,non-abo incompatibility with hemolytic transfusion reaction,Hemolytic Transfusion Reaction,0
10890,non-abo incompatibility with hemolytic transfusion reaction acute,Immediate hemolytic transfusion reaction,0
10891,non-abo incompatibility with hemolytic transfusion reaction delayed,Delayed Hemolytic Transfusion Reaction,0
10892,non-abo incompatibility with delayed serologic transfusion reaction,Delayed transfusion reaction,0
10893,rh incompatibility with hemolytic transfusion reaction,Hemolytic Transfusion Reaction,0
10894,rh incompatibility with hemolytic transfusion reaction acute,Immediate hemolytic transfusion reaction,0
10895,rh incompatibility with hemolytic transfusion reaction delayed,Delayed Hemolytic Transfusion Reaction,0
10896,rh incompatibility with delayed serologic transfusion reaction,Delayed transfusion reaction,0
10897,"twin gest placenta status unable to determine no. of placentae, amniotic sacs",Twin placenta,0
10898,triplet gestation placenta status,"Pregnancy, Triplet",0
10899,triplet gestation placenta status two or more monochorionic fetuses,"Pregnancy, Triplet",0
10900,triplet gestation placenta status two or more monoamniotic fetuses,"Pregnancy, Triplet",0
10901,"triplet gestation placenta status unable to determine number of placentae, amniotic sacs","Pregnancy, Triplet",0
10902,quadruplet gestation placenta status,Quadruplet pregnancy,0
10903,quadruplet gestation placenta status two or more monochorionic fetuses,Quadruplet pregnancy,0
10904,quadruplet gestation placenta status two or more monoamniotic fetuses,Quadruplet pregnancy,0
10905,"quadruplet gestation placenta status unable to determine number of placentae, amniotic sacs",Quadruplet pregnancy,0
10906,military combat stress reaction,Symptoms of stress,0
10907,influenza with bronchiolitis,Bronchiolitis,0
10908,influenza with bronchitis,Bronchitis,0
10909,Melanaemia,Melanins,0
10910,cerebromalacia due to cerebrovascular accident,Cerebrovascular accident,0
10911,influenza with enteritis,Enteritis,0
10912,influenza with ethmoiditis,Acute ethmoidal sinusitis,0
10913,congenital malformations corrected,Surgical repair,0
10914,hypospadia corrected,Surgical repair,0
10915,congenital anomaly of circulatory system (corrected),Surgical repair,0
10916,congenital anomaly of digestive system corrected,Surgical repair,0
10917,congenital anomalies of urinary system corrected,Surgical repair,0
10918,congenital anomalies of eye corrected,Surgical repair,0
10919,congenital ear deformity corrected,Surgical repair,0
10920,congenital anomalies of face and neck corrected,Surgical repair,0
10921,cleft lip corrected,Surgical repair,0
10922,cleft palate corrected,Surgical repair,0
10923,cleft palate with cleft lip corrected,Surgical repair,0
10924,congenital anomalies of respiratory system corrected,Surgical repair,0
10925,congenital musculoskeletal deformity (corrected),Surgical repair,0
10926,"tb eye - tb in sputum: (+) culture, (-) microscopy",Microbiologic culture of sputum positive,0
10927,tb female genital organs tb in sputum: (+) microscopy,Microbiologic culture of sputum positive,0
10928,"tb female genital organs tb in sputum: (+) culture, (-) microscopy",Microbiologic culture of sputum positive,0
10929,"tb female genital organs tb (+) histology, (-) bacteriology",Abnormal histological finding in specimen from female genital organ,0
10930,"tb male genital organs tb in sputum: (+) culture, (-) microscopy",Microbiologic culture of sputum positive,0
10931,"tb male genital organs tb (+) histology, (-) bacteriology",Abnormal histological finding in specimen from male genital organ,0
10932,Metastasis from malignant tumor of lung,adenocarcinoma of lung metastatic to brain,0
10933,idiopathic relapsing polyneuropathy,Idiopathic disease,0
10934,Bronchitis,influenza with bronchitis,0
10935,Pneumocystis jiroveci pneumonia,Plasma Cell Neoplasm,0
10936,neoplasm of uncertain behavior of anterior thymic cyst,Thymic Cyst,0
10937,Axis IV diagnosis,Axis IV problems primary support group,0
10938,Blood glucose monitoring equipment,functional exam use of a glucose monitor,0
10939,Quill,reported trauma foreign body retained animal quill,0
10940,Immediate hemolytic transfusion reaction,abo incompatibility with hemolytic transfusion reaction acute,0
10941,Immediate hemolytic transfusion reaction,non-abo incompatibility with hemolytic transfusion reaction acute,0
10942,Immediate hemolytic transfusion reaction,rh incompatibility with hemolytic transfusion reaction acute,0
10943,Malaise,acute space motion sickness involving malaise,0
10944,Plastic object,reported trauma foreign body retained plastic fragment,0
10945,Postnatal maternal examination,Obstetrical laceration,0
10946,Postnatal maternal examination,First-degree perineal laceration during delivery,0
10947,Postnatal maternal examination,Second degree perineal laceration,0
10948,Postnatal maternal examination,Third degree perineal laceration,0
10949,Postnatal maternal examination,Fourth degree perineal laceration,0
10950,iatrogenic hypertension,Iatrogenic Disease,0
10951,Dressing change assessment,assessment of bandage / dressing,0
10952,Dressing change assessment,bandage / dressing absent,0
10953,Dressing change assessment,bandage / dressing poor adherence,0
10954,Dressing change assessment,bandage / dressing poor absorption,0
10955,Dressing change assessment,bandage / dressing contaminated,0
10956,adenocarcinoma of lung metastatic to brain,Metastasis from malignant tumor of lung,0
10957,Bronchopneumonia,influenza A with bronchopneumonia,0
10958,Bronchopneumonia,influenza a h1n1 novel 2009 with bronchopneumonia,0
10959,Sphygmomanometers,functional exam use of a blood pressure machine,0
10960,Hemolytic Transfusion Reaction,abo incompatibility with hemolytic transfusion reaction,0
10961,Hemolytic Transfusion Reaction,non-abo incompatibility with hemolytic transfusion reaction,0
10962,Hemolytic Transfusion Reaction,rh incompatibility with hemolytic transfusion reaction,0
10963,Implants,"complication due to renal dialysis device, implant, or graft",0
10964,Thymic Cyst,neoplasm of uncertain behavior of anterior thymic cyst,0
10965,Pharyngitis,influenza A with pharyngitis,0
10966,Pharyngitis,influenza a h1n1 novel 2009 with pharyngitis,0
10967,Bronchiolitis,influenza with bronchiolitis,0
10968,Plasma Cell Neoplasm,Pneumocystis jiroveci pneumonia,0
10969,Traumatic injury,subacute primary traumatic iritis,0
10970,Idiopathic disease,idiopathic rhabdomyolysis,0
10971,Idiopathic disease,Banti's syndrome,0
10972,Idiopathic disease,idiopathic relapsing polyneuropathy,0
10973,Diabetic Ketoacidosis,uncontrolled type 1 diabetes mellitus with diabetic ketoacidosis,0
10974,Surgical repair,congenital malformations corrected,0
10975,Surgical repair,hypospadia corrected,0
10976,Surgical repair,congenital anomaly of circulatory system (corrected),0
10977,Surgical repair,congenital anomaly of digestive system corrected,0
10978,Surgical repair,congenital anomalies of urinary system corrected,0
10979,Surgical repair,congenital anomalies of eye corrected,0
10980,Surgical repair,congenital ear deformity corrected,0
10981,Surgical repair,congenital anomalies of face and neck corrected,0
10982,Surgical repair,cleft lip corrected,0
10983,Surgical repair,cleft palate corrected,0
10984,Surgical repair,cleft palate with cleft lip corrected,0
10985,Surgical repair,congenital anomalies of respiratory system corrected,0
10986,Surgical repair,congenital musculoskeletal deformity (corrected),0
10987,"Diabetes Mellitus, Non-Insulin-Dependent",Type 2 diabetes mellitus with hypoglycemia,0
10988,"Female condom, device",condoms used for birth control (history),0
10989,"Male condom, device",condoms used for birth control (history),0
10990,Microbiologic culture of sputum positive,"tb eye - tb in sputum: (+) culture, (-) microscopy",0
10991,Microbiologic culture of sputum positive,tb female genital organs tb in sputum: (+) microscopy,0
10992,Microbiologic culture of sputum positive,"tb female genital organs tb in sputum: (+) culture, (-) microscopy",0
10993,Microbiologic culture of sputum positive,"tb male genital organs tb in sputum: (+) culture, (-) microscopy",0
10994,Magnet <device>,reported trauma foreign body retained metal fragment magnetic,0
10995,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with diabetic amyotrophy or mononeuritis multiplex,0
10996,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with diabetic dermatitis,0
10997,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with foot ulcer,0
10998,Thymoma,acquired red blood cell aplasia with thymoma,0
10999,Laryngitis,influenza A with laryngitis,0
11000,Laryngitis,influenza a h1n1 novel 2009 with laryngitis,0
11001,Transfusion reaction due to isoantibody,transfusion complications intravascular non-abo incompatibility,0
11002,"Diabetes Mellitus, Insulin-Dependent",Autonomic neuropathy with type 1 diabetes mellitus,0
11003,"Diabetes Mellitus, Insulin-Dependent",Type 1 diabetes mellitus with hypoglycemia,0
11004,"Diabetes Mellitus, Insulin-Dependent",Type 1 diabetes mellitus with diabetic dermatitis,0
11005,"Diabetes Mellitus, Insulin-Dependent",type I necrobiosis lipoidica diabeticorum,0
11006,Acute upper respiratory infection,influenza A with acute uri,0
11007,Acute upper respiratory infection,influenza a h1n1 novel 2009 with acute uri,0
11008,Transfusion (procedure),hemochromatosis due to repeated rbc transfusions,0
11009,Temperature taking,functional exam use of temperature measuring equipment,0
11010,Melanins,Melanaemia,0
11011,Twin placenta,"twin gest placenta status unable to determine no. of placentae, amniotic sacs",0
11012,condoms used for birth control (history),"Female condom, device",0
11013,condoms used for birth control (history),"Male condom, device",0
11014,Quadruplet pregnancy,quadruplet gestation placenta status,0
11015,Quadruplet pregnancy,quadruplet gestation placenta status two or more monochorionic fetuses,0
11016,Quadruplet pregnancy,quadruplet gestation placenta status two or more monoamniotic fetuses,0
11017,Quadruplet pregnancy,"quadruplet gestation placenta status unable to determine number of placentae, amniotic sacs",0
11018,Medical Devices,functional exam medical devices,0
11019,"Pregnancy, Triplet",triplet gestation placenta status,0
11020,"Pregnancy, Triplet",triplet gestation placenta status two or more monochorionic fetuses,0
11021,"Pregnancy, Triplet",triplet gestation placenta status two or more monoamniotic fetuses,0
11022,"Pregnancy, Triplet","triplet gestation placenta status unable to determine number of placentae, amniotic sacs",0
11023,Enteritis,influenza with enteritis,0
11024,Palpation of abdomen,Abdomen firm on palpation,0
11025,Intrauterine pregnancy,abdominal pregnancy with intrauterine pregnancy,0
11026,Intrauterine pregnancy,Combined intrauterine and ovarian pregnancy,0
11027,Intrauterine pregnancy,cornual pregnancy with intrauterine pregnancy,0
11028,Intrauterine pregnancy,mural pregnancy with intrauterine pregnancy,0
11029,Antepartum fetal status,twin to twin transfusion as antepartum condition,0
11030,Antepartum fetal status,amniotic band syndrome as antepartum condition or complication,0
11031,Acute ethmoidal sinusitis,influenza with ethmoiditis,0
11032,Dark color,brown penile discharge,0
11033,Artificial skin,artificial skin on arm,0
11034,Artificial skin,artificial skin on scrotum,0
11035,Fibrinopurulent pleurisy,fibrinopurulent empyema,0
11036,Brain Diseases,influenza A with encephalopathy,0
11037,Brain Diseases,influenza a h1n1 novel 2009 with encephalopathy,0
11038,Delayed Hemolytic Transfusion Reaction,abo incompatibility with hemolytic transfusion reaction delayed,0
11039,Delayed Hemolytic Transfusion Reaction,non-abo incompatibility with hemolytic transfusion reaction delayed,0
11040,Delayed Hemolytic Transfusion Reaction,rh incompatibility with hemolytic transfusion reaction delayed,0
11041,Wood splinter,reported trauma with retained wood splinter,0
11042,Postpartum Period,twin to twin transfusion with baby delivered,0
11043,Postpartum Period,amniotic band syndrome with baby delivered,0
11044,Bacterial Infections,acute ascending bacterial myelitis,0
11045,amniotic band syndrome with baby delivered,Postpartum Period,0
11046,amniotic band syndrome as antepartum condition or complication,Antepartum fetal status,0
11047,Duodenal hemorrhage,arteriovenous malformation of duodenum with hemorrhage,0
11048,suppurative abdominal abscess due to anaerobic bacteria,Infection - suppurative,0
11049,suppurative abdominal abscess due to Bacteroides fragilis,Infection - suppurative,0
11050,Zoonotic bacterial disease,Animal inoculation: organism - finding,0
11051,uncontrolled type 1 diabetes mellitus with diabetic ketoacidosis,Diabetic Ketoacidosis,0
11052,Peritoneal dialysis catheter exit site infection,Catheterization,0
11053,Aplasia cutis congenita associated with fetus papyraceus (Type 5),Fetus papyraceous,0
11054,Infectious disease associated with acquired immune deficiency syndrome,Acquired Immunodeficiency Syndrome,0
11055,Infection of catheter exit site,Catheterization,0
11056,Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections,Streptococcal Infections,0
11057,Catheterization,Peritoneal dialysis catheter exit site infection,0
11058,Catheterization,Infection of catheter exit site,0
11059,Acquired Immunodeficiency Syndrome,Infectious disease associated with acquired immune deficiency syndrome,0
11060,Streptococcal Infections,Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections,0
11061,Fetus papyraceous,Aplasia cutis congenita associated with fetus papyraceus (Type 5),0
11062,x-ray of shoulder: subchondral lucency of right shoulder,Radiologic opacity,0
11063,x-ray of shoulder: subchondral lucency of left shoulder,Radiologic opacity,0
11064,x-ray of shoulder: subchondral lucency of superior aspect of shoulder,Radiologic opacity,0
11065,x-ray of shoulder: subchondral lucency of lateral aspect of shoulder,Radiologic opacity,0
11066,x-ray of shoulder: subchondral lucency of medial aspect of shoulder,Radiologic opacity,0
11067,x-ray of shoulder: subchondral lucency of anterior aspect of shoulder,Radiologic opacity,0
11068,x-ray of shoulder: subchondral lucency of posterior aspect of shoulder,Radiologic opacity,0
11069,Difficulty passing urine,Paruresis,0
11070,Lateral conjugate gaze,pain with eye movement to right,0
11071,Lateral conjugate gaze,pain with eye movement to left,0
11072,Downward conjugate gaze,pain in eye with downward eye movement,0
11073,Upward conjugate gaze,pain in eye with upward eye movement,0
11074,abnormal Pap Smear: endometrial hyperplasia,Abnormal cervical smear,0
11075,Contusion with intact skin,contusion with intact skin of right cheek,0
11076,Contusion with intact skin,contusion with intact skin of left cheek,0
11077,Finding related to sleep,Organic sleep related movement disorder,0
11078,Color finding,abdomen ostomy leakage color light tan,0
11079,Standing position,heart rate while standing,0
11080,belching from excessive swallowing of air,Aerophagy,0
11081,nausea seems associated with medications,Pharmacotherapy,0
11082,her water broke at term,Term pregnancy,0
11083,her water broke post-term,"Pregnancy, Prolonged",0
11084,abdominal pain relieved by not eating,Pain characterized by relieving factor,0
11085,pain with eye movement,Eye movement - finding,0
11086,pain in right eye with eye movement,Eye movement - finding,0
11087,pain in left eye with eye movement,Eye movement - finding,0
11088,pain in both eyes with eye movement,Eye movement - finding,0
11089,pain in eye with upward eye movement,Upward conjugate gaze,0
11090,pain in eye with downward eye movement,Downward conjugate gaze,0
11091,pain with eye movement to right,Lateral conjugate gaze,0
11092,pain with eye movement to left,Lateral conjugate gaze,0
11093,worsening distance vision making driving difficult,Difficulty driving a car,0
11094,neck pain radiating down right arm,Pain radiating to right arm,0
11095,neck pain radiating down left arm,Pain radiating to left arm,0
11096,neck pain radiating down both arms,Radiating pain,0
11097,visit for: adequacy testing for peritoneal dialysis,Peritoneal Dialysis,0
11098,Cardiovascular Surgical Procedures,cardiovascular surgery successful,0
11099,abdominal pain radiating to chest,Pain radiating to center of chest,0
11100,abdominal pain radiating to the substernal chest,Pain radiating to center of chest,0
11101,abdominal pain radiating to the right anterior chest,Pain radiating to right side of chest,0
11102,abdominal pain radiating to the left anterior chest,Pain radiating to left side of chest,0
11103,abdominal pain radiating to the right lateral chest,Pain radiating to right side of chest,0
11104,abdominal pain radiating to left lateral chest,Pain radiating to left side of chest,0
11105,abdominal pain relieved by lying down,Pain relief by supine position,0
11106,muscle spasm in midback,Spasm,0
11107,sharp abdominal pain,Sharp pain,0
11108,abdominal pain relieved by urination,Pain characterized by relieving factor,0
11109,Finding of walking,pain in calves of both legs worse with walking,0
11110,anal pain accompanied by discharge,Discharge from anus,0
11111,systolic blood pressure with stress,Stress,0
11112,diastolic blood pressure with stress,Stress,0
11113,Finding related to pregnancy,uterine softening in pregnancy,0
11114,Parity,history of specified pregnancy number (#___),0
11115,History of chewing nicotine-containing substances tobacco,Oral Tobacco,0
11116,Iatrogenic Disease,iatrogenic hemorrhage,0
11117,Iatrogenic Disease,iatrogenic stroke,0
11118,Iatrogenic Disease,iatrogenic male infertility due to infection,0
11119,Bone neoplasms,gardner's syndrome with extra-colonic manifestations,0
11120,Neoplasm of autonomic nerve,malignant neoplasm of autonomic nerves of orbit,0
11121,Neoplasm of autonomic nerve,malignant neoplasm of autonomic nerves of right orbit,0
11122,Neoplasm of autonomic nerve,malignant neoplasm of autonomic nerves of left orbit,0
11123,Neoplasm of autonomic nerve,benign neoplasm of autonomic nerve of orbit,0
11124,Peripheral Nervous System Neoplasms,malignant neoplasm of peripheral nerves of orbit,0
11125,Peripheral Nervous System Neoplasms,malignant neoplasm of peripheral nerves of right orbit,0
11126,Peripheral Nervous System Neoplasms,malignant neoplasm of peripheral nerves of left orbit,0
11127,Peripheral Nervous System Neoplasms,benign neoplasm of peripheral nerves of orbit,0
11128,Peripheral Nervous System Neoplasms,benign neoplasm of peripheral nerves of right orbit,0
11129,Peripheral Nervous System Neoplasms,benign neoplasm of peripheral nerves of left orbit,0
11130,Sickle cell-beta^+^-thalassemia,Hb-S B+ -thalassemia with crisis,0
11131,Sickle cell-beta^0^-thalassemia,Hb-S B0 -thalassemia with crisis,0
11132,caregiver effectiveness limited by fatigue,Fatigue,0
11133,caregiver effectiveness limited by physical fatigue,Exhaustion - physiological,0
11134,caregiver effectiveness limited by mental fatigue,Psychogenic fatigue,0
11135,role impairment as financial provider,Financial problem,0
11136,housing lice-infested mattress,Infestation by Anoplura,0
11137,Radiologic opacity,x-ray of shoulder: subchondral lucency of right shoulder,0
11138,Radiologic opacity,x-ray of shoulder: subchondral lucency of left shoulder,0
11139,Radiologic opacity,x-ray of shoulder: subchondral lucency of superior aspect of shoulder,0
11140,Radiologic opacity,x-ray of shoulder: subchondral lucency of lateral aspect of shoulder,0
11141,Radiologic opacity,x-ray of shoulder: subchondral lucency of medial aspect of shoulder,0
11142,Radiologic opacity,x-ray of shoulder: subchondral lucency of anterior aspect of shoulder,0
11143,Radiologic opacity,x-ray of shoulder: subchondral lucency of posterior aspect of shoulder,0
11144,Diarrheal disorder,flagellate diarrhea,0
11145,Secondary Neoplasm,metastasis from malignant neoplasm of cornea,0
11146,Secondary Neoplasm,metastasis from malignant neoplasm of large intestine,0
11147,Parathyroid Adenoma,primary hyperparathyroidism due to right superior adenoma,0
11148,Parathyroid Adenoma,primary hyperparathyroidism due to right inferior adenoma,0
11149,Parathyroid Adenoma,primary hyperparathyroidism due to left superior adenoma,0
11150,Parathyroid Adenoma,primary hyperparathyroidism due to left inferior adenoma,0
11151,Ectopic parathyroid adenoma,primary hyperparathyroidism due to ectopic adenoma,0
11152,Brain injury with open intracranial wound AND no loss of consciousness,gunshot wound of brain with no loss of consciousness,0
11153,Fruit Juices,mouth pain occurring recently with fruit juices,0
11154,electrocardiogram: PR interval increases until beat dropped,Dropped beats - heart,0
11155,Pressure (finding),Pressure point of skin,0
11156,Pressure (finding),skin pressure points occiput,0
11157,Pressure (finding),skin pressure points shoulder blades,0
11158,Pressure (finding),skin pressure points elbow,0
11159,Pressure (finding),skin pressure points hip,0
11160,Pressure (finding),skin pressure points sacrum,0
11161,Pressure (finding),skin pressure points heel,0
11162,Brain injury with open intracranial wound AND loss of consciousness,gunshot wound of brain with unconsciousness of unspecified duration,0
11163,Fall from building,attempted suicide by jumping from house,0
11164,Fall from building,attempted suicide by jumping from building,0
11165,Tumor stage T3,malignant neoplasm of large intestine TNM staging primary tumor (T) T3,0
11166,Tumor stage T3,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T3,0
11167,Tumor stage T3,malignant neoplasm of subglottis TNM staging primary tumor (T) T3,0
11168,Tumor stage T3,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T3,0
11169,Tumor stage T3,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T3,0
11170,Clinical stage IV B,malignant neoplasm of nasal cavity stage IVb,0
11171,Trying to give up smoking,Instructions - self-help group for smoking cessation (treatment),0
11172,Financial problem,role impairment as financial provider,0
11173,Symptom: generalized,diffuse joint tenderness,0
11174,Symptom: generalized,diffuse bone tenderness,0
11175,Exercise relieves symptom,chest pain relieved by exertion,0
11176,Rest relieves symptom,chest pain relieved by rest,0
11177,Symptom occurs at night,earache during night,0
11178,O/E - sign soft,soft neck mass,0
11179,O/E - sign firm,firm neck mass,0
11180,O/E - sign pulsatile,pulsatile neck mass,0
11181,Calculus = triple phosphate,nephrolithiasis with triple phosphate,0
11182,Placental finding,multiple gestation placenta status,0
11183,Placental finding,multiple gestation placenta status two or more monochorionic fetuses,0
11184,Placental finding,multiple gestation placenta status two or more monoamniotic fetuses,0
11185,Placental finding,"mult gest placenta status unable to determine no. of placentae, amniotic sacs",0
11186,abdominal pain relieved by passing gas,Pain characterized by relieving factor,0
11187,Mononeuritis multiplex with diabetes mellitus,uncontrolled type 2 diabetes mellitus with diabetic amyotrophy or mononeuritis multiplex,0
11188,Acute glomerulonephritis,acute hemorrhagic glomerulonephritis,0
11189,Basilar artery occlusion,medial medullary syndrome due to right basilar artery stroke,0
11190,Basilar artery occlusion,medial medullary syndrome due to left basilar artery stroke,0
11191,echocardiography: common ventricle enlarged,Congenital dilatation of cardiac ventricle,0
11192,echocardiography: common ventricle decreased,Congenital hypoplasia of cardiac ventricle,0
11193,heart rate while sitting,Sitting position,0
11194,heart rate while lying down,Supine Position,0
11195,heart rate while standing,Standing position,0
11196,heart rhythm regular with premature beats,Finding of heart rhythm,0
11197,visual function screening,Vision Screening,0
11198,Digital blood vessel injury,injury of blood vessel of second toe of right foot,0
11199,Digital blood vessel injury,injury of blood vessel of third toe of right foot,0
11200,Digital blood vessel injury,injury of blood vessel of fourth toe of right foot,0
11201,Digital blood vessel injury,injury of blood vessel of fifth toe of right foot,0
11202,Digital blood vessel injury,injury of blood vessel of second toe of left foot,0
11203,Digital blood vessel injury,injury of blood vessel of third toe of left foot,0
11204,Digital blood vessel injury,injury of blood vessel of fourth toe of left foot,0
11205,Digital blood vessel injury,injury of blood vessel of fifth toe of left foot,0
11206,attempted suicide by jumping from house,Fall from building,0
11207,attempted suicide by jumping from building,Fall from building,0
11208,attempted suicide by jumping from cliff,Fall from cliff,0
11209,attempted suicide by scalding,Burning due to contact with hot liquid,0
11210,attempted suicide by caustic substances,Caustic substance,0
11211,uncontrolled type 2 diabetes mellitus with diabetic amyotrophy or mononeuritis multiplex,Mononeuritis multiplex with diabetes mellitus,0
11212,uncontrolled type 2 diabetes mellitus with diabetic amyotrophy or mononeuritis multiplex,Diabetic lumbosacral radiculoplexus neuropathy,0
11213,uncontrolled type 1 diabetes mellitus with autonomic neuropathy,Type 1 diabetes mellitus uncontrolled,0
11214,uncontrolled type 2 diabetes mellitus with autonomic neuropathy,Type II diabetes mellitus uncontrolled,0
11215,attempted suicide by jumping from bridge,Fall from bridge,0
11216,closed bicondylar fracture of right tibia with cruciate ligament injury (Schatzker 5),Injury of cruciate ligament of knee,0
11217,closed bicondylar fracture of right tibia with lateral collateral injury (Schatzker 5),Injury of lateral collateral ligament of knee,0
11218,closed fracture of left knee bicondylar plateau (Schatzker 5) with cruciate ligament injury,Injury of cruciate ligament of knee,0
11219,closed fracture of left knee bicondylar plateau (Schatzker 5) with lateral collateral injury,Injury of lateral collateral ligament of knee,0
11220,open fracture of right medial tibial plateau with cruciate ligament injury (Schatzker 4),Injury of cruciate ligament of knee,0
11221,open fracture of right medial tibial plateau with lateral collateral injury (Schatzker 4),Injury of medial collateral ligament of knee,0
11222,open bicondylar fracture of right tibial plateau with lateral collateral injury (Schatzker 5),Injury of lateral collateral ligament of knee,0
11223,open fracture of left medial tibial plateau with cruciate ligament injury (Schatzker 4),Injury of cruciate ligament of knee,0
11224,open fracture of left medial tibial plateau with lateral collateral ligament injury (Schatzker 4),Injury of lateral collateral ligament of knee,0
11225,open fracture of left knee bicondylar plateau (Schatzker 5) with lateral collateral injury,Injury of lateral collateral ligament of knee,0
11226,Ectopic thyroid tissue (disorder),neoplasm of ectopic thyroid gland,0
11227,Status Migrainosus,classic migraine with acute-onset aura with status migrainosus,0
11228,Status Migrainosus,classic migraine with acute-onset aura with intractable migraine with status migrainosus,0
11229,Status Migrainosus,classic migraine with prolonged aura with status migrainosus,0
11230,Status Migrainosus,classic migraine with prolonged aura with intractable migraine with status migrainosus,0
11231,Status Migrainosus,familial hemiplegic migraine headache with status migrainosus,0
11232,Status Migrainosus,familial hemiplegic migraine headache with intractable migraine with status migrainosus,0
11233,neck pain radiating down arm,Radiating pain,0
11234,Exhaustion - physiological,caregiver effectiveness limited by physical fatigue,0
11235,Accidental Injuries,accidental obstruction of respiratory tract,0
11236,White color,Lochia alba (physical finding),0
11237,White color,burns color white,0
11238,White color,abdomen ostomy leakage color off-white,0
11239,White color,white urethral discharge on exam,0
11240,Burning due to contact with hot liquid,attempted suicide by scalding,0
11241,Sore nipple,currently breastfeeding and nipples are sore,0
11242,Erythema,perineum erythema,0
11243,Males,carcinoma in situ of male bladder,0
11244,Developmental delay (disorder),delayed developmental milestones language,0
11245,Developmental delay (disorder),Gross motor development delay,0
11246,Developmental delay (disorder),delayed developmental milestones fine motor,0
11247,Developmental delay (disorder),delayed developmental milestones social,0
11248,Developmental delay (disorder),delayed developmental speech milestones,0
11249,Dropped beats - heart,electrocardiogram: PR interval increases until beat dropped,0
11250,earache during night,Symptom occurs at night,0
11251,Discharge from anus,anal pain accompanied by discharge,0
11252,Retained foreign body of eyelid,abrasion of eyelids with foreign body,0
11253,Left ventricular wall echogenicity,echocardiography: echogenic mass of left ventricle,0
11254,Child developmental finding,milestone: balances on one foot for 10 seconds,0
11255,Caustic substance,attempted suicide by caustic substances,0
11256,milestone: attentive to voices,Finding of infant milestone,0
11257,Tumor stage T3a,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T3a,0
11258,Tumor stage T3a,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T3a,0
11259,Tumor stage T3a,malignant melanoma of skin TNM staging primary tumor (T) T3a,0
11260,Tumor stage T3b,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T3b,0
11261,diastolic blood pressure in right arm with stress,Stress,0
11262,diastolic blood pressure in left arm with stress,Stress,0
11263,Metastasis stage M1a,malignant neoplasm of esophagus TNM staging distal metastasis (M) M1a,0
11264,Metastasis stage M1b,malignant neoplasm of esophagus TNM staging distal metastasis (M) M1b,0
11265,Node stage N2a,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N2a,0
11266,Node stage N2b,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N2b,0
11267,Node stage N2c,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N2c,0
11268,Clinical stage 4,malignant neoplasm of nasal cavity stage IV,0
11269,Liquid (finding),abdomen ostomy leakage texture liquid,0
11270,black lesion of lip,Dark color,0
11271,mass of oral vestibule with bruit,Bruit,0
11272,mass of tongue with bruit,Bruit,0
11273,soft neck mass,O/E - sign soft,0
11274,firm neck mass,O/E - sign firm,0
11275,tender neck mass,O/E - tenderness,0
11276,pulsatile neck mass,O/E - sign pulsatile,0
11277,mass of nasopharynx with bruit,Bruit,0
11278,Edema,edematous neck mass,0
11279,Diabetic - poor control,diabetes with renal manifestations uncontrolled,0
11280,Diabetic - poor control,uncontrolled diabetes mellitus with autonomic neuropathy,0
11281,uncontrolled type 1 diabetes mellitus with diabetic nephropathy,Type 1 diabetes mellitus uncontrolled,0
11282,Echovirus Infections,echovirus infection associated with hemolytic uremic syndrome,0
11283,Metastasis stage MX,malignant neoplasm of large intestine TNM staging distant metastasis (M) MX,0
11284,Metastasis stage MX,malignant neoplasm of kidney TNM staging distant metastasis (M) MX,0
11285,Metastasis stage MX,malignant neoplasm of ureter TNM staging distant metastasis (M) MX,0
11286,primary hyperparathyroidism due to right superior adenoma,Parathyroid Adenoma,0
11287,primary hyperparathyroidism due to right inferior adenoma,Parathyroid Adenoma,0
11288,primary hyperparathyroidism due to left superior adenoma,Parathyroid Adenoma,0
11289,primary hyperparathyroidism due to left inferior adenoma,Parathyroid Adenoma,0
11290,primary hyperparathyroidism due to ectopic adenoma,Ectopic parathyroid adenoma,0
11291,flagellate diarrhea,Diarrheal disorder,0
11292,Diabetic retinal edema,Diabetes Mellitus,0
11293,malignant neoplasm of breast TNM staging primary tumor (T) TX,Tumor stage TX,0
11294,malignant neoplasm of breast TNM staging primary tumor (T) Tis,Tumor stage Tis,0
11295,malignant neoplasm of breast TNM staging primary tumor (T) T4,Tumor stage T4,0
11296,malignant neoplasm of breast TNM staging regional lymph node (N) NX,NX Stage Finding,0
11297,malignant neoplasm of lung TNM staging regional lymph node (N) NX,Lung TNM finding,0
11298,malignant neoplasm of lung TNM staging regional lymph node (N) N0,Lung TNM finding,0
11299,malignant neoplasm of lung TNM staging regional lymph node (N) N1,Lung TNM finding,0
11300,malignant neoplasm of lung TNM staging regional lymph node (N) N2,Lung TNM finding,0
11301,malignant neoplasm of lung TNM staging regional lymph node (N) N3,Lung TNM finding,0
11302,malignant neoplasm of lung TNM staging distant metastasis (M) MX,TNM tumor staging finding,0
11303,malignant neoplasm of lung TNM staging distant metastasis (M) M0,TNM tumor staging finding,0
11304,malignant neoplasm of lung TNM staging distant metastasis (M) M1,TNM tumor staging finding,0
11305,malignant neoplasm of large intestine TNM staging primary tumor (T) TX,Tumor stage TX,0
11306,malignant neoplasm of large intestine TNM staging primary tumor (T) Tis,Tumor stage Tis,0
11307,malignant neoplasm of large intestine TNM staging primary tumor (T) T2,Tumor stage T2,0
11308,malignant neoplasm of large intestine TNM staging primary tumor (T) T3,Tumor stage T3,0
11309,malignant neoplasm of large intestine TNM staging primary tumor (T) T4,Tumor stage T4,0
11310,malignant neoplasm of large intestine TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
11311,malignant neoplasm of large intestine TNM staging distant metastasis (M) MX,Metastasis stage MX,0
11312,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T3a,Tumor stage T3a,0
11313,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T3,Tumor stage T3,0
11314,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T3a,Tumor stage T3a,0
11315,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T3b,Tumor stage T3b,0
11316,malignant neoplasm of lip TNM staging regional lymph nodes (N) NX,Lip and oral cavity TNM finding,0
11317,malignant neoplasm of lip TNM staging regional lymph nodes (N) N0,Lip and oral cavity TNM finding,0
11318,malignant neoplasm of lip TNM staging regional lymph nodes (N) N1,Lip and oral cavity TNM finding,0
11319,malignant neoplasm of lip TNM staging regional lymph nodes (N) N2,Lip and oral cavity TNM finding,0
11320,malignant neoplasm of lip TNM staging regional lymph nodes (N) N3,Lip and oral cavity TNM finding,0
11321,malignant neoplasm of lip TNM staging distant metastasis (M) MX,Lip and oral cavity TNM finding,0
11322,malignant neoplasm of lip TNM staging distant metastasis (M) M0,Lip and oral cavity TNM finding,0
11323,malignant neoplasm of lip TNM staging distant metastasis (M) M1,Lip and oral cavity TNM finding,0
11324,malignant neoplasm of lip TNM staging primary tumor (T) T4a,Lip and oral cavity TNM finding,0
11325,malignant neoplasm of tongue TNM staging regional lymph nodes (N) NX,Lip and oral cavity TNM finding,0
11326,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N0,Lip and oral cavity TNM finding,0
11327,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N1,Lip and oral cavity TNM finding,0
11328,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N3,Lip and oral cavity TNM finding,0
11329,malignant neoplasm of tongue TNM staging distant metastasis (M) MX,Lip and oral cavity TNM finding,0
11330,malignant neoplasm of tongue TNM staging distant metastasis (M) M0,Lip and oral cavity TNM finding,0
11331,malignant neoplasm of tongue TNM staging distant metastasis (M) M1,Lip and oral cavity TNM finding,0
11332,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) NX,Lip and oral cavity TNM finding,0
11333,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N0,Lip and oral cavity TNM finding,0
11334,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N1,Lip and oral cavity TNM finding,0
11335,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N2,Lip and oral cavity TNM finding,0
11336,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N3,Lip and oral cavity TNM finding,0
11337,malignant neoplasm of oral cavity TNM staging distant metastasis (M) MX,Lip and oral cavity TNM finding,0
11338,malignant neoplasm of oral cavity TNM staging distant metastasis (M) M0,Lip and oral cavity TNM finding,0
11339,malignant neoplasm of oral cavity TNM staging distant metastasis (M) M1,Lip and oral cavity TNM finding,0
11340,malignant neoplasm of subglottis TNM staging primary tumor (T) T2,Tumor stage T2,0
11341,malignant neoplasm of subglottis TNM staging primary tumor (T) T3,Tumor stage T3,0
11342,malignant neoplasm of subglottis TNM staging primary tumor (T) T4,Tumor stage T4,0
11343,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T2,Tumor stage T2,0
11344,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T3,Tumor stage T3,0
11345,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T4,Tumor stage T4,0
11346,malignant neoplasm of nasal sinus TNM staging primary tumor (T) TX,Tumor stage TX,0
11347,malignant neoplasm of nasal sinus TNM staging primary tumor (T) Tis,Tumor stage Tis,0
11348,malignant neoplasm of nasal cavity TNM staging primary tumor (T) TX,Tumor stage TX,0
11349,malignant neoplasm of nasal cavity TNM staging primary tumor (T) Tis,Tumor stage Tis,0
11350,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T2,Tumor stage T2,0
11351,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T3,Tumor stage T3,0
11352,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T4,Tumor stage T4,0
11353,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
11354,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2,Nasal cavity and ethmoid sinus TNM finding,0
11355,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2a,Nasal cavity and ethmoid sinus TNM finding,0
11356,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2b,Nasal cavity and ethmoid sinus TNM finding,0
11357,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2c,Nasal cavity and ethmoid sinus TNM finding,0
11358,malignant neoplasm of nasal cavity stage IV,Clinical stage 4,0
11359,malignant neoplasm of nasal cavity stage IVa,Clinical stage IV A,0
11360,malignant neoplasm of nasal cavity stage IVb,Clinical stage IV B,0
11361,malignant neoplasm of nasal cavity stage IVC,Clinical stage IV C,0
11362,malignant neoplasm of glottis TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
11363,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N2a,Node stage N2a,0
11364,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N2b,Node stage N2b,0
11365,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N2c,Node stage N2c,0
11366,malignant neoplasm of esophagus TNM staging regional lymph nodes (N) N0,Esophagus TNM finding,0
11367,malignant neoplasm of esophagus TNM staging distant metastasis (M),Metastasis category finding,0
11368,malignant neoplasm of esophagus TNM staging distal metastasis (M) M1b,Metastasis stage M1b,0
11369,malignant neoplasm of esophagus TNM staging distal metastasis (M) M1a,Metastasis stage M1a,0
11370,malignant melanoma of skin TNM staging primary tumor (T) T3a,Tumor stage T3a,0
11371,malignant neoplasm of penis TNM staging regional lymph node (N) NX,TNM tumor staging finding,0
11372,malignant neoplasm of penis TNM staging regional lymph node (N) N0,TNM tumor staging finding,0
11373,malignant neoplasm of penis TNM staging regional lymph node (N) N1,TNM tumor staging finding,0
11374,malignant neoplasm of penis TNM staging regional lymph node (N) N2,TNM tumor staging finding,0
11375,malignant neoplasm of penis TNM staging regional lymph node (N) N3,TNM tumor staging finding,0
11376,malignant neoplasm of penis TNM staging distant metastasis (M) MX,TNM tumor staging finding,0
11377,malignant neoplasm of penis TNM staging distant metastasis (M) M0,TNM tumor staging finding,0
11378,malignant neoplasm of penis TNM staging distant metastasis (M) M1,TNM tumor staging finding,0
11379,malignant neoplasm of testis staging serum tumor markers (S) S0,Serum tumor marker stage S0,0
11380,malignant neoplasm of testis staging serum tumor markers (S) S1,Serum tumor marker stage S1,0
11381,malignant neoplasm of testis staging serum tumor markers (S) S2,Serum tumor marker stage S2,0
11382,malignant neoplasm of testis staging serum tumor markers (S) S3,Serum tumor marker stage S3,0
11383,malignant neoplasm of prostate TNM staging regional lymph nodes (N) NX,TNM tumor staging finding,0
11384,malignant neoplasm of prostate TNM staging regional lymph nodes (N) N0,TNM tumor staging finding,0
11385,malignant neoplasm of prostate TNM staging regional lymph nodes (N) N1,TNM tumor staging finding,0
11386,malignant neoplasm of prostate TNM staging distant metastasis (M) M1a,TNM tumor staging finding,0
11387,malignant neoplasm of prostate TNM staging distant metastasis (M) M1b,TNM tumor staging finding,0
11388,malignant neoplasm of prostate TNM staging distant metastasis MX,TNM tumor staging finding,0
11389,malignant neoplasm of prostate TNM staging distant metastasis (M) M0,TNM tumor staging finding,0
11390,malignant neoplasm of prostate TNM staging distant metastasis (M) M1,TNM tumor staging finding,0
11391,malignant neoplasm of prostate TNM staging distant metastasis (M) M1c,TNM tumor staging finding,0
11392,malignant neoplasm of prostate Jewett staging system,Tumor stage finding,0
11393,malignant neoplasm of prostate Jewett staging system stage A,Tumor stage finding,0
11394,malignant neoplasm of prostate Jewett staging system stage B,Tumor stage finding,0
11395,malignant neoplasm of prostate Jewett staging system stage C,Tumor stage finding,0
11396,malignant neoplasm of prostate Jewett staging system stage D,Tumor stage finding,0
11397,malignant neoplasm of kidney TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
11398,malignant neoplasm of kidney TNM staging distant metastasis (M) MX,Metastasis stage MX,0
11399,malignant neoplasm of ureter TNM staging primary tumor (T) TX,Tumor stage TX,0
11400,malignant neoplasm of ureter TNM staging primary tumor (T) Ta,Ta: Noninvasive papillary carcinoma (urinary tract),0
11401,malignant neoplasm of ureter TNM staging regional lymph nodes (N) NX,"Urinary bladder, ureter, or renal pelvis TNM finding",0
11402,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N0,"Urinary bladder, ureter, or renal pelvis TNM finding",0
11403,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N1,"Urinary bladder, ureter, or renal pelvis TNM finding",0
11404,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N2,"Urinary bladder, ureter, or renal pelvis TNM finding",0
11405,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N3,"Urinary bladder, ureter, or renal pelvis TNM finding",0
11406,malignant neoplasm of ureter TNM staging distant metastasis (M) MX,Metastasis stage MX,0
11407,nonspecific abnormal findings on neonatal screening,Neonatal Screening,0
11408,uncontrolled type 1 diabetes mellitus with diabetic ketoacidosis with coma,Type 1 diabetes mellitus uncontrolled,0
11409,uncontrolled type 2 diabetes mellitus with diabetic ketoacidosis,Type II diabetes mellitus uncontrolled,0
11410,calcific effusive pericarditis,Calcification of pericardium,0
11411,O/E - tenderness,tender neck mass,0
11412,fistula secondary to enterostomy,Enterostomy procedure,0
11413,uncontrolled type 2 diabetes mellitus with ophthalmic manifestations,Type II diabetes mellitus uncontrolled,0
11414,uncontrolled type 1 diabetes mellitus with ophthalmic manifestations,Type 1 diabetes mellitus uncontrolled,0
11415,uncontrolled type 2 diabetes mellitus with neurological complications,Type II diabetes mellitus uncontrolled,0
11416,uncontrolled type 1 diabetes mellitus with neurological complications,Type 1 diabetes mellitus uncontrolled,0
11417,uncontrolled Type 2 diabetes mellitus with manifestations,Type II diabetes mellitus uncontrolled,0
11418,"type 1 diabetic hypoglycemia, uncontrolled",Type 1 diabetes mellitus uncontrolled,0
11419,uncontrolled type 2 diabetes mellitus with hypoglycemia,Type II diabetes mellitus uncontrolled,0
11420,uncontrolled type 2 diabetes mellitus with diabetic dermatitis,Type II diabetes mellitus uncontrolled,0
11421,uncontrolled type I necrobiosis lipoidica diabeticorum,Type 1 diabetes mellitus uncontrolled,0
11422,uncontrolled type II necrobiosis lipoidica diabeticorum,Type II diabetes mellitus uncontrolled,0
11423,uncontrolled type 1 diabetes mellitus with gastropathy,Type 1 diabetes mellitus uncontrolled,0
11424,uncontrolled type 2 diabetes mellitus with gastropathy,Type II diabetes mellitus uncontrolled,0
11425,uncontrolled type 2 diabetes with foot ulcer,Type II diabetes mellitus uncontrolled,0
11426,acute hemorrhagic glomerulonephritis,Acute glomerulonephritis,0
11427,chronic membranous glomerulonephritis with sclerosing lesions,Membranous glomerulonephritis,0
11428,chronic membranous glomerulonephritis with focal glomerulosclerosis,Membranous glomerulonephritis,0
11429,nephritis with mixed membranous and proliferative glomerulonephritis,Membranous glomerulonephritis,0
11430,Incoordinate swallowing in newborn,uncoordinated swallow during breastfeeding,0
11431,adenofibromatous hypertrophy of prostate with urinary obstruction,Urinary tract obstruction,0
11432,prostatic polyp with urinary obstruction,polyps,0
11433,diabetic retinal edema of right eye,Diabetes Mellitus,0
11434,diabetic retinal edema of left eye,Diabetes Mellitus,0
11435,diabetic retinal edema of both eyes,Diabetes Mellitus,0
11436,uncontrolled type 2 diabetes with ophthalmic manifestations of right eye,Type II diabetes mellitus uncontrolled,0
11437,uncontrolled type 2 diabetes with ophthalmic manifestations of left eye,Type II diabetes mellitus uncontrolled,0
11438,uncontrolled type 2 diabetes with ophthalmic manifestations of both eyes,Type II diabetes mellitus uncontrolled,0
11439,uncontrolled type 1 diabetes mellitus with ophthalmic manifestations of right eye,Type 1 diabetes mellitus uncontrolled,0
11440,uncontrolled type 1 diabetes mellitus with ophthalmic manifestations of left eye,Type 1 diabetes mellitus uncontrolled,0
11441,uncontrolled type 1 diabetes mellitus with ophthalmic manifestations of both eyes,Type 1 diabetes mellitus uncontrolled,0
11442,Right hemiparesis,lacunar syndrome with right pure motor hemiparesis due to internal capsule infarction,0
11443,Left hemiparesis,lacunar syndrome with left pure motor hemiparesis due to internal capsule infarction,0
11444,delayed developmental milestones gross motor late walker,Finding related to ability to walk,0
11445,vitreous membranes and strands of right eye,Vitreous strands,0
11446,vitreous membranes and strands of right eye,Pathologic Vitreous membrane,0
11447,vitreous membranes and strands of left eye,Vitreous strands,0
11448,vitreous membranes and strands of left eye,Pathologic Vitreous membrane,0
11449,vitreous membranes and strands of both eyes,Vitreous strands,0
11450,vitreous membranes and strands of both eyes,Pathologic Vitreous membrane,0
11451,Organic sleep related movement disorder,Finding related to sleep,0
11452,Brain injury with open intracranial wound AND prolonged loss of consciousness (more than 24 hours) AND return to pre-existing conscious level,gunshot wound of brain with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,0
11453,Intimidation,patient's reaction to health care provider: anxiety or feelings of intimidation,0
11454,contusion with intact skin of right cheek,Contusion with intact skin,0
11455,contusion with intact skin of left cheek,Contusion with intact skin,0
11456,Brain injury with open intracranial wound AND brief loss of consciousness (less than one hour),gunshot wound of brain with brief (< 1 hr) loss of consciousness,0
11457,Vitreous strands,vitreous membranes and strands of right eye,0
11458,Vitreous strands,vitreous membranes and strands of left eye,0
11459,Vitreous strands,vitreous membranes and strands of both eyes,0
11460,problem with nipple shield during breastfeeding,Nipple shield,0
11461,abdominal pain relieved by belching,Pain characterized by relieving factor,0
11462,Injury of great toe,injury of blood vessel of first toe of right foot,0
11463,Injury of great toe,injury of blood vessel of first toe of left foot,0
11464,chest pain relieved by exertion,Exercise relieves symptom,0
11465,ADHD checklist,Attention deficit hyperactivity disorder,0
11466,pain in calves of both legs worse with walking,Finding of walking,0
11467,visit for: admission to long-term care facility,Admission for long-term care,0
11468,uncoordinated swallow during breastfeeding,Incoordinate swallowing in newborn,0
11469,patient's reaction to health care provider: anxiety or feelings of intimidation,Intimidation,0
11470,"Disease condition determination, uncontrolled",uncontrolled secondary diabetes mellitus,0
11471,skin graft of shoulder,Skin Transplantation,0
11472,skin graft of right shoulder,Skin Transplantation,0
11473,skin graft of anterior aspect of right shoulder,Skin Transplantation,0
11474,skin graft of superior aspect of right shoulder,Skin Transplantation,0
11475,skin graft of posterior aspect of right shoulder,Skin Transplantation,0
11476,skin graft of lateral aspect of right shoulder,Skin Transplantation,0
11477,skin graft of left shoulder,Skin Transplantation,0
11478,skin graft of anterior aspect of left shoulder,Skin Transplantation,0
11479,skin graft of superior aspect of left shoulder,Skin Transplantation,0
11480,skin graft of posterior aspect of left shoulder,Skin Transplantation,0
11481,skin graft of lateral aspect of left shoulder,Skin Transplantation,0
11482,Increased area of cardiac dullness,percussion dullness apex,0
11483,delayed developmental milestones language,Developmental delay (disorder),0
11484,Gross motor development delay,Developmental delay (disorder),0
11485,delayed developmental milestones fine motor,Developmental delay (disorder),0
11486,delayed developmental milestones social,Developmental delay (disorder),0
11487,recent emotional stress from chronic pain,Chronic pain,0
11488,stress associated with a terminal illness (history),Terminal illness,0
11489,Lochia alba (physical finding),White color,0
11490,burns color white,White color,0
11491,perineum erythema,Erythema,0
11492,visual function fixation preference,Vision Screening,0
11493,fixation preference right eye,Vision Screening,0
11494,fixation preference left eye,Vision Screening,0
11495,uterine softening in pregnancy,Finding related to pregnancy,0
11496,postpartum uterus,Postpartum Period,0
11497,postpartum fundus size,Postpartum Period,0
11498,postpartum fundus size 2+,Postpartum Period,0
11499,postpartum fundus size 1+,Postpartum Period,0
11500,postpartum fundus at symphysis pubis,Postpartum Period,0
11501,postpartum fundus size 1-,Postpartum Period,0
11502,postpartum fundus size 2-,Postpartum Period,0
11503,postpartum uterus boggy,Postpartum Period,0
11504,postpartum uterus firm,Postpartum Period,0
11505,diffuse joint tenderness,Symptom: generalized,0
11506,diffuse bone tenderness,Symptom: generalized,0
11507,berg balance scale (0-56),Berg balance test,0
11508,Pressure point of skin,Pressure (finding),0
11509,skin pressure points occiput,Pressure (finding),0
11510,skin pressure points shoulder blades,Pressure (finding),0
11511,skin pressure points elbow,Pressure (finding),0
11512,skin pressure points hip,Pressure (finding),0
11513,skin pressure points sacrum,Pressure (finding),0
11514,skin pressure points heel,Pressure (finding),0
11515,abdomen ostomy leakage texture liquid,Liquid (finding),0
11516,abdomen ostomy leakage texture soft,Abnormally soft consistency,0
11517,abdomen ostomy leakage texture solid,Solid consistencies,0
11518,abdomen ostomy leakage texture oily,Abnormal consistency,0
11519,abdomen ostomy leakage color brown,Dark color,0
11520,abdomen ostomy leakage color green,Green color,0
11521,abdomen ostomy leakage color black,Dark color,0
11522,abdomen ostomy leakage color maroon,Pale red color,0
11523,abdomen ostomy leakage color red,Redness,0
11524,abdomen ostomy leakage color light tan,Color finding,0
11525,abdomen ostomy leakage color off-white,White color,0
11526,abdomen ostomy leakage odor foul-smelling,Odor of specimen - finding,0
11527,abdomen ostomy leakage odor sickly sweet,Odor of specimen - finding,0
11528,x-ray of cervical spine: old fracture,Old healed fracture of bone,0
11529,Genitourinary tract problem,mucositis of genitourinary system,0
11530,Solid consistencies,abdomen ostomy leakage texture solid,0
11531,Difficulty driving a car,worsening distance vision making driving difficult,0
11532,Terminal illness,stress associated with a terminal illness (history),0
11533,Finding of heart rhythm,heart rhythm regular with premature beats,0
11534,Finding of infant milestone,milestone: attentive to voices,0
11535,postgastrectomy anemia,Postgastrectomy Syndromes,0
11536,Skin Transplantation,skin graft of shoulder,0
11537,Skin Transplantation,skin graft of right shoulder,0
11538,Skin Transplantation,skin graft of anterior aspect of right shoulder,0
11539,Skin Transplantation,skin graft of superior aspect of right shoulder,0
11540,Skin Transplantation,skin graft of posterior aspect of right shoulder,0
11541,Skin Transplantation,skin graft of lateral aspect of right shoulder,0
11542,Skin Transplantation,skin graft of left shoulder,0
11543,Skin Transplantation,skin graft of anterior aspect of left shoulder,0
11544,Skin Transplantation,skin graft of superior aspect of left shoulder,0
11545,Skin Transplantation,skin graft of posterior aspect of left shoulder,0
11546,Skin Transplantation,skin graft of lateral aspect of left shoulder,0
11547,Admission for long-term care,visit for: admission to long-term care facility,0
11548,nephrolithiasis with triple phosphate,Calculus = triple phosphate,0
11549,Aerophagy,belching from excessive swallowing of air,0
11550,Old healed fracture of bone,x-ray of cervical spine: old fracture,0
11551,patient appeared to understand therapeutic regimen,Assessment of compliance with therapeutic regimen,0
11552,patient appeared uninterested in therapeutic regimen,Assessment of compliance with therapeutic regimen,0
11553,patient and family appeared to understand therapeutic regimen,Assessment of compliance with therapeutic regimen,0
11554,Left sided cerebral infarction,dysarthria-clumsy hand sydrome due to left sided infarction of brain,0
11555,Right sided cerebral infarction,dysarthria-clumsy hand sydrome due to right sided infarction of brain,0
11556,echovirus infection associated with hemolytic uremic syndrome,Echovirus Infections,0
11557,mucositis of genitourinary system,Genitourinary tract problem,0
11558,iatrogenic hemorrhage,Iatrogenic Disease,0
11559,Hb-S B+ -thalassemia with crisis,Sickle cell-beta^+^-thalassemia,0
11560,Hb-S B0 -thalassemia with crisis,Sickle cell-beta^0^-thalassemia,0
11561,HIV infection CDC classification asymptomatic,HIV CDC category finding,0
11562,Serum tumor marker stage S0,malignant neoplasm of testis staging serum tumor markers (S) S0,0
11563,Serum tumor marker stage S1,malignant neoplasm of testis staging serum tumor markers (S) S1,0
11564,Serum tumor marker stage S2,malignant neoplasm of testis staging serum tumor markers (S) S2,0
11565,Serum tumor marker stage S3,malignant neoplasm of testis staging serum tumor markers (S) S3,0
11566,uncontrolled secondary diabetes mellitus,"Disease condition determination, uncontrolled",0
11567,classic migraine with acute-onset aura with status migrainosus,Status Migrainosus,0
11568,classic migraine with acute-onset aura with intractable migraine with status migrainosus,Status Migrainosus,0
11569,classic migraine with prolonged aura with status migrainosus,Status Migrainosus,0
11570,classic migraine with prolonged aura with intractable migraine with status migrainosus,Status Migrainosus,0
11571,classic migraine with prolonged aura with intractable migraine with status migrainosus,Refractory migraine,0
11572,familial hemiplegic migraine headache with intractable migraine,Refractory migraine,0
11573,familial hemiplegic migraine headache with status migrainosus,Status Migrainosus,0
11574,familial hemiplegic migraine headache with intractable migraine with status migrainosus,Status Migrainosus,0
11575,familial hemiplegic migraine headache with intractable migraine with status migrainosus,Refractory migraine,0
11576,postvaccination pyrexia,Administration of vaccine to produce active immunity,0
11577,uncontrolled secondary diabetic hypoglycemia,Secondary diabetes mellitus,0
11578,gout with spondylitis,Spondylitis,0
11579,gout with synovitis,Synovitis,0
11580,multiple gestation placenta status,Placental finding,0
11581,multiple gestation placenta status two or more monochorionic fetuses,Placental finding,0
11582,multiple gestation placenta status two or more monoamniotic fetuses,Placental finding,0
11583,"mult gest placenta status unable to determine no. of placentae, amniotic sacs",Placental finding,0
11584,diabetes with renal manifestations uncontrolled,Diabetic - poor control,0
11585,type 2 diabetes with renal manifestations - uncontrolled,Type II diabetes mellitus uncontrolled,0
11586,uncontrolled type 1 diabetes with renal manifestations,Type 1 diabetes mellitus uncontrolled,0
11587,gardner's syndrome with extra-colonic manifestations,Bone neoplasms,0
11588,gardner's syndrome with extra-colonic manifestations,Soft Tissue Neoplasms,0
11589,traumatic lumbar puncture headache,Complication of puncture procedure,0
11590,medial medullary syndrome due to right basilar artery stroke,Basilar artery occlusion,0
11591,medial medullary syndrome due to left basilar artery stroke,Basilar artery occlusion,0
11592,lacunar syndrome with right pure motor hemiparesis due to internal capsule infarction,Right hemiparesis,0
11593,lacunar syndrome with left pure motor hemiparesis due to internal capsule infarction,Left hemiparesis,0
11594,dysarthria-clumsy hand sydrome due to right sided infarction of brain,Right sided cerebral infarction,0
11595,dysarthria-clumsy hand sydrome due to left sided infarction of brain,Left sided cerebral infarction,0
11596,Claude's syndrome due to right-sided lesion,Brain Stem Infarctions,0
11597,Claude's syndrome due to left-sided lesion,Brain Stem Infarctions,0
11598,Benedikt syndrome (right side),Brain Stem Infarctions,0
11599,Benedikt syndrome (left side),Brain Stem Infarctions,0
11600,hypertensive hemorrhage of cerebral lobe,Hypertensive disease,0
11601,hypertensive hemorrhage of right frontal lobe,Hypertensive disease,0
11602,hypertensive hemorrhage of left frontal lobe,Hypertensive disease,0
11603,hypertensive hemorrhage of right temporal lobe,Hypertensive disease,0
11604,hypertensive hemorrhage of left temporal lobe,Hypertensive disease,0
11605,hypertensive hemorrhage of right parietal lobe,Hypertensive disease,0
11606,hypertensive hemorrhage of left parietal lobe,Hypertensive disease,0
11607,hypertensive intracerebral hemorrhage of right occipital lobe,Hypertensive disease,0
11608,hypertensive intracerebral hemorrhage of left occipital lobe,Hypertensive disease,0
11609,hypertensive intracerebral hemorrhage of basal ganglia,Hypertensive disease,0
11610,hypertensive intracerebral hemorrhage of right basal ganglia,Hypertensive disease,0
11611,hypertensive intracerebral hemorrhage of left basal ganglia,Hypertensive disease,0
11612,hypertensive intracerebral hemorrhage of thalamus,Hypertensive disease,0
11613,hypertensive hemorrhage of right thalamus,Hypertensive disease,0
11614,hypertensive hemorrhage of left thalamus,Hypertensive disease,0
11615,hypertensive pontine hemorrhage,Hypertensive disease,0
11616,hypertensive cerebellar hemorrhage,Hypertensive disease,0
11617,hypertensive hemorrhage of right cerebellum,Hypertensive disease,0
11618,hypertensive hemorrhage of left cerebellum,Hypertensive disease,0
11619,Clinical stage IV C,malignant neoplasm of nasal cavity stage IVC,0
11620,aortic stenosis with bicuspid valve,Bicuspid aortic valve,0
11621,Nipple shield,problem with nipple shield during breastfeeding,0
11622,Sitting position,heart rate while sitting,0
11623,chest pain relieved by rest,Rest relieves symptom,0
11624,Administration of vaccine to produce active immunity,postvaccination pyrexia,0
11625,Paruresis,Difficulty passing urine,0
11626,mouth pain occurring recently with fruit juices,Fruit Juices,0
11627,hypertrophy of morphologic left ventricle,Left Ventricular Hypertrophy,0
11628,hypertrophy of morphologic right ventricle,Right Ventricular Hypertrophy,0
11629,tetralogy of Fallot with left to right shunt,Left to right cardiovascular shunt (finding),0
11630,tetralogy of Fallot with right to left shunt,Right to left cardiovascular shunt (finding),0
11631,Intrafamilial sexual abuse,adult sexual abuse by stepfather,0
11632,Intrafamilial sexual abuse,adult sexual abuse by mother,0
11633,Intrafamilial sexual abuse,adult sexual abuse by stepmother,0
11634,Intrafamilial sexual abuse,adult sexual abuse by grandparent,0
11635,Complication of puncture procedure,traumatic lumbar puncture headache,0
11636,"Pain, Burning",burning abdominal pain,0
11637,Abnormally soft consistency,abdomen ostomy leakage texture soft,0
11638,Odor of specimen - finding,abdomen ostomy leakage odor foul-smelling,0
11639,Odor of specimen - finding,abdomen ostomy leakage odor sickly sweet,0
11640,Eye movement - finding,pain with eye movement,0
11641,Eye movement - finding,pain in right eye with eye movement,0
11642,Eye movement - finding,pain in left eye with eye movement,0
11643,Eye movement - finding,pain in both eyes with eye movement,0
11644,Finding related to ability to walk,delayed developmental milestones gross motor late walker,0
11645,Ta: Noninvasive papillary carcinoma (urinary tract),malignant neoplasm of ureter TNM staging primary tumor (T) Ta,0
11646,Patient condition resolved,abdominal mass not present on repeated examination,0
11647,abrasion of eyelids with foreign body,Retained foreign body of eyelid,0
11648,post-surgical cataract fragments in eye,Postoperative Complications,0
11649,Hypertensive disease,hypertensive hemorrhage of cerebral lobe,0
11650,Hypertensive disease,hypertensive hemorrhage of right frontal lobe,0
11651,Hypertensive disease,hypertensive hemorrhage of left frontal lobe,0
11652,Hypertensive disease,hypertensive hemorrhage of right temporal lobe,0
11653,Hypertensive disease,hypertensive hemorrhage of left temporal lobe,0
11654,Hypertensive disease,hypertensive hemorrhage of right parietal lobe,0
11655,Hypertensive disease,hypertensive hemorrhage of left parietal lobe,0
11656,Hypertensive disease,hypertensive intracerebral hemorrhage of right occipital lobe,0
11657,Hypertensive disease,hypertensive intracerebral hemorrhage of left occipital lobe,0
11658,Hypertensive disease,hypertensive intracerebral hemorrhage of basal ganglia,0
11659,Hypertensive disease,hypertensive intracerebral hemorrhage of right basal ganglia,0
11660,Hypertensive disease,hypertensive intracerebral hemorrhage of left basal ganglia,0
11661,Hypertensive disease,hypertensive intracerebral hemorrhage of thalamus,0
11662,Hypertensive disease,hypertensive hemorrhage of right thalamus,0
11663,Hypertensive disease,hypertensive hemorrhage of left thalamus,0
11664,Hypertensive disease,hypertensive pontine hemorrhage,0
11665,Hypertensive disease,hypertensive cerebellar hemorrhage,0
11666,Hypertensive disease,hypertensive hemorrhage of right cerebellum,0
11667,Hypertensive disease,hypertensive hemorrhage of left cerebellum,0
11668,iatrogenic stroke,Iatrogenic Disease,0
11669,HIV CDC category finding,HIV infection CDC classification asymptomatic,0
11670,Tumor stage finding,malignant neoplasm of prostate Jewett staging system,0
11671,Tumor stage finding,malignant neoplasm of prostate Jewett staging system stage A,0
11672,Tumor stage finding,malignant neoplasm of prostate Jewett staging system stage B,0
11673,Tumor stage finding,malignant neoplasm of prostate Jewett staging system stage C,0
11674,Tumor stage finding,malignant neoplasm of prostate Jewett staging system stage D,0
11675,TNM tumor staging finding,malignant neoplasm of lung TNM staging distant metastasis (M) MX,0
11676,TNM tumor staging finding,malignant neoplasm of lung TNM staging distant metastasis (M) M0,0
11677,TNM tumor staging finding,malignant neoplasm of lung TNM staging distant metastasis (M) M1,0
11678,TNM tumor staging finding,malignant neoplasm of penis TNM staging regional lymph node (N) NX,0
11679,TNM tumor staging finding,malignant neoplasm of penis TNM staging regional lymph node (N) N0,0
11680,TNM tumor staging finding,malignant neoplasm of penis TNM staging regional lymph node (N) N1,0
11681,TNM tumor staging finding,malignant neoplasm of penis TNM staging regional lymph node (N) N2,0
11682,TNM tumor staging finding,malignant neoplasm of penis TNM staging regional lymph node (N) N3,0
11683,TNM tumor staging finding,malignant neoplasm of penis TNM staging distant metastasis (M) MX,0
11684,TNM tumor staging finding,malignant neoplasm of penis TNM staging distant metastasis (M) M0,0
11685,TNM tumor staging finding,malignant neoplasm of penis TNM staging distant metastasis (M) M1,0
11686,TNM tumor staging finding,malignant neoplasm of prostate TNM staging regional lymph nodes (N) NX,0
11687,TNM tumor staging finding,malignant neoplasm of prostate TNM staging regional lymph nodes (N) N0,0
11688,TNM tumor staging finding,malignant neoplasm of prostate TNM staging regional lymph nodes (N) N1,0
11689,TNM tumor staging finding,malignant neoplasm of prostate TNM staging distant metastasis (M) M1a,0
11690,TNM tumor staging finding,malignant neoplasm of prostate TNM staging distant metastasis (M) M1b,0
11691,TNM tumor staging finding,malignant neoplasm of prostate TNM staging distant metastasis MX,0
11692,TNM tumor staging finding,malignant neoplasm of prostate TNM staging distant metastasis (M) M0,0
11693,TNM tumor staging finding,malignant neoplasm of prostate TNM staging distant metastasis (M) M1,0
11694,TNM tumor staging finding,malignant neoplasm of prostate TNM staging distant metastasis (M) M1c,0
11695,Metastasis category finding,malignant neoplasm of esophagus TNM staging distant metastasis (M),0
11696,Lung TNM finding,malignant neoplasm of lung TNM staging regional lymph node (N) NX,0
11697,Lung TNM finding,malignant neoplasm of lung TNM staging regional lymph node (N) N0,0
11698,Lung TNM finding,malignant neoplasm of lung TNM staging regional lymph node (N) N1,0
11699,Lung TNM finding,malignant neoplasm of lung TNM staging regional lymph node (N) N2,0
11700,Lung TNM finding,malignant neoplasm of lung TNM staging regional lymph node (N) N3,0
11701,Postoperative Complications,post-surgical cataract fragments in eye,0
11702,Postoperative Complications,post-surgical cataract fragments of right eye,0
11703,Postoperative Complications,post-surgical cataract fragments of left eye,0
11704,Postoperative Complications,post-surgical cataract fragments of both eyes,0
11705,metastasis from malignant neoplasm of cornea,Secondary Neoplasm,0
11706,Redness,abdomen ostomy leakage color red,0
11707,Pale red color,abdomen ostomy leakage color maroon,0
11708,Soft Tissue Neoplasms,gardner's syndrome with extra-colonic manifestations,0
11709,small cell carcinoma of lung metastatic to brain,Metastatic malignant neoplasm to brain,0
11710,small cell carcinoma of lung metastatic to bone,Secondary malignant neoplasm of bone,0
11711,metastasis from malignant neoplasm of large intestine,Secondary Neoplasm,0
11712,malignant neoplasm of large intestine metastatic to liver,Secondary malignant neoplasm of liver,0
11713,malignant neoplasm of large intestine metastatic to ovaries,Krukenberg Tumor,0
11714,Diabetic lumbosacral radiculoplexus neuropathy,uncontrolled type 2 diabetes mellitus with diabetic amyotrophy or mononeuritis multiplex,0
11715,neoplasm of ectopic testis,Ectopic testis,0
11716,neoplasm of right ectopic testis,Ectopic testis,0
11717,neoplasm of left ectopic testis,Ectopic testis,0
11718,neoplasm of bilateral ectopic testes,Ectopic testis,0
11719,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging regional lymph nodes (N) NX,0
11720,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging regional lymph nodes (N) N0,0
11721,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging regional lymph nodes (N) N1,0
11722,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging regional lymph nodes (N) N2,0
11723,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging regional lymph nodes (N) N3,0
11724,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging distant metastasis (M) MX,0
11725,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging distant metastasis (M) M0,0
11726,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging distant metastasis (M) M1,0
11727,Lip and oral cavity TNM finding,malignant neoplasm of lip TNM staging primary tumor (T) T4a,0
11728,Lip and oral cavity TNM finding,malignant neoplasm of tongue TNM staging regional lymph nodes (N) NX,0
11729,Lip and oral cavity TNM finding,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N0,0
11730,Lip and oral cavity TNM finding,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N1,0
11731,Lip and oral cavity TNM finding,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N3,0
11732,Lip and oral cavity TNM finding,malignant neoplasm of tongue TNM staging distant metastasis (M) MX,0
11733,Lip and oral cavity TNM finding,malignant neoplasm of tongue TNM staging distant metastasis (M) M0,0
11734,Lip and oral cavity TNM finding,malignant neoplasm of tongue TNM staging distant metastasis (M) M1,0
11735,Lip and oral cavity TNM finding,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) NX,0
11736,Lip and oral cavity TNM finding,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N0,0
11737,Lip and oral cavity TNM finding,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N1,0
11738,Lip and oral cavity TNM finding,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N2,0
11739,Lip and oral cavity TNM finding,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N3,0
11740,Lip and oral cavity TNM finding,malignant neoplasm of oral cavity TNM staging distant metastasis (M) MX,0
11741,Lip and oral cavity TNM finding,malignant neoplasm of oral cavity TNM staging distant metastasis (M) M0,0
11742,Lip and oral cavity TNM finding,malignant neoplasm of oral cavity TNM staging distant metastasis (M) M1,0
11743,Nasal cavity and ethmoid sinus TNM finding,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2,0
11744,Nasal cavity and ethmoid sinus TNM finding,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2a,0
11745,Nasal cavity and ethmoid sinus TNM finding,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2b,0
11746,Nasal cavity and ethmoid sinus TNM finding,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2c,0
11747,"Urinary bladder, ureter, or renal pelvis TNM finding",malignant neoplasm of ureter TNM staging regional lymph nodes (N) NX,0
11748,"Urinary bladder, ureter, or renal pelvis TNM finding",malignant neoplasm of ureter TNM staging regional lymph nodes (N) N0,0
11749,"Urinary bladder, ureter, or renal pelvis TNM finding",malignant neoplasm of ureter TNM staging regional lymph nodes (N) N1,0
11750,"Urinary bladder, ureter, or renal pelvis TNM finding",malignant neoplasm of ureter TNM staging regional lymph nodes (N) N2,0
11751,"Urinary bladder, ureter, or renal pelvis TNM finding",malignant neoplasm of ureter TNM staging regional lymph nodes (N) N3,0
11752,Esophagus TNM finding,malignant neoplasm of esophagus TNM staging regional lymph nodes (N) N0,0
11753,malignant neoplasm of autonomic nerves of orbit,Neoplasm of autonomic nerve,0
11754,malignant neoplasm of autonomic nerves of right orbit,Neoplasm of autonomic nerve,0
11755,malignant neoplasm of autonomic nerves of left orbit,Neoplasm of autonomic nerve,0
11756,malignant neoplasm of peripheral nerves of orbit,Peripheral Nervous System Neoplasms,0
11757,malignant neoplasm of peripheral nerves of right orbit,Peripheral Nervous System Neoplasms,0
11758,malignant neoplasm of peripheral nerves of left orbit,Peripheral Nervous System Neoplasms,0
11759,Supine Position,heart rate while lying down,0
11760,Berg balance test,berg balance scale (0-56),0
11761,Attention deficit hyperactivity disorder,ADHD checklist,0
11762,Vision Screening,visual function screening,0
11763,Vision Screening,visual function fixation preference,0
11764,Vision Screening,fixation preference right eye,0
11765,Vision Screening,fixation preference left eye,0
11766,Counseling,patient appeared to understand counseling,0
11767,Counseling,patient appeared uninterested in counseling,0
11768,Benign neoplasm of autonomic nerve,benign neoplasm of autonomic nerve of right orbit,0
11769,Benign neoplasm of autonomic nerve,benign neoplasm of autonomic nerve of left orbit,0
11770,Assessment of compliance with therapeutic regimen,patient appeared to understand therapeutic regimen,0
11771,Assessment of compliance with therapeutic regimen,patient appeared uninterested in therapeutic regimen,0
11772,Assessment of compliance with therapeutic regimen,patient and family appeared to understand therapeutic regimen,0
11773,Synovitis,gout with synovitis,0
11774,Pharmacotherapy,nausea seems associated with medications,0
11775,Instructions - self-help group for smoking cessation (treatment),Trying to give up smoking,0
11776,Lensometer,lensometry,0
11777,Lensometer,lensometry contacts right lens,0
11778,Lensometer,lensometry contacts left lens,0
11779,Refractory migraine,classic migraine with prolonged aura with intractable migraine with status migrainosus,0
11780,Refractory migraine,familial hemiplegic migraine headache with intractable migraine,0
11781,Refractory migraine,familial hemiplegic migraine headache with intractable migraine with status migrainosus,0
11782,Kidney Failure,nephrosclerosis with malignant hypertension and renal failure,0
11783,Pain radiating to left shoulder,abdominal pain radiating to left shoulder,0
11784,Pain radiating to left arm,neck pain radiating down left arm,0
11785,Pain characterized by relieving factor,abdominal pain relieved by not eating,0
11786,Pain characterized by relieving factor,abdominal pain relieved by urination,0
11787,Pain characterized by relieving factor,abdominal pain relieved by passing gas,0
11788,Pain characterized by relieving factor,abdominal pain relieved by belching,0
11789,Pain characterized by relieving factor,factors relieving abdominal pain,0
11790,Pain characterized by relieving factor,abdominal pain relieved by food,0
11791,Pain characterized by relieving factor,abdominal pain relieved suddenly for no known reason,0
11792,Pain characterized by relieving factor,abdominal pain relieved by bowel movement,0
11793,Pain characterized by relieving factor,abdominal pain relieved by vomiting,0
11794,Pain radiating to right shoulder,abdominal pain radiating to right shoulder,0
11795,Pain provoked by eating,onset of abdominal pain 1-4 hours after eating,0
11796,Calcification of pericardium,calcific effusive pericarditis,0
11797,Pain radiating to right arm,neck pain radiating down right arm,0
11798,Pain radiating to right side of chest,abdominal pain radiating to the right anterior chest,0
11799,Pain radiating to right side of chest,abdominal pain radiating to the right lateral chest,0
11800,Pain radiating to left side of chest,abdominal pain radiating to the left anterior chest,0
11801,Pain radiating to left side of chest,abdominal pain radiating to left lateral chest,0
11802,Pain radiating to center of chest,abdominal pain radiating to chest,0
11803,Pain radiating to center of chest,abdominal pain radiating to the substernal chest,0
11804,Pain relief by supine position,abdominal pain relieved by lying down,0
11805,Pain relief related to position,abdominal pain relieved by leaning forward,0
11806,Pain relief by antacid,abdominal pain relieved by antacids,0
11807,Abuse by relative of victim,adult sexual abuse by other relative,0
11808,Abuse by unrelated caregiver,adult sexual abuse by non-related caregiver,0
11809,Cerebral Infarction,right medial medullary syndrome due to basilar artery cerebral infarction,0
11810,Cerebral Infarction,left medial medullary syndrome due to basilar artery cerebral infarction,0
11811,Abuse by sibling,adult sexual abuse by sibling,0
11812,Abnormal cervical smear,abnormal Pap Smear: endometrial hyperplasia,0
11813,polyps,prostatic polyp with urinary obstruction,0
11814,Psychogenic fatigue,caregiver effectiveness limited by mental fatigue,0
11815,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with autonomic neuropathy,0
11816,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with diabetic ketoacidosis,0
11817,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with ophthalmic manifestations,0
11818,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with neurological complications,0
11819,Type II diabetes mellitus uncontrolled,uncontrolled Type 2 diabetes mellitus with manifestations,0
11820,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with hypoglycemia,0
11821,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with diabetic dermatitis,0
11822,Type II diabetes mellitus uncontrolled,uncontrolled type II necrobiosis lipoidica diabeticorum,0
11823,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with gastropathy,0
11824,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes with foot ulcer,0
11825,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes with ophthalmic manifestations of right eye,0
11826,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes with ophthalmic manifestations of left eye,0
11827,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes with ophthalmic manifestations of both eyes,0
11828,Type II diabetes mellitus uncontrolled,type 2 diabetes with renal manifestations - uncontrolled,0
11829,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with ophthalmoplegia,0
11830,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with diabetic nephropathy,0
11831,Type II diabetes mellitus uncontrolled,uncontrolled type II diabetes mellitus with peripheral neuropathy (diagnosis),0
11832,Type II diabetes mellitus uncontrolled,uncontrolled type 2 diabetes mellitus with peripheral circulatory disorder,0
11833,Tumor stage Tis,malignant neoplasm of breast TNM staging primary tumor (T) Tis,0
11834,Tumor stage Tis,malignant neoplasm of large intestine TNM staging primary tumor (T) Tis,0
11835,Tumor stage Tis,malignant neoplasm of nasal sinus TNM staging primary tumor (T) Tis,0
11836,Tumor stage Tis,malignant neoplasm of nasal cavity TNM staging primary tumor (T) Tis,0
11837,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with autonomic neuropathy,0
11838,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with diabetic nephropathy,0
11839,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with diabetic ketoacidosis with coma,0
11840,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with ophthalmic manifestations,0
11841,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with neurological complications,0
11842,Type 1 diabetes mellitus uncontrolled,"type 1 diabetic hypoglycemia, uncontrolled",0
11843,Type 1 diabetes mellitus uncontrolled,uncontrolled type I necrobiosis lipoidica diabeticorum,0
11844,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with gastropathy,0
11845,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with ophthalmic manifestations of right eye,0
11846,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with ophthalmic manifestations of left eye,0
11847,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with ophthalmic manifestations of both eyes,0
11848,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes with renal manifestations,0
11849,Type 1 diabetes mellitus uncontrolled,uncontrolled type I diabetes mellitus with peripheral neuropathy (diagnosis),0
11850,Type 1 diabetes mellitus uncontrolled,uncontrolled type 1 diabetes mellitus with peripheral circulatory disorder,0
11851,Injury of cruciate ligament of knee,closed bicondylar fracture of right tibia with cruciate ligament injury (Schatzker 5),0
11852,Injury of cruciate ligament of knee,closed fracture of left knee bicondylar plateau (Schatzker 5) with cruciate ligament injury,0
11853,Injury of cruciate ligament of knee,open fracture of right medial tibial plateau with cruciate ligament injury (Schatzker 4),0
11854,Injury of cruciate ligament of knee,open fracture of left medial tibial plateau with cruciate ligament injury (Schatzker 4),0
11855,Injury of medial collateral ligament of knee,open fracture of right medial tibial plateau with lateral collateral injury (Schatzker 4),0
11856,Injury of lateral collateral ligament of knee,closed bicondylar fracture of right tibia with lateral collateral injury (Schatzker 5),0
11857,Injury of lateral collateral ligament of knee,closed fracture of left knee bicondylar plateau (Schatzker 5) with lateral collateral injury,0
11858,Injury of lateral collateral ligament of knee,open bicondylar fracture of right tibial plateau with lateral collateral injury (Schatzker 5),0
11859,Injury of lateral collateral ligament of knee,open fracture of left medial tibial plateau with lateral collateral ligament injury (Schatzker 4),0
11860,Injury of lateral collateral ligament of knee,open fracture of left knee bicondylar plateau (Schatzker 5) with lateral collateral injury,0
11861,Assessment using assessment scale,Dubowitz score (physical finding),0
11862,cardiovascular surgery successful,Cardiovascular Surgical Procedures,0
11863,Fall from cliff,attempted suicide by jumping from cliff,0
11864,Spasm,muscle spasm in midback,0
11865,Pathologic Vitreous membrane,vitreous membranes and strands of right eye,0
11866,Pathologic Vitreous membrane,vitreous membranes and strands of left eye,0
11867,Pathologic Vitreous membrane,vitreous membranes and strands of both eyes,0
11868,abdominal pain radiation,Radiating pain,0
11869,abdominal pain radiating to left shoulder,Pain radiating to left shoulder,0
11870,currently breastfeeding and nipples are sore,Sore nipple,0
11871,abdominal pain radiating to right shoulder,Pain radiating to right shoulder,0
11872,burning abdominal pain,"Pain, Burning",0
11873,dull abdominal pain,Dull pain,0
11874,onset of abdominal pain 1-4 hours after eating,Pain provoked by eating,0
11875,Ectopic testis,neoplasm of ectopic testis,0
11876,Ectopic testis,neoplasm of right ectopic testis,0
11877,Ectopic testis,neoplasm of left ectopic testis,0
11878,Ectopic testis,neoplasm of bilateral ectopic testes,0
11879,factors relieving abdominal pain,Pain characterized by relieving factor,0
11880,abdominal pain relieved by food,Pain characterized by relieving factor,0
11881,abdominal pain relieved by antacids,Pain relief by antacid,0
11882,Brain injury with open intracranial wound AND concussion,gunshot wound of brain with concussion,0
11883,abdominal pain relieved suddenly for no known reason,Pain characterized by relieving factor,0
11884,abdominal pain relieved by leaning forward,Pain relief related to position,0
11885,abdominal pain relieved by bowel movement,Pain characterized by relieving factor,0
11886,abdominal pain relieved by vomiting,Pain characterized by relieving factor,0
11887,history of specified pregnancy number (#___),Parity,0
11888,Green color,abdomen ostomy leakage color green,0
11889,Air gun,gunshot wound caused by air gun,0
11890,Left Ventricular Hypertrophy,hypertrophy of morphologic left ventricle,0
11891,white urethral discharge on exam,White color,0
11892,Fall from bridge,attempted suicide by jumping from bridge,0
11893,Neonatal Screening,nonspecific abnormal findings on neonatal screening,0
11894,delayed developmental speech milestones,Developmental delay (disorder),0
11895,lensometry,Lensometer,0
11896,Tumor stage T4,malignant neoplasm of breast TNM staging primary tumor (T) T4,0
11897,Tumor stage T4,malignant neoplasm of large intestine TNM staging primary tumor (T) T4,0
11898,Tumor stage T4,malignant neoplasm of subglottis TNM staging primary tumor (T) T4,0
11899,Tumor stage T4,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T4,0
11900,Tumor stage T4,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T4,0
11901,Visual field study,Visual field study,0
11902,Left to right cardiovascular shunt (finding),tetralogy of Fallot with left to right shunt,0
11903,Tumor stage TX,malignant neoplasm of breast TNM staging primary tumor (T) TX,0
11904,Tumor stage TX,malignant neoplasm of large intestine TNM staging primary tumor (T) TX,0
11905,Tumor stage TX,malignant neoplasm of nasal sinus TNM staging primary tumor (T) TX,0
11906,Tumor stage TX,malignant neoplasm of nasal cavity TNM staging primary tumor (T) TX,0
11907,Tumor stage TX,malignant neoplasm of ureter TNM staging primary tumor (T) TX,0
11908,Tumor stage T2,malignant neoplasm of large intestine TNM staging primary tumor (T) T2,0
11909,Tumor stage T2,malignant neoplasm of subglottis TNM staging primary tumor (T) T2,0
11910,Tumor stage T2,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T2,0
11911,Tumor stage T2,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T2,0
11912,lensometry contacts right lens,Lensometer,0
11913,lensometry contacts left lens,Lensometer,0
11914,headache preceded by unilateral paresthesia of one extremity,Paresthesia,0
11915,Psychotic Disorders,severe involutional melancholia (MDD) with psychotic behavior,0
11916,Psychotic Disorders,severe postpartum depression with psychotic behavior,0
11917,edematous neck mass,Edema,0
11918,percussion dullness apex,Increased area of cardiac dullness,0
11919,Bruit,mass of oral vestibule with bruit,0
11920,Bruit,mass of tongue with bruit,0
11921,Bruit,mass of nasopharynx with bruit,0
11922,dyskinetic apical impulse,Dyskinetic syndrome,0
11923,Peritoneal Dialysis,visit for: adequacy testing for peritoneal dialysis,0
11924,Urinary tract obstruction,adenofibromatous hypertrophy of prostate with urinary obstruction,0
11925,Clinical stage IV A,malignant neoplasm of nasal cavity stage IVa,0
11926,Bicuspid aortic valve,aortic stenosis with bicuspid valve,0
11927,Dark color,black lesion of lip,0
11928,Dark color,abdomen ostomy leakage color brown,0
11929,Dark color,abdomen ostomy leakage color black,0
11930,Diabetes Mellitus,Diabetic retinal edema,0
11931,Diabetes Mellitus,diabetic retinal edema of right eye,0
11932,Diabetes Mellitus,diabetic retinal edema of left eye,0
11933,Diabetes Mellitus,diabetic retinal edema of both eyes,0
11934,Stress,systolic blood pressure with stress,0
11935,Stress,diastolic blood pressure with stress,0
11936,Stress,diastolic blood pressure in right arm with stress,0
11937,Stress,diastolic blood pressure in left arm with stress,0
11938,Infestation by Anoplura,housing lice-infested mattress,0
11939,Membranous glomerulonephritis,chronic membranous glomerulonephritis with sclerosing lesions,0
11940,Membranous glomerulonephritis,chronic membranous glomerulonephritis with focal glomerulosclerosis,0
11941,Membranous glomerulonephritis,nephritis with mixed membranous and proliferative glomerulonephritis,0
11942,patient appeared to understand counseling,Counseling,0
11943,patient appeared uninterested in counseling,Counseling,0
11944,NX Stage Finding,malignant neoplasm of breast TNM staging regional lymph node (N) NX,0
11945,NX Stage Finding,malignant neoplasm of large intestine TNM staging regional lymph nodes (N) NX,0
11946,NX Stage Finding,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) NX,0
11947,NX Stage Finding,malignant neoplasm of glottis TNM staging regional lymph nodes (N) NX,0
11948,NX Stage Finding,malignant neoplasm of kidney TNM staging regional lymph nodes (N) NX,0
11949,Right to left cardiovascular shunt (finding),tetralogy of Fallot with right to left shunt,0
11950,Postgastrectomy Syndromes,postgastrectomy anemia,0
11951,Oral Tobacco,History of chewing nicotine-containing substances tobacco,0
11952,echocardiography: echogenic mass of left ventricle,Left ventricular wall echogenicity,0
11953,Chronic pain,recent emotional stress from chronic pain,0
11954,Dull pain,dull abdominal pain,0
11955,Spondylitis,gout with spondylitis,0
11956,Fatigue,caregiver effectiveness limited by fatigue,0
11957,Brain injury with open intracranial wound AND moderate loss of consciousness (1-24 hours),gunshot wound of brain with moderate (1-24 hrs) loss of consciousness,0
11958,Brain injury with open intracranial wound AND prolonged loss of consciousness (more than 24 hours) without return to pre-existing conscious level,gunshot wound of brain with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,0
11959,Postpartum Period,postpartum uterus,0
11960,Postpartum Period,postpartum fundus size,0
11961,Postpartum Period,postpartum fundus size 2+,0
11962,Postpartum Period,postpartum fundus size 1+,0
11963,Postpartum Period,postpartum fundus at symphysis pubis,0
11964,Postpartum Period,postpartum fundus size 1-,0
11965,Postpartum Period,postpartum fundus size 2-,0
11966,Postpartum Period,postpartum uterus boggy,0
11967,Postpartum Period,postpartum uterus firm,0
11968,Visual field study,Visual field study,0
11969,Abnormal consistency,abdomen ostomy leakage texture oily,0
11970,Sharp pain,sharp abdominal pain,0
11971,Enterostomy procedure,fistula secondary to enterostomy,0
11972,Term pregnancy,her water broke at term,0
11973,Secondary diabetes mellitus,uncontrolled secondary diabetic hypoglycemia,0
11974,Helicobacter-associated gastritis,acute erosive gastritis associated with Helicobacter pylori with hemorrhage,0
11975,Right Ventricular Hypertrophy,hypertrophy of morphologic right ventricle,0
11976,benign neoplasm of autonomic nerve of orbit,Neoplasm of autonomic nerve,0
11977,benign neoplasm of autonomic nerve of right orbit,Benign neoplasm of autonomic nerve,0
11978,benign neoplasm of autonomic nerve of left orbit,Benign neoplasm of autonomic nerve,0
11979,benign neoplasm of peripheral nerves of orbit,Peripheral Nervous System Neoplasms,0
11980,benign neoplasm of peripheral nerves of right orbit,Peripheral Nervous System Neoplasms,0
11981,benign neoplasm of peripheral nerves of left orbit,Peripheral Nervous System Neoplasms,0
11982,post-surgical cataract fragments of right eye,Postoperative Complications,0
11983,post-surgical cataract fragments of left eye,Postoperative Complications,0
11984,post-surgical cataract fragments of both eyes,Postoperative Complications,0
11985,"Pregnancy, Prolonged",her water broke post-term,0
11986,Paresthesia,headache preceded by unilateral paresthesia of one extremity,0
11987,neoplasm of ectopic thyroid gland,Ectopic thyroid tissue (disorder),0
11988,adult sexual abuse by stepfather,Intrafamilial sexual abuse,0
11989,adult sexual abuse by mother,Intrafamilial sexual abuse,0
11990,adult sexual abuse by stepmother,Intrafamilial sexual abuse,0
11991,adult sexual abuse by sibling,Abuse by sibling,0
11992,adult sexual abuse by grandparent,Intrafamilial sexual abuse,0
11993,adult sexual abuse by other relative,Abuse by relative of victim,0
11994,adult sexual abuse by non-related caregiver,Abuse by unrelated caregiver,0
11995,injury of blood vessel of first toe of right foot,Injury of great toe,0
11996,injury of blood vessel of second toe of right foot,Digital blood vessel injury,0
11997,injury of blood vessel of third toe of right foot,Digital blood vessel injury,0
11998,injury of blood vessel of fourth toe of right foot,Digital blood vessel injury,0
11999,injury of blood vessel of fifth toe of right foot,Digital blood vessel injury,0
12000,uncontrolled diabetes mellitus with autonomic neuropathy,Diabetic - poor control,0
12001,uncontrolled type 2 diabetes mellitus with ophthalmoplegia,Type II diabetes mellitus uncontrolled,0
12002,severe involutional melancholia (MDD) with psychotic behavior,Psychotic Disorders,0
12003,abdominal mass not present on repeated examination,Patient condition resolved,0
12004,nephrosclerosis with malignant hypertension and renal failure,Kidney Failure,0
12005,right medial medullary syndrome due to basilar artery cerebral infarction,Cerebral Infarction,0
12006,left medial medullary syndrome due to basilar artery cerebral infarction,Cerebral Infarction,0
12007,Congenital dilatation of cardiac ventricle,echocardiography: common ventricle enlarged,0
12008,Congenital hypoplasia of cardiac ventricle,echocardiography: common ventricle decreased,0
12009,severe postpartum depression with psychotic behavior,Psychotic Disorders,0
12010,Secondary malignant neoplasm of bone,small cell carcinoma of lung metastatic to bone,0
12011,Metastatic malignant neoplasm to brain,small cell carcinoma of lung metastatic to brain,0
12012,Secondary malignant neoplasm of liver,malignant neoplasm of large intestine metastatic to liver,0
12013,Krukenberg Tumor,malignant neoplasm of large intestine metastatic to ovaries,0
12014,gunshot wound of brain with no loss of consciousness,Brain injury with open intracranial wound AND no loss of consciousness,0
12015,gunshot wound of brain with brief (< 1 hr) loss of consciousness,Brain injury with open intracranial wound AND brief loss of consciousness (less than one hour),0
12016,gunshot wound of brain with moderate (1-24 hrs) loss of consciousness,Brain injury with open intracranial wound AND moderate loss of consciousness (1-24 hours),0
12017,gunshot wound of brain with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,Brain injury with open intracranial wound AND prolonged loss of consciousness (more than 24 hours) AND return to pre-existing conscious level,0
12018,gunshot wound of brain with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,Brain injury with open intracranial wound AND prolonged loss of consciousness (more than 24 hours) without return to pre-existing conscious level,0
12019,gunshot wound of brain with unconsciousness of unspecified duration,Brain injury with open intracranial wound AND loss of consciousness,0
12020,gunshot wound of brain with concussion,Brain injury with open intracranial wound AND concussion,0
12021,Brain Stem Infarctions,Claude's syndrome due to right-sided lesion,0
12022,Brain Stem Infarctions,Claude's syndrome due to left-sided lesion,0
12023,Brain Stem Infarctions,Benedikt syndrome (right side),0
12024,Brain Stem Infarctions,Benedikt syndrome (left side),0
12025,accidental obstruction of respiratory tract,Accidental Injuries,0
12026,gunshot wound caused by air gun,Air gun,0
12027,iatrogenic male infertility due to infection,Iatrogenic Disease,0
12028,acute erosive gastritis associated with Helicobacter pylori with hemorrhage,Helicobacter-associated gastritis,0
12029,injury of blood vessel of first toe of left foot,Injury of great toe,0
12030,injury of blood vessel of second toe of left foot,Digital blood vessel injury,0
12031,injury of blood vessel of third toe of left foot,Digital blood vessel injury,0
12032,injury of blood vessel of fourth toe of left foot,Digital blood vessel injury,0
12033,injury of blood vessel of fifth toe of left foot,Digital blood vessel injury,0
12034,Dyskinetic syndrome,dyskinetic apical impulse,0
12035,carcinoma in situ of male bladder,Males,0
12036,Dubowitz score (physical finding),Assessment using assessment scale,0
12037,milestone: balances on one foot for 10 seconds,Child developmental finding,0
12038,Radiating pain,neck pain radiating down both arms,0
12039,Radiating pain,neck pain radiating down arm,0
12040,Radiating pain,abdominal pain radiation,0
12041,uncontrolled type 2 diabetes mellitus with diabetic nephropathy,Type II diabetes mellitus uncontrolled,0
12042,uncontrolled type II diabetes mellitus with peripheral neuropathy (diagnosis),Type II diabetes mellitus uncontrolled,0
12043,uncontrolled type I diabetes mellitus with peripheral neuropathy (diagnosis),Type 1 diabetes mellitus uncontrolled,0
12044,uncontrolled type 2 diabetes mellitus with peripheral circulatory disorder,Type II diabetes mellitus uncontrolled,0
12045,uncontrolled type 1 diabetes mellitus with peripheral circulatory disorder,Type 1 diabetes mellitus uncontrolled,0
12046,Advanced maculopathy with diabetes mellitus,Diabetes Mellitus,0
12047,Double inlet ventricle,Abnormality of right atrioventricular valve in double inlet ventricle,0
12048,Double inlet ventricle,Tricuspid Atresia,0
12049,Double inlet ventricle,Imperforate right atrioventricular valve,0
12050,Double inlet ventricle,Right atrioventricular valve dysplasia,0
12051,Double inlet ventricle,Right atrioventricular valve hypoplasia,0
12052,Double inlet ventricle,Right atrioventricular valve regurgitation,0
12053,Double inlet ventricle,Overriding right atrioventricular valve,0
12054,Double inlet ventricle,Straddling right atrioventricular valve,0
12055,Double inlet ventricle,Common atrioventricular orifice in double inlet ventricle,0
12056,Double inlet ventricle,Right atrioventricular valve leaflets absent in double inlet ventricle (unguarded orifice),0
12057,Double inlet ventricle,Two atrioventricular valves in double inlet ventricle,0
12058,Double inlet ventricle,Congenital abnormality of left atrioventricular valve in double inlet ventricle,0
12059,Double inlet ventricle,Congenital abnormality of right atrioventricular valve leaflet in double inlet ventricle,0
12060,Double inlet ventricle,Congenital abnormality of right atrioventricular valve papillary muscle in double inlet ventricle,0
12061,Double inlet ventricle,Hypoplasia of right atrioventricular valve annulus in double inlet ventricle,0
12062,Double inlet ventricle,Ebstein's anomaly of left atrioventricular valve in functionally univentricular heart,0
12063,Double inlet ventricle,Congenital abnormality of left atrioventricular valve chordae tendinae in double inlet ventricle,0
12064,Double inlet ventricle,Left atrioventricular valve stenosis in double inlet ventricle,0
12065,Double inlet ventricle,Double orifice of right atrioventricular valve in double inlet ventricle,0
12066,Double inlet ventricle,Hypoplasia of left atrioventricular valve annulus in double inlet ventricle,0
12067,Double inlet ventricle,Congenital abnormality of right atrioventricular valve chordae tendinae in double inlet ventricle,0
12068,Double inlet ventricle,Congenital abnormality of right atrioventricular valve in double inlet ventricle,0
12069,Congenital abnormality of atrioventricular valves in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12070,Atrioventricular septal defect and common atrioventricular junction,Congenital abnormality of atrioventricular valves in atrioventricular septal defect,0
12071,Atrioventricular septal defect and common atrioventricular junction,Abnormality of common atrioventricular valve in atrioventricular septal defect,0
12072,Atrioventricular septal defect and common atrioventricular junction,Atresia of common atrioventricular valve,0
12073,Atrioventricular septal defect and common atrioventricular junction,Imperforate common atrioventricular valve,0
12074,Atrioventricular septal defect and common atrioventricular junction,Hypoplasia of common atrioventricular valve,0
12075,Atrioventricular septal defect and common atrioventricular junction,Dysplasia of common atrioventricular valve,0
12076,Atrioventricular septal defect and common atrioventricular junction,Regurgitation of common atrioventricular valve,0
12077,Atrioventricular septal defect and common atrioventricular junction,Common atrioventricular valve limited to one ventricle,0
12078,Atrioventricular septal defect and common atrioventricular junction,Common atrioventricular valve stenosis,0
12079,Atrioventricular septal defect and common atrioventricular junction,Common atrioventricular valve leaflet abnormality,0
12080,Atrioventricular septal defect and common atrioventricular junction,Common atrioventricular valve prolapse,0
12081,Atrioventricular septal defect and common atrioventricular junction,True cleft of common atrioventricular valve leaflet,0
12082,Atrioventricular septal defect and common atrioventricular junction,Accessory tissue on common atrioventricular valve leaflet,0
12083,Atrioventricular septal defect and common atrioventricular junction,Double orifice of common atrioventricular valve,0
12084,Atrioventricular septal defect and common atrioventricular junction,Triple orifice of left ventricular component of common atrioventricular valve,0
12085,Atrioventricular septal defect and common atrioventricular junction,Ebstein's anomaly of common atrioventricular valve,0
12086,Atrioventricular septal defect and common atrioventricular junction,Abnormality of common atrioventricular valve chordae tendinae,0
12087,Atrioventricular septal defect and common atrioventricular junction,Common atrioventricular valve chordae too short,0
12088,Atrioventricular septal defect and common atrioventricular junction,Common atrioventricular valve chordae too long,0
12089,Atrioventricular septal defect and common atrioventricular junction,Common atrioventricular valve chordae to outlet septum,0
12090,Atrioventricular septal defect and common atrioventricular junction,Arcade abnormality of common atrioventricular valve chordae,0
12091,Atrioventricular septal defect and common atrioventricular junction,Abnormality of common atrioventricular valve papillary muscle,0
12092,Atrioventricular septal defect and common atrioventricular junction,Parachute malformation of common atrioventricular valve,0
12093,Atrioventricular septal defect and common atrioventricular junction,Absent common atrioventricular valve papillary muscle,0
12094,Atrioventricular septal defect and common atrioventricular junction,Fused common atrioventricular valve papillary muscle,0
12095,Atrioventricular septal defect and common atrioventricular junction,Hypoplastic common atrioventricular valve papillary muscle,0
12096,Atrioventricular septal defect and common atrioventricular junction,Trifoliate left atrioventricular valve,0
12097,Atrioventricular septal defect and common atrioventricular junction,Left atrioventricular valve bifoliate with fused left sided superior and inferior bridging leaflet,0
12098,Atrioventricular septal defect and common atrioventricular junction,Gelatinous atrioventricular valve leaflet in atrioventricular septal defect,0
12099,Atrioventricular septal defect and common atrioventricular junction,Noncoapting atrioventricular valve leaflet in atrioventricular septal defect,0
12100,Atrioventricular septal defect and common atrioventricular junction,Deficiency of atrioventricular valve leaflet in atrioventricular septal defect,0
12101,Atrioventricular septal defect and common atrioventricular junction,Thickened atrioventricular valve leaflet in atrioventricular septal defect,0
12102,Atrioventricular septal defect and common atrioventricular junction,Flail atrioventricular valve leaflet in atrioventricular septal defect,0
12103,Atrioventricular septal defect and common atrioventricular junction,Fenestration of atrioventricular valve leaflet in atrioventricular septal defect,0
12104,Atrioventricular septal defect and common atrioventricular junction,Mass associated with atrioventricular valve leaflet in atrioventricular septal defect,0
12105,Atrioventricular septal defect and common atrioventricular junction,Congenital abnormality of atrioventricular valve leaflet in atrioventricular septal defect,0
12106,Atrioventricular septal defect and common atrioventricular junction,Congenital abnormality of atrioventricular valve papillary muscle in atrioventricular septal defect,0
12107,Atrioventricular septal defect and common atrioventricular junction,Abnormality of atrioventricular valve leaflet in atrioventricular septal defect,0
12108,Abnormality of common atrioventricular valve in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12109,Atresia of common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12110,Imperforate common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12111,Hypoplasia of common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12112,Dysplasia of common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12113,Regurgitation of common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12114,Common atrioventricular valve limited to one ventricle,Atrioventricular septal defect and common atrioventricular junction,0
12115,Common atrioventricular valve stenosis,Atrioventricular septal defect and common atrioventricular junction,0
12116,Common atrioventricular valve leaflet abnormality,Atrioventricular septal defect and common atrioventricular junction,0
12117,Common atrioventricular valve prolapse,Atrioventricular septal defect and common atrioventricular junction,0
12118,True cleft of common atrioventricular valve leaflet,Atrioventricular septal defect and common atrioventricular junction,0
12119,Accessory tissue on common atrioventricular valve leaflet,Atrioventricular septal defect and common atrioventricular junction,0
12120,Double orifice of common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12121,Triple orifice of left ventricular component of common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12122,Ebstein's anomaly of common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12123,Abnormality of common atrioventricular valve chordae tendinae,Atrioventricular septal defect and common atrioventricular junction,0
12124,Common atrioventricular valve chordae too short,Atrioventricular septal defect and common atrioventricular junction,0
12125,Common atrioventricular valve chordae too long,Atrioventricular septal defect and common atrioventricular junction,0
12126,Common atrioventricular valve chordae to outlet septum,Atrioventricular septal defect and common atrioventricular junction,0
12127,Arcade abnormality of common atrioventricular valve chordae,Atrioventricular septal defect and common atrioventricular junction,0
12128,Abnormality of common atrioventricular valve papillary muscle,Atrioventricular septal defect and common atrioventricular junction,0
12129,Parachute malformation of common atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12130,Absent common atrioventricular valve papillary muscle,Atrioventricular septal defect and common atrioventricular junction,0
12131,Fused common atrioventricular valve papillary muscle,Atrioventricular septal defect and common atrioventricular junction,0
12132,Hypoplastic common atrioventricular valve papillary muscle,Atrioventricular septal defect and common atrioventricular junction,0
12133,Abnormality of right atrioventricular valve in double inlet ventricle,Double inlet ventricle,0
12134,Tricuspid Atresia,Double inlet ventricle,0
12135,Imperforate right atrioventricular valve,Double inlet ventricle,0
12136,Right atrioventricular valve dysplasia,Double inlet ventricle,0
12137,Right atrioventricular valve hypoplasia,Double inlet ventricle,0
12138,Right atrioventricular valve regurgitation,Double inlet ventricle,0
12139,Overriding right atrioventricular valve,Double inlet ventricle,0
12140,Straddling right atrioventricular valve,Double inlet ventricle,0
12141,Advanced retinal disease with diabetes mellitus,Diabetes Mellitus,0
12142,Pharmaceutical Preparations,Adverse medication interaction with food,0
12143,Pharmaceutical Preparations,Adverse medication interaction with alcohol,0
12144,Pharmaceutical Preparations,Adverse drug interaction,0
12145,Pharmaceutical Preparations,Adverse medication interaction with medication,0
12146,Common atrioventricular orifice in double inlet ventricle,Double inlet ventricle,0
12147,Right atrioventricular valve leaflets absent in double inlet ventricle (unguarded orifice),Double inlet ventricle,0
12148,Two atrioventricular valves in double inlet ventricle,Double inlet ventricle,0
12149,Solitary ventricle of indeterminate morphology,Outflow tract abnormality in solitary indeterminate ventricle,0
12150,Solitary ventricle of indeterminate morphology,Outflow tract obstruction in solitary indeterminate ventricle,0
12151,Solitary ventricle of indeterminate morphology,Subaortic outflow tract obstruction in solitary indeterminate ventricle,0
12152,Solitary ventricle of indeterminate morphology,Subpulmonary outflow tract obstruction in solitary indeterminate ventricle,0
12153,Trifoliate left atrioventricular valve,Atrioventricular septal defect and common atrioventricular junction,0
12154,Double outlet ventriculoarterial connections,Doubly committed ventricular septal defect in double outlet ventriculoarterial connection,0
12155,Atrioventricular septal defect associated with tetralogy of Fallot,Tetralogy of Fallot,0
12156,Left atrioventricular valve bifoliate with fused left sided superior and inferior bridging leaflet,Atrioventricular septal defect and common atrioventricular junction,0
12157,Adverse medication interaction with food,Pharmaceutical Preparations,0
12158,Adverse medication interaction with alcohol,Pharmaceutical Preparations,0
12159,Adverse drug interaction,Pharmaceutical Preparations,0
12160,Adverse medication interaction with medication,Pharmaceutical Preparations,0
12161,Gelatinous atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12162,Noncoapting atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12163,Deficiency of atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12164,Thickened atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12165,Outflow tract abnormality in solitary indeterminate ventricle,Solitary ventricle of indeterminate morphology,0
12166,Congenital abnormality of left atrioventricular valve in double inlet ventricle,Double inlet ventricle,0
12167,Flail atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12168,Fenestration of atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12169,Congenital abnormality of right atrioventricular valve leaflet in double inlet ventricle,Double inlet ventricle,0
12170,Congenital abnormality of right atrioventricular valve papillary muscle in double inlet ventricle,Double inlet ventricle,0
12171,Hypoplasia of right atrioventricular valve annulus in double inlet ventricle,Double inlet ventricle,0
12172,Ebstein's anomaly of left atrioventricular valve in functionally univentricular heart,Double inlet ventricle,0
12173,Congenital abnormality of left atrioventricular valve chordae tendinae in double inlet ventricle,Double inlet ventricle,0
12174,Left atrioventricular valve stenosis in double inlet ventricle,Double inlet ventricle,0
12175,Double orifice of right atrioventricular valve in double inlet ventricle,Double inlet ventricle,0
12176,Doubly committed ventricular septal defect in double outlet ventriculoarterial connection,Double outlet ventriculoarterial connections,0
12177,Mass associated with atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12178,Hypoplasia of left atrioventricular valve annulus in double inlet ventricle,Double inlet ventricle,0
12179,Congenital abnormality of right atrioventricular valve chordae tendinae in double inlet ventricle,Double inlet ventricle,0
12180,Congenital abnormality of right atrioventricular valve in double inlet ventricle,Double inlet ventricle,0
12181,Congenital abnormality of atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12182,Congenital abnormality of atrioventricular valve papillary muscle in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12183,Abnormality of atrioventricular valve leaflet in atrioventricular septal defect,Atrioventricular septal defect and common atrioventricular junction,0
12184,Outflow tract obstruction in solitary indeterminate ventricle,Solitary ventricle of indeterminate morphology,0
12185,Subaortic outflow tract obstruction in solitary indeterminate ventricle,Solitary ventricle of indeterminate morphology,0
12186,Subpulmonary outflow tract obstruction in solitary indeterminate ventricle,Solitary ventricle of indeterminate morphology,0
12187,Diabetes Mellitus,Advanced maculopathy with diabetes mellitus,0
12188,Diabetes Mellitus,Advanced retinal disease with diabetes mellitus,0
12189,Tetralogy of Fallot,Atrioventricular septal defect associated with tetralogy of Fallot,0
12190,Blindness AND/OR vision impairment level,combined hearing and vision loss with blindness,0
12191,Blindness AND/OR vision impairment level,Total visual and total hearing impairment,0
12192,Emotional state observations,milestone: indicates pleasure and displeasure,0
12193,Learning finding (finding),Education Risk Assessment: reading and doing math at grade level,0
12194,Porifera,sting by sea sponge,0
12195,Standing position,overexertion from prolonged standing,0
12196,chest pain relieved by nitroglycerin in under five minutes,Pain relief by medication,0
12197,chest pain relieved by nitroglycerin faster than rest alone,Pain relief by medication,0
12198,chest pain increasingly less responsive to nitroglycerin,Pain relief by medication,0
12199,Red rash,Redness,0
12200,red skin rash blanches with pressure,Redness,0
12201,chest pain relieved by analgesics,Pain relief by medication,0
12202,yellow discoloration of fingernail,Yellow color on exam,0
12203,yellow discoloration of right thumbnail,Yellow color on exam,0
12204,yellow discoloration of index fingernail of right hand,Yellow color on exam,0
12205,yellow discoloration of middle fingernail of right hand,Yellow color on exam,0
12206,yellow discoloration of ring fingernail of right hand,Yellow color on exam,0
12207,yellow discoloration of little fingernail of right hand,Yellow color on exam,0
12208,yellow discoloration of left thumbnail,Yellow color on exam,0
12209,yellow discoloration of index fingernail of left hand,Yellow color on exam,0
12210,yellow discoloration of middle fingernail of left hand,Yellow color on exam,0
12211,yellow discoloration of ring fingernail of left hand,Yellow color on exam,0
12212,yellow discoloration of little fingernail of left hand,Yellow color on exam,0
12213,yellow discoloration of toenail,Yellow color on exam,0
12214,yellow discoloration of great toenail of right foot,Yellow color on exam,0
12215,yellow discoloration of second toenail of right foot,Yellow color on exam,0
12216,yellow discoloration of third toenail of right foot,Yellow color on exam,0
12217,yellow discoloration of fourth toenail of right foot,Yellow color on exam,0
12218,yellow discoloration of fifth toenail of right foot,Yellow color on exam,0
12219,yellow discoloration of great toenail of left foot,Yellow color on exam,0
12220,yellow discoloration of second toenail of left foot,Yellow color on exam,0
12221,yellow discoloration of third toenail of left foot,Yellow color on exam,0
12222,yellow discoloration of fourth toenail of left foot,Yellow color on exam,0
12223,yellow discoloration of fifth toenail of left foot,Yellow color on exam,0
12224,Cognitive perceptual finding,milestone: understands and follows simple commands,0
12225,Communication finding,Education Risk Assessment: talks about what goes on in school,0
12226,Communication finding,Education Risk Assessment: communicates with teacher,0
12227,Procedure to abduct extremity,shoulder abduction test,0
12228,Neoplastic disease of uncertain behavior,Neoplasm of uncertain behavior of plasma cells,0
12229,Fitting - action,visit for: fitting and adjustment of device,0
12230,using toilet with hand bar can be done without assistance,Self-Help Devices,0
12231,Polyserositis,Familial Mediterranean Fever,0
12232,Iatrogenic Disease,iatrogenic esophageal perforation,0
12233,Iatrogenic Disease,iatrogenic colonic perforation due to malfunctioning laparoscopic device,0
12234,Iatrogenic Disease,iatrogenic male infertility,0
12235,Iatrogenic Disease,iatrogenic colonic perforation,0
12236,Iatrogenic Disease,iatrogenic pulmonary embolism,0
12237,Iatrogenic Disease,iatrogenic pulmonary infarction,0
12238,Iatrogenic Disease,iatrogenic male infertility due to drug therapy,0
12239,Iatrogenic Disease,iatrogenic iris atrophy,0
12240,Infectious gastroenteritis,infectious gastroenteritis with arthropathy,0
12241,Foreign Bodies,allergic urticaria due to foreign body,0
12242,automatism chewing,Chewing symptoms,0
12243,automatism blinking eyelids,Blinking,0
12244,automatism head turning (symptom),Head movements abnormal,0
12245,Diabetic Nephropathy,secondary diabetes mellitus with renal manifestations,0
12246,Diabetic Nephropathy,secondary diabetes mellitus with diabetic nephropathy,0
12247,Diabetic Nephropathy,secondary diabetes mellitus with diabetic chronic kidney disease,0
12248,Diabetic Nephropathy,chemical-induced diabetes mellitus with renal manifestations,0
12249,Diabetic Nephropathy,chemical-induced diabetes mellitus with diabetic nephropathy,0
12250,Diabetic Nephropathy,chemical-induced diabetes mellitus with diabetic chronic kidney disease,0
12251,Diabetic peripheral angiopathy,diabetes mellitus secondary with diabetic peripheral angiopathy,0
12252,Diabetic peripheral angiopathy,secondary diabetes mellitus with diabetic peripheral angiopathy with gangrene,0
12253,Diabetic peripheral angiopathy,chemical-induced diabetes mellitus with diabetic peripheral angiopathy,0
12254,Diabetic peripheral angiopathy,type 1 diabetes with diabetic peripheral angiopathy,0
12255,Diabetic peripheral angiopathy,type 1 diabetes with diabetic peripheral angiopathy with gangrene,0
12256,Diabetic peripheral angiopathy,type 1 diabetes with diabetic peripheral angiopathy without gangrene,0
12257,Diabetic peripheral angiopathy,type 2 diabetes with diabetic peripheral angiopathy,0
12258,Diabetic peripheral angiopathy,type 2 diabetes with diabetic peripheral angiopathy with gangrene,0
12259,Diabetic peripheral angiopathy,type 2 diabetes with diabetic peripheral angiopathy without gangrene,0
12260,Traumatic AND/OR non-traumatic brain injury,speech impediment due to brain injury,0
12261,Cellulitis,Gangrenous cellulitis,0
12262,preferred language Chinese,Born in China,0
12263,preferred language Hungarian,Born in Hungary,0
12264,preferred language Laotian,Born in Laos,0
12265,taking medication for a long time osteoclast inhibitors,Antiresorptive Agents,0
12266,taking medication for a long time bisphosphonates,Diphosphonates,0
12267,discharge weight (___)grams,Patient Discharge,0
12268,Independent with dressing,Dressing Without Help,0
12269,Independent with dressing,milestone: dresses without supervision,0
12270,Postoperative myocardial infarction,myocardial infarction cardiogenic shock postoperative,0
12271,Physical activity finding,overexertion from prolonged activity,0
12272,Social interaction finding,5-year milestones: plays interactive games with peers,0
12273,Social interaction finding,milestone: plays peek-a-boo,0
12274,Social interaction finding,milestone: enjoys vocal turn-taking,0
12275,Social interaction finding,milestone: enjoys personal interactions,0
12276,Social interaction finding,milestone: interacts with peers,0
12277,Social interaction finding,activities risk assessment: gets along well with family and friends,0
12278,Social interaction finding,milestone: shy with strangers,0
12279,Social interaction finding,milestone: helps with simple tasks,0
12280,Social interaction finding,milestone: separates from parent easily,0
12281,Hemorrhage,antiphospholipid antibody syndrome with hemorrhagic disorder,0
12282,Tumor stage T3,malignant neoplasm of lung TNM staging primary tumor (T) T3,0
12283,Tumor stage T3,malignant neoplasm of small intestine TNM staging primary tumor (T) T3,0
12284,Tumor stage T3,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T3,0
12285,Tumor stage T3,malignant neoplasm of oropharynx TNM staging primary tumor (T) T3,0
12286,Tumor stage T3,malignant neoplasm of pharynx TNM staging primary tumor (T) T3,0
12287,Tumor stage T3,malignant neoplasm of soft palate TNM staging primary tumor (T) T3,0
12288,Tumor stage T3,malignant neoplasm of uvula TNM staging primary tumor (T) T3,0
12289,Tumor stage T3,malignant neoplasm of lip TNM staging primary tumor (T) T3,0
12290,Tumor stage T3,malignant neoplasm of tongue TNM staging primary tumor (T) T3,0
12291,Tumor stage T3,malignant neoplasm of gingiva TNM staging primary tumor (T) T3,0
12292,Tumor stage T3,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T3,0
12293,Tumor stage T3,malignant neoplasm of oral cavity TNM staging primary tumor (T) T3,0
12294,Tumor stage T3,malignant neoplasm of hard palate TNM staging primary tumor (T) T3,0
12295,Tumor stage T3,malignant neoplasm of retromolar area TNM staging primary tumor (T) T3,0
12296,Tumor stage T3,malignant neoplasm of parotid TNM staging primary tumor (T) T3,0
12297,Tumor stage T3,malignant neoplasm of salivary gland TNM staging primary tumor (T) T3,0
12298,Tumor stage T3,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T3,0
12299,Tumor stage T3,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T3,0
12300,Tumor stage T3,malignant neoplasm of glottis TNM staging primary tumor (T) T3,0
12301,Tumor stage T3,malignant neoplasm of esophagus TNM staging primary tumor (T) T3,0
12302,Tumor stage T3,malignant neoplasm of stomach TNM staging primary tumor (T) T3,0
12303,Tumor stage T3,malignant neoplasm of liver TNM staging primary tumor (T) T3,0
12304,Tumor stage T3,malignant neoplasm of gallbladder TNM staging primary tumor (T) T3,0
12305,Tumor stage T3,malignant melanoma of skin TNM staging primary tumor (T) T3,0
12306,Tumor stage T3,malignant neoplasm of vulva TNM staging primary tumor (T) T3/III,0
12307,Tumor stage T3,malignant neoplasm of penis TNM staging primary tumor (T) T3,0
12308,Tumor stage T3,malignant neoplasm of testis TNM staging primary tumor (T) T3,0
12309,Tumor stage T3,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T3,0
12310,Tumor stage T3,malignant neoplasm of ureter TNM staging primary tumor (T) T3,0
12311,Tumor stage T3,malignant neoplasm of thyroid TNM staging primary tumor (T) T3,0
12312,Tumor stage T3,Tumor stage T3,0
12313,Phacoanaphylaxis,phacoanaphylactic glaucoma,0
12314,Hyperosmolarity,secondary diabetes mellitus with hyperosmolarity,0
12315,Hyperosmolarity,diabetes mellitus chemical-induced with hyperosmolarity,0
12316,computed tomography of neck: post-surgical change of thyroid,Postoperative state,0
12317,Chewing symptoms,automatism chewing,0
12318,Symptom aggravating factors,chest pain made worse by swallowing,0
12319,Movement aggravates symptom,chest pain made worse by neck movement,0
12320,Movement aggravates symptom,chest pain made worse by arm movement,0
12321,Movement aggravates symptom,chest pain made worse by right arm movement,0
12322,Movement aggravates symptom,chest pain made worse by left arm movement,0
12323,Movement aggravates symptom,chest pain made worse by body movement,0
12324,Movement aggravates symptom,chest pain made worse by bending over,0
12325,thyroid biopsy follicular carcinoma metastatic to lung,Secondary malignant neoplasm of lung,0
12326,Independent walking,milestone: walks unassisted,0
12327,Child 8-9 month examination,9-month milestones,0
12328,Child 8-9 month examination,milestone: responds to own name,0
12329,Child 8-9 month examination,milestone: crawls and/or creeps,0
12330,Child 8-9 month examination,milestone: feeds self with fingers,0
12331,Child 8-9 month examination,9-month milestones: object permanence,0
12332,Child 8-9 month examination,milestone: looks at books,0
12333,Child 8-9 month examination,milestone: makes purposeful sounds,0
12334,Child 8-9 month examination,milestone: points out objects,0
12335,Child 8-9 month examination,milestone: seeks parents for comfort,0
12336,Child 8-9 month examination,milestone: sits independently,0
12337,Child 8-9 month examination,milestone: shy with strangers,0
12338,Child 8-9 month examination,milestone: plays pat-a-cake,0
12339,Child 8-9 month examination,milestone: pulls self to a standing position,0
12340,Child 18 month examination,milestone: names favorite book,0
12341,Child 18 month examination,milestone: laughs in response to others,0
12342,Child 18 month examination,milestone: points to one or more body parts,0
12343,Child 18 month examination,milestone: uses spoon with minimal spilling,0
12344,Child 18 month examination,milestone: runs,0
12345,Child 18 month examination,18-month milestones,0
12346,Child 18 month examination,milestone: uses a spoon,0
12347,Child 18 month examination,milestone: helps with simple tasks,0
12348,Child 18 month examination,18-month milestones: removes clothes,0
12349,Child 18 month examination,milestone: turns pages without ripping them,0
12350,Child 18 month examination,milestone: stacks 3-4 blocks,0
12351,Child 18 month examination,milestone: dumps raisins from bottle,0
12352,Child 18 month examination,milestone: combines two different words,0
12353,Child 18 month examination,milestone: names an animal in a picture,0
12354,Child 18 month examination,milestone: vocabulary of 7-20 words,0
12355,Child 18 month examination,milestone: kicks ball forward,0
12356,Child 18 month examination,18-month milestones: walks up steps,0
12357,yellow urethral discharge on exam,Yellow color on exam,0
12358,x-ray of pelvis: fracture pathologic bony remodeling,Bone remodeling,0
12359,Elective abortion,incomplete elective abortion complicated by metabolic disorder,0
12360,Elective abortion,incomplete elective abortion with complication,0
12361,Elective abortion,incomplete elective abortion complicated by pelvic infection,0
12362,Elective abortion,incomplete elective abortion complicated by excessive pelvic hemorrhage,0
12363,Elective abortion,incomplete elective abortion complicated by damage to pelvic organs,0
12364,Elective abortion,incomplete elective abortion complicated by renal failure,0
12365,Elective abortion,incomplete elective abortion complicated by shock,0
12366,Elective abortion,incomplete elective abortion complicated by embolism,0
12367,Demand pacing,3-lead electrocardiogram rhythm strip: fully dependent pacemaker in place,0
12368,visit for: fitting and adjustment of device,Fitting - action,0
12369,visit for: fitting and adjustment of a peritoneal dialysis catheter,Peritoneal dialysis catheter,0
12370,Complication of implant,iatrogenic osseointegration failure of dental implant,0
12371,Explosion,acoustic trauma from explosions,0
12372,Postoperative state,computed tomography of neck: post-surgical change of thyroid,0
12373,Postoperative state,postsurgical state acquired absence of organ joint,0
12374,Postoperative state,postsurgical state acquired absence of hip joint,0
12375,Postoperative state,postsurgical state acquired absence of knee joint,0
12376,Postoperative state,postsurg acquired absence hip joint w/ antibiotic-impreg cement spacer,0
12377,Postoperative state,postsurg acquired absence knee joint w/ antibiotic-impreg cement spacer,0
12378,Postoperative state,postsurg acquired absence joint w/ antibiotic-impregnated cement spacer,0
12379,Postoperative state,iatrogenic postoperative hypotension,0
12380,Neuropathic arthropathy due to diabetes mellitus,secondary diabetes mellitus with diabetic neuropathic arthropathy,0
12381,Neuropathic arthropathy due to diabetes mellitus,chemical-induced diabetes mellitus with diabetic neuropathic arthropathy,0
12382,weeping laceration of right upper paraspinal region,Wound discharge finding,0
12383,dehiscence of laceration of right upper paraspinal region,Wound dehiscence,0
12384,weeping laceration of left upper paraspinal region,Wound discharge finding,0
12385,dehiscence of laceration of left upper paraspinal region,Wound dehiscence,0
12386,weeping laceration of right mid paraspinal region,Wound discharge finding,0
12387,weeping laceration of left mid paraspinal region,Wound discharge finding,0
12388,dehiscence of laceration of left mid paraspinal region,Wound dehiscence,0
12389,weeping laceration of right lower paraspinal region,Wound discharge finding,0
12390,dehiscence of laceration of right lower paraspinal region,Wound dehiscence,0
12391,weeping laceration of left lower paraspinal region,Wound discharge finding,0
12392,dehiscence of laceration of left lower paraspinal region,Wound dehiscence,0
12393,incomplete elective abortion complicated by metabolic disorder,Elective abortion,0
12394,incomplete elective abortion with complication,Elective abortion,0
12395,self-induced abortion complicated by metabolic disorder,Self-induced termination of pregnancy,0
12396,self-induced abortion with complication,Self-induced termination of pregnancy,0
12397,infectious gastroenteritis with arthropathy,Infectious gastroenteritis,0
12398,sedative poisoning with undetermined intent,Poisoning of unknown intent,0
12399,psychotropic agent poisoning with undetermined intent,Poisoning of unknown intent,0
12400,poisoning by agricultural chemicals with undetermined intent,Poisoning of unknown intent,0
12401,poisoning by arsenic with undetermined intent,Poisoning of unknown intent,0
12402,"Injury undetermined whether accidentally or purposely inflicted, poisoning by gas distributed by pipeline",Poisoning of unknown intent,0
12403,poisoning by liquefied petroleum gas with undetermined intent,Poisoning of unknown intent,0
12404,poisoning by utility gas with undetermined intent,Poisoning of unknown intent,0
12405,poisoning by carbon monoxide with undetermined intent,Poisoning of unknown intent,0
12406,Diffuse pain,diffuse joint pains started suddenly,0
12407,poisoning by ethyl alcohol with undetermined intent,Poisoning of unknown intent,0
12408,poisoning by alcoholic beverages with undetermined intent,Poisoning of unknown intent,0
12409,poisoning by isopropyl alcohol with undetermined intent,Poisoning of unknown intent,0
12410,poisoning by wood alcohol with undetermined intent,Poisoning of unknown intent,0
12411,poisoning by methyl alcohol with undetermined intent,Poisoning of unknown intent,0
12412,poisoning by fusel oil with undetermined intent,Poisoning of unknown intent,0
12413,poisoning by alcohol with undetermined intent,Poisoning of unknown intent,0
12414,poisoning by acids with undetermined intent,Poisoning of unknown intent,0
12415,poisoning by corrosive alkalis due to undetermined intent,Poisoning of unknown intent,0
12416,poisoning by carbolic acid with undetermined intent,Poisoning of unknown intent,0
12417,poisoning by aniline with undetermined intent,Poisoning of unknown intent,0
12418,poisoning by phenol or phenol homologues due to undetermined intent,Poisoning of unknown intent,0
12419,poisoning by aromatics with undetermined intent,Poisoning of unknown intent,0
12420,poisoning by bromates or chlorates with undetermined intent,Poisoning of unknown intent,0
12421,poisoning by naphthalene or mothballs with undetermined intent,Poisoning of unknown intent,0
12422,poisoning by phosphorus with undetermined intent,Poisoning of unknown intent,0
12423,poisoning by antimony with undetermined intent,Poisoning of unknown intent,0
12424,poisoning by barium with undetermined intent,Poisoning of unknown intent,0
12425,poisoning by bismuth with undetermined intent,Poisoning of unknown intent,0
12426,poisoning by brass fumes with undetermined intent,Poisoning of unknown intent,0
12427,poisoning by cadmium with undetermined intent,Poisoning of unknown intent,0
12428,poisoning by copper with undetermined intent,Poisoning of unknown intent,0
12429,poisoning by lead with undetermined intent,Poisoning of unknown intent,0
12430,poisoning by manganese with undetermined intent,Poisoning of unknown intent,0
12431,poisoning by magnesium with undetermined intent,Poisoning of unknown intent,0
12432,poisoning by mercury with undetermined intent,Poisoning of unknown intent,0
12433,poisoning by nickel compounds with undetermined intent,Poisoning of unknown intent,0
12434,poisoning by silver with undetermined intent,Poisoning of unknown intent,0
12435,poisoning by thallium with undetermined intent,Poisoning of unknown intent,0
12436,poisoning by uranium with undetermined intent,Poisoning of unknown intent,0
12437,poisoning by beryllium with undetermined intent,Poisoning of unknown intent,0
12438,poisoning by chromium with undetermined intent,Poisoning of unknown intent,0
12439,heavy metal anti-infective agent poisoning with undetermined intent,Poisoning of unknown intent,0
12440,poisoning by carbamates with undetermined intent,Poisoning of unknown intent,0
12441,poisoning by fumigants with undetermined intent,Poisoning of unknown intent,0
12442,poisoning by fungicides with undetermined intent,Poisoning of unknown intent,0
12443,poisoning by herbicides with undetermined intent,Poisoning of unknown intent,0
12444,poisoning by paraquat with undetermined intent,Poisoning of unknown intent,0
12445,poisoning by DDT with undetermined intent,Poisoning of unknown intent,0
12446,poisoning by organochlorine insecticides with undetermined intent,Poisoning of unknown intent,0
12447,poisoning by organophosphorus insecticides with undetermined intent,Poisoning of unknown intent,0
12448,poisoning by organophosphate insecticides due to undetermined intent,Poisoning of unknown intent,0
12449,poisoning by insecticides mixtures with undetermined intent,Poisoning of unknown intent,0
12450,poisoning by insecticides with undetermined intent,Poisoning of unknown intent,0
12451,poisoning by rodenticides with undetermined intent,Poisoning of unknown intent,0
12452,poisoning by pentachlorophenol with undetermined intent,Poisoning of unknown intent,0
12453,poisoning by synthetic detergents or shampoos with undetermined intent,Poisoning of unknown intent,0
12454,poisoning by soap products with undetermined intent,Poisoning of unknown intent,0
12455,poisoning by polishes with undetermined intent,Poisoning of unknown intent,0
12456,poisoning by disinfectants with undetermined intent,Poisoning of unknown intent,0
12457,poisoning by lead paint with undetermined intent,Poisoning of unknown intent,0
12458,poisoning by paints and varnishes with undetermined intent,Poisoning of unknown intent,0
12459,poisoning by cleaning agents or paints with undetermined intent,Poisoning of unknown intent,0
12460,poisoning by carbon monoxide from domestic fuels with undetermined intent,Poisoning of unknown intent,0
12461,poisoning by carbon monoxide from gas containers with undetermined intent,Poisoning of unknown intent,0
12462,poisoning by carbon monoxide from piped gas with undetermined intent,Poisoning of unknown intent,0
12463,poisoning by coal gas with undetermined intent,Poisoning of unknown intent,0
12464,poisoning by natural gas with undetermined intent,Poisoning of unknown intent,0
12465,poisoning by butane with undetermined intent,Poisoning of unknown intent,0
12466,poisoning by propane due to undetermined intent,Poisoning of unknown intent,0
12467,poisoning by chlorine gas with undetermined intent,Poisoning of unknown intent,0
12468,poisoning by freon with undetermined intent,Poisoning of unknown intent,0
12469,poisoning by lacrimogenic gas with undetermined intent,Poisoning of unknown intent,0
12470,poisoning by nitrogen oxides with undetermined intent,Poisoning of unknown intent,0
12471,poisoning by sulfur dioxide with undetermined intent,Poisoning of unknown intent,0
12472,poisoning by hydrocyanic acid gas with undetermined intent,Poisoning of unknown intent,0
12473,poisoning by carbon tetrachloride vapors with undetermined intent,Poisoning of unknown intent,0
12474,poisoning by oxygen with undetermined intent,Poisoning of unknown intent,0
12475,poisoning by cyanide with undetermined intent,Poisoning of unknown intent,0
12476,poisoning by cosmetics with undetermined intent,Poisoning of unknown intent,0
12477,poisoning by glues and adhesives with undetermined intent,Poisoning of unknown intent,0
12478,poisoning by formaldehyde with undetermined intent,Poisoning of unknown intent,0
12479,poisoning by inorganic lead compounds with undetermined intent,Poisoning of unknown intent,0
12480,poisoning by organic lead compounds with undetermined intent,Poisoning of unknown intent,0
12481,poisoning by iron compounds with undetermined intent,Poisoning of unknown intent,0
12482,poisoning by monosodium glutamate (MSG) with undetermined intent,Poisoning of unknown intent,0
12483,poisoning by diesel fuel with undetermined intent,Poisoning of unknown intent,0
12484,poisoning by petroleum fuels and cleaners with undetermined intent,Poisoning of unknown intent,0
12485,poisoning by lubricating oils with undetermined intent,Poisoning of unknown intent,0
12486,poisoning by paraffin wax with undetermined intent,Poisoning of unknown intent,0
12487,poisoning by petroleum solids with undetermined intent,Poisoning of unknown intent,0
12488,poisoning by petroleum solvents with undetermined intent,Poisoning of unknown intent,0
12489,poisoning by petroleum products with undetermined intent,Poisoning of unknown intent,0
12490,poisoning by benzene with undetermined intent,Poisoning of unknown intent,0
12491,poisoning by carbon disulfide with undetermined intent,Poisoning of unknown intent,0
12492,poisoning by nitroglycol with undetermined intent,Poisoning of unknown intent,0
12493,poisoning by toluene with undetermined intent,Poisoning of unknown intent,0
12494,poisoning by glycols with undetermined intent,Poisoning of unknown intent,0
12495,Trichloroethylene poisoning of undetermined intent,Poisoning due to chemical substance,0
12496,poisoning by N-hexamemethyl-N-butyl ketone with undetermined intent,Poisoning of unknown intent,0
12497,poisoning by tetrachloroethylene with undetermined intent,Poisoning of unknown intent,0
12498,poisoning by solvents with undetermined intent,Poisoning of unknown intent,0
12499,poisoning by strychnine and salts with undetermined intent,Poisoning of unknown intent,0
12500,poisoning by sulfides with undetermined intent,Poisoning of unknown intent,0
12501,poisoning by aflatoxin with undetermined intent,Poisoning of unknown intent,0
12502,poisoning by asbestos with undetermined intent,Poisoning of unknown intent,0
12503,poisoning by latex with undetermined intent,Poisoning of unknown intent,0
12504,poisoning by silicone with undetermined intent,Poisoning of unknown intent,0
12505,poisoning by tobacco with undetermined intent,Poisoning of unknown intent,0
12506,poisoning by plant foods or fertilizers with undetermined intent,Poisoning of unknown intent,0
12507,boric acid poisoning with undetermined intent,Poisoning of unknown intent,0
12508,iodine poisoning with undetermined intent,Poisoning of unknown intent,0
12509,local anti-infective poisoning with undetermined intent,Poisoning of unknown intent,0
12510,anti-infective poisoning with undetermined intent,Poisoning of unknown intent,0
12511,anticholinergic poisoning with undetermined intent,Poisoning of unknown intent,0
12512,parasympatholytic poisoning with undetermined intent,Poisoning of unknown intent,0
12513,parasympathomimetic poisoning with undetermined intent,Poisoning of unknown intent,0
12514,beta adrenergic blocking agent poisoning with undetermined intent,Poisoning of unknown intent,0
12515,sympatholytic poisoning with undetermined intent,Poisoning of unknown intent,0
12516,dopamine poisoning with undetermined intent,Poisoning of unknown intent,0
12517,Adrenalin poisoning of undetermined intent,Poisoning of unknown intent,0
12518,sympathomimetic poisoning with undetermined intent,Poisoning of unknown intent,0
12519,autonomic nervous system-acting medication poisoning with undetermined intent,Poisoning of unknown intent,0
12520,topical or infiltration anesthetic poisoning with undetermined intent,Poisoning of unknown intent,0
12521,gaseous anesthetic poisoning with undetermined intent,Poisoning of unknown intent,0
12522,muscle-tone depressant poisoning with undetermined intent,Poisoning of unknown intent,0
12523,phencyclidine poisoning with undetermined intent,Poisoning of unknown intent,0
12524,intravenous anesthetic poisoning with undetermined intent,Poisoning of unknown intent,0
12525,local anesthetic poisoning with undetermined intent,Poisoning of unknown intent,0
12526,anesthetic poisoning with undetermined intent,Poisoning of unknown intent,0
12527,pyrazole derivative poisoning with undetermined intent,Poisoning of unknown intent,0
12528,non-narcotic analgesic poisoning with undetermined intent,Poisoning of unknown intent,0
12529,phenacetin poisoning with undetermined intent,Poisoning of unknown intent,0
12530,iron salt poisoning with undetermined intent,Poisoning of unknown intent,0
12531,natural blood poisoning with undetermined intent,Poisoning of unknown intent,0
12532,blood constituent agent poisoning with undetermined intent,Poisoning of unknown intent,0
12533,antidote poisoning with undetermined intent,Poisoning of unknown intent,0
12534,hydantoin derivative poisoning with undetermined intent,Poisoning of unknown intent,0
12535,oxazolidine derivative poisoning with undetermined intent,Poisoning of unknown intent,0
12536,toxicity from anticonvulsants/antiparkinsonism drugs due to undetermined intent,Poisoning of unknown intent,0
12537,encainide poisoning with undetermined intent,Poisoning of unknown intent,0
12538,flecainide poisoning with undetermined intent,Poisoning of unknown intent,0
12539,cinchonism poisoning with undetermined intent,Poisoning of unknown intent,0
12540,antiarrhythmic poisoning with undetermined intent,Poisoning of unknown intent,0
12541,reserpine poisoning with undetermined intent,Poisoning of unknown intent,0
12542,cholestyramine poisoning with undetermined intent,Poisoning of unknown intent,0
12543,HMG-CoA reductase inhibitor poisoning with undetermined intent,Poisoning of unknown intent,0
12544,antilipemic poisoning with undetermined intent,Poisoning of unknown intent,0
12545,cardiac glycoside poisoning with undetermined intent,Poisoning of unknown intent,0
12546,ganglion-blocking agent poisoning with undetermined intent,Poisoning of unknown intent,0
12547,nifedipine poisoning with undetermined intent,Poisoning of unknown intent,0
12548,antivaricose drug poisoning with undetermined intent,Poisoning of unknown intent,0
12549,capillary-active drug poisoning with undetermined intent,Poisoning of unknown intent,0
12550,vasodilator poisoning with undetermined intent,Poisoning of unknown intent,0
12551,cardiovascular medication poisoning with undetermined intent,Poisoning of unknown intent,0
12552,analeptic poisoning with undetermined intent,Poisoning of unknown intent,0
12553,opiate antagonist poisoning with undetermined intent,Poisoning of unknown intent,0
12554,strychnine poisoning with undetermined intent,Poisoning of unknown intent,0
12555,central nervous system stimulant poisoning with undetermined intent,Poisoning of unknown intent,0
12556,topical dental medication poisoning with undetermined intent,Poisoning of unknown intent,0
12557,antipruritic poisoning with undetermined intent,Poisoning of unknown intent,0
12558,Local astringent and detergent poisoning of undetermined intent,Poisoning of unknown intent,0
12559,"emollient, demulcent, and protectant poisoning with undetermined intent",Poisoning of unknown intent,0
12560,exfoliant poisoning with undetermined intent,Poisoning of unknown intent,0
12561,cantharidin poisoning with undetermined intent,Poisoning of unknown intent,0
12562,dermatological poisoning with undetermined intent,Poisoning of unknown intent,0
12563,poisoning with ENT preparations with undetermined intent,Poisoning of unknown intent by drug,0
12564,magnesium trisilicate poisoning with undetermined intent,Poisoning of unknown intent,0
12565,antacid poisoning with undetermined intent,Poisoning of unknown intent,0
12566,emollient cathartic poisoning with undetermined intent,Poisoning of unknown intent,0
12567,irritant cathartic poisoning with undetermined intent,Poisoning of unknown intent,0
12568,cathartic poisoning with undetermined intent,Poisoning of unknown intent,0
12569,digestant poisoning with undetermined intent,Poisoning of unknown intent,0
12570,antidiarrheal poisoning with undetermined intent,Poisoning of unknown intent,0
12571,emetic poisoning with undetermined intent,Poisoning of unknown intent,0
12572,gastrointestinal medication poisoning with undetermined intent,Poisoning of unknown intent,0
12573,hormone poisoning with undetermined intent,Poisoning of unknown intent,0
12574,immunosuppressive poisoning with undetermined intent,Poisoning of unknown intent,0
12575,lipotropic medication poisoning with undetermined intent,Poisoning of unknown intent,0
12576,mineral salt poisoning with undetermined intent,Poisoning of unknown intent,0
12577,ethacrynic acid poisoning with undetermined intent,Poisoning of unknown intent,0
12578,spironolactone poisoning with undetermined intent,Poisoning of unknown intent,0
12579,mercurial diuretic poisoning with undetermined intent,Poisoning of unknown intent,0
12580,purine derivative diuretic poisoning with undetermined intent,Poisoning of unknown intent,0
12581,diuretic poisoning with undetermined intent,Poisoning of unknown intent,0
12582,thiazide poisoning with undetermined intent,Poisoning of unknown intent,0
12583,carbonic acid anhydrase inhibitor poisoning with undetermined intent,Poisoning of unknown intent,0
12584,antimetabolite poisoning with undetermined intent,Poisoning of unknown intent,0
12585,metabolism medication poisoning with undetermined intent,Poisoning of unknown intent,0
12586,skeletal muscle relaxant poisoning with undetermined intent,Poisoning of unknown intent,0
12587,smooth muscle relaxant poisoning with undetermined intent,Poisoning of unknown intent,0
12588,muscle relaxant poisoning with undetermined intent,Poisoning of unknown intent,0
12589,Pethidine poisoning of undetermined intent,Poisoning of unknown intent,0
12590,ophthalmological poisoning with undetermined intent,Poisoning of unknown intent,0
12591,marijuana poisoning with undetermined intent,Poisoning of unknown intent,0
12592,monoamine oxidase inhibitor poisoning with undetermined intent,Poisoning of unknown intent,0
12593,phenothiazine-based tranquilizer poisoning with undetermined intent,Poisoning of unknown intent,0
12594,butyrophenone poisoning with undetermined intent,Poisoning of unknown intent,0
12595,minor tranquilizer poisoning with undetermined intent,Poisoning of unknown intent,0
12596,tranquilizer poisoning with undetermined intent,Poisoning of unknown intent,0
12597,antitussive poisoning with undetermined intent,Poisoning of unknown intent,0
12598,expectorant poisoning with undetermined intent,Poisoning of unknown intent,0
12599,antiasthmatic poisoning with undetermined intent,Poisoning of unknown intent,0
12600,respiratory medication poisoning with undetermined intent,Poisoning of unknown intent,0
12601,Pentobarbitone poisoning of undetermined intent,Poisoning of unknown intent,0
12602,bromide poisoning with undetermined intent,Poisoning of unknown intent,0
12603,glutethimide poisoning with undetermined intent,Poisoning of unknown intent,0
12604,methaqualone poisoning with undetermined intent,Poisoning of unknown intent,0
12605,mixed sedative poisoning with undetermined intent,Poisoning of unknown intent,0
12606,sleeping pill poisoning with undetermined intent,Poisoning of unknown intent,0
12607,enzyme poisoning with undetermined intent,Poisoning of unknown intent,0
12608,systemic agent poisoning with undetermined intent,Poisoning of unknown intent,0
12609,pertussis vaccine poisoning with undetermined intent,Poisoning of unknown intent,0
12610,typhoid paratyphoid vaccine poisoning with undetermined intent,Poisoning of unknown intent,0
12611,mixed bacterial vaccine poisoning with undetermined intent,Poisoning of unknown intent,0
12612,bacterial vaccine poisoning with undetermined intent,Poisoning of unknown intent,0
12613,mixed viral-rickettsial and bacterial vaccine poisoning with undetermined intent,Poisoning of unknown intent,0
12614,vaccine poisoning with undetermined intent,Poisoning of unknown intent,0
12615,Poisoning of unknown intent by drug,Poisoning of unknown intent,0
12616,interleukin-2 poisoning with undetermined intent,Poisoning of unknown intent,0
12617,Menopausal symptom,Symptomatic premature menopause,0
12618,Homozygote,targeted genetic analysis deleterious mutation homozygous,0
12619,Homozygote,genetic sequence analysis deleterious mutation homozygous,0
12620,Homozygote,CSGE deleterious mutation detected homozygous,0
12621,Homozygote,DGGE deleterious mutation detected homozygous,0
12622,Homozygote,protein truncation assay deleterious mutation homozygous,0
12623,Homozygote,Southern blot analysis deleterious mutation homozygous,0
12624,Homozygote,Northern blot analysis deleterious mutation homozygous,0
12625,3-lead electrocardiogram rhythm strip: sinus rhythm with ectopic beats,Premature Cardiac Complex,0
12626,3-lead electrocardiogram rhythm strip: atrial flutter with ectopic beats,Premature Cardiac Complex,0
12627,3-lead electrocardiogram rhythm strip: fully dependent pacemaker in place,Demand pacing,0
12628,Adolescence,Adolescent X-linked adrenoleukodystrophy,0
12629,Checking dressing of skin,surgical dressing present,0
12630,Checking dressing of skin,surgical dressing on head,0
12631,Checking dressing of skin,surgical dressing on scalp,0
12632,Checking dressing of skin,surgical dressing on face,0
12633,Checking dressing of skin,surgical dressing on neck,0
12634,Checking dressing of skin,surgical dressing on chest,0
12635,Checking dressing of skin,surgical dressing on abdomen,0
12636,Checking dressing of skin,surgical dressing on back,0
12637,Checking dressing of skin,surgical dressing on groin,0
12638,Checking dressing of skin,surgical dressing on right upper extremity,0
12639,Checking dressing of skin,surgical dressing on left upper extremity,0
12640,Checking dressing of skin,surgical dressing on right lower extremity,0
12641,Checking dressing of skin,surgical dressing on left lower extremity,0
12642,Finding related to recognition,milestone: recognizes letters of alphabet,0
12643,Finding related to recognition,milestone: recognizes 3 of 4 colors,0
12644,Eating finding,nutrition risk assessment: eats healthy food and snacks,0
12645,Wound dehiscence,dehiscence of laceration of right upper paraspinal region,0
12646,Wound dehiscence,dehiscence of laceration of left upper paraspinal region,0
12647,Wound dehiscence,dehiscence of laceration of left mid paraspinal region,0
12648,Wound dehiscence,dehiscence of laceration of right lower paraspinal region,0
12649,Wound dehiscence,dehiscence of laceration of left lower paraspinal region,0
12650,Smiles (finding),Smiles spontaneously,0
12651,Smiles (finding),milestone: has a social smile,0
12652,Finding relating to autonomy and empowerment,Mental Health Risk Assessment: increasingly independent,0
12653,Finding relating to autonomy and empowerment,Mental Health Risk Assessment: increasingly responsible,0
12654,Finding relating to showing respect,home risk assessment: does chores at home when asked,0
12655,Hyporeflexia,milestone: diminished newborn reflexes,0
12656,poisoning by cyanogen chloride with undetermined intent,Poisoning of unknown intent,0
12657,Status Migrainosus,classic migraine with aura with status migrainosus,0
12658,Status Migrainosus,basilar migraine headache with status migrainosus,0
12659,Status Migrainosus,basilar migraine headache with intractable migraine with status migrainosus,0
12660,Status Migrainosus,retinal migraine headache with status migrainosus,0
12661,Status Migrainosus,retinal migraine headache with intractable migraine with status migrainosus,0
12662,Status Migrainosus,classic migraine with typical aura with status migrainosus,0
12663,Status Migrainosus,classic migraine with typical aura with intractable migraine with status migrainosus,0
12664,Status Migrainosus,cyclic vomiting syndrome associated with status migrainosus,0
12665,Status Migrainosus,cyclic vomiting syndrome associated with intractable migraine and status migrainosus,0
12666,Status Migrainosus,sporadic hemiplegic migraine headache with status migrainosus,0
12667,Status Migrainosus,sporadic hemiplegic migraine headache with intractable migraine and status migrainosus,0
12668,Diabetic Neuropathies,secondary diabetes mellitus with diabetic neuropathy,0
12669,Diabetic Neuropathies,chemical-induced diabetes mellitus with diabetic neuropathy,0
12670,Diabetic Neuropathies,type 1 diabetes with diabetic neuropathy,0
12671,Diabetic Mononeuropathy,secondary diabetes mellitus with diabetic mononeuropathy,0
12672,Diabetic Mononeuropathy,chemical-induced diabetes mellitus with diabetic mononeuropathy,0
12673,Diabetic Mononeuropathy,type 1 diabetes with diabetic mononeuropathy,0
12674,Diabetic Mononeuropathy,type 2 diabetes with diabetic mononeuropathy,0
12675,Tumor stage T1,malignant neoplasm of large intestine TNM staging primary tumor (T) T1,0
12676,Tumor stage T1,malignant neoplasm of small intestine TNM staging primary tumor (T) T0,0
12677,Tumor stage T1,malignant neoplasm of small intestine TNM staging primary tumor (T) T1,0
12678,Tumor stage T1,malignant neoplasm of bladder TNM staging primary tumor (T) T1,0
12679,Tumor stage T1,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T1,0
12680,Tumor stage T1,malignant neoplasm of nasopharynx TNM staging primary tumor (T)T1,0
12681,Tumor stage T1,malignant neoplasm of oropharynx TNM staging primary tumor (T) T1,0
12682,Tumor stage T1,malignant neoplasm of pharynx TNM staging primary tumor (T) T1,0
12683,Tumor stage T1,malignant neoplasm of soft palate TNM staging primary tumor (T) T1,0
12684,Tumor stage T1,malignant neoplasm of uvula TNM staging primary tumor (T) T1,0
12685,Tumor stage T1,malignant neoplasm of lip TNM staging primary tumor (T) T1,0
12686,Tumor stage T1,malignant neoplasm of tongue TNM staging primary tumor (T) T1,0
12687,Tumor stage T1,malignant neoplasm of gingiva TNM staging primary tumor (T) T1,0
12688,Tumor stage T1,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T1,0
12689,Tumor stage T1,malignant neoplasm of oral cavity TNM staging primary tumor (T) T1,0
12690,Tumor stage T1,malignant neoplasm of hard palate TNM staging primary tumor (T) T1,0
12691,Tumor stage T1,malignant neoplasm of retromolar area TNM staging primary tumor (T) T1,0
12692,Tumor stage T1,malignant neoplasm of parotid TNM staging primary tumor (T) T1,0
12693,Tumor stage T1,malignant neoplasm of salivary gland TNM staging primary tumor (T) T1,0
12694,Tumor stage T1,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T1,0
12695,Tumor stage T1,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T1,0
12696,Tumor stage T1,malignant neoplasm of subglottis TNM staging primary tumor (T) T1,0
12697,Tumor stage T1,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T1,0
12698,Tumor stage T1,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T1,0
12699,Tumor stage T1,malignant neoplasm of glottis TNM staging primary tumor (T) T1,0
12700,Tumor stage T1,malignant neoplasm of esophagus TNM staging primary tumor (T) T1,0
12701,Tumor stage T1,malignant neoplasm of stomach TNM staging primary tumor (T) T1,0
12702,Tumor stage T1,malignant neoplasm of gallbladder TNM staging primary tumor (T) T1,0
12703,Tumor stage T1,malignant melanoma of skin TNM staging primary tumor (T) T1,0
12704,Tumor stage T1,malignant neoplasm of cervix TNM staging primary tumor (T) T1/I,0
12705,Tumor stage T1,malignant neoplasm of vulva TNM staging primary tumor (T) T1/I,0
12706,Tumor stage T1,malignant neoplasm of penis TNM staging primary tumor (T) T1,0
12707,Tumor stage T1,malignant neoplasm of testis TNM staging primary tumor (T) T1,0
12708,Tumor stage T1,malignant neoplasm of prostate TNM staging primary tumor (T) T1,0
12709,Tumor stage T1,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T1,0
12710,Tumor stage T1,malignant neoplasm of ureter TNM staging primary tumor (T) T1,0
12711,Tumor stage T1,malignant neoplasm of thyroid TNM staging primary tumor (T) T1,0
12712,Tumor stage T1,Tumor stage T1,0
12713,Tumor stage T1,oncologic disorders,0
12714,Central venous cannula insertion,local infection due to central venous catheter,0
12715,Cannulation of subcutaneous reservoir,infection due to portacath catheter,0
12716,Hemopoietic stem cell transplant,complications of organ transplant stem cells,0
12717,Acquired coagulation disorder,Acquired hemophilia,0
12718,Rheumatic Heart Disease,rheumatic biventricular failure,0
12719,Hypoglycemic state due to diabetes mellitus,chemical-induced diabetes mellitus with hypoglycemia,0
12720,Hypoglycemic state due to diabetes mellitus,Type 1 diabetes mellitus with hypoglycemia,0
12721,Hypoglycemic state due to diabetes mellitus,diabetes mellitus type 1 with hypoglycemia without coma,0
12722,Hypoglycemic state due to diabetes mellitus,Type 2 diabetes mellitus with hypoglycemia,0
12723,Hypoglycemic state due to diabetes mellitus,Type 2 diabetes mellitus with hypoglycemia without coma,0
12724,Diabetic dermopathy,diabetes mellitus secondary with dermatological manifestations,0
12725,Diabetic dermopathy,chemical-induced diabetes mellitus with dermatological manifestations,0
12726,Wound discharge finding,weeping laceration of right upper paraspinal region,0
12727,Wound discharge finding,weeping laceration of left upper paraspinal region,0
12728,Wound discharge finding,weeping laceration of right mid paraspinal region,0
12729,Wound discharge finding,weeping laceration of left mid paraspinal region,0
12730,Wound discharge finding,weeping laceration of right lower paraspinal region,0
12731,Wound discharge finding,weeping laceration of left lower paraspinal region,0
12732,rasping systolic interscapular region,Systolic Murmurs,0
12733,vibratory systolic interscapular region,Systolic Murmurs,0
12734,rasping diastolic interscapular murmur,Diastolic Murmurs,0
12735,pitch of apical systolic murmur,Systolic Murmurs,0
12736,pitch of axillary systolic murmur,Systolic Murmurs,0
12737,pitch of axillary diastolic murmur,Diastolic Murmurs,0
12738,quality of systolic interscapular murmur,Systolic Murmurs,0
12739,pitch of systolic interscapular murmur,Systolic Murmurs,0
12740,pitch of diastolic interscapular murmur,Diastolic Murmurs,0
12741,Poisoning of unknown intent by drug,poisoning with ENT preparations with undetermined intent,0
12742,Poisoning of unknown intent by drug,posterior pituitary hormone poisoning with undetermined intent,0
12743,yellow nasal discharge,Yellow color on exam,0
12744,Gaze,milestone: follows gaze,0
12745,Gaze,milestone: gaze follows past midline,0
12746,Sore to touch,iv catheter site tender,0
12747,Finding of functional performance and activity,milestone: visually explores surroundings,0
12748,Must strain to pass urine,urinary urgency with straining,0
12749,Lower facial weakness,central facial nerve weakness involving lower face only,0
12750,Disorder of eye due to diabetes mellitus,secondary diabetes mellitus with ophthalmic manifestations,0
12751,Disorder of eye due to diabetes mellitus,chemical-induced diabetes mellitus with ophthalmic manifestations,0
12752,Recurrent tumor,thyroid biopsy recurrence of medullary carcinoma,0
12753,Cystocele (female),vaginal wall prolapse with lateral cystocele,0
12754,Squamous cell carcinoma of lung,squamous cell carcinoma of lung with metastasis to mediastinal lymph nodes,0
12755,Papillary thyroid carcinoma,malignant papillary carcinoma metastatic to mediastinal node,0
12756,Heart Valve Prosthesis,fibrosis due to heart valve prosthesis,0
12757,Heart Valve Prosthesis,hemorrhage due to heart valve prosthesis,0
12758,Heart Valve Prosthesis,pain due to heart valve prosthesis,0
12759,Heart Valve Prosthesis,stenosis due to heart valve prosthesis,0
12760,Heart Valve Prosthesis,thrombus due to heart valve prosthesis,0
12761,Periodontal Diseases,diabetes mellitus secondary with periodontal disease,0
12762,Periodontal Diseases,chemical-induced diabetes mellitus with periodontal disease,0
12763,Periodontal Diseases,Type 1 diabetes mellitus with periodontal disease,0
12764,Periodontal Diseases,Diabetes mellitus type 2 with periodontal disease,0
12765,3-lead electrocardiogram rhythm strip: heart rate with stress,Cardiovascular stress testing,0
12766,Tube drain,incision drainage tube leaking bile,0
12767,Speech babble finding,milestone: babbles,0
12768,3-lead electrocardiogram rhythm strip: RR interval with stress,Cardiovascular stress testing,0
12769,Vascular Catheters,IV catheter site appearance,0
12770,Vascular Catheters,iv catheter site erythematous,0
12771,Vascular Catheters,iv catheter site swollen,0
12772,Vascular Catheters,iv catheter site discharge,0
12773,Vascular Catheters,iv catheter site discharge clear,0
12774,Vascular Catheters,iv catheter site discharge serosanguineous,0
12775,Vascular Catheters,iv catheter site discharge bloody,0
12776,Vascular Catheters,iv catheter site occluded,0
12777,2-month milestones: vocalizes,Vocalization (finding),0
12778,milestone: rakes small objects,Finding related to ability to move hand,0
12779,9-month milestones,Child 8-9 month examination,0
12780,milestone: responds to own name,Child 8-9 month examination,0
12781,milestone: responds to own name,Able to respond to communication by others,0
12782,milestone: stands when placed,Able to stand,0
12783,milestone: crawls and/or creeps,Child 8-9 month examination,0
12784,milestone: crawls and/or creeps,Able to crawl,0
12785,milestone: feeds self with fingers,Child 8-9 month examination,0
12786,milestone: feeds self with fingers,Able to use hands to feed self,0
12787,15-month milestones,Child 15 month examination,0
12788,milestone: uses words to communicate,Able to use words,0
12789,milestone: uses words to communicate,Child 15 month examination,0
12790,milestone: vocabulary of 3-6 words,Child 15 month examination,0
12791,milestone: vocabulary of 3-6 words,Able to spontaneously say three or more words,0
12792,milestone: understands and follows simple commands,Cognitive perceptual finding,0
12793,milestone: understands and follows simple commands,Child 15 month examination,0
12794,"milestone: walks well, stoops, and climbs stairs",Able to walk up stairs,0
12795,"milestone: walks well, stoops, and climbs stairs",Child 15 month examination,0
12796,milestone: listens to a story,Cognitive function observations,0
12797,milestone: listens to a story,Child 15 month examination,0
12798,milestone: stacks two blocks,Finding related to ability to perform fine motor function,0
12799,milestone: stacks two blocks,Child 15 month examination,0
12800,milestone: vocabulary of 20 words or more,Finding related to ability to use words,0
12801,milestone: can copy a cross,Able to perform drawing activities,0
12802,milestone: can sing a song,Able to produce voice,0
12803,milestone: knows about food and appliances in home,Able to recognize objects,0
12804,milestone: can draw a person with three parts,Does perform drawing activities,0
12805,milestone: can distinguish fantasy from reality,Thought process - finding,0
12806,Dressing Without Help,Independent with dressing,0
12807,"milestone: draws person with head, body, arms, legs",Able to perform drawing activities,0
12808,milestone: recognizes letters of alphabet,Finding related to recognition,0
12809,milestone: can print letters of alphabet,Able to perform drawing activities,0
12810,5-year milestones: skips,Does skip,0
12811,milestone: plays make-believe,Use of imagination - finding,0
12812,milestone: friendly or hostile/aggressive behavior,Behavior,0
12813,5-year milestones: plays interactive games with peers,Social interaction finding,0
12814,milestone: copies a triangle or square,Able to perform drawing activities,0
12815,Mental Health Risk Assessment: appropriate behavior at home,Interpretations of behavior finding,0
12816,Mental Health Risk Assessment: appropriate behavior at school,Interpretations of behavior finding,0
12817,Mental Health Risk Assessment: appropriate behavior when playing with friends,Interpretations of behavior finding,0
12818,Education Risk Assessment: reading and doing math at grade level,Learning finding (finding),0
12819,Education Risk Assessment: reading and doing math at grade level,Educational achievement - finding,0
12820,Mental Health Risk Assessment: pride in achievements,Character trait finding of level of pride,0
12821,Education Risk Assessment: talks about what goes on in school,Communication finding,0
12822,Education Risk Assessment: completes school work,Education and/or schooling finding,0
12823,milestone: plays peek-a-boo,Social interaction finding,0
12824,Tumor stage T1a,malignant neoplasm of glottis TNM staging primary tumor (T) T1a,0
12825,Tumor stage T1a,malignant neoplasm of gallbladder TNM staging primary tumor (T) T1a,0
12826,Tumor stage T1a,malignant melanoma of skin TNM staging primary tumor (T) T1a,0
12827,Tumor stage T1a,malignant neoplasm of vulva TNM staging primary tumor (T) T1a/Ia,0
12828,Tumor stage T1a,malig neoplasm tnm staging primary tumor (t) t1a,0
12829,Tumor stage T1b,malignant neoplasm of glottis TNM staging primary tumor (T) T1b,0
12830,Tumor stage T1b,malignant neoplasm of gallbladder TNM staging primary tumor (T) T1b,0
12831,Tumor stage T1b,malignant melanoma of skin TNM staging primary tumor (T) T1b,0
12832,Tumor stage T1b,malignant neoplasm of vulva TNM staging primary tumor (T) T1b/Ib,0
12833,Tumor stage T1b,malig neoplasm tnm staging primary tumor (t) t1b,0
12834,Tumor stage T2a,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T2a,0
12835,Tumor stage T2a,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T2a,0
12836,Tumor stage T2a,malignant neoplasm of oropharynx TNM staging primary tumor (T) T2a,0
12837,Tumor stage T2a,malignant neoplasm of pharynx TNM staging primary tumor (T) T2a,0
12838,Tumor stage T2a,malignant neoplasm of soft palate TNM staging primary tumor (T) T2a,0
12839,Tumor stage T2a,malignant neoplasm of uvula TNM staging primary tumor (T) T2a,0
12840,Tumor stage T2a,malignant neoplasm of lip TNM staging primary tumor (T) T2a,0
12841,Tumor stage T2a,malignant neoplasm of tongue TNM staging primary tumor (T) T2a,0
12842,Tumor stage T2a,malignant neoplasm of gingiva TNM staging primary tumor (T) T2a,0
12843,Tumor stage T2a,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T2a,0
12844,Tumor stage T2a,malignant neoplasm of oral cavity TNM staging primary tumor (T) T2a,0
12845,Tumor stage T2a,malignant neoplasm of hard palate TNM staging primary tumor (T) T2a,0
12846,Tumor stage T2a,malignant neoplasm of retromolar area TNM staging primary tumor (T) T2a,0
12847,Tumor stage T2a,malignant neoplasm of stomach TNM staging primary tumor (T) T2a,0
12848,Tumor stage T2a,malignant melanoma of skin TNM staging primary tumor (T) T2a,0
12849,Tumor stage T2b,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T2b,0
12850,Tumor stage T2b,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T2b,0
12851,Tumor stage T2b,malignant neoplasm of oropharynx TNM staging primary tumor (T) T2b,0
12852,Tumor stage T2b,malignant neoplasm of pharynx TNM staging primary tumor (T) T2b,0
12853,Tumor stage T2b,malignant neoplasm of soft palate TNM staging primary tumor (T) T2b,0
12854,Tumor stage T2b,malignant neoplasm of uvula TNM staging primary tumor (T) T2b,0
12855,Tumor stage T2b,malignant neoplasm of lip TNM staging primary tumor (T) T2b,0
12856,Tumor stage T2b,malignant neoplasm of tongue TNM staging primary tumor (T) T2b,0
12857,Tumor stage T2b,malignant neoplasm of gingiva TNM staging primary tumor (T) T2b,0
12858,Tumor stage T2b,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T2b,0
12859,Tumor stage T2b,malignant neoplasm of oral cavity TNM staging primary tumor (T) T2b,0
12860,Tumor stage T2b,malignant neoplasm of hard palate TNM staging primary tumor (T) T2b,0
12861,Tumor stage T2b,malignant neoplasm of retromolar area TNM staging primary tumor (T) T2b,0
12862,Tumor stage T2b,malignant neoplasm of stomach TNM staging primary tumor (T) T2b,0
12863,Tumor stage T2b,malignant melanoma of skin TNM staging primary tumor (T) T2b,0
12864,Tumor stage T2b,malignant neoplasm of prostate TNM staging primary tumor (T) T2b,0
12865,Tumor stage T2b,Tumor stage T2b,0
12866,Tumor stage T2c,malignant neoplasm of prostate TNM staging primary tumor (T) T2c,0
12867,Tumor stage T3b,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T3b,0
12868,Tumor stage T3b,malignant melanoma of skin TNM staging primary tumor (T) T3b,0
12869,Tumor stage T4a,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T4a,0
12870,Tumor stage T4a,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T4a,0
12871,Tumor stage T4a,malignant neoplasm of lip TNM staging primary tumor (T) T4a,0
12872,Tumor stage T4a,malignant neoplasm of tongue TNM staging primary tumor (T) T4a,0
12873,Tumor stage T4a,malignant neoplasm of gingiva TNM staging primary tumor (T) T4a,0
12874,Tumor stage T4a,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T4a,0
12875,Tumor stage T4a,malignant neoplasm of oral cavity TNM staging primary tumor (T) T4a,0
12876,Tumor stage T4a,malignant neoplasm of hard palate TNM staging primary tumor (T) T4a,0
12877,Tumor stage T4a,malignant neoplasm of retromolar area TNM staging primary tumor (T) T4a,0
12878,Tumor stage T4a,malignant neoplasm of parotid TNM staging primary tumor (T) T4a,0
12879,Tumor stage T4a,malignant neoplasm of salivary gland TNM staging primary tumor (T) T4a,0
12880,Tumor stage T4a,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T4a,0
12881,Tumor stage T4a,malignant melanoma of skin TNM staging primary tumor (T) T4a,0
12882,Tumor stage T4a,malignant neoplasm of thyroid TNM staging primary tumor (T) T4a,0
12883,Tumor stage T4a,Tumor stage T4a,0
12884,Tumor stage T4b,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T4b,0
12885,Tumor stage T4b,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T4b,0
12886,Tumor stage T4b,malignant neoplasm of lip TNM staging primary tumor (T) T4b,0
12887,Tumor stage T4b,malignant neoplasm of tongue TNM staging primary tumor (T) T4b,0
12888,Tumor stage T4b,malignant neoplasm of gingiva TNM staging primary tumor (T) T4b,0
12889,Tumor stage T4b,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T4b,0
12890,Tumor stage T4b,malignant neoplasm of oral cavity TNM staging primary tumor (T) T4b,0
12891,Tumor stage T4b,malignant neoplasm of hard palate TNM staging primary tumor (T) T4b,0
12892,Tumor stage T4b,malignant neoplasm of retromolar area TNM staging primary tumor (T) T4b,0
12893,Tumor stage T4b,malignant neoplasm of parotid TNM staging primary tumor (T) T4b,0
12894,Tumor stage T4b,malignant neoplasm of salivary gland TNM staging primary tumor (T) T4b,0
12895,Tumor stage T4b,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T4b,0
12896,Tumor stage T4b,malignant melanoma of skin TNM staging primary tumor (T) T4b,0
12897,Tumor stage T4b,malignant neoplasm of thyroid TNM staging primary tumor (T) T4b,0
12898,Tumor stage T4b,Tumor stage T4b,0
12899,Metastasis stage M1a,malignant melanoma of skin TNM staging distant metastasis (M) M1a,0
12900,Metastasis stage M1a,malignant neoplasm of testis TNM staging distant metastasis (M) M1a,0
12901,Metastasis stage M1a,malignant neoplasm of prostate TNM staging distant metastasis (M) M1a,0
12902,Metastasis stage M1b,malignant melanoma of skin TNM staging distant metastasis (M) M1b,0
12903,Metastasis stage M1b,malignant neoplasm of testis TNM staging distant metastasis (M) M1b,0
12904,Metastasis stage M1b,malignant neoplasm of prostate TNM staging distant metastasis (M) M1b,0
12905,Metastasis stage M1c,malignant melanoma of skin TNM staging distant metastasis (M) M1c,0
12906,Metastasis stage M1c,malignant neoplasm of prostate TNM staging distant metastasis (M) M1c,0
12907,Node stage N2a,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N2a,0
12908,Node stage N2a,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N2a,0
12909,Node stage N2a,malignant neoplasm of sinus TNM staging regional lymph nodes N2a,0
12910,Node stage N2a,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2a,0
12911,Node stage N2a,malignant melanoma of skin TNM staging regional lymph nodes (N) N2a,0
12912,Node stage N2b,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N2b,0
12913,Node stage N2b,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N2b,0
12914,Node stage N2b,malignant neoplasm of sinus TNM staging regional lymph nodes N2b,0
12915,Node stage N2b,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2b,0
12916,Node stage N2b,malignant melanoma of skin TNM staging regional lymph nodes (N) N2b,0
12917,Node stage N2c,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N2c,0
12918,Node stage N2c,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N2c,0
12919,Node stage N2c,malignant neoplasm of sinus TNM staging regional lymph nodes N2c,0
12920,Node stage N2c,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2c,0
12921,Node stage N2c,malignant melanoma of skin TNM staging regional lymph nodes (N) N2c,0
12922,Diabetic coma with ketoacidosis,chemical-induced diabetes mellitus with ketoacidosis with coma,0
12923,renal artery bruit heard in right abdomen,Finding of auscultation of abdomen,0
12924,shoulder abduction test,Procedure to abduct extremity,0
12925,Toilet trained (finding),milestone: toilet-trained during day,0
12926,Injury undetermined whether accidentally or purposely inflicted,injury due to fall with undetermined intent,0
12927,Poisoning of unknown intent,sedative poisoning with undetermined intent,0
12928,Poisoning of unknown intent,psychotropic agent poisoning with undetermined intent,0
12929,Poisoning of unknown intent,poisoning by agricultural chemicals with undetermined intent,0
12930,Poisoning of unknown intent,poisoning by arsenic with undetermined intent,0
12931,Poisoning of unknown intent,"Injury undetermined whether accidentally or purposely inflicted, poisoning by gas distributed by pipeline",0
12932,Poisoning of unknown intent,poisoning by liquefied petroleum gas with undetermined intent,0
12933,Poisoning of unknown intent,poisoning by utility gas with undetermined intent,0
12934,Poisoning of unknown intent,poisoning by carbon monoxide with undetermined intent,0
12935,Poisoning of unknown intent,poisoning by ethyl alcohol with undetermined intent,0
12936,Poisoning of unknown intent,poisoning by alcoholic beverages with undetermined intent,0
12937,Poisoning of unknown intent,poisoning by isopropyl alcohol with undetermined intent,0
12938,Poisoning of unknown intent,poisoning by wood alcohol with undetermined intent,0
12939,Poisoning of unknown intent,poisoning by methyl alcohol with undetermined intent,0
12940,Poisoning of unknown intent,poisoning by fusel oil with undetermined intent,0
12941,Poisoning of unknown intent,poisoning by alcohol with undetermined intent,0
12942,Poisoning of unknown intent,poisoning by acids with undetermined intent,0
12943,Poisoning of unknown intent,poisoning by corrosive alkalis due to undetermined intent,0
12944,Poisoning of unknown intent,poisoning by carbolic acid with undetermined intent,0
12945,Poisoning of unknown intent,poisoning by aniline with undetermined intent,0
12946,Poisoning of unknown intent,poisoning by phenol or phenol homologues due to undetermined intent,0
12947,Poisoning of unknown intent,poisoning by aromatics with undetermined intent,0
12948,Poisoning of unknown intent,poisoning by bromates or chlorates with undetermined intent,0
12949,Poisoning of unknown intent,poisoning by naphthalene or mothballs with undetermined intent,0
12950,Poisoning of unknown intent,poisoning by phosphorus with undetermined intent,0
12951,Poisoning of unknown intent,poisoning by antimony with undetermined intent,0
12952,Poisoning of unknown intent,poisoning by barium with undetermined intent,0
12953,Poisoning of unknown intent,poisoning by bismuth with undetermined intent,0
12954,Poisoning of unknown intent,poisoning by brass fumes with undetermined intent,0
12955,Poisoning of unknown intent,poisoning by cadmium with undetermined intent,0
12956,Poisoning of unknown intent,poisoning by copper with undetermined intent,0
12957,Poisoning of unknown intent,poisoning by lead with undetermined intent,0
12958,Poisoning of unknown intent,poisoning by manganese with undetermined intent,0
12959,Poisoning of unknown intent,poisoning by magnesium with undetermined intent,0
12960,Poisoning of unknown intent,poisoning by mercury with undetermined intent,0
12961,Poisoning of unknown intent,poisoning by nickel compounds with undetermined intent,0
12962,Poisoning of unknown intent,poisoning by silver with undetermined intent,0
12963,Poisoning of unknown intent,poisoning by thallium with undetermined intent,0
12964,Poisoning of unknown intent,poisoning by uranium with undetermined intent,0
12965,Poisoning of unknown intent,poisoning by beryllium with undetermined intent,0
12966,Poisoning of unknown intent,poisoning by chromium with undetermined intent,0
12967,Poisoning of unknown intent,heavy metal anti-infective agent poisoning with undetermined intent,0
12968,Poisoning of unknown intent,poisoning by carbamates with undetermined intent,0
12969,Poisoning of unknown intent,poisoning by fumigants with undetermined intent,0
12970,Poisoning of unknown intent,poisoning by fungicides with undetermined intent,0
12971,Poisoning of unknown intent,poisoning by herbicides with undetermined intent,0
12972,Poisoning of unknown intent,poisoning by paraquat with undetermined intent,0
12973,Poisoning of unknown intent,poisoning by DDT with undetermined intent,0
12974,Poisoning of unknown intent,poisoning by organochlorine insecticides with undetermined intent,0
12975,Poisoning of unknown intent,poisoning by organophosphorus insecticides with undetermined intent,0
12976,Poisoning of unknown intent,poisoning by organophosphate insecticides due to undetermined intent,0
12977,Poisoning of unknown intent,poisoning by insecticides mixtures with undetermined intent,0
12978,Poisoning of unknown intent,poisoning by insecticides with undetermined intent,0
12979,Poisoning of unknown intent,poisoning by rodenticides with undetermined intent,0
12980,Poisoning of unknown intent,poisoning by pentachlorophenol with undetermined intent,0
12981,Poisoning of unknown intent,poisoning by synthetic detergents or shampoos with undetermined intent,0
12982,Poisoning of unknown intent,poisoning by soap products with undetermined intent,0
12983,Poisoning of unknown intent,poisoning by polishes with undetermined intent,0
12984,Poisoning of unknown intent,poisoning by disinfectants with undetermined intent,0
12985,Poisoning of unknown intent,poisoning by lead paint with undetermined intent,0
12986,Poisoning of unknown intent,poisoning by paints and varnishes with undetermined intent,0
12987,Poisoning of unknown intent,poisoning by cleaning agents or paints with undetermined intent,0
12988,Poisoning of unknown intent,poisoning by carbon monoxide from domestic fuels with undetermined intent,0
12989,Poisoning of unknown intent,poisoning by carbon monoxide from gas containers with undetermined intent,0
12990,Poisoning of unknown intent,poisoning by carbon monoxide from piped gas with undetermined intent,0
12991,Poisoning of unknown intent,poisoning by coal gas with undetermined intent,0
12992,Poisoning of unknown intent,poisoning by natural gas with undetermined intent,0
12993,Poisoning of unknown intent,poisoning by butane with undetermined intent,0
12994,Poisoning of unknown intent,poisoning by propane due to undetermined intent,0
12995,Poisoning of unknown intent,poisoning by chlorine gas with undetermined intent,0
12996,Poisoning of unknown intent,poisoning by freon with undetermined intent,0
12997,Poisoning of unknown intent,poisoning by lacrimogenic gas with undetermined intent,0
12998,Poisoning of unknown intent,poisoning by nitrogen oxides with undetermined intent,0
12999,Poisoning of unknown intent,poisoning by sulfur dioxide with undetermined intent,0
13000,Poisoning of unknown intent,poisoning by hydrocyanic acid gas with undetermined intent,0
13001,Poisoning of unknown intent,poisoning by carbon tetrachloride vapors with undetermined intent,0
13002,Poisoning of unknown intent,poisoning by oxygen with undetermined intent,0
13003,Poisoning of unknown intent,poisoning by cyanide with undetermined intent,0
13004,Poisoning of unknown intent,poisoning by cosmetics with undetermined intent,0
13005,Poisoning of unknown intent,poisoning by glues and adhesives with undetermined intent,0
13006,Poisoning of unknown intent,poisoning by formaldehyde with undetermined intent,0
13007,Poisoning of unknown intent,poisoning by inorganic lead compounds with undetermined intent,0
13008,Poisoning of unknown intent,poisoning by organic lead compounds with undetermined intent,0
13009,Poisoning of unknown intent,poisoning by iron compounds with undetermined intent,0
13010,Poisoning of unknown intent,poisoning by monosodium glutamate (MSG) with undetermined intent,0
13011,Poisoning of unknown intent,poisoning by diesel fuel with undetermined intent,0
13012,Poisoning of unknown intent,poisoning by petroleum fuels and cleaners with undetermined intent,0
13013,Poisoning of unknown intent,poisoning by lubricating oils with undetermined intent,0
13014,Poisoning of unknown intent,poisoning by paraffin wax with undetermined intent,0
13015,Poisoning of unknown intent,poisoning by petroleum solids with undetermined intent,0
13016,Poisoning of unknown intent,poisoning by petroleum solvents with undetermined intent,0
13017,Poisoning of unknown intent,poisoning by petroleum products with undetermined intent,0
13018,Poisoning of unknown intent,poisoning by benzene with undetermined intent,0
13019,Poisoning of unknown intent,poisoning by carbon disulfide with undetermined intent,0
13020,Poisoning of unknown intent,poisoning by nitroglycol with undetermined intent,0
13021,Poisoning of unknown intent,poisoning by toluene with undetermined intent,0
13022,Poisoning of unknown intent,poisoning by glycols with undetermined intent,0
13023,Poisoning of unknown intent,poisoning by N-hexamemethyl-N-butyl ketone with undetermined intent,0
13024,Poisoning of unknown intent,poisoning by tetrachloroethylene with undetermined intent,0
13025,Poisoning of unknown intent,poisoning by solvents with undetermined intent,0
13026,Poisoning of unknown intent,poisoning by strychnine and salts with undetermined intent,0
13027,Poisoning of unknown intent,poisoning by sulfides with undetermined intent,0
13028,Poisoning of unknown intent,poisoning by aflatoxin with undetermined intent,0
13029,Poisoning of unknown intent,poisoning by asbestos with undetermined intent,0
13030,Poisoning of unknown intent,poisoning by latex with undetermined intent,0
13031,Poisoning of unknown intent,poisoning by silicone with undetermined intent,0
13032,Poisoning of unknown intent,poisoning by tobacco with undetermined intent,0
13033,Poisoning of unknown intent,poisoning by plant foods or fertilizers with undetermined intent,0
13034,Poisoning of unknown intent,boric acid poisoning with undetermined intent,0
13035,Poisoning of unknown intent,iodine poisoning with undetermined intent,0
13036,Poisoning of unknown intent,local anti-infective poisoning with undetermined intent,0
13037,Poisoning of unknown intent,anti-infective poisoning with undetermined intent,0
13038,Poisoning of unknown intent,anticholinergic poisoning with undetermined intent,0
13039,Poisoning of unknown intent,parasympatholytic poisoning with undetermined intent,0
13040,Poisoning of unknown intent,parasympathomimetic poisoning with undetermined intent,0
13041,Poisoning of unknown intent,beta adrenergic blocking agent poisoning with undetermined intent,0
13042,Poisoning of unknown intent,sympatholytic poisoning with undetermined intent,0
13043,Poisoning of unknown intent,dopamine poisoning with undetermined intent,0
13044,Poisoning of unknown intent,Adrenalin poisoning of undetermined intent,0
13045,Poisoning of unknown intent,sympathomimetic poisoning with undetermined intent,0
13046,Poisoning of unknown intent,autonomic nervous system-acting medication poisoning with undetermined intent,0
13047,Poisoning of unknown intent,topical or infiltration anesthetic poisoning with undetermined intent,0
13048,Poisoning of unknown intent,gaseous anesthetic poisoning with undetermined intent,0
13049,Poisoning of unknown intent,muscle-tone depressant poisoning with undetermined intent,0
13050,Poisoning of unknown intent,phencyclidine poisoning with undetermined intent,0
13051,Poisoning of unknown intent,intravenous anesthetic poisoning with undetermined intent,0
13052,Poisoning of unknown intent,local anesthetic poisoning with undetermined intent,0
13053,Poisoning of unknown intent,anesthetic poisoning with undetermined intent,0
13054,Poisoning of unknown intent,pyrazole derivative poisoning with undetermined intent,0
13055,Poisoning of unknown intent,non-narcotic analgesic poisoning with undetermined intent,0
13056,Poisoning of unknown intent,phenacetin poisoning with undetermined intent,0
13057,Poisoning of unknown intent,iron salt poisoning with undetermined intent,0
13058,Poisoning of unknown intent,natural blood poisoning with undetermined intent,0
13059,Poisoning of unknown intent,blood constituent agent poisoning with undetermined intent,0
13060,Poisoning of unknown intent,antidote poisoning with undetermined intent,0
13061,Poisoning of unknown intent,hydantoin derivative poisoning with undetermined intent,0
13062,Poisoning of unknown intent,oxazolidine derivative poisoning with undetermined intent,0
13063,Poisoning of unknown intent,toxicity from anticonvulsants/antiparkinsonism drugs due to undetermined intent,0
13064,Poisoning of unknown intent,encainide poisoning with undetermined intent,0
13065,Poisoning of unknown intent,flecainide poisoning with undetermined intent,0
13066,Poisoning of unknown intent,cinchonism poisoning with undetermined intent,0
13067,Poisoning of unknown intent,antiarrhythmic poisoning with undetermined intent,0
13068,Poisoning of unknown intent,reserpine poisoning with undetermined intent,0
13069,Poisoning of unknown intent,cholestyramine poisoning with undetermined intent,0
13070,Poisoning of unknown intent,HMG-CoA reductase inhibitor poisoning with undetermined intent,0
13071,Poisoning of unknown intent,antilipemic poisoning with undetermined intent,0
13072,Poisoning of unknown intent,cardiac glycoside poisoning with undetermined intent,0
13073,Poisoning of unknown intent,ganglion-blocking agent poisoning with undetermined intent,0
13074,Poisoning of unknown intent,nifedipine poisoning with undetermined intent,0
13075,Poisoning of unknown intent,antivaricose drug poisoning with undetermined intent,0
13076,Poisoning of unknown intent,capillary-active drug poisoning with undetermined intent,0
13077,Poisoning of unknown intent,vasodilator poisoning with undetermined intent,0
13078,Poisoning of unknown intent,cardiovascular medication poisoning with undetermined intent,0
13079,Poisoning of unknown intent,analeptic poisoning with undetermined intent,0
13080,Poisoning of unknown intent,opiate antagonist poisoning with undetermined intent,0
13081,Poisoning of unknown intent,strychnine poisoning with undetermined intent,0
13082,Poisoning of unknown intent,central nervous system stimulant poisoning with undetermined intent,0
13083,Poisoning of unknown intent,topical dental medication poisoning with undetermined intent,0
13084,Poisoning of unknown intent,antipruritic poisoning with undetermined intent,0
13085,Poisoning of unknown intent,Local astringent and detergent poisoning of undetermined intent,0
13086,Poisoning of unknown intent,"emollient, demulcent, and protectant poisoning with undetermined intent",0
13087,Poisoning of unknown intent,exfoliant poisoning with undetermined intent,0
13088,Poisoning of unknown intent,cantharidin poisoning with undetermined intent,0
13089,Poisoning of unknown intent,dermatological poisoning with undetermined intent,0
13090,Poisoning of unknown intent,magnesium trisilicate poisoning with undetermined intent,0
13091,Poisoning of unknown intent,antacid poisoning with undetermined intent,0
13092,Poisoning of unknown intent,emollient cathartic poisoning with undetermined intent,0
13093,Poisoning of unknown intent,irritant cathartic poisoning with undetermined intent,0
13094,Poisoning of unknown intent,cathartic poisoning with undetermined intent,0
13095,Poisoning of unknown intent,digestant poisoning with undetermined intent,0
13096,Poisoning of unknown intent,antidiarrheal poisoning with undetermined intent,0
13097,Poisoning of unknown intent,emetic poisoning with undetermined intent,0
13098,Poisoning of unknown intent,gastrointestinal medication poisoning with undetermined intent,0
13099,Poisoning of unknown intent,hormone poisoning with undetermined intent,0
13100,Poisoning of unknown intent,immunosuppressive poisoning with undetermined intent,0
13101,Poisoning of unknown intent,lipotropic medication poisoning with undetermined intent,0
13102,Poisoning of unknown intent,mineral salt poisoning with undetermined intent,0
13103,Poisoning of unknown intent,ethacrynic acid poisoning with undetermined intent,0
13104,Poisoning of unknown intent,spironolactone poisoning with undetermined intent,0
13105,Poisoning of unknown intent,mercurial diuretic poisoning with undetermined intent,0
13106,Poisoning of unknown intent,purine derivative diuretic poisoning with undetermined intent,0
13107,Poisoning of unknown intent,diuretic poisoning with undetermined intent,0
13108,Poisoning of unknown intent,thiazide poisoning with undetermined intent,0
13109,Poisoning of unknown intent,carbonic acid anhydrase inhibitor poisoning with undetermined intent,0
13110,Poisoning of unknown intent,antimetabolite poisoning with undetermined intent,0
13111,Poisoning of unknown intent,metabolism medication poisoning with undetermined intent,0
13112,Poisoning of unknown intent,skeletal muscle relaxant poisoning with undetermined intent,0
13113,Poisoning of unknown intent,smooth muscle relaxant poisoning with undetermined intent,0
13114,Poisoning of unknown intent,muscle relaxant poisoning with undetermined intent,0
13115,Poisoning of unknown intent,Pethidine poisoning of undetermined intent,0
13116,Poisoning of unknown intent,ophthalmological poisoning with undetermined intent,0
13117,Poisoning of unknown intent,marijuana poisoning with undetermined intent,0
13118,Poisoning of unknown intent,monoamine oxidase inhibitor poisoning with undetermined intent,0
13119,Poisoning of unknown intent,phenothiazine-based tranquilizer poisoning with undetermined intent,0
13120,Poisoning of unknown intent,butyrophenone poisoning with undetermined intent,0
13121,Poisoning of unknown intent,minor tranquilizer poisoning with undetermined intent,0
13122,Poisoning of unknown intent,tranquilizer poisoning with undetermined intent,0
13123,Poisoning of unknown intent,antitussive poisoning with undetermined intent,0
13124,Poisoning of unknown intent,expectorant poisoning with undetermined intent,0
13125,Poisoning of unknown intent,antiasthmatic poisoning with undetermined intent,0
13126,Poisoning of unknown intent,respiratory medication poisoning with undetermined intent,0
13127,Poisoning of unknown intent,Pentobarbitone poisoning of undetermined intent,0
13128,Poisoning of unknown intent,bromide poisoning with undetermined intent,0
13129,Poisoning of unknown intent,glutethimide poisoning with undetermined intent,0
13130,Poisoning of unknown intent,methaqualone poisoning with undetermined intent,0
13131,Poisoning of unknown intent,mixed sedative poisoning with undetermined intent,0
13132,Poisoning of unknown intent,sleeping pill poisoning with undetermined intent,0
13133,Poisoning of unknown intent,enzyme poisoning with undetermined intent,0
13134,Poisoning of unknown intent,systemic agent poisoning with undetermined intent,0
13135,Poisoning of unknown intent,pertussis vaccine poisoning with undetermined intent,0
13136,Poisoning of unknown intent,typhoid paratyphoid vaccine poisoning with undetermined intent,0
13137,Poisoning of unknown intent,mixed bacterial vaccine poisoning with undetermined intent,0
13138,Poisoning of unknown intent,bacterial vaccine poisoning with undetermined intent,0
13139,Poisoning of unknown intent,mixed viral-rickettsial and bacterial vaccine poisoning with undetermined intent,0
13140,Poisoning of unknown intent,vaccine poisoning with undetermined intent,0
13141,Poisoning of unknown intent,Poisoning of unknown intent by drug,0
13142,Poisoning of unknown intent,interleukin-2 poisoning with undetermined intent,0
13143,Poisoning of unknown intent,poisoning by cyanogen chloride with undetermined intent,0
13144,Poisoning of unknown intent,thiamphenicol poisoning with undetermined intent,0
13145,Poisoning of unknown intent,cactinomycin poisoning with undetermined intent,0
13146,Poisoning of unknown intent,para-aminosalicylic acid derivative poisoning with undetermined intent,0
13147,Poisoning of unknown intent,androgen poisoning with undetermined intent,0
13148,Poisoning of unknown intent,biguanide poisoning with undetermined intent,0
13149,Poisoning of unknown intent,dextrothyroxine poisoning with undetermined intent,0
13150,Poisoning of unknown intent,thiourea poisoning with undetermined intent,0
13151,Poisoning of unknown intent,thonzylamine poisoning with undetermined intent,0
13152,Poisoning of unknown intent,tripelennamine poisoning with undetermined intent,0
13153,Poisoning of unknown intent,Cytarabine poisoning of undetermined intent,0
13154,Poisoning of unknown intent,hexadimethrine poisoning with undetermined intent,0
13155,Poisoning of unknown intent,acetanilid poisoning with undetermined intent,0
13156,Poisoning of unknown intent,acetophenetidin poisoning with undetermined intent,0
13157,Poisoning of unknown intent,aminophenazone poisoning with undetermined intent,0
13158,Poisoning of unknown intent,paramethadione poisoning with undetermined intent,0
13159,Poisoning of unknown intent,trimethadione poisoning with undetermined intent,0
13160,Poisoning of unknown intent,bromide poisoning with undetermined intent,0
13161,Poisoning of unknown intent,carbromal poisoning with undetermined intent,0
13162,Poisoning of unknown intent,central nervous system muscle-tone depressant poisoning with undetermined intent,0
13163,Poisoning of unknown intent,chlorphenesin poisoning with undetermined intent,0
13164,Poisoning of unknown intent,mephenesin poisoning with undetermined intent,0
13165,Poisoning of unknown intent,methocarbamol poisoning with undetermined intent,0
13166,Poisoning of unknown intent,halogenated derivative poisoning with undetermined intent,0
13167,Poisoning of unknown intent,thiobarbiturate poisoning with undetermined intent,0
13168,Poisoning of unknown intent,spiperone poisoning with undetermined intent,0
13169,Poisoning of unknown intent,hydroxyzine poisoning with undetermined intent,0
13170,Poisoning of unknown intent,psilocin poisoning with undetermined intent,0
13171,Poisoning of unknown intent,lobeline poisoning with undetermined intent,0
13172,Poisoning of unknown intent,quaternary ammonium derivative poisoning with undetermined intent,0
13173,Poisoning of unknown intent,digitalis glycoside poisoning with undetermined intent,0
13174,Poisoning of unknown intent,digitoxin poisoning with undetermined intent,0
13175,Poisoning of unknown intent,strophanthin poisoning with undetermined intent,0
13176,Poisoning of unknown intent,pentamethonium bromide poisoning with undetermined intent,0
13177,Poisoning of unknown intent,cyclandelate poisoning with undetermined intent,0
13178,Poisoning of unknown intent,papaverine poisoning with undetermined intent,0
13179,Poisoning of unknown intent,rauwolfia alkaloid poisoning with undetermined intent,0
13180,Poisoning of unknown intent,sodium morrhuate poisoning with undetermined intent,0
13181,Poisoning of unknown intent,zinc salt poisoning with undetermined intent,0
13182,Poisoning of unknown intent,adrenochrome derivative poisoning with undetermined intent,0
13183,Poisoning of unknown intent,local anti-inflammatory poisoning with undetermined intent,0
13184,Poisoning of unknown intent,keratolytic agent poisoning with undetermined intent,0
13185,Poisoning of unknown intent,keratoplastic agent poisoning with undetermined intent,0
13186,Poisoning of unknown intent,vaginal preparation poisoning with undetermined intent,0
13187,Poisoning of unknown intent,diagnostic agent poisoning with undetermined intent,0
13188,Poisoning of unknown intent,pertussis combination vaccine poisoning with undetermined intent,0
13189,Poisoning of unknown intent,poisoning by denatured alcohol with undetermined intent,0
13190,Poisoning of unknown intent,poisoning by gasoline with undetermined intent,0
13191,Poisoning of unknown intent,poisoning by kerosene with undetermined intent,0
13192,Poisoning of unknown intent,poisoning by petroleum spirits with undetermined intent,0
13193,Poisoning of unknown intent,poisoning by naphtha with undetermined intent,0
13194,Poisoning of unknown intent,poisoning by acetone with undetermined intent,0
13195,Poisoning of unknown intent,poisoning by cresol with undetermined intent,0
13196,Poisoning of unknown intent,poisoning by lye with undetermined intent,0
13197,Poisoning of unknown intent,potassium hydroxide poisoning of undetermined intent,0
13198,Poisoning of unknown intent,poisoning by sodium hydroxide with undetermined intent,0
13199,Poisoning of unknown intent,poisoning by lead salts with undetermined intent,0
13200,Poisoning of unknown intent,poisoning by tetraethyl lead with undetermined intent,0
13201,Poisoning of unknown intent,poisoning by hydrocyanic acid with undetermined intent,0
13202,Poisoning of unknown intent,poisoning by potassium cyanide with undetermined intent,0
13203,Poisoning of unknown intent,poisoning by sodium cyanide with undetermined intent,0
13204,Poisoning of unknown intent,poisoning by aldrin with undetermined intent,0
13205,Poisoning of unknown intent,poisoning by chlordane with undetermined intent,0
13206,Poisoning of unknown intent,poisoning by dieldrin with undetermined intent,0
13207,Poisoning of unknown intent,poisoning by mycotoxin with undetermined intent,0
13208,Poisoning of unknown intent,poisoning by kerosene insecticides with undetermined intent,0
13209,Poisoning of unknown intent,poisoning by mixtures of fertilizers with herbicides with undetermined intent,0
13210,Poisoning of unknown intent,poisoning by chlorates with undetermined intent,0
13211,Poisoning of unknown intent,poisoning by carbon monoxide from incomplete liquid propane gas combustion with undetermined intent,0
13212,Poisoning of unknown intent,poisoning by acetylene with undetermined intent,0
13213,Poisoning of unknown intent,poisoning by water gas with undetermined intent,0
13214,Poisoning of unknown intent,selective serotonin reuptake inhibitor (SSRI) poisoning of undetermined intent,0
13215,Poisoning of unknown intent,tetracyclic antidepressant poisoning of undetermined intent,0
13216,Poisoning of unknown intent,methylphenidate poisoning of undetermined intent,0
13217,Poisoning of unknown intent,drug toxicity olanzapine intent undetermined,0
13218,Poisoning of unknown intent,poisoning solvents carbon tetrachloride intent undetermined,0
13219,Poisoning of unknown intent,poisoning scouring powders intent undetermined,0
13220,Poisoning of unknown intent,poisoning from vitamin B6 due to undetermined intent,0
13221,Poisoning of unknown intent,poisoning by unspecified solid or liquid substance with undetermined intent,0
13222,Poisoning of unknown intent,"poisoning by gases, fumes, or vapors due to undetermined intent",0
13223,Poisoning of unknown intent,antibiotic poisoning with undetermined intent,0
13224,Poisoning of unknown intent,penicillin poisoning with undetermined intent,0
13225,Poisoning of unknown intent,antifungal poisoning with undetermined intent,0
13226,Poisoning of unknown intent,macrolide poisoning with undetermined intent,0
13227,Poisoning of unknown intent,cephalosporin poisoning with undetermined intent,0
13228,Poisoning of unknown intent,antimycobacterial poisoning with undetermined intent,0
13229,Poisoning of unknown intent,aminoglycoside poisoning with undetermined intent,0
13230,Poisoning of unknown intent,chemotherapeutic poisoning with undetermined intent,0
13231,Poisoning of unknown intent,anthelmintic poisoning with undetermined intent,0
13232,Poisoning of unknown intent,antimalarial poisoning with undetermined intent,0
13233,Poisoning of unknown intent,antiprotozoal drug poisoning with undetermined intent,0
13234,Poisoning of unknown intent,metronidazole poisoning with undetermined intent,0
13235,Poisoning of unknown intent,antiviral poisoning with undetermined intent,0
13236,Poisoning of unknown intent,arsenical anti-infective poisoning with undetermined intent,0
13237,Poisoning of unknown intent,sulfonamide poisoning with undetermined intent,0
13238,Poisoning of unknown intent,heavy metal anti-infective agent poisoning with undetermined intent,0
13239,Poisoning of unknown intent,anti-infective antimony compound poisoning with undetermined intent,0
13240,Poisoning of unknown intent,anti-infective bismuth compound poisoning with undetermined intent,0
13241,Poisoning of unknown intent,anti-infective lead compound poisoning with undetermined intent,0
13242,Poisoning of unknown intent,anti-infective mercury compound poisoning with undetermined intent,0
13243,Poisoning of unknown intent,quinoline poisoning with undetermined intent,0
13244,Poisoning of unknown intent,adrenocorticosteroid poisoning with undetermined intent,0
13245,Poisoning of unknown intent,topical ocular corticosteroid poisoning with undetermined intent,0
13246,Poisoning of unknown intent,anabolic steroids poisoning with undetermined intent,0
13247,Poisoning of unknown intent,ovarian hormone poisoning with undetermined intent,0
13248,Poisoning of unknown intent,Oral contraceptive poisoning of undetermined intent,0
13249,Poisoning of unknown intent,antidiabetic agent poisoning with undetermined intent,0
13250,Poisoning of unknown intent,oral hypoglycemic poisoning with undetermined intent,0
13251,Poisoning of unknown intent,sulfonylurea toxicity poisoning with undetermined intent,0
13252,Poisoning of unknown intent,anterior pituitary hormone poisoning with undetermined intent,0
13253,Poisoning of unknown intent,Corticotropin poisoning of undetermined intent,0
13254,Poisoning of unknown intent,Gonadotrophin poisoning of undetermined intent,0
13255,Poisoning of unknown intent,antithyroid poisoning with undetermined intent,0
13256,Poisoning of unknown intent,antihistamine poisoning with undetermined intent,0
13257,Poisoning of unknown intent,acidifying agent poisoning with undetermined intent,0
13258,Poisoning of unknown intent,alkalizing agent poisoning with undetermined intent,0
13259,Poisoning of unknown intent,heavy metal antagonist poisoning with undetermined intent,0
13260,Poisoning of unknown intent,vitamin poisoning with undetermined intent,0
13261,Poisoning of unknown intent,penicillamine poisoning with undetermined intent,0
13262,Poisoning of unknown intent,anticoagulant poisoning with undetermined intent,0
13263,Poisoning of unknown intent,warfarin poisoning with undetermined intent,0
13264,Poisoning of unknown intent,"toxicity from analgesics, antipyretics, and antirheumatics due to undetermined intent",0
13265,Poisoning of unknown intent,opioid poisoning with undetermined intent,0
13266,Metastasis stage MX,malignant neoplasm of lung TNM staging distant metastasis (M) MX,0
13267,Metastasis stage MX,malignant neoplasm of small intestine TNM staging distant metastasis (M) MX,0
13268,Metastasis stage MX,malignant neoplasm of bladder TNM staging distant metastasis (M) MX,0
13269,Metastasis stage MX,malignant neoplasm of adrenal gland TNM staging distant metastasis (M) MX,0
13270,Metastasis stage MX,malignant neoplasm of nasopharynx TNM staging distant metastasis (M) MX,0
13271,Metastasis stage MX,malignant neoplasm of oropharynx TNM staging distant metastasis (M) MX,0
13272,Metastasis stage MX,malignant neoplasm of pharynx TNM staging distant metastasis (M) MX,0
13273,Metastasis stage MX,malignant neoplasm of soft palate TNM staging distant metastasis (M) MX,0
13274,Metastasis stage MX,malignant neoplasm of uvula TNM staging distant metastasis (M) MX,0
13275,Metastasis stage MX,malignant neoplasm of lip TNM staging distant metastasis (M) MX,0
13276,Metastasis stage MX,malignant neoplasm of tongue TNM staging distant metastasis (M) MX,0
13277,Metastasis stage MX,malignant neoplasm of gingiva TNM staging distant metastasis (M) MX,0
13278,Metastasis stage MX,malignant neoplasm of floor of mouth TNM staging distant metastasis (M) MX,0
13279,Metastasis stage MX,malignant neoplasm of oral cavity TNM staging distant metastasis (M) MX,0
13280,Metastasis stage MX,malignant neoplasm of hard palate TNM staging distant metastasis (M) MX,0
13281,Metastasis stage MX,malignant neoplasm of retromolar area TNM staging distant metastasis (M) MX,0
13282,Metastasis stage MX,malignant neoplasm of parotid TNM staging distant metastasis (M) MX,0
13283,Metastasis stage MX,malignant neoplasm of salivary gland TNM staging distant metastasis (M) MX,0
13284,Metastasis stage MX,malignant neoplasm of hypopharynx TNM staging distant metastasis (M) MX,0
13285,Metastasis stage MX,malignant neoplasm of stomach TNM staging distant metastasis (M) MX,0
13286,Metastasis stage MX,malignant neoplasm of liver TNM staging distant metastasis (M) MX,0
13287,Metastasis stage MX,malignant neoplasm of extrahepatic bile duct TNM staging distant metastasis (M) MX,0
13288,Metastasis stage MX,malignant neoplasm of gallbladder TNM staging distant metastasis (M) MX,0
13289,Metastasis stage MX,malignant melanoma of skin TNM staging distant metastasis (M) MX,0
13290,Metastasis stage MX,malignant neoplasm of cervix TNM staging distant metastasis (M) MX,0
13291,Metastasis stage MX,malignant neoplasm of vulva TNM staging distant metastasis (M) MX,0
13292,Metastasis stage MX,malignant neoplasm of penis TNM staging distant metastasis (M) MX,0
13293,Metastasis stage MX,malignant neoplasm of testis TNM staging distant metastasis (M) MX,0
13294,Metastasis stage MX,malignant neoplasm of prostate TNM staging distant metastasis MX,0
13295,Metastasis stage MX,malignant neoplasm of renal pelvis TNM staging distant metastasis (M) MX,0
13296,Metastasis stage MX,malignant neoplasm of thyroid TNM staging distant metastasis (M) MX,0
13297,Metastasis stage MX,Metastasis stage MX,0
13298,Head movements abnormal,automatism head turning (symptom),0
13299,Deafness symptom,combined hearing and vision loss with deafness,0
13300,Deafness symptom,Total visual and total hearing impairment,0
13301,malignant neoplasm of breast TNM staging primary tumor (T) T0,T0 stage,0
13302,malignant neoplasm of breast TNM staging regional lymph node (N) N0,Node stage N0,0
13303,malignant neoplasm of breast TNM staging regional lymph node (N) N1,N1 category,0
13304,malignant neoplasm of breast TNM staging regional lymph node (N) N2,N2 category,0
13305,malignant neoplasm of breast TNM staging regional lymph node (N) N3,N3 category,0
13306,malignant neoplasm of breast TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13307,malignant neoplasm of breast TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13308,malignant neoplasm of lung TNM staging primary tumor (T) TX,Tumor stage TX,0
13309,malignant neoplasm of lung TNM staging primary tumor (T) T0,T0 stage,0
13310,malignant neoplasm of lung TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13311,malignant neoplasm of lung TNM staging primary tumor (T) T2 (diagnosis),Tumor stage T2,0
13312,malignant neoplasm of lung TNM staging primary tumor (T) T3,Tumor stage T3,0
13313,malignant neoplasm of lung TNM staging primary tumor (T) T4,Tumor stage T4,0
13314,malignant neoplasm of lung TNM staging regional lymph node (N) NX,NX Stage Finding,0
13315,malignant neoplasm of lung TNM staging regional lymph node (N) N0,Node stage N0,0
13316,malignant neoplasm of lung TNM staging regional lymph node (N) N1,N1 category,0
13317,malignant neoplasm of lung TNM staging regional lymph node (N) N2,N2 category,0
13318,malignant neoplasm of lung TNM staging regional lymph node (N) N3,N3 category,0
13319,malignant neoplasm of lung TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13320,malignant neoplasm of lung TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13321,malignant neoplasm of lung TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13322,malignant neoplasm of large intestine TNM staging primary tumor (T) T0,T0 stage,0
13323,malignant neoplasm of large intestine TNM staging primary tumor (T) T1,Tumor stage T1,0
13324,malignant neoplasm of large intestine TNM staging regional lymph nodes (N) N0,Node stage N0,0
13325,malignant neoplasm of large intestine TNM staging regional lymph nodes (N) N1,N1 category,0
13326,malignant neoplasm of large intestine TNM staging regional lymph nodes (N) N2,N2 category,0
13327,malignant neoplasm of large intestine TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13328,malignant neoplasm of large intestine TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13329,malignant neoplasm of small intestine TNM staging primary tumor (T) TX,Tumor stage TX,0
13330,malignant neoplasm of small intestine TNM staging primary tumor (T) T0,Tumor stage T1,0
13331,malignant neoplasm of small intestine TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13332,malignant neoplasm of small intestine TNM staging primary tumor (T) T1,Tumor stage T1,0
13333,malignant neoplasm of small intestine TNM staging primary tumor (T) T2,Tumor stage T2,0
13334,malignant neoplasm of small intestine TNM staging primary tumor (T) T3,Tumor stage T3,0
13335,malignant neoplasm of small intestine TNM staging primary tumor (T) T4,Tumor stage T4,0
13336,malignant neoplasm of small intestine TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13337,malignant neoplasm of small intestine TNM staging regional lymph nodes (N) N0,Node stage N0,0
13338,malignant neoplasm of small intestine TNM staging regional lymph nodes (N) N1,N1 category,0
13339,malignant neoplasm of small intestine TNM staging regional lymph nodes (N) N2,N2 category,0
13340,malignant neoplasm of small intestine TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13341,malignant neoplasm of small intestine TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13342,malignant neoplasm of small intestine TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13343,malignant neoplasm of bladder TNM staging primary tumor (T) TX,Tumor stage TX,0
13344,malignant neoplasm of bladder TNM staging primary tumor (T) T0,T0 stage,0
13345,malignant neoplasm of bladder TNM staging primary tumor (T) T1,Tumor stage T1,0
13346,malignant neoplasm of bladder TNM staging regional lymph node (N) NX,NX Stage Finding,0
13347,malignant neoplasm of bladder TNM staging regional lymph node (N) N0,Node stage N0,0
13348,malignant neoplasm of bladder TNM staging regional lymph node (N) N1,N1 category,0
13349,malignant neoplasm of bladder TNM staging regional lymph node (N) N2,N2 category,0
13350,malignant neoplasm of bladder TNM staging regional lymph node (N) N3,N3 category,0
13351,malignant neoplasm of bladder TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13352,malignant neoplasm of bladder TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13353,malignant neoplasm of bladder TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13354,malignant neoplasm of adrenal gland TNM staging primary tumor (T) TX,Tumor stage TX,0
13355,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T0,T0 stage,0
13356,malignant neoplasm of adrenal gland TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13357,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T1,Tumor stage T1,0
13358,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T2,Tumor stage T2,0
13359,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13360,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13361,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T3,Tumor stage T3,0
13362,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T3b,Tumor stage T3b,0
13363,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T4,Tumor stage T4,0
13364,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13365,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13366,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) NX,NX Stage Finding,0
13367,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) N0,Node stage N0,0
13368,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) N1,N1 category,0
13369,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) N2,N2 category,0
13370,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) N3,N3 category,0
13371,malignant neoplasm of adrenal gland TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13372,malignant neoplasm of adrenal gland TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13373,malignant neoplasm of adrenal gland TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13374,malignant neoplasm of nasopharynx TNM staging primary tumor (T) TX,Tumor stage TX,0
13375,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T0,T0 stage,0
13376,malignant neoplasm of nasopharynx TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13377,malignant neoplasm of nasopharynx TNM staging primary tumor (T)T1,Tumor stage T1,0
13378,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T2,Tumor stage T2,0
13379,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13380,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13381,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T4,Tumor stage T4,0
13382,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13383,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13384,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13385,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) N0,Node stage N0,0
13386,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) N1,N1 category,0
13387,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) N2,N2 category,0
13388,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) N3,N3 category,0
13389,malignant neoplasm of nasopharynx TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13390,malignant neoplasm of nasopharynx TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13391,malignant neoplasm of nasopharynx TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13392,malignant neoplasm of oropharynx TNM staging primary tumor (T) TX,Tumor stage TX,0
13393,malignant neoplasm of oropharynx TNM staging primary tumor (T) T0,T0 stage,0
13394,malignant neoplasm of oropharynx TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13395,malignant neoplasm of oropharynx TNM staging primary tumor (T) T1,Tumor stage T1,0
13396,malignant neoplasm of oropharynx TNM staging primary tumor (T) T2,Tumor stage T2,0
13397,malignant neoplasm of oropharynx TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13398,malignant neoplasm of oropharynx TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13399,malignant neoplasm of oropharynx TNM staging primary tumor (T) T3,Tumor stage T3,0
13400,malignant neoplasm of oropharynx TNM staging primary tumor (T) T4,Tumor stage T4,0
13401,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13402,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) N0,Node stage N0,0
13403,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) N1,N1 category,0
13404,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) N2,N2 category,0
13405,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) N3,N3 category,0
13406,malignant neoplasm of oropharynx TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13407,malignant neoplasm of oropharynx TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13408,malignant neoplasm of oropharynx TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13409,malignant neoplasm of pharynx TNM staging primary tumor (T) TX,Tumor stage TX,0
13410,malignant neoplasm of pharynx TNM staging primary tumor (T) T0,T0 stage,0
13411,malignant neoplasm of pharynx TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13412,malignant neoplasm of pharynx TNM staging primary tumor (T) T1,Tumor stage T1,0
13413,malignant neoplasm of pharynx TNM staging primary tumor (T) T2,Tumor stage T2,0
13414,malignant neoplasm of pharynx TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13415,malignant neoplasm of pharynx TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13416,malignant neoplasm of pharynx TNM staging primary tumor (T) T3,Tumor stage T3,0
13417,malignant neoplasm of pharynx TNM staging primary tumor (T) T4,Tumor stage T4,0
13418,malignant neoplasm of pharynx TNM staging regional lymph node (N) NX,NX Stage Finding,0
13419,malignant neoplasm of pharynx TNM staging regional lymph node (N) N0,Node stage N0,0
13420,malignant neoplasm of pharynx TNM staging regional lymph node (N) N1,N1 category,0
13421,malignant neoplasm of pharynx TNM staging regional lymph node (N) N2,N2 category,0
13422,malignant neoplasm of pharynx TNM staging regional lymph node (N) N3,N3 category,0
13423,malignant neoplasm of pharynx TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13424,malignant neoplasm of pharynx TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13425,malignant neoplasm of pharynx TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13426,malignant neoplasm of soft palate TNM staging primary tumor (T) TX,Tumor stage TX,0
13427,malignant neoplasm of soft palate TNM staging primary tumor (T) T0,T0 stage,0
13428,malignant neoplasm of soft palate TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13429,malignant neoplasm of soft palate TNM staging primary tumor (T) T1,Tumor stage T1,0
13430,malignant neoplasm of soft palate TNM staging primary tumor (T) T2,Tumor stage T2,0
13431,malignant neoplasm of soft palate TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13432,malignant neoplasm of soft palate TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13433,malignant neoplasm of soft palate TNM staging primary tumor (T) T3,Tumor stage T3,0
13434,malignant neoplasm of soft palate TNM staging primary tumor (T) T4,Tumor stage T4,0
13435,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13436,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) N0,Node stage N0,0
13437,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) N1,N1 category,0
13438,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) N2,N2 category,0
13439,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) N3,N3 category,0
13440,malignant neoplasm of soft palate TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13441,malignant neoplasm of soft palate TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13442,malignant neoplasm of soft palate TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13443,malignant neoplasm of uvula TNM staging primary tumor (T) TX,Tumor stage TX,0
13444,War injury,intentional submersion during conventional warfare,0
13445,War injury,war injury by strangulation during conventional warfare,0
13446,War injury,injured by piercing instrument during conventional warfare,0
13447,War injury,injured by blunt object during conventional warfare,0
13448,malignant neoplasm of uvula TNM staging primary tumor (T) T0,T0 stage,0
13449,malignant neoplasm of uvula TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13450,malignant neoplasm of uvula TNM staging primary tumor (T) T1,Tumor stage T1,0
13451,malignant neoplasm of uvula TNM staging primary tumor (T) T2,Tumor stage T2,0
13452,malignant neoplasm of uvula TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13453,malignant neoplasm of uvula TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13454,malignant neoplasm of uvula TNM staging primary tumor (T) T3,Tumor stage T3,0
13455,malignant neoplasm of uvula TNM staging primary tumor (T) T4,Tumor stage T4,0
13456,malignant neoplasm of uvula TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13457,malignant neoplasm of uvula TNM staging regional lymph nodes (N) N0,Node stage N0,0
13458,malignant neoplasm of uvula TNM staging regional lymph nodes (N) N1,N1 category,0
13459,malignant neoplasm of uvula TNM staging regional lymph nodes (N) N2,N2 category,0
13460,malignant neoplasm of uvula TNM staging regional lymph nodes (N) N3,N3 category,0
13461,malignant neoplasm of uvula TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13462,malignant neoplasm of uvula TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13463,malignant neoplasm of uvula TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13464,malignant neoplasm of lip TNM staging primary tumor (T) TX,Tumor stage TX,0
13465,malignant neoplasm of lip TNM staging primary tumor (T) T0,T0 stage,0
13466,malignant neoplasm of lip TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13467,malignant neoplasm of lip TNM staging primary tumor (T) T1,Tumor stage T1,0
13468,malignant neoplasm of lip TNM staging primary tumor (T) T2,Tumor stage T2,0
13469,malignant neoplasm of lip TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13470,malignant neoplasm of lip TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13471,malignant neoplasm of lip TNM staging primary tumor (T) T3,Tumor stage T3,0
13472,malignant neoplasm of lip TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13473,malignant neoplasm of lip TNM staging regional lymph nodes (N) N0,Node stage N0,0
13474,malignant neoplasm of lip TNM staging regional lymph nodes (N) N1,N1 category,0
13475,malignant neoplasm of lip TNM staging regional lymph nodes (N) N2,N2 category,0
13476,malignant neoplasm of lip TNM staging regional lymph nodes (N) N3,N3 category,0
13477,malignant neoplasm of lip TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13478,malignant neoplasm of lip TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13479,malignant neoplasm of lip TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13480,malignant neoplasm of lip TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13481,malignant neoplasm of lip TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13482,malignant neoplasm of tongue TNM staging primary tumor (T) TX,Tumor stage TX,0
13483,malignant neoplasm of tongue TNM staging primary tumor (T) T0,T0 stage,0
13484,malignant neoplasm of tongue TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13485,malignant neoplasm of tongue TNM staging primary tumor (T) T1,Tumor stage T1,0
13486,malignant neoplasm of tongue TNM staging primary tumor (T) T2,Tumor stage T2,0
13487,malignant neoplasm of tongue TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13488,malignant neoplasm of tongue TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13489,malignant neoplasm of tongue TNM staging primary tumor (T) T3,Tumor stage T3,0
13490,malignant neoplasm of tongue TNM staging primary tumor (T) T4,Tumor stage T4,0
13491,malignant neoplasm of tongue TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13492,malignant neoplasm of tongue TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13493,malignant neoplasm of tongue TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13494,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N0,Node stage N0,0
13495,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N1,N1 category,0
13496,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N2,N2 category,0
13497,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N3,N3 category,0
13498,malignant neoplasm of tongue TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13499,malignant neoplasm of tongue TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13500,malignant neoplasm of tongue TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13501,malignant neoplasm of gingiva TNM staging primary tumor (T) TX,Tumor stage TX,0
13502,malignant neoplasm of gingiva TNM staging primary tumor (T) T0,T0 stage,0
13503,malignant neoplasm of gingiva TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13504,malignant neoplasm of gingiva TNM staging primary tumor (T) T1,Tumor stage T1,0
13505,malignant neoplasm of gingiva TNM staging primary tumor (T) T2,Tumor stage T2,0
13506,malignant neoplasm of gingiva TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13507,malignant neoplasm of gingiva TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13508,malignant neoplasm of gingiva TNM staging primary tumor (T) T3,Tumor stage T3,0
13509,malignant neoplasm of gingiva TNM staging primary tumor (T) T4,Tumor stage T4,0
13510,malignant neoplasm of gingiva TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13511,malignant neoplasm of gingiva TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13512,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13513,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) N0,Node stage N0,0
13514,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) N1,N1 category,0
13515,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) N2,N2 category,0
13516,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) N3,N3 category,0
13517,malignant neoplasm of gingiva TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13518,malignant neoplasm of gingiva TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13519,malignant neoplasm of gingiva TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13520,malignant neoplasm of floor of mouth TNM staging primary tumor TX,Tumor stage TX,0
13521,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T0,T0 stage,0
13522,malignant neoplasm of floor of mouth TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13523,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T1,Tumor stage T1,0
13524,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T2,Tumor stage T2,0
13525,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13526,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13527,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T3,Tumor stage T3,0
13528,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T4,Tumor stage T4,0
13529,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13530,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13531,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13532,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) N0,Node stage N0,0
13533,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) N1,N1 category,0
13534,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) N2,N2 category,0
13535,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) N3,N3 category,0
13536,malignant neoplasm of floor of mouth TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13537,malignant neoplasm of floor of mouth TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13538,malignant neoplasm of floor of mouth TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13539,malignant neoplasm of oral cavity TNM staging primary tumor (T) TX,Tumor stage TX,0
13540,malignant neoplasm of oral cavity TNM staging primary tumor (T) T0,T0 stage,0
13541,malignant neoplasm of oral cavity TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13542,malignant neoplasm of oral cavity TNM staging primary tumor (T) T1,Tumor stage T1,0
13543,malignant neoplasm of oral cavity TNM staging primary tumor (T) T2,Tumor stage T2,0
13544,malignant neoplasm of oral cavity TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13545,malignant neoplasm of oral cavity TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13546,malignant neoplasm of oral cavity TNM staging primary tumor (T) T3,Tumor stage T3,0
13547,malignant neoplasm of oral cavity TNM staging primary tumor (T) T4,Tumor stage T4,0
13548,malignant neoplasm of oral cavity TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13549,malignant neoplasm of oral cavity TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13550,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13551,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N0,Node stage N0,0
13552,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N1,N1 category,0
13553,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N2,N2 category,0
13554,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N3,N3 category,0
13555,malignant neoplasm of oral cavity TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13556,malignant neoplasm of oral cavity TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13557,malignant neoplasm of oral cavity TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13558,malignant neoplasm of hard palate TNM staging primary tumor (T) TX,Tumor stage TX,0
13559,malignant neoplasm of hard palate TNM staging primary tumor (T) T0,T0 stage,0
13560,malignant neoplasm of hard palate TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13561,malignant neoplasm of hard palate TNM staging primary tumor (T) T1,Tumor stage T1,0
13562,malignant neoplasm of hard palate TNM staging primary tumor (T) T2,Tumor stage T2,0
13563,malignant neoplasm of hard palate TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13564,malignant neoplasm of hard palate TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13565,malignant neoplasm of hard palate TNM staging primary tumor (T) T3,Tumor stage T3,0
13566,malignant neoplasm of hard palate TNM staging primary tumor (T) T4,Tumor stage T4,0
13567,malignant neoplasm of hard palate TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13568,malignant neoplasm of hard palate TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13569,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13570,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) N0,Node stage N0,0
13571,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) N1,N1 category,0
13572,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) N2,N2 category,0
13573,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) N3,N3 category,0
13574,malignant neoplasm of hard palate TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13575,malignant neoplasm of hard palate TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13576,malignant neoplasm of hard palate TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13577,malignant neoplasm of retromolar area TNM staging primary tumor (T) TX,Tumor stage TX,0
13578,malignant neoplasm of retromolar area TNM staging primary tumor (T) T0,T0 stage,0
13579,malignant neoplasm of retromolar area TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13580,malignant neoplasm of retromolar area TNM staging primary tumor (T) T1,Tumor stage T1,0
13581,malignant neoplasm of retromolar area TNM staging primary tumor (T) T2,Tumor stage T2,0
13582,malignant neoplasm of retromolar area TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13583,malignant neoplasm of retromolar area TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13584,malignant neoplasm of retromolar area TNM staging primary tumor (T) T3,Tumor stage T3,0
13585,malignant neoplasm of retromolar area TNM staging primary tumor (T) T4,Tumor stage T4,0
13586,malignant neoplasm of retromolar area TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13587,malignant neoplasm of retromolar area TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13588,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13589,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) N0,Node stage N0,0
13590,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) N1,N1 category,0
13591,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) N2,N2 category,0
13592,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) N3,N3 category,0
13593,malignant neoplasm of retromolar area TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13594,malignant neoplasm of retromolar area TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13595,malignant neoplasm of retromolar area TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13596,malignant neoplasm of parotid TNM staging primary tumor (T) TX,Tumor stage TX,0
13597,malignant neoplasm of parotid TNM staging primary tumor (T) T0,T0 stage,0
13598,malignant neoplasm of parotid TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13599,malignant neoplasm of parotid TNM staging primary tumor (T) T1,Tumor stage T1,0
13600,malignant neoplasm of parotid TNM staging primary tumor (T) T2,Tumor stage T2,0
13601,malignant neoplasm of parotid TNM staging primary tumor (T) T3,Tumor stage T3,0
13602,malignant neoplasm of parotid TNM staging primary tumor (T) T4,Tumor stage T4,0
13603,malignant neoplasm of parotid TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13604,malignant neoplasm of parotid TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13605,malignant neoplasm of parotid TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13606,malignant neoplasm of parotid TNM staging regional lymph nodes (N) N0,Node stage N0,0
13607,malignant neoplasm of parotid TNM staging regional lymph nodes (N) N1,N1 category,0
13608,malignant neoplasm of parotid TNM staging regional lymph nodes (N) N2,N2 category,0
13609,malignant neoplasm of parotid TNM staging regional lymph nodes (N) N3,N3 category,0
13610,malignant neoplasm of parotid TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13611,malignant neoplasm of parotid TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13612,malignant neoplasm of parotid TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13613,malignant neoplasm of salivary gland TNM staging primary tumor (T) TX,Tumor stage TX,0
13614,malignant neoplasm of salivary gland TNM staging primary tumor (T) T0,T0 stage,0
13615,malignant neoplasm of salivary gland TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13616,malignant neoplasm of salivary gland TNM staging primary tumor (T) T1,Tumor stage T1,0
13617,malignant neoplasm of salivary gland TNM staging primary tumor T2,Tumor stage T2,0
13618,malignant neoplasm of salivary gland TNM staging primary tumor (T) T3,Tumor stage T3,0
13619,malignant neoplasm of salivary gland TNM staging primary tumor (T) T4,Tumor stage T4,0
13620,malignant neoplasm of salivary gland TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13621,malignant neoplasm of salivary gland TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13622,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13623,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) N0,Node stage N0,0
13624,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) N1,N1 category,0
13625,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) N2,N2 category,0
13626,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) N3,N3 category,0
13627,malignant neoplasm of salivary gland TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13628,malignant neoplasm of salivary gland TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13629,malignant neoplasm of salivary gland TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13630,malignant neoplasm of hypopharynx TNM staging primary tumor (T) TX,Tumor stage TX,0
13631,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T0,T0 stage,0
13632,malignant neoplasm of hypopharynx TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13633,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T1,Tumor stage T1,0
13634,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T2,Tumor stage T2,0
13635,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T3,Tumor stage T3,0
13636,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T4,Tumor stage T4,0
13637,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13638,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13639,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13640,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) N0,Node stage N0,0
13641,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) N1,N1 category,0
13642,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) N2,N2 category,0
13643,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) N3,N3 category,0
13644,malignant neoplasm of hypopharynx TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13645,malignant neoplasm of hypopharynx TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13646,malignant neoplasm of hypopharynx TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13647,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N2a,Node stage N2a,0
13648,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T0,T0 stage,0
13649,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N2b,Node stage N2b,0
13650,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T1,Tumor stage T1,0
13651,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T2,Tumor stage T2,0
13652,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T3,Tumor stage T3,0
13653,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T4,Tumor stage T4,0
13654,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N2c,Node stage N2c,0
13655,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13656,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N1,N1 category,0
13657,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N2,N2 category,0
13658,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N3,N3 category,0
13659,malignant neoplasm of subglottis TNM staging primary tumor (T) T0,T0 stage,0
13660,malignant neoplasm of subglottis TNM staging primary tumor (T) T1,Tumor stage T1,0
13661,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13662,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N1,N1 category,0
13663,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N2,N2 category,0
13664,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N2a,Node stage N2a,0
13665,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N2b,Node stage N2b,0
13666,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N2c,Node stage N2c,0
13667,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N3,N3 category,0
13668,Delayed developmental milestones,delayed developmental milestones gross motor late walker,0
13669,Delayed developmental milestones,delayed developmental milestones language late talker,0
13670,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T0,T0 stage,0
13671,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T1,Tumor stage T1,0
13672,malignant neoplasm of sinus TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13673,malignant neoplasm of sinus TNM staging regional lymph nodes (N) N1,N1 category,0
13674,malignant neoplasm of sinus TNM staging regional lymph nodes (N) N2,N2 category,0
13675,malignant neoplasm of sinus TNM staging regional lymph nodes N2a,Node stage N2a,0
13676,malignant neoplasm of sinus TNM staging regional lymph nodes N2b,Node stage N2b,0
13677,malignant neoplasm of sinus TNM staging regional lymph nodes N2c,Node stage N2c,0
13678,malignant neoplasm of sinus TNM staging regional lymph nodes (N) N3,N3 category,0
13679,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T0,T0 stage,0
13680,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T1,Tumor stage T1,0
13681,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N1,N1 category,0
13682,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2,N2 category,0
13683,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2a,Node stage N2a,0
13684,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2b,Node stage N2b,0
13685,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2c,Node stage N2c,0
13686,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N3,N3 category,0
13687,malignant neoplasm of glottis TNM staging primary tumor (T) T0,T0 stage,0
13688,malignant neoplasm of glottis TNM staging primary tumor (T) T1,Tumor stage T1,0
13689,malignant neoplasm of glottis TNM staging primary tumor (T) T2,Tumor stage T2,0
13690,malignant neoplasm of glottis TNM staging primary tumor (T) T3,Tumor stage T3,0
13691,malignant neoplasm of glottis TNM staging primary tumor (T) T4,Tumor stage T4,0
13692,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N1,N1 category,0
13693,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N2,N2 category,0
13694,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N3,N3 category,0
13695,malignant neoplasm of glottis TNM staging primary tumor (T) T1a,Tumor stage T1a,0
13696,malignant neoplasm of glottis TNM staging primary tumor (T) T1b,Tumor stage T1b,0
13697,malignant neoplasm of esophagus TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13698,malignant neoplasm of esophagus TNM staging primary tumor (T) T1,Tumor stage T1,0
13699,malignant neoplasm of esophagus TNM staging primary tumor (T) T2,Tumor stage T2,0
13700,malignant neoplasm of esophagus TNM staging primary tumor (T) T3,Tumor stage T3,0
13701,malignant neoplasm of esophagus TNM staging primary tumor (T) T4,Tumor stage T4,0
13702,malignant neoplasm of esophagus TNM staging regional lymph nodes (N) N0,Node stage N0,0
13703,malignant neoplasm of esophagus TNM staging regional lymph nodes (N) N1,N1 category,0
13704,malignant neoplasm of stomach TNM staging primary tumor (T) TX,Tumor stage TX,0
13705,malignant neoplasm of stomach TNM staging primary tumor (T) T0,T0 stage,0
13706,malignant neoplasm of stomach TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13707,malignant neoplasm of stomach TNM staging primary tumor (T) T1,Tumor stage T1,0
13708,malignant neoplasm of stomach TNM staging primary tumor (T) T3,Tumor stage T3,0
13709,malignant neoplasm of stomach TNM staging primary tumor (T) T4,Tumor stage T4,0
13710,malignant neoplasm of stomach TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13711,malignant neoplasm of stomach TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13712,malignant neoplasm of stomach TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13713,malignant neoplasm of stomach TNM staging regional lymph nodes (N) N0,Node stage N0,0
13714,malignant neoplasm of stomach TNM staging regional lymph nodes (N) N1,N1 category,0
13715,malignant neoplasm of stomach TNM staging regional lymph nodes (N) N2,N2 category,0
13716,malignant neoplasm of stomach TNM staging regional lymph nodes (N) N3,N3 category,0
13717,malignant neoplasm of stomach TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13718,malignant neoplasm of stomach TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13719,malignant neoplasm of stomach TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13720,malignant neoplasm of liver TNM staging primary tumor (T) T0,T0 stage,0
13721,malignant neoplasm of liver TNM staging primary tumor (T) T2 (diagnosis),Tumor stage T2,0
13722,malignant neoplasm of liver TNM staging primary tumor (T) T3,Tumor stage T3,0
13723,malignant neoplasm of liver TNM staging primary tumor (T) T4,Tumor stage T4,0
13724,malignant neoplasm of liver TNM staging regional lymph nodes (N) N0,Node stage N0,0
13725,malignant neoplasm of liver TNM staging regional lymph nodes (N) N1,N1 category,0
13726,malignant neoplasm of liver TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13727,malignant neoplasm of liver TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13728,malignant neoplasm of liver TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13729,malignant neoplasm of liver TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13730,malignant neoplasm of extrahepatic bile duct TNM staging primary tumor (T) T2,Tumor stage T2,0
13731,malignant neoplasm of extrahepatic bile duct TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13732,malignant neoplasm of extrahepatic bile duct TNM staging regional lymph nodes (N) N0,Node stage N0,0
13733,malignant neoplasm of extrahepatic bile duct TNM staging regional lymph nodes (N) N1,N1 category,0
13734,malignant neoplasm of extrahepatic bile duct TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13735,malignant neoplasm of extrahepatic bile duct TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13736,malignant neoplasm of extrahepatic bile duct TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13737,malignant neoplasm of gallbladder TNM staging primary tumor (T) TX,Tumor stage TX,0
13738,malignant neoplasm of gallbladder TNM staging primary tumor (T) T0,T0 stage,0
13739,malignant neoplasm of gallbladder TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13740,malignant neoplasm of gallbladder TNM staging primary tumor (T) T1,Tumor stage T1,0
13741,malignant neoplasm of gallbladder TNM staging primary tumor (T) T2,Tumor stage T2,0
13742,malignant neoplasm of gallbladder TNM staging primary tumor (T) T1b,Tumor stage T1b,0
13743,malignant neoplasm of gallbladder TNM staging primary tumor (T) T3,Tumor stage T3,0
13744,malignant neoplasm of gallbladder TNM staging primary tumor (T) T4,Tumor stage T4,0
13745,malignant neoplasm of gallbladder TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13746,malignant neoplasm of gallbladder TNM staging regional lymph nodes (N) N0,Node stage N0,0
13747,malignant neoplasm of gallbladder TNM staging regional lymph nodes (N) N1,N1 category,0
13748,malignant neoplasm of gallbladder TNM staging regional lymph nodes (N) N2,N2 category,0
13749,malignant neoplasm of gallbladder TNM staging primary tumor (T) T1a,Tumor stage T1a,0
13750,malignant neoplasm of gallbladder TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13751,malignant neoplasm of gallbladder TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13752,malignant neoplasm of gallbladder TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13753,malignant melanoma of skin TNM staging primary tumor (T) T1a,Tumor stage T1a,0
13754,malignant melanoma of skin TNM staging primary tumor (T) TX,Tumor stage TX,0
13755,malignant melanoma of skin TNM staging primary tumor (T) T0,T0 stage,0
13756,malignant melanoma of skin TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13757,malignant melanoma of skin TNM staging primary tumor (T) T1,Tumor stage T1,0
13758,malignant melanoma of skin TNM staging primary tumor (T) T2a,Tumor stage T2a,0
13759,malignant melanoma of skin TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13760,malignant melanoma of skin TNM staging primary tumor (T) T3,Tumor stage T3,0
13761,malignant melanoma of skin TNM staging primary tumor (T) T3b,Tumor stage T3b,0
13762,malignant melanoma of skin TNM staging primary tumor (T) T4,Tumor stage T4,0
13763,malignant melanoma of skin TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13764,malignant melanoma of skin TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13765,malignant melanoma of skin TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13766,malignant melanoma of skin TNM staging regional lymph nodes (N) N0,Node stage N0,0
13767,malignant melanoma of skin TNM staging regional lymph nodes (N) N1a,Node stage N1a,0
13768,malignant melanoma of skin TNM staging regional lymph nodes (N) N2a,Node stage N2a,0
13769,malignant melanoma of skin TNM staging regional lymph nodes (N) N3,N3 category,0
13770,malignant melanoma of skin TNM staging distant metastasis (M),Metastasis category finding,0
13771,malignant melanoma of skin TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13772,malignant melanoma of skin TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13773,malignant melanoma of skin TNM staging distant metastasis (M) M1a,Metastasis stage M1a,0
13774,malignant melanoma of skin TNM staging primary tumor (T) T1b,Tumor stage T1b,0
13775,malignant melanoma of skin TNM staging regional lymph nodes (N) N1b,Node stage N1b,0
13776,malignant melanoma of skin TNM staging regional lymph nodes (N) N2b,Node stage N2b,0
13777,malignant melanoma of skin TNM staging regional lymph nodes (N) N2c,Node stage N2c,0
13778,malignant melanoma of skin TNM staging distant metastasis (M) M1b,Metastasis stage M1b,0
13779,malignant melanoma of skin TNM staging distant metastasis (M) M1c,Metastasis stage M1c,0
13780,malignant neoplasm of cervix TNM staging primary tumor (T) TX,Tumor stage TX,0
13781,malignant neoplasm of cervix TNM staging primary tumor (T) T0,T0 stage,0
13782,malignant neoplasm of cervix TNM staging primary tumor (T) T1/I,Tumor stage T1,0
13783,malignant neoplasm of cervix TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13784,malignant neoplasm of cervix TNM staging regional lymph nodes (N) N0,Node stage N0,0
13785,malignant neoplasm of cervix TNM staging regional lymph nodes (N) N1,N1 category,0
13786,malignant neoplasm of cervix TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13787,malignant neoplasm of cervix TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13788,malignant neoplasm of cervix TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13789,malignant neoplasm of cervix TNM staging primary tumor (T) M1/IVb,M1 (IVB): Distant metastasis,0
13790,malignant neoplasm of vulva TNM staging primary tumor (T) TX,Tumor stage TX,0
13791,malignant neoplasm of vulva TNM staging primary tumor (T) T0,T0 stage,0
13792,malignant neoplasm of vulva TNM staging primary tumor (T) Tis/0,Tumor stage Tis,0
13793,malignant neoplasm of vulva TNM staging primary tumor (T) T1/I,Tumor stage T1,0
13794,malignant neoplasm of vulva TNM staging primary tumor (T) T1a/Ia,Tumor stage T1a,0
13795,malignant neoplasm of vulva TNM staging primary tumor (T) T1b/Ib,Tumor stage T1b,0
13796,malignant neoplasm of vulva TNM staging primary tumor (T) T1B1/IB1,Tumor stage T1b1,0
13797,malignant neoplasm of vulva TNM staging primary tumor (T) T1B2/IB2,Tumor stage T1b2,0
13798,malignant neoplasm of vulva TNM staging primary tumor (T) T2/II,Tumor stage T2,0
13799,malignant neoplasm of vulva TNM staging primary tumor (T) T3/III,Tumor stage T3,0
13800,malignant neoplasm of vulva TNM staging primary tumor (T) T4/IVa,Tumor stage T4,0
13801,malignant neoplasm of vulva TNM staging regional lymph nodes (N),Node category finding,0
13802,malignant neoplasm of vulva TNM staging regional lymph nodes NX,NX Stage Finding,0
13803,malignant neoplasm of vulva TNM staging regional lymph nodes N0,Node stage N0,0
13804,malignant neoplasm of vulva TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13805,malignant neoplasm of vulva TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13806,malignant neoplasm of penis TNM staging primary tumor (T) TX,Tumor stage TX,0
13807,malignant neoplasm of penis TNM staging primary tumor (T) T0,T0 stage,0
13808,malignant neoplasm of penis TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13809,malignant neoplasm of penis TNM staging primary tumor (T) T1,Tumor stage T1,0
13810,malignant neoplasm of penis TNM staging primary tumor (T) T2,Tumor stage T2,0
13811,malignant neoplasm of penis TNM staging primary tumor (T) T3,Tumor stage T3,0
13812,malignant neoplasm of penis TNM staging primary tumor (T) T4,Tumor stage T4,0
13813,malignant neoplasm of penis TNM staging regional lymph node (N) NX,NX Stage Finding,0
13814,malignant neoplasm of penis TNM staging regional lymph node (N) N0,Node stage N0,0
13815,malignant neoplasm of penis TNM staging regional lymph node (N) N1,N1 category,0
13816,malignant neoplasm of penis TNM staging regional lymph node (N) N2,N2 category,0
13817,malignant neoplasm of penis TNM staging regional lymph node (N) N3,N3 category,0
13818,malignant neoplasm of penis TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13819,malignant neoplasm of penis TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13820,malignant neoplasm of penis TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13821,malignant neoplasm of testis TNM staging primary tumor (T) TX,Tumor stage TX,0
13822,malignant neoplasm of testis TNM staging primary tumor (T) T0,T0 stage,0
13823,malignant neoplasm of testis TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13824,malignant neoplasm of testis TNM staging distant metastasis (M) M1a,Metastasis stage M1a,0
13825,malignant neoplasm of testis TNM staging primary tumor (T) T1,Tumor stage T1,0
13826,malignant neoplasm of testis TNM staging primary tumor (T) T2,Tumor stage T2,0
13827,malignant neoplasm of testis TNM staging primary tumor (T) T3,Tumor stage T3,0
13828,malignant neoplasm of testis TNM staging primary tumor (T) T4,Tumor stage T4,0
13829,malignant neoplasm of testis TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13830,malignant neoplasm of testis TNM staging regional lymph nodes (N) N0,Node stage N0,0
13831,malignant neoplasm of testis TNM staging regional lymph nodes(N) N1,N1 category,0
13832,malignant neoplasm of testis TNM staging regional lymph nodes (N) N2,N2 category,0
13833,malignant neoplasm of testis TNM staging regional lymph nodes (N) N3,N3 category,0
13834,malignant neoplasm of testis TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13835,malignant neoplasm of testis TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13836,malignant neoplasm of testis TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13837,malignant neoplasm of testis TNM staging distant metastasis (M) M1b,Metastasis stage M1b,0
13838,malignant neoplasm of prostate TNM staging primary tumor (T) TX,Tumor stage TX,0
13839,malignant neoplasm of prostate TNM staging primary tumor (T) T0,T0 stage,0
13840,malignant neoplasm of prostate TNM staging primary tumor (T) T1,Tumor stage T1,0
13841,Open insertion of Hickman central venous catheter,local infection due to hickman catheter,0
13842,malignant neoplasm of prostate TNM staging primary tumor (T) T2b,Tumor stage T2b,0
13843,malignant neoplasm of prostate TNM staging primary tumor (T) T4,Tumor stage T4,0
13844,malignant neoplasm of prostate TNM staging primary tumor (T) T2c,Tumor stage T2c,0
13845,malignant neoplasm of prostate TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13846,malignant neoplasm of prostate TNM staging regional lymph nodes (N) N0,Node stage N0,0
13847,malignant neoplasm of prostate TNM staging regional lymph nodes (N) N1,N1 category,0
13848,malignant neoplasm of prostate TNM staging distant metastasis (M) M1a,Metastasis stage M1a,0
13849,malignant neoplasm of prostate TNM staging distant metastasis (M) M1b,Metastasis stage M1b,0
13850,malignant neoplasm of prostate TNM staging distant metastasis MX,Metastasis stage MX,0
13851,malignant neoplasm of prostate TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13852,malignant neoplasm of prostate TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13853,malignant neoplasm of prostate TNM staging distant metastasis (M) M1c,Metastasis stage M1c,0
13854,malignant neoplasm of kidney TNM staging primary tumor (T) TX,Tumor stage TX,0
13855,malignant neoplasm of kidney TNM staging primary tumor (T) T0,T0 stage,0
13856,malignant neoplasm of kidney TNM staging regional lymph nodes (N) N0,Node stage N0,0
13857,malignant neoplasm of kidney TNM staging regional lymph nodes (N) N1,N1 category,0
13858,malignant neoplasm of kidney TNM staging regional lymph nodes (N) N2,N2 category,0
13859,malignant neoplasm of kidney TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13860,malignant neoplasm of kidney TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13861,malignant neoplasm of renal pelvis TNM staging primary tumor (T) TX,Tumor stage TX,0
13862,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T0,T0 stage,0
13863,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T1,Tumor stage T1,0
13864,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T2,Tumor stage T2,0
13865,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T3,Tumor stage T3,0
13866,malignant neoplasm of renal pelvis TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13867,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) N3,N3 category,0
13868,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T4,Tumor stage T4,0
13869,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13870,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) N0,Node stage N0,0
13871,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) N1,N1 category,0
13872,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) N2,N2 category,0
13873,malignant neoplasm of renal pelvis TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13874,malignant neoplasm of renal pelvis TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13875,malignant neoplasm of renal pelvis TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13876,malignant neoplasm of ureter TNM staging primary tumor (T) T0,T0 stage,0
13877,malignant neoplasm of ureter TNM staging primary tumor (T) Tis,Tumor stage Tis,0
13878,malignant neoplasm of ureter TNM staging primary tumor (T) T1,Tumor stage T1,0
13879,malignant neoplasm of ureter TNM staging primary tumor (T) T2,Tumor stage T2,0
13880,malignant neoplasm of ureter TNM staging primary tumor (T) T3,Tumor stage T3,0
13881,malignant neoplasm of ureter TNM staging primary tumor (T) T4,Tumor stage T4,0
13882,malignant neoplasm of ureter TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13883,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N0,Node stage N0,0
13884,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N1,N1 category,0
13885,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N2,N2 category,0
13886,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N3,N3 category,0
13887,malignant neoplasm of ureter TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13888,malignant neoplasm of ureter TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13889,malignant neoplasm of thyroid TNM staging primary tumor (T) TX,Tumor stage TX,0
13890,malignant neoplasm of thyroid TNM staging primary tumor (T) T0,T0 stage,0
13891,malignant neoplasm of thyroid TNM staging primary tumor (T) T1,Tumor stage T1,0
13892,malignant neoplasm of thyroid TNM staging primary tumor (T) T2,Tumor stage T2,0
13893,malignant neoplasm of thyroid TNM staging primary tumor (T) T3,Tumor stage T3,0
13894,malignant neoplasm of thyroid TNM staging primary tumor (T) T4b,Tumor stage T4b,0
13895,malignant neoplasm of thyroid TNM staging primary tumor (T) T4a,Tumor stage T4a,0
13896,malignant neoplasm of thyroid TNM staging regional lymph nodes (N) NX,NX Stage Finding,0
13897,malignant neoplasm of thyroid TNM staging regional lymph nodes (N) N0,Node stage N0,0
13898,malignant neoplasm of thyroid TNM staging regional lymph nodes (N) N1,N1 category,0
13899,malignant neoplasm of thyroid TNM staging distant metastasis (M) MX,Metastasis stage MX,0
13900,malignant neoplasm of thyroid TNM staging distant metastasis (M) M0,M0 Stage Finding,0
13901,malignant neoplasm of thyroid TNM staging distant metastasis (M) M1,Metastasis stage M1,0
13902,vaginal wall prolapse with lateral cystocele,Cystocele (female),0
13903,rheumatic biventricular failure,Rheumatic Heart Disease,0
13904,postphlebitic syndrome with chronic venous hypertension,Chronic peripheral venous hypertension,0
13905,postoperative iatrogenic pneumothorax,Postoperative Complications,0
13906,Node stage N1a,malignant melanoma of skin TNM staging regional lymph nodes (N) N1a,0
13907,Node stage N1b,malignant melanoma of skin TNM staging regional lymph nodes (N) N1b,0
13908,Cord cell transfusion,complications of organ transplant stem cells umbilical cord,0
13909,Peripheral Stem Cell Transplantation,complications of organ transplant stem cells peripheral blood,0
13910,Vocalization (finding),milestone: coos,0
13911,Gangrenous cellulitis,Cellulitis,0
13912,circular rash at site of tick bite,Tick bite (disorder),0
13913,visit for: insulin pump status,Insulin pump,0
13914,Teeth yellow,Yellow color on exam,0
13915,chest pain made worse by neck movement,Movement aggravates symptom,0
13916,chest pain made worse by arm movement,Movement aggravates symptom,0
13917,chest pain made worse by right arm movement,Movement aggravates symptom,0
13918,chest pain made worse by left arm movement,Movement aggravates symptom,0
13919,chest pain gradually relieved by nitroglycerin,Pain relief by medication,0
13920,diffuse joint pains started suddenly,Diffuse pain,0
13921,Able to walk up step,18-month milestones: walks up steps,0
13922,Able to walk up stairs,"milestone: walks well, stoops, and climbs stairs",0
13923,Does stand alone,milestone: stands well alone,0
13924,Able to stand on one leg,milestone: balances on one foot for 1 second,0
13925,Able to stand on one leg,milestone: balances on one foot for 5 seconds,0
13926,Able to run,milestone: runs,0
13927,Does run (finding),milestone: runs well,0
13928,Does skip,5-year milestones: skips,0
13929,Does skip on one foot,milestone: jumps on one foot,0
13930,milestone: visual track 180 degrees,Eye movement - finding,0
13931,9-month milestones: object permanence,Child 8-9 month examination,0
13932,Does jump,milestone: jumps in place,0
13933,Able to crawl,milestone: crawls and/or creeps,0
13934,Able to roll over,milestone: rolls from front onto back,0
13935,Does roll over,milestone: rolls over from back to front,0
13936,sharp flank pain,Sharp pain,0
13937,knifelike flank pain,Stabbing pain,0
13938,dull flank pain,Dull pain,0
13939,Does reach,milestone: reaches for objects,0
13940,Able to pull to standing from sitting,milestone: pulls self to a standing position,0
13941,Able to sit,milestone: sits briefly leaning forward,0
13942,Able to stand,milestone: stands when placed,0
13943,urinary urgency with straining,Must strain to pass urine,0
13944,Able to control head posture,milestone: head steady in upright position,0
13945,Able to control head posture,milestone: no head lag when pulled to sit position,0
13946,Able to kick,milestone: kicks ball forward,0
13947,Does use pincer grip,milestone: neat pincer grasp,0
13948,Does bang objects together,12-month milestones: bangs objects together,0
13949,Finding relating to psychosocial functioning,milestone: calms to voice,0
13950,Finding relating to psychosocial functioning,milestone: can be calmed,0
13951,Finding relating to psychosocial functioning,milestone: calms self,0
13952,Able to dress,24-month milestones: puts on clothing,0
13953,Able to dress,milestone: dresses with supervision,0
13954,Able to undress,18-month milestones: removes clothes,0
13955,Able to recognize objects,milestone: knows about food and appliances in home,0
13956,Able to recognize objects,milestone: looks at books,0
13957,Able to recognize objects,milestone: points out objects,0
13958,Able to recognize faces,milestone: follows faces,0
13959,Able to recognize faces,milestone: fixes on faces,0
13960,Able to recognize sounds,milestone: knows correct animal sounds,0
13961,Able to recognize parts of own body,milestone: points to one or more body parts,0
13962,Able to recognize parts of own body,milestone: points to 6 body parts,0
13963,Able to control anger,Mental Health Risk Assessment: can manage anger,0
13964,Able to make speech sounds,milestone: makes vowel sounds,0
13965,Able to make speech sounds,milestone: makes purposeful sounds,0
13966,Able to produce voice,milestone: can sing a song,0
13967,Vocalization (finding),2-month milestones: vocalizes,0
13968,Able to imitate vocalization,milestone: imitates sounds,0
13969,Character trait finding of level of pride,Mental Health Risk Assessment: pride in achievements,0
13970,Able to throw objects,milestone: throws ball overhand,0
13971,Able to pass things from hand to hand,milestone: passes objects from hand to hand,0
13972,Able to turn pages,milestone: turns single pages,0
13973,Does turn pages,milestone: turns pages without ripping them,0
13974,Able to perform drawing activities,milestone: can copy a cross,0
13975,Able to perform drawing activities,"milestone: draws person with head, body, arms, legs",0
13976,Able to perform drawing activities,milestone: can print letters of alphabet,0
13977,Able to perform drawing activities,milestone: copies a triangle or square,0
13978,Able to perform drawing activities,milestone: can copy a circle,0
13979,Able to perform drawing activities,milestone: can draw a person,0
13980,Does perform drawing activities,milestone: can draw a person with three parts,0
13981,Finding relating to laughing,milestone: laughs in response to others,0
13982,Able to perform washing and drying of self activities,milestone: washes and dries hands,0
13983,Able to use words,milestone: uses words to communicate,0
13984,Able to use words,milestone: uses 2-3 word sentences,0
13985,Able to use words,milestone: uses plurals,0
13986,Able to respond to communication by others,milestone: responds to own name,0
13987,Able to respond to communication by others,milestone: responds to affection,0
13988,Able to communicate about self,milestone: can indicate boredom,0
13989,Able to drink from a feeder cup,milestone: drinks from a cup,0
13990,Able to use hands to feed self,milestone: feeds self with fingers,0
13991,Able to use spoon to feed self,milestone: uses spoon with minimal spilling,0
13992,Able to use spoon to feed self,milestone: uses a spoon,0
13993,Able to perform mouthcare activities,milestone: brushes teeth with help,0
13994,Able to perform mouthcare activities,milestone: brushes teeth independently,0
13995,Able to manage clothes fastenings,36-month milestones: buttons clothes,0
13996,artificial; larynx present (finding),Prosthetic voice box,0
13997,delayed developmental milestones gross motor late walker,Delayed developmental milestones,0
13998,delayed developmental milestones language late talker,Delayed developmental milestones,0
13999,choroidal nevus of right eye with drusen,Optic Disk Drusen,0
14000,choroidal nevus of left eye with drusen,Optic Disk Drusen,0
14001,Glycogen Storage Disease,Pulmonary interstitial glycogenosis,0
14002,milestone: vocabulary,Speech and language development finding,0
14003,milestone: vocabulary of 50 words or more,Finding related to ability to use words,0
14004,milestone: vocabulary of ___ words,Finding related to ability to use words,0
14005,forearm PIV site appearance,Peripheral vascular catheter,0
14006,surgical dressing present,Checking dressing of skin,0
14007,surgical dressing on head,Checking dressing of skin,0
14008,surgical dressing on scalp,Checking dressing of skin,0
14009,surgical dressing on face,Checking dressing of skin,0
14010,surgical dressing on neck,Checking dressing of skin,0
14011,surgical dressing on chest,Checking dressing of skin,0
14012,surgical dressing on abdomen,Checking dressing of skin,0
14013,surgical dressing on back,Checking dressing of skin,0
14014,surgical dressing on groin,Checking dressing of skin,0
14015,surgical dressing on right upper extremity,Checking dressing of skin,0
14016,surgical dressing on left upper extremity,Checking dressing of skin,0
14017,surgical dressing on right lower extremity,Checking dressing of skin,0
14018,surgical dressing on left lower extremity,Checking dressing of skin,0
14019,incision drainage tube leaking bile,Tube drain,0
14020,milestone: brushes teeth with help,Able to perform mouthcare activities,0
14021,milestone: follows faces,Able to recognize faces,0
14022,milestone: calms to voice,Finding relating to psychosocial functioning,0
14023,milestone: can be calmed,Finding relating to psychosocial functioning,0
14024,Smiles spontaneously,Smiles (finding),0
14025,milestone: diminished newborn reflexes,Hyporeflexia,0
14026,milestone: symmetric movement,Finding related to ability to move,0
14027,milestone: can indicate boredom,Able to communicate about self,0
14028,milestone: coos,Vocalization (finding),0
14029,milestone: different cry for different needs,Finding related to ability to communicate,0
14030,milestone: looks at parents,Finding related to ability to recognize familiar people,0
14031,milestone: responds to affection,Able to respond to communication by others,0
14032,milestone: elicits attention,Finding related to ability to direct attention,0
14033,milestone: indicates pleasure and displeasure,Emotional state observations,0
14034,milestone: calms self,Finding relating to psychosocial functioning,0
14035,milestone: sits briefly leaning forward,Able to sit,0
14036,milestone: visually explores surroundings,Finding of functional performance and activity,0
14037,milestone: puts objects in mouth,Oral habits - finding,0
14038,milestone: makes vowel sounds,Able to make speech sounds,0
14039,milestone: enjoys vocal turn-taking,Social interaction finding,0
14040,milestone: enjoys personal interactions,Social interaction finding,0
14041,milestone: looks at books,Child 8-9 month examination,0
14042,milestone: looks at books,Able to recognize objects,0
14043,milestone: makes purposeful sounds,Child 8-9 month examination,0
14044,milestone: makes purposeful sounds,Able to make speech sounds,0
14045,milestone: points out objects,Child 8-9 month examination,0
14046,milestone: points out objects,Able to recognize objects,0
14047,milestone: seeks parents for comfort,Child 8-9 month examination,0
14048,milestone: seeks parents for comfort,Finding related to ability to interact with others,0
14049,milestone: imitates sounds,Able to imitate vocalization,0
14050,milestone: follows gaze,Gaze,0
14051,milestone: cries when you leave,Finding relating to crying,0
14052,milestone: offers a book to read,Tries to communicate with gestures,0
14053,milestone: tries to do what parents do,Finding related to ability to imitate gesture,0
14054,milestone: tries to do what parents do,Child 15 month examination,0
14055,milestone: brings and shows toys,Finding related to ability to interact with others,0
14056,milestone: brings and shows toys,Child 15 month examination,0
14057,milestone: scribbles,Finding related to ability to perform drawing activities,0
14058,milestone: scribbles,Child 15 month examination,0
14059,milestone: drinks with minimal spilling,Finding related to ability to drink,0
14060,milestone: drinks with minimal spilling,Child 15 month examination,0
14061,milestone: names favorite book,Child 18 month examination,0
14062,milestone: names favorite book,Cognitive function observations,0
14063,milestone: laughs in response to others,Child 18 month examination,0
14064,milestone: laughs in response to others,Finding relating to laughing,0
14065,milestone: points to one or more body parts,Child 18 month examination,0
14066,milestone: points to one or more body parts,Able to recognize parts of own body,0
14067,milestone: uses spoon with minimal spilling,Child 18 month examination,0
14068,milestone: uses spoon with minimal spilling,Able to use spoon to feed self,0
14069,milestone: runs,Child 18 month examination,0
14070,milestone: runs,Able to run,0
14071,milestone: mimics parent's activities,Finding related to ability to imitate forms of communication,0
14072,milestone: plays 'pretend',Use of imagination - finding,0
14073,milestone: parallel play (alongside children),Able to participate in games for play,0
14074,milestone: follows 2-step commands,Finding related to ability to comprehend,0
14075,milestone: other people understand half of spoken words,Finding related to ability to use verbal communication,0
14076,milestone: points to 6 body parts,Able to recognize parts of own body,0
14077,milestone: knows correct animal sounds,Able to recognize sounds,0
14078,milestone: can speak multiple sentences,Finding related to ability to use words,0
14079,milestone: most spoken words are understandable,Finding related to ability to use verbal communication,0
14080,milestone: can name a friend,Cognitive function observations,0
14081,milestone: builds tower of 6-8 blocks,Finding related to ability to perform fine motor function,0
14082,milestone: toilet-trained during day,Toilet trained (finding),0
14083,milestone: interacts with peers,Social interaction finding,0
14084,milestone: brushes teeth independently,Able to perform mouthcare activities,0
14085,milestone: able to tie a knot,Finding related to ability to perform hand functions,0
14086,milestone: articulates clearly,Finding related to ability to articulate,0
14087,milestone: counts to 10,Able to count up to 10,0
14088,milestone: is attentive,Finding related to attentiveness,0
14089,nutrition risk assessment: eats healthy food and snacks,Eating finding,0
14090,Mental Health Risk Assessment: increasingly independent,Finding relating to autonomy and empowerment,0
14091,Mental Health Risk Assessment: increasingly responsible,Finding relating to autonomy and empowerment,0
14092,Mental Health Risk Assessment: can manage anger,Able to control anger,0
14093,Mental Health Risk Assessment: displays pre-adolescent behavior,Behavior,0
14094,home risk assessment: does chores at home when asked,Finding relating to showing respect,0
14095,activities risk assessment: gets along well with family and friends,Social interaction finding,0
14096,Mental Health Risk Assessment: has a positive self-image,Finding related to self-esteem,0
14097,Education Risk Assessment: shows interest in school,Level of interest - finding,0
14098,Education Risk Assessment: communicates with teacher,Communication finding,0
14099,activities risk assessment: engages in after-school activities,Able to participate in school activities,0
14100,Wound moist,iv catheter site moist,0
14101,Responds to sound (finding),2-4 week milestones: responds to sound,0
14102,Responds to voice,milestone: turns toward voices,0
14103,Finding of auscultation of abdomen,renal artery bruit heard in right abdomen,0
14104,Able to play,milestone: plays pat-a-cake,0
14105,Able to participate in games for play,milestone: parallel play (alongside children),0
14106,Able to participate in games for play,milestone: plays interactively with other children,0
14107,Able to ride and propel toy,milestone: can ride tricycle,0
14108,iatrogenic esophageal perforation,Iatrogenic Disease,0
14109,Able to manage stairs,milestone: walks up and down stairs,0
14110,Able to raise head,milestone: lifts chin off surface,0
14111,Able to raise head,milestone: lifts head and chest off surface,0
14112,Optic disc normal,primary angle closure without glaucoma damage,0
14113,Able to sit unsupported,milestone: sits independently,0
14114,Finding relating to crying,milestone: cries when you leave,0
14115,Able to push,milestone: uses arms to push chest off surface,0
14116,Laughs spontaneously,milestone: laughs,0
14117,"chest pain sudden, sharp, and tearing",Sharp pain,0
14118,Old healed fracture of bone,x-ray of pelvis: old fracture,0
14119,Old healed fracture of bone,x-ray of lower leg: old fracture,0
14120,Diastolic Murmurs,rasping diastolic interscapular murmur,0
14121,Diastolic Murmurs,pitch of axillary diastolic murmur,0
14122,Diastolic Murmurs,pitch of diastolic interscapular murmur,0
14123,Diastolic Murmurs,low-pitched apical diastolic murmur,0
14124,Diastolic Murmurs,medium-pitched apical diastolic murmur,0
14125,Diastolic Murmurs,high-pitched apical diastolic murmur,0
14126,Diastolic Murmurs,low-pitched axillary diastolic murmur,0
14127,Diastolic Murmurs,medium-pitched axillary diastolic murmur,0
14128,Diastolic Murmurs,high-pitched axillary diastolic murmur,0
14129,Diastolic Murmurs,diastolic interscapular murmur with crescendo pattern,0
14130,Diastolic Murmurs,diastolic interscapular murmur with decrescendo pattern,0
14131,Diastolic Murmurs,diastolic interscapular murmur with crescendo-decrescendo pattern,0
14132,Diastolic Murmurs,diastolic interscapular murmur with presystolic accentuation pattern,0
14133,Diastolic Murmurs,low-pitched diastolic interscapular murmur,0
14134,Diastolic Murmurs,medium-pitched diastolic interscapular murmur,0
14135,Diastolic Murmurs,high-pitched diastolic interscapular murmur,0
14136,Diastolic Murmurs,harsh diastolic interscapular murmur,0
14137,Diastolic Murmurs,musical diastolic interscapular murmur,0
14138,Diastolic Murmurs,blowing diastolic interscapular murmur,0
14139,Diastolic Murmurs,rumbling diastolic interscapular murmur,0
14140,infusion pump status,Infusion Pump,0
14141,infusion pump failing to infuse,Infusion Pump,0
14142,infusion pump needs calibration,Infusion Pump,0
14143,infusion pump wiring frayed,Infusion Pump,0
14144,IV catheter site appearance,Vascular Catheters,0
14145,iv catheter site erythematous,Vascular Catheters,0
14146,iv catheter site swollen,Vascular Catheters,0
14147,iv catheter site tender,Sore to touch,0
14148,iv catheter site moist,Wound moist,0
14149,iv catheter site discharge,Vascular Catheters,0
14150,iv catheter site discharge clear,Vascular Catheters,0
14151,iv catheter site discharge serosanguineous,Vascular Catheters,0
14152,iv catheter site discharge bloody,Vascular Catheters,0
14153,iv catheter site occluded,Vascular Catheters,0
14154,assessment & intervention dementia severity classified mild,Mental health assessment,0
14155,assessment & intervention dementia severity classified moderate,Mental health assessment,0
14156,assessment & intervention dementia severity classified severe,Mental health assessment,0
14157,M0 Stage Finding,malignant neoplasm of breast TNM staging distant metastasis (M) M0,0
14158,M0 Stage Finding,malignant neoplasm of lung TNM staging distant metastasis (M) M0,0
14159,M0 Stage Finding,malignant neoplasm of large intestine TNM staging distant metastasis (M) M0,0
14160,M0 Stage Finding,malignant neoplasm of small intestine TNM staging distant metastasis (M) M0,0
14161,M0 Stage Finding,malignant neoplasm of bladder TNM staging distant metastasis (M) M0,0
14162,M0 Stage Finding,malignant neoplasm of adrenal gland TNM staging distant metastasis (M) M0,0
14163,M0 Stage Finding,malignant neoplasm of nasopharynx TNM staging distant metastasis (M) M0,0
14164,M0 Stage Finding,malignant neoplasm of oropharynx TNM staging distant metastasis (M) M0,0
14165,M0 Stage Finding,malignant neoplasm of pharynx TNM staging distant metastasis (M) M0,0
14166,M0 Stage Finding,malignant neoplasm of soft palate TNM staging distant metastasis (M) M0,0
14167,M0 Stage Finding,malignant neoplasm of uvula TNM staging distant metastasis (M) M0,0
14168,M0 Stage Finding,malignant neoplasm of lip TNM staging distant metastasis (M) M0,0
14169,M0 Stage Finding,malignant neoplasm of tongue TNM staging distant metastasis (M) M0,0
14170,M0 Stage Finding,malignant neoplasm of gingiva TNM staging distant metastasis (M) M0,0
14171,M0 Stage Finding,malignant neoplasm of floor of mouth TNM staging distant metastasis (M) M0,0
14172,M0 Stage Finding,malignant neoplasm of oral cavity TNM staging distant metastasis (M) M0,0
14173,M0 Stage Finding,malignant neoplasm of hard palate TNM staging distant metastasis (M) M0,0
14174,M0 Stage Finding,malignant neoplasm of retromolar area TNM staging distant metastasis (M) M0,0
14175,M0 Stage Finding,malignant neoplasm of parotid TNM staging distant metastasis (M) M0,0
14176,M0 Stage Finding,malignant neoplasm of salivary gland TNM staging distant metastasis (M) M0,0
14177,M0 Stage Finding,malignant neoplasm of hypopharynx TNM staging distant metastasis (M) M0,0
14178,M0 Stage Finding,malignant neoplasm of stomach TNM staging distant metastasis (M) M0,0
14179,M0 Stage Finding,malignant neoplasm of liver TNM staging distant metastasis (M) M0,0
14180,M0 Stage Finding,malignant neoplasm of extrahepatic bile duct TNM staging distant metastasis (M) M0,0
14181,M0 Stage Finding,malignant neoplasm of gallbladder TNM staging distant metastasis (M) M0,0
14182,M0 Stage Finding,malignant melanoma of skin TNM staging distant metastasis (M) M0,0
14183,M0 Stage Finding,malignant neoplasm of cervix TNM staging distant metastasis (M) M0,0
14184,M0 Stage Finding,malignant neoplasm of vulva TNM staging distant metastasis (M) M0,0
14185,M0 Stage Finding,malignant neoplasm of penis TNM staging distant metastasis (M) M0,0
14186,M0 Stage Finding,malignant neoplasm of testis TNM staging distant metastasis (M) M0,0
14187,M0 Stage Finding,malignant neoplasm of prostate TNM staging distant metastasis (M) M0,0
14188,M0 Stage Finding,malignant neoplasm of kidney TNM staging distant metastasis (M) M0,0
14189,M0 Stage Finding,malignant neoplasm of renal pelvis TNM staging distant metastasis (M) M0,0
14190,M0 Stage Finding,malignant neoplasm of ureter TNM staging distant metastasis (M) M0,0
14191,M0 Stage Finding,malignant neoplasm of thyroid TNM staging distant metastasis (M) M0,0
14192,M0 Stage Finding,M0 Stage Finding,0
14193,M0 Stage Finding,malig ovarian neoplasm tnm staging distant metastasis (m) m0,0
14194,thiamphenicol poisoning with undetermined intent,Poisoning of unknown intent,0
14195,cactinomycin poisoning with undetermined intent,Poisoning of unknown intent,0
14196,para-aminosalicylic acid derivative poisoning with undetermined intent,Poisoning of unknown intent,0
14197,androgen poisoning with undetermined intent,Poisoning of unknown intent,0
14198,biguanide poisoning with undetermined intent,Poisoning of unknown intent,0
14199,dextrothyroxine poisoning with undetermined intent,Poisoning of unknown intent,0
14200,thiourea poisoning with undetermined intent,Poisoning of unknown intent,0
14201,thonzylamine poisoning with undetermined intent,Poisoning of unknown intent,0
14202,tripelennamine poisoning with undetermined intent,Poisoning of unknown intent,0
14203,Cytarabine poisoning of undetermined intent,Poisoning of unknown intent,0
14204,hexadimethrine poisoning with undetermined intent,Poisoning of unknown intent,0
14205,acetanilid poisoning with undetermined intent,Poisoning of unknown intent,0
14206,acetophenetidin poisoning with undetermined intent,Poisoning of unknown intent,0
14207,aminophenazone poisoning with undetermined intent,Poisoning of unknown intent,0
14208,paramethadione poisoning with undetermined intent,Poisoning of unknown intent,0
14209,trimethadione poisoning with undetermined intent,Poisoning of unknown intent,0
14210,bromide poisoning with undetermined intent,Poisoning of unknown intent,0
14211,carbromal poisoning with undetermined intent,Poisoning of unknown intent,0
14212,central nervous system muscle-tone depressant poisoning with undetermined intent,Poisoning of unknown intent,0
14213,chlorphenesin poisoning with undetermined intent,Poisoning of unknown intent,0
14214,mephenesin poisoning with undetermined intent,Poisoning of unknown intent,0
14215,methocarbamol poisoning with undetermined intent,Poisoning of unknown intent,0
14216,halogenated derivative poisoning with undetermined intent,Poisoning of unknown intent,0
14217,thiobarbiturate poisoning with undetermined intent,Poisoning of unknown intent,0
14218,spiperone poisoning with undetermined intent,Poisoning of unknown intent,0
14219,hydroxyzine poisoning with undetermined intent,Poisoning of unknown intent,0
14220,psilocin poisoning with undetermined intent,Poisoning of unknown intent,0
14221,lobeline poisoning with undetermined intent,Poisoning of unknown intent,0
14222,quaternary ammonium derivative poisoning with undetermined intent,Poisoning of unknown intent,0
14223,digitalis glycoside poisoning with undetermined intent,Poisoning of unknown intent,0
14224,digitoxin poisoning with undetermined intent,Poisoning of unknown intent,0
14225,strophanthin poisoning with undetermined intent,Poisoning of unknown intent,0
14226,pentamethonium bromide poisoning with undetermined intent,Poisoning of unknown intent,0
14227,cyclandelate poisoning with undetermined intent,Poisoning of unknown intent,0
14228,papaverine poisoning with undetermined intent,Poisoning of unknown intent,0
14229,rauwolfia alkaloid poisoning with undetermined intent,Poisoning of unknown intent,0
14230,sodium morrhuate poisoning with undetermined intent,Poisoning of unknown intent,0
14231,zinc salt poisoning with undetermined intent,Poisoning of unknown intent,0
14232,adrenochrome derivative poisoning with undetermined intent,Poisoning of unknown intent,0
14233,local anti-inflammatory poisoning with undetermined intent,Poisoning of unknown intent,0
14234,keratolytic agent poisoning with undetermined intent,Poisoning of unknown intent,0
14235,keratoplastic agent poisoning with undetermined intent,Poisoning of unknown intent,0
14236,vaginal preparation poisoning with undetermined intent,Poisoning of unknown intent,0
14237,diagnostic agent poisoning with undetermined intent,Poisoning of unknown intent,0
14238,pertussis combination vaccine poisoning with undetermined intent,Poisoning of unknown intent,0
14239,poisoning by denatured alcohol with undetermined intent,Poisoning of unknown intent,0
14240,poisoning by gasoline with undetermined intent,Poisoning of unknown intent,0
14241,poisoning by kerosene with undetermined intent,Poisoning of unknown intent,0
14242,poisoning by petroleum spirits with undetermined intent,Poisoning of unknown intent,0
14243,poisoning by naphtha with undetermined intent,Poisoning of unknown intent,0
14244,poisoning by acetone with undetermined intent,Poisoning of unknown intent,0
14245,poisoning by cresol with undetermined intent,Poisoning of unknown intent,0
14246,poisoning by lye with undetermined intent,Poisoning of unknown intent,0
14247,potassium hydroxide poisoning of undetermined intent,Poisoning of unknown intent,0
14248,poisoning by sodium hydroxide with undetermined intent,Poisoning of unknown intent,0
14249,poisoning by lead dioxide with undetermined intent,Poisoning due to chemical substance,0
14250,poisoning by lead salts with undetermined intent,Poisoning of unknown intent,0
14251,poisoning by lead acetate with undetermined intent,Poisoning due to chemical substance,0
14252,poisoning by tetraethyl lead with undetermined intent,Poisoning of unknown intent,0
14253,poisoning by hydrocyanic acid with undetermined intent,Poisoning of unknown intent,0
14254,poisoning by potassium cyanide with undetermined intent,Poisoning of unknown intent,0
14255,poisoning by sodium cyanide with undetermined intent,Poisoning of unknown intent,0
14256,poisoning by aldrin with undetermined intent,Poisoning of unknown intent,0
14257,poisoning by chlordane with undetermined intent,Poisoning of unknown intent,0
14258,poisoning by dieldrin with undetermined intent,Poisoning of unknown intent,0
14259,poisoning by mycotoxin with undetermined intent,Poisoning of unknown intent,0
14260,fibrosis due to heart valve prosthesis,Heart Valve Prosthesis,0
14261,hemorrhage due to heart valve prosthesis,Heart Valve Prosthesis,0
14262,pain due to heart valve prosthesis,Heart Valve Prosthesis,0
14263,stenosis due to heart valve prosthesis,Heart Valve Prosthesis,0
14264,thrombus due to heart valve prosthesis,Heart Valve Prosthesis,0
14265,poisoning by kerosene insecticides with undetermined intent,Poisoning of unknown intent,0
14266,poisoning by mixtures of fertilizers with herbicides with undetermined intent,Poisoning of unknown intent,0
14267,poisoning by chlorates with undetermined intent,Poisoning of unknown intent,0
14268,poisoning by carbon monoxide from incomplete liquid propane gas combustion with undetermined intent,Poisoning of unknown intent,0
14269,poisoning by acetylene with undetermined intent,Poisoning of unknown intent,0
14270,poisoning by water gas with undetermined intent,Poisoning of unknown intent,0
14271,iatrogenic colonic perforation due to malfunctioning laparoscopic device,Iatrogenic Disease,0
14272,Self-induced termination of pregnancy,self-induced abortion complicated by metabolic disorder,0
14273,Self-induced termination of pregnancy,self-induced abortion with complication,0
14274,Self-induced termination of pregnancy,self-induced abortion complicated by pelvic infection,0
14275,Self-induced termination of pregnancy,self-induced abortion complicated by excessive pelvic hemorrhage,0
14276,Self-induced termination of pregnancy,self-induced abortion complicated by damage to pelvic organs,0
14277,Self-induced termination of pregnancy,self-induced abortion complicated by renal failure,0
14278,Self-induced termination of pregnancy,self-induced abortion complicated by shock,0
14279,Self-induced termination of pregnancy,self-induced abortion complicated by embolism,0
14280,Self-induced termination of pregnancy,complete self-induced abortion,0
14281,Familial Mediterranean Fever,Polyserositis,0
14282,iatrogenic osseointegration failure of dental implant,Complication of implant,0
14283,combined hearing and vision loss with deafness,Deafness symptom,0
14284,combined hearing and vision loss with blindness,Blindness AND/OR vision impairment level,0
14285,Total visual and total hearing impairment,Blindness AND/OR vision impairment level,0
14286,Total visual and total hearing impairment,Deafness symptom,0
14287,Mild non-proliferative diabetic retinopathy,secondary diabetes mellitus with mild nonproliferative diabetic retinopathy,0
14288,Mild non-proliferative diabetic retinopathy,chemical-induced diabetes mellitus with mild nonproliferative diabetic retinopathy,0
14289,Mild non-proliferative diabetic retinopathy,chemical-induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema,0
14290,Mild non-proliferative diabetic retinopathy,type 1 diabetes with mild nonproliferative diabetic retinopathy,0
14291,Mild non-proliferative diabetic retinopathy,type 1 diabetes with mild nonproliferative diabetic retinopathy without macular edema,0
14292,Mild non-proliferative diabetic retinopathy,type 2 diabetes with mild nonproliferative diabetic retinopathy,0
14293,Mild non-proliferative diabetic retinopathy,type 2 diabetes with mild nonproliferative diabetic retinopathy without macular edema,0
14294,Moderate nonproliferative diabetic retinopathy,secondary diabetes mellitus with moderate nonproliferative diabetic retinopathy,0
14295,Moderate nonproliferative diabetic retinopathy,chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy,0
14296,Moderate nonproliferative diabetic retinopathy,chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema,0
14297,Moderate nonproliferative diabetic retinopathy,type 1 diabetes with moderate nonproliferative diabetic retinopathy,0
14298,Moderate nonproliferative diabetic retinopathy,type 1 diabetes with moderate nonproliferative diabetic retinopathy without macular edema,0
14299,Moderate nonproliferative diabetic retinopathy,type 2 diabetes with moderate nonproliferative diabetic retinopathy,0
14300,Moderate nonproliferative diabetic retinopathy,type 2 diabetes with moderate nonproliferative diabetic retinopathy without macular edema,0
14301,Severe nonproliferative diabetic retinopathy,secondary diabetes mellitus with severe nonproliferative diabetic retinopathy,0
14302,Severe nonproliferative diabetic retinopathy,chemical-induced diabetes mellitus with severe nonproliferative diabetic retinopathy,0
14303,Severe nonproliferative diabetic retinopathy,type 1 diabetes with severe nonproliferative diabetic retinopathy,0
14304,Severe nonproliferative diabetic retinopathy,type 1 diabetes with severe nonproliferative diabetic retinopathy without macular edema,0
14305,Severe nonproliferative diabetic retinopathy,type 2 diabetes with severe nonproliferative diabetic retinopathy,0
14306,Severe nonproliferative diabetic retinopathy,type 2 diabetes with severe nonproliferative diabetic retinopathy without macular edema,0
14307,Macular edema due to diabetes mellitus,secondary diabetes mellitus with diabetic retinopathy with macular edema,0
14308,Macular edema due to diabetes mellitus,chemical-induced diabetes mellitus with diabetic retinopathy with macular edema,0
14309,Macular edema due to diabetes mellitus,chemical-induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema,0
14310,Macular edema due to diabetes mellitus,chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema,0
14311,Macular edema due to diabetes mellitus,type 1 diabetes with diabetic retinopathy with macular edema,0
14312,Tumor stage T1b1,malignant neoplasm of vulva TNM staging primary tumor (T) T1B1/IB1,0
14313,Tumor stage T1b2,malignant neoplasm of vulva TNM staging primary tumor (T) T1B2/IB2,0
14314,Neoplasm of uncertain behavior of plasma cells,Neoplastic disease of uncertain behavior,0
14315,Spacer device in use,postsurg acquired absence hip joint w/ antibiotic-impreg cement spacer,0
14316,Spacer device in use,postsurg acquired absence knee joint w/ antibiotic-impreg cement spacer,0
14317,Spacer device in use,postsurg acquired absence joint w/ antibiotic-impregnated cement spacer,0
14318,classic migraine with aura with status migrainosus,Status Migrainosus,0
14319,basilar migraine headache with status migrainosus,Status Migrainosus,0
14320,basilar migraine headache with intractable migraine with status migrainosus,Status Migrainosus,0
14321,basilar migraine headache with intractable migraine with status migrainosus,Refractory migraine,0
14322,retinal migraine headache with intractable migraine,Refractory migraine,0
14323,retinal migraine headache with status migrainosus,Status Migrainosus,0
14324,retinal migraine headache with intractable migraine with status migrainosus,Status Migrainosus,0
14325,retinal migraine headache with intractable migraine with status migrainosus,Refractory migraine,0
14326,infection due to portacath catheter,Cannulation of subcutaneous reservoir,0
14327,overexertion from prolonged static position,Body position,0
14328,overexertion from prolonged holding,Body position,0
14329,overexertion from prolonged sitting,Sitting position,0
14330,overexertion from prolonged standing,Standing position,0
14331,overexertion from prolonged activity,Physical activity finding,0
14332,secondary diabetes mellitus with ketoacidosis,Ketoacidosis,0
14333,secondary diabetes mellitus with hyperosmolarity,Hyperosmolarity,0
14334,secondary diabetes mellitus with neurological manifestations,Nervous system disorder due to diabetes mellitus,0
14335,secondary diabetes mellitus with ophthalmic manifestations,Disorder of eye due to diabetes mellitus,0
14336,secondary diabetes mellitus with peripheral circulatory disorders,Peripheral vascular disorder due to diabetes mellitus,0
14337,secondary diabetes mellitus with renal manifestations,Diabetic Nephropathy,0
14338,secondary diabetes mellitus with complication,Complications of Diabetes Mellitus,0
14339,uncontrolled secondary diabetes mellitus with complication,Complications of Diabetes Mellitus,0
14340,Hypnic Headache,Pain onset during sleep,0
14341,Migraine-triggered seizure,Migraine Disorders,0
14342,classic migraine with typical aura with intractable migraine,Refractory migraine,0
14343,classic migraine with typical aura with status migrainosus,Status Migrainosus,0
14344,classic migraine with typical aura with intractable migraine with status migrainosus,Status Migrainosus,0
14345,classic migraine with typical aura with intractable migraine with status migrainosus,Refractory migraine,0
14346,cyclic vomiting syndrome associated with migraine,Migraine Disorders,0
14347,cyclic vomiting syndrome associated with intractable migraine,Refractory migraine,0
14348,cyclic vomiting syndrome associated with status migrainosus,Status Migrainosus,0
14349,cyclic vomiting syndrome associated with intractable migraine and status migrainosus,Status Migrainosus,0
14350,cyclic vomiting syndrome associated with intractable migraine and status migrainosus,Refractory migraine,0
14351,sporadic hemiplegic migraine headache with intractable migraine,Refractory migraine,0
14352,sporadic hemiplegic migraine headache with status migrainosus,Status Migrainosus,0
14353,sporadic hemiplegic migraine headache with intractable migraine and status migrainosus,Status Migrainosus,0
14354,sporadic hemiplegic migraine headache with intractable migraine and status migrainosus,Refractory migraine,0
14355,poorly differentiated malignant neuroendocrine neoplasm,Poorly differentiated histological grade finding,0
14356,idiopathic refractory anemia,Idiopathic disease,0
14357,sting by sea sponge,Porifera,0
14358,stings by annelid worms,Annelida,0
14359,selective serotonin reuptake inhibitor (SSRI) poisoning of undetermined intent,Poisoning of unknown intent,0
14360,tetracyclic antidepressant poisoning of undetermined intent,Poisoning of unknown intent,0
14361,methylphenidate poisoning of undetermined intent,Poisoning of unknown intent,0
14362,intentional submersion during conventional warfare,War injury,0
14363,war injury by strangulation during conventional warfare,War injury,0
14364,injured by piercing instrument during conventional warfare,War injury,0
14365,injured by blunt object during conventional warfare,War injury,0
14366,secondary neuroendocrine tumor with metastasis to liver,Secondary malignant neoplasm of liver,0
14367,secondary neuroendocrine tumor with metastasis to bone,Secondary malignant neoplasm of bone,0
14368,speech impediment due to brain injury,Traumatic AND/OR non-traumatic brain injury,0
14369,diabetes mellitus secondary with peripheral neuropathy,Diabetic peripheral neuropathy,0
14370,drug toxicity olanzapine intent undetermined,Poisoning of unknown intent,0
14371,poisoning solvents carbon tetrachloride intent undetermined,Poisoning of unknown intent,0
14372,dementia of unknown (axis iii) etiology without behavioral disturbance,Axis III diagnosis,0
14373,dementia of unknown (axis iii) etiology with behavioral disturbance,Axis III diagnosis,0
14374,lambert-eaton syndrome in neoplastic disease,Neoplastic disease,0
14375,novel influenza A with bronchopneumonia,Bronchopneumonia,0
14376,acute respiratory failure post traumatic,Posttraumatic state,0
14377,acute respiratory failure post surgical,Complication of surgical procedure,0
14378,post traumatic acute and chronic respiratory failure,Posttraumatic state,0
14379,post surgical acute and chronic respiratory failure,Complication of surgical procedure,0
14380,digestive system complications due to bariatric procedure,Bariatric operative procedure,0
14381,digestive system complications due to gastric banding procedure,Banding procedure,0
14382,Infection due to gastric band procedure,Banding procedure,0
14383,Infection due to bariatric procedure,Bariatric operative procedure,0
14384,complications of organ transplant stem cells,Hemopoietic stem cell transplant,0
14385,complications of organ transplant stem cells peripheral blood,Peripheral Stem Cell Transplantation,0
14386,complications of organ transplant stem cells umbilical cord,Cord cell transfusion,0
14387,local infection due to central venous catheter,Central venous cannula insertion,0
14388,local infection due to hickman catheter,Open insertion of Hickman central venous catheter,0
14389,local infection due to peripherally inserted central catheter,Insertion of peripherally inserted central catheter,0
14390,local infection due to triple lumen catheter,Catheterization,0
14391,local infection due to umbilical venous catheter,Catheterization of umbilical vein,0
14392,postsurgical state acquired absence of organ joint,Postoperative state,0
14393,postsurgical state acquired absence of hip joint,Postoperative state,0
14394,postsurgical state acquired absence of knee joint,Postoperative state,0
14395,Acquired hemophilia,Acquired coagulation disorder,0
14396,antiphospholipid antibody syndrome with hemorrhagic disorder,Hemorrhage,0
14397,lupus anticoagulant with hemorrhagic disorder,Blood Coagulation Disorders,0
14398,lupus inhibitor with hypercoagulable state,Thrombophilia,0
14399,primary angle closure without glaucoma damage,Optic disc normal,0
14400,interstitial pneumonia lymphoid idiopathic,Idiopathic disease,0
14401,Pulmonary interstitial glycogenosis,Glycogen Storage Disease,0
14402,Complication of cystostomy,Incision of bladder,0
14403,complication of cystostomy infection,Incision of bladder,0
14404,labor onset 37-39 weeks; cesarean section as planned - delivered with postpartum complication,Complication of the puerperium,0
14405,myocardial infarction cardiogenic shock postoperative,Postoperative myocardial infarction,0
14406,shock postoperative septic gram-negative,Postoperative Complications,0
14407,poisoning scouring powders intent undetermined,Poisoning of unknown intent,0
14408,postsurg acquired absence hip joint w/ antibiotic-impreg cement spacer,Postoperative state,0
14409,postsurg acquired absence hip joint w/ antibiotic-impreg cement spacer,Spacer device in use,0
14410,postsurg acquired absence knee joint w/ antibiotic-impreg cement spacer,Postoperative state,0
14411,postsurg acquired absence knee joint w/ antibiotic-impreg cement spacer,Spacer device in use,0
14412,postsurg acquired absence joint w/ antibiotic-impregnated cement spacer,Postoperative state,0
14413,postsurg acquired absence joint w/ antibiotic-impregnated cement spacer,Spacer device in use,0
14414,phacoanaphylactic glaucoma,Phacoanaphylaxis,0
14415,neurocutaneous melanocytosis,Neurocutaneous Syndromes,0
14416,shock postoperative hemorrhagic,Postoperative Complications,0
14417,stent-related vessel entrapment,Vascular stent,0
14418,hemoglobin d thalassemia,Hemoglobin D,0
14419,complication of cystostomy stricture,Incision of bladder,0
14420,secondary diabetes mellitus with diabetic nephropathy,Diabetic Nephropathy,0
14421,secondary diabetes mellitus with diabetic chronic kidney disease,Diabetic Nephropathy,0
14422,secondary diabetes mellitus with diabetic retinopathy,Diabetic Retinopathy,0
14423,secondary diabetes mellitus with diabetic retinopathy with macular edema,Macular edema due to diabetes mellitus,0
14424,secondary diabetes mellitus with mild nonproliferative diabetic retinopathy,Mild non-proliferative diabetic retinopathy,0
14425,secondary diabetes mellitus with moderate nonproliferative diabetic retinopathy,Moderate nonproliferative diabetic retinopathy,0
14426,secondary diabetes mellitus with severe nonproliferative diabetic retinopathy,Severe nonproliferative diabetic retinopathy,0
14427,secondary diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,Severe nonproliferative diabetic retinopathy with clinically significant macular edema,0
14428,secondary diabetes mellitus with proliferative diabetic retinopathy,Proliferative diabetic retinopathy,0
14429,secondary diabetes mellitus with proliferative diabetic retinopathy with macular edema,Proliferative diabetic retinopathy - high risk with clinically significant macular edema,0
14430,secondary diabetes mellitus with proliferative diabetic retinopathy with macular edema,Non-high-risk proliferative diabetic retinopathy with clinically significant macular edema,0
14431,secondary diabetes mellitus with diabetic cataract,Cataract due to diabetes mellitus,0
14432,secondary diabetes mellitus with diabetic neuropathy,Diabetic Neuropathies,0
14433,secondary diabetes mellitus with diabetic mononeuropathy,Diabetic Mononeuropathy,0
14434,diabetes mellitus secondary with diabetic polyneuropathy,Diabetic Polyneuropathies,0
14435,diabetes mellitus secondary with diabetic autonomic neuropathy,Diabetic Autonomic Neuropathy,0
14436,diabetes mellitus secondary with diabetic amyotrophy,Diabetic lumbosacral radiculoplexus neuropathy,0
14437,diabetes mellitus secondary with diabetic peripheral angiopathy,Diabetic peripheral angiopathy,0
14438,secondary diabetes mellitus with diabetic peripheral angiopathy with gangrene,Diabetic peripheral angiopathy,0
14439,diabetes mellitus secondary with diabetic arthropathy,Arthropathy associated with an endocrine AND/OR metabolic disorder,0
14440,secondary diabetes mellitus with diabetic neuropathic arthropathy,Neuropathic arthropathy due to diabetes mellitus,0
14441,diabetes mellitus secondary with dermatological manifestations,Diabetic dermopathy,0
14442,diabetes mellitus secondary with skin ulcer,Diabetic skin ulcer,0
14443,diabetes mellitus secondary with skin ulcer foot,Diabetic foot ulcer,0
14444,diabetes mellitus secondary with oral cavity manifestations,Disorder of oral soft tissues,0
14445,diabetes mellitus secondary with periodontal disease,Periodontal Diseases,0
14446,diabetes mellitus secondary with hyperglycemia,Hyperglycemia,0
14447,diabetes mellitus chemical-induced with hyperosmolarity,Hyperosmolarity,0
14448,chemical-induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma,Non-ketotic non-hyperosmolar coma associated with diabetes mellitus,0
14449,chemical-induced diabetes mellitus with ketoacidosis,Diabetic Ketoacidosis,0
14450,chemical-induced diabetes mellitus with ketoacidosis with coma,Diabetic coma with ketoacidosis,0
14451,chemical-induced diabetes mellitus with renal manifestations,Diabetic Nephropathy,0
14452,chemical-induced diabetes mellitus with diabetic nephropathy,Diabetic Nephropathy,0
14453,chemical-induced diabetes mellitus with diabetic chronic kidney disease,Diabetic Nephropathy,0
14454,chemical-induced diabetes mellitus with ophthalmic manifestations,Disorder of eye due to diabetes mellitus,0
14455,chemical-induced diabetes mellitus with diabetic retinopathy,Diabetic Retinopathy,0
14456,chemical-induced diabetes mellitus with diabetic retinopathy with macular edema,Macular edema due to diabetes mellitus,0
14457,chemical-induced diabetes mellitus with mild nonproliferative diabetic retinopathy,Mild non-proliferative diabetic retinopathy,0
14458,chemical-induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema,Mild non-proliferative diabetic retinopathy,0
14459,chemical-induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema,Macular edema due to diabetes mellitus,0
14460,chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy,Moderate nonproliferative diabetic retinopathy,0
14461,chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema,Moderate nonproliferative diabetic retinopathy,0
14462,chemical-induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema,Macular edema due to diabetes mellitus,0
14463,chemical-induced diabetes mellitus with severe nonproliferative diabetic retinopathy,Severe nonproliferative diabetic retinopathy,0
14464,chemical-induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,Severe nonproliferative diabetic retinopathy with clinically significant macular edema,0
14465,chemical-induced diabetes mellitus with proliferative diabetic retinopathy,Proliferative diabetic retinopathy,0
14466,chemical-induced diabetes mellitus with proliferative diabetic retinopathy with macular edema,Proliferative diabetic retinopathy - high risk with clinically significant macular edema,0
14467,chemical-induced diabetes mellitus with proliferative diabetic retinopathy with macular edema,Non-high-risk proliferative diabetic retinopathy with clinically significant macular edema,0
14468,chemical-induced diabetes mellitus with diabetic cataract,Cataract due to diabetes mellitus,0
14469,chemical-induced diabetes mellitus with neurological manifestations,Nervous system disorder due to diabetes mellitus,0
14470,chemical-induced diabetes mellitus with diabetic neuropathy,Diabetic Neuropathies,0
14471,chemical-induced diabetes mellitus with diabetic mononeuropathy,Diabetic Mononeuropathy,0
14472,chemical-induced diabetes mellitus with diabetic polyneuropathy,Diabetic Polyneuropathies,0
14473,chemical-induced diabetes mellitus with peripheral neuropathy,Diabetic peripheral neuropathy,0
14474,chemical-induced diabetes mellitus with diabetic autonomic neuropathy,Diabetic Autonomic Neuropathy,0
14475,chemical-induced diabetes mellitus with diabetic amyotrophy,Diabetic lumbosacral radiculoplexus neuropathy,0
14476,chemical-induced diabetes mellitus with peripheral circulatory disorders,Peripheral vascular disorder due to diabetes mellitus,0
14477,chemical-induced diabetes mellitus with diabetic peripheral angiopathy,Diabetic peripheral angiopathy,0
14478,chemical-induced diabetes mellitus with complication,Complications of Diabetes Mellitus,0
14479,chemical-induced diabetes mellitus with diabetic arthropathy,Arthropathy associated with an endocrine AND/OR metabolic disorder,0
14480,chemical-induced diabetes mellitus with diabetic neuropathic arthropathy,Neuropathic arthropathy due to diabetes mellitus,0
14481,chemical-induced diabetes mellitus with hyperglycemia,Hyperglycemia,0
14482,chemical-induced diabetes mellitus with dermatological manifestations,Diabetic dermopathy,0
14483,chemical-induced diabetes mellitus with skin ulcer,Diabetic skin ulcer,0
14484,chemical-induced diabetes mellitus with skin ulcer on foot,Diabetic foot ulcer,0
14485,chemical-induced diabetes mellitus with oral cavity manifestations,Disorder of oral soft tissues,0
14486,chemical-induced diabetes mellitus with periodontal disease,Periodontal Diseases,0
14487,chemical-induced diabetes mellitus with hypoglycemia,Hypoglycemic state due to diabetes mellitus,0
14488,chemical-induced diabetes mellitus with hypoglycemia with coma,Hypoglycemic coma in diabetes mellitus,0
14489,type 1 diabetes with diabetic retinopathy,Diabetic Retinopathy,0
14490,type 1 diabetes with diabetic retinopathy with macular edema,Macular edema due to diabetes mellitus,0
14491,type 1 diabetes with ketoacidosis without coma,"Diabetes Mellitus, Insulin-Dependent",0
14492,type 1 diabetes with diabetic retinopathy without macular edema,Diabetic Retinopathy,0
14493,type 1 diabetes with mild nonproliferative diabetic retinopathy,Mild non-proliferative diabetic retinopathy,0
14494,type 1 diabetes with moderate nonproliferative diabetic retinopathy,Moderate nonproliferative diabetic retinopathy,0
14495,type 1 diabetes with severe nonproliferative diabetic retinopathy,Severe nonproliferative diabetic retinopathy,0
14496,type 1 diabetes with severe nonproliferative diabetic retinopathy with macular edema,Severe nonproliferative diabetic retinopathy with clinically significant macular edema,0
14497,type 1 diabetes with proliferative diabetic retinopathy,Proliferative diabetic retinopathy,0
14498,type 1 diabetes with proliferative diabetic retinopathy with macular edema,Proliferative diabetic retinopathy - high risk with clinically significant macular edema,0
14499,type 1 diabetes with proliferative diabetic retinopathy with macular edema,Non-high-risk proliferative diabetic retinopathy with clinically significant macular edema,0
14500,type 1 diabetes with diabetic cataract,Cataract due to diabetes mellitus,0
14501,type 1 diabetes with mild nonproliferative diabetic retinopathy without macular edema,Mild non-proliferative diabetic retinopathy,0
14502,type 1 diabetes with moderate nonproliferative diabetic retinopathy without macular edema,Moderate nonproliferative diabetic retinopathy,0
14503,type 1 diabetes with severe nonproliferative diabetic retinopathy without macular edema,Severe nonproliferative diabetic retinopathy,0
14504,type 1 diabetes with proliferative diabetic retinopathy without macular edema,Proliferative diabetic retinopathy,0
14505,type 1 diabetes with diabetic neuropathy,Diabetic Neuropathies,0
14506,type 1 diabetes with diabetic mononeuropathy,Diabetic Mononeuropathy,0
14507,type 1 diabetes with diabetic polyneuropathy,Diabetic Polyneuropathies,0
14508,type 1 diabetes with diabetic amyotrophy,Diabetic lumbosacral radiculoplexus neuropathy,0
14509,type 1 diabetes with diabetic peripheral angiopathy,Diabetic peripheral angiopathy,0
14510,type 1 diabetes with diabetic peripheral angiopathy with gangrene,Diabetic peripheral angiopathy,0
14511,type 1 diabetes with diabetic peripheral angiopathy without gangrene,Diabetic peripheral angiopathy,0
14512,diabetes mellitus type 1 with hyperglycemia,Hyperglycemia,0
14513,diabetes mellitus with dermatological manifestations type 1,"Diabetes Mellitus, Insulin-Dependent",0
14514,diabetes mellitus with dermatological manifestations type 2,"Diabetes Mellitus, Non-Insulin-Dependent",0
14515,type 1 diabetes mellitus with skin ulcer,"Diabetes Mellitus, Insulin-Dependent",0
14516,diabetes mellitus with skin ulcer type 2,"Diabetes Mellitus, Non-Insulin-Dependent",0
14517,diabetes mellitus with oral cavity manifestations,Diabetes Mellitus,0
14518,type 1 diabetes mellitus with oral cavity manifestations,Disorder of oral soft tissues,0
14519,type 2 diabetes mellitus with oral cavity manifestations,Disorder of oral soft tissues,0
14520,diabetes mellitus with periodontal disease,Diabetes Mellitus,0
14521,Type 1 diabetes mellitus with periodontal disease,Periodontal Diseases,0
14522,Diabetes mellitus type 2 with periodontal disease,Periodontal Diseases,0
14523,Type 1 diabetes mellitus with hypoglycemia,Hypoglycemic state due to diabetes mellitus,0
14524,diabetes mellitus type 1 with hypoglycemia without coma,Hypoglycemic state due to diabetes mellitus,0
14525,type 2 diabetes with diabetic retinopathy without macular edema,Diabetic Retinopathy,0
14526,type 2 diabetes with mild nonproliferative diabetic retinopathy,Mild non-proliferative diabetic retinopathy,0
14527,type 2 diabetes with mild nonproliferative diabetic retinopathy without macular edema,Mild non-proliferative diabetic retinopathy,0
14528,type 2 diabetes with moderate nonproliferative diabetic retinopathy,Moderate nonproliferative diabetic retinopathy,0
14529,type 2 diabetes with moderate nonproliferative diabetic retinopathy without macular edema,Moderate nonproliferative diabetic retinopathy,0
14530,type 2 diabetes with severe nonproliferative diabetic retinopathy,Severe nonproliferative diabetic retinopathy,0
14531,type 2 diabetes with severe nonproliferative diabetic retinopathy with macular edema,Severe nonproliferative diabetic retinopathy with clinically significant macular edema,0
14532,type 2 diabetes with severe nonproliferative diabetic retinopathy without macular edema,Severe nonproliferative diabetic retinopathy,0
14533,type 2 diabetes with proliferative diabetic retinopathy,Proliferative diabetic retinopathy,0
14534,type 2 diabetes with diabetic retinopathy proliferative with macular edema,Proliferative diabetic retinopathy - high risk with clinically significant macular edema,0
14535,type 2 diabetes with diabetic retinopathy proliferative with macular edema,Non-high-risk proliferative diabetic retinopathy with clinically significant macular edema,0
14536,type 2 diabetes with proliferative diabetic retinopathy without macular edema,Proliferative diabetic retinopathy,0
14537,type 2 diabetes with diabetic mononeuropathy,Diabetic Mononeuropathy,0
14538,type 2 diabetes with diabetic polyneuropathy,Diabetic Polyneuropathies,0
14539,type 2 diabetes with diabetic autonomic neuropathy,Diabetic Autonomic Neuropathy,0
14540,type 2 diabetes with diabetic amyotrophy,Diabetic lumbosacral radiculoplexus neuropathy,0
14541,type 2 diabetes with diabetic peripheral angiopathy,Diabetic peripheral angiopathy,0
14542,type 2 diabetes with diabetic peripheral angiopathy with gangrene,Diabetic peripheral angiopathy,0
14543,type 2 diabetes with diabetic peripheral angiopathy without gangrene,Diabetic peripheral angiopathy,0
14544,diabetes mellitus type 2 with hyperglycemia,Hyperglycemia,0
14545,Type 2 diabetes mellitus with hypoglycemia,Hypoglycemic state due to diabetes mellitus,0
14546,Type 2 diabetes mellitus with hypoglycemia without coma,Hypoglycemic state due to diabetes mellitus,0
14547,diabetes mellitus with diabetic arthropathy,Diabetes Mellitus,0
14548,diabetes mellitus with hyperglycemia,Diabetes Mellitus,0
14549,Symptomatic premature menopause,Menopausal symptom,0
14550,Asymptomatic premature menopause,Asymptomatic,0
14551,Vitamin A deficiency with night blindness,Nyctalopia,0
14552,Morbid obesity,Excessive dietary caloric intake,0
14553,accidental poisoning by vitamin B6,Accidental poisoning NOS,0
14554,poisoning from vitamin B6 due to self-inflicted overdose,Self-administered poisoning,0
14555,intentional poisoning by vitamin B6,Intentional poisoning,0
14556,poisoning from vitamin B6 due to undetermined intent,Poisoning of unknown intent,0
14557,Adolescent X-linked adrenoleukodystrophy,Adolescence,0
14558,Born in China,preferred language Chinese,0
14559,Tumor stage TX,Tumor stage TX,0
14560,T0 stage,T0 stage,0
14561,Tumor stage Tis,Tumor stage Tis,0
14562,Tumor stage T1,Tumor stage T1,0
14563,Tumor stage T2,Tumor stage T2,0
14564,Tumor stage T2b,Tumor stage T2b,0
14565,Tumor stage T3,Tumor stage T3,0
14566,Born in Hungary,preferred language Hungarian,0
14567,Tumor stage T4,Tumor stage T4,0
14568,Tumor stage T4a,Tumor stage T4a,0
14569,Tumor stage T4b,Tumor stage T4b,0
14570,NX Stage Finding,NX Stage Finding,0
14571,Node stage N0,Node stage N0,0
14572,N1 category,N1 category,0
14573,N2 category,N2 category,0
14574,N3 category,N3 category,0
14575,Metastasis stage MX,Metastasis stage MX,0
14576,M0 Stage Finding,M0 Stage Finding,0
14577,Metastasis stage M1,Metastasis stage M1,0
14578,Born in Laos,preferred language Laotian,0
14579,malig neoplasm tnm staging primary tumor (t) t1a,Tumor stage T1a,0
14580,malig neoplasm tnm staging primary tumor (t) t1b,Tumor stage T1b,0
14581,malig ovarian neoplasm tnm staging distant metastasis (m) m0,M0 Stage Finding,0
14582,Systolic Murmurs,rasping systolic interscapular region,0
14583,Systolic Murmurs,vibratory systolic interscapular region,0
14584,Systolic Murmurs,pitch of apical systolic murmur,0
14585,Systolic Murmurs,pitch of axillary systolic murmur,0
14586,Systolic Murmurs,quality of systolic interscapular murmur,0
14587,Systolic Murmurs,pitch of systolic interscapular murmur,0
14588,Systolic Murmurs,low-pitched apical systolic murmur,0
14589,Systolic Murmurs,medium-pitched apical systolic murmur,0
14590,Systolic Murmurs,high-pitched apical systolic murmur,0
14591,Systolic Murmurs,low-pitched axillary systolic murmur,0
14592,Systolic Murmurs,medium-pitched axillary systolic murmur,0
14593,Systolic Murmurs,high-pitched axillary systolic murmur,0
14594,Systolic Murmurs,grade I systolic interscapular murmur,0
14595,Systolic Murmurs,grade II systolic interscapular murmur,0
14596,Systolic Murmurs,grade III systolic interscapular murmur,0
14597,Systolic Murmurs,grade IV systolic interscapular murmur,0
14598,Systolic Murmurs,grade V systolic interscapular murmur,0
14599,Systolic Murmurs,grade VI systolic interscapular murmur,0
14600,Systolic Murmurs,murmur interscapular systolic constant,0
14601,Systolic Murmurs,systolic interscapular murmur with crescendo pattern,0
14602,Systolic Murmurs,systolic interscapular murmur with decrescendo pattern,0
14603,Systolic Murmurs,systolic interscapular murmur with crescendo-decrescendo pattern,0
14604,Systolic Murmurs,low-pitched systolic interscapular murmur,0
14605,Systolic Murmurs,medium-pitched systolic interscapular murmur,0
14606,Systolic Murmurs,high-pitched systolic interscapular murmur,0
14607,Systolic Murmurs,harsh systolic interscapular region,0
14608,Systolic Murmurs,musical systolic interscapular region,0
14609,Systolic Murmurs,blowing systolic interscapular region,0
14610,Systolic Murmurs,rumbling systolic interscapular region,0
14611,chest pain made worse by body movement,Movement aggravates symptom,0
14612,targeted genetic analysis deleterious mutation homozygous,Homozygote,0
14613,genetic sequence analysis deleterious mutation homozygous,Homozygote,0
14614,CSGE deleterious mutation detected homozygous,Homozygote,0
14615,DGGE deleterious mutation detected homozygous,Homozygote,0
14616,protein truncation assay deleterious mutation homozygous,Homozygote,0
14617,Southern blot analysis deleterious mutation homozygous,Homozygote,0
14618,Northern blot analysis deleterious mutation homozygous,Homozygote,0
14619,chest pain made worse by bending over,Movement aggravates symptom,0
14620,chest pain made worse by swallowing,Symptom aggravating factors,0
14621,Premature Cardiac Complex,3-lead electrocardiogram rhythm strip: sinus rhythm with ectopic beats,0
14622,Premature Cardiac Complex,3-lead electrocardiogram rhythm strip: atrial flutter with ectopic beats,0
14623,Sitting position,overexertion from prolonged sitting,0
14624,Optic Disk Drusen,choroidal nevus of right eye with drusen,0
14625,Optic Disk Drusen,choroidal nevus of left eye with drusen,0
14626,chest pain relieved by nitroglycerin,Pain relief by medication,0
14627,chest pain relieved by antacids,Pain relief by antacid,0
14628,chest pain relieved by sitting up,Pain relief by sitting up,0
14629,iatrogenic male infertility,Iatrogenic Disease,0
14630,iatrogenic colonic perforation,Iatrogenic Disease,0
14631,self-induced abortion complicated by pelvic infection,Self-induced termination of pregnancy,0
14632,self-induced abortion complicated by excessive pelvic hemorrhage,Self-induced termination of pregnancy,0
14633,Blinking,automatism blinking eyelids,0
14634,effusive pericarditis,Pericardial effusion,0
14635,Vascular stent,stent-related vessel entrapment,0
14636,Prosthetic voice box,artificial; larynx present (finding),0
14637,Peritoneal dialysis catheter,visit for: fitting and adjustment of a peritoneal dialysis catheter,0
14638,Self-Help Devices,using toilet with hand bar can be done without assistance,0
14639,Self-administered poisoning,poisoning from vitamin B6 due to self-inflicted overdose,0
14640,Finding related to ability to drink,milestone: drinks with minimal spilling,0
14641,Finding related to ability to move,milestone: symmetric movement,0
14642,Finding related to ability to move limb,milestone: extremities move equally,0
14643,Finding related to ability to move hand,milestone: rakes small objects,0
14644,Finding related to ability to move hand,milestone: brings hands together,0
14645,Finding related to ability to move hand,milestone: waves bye-bye,0
14646,Finding related to ability to perform fine motor function,milestone: stacks two blocks,0
14647,Finding related to ability to perform fine motor function,milestone: builds tower of 6-8 blocks,0
14648,Finding related to ability to perform fine motor function,milestone: stacks 3-4 blocks,0
14649,Finding related to ability to perform fine motor function,milestone: dumps raisins from bottle,0
14650,Finding related to ability to perform fine motor function,milestone: stacks 5 or more blocks,0
14651,Finding related to ability to perform hand functions,milestone: able to tie a knot,0
14652,Finding related to ability to articulate,milestone: articulates clearly,0
14653,Finding related to ability to communicate,milestone: different cry for different needs,0
14654,Finding related to ability to use verbal communication,milestone: other people understand half of spoken words,0
14655,Finding related to ability to use verbal communication,milestone: most spoken words are understandable,0
14656,Finding related to ability to use words,milestone: vocabulary of 20 words or more,0
14657,Finding related to ability to use words,milestone: vocabulary of 50 words or more,0
14658,Finding related to ability to use words,milestone: vocabulary of ___ words,0
14659,Finding related to ability to use words,milestone: can speak multiple sentences,0
14660,Finding related to ability to use words,milestone: combines two different words,0
14661,Finding related to ability to use words,milestone: vocabulary of 7-20 words,0
14662,Finding related to ability to use words,milestone: uses prepositions,0
14663,Finding related to ability to use words,milestone: uses pronouns,0
14664,Finding related to ability to direct attention,milestone: elicits attention,0
14665,Finding related to ability to imitate forms of communication,milestone: mimics parent's activities,0
14666,Finding related to ability to imitate forms of communication,milestone: imitates simple daily tasks,0
14667,Finding related to ability to imitate forms of communication,milestone: imitates a vertical line,0
14668,Finding related to ability to imitate gesture,milestone: tries to do what parents do,0
14669,Finding related to ability to perform drawing activities,milestone: scribbles,0
14670,Finding related to ability to perform drawing activities,milestone: colors with crayons,0
14671,Thought process - finding,milestone: can distinguish fantasy from reality,0
14672,Use of imagination - finding,milestone: plays make-believe,0
14673,Use of imagination - finding,milestone: plays 'pretend',0
14674,Finding related to ability to play,milestone: symbolic play,0
14675,Education and/or schooling finding,Education Risk Assessment: completes school work,0
14676,Educational achievement - finding,Education Risk Assessment: reading and doing math at grade level,0
14677,Level of interest - finding,Education Risk Assessment: shows interest in school,0
14678,Finding related to ability to recognize objects,milestone: names an animal in a picture,0
14679,Finding related to ability to recognize familiar people,milestone: looks at parents,0
14680,Finding related to self-esteem,Mental Health Risk Assessment: has a positive self-image,0
14681,Oral habits - finding,milestone: puts objects in mouth,0
14682,Interpretations of behavior finding,Mental Health Risk Assessment: appropriate behavior at home,0
14683,Interpretations of behavior finding,Mental Health Risk Assessment: appropriate behavior at school,0
14684,Interpretations of behavior finding,Mental Health Risk Assessment: appropriate behavior when playing with friends,0
14685,Finding related to ability to interact with others,milestone: seeks parents for comfort,0
14686,Finding related to ability to interact with others,milestone: brings and shows toys,0
14687,Finding related to ability to interact with others,milestone: waves bye-bye,0
14688,Finding related to ability to interact with others,milestone: rolls a ball back to examiner,0
14689,Eye movement - finding,milestone: visual track 180 degrees,0
14690,Form of hand - finding,milestone: hands open 50% of the time,0
14691,Finding related to ability to walk,milestone: walks holding onto furniture,0
14692,Finding related to ability to walk up stairs,milestone: alternates feet walking up stairs,0
14693,M1 (IVB): Distant metastasis,malignant neoplasm of cervix TNM staging primary tumor (T) M1/IVb,0
14694,Bone remodeling,x-ray of pelvis: fracture pathologic bony remodeling,0
14695,Diabetic foot ulcer,diabetes mellitus secondary with skin ulcer foot,0
14696,Diabetic foot ulcer,chemical-induced diabetes mellitus with skin ulcer on foot,0
14697,allergic urticaria due to foreign body,Foreign Bodies,0
14698,Poorly differentiated histological grade finding,poorly differentiated malignant neuroendocrine neoplasm,0
14699,Cognitive function observations,milestone: listens to a story,0
14700,Cognitive function observations,milestone: names favorite book,0
14701,Cognitive function observations,milestone: can name a friend,0
14702,Cognitive function observations,milestone: imitates simple daily tasks,0
14703,Pericardial effusion,effusive pericarditis,0
14704,self-induced abortion complicated by damage to pelvic organs,Self-induced termination of pregnancy,0
14705,self-induced abortion complicated by renal failure,Self-induced termination of pregnancy,0
14706,self-induced abortion complicated by shock,Self-induced termination of pregnancy,0
14707,self-induced abortion complicated by embolism,Self-induced termination of pregnancy,0
14708,Migraine Disorders,Migraine-triggered seizure,0
14709,Migraine Disorders,cyclic vomiting syndrome associated with migraine,0
14710,Posttraumatic state,acute respiratory failure post traumatic,0
14711,Posttraumatic state,post traumatic acute and chronic respiratory failure,0
14712,iatrogenic pulmonary embolism,Iatrogenic Disease,0
14713,iatrogenic pulmonary infarction,Iatrogenic Disease,0
14714,Finding related to ability to comprehend,milestone: follows 2-step commands,0
14715,Finding related to ability to comprehend,"milestone: knows name, age, and sex",0
14716,Finding related to ability to comprehend,"milestone: comprehends cold, hungry, and tired",0
14717,Metastasis category finding,malignant melanoma of skin TNM staging distant metastasis (M),0
14718,Node category finding,malignant neoplasm of vulva TNM staging regional lymph nodes (N),0
14719,Postoperative Complications,postoperative iatrogenic pneumothorax,0
14720,Postoperative Complications,shock postoperative septic gram-negative,0
14721,Postoperative Complications,shock postoperative hemorrhagic,0
14722,oncologic disorders,Tumor stage T1,0
14723,oncologic disorders,T0 stage,0
14724,Redness,Red rash,0
14725,Redness,red skin rash blanches with pressure,0
14726,squamous cell carcinoma of lung with metastasis to mediastinal lymph nodes,Squamous cell carcinoma of lung,0
14727,malignant neoplasm of small intestine metastatic to regional lymph nodes,Secondary malignant neoplasm of intestinal lymph nodes,0
14728,malignant neoplasm of small intestine metastatic to liver,Secondary malignant neoplasm of liver,0
14729,Diabetic lumbosacral radiculoplexus neuropathy,diabetes mellitus secondary with diabetic amyotrophy,0
14730,Diabetic lumbosacral radiculoplexus neuropathy,chemical-induced diabetes mellitus with diabetic amyotrophy,0
14731,Diabetic lumbosacral radiculoplexus neuropathy,type 1 diabetes with diabetic amyotrophy,0
14732,Diabetic lumbosacral radiculoplexus neuropathy,type 2 diabetes with diabetic amyotrophy,0
14733,Mental health assessment,assessment & intervention dementia severity classified mild,0
14734,Mental health assessment,assessment & intervention dementia severity classified moderate,0
14735,Mental health assessment,assessment & intervention dementia severity classified severe,0
14736,Bronchopneumonia,novel influenza A with bronchopneumonia,0
14737,Arthropathy associated with an endocrine AND/OR metabolic disorder,diabetes mellitus secondary with diabetic arthropathy,0
14738,Arthropathy associated with an endocrine AND/OR metabolic disorder,chemical-induced diabetes mellitus with diabetic arthropathy,0
14739,Aseptic Necrosis of Bone,Gaucher disease type I with osteonecrosis,0
14740,Arthropathy,Reiter Syndrome,0
14741,Severe nonproliferative diabetic retinopathy with clinically significant macular edema,secondary diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,0
14742,Severe nonproliferative diabetic retinopathy with clinically significant macular edema,chemical-induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,0
14743,Severe nonproliferative diabetic retinopathy with clinically significant macular edema,type 1 diabetes with severe nonproliferative diabetic retinopathy with macular edema,0
14744,Severe nonproliferative diabetic retinopathy with clinically significant macular edema,type 2 diabetes with severe nonproliferative diabetic retinopathy with macular edema,0
14745,Proliferative diabetic retinopathy - high risk with clinically significant macular edema,secondary diabetes mellitus with proliferative diabetic retinopathy with macular edema,0
14746,Proliferative diabetic retinopathy - high risk with clinically significant macular edema,chemical-induced diabetes mellitus with proliferative diabetic retinopathy with macular edema,0
14747,Proliferative diabetic retinopathy - high risk with clinically significant macular edema,type 1 diabetes with proliferative diabetic retinopathy with macular edema,0
14748,Proliferative diabetic retinopathy - high risk with clinically significant macular edema,type 2 diabetes with diabetic retinopathy proliferative with macular edema,0
14749,Non-high-risk proliferative diabetic retinopathy with clinically significant macular edema,secondary diabetes mellitus with proliferative diabetic retinopathy with macular edema,0
14750,Non-high-risk proliferative diabetic retinopathy with clinically significant macular edema,chemical-induced diabetes mellitus with proliferative diabetic retinopathy with macular edema,0
14751,Non-high-risk proliferative diabetic retinopathy with clinically significant macular edema,type 1 diabetes with proliferative diabetic retinopathy with macular edema,0
14752,Non-high-risk proliferative diabetic retinopathy with clinically significant macular edema,type 2 diabetes with diabetic retinopathy proliferative with macular edema,0
14753,Incision of bladder,Complication of cystostomy,0
14754,Incision of bladder,complication of cystostomy infection,0
14755,Incision of bladder,complication of cystostomy stricture,0
14756,Finding related to attentiveness,milestone: is attentive,0
14757,Intentional poisoning,intentional poisoning by vitamin B6,0
14758,Child 15 month examination,15-month milestones,0
14759,Child 15 month examination,milestone: uses words to communicate,0
14760,Child 15 month examination,milestone: vocabulary of 3-6 words,0
14761,Child 15 month examination,milestone: understands and follows simple commands,0
14762,Child 15 month examination,"milestone: walks well, stoops, and climbs stairs",0
14763,Child 15 month examination,milestone: listens to a story,0
14764,Child 15 month examination,milestone: stacks two blocks,0
14765,Child 15 month examination,milestone: tries to do what parents do,0
14766,Child 15 month examination,milestone: brings and shows toys,0
14767,Child 15 month examination,milestone: scribbles,0
14768,Child 15 month examination,milestone: drinks with minimal spilling,0
14769,Disorder of oral soft tissues,diabetes mellitus secondary with oral cavity manifestations,0
14770,Disorder of oral soft tissues,chemical-induced diabetes mellitus with oral cavity manifestations,0
14771,Disorder of oral soft tissues,type 1 diabetes mellitus with oral cavity manifestations,0
14772,Disorder of oral soft tissues,type 2 diabetes mellitus with oral cavity manifestations,0
14773,abdominal trauma during pregnancy,Patient currently pregnant,0
14774,Idiopathic disease,idiopathic refractory anemia,0
14775,Idiopathic disease,interstitial pneumonia lymphoid idiopathic,0
14776,Diabetic Ketoacidosis,chemical-induced diabetes mellitus with ketoacidosis,0
14777,Annelida,stings by annelid worms,0
14778,Hypoglycemic coma in diabetes mellitus,chemical-induced diabetes mellitus with hypoglycemia with coma,0
14779,Peripheral vascular disorder due to diabetes mellitus,secondary diabetes mellitus with peripheral circulatory disorders,0
14780,Peripheral vascular disorder due to diabetes mellitus,chemical-induced diabetes mellitus with peripheral circulatory disorders,0
14781,Non-ketotic non-hyperosmolar coma associated with diabetes mellitus,chemical-induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma,0
14782,Nervous system disorder due to diabetes mellitus,secondary diabetes mellitus with neurological manifestations,0
14783,Nervous system disorder due to diabetes mellitus,chemical-induced diabetes mellitus with neurological manifestations,0
14784,Diabetic skin ulcer,diabetes mellitus secondary with skin ulcer,0
14785,Diabetic skin ulcer,chemical-induced diabetes mellitus with skin ulcer,0
14786,Able to spontaneously say one or two words,milestone: says mama or dada specifically,0
14787,Chronic peripheral venous hypertension,postphlebitic syndrome with chronic venous hypertension,0
14788,Tries to communicate with gestures,milestone: offers a book to read,0
14789,Refractory migraine,basilar migraine headache with intractable migraine with status migrainosus,0
14790,Refractory migraine,retinal migraine headache with intractable migraine,0
14791,Refractory migraine,retinal migraine headache with intractable migraine with status migrainosus,0
14792,Refractory migraine,classic migraine with typical aura with intractable migraine,0
14793,Refractory migraine,classic migraine with typical aura with intractable migraine with status migrainosus,0
14794,Refractory migraine,cyclic vomiting syndrome associated with intractable migraine,0
14795,Refractory migraine,cyclic vomiting syndrome associated with intractable migraine and status migrainosus,0
14796,Refractory migraine,sporadic hemiplegic migraine headache with intractable migraine,0
14797,Refractory migraine,sporadic hemiplegic migraine headache with intractable migraine and status migrainosus,0
14798,Able to spontaneously say three or more words,milestone: vocabulary of 3-6 words,0
14799,Able to spontaneously say three or more words,"milestone: says mama, dada, and 3 additional words",0
14800,Diabetic peripheral neuropathy,diabetes mellitus secondary with peripheral neuropathy,0
14801,Diabetic peripheral neuropathy,chemical-induced diabetes mellitus with peripheral neuropathy,0
14802,Speech and language development finding,milestone: vocabulary,0
14803,Insertion of peripherally inserted central catheter,local infection due to peripherally inserted central catheter,0
14804,Catheterization of umbilical vein,local infection due to umbilical venous catheter,0
14805,Pain relief by medication,chest pain relieved by nitroglycerin in under five minutes,0
14806,Pain relief by medication,chest pain relieved by nitroglycerin faster than rest alone,0
14807,Pain relief by medication,chest pain increasingly less responsive to nitroglycerin,0
14808,Pain relief by medication,chest pain relieved by analgesics,0
14809,Pain relief by medication,chest pain gradually relieved by nitroglycerin,0
14810,Pain relief by medication,chest pain relieved by nitroglycerin,0
14811,Pain onset during sleep,Hypnic Headache,0
14812,Pain relief by sitting up,chest pain relieved by sitting up,0
14813,Pain relief by antacid,chest pain relieved by antacids,0
14814,Infusion Pump,infusion pump status,0
14815,Infusion Pump,infusion pump failing to infuse,0
14816,Infusion Pump,infusion pump needs calibration,0
14817,Infusion Pump,infusion pump wiring frayed,0
14818,Excessive dietary caloric intake,Morbid obesity,0
14819,Bariatric operative procedure,digestive system complications due to bariatric procedure,0
14820,Bariatric operative procedure,Infection due to bariatric procedure,0
14821,Cataract due to diabetes mellitus,secondary diabetes mellitus with diabetic cataract,0
14822,Cataract due to diabetes mellitus,chemical-induced diabetes mellitus with diabetic cataract,0
14823,Cataract due to diabetes mellitus,type 1 diabetes with diabetic cataract,0
14824,"Diabetes Mellitus, Non-Insulin-Dependent",diabetes mellitus with dermatological manifestations type 2,0
14825,"Diabetes Mellitus, Non-Insulin-Dependent",diabetes mellitus with skin ulcer type 2,0
14826,Able to count up to 10,milestone: counts to 10,0
14827,Poisoning due to chemical substance,Trichloroethylene poisoning of undetermined intent,0
14828,Poisoning due to chemical substance,poisoning by lead dioxide with undetermined intent,0
14829,Poisoning due to chemical substance,poisoning by lead acetate with undetermined intent,0
14830,Tumor stage Tis,malignant neoplasm of lung TNM staging primary tumor (T) Tis,0
14831,Tumor stage Tis,malignant neoplasm of small intestine TNM staging primary tumor (T) Tis,0
14832,Tumor stage Tis,malignant neoplasm of adrenal gland TNM staging primary tumor (T) Tis,0
14833,Tumor stage Tis,malignant neoplasm of nasopharynx TNM staging primary tumor (T) Tis,0
14834,Tumor stage Tis,malignant neoplasm of oropharynx TNM staging primary tumor (T) Tis,0
14835,Tumor stage Tis,malignant neoplasm of pharynx TNM staging primary tumor (T) Tis,0
14836,Tumor stage Tis,malignant neoplasm of soft palate TNM staging primary tumor (T) Tis,0
14837,Tumor stage Tis,malignant neoplasm of uvula TNM staging primary tumor (T) Tis,0
14838,Tumor stage Tis,malignant neoplasm of lip TNM staging primary tumor (T) Tis,0
14839,Tumor stage Tis,malignant neoplasm of tongue TNM staging primary tumor (T) Tis,0
14840,Tumor stage Tis,malignant neoplasm of gingiva TNM staging primary tumor (T) Tis,0
14841,Tumor stage Tis,malignant neoplasm of floor of mouth TNM staging primary tumor (T) Tis,0
14842,Tumor stage Tis,malignant neoplasm of oral cavity TNM staging primary tumor (T) Tis,0
14843,Tumor stage Tis,malignant neoplasm of hard palate TNM staging primary tumor (T) Tis,0
14844,Tumor stage Tis,malignant neoplasm of retromolar area TNM staging primary tumor (T) Tis,0
14845,Tumor stage Tis,malignant neoplasm of parotid TNM staging primary tumor (T) Tis,0
14846,Tumor stage Tis,malignant neoplasm of salivary gland TNM staging primary tumor (T) Tis,0
14847,Tumor stage Tis,malignant neoplasm of hypopharynx TNM staging primary tumor (T) Tis,0
14848,Tumor stage Tis,malignant neoplasm of esophagus TNM staging primary tumor (T) Tis,0
14849,Tumor stage Tis,malignant neoplasm of stomach TNM staging primary tumor (T) Tis,0
14850,Tumor stage Tis,malignant neoplasm of gallbladder TNM staging primary tumor (T) Tis,0
14851,Tumor stage Tis,malignant melanoma of skin TNM staging primary tumor (T) Tis,0
14852,Tumor stage Tis,malignant neoplasm of vulva TNM staging primary tumor (T) Tis/0,0
14853,Tumor stage Tis,malignant neoplasm of penis TNM staging primary tumor (T) Tis,0
14854,Tumor stage Tis,malignant neoplasm of testis TNM staging primary tumor (T) Tis,0
14855,Tumor stage Tis,malignant neoplasm of renal pelvis TNM staging primary tumor (T) Tis,0
14856,Tumor stage Tis,malignant neoplasm of ureter TNM staging primary tumor (T) Tis,0
14857,Tumor stage Tis,Tumor stage Tis,0
14858,Able to participate in school activities,activities risk assessment: engages in after-school activities,0
14859,Peripheral vascular catheter,forearm PIV site appearance,0
14860,Catheterization,local infection due to triple lumen catheter,0
14861,N2 category,malignant neoplasm of breast TNM staging regional lymph node (N) N2,0
14862,N2 category,malignant neoplasm of lung TNM staging regional lymph node (N) N2,0
14863,N2 category,malignant neoplasm of large intestine TNM staging regional lymph nodes (N) N2,0
14864,N2 category,malignant neoplasm of small intestine TNM staging regional lymph nodes (N) N2,0
14865,N2 category,malignant neoplasm of bladder TNM staging regional lymph node (N) N2,0
14866,N2 category,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) N2,0
14867,N2 category,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) N2,0
14868,N2 category,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) N2,0
14869,N2 category,malignant neoplasm of pharynx TNM staging regional lymph node (N) N2,0
14870,N2 category,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) N2,0
14871,N2 category,malignant neoplasm of uvula TNM staging regional lymph nodes (N) N2,0
14872,N2 category,malignant neoplasm of lip TNM staging regional lymph nodes (N) N2,0
14873,N2 category,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N2,0
14874,N2 category,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) N2,0
14875,N2 category,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) N2,0
14876,N2 category,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N2,0
14877,N2 category,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) N2,0
14878,N2 category,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) N2,0
14879,N2 category,malignant neoplasm of parotid TNM staging regional lymph nodes (N) N2,0
14880,N2 category,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) N2,0
14881,N2 category,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) N2,0
14882,N2 category,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N2,0
14883,N2 category,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N2,0
14884,N2 category,malignant neoplasm of sinus TNM staging regional lymph nodes (N) N2,0
14885,N2 category,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N2,0
14886,N2 category,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N2,0
14887,N2 category,malignant neoplasm of stomach TNM staging regional lymph nodes (N) N2,0
14888,N2 category,malignant neoplasm of gallbladder TNM staging regional lymph nodes (N) N2,0
14889,N2 category,malignant neoplasm of penis TNM staging regional lymph node (N) N2,0
14890,N2 category,malignant neoplasm of testis TNM staging regional lymph nodes (N) N2,0
14891,N2 category,malignant neoplasm of kidney TNM staging regional lymph nodes (N) N2,0
14892,N2 category,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) N2,0
14893,N2 category,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N2,0
14894,N2 category,N2 category,0
14895,"Diabetes Mellitus, Insulin-Dependent",type 1 diabetes with ketoacidosis without coma,0
14896,"Diabetes Mellitus, Insulin-Dependent",diabetes mellitus with dermatological manifestations type 1,0
14897,"Diabetes Mellitus, Insulin-Dependent",type 1 diabetes mellitus with skin ulcer,0
14898,Diabetic Retinopathy,secondary diabetes mellitus with diabetic retinopathy,0
14899,Diabetic Retinopathy,chemical-induced diabetes mellitus with diabetic retinopathy,0
14900,Diabetic Retinopathy,type 1 diabetes with diabetic retinopathy,0
14901,Diabetic Retinopathy,type 1 diabetes with diabetic retinopathy without macular edema,0
14902,Diabetic Retinopathy,type 2 diabetes with diabetic retinopathy without macular edema,0
14903,Diabetic Polyneuropathies,diabetes mellitus secondary with diabetic polyneuropathy,0
14904,Diabetic Polyneuropathies,chemical-induced diabetes mellitus with diabetic polyneuropathy,0
14905,Diabetic Polyneuropathies,type 1 diabetes with diabetic polyneuropathy,0
14906,Diabetic Polyneuropathies,type 2 diabetes with diabetic polyneuropathy,0
14907,Internuclear Ophthalmoplegia,internuclear ophthalmoplegia as caloric response,0
14908,Diabetic Autonomic Neuropathy,diabetes mellitus secondary with diabetic autonomic neuropathy,0
14909,Diabetic Autonomic Neuropathy,chemical-induced diabetes mellitus with diabetic autonomic neuropathy,0
14910,Diabetic Autonomic Neuropathy,type 2 diabetes with diabetic autonomic neuropathy,0
14911,Banding procedure,digestive system complications due to gastric banding procedure,0
14912,Banding procedure,Infection due to gastric band procedure,0
14913,N1 category,malignant neoplasm of breast TNM staging regional lymph node (N) N1,0
14914,N1 category,malignant neoplasm of lung TNM staging regional lymph node (N) N1,0
14915,N1 category,malignant neoplasm of large intestine TNM staging regional lymph nodes (N) N1,0
14916,N1 category,malignant neoplasm of small intestine TNM staging regional lymph nodes (N) N1,0
14917,N1 category,malignant neoplasm of bladder TNM staging regional lymph node (N) N1,0
14918,N1 category,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) N1,0
14919,N1 category,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) N1,0
14920,N1 category,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) N1,0
14921,N1 category,malignant neoplasm of pharynx TNM staging regional lymph node (N) N1,0
14922,N1 category,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) N1,0
14923,N1 category,malignant neoplasm of uvula TNM staging regional lymph nodes (N) N1,0
14924,N1 category,malignant neoplasm of lip TNM staging regional lymph nodes (N) N1,0
14925,N1 category,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N1,0
14926,N1 category,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) N1,0
14927,N1 category,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) N1,0
14928,N1 category,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N1,0
14929,N1 category,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) N1,0
14930,N1 category,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) N1,0
14931,N1 category,malignant neoplasm of parotid TNM staging regional lymph nodes (N) N1,0
14932,N1 category,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) N1,0
14933,N1 category,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) N1,0
14934,N1 category,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N1,0
14935,N1 category,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N1,0
14936,N1 category,malignant neoplasm of sinus TNM staging regional lymph nodes (N) N1,0
14937,N1 category,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N1,0
14938,N1 category,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N1,0
14939,N1 category,malignant neoplasm of esophagus TNM staging regional lymph nodes (N) N1,0
14940,N1 category,malignant neoplasm of stomach TNM staging regional lymph nodes (N) N1,0
14941,N1 category,malignant neoplasm of liver TNM staging regional lymph nodes (N) N1,0
14942,N1 category,malignant neoplasm of extrahepatic bile duct TNM staging regional lymph nodes (N) N1,0
14943,N1 category,malignant neoplasm of gallbladder TNM staging regional lymph nodes (N) N1,0
14944,N1 category,malignant neoplasm of cervix TNM staging regional lymph nodes (N) N1,0
14945,N1 category,malignant neoplasm of penis TNM staging regional lymph node (N) N1,0
14946,N1 category,malignant neoplasm of testis TNM staging regional lymph nodes(N) N1,0
14947,N1 category,malignant neoplasm of prostate TNM staging regional lymph nodes (N) N1,0
14948,N1 category,malignant neoplasm of kidney TNM staging regional lymph nodes (N) N1,0
14949,N1 category,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) N1,0
14950,N1 category,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N1,0
14951,N1 category,malignant neoplasm of thyroid TNM staging regional lymph nodes (N) N1,0
14952,N1 category,N1 category,0
14953,acoustic trauma from explosions,Explosion,0
14954,Stabbing pain,knifelike flank pain,0
14955,Neoplastic disease,lambert-eaton syndrome in neoplastic disease,0
14956,Metastasis stage M1,malignant neoplasm of breast TNM staging distant metastasis (M) M1,0
14957,Metastasis stage M1,malignant neoplasm of lung TNM staging distant metastasis (M) M1,0
14958,Metastasis stage M1,malignant neoplasm of large intestine TNM staging distant metastasis (M) M1,0
14959,Metastasis stage M1,malignant neoplasm of small intestine TNM staging distant metastasis (M) M1,0
14960,Metastasis stage M1,malignant neoplasm of bladder TNM staging distant metastasis (M) M1,0
14961,Metastasis stage M1,malignant neoplasm of adrenal gland TNM staging distant metastasis (M) M1,0
14962,Metastasis stage M1,malignant neoplasm of nasopharynx TNM staging distant metastasis (M) M1,0
14963,Metastasis stage M1,malignant neoplasm of oropharynx TNM staging distant metastasis (M) M1,0
14964,Metastasis stage M1,malignant neoplasm of pharynx TNM staging distant metastasis (M) M1,0
14965,Metastasis stage M1,malignant neoplasm of soft palate TNM staging distant metastasis (M) M1,0
14966,Metastasis stage M1,malignant neoplasm of uvula TNM staging distant metastasis (M) M1,0
14967,Metastasis stage M1,malignant neoplasm of lip TNM staging distant metastasis (M) M1,0
14968,Metastasis stage M1,malignant neoplasm of tongue TNM staging distant metastasis (M) M1,0
14969,Metastasis stage M1,malignant neoplasm of gingiva TNM staging distant metastasis (M) M1,0
14970,Metastasis stage M1,malignant neoplasm of floor of mouth TNM staging distant metastasis (M) M1,0
14971,Metastasis stage M1,malignant neoplasm of oral cavity TNM staging distant metastasis (M) M1,0
14972,Metastasis stage M1,malignant neoplasm of hard palate TNM staging distant metastasis (M) M1,0
14973,Metastasis stage M1,malignant neoplasm of retromolar area TNM staging distant metastasis (M) M1,0
14974,Metastasis stage M1,malignant neoplasm of parotid TNM staging distant metastasis (M) M1,0
14975,Metastasis stage M1,malignant neoplasm of salivary gland TNM staging distant metastasis (M) M1,0
14976,Metastasis stage M1,malignant neoplasm of hypopharynx TNM staging distant metastasis (M) M1,0
14977,Metastasis stage M1,malignant neoplasm of stomach TNM staging distant metastasis (M) M1,0
14978,Metastasis stage M1,malignant neoplasm of liver TNM staging distant metastasis (M) M1,0
14979,Metastasis stage M1,malignant neoplasm of extrahepatic bile duct TNM staging distant metastasis (M) M1,0
14980,Metastasis stage M1,malignant neoplasm of gallbladder TNM staging distant metastasis (M) M1,0
14981,Metastasis stage M1,malignant neoplasm of cervix TNM staging distant metastasis (M) M1,0
14982,Metastasis stage M1,malignant neoplasm of penis TNM staging distant metastasis (M) M1,0
14983,Metastasis stage M1,malignant neoplasm of testis TNM staging distant metastasis (M) M1,0
14984,Metastasis stage M1,malignant neoplasm of prostate TNM staging distant metastasis (M) M1,0
14985,Metastasis stage M1,malignant neoplasm of kidney TNM staging distant metastasis (M) M1,0
14986,Metastasis stage M1,malignant neoplasm of renal pelvis TNM staging distant metastasis (M) M1,0
14987,Metastasis stage M1,malignant neoplasm of ureter TNM staging distant metastasis (M) M1,0
14988,Metastasis stage M1,malignant neoplasm of thyroid TNM staging distant metastasis (M) M1,0
14989,Metastasis stage M1,Metastasis stage M1,0
14990,Ketoacidosis,secondary diabetes mellitus with ketoacidosis,0
14991,Nystagmus,caloric responses nystagmus,0
14992,Patient Discharge,discharge weight (___)grams,0
14993,N3 category,malignant neoplasm of breast TNM staging regional lymph node (N) N3,0
14994,N3 category,malignant neoplasm of lung TNM staging regional lymph node (N) N3,0
14995,N3 category,malignant neoplasm of bladder TNM staging regional lymph node (N) N3,0
14996,N3 category,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) N3,0
14997,N3 category,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) N3,0
14998,N3 category,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) N3,0
14999,N3 category,malignant neoplasm of pharynx TNM staging regional lymph node (N) N3,0
15000,N3 category,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) N3,0
15001,N3 category,malignant neoplasm of uvula TNM staging regional lymph nodes (N) N3,0
15002,N3 category,malignant neoplasm of lip TNM staging regional lymph nodes (N) N3,0
15003,N3 category,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N3,0
15004,N3 category,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) N3,0
15005,N3 category,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) N3,0
15006,N3 category,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N3,0
15007,N3 category,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) N3,0
15008,N3 category,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) N3,0
15009,N3 category,malignant neoplasm of parotid TNM staging regional lymph nodes (N) N3,0
15010,N3 category,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) N3,0
15011,N3 category,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) N3,0
15012,N3 category,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) N3,0
15013,N3 category,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) N3,0
15014,N3 category,malignant neoplasm of sinus TNM staging regional lymph nodes (N) N3,0
15015,N3 category,malignant neoplasm of nasal cavity TNM staging regional lymph nodes (N) N3,0
15016,N3 category,malignant neoplasm of glottis TNM staging regional lymph nodes (N) N3,0
15017,N3 category,malignant neoplasm of stomach TNM staging regional lymph nodes (N) N3,0
15018,N3 category,malignant melanoma of skin TNM staging regional lymph nodes (N) N3,0
15019,N3 category,malignant neoplasm of penis TNM staging regional lymph node (N) N3,0
15020,N3 category,malignant neoplasm of testis TNM staging regional lymph nodes (N) N3,0
15021,N3 category,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) N3,0
15022,N3 category,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N3,0
15023,N3 category,N3 category,0
15024,T0 stage,malignant neoplasm of breast TNM staging primary tumor (T) T0,0
15025,T0 stage,malignant neoplasm of lung TNM staging primary tumor (T) T0,0
15026,T0 stage,malignant neoplasm of large intestine TNM staging primary tumor (T) T0,0
15027,T0 stage,malignant neoplasm of bladder TNM staging primary tumor (T) T0,0
15028,T0 stage,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T0,0
15029,T0 stage,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T0,0
15030,T0 stage,malignant neoplasm of oropharynx TNM staging primary tumor (T) T0,0
15031,T0 stage,malignant neoplasm of pharynx TNM staging primary tumor (T) T0,0
15032,T0 stage,malignant neoplasm of soft palate TNM staging primary tumor (T) T0,0
15033,T0 stage,malignant neoplasm of uvula TNM staging primary tumor (T) T0,0
15034,T0 stage,malignant neoplasm of lip TNM staging primary tumor (T) T0,0
15035,T0 stage,malignant neoplasm of tongue TNM staging primary tumor (T) T0,0
15036,T0 stage,malignant neoplasm of gingiva TNM staging primary tumor (T) T0,0
15037,T0 stage,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T0,0
15038,T0 stage,malignant neoplasm of oral cavity TNM staging primary tumor (T) T0,0
15039,T0 stage,malignant neoplasm of hard palate TNM staging primary tumor (T) T0,0
15040,T0 stage,malignant neoplasm of retromolar area TNM staging primary tumor (T) T0,0
15041,T0 stage,malignant neoplasm of parotid TNM staging primary tumor (T) T0,0
15042,T0 stage,malignant neoplasm of salivary gland TNM staging primary tumor (T) T0,0
15043,T0 stage,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T0,0
15044,T0 stage,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T0,0
15045,T0 stage,malignant neoplasm of subglottis TNM staging primary tumor (T) T0,0
15046,T0 stage,malignant neoplasm of nasal sinus TNM staging primary tumor (T) T0,0
15047,T0 stage,malignant neoplasm of nasal cavity TNM staging primary tumor (T) T0,0
15048,T0 stage,malignant neoplasm of glottis TNM staging primary tumor (T) T0,0
15049,T0 stage,malignant neoplasm of stomach TNM staging primary tumor (T) T0,0
15050,T0 stage,malignant neoplasm of liver TNM staging primary tumor (T) T0,0
15051,T0 stage,malignant neoplasm of gallbladder TNM staging primary tumor (T) T0,0
15052,T0 stage,malignant melanoma of skin TNM staging primary tumor (T) T0,0
15053,T0 stage,malignant neoplasm of cervix TNM staging primary tumor (T) T0,0
15054,T0 stage,malignant neoplasm of vulva TNM staging primary tumor (T) T0,0
15055,T0 stage,malignant neoplasm of penis TNM staging primary tumor (T) T0,0
15056,T0 stage,malignant neoplasm of testis TNM staging primary tumor (T) T0,0
15057,T0 stage,malignant neoplasm of prostate TNM staging primary tumor (T) T0,0
15058,T0 stage,malignant neoplasm of kidney TNM staging primary tumor (T) T0,0
15059,T0 stage,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T0,0
15060,T0 stage,malignant neoplasm of ureter TNM staging primary tumor (T) T0,0
15061,T0 stage,malignant neoplasm of thyroid TNM staging primary tumor (T) T0,0
15062,T0 stage,T0 stage,0
15063,T0 stage,oncologic disorders,0
15064,Proliferative diabetic retinopathy,secondary diabetes mellitus with proliferative diabetic retinopathy,0
15065,Proliferative diabetic retinopathy,chemical-induced diabetes mellitus with proliferative diabetic retinopathy,0
15066,Proliferative diabetic retinopathy,type 1 diabetes with proliferative diabetic retinopathy,0
15067,Proliferative diabetic retinopathy,type 1 diabetes with proliferative diabetic retinopathy without macular edema,0
15068,Proliferative diabetic retinopathy,type 2 diabetes with proliferative diabetic retinopathy,0
15069,Proliferative diabetic retinopathy,type 2 diabetes with proliferative diabetic retinopathy without macular edema,0
15070,Continuous murmur,continuous interscapular murmur,0
15071,Continuous murmur,low-pitched continuous apical murmur,0
15072,Continuous murmur,medium-pitched continuous apical murmur,0
15073,Continuous murmur,high-pitched continuous apical murmur,0
15074,Continuous murmur,low-pitched continuous axillary murmur,0
15075,Continuous murmur,medium-pitched continuous axillary murmur,0
15076,Continuous murmur,high-pitched continuous axillary murmur,0
15077,Continuous murmur,low-pitched continuous interscapular murmur,0
15078,Continuous murmur,medium-pitched continuous interscapular murmur,0
15079,Continuous murmur,high-pitched continuous interscapular murmur,0
15080,Node stage N0,malignant neoplasm of breast TNM staging regional lymph node (N) N0,0
15081,Node stage N0,malignant neoplasm of lung TNM staging regional lymph node (N) N0,0
15082,Node stage N0,malignant neoplasm of large intestine TNM staging regional lymph nodes (N) N0,0
15083,Node stage N0,malignant neoplasm of small intestine TNM staging regional lymph nodes (N) N0,0
15084,Node stage N0,malignant neoplasm of bladder TNM staging regional lymph node (N) N0,0
15085,Node stage N0,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) N0,0
15086,Node stage N0,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) N0,0
15087,Node stage N0,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) N0,0
15088,Node stage N0,malignant neoplasm of pharynx TNM staging regional lymph node (N) N0,0
15089,Node stage N0,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) N0,0
15090,Node stage N0,malignant neoplasm of uvula TNM staging regional lymph nodes (N) N0,0
15091,Node stage N0,malignant neoplasm of lip TNM staging regional lymph nodes (N) N0,0
15092,Node stage N0,malignant neoplasm of tongue TNM staging regional lymph nodes (N) N0,0
15093,Node stage N0,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) N0,0
15094,Node stage N0,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) N0,0
15095,Node stage N0,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) N0,0
15096,Node stage N0,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) N0,0
15097,Node stage N0,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) N0,0
15098,Node stage N0,malignant neoplasm of parotid TNM staging regional lymph nodes (N) N0,0
15099,Node stage N0,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) N0,0
15100,Node stage N0,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) N0,0
15101,Node stage N0,malignant neoplasm of esophagus TNM staging regional lymph nodes (N) N0,0
15102,Node stage N0,malignant neoplasm of stomach TNM staging regional lymph nodes (N) N0,0
15103,Node stage N0,malignant neoplasm of liver TNM staging regional lymph nodes (N) N0,0
15104,Node stage N0,malignant neoplasm of extrahepatic bile duct TNM staging regional lymph nodes (N) N0,0
15105,Node stage N0,malignant neoplasm of gallbladder TNM staging regional lymph nodes (N) N0,0
15106,Node stage N0,malignant melanoma of skin TNM staging regional lymph nodes (N) N0,0
15107,Node stage N0,malignant neoplasm of cervix TNM staging regional lymph nodes (N) N0,0
15108,Node stage N0,malignant neoplasm of vulva TNM staging regional lymph nodes N0,0
15109,Node stage N0,malignant neoplasm of penis TNM staging regional lymph node (N) N0,0
15110,Node stage N0,malignant neoplasm of testis TNM staging regional lymph nodes (N) N0,0
15111,Node stage N0,malignant neoplasm of prostate TNM staging regional lymph nodes (N) N0,0
15112,Node stage N0,malignant neoplasm of kidney TNM staging regional lymph nodes (N) N0,0
15113,Node stage N0,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) N0,0
15114,Node stage N0,malignant neoplasm of ureter TNM staging regional lymph nodes (N) N0,0
15115,Node stage N0,malignant neoplasm of thyroid TNM staging regional lymph nodes (N) N0,0
15116,Node stage N0,Node stage N0,0
15117,continuous interscapular murmur,Continuous murmur,0
15118,low-pitched apical systolic murmur,Systolic Murmurs,0
15119,medium-pitched apical systolic murmur,Systolic Murmurs,0
15120,high-pitched apical systolic murmur,Systolic Murmurs,0
15121,low-pitched apical diastolic murmur,Diastolic Murmurs,0
15122,medium-pitched apical diastolic murmur,Diastolic Murmurs,0
15123,high-pitched apical diastolic murmur,Diastolic Murmurs,0
15124,low-pitched continuous apical murmur,Continuous murmur,0
15125,medium-pitched continuous apical murmur,Continuous murmur,0
15126,high-pitched continuous apical murmur,Continuous murmur,0
15127,low-pitched axillary systolic murmur,Systolic Murmurs,0
15128,medium-pitched axillary systolic murmur,Systolic Murmurs,0
15129,high-pitched axillary systolic murmur,Systolic Murmurs,0
15130,low-pitched axillary diastolic murmur,Diastolic Murmurs,0
15131,medium-pitched axillary diastolic murmur,Diastolic Murmurs,0
15132,high-pitched axillary diastolic murmur,Diastolic Murmurs,0
15133,low-pitched continuous axillary murmur,Continuous murmur,0
15134,medium-pitched continuous axillary murmur,Continuous murmur,0
15135,high-pitched continuous axillary murmur,Continuous murmur,0
15136,grade I systolic interscapular murmur,Systolic Murmurs,0
15137,grade II systolic interscapular murmur,Systolic Murmurs,0
15138,grade III systolic interscapular murmur,Systolic Murmurs,0
15139,grade IV systolic interscapular murmur,Systolic Murmurs,0
15140,grade V systolic interscapular murmur,Systolic Murmurs,0
15141,grade VI systolic interscapular murmur,Systolic Murmurs,0
15142,murmur interscapular systolic constant,Systolic Murmurs,0
15143,systolic interscapular murmur with crescendo pattern,Systolic Murmurs,0
15144,systolic interscapular murmur with decrescendo pattern,Systolic Murmurs,0
15145,systolic interscapular murmur with crescendo-decrescendo pattern,Systolic Murmurs,0
15146,low-pitched systolic interscapular murmur,Systolic Murmurs,0
15147,medium-pitched systolic interscapular murmur,Systolic Murmurs,0
15148,high-pitched systolic interscapular murmur,Systolic Murmurs,0
15149,harsh systolic interscapular region,Systolic Murmurs,0
15150,musical systolic interscapular region,Systolic Murmurs,0
15151,blowing systolic interscapular region,Systolic Murmurs,0
15152,rumbling systolic interscapular region,Systolic Murmurs,0
15153,diastolic interscapular murmur with crescendo pattern,Diastolic Murmurs,0
15154,diastolic interscapular murmur with decrescendo pattern,Diastolic Murmurs,0
15155,diastolic interscapular murmur with crescendo-decrescendo pattern,Diastolic Murmurs,0
15156,diastolic interscapular murmur with presystolic accentuation pattern,Diastolic Murmurs,0
15157,low-pitched diastolic interscapular murmur,Diastolic Murmurs,0
15158,medium-pitched diastolic interscapular murmur,Diastolic Murmurs,0
15159,high-pitched diastolic interscapular murmur,Diastolic Murmurs,0
15160,harsh diastolic interscapular murmur,Diastolic Murmurs,0
15161,musical diastolic interscapular murmur,Diastolic Murmurs,0
15162,blowing diastolic interscapular murmur,Diastolic Murmurs,0
15163,rumbling diastolic interscapular murmur,Diastolic Murmurs,0
15164,low-pitched continuous interscapular murmur,Continuous murmur,0
15165,medium-pitched continuous interscapular murmur,Continuous murmur,0
15166,high-pitched continuous interscapular murmur,Continuous murmur,0
15167,Blood Coagulation Disorders,lupus anticoagulant with hemorrhagic disorder,0
15168,Nyctalopia,Vitamin A deficiency with night blindness,0
15169,Ectopic pituitary tissue,location of ectopic neoplasm of Rathke's pouch,0
15170,Ectopic pituitary tissue,location of ectopic neoplasm of pituitary gland,0
15171,Tumor stage T4,malignant neoplasm of lung TNM staging primary tumor (T) T4,0
15172,Tumor stage T4,malignant neoplasm of small intestine TNM staging primary tumor (T) T4,0
15173,Tumor stage T4,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T4,0
15174,Tumor stage T4,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T4,0
15175,Tumor stage T4,malignant neoplasm of oropharynx TNM staging primary tumor (T) T4,0
15176,Tumor stage T4,malignant neoplasm of pharynx TNM staging primary tumor (T) T4,0
15177,Tumor stage T4,malignant neoplasm of soft palate TNM staging primary tumor (T) T4,0
15178,Tumor stage T4,malignant neoplasm of uvula TNM staging primary tumor (T) T4,0
15179,Tumor stage T4,malignant neoplasm of tongue TNM staging primary tumor (T) T4,0
15180,Tumor stage T4,malignant neoplasm of gingiva TNM staging primary tumor (T) T4,0
15181,Tumor stage T4,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T4,0
15182,Tumor stage T4,malignant neoplasm of oral cavity TNM staging primary tumor (T) T4,0
15183,Tumor stage T4,malignant neoplasm of hard palate TNM staging primary tumor (T) T4,0
15184,Tumor stage T4,malignant neoplasm of retromolar area TNM staging primary tumor (T) T4,0
15185,Tumor stage T4,malignant neoplasm of parotid TNM staging primary tumor (T) T4,0
15186,Tumor stage T4,malignant neoplasm of salivary gland TNM staging primary tumor (T) T4,0
15187,Tumor stage T4,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T4,0
15188,Tumor stage T4,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T4,0
15189,Tumor stage T4,malignant neoplasm of glottis TNM staging primary tumor (T) T4,0
15190,Tumor stage T4,malignant neoplasm of esophagus TNM staging primary tumor (T) T4,0
15191,Tumor stage T4,malignant neoplasm of stomach TNM staging primary tumor (T) T4,0
15192,Tumor stage T4,malignant neoplasm of liver TNM staging primary tumor (T) T4,0
15193,Tumor stage T4,malignant neoplasm of gallbladder TNM staging primary tumor (T) T4,0
15194,Tumor stage T4,malignant melanoma of skin TNM staging primary tumor (T) T4,0
15195,Tumor stage T4,malignant neoplasm of vulva TNM staging primary tumor (T) T4/IVa,0
15196,Tumor stage T4,malignant neoplasm of penis TNM staging primary tumor (T) T4,0
15197,Tumor stage T4,malignant neoplasm of testis TNM staging primary tumor (T) T4,0
15198,Tumor stage T4,malignant neoplasm of prostate TNM staging primary tumor (T) T4,0
15199,Tumor stage T4,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T4,0
15200,Tumor stage T4,malignant neoplasm of ureter TNM staging primary tumor (T) T4,0
15201,Tumor stage T4,Tumor stage T4,0
15202,Tumor stage TX,malignant neoplasm of lung TNM staging primary tumor (T) TX,0
15203,Tumor stage TX,malignant neoplasm of small intestine TNM staging primary tumor (T) TX,0
15204,Tumor stage TX,malignant neoplasm of bladder TNM staging primary tumor (T) TX,0
15205,Tumor stage TX,malignant neoplasm of adrenal gland TNM staging primary tumor (T) TX,0
15206,Tumor stage TX,malignant neoplasm of nasopharynx TNM staging primary tumor (T) TX,0
15207,Tumor stage TX,malignant neoplasm of oropharynx TNM staging primary tumor (T) TX,0
15208,Tumor stage TX,malignant neoplasm of pharynx TNM staging primary tumor (T) TX,0
15209,Tumor stage TX,malignant neoplasm of soft palate TNM staging primary tumor (T) TX,0
15210,Tumor stage TX,malignant neoplasm of uvula TNM staging primary tumor (T) TX,0
15211,Tumor stage TX,malignant neoplasm of lip TNM staging primary tumor (T) TX,0
15212,Tumor stage TX,malignant neoplasm of tongue TNM staging primary tumor (T) TX,0
15213,Tumor stage TX,malignant neoplasm of gingiva TNM staging primary tumor (T) TX,0
15214,Tumor stage TX,malignant neoplasm of floor of mouth TNM staging primary tumor TX,0
15215,Tumor stage TX,malignant neoplasm of oral cavity TNM staging primary tumor (T) TX,0
15216,Tumor stage TX,malignant neoplasm of hard palate TNM staging primary tumor (T) TX,0
15217,Tumor stage TX,malignant neoplasm of retromolar area TNM staging primary tumor (T) TX,0
15218,Tumor stage TX,malignant neoplasm of parotid TNM staging primary tumor (T) TX,0
15219,Tumor stage TX,malignant neoplasm of salivary gland TNM staging primary tumor (T) TX,0
15220,Tumor stage TX,malignant neoplasm of hypopharynx TNM staging primary tumor (T) TX,0
15221,Tumor stage TX,malignant neoplasm of stomach TNM staging primary tumor (T) TX,0
15222,Tumor stage TX,malignant neoplasm of gallbladder TNM staging primary tumor (T) TX,0
15223,Tumor stage TX,malignant melanoma of skin TNM staging primary tumor (T) TX,0
15224,Tumor stage TX,malignant neoplasm of cervix TNM staging primary tumor (T) TX,0
15225,Tumor stage TX,malignant neoplasm of vulva TNM staging primary tumor (T) TX,0
15226,Tumor stage TX,malignant neoplasm of penis TNM staging primary tumor (T) TX,0
15227,Tumor stage TX,malignant neoplasm of testis TNM staging primary tumor (T) TX,0
15228,Tumor stage TX,malignant neoplasm of prostate TNM staging primary tumor (T) TX,0
15229,Tumor stage TX,malignant neoplasm of kidney TNM staging primary tumor (T) TX,0
15230,Tumor stage TX,malignant neoplasm of renal pelvis TNM staging primary tumor (T) TX,0
15231,Tumor stage TX,malignant neoplasm of thyroid TNM staging primary tumor (T) TX,0
15232,Tumor stage TX,Tumor stage TX,0
15233,Tumor stage T2,malignant neoplasm of lung TNM staging primary tumor (T) T2 (diagnosis),0
15234,Tumor stage T2,malignant neoplasm of small intestine TNM staging primary tumor (T) T2,0
15235,Tumor stage T2,malignant neoplasm of adrenal gland TNM staging primary tumor (T) T2,0
15236,Tumor stage T2,malignant neoplasm of nasopharynx TNM staging primary tumor (T) T2,0
15237,Tumor stage T2,malignant neoplasm of oropharynx TNM staging primary tumor (T) T2,0
15238,Tumor stage T2,malignant neoplasm of pharynx TNM staging primary tumor (T) T2,0
15239,Tumor stage T2,malignant neoplasm of soft palate TNM staging primary tumor (T) T2,0
15240,Tumor stage T2,malignant neoplasm of uvula TNM staging primary tumor (T) T2,0
15241,Tumor stage T2,malignant neoplasm of lip TNM staging primary tumor (T) T2,0
15242,Tumor stage T2,malignant neoplasm of tongue TNM staging primary tumor (T) T2,0
15243,Tumor stage T2,malignant neoplasm of gingiva TNM staging primary tumor (T) T2,0
15244,Tumor stage T2,malignant neoplasm of floor of mouth TNM staging primary tumor (T) T2,0
15245,Tumor stage T2,malignant neoplasm of oral cavity TNM staging primary tumor (T) T2,0
15246,Tumor stage T2,malignant neoplasm of hard palate TNM staging primary tumor (T) T2,0
15247,Tumor stage T2,malignant neoplasm of retromolar area TNM staging primary tumor (T) T2,0
15248,Tumor stage T2,malignant neoplasm of parotid TNM staging primary tumor (T) T2,0
15249,Tumor stage T2,malignant neoplasm of salivary gland TNM staging primary tumor T2,0
15250,Tumor stage T2,malignant neoplasm of hypopharynx TNM staging primary tumor (T) T2,0
15251,Tumor stage T2,malignant neoplasm of ethmoid sinus TNM staging primary tumor (T) T2,0
15252,Tumor stage T2,malignant neoplasm of glottis TNM staging primary tumor (T) T2,0
15253,Tumor stage T2,malignant neoplasm of esophagus TNM staging primary tumor (T) T2,0
15254,Tumor stage T2,malignant neoplasm of liver TNM staging primary tumor (T) T2 (diagnosis),0
15255,Tumor stage T2,malignant neoplasm of extrahepatic bile duct TNM staging primary tumor (T) T2,0
15256,Tumor stage T2,malignant neoplasm of gallbladder TNM staging primary tumor (T) T2,0
15257,Tumor stage T2,malignant neoplasm of vulva TNM staging primary tumor (T) T2/II,0
15258,Tumor stage T2,malignant neoplasm of penis TNM staging primary tumor (T) T2,0
15259,Tumor stage T2,malignant neoplasm of testis TNM staging primary tumor (T) T2,0
15260,Tumor stage T2,malignant neoplasm of renal pelvis TNM staging primary tumor (T) T2,0
15261,Tumor stage T2,malignant neoplasm of ureter TNM staging primary tumor (T) T2,0
15262,Tumor stage T2,malignant neoplasm of thyroid TNM staging primary tumor (T) T2,0
15263,Tumor stage T2,Tumor stage T2,0
15264,Insulin pump,visit for: insulin pump status,0
15265,Accidental poisoning NOS,accidental poisoning by vitamin B6,0
15266,Diabetes Mellitus,diabetes mellitus with oral cavity manifestations,0
15267,Diabetes Mellitus,diabetes mellitus with periodontal disease,0
15268,Diabetes Mellitus,diabetes mellitus with diabetic arthropathy,0
15269,Diabetes Mellitus,diabetes mellitus with hyperglycemia,0
15270,Complications of Diabetes Mellitus,secondary diabetes mellitus with complication,0
15271,Complications of Diabetes Mellitus,uncontrolled secondary diabetes mellitus with complication,0
15272,Complications of Diabetes Mellitus,chemical-induced diabetes mellitus with complication,0
15273,Thrombophilia,lupus inhibitor with hypercoagulable state,0
15274,Cardiovascular stress testing,3-lead electrocardiogram rhythm strip: heart rate with stress,0
15275,Cardiovascular stress testing,3-lead electrocardiogram rhythm strip: RR interval with stress,0
15276,Patient currently pregnant,abdominal trauma during pregnancy,0
15277,Neurocutaneous Syndromes,neurocutaneous melanocytosis,0
15278,NX Stage Finding,malignant neoplasm of lung TNM staging regional lymph node (N) NX,0
15279,NX Stage Finding,malignant neoplasm of small intestine TNM staging regional lymph nodes (N) NX,0
15280,NX Stage Finding,malignant neoplasm of bladder TNM staging regional lymph node (N) NX,0
15281,NX Stage Finding,malignant neoplasm of adrenal gland TNM staging regional lymph node (N) NX,0
15282,NX Stage Finding,malignant neoplasm of nasopharynx TNM staging regional lymph nodes (N) NX,0
15283,NX Stage Finding,malignant neoplasm of oropharynx TNM staging regional lymph nodes (N) NX,0
15284,NX Stage Finding,malignant neoplasm of pharynx TNM staging regional lymph node (N) NX,0
15285,NX Stage Finding,malignant neoplasm of soft palate TNM staging regional lymph nodes (N) NX,0
15286,NX Stage Finding,malignant neoplasm of uvula TNM staging regional lymph nodes (N) NX,0
15287,NX Stage Finding,malignant neoplasm of lip TNM staging regional lymph nodes (N) NX,0
15288,NX Stage Finding,malignant neoplasm of tongue TNM staging regional lymph nodes (N) NX,0
15289,NX Stage Finding,malignant neoplasm of gingiva TNM staging regional lymph nodes (N) NX,0
15290,NX Stage Finding,malignant neoplasm of floor of mouth TNM staging regional lymph nodes (N) NX,0
15291,NX Stage Finding,malignant neoplasm of oral cavity TNM staging regional lymph nodes (N) NX,0
15292,NX Stage Finding,malignant neoplasm of hard palate TNM staging regional lymph nodes (N) NX,0
15293,NX Stage Finding,malignant neoplasm of retromolar area TNM staging regional lymph nodes (N) NX,0
15294,NX Stage Finding,malignant neoplasm of parotid TNM staging regional lymph nodes (N) NX,0
15295,NX Stage Finding,malignant neoplasm of salivary gland TNM staging regional lymph nodes (N) NX,0
15296,NX Stage Finding,malignant neoplasm of hypopharynx TNM staging regional lymph nodes (N) NX,0
15297,NX Stage Finding,malignant neoplasm of ethmoid sinus TNM staging regional lymph nodes (N) NX,0
15298,NX Stage Finding,malignant neoplasm of subglottis TNM staging regional lymph nodes (N) NX,0
15299,NX Stage Finding,malignant neoplasm of sinus TNM staging regional lymph nodes (N) NX,0
15300,NX Stage Finding,malignant neoplasm of stomach TNM staging regional lymph nodes (N) NX,0
15301,NX Stage Finding,malignant neoplasm of liver TNM staging regional lymph nodes (N) NX,0
15302,NX Stage Finding,malignant neoplasm of extrahepatic bile duct TNM staging regional lymph nodes (N) NX,0
15303,NX Stage Finding,malignant neoplasm of gallbladder TNM staging regional lymph nodes (N) NX,0
15304,NX Stage Finding,malignant melanoma of skin TNM staging regional lymph nodes (N) NX,0
15305,NX Stage Finding,malignant neoplasm of cervix TNM staging regional lymph nodes (N) NX,0
15306,NX Stage Finding,malignant neoplasm of vulva TNM staging regional lymph nodes NX,0
15307,NX Stage Finding,malignant neoplasm of penis TNM staging regional lymph node (N) NX,0
15308,NX Stage Finding,malignant neoplasm of testis TNM staging regional lymph nodes (N) NX,0
15309,NX Stage Finding,malignant neoplasm of prostate TNM staging regional lymph nodes (N) NX,0
15310,NX Stage Finding,malignant neoplasm of renal pelvis TNM staging regional lymph nodes (N) NX,0
15311,NX Stage Finding,malignant neoplasm of ureter TNM staging regional lymph nodes (N) NX,0
15312,NX Stage Finding,malignant neoplasm of thyroid TNM staging regional lymph nodes (N) NX,0
15313,NX Stage Finding,NX Stage Finding,0
15314,x-ray of pelvis: old fracture,Old healed fracture of bone,0
15315,Complication of the puerperium,labor onset 37-39 weeks; cesarean section as planned - delivered with postpartum complication,0
15316,x-ray of lower leg: old fracture,Old healed fracture of bone,0
15317,Hyperglycemia,diabetes mellitus secondary with hyperglycemia,0
15318,Hyperglycemia,chemical-induced diabetes mellitus with hyperglycemia,0
15319,Hyperglycemia,diabetes mellitus type 1 with hyperglycemia,0
15320,Hyperglycemia,diabetes mellitus type 2 with hyperglycemia,0
15321,thyroid biopsy follicular carcinoma metastatic to bone,Secondary malignant neoplasm of bone,0
15322,thyroid biopsy papillary carcinoma metastatic to lymph nodes,Secondary malignant neoplasm of lymph node,0
15323,malignant papillary carcinoma metastatic to mediastinal node,Papillary thyroid carcinoma,0
15324,thyroid biopsy recurrence of medullary carcinoma,Recurrent tumor,0
15325,Dull pain,dull flank pain,0
15326,Asymptomatic,Asymptomatic premature menopause,0
15327,Behavior,milestone: friendly or hostile/aggressive behavior,0
15328,Behavior,Mental Health Risk Assessment: displays pre-adolescent behavior,0
15329,central facial nerve weakness involving lower face only,Lower facial weakness,0
15330,caloric responses nystagmus,Nystagmus,0
15331,caloric responses nystagmus conjugate phasic,Conjugate Nystagmus,0
15332,internuclear ophthalmoplegia as caloric response,Internuclear Ophthalmoplegia,0
15333,Sharp pain,sharp flank pain,0
15334,Sharp pain,"chest pain sudden, sharp, and tearing",0
15335,Complication of surgical procedure,acute respiratory failure post surgical,0
15336,Complication of surgical procedure,post surgical acute and chronic respiratory failure,0
15337,Axis III diagnosis,dementia of unknown (axis iii) etiology without behavioral disturbance,0
15338,Axis III diagnosis,dementia of unknown (axis iii) etiology with behavioral disturbance,0
15339,Hemoglobin D,hemoglobin d thalassemia,0
15340,location of ectopic neoplasm of Rathke's pouch,Ectopic pituitary tissue,0
15341,Yellow color on exam,yellow discoloration of fingernail,0
15342,Yellow color on exam,yellow discoloration of right thumbnail,0
15343,Yellow color on exam,yellow discoloration of index fingernail of right hand,0
15344,Yellow color on exam,yellow discoloration of middle fingernail of right hand,0
15345,Yellow color on exam,yellow discoloration of ring fingernail of right hand,0
15346,Yellow color on exam,yellow discoloration of little fingernail of right hand,0
15347,Yellow color on exam,yellow discoloration of left thumbnail,0
15348,Yellow color on exam,yellow discoloration of index fingernail of left hand,0
15349,Yellow color on exam,yellow discoloration of middle fingernail of left hand,0
15350,Yellow color on exam,yellow discoloration of ring fingernail of left hand,0
15351,Yellow color on exam,yellow discoloration of little fingernail of left hand,0
15352,Yellow color on exam,yellow discoloration of toenail,0
15353,Yellow color on exam,yellow discoloration of great toenail of right foot,0
15354,Yellow color on exam,yellow discoloration of second toenail of right foot,0
15355,Yellow color on exam,yellow discoloration of third toenail of right foot,0
15356,Yellow color on exam,yellow discoloration of fourth toenail of right foot,0
15357,Yellow color on exam,yellow discoloration of fifth toenail of right foot,0
15358,Yellow color on exam,yellow discoloration of great toenail of left foot,0
15359,Yellow color on exam,yellow discoloration of second toenail of left foot,0
15360,Yellow color on exam,yellow discoloration of third toenail of left foot,0
15361,Yellow color on exam,yellow discoloration of fourth toenail of left foot,0
15362,Yellow color on exam,yellow discoloration of fifth toenail of left foot,0
15363,Yellow color on exam,yellow urethral discharge on exam,0
15364,Yellow color on exam,yellow nasal discharge,0
15365,Yellow color on exam,Teeth yellow,0
15366,Gaucher disease type I with osteonecrosis,Aseptic Necrosis of Bone,0
15367,location of ectopic neoplasm of pituitary gland,Ectopic pituitary tissue,0
15368,incomplete elective abortion complicated by pelvic infection,Elective abortion,0
15369,complete self-induced abortion,Self-induced termination of pregnancy,0
15370,incomplete elective abortion complicated by excessive pelvic hemorrhage,Elective abortion,0
15371,incomplete elective abortion complicated by damage to pelvic organs,Elective abortion,0
15372,incomplete elective abortion complicated by renal failure,Elective abortion,0
15373,incomplete elective abortion complicated by shock,Elective abortion,0
15374,incomplete elective abortion complicated by embolism,Elective abortion,0
15375,Secondary malignant neoplasm of bone,secondary neuroendocrine tumor with metastasis to bone,0
15376,Secondary malignant neoplasm of bone,thyroid biopsy follicular carcinoma metastatic to bone,0
15377,Secondary malignant neoplasm of intestinal lymph nodes,malignant neoplasm of small intestine metastatic to regional lymph nodes,0
15378,Secondary malignant neoplasm of liver,secondary neuroendocrine tumor with metastasis to liver,0
15379,Secondary malignant neoplasm of liver,malignant neoplasm of small intestine metastatic to liver,0
15380,Secondary malignant neoplasm of lung,thyroid biopsy follicular carcinoma metastatic to lung,0
15381,Secondary malignant neoplasm of lymph node,thyroid biopsy papillary carcinoma metastatic to lymph nodes,0
15382,Conjugate Nystagmus,caloric responses nystagmus conjugate phasic,0
15383,poisoning by unspecified solid or liquid substance with undetermined intent,Poisoning of unknown intent,0
15384,"poisoning by gases, fumes, or vapors due to undetermined intent",Poisoning of unknown intent,0
15385,injury due to fall with undetermined intent,Injury undetermined whether accidentally or purposely inflicted,0
15386,iatrogenic postoperative hypotension,Postoperative state,0
15387,Tick bite (disorder),circular rash at site of tick bite,0
15388,iatrogenic male infertility due to drug therapy,Iatrogenic Disease,0
15389,Antiresorptive Agents,taking medication for a long time osteoclast inhibitors,0
15390,Diphosphonates,taking medication for a long time bisphosphonates,0
15391,antibiotic poisoning with undetermined intent,Poisoning of unknown intent,0
15392,penicillin poisoning with undetermined intent,Poisoning of unknown intent,0
15393,antifungal poisoning with undetermined intent,Poisoning of unknown intent,0
15394,macrolide poisoning with undetermined intent,Poisoning of unknown intent,0
15395,cephalosporin poisoning with undetermined intent,Poisoning of unknown intent,0
15396,antimycobacterial poisoning with undetermined intent,Poisoning of unknown intent,0
15397,aminoglycoside poisoning with undetermined intent,Poisoning of unknown intent,0
15398,chemotherapeutic poisoning with undetermined intent,Poisoning of unknown intent,0
15399,anthelmintic poisoning with undetermined intent,Poisoning of unknown intent,0
15400,antimalarial poisoning with undetermined intent,Poisoning of unknown intent,0
15401,antiprotozoal drug poisoning with undetermined intent,Poisoning of unknown intent,0
15402,metronidazole poisoning with undetermined intent,Poisoning of unknown intent,0
15403,antiviral poisoning with undetermined intent,Poisoning of unknown intent,0
15404,arsenical anti-infective poisoning with undetermined intent,Poisoning of unknown intent,0
15405,sulfonamide poisoning with undetermined intent,Poisoning of unknown intent,0
15406,heavy metal anti-infective agent poisoning with undetermined intent,Poisoning of unknown intent,0
15407,anti-infective antimony compound poisoning with undetermined intent,Poisoning of unknown intent,0
15408,anti-infective bismuth compound poisoning with undetermined intent,Poisoning of unknown intent,0
15409,anti-infective lead compound poisoning with undetermined intent,Poisoning of unknown intent,0
15410,anti-infective mercury compound poisoning with undetermined intent,Poisoning of unknown intent,0
15411,quinoline poisoning with undetermined intent,Poisoning of unknown intent,0
15412,Reiter Syndrome,Arthropathy,0
15413,iatrogenic iris atrophy,Iatrogenic Disease,0
15414,adrenocorticosteroid poisoning with undetermined intent,Poisoning of unknown intent,0
15415,topical ocular corticosteroid poisoning with undetermined intent,Poisoning of unknown intent,0
15416,anabolic steroids poisoning with undetermined intent,Poisoning of unknown intent,0
15417,ovarian hormone poisoning with undetermined intent,Poisoning of unknown intent,0
15418,Oral contraceptive poisoning of undetermined intent,Poisoning of unknown intent,0
15419,antidiabetic agent poisoning with undetermined intent,Poisoning of unknown intent,0
15420,oral hypoglycemic poisoning with undetermined intent,Poisoning of unknown intent,0
15421,sulfonylurea toxicity poisoning with undetermined intent,Poisoning of unknown intent,0
15422,anterior pituitary hormone poisoning with undetermined intent,Poisoning of unknown intent,0
15423,Corticotropin poisoning of undetermined intent,Poisoning of unknown intent,0
15424,Gonadotrophin poisoning of undetermined intent,Poisoning of unknown intent,0
15425,posterior pituitary hormone poisoning with undetermined intent,Poisoning of unknown intent by drug,0
15426,antithyroid poisoning with undetermined intent,Poisoning of unknown intent,0
15427,antihistamine poisoning with undetermined intent,Poisoning of unknown intent,0
15428,acidifying agent poisoning with undetermined intent,Poisoning of unknown intent,0
15429,alkalizing agent poisoning with undetermined intent,Poisoning of unknown intent,0
15430,heavy metal antagonist poisoning with undetermined intent,Poisoning of unknown intent,0
15431,vitamin poisoning with undetermined intent,Poisoning of unknown intent,0
15432,penicillamine poisoning with undetermined intent,Poisoning of unknown intent,0
15433,anticoagulant poisoning with undetermined intent,Poisoning of unknown intent,0
15434,warfarin poisoning with undetermined intent,Poisoning of unknown intent,0
15435,"toxicity from analgesics, antipyretics, and antirheumatics due to undetermined intent",Poisoning of unknown intent,0
15436,opioid poisoning with undetermined intent,Poisoning of unknown intent,0
15437,Body position,overexertion from prolonged static position,0
15438,Body position,overexertion from prolonged holding,0
15439,18-month milestones,Child 18 month examination,0
15440,2-4 week milestones: responds to sound,Responds to sound (finding),0
15441,milestone: fixes on faces,Able to recognize faces,0
15442,milestone: extremities move equally,Finding related to ability to move limb,0
15443,milestone: lifts chin off surface,Able to raise head,0
15444,milestone: has a social smile,Smiles (finding),0
15445,milestone: gaze follows past midline,Gaze,0
15446,milestone: lifts head and chest off surface,Able to raise head,0
15447,milestone: head steady in upright position,Able to control head posture,0
15448,milestone: hands open 50% of the time,Form of hand - finding,0
15449,milestone: turns toward voices,Responds to voice,0
15450,milestone: laughs,Laughs spontaneously,0
15451,milestone: uses arms to push chest off surface,Able to push,0
15452,milestone: rolls from front onto back,Able to roll over,0
15453,milestone: no head lag when pulled to sit position,Able to control head posture,0
15454,milestone: brings hands together,Finding related to ability to move hand,0
15455,milestone: reaches for objects,Does reach,0
15456,milestone: babbles,Speech babble finding,0
15457,milestone: rolls over from back to front,Does roll over,0
15458,milestone: sits independently,Child 8-9 month examination,0
15459,milestone: sits independently,Able to sit unsupported,0
15460,milestone: passes objects from hand to hand,Able to pass things from hand to hand,0
15461,milestone: shy with strangers,Social interaction finding,0
15462,milestone: shy with strangers,Child 8-9 month examination,0
15463,milestone: plays pat-a-cake,Child 8-9 month examination,0
15464,milestone: plays pat-a-cake,Able to play,0
15465,milestone: waves bye-bye,Finding related to ability to move hand,0
15466,milestone: waves bye-bye,Finding related to ability to interact with others,0
15467,milestone: imitates simple daily tasks,Finding related to ability to imitate forms of communication,0
15468,milestone: imitates simple daily tasks,Cognitive function observations,0
15469,milestone: rolls a ball back to examiner,Finding related to ability to interact with others,0
15470,12-month milestones: bangs objects together,Does bang objects together,0
15471,milestone: neat pincer grasp,Does use pincer grip,0
15472,milestone: says mama or dada specifically,Able to spontaneously say one or two words,0
15473,"milestone: says mama, dada, and 3 additional words",Able to spontaneously say three or more words,0
15474,milestone: drinks from a cup,Able to drink from a feeder cup,0
15475,milestone: pulls self to a standing position,Child 8-9 month examination,0
15476,milestone: pulls self to a standing position,Able to pull to standing from sitting,0
15477,milestone: walks holding onto furniture,Finding related to ability to walk,0
15478,milestone: stands well alone,Does stand alone,0
15479,milestone: walks unassisted,Independent walking,0
15480,milestone: uses a spoon,Child 18 month examination,0
15481,milestone: uses a spoon,Able to use spoon to feed self,0
15482,milestone: helps with simple tasks,Social interaction finding,0
15483,milestone: helps with simple tasks,Child 18 month examination,0
15484,18-month milestones: removes clothes,Child 18 month examination,0
15485,18-month milestones: removes clothes,Able to undress,0
15486,milestone: turns pages without ripping them,Child 18 month examination,0
15487,milestone: turns pages without ripping them,Does turn pages,0
15488,milestone: stacks 3-4 blocks,Child 18 month examination,0
15489,milestone: stacks 3-4 blocks,Finding related to ability to perform fine motor function,0
15490,milestone: dumps raisins from bottle,Child 18 month examination,0
15491,milestone: dumps raisins from bottle,Finding related to ability to perform fine motor function,0
15492,milestone: combines two different words,Child 18 month examination,0
15493,milestone: combines two different words,Finding related to ability to use words,0
15494,milestone: names an animal in a picture,Child 18 month examination,0
15495,milestone: names an animal in a picture,Finding related to ability to recognize objects,0
15496,milestone: vocabulary of 7-20 words,Child 18 month examination,0
15497,milestone: vocabulary of 7-20 words,Finding related to ability to use words,0
15498,milestone: kicks ball forward,Child 18 month examination,0
15499,milestone: kicks ball forward,Able to kick,0
15500,milestone: throws ball overhand,Able to throw objects,0
15501,18-month milestones: walks up steps,Child 18 month examination,0
15502,18-month milestones: walks up steps,Able to walk up step,0
15503,24-month milestones: puts on clothing,Able to dress,0
15504,milestone: washes and dries hands,Able to perform washing and drying of self activities,0
15505,milestone: separates from parent easily,Social interaction finding,0
15506,milestone: plays interactively with other children,Able to participate in games for play,0
15507,milestone: stacks 5 or more blocks,Finding related to ability to perform fine motor function,0
15508,milestone: turns single pages,Able to turn pages,0
15509,milestone: colors with crayons,Finding related to ability to perform drawing activities,0
15510,milestone: imitates a vertical line,Finding related to ability to imitate forms of communication,0
15511,milestone: uses 2-3 word sentences,Able to use words,0
15512,milestone: uses plurals,Able to use words,0
15513,"milestone: knows name, age, and sex",Finding related to ability to comprehend,0
15514,milestone: balances on one foot for 1 second,Able to stand on one leg,0
15515,milestone: jumps in place,Does jump,0
15516,milestone: can ride tricycle,Able to ride and propel toy,0
15517,milestone: runs well,Does run (finding),0
15518,milestone: walks up and down stairs,Able to manage stairs,0
15519,36-month milestones: buttons clothes,Able to manage clothes fastenings,0
15520,milestone: dresses with supervision,Able to dress,0
15521,milestone: dresses without supervision,Independent with dressing,0
15522,milestone: symbolic play,Finding related to ability to play,0
15523,milestone: can copy a circle,Able to perform drawing activities,0
15524,milestone: can draw a person,Able to perform drawing activities,0
15525,"milestone: comprehends cold, hungry, and tired",Finding related to ability to comprehend,0
15526,milestone: uses prepositions,Finding related to ability to use words,0
15527,milestone: uses pronouns,Finding related to ability to use words,0
15528,milestone: recognizes 3 of 4 colors,Finding related to recognition,0
15529,milestone: balances on one foot for 5 seconds,Able to stand on one leg,0
15530,milestone: jumps on one foot,Does skip on one foot,0
15531,milestone: alternates feet walking up stairs,Finding related to ability to walk up stairs,0
15532,Renal sclerosis with hypertension,Hypertensive disease,0
15533,Arteriolar nephritis,Hypertensive disease,0
15534,Administration of medication,Intravasation of drug or medicament,0
15535,Cystic Fibrosis,Diabetes mellitus associated with cystic fibrosis,0
15536,Benign hypertensive renal disease,Hypertensive disease,0
15537,Hypertensive renal disease with renal failure,Hypertensive disease,0
15538,"Renal hypertension complicating pregnancy, childbirth and the puerperium",Hypertensive disease,0
15539,"Renal hypertension complicating pregnancy, childbirth and the puerperium - delivered",Hypertensive disease,0
15540,"Renal hypertension complicating pregnancy, childbirth and the puerperium - delivered with postnatal complication",Hypertensive disease,0
15541,"Renal hypertension complicating pregnancy, childbirth and the puerperium - not delivered",Hypertensive disease,0
15542,"Renal hypertension complicating pregnancy, childbirth and the puerperium with postnatal complication",Hypertensive disease,0
15543,Hereditary Diseases,Rabson-Mendenhall Syndrome,0
15544,Hereditary Diseases,Wolfram Syndrome,0
15545,Nephrosclerosis,Hypertensive disease,0
15546,Rabson-Mendenhall Syndrome,Hereditary Diseases,0
15547,Hypertensive disease,Renal sclerosis with hypertension,0
15548,Hypertensive disease,Arteriolar nephritis,0
15549,Hypertensive disease,Benign hypertensive renal disease,0
15550,Hypertensive disease,Hypertensive renal disease with renal failure,0
15551,Hypertensive disease,"Renal hypertension complicating pregnancy, childbirth and the puerperium",0
15552,Hypertensive disease,"Renal hypertension complicating pregnancy, childbirth and the puerperium - delivered",0
15553,Hypertensive disease,"Renal hypertension complicating pregnancy, childbirth and the puerperium - delivered with postnatal complication",0
15554,Hypertensive disease,"Renal hypertension complicating pregnancy, childbirth and the puerperium - not delivered",0
15555,Hypertensive disease,"Renal hypertension complicating pregnancy, childbirth and the puerperium with postnatal complication",0
15556,Hypertensive disease,Nephrosclerosis,0
15557,Hypertensive disease,hypertensive nephropathy,0
15558,Hypertensive disease,Hypertensive complication,0
15559,Hypertensive disease,Hypertensive renal disease complicating AND/OR reason for care during childbirth,0
15560,Hypertensive disease,Hypertensive renal failure,0
15561,Hypertensive disease,Hypertensive Encephalopathy,0
15562,Hypertensive disease,Hypertensive renal disease complicating AND/OR reason for care during puerperium,0
15563,Hypertensive disease,Benign arteriolar nephrosclerosis,0
15564,Hypertensive disease,Malignant hypertensive renal disease,0
15565,Hypertensive disease,Hypertensive renal disease complicating AND/OR reason for care during pregnancy,0
15566,Hypertensive disease,Hypertensive Retinopathy,0
15567,Hypertensive disease,Hypertensive renal disease in obstetric context,0
15568,Hypertensive disease,Chronic hypertensive uremia,0
15569,Hypertensive disease,Malignant arteriolar nephrosclerosis,0
15570,Hypertensive disease,Arteriolar nephrosclerosis,0
15571,hypertensive nephropathy,Hypertensive disease,0
15572,Diabetes mellitus associated with cystic fibrosis,Cystic Fibrosis,0
15573,Hypertensive complication,Hypertensive disease,0
15574,Diffuse infiltrative lymphocytosis syndrome,HIV Infections,0
15575,Intravasation of drug or medicament,Administration of medication,0
15576,Hypertensive renal disease complicating AND/OR reason for care during childbirth,Hypertensive disease,0
15577,Hypertensive renal failure,Hypertensive disease,0
15578,Hypertensive Encephalopathy,Hypertensive disease,0
15579,Hypertensive renal disease complicating AND/OR reason for care during puerperium,Hypertensive disease,0
15580,Benign arteriolar nephrosclerosis,Hypertensive disease,0
15581,Malignant hypertensive renal disease,Hypertensive disease,0
15582,Hypertensive renal disease complicating AND/OR reason for care during pregnancy,Hypertensive disease,0
15583,Hypertensive Retinopathy,Hypertensive disease,0
15584,Wolfram Syndrome,Hereditary Diseases,0
15585,Hypertensive renal disease in obstetric context,Hypertensive disease,0
15586,Chronic hypertensive uremia,Hypertensive disease,0
15587,Malignant arteriolar nephrosclerosis,Hypertensive disease,0
15588,HIV Infections,Diffuse infiltrative lymphocytosis syndrome,0
15589,Arteriolar nephrosclerosis,Hypertensive disease,0
15590,Shrapnel,puncture of sternum consistent with shrapnel entry wound,0
15591,Shrapnel,puncture of sternum consistent with entry wound of specified shrapnel fragment (#___),0
15592,Shrapnel,puncture of sternum consistent with entry wound of multiple shrapnel fragments,0
15593,Shrapnel,puncture of right breast consistent with shrapnel entry wound,0
15594,Shrapnel,puncture of right breast consistent with entry wound of specified shrapnel fragment (#___),0
15595,Shrapnel,puncture of right breast consistent with entry wound of multiple shrapnel fragments,0
15596,Shrapnel,puncture of right breast consistent with shrapnel exit wound,0
15597,Shrapnel,puncture of right breast consistent with exit wound of specified shrapnel fragment (#___),0
15598,Shrapnel,puncture of right breast consistent with exit wound of multiple shrapnel fragments,0
15599,Shrapnel,puncture of left breast consistent with shrapnel entry wound,0
15600,Shrapnel,puncture of left breast consistent with entry wound of specified shrapnel fragment (#___),0
15601,Shrapnel,puncture of left breast consistent with entry wound of multiple shrapnel fragments,0
15602,Straining,chest pain made worse by straining,0
15603,Warm skin,warmth of stump wound of right ankle amputation,0
15604,Warm skin,warmth of stump wound of left ankle amputation,0
15605,Warm skin,warmth of stump of right forearm amputation,0
15606,Warm skin,warmth of stump of left forearm amputation,0
15607,Warm skin,warmth of stump of right arm amputation,0
15608,Warm skin,warmth of stump of left arm amputation,0
15609,Warm skin,warmth of stump of right thigh amputation,0
15610,Warm skin,warmth of stump of left thigh amputation,0
15611,Warm skin,stump assessment of right lower leg showed warmth,0
15612,Warm skin,stump assessment of left lower leg showed warmth,0
15613,Warm skin,warmth of stump of foot amputation,0
15614,Warm skin,breast lump feels warm,0
15615,Regurgitation of food,heartburn with regurgitation,0
15616,mastectomy scar on right side,Excision of breast tissue,0
15617,mastectomy scar on left side,Excision of breast tissue,0
15618,electrocardiogram: PR segment elevated during chest pain only,Chest Pain,0
15619,electrocardiogram: PR segment depressed during chest pain only,Chest Pain,0
15620,mammogram mass #1 of superior lateral quadrant of right breast with spicules,Mass in breast,0
15621,mammogram mass #2 of superior lateral quadrant of right breast with spicules,Mass in breast,0
15622,mammogram mass #3 of superior lateral quadrant of right breast with spicules,Mass in breast,0
15623,mammogram mass #1 of superior lateral quadrant of right breast compared with previous mass,Mass in breast,0
15624,mammogram increased size of mass #1 of superior lateral quadrant of right breast,Mass in breast,0
15625,mammogram decreased size of mass #1 of superior lateral quadrant of right breast,Mass in breast,0
15626,mammogram unchanged size of mass #1 of superior lateral quadrant of right breast,Mass in breast,0
15627,mammogram previous mass #1 of superior lateral quadrant of right breast with unchanged spicules,Spiculated lesion,0
15628,mammogram previous mass #1 of superior lateral quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15629,mammogram mass #1 of inferior lateral quadrant of right breast with spicules,Mass in breast,0
15630,mammogram mass #2 of inferior lateral quadrant of right breast with spicules,Mass in breast,0
15631,mammogram mass #3 of inferior lateral quadrant of right breast with spicules,Mass in breast,0
15632,mammogram mass #1 of superior medial quadrant of right breast with spicules,Mass in breast,0
15633,mammogram mass #2 of superior medial quadrant of right breast with spicules,Mass in breast,0
15634,mammogram mass #3 of superior medial quadrant of right breast with spicules,Mass in breast,0
15635,mammogram mass #1 of inferior medial quadrant of right breast with spicules,Mass in breast,0
15636,mammogram mass #2 of inferior medial quadrant of right breast with spicules,Mass in breast,0
15637,mammogram mass #3 of inferior medial quadrant of right breast with spicules,Mass in breast,0
15638,mammogram mass #1 of superior lateral quadrant of left breast with spicules,Spiculated lesion,0
15639,mammogram mass #1 of superior lateral quadrant of left breast with spicules,Mass in breast,0
15640,mammogram mass #2 of superior lateral quadrant of left breast with spicules,Mass in breast,0
15641,mammogram mass #3 of superior lateral quadrant of left breast with spicules,Mass in breast,0
15642,mammogram mass #1 of superior lateral quadrant of left breast compared with previous mass,Mass in breast,0
15643,mammogram increased size of mass #1 of superior lateral quadrant of left breast,Mass in breast,0
15644,mammogram decreased size of mass #1 of superior lateral quadrant of left breast,Mass in breast,0
15645,mammogram unchanged size of mass #1 of superior lateral quadrant of left breast,Mass in breast,0
15646,mammogram previous mass #1 of superior lateral quadrant of left breast with unchanged spicules,Spiculated lesion,0
15647,mammogram previous mass #1 of superior lateral quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15648,mammogram mass #1 of inferior lateral quadrant of left breast with spicules,Mass in breast,0
15649,mammogram mass #2 of inferior lateral quadrant of left breast with spicules,Mass in breast,0
15650,mammogram mass #3 of inferior lateral quadrant of left breast with spicules,Mass in breast,0
15651,mammogram mass #1 of superior medial quadrant of left breast with spicules,Mass in breast,0
15652,mammogram mass #2 of superior medial quadrant of left breast with spicules,Mass in breast,0
15653,mammogram mass #3 of superior medial quadrant of left breast with spicules,Mass in breast,0
15654,mammogram mass #1 of inferior medial quadrant of left breast with spicules,Mass in breast,0
15655,mammogram mass #2 of inferior medial quadrant of left breast with spicules,Mass in breast,0
15656,mammogram mass #3 of inferior medial quadrant of left breast with spicules,Mass in breast,0
15657,mammogram mass #2 of superior lateral quadrant of right breast compared with previous mass,Mass in breast,0
15658,mammogram increased size of mass #2 of superior lateral quadrant of right breast,Mass in breast,0
15659,mammogram decreased size of mass #2 of superior lateral quadrant of right breast,Mass in breast,0
15660,mammogram unchanged size of mass #2 of superior lateral quadrant of right breast,Mass in breast,0
15661,mammogram previous mass #2 of superior lateral quadrant of right breast with unchanged spicules,Spiculated lesion,0
15662,mammogram previous mass #2 of superior lateral quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15663,mammogram mass #3 of superior lateral quadrant of right breast compared with previous mass,Mass in breast,0
15664,mammogram increased size of mass #3 of superior lateral quadrant of right breast,Mass in breast,0
15665,mammogram decreased size of mass #3 of superior lateral quadrant of right breast,Mass in breast,0
15666,mammogram unchanged size of mass #3 of superior lateral quadrant of right breast,Mass in breast,0
15667,mammogram previous mass #3 of superior lateral quadrant of right breast with unchanged spicules,Spiculated lesion,0
15668,mammogram previous mass #3 of superior lateral quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15669,mammogram increased number of masses of superior lateral quadrant of right breast,Number of lumps - finding,0
15670,mammogram decreased number of masses of superior lateral quadrant of right breast,Number of lumps - finding,0
15671,mammogram unchanged number of masses of superior lateral quadrant of right breast,Number of lumps - finding,0
15672,mammogram mass #1 of inferior lateral quadrant of right breast compared with previous mass,Mass in breast,0
15673,mammogram increased size of mass #1 of inferior lateral quadrant of right breast,Mass in breast,0
15674,mammogram decreased size of mass #1 of inferior lateral quadrant of right breast,Mass in breast,0
15675,mammogram unchanged size of mass #1 of inferior lateral quadrant of right breast,Mass in breast,0
15676,mammogram previous mass #1 of inferior lateral quadrant of right breast with unchanged spicules,Spiculated lesion,0
15677,mammogram previous mass #1 of inferior lateral quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15678,mammogram mass #2 of inferior lateral quadrant of right breast compared with previous mass,Mass in breast,0
15679,mammogram increased size of mass #2 of inferior lateral quadrant of right breast,Mass in breast,0
15680,mammogram decreased size of mass #2 of inferior lateral quadrant of right breast,Mass in breast,0
15681,mammogram unchanged size of mass #2 of inferior lateral quadrant of right breast,Mass in breast,0
15682,mammogram previous mass #2 of inferior lateral quadrant of right breast with unchanged spicules,Spiculated lesion,0
15683,mammogram previous mass #2 of inferior lateral quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15684,mammogram mass #3 of inferior lateral quadrant of right breast compared with previous mass,Mass in breast,0
15685,mammogram increased size of mass #3 of inferior lateral quadrant of right breast,Mass in breast,0
15686,mammogram decreased size of mass #3 of inferior lateral quadrant of right breast,Mass in breast,0
15687,mammogram unchanged size of mass #3 of inferior lateral quadrant of right breast,Mass in breast,0
15688,mammogram previous mass #3 of inferior lateral quadrant of right breast with unchanged spicules,Spiculated lesion,0
15689,mammogram previous mass #3 of inferior lateral quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15690,mammogram increased number of masses of inferior lateral quadrant of right breast,Number of lumps - finding,0
15691,mammogram decreased number of masses of inferior lateral quadrant of right breast,Number of lumps - finding,0
15692,mammogram unchanged number of masses of inferior lateral quadrant of right breast,Number of lumps - finding,0
15693,mammogram mass #1 of superior medial quadrant of right breast compared with previous mass,Mass in breast,0
15694,mammogram increased size of mass #1 of superior medial quadrant of right breast,Mass in breast,0
15695,mammogram decreased size of mass #1 of superior medial quadrant of right breast,Mass in breast,0
15696,mammogram unchanged size of mass #1 of superior medial quadrant of right breast,Mass in breast,0
15697,mammogram previous mass #1 of superior medial quadrant of right breast with unchanged spicules,Spiculated lesion,0
15698,mammogram previous mass #1 of superior medial quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15699,mammogram mass #2 of superior medial quadrant of right breast compared with previous mass,Mass in breast,0
15700,mammogram increased size of mass #2 of superior medial quadrant of right breast,Mass in breast,0
15701,mammogram decreased size of mass #2 of superior medial quadrant of right breast,Mass in breast,0
15702,mammogram unchanged size of mass #2 of superior medial quadrant of right breast,Mass in breast,0
15703,mammogram previous mass #2 of superior medial quadrant of right breast with unchanged spicules,Spiculated lesion,0
15704,mammogram previous mass #2 of superior medial quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15705,mammogram mass #3 of superior medial quadrant of right breast compared with previous mass,Mass in breast,0
15706,mammogram increased size of mass #3 of superior medial quadrant of right breast,Mass in breast,0
15707,mammogram decreased size of mass #3 of superior medial quadrant of right breast,Mass in breast,0
15708,mammogram unchanged size of mass #3 of superior medial quadrant of right breast,Mass in breast,0
15709,mammogram previous mass #3 of superior medial quadrant of right breast with unchanged spicules,Spiculated lesion,0
15710,mammogram previous mass #3 of superior medial quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15711,mammogram increased number of masses of superior medial quadrant of right breast,Number of lumps - finding,0
15712,mammogram decreased number of masses of superior medial quadrant of right breast,Number of lumps - finding,0
15713,mammogram unchanged number of masses of superior medial quadrant of right breast,Number of lumps - finding,0
15714,mammogram mass #1 of inferior medial quadrant of right breast compared with previous mass,Mass in breast,0
15715,mammogram increased size of mass #1 of inferior medial quadrant of right breast,Mass in breast,0
15716,mammogram decreased size of mass #1 of inferior medial quadrant of right breast,Mass in breast,0
15717,mammogram unchanged size of mass #1 of inferior medial quadrant of right breast,Mass in breast,0
15718,mammogram previous mass #1 of inferior medial quadrant of right breast with unchanged spicules,Spiculated lesion,0
15719,mammogram previous mass #1 of inferior medial quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15720,mammogram mass #2 of inferior medial quadrant of right breast compared with previous mass,Mass in breast,0
15721,mammogram increased size of mass #2 of inferior medial quadrant of right breast,Mass in breast,0
15722,mammogram decreased size of mass #2 of inferior medial quadrant of right breast,Mass in breast,0
15723,mammogram unchanged size of mass #2 of inferior medial quadrant of right breast,Mass in breast,0
15724,mammogram previous mass #2 of inferior medial quadrant of right breast with unchanged spicules,Spiculated lesion,0
15725,mammogram previous mass #2 of inferior medial quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15726,mammogram mass #3 of inferior medial quadrant of right breast compared with previous mass,Mass in breast,0
15727,mammogram increased size of mass #3 of inferior medial quadrant of right breast,Mass in breast,0
15728,mammogram decreased size of mass #3 of inferior medial quadrant of right breast,Mass in breast,0
15729,mammogram unchanged size of mass #3 of inferior medial quadrant of right breast,Mass in breast,0
15730,mammogram previous mass #3 of inferior medial quadrant of right breast with unchanged spicules,Spiculated lesion,0
15731,mammogram previous mass #3 of inferior medial quadrant of right breast with unchanged microcalcifications,Breast Microcalcification,0
15732,mammogram increased number of masses of inferior medial quadrant of right breast,Number of lumps - finding,0
15733,mammogram decreased number of masses of inferior medial quadrant of right breast,Number of lumps - finding,0
15734,mammogram unchanged number of masses of inferior medial quadrant of right breast,Number of lumps - finding,0
15735,mammogram mass #2 of superior lateral quadrant of left breast compared with previous mass,Mass in breast,0
15736,mammogram mass #3 of superior lateral quadrant of left breast compared with previous mass,Mass in breast,0
15737,mammogram increased size of mass #2 of superior lateral quadrant of left breast,Mass in breast,0
15738,mammogram decreased size of mass #2 of superior lateral quadrant of left breast,Mass in breast,0
15739,mammogram unchanged size of mass #2 of superior lateral quadrant of left breast,Mass in breast,0
15740,mammogram previous mass #2 of superior lateral quadrant of left breast with unchanged spicules,Spiculated lesion,0
15741,mammogram previous mass #2 of superior lateral quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15742,mammogram increased size of mass #3 of superior lateral quadrant of left breast,Mass in breast,0
15743,mammogram decreased size of mass #3 of superior lateral quadrant of left breast,Mass in breast,0
15744,mammogram unchanged size of mass #3 of superior lateral quadrant of left breast,Mass in breast,0
15745,mammogram previous mass #3 of superior lateral quadrant of left breast with unchanged spicules,Spiculated lesion,0
15746,mammogram previous mass #3 of superior lateral quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15747,mammogram increased number of masses of superior lateral quadrant of left breast,Number of lumps - finding,0
15748,mammogram decreased number of previous masses of superior lateral quadrant of left breast,Number of lumps - finding,0
15749,mammogram unchanged number of masses of superior lateral quadrant of left breast,Number of lumps - finding,0
15750,mammogram mass #1 of inferior lateral quadrant of left breast compared with previous mass,Mass in breast,0
15751,mammogram increased size of mass #1 of inferior lateral quadrant of left breast,Mass in breast,0
15752,mammogram decreased size of mass #1 of inferior lateral quadrant of left breast,Mass in breast,0
15753,mammogram unchanged size of mass #1 of inferior lateral quadrant of left breast,Mass in breast,0
15754,mammogram previous mass #1 of inferior lateral quadrant of left breast with unchanged spicules,Spiculated lesion,0
15755,mammogram previous mass #1 of inferior lateral quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15756,mammogram mass #2 of inferior lateral quadrant of left breast compared with previous mass,Mass in breast,0
15757,mammogram increased size of mass #2 of inferior lateral quadrant of left breast,Mass in breast,0
15758,mammogram decreased size of mass #2 of inferior lateral quadrant of left breast,Mass in breast,0
15759,mammogram unchanged size of mass #2 of inferior lateral quadrant of left breast,Mass in breast,0
15760,mammogram previous mass #2 of inferior lateral quadrant of left breast with unchanged spicules,Spiculated lesion,0
15761,mammogram previous mass #2 of inferior lateral quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15762,mammogram mass #3 of inferior lateral quadrant of left breast compared with previous mass,Mass in breast,0
15763,mammogram increased size of mass #3 of inferior lateral quadrant of left breast,Mass in breast,0
15764,mammogram decreased size of mass #3 of inferior lateral quadrant of left breast,Mass in breast,0
15765,mammogram unchanged size of mass #3 of inferior lateral quadrant of left breast,Mass in breast,0
15766,mammogram previous mass #3 of inferior lateral quadrant of left breast with unchanged spicules,Spiculated lesion,0
15767,mammogram previous mass #3 of inferior lateral quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15768,mammogram increased number of masses of inferior lateral quadrant of left breast,Number of lumps - finding,0
15769,mammogram decreased number of previous masses of inferior lateral quadrant of left breast,Number of lumps - finding,0
15770,mammogram unchanged number of masses of inferior lateral quadrant of left breast,Number of lumps - finding,0
15771,mammogram mass #1 of superior medial quadrant of left breast compared with previous mass,Mass in breast,0
15772,mammogram increased size of mass #1 of superior medial quadrant of left breast,Mass in breast,0
15773,mammogram decreased size of mass #1 of superior medial quadrant of left breast,Mass in breast,0
15774,mammogram unchanged size of mass #1 of superior medial quadrant of left breast,Mass in breast,0
15775,mammogram previous mass #1 of superior medial quadrant of left breast with unchanged spicules,Spiculated lesion,0
15776,mammogram previous mass #1 of superior medial quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15777,mammogram mass #2 of superior medial quadrant of left breast compared with previous mass,Mass in breast,0
15778,mammogram increased size of mass #2 of superior medial quadrant of left breast,Mass in breast,0
15779,mammogram decreased size of mass #2 of superior medial quadrant of left breast,Mass in breast,0
15780,mammogram unchanged size of mass #2 of superior medial quadrant of left breast,Mass in breast,0
15781,mammogram previous mass #2 of superior medial quadrant of left breast with spicules unchanged,Spiculated lesion,0
15782,mammogram previous mass #2 of superior medial quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15783,mammogram mass #3 of superior medial quadrant of left breast compared with previous mass,Mass in breast,0
15784,mammogram increased size of mass #3 of superior medial quadrant of left breast,Mass in breast,0
15785,mammogram decreased size of mass #3 of superior medial quadrant of left breast,Mass in breast,0
15786,mammogram unchanged size of mass #3 of superior medial quadrant of left breast,Mass in breast,0
15787,mammogram previous mass #3 of superior medial quadrant of left breast with unchanged spicules,Spiculated lesion,0
15788,mammogram previous mass #3 of superior medial quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15789,mammogram increased number of masses of superior medial quadrant of left breast,Number of lumps - finding,0
15790,mammogram decreased number of previous masses of superior medial quadrant of left breast,Number of lumps - finding,0
15791,mammogram unchanged number of masses of superior medial quadrant of left breast,Number of lumps - finding,0
15792,mammogram mass #1 of inferior medial quadrant of left breast compared with previous result,Mass in breast,0
15793,mammogram increased size of mass #1 inferior medial quadrant left breast,Mass in breast,0
15794,mammogram decreased size of mass #1 of inferior medial quadrant left breast,Mass in breast,0
15795,mammogram unchanged size of mass #1 of inferior medial quadrant of left breast,Mass in breast,0
15796,mammogram previous mass #1 of inferior medial quadrant of left breast with unchanged spicules,Spiculated lesion,0
15797,mammogram previous mass #1 of inferior medial quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15798,mammogram mass #2 of inferior medial quadrant of left breast compared with previous result,Mass in breast,0
15799,mammogram increased size of mass #2 of inferior medial quadrant of left breast,Mass in breast,0
15800,mammogram decreased size of mass #2 of inferior medial quadrant of left breast,Mass in breast,0
15801,mammogram unchanged size of mass #2 of inferior medial quadrant of left breast,Mass in breast,0
15802,mammogram previous mass #2 of inferior medial quadrant of left breast with unchanged spicules,Spiculated lesion,0
15803,mammogram previous mass #2 of inferior medial quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15804,mammogram mass #3 of inferior medial quadrant of left breast compared with previous result,Mass in breast,0
15805,mammogram increased size of mass #3 of inferior medial quadrant of left breast,Mass in breast,0
15806,mammogram decreased size of mass #3 of inferior medial quadrant of left breast,Mass in breast,0
15807,mammogram unchanged size of mass #3 of inferior medial quadrant of left breast,Mass in breast,0
15808,mammogram previous mass #3 of inferior medial quadrant of left breast with unchanged spicules,Spiculated lesion,0
15809,mammogram previous mass #3 of inferior medial quadrant of left breast with unchanged microcalcifications,Breast Microcalcification,0
15810,mammogram increased number of masses of inferior medial quadrant of left breast,Number of lumps - finding,0
15811,mammogram decreased number of previous masses of inferior medial quadrant of left breast,Number of lumps - finding,0
15812,mammogram unchanged number of masses of inferior medial quadrant of left breast,Number of lumps - finding,0
15813,Poor education,parental education limited,0
15814,rectal pain after anal sex,Anal penetration,0
15815,foot pain occurring often at night,Symptom occurs at night,0
15816,black skin crust,Dark color,0
15817,brown skin crust,Dark color,0
15818,Medical tuning fork,vibration test foot using tuning fork,0
15819,Medical tuning fork,vibration test right foot using tuning fork,0
15820,Medical tuning fork,vibration test left foot using tuning fork,0
15821,Medical tuning fork,sensation tuning fork test decreased sensation,0
15822,Medical tuning fork,sensation tuning fork test decreased sensation right foot,0
15823,Medical tuning fork,sensation tuning fork test decreased sensation left foot,0
15824,symmetrical gynecomastia,Symmetrical breasts,0
15825,Diabetic ketoacidosis without coma,chemical-induced diabetes mellitus with ketoacidosis without coma,0
15826,neck pain radiating to right shoulder,Pain radiating to right shoulder,0
15827,neck pain radiating to left shoulder,Pain radiating to left shoulder,0
15828,neck pain radiating to both shoulders,Radiating pain,0
15829,muscle cramps in thigh precipitated by exercise,Exercise aggravates symptom,0
15830,muscle cramps in thigh especially in cold weather,Cold weather,0
15831,ankle joint suddenly gives way going upstairs,Finding related to ability to walk up stairs,0
15832,lower back pain radiating to legs worse on right,Pain radiating to right leg,0
15833,lower back pain radiating to legs worse on left,Pain radiating to left leg,0
15834,lower back pain worsens with bending forward,Symptom aggravating factors,0
15835,lower back pain worsens with bending backward,Symptom aggravating factors,0
15836,lower back pain worsens with bending to right,Symptom aggravating factors,0
15837,lower back pain worsens with bending to left,Symptom aggravating factors,0
15838,lower back pain worsens with turning,Symptom aggravating factors,0
15839,Prosthetic valve,prosthetic valve functioning normally,0
15840,Prosthetic valve,prosthetic aortic valve functioning normally,0
15841,Prosthetic valve,prosthetic mitral valve functioning normally,0
15842,Prosthetic valve,prosthetic pulmonary valve functioning normally,0
15843,Prosthetic valve,prosthetic tricuspid valve functioning normally,0
15844,black discoloration of fingernail,Dark color,0
15845,black discoloration of right thumbnail,Dark color,0
15846,black discoloration of index fingernail of right hand,Dark color,0
15847,black discoloration of middle fingernail of right hand,Dark color,0
15848,black discoloration of ring fingernail of right hand,Dark color,0
15849,black discoloration of little fingernail of right hand,Dark color,0
15850,black discoloration of left thumbnail,Dark color,0
15851,black discoloration of index fingernail of left hand,Dark color,0
15852,black discoloration of middle fingernail of left hand,Dark color,0
15853,black discoloration of ring fingernail of left hand,Dark color,0
15854,black discoloration of little fingernail of left hand,Dark color,0
15855,blue discoloration of fingernail,Blue color,0
15856,blue discoloration of right thumbnail,Blue color,0
15857,blue discoloration of index fingernail of right hand,Blue color,0
15858,blue discoloration of middle fingernail of right hand,Blue color,0
15859,blue discoloration of ring fingernail of right hand,Blue color,0
15860,blue discoloration of little fingernail of right hand,Blue color,0
15861,blue discoloration of left thumbnail,Blue color,0
15862,blue discoloration of index fingernail of left hand,Blue color,0
15863,blue discoloration of middle fingernail of left hand,Blue color,0
15864,blue discoloration of ring fingernail of left hand,Blue color,0
15865,blue discoloration of little fingernail of left hand,Blue color,0
15866,lower back pain relieved by frequent position changes while sitting,Pain relief related to position,0
15867,lower back pain relieved by lying on back with pillow between knees,Pain relief by supine position,0
15868,lower back pain relieved by sitting,Pain relief related to position,0
15869,lower back pain relieved by standing,Pain relief related to position,0
15870,lower back pain relieved by movement walking,Pain relief by walking,0
15871,lower back pain relieved by leaning forward,Pain relief related to position,0
15872,foot pain relieved by rest,Rest relieves symptom,0
15873,foot pain precipitated by wearing shoes,Shoes,0
15874,foot pain precipitated by cold weather,Cold weather,0
15875,foot pain worsens with weightbearing,Weight Bearing,0
15876,foot pain worsens with walking,Pain provoked by walking,0
15877,foot pain worsens with running,Pain provoked by running,0
15878,soft tissue pain in finger with blue discoloration,Discoloration of skin,0
15879,soft tissue pain in finger with white discoloration,White discoloration of skin,0
15880,soft tissue pain in finger with black discoloration,Discoloration of skin,0
15881,chronic wheezing has not changed,Patient condition unchanged,0
15882,chronic wheezing suddenly much worse,Patient's condition worsened,0
15883,chronic wheezing slowly much worse,Patient's condition worsened,0
15884,foot pain relieved by cessation of activity,Rest relieves symptom,0
15885,blue-green urine,Blue color,0
15886,disorientation only at night,Symptom occurs at night,0
15887,disorientation steadily worsening,Patient's condition deteriorating,0
15888,lower back pain relieved by leaning backward,Pain relief related to position,0
15889,unreasonable fear of injury related events,Traumatic injury,0
15890,unreasonable fear of seeing an injury,Traumatic injury,0
15891,lower back pain worsens with cold temperatures,Cold aggravates symptom,0
15892,lower back pain relieved by medication,Pain relief by medication,0
15893,lower back pain relieved by bracing,Pain characterized by relieving factor,0
15894,lower back pain relieved by heat,Heat relieves symptom,0
15895,lower back pain relieved by ice,Cold relieves symptom,0
15896,lower back pain relieved by firm mattress,Pain characterized by relieving factor,0
15897,lower back pain relieved by softer mattress,Pain characterized by relieving factor,0
15898,lower back pain relieved by waterbed,Pain characterized by relieving factor,0
15899,lower back pain relieved by alternative medicine approach,Pain characterized by relieving factor,0
15900,hip joint pain improved by medication,Pain relief by medication,0
15901,hip joint pain improved by non-steroidal anti-inflammatory drugs (NSAIDs),Pain relief by medication,0
15902,thigh pain improved by rest,Pain relief by rest,0
15903,thigh pain improved by medication,Pain relief by medication,0
15904,thigh pain improved by acetaminophen,Pain relief by medication,0
15905,thigh pain improved by non-steroidal anti-inflammatory drugs (NSAIDs),Pain relief by medication,0
15906,thigh pain improved by narcotics,Pain relief by medication,0
15907,factors relieving muscle cramps in thigh,Symptom relieving factors,0
15908,muscle cramps in thigh relieved by medication,Pain relief by medication,0
15909,muscle cramps in thigh relieved by heat,Heat relieves symptom,0
15910,muscle cramps in thigh relieved by ice,Cold relieves symptom,0
15911,muscle cramps in thigh relieved by stretching,Movement relieves symptom,0
15912,muscle cramps in thigh relieved by ice cream,Food relieves symptom,0
15913,foot pain relieved by medication,Pain relief by medication,0
15914,Complication of procedure,maternal medical procedure affecting newborn,0
15915,muscle cramps in thigh especially in hot weather,Hot weather,0
15916,Finding related to pregnancy,"yellow skin or eyes during pregnancy, subsiding afterwards",0
15917,Postpartum finding,cervical laceration during delivery as postpartum condition,0
15918,Delivery finding,Laceration of cervix - obstetric,0
15919,Prolapse of urethra,vaginal wall prolapse with urethrocele,0
15920,Measurement,examination of heart rate,0
15921,reported abnormal breathing function tests,Lung function testing abnormal,0
15922,mammogram difficulty due to excessive breast size,Macromastia,0
15923,Open wound,open wound with avulsion,0
15924,Jejunostomy tube,percutaneous jejunostomy tube site tissue avulsion,0
15925,Diabetic peripheral angiopathy,chemical-induced diabetes mellitus with diabetic peripheral angiopathy without gangrene,0
15926,Traumatic brain injury with no loss of consciousness,"Closed fracture of vault of skull with cerebral laceration and contusion, with no loss of consciousness",0
15927,Traumatic brain injury with no loss of consciousness,closed fracture of skull with cerebral laceration and contusion without loss of consciousness,0
15928,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,closed fracture of skull vault with intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,0
15929,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,closed fracture of base of skull with intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,0
15930,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,closed fracture of base of skull with intracranial injury with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,0
15931,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,closed fracture of skull vault with cerebral laceration and contusion with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,0
15932,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,"closed fracture of base of skull with subarachnoid, subdural, or extradural hemorrhage with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness",0
15933,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,"closed fracture of skull with subarachnoid, subdural, or extradural hemorrhage with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness",0
15934,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,closed fracture of skull with unspecified intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,0
15935,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,closed fracture of skull with unspecified intracranial injury with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,0
15936,Intracranial hemorrhage following injury with prolonged loss of consciousness without return to pre-existing conscious level,closed fracture of skull vault with intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,0
15937,Intracranial hemorrhage following injury with prolonged loss of consciousness without return to pre-existing conscious level,closed fracture of base of skull with intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,0
15938,Intracranial hemorrhage following injury with prolonged loss of consciousness without return to pre-existing conscious level,"closed fracture of base of skull with subarachnoid, subdural, or extradural hemorrhage with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness",0
15939,Intracranial hemorrhage following injury with prolonged loss of consciousness without return to pre-existing conscious level,"closed fracture of skull with subarachnoid, subdural, or extradural hemorrhage with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness",0
15940,Intracranial hemorrhage following injury with prolonged loss of consciousness without return to pre-existing conscious level,closed fracture of skull with unspecified intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,0
15941,Intracranial hemorrhage following injury with prolonged loss of consciousness without return to pre-existing conscious level,closed fracture of skull with unspecified intracranial injury with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,0
15942,Inflammatory disorder,Pingueculitis,0
15943,hearing handicap inventory for the elderly (hhie-s) ___(0-40),Hearing assessment,0
15944,accident caused by accidental discharge of weapon,Weapons,0
15945,housing facilities bathtub,Bathtub,0
15946,housing facilities bathtub nonfunctioning,Bathtub,0
15947,housing facilities shower,Shower bath device,0
15948,housing facilities bathtub no grab bars,Bathtub rails,0
15949,reported tests: breathing function peak flow in 'green zone' (80-100%),More than 80% of predicted peak flow rate,0
15950,reported tests: breathing function peak flow in 'red zone' (0-49%),Peak flow rate abnormal,0
15951,lost faith in medical regimen,Medical therapy,0
15952,medication intolerance anticoagulant medication,Anticoagulants,0
15953,Postprocedural state finding,postprocedural oliguria,0
15954,Postprocedural state finding,postprocedural anuria,0
15955,Postprocedural state finding,Postprocedural renal failure,0
15956,Extremely dense breast composition,inconclusive mammogram due to dense breasts,0
15957,Spiculated lesion,mammogram previous mass #1 of superior lateral quadrant of right breast with unchanged spicules,0
15958,Spiculated lesion,mammogram mass #1 of superior lateral quadrant of left breast with spicules,0
15959,Spiculated lesion,mammogram previous mass #1 of superior lateral quadrant of left breast with unchanged spicules,0
15960,Spiculated lesion,mammogram previous mass #2 of superior lateral quadrant of right breast with unchanged spicules,0
15961,Spiculated lesion,mammogram previous mass #3 of superior lateral quadrant of right breast with unchanged spicules,0
15962,Spiculated lesion,mammogram previous mass #1 of inferior lateral quadrant of right breast with unchanged spicules,0
15963,Spiculated lesion,mammogram previous mass #2 of inferior lateral quadrant of right breast with unchanged spicules,0
15964,Spiculated lesion,mammogram previous mass #3 of inferior lateral quadrant of right breast with unchanged spicules,0
15965,Spiculated lesion,mammogram previous mass #1 of superior medial quadrant of right breast with unchanged spicules,0
15966,Spiculated lesion,mammogram previous mass #2 of superior medial quadrant of right breast with unchanged spicules,0
15967,Spiculated lesion,mammogram previous mass #3 of superior medial quadrant of right breast with unchanged spicules,0
15968,Spiculated lesion,mammogram previous mass #1 of inferior medial quadrant of right breast with unchanged spicules,0
15969,Spiculated lesion,mammogram previous mass #2 of inferior medial quadrant of right breast with unchanged spicules,0
15970,Spiculated lesion,mammogram previous mass #3 of inferior medial quadrant of right breast with unchanged spicules,0
15971,Spiculated lesion,mammogram previous mass #2 of superior lateral quadrant of left breast with unchanged spicules,0
15972,Spiculated lesion,mammogram previous mass #3 of superior lateral quadrant of left breast with unchanged spicules,0
15973,Spiculated lesion,mammogram previous mass #1 of inferior lateral quadrant of left breast with unchanged spicules,0
15974,Spiculated lesion,mammogram previous mass #2 of inferior lateral quadrant of left breast with unchanged spicules,0
15975,Spiculated lesion,mammogram previous mass #3 of inferior lateral quadrant of left breast with unchanged spicules,0
15976,Spiculated lesion,mammogram previous mass #1 of superior medial quadrant of left breast with unchanged spicules,0
15977,Spiculated lesion,mammogram previous mass #2 of superior medial quadrant of left breast with spicules unchanged,0
15978,Spiculated lesion,mammogram previous mass #3 of superior medial quadrant of left breast with unchanged spicules,0
15979,Spiculated lesion,mammogram previous mass #1 of inferior medial quadrant of left breast with unchanged spicules,0
15980,Spiculated lesion,mammogram previous mass #2 of inferior medial quadrant of left breast with unchanged spicules,0
15981,Spiculated lesion,mammogram previous mass #3 of inferior medial quadrant of left breast with unchanged spicules,0
15982,Radiographic calcification,ultrasound of pelvis: calcified mass of uterus,0
15983,Hemorrhage,bleeding laceration of right temporomandibular joint,0
15984,Hemorrhage,bleeding laceration of left temporomandibular joint,0
15985,Hemorrhage,bleeding laceration of anterior neck,0
15986,Hemorrhage,bleeding laceration of posterior neck,0
15987,Hemorrhage,bleeding laceration of right side of neck,0
15988,Hemorrhage,bleeding laceration of left side of neck,0
15989,Hemorrhage,bleeding laceration of right shoulder,0
15990,Hemorrhage,bleeding laceration of left shoulder,0
15991,Hemorrhage,bleeding laceration of right arm,0
15992,Hemorrhage,bleeding laceration of left arm,0
15993,Hemorrhage,bleeding laceration of right elbow,0
15994,Hemorrhage,bleeding laceration of left elbow,0
15995,Hemorrhage,bleeding laceration of right forearm (physical finding),0
15996,Hemorrhage,bleeding laceration of left forearm,0
15997,Hemorrhage,bleeding laceration of right wrist,0
15998,Hemorrhage,bleeding laceration of left wrist,0
15999,Hemorrhage,bleeding laceration of right hand,0
16000,Hemorrhage,bleeding laceration of left hand,0
16001,Hemorrhage,bleeding laceration of right anterior chest wall,0
16002,Hemorrhage,bleeding laceration of left anterior chest wall,0
16003,Hemorrhage,bleeding laceration of sternum,0
16004,Hemorrhage,bleeding laceration of right lateral chest wall,0
16005,Hemorrhage,bleeding laceration of left lateral chest wall,0
16006,Hemorrhage,bleeding laceration of right upper back,0
16007,Hemorrhage,bleeding laceration of left upper back,0
16008,Hemorrhage,bleeding laceration of right pelvic region,0
16009,Hemorrhage,bleeding laceration of left pelvic region,0
16010,Hemorrhage,bleeding laceration of right buttock,0
16011,Hemorrhage,bleeding laceration of left buttock,0
16012,Hemorrhage,bleeding laceration of right hip,0
16013,Hemorrhage,bleeding laceration of left hip,0
16014,Hemorrhage,bleeding laceration of right thigh,0
16015,Hemorrhage,bleeding laceration of left thigh,0
16016,Hemorrhage,bleeding laceration of right knee,0
16017,Hemorrhage,bleeding laceration of left knee,0
16018,Hemorrhage,bleeding laceration of right lower leg,0
16019,Hemorrhage,bleeding laceration of left lower leg,0
16020,Hemorrhage,bleeding laceration of right ankle,0
16021,Hemorrhage,bleeding laceration of left ankle,0
16022,Hemorrhage,bleeding laceration of right foot,0
16023,Hemorrhage,bleeding laceration of left foot,0
16024,Hemorrhage,bleeding laceration of right upper paraspinal region,0
16025,Hemorrhage,bleeding laceration of left upper paraspinal region,0
16026,Hemorrhage,bleeding laceration of right mid back,0
16027,Hemorrhage,bleeding laceration of tissue of right mid back,0
16028,Hemorrhage,bleeding laceration of right mid paraspinal region,0
16029,Hemorrhage,bleeding laceration of left mid paraspinal region,0
16030,Hemorrhage,bleeding laceration of left mid back,0
16031,Hemorrhage,bleeding laceration of right lower back,0
16032,Hemorrhage,bleeding laceration of right lower paraspinal region,0
16033,Hemorrhage,bleeding laceration of left lower paraspinal region,0
16034,Hemorrhage,bleeding laceration of left lower back,0
16035,Hemorrhage,bleeding laceration of toe,0
16036,Hemorrhage,bleeding laceration of finger,0
16037,Hemorrhage,bleeding laceration of right ear,0
16038,Hemorrhage,bleeding laceration of left ear,0
16039,Hemorrhage,laceration of penis with active bleeding,0
16040,Hemorrhage,laceration of right labia majora with active bleeding,0
16041,Hemorrhage,laceration of left labia majora with active bleeding,0
16042,Hemorrhage,laceration of right labia minora with active bleeding,0
16043,Hemorrhage,laceration of left labia minora with active bleeding,0
16044,Hemorrhage,size of laceration on anterior vaginal wall with active bleeding,0
16045,Hemorrhage,size of laceration on vaginal sidewall with active bleeding,0
16046,Hemorrhage,size of laceration on posterior vaginal wall with active bleeding,0
16047,Hemorrhage,actively bleeding laceration of cervix at specified location,0
16048,Hemorrhage,hemorrhagic mass of buccal mucosa,0
16049,Hemorrhage,bleeding laceration of genitalia,0
16050,Hemorrhage,bleeding laceration of perineum,0
16051,Hemorrhage,bleeding laceration of anus,0
16052,Hemorrhage,bleeding laceration of right breast,0
16053,Hemorrhage,bleeding laceration of left breast,0
16054,Hemorrhage,hemorrhage due to afibrinogenemia following molar pregnancy,0
16055,Hemorrhage,bleeding laceration,0
16056,Hemorrhage,laceration with active blood loss,0
16057,Hemorrhage,bleeding laceration of scalp,0
16058,Hemorrhage,bleeding laceration of top of head,0
16059,Hemorrhage,bleeding laceration of forehead,0
16060,Hemorrhage,bleeding laceration of face,0
16061,Hemorrhage,bleeding laceration of temple,0
16062,Hemorrhage,bleeding laceration of back of head,0
16063,Hemorrhage,bleeding laceration of abdominal wall,0
16064,electrocardiogram: inverted T waves while ST segment elevated,ST segment elevation (finding),0
16065,Anastomosis of pulmonary-subclavian artery by Blalock-Taussig operation,echocardiography: Blalock-Taussig shunt patent,0
16066,Anastomosis of pulmonary-subclavian artery by Blalock-Taussig operation,echocardiography: Blalock-Taussig shunt obstructed,0
16067,Anastomosis of pulmonary-subclavian artery by Blalock-Taussig operation,echocardiography: flow velocity of Blalock-Taussig shunt,0
16068,barium swallow: surgical clips in esophagus,Surgical Clips,0
16069,barium swallow: post-surgical change of esophagus,Operation on esophagus (procedure),0
16070,barium swallow: esophageal surgical colonic interposition,Intrathoracic esophageal anastomosis with interposition of colon,0
16071,barium swallow: nasogastric tube in place,Nasogastric tube,0
16072,barium swallow: surgical clips in stomach,Surgical Clips,0
16073,barium swallow: post-surgical change of stomach,Operation on stomach,0
16074,barium swallow: partial gastrectomy,Subtotal gastrectomy,0
16075,X-ray UGI Ba swallow- surgical change total gastrectomy,Total excision of stomach,0
16076,barium swallow: post-surgical change gastroduodenostomy Billroth I,Billroth I Procedure,0
16077,barium swallow: post-surgical change gastrojejunostomy Billroth II,Billroth II Procedure,0
16078,Barium swallow surgical change - gastroenterostomy,Gastroenterostomy,0
16079,barium swallow: surgical clips in duodenum,Surgical Clips,0
16080,x-ray series of small bowel: mucosal inflammation with ischemia,Vascular insufficiency of intestine,0
16081,color of crust,Observation of color of skin,0
16082,Artificial cardiac pacemaker,Finding of cardiac pacemaker,0
16083,barium enema surgical clips in rectum,Surgical Clips,0
16084,barium enema surgical clips in sigmoid colon,Surgical Clips,0
16085,barium enema surgical clips in descending colon,Surgical Clips,0
16086,barium enema surgical clips in splenic flexure,Surgical Clips,0
16087,barium enema constricting mass lesion of transverse colon,Colonic Stenosis,0
16088,barium enema surgical clips in transverse colon,Surgical Clips,0
16089,barium enema surgical clips in hepatic flexure,Surgical Clips,0
16090,barium enema surgical clips in ascending colon,Surgical Clips,0
16091,barium enema surgical clips in cecum,Surgical Clips,0
16092,barium enema surgical clips in appendix,Surgical Clips,0
16093,barium enema surgical clips in terminal ileum,Surgical Clips,0
16094,Shower bath device,housing facilities shower,0
16095,Aspirator,dependence on aspirator,0
16096,ultrasound of pelvis: calcified mass of uterus,Radiographic calcification,0
16097,Injury of liver with open wound into abdominal cavity,laceration of liver with open wound into cavity,0
16098,chest pain accompanied by difficulty breathing,Dyspnea,0
16099,chest pain accompanied by palpitations,Palpitations,0
16100,chest pain accompanied by upset stomach,Upset stomach,0
16101,chest pain accompanied by sweating,Sweating,0
16102,Illiteracy,parents are illiterate,0
16103,Upset stomach,chest pain accompanied by upset stomach,0
16104,Fluctuation,fluctuant effusion in knee,0
16105,Fluctuation,fluctuant effusion in right knee,0
16106,Fluctuation,fluctuant effusion in left knee,0
16107,Fluctuation,fluctuant effusion in both knees,0
16108,Symptom aggravating factors,lower back pain worsens with bending forward,0
16109,Symptom aggravating factors,lower back pain worsens with bending backward,0
16110,Symptom aggravating factors,lower back pain worsens with bending to right,0
16111,Symptom aggravating factors,lower back pain worsens with bending to left,0
16112,Symptom aggravating factors,lower back pain worsens with turning,0
16113,Symptom aggravating factors,lower back pain worsens with bending,0
16114,Symptom aggravating factors,lower back pain worsened by lying down,0
16115,Exercise aggravates symptom,muscle cramps in thigh precipitated by exercise,0
16116,Exercise aggravates symptom,diplopia worsens with exercise,0
16117,Exercise aggravates symptom,foot pain with exercise,0
16118,Heat aggravates symptom,diplopia worsens with heat,0
16119,Cold aggravates symptom,lower back pain worsens with cold temperatures,0
16120,Symptom relieving factors,factors relieving muscle cramps in thigh,0
16121,Food relieves symptom,muscle cramps in thigh relieved by ice cream,0
16122,Movement relieves symptom,muscle cramps in thigh relieved by stretching,0
16123,Movement relieves symptom,lower back pain relieved by movement,0
16124,Rest relieves symptom,foot pain relieved by rest,0
16125,Rest relieves symptom,foot pain relieved by cessation of activity,0
16126,Heat relieves symptom,lower back pain relieved by heat,0
16127,Heat relieves symptom,muscle cramps in thigh relieved by heat,0
16128,Heat relieves symptom,headache relieved by heat,0
16129,Cold relieves symptom,lower back pain relieved by ice,0
16130,Cold relieves symptom,muscle cramps in thigh relieved by ice,0
16131,Cold relieves symptom,headache relieved by ice,0
16132,Symptom occurs at night,foot pain occurring often at night,0
16133,Symptom occurs at night,disorientation only at night,0
16134,Operation on stomach,barium swallow: post-surgical change of stomach,0
16135,macular puckering of right eye with anterior-posterior traction,Retinal traction,0
16136,macular puckering of right eye with tangential traction and pseudohole,Retinal traction,0
16137,macular puckering of right eye with tangential traction and pseudohole,Macular pseudohole,0
16138,macular puckering of right eye with tangential traction,Retinal traction,0
16139,macular puckering of left eye with tangential traction,Retinal traction,0
16140,macular puckering of left eye with tangential traction and pseudohole,Retinal traction,0
16141,macular puckering of left eye with tangential traction and pseudohole,Macular pseudohole,0
16142,macular puckering of left eye with anterior-posterior traction,Retinal traction,0
16143,nasal discharge lasting more than 3 weeks,Prolonged menses,0
16144,fluctuant effusion in knee,Fluctuation,0
16145,fluctuant effusion in right knee,Fluctuation,0
16146,fluctuant effusion in left knee,Fluctuation,0
16147,fluctuant effusion in both knees,Fluctuation,0
16148,warmth of stump wound of right ankle amputation,Warm skin,0
16149,drainage of stump wound of right ankle amputation,Wound discharge finding,0
16150,sanguineous drainage of stump wound of right ankle amputation,Sanguineous discharge from wound,0
16151,serosanguineous drainage of stump of right ankle amputation,Serosanguineous discharge from wound,0
16152,clear drainage of stump wound of right ankle amputation,Non-purulent discharge from wound,0
16153,"clean, dry, and intact stump wound of right ankle amputation",Actual Effective Skin Integrity,0
16154,warmth of stump wound of left ankle amputation,Warm skin,0
16155,drainage of stump wound of left ankle amputation,Wound discharge finding,0
16156,sanguineous drainage of stump wound of left ankle amputation,Sanguineous discharge from wound,0
16157,serosanguineous drainage of stump of left ankle amputation,Serosanguineous discharge from wound,0
16158,clear drainage of stump wound of left ankle amputation,Non-purulent discharge from wound,0
16159,"clean, dry, and intact stump wound of left ankle amputation",Actual Effective Skin Integrity,0
16160,Nasogastric tube,barium swallow: nasogastric tube in place,0
16161,Parasitic Diseases,parasites in hair,0
16162,Ruptured ectopic pregnancy,cervical pregnancy with intrauterine pregnancy with rupture,0
16163,lower back pain relieved by movement,Movement relieves symptom,0
16164,warmth of stump of right forearm amputation,Warm skin,0
16165,drainage of stump of right forearm amputation,Wound discharge finding,0
16166,sanguineous drainage of stump of right forearm amputation,Sanguineous discharge from wound,0
16167,serosanguineous drainage of stump of right forearm amputation,Serosanguineous discharge from wound,0
16168,clear drainage of stump of right forearm amputation,Non-purulent discharge from wound,0
16169,"clean, dry, and intact stump wound of right forearm amputation",Actual Effective Skin Integrity,0
16170,warmth of stump of left forearm amputation,Warm skin,0
16171,drainage of stump of left forearm amputation,Wound discharge finding,0
16172,sanguineous drainage of stump of left forearm amputation,Sanguineous discharge from wound,0
16173,serosanguineous drainage of stump of left forearm amputation,Serosanguineous discharge from wound,0
16174,clear drainage of stump of left forearm amputation,Non-purulent discharge from wound,0
16175,"clean, dry, and intact stump wound of left forearm amputation",Actual Effective Skin Integrity,0
16176,warmth of stump of right arm amputation,Warm skin,0
16177,drainage of stump of right arm amputation,Wound discharge finding,0
16178,sanguineous drainage of stump of right arm amputation,Sanguineous discharge from wound,0
16179,serosanguineous drainage of stump of right arm amputation,Serosanguineous discharge from wound,0
16180,clear drainage of stump of right arm amputation,Non-purulent discharge from wound,0
16181,"clean, dry, and intact stump wound of right arm amputation",Actual Effective Skin Integrity,0
16182,warmth of stump of left arm amputation,Warm skin,0
16183,drainage of stump of left arm amputation,Wound discharge finding,0
16184,sanguineous drainage of stump of left arm amputation,Sanguineous discharge from wound,0
16185,serosanguineous drainage of stump of left arm amputation,Serosanguineous discharge from wound,0
16186,clear drainage of stump of left arm amputation,Non-purulent discharge from wound,0
16187,"clean, dry, and intact stump wound of left arm amputation",Actual Effective Skin Integrity,0
16188,warmth of stump of right thigh amputation,Warm skin,0
16189,drainage of stump of right thigh amputation,Wound discharge finding,0
16190,sanguineous drainage of stump of right thigh amputation,Sanguineous discharge from wound,0
16191,serosanguineous drainage of stump of right thigh amputation,Serosanguineous discharge from wound,0
16192,clear drainage of stump of right thigh amputation,Non-purulent discharge from wound,0
16193,"clean, dry, and intact stump wound of right thigh amputation",Actual Effective Skin Integrity,0
16194,warmth of stump of left thigh amputation,Warm skin,0
16195,drainage of stump of left thigh amputation,Wound discharge finding,0
16196,sanguineous drainage of stump of left thigh amputation,Sanguineous discharge from wound,0
16197,serosanguineous drainage of stump of left thigh amputation,Serosanguineous discharge from wound,0
16198,clear drainage of stump of left thigh amputation,Non-purulent discharge from wound,0
16199,"clean, dry, and intact stump wound of left thigh amputation",Actual Effective Skin Integrity,0
16200,stump assessment of right lower leg showed warmth,Warm skin,0
16201,stump assessment of right lower leg showed drainage,Wound discharge finding,0
16202,stump assessment of right lower leg showed sanguineous drainage,Sanguineous discharge from wound,0
16203,stump assessment of right lower leg showed serosanguineous drainage,Serosanguineous discharge from wound,0
16204,stump assessment of right lower leg showed clear drainage,Non-purulent discharge from wound,0
16205,"stump assessment of right lower leg showed a wound which was clean, dry , and intact",Actual Effective Skin Integrity,0
16206,stump assessment of left lower leg showed warmth,Warm skin,0
16207,stump assessment of left lower leg showed drainage,Wound discharge finding,0
16208,stump assessment of left lower leg showed sanguineous drainage,Sanguineous discharge from wound,0
16209,stump assessment of left lower leg showed serosanguineous drainage,Serosanguineous discharge from wound,0
16210,stump assessment of left lower leg showed clear drainage,Non-purulent discharge from wound,0
16211,"stump assessment of left lower leg showed a wound which was clean, dry, and intact",Actual Effective Skin Integrity,0
16212,neck pain radiating up back of head on right,Pain radiating to head,0
16213,neck pain radiating up back of head on left,Pain radiating to head,0
16214,bleeding laceration of right temporomandibular joint,Hemorrhage,0
16215,laceration of right temporomandibular joint with arterial bleeding,Arterial hemorrhage,0
16216,laceration of right temporomandibular joint with venous bleeding,Rupture of vein,0
16217,weeping laceration of right temporomandibular joint,Wound discharge finding,0
16218,serous drainage from laceration of right temporomandibular joint,Serous discharge from wound,0
16219,bloody laceration of right temporomandibular joint,Sanguinous exudate from wound,0
16220,purulent laceration of right temporomandibular joint,Purulent discharge from wound,0
16221,laceration of right temporomandibular joint with aligned margins,Wound edges approximated,0
16222,dehiscence of laceration of right temporomandibular joint,Wound dehiscence,0
16223,bleeding laceration of left temporomandibular joint,Hemorrhage,0
16224,laceration of left temporomandibular joint with arterial bleeding,Arterial hemorrhage,0
16225,laceration of left temporomandibular joint with venous bleeding,Rupture of vein,0
16226,weeping laceration of left temporomandibular joint,Wound discharge finding,0
16227,serous drainage from laceration of left temporomandibular joint,Serous discharge from wound,0
16228,bloody laceration of left temporomandibular joint,Sanguinous exudate from wound,0
16229,purulent laceration of left temporomandibular joint,Purulent discharge from wound,0
16230,laceration of left temporomandibular joint with aligned margins,Wound edges approximated,0
16231,dehiscence of laceration of left temporomandibular joint,Wound dehiscence,0
16232,bleeding laceration of anterior neck,Hemorrhage,0
16233,laceration of anterior neck with arterial bleeding,Arterial hemorrhage,0
16234,laceration of anterior neck with venous bleeding,Rupture of vein,0
16235,weeping laceration of anterior neck,Wound discharge finding,0
16236,serous drainage from laceration of anterior neck,Serous discharge from wound,0
16237,bloody laceration of anterior neck,Sanguinous exudate from wound,0
16238,purulent laceration of anterior neck,Purulent discharge from wound,0
16239,laceration of anterior neck with aligned margins,Wound edges approximated,0
16240,dehiscence of laceration of anterior neck,Wound dehiscence,0
16241,bleeding laceration of posterior neck,Hemorrhage,0
16242,laceration of posterior neck with arterial bleeding,Arterial hemorrhage,0
16243,laceration of posterior neck with venous bleeding,Rupture of vein,0
16244,weeping laceration of posterior neck,Wound discharge finding,0
16245,serous drainage from laceration of posterior neck,Serous discharge from wound,0
16246,serosanguineous drainage from laceration of posterior neck,Serosanguineous discharge from wound,0
16247,bloody laceration of posterior neck,Sanguinous exudate from wound,0
16248,purulent laceration of posterior neck,Purulent discharge from wound,0
16249,laceration of posterior neck with aligned margins,Wound edges approximated,0
16250,dehiscence of laceration of posterior neck,Wound dehiscence,0
16251,bleeding laceration of right side of neck,Hemorrhage,0
16252,laceration of right side of neck with arterial bleeding,Arterial hemorrhage,0
16253,laceration of right side of neck with venous bleeding,Rupture of vein,0
16254,weeping laceration of right side of neck,Wound discharge finding,0
16255,serous drainage from laceration of right side of neck,Serous discharge from wound,0
16256,bloody laceration of right side of neck,Sanguinous exudate from wound,0
16257,purulent laceration of right side of neck,Purulent discharge from wound,0
16258,laceration of right side of neck with aligned margins,Wound edges approximated,0
16259,dehiscence of laceration of right side of neck,Wound dehiscence,0
16260,bleeding laceration of left side of neck,Hemorrhage,0
16261,laceration of left side of neck with arterial bleeding,Arterial hemorrhage,0
16262,laceration of left side of neck with venous bleeding,Rupture of vein,0
16263,weeping laceration of left side of neck,Wound discharge finding,0
16264,serous drainage from laceration of left side of neck,Serous discharge from wound,0
16265,bloody laceration of left side of neck,Sanguinous exudate from wound,0
16266,purulent laceration of left side of neck,Purulent discharge from wound,0
16267,laceration of left side of neck with aligned margins,Wound edges approximated,0
16268,dehiscence of laceration of left side of neck,Wound dehiscence,0
16269,bleeding laceration of right shoulder,Hemorrhage,0
16270,laceration of right shoulder with arterial bleeding,Arterial hemorrhage,0
16271,laceration of right shoulder with venous bleeding,Rupture of vein,0
16272,weeping laceration of right shoulder,Wound discharge finding,0
16273,serous laceration of right shoulder,Serous discharge from wound,0
16274,bloody laceration of right shoulder,Sanguinous exudate from wound,0
16275,purulent laceration of right shoulder,Purulent discharge from wound,0
16276,laceration of right shoulder with aligned margins,Wound edges approximated,0
16277,dehiscence of laceration of right shoulder,Wound dehiscence,0
16278,bleeding laceration of left shoulder,Hemorrhage,0
16279,laceration of left shoulder with arterial bleeding,Arterial hemorrhage,0
16280,laceration of left shoulder with venous bleeding,Rupture of vein,0
16281,weeping laceration of left shoulder,Wound discharge finding,0
16282,serous drainage from laceration of left shoulder,Serous discharge from wound,0
16283,bloody laceration of left shoulder,Sanguinous exudate from wound,0
16284,purulent laceration of left shoulder,Purulent discharge from wound,0
16285,laceration of left shoulder with aligned margins,Wound edges approximated,0
16286,dehiscence of laceration of left shoulder,Wound dehiscence,0
16287,bleeding laceration of right arm,Hemorrhage,0
16288,laceration of right arm with arterial bleeding,Arterial hemorrhage,0
16289,laceration of right arm with venous bleeding,Rupture of vein,0
16290,weeping laceration of right arm,Wound discharge finding,0
16291,serous drainage from laceration of right arm,Serous discharge from wound,0
16292,bloody laceration of right arm,Sanguinous exudate from wound,0
16293,purulent laceration of right arm,Purulent discharge from wound,0
16294,laceration of right arm with aligned margins,Wound edges approximated,0
16295,dehiscence of laceration of right arm,Wound dehiscence,0
16296,bleeding laceration of left arm,Hemorrhage,0
16297,laceration of left arm with arterial bleeding,Arterial hemorrhage,0
16298,laceration of left arm with venous bleeding,Rupture of vein,0
16299,weeping laceration of left arm,Wound discharge finding,0
16300,serous drainage from laceration of left arm,Serous discharge from wound,0
16301,bloody laceration of left arm,Sanguinous exudate from wound,0
16302,purulent laceration of left arm,Purulent discharge from wound,0
16303,laceration of left arm with aligned margins,Wound edges approximated,0
16304,dehiscence of laceration of left arm,Wound dehiscence,0
16305,bleeding laceration of right elbow,Hemorrhage,0
16306,laceration of right elbow with arterial bleeding,Arterial hemorrhage,0
16307,laceration of right elbow with venous bleeding,Rupture of vein,0
16308,weeping laceration of right elbow,Wound discharge finding,0
16309,serous drainage from laceration of right elbow,Serous discharge from wound,0
16310,bloody laceration of right elbow,Sanguinous exudate from wound,0
16311,purulent laceration of right elbow,Purulent discharge from wound,0
16312,laceration of right elbow with aligned margins,Wound edges approximated,0
16313,dehiscence of laceration of right elbow,Wound dehiscence,0
16314,bleeding laceration of left elbow,Hemorrhage,0
16315,laceration of left elbow with arterial bleeding,Arterial hemorrhage,0
16316,laceration of left elbow with venous bleeding,Rupture of vein,0
16317,weeping laceration of left elbow,Wound discharge finding,0
16318,serous drainage from laceration of left elbow,Serous discharge from wound,0
16319,bloody laceration of left elbow,Sanguinous exudate from wound,0
16320,purulent laceration of left elbow,Purulent discharge from wound,0
16321,laceration of left elbow with aligned margins,Wound edges approximated,0
16322,dehiscence of laceration of left elbow,Wound dehiscence,0
16323,bleeding laceration of right forearm (physical finding),Hemorrhage,0
16324,laceration of right forearm with arterial bleeding,Arterial hemorrhage,0
16325,laceration of right forearm with venous bleeding,Rupture of vein,0
16326,weeping laceration of right forearm,Wound discharge finding,0
16327,serous drainage from laceration of right forearm,Serous discharge from wound,0
16328,bloody laceration of right forearm,Sanguinous exudate from wound,0
16329,purulent laceration of right forearm,Purulent discharge from wound,0
16330,laceration of right forearm with aligned margins,Wound edges approximated,0
16331,dehiscence of laceration of right forearm,Wound dehiscence,0
16332,Doctor/patient problems,patient complaints: insufficient time with provider,0
16333,Proteus Infections,burn with secondary proteus infection,0
16334,Gastroenterostomy,Barium swallow surgical change - gastroenterostomy,0
16335,dependence on aspirator,Aspirator,0
16336,Colonic Stenosis,barium enema constricting mass lesion of transverse colon,0
16337,Late effects of cerebrovascular disease,facial weakness as late effect of cerebrovascular disease,0
16338,Postoperative state,postoperative dural tear,0
16339,Postoperative state,postsurgical state acquired absence of organ breast,0
16340,Postoperative state,postsurgical state acquired absence of organ breast right,0
16341,Postoperative state,postsurgical state acquired absence of organ breast left,0
16342,Acquired pyloric stricture,adult hypertrophic pyloric stenosis with stricture,0
16343,Concretion of intestine,fecal impaction with enterolith,0
16344,bleeding laceration of left forearm,Hemorrhage,0
16345,laceration of left forearm with arterial bleeding,Arterial hemorrhage,0
16346,laceration of left forearm with venous bleeding,Rupture of vein,0
16347,weeping laceration of left forearm,Wound discharge finding,0
16348,serous drainage from laceration of left forearm,Serous discharge from wound,0
16349,bloody laceration of left forearm,Sanguinous exudate from wound,0
16350,purulent laceration of left forearm,Purulent discharge from wound,0
16351,laceration of left forearm with aligned margins,Wound edges approximated,0
16352,dehiscence of laceration of left forearm,Wound dehiscence,0
16353,bleeding laceration of right wrist,Hemorrhage,0
16354,laceration of right wrist with arterial bleeding,Arterial hemorrhage,0
16355,laceration of right wrist with venous bleeding,Rupture of vein,0
16356,weeping laceration of right wrist,Wound discharge finding,0
16357,serous drainage from laceration of right wrist,Serous discharge from wound,0
16358,bloody laceration of right wrist,Sanguinous exudate from wound,0
16359,purulent laceration of right wrist,Purulent discharge from wound,0
16360,laceration of right wrist with aligned margins,Wound edges approximated,0
16361,dehiscence of laceration of right wrist,Wound dehiscence,0
16362,bleeding laceration of left wrist,Hemorrhage,0
16363,laceration of left wrist with arterial bleeding,Arterial hemorrhage,0
16364,laceration of left wrist with venous bleeding,Rupture of vein,0
16365,weeping laceration of left wrist,Wound discharge finding,0
16366,serous drainage from laceration of left wrist,Serous discharge from wound,0
16367,bloody laceration of left wrist,Sanguinous exudate from wound,0
16368,purulent laceration of left wrist,Purulent discharge from wound,0
16369,laceration of left wrist with aligned margins,Wound edges approximated,0
16370,dehiscence of laceration of left wrist,Wound dehiscence,0
16371,bleeding laceration of right hand,Hemorrhage,0
16372,laceration of right hand with arterial bleeding,Arterial hemorrhage,0
16373,laceration of right hand with venous bleeding,Rupture of vein,0
16374,weeping laceration of right hand,Wound discharge finding,0
16375,serous drainage from laceration of right hand,Serous discharge from wound,0
16376,bloody laceration of right hand,Sanguinous exudate from wound,0
16377,purulent laceration of right hand,Purulent discharge from wound,0
16378,laceration of right hand with aligned margins,Wound edges approximated,0
16379,dehiscence of laceration of right hand,Wound dehiscence,0
16380,bleeding laceration of left hand,Hemorrhage,0
16381,laceration of left hand with arterial bleeding,Arterial hemorrhage,0
16382,laceration of left hand with venous bleeding,Rupture of vein,0
16383,weeping laceration of left hand,Wound discharge finding,0
16384,serous drainage from laceration of left hand,Serous discharge from wound,0
16385,bloody laceration of left hand,Sanguinous exudate from wound,0
16386,purulent laceration of left hand,Purulent discharge from wound,0
16387,laceration of left hand with aligned margins,Wound edges approximated,0
16388,dehiscence of laceration of left hand,Wound dehiscence,0
16389,bleeding laceration of right anterior chest wall,Hemorrhage,0
16390,laceration of right anterior chest wall with arterial bleeding,Arterial hemorrhage,0
16391,laceration of right anterior chest wall with venous bleeding,Rupture of vein,0
16392,weeping laceration of right anterior chest wall,Wound discharge finding,0
16393,serous drainage from laceration of right anterior chest wall,Serous discharge from wound,0
16394,bloody laceration of right anterior chest wall,Sanguinous exudate from wound,0
16395,purulent laceration of right anterior chest wall,Purulent discharge from wound,0
16396,laceration of right anterior chest wall with aligned margins,Wound edges approximated,0
16397,dehiscence of laceration of right anterior chest wall,Wound dehiscence,0
16398,bleeding laceration of left anterior chest wall,Hemorrhage,0
16399,laceration of left anterior chest wall with arterial bleeding,Arterial hemorrhage,0
16400,laceration of left anterior chest wall with venous bleeding,Rupture of vein,0
16401,serous drainage from laceration of left anterior chest wall,Serous discharge from wound,0
16402,bloody laceration of left anterior chest wall,Sanguinous exudate from wound,0
16403,purulent laceration of left anterior chest wall,Purulent discharge from wound,0
16404,laceration of left anterior chest wall with aligned margins,Wound edges approximated,0
16405,dehiscence of laceration of left anterior chest wall,Wound dehiscence,0
16406,bleeding laceration of sternum,Hemorrhage,0
16407,laceration of sternum with arterial bleeding,Arterial hemorrhage,0
16408,laceration of sternum with venous bleeding,Rupture of vein,0
16409,weeping laceration of sternum,Wound discharge finding,0
16410,serous drainage from laceration of sternum,Serous discharge from wound,0
16411,bloody laceration of sternum,Sanguinous exudate from wound,0
16412,purulent laceration of sternum,Purulent discharge from wound,0
16413,laceration of sternum with aligned margins,Wound edges approximated,0
16414,dehiscence of laceration of sternum,Wound dehiscence,0
16415,puncture of sternum consistent with bullet entry wound,Gunshot entry wound,0
16416,puncture of sternum consistent with entry wound of specified bullet (#___),Gunshot entry wound,0
16417,puncture of sternum consistent with entry wound of multiple bullets,Gunshot entry wound,0
16418,bleeding laceration of right lateral chest wall,Hemorrhage,0
16419,laceration of right lateral chest wall with arterial bleeding,Arterial hemorrhage,0
16420,laceration of right lateral chest wall with venous bleeding,Rupture of vein,0
16421,weeping laceration of right lateral chest wall,Wound discharge finding,0
16422,serous drainage from laceration of right lateral chest wall,Serous discharge from wound,0
16423,bloody laceration of right lateral chest wall,Sanguinous exudate from wound,0
16424,purulent laceration of right lateral chest wall,Purulent discharge from wound,0
16425,laceration of right lateral chest wall with aligned margins,Wound edges approximated,0
16426,dehiscence of laceration of right lateral chest wall,Wound dehiscence,0
16427,bleeding laceration of left lateral chest wall,Hemorrhage,0
16428,laceration of left lateral chest wall with arterial bleeding,Arterial hemorrhage,0
16429,laceration of left lateral chest wall with venous bleeding,Rupture of vein,0
16430,weeping laceration of left lateral chest wall,Wound discharge finding,0
16431,serous drainage from laceration of left lateral chest wall,Serous discharge from wound,0
16432,bloody laceration of left lateral chest wall,Sanguinous exudate from wound,0
16433,purulent laceration of left lateral chest wall,Purulent discharge from wound,0
16434,laceration of left lateral chest wall with aligned margins,Wound edges approximated,0
16435,dehiscence of laceration of left lateral chest wall,Wound dehiscence,0
16436,bleeding laceration of right upper back,Hemorrhage,0
16437,laceration of right upper back with arterial bleeding,Arterial hemorrhage,0
16438,laceration of right upper back with venous bleeding,Rupture of vein,0
16439,weeping laceration of right upper back,Wound discharge finding,0
16440,serous drainage from laceration of right upper back,Serous discharge from wound,0
16441,bloody laceration of right upper back,Sanguinous exudate from wound,0
16442,purulent laceration of right upper back,Purulent discharge from wound,0
16443,laceration of right upper back with aligned margins,Wound edges approximated,0
16444,dehiscence of laceration of right upper back,Wound dehiscence,0
16445,bleeding laceration of left upper back,Hemorrhage,0
16446,laceration of left upper back with arterial bleeding,Arterial hemorrhage,0
16447,laceration of left upper back with venous bleeding,Rupture of vein,0
16448,weeping laceration of left upper back,Wound discharge finding,0
16449,serous drainage from laceration of left upper back,Serous discharge from wound,0
16450,bloody laceration of left upper back,Sanguinous exudate from wound,0
16451,purulent laceration of left upper back,Purulent discharge from wound,0
16452,laceration of left upper back with aligned margins,Wound edges approximated,0
16453,dehiscence of laceration of left upper back,Wound dehiscence,0
16454,"Lupus Erythematosus, Discoid",lupus panniculitis with discoid lupus erythematosus,0
16455,bleeding laceration of right pelvic region,Hemorrhage,0
16456,laceration of right pelvic region with arterial bleeding,Arterial hemorrhage,0
16457,laceration of right pelvic region with venous bleeding,Rupture of vein,0
16458,weeping laceration of right pelvic region,Wound discharge finding,0
16459,serous drainage from laceration of right pelvic region,Serous discharge from wound,0
16460,bloody laceration of right pelvic region,Sanguinous exudate from wound,0
16461,purulent laceration of right pelvic region,Purulent discharge from wound,0
16462,laceration of right pelvic region with aligned margins,Wound edges approximated,0
16463,dehiscence of laceration of right pelvic region,Wound dehiscence,0
16464,bleeding laceration of left pelvic region,Hemorrhage,0
16465,laceration of left pelvic region with arterial bleeding,Arterial hemorrhage,0
16466,laceration of left pelvic region with venous bleeding,Rupture of vein,0
16467,weeping laceration of left pelvic region,Wound discharge finding,0
16468,serous drainage from laceration of left pelvic region,Serous discharge from wound,0
16469,bloody laceration of left pelvic region,Sanguinous exudate from wound,0
16470,purulent laceration of left pelvic region,Purulent discharge from wound,0
16471,laceration of left pelvic region with aligned margins,Wound edges approximated,0
16472,dehiscence of laceration of left pelvic region,Wound dehiscence,0
16473,bleeding laceration of right buttock,Hemorrhage,0
16474,laceration of right buttock with arterial bleeding,Arterial hemorrhage,0
16475,laceration of right buttock with venous bleeding,Rupture of vein,0
16476,weeping laceration of right buttock,Wound discharge finding,0
16477,serous drainage from laceration of right buttock,Serous discharge from wound,0
16478,bloody laceration of right buttock,Sanguinous exudate from wound,0
16479,purulent laceration of right buttock,Purulent discharge from wound,0
16480,laceration of right buttock with aligned margins,Wound edges approximated,0
16481,dehiscence of laceration of right buttock,Wound dehiscence,0
16482,bleeding laceration of left buttock,Hemorrhage,0
16483,laceration of left buttock with arterial bleeding,Arterial hemorrhage,0
16484,laceration of left buttock with venous bleeding,Rupture of vein,0
16485,weeping laceration of left buttock,Wound discharge finding,0
16486,serous drainage from laceration of left buttock,Serous discharge from wound,0
16487,bloody laceration of left buttock,Sanguinous exudate from wound,0
16488,purulent laceration of left buttock,Purulent discharge from wound,0
16489,laceration of left buttock with aligned margins,Wound edges approximated,0
16490,dehiscence of laceration of left buttock,Wound dehiscence,0
16491,bleeding laceration of right hip,Hemorrhage,0
16492,laceration of right hip with arterial bleeding,Arterial hemorrhage,0
16493,laceration of right hip with venous bleeding,Rupture of vein,0
16494,weeping laceration of right hip,Wound discharge finding,0
16495,serous drainage from laceration of right hip,Serous discharge from wound,0
16496,bloody laceration of right hip,Sanguinous exudate from wound,0
16497,purulent laceration of right hip,Purulent discharge from wound,0
16498,laceration of right hip with aligned margins,Wound edges approximated,0
16499,dehiscence of laceration of right hip,Wound dehiscence,0
16500,bleeding laceration of left hip,Hemorrhage,0
16501,laceration of left hip with arterial bleeding,Arterial hemorrhage,0
16502,laceration of left hip with venous bleeding,Rupture of vein,0
16503,weeping laceration of left hip,Wound discharge finding,0
16504,serous drainage from laceration of left hip,Serous discharge from wound,0
16505,bloody laceration of left hip,Sanguinous exudate from wound,0
16506,purulent laceration of left hip,Purulent discharge from wound,0
16507,laceration of left hip with aligned margins,Wound edges approximated,0
16508,dehiscence of laceration of left hip,Wound dehiscence,0
16509,bleeding laceration of right thigh,Hemorrhage,0
16510,laceration of right thigh with arterial bleeding,Arterial hemorrhage,0
16511,laceration of right thigh with venous bleeding,Rupture of vein,0
16512,weeping laceration of right thigh,Wound discharge finding,0
16513,serous drainage from laceration of right thigh,Serous discharge from wound,0
16514,bloody laceration of right thigh,Sanguinous exudate from wound,0
16515,purulent laceration of right thigh,Purulent discharge from wound,0
16516,laceration of right thigh with aligned margins,Wound edges approximated,0
16517,dehiscence of laceration of right thigh,Wound dehiscence,0
16518,bleeding laceration of left thigh,Hemorrhage,0
16519,laceration of left thigh with arterial bleeding,Arterial hemorrhage,0
16520,laceration of left thigh with venous bleeding,Rupture of vein,0
16521,weeping laceration of left thigh,Wound discharge finding,0
16522,serous drainage from laceration of left thigh,Serous discharge from wound,0
16523,bloody laceration of left thigh,Sanguinous exudate from wound,0
16524,purulent laceration of left thigh,Purulent discharge from wound,0
16525,laceration of left thigh with aligned margins,Wound edges approximated,0
16526,dehiscence of laceration of left thigh,Wound dehiscence,0
16527,bleeding laceration of right knee,Hemorrhage,0
16528,laceration of right knee with arterial bleeding,Arterial hemorrhage,0
16529,laceration of right knee with venous bleeding,Rupture of vein,0
16530,weeping laceration of right knee,Wound discharge finding,0
16531,serous drainage from laceration of right knee,Serous discharge from wound,0
16532,bloody laceration of right knee,Sanguinous exudate from wound,0
16533,purulent laceration of right knee,Purulent discharge from wound,0
16534,laceration of right knee with aligned margins,Wound edges approximated,0
16535,dehiscence of laceration of right knee,Wound dehiscence,0
16536,bleeding laceration of left knee,Hemorrhage,0
16537,laceration of left knee with arterial bleeding,Arterial hemorrhage,0
16538,laceration of left knee with venous bleeding,Rupture of vein,0
16539,serous drainage from laceration of left knee,Serous discharge from wound,0
16540,bloody laceration of left knee,Sanguinous exudate from wound,0
16541,purulent laceration of left knee,Purulent discharge from wound,0
16542,laceration of left knee with aligned margins,Wound edges approximated,0
16543,dehiscence of laceration of left knee,Wound dehiscence,0
16544,bleeding laceration of right lower leg,Hemorrhage,0
16545,laceration of right lower leg with arterial bleeding,Arterial hemorrhage,0
16546,laceration of right lower leg with venous bleeding,Rupture of vein,0
16547,weeping laceration of right lower leg,Wound discharge finding,0
16548,serous drainage from laceration of right lower leg,Serous discharge from wound,0
16549,bloody laceration of right lower leg,Sanguinous exudate from wound,0
16550,purulent laceration of right lower leg,Purulent discharge from wound,0
16551,laceration of right lower leg with aligned margins,Wound edges approximated,0
16552,dehiscence of laceration of right lower leg,Wound dehiscence,0
16553,bleeding laceration of left lower leg,Hemorrhage,0
16554,laceration of left lower leg with arterial bleeding,Arterial hemorrhage,0
16555,laceration of left lower leg with venous bleeding,Rupture of vein,0
16556,weeping laceration of left lower leg,Wound discharge finding,0
16557,serous drainage from laceration of left lower leg,Serous discharge from wound,0
16558,bloody laceration of left lower leg,Sanguinous exudate from wound,0
16559,purulent laceration of left lower leg,Purulent discharge from wound,0
16560,laceration of left lower leg with aligned margins,Wound edges approximated,0
16561,dehiscence of laceration of left lower leg,Wound dehiscence,0
16562,bleeding laceration of right ankle,Hemorrhage,0
16563,laceration of right ankle with arterial bleeding,Arterial hemorrhage,0
16564,laceration of right ankle with venous bleeding,Rupture of vein,0
16565,weeping laceration of right ankle,Wound discharge finding,0
16566,serous drainage from laceration of right ankle,Serous discharge from wound,0
16567,bloody laceration of right ankle,Sanguinous exudate from wound,0
16568,purulent laceration of right ankle,Purulent discharge from wound,0
16569,laceration of right ankle with aligned margins,Wound edges approximated,0
16570,dehiscence of laceration of right ankle,Wound dehiscence,0
16571,bleeding laceration of left ankle,Hemorrhage,0
16572,laceration of left ankle with arterial bleeding,Arterial hemorrhage,0
16573,laceration of left ankle with venous bleeding,Rupture of vein,0
16574,serous drainage from laceration of left ankle,Serous discharge from wound,0
16575,bloody laceration of left ankle,Sanguinous exudate from wound,0
16576,purulent laceration of left ankle,Purulent discharge from wound,0
16577,laceration of left ankle with aligned margins,Wound edges approximated,0
16578,dehiscence of laceration of left ankle,Wound dehiscence,0
16579,bleeding laceration of right foot,Hemorrhage,0
16580,laceration of right foot with arterial bleeding,Arterial hemorrhage,0
16581,laceration of right foot with venous bleeding,Rupture of vein,0
16582,weeping laceration of right foot,Wound discharge finding,0
16583,serous drainage from laceration of right foot,Serous discharge from wound,0
16584,bloody laceration of right foot,Sanguinous exudate from wound,0
16585,purulent laceration of right foot,Purulent discharge from wound,0
16586,laceration of right foot with aligned margins,Wound edges approximated,0
16587,dehiscence of laceration of right foot,Wound dehiscence,0
16588,Chondrolysis of the femoral head,closed fracture of right acetabulum with chondral lesion on femoral head,0
16589,Chondrolysis of the femoral head,closed fracture of left acetabulum with chondral lesion on femoral head (delta 1),0
16590,bleeding laceration of left foot,Hemorrhage,0
16591,laceration of left foot with arterial bleeding,Arterial hemorrhage,0
16592,laceration of left foot with venous bleeding,Rupture of vein,0
16593,weeping laceration of left foot,Wound discharge finding,0
16594,serous drainage from laceration of left foot,Serous discharge from wound,0
16595,Loose body in hip joint,closed fracture of right acetabulum with intra-articular fragment requiring surgical removal (Epsilon 1),0
16596,Loose body in hip joint,closed fracture of left acetabulum with intra-articular fragment requiring surgical removal (Epsilon 1),0
16597,bloody laceration of left foot,Sanguinous exudate from wound,0
16598,purulent laceration of left foot,Purulent discharge from wound,0
16599,laceration of left foot with aligned margins,Wound edges approximated,0
16600,dehiscence of laceration of left foot,Wound dehiscence,0
16601,bleeding laceration of right upper paraspinal region,Hemorrhage,0
16602,laceration of right upper paraspinal region with arterial bleeding,Arterial hemorrhage,0
16603,laceration of right upper paraspinal region with venous bleeding,Rupture of vein,0
16604,serous drainage from laceration of right upper paraspinal region,Serous discharge from wound,0
16605,bloody laceration of right upper paraspinal region,Sanguinous exudate from wound,0
16606,purulent laceration of right upper paraspinal region,Purulent discharge from wound,0
16607,laceration of right upper paraspinal region with aligned margins,Wound edges approximated,0
16608,bleeding laceration of left upper paraspinal region,Hemorrhage,0
16609,laceration of left upper paraspinal region with arterial bleeding,Arterial hemorrhage,0
16610,laceration of left upper paraspinal region with venous bleeding,Rupture of vein,0
16611,serous drainage from laceration of left upper paraspinal region,Serous discharge from wound,0
16612,bloody laceration of left upper paraspinal region,Sanguinous exudate from wound,0
16613,purulent laceration of left upper paraspinal region,Purulent discharge from wound,0
16614,laceration of left upper paraspinal region with aligned margins,Wound edges approximated,0
16615,bleeding laceration of right mid back,Hemorrhage,0
16616,laceration of right mid back with arterial bleeding,Arterial hemorrhage,0
16617,laceration of right mid back with venous bleeding,Rupture of vein,0
16618,bleeding laceration of tissue of right mid back,Hemorrhage,0
16619,weeping laceration of right mid back,Wound discharge finding,0
16620,laceration of right mid back with serous drainage,Serous discharge from wound,0
16621,bloody laceration of right mid back,Sanguinous exudate from wound,0
16622,purulent laceration of right mid back,Purulent discharge from wound,0
16623,laceration of right mid back with aligned margins,Wound edges approximated,0
16624,dehiscence of laceration of right mid back,Wound dehiscence,0
16625,bleeding laceration of right mid paraspinal region,Hemorrhage,0
16626,laceration of right mid paraspinal region with arterial bleeding,Arterial hemorrhage,0
16627,laceration of right mid paraspinal region with venous bleeding,Rupture of vein,0
16628,serous drainage from laceration of right mid paraspinal region,Serous discharge from wound,0
16629,bloody laceration of right mid paraspinal region,Sanguinous exudate from wound,0
16630,purulent laceration of right mid paraspinal region,Purulent discharge from wound,0
16631,laceration of right mid paraspinal region with aligned margins,Wound edges approximated,0
16632,dehiscence of laceration of right mid paraspinal region,Wound dehiscence,0
16633,Clicking hip,laxity of right hip with click,0
16634,Clicking hip,laxity of left hip with click,0
16635,bleeding laceration of left mid paraspinal region,Hemorrhage,0
16636,laceration of left mid paraspinal region with arterial bleeding,Arterial hemorrhage,0
16637,laceration of left mid paraspinal region with venous bleeding,Rupture of vein,0
16638,serous drainage from laceration of left mid paraspinal region,Serous discharge from wound,0
16639,bloody laceration of left mid paraspinal region,Sanguinous exudate from wound,0
16640,purulent laceration of left mid paraspinal region,Purulent discharge from wound,0
16641,laceration of left mid paraspinal region with aligned margins,Wound edges approximated,0
16642,bleeding laceration of left mid back,Hemorrhage,0
16643,laceration of left mid back with arterial bleeding,Arterial hemorrhage,0
16644,laceration of left mid back with venous bleeding,Rupture of vein,0
16645,weeping laceration of left mid back,Wound discharge finding,0
16646,serous drainage from laceration of left mid back,Serous discharge from wound,0
16647,bloody laceration of left mid back,Sanguinous exudate from wound,0
16648,purulent laceration of left mid back,Purulent discharge from wound,0
16649,laceration of left mid back with aligned margins,Wound edges approximated,0
16650,dehiscence of laceration of left mid back,Wound dehiscence,0
16651,bleeding laceration of right lower back,Hemorrhage,0
16652,laceration of right lower back with arterial bleeding,Arterial hemorrhage,0
16653,laceration of right lower back with venous bleeding,Rupture of vein,0
16654,weeping laceration of right lower back,Wound discharge finding,0
16655,serous drainage from laceration of right lower back,Serous discharge from wound,0
16656,bloody laceration of right lower back,Sanguinous exudate from wound,0
16657,purulent laceration of right lower back,Purulent discharge from wound,0
16658,laceration of right lower back with aligned margins,Wound edges approximated,0
16659,dehiscence of laceration of right lower back,Wound dehiscence,0
16660,bleeding laceration of right lower paraspinal region,Hemorrhage,0
16661,laceration of right lower paraspinal region with arterial bleeding,Arterial hemorrhage,0
16662,laceration of right lower paraspinal region with venous bleeding,Rupture of vein,0
16663,serous drainage from laceration of right lower paraspinal region,Serous discharge from wound,0
16664,bloody laceration of right lower paraspinal region,Sanguinous exudate from wound,0
16665,purulent laceration of right lower paraspinal region,Purulent discharge from wound,0
16666,laceration of right lower paraspinal region with aligned margins,Wound edges approximated,0
16667,bleeding laceration of left lower paraspinal region,Hemorrhage,0
16668,laceration of left lower paraspinal region with arterial bleeding,Arterial hemorrhage,0
16669,laceration of left lower paraspinal region with venous bleeding,Rupture of vein,0
16670,serous drainage from laceration of left lower paraspinal region,Serous discharge from wound,0
16671,bloody laceration of left lower paraspinal region,Sanguinous exudate from wound,0
16672,purulent laceration of left lower paraspinal region,Purulent discharge from wound,0
16673,laceration of left lower paraspinal region with aligned margins,Wound edges approximated,0
16674,bleeding laceration of left lower back,Hemorrhage,0
16675,laceration of left lower back with arterial bleeding,Arterial hemorrhage,0
16676,laceration of left lower back with venous bleeding,Rupture of vein,0
16677,weeping laceration of left lower back,Wound discharge finding,0
16678,serous drainage from laceration of left lower back,Serous discharge from wound,0
16679,bloody laceration of left lower back,Sanguinous exudate from wound,0
16680,purulent laceration of left lower back,Purulent discharge from wound,0
16681,laceration of left lower back with aligned margins,Wound edges approximated,0
16682,dehiscence of laceration of left lower back,Wound dehiscence,0
16683,sparse hair of feet,Poor hair growth,0
16684,absence of hair on feet,Hair absent (finding),0
16685,examination of heart rate,Measurement,0
16686,puncture of sternum consistent with shrapnel entry wound,Shrapnel,0
16687,puncture of sternum consistent with entry wound of specified shrapnel fragment (#___),Shrapnel,0
16688,puncture of sternum consistent with entry wound of multiple shrapnel fragments,Shrapnel,0
16689,perio-endo defect of gingiva of right upper first bicuspid,Periodontal and endodontic lesion,0
16690,perio-endo defect of gingiva of right lower first bicuspid,Periodontal and endodontic lesion,0
16691,perio-endo defect of gingiva of left upper first bicuspid,Periodontal and endodontic lesion,0
16692,perio-endo defect of gingiva of defect left lower first bicuspid,Periodontal and endodontic lesion,0
16693,perio-endo defect of gingiva of right upper second bicuspid,Periodontal and endodontic lesion,0
16694,perio-endo defect of gingiva of right lower second bicuspid,Periodontal and endodontic lesion,0
16695,perio-endo defect of gingiva of left upper second bicuspid,Periodontal and endodontic lesion,0
16696,perio-endo defect of gingiva of left lower second bicuspid,Periodontal and endodontic lesion,0
16697,perio-endo defect of gingiva of right upper first molar,Periodontal and endodontic lesion,0
16698,perio-endo defect of gingiva of right lower first molar,Periodontal and endodontic lesion,0
16699,perio-endo defect of gingiva of left upper first molar,Periodontal and endodontic lesion,0
16700,perio-endo defect of gingiva of left lower first molar,Periodontal and endodontic lesion,0
16701,perio-endo defect of gingiva of right upper third molar,Periodontal and endodontic lesion,0
16702,perio-endo defect of gingiva of right lower third molar,Periodontal and endodontic lesion,0
16703,perio-endo defect of gingiva of left upper third molar,Periodontal and endodontic lesion,0
16704,perio-endo defect of gingiva of left lower third molar,Periodontal and endodontic lesion,0
16705,perio-endo defect of gingiva of right upper second molar,Periodontal and endodontic lesion,0
16706,perio-endo defect of gingiva of right lower second molar,Periodontal and endodontic lesion,0
16707,perio-endo defect of gingiva of left upper second molar,Periodontal and endodontic lesion,0
16708,perio-endo defect of gingiva of left lower second molar,Periodontal and endodontic lesion,0
16709,generalized perio-endo defect of gingiva,Periodontal and endodontic lesion,0
16710,spontaneous gingival hemorrhage of mesial surface at upper central incisor on right,Spontaneous hemorrhage,0
16711,spontaneous gingival hemorrhage of distal surface at upper central incisor on right,Spontaneous hemorrhage,0
16712,spontaneous gingival hemorrhage of labial surface at upper central incisor on right,Spontaneous hemorrhage,0
16713,spontaneous gingival hemorrhage of palatal surface at upper central incisor on right,Spontaneous hemorrhage,0
16714,spontaneous gingival hemorrhage of mesial surface at lower central incisor on right,Spontaneous hemorrhage,0
16715,spontaneous gingival hemorrhage at distal lower central incisor on right,Spontaneous hemorrhage,0
16716,spontaneous gingival hemorrhage at labial lower central incisor on right,Spontaneous hemorrhage,0
16717,spontaneous hemorrhage of gingiva on lingual surface of right mandibular central incisor,Spontaneous hemorrhage,0
16718,spontaneous hemorrhage of gingiva on mesial surface of left maxillary central incisor,Spontaneous hemorrhage,0
16719,spontaneous hemorrhage of gingiva on distal surface of left maxillary central incisor,Spontaneous hemorrhage,0
16720,spontaneous hemorrhage of gingiva on labial surface of left maxillary central incisor,Spontaneous hemorrhage,0
16721,spontaneous hemorrhage of gingiva on palatal surface of left maxillary central incisor,Spontaneous hemorrhage,0
16722,spontaneous gingival hemorrhage of mesial aspect of left lower central incisor,Spontaneous hemorrhage,0
16723,spontaneous gingival hemorrhage at distal left lower central incisor,Spontaneous hemorrhage,0
16724,gingival hemorrhage at left lower central incisor labial spontaneous,Spontaneous hemorrhage,0
16725,gingival hemorrhage at left lower central incisor lingual spontaneous,Spontaneous hemorrhage,0
16726,spontaneous hemorrhage of gingiva on mesial surface of right maxillary lateral incisor,Spontaneous hemorrhage,0
16727,spontaneous hemorrhage of gingiva on distal surface of right maxillary lateral incisor,Spontaneous hemorrhage,0
16728,spontaneous hemorrhage of gingiva on labial surface of right maxillary lateral incisor,Spontaneous hemorrhage,0
16729,spontaneous hemorrhage of gingiva on palatal surface of right maxillary lateral incisor,Spontaneous hemorrhage,0
16730,spontaneous hemorrhage of gingiva on mesial surface of right mandibular lateral incisor,Spontaneous hemorrhage,0
16731,spontaneous hemorrhage of gingiva on distal surface of right mandibular lateral incisor,Spontaneous hemorrhage,0
16732,spontaneous hemorrhage of gingiva on labial surface of right mandibular lateral incisor,Spontaneous hemorrhage,0
16733,spontaneous hemorrhage of gingiva on lingual surface of right mandibular lateral incisor,Spontaneous hemorrhage,0
16734,spontaneous hemorrhage of gingiva on mesial surface of left maxillary lateral incisor,Spontaneous hemorrhage,0
16735,spontaneous hemorrhage of gingiva on distal surface of left maxillary lateral incisor,Spontaneous hemorrhage,0
16736,spontaneous hemorrhage of gingiva on labial surface of left maxillary lateral incisor,Spontaneous hemorrhage,0
16737,spontaneous hemorrhage of gingiva on palatal surface of left maxillary lateral incisor,Spontaneous hemorrhage,0
16738,spontaneous hemorrhage of gingiva on mesial surface of left mandibular lateral incisor,Spontaneous hemorrhage,0
16739,spontaneous hemorrhage of gingiva on distal surface of left mandibular lateral incisor,Spontaneous hemorrhage,0
16740,spontaneous hemorrhage of gingiva on labial surface of left mandibular lateral incisor,Spontaneous hemorrhage,0
16741,spontaneous hemorrhage of gingiva on lingual surface of left mandibular lateral incisor,Spontaneous hemorrhage,0
16742,spontaneous hemorrhage of gingiva on mesial surface of right maxillary cuspid,Spontaneous hemorrhage,0
16743,spontaneous hemorrhage of gingiva on distal surface of right maxillary cuspid,Spontaneous hemorrhage,0
16744,spontaneous hemorrhage of gingiva on labial surface of right maxillary cuspid,Spontaneous hemorrhage,0
16745,spontaneous hemorrhage of gingiva on palatal surface of right maxillary cuspid,Spontaneous hemorrhage,0
16746,spontaneous hemorrhage of gingiva on mesial surface of right mandibular cuspid,Spontaneous hemorrhage,0
16747,spontaneous hemorrhage of gingiva on distal surface of right mandibular cuspid,Spontaneous hemorrhage,0
16748,spontaneous hemorrhage of gingiva on labial surface of right mandibular cuspid,Spontaneous hemorrhage,0
16749,spontaneous hemorrhage of gingiva on lingual surface of right mandibular cuspid,Spontaneous hemorrhage,0
16750,spontaneous hemorrhage of gingiva on mesial surface of left maxillary cuspid,Spontaneous hemorrhage,0
16751,spontaneous hemorrhage of gingiva on distal surface of left maxillary cuspid,Spontaneous hemorrhage,0
16752,spontaneous hemorrhage of gingiva on labial surface of left maxillary cuspid,Spontaneous hemorrhage,0
16753,spontaneous hemorrhage of gingiva on palatal surface of left maxillary cuspid,Spontaneous hemorrhage,0
16754,spontaneous hemorrhage of gingiva on mesial surface of left mandibular cuspid,Spontaneous hemorrhage,0
16755,spontaneous hemorrhage of gingiva on distal surface of left mandibular cuspid,Spontaneous hemorrhage,0
16756,spontaneous hemorrhage of gingiva on labial surface of left mandibular cuspid,Spontaneous hemorrhage,0
16757,spontaneous hemorrhage of gingiva on lingual surface of left mandibular cuspid,Spontaneous hemorrhage,0
16758,spontaneous hemorrhage of gingiva on mesial surface of right maxillary first bicuspid,Spontaneous hemorrhage,0
16759,spontaneous hemorrhage of gingiva on distal surface of right maxillary first bicuspid,Spontaneous hemorrhage,0
16760,spontaneous hemorrhage of gingiva on buccal surface of right maxillary first bicuspid,Spontaneous hemorrhage,0
16761,spontaneous hemorrhage of gingiva on palatal surface of right maxillary first bicuspid,Spontaneous hemorrhage,0
16762,spontaneous hemorrhage of gingiva on mesial surface of right mandibular first bicuspid,Spontaneous hemorrhage,0
16763,spontaneous hemorrhage of gingiva on distal surface of right mandibular first bicuspid,Spontaneous hemorrhage,0
16764,spontaneous hemorrhage of gingiva on buccal surface of right mandibular first bicuspid,Spontaneous hemorrhage,0
16765,spontaneous hemorrhage of gingiva on lingual surface of right mandibular first bicuspid,Spontaneous hemorrhage,0
16766,spontaneous hemorrhage of gingiva on mesial surface of left maxillary first bicuspid,Spontaneous hemorrhage,0
16767,spontaneous hemorrhage of gingiva on distal surface of left maxillary first bicuspid,Spontaneous hemorrhage,0
16768,spontaneous hemorrhage of gingiva on buccal surface of left maxillary first bicuspid,Spontaneous hemorrhage,0
16769,spontaneous hemorrhage of gingiva on palatal surface of left maxillary first bicuspid,Spontaneous hemorrhage,0
16770,spontaneous hemorrhage of gingiva on mesial surface of left mandibular first bicuspid,Spontaneous hemorrhage,0
16771,spontaneous hemorrhage of gingiva on distal surface of left mandibular first bicuspid,Spontaneous hemorrhage,0
16772,spontaneous hemorrhage of gingiva on buccal surface of left mandibular first bicuspid,Spontaneous hemorrhage,0
16773,spontaneous hemorrhage of gingiva on lingual surface of left mandibular first bicuspid,Spontaneous hemorrhage,0
16774,spontaneous hemorrhage of gingiva on mesial surface of right maxillary second bicuspid,Spontaneous hemorrhage,0
16775,spontaneous hemorrhage of gingiva on distal surface of right maxillary second bicuspid,Spontaneous hemorrhage,0
16776,spontaneous hemorrhage of gingiva on buccal surface of right maxillary second bicuspid,Spontaneous hemorrhage,0
16777,spontaneous hemorrhage of gingiva on palatal surface of right maxillary second bicuspid,Spontaneous hemorrhage,0
16778,spontaneous hemorrhage of gingiva on mesial surface of right mandibular second bicuspid,Spontaneous hemorrhage,0
16779,spontaneous hemorrhage of gingiva on distal surface of right mandibular second bicuspid,Spontaneous hemorrhage,0
16780,spontaneous hemorrhage of gingiva on buccal surface of right mandibular second bicuspid,Spontaneous hemorrhage,0
16781,spontaneous hemorrhage of gingiva on lingual surface of right mandibular second bicuspid,Spontaneous hemorrhage,0
16782,spontaneous hemorrhage of gingiva on mesial surface of left maxillary second bicuspid,Spontaneous hemorrhage,0
16783,spontaneous hemorrhage of gingiva on distal surface of left maxillary second bicuspid,Spontaneous hemorrhage,0
16784,spontaneous hemorrhage of gingiva on buccal surface of left maxillary second bicuspid,Spontaneous hemorrhage,0
16785,spontaneous hemorrhage of gingiva on palatal surface of left maxillary second bicuspid,Spontaneous hemorrhage,0
16786,spontaneous hemorrhage of gingiva on mesial surface of left mandibular second bicuspid,Spontaneous hemorrhage,0
16787,spontaneous hemorrhage of gingiva on distal surface of left mandibular second bicuspid,Spontaneous hemorrhage,0
16788,spontaneous hemorrhage of gingiva on buccal surface of left mandibular second bicuspid,Spontaneous hemorrhage,0
16789,spontaneous hemorrhage of gingiva on lingual surface of left mandibular second bicuspid,Spontaneous hemorrhage,0
16790,spontaneous hemorrhage of gingiva on mesial surface of right maxillary first molar,Spontaneous hemorrhage,0
16791,spontaneous hemorrhage of gingiva on distal surface of right maxillary first molar,Spontaneous hemorrhage,0
16792,spontaneous hemorrhage of gingiva on buccal surface of right maxillary first molar,Spontaneous hemorrhage,0
16793,spontaneous hemorrhage of gingiva on palatal surface of right maxillary first molar,Spontaneous hemorrhage,0
16794,spontaneous hemorrhage of gingiva on mesial surface of right mandibular first molar,Spontaneous hemorrhage,0
16795,spontaneous hemorrhage of gingiva on distal surface of right mandibular first molar,Spontaneous hemorrhage,0
16796,spontaneous hemorrhage of gingiva on buccal surface of right mandibular first molar,Spontaneous hemorrhage,0
16797,spontaneous hemorrhage of gingiva on lingual surface of right mandibular first molar,Spontaneous hemorrhage,0
16798,spontaneous hemorrhage of gingiva on mesial surface of left maxillary first molar,Spontaneous hemorrhage,0
16799,spontaneous hemorrhage of gingiva on distal surface of left maxillary first molar,Spontaneous hemorrhage,0
16800,spontaneous hemorrhage of gingiva on buccal surface of left maxillary first molar,Spontaneous hemorrhage,0
16801,spontaneous hemorrhage of gingiva on palatal surface of left maxillary first molar,Spontaneous hemorrhage,0
16802,spontaneous hemorrhage of gingiva on mesial surface of left mandibular first molar,Spontaneous hemorrhage,0
16803,spontaneous hemorrhage of gingiva on distal surface of left mandibular first molar,Spontaneous hemorrhage,0
16804,spontaneous hemorrhage of gingiva on buccal surface of left mandibular first molar,Spontaneous hemorrhage,0
16805,spontaneous hemorrhage of gingiva on lingual surface of left mandibular first molar,Spontaneous hemorrhage,0
16806,spontaneous hemorrhage of gingiva on mesial surface of right maxillary second molar,Spontaneous hemorrhage,0
16807,spontaneous hemorrhage of gingiva on distal surface of right maxillary second molar,Spontaneous hemorrhage,0
16808,spontaneous hemorrhage of gingiva on buccal surface of right maxillary second molar,Spontaneous hemorrhage,0
16809,spontaneous hemorrhage of gingiva on palatal surface of right maxillary second molar,Spontaneous hemorrhage,0
16810,spontaneous hemorrhage of gingiva on mesial surface of right mandibular second molar,Spontaneous hemorrhage,0
16811,spontaneous hemorrhage of gingiva on distal surface of right mandibular second molar,Spontaneous hemorrhage,0
16812,spontaneous hemorrhage of gingiva on buccal surface of right mandibular second molar,Spontaneous hemorrhage,0
16813,spontaneous hemorrhage of gingiva on lingual surface of right mandibular second molar,Spontaneous hemorrhage,0
16814,spontaneous hemorrhage of gingiva on mesial surface of left maxillary second molar,Spontaneous hemorrhage,0
16815,spontaneous hemorrhage of gingiva on distal surface of left maxillary second molar,Spontaneous hemorrhage,0
16816,spontaneous hemorrhage of gingiva on buccal surface of left maxillary second molar,Spontaneous hemorrhage,0
16817,spontaneous hemorrhage of gingiva on palatal surface of left maxillary second molar,Spontaneous hemorrhage,0
16818,spontaneous hemorrhage of gingiva on mesial surface of left mandibular second molar,Spontaneous hemorrhage,0
16819,spontaneous hemorrhage of gingiva on distal surface of left mandibular second molar,Spontaneous hemorrhage,0
16820,spontaneous hemorrhage of gingiva on buccal surface of left mandibular second molar,Spontaneous hemorrhage,0
16821,spontaneous hemorrhage of gingiva on lingual surface of left mandibular second molar,Spontaneous hemorrhage,0
16822,spontaneous hemorrhage of gingiva on mesial surface of right maxillary third molar,Spontaneous hemorrhage,0
16823,spontaneous hemorrhage of gingiva on distal surface of right maxillary third molar,Spontaneous hemorrhage,0
16824,spontaneous hemorrhage of gingiva on buccal surface of right maxillary third molar,Spontaneous hemorrhage,0
16825,spontaneous hemorrhage of gingiva on palatal surface of right maxillary third molar,Spontaneous hemorrhage,0
16826,spontaneous hemorrhage of gingiva on mesial surface of right mandibular third molar,Spontaneous hemorrhage,0
16827,spontaneous hemorrhage of gingiva on distal surface of right mandibular third molar,Spontaneous hemorrhage,0
16828,spontaneous hemorrhage of gingiva on buccal surface of right mandibular third molar,Spontaneous hemorrhage,0
16829,spontaneous hemorrhage of gingiva on lingual surface of right mandibular third molar,Spontaneous hemorrhage,0
16830,spontaneous hemorrhage of gingiva on mesial surface of left maxillary third molar,Spontaneous hemorrhage,0
16831,spontaneous hemorrhage of gingiva on distal surface of left maxillary third molar,Spontaneous hemorrhage,0
16832,spontaneous hemorrhage of gingiva on buccal surface of left maxillary third molar,Spontaneous hemorrhage,0
16833,spontaneous hemorrhage of gingiva on palatal surface of left maxillary third molar,Spontaneous hemorrhage,0
16834,spontaneous hemorrhage of gingiva on mesial surface of left mandibular third molar,Spontaneous hemorrhage,0
16835,spontaneous hemorrhage of gingiva on distal surface of left mandibular third molar,Spontaneous hemorrhage,0
16836,spontaneous hemorrhage of gingiva on buccal surface of left mandibular third molar,Spontaneous hemorrhage,0
16837,spontaneous hemorrhage of gingiva on lingual surface of left mandibular third molar,Spontaneous hemorrhage,0
16838,tender mass of buccal mucosa,Sore to touch,0
16839,mastectomy scars of both breasts,Excision of breast tissue,0
16840,Concussion with more than 24 hours loss of consciousness and return to pre-existing conscious level,fracture of middle cranial fossa with loss of consciousness over 24 hours with return to previous level,0
16841,Concussion with more than 24 hours loss of consciousness without return to pre-existing conscious level,fracture of middle cranial fossa with loss of consciousness over 24 hours without return to prior level,0
16842,closed fracture of skull vault with intracranial hemorrhage with brief (< 1 hr) loss of consciousness,Brief loss of consciousness,0
16843,closed fracture of skull vault with intracranial hemorrhage with moderate loss of consciousness,Moderate loss of consciousness,0
16844,closed fracture of skull vault with intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,0
16845,closed fracture of skull vault with intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,Intracranial hemorrhage following injury with prolonged loss of consciousness without return to pre-existing conscious level,0
16846,closed fracture of base of skull with intracranial hemorrhage with brief (< 1 hr) loss of consciousness,Brief loss of consciousness,0
16847,closed fracture of base of skull with intracranial hemorrhage with moderate loss of consciousness,Moderate loss of consciousness,0
16848,closed fracture of base of skull with intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,0
16849,closed fracture of base of skull with intracranial hemorrhage with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,Intracranial hemorrhage following injury with prolonged loss of consciousness without return to pre-existing conscious level,0
16850,closed fracture of base of skull with intracranial injury with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,Intracranial hemorrhage following injury with prolonged loss of consciousness AND return to pre-existing conscious level,0
16851,"Contusion, shoulder and upper arm, multiple sites",contusion with intact skin of multiple locations of shoulder and upper arm,0
16852,multiple closed fractures of skull with moderate (1-24 hrs) loss of consciousness,Moderate loss of consciousness,0
16853,multiple closed fractures of skull with prolonged (> 24 hrs) loss of consciousness with return to prior level of consciousness,Prolonged loss of consciousness,0
16854,multiple closed fractures of skull with prolonged (> 24 hrs) loss of consciousness without return to prior level of consciousness,Prolonged loss of consciousness,0
16855,multiple closed fractures of skull with cerebral laceration and contusion with moderate loss of consciousness,Moderate loss of consciousness,0
16856,"multiple closed fractures of skull with subarachnoid, subdural, or extradural hemorrhage with moderate loss of consciousness",Moderate loss of consciousness,0
16857,closed Frykman type II fracture of right radius,Fracture of ulnar styloid,0
16858,closed Frykman type II fracture of left radius,Fracture of ulnar styloid,0
16859,Diffuse pain,Arthralgia,0
16860,closed fracture of right acetabulum with chondral lesion on surface,Chondrolysis of articular cartilage,0
16861,closed fracture of right acetabulum with chondral lesion on femoral head,Chondrolysis of the femoral head,0
16862,closed fracture of right acetabulum with intra-articular fragment requiring surgical removal (Epsilon 1),Loose body in hip joint,0
16863,closed fracture of left acetabulum with chondral lesion on surface (gamma 1),Chondrolysis of articular cartilage,0
16864,closed fracture of left acetabulum with chondral lesion on femoral head (delta 1),Chondrolysis of the femoral head,0
16865,closed fracture of left acetabulum with intra-articular fragment requiring surgical removal (Epsilon 1),Loose body in hip joint,0
16866,closed fracture of right medial tibial plateau with cruciate ligament injury (Schatzker 4),Injury of cruciate ligament of knee,0
16867,closed fracture of right medial tibial plateau with lateral collateral injury (Schatzker 4),Injury of lateral collateral ligament of knee,0
16868,closed fracture of left medial tibial plateau with cruciate ligament injury (Schatzker 4),Injury of cruciate ligament of knee,0
16869,closed fracture of left medial tibial plateau with lateral collateral injury (Schatzker 4),Injury of lateral collateral ligament of knee,0
16870,Anal penetration,rectal pain after anal sex,0
16871,echocardiography: Blalock-Taussig shunt patent,Anastomosis of pulmonary-subclavian artery by Blalock-Taussig operation,0
16872,echocardiography: Blalock-Taussig shunt obstructed,Anastomosis of pulmonary-subclavian artery by Blalock-Taussig operation,0
16873,echocardiography: flow velocity of Blalock-Taussig shunt,Anastomosis of pulmonary-subclavian artery by Blalock-Taussig operation,0
16874,thyrotoxic phase of subacute thyroiditis,Thyrotoxicosis,0
16875,Pain,Displacement of intervertebral disc without myelopathy,0
16876,Only received primary school education,parents educated through grade school only,0
16877,Educated to secondary school level,parents' education ended with high school graduation,0
16878,Purulent discharge from wound,purulent laceration of right temporomandibular joint,0
16879,Purulent discharge from wound,purulent laceration of left temporomandibular joint,0
16880,Purulent discharge from wound,purulent laceration of anterior neck,0
16881,Purulent discharge from wound,purulent laceration of posterior neck,0
16882,Purulent discharge from wound,purulent laceration of right side of neck,0
16883,Purulent discharge from wound,purulent laceration of left side of neck,0
16884,Purulent discharge from wound,purulent laceration of right shoulder,0
16885,Purulent discharge from wound,purulent laceration of left shoulder,0
16886,Purulent discharge from wound,purulent laceration of right arm,0
16887,Purulent discharge from wound,purulent laceration of left arm,0
16888,Purulent discharge from wound,purulent laceration of right elbow,0
16889,Purulent discharge from wound,purulent laceration of left elbow,0
16890,Purulent discharge from wound,purulent laceration of right forearm,0
16891,Purulent discharge from wound,purulent laceration of left forearm,0
16892,Purulent discharge from wound,purulent laceration of right wrist,0
16893,Purulent discharge from wound,purulent laceration of left wrist,0
16894,Purulent discharge from wound,purulent laceration of right hand,0
16895,Purulent discharge from wound,purulent laceration of left hand,0
16896,Purulent discharge from wound,purulent laceration of right anterior chest wall,0
16897,Purulent discharge from wound,purulent laceration of left anterior chest wall,0
16898,Purulent discharge from wound,purulent laceration of sternum,0
16899,Purulent discharge from wound,purulent laceration of right lateral chest wall,0
16900,Purulent discharge from wound,purulent laceration of left lateral chest wall,0
16901,Purulent discharge from wound,purulent laceration of right upper back,0
16902,Purulent discharge from wound,purulent laceration of left upper back,0
16903,Purulent discharge from wound,purulent laceration of right pelvic region,0
16904,Purulent discharge from wound,purulent laceration of left pelvic region,0
16905,Purulent discharge from wound,purulent laceration of right buttock,0
16906,Purulent discharge from wound,purulent laceration of left buttock,0
16907,Purulent discharge from wound,purulent laceration of right hip,0
16908,Purulent discharge from wound,purulent laceration of left hip,0
16909,Purulent discharge from wound,purulent laceration of right thigh,0
16910,Purulent discharge from wound,purulent laceration of left thigh,0
16911,Purulent discharge from wound,purulent laceration of right knee,0
16912,Purulent discharge from wound,purulent laceration of left knee,0
16913,Purulent discharge from wound,purulent laceration of right lower leg,0
16914,Purulent discharge from wound,purulent laceration of left lower leg,0
16915,Purulent discharge from wound,purulent laceration of right ankle,0
16916,Purulent discharge from wound,purulent laceration of left ankle,0
16917,Purulent discharge from wound,purulent laceration of right foot,0
16918,Purulent discharge from wound,purulent laceration of left foot,0
16919,Purulent discharge from wound,purulent laceration of right upper paraspinal region,0
16920,Purulent discharge from wound,purulent laceration of left upper paraspinal region,0
16921,Purulent discharge from wound,purulent laceration of right mid back,0
16922,Purulent discharge from wound,purulent laceration of right mid paraspinal region,0
16923,Purulent discharge from wound,purulent laceration of left mid paraspinal region,0
16924,Purulent discharge from wound,purulent laceration of left mid back,0
16925,Purulent discharge from wound,purulent laceration of right lower back,0
16926,Purulent discharge from wound,purulent laceration of right lower paraspinal region,0
16927,Purulent discharge from wound,purulent laceration of left lower paraspinal region,0
16928,Purulent discharge from wound,purulent laceration of left lower back,0
16929,Purulent discharge from wound,purulent laceration of toe,0
16930,Purulent discharge from wound,purulent laceration of finger,0
16931,Purulent discharge from wound,purulent laceration of right ear,0
16932,Purulent discharge from wound,purulent laceration of left ear,0
16933,Purulent discharge from wound,laceration of penis with purulent drainage,0
16934,Purulent discharge from wound,size of laceration on anterior vaginal wall with purulent discharge,0
16935,Purulent discharge from wound,size of laceration on vaginal sidewall with purulent discharge,0
16936,Purulent discharge from wound,size of laceration on posterior vaginal wall with purulent discharge,0
16937,Purulent discharge from wound,purulent laceration of genitalia,0
16938,Purulent discharge from wound,purulent laceration of perineum,0
16939,Purulent discharge from wound,purulent laceration of anus,0
16940,Purulent discharge from wound,purulent laceration of right breast,0
16941,Purulent discharge from wound,purulent laceration of left breast,0
16942,Purulent discharge from wound,purulent laceration,0
16943,Purulent discharge from wound,purulent laceration of scalp,0
16944,Purulent discharge from wound,purulent laceration of top of head,0
16945,Purulent discharge from wound,purulent laceration of forehead,0
16946,Purulent discharge from wound,purulent laceration of face,0
16947,Purulent discharge from wound,purulent laceration of temple,0
16948,Purulent discharge from wound,purulent laceration of back of head,0
16949,Purulent discharge from wound,purulent laceration of abdominal wall,0
16950,Wound dehiscence,dehiscence of laceration of right temporomandibular joint,0
16951,Wound dehiscence,dehiscence of laceration of left temporomandibular joint,0
16952,Wound dehiscence,dehiscence of laceration of anterior neck,0
16953,Wound dehiscence,dehiscence of laceration of posterior neck,0
16954,Wound dehiscence,dehiscence of laceration of right side of neck,0
16955,Wound dehiscence,dehiscence of laceration of left side of neck,0
16956,Wound dehiscence,dehiscence of laceration of right shoulder,0
16957,Wound dehiscence,dehiscence of laceration of left shoulder,0
16958,Wound dehiscence,dehiscence of laceration of right arm,0
16959,Wound dehiscence,dehiscence of laceration of left arm,0
16960,Wound dehiscence,dehiscence of laceration of right elbow,0
16961,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ETHAVERINE HYDROCHLORIDE,0
16962,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pneumococcal capsular polysaccharide type 2 vaccine,0
16963,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acetomenaphthone,0
16964,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cnidium monnieri Fruit,0
16965,NCPDP Strength Form Terminology,Solid Dose Form,0
16966,CTRP Agent Terminology,Forodesine hydrochloride,0
16967,FDA Established Names and Unique Ingredient Identifier Codes Terminology,LEDISMASE,0
16968,FDA CDRH GUDID Terminology,Recommended Storage Humidity,0
16969,CTRP Terminology,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,0
16970,CTRP Agent Terminology,EGFRvIII-specific CAR-transduced Autologous T Lymphocytes,0
16971,CDISC QRS Terminology,HAMD-21 - Insomnia Early,0
16972,CareLex eTMF Terminology,Vendor Information Documentation,0
16973,Pediatric Terminology,Perinatal respiratory distress,0
16974,Clinical Data Interchange Standards Consortium Terminology,Experimental Organism Benign Stromal Tumor Neoplasm,0
16975,CDISC SDTM Terminology,Percent Recovered Infinity Observed Normalized by Weight,0
16976,CDISC SDTM Unit of Measure Terminology,Milliliter per gram,0
16977,Perinatal Terminology,Hydatidiform Mole,0
16978,CDISC SDTM Medical Evaluator Terminology,Oncologist 2,0
16979,CDISC CDASH Terminology,Puerto Ricans,0
16980,CDISC SEND Terminology,Feces,0
16981,CDISC SDTM Laboratory Test Terminology by Name,Basophil To Leukocyte Ratio,0
16982,CDISC SDTM PK Unit of Measure Kilogram Weight Terminology,Minute Times Microgram Per Milliliter Per Kilogram,0
16983,CDISC Questionnaire DAD Test Name Terminology,DAD - Adequately Organize Correspondence,0
16984,CDISC SDTM Trial Summary Parameter Terminology by Code,Country of Manufacture,0
16985,CDISC SDTM Terminology,Galactography,0
16986,CDISC QRS Terminology,NPI - Increase in Appetite,0
16987,CTRP Agent Terminology,umbralisib,0
16988,Oral Health Impact Profile,"Unsatisfactory Diet due to Problem with Teeth, Denture or Mouth",0
16989,CDISC SEND Body System Terminology,Endocrine finding,0
16990,CDISC SDTM Terminology,mCi/kg,0
16991,Clinical Data Interchange Standards Consortium Terminology,Human parainfluenza viruses,0
16992,Clinical Data Interchange Standards Consortium Terminology,GAD-7 - Becoming Easily Annoyed or Irritable,0
16993,Patient Reported Outcomes Version of CTCAE,Past Seven Days Pain Interfering with Usual or Daily Activities,0
16994,Stability Container Type Terminology,Flask,0
16995,CDISC SDTM Terminology,Bacteriological Cure,0
16996,Neonatal Research Network Terminology,Muscle hypotonia,0
16997,Clinical Data Interchange Standards Consortium Terminology,DAD - Eat Meals at a Normal Pace and with Appropriate Manners,0
16998,Neonatal Research Network Terminology,Anemia,0
16999,CareLex eTMF Terminology,Database Validation Plan,0
17000,Clinical Data Interchange Standards Consortium Terminology,Corynebacterium accolens,0
17001,CTRP Agent Terminology,CC-115,0
17002,CDISC Variable Terminology,Microbiology Susceptibility Elapsed Time,0
17003,CDISC SDTM Terminology,New Tumor Confirmation,0
17004,Neonatal Research Network Terminology,Congenital His bundle tachycardia,0
17005,US Counties Terminology,"Gallatin County, KY",0
17006,Adverse Event Outcome ICSR Terminology,Adverse Event Emergency Room Visit,0
17007,Clinical Data Interchange Standards Consortium Terminology,Thyroid/Parathyroid,0
17008,CTRP Agent Terminology,Extended Release Flucytosine,0
17009,CDISC SDTM Adverse Event Outcome Terminology,Death Related to Adverse Event,0
17010,CTRP Terminology,Adult Central Nervous System Choriocarcinoma,0
17011,eCTD Promotional Material Type Terminology,Giveaway,0
17012,Neurological Development Terminology,Asperger Syndrome,0
17013,CDISC SDTM Terminology,C-SSRS Children's Baseline - Most Lethal Suicide Attempt Date,0
17014,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Phosphorus 32,0
17015,CDISC Questionnaire Terminology,Generalized Anxiety Disorder Scale,0
17016,CTRP Terminology,Cantuzumab ravtansine,0
17017,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Oxetacillin,0
17018,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ditiocarb,0
17019,NCIt Antineoplastic Agent Terminology,shosaiko-to,0
17020,FDA Established Names and Unique Ingredient Identifier Codes Terminology,calcium lactate,0
17021,NCIt Antineoplastic Agent Terminology,Cintredekin Besudotox,0
17022,CDISC Questionnaire C-SSRS Children's Baseline Test Name Terminology,C-SSRS Children's Baseline - Most Lethal Suicide Attempt Actual Lethality/Medical Damage,0
17023,CDISC SDTM Laboratory Test Terminology by Name,Hepatitis C Virus Antigen Measurement,0
17024,FDA Device Component Code Hierarchy,Ferrule Device,0
17025,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Squalene,0
17026,CDISC Variable Terminology,Questionnaire Reason Not Done,0
17027,CDISC SDTM Terminology,"Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire",0
17028,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Peraclopone,0
17029,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cicloprolol hydrochloride,0
17030,Clinical Data Interchange Standards Consortium Terminology,Barnes Akathisia Rating Scale Questionnaire,0
17031,Medical Outcomes Study Your Feelings Questionnaire,Extremely Happy,0
17032,CDISC QRS Terminology,C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Lifetime),0
17033,FDA Established Names and Unique Ingredient Identifier Codes Terminology,timolol anhydrous,0
17034,CDISC Questionnaire PHQ Screener Version Test Code Terminology,PHQ Screener Version - Feeling Nervous or Anxious,0
17035,FDA Device Problem Code Hierarchy,Moisture Damage,0
17036,FDA Established Names and Unique Ingredient Identifier Codes Terminology,efegatran sulfate,0
17037,Pediatric Terminology,Weight Gain,0
17038,"Geopolitical Entities, Names, and Codes Terminology",Cyprus,0
17039,Clinical Data Interchange Standards Consortium Terminology,CRQ-SAS Follow-Up Administration Version - Felt Frustrated or Impatient,0
17040,Clinical Data Interchange Standards Consortium Terminology,Billion Organisms,0
17041,Clinical Data Interchange Standards Consortium Terminology,Multi-Drug Resistance,0
17042,CTRP Terminology,Adult Epithelioid Sarcoma,0
17043,CDISC SEND Terminology,Trimonthly,0
17044,Pediatric Terminology,Nephropathy induced by heavy metals,0
17045,CDISC QRS Terminology,CDISC Questionnaire GCGI v1 Test Name Terminology,0
17046,US Counties Terminology,"Logan County, ND",0
17047,CTRP Terminology,brincidofovir,0
17048,Clinical Data Interchange Standards Consortium Terminology,Actinomyces israelii (bacteria),0
17049,CTRP Terminology,Levofloxacin,0
17050,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sodium gentisate,0
17051,FDA Established Names and Unique Ingredient Identifier Codes Terminology,clenbuterol hydrochloride,0
17052,Sleep Quality Question,Occasionally Have Trouble Getting to Sleep and Staying Asleep,0
17053,FDA Established Names and Unique Ingredient Identifier Codes Terminology,trandolapril,0
17054,CDISC Questionnaire Terminology,"C-SSRS Since Last Visit - Description of Ideation With Intent, No Plan",0
17055,CDISC Questionnaire BPI Test Name Terminology,BPI - Need more Pain Medication than Prescribed,0
17056,CDISC SDTM Microorganism Terminology,Streptococcus agalactiae,0
17057,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"Fluoxetine Hydrochloride, (R)-",0
17058,CDISC SDTM Terminology,Cylindrical Refractive Error,0
17059,NCPDP Quantity Unit of Measure Terminology,bottle - unit dose,0
17060,CTRP Terminology,Isolated limb perfusion,0
17061,NCIt Antineoplastic Agent Terminology,Synthetic hTERT DNA Vaccine INO-1400,0
17062,NCIt Neoplasm Core Terminology,Thymic Small Cell Carcinoma,0
17063,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Inosine Pranobex,0
17064,CDISC QRS Terminology,C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Lifetime),0
17065,CDISC SEND Terminology,Minute Times Milligram Per Milliliter Per Milligram Per Gram,0
17066,CTRP Agent Terminology,CD4+ CD25+ Regulatory T Cells,0
17067,Clinical Data Interchange Standards Consortium Terminology,Pancreatic duct,0
17068,Neonatal Research Network Terminology,Classical galactosemia,0
17069,CDISC Variable Terminology,Skin Response Evaluator,0
17070,CDISC SDTM Terminology,ADCS-ADL - Usual Conversation Participation,0
17071,CTRP Agent Terminology,Macitentan,0
17072,Clinical Data Interchange Standards Consortium Terminology,Lambda Z,0
17073,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fenproporex,0
17074,CDISC SDTM Terminology,Long-term Follow-up,0
17075,US Counties Terminology,"Penuelas Municipio, PR",0
17076,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ethynodiol,0
17077,US Counties Terminology,"Calhoun County, MI",0
17078,CDISC Questionnaire SGRQ Past 3 Months Version Test Name Terminology,SGRQ Past 3 Months Version - Breathing Makes Difficult to Walk Up Hills,0
17079,Clinical Data Interchange Standards Consortium Terminology,SGRQ Past 3 Months Version - Breathing Makes Difficult to Walk Up Hills,0
17080,SPL Pharmaceutical Dosage Form Terminology,Aerosol Spray Dosage Form,0
17081,FDA Established Names and Unique Ingredient Identifier Codes Terminology,levoxadrol,0
17082,CDISC SDTM Microorganism Terminology,Nosema,0
17083,Pediatric Terminology,Split-Hand/Foot Malformation,0
17084,CDISC SEND Terminology,follow-up,0
17085,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ZSTK474,0
17086,CTRP Agent Terminology,ZSTK474,0
17087,Perinatal Terminology,Splenic Rupture Related to Birth,0
17088,CDISC Questionnaire Terminology,GOSE - Epilepsy: Most Important Factor in Outcome,0
17089,Pediatric Terminology,Respiratory Depression,0
17090,Clinical Data Interchange Standards Consortium Terminology,Streptococcus gallolyticus,0
17091,CDISC SDTM Terminology,DNA,0
17092,CTRP Agent Terminology,Cytokine-Induced Killer Cells,0
17093,CDISC SDTM Terminology,Lactobacillus gasseri,0
17094,CTRP Terminology,Milademetan Tosylate,0
17095,FDA Established Names and Unique Ingredient Identifier Codes Terminology,geldanamycin,0
17096,CTRP Disease Terminology,Heart Diseases,0
17097,CDISC SEND Tumor Findings Results Terminology,Benign Cardiac Schwannoma,0
17098,CDISC SDTM Microorganism Terminology,Veillonella atypica,0
17099,CDISC SDTM Terminology,Oidiodendron,0
17100,CDISC Clinical Classification Terminology,Coronary Thrombus TIMI Grade Clinical Classification,0
17101,CDISC Questionnaire C-SSRS Children's Baseline Test Code Terminology,C-SSRS Children's Baseline - Number of Actual Suicide Attempts,0
17102,CTRP Terminology,"Leukemia, Myelocytic, Acute",0
17103,FDA Device Problem Code Hierarchy,Unstable Medical Device Problem,0
17104,CDISC Questionnaire ADCS-ADL Test Code Terminology,ADCS-ADL - Dispose of Garbage in Appropriate Place at Home,0
17105,Clinical Data Interchange Standards Consortium Terminology,Milli-International Unit per Milliliter per Kilogram,0
17106,Clinical Data Interchange Standards Consortium Terminology,Minute Times Femtogram Per Milliliter Per Kilogram,0
17107,CDISC SEND Terminology,Day Times gram Per Milliliter Per Milligram Per Gram,0
17108,Clinical Data Interchange Standards Consortium Terminology,CDISC Functional Test BACS Test Code Terminology,0
17109,CDISC SDTM Unit of Measure Terminology,osmole (unit of measure),0
17110,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fropenem,0
17111,Pediatric Adverse Events Terminology,Basophilopenia,0
17112,Hospital Anxiety and Depression Scale Questionnaire,"Yes, But Not Too Badly",0
17113,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cephradine Anhydrous,0
17114,Pediatric Terminology,Macrophage Activation Syndrome,0
17115,CDISC SEND Terminology,Left Ventricular Apical Lateral Segment,0
17116,CDISC SDTM Terminology,Brevibacterium,0
17117,US Counties Terminology,"Bourbon County, KS",0
17118,CDISC SDTM Microorganism Terminology,Vorticella,0
17119,CTRP Terminology,Recurrent Urethral Cancer,0
17120,NCIt Neoplasm Core Terminology,Chondrosarcoma,0
17121,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ampyzine,0
17122,FDA Established Names and Unique Ingredient Identifier Codes Terminology,dimethophrine,0
17123,CDISC SDTM Terminology,Drop Dosing Unit,0
17124,Quality of Life Questionnaire - Pancreatic Cancer 26,Adequate Information Given About Physical Condition and Treatment,0
17125,Stability Product Form Terminology,Packing Dosage Form,0
17126,Pediatric Nephrology Terminology,Urachal Cyst,0
17127,CDISC SDTM Anatomical Location Terminology,Internal iliac lymph node,0
17128,SPL Unit of Presentation Terminology,Pouch Dosing Unit,0
17129,Pediatric Terminology,Phonophobia,0
17130,CDISC SDTM Terminology,Cystobasidium minutum,0
17131,CDISC QRS Terminology,ADNI AVLT - List A Recall 4 Word 2,0
17132,NCIt Antineoplastic Agent Terminology,Halofuginone hydrobromide,0
17133,US Counties Terminology,"Ware County, GA",0
17134,CDISC SDTM Terminology,"C-SSRS Children's Baseline - Self-injurious Behavior, Intent Unknown",0
17135,CDISC SDTM Microorganism Terminology,Leifsonia aquatica,0
17136,Pediatric Terminology,Chest wall pain,0
17137,Neonatal Research Network Terminology,Holocarboxylase Synthetase Deficiency,0
17138,CDISC SDTM Microorganism Terminology,Streptococcus milleri,0
17139,CDISC QRS Terminology,Stent Thrombosis Coronary ARC Grade Clinical Classification,0
17140,CDISC Questionnaire HADS Test Code Terminology,HADS - I Can Sit at Ease and Feel Relaxed,0
17141,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fengabine,0
17142,Clinical Data Interchange Standards Consortium Terminology,SGRQ Past 3 Months Version - I Get Exhausted Easily,0
17143,Clinical Data Interchange Standards Consortium Terminology,Pichia kudriavzevii,0
17144,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Piberaline,0
17145,Clinical Data Interchange Standards Consortium Terminology,Bone marrow of humerus,0
17146,Pediatric Terminology,Pounds,0
17147,CDISC SEND Terminology,Craniorachischisis,0
17148,Neurological Development Terminology,Pervasive Development Disorder,0
17149,CTRP Terminology,Adenocarcinoma of pancreas,0
17150,CDISC SDTM Terminology,CDISC Clinical Classification BODE Index Test Name Terminology,0
17151,NCIt Neoplasm Core Terminology,Adenomatoid Tumor,0
17152,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fesoterodine Fumarate,0
17153,CDISC Questionnaire Terminology,SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Do Heavy Manual Work,0
17154,CDISC SDTM Terminology,Geotrichum,0
17155,CDISC SDTM Terminology,Minute Times Nanogram Per Milliliter Per Milligram Per Gram Per Day,0
17156,NCIt Neoplasm Core Terminology,"Myelodysplastic syndrome, no ICD-O subtype",0
17157,CDISC SDTM Laboratory Test Terminology by Code,Immature Lymphocytes Measurement,0
17158,Type Of Reporter ICSR Terminology,Importer,0
17159,CTRP Terminology,muparfostat,0
17160,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Iothalamic Acid,0
17161,Clinical Data Interchange Standards Consortium Terminology,AUDIT - How Many Alcohol Drinks on a Typical Day,0
17162,FDA Established Names and Unique Ingredient Identifier Codes Terminology,noberastine,0
17163,FDA Established Names and Unique Ingredient Identifier Codes Terminology,camostate-mesilate,0
17164,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Doretinel,0
17165,CDISC SDTM Terminology,Ganglia,0
17166,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"Cefprozil, (Z)-",0
17167,Clinical Data Interchange Standards Consortium Terminology,Spina Bifida,0
17168,NCIt Neoplasm Core Terminology,"Thymoma, type B1",0
17169,CDISC CDASH Concomitant Medication Dosing Frequency per Interval Terminology,Four times daily,0
17170,CDISC SDTM Terminology,Desmoglein 3 Antibody Measurement,0
17171,Observation ICSR Terminology,sex,0
17172,TAPS Tool - Interviewer Version,"Frequency Medication Use For the Feeling, To Get High, More Often, or in Larger Doses than Prescribed",0
17173,CDISC Variable Terminology,Clinical Study Sponsor,0
17174,CDISC Questionnaire Terminology,"ADCS-ADL MCI - Perform Pastime, Hobby or Game: Gardening",0
17175,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cefdinir,0
17176,CDISC SEND Terminology,Urinary Bladder,0
17177,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Linarotene,0
17178,Pediatric Immunization Terminology,Deafness,0
17179,FDA Established Names and Unique Ingredient Identifier Codes Terminology,posizolid,0
17180,Human Activity Profile Test,Kneeling or Squatting to Do Light Work,0
17181,CDISC SDTM Terminology,Thrombin to Antithrombin Ratio Measurement,0
17182,PROMIS Global Health Questionnaire,In General Please Rate How Well You Carry Out Your Usual Social Activities And Roles,0
17183,CDISC SDTM Terminology,BPI - Things that Make Pain Feel Better,0
17184,FDA Established Names and Unique Ingredient Identifier Codes Terminology,avorelin,0
17185,CDISC SDTM Terminology,HAQ-DI With VAS - Able to Reach and Get Down Object From Above Head,0
17186,Clinical Data Interchange Standards Consortium Terminology,Benign Carotid Body Paraganglioma,0
17187,CDISC SDTM Terminology,ADCS-ADL - Description of Highest Performance of Telephone Use,0
17188,FDA eManufacturing Terminology,Sterile Cell Culture Product Processing,0
17189,FDA Established Names and Unique Ingredient Identifier Codes Terminology,saracatinib,0
17190,CDISC QRS Terminology,GDS-SF - Feel Life Is Empty,0
17191,CDISC SDTM Terminology,Kidney,0
17192,CDISC SDTM Terminology,Protocol Agent,0
17193,CDISC Functional Test Terminology,CDISC Functional Test TMT Test Name Terminology,0
17194,CDISC QRS Terminology,CDISC Functional Test TMT Test Name Terminology,0
17195,CDISC QRS Terminology,ADCS-ADL MCI - Description of Optimal Performance of Driving Car,0
17196,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Alphadolone acetate,0
17197,Clinical Data Interchange Standards Consortium Terminology,ARC Stent Thrombosis Timing Subacute,0
17198,Clinical Data Interchange Standards Consortium Terminology,Trichinella,0
17199,Patient Problem Codes FDA CDRH,"Tachycardia, Ventricular",0
17200,CTRP Terminology,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17201,Perinatal Terminology,Breast Feeding,0
17202,CTRP Agent Terminology,Multivitamin preparation,0
17203,CDISC SEND Terminology,Curacao (geographic location),0
17204,CDISC SDTM Terminology,Active Control,0
17205,FDA Established Names and Unique Ingredient Identifier Codes Terminology,clemizole,0
17206,CDISC Clinical Classification Terminology,APACHE II - Serum Sodium,0
17207,CDISC CDASH Variable Terminology,Visit Number,0
17208,NCIt Antineoplastic Agent Terminology,DOTAP:Cholesterol-Fus1 Liposome Complex,0
17209,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Metizoline Hydrochloride,0
17210,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Tyrosine,0
17211,CDISC Questionnaire Terminology,FACT-P Version 4 - Satisfied With How I Am Coping,0
17212,"Toronto Extremity Salvage Score, Upper Extremity",Ability to Work My Usual Number of Hours,0
17213,FDA Established Names and Unique Ingredient Identifier Codes Terminology,rofecoxib,0
17214,CDISC SDTM Terminology,baseline - TableCellVerticalAlign,0
17215,CTRP Disease Terminology,Odontogenic Tumors,0
17216,CTRP Terminology,Childhood Grade III Lymphomatoid Granulomatosis,0
17217,Stability Study Method Type Terminology,Proprietary Method,0
17218,CTRP Terminology,Caregiver-Assisted Training,0
17219,CDISC SDTM Terminology,GOSE - Family and Friendships: Problems with Family or Friends Before Injury,0
17220,US Counties Terminology,"Henry County, OH",0
17221,Neonatal Research Network Terminology,Laboratory Procedures,0
17222,CDISC Questionnaire Terminology,ADCS-ADL - Talk About TV Content While Watching,0
17223,CTRP Agent Terminology,Thioguanine,0
17224,CDISC SDTM Laboratory Test Terminology by Name,ABO blood grouping,0
17225,US Counties Terminology,"San Diego County, CA",0
17226,CDISC SDTM Terminology,Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire,0
17227,Clinical Data Interchange Standards Consortium Terminology,Long QT Syndrome,0
17228,Pediatric Terminology,Lassitude,0
17229,CDISC SDTM Unit of Measure Terminology,Log10 Copies per Milliliter,0
17230,CDISC SDTM Terminology,FACT-G Version 4 - I Get Emotional Support From My Family,0
17231,integrated Cancer Repository for Cancer Research,Business Operations Specialists,0
17232,Clinical Data Interchange Standards Consortium Terminology,Nonspecific Intraventricular Conduction Delay by ECG Finding,0
17233,CTRP Agent Terminology,Cilengitide,0
17234,FDA Established Names and Unique Ingredient Identifier Codes Terminology,methallenestril,0
17235,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pneumococcal capsular polysaccharide type 19F vaccine,0
17236,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Azaclorzine Hydrochloride,0
17237,CTRP Agent Terminology,ERK Inhibitor GDC-0994,0
17238,Clinical Data Interchange Standards Consortium Terminology,Rescue Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction After Failed Full-Dose Thrombolytic Therapy,0
17239,NCIt Neoplasm Core Terminology,Carcinoma of anal margin,0
17240,CDISC SDTM Laboratory Test Terminology by Name,Sulfa Crystal Measurement,0
17241,Clinical Data Interchange Standards Consortium Terminology,Trace Dosing Unit,0
17242,Medical Outcomes Study Social Activities,All of the Time,0
17243,Epworth Sleepiness Scale Questionnaire,Watching TV,0
17244,Borg Scale Rating of Perceived Exertion Questionnaire,Borg Scale Rating of Perceived Exertion Score 19,0
17245,ICH Unit of Measure Terminology,Enzyme-Linked Immunosorbent Assay Unit per Milliliter,0
17246,CDISC SDTM Laboratory Test Terminology by Name,Chemokine (C-C Motif) Ligand 18 Measurement,0
17247,CDISC SDTM Pharmaceutical Dosage Form Terminology,Aerosol Dose Form,0
17248,CTRP Terminology,Recurrent Childhood Gliosarcoma,0
17249,CDISC SDTM Terminology,Forced Inspiratory Flow at 25%,0
17250,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dextofisopam,0
17251,FDA Established Names and Unique Ingredient Identifier Codes Terminology,nomegestrol acetate,0
17252,SPL Drug Route of Administration Terminology,Intravenous Route of Drug Administration,0
17253,Clinical Data Interchange Standards Consortium Terminology,Intravenous Route of Drug Administration,0
17254,Clinical Data Interchange Standards Consortium Terminology,Human Anti-Sheep IgM Antibody Measurement,0
17255,FDA Established Names and Unique Ingredient Identifier Codes Terminology,common sagebrush pollen extract,0
17256,CDISC SEND Organ Measurement Test Name Terminology,Organ to Brain Weight Ratio,0
17257,CTRP Terminology,Adult Diffuse Large Cell Lymphoma,0
17258,CDISC Variable Terminology,Exclude Laboratory Test Data From Statistics Indicator,0
17259,Clinical Data Interchange Standards Consortium Terminology,Injury Site,0
17260,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Lifetime),0
17261,CDISC Questionnaire Terminology,Expanded DRS-PI Survivor Version - Perform Jobs or Manage a Home Independently,0
17262,CDISC Questionnaire CHART-SF Paper Version Test Name Terminology,CHART-SF Paper Version - Associates Contacted per Month,0
17263,CDISC SDTM Terminology,Lower Extremity,0
17264,CTRP Agent Terminology,Acolbifene Hydrochloride,0
17265,Neonatal Research Network Terminology,Cerebrovascular accident,0
17266,CDISC SDTM Terminology,Grimontia hollisae,0
17267,CDISC SDTM Anatomical Location Terminology,Choroid,0
17268,CDISC SEND Cardiovascular Test Name Terminology,Systolic Pressure,0
17269,Clinical Data Interchange Standards Consortium Terminology,Systolic Pressure,0
17270,CDISC SEND Terminology,Saudi Arabia,0
17271,FDA Device Component Code Hierarchy,Dehumidifiers,0
17272,CTRP Terminology,Subcutaneous Hormonal Therapy,0
17273,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Preparatory Acts or Behaviors Toward Suicide Attempt,0
17274,CTRP Terminology,Transthyretin Antisense Oligonucleotide ISIS-TTR Rx,0
17275,CDISC SDTM Microorganism Terminology,Eubacterium nodatum,0
17276,CDISC QRS Terminology,IIEF - Satisfied with Overall Sex Life,0
17277,FDA Established Names and Unique Ingredient Identifier Codes Terminology,anidoxime,0
17278,CDISC Functional Test NHPT Test Code Terminology,NHPT - Time to Complete 9-Hole Peg Test,0
17279,CDISC SDTM Trial Summary Parameter Terminology by Code,SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator,0
17280,CDISC SDTM Terminology,Infraclavicular lymph node group,0
17281,FDA Established Names and Unique Ingredient Identifier Codes Terminology,spirapril,0
17282,Multidimensional Body-Self Relations Questionnaire Appearance Orientation,Score,0
17283,Regulated Product Submission Reporting Terminology,Request for a Waiver,0
17284,Pediatric Terminology,Perinatal Drug Withdrawal,0
17285,CTRP Agent Terminology,panobinostat,0
17286,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Eucaine,0
17287,Clinical Data Interchange Standards Consortium Terminology,DLQI - Skin Prevent Work or Study,0
17288,CTRP Agent Terminology,XK 469,0
17289,CDISC Questionnaire Category Terminology,Geriatric depression scale short form,0
17290,CDISC SDTM Microorganism Terminology,Serratia plymuthica,0
17291,CDISC Questionnaire Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Potential Lethality,0
17292,CDISC SDTM Terminology,Bone structure of face,0
17293,CDISC SEND Terminology,Bone structure of face,0
17294,Clinical Data Interchange Standards Consortium Terminology,Gut associated lymphoid tissue,0
17295,NCIt Neoplasm Core Terminology,Adenocarcinoma of colon,0
17296,Clinical Data Interchange Standards Consortium Terminology,Prolonged QT interval,0
17297,FDA Established Names and Unique Ingredient Identifier Codes Terminology,evatanepag,0
17298,CDISC QRS Terminology,ESRS-A - Dystonia: Jaw,0
17299,CDISC SDTM Microorganism Terminology,Pichia anomala,0
17300,FDA Individual Case Safety Report Terminology,Negative Rechallenge Indicator,0
17301,CDISC SEND Terminology,Centromere IgG Antibody Measurement,0
17302,Pediatric Terminology,Anoxia,0
17303,CDISC SEND Terminology,Rheumatoid Factor Measurement,0
17304,CDISC SEND Terminology,CDISC SEND Implantation Findings Result Terminology,0
17305,NCIt Antineoplastic Agent Terminology,Pegargiminase,0
17306,CDISC Clinical Classification CRS-R Test Code Terminology,CRS-R - Arousal Scale,0
17307,CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Code Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Actual Lethality/Medical Damage,0
17308,CDISC SDTM Terminology,DAD - Decide to Go Out at an Appropriate Time,0
17309,CDISC Questionnaire EPIC-26 Test Name Terminology,EPIC-26 - Increased Frequency of Bowel Movements,0
17310,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ethylparaben sodium,0
17311,CDISC Questionnaire MDS-UPDRS Test Name Terminology,MDS-UPDRS - Rigidity Right Lower Extremity,0
17312,CDISC SEND Terminology,Hour Times Microgram per Milliliter,0
17313,Clinical Data Interchange Standards Consortium Terminology,acute,0
17314,CDISC Functional Test AVLT-REY Test Code Terminology,AVLT-REY - List B Word 4,0
17315,Pediatric Infectious Disease Terminology,Smallpox,0
17316,CDISC SEND Terminology,Day Times Nanogram Per Milliliter Per Milligram Per Gram,0
17317,Clinical Data Interchange Standards Consortium Terminology,AVLT-REY - List B Word 6,0
17318,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Xidecaflur,0
17319,CTRP Terminology,Untreated Childhood Anaplastic Oligoastrocytoma,0
17320,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cinepazide,0
17321,CDISC Variable Terminology,Subject Characteristics Character Result in Standard Unit,0
17322,Pediatric Rheumatology Terminology,Chloroquine Compound,0
17323,CDISC SDTM Terminology,PHQ-9 - Little Interest or Pleasure in Doing Things,0
17324,CDISC SDTM Terminology,Absorbance Unit per Milliliter,0
17325,CDISC Questionnaire Terminology,NCCN-FACT FKSI-19 Version 2 - I Have Pain,0
17326,US Counties Terminology,"Eddy County, NM",0
17327,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ornoprostil,0
17328,CDISC Questionnaire Terminology,CDISC Questionnaire SGRQ Past 4 Weeks Version Test Code Terminology,0
17329,CDISC Questionnaire ADCS-ADL Test Code Terminology,ADCS-ADL - Number of 'Don't Know' Responses,0
17330,CTRP Terminology,Stage IA Pancreatic Cancer AJCC v6 and v7,0
17331,CDISC SDTM PK Unit of Measure Kilogram Weight Terminology,Hour Times Microgram per Milliliter per Milligram,0
17332,CDISC SEND Biospecimens Terminology,Peritoneal Fluid (body substance),0
17333,Clinical Data Interchange Standards Consortium Terminology,Salmonella Serotype Group C,0
17334,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pamicogrel,0
17335,Pediatric Rheumatology Terminology,SS A antibodies,0
17336,Clinical Data Interchange Standards Consortium Terminology,Staphylococcus chromogenes,0
17337,"Geopolitical Entities, Names, and Codes Terminology",Saint Pierre and Miquelon,0
17338,CDISC SDTM Laboratory Test Terminology by Code,Clarity Measurement,0
17339,SPL Drug Route of Administration Terminology,Endotracheal Route of Drug Administration,0
17340,CDISC Questionnaire FAQ-NACC Version Test Name Terminology,FAQ-NACC Version - Shop Alone,0
17341,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Theophylline,0
17342,CDISC SDTM Terminology,Coat Dosing Unit,0
17343,NCI CTEP Simplified Disease Classification Terminology,Treatment related acute myeloid leukaemia,0
17344,CDISC QRS Terminology,St. George's Respiratory Questionnaire for Chronic Obstructive Pulmonary Disease Patients,0
17345,CDISC SDTM Terminology,Right Atrial Appendage,0
17346,CDISC SDTM Terminology,Staphylococcus cohnii,0
17347,Clinical Data Interchange Standards Consortium Terminology,Interleukin 4 Measurement,0
17348,CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Name Terminology,NCCN-FACT FKSI-19 Version 2 - I Feel Fatigued,0
17349,Pediatric Nephrology Terminology,Voiding Disorders,0
17350,CDISC QRS Terminology,NCCN-FACT-FPSI 17 Version 2 - I Have Pain,0
17351,Clinical Data Interchange Standards Consortium Terminology,Supernumerary Cranial Sutures,0
17352,PI-RADS Terminology,Structure of left seminal vesicle,0
17353,CDISC QRS Terminology,CDISC Questionnaire VFQ25-Interviewer Administered Format Test Code Terminology,0
17354,NCIt Antineoplastic Agent Terminology,Anti-Programmed Cell Death Protein 1 Antibody Expressing Pluripotent Killer T-Lymphocytes,0
17355,CDISC SDTM Terminology,CDISC ADAS-Cog - Delayed Word Recall: Word 10,0
17356,CDISC SDTM ECG Finding Terminology,Repolarization abnormalities,0
17357,CTRP Agent Terminology,Titanium Dioxide/Zinc Oxide Sunscreen,0
17358,CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Code Terminology,NCCN-FACT FKSI-19 Version 2 - I Have Been Short of Breath,0
17359,CDISC SEND Fetal Measurement Test Code Terminology,Biparietal Distance,0
17360,CTRP Terminology,Ultrasound-Guided Transbronchial Needle Aspiration,0
17361,CDISC Questionnaire Terminology,ESS - As a Passenger in a Car for an Hour Without a Break,0
17362,CDISC SDTM Terminology,FAMS - I Feel Tired,0
17363,CDISC Variable Terminology,Questionnaire Planned Time Point Number,0
17364,CDISC QRS Terminology,EQ-5D-3L - EQ VAS Score,0
17365,CDISC SEND Terminology,Temporal Arteries,0
17366,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Spinosad Factor D,0
17367,CTRP Agent Terminology,doxycycline hyclate,0
17368,NCIt Antineoplastic Agent Terminology,clanfenur,0
17369,Clinical Data Interchange Standards Consortium Terminology,AVLT-REY - Recognition Intrusions,0
17370,CDISC Observation Class Terminology,External Filename,0
17371,Clinical Data Interchange Standards Consortium Terminology,Fetal Weight,0
17372,CDISC Questionnaire Terminology,ADCS-ADL MCI - Description of Usual Performance of Finding Belongings,0
17373,NCIt Antineoplastic Agent Terminology,pemetrexed,0
17374,CDISC SDTM Terminology,Stem Cell Factor Measurement,0
17375,CDISC SDTM Laboratory Test Terminology by Code,Blast to Leukocyte Ratio Measurement,0
17376,CDISC SDTM Terminology,Minimum Concentration Normalized by Weight,0
17377,US Counties Terminology,"Hidalgo County, NM",0
17378,NCIt Antineoplastic Agent Terminology,Trientine hydrochloride,0
17379,CTRP Agent Terminology,Pacritinib,0
17380,NCIt Antineoplastic Agent Terminology,Topixantrone,0
17381,US Counties Terminology,"Metcalfe County, KY",0
17382,NCPDP Strength Form Terminology,Dental dosage form,0
17383,CDISC SDTM Terminology,MHIS-NACC - Emotional Incontinence,0
17384,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Butethamine Formate,0
17385,NCI CTEP Simplified Disease Classification Terminology,Invasive carcinoma of breast,0
17386,Patient Problem Codes FDA CDRH,Pneumonia,0
17387,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Erodium cicutarium extract,0
17388,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,Volume of Distribution Observed Normalized by Surface Area,0
17389,UCUM Terminology,Inhalation Dosing Unit,0
17390,Expanded Prostate Cancer Index Composite,How Often had Stools That Were Loose or Liquid,0
17391,CDISC SDTM Laboratory Test Terminology by Name,Hematocrit Corrected Reticulocyte Count,0
17392,CDISC Questionnaire PHQ Screener Version Test Name Terminology,"PHQ Screener Version - Avoid Gaining Weight, Fasted at Least 24 Hours",0
17393,CDISC SEND Terminology,Mediastinal lymph node group,0
17394,Clinical Data Interchange Standards Consortium Terminology,FAQ-NACC Version - Remember,0
17395,CDISC SDTM Terminology,Right cerebral hemisphere,0
17396,Pediatric Terminology,"Lymphangioma, Cystic",0
17397,US Counties Terminology,"Lincoln County, NM",0
17398,FDA Established Names and Unique Ingredient Identifier Codes Terminology,glucosyl-ifosfamide mustard,0
17399,GAIA Terminology,GAIA Level 4 First Trimester Spontaneous Abortion,0
17400,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Calcium Cyclamate,0
17401,CTRP Terminology,Stage I Adult Lymphoblastic Lymphoma,0
17402,CDISC Questionnaire Terminology,RPQ - Light Sensitivity,0
17403,CDISC SEND Terminology,Microgram per Liter,0
17404,US Counties Terminology,"Pitt County, NC",0
17405,CDISC QRS Terminology,Expanded DRS-PI Survivor Version - Understand and Follow Directions,0
17406,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Date,0
17407,CDISC SDTM Terminology,ADCS-ADL MCI - Description of Usual Performance of Physically Getting Dressed,0
17408,FDA Established Names and Unique Ingredient Identifier Codes Terminology,SOY ISOFLAVONES,0
17409,Pediatric Terminology,"Polycystic Kidney, Type 1 Autosomal Dominant Disease",0
17410,Pediatric Terminology,Stenosis of intestine,0
17411,FDA Established Names and Unique Ingredient Identifier Codes Terminology,glucuronamide,0
17412,CDISC Variable Terminology,Body Weight Gain Result Standard Unit,0
17413,CDISC SDTM Terminology,grain unit of measure,0
17414,CDISC SDTM Terminology,SGRQ Past 4 Weeks Version - I Have Coughed,0
17415,CDISC Questionnaire Terminology,NPI - Appetite and Eating Disorders Frequency,0
17416,Clinical Data Interchange Standards Consortium Terminology,ADNI AVLT - List B Recall Word 13,0
17417,CDISC QRS Terminology,NPI - Gained Weight,0
17418,NCIt Antineoplastic Agent Terminology,Transferrin Receptor-Targeted Liposomal p53 cDNA,0
17419,Clinical Data Interchange Standards Consortium Terminology,Odoribacter splanchnicus,0
17420,Lymphedema and Breast Cancer Questionnaire,Have Limited Movement of Fingers,0
17421,Patient Problem Codes FDA CDRH,Neuropathy,0
17422,FDA Established Names and Unique Ingredient Identifier Codes Terminology,peonidin,0
17423,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pipecuronium,0
17424,Pediatric Terminology,Uterine Cervical Incompetence,0
17425,CDISC Questionnaire Terminology,International Index of Erectile Function Questionnaire,0
17426,Neonatal Research Network Terminology,Amino acids measurement,0
17427,FDA Established Names and Unique Ingredient Identifier Codes Terminology,telenzepine,0
17428,CDISC SEND Terminology,Unifocal PVCs,0
17429,US Counties Terminology,"Clinch County, GA",0
17430,CDISC SEND Terminology,Myelolipoma,0
17431,CDISC SDTM Terminology,Septal Perforator Artery,0
17432,CDISC Questionnaire Terminology,C-SSRS Children's Baseline/Screening - Description of Actual Suicide Attempt,0
17433,Pediatric Terminology,Cephalopelvic Disproportion,0
17434,CDISC QRS Terminology,"ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other",0
17435,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Linagliptin,0
17436,CDISC QRS Terminology,C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Specific Plan and Intent,0
17437,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Taurosteine,0
17438,NCI CTEP SDC Clear Cell Sarcoma of the Kidney Sub-Category Terminology,Clear cell sarcoma of kidney,0
17439,CDISC SDTM Terminology,Aerococcus urinae,0
17440,CDISC SEND Terminology,Epidural Route of Drug Administration,0
17441,CDISC SDTM Submission Domain Abbreviation Terminology,Urinary System Findings Domain,0
17442,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Atliprofen,0
17443,CDISC Questionnaire Terminology,SOAPP-R - Others Expressed Concern Over Medication Use,0
17444,CDISC SDTM Terminology,Adipose tissue,0
17445,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Iodofiltic acid (123-I),0
17446,CDISC SDTM Microorganism Terminology,Salmonella Serotype Group A,0
17447,CDISC SDTM Terminology,Human herpes simplex virus,0
17448,CDISC Variable Terminology,Concomitant Medication Use Duration,0
17449,CTRP Terminology,Bladder Squamous Cell Carcinoma,0
17450,Clinical Data Interchange Standards Consortium Terminology,FIQR - Activities Sub-Total,0
17451,CDISC QRS Terminology,SOAPP-R - How Often Friends Had Problem,0
17452,Clinical Data Interchange Standards Consortium Terminology,Fragment of (qualifier value),0
17453,CDISC SDTM Terminology,"ADCS-ADL MCI - Perform Pastime, Hobby or Game: Sewing",0
17454,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Tamsulosin hydrochloride,0
17455,CTRP Agent Terminology,Mechlorethamine hydrochloride,0
17456,FDA Established Names and Unique Ingredient Identifier Codes Terminology,AVN 944,0
17457,Observation ICSR Terminology,Positive Rechallenge Indicator,0
17458,CDISC SDTM Terminology,Milliliter per Day per Kilogram per Meter Squared,0
17459,"Geopolitical Entities, Names, and Codes Terminology",New Zealand,0
17460,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pneumococcal capsular polysaccharide type 6B vaccine,0
17461,National Health Interview Survey,Ten,0
17462,CDISC Questionnaire ADCS-ADL Test Name Terminology,ADCS-ADL - Description of Most Complicated Writings,0
17463,Clinical Data Interchange Standards Consortium Terminology,Chlamydia pneumoniae IgA Antibody Measurement,0
17464,CDISC Questionnaire Terminology,NCCN-FACT-FPSI 17 Version 2 - I Have Bone Pain,0
17465,FDA Established Names and Unique Ingredient Identifier Codes Terminology,diphemanil methylsulfate,0
17466,CDISC SDTM Frequency Terminology,Seven times weekly,0
17467,CDISC Questionnaire OAB-q Short Form Test Name Terminology,OAB-q Short Form - Avoid Activities Away From Restrooms,0
17468,Clinical Data Interchange Standards Consortium Terminology,Mild Adverse Event,0
17469,Clinical Data Interchange Standards Consortium Terminology,Left Ventricular Mid Inferolateral Segment,0
17470,Pediatric Terminology,Rheumatoid Arthritis,0
17471,Clinical Data Interchange Standards Consortium Terminology,ADNI AVLT - List A 30 Min Delay Recall Word 1,0
17472,CTRP Agent Terminology,tazarotene,0
17473,CDISC SEND Terminology,Structure of left cusp of pulmonic valve,0
17474,Pediatric Terminology,Cyanosis,0
17475,Neonatal Research Network Terminology,Cri-du-Chat Syndrome,0
17476,CDISC SDTM Holter ECG Results Terminology,electrocardiogram left posterior hemiblock (finding),0
17477,CDISC Questionnaire Terminology,OAB-q Short Form - Awakened You During Sleep,0
17478,Clinical Data Interchange Standards Consortium Terminology,weber,0
17479,NCIt Antineoplastic Agent Terminology,Anti-CD70 Monoclonal Antibody MDX-1411,0
17480,CDISC Functional Test Terminology,AVLT-REY - List B Word 3,0
17481,CDISC SDTM Pharmaceutical Dosage Form Terminology,Tablet For Suspension Dosage Form,0
17482,CDISC Questionnaire Terminology,AUDIT-C - How Often Have Alcohol Drink,0
17483,CDISC QRS Terminology,AVLT-REY - List B Word 12,0
17484,CDISC Functional Test AVLT-REY Test Name Terminology,AVLT-REY - List B Word 12,0
17485,CDISC SDTM Terminology,MSQOL-54 - Describe How You Feel About Your Life,0
17486,FDA Device Component Code Hierarchy,electrode,0
17487,CTRP Terminology,Cutaneous T-cell lymphoma stage IV,0
17488,GAIA Dysfunctional Labor Level of Diagnostic Certainty Terminology,GAIA Level 1 Dysfunctional Second Stage of Labor,0
17489,CDISC SDTM Frequency Terminology,Six Times Monthly,0
17490,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Blackberries,0
17491,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sorghum bicolor pollen extract,0
17492,CDISC SEND Tumor Findings Results Terminology,Leptomeningeal sarcoma,0
17493,GAIA Preterm Birth Level of Diagnostic Certainty Terminology,GAIA Level 3b Assessment of Gestational Age,0
17494,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bencyclane,0
17495,Pediatric Adverse Events Terminology,Testosterone excess,0
17496,Regulated Product Submission Reporting Terminology,Application Form: FDA Form 356h,0
17497,CTRP Agent Terminology,MART-1:26-35(27L) Peptide Vaccine,0
17498,CDISC SDTM Terminology,Agar Dilution Method,0
17499,CTRP Agent Terminology,HE 3235,0
17500,Perinatal Terminology,Brachial plexus palsy due to birth trauma,0
17501,Clinical Data Interchange Standards Consortium Terminology,Granulocyte to Total Cell Ratio Measurement,0
17502,CDISC SEND Non-Neoplastic Finding Type Terminology,Cellular infiltrate,0
17503,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Propiopromazine hydrochloride,0
17504,FDA Established Names and Unique Ingredient Identifier Codes Terminology,aprosulate,0
17505,FDA Established Names and Unique Ingredient Identifier Codes Terminology,lorapride,0
17506,CDISC SDTM Terminology,Bone structure of trapezium,0
17507,CTRP Agent Terminology,"insulin aspart, human",0
17508,CDISC Questionnaire Terminology,BPI - Education,0
17509,Pediatric Terminology,Lymphangioma,0
17510,CDISC SDTM Anatomical Location Terminology,Structure of anterior leaflet of mitral valve,0
17511,CDISC SDTM Terminology,Mycobacterium leprae,0
17512,CDISC SDTM Submission Domain Abbreviation Terminology,Microbiology Specimen Domain,0
17513,Clinical Data Interchange Standards Consortium Terminology,Uterine gland,0
17514,Pediatric Terminology,Benign Rolandic Epilepsy,0
17515,Pediatric Infectious Disease Terminology,Rat-Bite Fever,0
17516,Pediatric Terminology,Rat-Bite Fever,0
17517,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Lifetime),0
17518,CDISC SDTM Terminology,SGRQ Past 3 Months Version - Cannot Go Out for Entertainment,0
17519,US Counties Terminology,"Chester County, TN",0
17520,FDA Individual Case Safety Report Terminology,Report Source document,0
17521,Clinical Data Interchange Standards Consortium Terminology,Small Colon,0
17522,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Simetride,0
17523,GAIA Terminology,GAIA Level 4 Second Trimester Spontaneous Abortion,0
17524,CDISC Clinical Classification Category Terminology,ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification,0
17525,CDISC SDTM Terminology,AUC Over Dosing Interval Normalized by Body Mass Index,0
17526,FDA Individual Case Safety Report Terminology,Medical technologist,0
17527,Clinical Data Interchange Standards Consortium Terminology,Capnocytophaga,0
17528,CDISC SDTM Microorganism Terminology,Providencia stuartii,0
17529,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Rolitetracycline,0
17530,CDISC SEND Non-Neoplastic Finding Type Terminology,Lipoid Proteinosis of Urbach and Wiethe,0
17531,US Counties Terminology,"Wheeler County, OR",0
17532,CTRP Agent Terminology,isavuconazole,0
17533,NCIt Antineoplastic Agent Terminology,pseudoisocytidine,0
17534,Clinical Data Interchange Standards Consortium Terminology,EPIC-CP - Overall Problem Urinary Function,0
17535,CDISC SDTM Laboratory Test Terminology by Code,Total immunoglobulin measurement,0
17536,FDA Device Problem Code Hierarchy,Device Ingredient or Reagent Problem,0
17537,FDA Device Problem Code Hierarchy,Inaccurate Delivery,0
17538,CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Name Terminology,"C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime)",0
17539,CDISC SDTM Terminology,Anaerococcus prevotii,0
17540,CDISC Questionnaire Terminology,MPAI-4 - Abilities: Novel Problem-Solving,0
17541,NCIt Antineoplastic Agent Terminology,trametinib,0
17542,CDISC SDTM Terminology,Malassezia furfur,0
17543,CTRP Agent Terminology,CPG-ODN,0
17544,NCIt Neoplasm Core Terminology,Acanthoma,0
17545,CTRP Agent Terminology,CD5789 Cream,0
17546,Neonatal Research Network Terminology,Hereditary fructose intolerance syndrome,0
17547,Pediatric Terminology,Congenital facial nerve palsy,0
17548,CDISC Questionnaire ADCS-ADL Test Name Terminology,ADCS-ADL - Go Shopping,0
17549,CTRP Terminology,Pralatrexate,0
17550,Clinical Data Interchange Standards Consortium Terminology,Plasma Cell to Total Cell Ratio Measurement,0
17551,US Counties Terminology,"Lee County, IL",0
17552,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,Total Body Clearance for Dose Interval Normalized by Weight,0
17553,Perinatal Terminology,Cerebral Palsy,0
17554,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sepimostat,0
17555,CDISC SDTM Terminology,Morphologic Complete Response,0
17556,CDISC SDTM Terminology,12 Lead ECG Extracted From 12 Lead Continuous ECG Recording,0
17557,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Metalkonium Chloride,0
17558,Pediatric Terminology,Rotavirus,0
17559,FDA Established Names and Unique Ingredient Identifier Codes Terminology,prethcamide,0
17560,CDISC SEND Terminology,Joint structure of shoulder region,0
17561,CDISC SEND Biospecimens Terminology,Joint structure of shoulder region,0
17562,CDISC SDTM Terminology,Syncope with High Risk Cardiac Characteristics,0
17563,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,AUC Over Dosing Interval Normalized by Weight,0
17564,CDISC SEND Fetal Pathology Findings Result Terminology,Thoracoceloschisis,0
17565,CDISC Questionnaire FAMS Test Name Terminology,FAMS - I Feel Useless,0
17566,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acrocinonide,0
17567,CDISC Questionnaire NPI Test Code Terminology,NPI - Unwelcome Guests are Living in His/Her House,0
17568,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pneumococcal capsular polysaccharide type 5 vaccine,0
17569,CDISC Questionnaire Terminology,FACIT-F Version 4 - Trouble Meeting Needs of Family,0
17570,US Counties Terminology,"Macon County, MO",0
17571,CDISC Variable Terminology,Disposition Start Date,0
17572,NCIt Neoplasm Core Terminology,Type II Endometrial Adenocarcinoma,0
17573,CTRP Terminology,PEP-3-KLH Conjugate Vaccine,0
17574,Clinical Data Interchange Standards Consortium Terminology,Exiguobacterium,0
17575,Clinical Data Interchange Standards Consortium Terminology,PHQ Screener Version - Problems Made It Difficult to Work,0
17576,CDISC SDTM Submission Domain Abbreviation Terminology,Questionnaire Domain,0
17577,Pediatric Terminology,Community acquired pneumonia,0
17578,CDISC Questionnaire Terminology,RAND-36 - Physical Health Difficulty Performing Work,0
17579,CDISC Questionnaire VFQ25-Self Administered Format Test Name Terminology,VFQ25-Self Administered Format - Time Spent Worry About Eyesight,0
17580,Clinical Data Interchange Standards Consortium Terminology,Palatine bone structure,0
17581,CDISC Variable Terminology,Occurrence of Adverse Event,0
17582,CTRP Terminology,Assessment of Therapy Complications,0
17583,CDISC SDTM Terminology,FIQR - Sit in a Chair for 45 Minutes,0
17584,CTRP Agent Terminology,Elesclomol Sodium,0
17585,CTRP Agent Terminology,B3(Fv)-PE38KDEL recombinant immunotoxin,0
17586,CDISC SDTM Laboratory Test Terminology by Code,rubeola IgM antibody test,0
17587,Clinical Data Interchange Standards Consortium Terminology,Gizzard,0
17588,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Escitalopram oxalate,0
17589,NCIt Antineoplastic Agent Terminology,ncmtRNA Oligonucleotide Andes-1537,0
17590,CDISC SDTM Terminology,Pyridinoline measurement,0
17591,NCIt Antineoplastic Agent Terminology,ALVAC(2) Melanoma Multi-antigen Vaccine,0
17592,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Neomycin B Sulfate,0
17593,Fatigue Severity Scale,Fatigue Prevents Sustained Physical Functioning,0
17594,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Lettuce - dietary,0
17595,CDISC SDTM Country Terminology,Democratic Republic of the Congo,0
17596,CDISC SDTM Laboratory Test Terminology by Code,Squamous Transitional Epithelial Cell Count,0
17597,FDA Manufacturer Evaluation Result Code Hierarchy,Software Runtime Error,0
17598,CDISC Questionnaire Terminology,AUDIT-C - How Often Have Six or More Drinks,0
17599,CDISC Questionnaire Terminology,ODI v2.1a - Pain Intensity,0
17600,Clinical Data Interchange Standards Consortium Terminology,New Anterior Myocardial Infarction by ECG Finding,0
17601,CDISC SDTM Terminology,Colony Forming Unit per Gram,0
17602,CDISC SEND Terminology,Pack unit,0
17603,FDA Established Names and Unique Ingredient Identifier Codes Terminology,alpha-amylase A type 1-2,0
17604,US Counties Terminology,"Greenwood County, SC",0
17605,CDISC SDTM Terminology,RPQ - Noise Sensitivity,0
17606,CDISC Questionnaire EQ-5D-5L Test Code Terminology,EQ-5D-5L - Mobility,0
17607,Clinical Data Interchange Standards Consortium Terminology,Left Ventricular Mid Anterior Segment,0
17608,Pediatric Infectious Disease Terminology,Asymptomatic Infections,0
17609,CDISC Questionnaire Terminology,ADCS-ADL MCI - Use Household Appliance: Dryer,0
17610,CDISC SEND Terminology,"Hemangiopericytoma, Malignant",0
17611,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sulosemide,0
17612,CDISC Questionnaire C-SSRS Children's Baseline Test Name Terminology,C-SSRS Children's Baseline - Most Lethal Suicide Attempt Potential Lethality,0
17613,CDISC SDTM Terminology,CRQ-SAS First Administration Version - Participate in Social Activities,0
17614,CDISC QRS Terminology,CRQ-SAS First Administration Version - Participate in Social Activities,0
17615,NCIt Neoplasm Core Terminology,Blepharal carcinoma,0
17616,Clinical Data Interchange Standards Consortium Terminology,Posterior Annulus of the Mitral Valve,0
17617,CDISC QRS Terminology,PHQ Screener Version - Shortness of Breath,0
17618,NCIt Antineoplastic Agent Terminology,Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107,0
17619,Clinical Data Interchange Standards Consortium Terminology,RDQ - Hold on to Get Out of a Chair,0
17620,CDISC SDTM Terminology,Day Times Micromole Per Liter Per Kilogram,0
17621,Clinical Data Interchange Standards Consortium Terminology,White Blood Cell Cast Measurement,0
17622,Clinical Data Interchange Standards Consortium Terminology,Calprotectin Measurement,0
17623,CDISC Questionnaire EQ-5D-5L Test Code Terminology,EQ-5D-5L - Usual Activities,0
17624,CDISC Questionnaire Terminology,NPI - Talk Big or Claim to Have More Abilities or Wealth Than is True,0
17625,CDISC SEND Terminology,AUMC Over Dosing Interval Normalized by Dose,0
17626,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Monalazone,0
17627,CDISC Questionnaire CRQ-SAS First Administration Version Test Code Terminology,CRQ-SAS First Administration Version - Feeling of Fear or Panic,0
17628,CDISC SEND Terminology,Observed Area Under the Curve Infinity,0
17629,CTRP Terminology,Stage I Uterine Corpus Cancer AJCC v6,0
17630,CDISC QRS Terminology,FAMS - I Am Frustrated by My Condition,0
17631,Clinical Data Interchange Standards Consortium Terminology,RDQ - Get Dressed More Slowly,0
17632,NCIt Antineoplastic Agent Terminology,Lontucirev,0
17633,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tiquinamide,0
17634,CTRP Terminology,Stage IIIA Ovarian Cancer AJCC v6 and v7,0
17635,US Counties Terminology,"Shawano County, WI",0
17636,Pediatric Terminology,Paragonimiasis,0
17637,CDISC QRS Terminology,EPIC-26 - Overall Problem Sexual Function,0
17638,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acriflavine hydrochloride,0
17639,CDISC QRS Terminology,SGRQ-C - Have Shortness of Breath,0
17640,CDISC SDTM Procedure Terminology,Right Cardiac Ventricle Assist Device Procedure,0
17641,Clinical Data Interchange Standards Consortium Terminology,Hemoglobin A1C to Hemoglobin Ratio Measurement,0
17642,FDA Established Names and Unique Ingredient Identifier Codes Terminology,teduglutide,0
17643,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nitricholine Perchlorate,0
17644,Neonatal Research Network Terminology,Congenital hypoplasia of aortic arch,0
17645,Clinical Data Interchange Standards Consortium Terminology,Human Epidermal Growth Factor Receptor 2 Measurement,0
17646,Clinical Data Interchange Standards Consortium Terminology,BLCS - Altered Activities Because Bladder Problems,0
17647,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Micro-International Units per Milliliter per Milligram per Kilogram per Day,0
17648,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - Use a Telephone,0
17649,CDISC SEND Terminology,Prostaglandin D2 Measurement,0
17650,CDISC SDTM Terminology,Prostaglandin D2 Measurement,0
17651,CDISC SDTM Frequency Terminology,Two Times Yearly,0
17652,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,Observed Area Under the First Moment Curve Infinity,0
17653,CTRP Agent Terminology,Ritonavir,0
17654,CDISC SDTM Microorganism Terminology,Entamoeba coli,0
17655,Clinical Data Interchange Standards Consortium Terminology,MPAI-4 - Participation: Other Employment-Social Role,0
17656,NCI CTEP Simplified Disease Classification Terminology,Ependymoma,0
17657,NCIt Neoplasm Core Terminology,Ependymoma,0
17658,CDISC SDTM Terminology,Schistosoma japonicum,0
17659,CDISC SDTM Terminology,CDISC Questionnaire UPS Test Name Terminology,0
17660,Hospital Anxiety and Depression Scale Questionnaire,Not at all,0
17661,CDISC SDTM COPD Findings About Test Code Terminology,Number of Moderate Episodes,0
17662,CDISC QRS Terminology,RAND-36 - Health Limit Bending or Stooping,0
17663,Pediatric Terminology,Disease,0
17664,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hexobarbital,0
17665,Modified Barium Swallow Impairment Profile,No Visible Initiation of Pharyngeal Swallow at Any Location,0
17666,Pediatric Terminology,Medical Device Dislodged,0
17667,CDISC QRS Terminology,CDISC Questionnaire UPS Test Code Terminology,0
17668,CDISC QRS Terminology,BWCS - Been Constipated,0
17669,CDISC SDTM Terminology,Mycobacterium haemophilum,0
17670,CTRP Terminology,Fluphenazine Hydrochloride,0
17671,FDA Established Names and Unique Ingredient Identifier Codes Terminology,flutropium,0
17672,Clinical Data Interchange Standards Consortium Terminology,Hypertrophy and Hyperplasia,0
17673,Clinical Data Interchange Standards Consortium Terminology,CDISC ADAS-Cog - Naming Objects and Fingers: 4,0
17674,ICH Unit of Measure Terminology,Fluorescent Assay Infectious Dose 50 Percent,0
17675,FDA Established Names and Unique Ingredient Identifier Codes Terminology,clivatuzumab,0
17676,Clinical Data Interchange Standards Consortium Terminology,NPI - Talk to Total Strangers as if He/She Knew Them,0
17677,CDISC SDTM Microorganism Terminology,Actinomyces viscosus,0
17678,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Antimony Triiodide,0
17679,Clinical Data Interchange Standards Consortium Terminology,ADNI AVLT - List A Recall 6 (After B) Word 12,0
17680,Pediatric Adverse Events Terminology,recurrent muscle twitches (symptom),0
17681,CDISC SDTM Terminology,MDS-UPDRS - Rest Tremor Amplitude Right Upper Extremity,0
17682,Clinical Data Interchange Standards Consortium Terminology,Tricuspid Valve Regurgitant Volume,0
17683,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pregnanolone,0
17684,CDISC SDTM Terminology,Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Since Last Visit - Clinical Questionnaire,0
17685,Clinical Data Interchange Standards Consortium Terminology,Academic Research Council Subacute Stent Thrombosis,0
17686,SPL Pharmaceutical Dosage Form Terminology,Prolonged-release oral granules,0
17687,CDISC Questionnaire Terminology,FACT-P Version 4 - I Have Pain,0
17688,Clinical Data Interchange Standards Consortium Terminology,Spontaneous Sustained Ventricular Tachycardia by ECG Finding,0
17689,CDISC Questionnaire MPAI-4 Test Name Terminology,MPAI-4 - Alcohol Use Post-Injury,0
17690,Clinical Data Interchange Standards Consortium Terminology,Liter per Day per Milligram per Kilogram per Day,0
17691,Pediatric Terminology,Enterobiasis,0
17692,Pediatric Nephrology Terminology,Simple renal cyst,0
17693,Clinical Data Interchange Standards Consortium Terminology,12-Item Multiple Sclerosis Walking Scale Questionnaire,0
17694,CDISC SDTM Laboratory Test Terminology by Code,Sperm Motility Measurement,0
17695,Clinical Data Interchange Standards Consortium Terminology,Ischemic Evidence Type,0
17696,CDISC SDTM Terminology,CDISC ADAS-Cog - Naming Objects and Fingers: 6,0
17697,Clinical Data Interchange Standards Consortium Terminology,Expanded DRS-PI Caregiver Version - Require Assistance Thinking Tasks,0
17698,FDA Established Names and Unique Ingredient Identifier Codes Terminology,canary grass pollen extract,0
17699,CDISC SDTM Anatomical Location Terminology,peripheral blood,0
17700,CDISC Questionnaire NPI Test Code Terminology,NPI - Say Crude Things or Make Sexual Remarks,0
17701,CDISC Questionnaire FACT-P Version 4 Test Code Terminology,FACT-P Version 4 - Bothered by Treatment Side Effect,0
17702,US Counties Terminology,"Dinwiddie County, VA",0
17703,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Picogram per Day,0
17704,FDA Device Component Code Hierarchy,Electrode Contact Device,0
17705,CDISC SDTM Cardiovascular Findings About Test Name Terminology,Clinical Change by Non-Invasive Imaging Procedure,0
17706,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,Last Concentration Normalized by Body Mass Index,0
17707,CDISC QRS Terminology,SDS - Days Lost,0
17708,CDISC Questionnaire Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Potential Lethality,0
17709,CDISC SDTM Category of Oncology Response Assessment Terminology,Blazer Colorectal Cancer 2008 Oncology Response Criteria,0
17710,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chloroform,0
17711,CDISC SDTM Laboratory Test Terminology by Code,Hyaline Cast Measurement,0
17712,CDISC SDTM Terminology,Every ten hours,0
17713,CDISC SDTM Reason Coronary Sinus Access or Left Ventricular Lead Not Implanted Terminology,Unable to Obtain Acceptable Pacing Thresholds,0
17714,CDISC SDTM Terminology,SDS - Days Unproductive,0
17715,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Astacus astacus (eukaryote),0
17716,CDISC SDTM Anatomical Location Terminology,Structure of splenic artery,0
17717,MD Anderson Symptom Inventory - Head and Neck,Swallowing or Chewing Difficulties at its Worst,0
17718,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fampronil,0
17719,CDISC Questionnaire Terminology,EQ-5D-5L - Anxiety or Depression,0
17720,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Millimole per Liter per Milligram per Meter Squared,0
17721,Clinical Data Interchange Standards Consortium Terminology,FAMS - Family Has Trouble Understanding When My Condition Gets Worse,0
17722,NCIt Antineoplastic Agent Terminology,Ad5-SGE-REIC/Dkk-3,0
17723,Clinical Data Interchange Standards Consortium Terminology,Boonsirikamchai Colorectal Cancer 2011 Oncology Response Criteria,0
17724,CDISC Questionnaire Category Terminology,Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire,0
17725,Clinical Data Interchange Standards Consortium Terminology,Liter per Day per Microgram per Kilogram per Day,0
17726,NCIt Neoplasm Core Terminology,Papillary glioneuronal tumor,0
17727,CDISC Questionnaire Terminology,Expanded DRS-PI Caregiver Version - Need Help With All Major Activities,0
17728,CDISC SDTM Laboratory Test Terminology by Name,Sideroblast Measurement,0
17729,Clinical Data Interchange Standards Consortium Terminology,PASAT - More Than One Attempt,0
17730,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Epoprostenol Sodium,0
17731,CDISC SDTM Terminology,Congenital Abnormality Indicator,0
17732,Medical Outcomes Study Your Feelings Questionnaire,Have You Felt Loved and Wanted,0
17733,CDISC SDTM Terminology,Bruggemann MRD 2010 Oncology Response Criteria,0
17734,CDISC SDTM Social Risk Factor Terminology,Long-term Facility Resident,0
17735,CDISC QRS Terminology,PHQ Screener Version - Headaches,0
17736,CDISC QRS Terminology,CRQ-SAS First Administration Version - Take Care of Basic Needs,0
17737,FACT-Hep Questionnaire,Content with Quality of Life,0
17738,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fluticasone,0
17739,CDISC SDTM ECG Test Terminology by Code,S Wave Amplitude Aggregate,0
17740,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List B Recall Word 1,0
17741,CDISC SEND Terminology,First Right Posterolateral Artery,0
17742,CDISC SEND Terminology,Kyphosis deformity of spine,0
17743,"Expanded Prostate Cancer Index Composite, Sexual Medications/Devices Supplement",None,0
17744,CDISC Variable Terminology,Pharmacokinetic Concentration Specimen Type,0
17745,SPL Pharmaceutical Dosage Form Terminology,Augmented Lotion Dosage Form,0
17746,Pediatric Terminology,D - transposition of the great vessels,0
17747,CDISC SDTM ECG Test Terminology by Code,Aggregate J-T Peak Interval,0
17748,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Past X Months),0
17749,Pediatric Terminology,Impetigo,0
17750,CDISC QRS Terminology,ADCS-ADL MCI - Write Things Down,0
17751,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tetronasin,0
17752,Clinical Data Interchange Standards Consortium Terminology,Sharp van der Heijde Joint Space Narrowing Score,0
17753,integrated Cancer Repository for Cancer Research,Other Construction and Related Workers,0
17754,CTRP Agent Terminology,Anti-EGFR Monoclonal Antibody SYN004,0
17755,Clinical Data Interchange Standards Consortium Terminology,Microgram per Square Meter per Minute,0
17756,CTRP Agent Terminology,Antibody-drug Conjugate ABBV-085,0
17757,Clinical Data Interchange Standards Consortium Terminology,Radioimmunoassay,0
17758,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,mol/min,0
17759,CDISC SDTM Terminology,Every sixteen hours,0
17760,Clinical Data Interchange Standards Consortium Terminology,Non-Target Lesion Identification,0
17761,CDISC SEND Terminology,Country of Turkey,0
17762,Clinical Data Interchange Standards Consortium Terminology,ECG Evaluation Not Performed Due to Unknown ECG Amplitude Gain or Recording Speed,0
17763,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Levomefolic Acid,0
17764,GAIA Terminology,GAIA Level 2 Morbidly Adherent Placentation,0
17765,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Name Terminology,C-SSRS Children's Baseline/Screening - Description of Aborted Suicide Attempt,0
17766,CDISC SDTM Laboratory Test Terminology by Code,Alpha one fetoprotein measurement,0
17767,FDA Established Names and Unique Ingredient Identifier Codes Terminology,anipamil,0
17768,CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Name Terminology,MSQOL-54 - Extend Physical Health or Emotional Problem Interfere With Social Activities,0
17769,Clinical Data Interchange Standards Consortium Terminology,T Peak-T End Interval Single Beat,0
17770,CDISC Questionnaire Terminology,VFQ25-Self Administered Format - Stay Home Because of Eyesight,0
17771,Clinical Data Interchange Standards Consortium Terminology,immature granulocyte count,0
17772,US Counties Terminology,"Taylor County, KY",0
17773,CTRP Agent Terminology,Axicabtagene ciloleucel,0
17774,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Levopropoxyphene Napsylate Anhydrous,0
17775,CTRP Agent Terminology,Iodine I-123 ADAM,0
17776,CTRP Terminology,Iodine I-123 ADAM,0
17777,Clinical Data Interchange Standards Consortium Terminology,Single Beat JT Interval,0
17778,CDISC Functional Test Terminology,PASAT - Total Omission Errors,0
17779,FACT-Hep Questionnaire,Enjoy Things for Fun,0
17780,Clinical Data Interchange Standards Consortium Terminology,Malignant Cell Count,0
17781,US Counties Terminology,"Kimball County, NE",0
17782,CDISC SDTM Terminology,Influenza B Antigen Measurement,0
17783,Newborn Screening Terminology,Arm Recoil Test,0
17784,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - Time Taken to Complete Complex Activities,0
17785,CDISC SDTM Terminology,Case Study,0
17786,CDISC SDTM Terminology,Douche Dosage Form,0
17787,Clinical Data Interchange Standards Consortium Terminology,Cupriavidus,0
17788,Neonatal Research Network Terminology,Persistent Fetal Circulation Syndrome,0
17789,NCIt Antineoplastic Agent Terminology,GDC-0623,0
17790,FDA CDRH GUDID Terminology,Magnetic Resonance Imaging Safety Labeling Information,0
17791,CDISC Questionnaire NPI Test Name Terminology,NPI - Play Childish Pranks,0
17792,CDISC SDTM Reproductive System Findings Test Name Terminology,Estimated date of conception,0
17793,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chloral Hydrate,0
17794,FACT-BMT Questionnaire,Family Accepts Illness,0
17795,Clinical Data Interchange Standards Consortium Terminology,Implantable Cardioverter-Defibrillator Placement,0
17796,CDISC SEND Terminology,Proximal Urethra,0
17797,Pediatric Adverse Events Terminology,Vaginitis,0
17798,CTRP Intervention Terminology,Chemosensitivity Assay,0
17799,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Benzocaine,0
17800,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Shark - food,0
17801,NCIt Neoplasm Core Terminology,Parathyroid Adenoma,0
17802,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - Explain Extenuating Circumstance,0
17803,US Counties Terminology,"Lancaster County, NE",0
17804,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Pastime: Golf,0
17805,CDISC Variable Terminology,Concomitant Medication Start Timepoint,0
17806,Clinical Data Interchange Standards Consortium Terminology,DRS - Level of Functioning,0
17807,NCIt Antineoplastic Agent Terminology,VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593,0
17808,Voice handicap index,Sound of Voice Varies Throughout Day,0
17809,CDISC Questionnaire AIMS Test Name Terminology,AIMS - Muscles of Facial Expression,0
17810,CDISC Variable Terminology,Electrocardiogram Planned Start of Assessment Interval,0
17811,US Counties Terminology,"Houghton County, MI",0
17812,CDISC Questionnaire Terminology,CDISC ADAS-Cog - Naming Objects and Fingers: 1,0
17813,Clinical Data Interchange Standards Consortium Terminology,Member of High Risk Population,0
17814,CDISC Questionnaire UPDRS Test Name Terminology,"UPDRS - Motor Examination: Hand Grips, Right",0
17815,Pediatric Terminology,Labored breathing,0
17816,CDISC SEND Terminology,mmol/h,0
17817,Pediatric Rheumatology Terminology,NLRP12-associated hereditary periodic fever syndrome,0
17818,Clinical Data Interchange Standards Consortium Terminology,VFQ25-Interviewer Administered Format - Difficulty Finding Something On a Shelf,0
17819,CDISC Questionnaire NPI Test Name Terminology,NPI - Seem to Act Impulsively Without Thinking,0
17820,CDISC Questionnaire UPDRS Test Name Terminology,UPDRS - Symptomatic Orthostasis: Weight,0
17821,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Lifetime),0
17822,CDISC SEND Terminology,Gluteal muscle,0
17823,FDA Established Names and Unique Ingredient Identifier Codes Terminology,olanzapine,0
17824,CDISC Questionnaire Terminology,GCGI - Global Improvement of Pain,0
17825,CDISC Questionnaire FIQR Test Name Terminology,FIQR - Prepare a Homemade Meal,0
17826,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acrylamide,0
17827,CDISC SDTM Terminology,Interstitial Fluid,0
17828,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Phenprocoumon,0
17829,CDISC Questionnaire Terminology,VFQ25-Interviewer Administered Format - Difficulty Noticing Objects Off to the Side While Walking,0
17830,Clinical Data Interchange Standards Consortium Terminology,Rostral,0
17831,CDISC SDTM Laboratory Test Terminology by Code,Aldosterone to Renin Activity Ratio Measurement,0
17832,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ufiprazole,0
17833,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Artemisia vulgaris whole extract,0
17834,Pediatric Terminology,Maternal Postnatal Stage,0
17835,CDISC SDTM PK Unit of Measure Gram Weight Terminology,Nanomole per Liter per Gram,0
17836,CDISC SEND Terminology,Day Times Femtogram Per Milliliter Per Gram,0
17837,Hospital Anxiety and Depression Scale Questionnaire,Rather Less,0
17838,CDISC SDTM Terminology,Nocardia,0
17839,Borg Category-Ratio 10 Scale Score 11 Point Scale,Borg Category-Ratio 10 Perceived Exertion Score 2,0
17840,CDISC SDTM Terminology,CDISC ADAS-Cog - Orientation: Year,0
17841,CDISC SDTM Terminology,Structure of locus ceruleus,0
17842,CTRP Terminology,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17843,CDISC SDTM Terminology,FIQR - Lift and Carry a Bag Full of Groceries,0
17844,CareLex eTMF Terminology,Medical Imaging and Imaging Technique Documentation,0
17845,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Prior to Study Entry),0
17846,Pediatric Nephrology Terminology,IgM - Associated Nephropathy,0
17847,"Geopolitical Entities, Names, and Codes Terminology",Martinique,0
17848,CDISC Questionnaire UPDRS Test Code Terminology,UPDRS - Activities of Daily Living: Walking,0
17849,CDISC SEND Terminology,Minute Times Millimole per Milliliter,0
17850,Neonatal Research Network Terminology,Avascular necrosis,0
17851,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Past 3 Months),0
17852,CDISC SDTM Holter ECG Test Code Terminology,Comparison to a Prior ECG,0
17853,CDISC SDTM Terminology,Invalid ECG Waveforms,0
17854,CDISC SEND Terminology,Standing position,0
17855,CDISC Questionnaire C-SSRS Baseline/Screening Version Test Name Terminology,C-SSRS Baseline/Screening Version - Description of Wish to be Dead,0
17856,CDISC SEND Terminology,Bone structure of shaft of humerus,0
17857,CDISC SDTM Terminology,Kluyvera,0
17858,CDISC SEND Terminology,Day Times Gram Per Milliliter Per Gram,0
17859,Clinical Data Interchange Standards Consortium Terminology,Non-Measurable Tumor Identification,0
17860,Patient Problem Codes FDA CDRH,Peripheral Vascular Diseases,0
17861,Clinical Data Interchange Standards Consortium Terminology,Listeria innocua,0
17862,Clinical Data Interchange Standards Consortium Terminology,Rickettsia prowazekii,0
17863,CDISC SEND Terminology,raphe nuclei,0
17864,CDISC SDTM Terminology,Microgram/cm2,0
17865,Perinatal Terminology,Normal delivery,0
17866,Pediatric Terminology,Coombs test positive,0
17867,US Counties Terminology,"Monroe County, MO",0
17868,CDISC Questionnaire MDS-UPDRS Test Code Terminology,MDS-UPDRS - Features of Dopamine Dysregulation Syndrome,0
17869,CDISC SEND Terminology,Day Times Gram Per Milliliter Per Kilogram,0
17870,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pavatrine Hydrochloride,0
17871,CDISC SEND Laboratory Animal Species Terminology,Quail,0
17872,Generalized Anxiety Disorder Scale,Becoming Easily Annoyed or Irritable,0
17873,CDISC SDTM Tumor Response Result Terminology,Not All Tumors Evaluated,0
17874,CTRP Agent Terminology,2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a,0
17875,CDISC SDTM Holter ECG Results Terminology,Early R Wave Transition by ECG Finding,0
17876,Pediatric Terminology,P1 Hydronephrosis,0
17877,FDA Manufacturer Evaluation Result Code Hierarchy,Thermal Problem,0
17878,CDISC QRS Terminology,CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Name Terminology,0
17879,CTRP Terminology,Mantle cell lymphoma stage IV,0
17880,Clinical Data Interchange Standards Consortium Terminology,Peptoniphilus,0
17881,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bicyclohexylammonium fumagillin,0
17882,CTRP Terminology,Marginal zone lymphoma recurrent,0
17883,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Methoxypromazine Maleate,0
17884,US Counties Terminology,"Cumberland County, PA",0
17885,CDISC Variable Terminology,Morphology Numeric Result in Standard Unit,0
17886,Hot Flash Related Daily Inference Scale,Sexuality,0
17887,US Counties Terminology,"Adams County, OH",0
17888,CDISC Questionnaire Terminology,C-SSRS Children's Baseline/Screening - Number of Interrupted Suicide Attempts,0
17889,CDISC SDTM Anatomical Location Terminology,Anus,0
17890,CDISC Questionnaire NPI Test Code Terminology,NPI - Shout or Curse Angrily,0
17891,CDISC QRS Terminology,FOSI - I Have Swelling in Stomach Area,0
17892,NCPDP Strength Form Terminology,Oral Ointment,0
17893,Clinical Data Interchange Standards Consortium Terminology,Albumin measurement,0
17894,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Transforming Growth Factor Beta 2,0
17895,CDISC SDTM Laboratory Test Terminology by Code,Basophilic Stippling Measurement,0
17896,CDISC SDTM Submission Domain Abbreviation Terminology,Electrocardiogram Domain,0
17897,CDISC SEND Domain Abbreviation Terminology,Electrocardiogram Domain,0
17898,CDISC Questionnaire Terminology,C-SSRS Children's Baseline/Screening - Description of Interrupted Suicide Attempt,0
17899,CDISC Questionnaire Category Terminology,Functional Activities Questionnaire-NACC Version,0
17900,CDISC SDTM Terminology,Smith Antibody Measurement,0
17901,US Counties Terminology,"Phelps County, MO",0
17902,CDISC Questionnaire C-SSRS Screening Test Code Terminology,C-SSRS Screening - Actual Suicide Attempt,0
17903,CDISC Questionnaire BPI Test Code Terminology,BPI - Relief Pain Treatments Provided,0
17904,CDISC SDTM Laboratory Test Terminology by Code,Platelet aggregation measurement,0
17905,CDISC Functional Test Terminology,ADNI AVLT - List A Recall 4 Word 7,0
17906,NCIt Antineoplastic Agent Terminology,Coxsackievirus A21,0
17907,CDISC QRS Terminology,VFQ25-Self Administered Format - Difficulty Going Out to See Movies,0
17908,European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30,Very Much,0
17909,FDA Established Names and Unique Ingredient Identifier Codes Terminology,CHROMIUM CR-51,0
17910,NCIt Antineoplastic Agent Terminology,Melan-A/MAGE-3.DP4 Peptide Vaccine,0
17911,FACT-BMT Questionnaire,Work is Fulfilling,0
17912,CDISC Questionnaire Terminology,NPI - Seem Sad or Depressed,0
17913,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Benoxinate,0
17914,FDA Established Names and Unique Ingredient Identifier Codes Terminology,azolimine,0
17915,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mersalyl Acid,0
17916,CDISC SDTM Method Terminology,Polysomnography,0
17917,CDISC SDTM Laboratory Test Terminology by Name,Pseudocholinesterase Measurement,0
17918,Perceived stress scale,How Often Felt Confident About Ability to Handle Problems in the Last Month,0
17919,Clinical Data Interchange Standards Consortium Terminology,Legionella pneumophila IgG Antibody Measurement,0
17920,US Counties Terminology,"DeKalb County, IL",0
17921,FDA Established Names and Unique Ingredient Identifier Codes Terminology,proquazone,0
17922,CTRP Terminology,Stage IIIB Gallbladder Cancer AJCC v7,0
17923,US Counties Terminology,"San Sebastian Municipio, PR",0
17924,CDISC SDTM Laboratory Test Terminology by Name,Human Papillomavirus 16 Antibody Measurement,0
17925,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fluminorex,0
17926,CDISC SDTM Cardiovascular Test Name Terminology,Pulmonic Valve Regurgitant Jet Width,0
17927,CDISC QRS Terminology,CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Code Terminology,0
17928,CDISC Questionnaire Terminology,Influenza Intensity and Impact Questionnaire Twice Daily Version,0
17929,FDA Device Component Code Hierarchy,Holder Device,0
17930,CDISC Questionnaire Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Wish to be Dead,0
17931,Brief Fatigue Inventory,Usual Level of Fatigue,0
17932,CDISC SDTM Terminology,Microcyte Count procedure,0
17933,CDISC Questionnaire MPAI-4 Test Name Terminology,MPAI-4 - Participation: Paid Employment,0
17934,NCIt Antineoplastic Agent Terminology,Anhydrovinblastine,0
17935,CDISC SEND Terminology,Peeling of skin,0
17936,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Milnacipran hydrochloride,0
17937,CDISC QRS Terminology,BPI Short Form - Pain Interfered with Relations,0
17938,PROMIS Pediatric Short Form - Pain Interference,Hard to Run When in Pain,0
17939,Clinical Data Interchange Standards Consortium Terminology,SGRQ-C - Feel Breathless Walking Outside on Level Ground,0
17940,CDISC QRS Terminology,Functional Assessment of Cancer Therapy-General Version 4 Questionnaire,0
17941,CDISC SDTM Unit of Measure Terminology,Per 100 High Powered Fields,0
17942,NCIt Antineoplastic Agent Terminology,PPI 2458,0
17943,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pibrozelesin Hydrobromide,0
17944,CDISC Questionnaire Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Lifetime),0
17945,Clinical Data Interchange Standards Consortium Terminology,Hartley Albino Hairless Guinea Pig,0
17946,Clinical Data Interchange Standards Consortium Terminology,Nocardia farcinica,0
17947,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Hour Times Nanogram per Milliliter per Gram,0
17948,CDISC SDTM PK Unit of Measure Kilogram Weight Terminology,Hour Times Nanogram per Milliliter per Gram,0
17949,GAIA Stillbirth Level of Diagnostic Certainty Terminology,GAIA Level 2 Intrapartum Stillbirth,0
17950,Patient Problem Codes FDA CDRH,Pulmonary Infarction,0
17951,CDISC SDTM Terminology,Dose Not Changed,0
17952,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Radafaxine Hydrochloride,0
17953,Clinical Data Interchange Standards Consortium Terminology,Fusobacterium necrophorum,0
17954,CDISC Questionnaire Terminology,SGRQ-C - Feel Breathless Walking Up a Flight of Stairs,0
17955,CDISC Functional Test Terminology,CDISC Functional Test TUG Test Name Terminology,0
17956,Clinical Data Interchange Standards Consortium Terminology,Pressure at dP/dt Maximum,0
17957,CDISC SDTM Terminology,South American,0
17958,Clinical Data Interchange Standards Consortium Terminology,CDISC Clinical Classification HAMD 17 Test Name Terminology,0
17959,CDISC Questionnaire CHART-SF Interview Version Test Code Terminology,CHART-SF Interview Version - Hours Out of Bed per Day,0
17960,FDA Device Problem Code Hierarchy,Failure to Deliver,0
17961,NCIt Neoplasm Core Terminology,Astrocytoma,0
17962,CDISC SDTM Laboratory Test Terminology by Name,Pronormoblast to Total Cell Ratio Measurement,0
17963,FDA Established Names and Unique Ingredient Identifier Codes Terminology,enzacamene,0
17964,US Counties Terminology,"Johnson County, KY",0
17965,Clinical Data Interchange Standards Consortium Terminology,Expanded DRS-PI Caregiver Version - Function With Independent Work or Social Situations,0
17966,CDISC SDTM Laboratory Test Terminology by Code,Beta-glucuronidase measurement,0
17967,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Lilium candidum,0
17968,CDISC SDTM Laboratory Test Terminology by Name,Activated Protein C Resistance Measurement,0
17969,CTRP Terminology,Desipramine Hydrochloride,0
17970,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Name Terminology,Expanded DRS-PI Caregiver Version - Function Completely Independently,0
17971,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Code Terminology,"C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan",0
17972,Clinical Data Interchange Standards Consortium Terminology,VFQ25-Self Administered Format - Difficulty Driving at Night,0
17973,CDISC SDTM Terminology,COMM - Been in an Argument,0
17974,CDISC SDTM Method Terminology,Hemocytometry,0
17975,CDISC Variable Terminology,Country,0
17976,NCPDP Strength Unit of Measure Terminology,GBq,0
17977,CDISC SEND Terminology,GBq,0
17978,NCIt Neoplasm Core Terminology,Anaplastic Oligoastrocytoma,0
17979,FACT-BRM Questionnaire,Feel Uncertain About My Future Health,0
17980,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Code Terminology,Expanded DRS-PI Caregiver Version - Understand and Follow Directions,0
17981,CDISC Observation Class Terminology,Reason for Exclusion from Statistics,0
17982,Pediatric Terminology,Noonan Syndrome,0
17983,Pediatric Terminology,Disorder of ureter,0
17984,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Stigmasterol,0
17985,Clinical Data Interchange Standards Consortium Terminology,CD13 Expressing Cell Count,0
17986,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bupivacaine,0
17987,CDISC SDTM Terminology,Medium,0
17988,Patient Problem Codes FDA CDRH,Chronic Obstructive Airway Disease,0
17989,CDISC SDTM Laboratory Test Terminology by Name,Sjogren's SS-B Antibody Measurement,0
17990,CDISC SEND Terminology,Absorbance Unit per Minute,0
17991,CDISC Questionnaire Terminology,Expanded DRS-PI Caregiver Version - Keep Track of Time,0
17992,CTRP Terminology,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
17993,CDISC SDTM Terminology,Notched P wave,0
17994,Pediatric Adverse Events Terminology,Thrombocytosis,0
17995,CDISC SDTM Terminology,Expanded DRS-PI Survivor Version - Use Toilet Independently,0
17996,Brief Fatigue Inventory,Fatigue Rating Score 4,0
17997,CTRP Agent Terminology,Ovarian Cancer Peptide Vaccine,0
17998,NCIt Antineoplastic Agent Terminology,paclitaxel liposome,0
17999,Pediatric Terminology,Placental Lesion,0
18000,CDISC SDTM Terminology,TDI - Change in Magnitude of Effort,0
18001,CDISC Questionnaire Short-Form MPQ-2 Test Name Terminology,SF-MPQ-2 - Sharp Pain,0
18002,CDISC SDTM Laboratory Test Terminology by Name,Yeast Hyphae Screening,0
18003,Clinical Data Interchange Standards Consortium Terminology,FACT-B Version 4 - I Am Able to Feel Like a Woman,0
18004,Pediatric Terminology,Impulsive Behavior,0
18005,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hydroxindasol,0
18006,FACT-L Questionnaire,Breathing is Easy,0
18007,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Promethazine Hydrochloride,0
18008,CTRP Terminology,Autologous 4-1BB Selected Tumor Infiltrating Lymphocytes,0
18009,Clinical Data Interchange Standards Consortium Terminology,Liter per Hour per Milligram per Day,0
18010,CDISC Questionnaire NPS Test Name Terminology,NPS - Tell Us How Cold Your Pain Feels,0
18011,Neurological Development Terminology,Intellectual Disability,0
18012,US Counties Terminology,"Kanawha County, WV",0
18013,Pediatric Terminology,Single transverse palmar crease,0
18014,NCIt Antineoplastic Agent Terminology,eribulin mesylate,0
18015,CDISC SDTM Anatomical Location Terminology,Shoulder,0
18016,Report Source ICSR Terminology,Clinical Research,0
18017,Perinatal Terminology,Post inflammatory hydrocephalus,0
18018,Clinical Data Interchange Standards Consortium Terminology,Pharmacology: Primary Pharmacodynamics,0
18019,CDISC Questionnaire NPS Test Name Terminology,NPS - Tell Us How Sensitive Your Skin is to Light Touch or Clothing,0
18020,CDISC QRS Terminology,NPS - Tell Us How Sensitive Your Skin is to Light Touch or Clothing,0
18021,CDISC SDTM Terminology,Streptococcus thermophilus,0
18022,CDISC SDTM Terminology,FOSI - I Have a Lack of Energy,0
18023,CDISC SDTM Lead Abnormality Terminology,Cardiac Lead Dislodgement Requiring Reposition/Reoperation,0
18024,CDISC SEND Terminology,lymphangiosarcoma,0
18025,CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Code Terminology,NCCN-FACT FKSI-19 Version 2 - I Am Able to Enjoy Life,0
18026,Clinical Data Interchange Standards Consortium Terminology,Atomic Mass Unit,0
18027,NCIt Neoplasm Core Terminology,Colon Intramucosal Adenocarcinoma,0
18028,Clinical Data Interchange Standards Consortium Terminology,Meningocele - cranial,0
18029,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Defactinib Hydrochloride,0
18030,FDA CDRH GUDID Terminology,Exempt Device,0
18031,Clinical Data Interchange Standards Consortium Terminology,Pharmacology: Secondary Pharmacodynamics,0
18032,CTRP Terminology,Non-small cell lung cancer stage III,0
18033,Clinical Data Interchange Standards Consortium Terminology,Cytogenetic Minor Response,0
18034,Clinical Data Interchange Standards Consortium Terminology,TMT - Time to Complete Trails A,0
18035,Pediatric Terminology,Venous Stroke,0
18036,CDISC QRS Terminology,NPI - Difficulty Sleeping,0
18037,US Counties Terminology,"Tallahatchie County, MS",0
18038,Clinical Data Interchange Standards Consortium Terminology,GDS - Feel Life Is Empty,0
18039,NCIt Antineoplastic Agent Terminology,"LHRH, lysine(6)-doxorubicin",0
18040,CDISC SEND Terminology,Head of pancreas,0
18041,FDA Established Names and Unique Ingredient Identifier Codes Terminology,testosterone cypionate,0
18042,CDISC SEND Terminology,Day Times Gram per Milliliter per Meter Squared,0
18043,CDISC SDTM Device Tracking and Disposition Event Dictionary Derived Term Terminology,Lost Medical Device,0
18044,NCIt Neoplasm Core Terminology,Ear carcinoma,0
18045,CDISC Questionnaire Short-Form MPQ-2 Test Name Terminology,SF-MPQ-2 - Aching Pain,0
18046,FDA Device Problem Code Hierarchy,Component or Accessory Incompatibility,0
18047,Clinical Data Interchange Standards Consortium Terminology,Ornithine measurement,0
18048,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,AUMC Over Dosing Interval Normalized by Weight,0
18049,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Lifetime/Recent Version - Wish to be Dead (Lifetime),0
18050,CDISC QRS Terminology,GDS - Often Get Bored,0
18051,CDISC SDTM Tumor Response Assessment Test Code Terminology,Cytogenetic response,0
18052,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sucrose,0
18053,CDISC SDTM Terminology,Temperature,0
18054,CTRP Terminology,Fentanyl Citrate Pectin-Based Nasal Spray,0
18055,NCIt Antineoplastic Agent Terminology,GDC-0152,0
18056,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ifetroban Sodium,0
18057,CDISC SDTM Microorganism Terminology,Lactococcus lactis subsp. cremoris,0
18058,CDISC SDTM Terminology,Accumulation Ratio Cmax,0
18059,Clinical Data Interchange Standards Consortium Terminology,PHQ Screener Version - Anxiety Attack Happened Before,0
18060,Clinical Data Interchange Standards Consortium Terminology,Corpus striatum structure,0
18061,Neonatal Research Network Terminology,Lithium Induced Birth Defect,0
18062,CDISC SDTM Tumor Identification Test Code Terminology,Lesion Identification,0
18063,ICH Unit of Measure Terminology,Microkatal,0
18064,CDISC Questionnaire BPRS-A Test Code Terminology,BPRS-A - Anxiety,0
18065,CTRP Terminology,vinflunine,0
18066,CTRP Agent Terminology,vinflunine,0
18067,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pempidine,0
18068,CTRP Terminology,Lymphoma,0
18069,CDISC Questionnaire ADAS-Cog CDISC Version Test Code Terminology,CDISC ADAS-Cog - Naming Objects and Fingers: 11,0
18070,Patient Problem Codes FDA CDRH,Hyperemia,0
18071,CTRP Terminology,"Lymphoma, Mixed-Cell, Follicular",0
18072,FDA Established Names and Unique Ingredient Identifier Codes Terminology,zindoxifene,0
18073,NCIt Antineoplastic Agent Terminology,Vaccinia-Tyrosinase Vaccine,0
18074,"NCI CTEP SDC Bone Neoplasm, Miscellaneous Sub-Category Terminology",Malignant Bone Neoplasm,0
18075,CDISC SEND Non-Neoplastic Finding Type Terminology,Abnormal degeneration,0
18076,Pediatric Adverse Events Terminology,Esophageal Dysphagia,0
18077,NCIt Antineoplastic Agent Terminology,Autologous Mesenchymal Stem Cells Apceth_101,0
18078,Clinical Data Interchange Standards Consortium Terminology,Requires Secure Email Delivery of XML Indicator,0
18079,Adult Hope Scale,Energetically Pursue Goals,0
18080,CTRP Terminology,Gallium Ga 68-labeled MLN6907,0
18081,Clinical Data Interchange Standards Consortium Terminology,Inpatient Rehabilitation Facility Including Rehabilitation distinct Part Units of a Hospital,0
18082,UCUM Terminology,"Mole, unit of measurement",0
18083,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Prior to Study Entry),0
18084,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mindodilol,0
18085,CDISC SDTM Terminology,Amount Recovered from T1 to T2,0
18086,CDISC QRS Terminology,EXACT - Short of Breath When Performing Usual Activities Outside,0
18087,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Prior to Study Entry),0
18088,FDA Established Names and Unique Ingredient Identifier Codes Terminology,penciclovir,0
18089,CDISC SDTM Subject Status Response Terminology,Unknown,0
18090,Pediatric Terminology,Rumination Disorders,0
18091,NCIt Antineoplastic Agent Terminology,Plevitrexed,0
18092,US Counties Terminology,"Todd County, SD",0
18093,FDA Established Names and Unique Ingredient Identifier Codes Terminology,seractide acetate,0
18094,Clinical Data Interchange Standards Consortium Terminology,SF-MPQ-2 - Itching,0
18095,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fazarabine,0
18096,CDISC SDTM Terminology,Model Number,0
18097,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ST. JOHN'S WORT EXTRACT,0
18098,CDISC SDTM Terminology,NCCN-FACT FBLSI-18 Version 2 - I Have a Lack of Energy,0
18099,CDISC SDTM Microorganism Terminology,Nocardia brasiliensis,0
18100,Pediatric Terminology,Cushing Syndrome,0
18101,CDISC Questionnaire Terminology,CDISC ADAS-Cog - Naming Objects and Fingers: Pointer,0
18102,CDISC QRS Terminology,C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Prior to Study Entry),0
18103,CDISC SDTM Terminology,Autologous vein graft,0
18104,US Counties Terminology,"Dewey County, OK",0
18105,CDISC SDTM Coronary Artery Disease Risk Terminology,Low Coronary Artery Disease Risk,0
18106,Clinical Data Interchange Standards Consortium Terminology,GOSE - Independence Outside the Home: Travel Locally Without Assistance,0
18107,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - Watch Television,0
18108,US Counties Terminology,"Torrance County, NM",0
18109,Pediatric Terminology,Selective Mutism,0
18110,Regulated Product Submission Reporting Terminology,Drug Substance: Controls of Critical Steps and Intermediates,0
18111,US Counties Terminology,"Lawrence County, KY",0
18112,FDA Established Names and Unique Ingredient Identifier Codes Terminology,levotofisopam,0
18113,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Riluzole,0
18114,Neurological Development Terminology,Bulimia Nervosa,0
18115,FDA CDRH GUDID Terminology,prescription document,0
18116,Clinical Data Interchange Standards Consortium Terminology,Lead Placement Frank,0
18117,NCPDP Quantity Unit of Measure Terminology,Film Dosing Unit,0
18118,NCIt Antineoplastic Agent Terminology,Multipeptide Vaccine S-588210,0
18119,CDISC Variable Terminology,Related Domain Abbreviation,0
18120,Clinical Data Interchange Standards Consortium Terminology,Cellulomonas turbata,0
18121,CTRP Terminology,AKT 1/2 Inhibitor BAY1125976,0
18122,CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Name Terminology,MSQOL-54 - Feel Weighed Down by Health Problem,0
18123,CDISC SDTM Laboratory Test Terminology by Name,Vitamin B6 measurement,0
18124,CDISC SDTM Terminology,Extended Glasgow Outcome Scale Questionnaire,0
18125,CTRP Terminology,Carcinoid Tumor,0
18126,CDISC SDTM Terminology,Segmented Neutrophils to Neutrophils Ratio Measurement,0
18127,CDISC SEND Terminology,QRS Axis Indeterminate,0
18128,CDISC Questionnaire UPDRS Test Name Terminology,UPDRS - UPDRS Total,0
18129,CDISC SDTM Terminology,GOSE - Work: Able to Work to Previous Capacity,0
18130,CDISC Questionnaire C-SSRS Children's Since Last Visit Test Code Terminology,C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Specific Plan and Intent,0
18131,CDISC Questionnaire Impact of Visual Impairment Scale Test Name Terminology,IVIS - Read or Access Dials,0
18132,Patient Problem Codes FDA CDRH,Cerebrospinal fluid leak,0
18133,Clinical Data Interchange Standards Consortium Terminology,UPDRS - Motor Examination Sub-total,0
18134,NCI CTEP Simplified Disease Classification Terminology,Lip and Oral Cavity Squamous Cell Carcinoma,0
18135,CDISC SDTM Laboratory Test Terminology by Code,Mycobacterium tuberculosis IgA Antibody Measurement,0
18136,Adult Hope Scale,Slightly False,0
18137,Clinical Data Interchange Standards Consortium Terminology,Total Carnitine Measurement,0
18138,CDISC Questionnaire Impact of Visual Impairment Scale Test Name Terminology,IVIS - Watch TV or Identify Faces From Distance,0
18139,Operator of Medical Device ICSR Terminology,Other Caregiver,0
18140,CDISC SEND Trial Summary Parameter Short Name Terminology,Strain Substrain Details,0
18141,CareLex eTMF Terminology,Clinical Trial Site Task Assignment Document,0
18142,Clinical Data Interchange Standards Consortium Terminology,Passive Case Search,0
18143,CDISC SDTM Tumor Response Result Terminology,Cytogenetic Complete Response,0
18144,CDISC SDTM Terminology,Proprotein Convertase Subtilisin/Kexin Type 9 Measurement,0
18145,Pediatric Nephrology Terminology,Membranous glomerulonephritis,0
18146,CDISC SDTM Laboratory Test Terminology by Name,Mycobacterium tuberculosis IgE Antibody Measurement,0
18147,Patient Reported Outcomes Version of CTCAE,Past Seven Days Frequency of Feeling Nothing Could Cheer You Up,0
18148,NCIt Antineoplastic Agent Terminology,Tubulin Inhibitor ALB 109564(a),0
18149,CDISC SDTM Laboratory Test Terminology by Code,Sodium to Potassium Ratio Measurement,0
18150,NCI CTEP Simplified Disease Classification Terminology,Malignant Testicular Germ Cell Tumor,0
18151,CTRP Terminology,Severe congenital neutropenia,0
18152,CDISC QRS Terminology,RPQ - Any Other Difficulties 2 (Text),0
18153,NCI CTEP Simplified Disease Classification Terminology,"NCI CTEP SDC Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) Category Terminology",0
18154,Feel Fatigue,Have Periods When Quite Tired or Fatigued,0
18155,Occupation ICSR Terminology,Dental Assistants,0
18156,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hydrocortamate hydrochloride,0
18157,CDISC SDTM Laboratory Test Terminology by Code,Mycobacterium tuberculosis IgG Antibody Measurement,0
18158,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Estrofurate,0
18159,CDISC Questionnaire Terminology,C-SSRS Baseline/Screening Version - First Suicide Attempt Date,0
18160,CDISC SDTM Anatomical Location Terminology,Buttocks,0
18161,CDISC Questionnaire DAD Test Code Terminology,DAD - Sub-Total Planning and Organization,0
18162,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Uterine Carcinosarcoma,0
18163,Smoking Self-Efficacy Questionnaire,Refrain from Smoking when Depressed,0
18164,CDISC QRS Terminology,Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study 1/14/09 Questionnaire,0
18165,CDISC SDTM Terminology,continuous electrocardiogram sinus tachycardia,0
18166,BPI Percentage Relief From Pain Treatment or Medication Likert Scale,Percentage Relief From Pain Treatment or Medication Score 40,0
18167,Pediatric Terminology,Fetal Macrosomia,0
18168,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version - First Suicide Attempt Actual Lethality/Medical Damage,0
18169,CDISC Questionnaire SOWS Subjective Test Code Terminology,SOWS Subjective (Handelsman) - I Have Goose Flesh,0
18170,CDISC QRS Terminology,SGRQ Past 4 Weeks Version - How Many Good Days You Had,0
18171,CDISC SEND Tumor Findings Results Terminology,Experimental Organism Malignant Hepatocholangiocellular Carcinoma,0
18172,Pediatric Adverse Events Terminology,Atrial Flutter,0
18173,FDA Established Names and Unique Ingredient Identifier Codes Terminology,liothyronine sodium,0
18174,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,Nonrenal Clearance Normalized by SA,0
18175,Pediatric Terminology,Congenital musculoskeletal anomalies,0
18176,Clinical Data Interchange Standards Consortium Terminology,EXACT - Difficult to Bring Up Mucus,0
18177,Pediatric Immunization Terminology,"Vaccines, Conjugate",0
18178,CDISC SDTM Device Properties Test Name Terminology,Indication,0
18179,CDISC SDTM Unit of Measure Terminology,Micromole per mole,0
18180,CDISC SDTM Anatomical Location Terminology,Left Atrial Appendage,0
18181,FDA Established Names and Unique Ingredient Identifier Codes Terminology,chinquapin oak pollen extract,0
18182,Clinical Data Interchange Standards Consortium Terminology,Ancylostoma caninum,0
18183,CDISC SEND Terminology,Uterine cavity,0
18184,CDISC SDTM PK Unit of Measure Gram Weight Terminology,Millimole per Liter per Gram,0
18185,Neonatal Research Network Terminology,Pediatric Non-Congenital Ventricular Tachycardia,0
18186,Clinical Data Interchange Standards Consortium Terminology,GDS-SF - Prefer to Stay Home,0
18187,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cupric Acetate Cu-64,0
18188,Edmonton symptom assessment system,best (quality),0
18189,Follow-Up Outcome Expectations Questionnaire,More Difficult than Expected,0
18190,US Counties Terminology,"Franklin County, ID",0
18191,CDISC Variable Terminology,Adverse Event MedDRA Low Level Term,0
18192,CDISC Questionnaire ADCS-ADL Severe Dementia Test Code Terminology,ADCS-ADL Severe Dementia - Use a Telephone,0
18193,Pediatric Adverse Events Terminology,Abnormal Virilization,0
18194,CDISC SEND Terminology,Drug emulsion,0
18195,CDISC SDTM Terminology,Structure of hepatic vein,0
18196,FDA Established Names and Unique Ingredient Identifier Codes Terminology,AMOPROXAN,0
18197,CDISC SDTM Laboratory Test Terminology by Code,Smooth muscle antibody measurement,0
18198,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bradykinin,0
18199,CDISC SEND Terminology,Anti-Saccharomyces cerevisiae Antibody Measurement,0
18200,Neonatal Research Network Terminology,Phrenic nerve paralysis,0
18201,UCUM Terminology,seconds,0
18202,CDISC SDTM Terminology,C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Since Study Start),0
18203,Clinical Data Interchange Standards Consortium Terminology,Pulmonary Function Test/Forced Expiratory Volume 1,0
18204,CDISC SEND Terminology,mkat,0
18205,NCIt Antineoplastic Agent Terminology,etaracizumab,0
18206,FDA Established Names and Unique Ingredient Identifier Codes Terminology,propatyl nitrate,0
18207,NCIt Neoplasm Core Terminology,Carcinoma in situ of ampulla of Vater,0
18208,CDISC SDTM Terminology,Inserted During a Non-Percutaneous Coronary Intervention,0
18209,Clinical Data Interchange Standards Consortium Terminology,Pregnancy Partner,0
18210,Modified Barium Swallow Impairment Profile,Brisk Tongue Motion,0
18211,Clinical Data Interchange Standards Consortium Terminology,Epidermis,0
18212,Clinical Data Interchange Standards Consortium Terminology,Percent Recovered Over Dosing Interval Normalized by Surface Area,0
18213,FDA Device Component Code Hierarchy,Hose Line Device,0
18214,Clinical Data Interchange Standards Consortium Terminology,Aspartate Aminotransferase Antigen Measurement,0
18215,CDISC SDTM Laboratory Test Terminology by Name,Aspartate Aminotransferase Antigen Measurement,0
18216,CDISC SDTM Terminology,Nucleated Red Blood Cell to Erythrocyte Ratio Measurement,0
18217,CDISC SDTM Terminology,Saphenous vein graft,0
18218,FDA Established Names and Unique Ingredient Identifier Codes Terminology,paclitaxel poliglumex,0
18219,CDISC QRS Terminology,MSQOL-54 - As Healthy as Anybody,0
18220,CDISC SDTM Terminology,Aggregate P Wave Duration,0
18221,Pediatric Terminology,Congenital Reproductive System Abnormality,0
18222,US Counties Terminology,"Orleans County, VT",0
18223,CDISC SDTM Terminology,Procollagen 3 N-Terminal Propeptide Measurement,0
18224,CDISC SDTM Terminology,"Paramyxovirus, NOS",0
18225,Clinical Data Interchange Standards Consortium Terminology,Liver carcinoma,0
18226,NCI CTEP SDC Germ Cell Tumors of the CNS Sub-Category Terminology,Nongerminomatous germ cell tumor of the central nervous system,0
18227,US Counties Terminology,"Cross County, AR",0
18228,SPL Package Type Terminology,Syringes,0
18229,CDISC Questionnaire FIQR Test Code Terminology,FIQR - Balance Problems,0
18230,CDISC QRS Terminology,EPIC-26 - Dripping or Leaking Urine,0
18231,CDISC SEND Tumor Findings Results Terminology,Craniopharyngioma,0
18232,Clinical Data Interchange Standards Consortium Terminology,Synthetic Vessel Graft,0
18233,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Serratia marcescens,0
18234,CDISC SDTM Microorganism Terminology,Fasciolopsis buski,0
18235,Newborn Screening Terminology,Ultrasonography,0
18236,CDISC SDTM Unit of Measure Terminology,Molecule of Equivalent Soluble Fluorochrome,0
18237,Clinical Data Interchange Standards Consortium Terminology,Pemphigoid antibody measurement,0
18238,CDISC Questionnaire NPI Test Code Terminology,NPI - Show Any Other Signs of Depression or Sadness,0
18239,CDISC SDTM Laboratory Test Terminology by Code,Protein S measurement,0
18240,ICH Unit of Measure Terminology,Mega United States Pharmacopeia Unit,0
18241,Clinical Data Interchange Standards Consortium Terminology,Rectum and sigmoid colon,0
18242,CDISC SDTM Terminology,Proximal Interphalangeal Joint 3 of the Hand,0
18243,Stability Container Type Terminology,Drug Kit,0
18244,CDISC SDTM Microorganism Terminology,Wolinella succinogenes,0
18245,CDISC Questionnaire C-SSRS Children's Since Last Visit Test Code Terminology,C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act,0
18246,CDISC SEND Laboratory Animal Species Terminology,Domestic Sheep,0
18247,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cobiprostone,0
18248,CDISC SDTM Microorganism Terminology,Chlamydophila pneumoniae,0
18249,CDISC QRS Terminology,MNSI - History Total,0
18250,FACT-BMT Questionnaire,Treatment Effects are Worse than Imagined,0
18251,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Adenine,0
18252,CDISC SDTM Terminology,Maximum QT Duration,0
18253,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"insulin glulisine, human",0
18254,Pediatric Terminology,Twin placenta,0
18255,Clinical Data Interchange Standards Consortium Terminology,Interleukin 11 Measurement,0
18256,CTRP Terminology,Ulocuplumab,0
18257,NCIt Neoplasm Core Terminology,Monomorphic Post-Transplant Lymphoproliferative Disorder,0
18258,CTRP Terminology,Iodine I 123 Anti-CEA Recombinant Diabody T84.66,0
18259,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chlorquinaldol,0
18260,FDA Individual Case Safety Report Terminology,Veterinary Anatomic Therapeutic Chemical Classification System Code,0
18261,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Liter per Day per Microgram per Meter Squared per Day,0
18262,NCIt Antineoplastic Agent Terminology,N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine,0
18263,CDISC QRS Terminology,"C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Some Intent to Act, without Specific Plan",0
18264,Clinical Data Interchange Standards Consortium Terminology,MNSI - Symptoms Worse at Night,0
18265,CDISC SDTM Terminology,NPI - Hallucinations Frequency,0
18266,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cyclomethycaine Sulfate,0
18267,CDISC SDTM Terminology,Uranyl Acetate Staining Method,0
18268,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cycloguanil,0
18269,FDA Individual Case Safety Report Terminology,Positive Dechallenge Reaction Indicator,0
18270,CDISC SDTM Laboratory Test Terminology by Name,Gamma Globulin to Total Protein Ratio Measurement,0
18271,Neonatal Research Network Terminology,Orbital Cellulitis,0
18272,Pediatric Terminology,Orbital Cellulitis,0
18273,Clinical Data Interchange Standards Consortium Terminology,Cardiologists,0
18274,CDISC QRS Terminology,NPI - Agitation/Aggression Frequency,0
18275,CDISC Functional Test Terminology,ADNI AVLT - List A Recall 5 Word 13,0
18276,Pediatric Terminology,Headache,0
18277,CDISC SDTM Terminology,Complete Hematologic Response,0
18278,CDISC QRS Terminology,"UPDRS - Mentation, Behavior and Mood Sub-total",0
18279,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tisopurine,0
18280,CDISC SEND Terminology,millimeter,0
18281,CDISC QRS Terminology,BPI - Tiring,0
18282,CDISC Questionnaire Terminology,MDS-UPDRS - Hoehn and Yahr Stage,0
18283,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Myosotis arvensis plant,0
18284,Cancer Patient Tobacco Use Questionnaire,Smoked a Cigarette Every Day,0
18285,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chloroquine Sulfate,0
18286,Pediatric Terminology,Hookworm Infections,0
18287,NCIt Antineoplastic Agent Terminology,Recombinant Modified Vaccinia Ankara-5T4 Vaccine,0
18288,CTRP Agent Terminology,Recombinant Modified Vaccinia Ankara-5T4 Vaccine,0
18289,Clinical Data Interchange Standards Consortium Terminology,Acute Anteroseptal Myocardial Infarction by ECG Finding,0
18290,Neonatal Research Network Terminology,Penoscrotal transposition,0
18291,Pediatric Rheumatology Terminology,Pediatric Vasculitis Activity Score,0
18292,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Androstenediol,0
18293,Clinical Data Interchange Standards Consortium Terminology,Repetition Time,0
18294,CDISC SDTM Country Terminology,Indonesia,0
18295,FACT-BMT Questionnaire,Concern about Ability to Have Children,0
18296,CDISC SDTM Terminology,Femtomole per Liter per Second,0
18297,CDISC SDTM Holter ECG Results Terminology,Acute High Lateral Myocardial Infarction by ECG Finding,0
18298,CDISC SDTM Terminology,ADNI AVLT - List A Recall 5 Word 15,0
18299,CDISC SEND Terminology,Cause of Death,0
18300,Clinical Data Interchange Standards Consortium Terminology,Prince T Cell Lymphoma 2010 Oncology Response Criteria,0
18301,CDISC SDTM Category of Oncology Response Assessment Terminology,Prince T Cell Lymphoma 2010 Oncology Response Criteria,0
18302,Clinical Data Interchange Standards Consortium Terminology,SOWS Subjective (Handelsman) - I'm Perspiring,0
18303,Pediatric Adverse Events Terminology,Renal transplant rejection,0
18304,US Counties Terminology,"Boone County, KY",0
18305,CDISC SDTM Frequency Terminology,Every Five Weeks,0
18306,US Counties Terminology,"Medina County, OH",0
18307,Pediatric Adverse Events Terminology,Gas retention,0
18308,CDISC SDTM Terminology,Skin Type (finding),0
18309,Pediatric Adverse Events Terminology,Mitochondrial enzyme deficiency,0
18310,GAIA Terminology,GAIA Level 2 Major External Structural Defect,0
18311,CDISC SDTM Laboratory Test Terminology by Code,Endogenous Thrombin Potential Peak Height Measurement,0
18312,Clinical Data Interchange Standards Consortium Terminology,BPI - Numb,0
18313,CTRP Agent Terminology,Narcotic Antagonists,0
18314,Clinical Data Interchange Standards Consortium Terminology,SOWS Subjective (Handelsman) - My Eyes Are Tearing,0
18315,Clinical Data Interchange Standards Consortium Terminology,Clinic Stay Indicator,0
18316,CTRP Terminology,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,0
18317,Clinical Data Interchange Standards Consortium Terminology,Acute Septal Myocardial Infarction by ECG Finding,0
18318,CDISC SDTM Directionality Terminology,Intermediate,0
18319,Neonatal Research Network Terminology,"Leukomalacia, Periventricular",0
18320,CDISC SDTM Microorganism Terminology,Acidovorax delafieldii,0
18321,US Counties Terminology,"Roberts County, TX",0
18322,CDISC SDTM Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Lifetime),0
18323,Perinatal Terminology,Late Term Birth,0
18324,CDISC QRS Terminology,C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime),0
18325,CTRP Agent Terminology,HPV 16 E7:86-93 Peptide Vaccine,0
18326,CDISC SEND Microscopic Histopathology Result Category Terminology,Metastatic to,0
18327,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Guanine,0
18328,CDISC SEND Study Type Terminology,Pharmacokinetics: Drug Interactions,0
18329,US Counties Terminology,"Marshall County, OK",0
18330,CDISC Questionnaire NCCN-FACT FBLSI-18 Version 2 Test Code Terminology,NCCN-FACT FBLSI-18 Version 2 - Bothered by Treatment Side Effect,0
18331,Clinical Data Interchange Standards Consortium Terminology,Medical Device Failure to Calibrate,0
18332,FDA Established Names and Unique Ingredient Identifier Codes Terminology,mafosfamide,0
18333,CDISC SDTM Terminology,C-SSRS Since Last Visit - Number of Interrupted Suicide Attempts,0
18334,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Burdock root extract,0
18335,CDISC SDTM Terminology,Popliteal Artery Below the Knee,0
18336,CDISC SEND Terminology,Pancreatic Lipase Measurement,0
18337,NCIt Antineoplastic Agent Terminology,volociximab,0
18338,Pediatric Terminology,Neonatal diabetes mellitus,0
18339,US Counties Terminology,"Wayne County, UT",0
18340,CDISC SEND Terminology,Thumb structure,0
18341,CTRP Terminology,Infrared Photocoagulation Therapy,0
18342,US Counties Terminology,"Guayama Municipio, PR",0
18343,Clinical Data Interchange Standards Consortium Terminology,Dosage,0
18344,FDA Established Names and Unique Ingredient Identifier Codes Terminology,diperodon,0
18345,Pediatric Adverse Events Terminology,Urinary Leakage,0
18346,CDISC CDASH Exposure Route of Administration Terminology,Rectal Route of Drug Administration,0
18347,CDISC QRS Terminology,CDISC Clinical Classification ASSIGN Score Test Name Terminology,0
18348,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Amenamevir,0
18349,CDISC SDTM Cardiovascular Findings About Results Terminology,Coronary revascularization,0
18350,CDISC Questionnaire Terminology,CDISC Questionnaire GAD-7 Test Name Terminology,0
18351,Pediatric Terminology,Congenital tracheal agenesis,0
18352,Pediatric Adverse Events Terminology,Hyperkalemia,0
18353,CDISC Questionnaire C-SSRS Children's Baseline Test Code Terminology,C-SSRS Children's Baseline - Describe Most Severe Ideation,0
18354,CTRP Agent Terminology,Telatinib Mesylate,0
18355,Pediatric Rheumatology Terminology,Scleritis,0
18356,CDISC SEND Terminology,Leptin measurement,0
18357,CDISC SEND Study Type Terminology,"Toxicology: Repeat Dose Toxicity [Species, Route, Duration]",0
18358,CTRP Terminology,Alvocidib Hydrochloride,0
18359,Clinical Data Interchange Standards Consortium Terminology,Acute lymphocytic leukemia,0
18360,CDISC SDTM Trial Summary Parameter Terminology by Code,EudraVigilance Sender Organization,0
18361,CDISC SEND Trial Summary Parameter Long Name Terminology,Set Label,0
18362,CTRP Agent Terminology,LY-3039478,0
18363,Clinical Data Interchange Standards Consortium Terminology,Set of regional lymph nodes,0
18364,CDISC SDTM Terminology,Number of Lymph Nodes Positive,0
18365,CDISC SDTM Terminology,Impaired exercise tolerance,0
18366,CDISC Questionnaire Terminology,FACT-B Version 4 - I Have Nausea,0
18367,NCIt Antineoplastic Agent Terminology,Interferon-gamma-expressing Adenovirus Vaccine ASN-002,0
18368,Clinical Data Interchange Standards Consortium Terminology,Sponsor Defined Group Code,0
18369,CTRP Terminology,Plasma Cell Neoplasm,0
18370,CTRP Terminology,ASP3026,0
18371,Patient Reported Outcomes Version of CTCAE,Worst Severity Past Seven Days Shortness of Breath,0
18372,Clinical Data Interchange Standards Consortium Terminology,Trichophyton yaoundei,0
18373,CDISC Questionnaire ADAS-Cog CDISC Version Test Name Terminology,CDISC ADAS-Cog - Commands: Pencil,0
18374,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Rabies Virus Strain Kissling Antigen (Propiolactone Inactivated),0
18375,CDISC QRS Terminology,SOAPP-R - Concerned People Will Judge You,0
18376,NCIt Antineoplastic Agent Terminology,NA17.A2 Peptide Vaccine,0
18377,NCIt Neoplasm Core Terminology,"Leukemia, Mast-Cell",0
18378,Clinical Data Interchange Standards Consortium Terminology,Fifth finger,0
18379,Neonatal Research Network Terminology,Metabolic myopathy,0
18380,CTRP Terminology,Stage IIIC Gastric Cancer AJCC v7,0
18381,Clinical Data Interchange Standards Consortium Terminology,High-performance Liquid Chromatography-UV,0
18382,CDISC Questionnaire Terminology,CDISC Questionnaire C-SSRS Children's Since Last Visit Test Name Terminology,0
18383,Pediatric Terminology,Nocturia,0
18384,Pediatric Terminology,Hypertransaminasaemia,0
18385,CDISC SDTM Laboratory Test Terminology by Name,Promyelocyte to Total Cell Ratio Measurement,0
18386,CDISC SDTM Terminology,CDISC SDTM Multiple Sclerosis Findings About Test Name Terminology,0
18387,FDA Device Component Code Hierarchy,Imager Device,0
18388,DICOM Terminology,Number of Frames,0
18389,CDISC SDTM Unit of Measure Terminology,w/v,0
18390,CDISC SEND Terminology,Extract Dosage Form,0
18391,CDISC Questionnaire Terminology,SGRQ-C - Cannot Take a Bath or Shower,0
18392,Pediatric Terminology,Chronic Kidney Diseases,0
18393,CDISC SDTM Terminology,Legionella,0
18394,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trifezolac,0
18395,FDA Established Names and Unique Ingredient Identifier Codes Terminology,balaglitazone,0
18396,CTRP Terminology,Cervical Squamous Cell Carcinoma,0
18397,FDA CDRH GUDID Terminology,French Catheter Gauge,0
18398,US Counties Terminology,"Maverick County, TX",0
18399,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Norbudrine,0
18400,CDISC SEND Terminology,Dominican Republic,0
18401,CDISC Variable Terminology,Exposure Location,0
18402,CDISC Questionnaire OAB-q Test Code Terminology,OAB-q - Decrease Your Physical Activities,0
18403,CDISC SEND Biospecimens Terminology,Trigeminal nerve structure,0
18404,CDISC SDTM Tumor Response Assessment Test Code Terminology,Response in Target Lesion,0
18405,US Counties Terminology,"Smith County, TN",0
18406,Perinatal Terminology,Fetus-to-fetus placental transfusion syndrome,0
18407,CDISC SDTM Cardiovascular Findings About Results Terminology,Rales,0
18408,US Counties Terminology,"Linn County, IA",0
18409,Newborn Screening Terminology,Modality,0
18410,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Hour Times Picogram Per Milliliter Per Milligram Per Gram Per Day,0
18411,Clinical Data Interchange Standards Consortium Terminology,CDISC ADAS-Cog - Delayed Word Recall: Word 1,0
18412,CDISC SEND Tumor Findings Results Terminology,Pineocytoma,0
18413,CDISC SDTM Method Terminology,Audiometry,0
18414,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Clofenetamine Hydrochloride,0
18415,CDISC Questionnaire ADCS-ADL Severe Dementia Test Name Terminology,ADCS-ADL Severe Dementia - Sum of Items 1-5,0
18416,Clinical Data Interchange Standards Consortium Terminology,Response in Non-Target Lesion,0
18417,CDISC SDTM Laboratory Test Terminology by Name,Cocaine measurement,0
18418,CDISC SDTM Holter ECG Results Terminology,Prolonged ST segment,0
18419,SPL Drug Route of Administration Terminology,Intracorneal Route of Drug Administration,0
18420,CDISC SEND Terminology,Milliliter per Minute per Milligram per Day,0
18421,CDISC Questionnaire Expanded DRS-PI Survivor Version Test Code Terminology,Expanded DRS-PI Survivor Version - Know How to Bathe and Wash,0
18422,CDISC SDTM Microorganism Terminology,Human Parvovirus B19 Virus,0
18423,Pediatric Adverse Events Terminology,Ptosis,0
18424,FDA Device Problem Code Hierarchy,Low Test Results,0
18425,Brief Fatigue Inventory,Fatigue Rating Score 10,0
18426,CDISC SDTM Terminology,Oval Fat Body Measurement,0
18427,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bupranolol,0
18428,US Counties Terminology,"Midland County, TX",0
18429,Clinical Data Interchange Standards Consortium Terminology,Microarray,0
18430,Clinical Data Interchange Standards Consortium Terminology,beats per minute,0
18431,CTRP Terminology,Stage 0 Uterine Corpus Cancer AJCC v6,0
18432,CDISC SDTM Laboratory Test Terminology by Name,Antidepressant Measurement,0
18433,CDISC SDTM Terminology,Acinetobacter calcoaceticus,0
18434,CDISC SDTM ECG Finding Terminology,Disconnected Precordial Electrode V2 by ECG Finding,0
18435,CDISC SDTM Laboratory Test Terminology by Name,CD2 Expressing Cell to Lymphocyte Ratio Measurement,0
18436,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Peppermint oil,0
18437,Clinical Data Interchange Standards Consortium Terminology,Vector Genomes per Dose,0
18438,NCIt Antineoplastic Agent Terminology,Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8,0
18439,CTRP Agent Terminology,Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8,0
18440,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology,C-SSRS Children's Baseline/Screening - Wish to be Dead (Lifetime),0
18441,Clinical Data Interchange Standards Consortium Terminology,Uterus/Ovaries,0
18442,CDISC SDTM Terminology,First Degree Relative,0
18443,CDISC SDTM Terminology,Pittsburgh sleep quality index,0
18444,Outcome Satisfaction Questionnaire,Somewhat Satisfied,0
18445,Stability Product Form Terminology,Salve Dosage Form,0
18446,CDISC SDTM Trial Phase Terminology,Trial Phase 5,0
18447,CDISC SEND Biospecimens Terminology,Teat,0
18448,NCI CTEP Simplified Disease Classification Terminology,Squamous cell carcinoma of penis,0
18449,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Tapioca starch,0
18450,Perinatal Terminology,Delayed Postpartum Hemorrhage,0
18451,Clinical Data Interchange Standards Consortium Terminology,Blunt-Tipped Tail,0
18452,CTRP Terminology,TLR7 Agonist ANA773 Tosylate,0
18453,Pediatric Terminology,Apnea,0
18454,FDA Established Names and Unique Ingredient Identifier Codes Terminology,carbuterol,0
18455,Stability Product Form Terminology,Shampoo Dosage Form,0
18456,CDISC QRS Terminology,ADNI AVLT - List A Recall 2 Word 15,0
18457,Perinatal Terminology,Postpartum Uterine Inversion,0
18458,CDISC SDTM Terminology,Viral Particles per Dose,0
18459,CDISC QRS Terminology,C-SSRS Children's Baseline/Screening - Description of Wish to be Dead,0
18460,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology,C-SSRS Children's Baseline/Screening - Description of Wish to be Dead,0
18461,US Counties Terminology,"Goshen County, WY",0
18462,CDISC SDTM Terminology,International Unit per Liter,0
18463,CDISC Questionnaire Terminology,FACT-P Version 4 - I Am Satisfied With My Sex Life,0
18464,Pediatric Adverse Events Terminology,Human Leukocyte Antigen Sensitization,0
18465,NCIt Antineoplastic Agent Terminology,Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine,0
18466,CTRP Terminology,Localized tumors of the Ewing's family,0
18467,Quality of Life Questionnaire-Brain Neoplasm 20,Get Headaches question,0
18468,CDISC Questionnaire Terminology,SGRQ Past 4 Weeks Version - Treatment Does Not Help Me Much,0
18469,NCIt Neoplasm Core Terminology,Fusion-Negative Rhabdomyosarcoma,0
18470,CDISC QRS Terminology,ADNI AVLT - List A Intrusions 2,0
18471,CDISC SDTM Microorganism Terminology,Absidia (fungus),0
18472,CDISC SDTM Terminology,Kytococcus,0
18473,SPL Unit of Presentation Terminology,Package Dosing Unit,0
18474,Clinical Data Interchange Standards Consortium Terminology,Abnormal color,0
18475,CDISC QRS Terminology,OAB-q - Plan Activities More Carefully,0
18476,Pediatric Terminology,Moderate Baseline Fetal Heart Rate Variability,0
18477,CDISC SEND Terminology,Growth Hormone Inhibiting Hormone Measurement,0
18478,FDA Established Names and Unique Ingredient Identifier Codes Terminology,HC Yellow No. 7,0
18479,CTRP Agent Terminology,Oraxol,0
18480,CDISC QRS Terminology,FPSR - How Much Do You Hurt,0
18481,Perinatal Terminology,Fetal tachyarrhythmia,0
18482,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Leteprinim,0
18483,CDISC SDTM Microorganism Terminology,Amoeba genus,0
18484,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hexamethonium Tartrate,0
18485,CDISC SDTM Terminology,CDISC Questionnaire FACT-B Version 4 Test Code Terminology,0
18486,CDISC SEND Terminology,Millimeter Mercury Per Liter Per Minute,0
18487,CTRP Terminology,Cutaneous T-cell lymphoma stage I,0
18488,Stability Product Form Terminology,Extended Release Patch Dosage Form,0
18489,NCIt Antineoplastic Agent Terminology,Recombinant Interleukin-12,0
18490,Clinical Data Interchange Standards Consortium Terminology,Percent Recovered Infinity Predicted Normalized by Surface Area,0
18491,Clinical Data Interchange Standards Consortium Terminology,Cheson Non-Hodgkins Lymphoma 1999 Oncology Response Criteria,0
18492,CTRP Terminology,Fluorine F 18 RGD-K5,0
18493,CDISC SDTM Laboratory Test Terminology by Name,Somatomedin-C measurement,0
18494,NCIt Antineoplastic Agent Terminology,LY2787106,0
18495,CDISC SDTM Terminology,Hour Times Milligram Per Milliliter Per Milligram Per Kilogram,0
18496,Stability Product Form Terminology,Tablet Coated Particle Dosage Form,0
18497,CDISC QRS Terminology,CDISC Questionnaire FOSI Test Name Terminology,0
18498,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Pastime: Fishing,0
18499,CDISC SDTM Trial Summary Parameter Terminology by Name,ECG T Wave Algorithm,0
18500,CDISC CDASH Concomitant Medication Route of Administration Terminology,Intralesional Route of Drug Administration,0
18501,CDISC SEND Terminology,Rib 3,0
18502,Pediatric Terminology,Late fetal death,0
18503,CDISC SEND Terminology,Right Posterior Atrioventricular Artery,0
18504,CDISC SDTM Microorganism Terminology,Beta-Lactamase Positive Staphylococcus Aureus,0
18505,Clinical Data Interchange Standards Consortium Terminology,Hour Squared Times Millimole per Milliliter,0
18506,CDISC SDTM Anatomical Location Terminology,Occipital lymph node group,0
18507,CDISC SEND Terminology,Body cavities,0
18508,Human Activity Profile Test,Putting Groceries on Shelves,0
18509,CDISC Questionnaire Terminology,GDS - Frequently Worry About Future,0
18510,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Clematis vitalba flower extract,0
18511,HL7 Unit of Measure Terminology,newton,0
18512,CDISC SDTM Mechanical Circulatory Support Placement Timing Terminology,Mechanical Circulatory Support in Place at Start of Procedure,0
18513,CDISC SDTM Terminology,HAQ-DI With VAS - Able to Open Milk Carton,0
18514,CTRP Agent Terminology,Caffeine,0
18515,Female Sexual Function Index,Difficulty of Reaching Orgasm with Sexual Stimulation or Intercourse,0
18516,CDISC Variable Terminology,Inclusion Exclusion Criterion Test,0
18517,CDISC Questionnaire MPAI-4 Test Name Terminology,MPAI-4 - Psychotic Symptoms Pre-Injury,0
18518,CDISC Variable Terminology,Laboratory Test Method,0
18519,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Naepaine,0
18520,CDISC SEND Terminology,Intralymphatic Route of Drug Administration,0
18521,CDISC SDTM Microorganism Terminology,Gram-negative pleomorphic bacillus,0
18522,US Counties Terminology,"Monroe County, MS",0
18523,Clinical Data Interchange Standards Consortium Terminology,Rib 12,0
18524,US Counties Terminology,"Madison County, AL",0
18525,NCIt Neoplasm Core Terminology,Malignant Glioma,0
18526,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Hour Squared Times Picogram per Milliliter,0
18527,CDISC SEND Terminology,Minimum RR Duration,0
18528,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Beloxepin,0
18529,CTRP Terminology,Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12,0
18530,CDISC QRS Terminology,FACIT-F Version 4 - Able to Do My Usual Activities,0
18531,Pediatric Infectious Disease Terminology,Virus Diseases,0
18532,CDISC SEND Terminology,Amyloid P Measurement,0
18533,FDA Established Names and Unique Ingredient Identifier Codes Terminology,traxoprodil,0
18534,CDISC Questionnaire Category Terminology,Hemophilia Quality of Life Questionnaire Adult Version,0
18535,CDISC SDTM Cardiac Procedure Indication Terminology,Medical or Surgical Procedure Requiring Relocation of Lead,0
18536,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Zolazepam,0
18537,CDISC SDTM ECG Test Name Terminology,Maximum RR Duration,0
18538,US Counties Terminology,"Lackawanna County, PA",0
18539,CDISC QRS Terminology,FACT-B Version 4 - Satisfied With How I Am Coping,0
18540,Pediatric Rheumatology Terminology,Panuveitis,0
18541,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Description of Usual Performance of Common Pastimes,0
18542,CareLex eTMF Terminology,Clinical Trial Principal Investigator License,0
18543,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Centella asiatica leaf extract,0
18544,Clinical Data Interchange Standards Consortium Terminology,Prolonged-release film-coated oral capsule,0
18545,CDISC QRS Terminology,Montgomery-Asberg Depression Rating Scale Questionnaire,0
18546,integrated Cancer Repository for Cancer Research,"Material Recording, Scheduling, Dispatching, and Distributing Workers",0
18547,CDISC SDTM Terminology,C-SSRS Since Last Visit - Reasons for Most Severe Ideation,0
18548,CDISC SEND Terminology,Neuron specific enolase measurement,0
18549,CDISC SDTM Laboratory Test Terminology by Code,Interleukin 28 Measurement,0
18550,NCIt Antineoplastic Agent Terminology,Oral Microencapsulated Diindolylmethane,0
18551,CDISC SEND Terminology,Hairy Cell Count,0
18552,CDISC SDTM Laboratory Test Terminology by Code,Hairy Cell Count,0
18553,CDISC SDTM Microorganism Terminology,Actinomyces meyerii,0
18554,National Health Interview Survey,Educational Status,0
18555,Clinical Data Interchange Standards Consortium Terminology,Soluble P-Selectin Measurement,0
18556,Newborn Screening Terminology,Birth time,0
18557,CDISC SDTM ECG Finding Terminology,"Q axis, left axis deviation",0
18558,US Counties Terminology,"Cherokee County, OK",0
18559,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sulfadimethoxine,0
18560,CDISC QRS Terminology,CDISC Clinical Classification West Haven Criteria Test Code Terminology,0
18561,CDISC SDTM Terminology,Intraovarian Route of Drug Administration,0
18562,CDISC SDTM Route of Administration Terminology,Intraovarian Route of Drug Administration,0
18563,CDISC SEND Terminology,Intraovarian Route of Drug Administration,0
18564,Newborn Screening Terminology,Health,0
18565,NCIt Antineoplastic Agent Terminology,mecarzole,0
18566,CDISC SEND Terminology,Interleukin 21 Measurement,0
18567,integrated Cancer Repository for Cancer Research,Ethylene Chlorohydrin,0
18568,CDISC Questionnaire HADS Test Code Terminology,HADS - Worrying Thoughts Go Through My Mind,0
18569,Clinical Data Interchange Standards Consortium Terminology,Minimum Vessel Lumen Diameter,0
18570,US Counties Terminology,"Izard County, AR",0
18571,CDISC QRS Terminology,CDISC Questionnaire EDSS Test Code Terminology,0
18572,DICOM Terminology,Content Creation Date,0
18573,CDISC Variable Terminology,Trial Sets Sequence Number,0
18574,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Proadifen,0
18575,CDISC Questionnaire NPI Test Name Terminology,NPI - Anxiety Distress,0
18576,CDISC Questionnaire SIQR Test Name Terminology,SIQR - Walk Continuously for 20 Minutes,0
18577,Pediatric Terminology,Visual Cortex Disorder,0
18578,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Oxonazine,0
18579,CDISC QRS Terminology,ASCVD 10-Year Risk Estimator - Risk Score,0
18580,CDISC SDTM Cardiovascular Test Name Terminology,Percent Diameter Stenosis Measurement,0
18581,US Counties Terminology,"Hill County, MT",0
18582,FDA Established Names and Unique Ingredient Identifier Codes Terminology,acetic anhydride,0
18583,Pediatric Terminology,Breathing Effort Score,0
18584,CDISC SEND Terminology,International Unit per Milliliter per Milligram per Kilogram,0
18585,CDISC SDTM Terminology,Nephelometry,0
18586,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dextromoramide tartrate,0
18587,CTRP Disease Terminology,Undifferentiated carcinoma of nasopharynx,0
18588,CDISC SEND Terminology,Platelet Derived Growth Factor Isoform AB Measurement,0
18589,CDISC SDTM Terminology,Polymorphonuclear Pancreatic Elastase Measurement,0
18590,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bemegride,0
18591,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid",0
18592,CDISC SEND Terminology,Trial Stages Domain,0
18593,CDISC Questionnaire SIQR Test Code Terminology,SIQR - Prepare a Homemade Meal,0
18594,Clinical Data Interchange Standards Consortium Terminology,CRQ-SAS Follow-Up Administration Version - Feel Upset When Had Difficulty Getting Breath,0
18595,CTRP Terminology,selenomethylselenocysteine,0
18596,CTRP Agent Terminology,iodine I 131 monoclonal antibody CC49-deltaCH2,0
18597,CDISC Questionnaire CHART-SF Paper Version Test Name Terminology,CHART-SF Paper Version - Nights Away From Home Last Year,0
18598,CDISC SEND Trial Summary Parameter Long Name Terminology,End Date Time Of Dose Interval,0
18599,CDISC SEND Biospecimens Terminology,Vitreous body structure,0
18600,FDA Individual Case Safety Report Terminology,Medical Equipment Company Technician or Representative,0
18601,CTRP Agent Terminology,utomilumab,0
18602,CDISC SDTM Respiratory Test Code Terminology,Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio,0
18603,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Oxytetracycline,0
18604,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Benzaldehyde Dimethane Sulfonate,0
18605,CTRP Agent Terminology,Prexigebersen,0
18606,CDISC QRS Terminology,NPI - Irritability/Lability Severity,0
18607,Pediatric Terminology,Genetic screening method,0
18608,CDISC SDTM Method Terminology,Auscultation,0
18609,Clinical Data Interchange Standards Consortium Terminology,Bradycardia by ECG Finding,0
18610,CDISC Variable Terminology,Respiratory System Findings Elapsed Time,0
18611,CDISC QRS Terminology,C-SSRS Baseline - Non-Specific Suicidal Thought,0
18612,CTRP Terminology,Mastocytosis,0
18613,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ranolazine,0
18614,CDISC Questionnaire Terminology,C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Past X Months),0
18615,CDISC Questionnaire C-SSRS Screening Test Code Terminology,C-SSRS Screening - Interrupted Suicide Attempt,0
18616,CDISC QRS Terminology,NPI - Irritability/Lability Distress,0
18617,MD Anderson Dysphagia Inventory,Have Low Self-Esteem due to Swallowing Problem,0
18618,CDISC Questionnaire Terminology,DAD - Undress Himself/Herself Completely,0
18619,Pediatric Infectious Disease Terminology,Wound Infection,0
18620,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cysteamine,0
18621,CTRP Terminology,Mixed osteosarcoma,0
18622,CDISC SEND Terminology,Structure of hilum of kidney,0
18623,CDISC SDTM Laboratory Test Terminology by Name,Red cell distribution width determination,0
18624,Neonatal Research Network Terminology,Interrupted aortic arch,0
18625,CTRP Terminology,B-cell small lymphocytic lymphoma stage IV,0
18626,NCIt Antineoplastic Agent Terminology,vadimezan,0
18627,Clinical Data Interchange Standards Consortium Terminology,Transtracheal Route of Drug Administration,0
18628,CDISC Questionnaire Terminology,ADCS-ADL MCI - Use Household Appliance: Other,0
18629,Clinical Data Interchange Standards Consortium Terminology,Day Times Milligram Per Milliliter Per Milligram Per Gram,0
18630,Perinatal Terminology,Pallor,0
18631,CDISC SEND Terminology,Distributing,0
18632,CDISC SDTM Terminology,ASEX-Female Version - Sexually Aroused,0
18633,CDISC Questionnaire HAQ-DI With VAS Test Name Terminology,HAQ-DI With VAS - Aids or Devices - Raised Toilet Seat,0
18634,CDISC QRS Terminology,NPI - Sleep Excessively During the Day,0
18635,Perinatal Terminology,Periodic Fetal Heart Rate Pattern,0
18636,Pediatric Infectious Disease Terminology,Colonization,0
18637,CDISC Variable Terminology,Procedure Date Time of Reference Timepoint,0
18638,CDISC SDTM Terminology,Oncologist 1,0
18639,CDISC SEND Terminology,Calcium/creatinine ratio measurement,0
18640,CTRP Terminology,Iron Overload,0
18641,Clinical Data Interchange Standards Consortium Terminology,HAMD-21 - Insomnia Early,0
18642,"Geopolitical Entities, Names, and Codes Terminology",South Africa,0
18643,CDISC SDTM Terminology,T lymphocyte count,0
18644,FDA Established Names and Unique Ingredient Identifier Codes Terminology,2-amino-2-methyl-1-propanol,0
18645,Clinical Data Interchange Standards Consortium Terminology,Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement,0
18646,Clinical Data Interchange Standards Consortium Terminology,Percent Recovered Infinity Observed Normalized by Weight,0
18647,CDISC SEND Terminology,Milliliter per gram,0
18648,CDISC Questionnaire Terminology,Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire,0
18649,SPL Equivalence Codes Terminology,Same,0
18650,Pediatric Terminology,Connective Tissue Diseases,0
18651,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,AURC from T1 to T2 Normalized by Body Mass Index,0
18652,CDISC Variable Terminology,Drug Accountability Record Subcategorization,0
18653,CDISC SDTM Laboratory Test Terminology by Code,Prolymphocyte to Lymphocyte Ratio Measurement,0
18654,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Verbena hastata,0
18655,NCIt Antineoplastic Agent Terminology,SLC-0111,0
18656,CDISC SDTM Terminology,ADCS-ADL Severe Dementia - Description of Usual Performance of Clearing Dishes,0
18657,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Screening - Aborted Suicide Attempt,0
18658,Human Activity Profile Test,Running or Jogging 1/2 Mile,0
18659,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Flavin-Adenine Dinucleotide,0
18660,CDISC QRS Terminology,ASEX-Female Version - Reach Orgasm,0
18661,CDISC SDTM Terminology,NPI - Increase in Appetite,0
18662,CDISC SDTM Terminology,Bead Dosage Form,0
18663,CDISC SDTM Tumor Response Assessment Test Name Terminology,Overall Response,0
18664,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Prazosin,0
18665,CDISC SDTM Microorganism Terminology,coxsackievirus A,0
18666,CDISC SDTM Terminology,Polychromatophilic stain reaction,0
18667,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Neuroblastoma,0
18668,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sumarotene,0
18669,CDISC SEND Tumor Findings Results Terminology,Experimental Organism Benign Thymoma Neoplasm,0
18670,NCIt Neoplasm Core Terminology,Retroperitoneal Carcinoma,0
18671,CDISC Clinical Classification Terminology,HAMD-21 - Insomnia Late,0
18672,CDISC Questionnaire Terminology,FACIT-F Version 4 - I Feel Tired,0
18673,CTRP Terminology,Recurrent Childhood Cerebral Astrocytoma,0
18674,NCIt Antineoplastic Agent Terminology,crenolanib,0
18675,CDISC SDTM Method Terminology,Ishihara Color Plates,0
18676,National Health Interview Survey,Mexican Americans,0
18677,CDISC Questionnaire FACT-B Version 4 Test Name Terminology,FACT-B Version 4 - My Family Has Accepted My Illness,0
18678,CDISC SDTM Terminology,Vomitus,0
18679,CDISC ADaM Terminology,Mean Observed Value in a Group Imputation Technique,0
18680,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Liter per Minute per Milligram per Meter Squared per Day,0
18681,Clinical Data Interchange Standards Consortium Terminology,Equivalent Weight,0
18682,FDA Device Problem Code Hierarchy,Erratic or Intermittent Display,0
18683,CDISC SDTM Microorganism Terminology,Salmonella bongori,0
18684,Memorial Symptom Assessment Scale - Short Form,Feel Irritable,0
18685,Memorial Symptom Assessment Scale,How Often Feeling Bloated,0
18686,NCIt Antineoplastic Agent Terminology,Iodine I 131 Monoclonal Antibody muJ591,0
18687,CDISC SEND Terminology,Sickle Cell to Erythrocyte Ratio Measurement,0
18688,Newborn Screening Terminology,Signs and Symptoms,0
18689,Pediatric Terminology,"Hallucinations, Visual",0
18690,CDISC Functional Test Terminology,AVLT-REY - List A Word 7,0
18691,CDISC SEND Terminology,Liter per Minute per Microgram per Kilogram per Day,0
18692,FDA Established Names and Unique Ingredient Identifier Codes Terminology,clothiapine,0
18693,Pediatric Terminology,Delayed Puberty,0
18694,Clinical Data Interchange Standards Consortium Terminology,Microabscess,0
18695,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Vaccaria hispanica Seed,0
18696,Pediatric Infectious Disease Terminology,Hidradenitis Suppurativa,0
18697,CDISC SEND Terminology,"Fibro-odontoma, Ameloblastic",0
18698,CDISC Questionnaire FACT-B Version 4 Test Code Terminology,FACT-B Version 4 - I Am Satisfied With My Sex Life,0
18699,CTRP Terminology,Musculoskeletal Complications Management,0
18700,Clinical Data Interchange Standards Consortium Terminology,Left Shift Neutrophil Measurement,0
18701,CTRP Terminology,MK-5108,0
18702,FDA Established Names and Unique Ingredient Identifier Codes Terminology,oxiperomide,0
18703,CDISC SDTM Method Terminology,Mass Spectrometry,0
18704,CDISC SDTM Terminology,HADS - I Get Frightened Feeling Like Butterflies in the Stomach,0
18705,CDISC SDTM Method Terminology,Peak Flowmetry,0
18706,CDISC SEND Terminology,Three times daily,0
18707,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Valategrast Hydrochloride,0
18708,CDISC SEND Terminology,Gram per Milliliter per Meter Squared,0
18709,NCI CTEP SDC Parathyroid Cancer Sub-Category Terminology,Parathyroid Gland Adenocarcinoma,0
18710,CDISC SEND Terminology,Kilogram per Mole,0
18711,CTRP Terminology,Adult Central Nervous System Neoplasm,0
18712,CDISC SEND Terminology,Fatty Acid Binding Protein 3 Measurement,0
18713,CDISC SDTM Microorganism Terminology,Coxiella burnetii,0
18714,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tizanidine,0
18715,National Health Interview Survey,completed fourth grade,0
18716,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 6 (After B) Word 2,0
18717,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pivagabine,0
18718,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dexnebivolol,0
18719,CDISC Variable Terminology,Exposure Dose Adjustment Reason,0
18720,FDA Established Names and Unique Ingredient Identifier Codes Terminology,roxindole,0
18721,GAIA Terminology,GAIA Level 1 Major Internal Structural Defect,0
18722,CDISC SDTM Terminology,C-SSRS Baseline - Most Recent Suicide Attempt Potential,0
18723,US Counties Terminology,"Morris County, TX",0
18724,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Egualen,0
18725,Pediatric Terminology,Muscular fasciculation,0
18726,CDISC Questionnaire ADCS-ADL MCI Test Code Terminology,ADCS-ADL MCI - Use Household Appliance,0
18727,CDISC SEND Terminology,Micromole per Liter per Meter Squared,0
18728,CDISC SEND Fetal Pathology Findings Result Terminology,Lordosis,0
18729,CTRP Terminology,Erlotinib Hydrochloride,0
18730,NCIt Antineoplastic Agent Terminology,Apitolisib,0
18731,CDISC QRS Terminology,CDISC Questionnaire AUDIT-C Test Name Terminology,0
18732,Pediatric Nephrology Terminology,Nephrotic Syndrome - LMX1B Associated,0
18733,CTRP Terminology,Dysgerminoma of ovary,0
18734,GAIA Neonatal Respiratory Distress Level of Diagnostic Certainty Terminology,GAIA Level 1 Neonatal Respiratory Distress,0
18735,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ADIPHENINE HCL,0
18736,CTRP Terminology,Cefixime,0
18737,Clinical Data Interchange Standards Consortium Terminology,Metatarsophalangeal Joint 5,0
18738,Pediatric Rheumatology Terminology,"Antibodies, Anticardiolipin",0
18739,CTRP Terminology,Naxitamab,0
18740,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Epetirimod,0
18741,Clinical Data Interchange Standards Consortium Terminology,Ten Million per Liter,0
18742,CDISC Questionnaire Terminology,C-SSRS Lifetime/Recent Version - First Suicide Attempt Actual Lethality/Medical Damage,0
18743,Pediatric Adverse Events Terminology,Urinary Incontinence,0
18744,CDISC QRS Terminology,"SGRQ-C - Respiratory Problems a Nuisance to Family, Friends or Neighbours",0
18745,Multinational Association of Supportive Care in Cancer Antiemesis Tool,Vomiting in the 24 Hours Since Chemotherapy,0
18746,CDISC SDTM Terminology,Mid-Circumflex Artery,0
18747,Clinical Data Interchange Standards Consortium Terminology,Local-Regional anatomy,0
18748,Pediatric Terminology,Delayed Graft Function,0
18749,CTRP Disease Terminology,POEMS Syndrome,0
18750,CDISC SDTM Terminology,CDISC Questionnaire CCQ 24 Hour Version Test Name Terminology,0
18751,Clinical Data Interchange Standards Consortium Terminology,Semilunar Bone,0
18752,CareLex eTMF Terminology,Term Source,0
18753,CDISC SDTM Terminology,Thousand per High Powered Field,0
18754,Clinical Data Interchange Standards Consortium Terminology,Enterobacter,0
18755,CTRP Terminology,Ovarian Embryonal Carcinoma,0
18756,CDISC Questionnaire C-SSRS Children's Baseline Test Name Terminology,"C-SSRS Children's Baseline - Frequency, Write Response",0
18757,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Aminopentamide,0
18758,CDISC Questionnaire GOSE Test Code Terminology,GOSE - Epilepsy: At Risk of Developing Epilepsy,0
18759,CDISC SDTM Anatomical Location Terminology,Structure of radial artery,0
18760,CDISC SDTM Terminology,Predicted Area Under the Urinary Excretion Rate Curve Percent Extrapolation,0
18761,FDA Device Problem Code Hierarchy,Energy Spectrum Incorrect,0
18762,Pediatric Adverse Events Terminology,Bronchopulmonary Dysplasia,0
18763,CDISC SDTM Terminology,ESRS-A - Rigidity: Upper Limbs,0
18764,Clinical Data Interchange Standards Consortium Terminology,Last Concentration,0
18765,Clinical Data Interchange Standards Consortium Terminology,Electrocardiogram: left ventricle hypertrophy (finding),0
18766,Clinical Data Interchange Standards Consortium Terminology,Thin Smear Technique,0
18767,Clinical Data Interchange Standards Consortium Terminology,CDISC Subject Level Analysis Dataset,0
18768,CTRP Disease Terminology,Colorectal Adenoma with Severe Dysplasia,0
18769,US Counties Terminology,"Douglas County, SD",0
18770,MD Anderson Dysphagia Inventory,Limit Food Intake due to Swallowing Difficulty,0
18771,Pediatric Terminology,Ovarian Germ Cell Tumor,0
18772,FDA Established Names and Unique Ingredient Identifier Codes Terminology,decamethonium dibromide,0
18773,CDISC QRS Terminology,CDISC Functional Test BACS Test Name Terminology,0
18774,GAIA Terminology,GAIA Level 1 Neonatal Death in a Preterm Live Birth,0
18775,CTRP Agent Terminology,Vitespen,0
18776,Patient Reported Outcomes Version of CTCAE,Worst Severity Past Seven Days Problems with Concentration,0
18777,CDISC Variable Terminology,Trial Summary Sequence Number,0
18778,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Past X Years),0
18779,FDA Established Names and Unique Ingredient Identifier Codes Terminology,myricetin,0
18780,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Candida albicans,0
18781,US Counties Terminology,"Franklin County, MS",0
18782,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pimagedine,0
18783,CTRP Agent Terminology,azaspirane,0
18784,CDISC SDTM Terminology,CDISC Questionnaire C-SSRS Screening Test Name Terminology,0
18785,CDISC SEND Terminology,"Transitional cell papilloma, benign",0
18786,Clinical Data Interchange Standards Consortium Terminology,Neurilemmoma,0
18787,Clinical Data Interchange Standards Consortium Terminology,"NPI - Wake Up at Night, Dress, and Plan to Go Out",0
18788,Clinical Data Interchange Standards Consortium Terminology,electrocardiogram: low voltage QRS complete,0
18789,CTRP Agent Terminology,Autologous Neuroblastoma Lysate/KLH-pulsed Dendritic Cell Vaccine,0
18790,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Milliliter per Milligram per Meter Squared,0
18791,Clinical Data Interchange Standards Consortium Terminology,SF-MPQ-2 - Tingling or 'Pins and Needles',0
18792,Neonatal Research Network Terminology,Benign congenital hypotonia,0
18793,CTRP Terminology,Childhood Protoplasmic Astrocytoma,0
18794,Clinical Data Interchange Standards Consortium Terminology,Cryptococcus terreus,0
18795,Clinical Data Interchange Standards Consortium Terminology,Paenibacillus glucanolyticus,0
18796,US Counties Terminology,"Menominee County, WI",0
18797,CDISC SDTM Microorganism Terminology,Streptococcus intermedius,0
18798,CTRP Terminology,Stage IV Urethral Cancer AJCC v7,0
18799,FDA Established Names and Unique Ingredient Identifier Codes Terminology,isobutylparaben,0
18800,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Date,0
18801,CDISC QRS Terminology,FAMS - I Have Nausea,0
18802,CTRP Agent Terminology,basiliximab,0
18803,CDISC SEND Terminology,Pouch Dosing Unit,0
18804,Breast Cancer Prevention Trial Symptom Scales,Bothered by General Aches and Pains Question,0
18805,CDISC Functional Test AVLT-REY Test Name Terminology,AVLT-REY - List A Word 2,0
18806,SPL Package Type Terminology,Box - unit dose,0
18807,CDISC SDTM Terminology,Day Times Millimole per Milliliter,0
18808,Pediatric Adverse Events Terminology,Breast Carcinoma,0
18809,CDISC Variable Terminology,Study Day of Tumor Identification,0
18810,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Porfiromycin,0
18811,CDISC QRS Terminology,BACS - Verbal Fluency Total,0
18812,CDISC SDTM Terminology,Minute Times Nanogram Per Milliliter Per Milligram Per Gram,0
18813,CDISC SDTM Terminology,Left Ventricular Basal Anterior Segment,0
18814,FDA Established Names and Unique Ingredient Identifier Codes Terminology,METHAPYRILENE HYDROCHLORIDE,0
18815,PROMIS Global Health Questionnaire,In General How Would You Rate Your Physical Health,0
18816,GAIA Terminology,GAIA Level 3b Postnatally Diagnosed Congenital Microcephaly,0
18817,Pediatric Adverse Events Terminology,Decreased Concentration,0
18818,FDA Device Component Code Hierarchy,Device Deployer Device,0
18819,NCPDP Measurement Unit Code Terminology,Pounds,0
18820,US Counties Terminology,"Uinta County, WY",0
18821,eCTD Product Name Type Terminology,Product Name Type,0
18822,Clinical Data Interchange Standards Consortium Terminology,PHQ Screener Version - Anxiety Attack Hot Flash or Chill,0
18823,Clinical Data Interchange Standards Consortium Terminology,Moraxella bovis,0
18824,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Day Times Mole per Liter per Meter Squared,0
18825,US Counties Terminology,"Gregory County, SD",0
18826,CDISC SDTM Terminology,SGRQ Past 3 Months Version - Embarrassed Using Medication in Public,0
18827,CareLex eTMF Terminology,Institutional Review Board Independent Ethics Committee Subject Information Document,0
18828,Neonatal Research Network Terminology,Little's Disease,0
18829,US Counties Terminology,"Gray County, KS",0
18830,CDISC Questionnaire Terminology,ADCS-ADL - Description of Usual Performance of Physically Getting Dressed,0
18831,Clinical Data Interchange Standards Consortium Terminology,Leminorella grimontii,0
18832,CDISC SDTM Terminology,Vanillyl Mandelic Acid Measurement,0
18833,CDISC SEND Terminology,Ganglia,0
18834,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - First Suicide Attempt Date,0
18835,Patient Reported Outcomes Version of CTCAE,Worst Severity Past Seven Days Headache,0
18836,NCIt Neoplasm Core Terminology,Breast adenoma,0
18837,CDISC Variable Terminology,Tumor Identifier Group Identifier,0
18838,FDA Established Names and Unique Ingredient Identifier Codes Terminology,niperotidine,0
18839,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pheniprazine Hydrochloride,0
18840,CDISC SDTM Terminology,Gliocladium,0
18841,CDISC QRS Terminology,CDISC Clinical Classification PANSS Test Code Terminology,0
18842,CDISC SEND Terminology,White Adipose Tissue,0
18843,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Captodiamine,0
18844,CTRP Disease Terminology,Adult Solid Neoplasm,0
18845,NCI CTEP Simplified Disease Classification Terminology,"Carcinoma, Neuroendocrine",0
18846,CTRP Agent Terminology,Tetanus-CMV Fusion Peptide Vaccine,0
18847,Bristol Stool Scale,Bristol Stool Type 1,0
18848,CDISC SEND Tumor Findings Results Terminology,Benign Carotid Body Paraganglioma,0
18849,CDISC Questionnaire BPI Test Name Terminology,BPI - Treatments Receiving for Pain,0
18850,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Asenapine,0
18851,Clinical Data Interchange Standards Consortium Terminology,Mandible,0
18852,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Euphorbia kansui,0
18853,Pediatric Adverse Events Terminology,Graves Disease,0
18854,CTRP Terminology,Localized Adrenal Gland Pheochromocytoma,0
18855,CDISC SEND Terminology,Calcium Clearance Measurement,0
18856,CDISC SDTM Microorganism Terminology,Salmonella Serotype Group C2,0
18857,Clinical Data Interchange Standards Consortium Terminology,Minimum Inhibitory Concentration measurement,0
18858,CDISC QRS Terminology,CDISC Questionnaire PI v1 Test Code Terminology,0
18859,CDISC SEND Terminology,Platelet Aggregometry Mean Curve Type,0
18860,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Imanixil,0
18861,Clinical Data Interchange Standards Consortium Terminology,Every four days,0
18862,CDISC QRS Terminology,HAQ-DI With VAS - Able to Bend Down and Pick Up Clothing From Floor,0
18863,CDISC SEND Terminology,Acute Myocardial Infarction by ECG Finding,0
18864,CDISC SDTM Subject Characteristic Test Name Terminology,Breast Fed Indicator,0
18865,CDISC Variable Terminology,Reproductive System Findings Reference Identifier,0
18866,CDISC Questionnaire ADCS-ADL Test Code Terminology,ADCS-ADL - Watch Television,0
18867,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cefuroxime axetil,0
18868,Pediatric Rheumatology Terminology,"SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder)",0
18869,NCIt Neoplasm Core Terminology,Flat adenoma,0
18870,CTRP Terminology,Amuvatinib,0
18871,CTRP Terminology,EphA2-targeting DOPC-encapsulated siRNA,0
18872,CDISC SDTM Anatomical Location Terminology,Head and neck structure,0
18873,Clinical Data Interchange Standards Consortium Terminology,Head and neck structure,0
18874,Clinical Data Interchange Standards Consortium Terminology,Sharp Genant Bone Erosion Score,0
18875,CDISC QRS Terminology,ADCS-ADL MCI - Use Household Appliance: Washer,0
18876,CDISC SDTM Laboratory Test Terminology by Name,Free Glycerol Measurement,0
18877,CDISC SDTM Terminology,CDISC SDTM Skin Response Test Code Terminology,0
18878,Quality of Life Questionnaire - Pancreatic Cancer 26,Worry About Future Health,0
18879,Clinical Data Interchange Standards Consortium Terminology,Nitric Oxide Measurement,0
18880,CDISC QRS Terminology,MSQOL-54 - Difficulty Having Orgasm,0
18881,CTRP Terminology,Secondary malignant neoplasm of peritoneum,0
18882,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Iobenguane I-123,0
18883,CDISC SDTM Terminology,GDS-SF - Good Spirits Most of Time,0
18884,CTRP Terminology,Childhood Grade I Meningioma,0
18885,CDISC SEND Trial Summary Parameter Long Name Terminology,Nonclinical Study Start Date,0
18886,CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Name Terminology,NCCN-FACT FKSI-19 Version 2 - I Have Bone Pain,0
18887,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tribromsalan,0
18888,CTRP Terminology,Urokinase-Derived Peptide A6,0
18889,Clinical Data Interchange Standards Consortium Terminology,FACT-P Version 4 - Losing Hope Against Illness,0
18890,CDISC QRS Terminology,GOSE - Family and Friendships: Problems with Family or Friends Before Injury,0
18891,CDISC SDTM Terminology,Fractional Excretion of Magnesium Measurement,0
18892,CDISC SDTM Terminology,MSQOL-54 - Health Limit Moderate Activities,0
18893,CDISC SEND Non-Neoplastic Finding Type Terminology,Germ Cell Depletion,0
18894,NCIt Antineoplastic Agent Terminology,Thioguanine,0
18895,Modified Barium Swallow Impairment Profile,Initiation of Pharyngeal Swallow,0
18896,CDISC Questionnaire Terminology,FACT-P Version 4 - Enjoy Things I Usually Do for Fun,0
18897,CDISC SDTM Terminology,CHART-SF Paper Version - Number of People You Live With,0
18898,CDISC SDTM Laboratory Test Terminology by Name,Hippuric Acid Crystal Measurement,0
18899,CDISC SDTM Terminology,Device Events Domain,0
18900,US Counties Terminology,"Boone County, IL",0
18901,"Toronto Extremity Salvage Score, Upper Extremity",Ability to Socialize with Friends and Family,0
18902,CDISC Questionnaire Terminology,"C-SSRS Children's Since Last Visit - Self-injurious Behavior, Intent Unknown",0
18903,CareLex eTMF Terminology,Electronic Case Report Form Technical Design Document,0
18904,CTRP Terminology,BCG Solution,0
18905,FDA Established Names and Unique Ingredient Identifier Codes Terminology,alfaxalone,0
18906,Children's Memory Scale,Word Pairs Total Score,0
18907,CTRP Agent Terminology,Adenosine A2A Receptor Antagonist PBF-509,0
18908,NCIt Neoplasm Core Terminology,Bile duct carcinoma,0
18909,CDISC SEND Tumor Findings Results Terminology,Experimental Organism Acidophil Carcinoma Neoplasm,0
18910,CDISC SDTM Laboratory Test Terminology by Code,Human Anti-Sheep IgG Antibody Measurement,0
18911,CDISC SDTM Microorganism Terminology,Rubulavirus,0
18912,CDISC SDTM Terminology,IIEF - Did You Have Feeling of Orgasm With or Without Ejaculation,0
18913,CDISC Variable Terminology,Laboratory Test Results End Day,0
18914,CDISC SDTM Terminology,Macrophage-Derived Chemokine measurement,0
18915,CDISC SDTM Terminology,ADNI AVLT - List A Recall 3 Word 11,0
18916,CTRP Terminology,Stage IIA Esophagus Carcinoma,0
18917,CTRP Agent Terminology,XL228,0
18918,CDISC SDTM Terminology,Inclusion Exclusion Domain,0
18919,FDA Established Names and Unique Ingredient Identifier Codes Terminology,nebivolol,0
18920,FDA Established Names and Unique Ingredient Identifier Codes Terminology,isometheptene bitartrate,0
18921,Clinical Data Interchange Standards Consortium Terminology,Wolchok Solid Tumors 2009 Oncology Response Criteria,0
18922,CDISC QRS Terminology,Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire,0
18923,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL MCI - Initiate Complex Daily Activities,0
18924,Clinical Data Interchange Standards Consortium Terminology,Bacterial Count Measurement,0
18925,CTRP Agent Terminology,R-CVP Regimen,0
18926,FACIT-Dyspnea 10 Item Short Form,Did Not Lift Something Weighing 10-20 Pounds,0
18927,Pediatric Adverse Events Terminology,Clostridium difficile colitis,0
18928,Pediatric Terminology,Fetal Doppler Monitoring,0
18929,Clinical Data Interchange Standards Consortium Terminology,PROSQOLI - Enjoying Time with Friends and Family,0
18930,Clinical Data Interchange Standards Consortium Terminology,UPDRS - Motor Examination: Postural Stability,0
18931,CDISC SDTM Unit of Measure Terminology,50 Percent Cell Culture Infective Dose per Dose,0
18932,FDA Device Problem Code Hierarchy,Visual Prompts will not Clear,0
18933,CDISC SEND Fetal Pathology Findings Result Terminology,Hemimelia,0
18934,Pediatric Terminology,Congenital diaphragmatic hernia,0
18935,CDISC SEND Terminology,Cerebral Intraventricular Route of Drug Administration,0
18936,NCIt Antineoplastic Agent Terminology,Ioflubenzamide I-131,0
18937,FDA Established Names and Unique Ingredient Identifier Codes Terminology,salt cedar pollen extract,0
18938,CDISC QRS Terminology,C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Past X Months),0
18939,CDISC SDTM Microorganism Terminology,Clostridium acetobutylicum,0
18940,NCIt Antineoplastic Agent Terminology,masitinib mesylate,0
18941,CDISC SDTM Terminology,Measured Tumor Identification,0
18942,CTRP Agent Terminology,survivin,0
18943,CDISC SDTM Trial Summary Parameter Terminology by Code,Retained Biospecimen Description,0
18944,CDISC Questionnaire Expanded DRS-PI Survivor Version Test Code Terminology,Expanded DRS-PI Survivor Version - Successful With Accommodations,0
18945,CDISC Variable Terminology,Skin Response Reason Not Done,0
18946,CTRP Terminology,Autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes,0
18947,CTRP Agent Terminology,ruxolitinib phosphate,0
18948,CDISC SEND Fetal Pathology Findings Result Terminology,Retroesophageal,0
18949,Regulated Product Submission Reporting Terminology,Request for Comments and Advice,0
18950,Clinical Data Interchange Standards Consortium Terminology,Histone 3 Antibody Measurement,0
18951,NCIt Antineoplastic Agent Terminology,P-cadherin Inhibitor PCA062,0
18952,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mozenavir,0
18953,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Jatropha curcas,0
18954,CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Name Terminology,C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Date,0
18955,CDISC SEND Non-Neoplastic Finding Type Terminology,Infarction,0
18956,Clinical Data Interchange Standards Consortium Terminology,SGRQ Past 3 Months Version - I Have Coughed,0
18957,Clinical Data Interchange Standards Consortium Terminology,Thoracic spinal cord structure,0
18958,Pediatric Terminology,Hemoglobin SC Disease,0
18959,CTRP Terminology,Adenomatous Polyposis Coli,0
18960,NCI CTEP Simplified Disease Classification Terminology,Cervix carcinoma,0
18961,Clinical Data Interchange Standards Consortium Terminology,Electrical alternation of heart,0
18962,FDA Established Names and Unique Ingredient Identifier Codes Terminology,burrobrush pollen extract,0
18963,CDISC SDTM Laboratory Test Terminology by Name,EDTA Clearance,0
18964,CDISC SEND Terminology,"Palate, Soft",0
18965,CDISC Functional Test Terminology,NHPT - More Than Two Attempts,0
18966,Regulated Product Submission Reporting Terminology,Promotional Material Document,0
18967,CTRP Intervention Terminology,Second line treatment,0
18968,CDISC SDTM Terminology,DAD - Carry Out an Appropriate Telephone Conversation,0
18969,Clinical Data Interchange Standards Consortium Terminology,CDISC CDASH Substance Usage Never Current Former Terminology,0
18970,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Code Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Past 3 Months),0
18971,Pediatric Terminology,Late latent syphilis,0
18972,UCUM Terminology,ug/g,0
18973,CDISC SDTM Laboratory Test Terminology by Code,Inulin renal clearance measurement,0
18974,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sodium Cyclamate,0
18975,Clinical Data Interchange Standards Consortium Terminology,Substudy Details,0
18976,CDISC QRS Terminology,FACT-G Version 4 - I Have Accepted My Illness,0
18977,FDA Manufacturer Evaluation Result Code Hierarchy,Endotoxin Contamination,0
18978,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Citatepine,0
18979,CDISC Variable Terminology,Exclude Cardiovascular System Findings Data From Statistics Indicator,0
18980,CDISC Variable Terminology,Exposure Fasting Status,0
18981,Pediatric Adverse Events Terminology,Dissection of aorta,0
18982,SPL Pharmaceutical Dosage Form Terminology,Orodispersible tablet,0
18983,Clinical Data Interchange Standards Consortium Terminology,CDISC SEND Implantation Findings Result Terminology,0
18984,CTRP Terminology,talaporfin sodium,0
18985,CDISC SEND Terminology,2:1 Atrioventricular Block by ECG Finding,0
18986,CDISC SDTM Terminology,EPIC-26 - Increased Frequency of Bowel Movements,0
18987,NCIt Antineoplastic Agent Terminology,Shared Anti-Idiotype-AB-S006,0
18988,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Microinternational Unit per Milliliter,0
18989,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire OAB-q Short Form Test Code Terminology,0
18990,NCIt Neoplasm Core Terminology,B Lymphoblastic Lymphoma,0
18991,NCIt Antineoplastic Agent Terminology,Deglycosylated Ricin A Chain-Conjugated Anti-CD19/Anti-CD22 Immunotoxins,0
18992,CDISC SDTM Terminology,Milliliter per Day per Milligram per Kilogram per Day,0
18993,Clinical Data Interchange Standards Consortium Terminology,Circulating Endothelial Cell Count,0
18994,CTRP Terminology,SB 743921,0
18995,CTRP Terminology,DNA analysis,0
18996,Clinical Data Interchange Standards Consortium Terminology,Asymptomatic,0
18997,NCIt Antineoplastic Agent Terminology,LY3009120,0
18998,Clinical Data Interchange Standards Consortium Terminology,"FAQ - Play Game of Skill, Work on Hobby",0
18999,Clinical Data Interchange Standards Consortium Terminology,Infratentorial brain structure,0
19000,CDISC Questionnaire PHQ-9 Test Code Terminology,PHQ-9 - Little Interest or Pleasure in Doing Things,0
19001,CDISC QRS Terminology,PHQ-9 - Little Interest or Pleasure in Doing Things,0
19002,CDISC SDTM Terminology,NCCN-FACT FKSI-19 Version 2 - I Have Pain,0
19003,CDISC QRS Terminology,"PHQ-9 - Trouble Falling or Staying Asleep, or Sleeping Too Much",0
19004,CDISC QRS Terminology,C-SSRS Children's Since Last Visit - Frequency of Most Severe Ideation,0
19005,Clinical Data Interchange Standards Consortium Terminology,NCCN-FACT-FPSI 17 Version 2 - I Have a Good Appetite,0
19006,FDA Established Names and Unique Ingredient Identifier Codes Terminology,AMINOPROPAZINE FUMARATE,0
19007,NCIt Antineoplastic Agent Terminology,Vincristine Sulfate,0
19008,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,milligram/day,0
19009,FDA Device Problem Code Hierarchy,High Sensing,0
19010,CDISC SDTM Microorganism Terminology,Staphylococcus chromogenes,0
19011,CTRP Agent Terminology,kang-lai-te,0
19012,Clinical Data Interchange Standards Consortium Terminology,IIEF - Able to Maintain Your Erection After You Had Penetrated Your Partner,0
19013,NCIt Antineoplastic Agent Terminology,Cyproterone Acetate,0
19014,Clinical Data Interchange Standards Consortium Terminology,Auricular Artery,0
19015,CDISC SEND Terminology,Distal (qualifier value),0
19016,CDISC SDTM Terminology,Virologic Partial Response,0
19017,Clinical Data Interchange Standards Consortium Terminology,Tip,0
19018,CDISC Questionnaire FAQ-NACC Version Test Code Terminology,FAQ-NACC Version - Shop Alone,0
19019,FDA Established Names and Unique Ingredient Identifier Codes Terminology,burning bush pollen extract,0
19020,CDISC SEND Trial Summary Parameter Short Name Terminology,Control Type (study treatment comparator),0
19021,European Quality of Life Five Dimension Five Level Scale Questionnaire,Not Anxious or Depressed,0
19022,Clinical Data Interchange Standards Consortium Terminology,Forced Vital Capacity in 6 Seconds,0
19023,US Counties Terminology,"Dorchester County, MD",0
19024,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tarextumab,0
19025,Clinical Data Interchange Standards Consortium Terminology,"RPQ - Forgetfulness, Poor Memory",0
19026,CTRP Terminology,Fosbretabulin Tromethamine,0
19027,CTRP Intervention Terminology,Pancreatectomy,0
19028,CDISC QRS Terminology,NPI - Aberrant Motor Behavior Severity,0
19029,Clinical Data Interchange Standards Consortium Terminology,NPI - Aberrant Motor Behavior Severity,0
19030,CDISC Questionnaire C-SSRS Baseline Test Code Terminology,"C-SSRS Baseline - Description of Ideation With Intent, No Plan",0
19031,CDISC SDTM Terminology,Container Dosing Unit,0
19032,CDISC Questionnaire Terminology,NCCN-FACT FKSI-19 Version 2 - I Have Been Short of Breath,0
19033,CDISC Questionnaire ESS Test Name Terminology,ESS - As a Passenger in a Car for an Hour Without a Break,0
19034,Clinical Data Interchange Standards Consortium Terminology,Lactobacillus brevis,0
19035,CTRP Agent Terminology,Carvedilol Phosphate Extended-Release Capsules,0
19036,CDISC SDTM Terminology,Ear structure,0
19037,CDISC SDTM Respiratory Test Name Terminology,Airway conductance,0
19038,CDISC QRS Terminology,CDISC Questionnaire VFQ25-Self Administered Format Test Name Terminology,0
19039,CDISC QRS Terminology,IIEF - How Many Times Have You Attempted Sexual Intercourse,0
19040,Pediatric Infectious Disease Terminology,"Myelitis, Acute Transverse",0
19041,CDISC SEND Terminology,Number of Early Resorptions,0
19042,CDISC SDTM Terminology,EQ-5D-3L - EQ VAS Score,0
19043,Clinical Data Interchange Standards Consortium Terminology,Temporal Arteries,0
19044,US Counties Terminology,"Monona County, IA",0
19045,CDISC SEND Terminology,Chloride measurement,0
19046,FDA Established Names and Unique Ingredient Identifier Codes Terminology,doxycycline hyclate,0
19047,CTRP Terminology,Stage IIB Pancreatic Cancer AJCC v6 and v7,0
19048,Clinical Data Interchange Standards Consortium Terminology,NCCN-FACT-FPSI 17 Version 2 - I Have Nausea,0
19049,Newborn Screening Terminology,Pregnancy Complications,0
19050,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Liter per Milligram per Meter Squared per Day,0
19051,CDISC SEND Terminology,International Unit per Milliliter per Microgram per Kilogram per Day,0
19052,Clinical Data Interchange Standards Consortium Terminology,Volume of Distribution Observed Normalized by Body Mass Index,0
19053,CDISC SEND Terminology,Blast to Leukocyte Ratio Measurement,0
19054,Clinical Data Interchange Standards Consortium Terminology,Creatinine measurement,0
19055,CDISC SDTM Terminology,Inch Unit of Length,0
19056,Perinatal Terminology,Congenital Phrenic Nerve Palsy,0
19057,CDISC Questionnaire IIEF Test Code Terminology,IIEF - How Often was it Satisfactory for You,0
19058,Clinical Data Interchange Standards Consortium Terminology,Entamoeba,0
19059,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hydroxyamphetamine Hydrobromide,0
19060,CDISC Variable Terminology,Medical History End Relative to Reference Period,0
19061,Pediatric Adverse Events Terminology,Myoglobinuria,0
19062,CDISC Clinical Classification HAMD 17 Test Name Terminology,HAMD-17 - Depressed Mood,0
19063,CDISC Clinical Classification Terminology,HAMD-17 - Depressed Mood,0
19064,Clinical Data Interchange Standards Consortium Terminology,Immunochemiluminometric assay,0
19065,NCIt Antineoplastic Agent Terminology,Cell Cycle Checkpoint/DNA Repair Antagonist IC83,0
19066,CTRP Terminology,Adult Fibrosarcoma,0
19067,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ciapilome,0
19068,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,Volume of Distribution Observed Normalized by Surface Area,0
19069,CDISC Questionnaire Terminology,ADCS-ADL MCI - Select First Clothes for the Day,0
19070,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ilomastat,0
19071,CDISC QRS Terminology,NPI - Sleep and Nighttime Behavior Disorders Severity,0
19072,GAIA Terminology,Ectopic Pregnancy,0
19073,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ethambutol,0
19074,CDISC SEND Biospecimens Terminology,Inguinal lymph node group,0
19075,CDISC SDTM Trial Summary Parameter Terminology by Code,ECG Planned Primary Lead for Study,0
19076,Clinical Data Interchange Standards Consortium Terminology,MPAI-4 - Abilities: Verbal Communication,0
19077,CDISC SDTM Terminology,HAMD-17 - Agitation,0
19078,CDISC SEND Terminology,Anogenital region,0
19079,FDA Established Names and Unique Ingredient Identifier Codes Terminology,magnesium acetate tetrahydrate,0
19080,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Aminolevulinic Acid,0
19081,Clinical Data Interchange Standards Consortium Terminology,Angiolipoma,0
19082,CDISC Functional Test Terminology,6MWT - Distance at 2 Minutes,0
19083,CDISC Questionnaire Terminology,"ADCS-ADL MCI - Perform Pastime, Hobby or Game: Bingo",0
19084,CDISC SDTM Laboratory Test Terminology by Code,"Indican measurement, urine",0
19085,CDISC SDTM Unit of Measure Terminology,Monthly (qualifier value),0
19086,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Lifetime),0
19087,CDISC Clinical Classification Terminology,CDISC Clinical Classification TIMI Thrombus Grade Test Name Terminology,0
19088,CDISC SDTM Terminology,CDISC Clinical Classification TIMI Thrombus Grade Test Name Terminology,0
19089,Pediatric Nephrology Terminology,Congenital Nephrotic Syndrome - Treponema Pallidum Associated,0
19090,CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Code Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Date,0
19091,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,International Unit per Milliliter per Gram,0
19092,FDA Established Names and Unique Ingredient Identifier Codes Terminology,poly(vinylpyrrolidone-co-vinyl-acetate),0
19093,CDISC SDTM Unit of Measure Terminology,grain unit of measure,0
19094,UCUM Terminology,ug/dL,0
19095,CDISC SDTM Terminology,BPI - Spouse's Occupation,0
19096,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Lavender extract,0
19097,CDISC SDTM Microorganism Terminology,Psychrobacter phenylpyruvicus,0
19098,CDISC SEND Terminology,Microgram Per Milliliter Per Milligram Per Kilogram Per Day,0
19099,CDISC Questionnaire Terminology,C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Lifetime),0
19100,Clinical Data Interchange Standards Consortium Terminology,Proximal Interphalangeal Joint 2 of the Foot,0
19101,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"1,2,3-trichloropropane",0
19102,CareLex eTMF Terminology,Central Trial Tracking Document,0
19103,SPL Limitation of Use Terminology,Adverse reactions,0
19104,CDISC ADaM Terminology,Year Month Day Imputed,0
19105,CTRP Terminology,Malignant Childhood Hemangiopericytoma,0
19106,CDISC QRS Terminology,AVLT-REY - List A Word 9,0
19107,CDISC SDTM Terminology,NPI - Change in Eating Behavior,0
19108,Clinical Data Interchange Standards Consortium Terminology,International Index of Erectile Function Questionnaire,0
19109,Clinical Data Interchange Standards Consortium Terminology,U/kg/min,0
19110,Clinical Data Interchange Standards Consortium Terminology,VLDL Cholesterol Subtype 3 Measurement,0
19111,FDA Device Component Code Hierarchy,Outer Cannula Device,0
19112,Clinical Data Interchange Standards Consortium Terminology,Medulloblastoma,0
19113,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dicloralurea,0
19114,CTRP Terminology,Calcium Carbonate,0
19115,CDISC SDTM Laboratory Test Terminology by Code,LDH Isoenzyme 3 to LDH Ratio Measurement,0
19116,Clinical Data Interchange Standards Consortium Terminology,Streptomyces,0
19117,Clinical Data Interchange Standards Consortium Terminology,Herpes Simplex Virus 2 IgG Antibody Measurement,0
19118,Clinical Data Interchange Standards Consortium Terminology,Three Vessel Coronary Disease,0
19119,CDISC Questionnaire Terminology,FACIT-F Version 4 - I Feel Close to My Friends,0
19120,CDISC SEND Terminology,Fluid-Filled,0
19121,CDISC SDTM ECG Finding Terminology,Ventricular Parasystole by ECG Finding,0
19122,Edmonton symptom assessment system,Worst Possible Anxiety,0
19123,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Turpentine,0
19124,CDISC QRS Terminology,C-SSRS Children's Baseline/Screening - Non-suicidal Self-injurious Behavior,0
19125,Pediatric Infectious Disease Terminology,Fungal keratitis,0
19126,CDISC SDTM Terminology,AVLT-REY - List A Word 11,0
19127,FDA Established Names and Unique Ingredient Identifier Codes Terminology,demexiptiline,0
19128,Clinical Data Interchange Standards Consortium Terminology,Gamma Glutamyl Transferase to Creatinine Ratio Measurement,0
19129,Clinical Data Interchange Standards Consortium Terminology,Microbial susceptibility tests,0
19130,Type of Reportable Event ICSR Terminology,Failure (biologic function),0
19131,CDISC SEND Terminology,Per Visual Field,0
19132,CTRP Intervention Terminology,Ablation,0
19133,CDISC SEND Terminology,Effervescent granules,0
19134,FDA Established Names and Unique Ingredient Identifier Codes Terminology,levodopa methyl ester,0
19135,Pediatric Adverse Events Terminology,Airway compromise,0
19136,CTRP Terminology,lonafarnib,0
19137,CDISC SDTM Terminology,New York Heart Association Class I,0
19138,Clinical Data Interchange Standards Consortium Terminology,Signal Width,0
19139,CDISC SDTM Laboratory Test Terminology by Name,Beta-1 Globulin to Total Protein Ratio Measurement,0
19140,Clinical Data Interchange Standards Consortium Terminology,Iontophoresis Route of Drug Administration,0
19141,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nictiazem,0
19142,MD Anderson Symptom Inventory - Core,Severity of Symptom Score 8,0
19143,European Quality of Life Five Dimension Five Level Scale Questionnaire,Some Problems Performing Usual Activities,0
19144,CDISC SDTM Terminology,FACT-P Version 4 - Problem Urinating Limits Activity,0
19145,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ACETIAMINE,0
19146,CDISC SEND Terminology,Picogram Per Milliliter Per Milligram Per Kilogram,0
19147,CDISC SDTM Holter ECG Results Terminology,New Inferior Myocardial Infarction by ECG Finding,0
19148,FDA Established Names and Unique Ingredient Identifier Codes Terminology,riboflavin 5'-phosphate sodium,0
19149,CDISC Questionnaire Terminology,"PHQ Screener Version - Last 4 Weeks, Trouble Falling or Staying Asleep",0
19150,Clinical Data Interchange Standards Consortium Terminology,"PHQ Screener Version - Last 4 Weeks, Trouble Falling or Staying Asleep",0
19151,CDISC SDTM Terminology,NCCN-FACT-FPSI 17 Version 2 - I Feel Fatigued,0
19152,CDISC SDTM Microorganism Terminology,Moraxella <genus>,0
19153,CDISC Questionnaire FAMS Test Code Terminology,FAMS - Feel Motivated to Do Things,0
19154,CTRP Terminology,Testicular Mixed Embryonal Carcinoma and Teratoma,0
19155,Pediatric Terminology,Secondary Adrenal Insufficiency,0
19156,Neurological Development Terminology,Generalized Anxiety Disorder,0
19157,CDISC SDTM Laboratory Test Terminology by Code,Beta-2 Globulin to Total Protein Ratio Measurement,0
19158,Clinical Data Interchange Standards Consortium Terminology,Ascites,0
19159,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Interferon gamma-1a,0
19160,Pediatric Adverse Events Terminology,Rhinorrhea,0
19161,CDISC SEND Terminology,New Lateral Myocardial Infarction by ECG Finding,0
19162,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fluorometholone,0
19163,CDISC SDTM Terminology,WPAI:SHP v2.0 - Currently Employed,0
19164,DICOM Terminology,Drug Finished Identifier,0
19165,CDISC SEND Terminology,Retroperitoneal Space,0
19166,CDISC SEND Cardiovascular Test Code Terminology,Diastolic blood pressure,0
19167,CDISC SDTM Terminology,ADNI AVLT - List A Recall 1 Word 7,0
19168,CDISC Questionnaire PHQ-9 Test Code Terminology,PHQ-9 - Moving or Speaking Slowly or the Opposite being Fidgety or Restless,0
19169,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Drazidox,0
19170,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pterocarpus marsupium Leaf,0
19171,Clinical Data Interchange Standards Consortium Terminology,Sublingual Lymph Node,0
19172,NCIt Antineoplastic Agent Terminology,N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide,0
19173,CDISC Questionnaire BPI Short Form Test Code Terminology,BPI Short Form - Pain at its Least in Last 24 Hours,0
19174,CDISC SDTM Terminology,Anti-Factor Xa Activity Measurement,0
19175,FDA Established Names and Unique Ingredient Identifier Codes Terminology,oxaflozane,0
19176,NCIt Antineoplastic Agent Terminology,Tranylcypromine sulfate,0
19177,NCIt Antineoplastic Agent Terminology,4-demethyl-4-cholesteryloxycarbonylpenclomedine,0
19178,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Aluminum Hydroxide Gel,0
19179,CDISC SDTM Relation to Reference Period Terminology,Concurrent,0
19180,CDISC Questionnaire GOSE Test Name Terminology,GOSE - GOSE Overall Score,0
19181,NCIt Antineoplastic Agent Terminology,Palladium-103,0
19182,PI-RADS Terminology,Right posterolateral basal peripheral zone of prostate,0
19183,Clinical Data Interchange Standards Consortium Terminology,Scaphoid-Capitate Joint,0
19184,NCIt Antineoplastic Agent Terminology,GD2-KLH Vaccine,0
19185,CDISC SDTM Unit of Measure Terminology,henry,0
19186,FDA Device Problem Code Hierarchy,Loss of Threshold,0
19187,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Thuja occidentalis,0
19188,Neonatal Research Network Terminology,Pseudovaginal Perineoscrotal Hypospadias,0
19189,FDA Established Names and Unique Ingredient Identifier Codes Terminology,dexlansoprazole,0
19190,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Specific Plan and Intent,0
19191,Patient Problem Codes FDA CDRH,Urgency of micturition,0
19192,Clinical Data Interchange Standards Consortium Terminology,Islet Cell Cytoplasmic IgG Antibody Measurement,0
19193,CDISC SDTM Terminology,CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Name Terminology,0
19194,Bayer Classification of Visual Acuity Changes,Bayer Visual Acuity Changes Grade 0,0
19195,Clinical Data Interchange Standards Consortium Terminology,Lymphangioma,0
19196,CTRP Agent Terminology,Plectin-1 Targeting Agent PTP-01,0
19197,Clinical Data Interchange Standards Consortium Terminology,NPI - Have Beliefs That You Know are Not True,0
19198,Clinical Data Interchange Standards Consortium Terminology,Fractional Excretion of Potassium,0
19199,CDISC SEND Terminology,Immunoglobulin G Subclass 1 Measurement,0
19200,CDISC SDTM Laboratory Test Terminology by Code,Immunoglobulin G Subclass 1 Measurement,0
19201,FACT-G Questionnaire,FACT-C Questionnaire,0
19202,CTRP Agent Terminology,Raloxifene,0
19203,FDA eManufacturing Terminology,Secondary Packaging,0
19204,CDISC SDTM Terminology,Accumulation Ratio Area Under the Curve from T1 to T2,0
19205,CTRP Terminology,CB-839,0
19206,CDISC QRS Terminology,PHQ-15 - Stomach Pain,0
19207,NCIt Antineoplastic Agent Terminology,Talotrexin Ammonium,0
19208,FDA Manufacturer Evaluation Result Code Hierarchy,Device Radiofrequency Interference Evaluation Result,0
19209,CDISC SDTM Microorganism Terminology,Bacteroides cellulosolvens,0
19210,CDISC SDTM Terminology,"ESS - Sitting, Inactive in a Public Place",0
19211,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past X Years),0
19212,CDISC QRS Terminology,PHQ Screener Version - Drank Alcohol at Work or School,0
19213,CDISC SDTM Laboratory Test Terminology by Code,Antibody to Scl-70 measurement,0
19214,Stability Product Form Terminology,Lyophilized powder for liposomal suspension for injection,0
19215,CDISC SEND Terminology,Total immunoglobulin measurement,0
19216,NCIt Antineoplastic Agent Terminology,Vector-peptide Conjugated Paclitaxel,0
19217,CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Code Terminology,"C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime)",0
19218,SPL Flavor Terminology,Mango Flavor,0
19219,CDISC SDTM Device Tracking and Disposition Event Dictionary Derived Term Terminology,Receive,0
19220,CDISC QRS Terminology,PHQ Screener Version - Missed Work Because of Drinking,0
19221,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Rocastine Hydrochloride,0
19222,CTRP Terminology,Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma,0
19223,CDISC CDASH Variable Terminology,Severity of Adverse Event,0
19224,CDISC SDTM Laboratory Test Terminology by Code,Urea nitrogen (procedure),0
19225,CTRP Terminology,Hyperpolarized Carbon C 13 Pyruvate,0
19226,Pediatric Terminology,Deficiency of mevalonate kinase,0
19227,CDISC SDTM Terminology,ADCS-ADL - Talk About Current Events,0
19228,CDISC SEND Terminology,Structure of vein of tail,0
19229,CDISC SEND Terminology,AUC Over Dosing Interval Normalized by Surface Area,0
19230,CDISC SDTM Microorganism Terminology,Pseudomonas chlororaphis,0
19231,Clinical Data Interchange Standards Consortium Terminology,Macroamylase measurement,0
19232,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL MCI - Subscore for Items 13 to 14,0
19233,Clinical Data Interchange Standards Consortium Terminology,Antimicrobial Dose Dependent Susceptibility Result,0
19234,NCIt Neoplasm Core Terminology,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,0
19235,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nabazenil,0
19236,CDISC SEND Laboratory Animal Species Terminology,Pan troglodytes,0
19237,Clinical Data Interchange Standards Consortium Terminology,CDISC SDTM Device-In-Use Test Name Terminology,0
19238,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Budesonide,0
19239,CDISC SDTM Trial Summary Parameter Terminology by Code,ECG Continuous Monitoring Indicator,0
19240,Pediatric Rheumatology Terminology,Low Complement,0
19241,NCIt Neoplasm Core Terminology,Multiple Myeloma,0
19242,US Counties Terminology,"Coles County, IL",0
19243,Stability Product Form Terminology,Oral coated capsule,0
19244,CDISC Variable Terminology,Electrocardiogram Time Point Reference,0
19245,US Counties Terminology,"Cherokee County, GA",0
19246,CDISC SEND Terminology,femtomole/liter,0
19247,CDISC SDTM Control Type Terminology,Dose Response Control,0
19248,CDISC SDTM Terminology,EudraVigilance Sender Identifier,0
19249,Memorial Symptom Assessment Scale,MSAS Global Distress Index,0
19250,CDISC Observation Class Terminology,Reference Date Time,0
19251,CDISC SEND Terminology,Oral coated pellets capsule,0
19252,CTRP Terminology,Multiple Sclerosis,0
19253,FDA Established Names and Unique Ingredient Identifier Codes Terminology,nifuroxazide,0
19254,Clinical Data Interchange Standards Consortium Terminology,m/s,0
19255,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire AIMS Test Code Terminology,0
19256,CDISC SEND Biospecimens Terminology,Gizzard,0
19257,FDA Established Names and Unique Ingredient Identifier Codes Terminology,varenicline tartrate,0
19258,Clinical Data Interchange Standards Consortium Terminology,Peak inspiratory flow rate,0
19259,CDISC QRS Terminology,"UPDRS - Complications of Therapy: Other Complications - Anorexia, Nausea, or Vomiting",0
19260,FDA Established Names and Unique Ingredient Identifier Codes Terminology,etoloxamine,0
19261,Clinical Data Interchange Standards Consortium Terminology,Protocol Keyword,0
19262,Pediatric Terminology,Preterm Neonatal Stage,0
19263,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Isobucaine,0
19264,CDISC SDTM Terminology,Helicobacter cinaedi,0
19265,CDISC SDTM Terminology,Tarsal Joints,0
19266,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Talmapimod,0
19267,CDISC SEND Nonclinical DART Trial Phases Terminology,Non-Clinical Pairing Trial Phase,0
19268,Clinical Data Interchange Standards Consortium Terminology,Candida intermedia,0
19269,CDISC SDTM Terminology,Progression or Relapse After Hematologic Improvement,0
19270,CDISC Clinical Classification Terminology,HAMA - Fears,0
19271,NCIt Antineoplastic Agent Terminology,Briciclib Sodium,0
19272,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - ADL Total Score,0
19273,FDA Individual Case Safety Report Terminology,foreign,0
19274,Pediatric Terminology,von Willebrand Disease,0
19275,CDISC SDTM Laboratory Test Standard Character Result Terminology,Negative Finding,0
19276,Clinical Data Interchange Standards Consortium Terminology,CDR - Sum of Boxes,0
19277,CDISC SDTM Species Terminology,Neisseria gonorrhoeae,0
19278,Neonatal Research Network Terminology,Thrombosis,0
19279,CDISC SEND Terminology,New Anterolateral Myocardial Infarction by ECG Finding,0
19280,CDISC SEND Terminology,Hour Times Gram Per Milliliter Per Gram,0
19281,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,AUMC Dosing to Last Concentration Normalized by Weight,0
19282,CDISC Variable Terminology,Adverse Event Start Date,0
19283,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Name Terminology,Expanded DRS-PI Caregiver Version - Give Correct Date and Time When Asked,0
19284,NCIt Neoplasm Core Terminology,Low Grade Endometrial Stromal Sarcoma,0
19285,CDISC SDTM Terminology,PANSS - Active Social Avoidance,0
19286,CTRP Terminology,Phosphaturic Mesenchymal Tumor,0
19287,CDISC SDTM PK Unit of Measure Kilogram Weight Terminology,Day Times Micromole Per Liter Per Kilogram,0
19288,National Health Interview Survey,Master's Degree Completion,0
19289,FDA Established Names and Unique Ingredient Identifier Codes Terminology,retapamulin,0
19290,CDISC Questionnaire RPQ Test Name Terminology,RPQ - Sleep Disturbance,0
19291,Clinical Data Interchange Standards Consortium Terminology,Percent Change From Nadir,0
19292,CDISC SEND Terminology,Layer of retina,0
19293,CDISC SEND Terminology,Visceral Examination,0
19294,Clinical Data Interchange Standards Consortium Terminology,SGRQ Past 3 Months Version - Washing or Dressing Yourself,0
19295,UCUM Terminology,Ten Thousand Cells per Kilogram,0
19296,FACT-G Questionnaire,day,0
19297,CTRP Agent Terminology,Nucleoside Analog DFP-10917,0
19298,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Espatropate,0
19299,CDISC SDTM Terminology,CDISC Functional Test 6MWT Test Code Terminology,0
19300,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fenaperone,0
19301,CDISC Variable Terminology,Microbiology Specimen Numeric Result in Standard Unit,0
19302,CDISC QRS Terminology,CDISC Questionnaire BARS Test Code Terminology,0
19303,US Counties Terminology,"Union County, NC",0
19304,CDISC QRS Terminology,CRQ-SAS First Administration Version - Feeling of Fear or Panic,0
19305,Pediatric Terminology,Excessive Bruising,0
19306,CDISC SDTM Laboratory Test Terminology by Name,Myelocyte count procedure,0
19307,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,ug/min,0
19308,NCIt Neoplasm Core Terminology,Giant fibroadenoma of breast,0
19309,US Counties Terminology,"Forsyth County, NC",0
19310,CDISC Questionnaire HAMA Test Name Terminology,HAMA - Depressed Mood,0
19311,Clinical Data Interchange Standards Consortium Terminology,Cheson Malignant Lymphoma 2007 Oncology Response Criteria,0
19312,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Benzaprinoxide,0
19313,Clinical Data Interchange Standards Consortium Terminology,WHO Clinical Staging of HIV/AIDS for Children - WHO Clinical Stage of HIV/AIDS,0
19314,Neonatal Research Network Terminology,Congenital hydroureter,0
19315,CDISC SEND Terminology,Experimental Organism Benign Epithelial Stromal Tumor,0
19316,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trigevolol,0
19317,CDISC SEND Terminology,Three Times Yearly,0
19318,NCIt Antineoplastic Agent Terminology,Brontictuzumab,0
19319,TAPS Tool - Interviewer Version,Use Heroin,0
19320,CDISC SDTM Microorganism Terminology,Actinomyces odontolyticus,0
19321,NCIt Neoplasm Core Terminology,Follicular T-cell lymphoma,0
19322,Clinical Data Interchange Standards Consortium Terminology,Day Times Millimole Per Liter Per Gram,0
19323,CDISC SDTM Laboratory Test Terminology by Code,Histone antibody Assay,0
19324,Clinical Data Interchange Standards Consortium Terminology,Trematoda,0
19325,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trimethadione,0
19326,CTRP Agent Terminology,Mouse Renal Adenocarcinoma Cell-Encapsulated Agarose-Agarose Macrobeads,0
19327,CDISC SDTM PK Unit of Measure Kilogram Weight Terminology,Hour Times Micromole Per Liter Per Kilogram,0
19328,NCIt Neoplasm Core Terminology,"Carcinoid, Goblet Cell",0
19329,FDA Established Names and Unique Ingredient Identifier Codes Terminology,perennial rye grass pollen extract,0
19330,CDISC SDTM Terminology,ADCS-ADL - Get Around Outside Home,0
19331,CDISC SDTM Terminology,Photography,0
19332,CTRP Terminology,Fentanyl Citrate,0
19333,CDISC SDTM Terminology,ADCS-ADL MCI - Description of Highest Level of Food Preparation,0
19334,NCIt Antineoplastic Agent Terminology,Vandortuzumab Vedotin,0
19335,National Health Interview Survey,Stratification,0
19336,Clinical Data Interchange Standards Consortium Terminology,Trichosporon mucoides,0
19337,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pimelautide,0
19338,NCIt Antineoplastic Agent Terminology,Long Peptide Vaccine 7,0
19339,US Counties Terminology,"Chippewa County, WI",0
19340,US Counties Terminology,"Linn County, MO",0
19341,CDISC Questionnaire Terminology,RAND-36 - Health Limit Walking More Than A Mile,0
19342,CDISC SDTM Terminology,Minute Times Milligram per Milliliter per Kilogram per Meter Squared,0
19343,Pediatric Adverse Events Terminology,Intraocular lens dislocation,0
19344,CDISC QRS Terminology,CDISC Questionnaire DLQI Test Name Terminology,0
19345,US Counties Terminology,"Jefferson County, OH",0
19346,CDISC SDTM Microorganism Terminology,Trichosporon,0
19347,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Salclobuzic Acid,0
19348,CDISC SDTM Terminology,Lower third of esophagus,0
19349,CDISC SDTM Cardiovascular Test Code Terminology,Cusp Thickening Severity,0
19350,CDISC Questionnaire Terminology,C-SSRS Screening - Wish to be Dead,0
19351,Clinical Data Interchange Standards Consortium Terminology,BWCS - Lost Control of Your Bowels,0
19352,Neonatal Research Network Terminology,Annular pancreas,0
19353,FACT-ES Questionnaire,Have Vaginal Discharge,0
19354,Clinical Data Interchange Standards Consortium Terminology,ADNI AVLT - List B Recall Word 9,0
19355,NCIt Neoplasm Core Terminology,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0
19356,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Aclatonium,0
19357,CDISC SDTM PK Unit of Measure Kilogram Weight Terminology,Hour Times Millimole Per Liter Per Kilogram,0
19358,CDISC Questionnaire Terminology,SDS - Symptoms Disrupted Social Life/Leisure Activities,0
19359,CDISC Questionnaire FACT-P Version 4 Test Code Terminology,FACT-P Version 4 - I Have Pain,0
19360,Regulated Product Submission Reporting Terminology,Patent and Exclusivity,0
19361,CDISC SDTM Cardiovascular Test Name Terminology,Chordae Tendineae Prolapse Indicator,0
19362,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Xenon-133,0
19363,CDISC SDTM Unit of Measure Terminology,diopters,0
19364,GAIA Terminology,GAIA Level 2 Assessment of Preterm Labor,0
19365,NCIt Antineoplastic Agent Terminology,"1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea",0
19366,CDISC Questionnaire C-SSRS Screening Test Code Terminology,C-SSRS Screening - Description of Wish to be Dead,0
19367,Clinical Data Interchange Standards Consortium Terminology,Plaque Forming Unit per Dose,0
19368,CTRP Terminology,Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7,0
19369,CDISC SDTM Terminology,Renal Clearance for Dose Interval Normalized by Weight,0
19370,Clinical Data Interchange Standards Consortium Terminology,Varicella Zoster Virus IgA Antibody Measurement,0
19371,NCPDP Strength Form Terminology,Lotion,0
19372,Clinical Data Interchange Standards Consortium Terminology,Standard Deviation of Thickness,0
19373,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Azaserine,0
19374,CTRP Agent Terminology,Tetanus Toxoid Helper Peptide,0
19375,Clinical Data Interchange Standards Consortium Terminology,Hour Times Nanogram Per Milliliter Per Milligram Per Gram Per Day,0
19376,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Norgestrienone,0
19377,CDISC SEND Terminology,Liter per Day per Milligram per Meter Squared,0
19378,CTRP Terminology,"Lymphoma, Large-Cell, Follicular",0
19379,NCIt Antineoplastic Agent Terminology,sialosyl-Tn antigen,0
19380,UCUM Terminology,centimeter,0
19381,Pediatric Terminology,Foodborne botulism,0
19382,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pamidronate Disodium Anhydrous,0
19383,Clinical Data Interchange Standards Consortium Terminology,Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator,0
19384,CDISC SDTM Terminology,CDISC SDTM Cardiovascular Findings About Results Terminology,0
19385,Clinical Data Interchange Standards Consortium Terminology,AUMC Infinity Observed Normalized by Dose,0
19386,FDA Established Names and Unique Ingredient Identifier Codes Terminology,epinastine hydrochloride,0
19387,US Counties Terminology,"Pottawattamie County, IA",0
19388,CDISC Questionnaire Terminology,EPIC-CP - Lack of Energy,0
19389,Clinical Data Interchange Standards Consortium Terminology,Facklamia,0
19390,"Adaptive Behavior Assessment System, Adult Rating Form",Functional Pre-Academics Skills,0
19391,CDISC Questionnaire Terminology,CDISC ADAS-Cog - Naming Objects and Fingers: 8,0
19392,Generalized Anxiety Disorder Scale,Has difficulty doing (qualifier value),0
19393,SPL Flavor Terminology,Curacao Flavor,0
19394,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sulfacytine,0
19395,"Knowledge, Understanding and Judgment Scale",Life Expectancy Less than Five Years,0
19396,CDISC SDTM ECG Finding Terminology,Suspicion of Limb Electrodes Reversal But Interpretation Assumes Reversal by ECG Finding,0
19397,CDISC QRS Terminology,BPI - Other Methods to Relieve Pain,0
19398,Clinical Data Interchange Standards Consortium Terminology,Hyaluronic Acid Test,0
19399,CDISC SEND Terminology,Caplet Dosing Unit,0
19400,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Liter per Day per Microgram per Day,0
19401,Clinical Data Interchange Standards Consortium Terminology,Malignant Granulosa Cell Tumor,0
19402,CTRP Agent Terminology,Algenpantucel-L,0
19403,Pediatric Terminology,"Discharge, body substance",0
19404,CDISC SEND Terminology,Chinese Syrian Hamster,0
19405,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pirfloxacin,0
19406,FDA Manufacturer Evaluation Result Code Hierarchy,Environment Problem Identified,0
19407,Clinical Data Interchange Standards Consortium Terminology,Findings About Events or Interventions Domain,0
19408,CDISC SDTM Terminology,Acute Myocardial Infarction From PCI Complication Type,0
19409,US Counties Terminology,"Comanche County, TX",0
19410,FACT-BMT Questionnaire,Feel Close to Friends,0
19411,Neonatal Research Network Terminology,Arterial thrombosis,0
19412,Clinical Data Interchange Standards Consortium Terminology,PHQ Screener Version - Pain During Intercourse,0
19413,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Intrusions 6,0
19414,Stability Product Form Terminology,Extended Release Intraruminal Device Dosage Form,0
19415,CDISC SEND Respiratory Test Code Terminology,Enhanced Pause,0
19416,NCIt Antineoplastic Agent Terminology,Anti-EGFRvIII Immunotoxin MR1-1,0
19417,NCIt Antineoplastic Agent Terminology,Chiauranib,0
19418,Vaccination Site on Body ICSR Terminology,Structure of right thigh,0
19419,CDISC SDTM Terminology,Thousand Colony Forming Units,0
19420,CDISC SDTM Microorganism Terminology,Bacteroides,0
19421,CDISC SDTM Terminology,Montreal cognitive assessment,0
19422,CTRP Agent Terminology,inotuzumab ozogamicin,0
19423,CDISC Questionnaire Terminology,CDISC Questionnaire PHQ-9 Test Name Terminology,0
19424,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Parodilol,0
19425,FDA Manufacturer Evaluation Result Code Hierarchy,Device Failure to Calibrate Evaluation Result,0
19426,CDISC SEND Terminology,Thyroid Gland Follicular Adenoma,0
19427,Clinical Data Interchange Standards Consortium Terminology,SGRQ Past 3 Months Version - How Long Did Worst Respiratory Attack Last,0
19428,FACT-H&N Questionnaire,Content with Quality of Life,0
19429,CTRP Terminology,veliparib,0
19430,Quality of Life Questionnaire - Pancreatic Cancer 26,Have Pain During the Night,0
19431,FDA Established Names and Unique Ingredient Identifier Codes Terminology,camazepam,0
19432,Clinical Data Interchange Standards Consortium Terminology,Meriones unguiculatus,0
19433,Clinical Data Interchange Standards Consortium Terminology,Yucatan Micropig,0
19434,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cintazone,0
19435,CDISC QRS Terminology,PR - Worst Pain Relief For Various Time Periods of Evaluation,0
19436,Regulated Product Submission Reporting Terminology,Other Toxicity Studies: Antigenicity,0
19437,NCIt Neoplasm Core Terminology,Acute Promyelocytic Leukemia,0
19438,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fencibutirol,0
19439,CDISC SDTM Terminology,Metatarsal bone structure,0
19440,CDISC SEND Terminology,Metatarsal bone structure,0
19441,Clinical Data Interchange Standards Consortium Terminology,Cross-Linking and Immunoprecipitation,0
19442,CDISC SDTM Terminology,Eosinophil Band Form Count,0
19443,CDISC SDTM Laboratory Test Terminology by Name,Turbidity Measurement,0
19444,NCIt Antineoplastic Agent Terminology,Transdermal 17beta-Estradiol Gel BHR-200,0
19445,FDA Established Names and Unique Ingredient Identifier Codes Terminology,levopropoxyphene napsylate,0
19446,CDISC SEND Terminology,mol/min,0
19447,NCIt Antineoplastic Agent Terminology,PD 184352,0
19448,NCIt Antineoplastic Agent Terminology,Melphalan,0
19449,NCIt Antineoplastic Agent Terminology,sotrastaurin,0
19450,CDISC SEND Terminology,Femtogram per Milliliter per Microgram per Day,0
19451,CDISC SDTM Directionality Terminology,Upper,0
19452,CDISC SDTM Terminology,Structure of lateral axillary lymph node,0
19453,CDISC SDTM Terminology,Clusterin measurement,0
19454,Pediatric Rheumatology Terminology,Antiphospholipid Syndrome,0
19455,CDISC SDTM Anatomical Location Terminology,Right main bronchus structure,0
19456,CDISC Questionnaire Terminology,MDS-UPDRS - Pain and Other Sensations,0
19457,US Counties Terminology,"Washington County, IA",0
19458,Patient Reported Outcomes Version of CTCAE,Worst Severity Past Seven Days Skin Cracking at the Corners of Mouth,0
19459,NCIt Antineoplastic Agent Terminology,alanosine,0
19460,CDISC SEND Terminology,Not Applicable,0
19461,Pediatric Terminology,Chemical pregnancy,0
19462,CDISC SDTM Microorganism Terminology,Prevotella disiens,0
19463,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Pastime: Reading,0
19464,Pediatric Terminology,Heart Rate Score,0
19465,CDISC Questionnaire Terminology,VFQ25-Self Administered Format - Feel Frustrated Because of Eyesight,0
19466,Clinical Data Interchange Standards Consortium Terminology,VFQ25-Self Administered Format - Feel Frustrated Because of Eyesight,0
19467,CDISC SDTM Laboratory Test Terminology by Code,cyclic GMP measurement (lab test),0
19468,FDA Manufacturer Evaluation Result Code Hierarchy,Device Improper Composition/Concentration,0
19469,CTRP Agent Terminology,Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes,0
19470,CDISC SDTM Terminology,SOAPP-R - How Often Borrowed Pain Medication,0
19471,Clinical Data Interchange Standards Consortium Terminology,Anti-Xa Activity International Unit,0
19472,Pediatric Adverse Events Terminology,Intentional Trauma,0
19473,CDISC QRS Terminology,NPI - Lost Interest in Friends and Family Members,0
19474,FDA Established Names and Unique Ingredient Identifier Codes Terminology,clobenzorex,0
19475,CDISC SDTM Terminology,Relative Fluorescence Unit,0
19476,CDISC SDTM Microorganism Terminology,Aggregatibacter aphrophilus,0
19477,CDISC SDTM Laboratory Test Terminology by Name,Anti-Neutrophil Cytoplasmic Antibody Measurement,0
19478,US Counties Terminology,"St. Joseph County, IN",0
19479,Clinical Data Interchange Standards Consortium Terminology,Morphine Measurement,0
19480,NCIt Antineoplastic Agent Terminology,erlotinib,0
19481,NCIt Antineoplastic Agent Terminology,IMMU-114,0
19482,CDISC SEND Terminology,Anti-Phospholipid IgG Antibody Measurement,0
19483,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sulbentine,0
19484,NCIt Neoplasm Core Terminology,Squamous cell carcinoma of skin,0
19485,CTRP Terminology,Small cell carcinoma of the cervix,0
19486,Clinical Data Interchange Standards Consortium Terminology,Insulin antibody measurement,0
19487,NCIt Antineoplastic Agent Terminology,glucarpidase,0
19488,Clinical Data Interchange Standards Consortium Terminology,Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight,0
19489,Borg Category-Ratio 10 Scale Questionnaire,Dyspnea Right Now,0
19490,SPL Substance Indexing Terminology,Axial S,0
19491,CDISC SDTM Laboratory Test Terminology by Code,Insulin C-peptide measurement,0
19492,CDISC SEND Fetal Pathology Findings Result Terminology,Meningoencephalocele,0
19493,Clinical Data Interchange Standards Consortium Terminology,Healthcare Encounter Type,0
19494,CDISC SDTM Route of Administration Terminology,Intrabiliary Route of Drug Administration,0
19495,CTRP Terminology,Fluorine F-18 HX4,0
19496,CDISC QRS Terminology,PANSS - Lack of Spontaneity,0
19497,CDISC SDTM Terminology,GOSE - Independence in the Home: Assistance Essential for Daily Living,0
19498,CDISC SDTM Respiratory Test Name Terminology,Peak Expiratory Flow Reversibility,0
19499,Clinical Data Interchange Standards Consortium Terminology,regional,0
19500,CDISC Questionnaire SOAPP-R Test Name Terminology,SOAPP-R - Score,0
19501,NCIt Antineoplastic Agent Terminology,regorafenib,0
19502,Pediatric Infectious Disease Terminology,Abscess,0
19503,CTRP Terminology,MEDI-547,0
19504,CDISC SDTM Terminology,CDISC ADAS-Cog - Orientation: Month,0
19505,CTRP Terminology,Image-Guided Adaptive Radiation Therapy,0
19506,CDISC QRS Terminology,MRS - Modified Rankin Scale Score,0
19507,CDISC Questionnaire Terminology,PHQ-15 - Feeling Your Heart Pound or Race,0
19508,CareLex eTMF Terminology,Local Laboratory Certification or Accreditation Document,0
19509,CDISC SEND Terminology,Inferior Myocardial Infarction by ECG Finding,0
19510,CDISC SDTM Terminology,Child-Pugh - Grade,0
19511,Clinical Data Interchange Standards Consortium Terminology,CDISC SDTM Location of Most Severe Stenosis Within a Graft Terminology,0
19512,CDISC Questionnaire UPDRS Test Code Terminology,UPDRS - Activities of Daily Living: Hygiene,0
19513,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Flounder (Dietary),0
19514,CDISC Questionnaire Terminology,Menstrual Distress Questionnaire Form-T (Today),0
19515,NCIt Antineoplastic Agent Terminology,Myeloma Ig Id-KLH Conjugate Vaccine,0
19516,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Furosemide,0
19517,Clinical Data Interchange Standards Consortium Terminology,PHQ-15 - Shortness of Breath,0
19518,CDISC SDTM Terminology,Structure of external iliac artery,0
19519,CDISC SDTM Terminology,Salmonella,0
19520,CDISC Questionnaire BPRS-A Test Code Terminology,BPRS-A - Somatic Concern,0
19521,Clinical Data Interchange Standards Consortium Terminology,Estonia,0
19522,NCIt Neoplasm Core Terminology,Skin carcinoma,0
19523,Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20,Have Difficulty Hearing,0
19524,Pediatric Terminology,Posterior Urethral Valves Type 1,0
19525,NCIt Antineoplastic Agent Terminology,Picoplatin,0
19526,Clinical Data Interchange Standards Consortium Terminology,Shigella,0
19527,US Counties Terminology,"Morgan County, CO",0
19528,CDISC SDTM Terminology,CDISC ADAS-Cog - Ideational Praxis: Insert,0
19529,Clinical Data Interchange Standards Consortium Terminology,Posterior lobe of prostate,0
19530,Clinical Data Interchange Standards Consortium Terminology,Bronchial-associated lymphoid tissue,0
19531,CDISC Questionnaire Terminology,AQ20 - Worry About Long Term Effects of Drugs for Chest Trouble,0
19532,CDISC SDTM Terminology,Lateral Myocardial Infarction by ECG Finding,0
19533,CDISC Questionnaire Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Past 3 Months),0
19534,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fumoxicillin,0
19535,Pediatric Nephrology Terminology,Diabetic Nephropathy,0
19536,CTRP Agent Terminology,Piperine Extract (Standardized),0
19537,CDISC SEND Terminology,Comparison to a Prior ECG,0
19538,CDISC SDTM Terminology,Listeria ivanovii,0
19539,CDISC Questionnaire PHQ-15 Test Code Terminology,"PHQ-15 - Constipation, Loose Bowels, or Diarrhea",0
19540,CDISC SEND Terminology,CDISC SEND Microscopic Histopathology Result Category Terminology,0
19541,CDISC SDTM Laboratory Test Terminology by Name,Mid-Molecule Parathyroid Hormone Measurement,0
19542,Clinical Data Interchange Standards Consortium Terminology,Pyrosequencing,0
19543,Clinical Data Interchange Standards Consortium Terminology,Microparticle Enzyme Immunoassay,0
19544,CTRP Terminology,Stage II Renal Cell Cancer,0
19545,CDISC SDTM Laboratory Test Terminology by Code,Complement C5a measurement,0
19546,Regulated Product Submission Reporting Terminology,Special Protocol Assessment Request: Carcinogenicity Study,0
19547,UCUM Terminology,Centi,0
19548,FDA eManufacturing Terminology,Production of Immunoassay Detection Reagent,0
19549,Occupation ICSR Terminology,Dietitian,0
19550,Pediatric Terminology,Influenza vaccination,0
19551,CTRP Agent Terminology,peginterferon alfa-2b,0
19552,CDISC QRS Terminology,PHQ-15 - Trouble Sleeping,0
19553,CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Name Terminology,C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage,0
19554,CTRP Terminology,Marginal zone lymphoma stage IV,0
19555,Perinatal Terminology,Pre-Eclampsia,0
19556,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Gloximonam,0
19557,Human Activity Profile Test,Carrying a Large Suitcase or Bowling 1 Game,0
19558,CDISC SEND Terminology,Strongyloides IgG Antibody Measurement,0
19559,CDISC SEND Terminology,Smudge Cell Count,0
19560,CDISC SEND Terminology,Intravenous Lethal Injection and Exsanguination Euthanasia,0
19561,CDISC SDTM Unit of Measure Terminology,decibel,0
19562,CDISC SDTM Terminology,"Mass, a measure of quantity of matter",0
19563,CDISC SDTM Biospecimen Characteristics Test Name Terminology,"Mass, a measure of quantity of matter",0
19564,CDISC SDTM Laboratory Test Terminology by Code,HLA-DR53 Antibody Measurement,0
19565,Clinical Data Interchange Standards Consortium Terminology,CDISC SDTM Submission Domain Abbreviation Terminology,0
19566,NCPDP Strength Form Terminology,Modified-release oral tablet,0
19567,CDISC SDTM Terminology,C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Since Study Start),0
19568,Pediatric Terminology,Gonococcal urethritis,0
19569,CTRP Agent Terminology,Anti-Met Monoclonal Antibody Mixture Sym015,0
19570,NCPDP Dose Unit of Measure Terminology,Each (qualifier value),0
19571,CDISC Questionnaire UPDRS Test Code Terminology,"UPDRS - Motor Examination: Action Tremor, Hand, Right",0
19572,US Counties Terminology,"Coweta County, GA",0
19573,FDA Established Names and Unique Ingredient Identifier Codes Terminology,mecasermin,0
19574,CTRP Agent Terminology,alanylglutamine,0
19575,CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Name Terminology,MSQOL-54 - Been a Nervous Person,0
19576,Clinical Data Interchange Standards Consortium Terminology,"C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Past 3 Months)",0
19577,CDISC SDTM Terminology,Umbilical Cord Blood,0
19578,CDISC Questionnaire Terminology,RDQ - Stay in Bed,0
19579,CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Name Terminology,C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Date,0
19580,CDISC SEND Terminology,HLA DR antigen typing,0
19581,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Prior to Study Entry),0
19582,Clinical Data Interchange Standards Consortium Terminology,Ventricular septum,0
19583,FDA Established Names and Unique Ingredient Identifier Codes Terminology,corticorelin ovine triflutate,0
19584,US Counties Terminology,"Otsego County, NY",0
19585,CDISC SEND Body Weight Test Code Terminology,Body Weight,0
19586,CDISC SDTM Terminology,ADNI AVLT - List A Recall 4 Word 6,0
19587,Patient Problem Codes FDA CDRH,First use syndrome,0
19588,US Counties Terminology,"Van Buren County, MI",0
19589,Pediatric Terminology,Chylothorax,0
19590,CDISC Questionnaire CCQ 24 Hour Version Test Name Terminology,CCQ 24 Hour Version - Breathing Problems Limit Daily Activity,0
19591,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Name Terminology,C-SSRS Children's Baseline/Screening - Description of Interrupted Suicide Attempt,0
19592,CDISC SEND Terminology,Macroscopic Findings Domain,0
19593,CDISC Questionnaire NPI Test Name Terminology,"NPI - Slam doors, Kick Furniture, Throw Things",0
19594,CDISC SEND Terminology,Scheuer Fibrosis Score,0
19595,CDISC SDTM Terminology,Microgram per Square Meter per Day,0
19596,Clinical Data Interchange Standards Consortium Terminology,Pharmacokinetics: Absorption,0
19597,Clinical Data Interchange Standards Consortium Terminology,Clinical Observation Domain,0
19598,US Counties Terminology,"Crisp County, GA",0
19599,CDISC SDTM Terminology,Bifidobacterium,0
19600,CTRP Terminology,Metastatic Adrenal Gland Pheochromocytoma,0
19601,FACT-G Questionnaire,Work is Fulfilling,0
19602,CDISC Questionnaire Category Terminology,Modified Rankin Scale Questionnaire,0
19603,US Counties Terminology,"Clark County, AR",0
19604,Pediatric Terminology,Pseudoaneurysm,0
19605,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acalypha indica,0
19606,Pittsburgh sleep quality index,Less than Once a Week,0
19607,CDISC SDTM Microorganism Terminology,Rothia dentocariosa,0
19608,CDISC SDTM Submission Domain Abbreviation Terminology,Death Diagnosis Domain,0
19609,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Name Terminology,Expanded DRS-PI Caregiver Version - Can Dress and Groom Self Independently,0
19610,NCPDP Strength Form Terminology,Injectable Lyophilized Powder Dosage Form,0
19611,Clinical Data Interchange Standards Consortium Terminology,Malignant odontogenic tumor,0
19612,CDISC SDTM Unit of Measure Terminology,mL/kg,0
19613,CDISC SDTM Terminology,MPAI-4 - Participation: Transportation,0
19614,CDISC Questionnaire MPAI-4 Test Name Terminology,MPAI-4 - Participation: Transportation,0
19615,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ipratropium Bromide,0
19616,Pediatric Terminology,Pseudohypoaldosteronism,0
19617,CDISC SEND Variable Terminology,Clinical Observations Body System or Organ Class,0
19618,CDISC SDTM Terminology,C-SSRS Screening - Description of Actual Suicide Attempt,0
19619,FDA Established Names and Unique Ingredient Identifier Codes Terminology,hydroxyphenamate,0
19620,Dexamethasone Symptom Questionnaire-Chronic,Have Diabetes,0
19621,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Polymyxin B Sulfate,0
19622,US Counties Terminology,"Washita County, OK",0
19623,CDISC SDTM Laboratory Test Terminology by Code,Amylase measurement,0
19624,FDA Individual Case Safety Report Terminology,No Information Available,0
19625,Memorial Symptom Assessment Scale - Short Form,Don't Look Like Myself,0
19626,CDISC SEND Terminology,Million per High Powered Field,0
19627,FDA eManufacturing Terminology,Cell Bank Maintenance,0
19628,Clinical Data Interchange Standards Consortium Terminology,ADCS-ADL - Pastime: Sewing,0
19629,NCIt Neoplasm Core Terminology,carcinoma of middle ear,0
19630,CTRP Agent Terminology,Icotinib Hydrochloride,0
19631,Clinical Data Interchange Standards Consortium Terminology,Specimen type - Transudate,0
19632,UCUM Terminology,Volume fraction,0
19633,Clinical Data Interchange Standards Consortium Terminology,Agenesis,0
19634,CDISC QRS Terminology,"C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime)",0
19635,FDA Established Names and Unique Ingredient Identifier Codes Terminology,deriglidole,0
19636,CDISC SDTM Terminology,BDI - Functional Impairment,0
19637,US Counties Terminology,"Wabaunsee County, KS",0
19638,Clinical Data Interchange Standards Consortium Terminology,VFQ25-Interviewer Administered Format - Time Spent Worry About Eyesight,0
19639,NCPDP Strength Unit of Measure Terminology,kBq,0
19640,Pediatric Rheumatology Terminology,Anti-dsDNA Antibody,0
19641,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cedar leaf oil,0
19642,CDISC SDTM Pharmaceutical Dosage Form Terminology,Metered Aerosol Dosage Form,0
19643,NCIt Antineoplastic Agent Terminology,teloxantrone,0
19644,CDISC SDTM Terminology,NCCN-FACT FKSI-19 Version 2 - I Have a Good Appetite,0
19645,CDISC Questionnaire UPDRS Test Name Terminology,"UPDRS - Motor Examination: Rigidity Lower Extremity, Left",0
19646,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Liter per Day per Milligram per Day,0
19647,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dimyristoylphosphatidylcholine,0
19648,CDISC SDTM Terminology,Median Ventricular Rate by Electrocardiogram,0
19649,CDISC SDTM Terminology,CHART-SF Interview Version - Hours Out of Bed per Day,0
19650,Pediatric Adverse Events Terminology,Nephroblastoma,0
19651,CDISC SDTM Anatomical Location Terminology,Structure of sciatic nerve,0
19652,CDISC Observation Class Terminology,Action Taken with Study Treatment,0
19653,CDISC SDTM Microorganism Terminology,Capnocytophaga canimorsus (organism),0
19654,CDISC SEND Terminology,Ethmoid bone structure,0
19655,FDA Established Names and Unique Ingredient Identifier Codes Terminology,zonisamide,0
19656,CDISC SDTM Genetic Sample Type Terminology,Heterogeneous Nuclear RNA,0
19657,CDISC SDTM Terminology,Greenland Eskimo - Alaska Native,0
19658,Pediatric Infectious Disease Terminology,Clonal Anergy,0
19659,CDISC SEND Terminology,hair root,0
19660,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Picogram per Milliliter per Kilogram per Meter Squared,0
19661,CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Name Terminology,NCCN-FACT FKSI-19 Version 2 - Worry My Condition Will Get Worse,0
19662,CDISC SDTM Laboratory Test Terminology by Name,Thyroid Antibody Measurement,0
19663,CDISC Questionnaire CHART-SF Interview Version Test Name Terminology,CHART-SF Interview Version - Nights Away From Home Last Year,0
19664,Clinical Data Interchange Standards Consortium Terminology,COMM - Trouble Controlling Anger,0
19665,CDISC SDTM Terminology,Structure of supraclavicular lymph node,0
19666,Clinical Data Interchange Standards Consortium Terminology,Hour Times Nanogram per Milliliter per Milligram per Kilogram,0
19667,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tucotuzumab celmoleukin,0
19668,Neonatal Research Network Terminology,Germ cell tumor,0
19669,Clinical Data Interchange Standards Consortium Terminology,Target Extra Nodal Tumor Identification,0
19670,CDISC SDTM Terminology,Enterococcus casseliflavus,0
19671,CDISC QRS Terminology,FAMS - Get Emotional Support From Family,0
19672,NCIt Neoplasm Core Terminology,Gallbladder adenocarcinoma,0
19673,CDISC Questionnaire Terminology,CHART-SF Interview Version - Number of Relatives You Live With,0
19674,Newborn Screening Terminology,Large for gestational age,0
19675,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Carlumab,0
19676,US Counties Terminology,"Fulton County, AR",0
19677,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Past 1 Month),0
19678,CDISC Questionnaire Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Past 1 Month),0
19679,Clinical Data Interchange Standards Consortium Terminology,Spermatocele,0
19680,CDISC SDTM Terminology,Self-Report,0
19681,CDISC SDTM Laboratory Test Terminology by Code,Androstenedione measurement,0
19682,CDISC SDTM Terminology,CDISC SDTM ECG Finding Terminology,0
19683,CDISC Questionnaire Terminology,MDS-UPDRS - Hallucinations and Psychosis,0
19684,CTRP Terminology,Iodine-125,0
19685,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Melizame,0
19686,Neonatal Research Network Terminology,Retinoblastoma,0
19687,CDISC Questionnaire TDI Test Name Terminology,TDI - Change in Magnitude of Effort,0
19688,CDISC SEND Terminology,Complement C4d measurement,0
19689,Clinical Data Interchange Standards Consortium Terminology,Paste,0
19690,US Counties Terminology,"Grant County, MN",0
19691,CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Name Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Past 6 Months),0
19692,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - Left on His or Her Own,0
19693,Stability Product Form Terminology,Powder for suspension for injection,0
19694,CDISC QRS Terminology,FACT-G Version 4 - I Have Nausea,0
19695,CTRP Terminology,Carney Complex,0
19696,CTRP Terminology,Adult Medulloblastoma,0
19697,CDISC SEND Terminology,NOD.CB17-Prkdc-scid/J Mouse,0
19698,Pediatric Adverse Events Terminology,Hypertrichosis,0
19699,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Lifetime),0
19700,Charlson Comorbidity Index Chart Review Version,Has a Cerebrovascular Accident or Transient Ischemic Disease,0
19701,Clinical Data Interchange Standards Consortium Terminology,Housing Humidity,0
19702,CDISC SDTM Terminology,Laser Capture Microdissection,0
19703,Clinical Data Interchange Standards Consortium Terminology,BPI Short Form - Pain on the Average,0
19704,CDISC Questionnaire C-SSRS Baseline/Screening Version Test Code Terminology,C-SSRS Baseline/Screening Version - Wish to be Dead (Past X Months),0
19705,Pediatric Terminology,Post inflammatory hydrocephalus,0
19706,CDISC Clinical Classification BODE Index Test Name Terminology,BODE Index - MMRC Dyspnea Scale,0
19707,NCIt Neoplasm Core Terminology,Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation,0
19708,FDA Established Names and Unique Ingredient Identifier Codes Terminology,miloxacin,0
19709,CDISC SDTM Terminology,Predicted Area Under the Curve Percent Extrapolation,0
19710,CDISC SDTM Terminology,Intersex,0
19711,CDISC SDTM Terminology,Clostridium tyrobutyricum,0
19712,CDISC SEND Tumor Findings Results Terminology,Carcinosarcoma,0
19713,CDISC SDTM Terminology,Major Axis Cross-sectional Diameter at End Ventricular Systole,0
19714,CDISC SDTM Anatomical Location Terminology,Ischiorectal fossa structure,0
19715,CTRP Terminology,Malignant lymphoma of testis,0
19716,Clinical Data Interchange Standards Consortium Terminology,Type I Collagen C-Telopeptide to Creatinine Ratio Measurement,0
19717,Was It Worth It Questionnaire,Worse than Expected,0
19718,Pediatric Rheumatology Terminology,Increased tendency to bruise,0
19719,Neonatal Research Network Terminology,Subgaleal hemorrhage,0
19720,NCIt Antineoplastic Agent Terminology,ofatumumab,0
19721,CDISC SDTM Cardiovascular Test Code Terminology,Minor Axis Cross-sectional Diameter at End Ventricular Diastole,0
19722,CDISC SDTM Anatomical Location Terminology,Occipital part of scalp,0
19723,CDISC Clinical Classification BODE Index Test Name Terminology,BODE Index - Score,0
19724,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mimbane,0
19725,CTRP Agent Terminology,Bromodeoxyuridine,0
19726,CDISC Clinical Classification HAMA Test Code Terminology,HAMA - Cardiovascular Symptoms,0
19727,CDISC Questionnaire Terminology,CDISC Questionnaire BPI Test Code Terminology,0
19728,CDISC SDTM Terminology,Salvage Therapy,0
19729,CDISC SDTM ECG Finding Terminology,Atrial Tachycardia With AV Block by ECG Finding,0
19730,CTRP Terminology,Eflornithine Hydrochloride Ointment,0
19731,European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30,Trouble Taking Short Walk Outside House,0
19732,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Day Times Microgram per Milliliter per Kilogram per Meter Squared,0
19733,Clinical Data Interchange Standards Consortium Terminology,EXACT - Short of Breath When Performing Usual Personal Care,0
19734,Occupation ICSR Terminology,Service Personnel,0
19735,CDISC SEND Terminology,Milligram per Gram per Minute,0
19736,CDISC SDTM ECG Test Name Terminology,Single Beat P Wave Duration,0
19737,US Counties Terminology,"Yell County, AR",0
19738,CareLex eTMF Terminology,Metadata Content Type,0
19739,FDA Established Names and Unique Ingredient Identifier Codes Terminology,gadofosveset,0
19740,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fludarabine,0
19741,Clinical Data Interchange Standards Consortium Terminology,Billion Colony Forming Units per Gram,0
19742,GAIA Terminology,GAIA Level 1 Gestational Diabetes Mellitus,0
19743,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chlorazanil Hydrochloride,0
19744,Pediatric Rheumatology Terminology,Late Disseminated Lyme Disease,0
19745,FDA eCTD Terminology,Applicant Contact Type,0
19746,FDA Device Component Code Hierarchy,Spectrometer Device,0
19747,CTRP Agent Terminology,Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine,0
19748,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Since Study Start),0
19749,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,AURC All Normalized by Weight,0
19750,CDISC Questionnaire Terminology,PHQ Screener Version - Anxiety Attacks Come Suddenly,0
19751,CVLT-C (California Verbal Learning Test Children's Version),List A Trial 5 Free Recall,0
19752,NCIt Neoplasm Core Terminology,Dermal Fibroma,0
19753,SPL REMS Requirement Terminology,Report Adverse Events,0
19754,Clinical Data Interchange Standards Consortium Terminology,Nocardia asteroides,0
19755,Pediatric Terminology,Post-Treatment Lyme Disease Syndrome,0
19756,CDISC SEND Terminology,per Square Millimeter,0
19757,US Counties Terminology,"Anderson County, KS",0
19758,US Counties Terminology,"Hardee County, FL",0
19759,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Prilocaine,0
19760,CDISC Functional Test Terminology,CDISC Functional Test SDMT Test Name Terminology,0
19761,Pediatric Terminology,Tertiary hyperparathyroidism,0
19762,Clinical Data Interchange Standards Consortium Terminology,Free hemoglobin (procedure),0
19763,CDISC SDTM Unit of Measure Terminology,mg/m2/hr,0
19764,Clinical Data Interchange Standards Consortium Terminology,BPRS-A - Conceptual Disorganization,0
19765,CDISC SDTM Terminology,Pulmonary Vein Dominance,0
19766,CDISC SDTM Terminology,NPI - Appetite/Eating Disorders FxS Score,0
19767,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dimoxaprost,0
19768,CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Name Terminology,MSQOL-54 - Discouraged by Health Problem,0
19769,CDISC SDTM Terminology,MSQOL-54 - Discouraged by Health Problem,0
19770,"Behavior Rating Inventory of Executive Function, Preschool Version",Plan/Organize Scale,0
19771,Clinical Data Interchange Standards Consortium Terminology,Trunk structure,0
19772,CTRP Terminology,Squamous cell carcinoma of the hypopharynx stage I,0
19773,CDISC SDTM Microorganism Terminology,Nocardia asteroides complex,0
19774,Human Activity Profile Test,Getting Clothes from Drawers or Closets,0
19775,Neonatal Research Network Terminology,Deficiency of steroid 21-monooxygenase,0
19776,CDISC SDTM Cardiovascular Findings About Results Terminology,Peripheral edema,0
19777,CDISC Questionnaire Terminology,GOSE - Independence Outside the Home: Able to Shop Without Assistance Before Injury,0
19778,CDISC SDTM Country Terminology,Sudan,0
19779,CDISC SDTM Terminology,ADCS-ADL MCI - Talk Within 24 Hours After Reading,0
19780,CDISC SDTM Laboratory Test Terminology by Name,Cholesteryl Ester Transfer Protein Measurement,0
19781,Memorial Symptom Assessment Scale - Short Form,How Much Distress Difficulty Concentrating,0
19782,CDISC Functional Test Category Terminology,Timed up and go mobility test,0
19783,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tiopronin,0
19784,CDISC QRS Terminology,MNSI - Right Foot Deformities,0
19785,CDISC Questionnaire Terminology,MSQOL-54 - Health a Worry in Life,0
19786,Clinical Data Interchange Standards Consortium Terminology,Hour Times Microgram per Milliliter per Kilogram per Meter Squared,0
19787,US Counties Terminology,"Benewah County, ID",0
19788,Clinical Data Interchange Standards Consortium Terminology,BPRS-A - Tension,0
19789,CDISC SDTM Terminology,Sloan Letter Eye Chart 1.25 Percent,0
19790,CDISC SDTM Terminology,Excretion Rate From T1 to T2 Normalized by BMI,0
19791,Clinical Data Interchange Standards Consortium Terminology,Calcium Phosphate Crystal Measurement,0
19792,Clinical Data Interchange Standards Consortium Terminology,"Musculoskeletal Findings, Connective and Soft Tissue Findings Domain",0
19793,CDISC SEND Terminology,Neuropeptide Y Measurement,0
19794,Clinical Data Interchange Standards Consortium Terminology,Cadaveric Arterial Graft,0
19795,CDISC SDTM Microorganism Terminology,Klebsiella pneumoniae ss. ozaenae,0
19796,CDISC SDTM Consensus Cardiac Classification Systems Test Code Terminology,Killip Class,0
19797,Pediatric Adverse Events Terminology,Choreoathetosis,0
19798,CDISC SDTM Terminology,Ochrobactrum intermedium,0
19799,Patient Reported Outcomes Version of CTCAE,Past Seven Days Increased Skin Sensitivity to Sunlight,0
19800,Pediatric Adverse Events Terminology,Anticonvulsant Hypersensitivity Syndrome,0
19801,Clinical Data Interchange Standards Consortium Terminology,Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index,0
19802,CDISC Questionnaire Terminology,MNSI - Able to Sense Feet When Walking,0
19803,CDISC SDTM Tumor or Lesion Properties Test Name Terminology,Sum of Diameters,0
19804,CDISC Questionnaire Terminology,BPRS-A - Mannerisms and Posturing,0
19805,NCIt Antineoplastic Agent Terminology,D1/3-Mage-3-His Fusion Protein,0
19806,CDISC Questionnaire OAB-q Test Code Terminology,OAB-q - Urine Loss Associated with a Strong Desire to Urinate,0
19807,CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Name Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Past 6 Months),0
19808,CDISC SDTM Terminology,Lead Placement McFee-Parungao,0
19809,US Counties Terminology,"Caribou County, ID",0
19810,Clinical Data Interchange Standards Consortium Terminology,SGRQ Past 4 Weeks Version - I Have Had Shortness of Breath,0
19811,US Counties Terminology,"Cass County, ND",0
19812,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 2 Word 1,0
19813,CDISC CDASH Concomitant Medication Dose Units Terminology,microgram,0
19814,CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Name Terminology,C-SSRS Lifetime/Recent Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt,0
19815,CTRP Terminology,Squamous cell carcinoma of nasopharynx,0
19816,CDISC SDTM Terminology,mg/mg,0
19817,Pediatric Terminology,Pleurisy,0
19818,CDISC SDTM Laboratory Test Terminology by Code,Thiamine Assay,0
19819,Pediatric Terminology,Juvenile arthritis,0
19820,CDISC SDTM Microorganism Terminology,Streptococcus porcinus,0
19821,CTRP Terminology,Lip and Oral Cavity Squamous Cell Carcinoma,0
19822,Clinical Data Interchange Standards Consortium Terminology,Symptom Indicator,0
19823,UCUM Terminology,picogram,0
19824,CDISC SDTM Laboratory Test Terminology by Name,Myeloid to Erythroid Ratio Measurement,0
19825,CDISC Questionnaire ADCS-ADL MCI Test Code Terminology,ADCS-ADL MCI - Talk About Content of Program After Watching Within a Day,0
19826,Clinical Data Interchange Standards Consortium Terminology,Old or Age Indeterminate Anterolateral Myocardial Infarction by ECG Finding,0
19827,Clinical Data Interchange Standards Consortium Terminology,Lipoprotein Associated Phospholipase A2 Measurement,0
19828,Clinical Data Interchange Standards Consortium Terminology,Cubic Millimeter,0
19829,Clinical Data Interchange Standards Consortium Terminology,AQ20 - Suffer From Breathlessness When Laugh,0
19830,Pediatric Terminology,Endocarditis,0
19831,Clinical Data Interchange Standards Consortium Terminology,Human leukocyte antigen (HLA) B antigen typing (procedure),0
19832,Clinical Data Interchange Standards Consortium Terminology,OAB-q - Feel Drowsy or Sleepy During the Day,0
19833,CDISC SDTM Microorganism Terminology,Streptococcus pyogenes,0
19834,Clinical Data Interchange Standards Consortium Terminology,Tumor Split,0
19835,"Geopolitical Entities, Names, and Codes Terminology",Uzbekistan,0
19836,CDISC SEND Terminology,Respiratory Diaphragm,0
19837,CDISC SDTM Terminology,RPQ - Any Other Difficulties 2 (Text),0
19838,Clinical Data Interchange Standards Consortium Terminology,World Health Organization Clinical Staging of HIV/AIDS for Children Clinical Classification,0
19839,FDA Established Names and Unique Ingredient Identifier Codes Terminology,99 Molybdenum,0
19840,Patient Problem Codes FDA CDRH,Change in Emotional State,0
19841,Extremity Functional Activity,Recreational Extremity Functional Restrictions,0
19842,SPL Pharmaceutical Dosage Form Terminology,Effervescent tablet,0
19843,Neonatal Research Network Terminology,Retinopathy of Prematurity,0
19844,Clinical Data Interchange Standards Consortium Terminology,Old or Age Indeterminate Extensive Anterior Myocardial Infarction by ECG Finding,0
19845,FACT-L Questionnaire,Bothered by Hair Loss,0
19846,Clinical Data Interchange Standards Consortium Terminology,Center for Disease Control and Prevention Classification System for HIV-Infected Adults and Adolescents Clinical Classification,0
19847,CDISC SDTM Laboratory Test Terminology by Name,Vitamin D3 measurement,0
19848,Pediatric Terminology,Syndrome,0
19849,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Imoxiterol,0
19850,CDISC Questionnaire Category Terminology,Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study 1/14/09 Questionnaire,0
19851,Clinical Data Interchange Standards Consortium Terminology,Moderately Abnormal Ejection Fraction,0
19852,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Orconazole,0
19853,Pediatric Adverse Events Terminology,Arthropathy,0
19854,SPL Shape Terminology,Octagon,0
19855,Clinical Data Interchange Standards Consortium Terminology,NSA-16 - Global Level of Functioning,0
19856,CDISC Variable Terminology,Morphology Location,0
19857,CTRP Agent Terminology,ontuxizumab,0
19858,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Neomycin,0
19859,FDA eManufacturing Terminology,Centrifugal Filtration,0
19860,CDISC SDTM Microorganism Terminology,Normal flora,0
19861,NCIt Antineoplastic Agent Terminology,molibresib,0
19862,CDISC Questionnaire Terminology,VFQ25-Interviewer Administered Format - Driving in Difficult Condition,0
19863,CDISC Questionnaire Terminology,CDISC Questionnaire Expanded DRS-PI Survivor Version Test Code Terminology,0
19864,US Counties Terminology,"Nance County, NE",0
19865,CDISC QRS Terminology,Disability Assessment for Dementia Questionnaire,0
19866,CDISC SDTM Category of Oncology Response Assessment Terminology,Size and Attenuation CT Criteria,0
19867,CDISC SDTM Terminology,"Aggregatibacter aphrophilus, Beta-lactamase Positive",0
19868,CDISC SDTM Terminology,VFQ25-Interviewer Administered Format - Worry About Embarrass Myself or Others Because of Eyesight,0
19869,CTRP Terminology,Omipalisib,0
19870,Clinical Data Interchange Standards Consortium Terminology,Red-Brown Material,0
19871,US Counties Terminology,"Clay County, SD",0
19872,CareLex eTMF Terminology,Data Management Filenote,0
19873,CDISC SDTM Anatomical Location Terminology,Uterine cavity,0
19874,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Arbaclofen Hydrochloride,0
19875,CDISC Questionnaire EXACT Test Code Terminology,EXACT - Have Chest Discomfort,0
19876,CDISC QRS Terminology,CDISC Questionnaire PHQ Screener Version Test Name Terminology,0
19877,US Counties Terminology,"Yuba County, CA",0
19878,NCIt Neoplasm Core Terminology,"Nevus, Intradermal",0
19879,Neonatal Research Network Terminology,Laryngeal web,0
19880,FDA Established Names and Unique Ingredient Identifier Codes Terminology,DENATONIUM,0
19881,Pediatric Terminology,Abnormal Virilization,0
19882,CDISC QRS Terminology,VFQ25-Interviewer Administered Format - Rate Your Overall Health,0
19883,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bisantrene dihydrochloride,0
19884,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acenocoumarol,0
19885,CTRP Intervention Terminology,Fluorescence Bronchoscopy,0
19886,CTRP Agent Terminology,Papaverine,0
19887,Clinical Data Interchange Standards Consortium Terminology,Renal pelvis,0
19888,CDISC QRS Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Past 3 Months),0
19889,Neonatal Research Network Terminology,Dehydration,0
19890,CDISC SEND Tumor Findings Results Terminology,Angiofibroma,0
19891,Clinical Data Interchange Standards Consortium Terminology,SOWS Subjective (Handelsman) - I Have Cold Flashes,0
19892,US Counties Terminology,"Huron County, MI",0
19893,CTRP Terminology,Remetinostat,0
19894,CDISC SDTM Anatomical Location Terminology,Pelvic lymph node group,0
19895,GAIA Terminology,GAIA Level 4 Major External Structural Defect,0
19896,CDISC Questionnaire Terminology,C-SSRS Children's Baseline/Screening - Description of Non-Specific Active Suicidal Thoughts,0
19897,US Counties Terminology,"Crawford County, AR",0
19898,CDISC QRS Terminology,GDS-SF - Think Wonderful to Be Alive,0
19899,CDISC SEND Terminology,Mean Atrial Rate by Electrocardiogram,0
19900,Clinical Data Interchange Standards Consortium Terminology,Employment status,0
19901,Pediatric Adverse Events Terminology,Developmental Coordination Disorder,0
19902,CDISC SEND Terminology,Prostaglandin E2 Measurement,0
19903,CDISC SEND Tumor Findings Results Terminology,Sarcoma,0
19904,NCIt Neoplasm Core Terminology,Malignant Fibrous Histiocytoma,0
19905,CDISC SDTM Terminology,Maximum PR Duration,0
19906,CDISC SDTM Terminology,Mole per Liter per Microgram per Day,0
19907,CDISC SDTM Laboratory Test Terminology by Name,Islet Cell 512 Antigen Measurement,0
19908,Clinical Data Interchange Standards Consortium Terminology,Sweat,0
19909,CDISC SEND Terminology,Sweat,0
19910,CDISC QRS Terminology,Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire,0
19911,CDISC SEND Biospecimens Terminology,Structure of deep peroneal nerve,0
19912,NCPDP Strength Form Terminology,Enema Tablet Dose Form,0
19913,CDISC Questionnaire EQ-5D-3L Test Code Terminology,EQ-5D-3L - Anxiety or Depression,0
19914,CDISC Variable Terminology,Morphology Analysis Method,0
19915,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,Percent Recovered Over Dosing Interval Normalized by Weight,0
19916,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Felbinac,0
19917,Clinical Data Interchange Standards Consortium Terminology,"Paramyxovirus, NOS",0
19918,Pediatric Terminology,Pertussis,0
19919,Clinical Data Interchange Standards Consortium Terminology,Interphalangeal Joint 1 of the Foot,0
19920,US Counties Terminology,"Yellow Medicine County, MN",0
19921,CDISC QRS Terminology,GCGI - Pain Treatment Preference,0
19922,Pediatric Terminology,New daily persistent headache,0
19923,Clinical Data Interchange Standards Consortium Terminology,Fasciolopsis buski,0
19924,CDISC Clinical Classification Terminology,CDISC Clinical Classification Category Terminology,0
19925,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Human Coagulation Factor VIII/Von Willebrand Factor Complex,0
19926,CDISC SEND Terminology,Factor VIII Activity Measurement,0
19927,CDISC SDTM Terminology,Thyroglobulin measurement,0
19928,US Counties Terminology,"Webster County, KY",0
19929,CDISC SDTM Terminology,Poikilocyte to Erythrocyte Ratio Measurement,0
19930,CTRP Terminology,Mycosis fungoides/Sezary syndrome stage IV,0
19931,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Biriperone,0
19932,Regulated Product Submission Reporting Terminology,Drug Substance: Structure,0
19933,CDISC SDTM Terminology,MNSI - Doctor Says Diabetic Neuropathy,0
19934,CDISC Questionnaire Terminology,NPI - Delusions Severity,0
19935,CDISC SDTM Terminology,Solobacterium moorei,0
19936,Bayer Classification of Visual Acuity Changes,Bayer Visual Acuity Changes Grade 4,0
19937,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mipitroban,0
19938,NCIt Antineoplastic Agent Terminology,Chlorodihydropyrimidine,0
19939,CTRP Agent Terminology,cobiprostone,0
19940,NCIt Neoplasm Core Terminology,Neoplastic Post-Transplant Lymphoproliferative Disorder,0
19941,Perinatal Terminology,Latent Phase of Labor,0
19942,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Euprocin Hydrochloride,0
19943,CDISC SDTM Terminology,Wheal Longest Diameter,0
19944,CDISC SDTM Laboratory Test Terminology by Name,Interleukin 1 Alpha Measurement,0
19945,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pentafluranol,0
19946,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Orphenadrine Citrate,0
19947,CTRP Agent Terminology,sofosbuvir,0
19948,CTRP Agent Terminology,PF-04217903,0
19949,CDISC SDTM Terminology,"Intravenous Diuretic, Inotropic or Vasodilator Augmentation for Heart Failure",0
19950,CDISC SDTM Terminology,Haptoglobin Analyses,0
19951,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Denufosol,0
19952,CDISC SEND Terminology,Interleukin 11 Measurement,0
19953,CDISC SDTM Terminology,Single Beat QTCF Interval,0
19954,Perceived Stress Scale - 14 Questionnaire,How Often Dealt Successfully with Day to Day Problems and Annoyances in the Last Month,0
19955,CDISC SEND Terminology,nanolitre,0
19956,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acyclovir,0
19957,CDISC SDTM Laboratory Test Terminology by Name,Leucine aminopeptidase measurement,0
19958,CDISC SDTM Microorganism Terminology,Genus Fusobacterium,0
19959,CDISC SEND Non-Neoplastic Finding Type Terminology,Experimental Organism Decidual Reaction,0
19960,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 5 Word 12,0
19961,Pediatric Terminology,Clotting of extracorporeal circuit,0
19962,CDISC Questionnaire MPAI-4 Test Name Terminology,MPAI-4 - Law Violations Post-Injury,0
19963,Clinical Data Interchange Standards Consortium Terminology,BPI - Exhausting,0
19964,Perinatal Terminology,Duration of Rupture of Membrane,0
19965,CDISC SEND Terminology,Minute Times Nanomole per Liter per Kilogram per Meter Squared,0
19966,CDISC QRS Terminology,MNSI - Legs Hurt When Walking,0
19967,CDISC SDTM PK Unit of Measure Kilogram Weight Terminology,Hour Times Picogram per Milliliter per Kilogram,0
19968,CDISC SDTM Unit of Measure Terminology,Becquerel per Gram,0
19969,CDISC CDASH Terminology,Pakistani race,0
19970,Clinical Data Interchange Standards Consortium Terminology,Clostridium,0
19971,NCIt Antineoplastic Agent Terminology,BMS-986012,0
19972,CDISC SDTM Terminology,Oxygen saturation measurement,0
19973,CDISC QRS Terminology,CDISC Questionnaire UPDRS Test Code Terminology,0
19974,CDISC SDTM Terminology,Sample hemolyzed,0
19975,Clinical Data Interchange Standards Consortium Terminology,VFQ25-Interviewer Administered Format - Are You Currently Driving,0
19976,CTRP Terminology,Golotimod,0
19977,Clinical Data Interchange Standards Consortium Terminology,Benign Neoplasm,0
19978,CDISC Variable Terminology,Respiratory System Findings Time Point Reference,0
19979,US Counties Terminology,"Abbeville County, SC",0
19980,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,IU/h,0
19981,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fabesetron,0
19982,Clinical Data Interchange Standards Consortium Terminology,Respiratory Tract Epithelial Alteration,0
19983,CTRP Terminology,Sebaceous Adenocarcinoma,0
19984,Clinical Data Interchange Standards Consortium Terminology,Myelin Basic Protein Measurement,0
19985,CDISC SDTM Sudden Death Syndrome Type Terminology,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)",0
19986,Pediatric Nephrology Terminology,Hematuria,0
19987,CDISC SDTM Terminology,Particle-Enhanced Turbidimetric Immunoassay,0
19988,US Counties Terminology,"Carter County, KY",0
19989,FACT-Cognitive Function,Have to Use Written Lists More Often than Usual to Not Forget Things,0
19990,Perinatal Terminology,Fetal Scalp Sampling,0
19991,CareLex eTMF Terminology,Master Randomization List,0
19992,Clinical Data Interchange Standards Consortium Terminology,Mumps Virus IgG Antibody Measurement,0
19993,Clinical Data Interchange Standards Consortium Terminology,Chrysosporium,0
19994,CDISC Questionnaire Terminology,BPI - Pain Interfered with Sleep,0
19995,CDISC Questionnaire MPAI-4 Test Code Terminology,MPAI-4 - Other Condition Causing Cognitive Impairment Post-Injury,0
19996,Perinatal Terminology,Basal Myofiber,0
19997,CDISC SDTM Laboratory Test Terminology by Code,Dihydrotestosterone Assay,0
19998,CDISC QRS Terminology,CDISC Questionnaire SOAPP-R Test Name Terminology,0
19999,CTRP Agent Terminology,tabalumab,0
20000,CDISC Questionnaire Terminology,BPI - Numb,0
20001,Pediatric Terminology,Basilar-Type Migraine,0
20002,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Minute Times Picomole per Liter per Kilogram per Meter Squared,0
20003,CDISC SEND Terminology,Rat Cholangiofibrosis,0
20004,CDISC SDTM Terminology,Pasteurella bettyae,0
20005,CDISC SDTM Microorganism Terminology,Pasteurella bettyae,0
20006,CDISC SDTM Terminology,VFQ25-Interviewer Administered Format - Have Less Control Because of Eyesight,0
20007,CDISC SDTM Terminology,heart rate,0
20008,CTRP Terminology,bortezomib,0
20009,CDISC SDTM Terminology,Right Ventricular Branch of Right Coronary Artery,0
20010,CDISC Questionnaire SOWS Subjective Test Code Terminology,SOWS Subjective (Handelsman) - I Feel Like Vomiting,0
20011,CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Code Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Description of Interrupted Suicide Attempt,0
20012,Clinical Data Interchange Standards Consortium Terminology,Normal,0
20013,NCIt Antineoplastic Agent Terminology,IDH1R132H-Specific Peptide Vaccine PEPIDH1M,0
20014,CDISC SDTM Terminology,NCCN-FACT FBLSI-18 Version 2 - I Have a Good Appetite,0
20015,CDISC SDTM Unit of Measure Terminology,Gram per Animal per Day,0
20016,CTRP Terminology,Creatine Monohydrate,0
20017,CDISC SDTM Laboratory Test Terminology by Code,Epstein-Barr Capsid IgM Antibody Measurement,0
20018,CDISC SDTM Contact Role for Clinical Study Terminology,Study Chair,0
20019,Clinical Data Interchange Standards Consortium Terminology,Bone structure of C5,0
20020,"Pediatric Quality of Life Inventory, Version 4",PedsQL-4 Child Report,0
20021,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Geum urbanum root extract,0
20022,CDISC Clinical Classification Terminology,CDISC Clinical Classification ESRS-A Test Code Terminology,0
20023,Pediatric Terminology,Erb-Duchenne Paralysis,0
20024,Clinical Data Interchange Standards Consortium Terminology,HAQ-DI With VAS - Able to Get On and Off Toilet,0
20025,CDISC SDTM Frequency Terminology,Hourly,0
20026,integrated Cancer Repository for Cancer Research,Food and Beverage Serving Workers,0
20027,CDISC SEND Terminology,Sacral lymph node group,0
20028,Healthy Volunteer Medical History Questionnaire,"Have Had a Tumor, Growth, Cyst, or Cancer",0
20029,Clinical Data Interchange Standards Consortium Terminology,Left Main Coronary Artery Body,0
20030,CDISC Questionnaire OAB-q Test Name Terminology,OAB-q - Frequent Urination During the Daytime,0
20031,FDA Established Names and Unique Ingredient Identifier Codes Terminology,proflavine dihydrochloride,0
20032,Stability Container Type Terminology,Dialpack (dose pack container),0
20033,CDISC SDTM Unit of Measure Terminology,Curie per Microliter,0
20034,FDA Established Names and Unique Ingredient Identifier Codes Terminology,silver birch pollen allergenic extract,0
20035,CDISC SDTM Microorganism Terminology,Chlamydia trachomatis,0
20036,CDISC SDTM Laboratory Test Terminology by Code,Hemoglobin C Crystals Measurement,0
20037,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Paclitaxel,0
20038,CTRP Terminology,Photochemotherapy,0
20039,CDISC SDTM Terminology,Bile acid measurement,0
20040,CDISC SDTM Terminology,NPI - Put Him/Herself Down or Say That He/She Feels Like a Failure,0
20041,CTRP Terminology,Recurrent Vulvar Carcinoma,0
20042,US Counties Terminology,"Pasquotank County, NC",0
20043,CDISC Questionnaire CHART-SF Paper Version Test Code Terminology,CHART-SF Paper Version - Hours of Homemaking per Week,0
20044,CDISC SEND Terminology,Film Dosage Form,0
20045,CDISC SEND Terminology,Planned Arm Code,0
20046,CDISC QRS Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Lifetime),0
20047,CDISC SDTM Relationship to Subject Terminology,Family member,0
20048,CDISC SEND Terminology,Picomole per Liter per Milligram per Kilogram per Day,0
20049,CDISC SDTM Laboratory Test Terminology by Name,ESTRONE MEASUREMENT,0
20050,CDISC SDTM Terminology,RDQ - Painful Almost All the Time,0
20051,Clinical Data Interchange Standards Consortium Terminology,Number of lymph nodes examined,0
20052,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Rimazolium Metilsulfate,0
20053,Pediatric Terminology,Scleritis,0
20054,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chloramphenicol sodium succinate,0
20055,Perinatal Terminology,Subchorionic hematoma,0
20056,CDISC SDTM Microorganism Terminology,Trueperella bernardiae,0
20057,CDISC SDTM Terminology,"CRQ-SAS First Administration Version - Feel Upset, Worried or Depressed",0
20058,CDISC SEND Terminology,T-Cell Large Granular Lymphocyte Leukemia,0
20059,CTRP Terminology,DNA ploidy analysis,0
20060,CDISC SDTM Terminology,Corynebacterium macginleyi,0
20061,CDISC SDTM Terminology,Bone structure of tibia,0
20062,CTRP Terminology,vismodegib,0
20063,Pediatric Terminology,Myositis Activities Profile,0
20064,Center For Epidemiologic Studies Depression Scale,Identifier,0
20065,CTRP Terminology,Stage IV Pleural Malignant Mesothelioma AJCC v7,0
20066,FDA Established Names and Unique Ingredient Identifier Codes Terminology,lodgepole pine pollen extract,0
20067,US Counties Terminology,"Lajas Municipio, PR",0
20068,Parameterized Data Type - Set,Household Environment,0
20069,CDISC QRS Terminology,HAMD-21 - Hypochondriasis,0
20070,CDISC Functional Test ADNI AVLT Test Code Terminology,ADNI AVLT - List A Recall 4 Word 15,0
20071,CDISC Variable Terminology,Disease Response Completion Status,0
20072,FACT-P Questionnaire,Have and Maintain an Erection,0
20073,Clinical Data Interchange Standards Consortium Terminology,Glucagon measurement,0
20074,Clinical Data Interchange Standards Consortium Terminology,Fusion Complex,0
20075,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Valproate Pivoxil,0
20076,CTRP Disease Terminology,Odontoameloblastoma,0
20077,Pediatric Adverse Events Terminology,First degree burn injury,0
20078,CDISC SDTM Terminology,Amyloid Beta 1-40 Measurement,0
20079,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Azadirachta indica flower extract,0
20080,Regulated Product Submission Reporting Terminology,Toxicology Written Summary,0
20081,CDISC SEND Non-Neoplastic Finding Type Terminology,Cholesterol cleft,0
20082,Pediatric Terminology,Metabolic myopathy,0
20083,FACT-BMT Questionnaire,"Concerned About Keeping My Job, Including Work at Home",0
20084,CDISC SDTM Relationship to Subject Terminology,Twin sibling (person),0
20085,Pediatric Terminology,Hantavirus Pulmonary Syndrome,0
20086,CDISC SDTM Dictionary Name Terminology,COSTART,0
20087,CDISC SDTM Method Terminology,High-performance Liquid Chromatography-UV,0
20088,CDISC SDTM Method Terminology,Reverse Transcriptase Polymerase Chain Reaction,0
20089,CDISC SDTM Microorganism Terminology,Trichosporon beigelii,0
20090,Pediatric Terminology,Chorioangioma,0
20091,CTRP Agent Terminology,glasdegib,0
20092,NCIt Antineoplastic Agent Terminology,alitretinoin,0
20093,FDA Established Names and Unique Ingredient Identifier Codes Terminology,alitretinoin,0
20094,GAIA Pathways to Preterm Birth Level of Diagnostic Certainty Terminology,GAIA Level 1 Assessment of Provider Initiated Preterm Delivery,0
20095,CTRP Intervention Terminology,Expiratory Muscle Strength Training,0
20096,CDISC Questionnaire Terminology,OAB-q - Waking Up at Night Because You had to Urinate,0
20097,CDISC Questionnaire SGRQ Past 3 Months Version Test Code Terminology,SGRQ Past 3 Months Version - Coughing Makes Me Tired,0
20098,Pediatric Terminology,Stuttering,0
20099,CDISC SEND Biospecimens Terminology,Structure of extraperitoneal space,0
20100,CTRP Terminology,Methylphenidate Hydrochloride,0
20101,SPL Flavor Terminology,Anise Flavor,0
20102,Neonatal Research Network Terminology,Hartnup Disease,0
20103,US Counties Terminology,"Kossuth County, IA",0
20104,CDISC SDTM Biospecimen Characteristics Test Name Terminology,Thick,0
20105,CDISC SEND Non-Neoplastic Finding Type Terminology,Vesicle (morphologic abnormality),0
20106,CDISC SDTM Country Terminology,Northern Mariana Islands,0
20107,Pediatric Terminology,Attending Health Care Provider,0
20108,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Azacosterol,0
20109,CDISC SDTM Microorganism Terminology,Trichophyton rubrum,0
20110,Clinical Data Interchange Standards Consortium Terminology,Study Protocol Uniform Resource Locator,0
20111,NCIt Antineoplastic Agent Terminology,GP2 Peptide/GM-CSF Vaccine,0
20112,CDISC SDTM Laboratory Test Terminology by Name,Sodium Clearance Measurement,0
20113,CDISC SDTM Terminology,OAB-q - Uncontrollable Urge to Urinate,0
20114,CDISC Questionnaire ASEX-Male Version Test Code Terminology,ASEX-Male Version - Keep Erection,0
20115,CDISC Variable Terminology,Disease Response Assessment Test Code,0
20116,FDA Established Names and Unique Ingredient Identifier Codes Terminology,2-(4-cyclohexyl-1-naphthalenyl)propanoic acid,0
20117,CDISC SDTM Reproductive System Findings Test Name Terminology,Age at menarche,0
20118,CDISC SDTM Terminology,C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Since Study Start),0
20119,CDISC SDTM Terminology,Trigeminal nerve structure,0
20120,Clinical Data Interchange Standards Consortium Terminology,Study Protocol Uniform Resource Locator Description,0
20121,CDISC SDTM Frequency Terminology,Biweekly,0
20122,CDISC Questionnaire MDS-UPDRS Test Code Terminology,MDS-UPDRS - Consistency of Rest Tremor,0
20123,FACT-Cognitive Function,Have Trouble Remembering Where I Put Things,0
20124,ICH Unit of Measure Terminology,QS -Quantity Sufficient (potency unit),0
20125,Clinical Data Interchange Standards Consortium Terminology,Freezing,0
20126,Clinical Data Interchange Standards Consortium Terminology,FACT-P Version 4 - Get Emotional Support From Family,0
20127,Quality of Life Questionnaire-Brain Neoplasm 20,Have Blurry Eyesight,0
20128,CDISC SDTM Method Terminology,Enzymatic Ultracentrifugation,0
20129,FDA Established Names and Unique Ingredient Identifier Codes Terminology,carmoxirole,0
20130,NCIt Antineoplastic Agent Terminology,vapreotide,0
20131,CDISC Questionnaire Terminology,DAD - Attempt to Telephone Someone at a Suitable Time,0
20132,CDISC QRS Terminology,DAD - Attempt to Telephone Someone at a Suitable Time,0
20133,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"Secretin human, synthetic",0
20134,Clinical Data Interchange Standards Consortium Terminology,Concentrate (activity),0
20135,Extremity Supports,No Support Needed,0
20136,CTRP Terminology,Osteolytic Lesions of Multiple Myeloma,0
20137,NCIt Antineoplastic Agent Terminology,pan-PI3K Inhibitor CLR457,0
20138,FDA Established Names and Unique Ingredient Identifier Codes Terminology,furnidipine,0
20139,CDISC SDTM Terminology,Extended Release Liquid Dosage Form,0
20140,Pediatric Rheumatology Terminology,Systemic sclerosis sine scleroderma,0
20141,CDISC SEND Biospecimens Terminology,Tail,0
20142,CDISC Questionnaire FACT-P Version 4 Test Name Terminology,FACT-P Version 4 - My Family Has Accepted My Illness,0
20143,NCPDP Strength Form Terminology,Intraperitoneal Solution,0
20144,SPL Shape Terminology,Tear Shape,0
20145,Clinical Data Interchange Standards Consortium Terminology,Rheumatoid Factor Antibody IgM Measurement,0
20146,CDISC SEND Terminology,FibroTest Score Measurement,0
20147,CDISC SDTM Terminology,Anti B2 glycoprotein 1 IgM antibody measurement,0
20148,NCIt Antineoplastic Agent Terminology,JI 101,0
20149,FDA Established Names and Unique Ingredient Identifier Codes Terminology,vicriviroc,0
20150,US Counties Terminology,"Modoc County, CA",0
20151,CDISC Variable Terminology,Trial Sets Value,0
20152,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Clevudine,0
20153,Clinical Data Interchange Standards Consortium Terminology,Respiratory Exchange Ratio,0
20154,Clinical Data Interchange Standards Consortium Terminology,Alpha 2 globulin measurement,0
20155,CDISC Questionnaire FACT-P Version 4 Test Code Terminology,FACT-P Version 4 - Satisfied With Family Communication,0
20156,CDISC SDTM ECG Finding Terminology,Acute Posterior Myocardial Infarction by ECG Finding,0
20157,Clinical Data Interchange Standards Consortium Terminology,CD20 Expressing Cell Measurement,0
20158,ICH Unit of Measure Terminology,Thousand Organisms per Gram,0
20159,Clinical Data Interchange Standards Consortium Terminology,Milliliter per Minute per Milligram per Kilogram per Day,0
20160,Clinical Data Interchange Standards Consortium Terminology,Gram Per Milliliter Per Milligram Per Kilogram Per Day,0
20161,CDISC SDTM Laboratory Test Terminology by Code,Glucose Clearance Measurement,0
20162,CTRP Terminology,Lymphocele,0
20163,US Counties Terminology,"Ventura County, CA",0
20164,US Counties Terminology,"Nantucket County, MA",0
20165,FDA Device Component Code Hierarchy,Cusp Device,0
20166,CDISC SDTM Terminology,Intrauterine Device Dosage Form,0
20167,US Counties Terminology,"Muskegon County, MI",0
20168,US Counties Terminology,"Antrim County, MI",0
20169,Clinical Data Interchange Standards Consortium Terminology,Jersey Island,0
20170,CDISC Questionnaire Terminology,C-SSRS Children's Baseline/Screening - Description of Wish to be Dead,0
20171,CDISC SEND Terminology,Skin tag,0
20172,CDISC SEND Terminology,Cholecystokinin Measurement,0
20173,CDISC SDTM Laboratory Test Terminology by Code,Glutamic Acid Decarboxylase Antibody Measurement,0
20174,Pediatric Terminology,Triploidy syndrome,0
20175,CTRP Terminology,Linaclotide Acetate,0
20176,NCIt Antineoplastic Agent Terminology,IMT-1012 Immunotherapeutic Vaccine,0
20177,Brief Pain Inventory Short Form Questionnaire,Pain Interference Score 4,0
20178,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 2 Total,0
20179,CDISC Questionnaire SIQR Test Code Terminology,SIQR - Change Bed Sheets,0
20180,Patient Problem Codes FDA CDRH,Iritis,0
20181,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mepivacaine Hydrochloride,0
20182,CTRP Agent Terminology,Smoothened Antagonist LEQ506,0
20183,FDA Established Names and Unique Ingredient Identifier Codes Terminology,isophosphamide mustard,0
20184,Clinical Data Interchange Standards Consortium Terminology,Test Subject Supplier Site,0
20185,Pediatric Terminology,Minimal baseline fetal heart rate variability,0
20186,Clinical Data Interchange Standards Consortium Terminology,per year,0
20187,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Eplivanserin Hemifumarate,0
20188,Clinical Data Interchange Standards Consortium Terminology,Microsecond,0
20189,CDISC SDTM Country Terminology,Togo,0
20190,CDISC QRS Terminology,NCCN-FACT FOSI-18 Version 2 - I Am Sleeping Well,0
20191,CDISC Questionnaire SIQR Test Code Terminology,SIQR - Sit in a Chair for 45 Minutes,0
20192,Clinical Data Interchange Standards Consortium Terminology,Package Dosing Unit,0
20193,CDISC SDTM Terminology,SGRQ Past 4 Weeks Version - My Cough is Embarrassing in Public,0
20194,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 3 Word 9,0
20195,CDISC Questionnaire SOAPP-R Test Name Terminology,SOAPP-R - Need Higher Doses of Medication,0
20196,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dichlorvos,0
20197,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Epinephrine,0
20198,CDISC SDTM Species Terminology,Micrococcus luteus,0
20199,CDISC Questionnaire Terminology,SGRQ Past 4 Weeks Version - Embarrassed Using Medication in Public,0
20200,CTRP Agent Terminology,Pomegranate-Extract Pill,0
20201,Neonatal Research Network Terminology,Vitamin Deficiency,0
20202,CDISC Questionnaire Terminology,ADCS-ADL - Pastime: Workshop,0
20203,CDISC SDTM Unit of Measure Terminology,Millimeter Mercury Per Liter Per Minute,0
20204,CDISC CDASH Unit of Drug Dispensed or Returned Terminology,Packet - Unit dose,0
20205,CTRP Agent Terminology,Calcium Aluminosilicate Anti-Diarrheal,0
20206,CDISC SEND Terminology,Percent Recovered Infinity Predicted Normalized by Surface Area,0
20207,Clinical Data Interchange Standards Consortium Terminology,Liter per Microgram,0
20208,NCIt Antineoplastic Agent Terminology,Pemlimogene Merolisbac,0
20209,Newborn Screening Terminology,Yawning,0
20210,Clinical Data Interchange Standards Consortium Terminology,Lactobacillus acidophilus,0
20211,CDISC SDTM Microorganism Terminology,Enterococcus faecium,0
20212,"Behavior Rating Inventory of Executive Function, Preschool Version",Global Executive Composite,0
20213,CDISC SDTM Terminology,RAND-36 - My Health is Excellent,0
20214,Clinical Data Interchange Standards Consortium Terminology,Minute Times Millimole per Liter per Meter Squared,0
20215,Clinical Data Interchange Standards Consortium Terminology,ASEX-Male Version - Sex Drive,0
20216,CDISC SEND Terminology,Percent Recovered Infinity Predicted Normalized by Weight,0
20217,CDISC SDTM Terminology,VFQ25-Interviewer Administered Format - Often Irritable Because of Eyesight,0
20218,Patient Reported Outcomes Version of CTCAE,Past Seven Days Rash,0
20219,CDISC Questionnaire HAQ-DI With VAS Test Name Terminology,HAQ-DI With VAS - Able to Lift Cup or Glass to Mouth,0
20220,CareLex eTMF Terminology,Institutional Review Board Independent Ethics Committee Informed Consent Document,0
20221,CDISC SDTM Terminology,Once (schedule frequency),0
20222,CDISC SDTM Terminology,MPAI-4 - Drug Use Post-Injury,0
20223,Pediatric Terminology,Primary Adrenal Insufficiency,0
20224,FDA Established Names and Unique Ingredient Identifier Codes Terminology,norgestomet,0
20225,CTRP Agent Terminology,durvalumab,0
20226,CDISC CDASH Terminology,Hispanics,0
20227,CDISC SDTM Microorganism Terminology,Prototheca zopfii,0
20228,CDISC SDTM Terminology,Corynebacterium kutscheri,0
20229,Pediatric Rheumatology Terminology,Connective Tissue,0
20230,CDISC QRS Terminology,FACIT-F Version 4 - I Am Sleeping Well,0
20231,Newborn Screening Terminology,"Vacuum Extraction, Obstetrical",0
20232,CTRP Terminology,Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine,0
20233,CDISC SDTM Submission Domain Abbreviation Terminology,Demographics Domain,0
20234,US Counties Terminology,"Kaufman County, TX",0
20235,CDISC SDTM Terminology,DAD - Dress in the Appropriate Order,0
20236,GAIA Preeclampsia Level of Diagnostic Certainty Terminology,GAIA Level 1 Preeclampsia with Severe Features,0
20237,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire AQ20 Test Name Terminology,0
20238,CDISC SEND Terminology,Injectable Solution,0
20239,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Triaziquone,0
20240,CDISC Questionnaire Terminology,DAD - Show an Interest in Leisure Activities,0
20241,FDA Established Names and Unique Ingredient Identifier Codes Terminology,entecavir,0
20242,CDISC CDASH Terminology,Russians,0
20243,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Nanogram per Milliliter per Milligram per Day,0
20244,CDISC SEND Terminology,Segmented neutrophil count,0
20245,Clinical Data Interchange Standards Consortium Terminology,Segmented neutrophil count,0
20246,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Coagulation Factor VIIa Human,0
20247,FDA Established Names and Unique Ingredient Identifier Codes Terminology,yttrium-90-ibritumomab tiuxetan,0
20248,CTRP Terminology,MRSA - Methicillin resistant Staphylococcus aureus infection,0
20249,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Phenylpropanolamine,0
20250,Neonatal Research Network Terminology,Tracheal web,0
20251,CDISC Questionnaire CHART-SF Paper Version Test Code Terminology,CHART-SF Paper Version - Paid Personal Care per Day,0
20252,CDISC SDTM Ophthalmic Exam Test Name Terminology,Color,0
20253,CDISC Questionnaire Terminology,C-SSRS Screening - Suicidal Behavior,0
20254,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trifluoperazine hydrochloride,0
20255,CDISC SEND Terminology,Structure of basilic vein,0
20256,CDISC QRS Terminology,ADCS-ADL Severe Dementia - Dispose of Garbage in Appropriate Place at Home,0
20257,CDISC Questionnaire FACIT-F Version 4 Test Name Terminology,FACIT-F Version 4 - Content With Quality of My Life,0
20258,CDISC SEND Terminology,R Wave Amplitude Aggregate,0
20259,CDISC QRS Terminology,COMM - Take More Medication Than Prescribed,0
20260,CDISC SEND Terminology,Parvovirus B19 IgM Antibody Measurement,0
20261,CDISC SDTM Anatomical Location Terminology,Rib 11,0
20262,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fenprinast,0
20263,GAIA Terminology,GAIA Insufficient Evidence for Diagnosis of Preeclampsia with Severe Features,0
20264,CDISC SDTM Terminology,HADS - I Still Enjoy the Things I Used to Enjoy,0
20265,Clinical Data Interchange Standards Consortium Terminology,FACT-B Version 4 - Satisfied With How I Am Coping,0
20266,CDISC QRS Terminology,CHART-SF Paper Version - Unpaid Personal Care per Day,0
20267,Clinical Data Interchange Standards Consortium Terminology,Non-High Density Lipoprotein Cholesterol Measurement,0
20268,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Liter Divided by Milligram per Meter Squared,0
20269,Clinical Data Interchange Standards Consortium Terminology,12 Lead Placement Standard Extended Left,0
20270,CDISC SDTM Terminology,FACT-P Version 4 - I Feel Ill,0
20271,NCIt Neoplasm Core Terminology,Juxtacortical chondrosarcoma,0
20272,CDISC SDTM Laboratory Test Terminology by Name,Beta Amyloid Measurement,0
20273,Edmonton symptom assessment system,Worst Possible Pain,0
20274,NCIt Antineoplastic Agent Terminology,LMB-9 Immunotoxin,0
20275,Clinical Data Interchange Standards Consortium Terminology,GDS - Frequently Feel Like Crying,0
20276,Pediatric Terminology,Posterior rhinorrhea,0
20277,CDISC Questionnaire ADCS-ADL Test Code Terminology,ADCS-ADL - Use Household Appliance to do Chores,0
20278,CDISC SDTM Terminology,Liter Divided by Microgram per Day,0
20279,NCIt Antineoplastic Agent Terminology,Oral Milataxel,0
20280,Clinical Data Interchange Standards Consortium Terminology,FAMS - Forced to Spend Time in Bed,0
20281,CDISC SDTM Terminology,Cedecea neteri,0
20282,Modified Barium Swallow Impairment Profile,Trace Residue Within or On Pharyngeal Structures Following Swallowing,0
20283,Clinical Data Interchange Standards Consortium Terminology,Auramine stain method,0
20284,FDA Established Names and Unique Ingredient Identifier Codes Terminology,piridocaine,0
20285,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Benclonidine,0
20286,CDISC SDTM Respiratory Test Name Terminology,Mean Carbon Monoxide Diffusing Capability Test,0
20287,CDISC SDTM Microorganism Terminology,Cedecea lapagei,0
20288,CDISC Variable Terminology,Microbiology Specimen Result Category,0
20289,CDISC SDTM Laboratory Test Terminology by Code,Osteoprotegerin Measurement,0
20290,Clinical Data Interchange Standards Consortium Terminology,Bordetella petrii,0
20291,CDISC SEND Terminology,Corrected Prolonged QT Interval by ECG Finding,0
20292,CTRP Agent Terminology,Innate Defense Regulator SGX942,0
20293,CDISC SEND Terminology,Lead site V3,0
20294,Pediatric Nephrology Terminology,Nephrotic Syndrome - Hepatitis C Virus Associated,0
20295,CDISC SDTM Terminology,Amount Recovered Infinity Predicted Normalized by Body Mass Index,0
20296,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Betamethasone benzoate,0
20297,Kind of Quantity - Terminology Subset,Quantity fraction,0
20298,CDISC Questionnaire Terminology,CDISC ADAS-Cog - Word Recognition: Word 22,0
20299,HL7 Unit of Measure Terminology,Units Of Measure - Gilbert,0
20300,Pediatric Nephrology Terminology,Nephrotic Syndrome - MEFV Associated,0
20301,CDISC SDTM Terminology,Parietal cell antibody analyses,0
20302,CDISC Questionnaire MDS-UPDRS Test Code Terminology,MDS-UPDRS - Urinary Problems,0
20303,Clinical Data Interchange Standards Consortium Terminology,MDS-UPDRS - Urinary Problems,0
20304,"Knowledge, Understanding and Judgment Scale",Most Common Complication After Radiotherapy for Prostate Cancer,0
20305,CDISC SDTM Terminology,Renal clearance diagnostic test,0
20306,CDISC Questionnaire NPI Test Name Terminology,NPI - Disinhibition Distress,0
20307,Breast Cancer Prevention Trial Symptom Scales,Bothered by Difficulty with Bladder Control at Other Times,0
20308,CTRP Terminology,Anti-CD40L Fc-Fusion Protein BMS-986004,0
20309,NCIt Neoplasm Core Terminology,Peripheral primitive neuroectodermal tumor of soft tissue,0
20310,CDISC QRS Terminology,HADS - I Feel Cheerful,0
20311,CDISC Questionnaire Terminology,Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire,0
20312,NCIt Antineoplastic Agent Terminology,rhizoxin,0
20313,FDA Established Names and Unique Ingredient Identifier Codes Terminology,butoconazole,0
20314,CDISC SDTM Terminology,FAMS - Urinate More Frequently Than Usual,0
20315,CDISC Questionnaire CRQ-SAS Follow-Up Administration Version Test Code Terminology,CRQ-SAS Follow-Up Administration Version - Feel Confident to Deal With Illness,0
20316,CDISC SDTM Laboratory Test Terminology by Name,Platelet Derived Growth Factor Isoform AB Measurement,0
20317,CDISC SDTM Laboratory Test Terminology by Code,Oxalate measurement,0
20318,CDISC Variable Terminology,Trial Sets Parameter,0
20319,CDISC QRS Terminology,ADNI AVLT - List A Recall 2 Word 10,0
20320,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Aminohippurate Sodium,0
20321,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire SGRQ Past 3 Months Version Test Code Terminology,0
20322,CDISC SDTM Respiratory Test Name Terminology,Percent Predicted Forced Expiratory Flow at 25-75 Percent,0
20323,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 6 (After B) Word 7,0
20324,Patient Problem Codes FDA CDRH,Osteogenesis,0
20325,Clinical Data Interchange Standards Consortium Terminology,Human Albumin Antibody Measurement,0
20326,NCIt Neoplasm Core Terminology,Squamous cell carcinoma of vagina,0
20327,FDA Established Names and Unique Ingredient Identifier Codes Terminology,oxindanac,0
20328,CTRP Terminology,iodine I 131 monoclonal antibody CC49-deltaCH2,0
20329,CDISC SDTM Unit of Measure Terminology,Immunoglobin A Phospholipid Unit per Milliliter,0
20330,CTRP Agent Terminology,carbon-11 methionine,0
20331,CDISC SEND Terminology,Cryptophthalmos,0
20332,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Choline Magnesium Trisalicyclate,0
20333,Clinical Data Interchange Standards Consortium Terminology,IIEF - Erections Hard Enough for Penetration,0
20334,CDISC SDTM Terminology,HIV Antibody Measurement,0
20335,Clinical Data Interchange Standards Consortium Terminology,MDS-UPDRS - Lightheadedness on Standing,0
20336,CTRP Terminology,gp100:280-288(288V) Peptide Vaccine,0
20337,CDISC SDTM Terminology,Bone structure of cranium,0
20338,FDA Established Names and Unique Ingredient Identifier Codes Terminology,dalfampridine,0
20339,CDISC Questionnaire Terminology,HAQ-DI With VAS - Able to Get In and Out of Car,0
20340,US Counties Terminology,"Chester County, SC",0
20341,CTRP Terminology,HPV-16 E7 TCR Expressing T-cells,0
20342,CDISC SEND Terminology,Bone structure of T11,0
20343,CDISC SDTM Terminology,ODI v2.1a - Oswestry Disability Index,0
20344,Clinical Data Interchange Standards Consortium Terminology,South Georgia and the South Sandwich Islands,0
20345,CDISC SDTM ECG Finding Terminology,Bradycardia by ECG Finding,0
20346,CTRP Terminology,Malignant mixed salivary gland tumor,0
20347,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Styrax benzoin,0
20348,NCIt Neoplasm Core Terminology,Gastric adenoma,0
20349,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Spectinomycin Sulfate,0
20350,CDISC SDTM Cardiovascular Test Name Terminology,Cusp Tethering Indicator,0
20351,CDISC SDTM Terminology,DAD - Decide to Care for His/Her Hair,0
20352,CDISC SDTM Laboratory Test Terminology by Code,transforming growth factor beta receptor activity,0
20353,US Counties Terminology,"Pratt County, KS",0
20354,FDA Established Names and Unique Ingredient Identifier Codes Terminology,iosarcol,0
20355,CDISC QRS Terminology,NPI - Awaken Too Early in Morning,0
20356,Clinical Data Interchange Standards Consortium Terminology,Predicted Steady State Volume of Distribution Normalized by Surface Area,0
20357,CTRP Agent Terminology,Yttrium Y 90 Glass Microspheres,0
20358,US Counties Terminology,"Fayette County, KY",0
20359,CTRP Terminology,Myelodysplastic-Myeloproliferative Diseases,0
20360,Clinical Data Interchange Standards Consortium Terminology,Isorhythmic Atrioventricular Dissociation,0
20361,Clinical Data Interchange Standards Consortium Terminology,Providencia alcalifaciens,0
20362,CDISC SDTM Microorganism Terminology,Providencia alcalifaciens,0
20363,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Clove,0
20364,CDISC Questionnaire Terminology,ASEX-Female Version - Sexually Aroused,0
20365,CDISC SDTM Terminology,Patch - Extended Release Film,0
20366,NCIt Antineoplastic Agent Terminology,bruceanol F,0
20367,CDISC QRS Terminology,VFQ25-Interviewer Administered Format - Difficulty Seeing and Enjoying Programs on TV,0
20368,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cyclamic Acid,0
20369,CDISC SDTM Laboratory Test Terminology by Code,Dacryocyte Analysis,0
20370,ICH Unit of Measure Terminology,Kilounit per Liter,0
20371,FDA Established Names and Unique Ingredient Identifier Codes Terminology,amyl acetate,0
20372,Wechsler Adult Intelligence Scale - Fourth Edition,Symbol Search Subtest (WAIS-IV),0
20373,NCIt Antineoplastic Agent Terminology,figitumumab,0
20374,CDISC SEND Terminology,Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement,0
20375,CDISC SDTM Terminology,A Proliferation-Inducing Ligand Measurement,0
20376,Clinical Data Interchange Standards Consortium Terminology,CDISC SDTM Contact Role for Clinical Study Terminology,0
20377,CDISC Variable Terminology,Physical Examination Test Code,0
20378,Pediatric Adverse Events Terminology,Pancytopenia,0
20379,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cimetropium bromide,0
20380,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Monosodium 3-Nitro-4-Hydroxyphenylarsonate,0
20381,Clinical Data Interchange Standards Consortium Terminology,CDISC SEND Cardiovascular Test Code Terminology,0
20382,CDISC Questionnaire HAQ-DI With VAS Test Code Terminology,HAQ-DI With VAS - Aids or Devices - Bathtub Bar,0
20383,CTRP Terminology,Levocarnitine,0
20384,CTRP Terminology,HDAC-42,0
20385,Clinical Data Interchange Standards Consortium Terminology,Every eight hours,0
20386,FDA Established Names and Unique Ingredient Identifier Codes Terminology,arpromidine,0
20387,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Razobazam,0
20388,CDISC SDTM Terminology,Terminal Half Life,0
20389,NCIt Antineoplastic Agent Terminology,Attenuated Chimpanzee Adenovirus 5T4 Vaccine,0
20390,CDISC Questionnaire C-SSRS Screening Test Name Terminology,C-SSRS Screening - Number of Aborted Suicide Attempts,0
20391,CareLex eTMF Terminology,Vendor Record Documentation,0
20392,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Povidone-Iodine,0
20393,CTRP Terminology,Untreated Adult Acute Lymphoblastic Leukemia,0
20394,Clinical Data Interchange Standards Consortium Terminology,Sustained Virologic Response,0
20395,Clinical Data Interchange Standards Consortium Terminology,Nasal-Associated Lymphoid Tissue,0
20396,CTRP Terminology,Enzastaurin Hydrochloride,0
20397,CDISC Questionnaire Terminology,C-SSRS Children's Baseline - Description of Interrupted Suicide Attempt,0
20398,NCIt Neoplasm Core Terminology,Extracardiac Rhabdomyoma,0
20399,CDISC SDTM Terminology,AURC Infinity Observed Normalized by Body Mass Index,0
20400,Clinical Data Interchange Standards Consortium Terminology,Natural grandmother,0
20401,NCIt Antineoplastic Agent Terminology,Immunotoxin CMD-193,0
20402,European Quality of Life Five Dimension Five Level Scale Questionnaire,No Problems Walking,0
20403,CDISC QRS Terminology,CRQ-SAS Follow-Up Administration Version - Take Care of Basic Needs,0
20404,Pediatric Infectious Disease Terminology,Southern tick-associated rash illness,0
20405,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Benzindopyrine,0
20406,CDISC Questionnaire Terminology,DAD - Decide to Take Medications at the Correct Time,0
20407,Clinical Data Interchange Standards Consortium Terminology,Symptoms,0
20408,CTRP Terminology,Childhood Ovarian Germ Cell Tumor,0
20409,Clinical Data Interchange Standards Consortium Terminology,C-SSRS Children's Baseline - Aborted Suicide Attempt,0
20410,CTRP Terminology,Stage IIA Rectal Cancer AJCC v7,0
20411,FDA Established Names and Unique Ingredient Identifier Codes Terminology,lanthanum cation (3+),0
20412,FDA Device Problem Code Hierarchy,Failure to Prime,0
20413,Clinical Data Interchange Standards Consortium Terminology,SGRQ Past 3 Months Version - Not in Control of My Respiratory Problems,0
20414,CDISC SDTM Terminology,Erythrocyte Mean Corpuscular Volume Measurement,0
20415,CDISC SEND Terminology,Inhalant dose form,0
20416,CDISC Questionnaire HADS Test Name Terminology,HADS - I Feel as if I am Slowed Down,0
20417,CDISC Questionnaire SGRQ Past 3 Months Version Test Name Terminology,SGRQ Past 3 Months Version - Take Long Time to Get Washed or Dressed,0
20418,FACIT-Dyspnea 10 Item Short Form,Dyspnea Severity Washing Dishes,0
20419,CDISC Questionnaire CRQ-SAS Follow-Up Administration Version Test Name Terminology,"CRQ-SAS Follow-Up Administration Version - Feel Upset, Worried or Depressed",0
20420,CDISC SDTM Terminology,DLQI - Treatment for Skin Make Home Messy,0
20421,CDISC Questionnaire Terminology,CDISC Questionnaire MRS Test Code Terminology,0
20422,CDISC SDTM Relationship to Subject Terminology,Donor person,0
20423,PROMIS-43 Adult Profile v2.0,Feel Depressed question,0
20424,FDA Established Names and Unique Ingredient Identifier Codes Terminology,furan,0
20425,CDISC QRS Terminology,PHQ Screener Version - Anxiety Attack Tremble or Shake,0
20426,Clinical Data Interchange Standards Consortium Terminology,Clostridium celatum,0
20427,US Counties Terminology,"Suffolk County, MA",0
20428,Perinatal Terminology,Dermoid Cyst,0
20429,CDISC SEND Trial Summary Parameter Long Name Terminology,Test Facility Country,0
20430,"Geopolitical Entities, Names, and Codes Terminology",Ghana,0
20431,NCIt Antineoplastic Agent Terminology,Hsp70-peptide TKD/IL-2-activated Autologous Natural Killer Cells,0
20432,Patient Problem Codes FDA CDRH,Eye Injuries,0
20433,Pediatric Terminology,Pharmacotherapy,0
20434,FDA Established Names and Unique Ingredient Identifier Codes Terminology,acamprosate,0
20435,CDISC SDTM Terminology,ADNI AVLT - List A Recall 6 (After B) Word 1,0
20436,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 6 (After B) Word 1,0
20437,CDISC QRS Terminology,C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Lifetime),0
20438,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Lifetime),0
20439,FDA Established Names and Unique Ingredient Identifier Codes Terminology,orchard grass pollen extract,0
20440,Memorial Symptom Assessment Scale,How Much Distress Feeling Bloated,0
20441,FDA Established Names and Unique Ingredient Identifier Codes Terminology,oxibendazole,0
20442,CDISC CDASH Exposure Dosing Frequency per Interval Terminology,Three times daily,0
20443,Pediatric Adverse Events Terminology,Diaper candidiasis,0
20444,CDISC Questionnaire Terminology,VFQ25-Interviewer Administered Format - Overall Health,0
20445,CDISC Questionnaire VFQ25-Interviewer Administered Format Test Code Terminology,VFQ25-Interviewer Administered Format - Overall Health,0
20446,CDISC QRS Terminology,Barnes Akathisia Rating Scale Questionnaire,0
20447,CDISC SEND Terminology,Micromole per Liter per Hour,0
20448,SPL Drug Route of Administration Terminology,Intrapulmonary Route of Drug Administration,0
20449,Clinical Data Interchange Standards Consortium Terminology,Kluyvera intermedia,0
20450,NCIt Antineoplastic Agent Terminology,Anti-DR5 Agonist Monoclonal Antibody TRA-8,0
20451,Pediatric Nephrology Terminology,Hantavirus nephropathy,0
20452,CDISC SDTM Terminology,CDISC Questionnaire PR v1 Test Code Terminology,0
20453,Clinical Data Interchange Standards Consortium Terminology,Actinomyces bovis,0
20454,CDISC Questionnaire Terminology,CRQ-SAS Follow-Up Administration Version - Feel Relaxed and Free of Tension,0
20455,Clinical Data Interchange Standards Consortium Terminology,"Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire",0
20456,CDISC SDTM Terminology,MFIS - Pace Myself in Physical Activities,0
20457,CDISC SDTM Terminology,MDS-UPDRS - Painful Off-state Dystonia,0
20458,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mifepristone,0
20459,CTRP Agent Terminology,MSCV-MGMT(P140K) Vaccine,0
20460,CDISC SDTM Method Terminology,"Echocardiography, Stress",0
20461,CDISC QRS Terminology,CRQ-SAS Follow-Up Administration Version - Felt Frustrated or Impatient,0
20462,NCIt Antineoplastic Agent Terminology,denosumab,0
20463,CDISC SDTM Terminology,APACHE II - Serum Creatinine,0
20464,Clinical Data Interchange Standards Consortium Terminology,Toes,0
20465,CDISC Clinical Classification HAMD 21 Test Name Terminology,HAMD-21 - Anxiety Somatic,0
20466,NCIt Neoplasm Core Terminology,Acute Myeloid Leukemia with t(5;17)(q35;q21),0
20467,Clinical Data Interchange Standards Consortium Terminology,Metatarsophalangeal Joint 4,0
20468,CDISC SDTM Terminology,ADCS-ADL MCI - Use Household Appliance,0
20469,CDISC Questionnaire OAB-q Test Code Terminology,OAB-q - Uncomfortable While Traveling With Others,0
20470,Clinical Data Interchange Standards Consortium Terminology,OAB-q - Uncomfortable While Traveling With Others,0
20471,NCIt Antineoplastic Agent Terminology,Leuprolide,0
20472,Pediatric Terminology,Susac Syndrome,0
20473,CDISC SDTM Terminology,Gram per Milliliter per Microgram,0
20474,CDISC SDTM Terminology,Number of Correct Eye Chart Letters,0
20475,CTRP Terminology,BCLC Stage C Adult Hepatocellular Carcinoma,0
20476,Clinical Data Interchange Standards Consortium Terminology,MFIS - Less Motivated to Do Anything That Requires Physical Effort,0
20477,CDISC QRS Terminology,HAQ-DI With VAS - Aids or Devices - Jar Opener (Jars Previously Opened),0
20478,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bismuth aluminate,0
20479,CDISC SDTM Microorganism Terminology,"Haemophilus influenzae, Penicillinase Positive",0
20480,NCIt Neoplasm Core Terminology,Acute Leukemia of Ambiguous Lineage,0
20481,Clinical Data Interchange Standards Consortium Terminology,ADHD Rating Scale-IV Home Version Questionnaire,0
20482,CDISC SEND Terminology,Predicted Area Under the First Moment Curve Percent Extrapolation,0
20483,Pediatric Adverse Events Terminology,Screaming,0
20484,Human Activity Profile Test,Shopping by Yourself,0
20485,CTRP Disease Terminology,alpha-Mannosidosis,0
20486,Patient Problem Codes FDA CDRH,Unspecified Abortion,0
20487,CDISC SDTM Terminology,CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Name Terminology,0
20488,CDISC SDTM Cardiovascular Findings About Results Terminology,ER or Office Visit Due to Heart Failure,0
20489,Clinical Data Interchange Standards Consortium Terminology,Square Millimole per Square Liter,0
20490,Pediatric Terminology,Chorioamnionitis,0
20491,FDA Established Names and Unique Ingredient Identifier Codes Terminology,moxifloxacin,0
20492,NCIt Antineoplastic Agent Terminology,bruceanol A,0
20493,Regulated Product Submission Reporting Terminology,Change of Address or Corporate Name,0
20494,CDISC QRS Terminology,ADCS-ADL MCI - Use Household Appliance: Power Tools,0
20495,CDISC Questionnaire Terminology,CRQ-SAS Follow-Up Administration Version - Felt Worn Out or Sluggish,0
20496,FDA Established Names and Unique Ingredient Identifier Codes Terminology,margetuximab,0
20497,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pheniprazine,0
20498,Neonatal Research Network Terminology,Necrotizing enterocolitis in fetus OR newborn,0
20499,Patient Military Status ICSR Terminology,Active Duty Status,0
20500,Pittsburgh sleep quality index,Have Long Pauses Between Breaths While Asleep,0
20501,Clinical Data Interchange Standards Consortium Terminology,Faces Pain Scale Revised Questionnaire,0
20502,CDISC Questionnaire Terminology,EXACT - Tired or Weak,0
20503,CDISC SEND Tumor Findings Results Terminology,Adamantinoma,0
20504,NCIt Antineoplastic Agent Terminology,Dendritic Cell Tumor Cell Lysate Vaccine,0
20505,CDISC SDTM Laboratory Test Terminology by Code,Precursor Plasma Cell Count,0
20506,Clinical Data Interchange Standards Consortium Terminology,Mid-Left Anterior Descending Artery,0
20507,CDISC SDTM Terminology,CDISC SDTM Pharmaceutical Dosage Form Terminology,0
20508,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Disulfiram,0
20509,CDISC QRS Terminology,MSQOL-54 - Health Limit Walking More than A Mile,0
20510,Pediatric Terminology,Cardiac Compression during Initial Resuscitation,0
20511,Pediatric Terminology,Staphylococcus aureus infection,0
20512,CDISC SDTM Microorganism Terminology,Oidiodendron,0
20513,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Limpet (Dietary),0
20514,CDISC SEND Terminology,Millivolt per Second,0
20515,CDISC SDTM Terminology,Maxillary Sinus,0
20516,CTRP Terminology,Malignant melanoma of eye,0
20517,CDISC SDTM Terminology,Intragingival Route of Administration,0
20518,CDISC SEND Fetal Measurement Test Code Terminology,Fetal Organ Weight,0
20519,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - Use Household Appliance: Microwave,0
20520,Patient Reported Outcomes Version of CTCAE,Past Seven Days Shortness of Breath Interfering with Usual or Daily Activities,0
20521,CDISC SEND Terminology,Volume of Distribution of Fraction Dose Observed Normalized by Surface Area,0
20522,CDISC Questionnaire Terminology,Karnofsky Performance Status Scale Questionnaire,0
20523,CDISC SDTM Terminology,In complete remission,0
20524,CDISC SDTM Laboratory Test Terminology by Code,Antibody to myelin measurement,0
20525,CTRP Terminology,Tozasertib Lactate,0
20526,CDISC SDTM Laboratory Test Terminology by Code,Glutathione-S-Transferase to Creatinine Ratio Measurement,0
20527,Pediatric Adverse Events Terminology,Portal Hypertension,0
20528,CTRP Terminology,Chordoma,0
20529,CTRP Agent Terminology,Vaccinia Prostate Specific Antigen Vaccine,0
20530,CDISC Questionnaire ADCS-ADL Test Code Terminology,ADCS-ADL - Description of Usual Performance of Garbage Disposal,0
20531,CDISC SDTM Terminology,Ocular orbit,0
20532,CTRP Agent Terminology,Deuterium Oxide,0
20533,Clinical Data Interchange Standards Consortium Terminology,Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire,0
20534,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Lincomycin Hydrochloride,0
20535,CTRP Agent Terminology,Famotidine,0
20536,Clinical Data Interchange Standards Consortium Terminology,CDISC SDTM Reproductive System Findings Test Name Terminology,0
20537,Neonatal Research Network Terminology,Retinal Diseases,0
20538,CDISC SDTM Unit of Measure Terminology,Picogram per Deciliter,0
20539,Pediatric Terminology,Deficiency of acetyl-CoA acetyltransferase,0
20540,Clinical Data Interchange Standards Consortium Terminology,Junctional premature complex (disorder),0
20541,Neonatal Research Network Terminology,Cerebral arterial aneurysm,0
20542,CTRP Agent Terminology,Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine,0
20543,CTRP Agent Terminology,Hydrocortisone sodium succinate,0
20544,CTRP Terminology,ACTH-producing pituitary tumor,0
20545,Clinical Data Interchange Standards Consortium Terminology,Stereotactic Surgery Frame Type,0
20546,CDISC SEND Terminology,B6C3 Mouse,0
20547,CDISC SDTM Terminology,Carpometacarpal Joint 1,0
20548,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Potassium Ion,0
20549,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Rhubarb food,0
20550,NCIt Antineoplastic Agent Terminology,Anti-CD123 Monoclonal Antibody KHK2823,0
20551,Perinatal Terminology,Variable deceleration - finding,0
20552,Pediatric Terminology,Collapsing glomerulopathy,0
20553,Medical Outcomes Study Your Feelings Questionnaire,Has Living Been a Wonderful Adventure,0
20554,CDISC SDTM Microorganism Terminology,Aspergillus flavus,0
20555,Pediatric Infectious Disease Terminology,Pre-Extensively Drug-Resistant Mycobacterium tuberculosis,0
20556,Contemplation Ladder for Smoking Cessation,Readiness to Quit Smoking,0
20557,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nerbacadol,0
20558,Pediatric Terminology,Supravalvular aortic stenosis,0
20559,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pituxate,0
20560,FDA Established Names and Unique Ingredient Identifier Codes Terminology,actinoquinol,0
20561,NCIt Antineoplastic Agent Terminology,therapeutic autologous dendritic cells,0
20562,FDA Established Names and Unique Ingredient Identifier Codes Terminology,iodine-131-tositumomab,0
20563,CDISC Functional Test ADNI AVLT Test Code Terminology,ADNI AVLT - List A Recall 4 Word 3,0
20564,CDISC Functional Test BACS Test Name Terminology,BACS - Symbol Coding Raw Score,0
20565,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bitter dock pollen extract,0
20566,Pediatric Adverse Events Terminology,Asphyxia,0
20567,Pediatric Adverse Events Terminology,Inflammatory disease of mucous membrane,0
20568,FACT-Hep Questionnaire,Have Control of Bowels,0
20569,Regulated Product Submission Reporting Terminology,Nonclinical Overview,0
20570,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hydrocortisone phosphate,0
20571,NCIt Antineoplastic Agent Terminology,Merestinib,0
20572,CDISC Questionnaire Terminology,UPDRS - Complications of Therapy: Clinical Fluctuations - Average Off Periods Per Day,0
20573,NCIt Antineoplastic Agent Terminology,apalutamide,0
20574,NCIt Antineoplastic Agent Terminology,ertumaxomab,0
20575,CDISC SDTM Trial Summary Parameter Terminology by Code,EMA Decision Number for Pediatric Investigation Plan,0
20576,US Counties Terminology,"Rota Municipality, MP",0
20577,Neonatal Research Network Terminology,Duodenal atresia,0
20578,NCIt Antineoplastic Agent Terminology,plocabulin,0
20579,CDISC SDTM Terminology,NHLBI Coronary Artery Dissection Type F,0
20580,CDISC SDTM Terminology,Epidermophyton floccosum,0
20581,CDISC SDTM Microorganism Terminology,Wangiella dermatitidis,0
20582,CDISC Questionnaire Terminology,CDISC Questionnaire Category Terminology,0
20583,CDISC SDTM Microorganism Terminology,Pseudopropionibacterium propionicum,0
20584,CTRP Agent Terminology,STAT3 Inhibitor OPB-51602,0
20585,CDISC SDTM Terminology,Candida parapsilosis,0
20586,CTRP Terminology,Cervical Adenosquamous Carcinoma,0
20587,Pediatric Terminology,Anger,0
20588,CTRP Agent Terminology,MK-0752,0
20589,CDISC SEND Terminology,Monocytoid Cell to Total Cell Ratio Measurement,0
20590,CDISC SDTM Terminology,Salmonella choleraesuis,0
20591,CDISC Questionnaire ADAS-Cog CDISC Version Test Code Terminology,CDISC ADAS-Cog - Word Recognition: Word 19,0
20592,CDISC SEND Terminology,Hour Times Millimole per Liter per Meter Squared,0
20593,SPL Marketing Category Terminology,Marketed as Unapproved Medical Gas,0
20594,Pediatric Nephrology Terminology,Membranous Nephropathy - Autoimmune Disorder Associated,0
20595,CDISC SDTM Terminology,Cryptococcus gattii,0
20596,US Counties Terminology,"Moca Municipio, PR",0
20597,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Girentuximab I-124,0
20598,CDISC SDTM Terminology,AV Block Second Degree Mobitz Type I by ECG Finding,0
20599,CDISC Questionnaire Terminology,FAQ - Remember,0
20600,US Counties Terminology,"Bedford County, VA",0
20601,CDISC QRS Terminology,GOSE - Family and Friendships: Disruptive Psychological Problems,0
20602,SPL Pharmacokinetic Effect Consequences Terminology,Increased Concomitant Drug Level,0
20603,CTRP Agent Terminology,Oxycodone Hydrochloride,0
20604,CDISC SDTM Terminology,Widowhood,0
20605,US Counties Terminology,"Morehouse Parish, LA",0
20606,NCIt Antineoplastic Agent Terminology,VEGFR/FGFR Inhibitor ODM-203,0
20607,CDISC Questionnaire Terminology,Brief Pain Inventory Short Form Questionnaire,0
20608,CTRP Terminology,Multivitamin preparation,0
20609,Clinical Data Interchange Standards Consortium Terminology,Eotaxin-1 Measurement,0
20610,CTRP Terminology,Radionuclide Angiography,0
20611,CDISC SEND Terminology,Head and neck structure,0
20612,FDA Established Names and Unique Ingredient Identifier Codes Terminology,liarozole,0
20613,CDISC SDTM Unit of Measure Terminology,Disintegration per Minute per Milliliter,0
20614,CDISC SDTM Laboratory Test Terminology by Code,Troponin T Assay,0
20615,CDISC SDTM Species Terminology,Bacillus anthracis,0
20616,CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Code Terminology,MSQOL-54 - Health Limit Vigorous Activities,0
20617,CDISC SDTM Terminology,MSQOL-54 - Health Limit Vigorous Activities,0
20618,CDISC SDTM Laboratory Test Terminology by Code,Nitric Oxide Measurement,0
20619,CDISC SEND Terminology,Atrioventricular Reentrant Tachycardia by ECG Finding,0
20620,CDISC SDTM Terminology,EPIC-26 - Ability to Reach Orgasm,0
20621,CDISC Questionnaire ADCS-ADL Test Code Terminology,ADCS-ADL - Select or Ask for Television Program,0
20622,CDISC SDTM Microorganism Terminology,Leuconostoc mesenteroides,0
20623,CDISC SEND Variable Terminology,Exclude ECG Data From Statistics Indicator,0
20624,Expanded Prostate Cancer Index Composite,Body Weight Loss Exceeding 10 Pounds,0
20625,Pediatric Terminology,Arteriovenous graft aneurysm,0
20626,Clinical Data Interchange Standards Consortium Terminology,CHART-SF Paper Version - Hours of Recreational Activities per Week,0
20627,CDISC SDTM Microorganism Terminology,Bacillus cereus,0
20628,CDISC Questionnaire FAQ Test Name Terminology,FAQ - Total Score,0
20629,FDA Established Names and Unique Ingredient Identifier Codes Terminology,naproxen-n-butyl nitrate,0
20630,GAIA Terminology,GAIA Level 3 Neonatal Respiratory Tract Infection,0
20631,CDISC SDTM Microorganism Terminology,Staphylococcus felis,0
20632,FDA Established Names and Unique Ingredient Identifier Codes Terminology,chrysarobin,0
20633,Clinical Data Interchange Standards Consortium Terminology,Coronary Artery Bypass Surgery,0
20634,Symptom Distress Scale,Breathing Distress Question,0
20635,Pediatric Adverse Events Terminology,Sedated state,0
20636,Pediatric Terminology,Long QT Syndrome,0
20637,CDISC SDTM Terminology,Hydrogen-Ion Concentration,0
20638,Clinical Data Interchange Standards Consortium Terminology,FACT-G Version 4 - I Get Emotional Support From My Family,0
20639,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hepatitis A Virus,0
20640,CDISC SDTM Terminology,IIEF - How Often Did You Ejaculate,0
20641,Clinical Data Interchange Standards Consortium Terminology,Pseudoclavibacter alba,0
20642,Pediatric Terminology,Pulmonary hemorrhage,0
20643,CDISC QRS Terminology,ADCS-ADL MCI - Description of Extent Needing Reminder,0
20644,NCI CTEP SDC Oligodendroglial Tumors Sub-Category Terminology,Well Differentiated Oligodendroglioma,0
20645,CDISC Questionnaire ADAS-Cog CDISC Version Test Code Terminology,CDISC ADAS-Cog - Number Cancellation: Errors,0
20646,Clinical Data Interchange Standards Consortium Terminology,Bacillus licheniformis,0
20647,Pediatric Infectious Disease Terminology,Direct Transmission,0
20648,CDISC SDTM Subject Characteristic Test Code Terminology,Social Risk Factor,0
20649,CTRP Agent Terminology,Cimetidine,0
20650,CTRP Terminology,GDC-0575,0
20651,Clinical Data Interchange Standards Consortium Terminology,Schistosoma haematobium,0
20652,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 3 Word 11,0
20653,Clinical Data Interchange Standards Consortium Terminology,Eubacterium contortum,0
20654,CDISC SDTM Terminology,Intravenous Route of Drug Administration,0
20655,CDISC SDTM Laboratory Test Terminology by Name,Matrix Metalloproteinase 1 Measurement,0
20656,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Merbromin,0
20657,Pediatric Terminology,Gesell Developmental Schedule,0
20658,CTRP Terminology,R-CVP Regimen,0
20659,CDISC Questionnaire Terminology,KFSS - Cerebral (or Mental) Functions,0
20660,NCIt Antineoplastic Agent Terminology,oblimersen sodium,0
20661,CDISC SDTM Terminology,Social Setting,0
20662,Parameterized Data Type - Set,Social Setting,0
20663,"Knowledge, Understanding and Judgment Scale",Prostate Cancer Will Spread in One of Three Patients Within Ten Years Without Treatment,0
20664,Clinical Data Interchange Standards Consortium Terminology,Catalytic RNA,0
20665,Clinical Data Interchange Standards Consortium Terminology,Bordetella parapertussis,0
20666,FDA Established Names and Unique Ingredient Identifier Codes Terminology,vadocaine,0
20667,NCIt Antineoplastic Agent Terminology,Nanoparticle Albumin-Bound Docetaxel,0
20668,NCIt Antineoplastic Agent Terminology,Genetically Engineered NY-ESO-1-specific T Lymphocytes,0
20669,CDISC SDTM Terminology,PROSQOLI - Enjoying Time with Friends and Family,0
20670,CTRP Agent Terminology,Curcumin,0
20671,NCIt Neoplasm Core Terminology,Submandibular Gland Squamous Cell Carcinoma,0
20672,FDA Established Names and Unique Ingredient Identifier Codes Terminology,rilotumumab,0
20673,FDA Established Names and Unique Ingredient Identifier Codes Terminology,nafiverine,0
20674,Clinical Data Interchange Standards Consortium Terminology,CHART-SF Paper Version - Associates Contacted per Month,0
20675,Pediatric Terminology,Subacute Sclerosing Panencephalitis,0
20676,FDA Established Names and Unique Ingredient Identifier Codes Terminology,butoxycaine HCl,0
20677,CDISC SDTM Terminology,Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization,0
20678,CDISC Questionnaire Terminology,Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire,0
20679,CDISC Clinical Classification Terminology,HAMD-21 - Diurnal Variation Severity,0
20680,CDISC SDTM Vital Sign Terminology by Name,Ideal Body Weight,0
20681,CDISC SEND Terminology,Retroesophageal,0
20682,National Health Interview Survey,Numbers,0
20683,Neonatal Research Network Terminology,Ventricular Septal Defects,0
20684,CDISC QRS Terminology,COWS - Sweating,0
20685,Clinical Data Interchange Standards Consortium Terminology,CDISC Clinical Classification MELD Test Name Terminology,0
20686,CDISC Questionnaire C-SSRS Baseline Test Code Terminology,C-SSRS Baseline - Control over Most Severe Ideation,0
20687,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dexrazoxane,0
20688,CDISC QRS Terminology,CDISC ADAS-Cog - Executive Function Maze: Time,0
20689,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Lifetime),0
20690,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Actual Lethality/Medical Damage,0
20691,CDISC Questionnaire Category Terminology,Eastern Cooperative Oncology Group Performance Status Questionnaire,0
20692,SPL Drug Route of Administration Terminology,Electro-osmosis Route of Drug Administration,0
20693,Pediatric Terminology,Laboratory test finding,0
20694,CDISC SDTM Laboratory Test Terminology by Name,Measurement of ratio of citrate to creatinine,0
20695,CDISC QRS Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Potential Lethality,0
20696,US Counties Terminology,"Apache County, AZ",0
20697,Clinical Data Interchange Standards Consortium Terminology,Hour Times Gram per Milliliter,0
20698,Patient Problem Codes FDA CDRH,Posterior Capsular Bag Tear,0
20699,FDA Established Names and Unique Ingredient Identifier Codes Terminology,diatrizoate sodium,0
20700,Pediatric Nephrology Terminology,Nephrotic Syndrome - Simian Virus 40 Associated,0
20701,Pediatric Terminology,Hypoplasia of thumb,0
20702,CDISC Clinical Classification HAMD 21 Test Code Terminology,HAMD-21 - Obsessional and Compulsive Symptoms,0
20703,FDA Established Names and Unique Ingredient Identifier Codes Terminology,camobucol,0
20704,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pine nut extract,0
20705,CDISC SDTM Microorganism Terminology,Leifsonia,0
20706,Pediatric Adverse Events Terminology,Peritoneal Dialysis Catheter-Associated Peritonitis,0
20707,CDISC SDTM Terminology,ESRS-A - Dystonia: Eyes/Upper and Lower Face/Larynx,0
20708,FDA Device Component Code Hierarchy,Contact Lenses,0
20709,Clinical Data Interchange Standards Consortium Terminology,Day Times mole Per Liter Per Milligram Per Gram Per Day,0
20710,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Imipramine,0
20711,MD Anderson Symptom Inventory - Head and Neck,no,0
20712,CTRP Terminology,Immunohistochemistry,0
20713,Neonatal Research Network Terminology,Bayley Scale of Infant Development III,0
20714,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Guaiacol,0
20715,Clinical Data Interchange Standards Consortium Terminology,Minute Times Nanogram Per Milliliter Per Kilogram,0
20716,Pediatric Terminology,Allis Clamp Fetal Scalp Stimulation,0
20717,CDISC SEND Terminology,Total Live Fetal Weight,0
20718,CDISC SEND Terminology,Experimental Organism Luteinized Unruptured Follicle,0
20719,NCCN Guidelines Distress Management Problem List Screening Tool Version 1.2011,Distress over Physical Problem with Bathing or Dressing,0
20720,NCIt Antineoplastic Agent Terminology,WNT-974,0
20721,CDISC SEND Terminology,Microinternational Unit per Milliliter,0
20722,CDISC SEND Terminology,Structure of apex of heart,0
20723,CDISC SEND Terminology,Iceland,0
20724,CDISC QRS Terminology,Hamilton Depression Rating Scale 21-Item Clinical Classification,0
20725,CDISC SDTM Microorganism Terminology,Geotrichum klebahnii,0
20726,CDISC SEND Terminology,Endosinusial Route of Drug Administration,0
20727,CTRP Terminology,MM-151,0
20728,Clinical Data Interchange Standards Consortium Terminology,Dextrocardia,0
20729,CDISC SDTM Terminology,Moraxella osloensis,0
20730,CDISC SEND Tumor Findings Results Terminology,Zymbal's Gland Adenoma,0
20731,FDA Individual Case Safety Report Terminology,Type of Follow-Up Report,0
20732,CDISC SDTM Terminology,C-SSRS Screening - Most Lethal Suicide Attempt Potential Lethality,0
20733,FDA Established Names and Unique Ingredient Identifier Codes Terminology,aconiazide,0
20734,NCI CTEP Simplified Disease Classification Terminology,NCI CTEP SDC Non-Rhabdomyosarcoma Soft Tissue Sarcoma Sub-Category Terminology,0
20735,CDISC CDASH Variable Terminology,Vital Signs Original Result Unit,0
20736,NCIt Antineoplastic Agent Terminology,peldesine,0
20737,CTRP Intervention Terminology,Physical Examination,0
20738,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bethanidine Sulfate,0
20739,CDISC Questionnaire FACT-G Version 4 Test Code Terminology,FACT-G Version 4 - Content With Quality of My Life,0
20740,Regulated Product Submission Reporting Terminology,Studies in which the Offspring (Juvenile Animals) are Dosed and/or Further Evaluated,0
20741,CDISC Variable Terminology,Adverse Event Outcome,0
20742,CDISC SDTM Frequency Terminology,Infrequent,0
20743,CDISC SDTM Vital Sign Terminology by Name,Total body water measurement,0
20744,CDISC SDTM Terminology,MRI Coil Type,0
20745,CDISC SDTM Microorganism Terminology,Streptococcus mutans,0
20746,Body Image Scale,Avoid People Due to Physical Appearance,0
20747,Clinical Data Interchange Standards Consortium Terminology,NPI - Seem Too Cheerful or Too Happy for No Reason,0
20748,CDISC Questionnaire Terminology,"FAQ - Heat water, Make Coffee, Turn Off Stove",0
20749,CDISC SDTM Terminology,Clarity Measurement,0
20750,CDISC Functional Test AVLT-REY Test Name Terminology,AVLT-REY - List B Word 8,0
20751,CDISC Questionnaire Terminology,IIEF - Able to Maintain Your Erection After You Had Penetrated Your Partner,0
20752,CDISC Functional Test AVLT-REY Test Name Terminology,AVLT-REY - List A Intrusions,0
20753,CTRP Terminology,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0
20754,CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Name Terminology,NCCN-FACT-FPSI 17 Version 2 - I Am Sleeping Well,0
20755,Memorial Symptom Assessment Scale,How Often Dizzy,0
20756,CDISC QRS Terminology,EPIC-26 - Abdominal or Pelvic or Rectal Pain,0
20757,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bifeprunox,0
20758,CDISC Questionnaire FAQ Test Code Terminology,FAQ - Prepare a Meal,0
20759,CDISC Questionnaire FAQ Test Name Terminology,"FAQ - Pay Attention, Understand, Discuss",0
20760,CDISC QRS Terminology,AVLT-REY - List B Word 9,0
20761,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Metformin,0
20762,Pediatric Terminology,Acquired hydrocephalus,0
20763,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"Camphorsulfonic Acid, (+)-",0
20764,CDISC SEND Terminology,Zygomatic salivary gland,0
20765,CDISC QRS Terminology,"FAQ-NACC Version - Play Game of Skill, Work on Hobby",0
20766,NCIt Antineoplastic Agent Terminology,Anti-IGF1/2 Monoclonal Antibody MEDI-573,0
20767,NCCN Guidelines Distress Management Problem List Screening Tool Version 1.2011,Distress over Physical Problem with Sleep,0
20768,CTRP Terminology,danusertib,0
20769,CDISC SEND Terminology,Intracoronary Route of Drug Administration,0
20770,CDISC SDTM Terminology,Placebo Control,0
20771,SPL Unit of Presentation Terminology,Container Dosing Unit,0
20772,CDISC SDTM Terminology,Staphylococcus epidermidis,0
20773,CDISC Questionnaire ESS Test Code Terminology,ESS - As a Passenger in a Car for an Hour Without a Break,0
20774,SPL Combination Product Type Terminology,Type 1: Convenience Kit or Co-Package,0
20775,CTRP Agent Terminology,Recombinant Interleukin-6,0
20776,CDISC SEND Terminology,Minimum Concentration Normalized by Surface Area,0
20777,CDISC SEND Terminology,Superficial,0
20778,CTRP Terminology,RO5424802,0
20779,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Milliliter per Hour per Milligram per Day,0
20780,CDISC SDTM Route of Administration Terminology,Interstitial Route of Drug Administration,0
20781,CDISC Functional Test AVLT-REY Test Code Terminology,AVLT-REY - Recognition Intrusions,0
20782,CDISC Questionnaire PHQ-15 Test Code Terminology,PHQ-15 - Headaches,0
20783,US Counties Terminology,"Elkhart County, IN",0
20784,CDISC SDTM Laboratory Test Terminology by Code,Procollagen Type I Carboxy Terminal Peptide Measurement,0
20785,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - Description of Usual Performance of Finding Belongings,0
20786,FDA Device Component Code Hierarchy,Control Switch Device,0
20787,CDISC Variable Terminology,Microscopic Findings Completion Status,0
20788,PROMIS Pain Rating Scale,Pain Rating Average Score 0,0
20789,CTRP Terminology,Stage II Prostate Cancer AJCC v7,0
20790,Clinical Data Interchange Standards Consortium Terminology,HAMD-17 - Work and Activities,0
20791,CDISC QRS Terminology,NPI - Sleep and Nighttime Behavior Disorders Frequency,0
20792,Pediatric Terminology,Respiratory Failure Related to Central Nervous System Disorder,0
20793,Pediatric Terminology,Somatotropin deficiency,0
20794,Newborn Screening Terminology,Anesthesia procedures,0
20795,CDISC SDTM Route of Administration Terminology,Intravascular Route of Drug Administration,0
20796,CDISC SDTM Terminology,Calcium measurement,0
20797,CDISC SDTM Laboratory Test Terminology by Code,Tissue Inhibitor of Metalloproteinase 1 Measurement,0
20798,CDISC SDTM Laboratory Test Terminology by Name,Interleukin 7 Measurement,0
20799,NCIt Antineoplastic Agent Terminology,teloxantrone hydrochloride,0
20800,CDISC Questionnaire ADAS-Cog CDISC Version Test Name Terminology,CDISC ADAS-Cog - Word Recall: Word 9,0
20801,CTRP Agent Terminology,Oligofructose-Enriched Inulin,0
20802,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Lisinopril,0
20803,CDISC Questionnaire Terminology,ADCS-ADL - Pay for Items Without Supervision or Physical Help,0
20804,FDA Established Names and Unique Ingredient Identifier Codes Terminology,2-mercaptoacetate,0
20805,Neonatal Research Network Terminology,Blood coagulation disorder due to liver disease,0
20806,CDISC SEND Terminology,Spinal artery,0
20807,Pediatric Infectious Disease Terminology,Pneumocystis jiroveci pneumonia,0
20808,CDISC SEND Terminology,Inguinal lymph node group,0
20809,CDISC SDTM Terminology,C-SSRS Already Enrolled Subjects - Completed Suicide (Since Study Start),0
20810,Clinical Data Interchange Standards Consortium Terminology,Experimental Organism Basal Cell Adenoma,0
20811,CTRP Terminology,Malignant tumor of pleura,0
20812,NCIt Antineoplastic Agent Terminology,Ganitumab,0
20813,CDISC SEND Biospecimens Terminology,Common iliac lymph node,0
20814,Pediatric Infectious Disease Terminology,Folliculitis,0
20815,Stability Product Form Terminology,"SPRAY, SUSPENSION",0
20816,FDA Manufacturer Evaluation Result Code Hierarchy,Degradation Problem Identified,0
20817,Pediatric Rheumatology Terminology,Polyarthritis,0
20818,NCIt Antineoplastic Agent Terminology,Lovastatin,0
20819,CDISC SDTM Terminology,C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Lifetime),0
20820,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Recombinant Vasopressin,0
20821,US Counties Terminology,"Fountain County, IN",0
20822,Patient Problem Codes FDA CDRH,Inadequate pain relief,0
20823,CDISC SDTM Terminology,Creatine Kinase MM to Total Creatine Kinase Ratio Measurement,0
20824,CDISC SDTM Laboratory Test Terminology by Code,Hydrogen measurement,0
20825,CDISC SEND Terminology,Histone 1 Antibody Measurement,0
20826,Clinical Data Interchange Standards Consortium Terminology,Photobacterium,0
20827,SPL Pharmaceutical Dosage Form Terminology,Stick Dosage Form,0
20828,CDISC SDTM Terminology,12 Lead Placement Standard,0
20829,Pediatric Terminology,"Gestational Diabetes Mellitus, A1",0
20830,CDISC Questionnaire Modified Fatigue Impact Scale Test Name Terminology,MFIS - Have Limited My Physical Activities,0
20831,Pediatric Terminology,fetal Doppler velocimetry,0
20832,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nystatin A1,0
20833,CDISC SDTM Unit of Measure Terminology,Cylinder Dosing Unit,0
20834,Pediatric Terminology,Proctitis,0
20835,Clinical Data Interchange Standards Consortium Terminology,MPAI-4 - Abilities: Attention or Concentration,0
20836,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Doxycycline,0
20837,Clinical Data Interchange Standards Consortium Terminology,"Oxygen measurement, partial pressure, arterial",0
20838,CDISC Questionnaire ADCS-ADL Test Name Terminology,ADCS-ADL - Subject Left on Their Own,0
20839,CDISC Questionnaire ADCS-ADL MCI Test Code Terminology,"ADCS-ADL MCI - Perform Pastime, Hobby or Game: Fishing",0
20840,CDISC Questionnaire AUDIT-SR Test Name Terminology,AUDIT - How Often Last Year You Feel Guilt or Remorse After Drinking,0
20841,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Piconol,0
20842,NCI CTEP SDC Embryonal Tumors of the CNS Sub-Category Terminology,Medulloblastoma,0
20843,FDA Established Names and Unique Ingredient Identifier Codes Terminology,FLUPIRTINE MALEATE,0
20844,"Geopolitical Entities, Names, and Codes Terminology",Norway,0
20845,CDISC Questionnaire SOAPP-R Test Code Terminology,SOAPP-R - Felt Craving for Medication,0
20846,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Calcium Carbonate,0
20847,CDISC SEND Variable Terminology,Tumor Findings Character Result in Standard Format,0
20848,CDISC SEND Terminology,Septal Perforator Artery,0
20849,NCI CTEP Simplified Disease Classification Terminology,Urothelial Carcinoma,0
20850,CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology,C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Specific Plan and Intent,0
20851,"Geopolitical Entities, Names, and Codes Terminology",Iraq,0
20852,CTRP Terminology,Tafamidis meglumine,0
20853,CDISC Questionnaire ADCS-ADL Test Code Terminology,ADCS-ADL - Left at Home for One Hour or Longer,0
20854,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Octafonium Chloride,0
20855,FDA Established Names and Unique Ingredient Identifier Codes Terminology,alacepril,0
20856,Clinical Data Interchange Standards Consortium Terminology,Graft Lesion Identification,0
20857,CDISC SDTM Country Terminology,Belgium,0
20858,NCI CTEP SDC Melanoma Sub-Category Terminology,melanoma,0
20859,FDA Established Names and Unique Ingredient Identifier Codes Terminology,delapril,0
20860,CDISC SDTM Laboratory Test Terminology by Code,LDH Isoenzyme 5 to LDH Ratio Measurement,0
20861,CDISC Functional Test AVLT-REY Test Code Terminology,AVLT-REY - List B Word 1,0
20862,CTRP Terminology,Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet,0
20863,CDISC Functional Test ADNI AVLT Test Code Terminology,ADNI AVLT - List A Recall 1 Word 5,0
20864,CDISC SDTM Terminology,AUDIT - Concerned About Your Drinking,0
20865,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"3,4-Methylenedioxyamphetamine",0
20866,CTRP Terminology,Childhood Langerhans Cell Histiocytosis,0
20867,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Silicon Dioxide,0
20868,CDISC QRS Terminology,OAB-q Short Form - Interfered with Getting Sleep,0
20869,Clinical Data Interchange Standards Consortium Terminology,Beta 2 globulin measurement,0
20870,FDA Established Names and Unique Ingredient Identifier Codes Terminology,ustekinumab,0
20871,CDISC SEND Terminology,Gigabecquerel per Milligram,0
20872,CDISC Questionnaire Terminology,CDISC ADAS-Cog - Spoken Language Ability,0
20873,Pediatric Terminology,Thrombocytopenia-Absent Radius Syndrome,0
20874,CDISC SEND Terminology,Tablet for Solution Dosage Form,0
20875,CDISC SDTM Terminology,Moraxella <genus>,0
20876,CDISC SDTM Terminology,ADCS-ADL MCI - List Hobbies Lost Ability to Perform,0
20877,CDISC Questionnaire Terminology,ADCS-ADL MCI - List Hobbies Lost Ability to Perform,0
20878,NCIt Antineoplastic Agent Terminology,Golvatinib,0
20879,Clinical Data Interchange Standards Consortium Terminology,electrocardiogram left posterior hemiblock (finding),0
20880,CDISC QRS Terminology,AVLT-REY - List B Word 11,0
20881,BPI Pain Rating Likert Scale,Pain Rating Score 4,0
20882,NCIt Antineoplastic Agent Terminology,Bcl-Xs Adenovirus Vaccine,0
20883,CDISC Questionnaire ADAS-Cog CDISC Version Test Code Terminology,CDISC ADAS-Cog - Word Difficulty in Spontaneous Speech,0
20884,Neonatal Research Network Terminology,"Tyrosinemia, Type I",0
20885,FDA Established Names and Unique Ingredient Identifier Codes Terminology,FEDRILATE,0
20886,HL7 Unit of Measure Terminology,Tesla - unit,0
20887,CDISC SDTM Terminology,PROSQOLI - Pain,0
20888,CDISC SEND Terminology,Fractional Excretion of Chloride,0
20889,CDISC SDTM Laboratory Test Terminology by Code,Alpha-GST Excretion Rate,0
20890,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trenbolone Acetate,0
20891,CDISC SEND Terminology,Leptomeningeal sarcoma,0
20892,CDISC SDTM Terminology,Disintegration per Minute per Milligram,0
20893,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Micro-International Units per Milliliter per Milligram per Meter Squared per Day,0
20894,FDA Established Names and Unique Ingredient Identifier Codes Terminology,flesinoxan,0
20895,CDISC SDTM Terminology,CD45 to Lymphocyte Ratio Measurement,0
20896,CDISC SDTM Microorganism Terminology,Proteus rettgeri,0
20897,Clinical Data Interchange Standards Consortium Terminology,Proteus rettgeri,0
20898,CTRP Terminology,Cancer Other,0
20899,FDA Established Names and Unique Ingredient Identifier Codes Terminology,pidobenzone,0
20900,Pediatric Terminology,Pseudovaginal Perineoscrotal Hypospadias,0
20901,Comprehensive Score for Financial Toxicity,Feel No Choice about Amount of Money Spent on Care,0
20902,CDISC SEND Biospecimens Terminology,Obex Region,0
20903,NCI CTEP Simplified Disease Classification Terminology,NCI CTEP SDC Germ Cell Tumors of the CNS Sub-Category Terminology,0
20904,CDISC SDTM Laboratory Test Terminology by Code,Fractional excretion of phosphate,0
20905,CDISC SEND Terminology,Fractional excretion of phosphate,0
20906,CDISC SDTM Terminology,Maximum Concentration Normalized by Body Mass Index,0
20907,CDISC Questionnaire MNSI Test Code Terminology,MNSI - Physical Assessment Total Score,0
20908,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Hydrazine sulfate,0
20909,CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Code Terminology,C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Specific Plan and Intent,0
20910,NCIt Antineoplastic Agent Terminology,HE 3235,0
20911,Pediatric Terminology,Urgency of micturition,0
20912,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cypripedium parviflorum var. pubescens,0
20913,CTRP Terminology,Gastrointestinal Carcinoid Tumor,0
20914,Neonatal Research Network Terminology,Early fetal heart deceleration,0
20915,CDISC SDTM Terminology,Observed Area Under the Urinary Excretion Rate Curve Percent Extrapolation,0
20916,NCIt Antineoplastic Agent Terminology,Anti-MUC1 Monoclonal Antibody BTH1704,0
20917,CDISC SDTM Terminology,ADCS-ADL MCI - Subscore for Items 4 to 7,0
20918,CDISC SEND Tumor Findings Results Terminology,Benign Histiocytoma,0
20919,NCIt Antineoplastic Agent Terminology,MART-1 Adenovirus Vaccine,0
20920,Quality of Life Questionnaire-Brain Neoplasm 20,Have Had Seizures,0
20921,NCPDP Strength Form Terminology,Lyophilized powder for suspension for injection,0
20922,CDISC SDTM Microorganism Terminology,Rahnella aquatilis,0
20923,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dextroamphetamine Phosphate,0
20924,CDISC Questionnaire Terminology,PHQ Screener Version - Often Eat Large Amount Food,0
20925,CDISC SEND Terminology,Scaphoid-Trapezium Joint,0
20926,CTRP Terminology,Raloxifene,0
20927,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nifurquinazol,0
20928,CDISC SDTM Anatomical Location Terminology,Structure of triangular bone,0
20929,CDISC SDTM Laboratory Test Terminology by Name,Chlamydia trachomatis IgG antibody test,0
20930,Clinical Data Interchange Standards Consortium Terminology,Nanomole per Liter per Milligram per Kilogram,0
20931,Clinical Data Interchange Standards Consortium Terminology,MPAI-4 - Abilities: Fund of Information,0
20932,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,AUC Over Dosing Interval Normalized by Body Mass Index,0
20933,Location of Event Occurrence ICSR Terminology,Cardiac Catheterization Suite,0
20934,Stability Product Form Terminology,Cone Dosage Form,0
20935,CDISC Questionnaire C-SSRS Children's Since Last Visit Test Code Terminology,C-SSRS Children's Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt,0
20936,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Triprolidine,0
20937,CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Name Terminology,RAND-36 - Health Limit Moderate Activities,0
20938,Pediatric Terminology,Systemic lupus erythematosus disease activity index,0
20939,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Ticagrelor,0
20940,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tocoretinate,0
20941,CDISC QRS Terminology,MFIS - Have Trouble Finishing Tasks That Require Thinking,0
20942,CDISC SDTM Terminology,Mole per Liter,0
20943,CareLex eTMF Terminology,Clinical Trial Regulatory Approval Documentation,0
20944,CTRP Terminology,Uterine Cancer,0
20945,Clinical Data Interchange Standards Consortium Terminology,Thousand per Deciliter,0
20946,CDISC SDTM Laboratory Test Terminology by Code,Sjogrens SS-A52 Antibody Measurement,0
20947,Clinical Data Interchange Standards Consortium Terminology,PROSQOLI - Constipation,0
20948,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Mycophenolic Acid,0
20949,FACT-Cx Questionnaire,Have Discomfort When Urinating,0
20950,CDISC SEND Terminology,Type II Collagen N-Telopeptide Measurement,0
20951,CDISC SEND Terminology,Perforation (observation),0
20952,US Counties Terminology,"Hays County, TX",0
20953,CTRP Terminology,Hypopharyngeal Carcinoma,0
20954,CDISC SDTM Laboratory Test Terminology by Code,Proinsulin to Insulin Ratio Measurement,0
20955,CDISC Questionnaire Terminology,MPAI-4 - Abilities: Visuospatial Abilities,0
20956,CDISC SEND Terminology,Unit of Gravity,0
20957,Newborn Screening Terminology,Physical Symmetry,0
20958,FDA Established Names and Unique Ingredient Identifier Codes Terminology,POLYETHYLENE GLYCOL 200,0
20959,CDISC SDTM Terminology,ECG Evaluator Blinding Parameters,0
20960,Neurological Development Terminology,Cerebral Palsy,0
20961,CDISC Questionnaire ADCS-ADL MCI Test Code Terminology,ADCS-ADL MCI - Subscore for Items 13 to 14,0
20962,US Counties Terminology,"Adams County, PA",0
20963,Clinical Data Interchange Standards Consortium Terminology,Malta,0
20964,CDISC Questionnaire Terminology,COWS - Tremor,0
20965,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Alfalfa sprout,0
20966,US Counties Terminology,"Butler County, PA",0
20967,CDISC SEND Terminology,Coarse Granular Cast Measurement,0
20968,Clinical Data Interchange Standards Consortium Terminology,FAI - Free androgen index measurement,0
20969,FDA Established Names and Unique Ingredient Identifier Codes Terminology,AQ4N,0
20970,CDISC Questionnaire Terminology,C-SSRS Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act,0
20971,CTRP Terminology,Stage 0 Vaginal Cancer AJCC v7,0
20972,CDISC SDTM Microorganism Terminology,Exiguobacterium acetylicum,0
20973,Cancer Patient Tobacco Use Questionnaire,Last Smoked a Cigarette Less than One Year Ago,0
20974,CDISC Questionnaire FACIT-F Version 4 Test Code Terminology,FACIT-F Version 4 - Trouble Meeting Needs of Family,0
20975,CDISC SDTM Unit of Measure Terminology,Cubic Meter,0
20976,CDISC SDTM Microorganism Terminology,Brevundimonas,0
20977,FDA Established Names and Unique Ingredient Identifier Codes Terminology,chloromethyl methyl ether,0
20978,US Counties Terminology,"Hill County, TX",0
20979,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Omeprazole,0
20980,CDISC SDTM Microorganism Terminology,Exiguobacterium,0
20981,NCPDP Strength Form Terminology,Gastro-resistant oral pellets capsule,0
20982,CDISC QRS Terminology,HAQ-DI With VAS - Help From Another Person - Errands and Chores,0
20983,Pediatric Adverse Events Terminology,Dysuria,0
20984,FDA Established Names and Unique Ingredient Identifier Codes Terminology,aziridine,0
20985,CDISC SDTM Terminology,m/s,0
20986,CDISC SEND Terminology,Concentrated Solution Dosage Form,0
20987,Clinical Data Interchange Standards Consortium Terminology,Temporal Lobe,0
20988,CTRP Terminology,B3(Fv)-PE38KDEL recombinant immunotoxin,0
20989,FDA Established Names and Unique Ingredient Identifier Codes Terminology,California juniper pollen extract,0
20990,CDISC SDTM Terminology,Paroxysmal ventricular tachycardia,0
20991,CDISC SDTM Trial Summary Parameter Terminology by Code,Protocol Keyword,0
20992,CDISC SEND Study Category Terminology,Pharmacology,0
20993,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tiflorex,0
20994,CDISC SDTM Terminology,Age at First Episode,0
20995,Clinical Data Interchange Standards Consortium Terminology,Tarsal Joints,0
20996,US Counties Terminology,"Shelby County, IA",0
20997,CTRP Agent Terminology,dotatate gallium ga-68,0
20998,CDISC Variable Terminology,Physical Examination Data Collection Day,0
20999,CTRP Agent Terminology,Calcitriol,0
21000,CDISC QRS Terminology,Expanded DRS-PI Caregiver Version - How They Communicate Primarily,0
21001,CTRP Terminology,Pancreatic Beta Cell Adenoma,0
21002,GAIA Terminology,GAIA Level 4 Ectopic Pregnancy,0
21003,CDISC Questionnaire Terminology,CDR - Sum of Boxes,0
21004,CVLT-C (California Verbal Learning Test Children's Version),T score,0
21005,Clinical Data Interchange Standards Consortium Terminology,MPAI-4 - Adjustment: Fatigue,0
21006,FDA Established Names and Unique Ingredient Identifier Codes Terminology,tertatolol,0
21007,CDISC QRS Terminology,C-SSRS Children's Baseline - Most Lethal Suicide Attempt Potential Lethality,0
21008,CDISC Questionnaire Terminology,C-SSRS Children's Baseline - Most Lethal Suicide Attempt Potential Lethality,0
21009,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cefminox,0
21010,CDISC SDTM Pharmacokinetic Parameter Short Name Terminology,AUMC Dosing to Last Concentration Normalized by Weight,0
21011,CDISC SDTM Terminology,Musculoskeletal System,0
21012,"Geopolitical Entities, Names, and Codes Terminology",Seychelles,0
21013,CDISC Observation Class Terminology,Normal Reference Range,0
21014,CTRP Terminology,Vandetanib,0
21015,CDISC SEND Terminology,Levocardia,0
21016,Clinical Data Interchange Standards Consortium Terminology,T25FW - More Than Two Attempts,0
21017,Clinical Data Interchange Standards Consortium Terminology,PHQ Screener Version - Feeling Your Heart Pound or Race,0
21018,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Sanguinaria canadensis root extract,0
21019,CDISC Questionnaire HAMA Test Name Terminology,HAMA - Intellectual,0
21020,CDISC QRS Terminology,HAMA - Intellectual,0
21021,CDISC SEND Terminology,Leghorn chicken,0
21022,CDISC Questionnaire Terminology,C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Past 6 Months),0
21023,NCIt Antineoplastic Agent Terminology,phenylacetate,0
21024,CTRP Terminology,Lanreotide Long-Acting Aqueous Gel,0
21025,CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Test Name Terminology,WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO Clinical Stage of HIV/AIDS,0
21026,CTRP Terminology,PSMA-targeted Docetaxel Nanoparticles BIND-014,0
21027,CDISC SDTM Terminology,WPAI:SHP v2.0 - Hours Actually Worked,0
21028,NCIt Antineoplastic Agent Terminology,HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine,0
21029,Observation ICSR Terminology,Length of Time between Product Exposure and Onset of Adverse Event Symptom,0
21030,CDISC SEND Terminology,Every Nineteen Hours,0
21031,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nitromifene Citrate,0
21032,CDISC Functional Test TUG Test Name Terminology,TUG - Time to Complete TUG Test,0
21033,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Taprizosin,0
21034,CDISC SDTM Terminology,Renal Clearance from T1 to T2 Normalized by Dose,0
21035,CDISC SDTM Microorganism Terminology,Mycoplasma hominis,0
21036,CTRP Disease Terminology,Granulomatous,0
21037,CTRP Agent Terminology,delanzomib,0
21038,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bevirimat Dimeglumine,0
21039,CDISC SDTM Terminology,Pericardial Wall,0
21040,FDA Established Names and Unique Ingredient Identifier Codes Terminology,phendimetrazine,0
21041,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Nemifitide,0
21042,CDISC Observation Class Terminology,Total Volume Administered Unit,0
21043,CDISC SEND Terminology,Cranial Nerves,0
21044,CDISC QRS Terminology,"PHQ Screener Version - Last 2 Weeks, Trouble Concentrating",0
21045,CDISC SDTM Terminology,Platelet Clumps Count,0
21046,CDISC SDTM Microorganism Terminology,Neisseria mucosa,0
21047,CTRP Terminology,"Trophoblastic tumor, epithelioid",0
21048,Clinical Data Interchange Standards Consortium Terminology,Femtogram per Milliliter per Microgram per Meter Squared per Day,0
21049,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trihexyphenidyl Hydrochloride,0
21050,CDISC SDTM Terminology,CRQ-SAS First Administration Version - Fatigue,0
21051,CDISC SDTM Laboratory Test Terminology by Name,Amorphous Crystal Measurement,0
21052,Clinical Data Interchange Standards Consortium Terminology,Liquid Dosage Form,0
21053,CDISC SDTM Terminology,Observational Study Sampling Method,0
21054,Clinical Data Interchange Standards Consortium Terminology,Observational Study Sampling Method,0
21055,CDISC Questionnaire Terminology,C-SSRS Baseline/Screening Version - Description of Aborted Suicide Attempt,0
21056,CDISC SEND Terminology,CDISC SEND Macroscopic Findings Test Name Terminology,0
21057,CTRP Terminology,Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A,0
21058,CDISC SEND Laboratory Animal Strain Terminology,Yucatan Miniature pig,0
21059,Modified Barium Swallow Impairment Profile,Initiation of Pharyngeal Swallow with Bolus Head a Posterior Laryngeal Surface of Epiglottis,0
21060,CDISC SDTM Terminology,FAMS - Feel Sense of Purpose in My Life,0
21061,FDA Established Names and Unique Ingredient Identifier Codes Terminology,resminostat,0
21062,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Name Terminology,Expanded DRS-PI Caregiver Version - Feed Independently Without Help,0
21063,CDISC SDTM Terminology,MPAI-4 - Participation: Other Employment,0
21064,CDISC QRS Terminology,KFSS - Other Functions,0
21065,CDISC SEND Terminology,Measurement of Bence Jones protein (procedure),0
21066,CDISC SDTM Terminology,WPAI:SHP v2.0 - Problem Affects Regular Daily Activity,0
21067,FDA Established Names and Unique Ingredient Identifier Codes Terminology,zolpidem,0
21068,CDISC SDTM Terminology,Human Epidermal Growth Factor Receptor 2 Measurement,0
21069,NCIt Antineoplastic Agent Terminology,Mouse Renal Adenocarcinoma Cell-Encapsulated Agarose-Agarose Macrobeads,0
21070,NCIt Antineoplastic Agent Terminology,acetylenic carbamate,0
21071,CDISC SDTM Unit of Measure Terminology,Billion Organisms per Milligram,0
21072,Regulated Product Submission Reporting Terminology,Study Reports and Related Information of Controlled Clinical Studies Pertinent to the Claimed Indication [Type of Control],0
21073,CDISC SDTM Terminology,EPIC-CP - Best Describes Urinary Control,0
21074,NCIt Neoplasm Core Terminology,Liver and Intrahepatic Biliary Tract Carcinoma,0
21075,CDISC Questionnaire Fatigue Severity Scale Test Code Terminology,FSS - Fatigue Prevents Sustained Physical Functioning,0
21076,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Almorexant,0
21077,Modified Barium Swallow Impairment Profile,Initiation of Pharyngeal Swallow with Bolus Head in Pyriforms,0
21078,FDA Device Component Code Hierarchy,EKG or ECG Device Subassembly Device,0
21079,Pediatric Adverse Events Terminology,Arch trunk position,0
21080,CDISC SEND Terminology,Central odontogenic fibroma,0
21081,FDA Established Names and Unique Ingredient Identifier Codes Terminology,acalabrutinib,0
21082,Pediatric Adverse Events Terminology,Medical Device Malfunction,0
21083,CDISC SEND Terminology,Minute Times Micromole per Liter per Meter Squared,0
21084,CDISC Questionnaire ADCS-ADL MCI Test Name Terminology,ADCS-ADL MCI - Description of Highest Level of Performance of Telephone Use,0
21085,CTRP Terminology,Lomustine,0
21086,CTRP Terminology,Positron-Emission Tomography,0
21087,NCPDP Strength Form Terminology,Oral Lozenge,0
21088,CDISC SDTM Terminology,Epidermal growth factor measurement,0
21089,US Counties Terminology,"McMullen County, TX",0
21090,CTRP Agent Terminology,Vandortuzumab Vedotin,0
21091,NCIt Antineoplastic Agent Terminology,Voxtalisib,0
21092,Clinical Data Interchange Standards Consortium Terminology,CDISC Questionnaire EXACT Test Name Terminology,0
21093,CDISC CDASH Unit of Drug Dispensed or Returned Terminology,Vial Dosing Unit,0
21094,CDISC SEND Terminology,Total Clearance Observed,0
21095,CDISC SDTM Terminology,RAND-36 - Health Limit Walking More Than A Mile,0
21096,CDISC SDTM Terminology,Staphylococcus kloosii,0
21097,CDISC SEND Terminology,Observed Volume of Distribution of Absorbed Fraction,0
21098,CDISC QRS Terminology,EPIC-CP - Problem Urinary Dripping/Leakage,0
21099,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"Cuttlefish, Dietary",0
21100,Stability Product Form Terminology,Graft Dosage Form,0
21101,Pediatric Infectious Disease Terminology,Mantoux test,0
21102,CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Name Terminology,RAND-36 - Health Limit Walking Several Blocks,0
21103,CDISC SEND Tumor Findings Test Code Terminology,Tumor Examination,0
21104,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Vinbarbital Sodium,0
21105,CDISC SDTM Terminology,FACT-P Version 4 - I Have Pain,0
21106,Clinical Data Interchange Standards Consortium Terminology,DNA Microarray Chip,0
21107,CTRP Agent Terminology,Oral Sodium Phenylbutyrate,0
21108,CDISC SDTM Terminology,Aerobic Gram Positive Bacillus,0
21109,CTRP Terminology,Biologic Sample Preservation Procedure,0
21110,CDISC SEND Terminology,Structure of vastus lateralis muscle,0
21111,CTRP Agent Terminology,Colchicine-Site Binding Agent ABT-751,0
21112,CTRP Agent Terminology,otlertuzumab,0
21113,CDISC SEND Terminology,Sperm Motility Measurement,0
21114,FDA Established Names and Unique Ingredient Identifier Codes Terminology,southern ragweed pollen extract,0
21115,CDISC SDTM Terminology,Academic Research Council Very Late Stent Thrombosis,0
21116,Pediatric Adverse Events Terminology,Paresthesia,0
21117,CDISC SDTM Terminology,peripheral blood,0
21118,CDISC Questionnaire Terminology,FACT-P Version 4 - Bothered by Treatment Side Effect,0
21119,Perinatal Terminology,Insufficient Breast Milk Syndrome,0
21120,CTRP Terminology,Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine,0
21121,NCIt Antineoplastic Agent Terminology,"3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea",0
21122,CDISC SDTM Terminology,Picogram per Day,0
21123,CDISC Functional Test Terminology,ADNI AVLT - List B Recall Word 11,0
21124,CTRP Agent Terminology,daratumumab,0
21125,SPL Flavor Terminology,crème de menthe,0
21126,FDA Stability Data Standards Terminology,Stability Study Storage Condition Terminology,0
21127,CDISC Questionnaire Terminology,SDS - Days Lost,0
21128,CDISC QRS Terminology,CCQ 1 Week Version - Breathing Problems Limit Daily Activity,0
21129,CDISC SEND Terminology,Consistency,0
21130,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Atinumab,0
21131,CTRP Agent Terminology,talactoferrin alfa,0
21132,CDISC QRS Terminology,VFQ25-Interviewer Administered Format - Don't Go Out of Home Alone Because of Eyesight,0
21133,CDISC SEND Terminology,Incus structure,0
21134,European Quality of Life Five Dimension Five Level Scale Questionnaire,Pain or Discomfort Today,0
21135,CDISC Functional Test Terminology,ADNI AVLT - List A Recall 6 (After B) Total,0
21136,Patient Problem Codes FDA CDRH,Tonic - clonic seizures,0
21137,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Parcetasal,0
21138,FDA Device Component Code Hierarchy,"Analyzer, device",0
21139,CDISC SDTM Terminology,Liter per Day per Microgram per Day,0
21140,CDISC SDTM Terminology,Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire,0
21141,Human Activity Profile Test,Vacuuming Carpets 5 Minutes Nonstop,0
21142,NCPDP Strength Form Terminology,Capsule 24 Hour Sustained Release Dosage Form,0
21143,CDISC Questionnaire Terminology,CRQ-SAS First Administration Version - Feeling Emotional,0
21144,CDISC QRS Terminology,VFQ25-Self Administered Format - Accomplish Less Because of Vision,0
21145,NCIt Antineoplastic Agent Terminology,Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008,0
21146,Clinical Data Interchange Standards Consortium Terminology,Rhodococcus,0
21147,CDISC SDTM Category of Oncology Response Assessment Terminology,Bruggemann MRD 2010 Oncology Response Criteria,0
21148,CDISC SDTM Reason Coronary Sinus Access or Left Ventricular Lead Not Implanted Terminology,Unable to Obtain Satisfactory Vascular Access,0
21149,CDISC SEND Terminology,Liter per Microgram per Minute,0
21150,Pediatric Terminology,Psychological Dependence,0
21151,CDISC SEND Tumor Findings Results Terminology,Benign Ovarian Sex Cord-Stromal Tumor,0
21152,Patient Problem Codes FDA CDRH,Heavier Menses,0
21153,NCIt Antineoplastic Agent Terminology,Lefitolimod,0
21154,CDISC SDTM Reproductive System Findings Test Code Terminology,ESTIMATED GESTATIONAL AGE,0
21155,CDISC SDTM Biospecimen Characteristics Test Name Terminology,size,0
21156,CDISC SDTM Terminology,Aggregate J-T Peak Interval,0
21157,Newborn Screening Terminology,Bacterial Infections,0
21158,FDA Individual Case Safety Report Terminology,Street address,0
21159,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Laurcetium,0
21160,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cefivitril,0
21161,Pediatric Terminology,Tracheal Diseases,0
21162,CDISC SDTM Terminology,Sharp van der Heijde Joint Space Narrowing Score,0
21163,US Counties Terminology,"Rensselaer County, NY",0
21164,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Menabitan Hydrochloride,0
21165,Vaccination Site on Body ICSR Terminology,Right gluteus medius,0
21166,US Counties Terminology,"Itasca County, MN",0
21167,CTRP Terminology,Testicular Mixed Choriocarcinoma and Seminoma,0
21168,CareLex eTMF Terminology,Clinical Trial Management Meeting Material,0
21169,Clinical Data Interchange Standards Consortium Terminology,"PHQ Screener Version - Last 2 Weeks, Trouble Falling or Staying Asleep",0
21170,CDISC SDTM Microorganism Terminology,Mannheimia haemolytica,0
21171,CDISC Questionnaire NPI Test Code Terminology,NPI - Hallucinations FxS Score,0
21172,CTRP Agent Terminology,Melphalan,0
21173,CDISC SEND Terminology,Upper,0
21174,Clinical Data Interchange Standards Consortium Terminology,Country of Turkey,0
21175,Pediatric Adverse Events Terminology,Intraocular Pressure Rise,0
21176,FACIT-Dyspnea 10 Item Short Form,Did Not Do This Past 7 Days,0
21177,CDISC SDTM Terminology,DRS - Feeding,0
21178,Pediatric Terminology,Congenital malformation syndrome,0
21179,Clinical Data Interchange Standards Consortium Terminology,Immature Monocyte to Leukocyte Ratio Measurement,0
21180,Pediatric Nephrology Terminology,Renal Tubular Acidosis Associated With Deafness,0
21181,US Counties Terminology,"Knox County, MO",0
21182,CDISC Questionnaire PR v1 Test Name Terminology,PR - Was There Perceptible Pain Relief,0
21183,Adverse Event Outcome ICSR Terminology,Not Applicable,0
21184,FDA Device Problem Code Hierarchy,Oversensing Medical Device Problem,0
21185,CDISC Variable Terminology,Clinical Events Sequence Number,0
21186,CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Code Terminology,C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Past 3 Months),0
21187,CDISC QRS Terminology,MSQOL-54 - Bodily Pain,0
21188,FDA Established Names and Unique Ingredient Identifier Codes Terminology,dexoxadrol hydrochloride,0
21189,CDISC Variable Terminology,Comment Value,0
21190,CDISC Questionnaire Terminology,PHQ Screener Version - Poor Appetite or Overeating,0
21191,Memorial Symptom Assessment Scale,Usual Severity Feeling Irritable,0
21192,CDISC QRS Terminology,ADCS-ADL - Pastime: Gardening,0
21193,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Hour Times Milligram Per Milliliter Per Milligram Per Gram,0
21194,CDISC Questionnaire Category Terminology,Alcohol Use Disorder Identification Test Self-Report Version Questionnaire,0
21195,CDISC QRS Terminology,C-SSRS Children's Baseline/Screening - First Suicide Attempt Actual Lethality/Medical Damage,0
21196,CDISC SEND Terminology,"Pheochromocytoma, malignant",0
21197,Clinical Data Interchange Standards Consortium Terminology,Tumor Complete Metabolic Response,0
21198,CDISC SEND Terminology,Sole of Foot,0
21199,CDISC SDTM Microorganism Terminology,Gram-Negative Anaerobic Cocci,0
21200,CDISC SDTM Priority of Tuberculosis Contact Terminology,Medium-priority Tuberculosis Subject,0
21201,CDISC SEND Terminology,continuous electrocardiogram sinus bradycardia (finding),0
21202,CTRP Intervention Terminology,Tethered Capsule Endoscope,0
21203,CDISC Questionnaire UPDRS Test Name Terminology,"UPDRS - Motor Examination: Leg Agility, Left",0
21204,CDISC CDASH Variable Terminology,Investigator Identifier,0
21205,Clinical Data Interchange Standards Consortium Terminology,whole blood specimen,0
21206,CDISC SDTM Laboratory Test Terminology by Code,Anti-Phospholipid IgG Antibody Measurement,0
21207,CDISC SDTM Anatomical Location Terminology,Thoracic esophagus,0
21208,CDISC SEND Terminology,Micromole Per Liter Per Second,0
21209,Dexamethasone Symptom Questionnaire-Chronic,Have Trouble Controlling Blood Sugar,0
21210,CDISC Variable Terminology,Clinical Events Start Date Time,0
21211,CDISC SDTM Terminology,SOAPP-R - Any Additional Information,0
21212,CDISC SDTM Terminology,Alpha Glucuronidase Measurement,0
21213,CDISC SDTM Terminology,C-SSRS Screening - Non-suicidal Self-injurious Behavior,0
21214,NCIt Antineoplastic Agent Terminology,monoclonal antibody 3F8,0
21215,CDISC Variable Terminology,Concomitant Medication Use Start Relative to Reference Period,0
21216,Clinical Data Interchange Standards Consortium Terminology,Area,0
21217,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Clopenthixol,0
21218,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cipropride,0
21219,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fiduxosin Hydrochloride,0
21220,CDISC SDTM ECG Finding Terminology,Ventricular Bigeminy by ECG Finding,0
21221,PROMIS Parent Proxy Short Form - Pain Interference,Child Had Trouble Sleeping When in Pain,0
21222,CDISC SEND Terminology,Iniencephaly,0
21223,CDISC SDTM Laboratory Test Terminology by Code,Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement,0
21224,FDA Established Names and Unique Ingredient Identifier Codes Terminology,broxaterol,0
21225,CDISC SDTM Terminology,COMM - Others Worry About Your Medications,0
21226,CDISC Variable Terminology,Microscopic Findings Location,0
21227,Pediatric Infectious Disease Terminology,Amebiasis,0
21228,Pediatric Adverse Events Terminology,Pharyngitis,0
21229,FACT-Ga Questionnaire,Digestive Problems Interfere with Usual Activities,0
21230,NCIt Antineoplastic Agent Terminology,EGFR Antagonist Hemay022,0
21231,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Code Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Specific Plan and Intent,0
21232,CDISC Questionnaire AQ20 Test Code Terminology,AQ20 - Partner Find Your Chest Trouble Upsetting,0
21233,Clinical Data Interchange Standards Consortium Terminology,AQ20 - Partner Find Your Chest Trouble Upsetting,0
21234,Pediatric Terminology,Adipose Tissue Deposition,0
21235,CTRP Agent Terminology,Mivebresib,0
21236,CDISC Questionnaire Terminology,UPDRS - Activities of Daily Living: Falling,0
21237,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Guanidine,0
21238,CTRP Agent Terminology,Immunomodulatory Agent CC-11006,0
21239,SPL Package Type Terminology,Package Type Not Applicable,0
21240,Regulated Product Submission Reporting Terminology,Patent Certification,0
21241,NCI CTEP Simplified Disease Classification Terminology,NCI CTEP SDC AIDS-related Malignancy and Condition Category Terminology,0
21242,CDISC SDTM Microorganism Terminology,Nocardia,0
21243,CDISC SDTM Terminology,Optical Mapping,0
21244,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Trodusquemine,0
21245,CDISC Functional Test Terminology,ADNI AVLT - List A 30 Min Delay Recall Word 15,0
21246,CDISC QRS Terminology,VFQ25-Interviewer Administered Format - Difficulty Going Down Steps at Night,0
21247,NCPDP Strength Unit of Measure Terminology,Kilogram per Cubic Meter,0
21248,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sunitinib,0
21249,CDISC SDTM Terminology,HAMD-17 - Genital Symptoms,0
21250,CDISC SDTM Cardiovascular Findings About Test Name Terminology,Heart Failure Therapy Intensification Type,0
21251,CDISC Questionnaire BPRS-A Test Name Terminology,BPRS-A - Hostility,0
21252,CTRP Terminology,High Dose Chemotherapy,0
21253,CDISC Questionnaire FACT-P Version 4 Test Name Terminology,FACT-P Version 4 - Trouble Meeting Needs of Family,0
21254,FDA Established Names and Unique Ingredient Identifier Codes Terminology,HC Red No. 3,0
21255,CDISC SDTM Terminology,Right atrial structure,0
21256,NCIt Antineoplastic Agent Terminology,CHP-HER-2 Peptide Vaccine,0
21257,CDISC SEND Terminology,Bone structure of shaft of fibula,0
21258,CDISC SDTM Terminology,Angiotensin converting enzyme measurement,0
21259,Pediatric Terminology,Cystic fibrosis with meconium ileus,0
21260,CDISC QRS Terminology,NPI - Describe Hearing Voices or Act as if He/She Hears Voices,0
21261,Clinical Data Interchange Standards Consortium Terminology,In Situ Hybridization,0
21262,CDISC SDTM Terminology,Yellow fever virus,0
21263,Clinical Data Interchange Standards Consortium Terminology,Complement C4a measurement,0
21264,NCIt Antineoplastic Agent Terminology,Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101,0
21265,Clinical Data Interchange Standards Consortium Terminology,Intracartilaginous Route of Drug Administration,0
21266,CDISC QRS Terminology,"PHQ-15 - Constipation, Loose Bowels, or Diarrhea",0
21267,US Counties Terminology,"Otero County, CO",0
21268,Clinical Data Interchange Standards Consortium Terminology,Glomerular Filtration Rate,0
21269,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Coconut Oil,0
21270,CDISC SDTM Laboratory Test Terminology by Name,Lysergic acid diethylamide measurement,0
21271,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Solitomab,0
21272,Pediatric Terminology,Goiter,0
21273,Pediatric Terminology,Coloboma of iris,0
21274,US Counties Terminology,"Dunn County, ND",0
21275,CDISC QRS Terminology,NPI - Talk to People Who Are Not There,0
21276,FACT-Ga Questionnaire,Have Difficulty Planning for Future Due to Illness,0
21277,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Migrenin,0
21278,CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology,C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Past 3 Months),0
21279,CDISC SDTM Terminology,Volume of Distribution for Dosing Interval Normalized by Dose,0
21280,Pediatric Terminology,Normal delivery,0
21281,Pediatric Adverse Events Terminology,Bulla,0
21282,CDISC SDTM Terminology,NCCN-FACT FKSI-19 Version 2 - Content With Quality of My Life,0
21283,CDISC Questionnaire Terminology,FOSI - I Have Been Vomiting,0
21284,CTRP Agent Terminology,Linsitinib,0
21285,CDISC SDTM Microorganism Terminology,Dorea,0
21286,FACT-Hep Questionnaire,Accepted Illness,0
21287,Pediatric Terminology,Pyramidal Tract Dysfunction,0
21288,CDISC SDTM Terminology,Day Times Gram Per Milliliter Per Kilogram,0
21289,Pediatric Terminology,Renal Artery Stenosis,0
21290,Patient Problem Codes FDA CDRH,Keratitis,0
21291,CDISC SDTM Terminology,Head of femur,0
21292,Clinical Data Interchange Standards Consortium Terminology,Concentration Divided by Dose,0
21293,CDISC SDTM Pharmacokinetic Parameter Long Name Terminology,Concentration Divided by Dose,0
21294,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cyclophenazine,0
21295,CDISC SDTM Holter ECG Results Terminology,ECG Evaluation Not Performed Due to Corrupted Digital ECG File,0
21296,CTRP Agent Terminology,Iodine I 124-cRGDY-PEG-C Dots,0
21297,CDISC SDTM Terminology,MDS-UPDRS - Sleep Problems,0
21298,CDISC SDTM Cardiovascular Test Name Terminology,"Mass, a measure of quantity of matter",0
21299,CDISC SEND Terminology,Right lobe of liver,0
21300,CDISC Questionnaire Terminology,HADS - Total Score Anxiety,0
21301,CDISC QRS Terminology,SF-MPQ-2 - Splitting Pain,0
21302,CDISC QRS Terminology,CDISC ADAS-Cog - Orientation: Time,0
21303,NCIt Antineoplastic Agent Terminology,MVF-HER-2(628-647)-CRL 1005 Vaccine,0
21304,FDA Established Names and Unique Ingredient Identifier Codes Terminology,timcodar,0
21305,CDISC SDTM Laboratory Test Terminology by Name,Megakaryoblast to Total Cell Ratio Measurement,0
21306,FDA Established Names and Unique Ingredient Identifier Codes Terminology,sitagliptin phosphate,0
21307,CDISC SDTM Specimen Type Terminology,Umbilical Cord Blood,0
21308,Clinical Data Interchange Standards Consortium Terminology,mL/cm H2O,0
21309,Clinical Data Interchange Standards Consortium Terminology,HLA DR antigen typing,0
21310,CDISC SDTM Terminology,Interrupter Technique,0
21311,SPL REMS Requirement Terminology,Do Not Dispense Refills,0
21312,Pediatric Terminology,Infection of peritoneal dialysis catheter,0
21313,Clinical Data Interchange Standards Consortium Terminology,ADNI AVLT - List A Recall 4 Word 6,0
21314,Clinical Data Interchange Standards Consortium Terminology,NPI - Describe Feeling Things on His/Her Skin,0
21315,Clinical Data Interchange Standards Consortium Terminology,RAND-36 - Felt Calm and Peaceful,0
21316,US Counties Terminology,"Crawford County, GA",0
21317,Clinical Data Interchange Standards Consortium Terminology,RDQ - Go Upstairs More Slowly,0
21318,CDISC SDTM Laboratory Test Terminology by Name,Metamyelocyte to Total Cell Ratio Measurement,0
21319,Clinical Data Interchange Standards Consortium Terminology,Metamyelocyte to Total Cell Ratio Measurement,0
21320,CDISC SDTM Terminology,Cuspid,0
21321,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cysteine,0
21322,FDA Established Names and Unique Ingredient Identifier Codes Terminology,alpha-aminobutyric acid,0
21323,CDISC Questionnaire C-SSRS Screening Test Name Terminology,C-SSRS Screening - Actual Suicide Attempt,0
21324,CDISC SDTM Unit of Measure Terminology,Cup Dosing Unit,0
21325,CDISC SDTM Terminology,Fresh Specimen,0
21326,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Agrostis gigantea Pollen,0
21327,Female Sexual Function Index,Level of Sexual Desire or Interest,0
21328,CDISC SEND Chronicity Terminology,Chronic active,0
21329,Pediatric Terminology,Oral candidiasis,0
21330,US Counties Terminology,"Kearney County, NE",0
21331,CDISC SEND Terminology,Thousand Colony Forming Units per Milliliter,0
21332,Clinical Data Interchange Standards Consortium Terminology,Prevotella buccae,0
21333,CDISC SDTM Terminology,CDISC SDTM Microbiology Test Name Terminology,0
21334,NCPDP Quantity Unit of Measure Terminology,Tray Dosing Unit,0
21335,Pediatric Terminology,Motor restlessness,0
21336,Patient Problem Codes FDA CDRH,Cicatrix,0
21337,CDISC SEND Terminology,Parasite Present,0
21338,Perinatal Terminology,Acardius,0
21339,CDISC Variable Terminology,Clinical Observations Body System or Organ Class,0
21340,Clinical Data Interchange Standards Consortium Terminology,Kinked Tail,0
21341,CDISC QRS Terminology,CDISC Questionnaire C-SSRS Baseline/Screening Version Test Code Terminology,0
21342,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Acer negundo,0
21343,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cephalexin hydrochloride,0
21344,HL7 Unit of Measure Terminology,International Steam Table Calorie,0
21345,Australia-Modified Karnofsky Performance Scale,Karnofsky Performance Status 80,0
21346,CDISC SDTM Terminology,Day Times Nanomole Per Liter Per Kilogram,0
21347,CDISC Variable Terminology,Microbiology Specimen Time Point Reference,0
21348,CDISC SDTM Terminology,CDISC Questionnaire EQ-5D-3L Test Name Terminology,0
21349,UCUM Terminology,Milliliter per Minute per 1.73 m2 of Body Surface Area,0
21350,CDISC SDTM Unit of Measure Terminology,Million per High Powered Field,0
21351,CTRP Terminology,Stage IV Penile Cancer AJCC v7,0
21352,CDISC Clinical Classification Terminology,HAMD-21 - Depressed Mood,0
21353,CDISC SEND Domain Abbreviation Terminology,Palpable Masses Domain,0
21354,NCIt Antineoplastic Agent Terminology,Nitroarginine,0
21355,US Counties Terminology,"Santa Isabel Municipio, PR",0
21356,SPL Limitation of Use Terminology,Limitation of Use Based on Duration of Use,0
21357,CDISC SDTM Laboratory Test Terminology by Name,Cardiolipin IgG Antibody Measurement,0
21358,Australia-Modified Karnofsky Performance Scale,Karnofsky Performance Status 70,0
21359,CDISC SDTM Terminology,Sum of Longest Perpendiculars,0
21360,CDISC SDTM Terminology,CDISC Questionnaire EQ-5D-3L Test Code Terminology,0
21361,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Name Terminology,Expanded DRS-PI Caregiver Version - Successful With Limited Choices,0
21362,CDISC SDTM Terminology,CCQ 1 Week Version - Concern About Breathing Get Worse,0
21363,CTRP Terminology,Acoustic Radiation Force Impulse Imaging,0
21364,NCIt Neoplasm Core Terminology,Perineurioma,0
21365,CDISC Questionnaire Terminology,CDISC Questionnaire GDS Test Code Terminology,0
21366,Clinical Data Interchange Standards Consortium Terminology,Caliciviridae,0
21367,UCUM Terminology,10*9 cells/L,0
21368,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Chlormethiazole,0
21369,CDISC SDTM Terminology,Liter per minute per meter squared,0
21370,CDISC SDTM Terminology,Balloon aortic valvotomy,0
21371,Pediatric Adverse Events Terminology,Beau's lines,0
21372,CDISC SEND Terminology,Pronormoblast to Total Cell Ratio Measurement,0
21373,CDISC SDTM Terminology,CCQ 1 Week Version - Depressed Because of Breathing Problem,0
21374,CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Code Terminology,Expanded DRS-PI Caregiver Version - Function With Independent Work or Social Situations,0
21375,Clinical Data Interchange Standards Consortium Terminology,Beta-glucuronidase measurement,0
21376,CTRP Terminology,Nutritional Supplement Drink,0
21377,Clinical Data Interchange Standards Consortium Terminology,Glutamic Acid Decarboxylase 2 Antibody Measurement,0
21378,Clinical Data Interchange Standards Consortium Terminology,Microsporum fulvum,0
21379,CDISC Questionnaire Terminology,PHQ-15 - Chest Pain,0
21380,CDISC SDTM Terminology,Echovirus,0
21381,CDISC Questionnaire FAMS Test Name Terminology,FAMS - Trouble Learning New Tasks or Directions,0
21382,CDISC SEND Cardiovascular Test Name Terminology,Pressure at dP/dt Minimum,0
21383,CDISC SDTM Terminology,Bifidobacterium longum,0
21384,Brief Fatigue Inventory,Fatigue Interferes with Work,0
21385,FDA Established Names and Unique Ingredient Identifier Codes Terminology,histapyrrodine,0
21386,CDISC SEND Non-Neoplastic Finding Type Terminology,Spermatic Stasis,0
21387,CDISC SDTM Laboratory Test Terminology by Code,Cholesterol to HDL-Cholesterol Ratio Measurement,0
21388,Pediatric Adverse Events Terminology,Skin depigmented,0
21389,CDISC SEND Terminology,Folic acid measurement,0
21390,CDISC SDTM Terminology,Picogram per Milliliter per Kilogram per Meter Squared,0
21391,Neonatal Research Network Terminology,Acute Kidney Tubular Necrosis,0
21392,Clinical Data Interchange Standards Consortium Terminology,Arthroderma obtusum,0
21393,Clinical Data Interchange Standards Consortium Terminology,"Rats, Cotton",0
21394,US Counties Terminology,"Sierra County, CA",0
21395,CDISC SEND Terminology,Anesthetized Lethal Injection Exsanguination Euthanasia,0
21396,CDISC QRS Terminology,NCCN-FACT FKSI-19 Version 2 - Worry My Condition Will Get Worse,0
21397,CDISC Questionnaire FAMS Test Name Terminology,FAMS - Feel Close to My Friends,0
21398,CareLex eTMF Terminology,Clinical Trial Team Documentation,0
21399,CDISC SDTM Unit of Measure Terminology,Daily,0
21400,Neonatal Research Network Terminology,Severe Bronchopulmonary Dysplasia,0
21401,CDISC SDTM PK Unit of Measure Microgram Dose Terminology,Gram per Milliliter per Microgram per Kilogram per Day,0
21402,Clinical Data Interchange Standards Consortium Terminology,Institution Not Defined,0
21403,CDISC SDTM Laboratory Test Terminology by Name,Free Carnitine Measurement,0
21404,Pediatric Adverse Events Terminology,Acquired Immunodeficiency Syndrome,0
21405,CDISC SDTM Terminology,Estrogen Receptor Measurement,0
21406,CDISC Questionnaire FAMS Test Code Terminology,FAMS - Get Emotional Support From Family,0
21407,Clinical Data Interchange Standards Consortium Terminology,CDISC CDASH Unit for Duration of Treatment Interruption Terminology,0
21408,NCPDP Strength Form Terminology,Ophthalmic Gel,0
21409,NCIt Antineoplastic Agent Terminology,Autologous MAGE-A3-specific HLA-A*01-Restricted T Cell Receptor Gene Engineered Lymphocytes,0
21410,US Counties Terminology,"Saginaw County, MI",0
21411,CDISC Questionnaire NPI Test Code Terminology,NPI - Rummage Around Opening and Unpacking Drawers or Closets,0
21412,NCIt Antineoplastic Agent Terminology,liarozole fumarate,0
21413,Clinical Data Interchange Standards Consortium Terminology,Expanded DRS-PI Caregiver Version - Perform Jobs or Manage a Home Independently,0
21414,CDISC SEND Biospecimens Terminology,Medulla Oblongata,0
21415,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline",0
21416,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Abies grandis Pollen,0
21417,CTRP Terminology,NovoTTF-100A Device,0
21418,CDISC QRS Terminology,CDISC Questionnaire EPIC-26 Test Code Terminology,0
21419,SPL Pharmaceutical Dosage Form Terminology,Powder for Solution Dosage Form,0
21420,Clinical Data Interchange Standards Consortium Terminology,Thyroperoxidase antibody assay,0
21421,CDISC SDTM Country Terminology,Liberia,0
21422,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Taraxacum officinale leaf extract,0
21423,NCPDP Strength Form Terminology,Ophthalmic Irrigation Solution,0
21424,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Faxeladol Hydrochloride,0
21425,CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Name Terminology,NCCN-FACT FKSI-19 Version 2 - Bothered by Treatment Side Effect,0
21426,CTRP Terminology,NY-ESO-1 Reactive TCR Retroviral Vector Transduced Autologous PBL,0
21427,FDA Established Names and Unique Ingredient Identifier Codes Terminology,taurultam,0
21428,CDISC SDTM Laboratory Test Terminology by Name,Aspartate Aminotransferase to Creatinine Ratio Measurement,0
21429,Perinatal Terminology,Neonatal hypoglycemia,0
21430,Regulated Product Submission Reporting Terminology,Fast Track Designation Withdrawal Request,0
21431,US Counties Terminology,"Marion County, MS",0
21432,CDISC Variable Terminology,Macroscopic Findings Anatomical Region of Specimen,0
21433,CTRP Terminology,Askin's tumor,0
21434,CDISC SDTM Terminology,C-SSRS Baseline/Screening Version - Wish to be Dead (Lifetime),0
21435,Clinical Data Interchange Standards Consortium Terminology,"Leydig cell tumor, benign",0
21436,Clinical Data Interchange Standards Consortium Terminology,Intervertebral disc structure,0
21437,CDISC Variable Terminology,Subject Status Reason Not Done,0
21438,CTRP Agent Terminology,docetaxel,0
21439,Pediatric Rheumatology Terminology,Biological Factors,0
21440,CDISC SDTM Terminology,CHART-SF Interview Version - Initiated Conversation With Strangers Last Month,0
21441,CDISC Questionnaire Terminology,NPI - Argumentative and Difficult to Get Along With,0
21442,NCIt Antineoplastic Agent Terminology,Anti-DKK-1 Monoclonal Antibody LY2812176,0
21443,Stability Product Form Terminology,Powder for prolonged-release suspension for injection,0
21444,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Liter per Hour per Milligram per Kilogram,0
21445,Clinical Data Interchange Standards Consortium Terminology,Liter per Hour per Milligram per Kilogram,0
21446,Pediatric Terminology,Hepatorenal Syndrome,0
21447,Clinical Data Interchange Standards Consortium Terminology,NCCN-FACT FOSI-18 Version 2 - I Have a Lack of Energy,0
21448,CDISC Questionnaire NCCN-FACT FOSI-18 Version 2 Test Code Terminology,NCCN-FACT FOSI-18 Version 2 - I Have a Lack of Energy,0
21449,CDISC Questionnaire Terminology,C-SSRS Since Last Visit - Duration of Most Severe Ideation,0
21450,CTRP Agent Terminology,Minocycline-EDTA,0
21451,Clinical Data Interchange Standards Consortium Terminology,Signal Recognition Particle RNA,0
21452,NCIt Antineoplastic Agent Terminology,2-fluoroadenine,0
21453,US Counties Terminology,"Haskell County, OK",0
21454,CDISC SEND Method of Termination Terminology,Intraperitoneal Lethal Injection Euthanasia,0
21455,CDISC SDTM Laboratory Test Terminology by Name,Angiotensinogen measurement,0
21456,CDISC Questionnaire Terminology,SF-MPQ-2 - Punishing-Cruel,0
21457,CDISC Questionnaire Short-Form MPQ-2 Test Name Terminology,SF-MPQ-2 - Punishing-Cruel,0
21458,Clinical Data Interchange Standards Consortium Terminology,HAMA - Somatic (Sensory),0
21459,CDISC Questionnaire Terminology,FACT-G Version 4 - I have pain,0
21460,CDISC SDTM Terminology,Pipe Dosing Unit,0
21461,Pediatric Terminology,Neurocutaneous Syndromes,0
21462,CTRP Terminology,Ultrasound Tomography,0
21463,CDISC SDTM Terminology,CDISC ADAS-Cog - Naming Objects and Fingers: 9,0
21464,CTRP Terminology,tolvaptan,0
21465,CTRP Agent Terminology,ofatumumab,0
21466,Perinatal Terminology,Umbilical cord occlusion,0
21467,NCIt Antineoplastic Agent Terminology,"2,3-dihydro-1H-imidazo(1,2-b)pyrazole",0
21468,Clinical Data Interchange Standards Consortium Terminology,Occipital part of scalp,0
21469,CDISC SEND Terminology,Tubulostromal Adenoma,0
21470,Clinical Data Interchange Standards Consortium Terminology,HAMA - Cardiovascular Symptoms,0
21471,Clinical Data Interchange Standards Consortium Terminology,Liter per Hour per Milligram per Meter Squared,0
21472,NCIt Antineoplastic Agent Terminology,taltobulin,0
21473,SPL Unit of Presentation Terminology,Inhaler Refill Dosing Unit,0
21474,Pediatric Terminology,Pyuria,0
21475,CDISC SEND Laboratory Animal Strain Terminology,db/db Mouse,0
21476,FDA Established Names and Unique Ingredient Identifier Codes Terminology,"1,2,6-hexanetriol",0
21477,CDISC SDTM Terminology,Megakaryoblast Cell Count,0
21478,CDISC SDTM Anatomical Location Terminology,Trapezoid bone structure,0
21479,CDISC SDTM Terminology,sq. cm,0
21480,CDISC Questionnaire ADAS-Cog CDISC Version Test Name Terminology,CDISC ADAS-Cog - Naming Objects and Fingers: 10,0
21481,US Counties Terminology,"Monroe County, WV",0
21482,Pediatric Terminology,amniotic fluid meconium stained,0
21483,US Counties Terminology,"Houston County, AL",0
21484,CTRP Agent Terminology,Conditionally Replicative Adenovirus 5/3-delta24,0
21485,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Dicyclomine,0
21486,CTRP Agent Terminology,Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809,0
21487,CDISC QRS Terminology,VFQ25-Self Administered Format - Difficulty Picking Out and Matching Own Clothes,0
21488,Clinical Data Interchange Standards Consortium Terminology,VFQ25-Self Administered Format - Difficulty Picking Out and Matching Own Clothes,0
21489,Clinical Data Interchange Standards Consortium Terminology,Experimental Organism Mesenchymal Proliferative Lesion,0
21490,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Pentylenetetrazole,0
21491,CTRP Terminology,metabolic abnormality assessment,0
21492,CTRP Terminology,Anti-von Willebrand Factor Nanobody,0
21493,SPL Unit of Presentation Terminology,Bead Dosing Unit,0
21494,NCI CTEP Simplified Disease Classification Terminology,NCI CTEP SDC Hematopoietic Neoplasm/Myeloma Category Terminology,0
21495,CDISC SDTM Terminology,HAQ-DI With VAS - Able to Dress Yourself,0
21496,Regulated Product Submission Reporting Terminology,Annotated Draft Labeling Text,0
21497,CDISC SDTM Terminology,Prostaglandin measurement,0
21498,NCIt Neoplasm Core Terminology,Serous Endometrial Intraepithelial Carcinoma,0
21499,Pediatric Terminology,Deep Vein Thrombosis,0
21500,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fenspiride,0
21501,CDISC SEND Terminology,Apolipoprotein CI Measurement,0
21502,CDISC SEND Terminology,mg/min,0
21503,FDA Established Names and Unique Ingredient Identifier Codes Terminology,hydroxyurea,0
21504,CDISC Variable Terminology,Morphology Reference Identifier,0
21505,CDISC QRS Terminology,SF-MPQ-2 - Pain Caused by Light Touch,0
21506,CDISC SDTM Microorganism Terminology,Kingella potus,0
21507,CDISC SDTM Terminology,11-Dehydro-Thromboxane B2 Measurement,0
21508,CDISC Questionnaire Terminology,CDISC Questionnaire RDQ Test Name Terminology,0
21509,CDISC SDTM Terminology,Anti BPI antibody level,0
21510,CDISC QRS Terminology,BPRS-A - Conceptual Disorganization,0
21511,CDISC SDTM Relation to Reference Period Terminology,Unknown,0
21512,CDISC SEND Terminology,Equatorial Guinea,0
21513,CDISC Questionnaire FACIT-F Version 4 Test Name Terminology,FACIT-F Version 4 - I Worry About Dying,0
21514,CDISC Observation Class Terminology,Accountable Party,0
21515,Clinical Data Interchange Standards Consortium Terminology,CDISC ADaM Date Imputation Flag Terminology,0
21516,Clinical Data Interchange Standards Consortium Terminology,Orthopoxvirus,0
21517,CTRP Terminology,Indium In 111 Anti-CD45 Monoclonal Antibody BC8,0
21518,CDISC Questionnaire MNSI Test Name Terminology,MNSI - Right Foot Infection,0
21519,FDA Established Names and Unique Ingredient Identifier Codes Terminology,seractide,0
21520,CDISC SEND Terminology,"ST Segment, T wave, and U wave ECG Assessment",0
21521,Clinical Data Interchange Standards Consortium Terminology,Hour Times Gram per Milliliter per Meter Squared,0
21522,Pediatric Terminology,Rhesus antibody titer measurement,0
21523,CDISC SEND Terminology,Idioventricular rhythm,0
21524,Perinatal Terminology,Face presentation,0
21525,FACT-Hep Questionnaire,Feel Close to Partner,0
21526,NCI CTEP Simplified Disease Classification Terminology,liposarcoma,0
21527,FDA Device Problem Code Hierarchy,Device Alarm System,0
21528,CDISC SDTM Unit of Measure Terminology,Milliliter per Cage per Day,0
21529,Clinical Data Interchange Standards Consortium Terminology,Bifidobacterium breve,0
21530,CDISC Questionnaire Terminology,C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Prior to Study Entry),0
21531,CTRP Terminology,LY2495655,0
21532,NCIt Neoplasm Core Terminology,Endometrial Small Cell Carcinoma,0
21533,US Counties Terminology,"Kent County, MD",0
21534,CDISC Questionnaire ADCS-ADL Test Name Terminology,ADCS-ADL - Usual Bowel and Bladder Function at Toilet,0
21535,NCPDP Strength Form Terminology,Cloth Dosage Form,0
21536,SPL Unit of Presentation Terminology,Piece Unit,0
21537,CDISC SDTM Terminology,Left Ventricular Conduction Delay by ECG Finding,0
21538,Pediatric Terminology,Maternal Proteinuria,0
21539,CDISC SDTM Terminology,Cadaveric Arterial Graft,0
21540,US Counties Terminology,"Kalamazoo County, MI",0
21541,CTRP Terminology,therapeutic autologous lymphocytes,0
21542,CDISC Questionnaire Terminology,Functional Assessment of Multiple Sclerosis Questionnaire,0
21543,GAIA Terminology,GAIA Level 1 Postnatally Diagnosed Congenital Microcephaly,0
21544,Pediatric Infectious Disease Terminology,Plague,0
21545,CDISC QRS Terminology,MNSI - Able to Sense Feet When Walking,0
21546,CDISC Variable Terminology,Healthcare Encounters Start Relative to Reference Timepoint,0
21547,CDISC SDTM Terminology,Cryotherapy,0
21548,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Intrusions 1,0
21549,FACT-M Questionnaire,Swelling Keeps Me from Doing Things I Want to Do,0
21550,CDISC SDTM Terminology,Cholesterol Crystal Measurement,0
21551,Clinical Data Interchange Standards Consortium Terminology,Andorra,0
21552,CDISC SEND Terminology,Intercellular Adhesion Molecule 1 Measurement,0
21553,Clinical Data Interchange Standards Consortium Terminology,UPDRS - UPDRS Total,0
21554,CDISC SDTM ECG Finding Terminology,Torsades de Pointes,0
21555,NCIt Antineoplastic Agent Terminology,Peptide 946 Melanoma Vaccine,0
21556,Clinical Data Interchange Standards Consortium Terminology,PHQ Screener Version - Anxiety Attack Sweat,0
21557,NCIt Neoplasm Core Terminology,Peritoneal cystic mesothelioma,0
21558,Clinical Data Interchange Standards Consortium Terminology,Hour Times Micromole per Liter per Kilogram per Meter Squared,0
21559,FDA Established Names and Unique Ingredient Identifier Codes Terminology,fonazine,0
21560,CDISC Variable Terminology,Findings About Events or Interventions Baseline Flag,0
21561,Clinical Data Interchange Standards Consortium Terminology,Albumin to Globulin Ratio Measurement,0
21562,CDISC SDTM Terminology,ADNI AVLT - List A Recall 2 Word 3,0
21563,CDISC Functional Test ADNI AVLT Test Name Terminology,ADNI AVLT - List A Recall 2 Word 3,0
21564,Clinical Data Interchange Standards Consortium Terminology,Right Ventricular Conduction Delay by ECG Finding,0
21565,CDISC Questionnaire Terminology,UPDRS - Motor Examination Sub-total,0
21566,CDISC SDTM Terminology,Non-HDL Cholesterol to HDL Cholesterol Ratio Measurement,0
21567,FACT-BR Questionnaire,Difficulty Expressing Thoughts,0
21568,Pediatric Nephrology Terminology,"Glomerulonephritis, Membranoproliferative",0
21569,CDISC SDTM Terminology,OAB-q - Frustrated Your Family and Friends,0
21570,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Tinzaparin sodium,0
21571,CDISC SDTM Terminology,RPQ - Any Other Difficulties 1 (number),0
21572,FDA Established Names and Unique Ingredient Identifier Codes Terminology,orotirelin,0
21573,FDA Established Names and Unique Ingredient Identifier Codes Terminology,bisdisulizole disodium,0
21574,CDISC SDTM Terminology,Which Diagnostic Criteria Met,0
21575,CDISC SDTM Terminology,Amygdaloid structure,0
21576,Medical Outcomes Study Your Feelings Questionnaire,Not Bothered at All,0
21577,CDISC SDTM Terminology,Triiodothyronine measurement,0
21578,CDISC SEND Terminology,Milliliter per Gram per Minute,0
21579,Pediatric Adverse Events Terminology,Chest Pain,0
21580,CDISC Questionnaire NPI Test Name Terminology,NPI - Rapidly Change Moods From One to Another,0
21581,NCIt Antineoplastic Agent Terminology,Tetanus Peptide Melanoma Vaccine,0
21582,Expanded Prostate Cancer Index Composite,How Big a Problem is Increased Frequency of Bowel Movements,0
21583,CDISC SDTM Device Tracking and Disposition Event Dictionary Derived Term Terminology,Implanted Medical Device (finding),0
21584,CDISC SDTM Terminology,Implanted Medical Device (finding),0
21585,Pediatric Infectious Disease Terminology,Common wart,0
21586,CDISC SDTM Evaluator Terminology,Research Personnel,0
21587,CDISC Variable Terminology,Palpable Masses Assessment Test Code,0
21588,CDISC SDTM Unit of Measure Terminology,Millijoules per Square Centimeter,0
21589,CDISC SDTM Terminology,umol/24h,0
21590,CDISC SDTM Terminology,NPI - Sudden Flares of Anger,0
21591,CDISC SDTM Tumor Response Result Terminology,Cytogenetic Minimal Response,0
21592,CDISC SDTM Laboratory Test Terminology by Name,Mycobacterium tuberculosis IgG Antibody Measurement,0
21593,FACT-P Questionnaire,How True,0
21594,Pediatric Terminology,Therapeutic procedure,0
21595,US Counties Terminology,"Morrill County, NE",0
21596,CDISC SEND Terminology,Vitamin B3 Assay,0
21597,Clinical Data Interchange Standards Consortium Terminology,Insignificant Disease by ECG Finding,0
21598,CDISC Questionnaire Terminology,ADCS-ADL Severe Dementia - Description of Optimal Performance of Grooming,0
21599,CDISC SDTM Terminology,Phialophora verrucosa,0
21600,CDISC CDASH Unit of Measure for Flow Rate Terminology,mL/min,0
21601,CDISC QRS Terminology,SOWS Subjective (Handelsman) - I Have Goose Flesh,0
21602,US Counties Terminology,"Sandusky County, OH",0
21603,CDISC QRS Terminology,AQ20 - Feel Drained After a Cold Because of Chest Trouble,0
21604,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cabergoline,0
21605,CTRP Terminology,Anti-IL-15 Monoclonal Antibody AMG 714,0
21606,CDISC Questionnaire EXACT Test Name Terminology,EXACT - Difficult to Bring Up Mucus,0
21607,NCIt Neoplasm Core Terminology,"Nevus, Blue",0
21608,CDISC SEND Terminology,Aggregate PP Interval,0
21609,CDISC SEND Terminology,Enzyme Unit,0
21610,CDISC Questionnaire Terminology,CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Code Terminology,0
21611,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cyclic GMP,0
21612,CDISC Questionnaire Terminology,VFQ25-Interviewer Administered Format - Worry About Embarrass Myself or Others Because of Eyesight,0
21613,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Bethanechol,0
21614,CDISC SDTM Terminology,Waldeyer's ring,0
21615,CDISC SDTM PK Unit of Measure Milligram Dose Terminology,Millimole per Liter per Gram,0
21616,CDISC Questionnaire Category Terminology,Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Questionnaire,0
21617,CDISC SDTM Terminology,Concentration measurement,0
21618,Pediatric Rheumatology Terminology,Parent Assessment of Overall Well-Being,0
21619,Newborn Screening Terminology,Multiple birth (finding),0
21620,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Piperocaine hydrochloride,0
21621,CDISC QRS Terminology,APACHE II - Mean Arterial Pressure,0
21622,NCIt Antineoplastic Agent Terminology,bisantrene dihydrochloride,0
21623,CDISC CDASH Terminology,CDISC CDASH Concomitant Medication Dose Form Terminology,0
21624,CDISC SDTM Terminology,Osmolality Measurement,0
21625,CDISC SDTM Terminology,FIQR - Memory Problems,0
21626,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Burodiline,0
21627,CDISC SDTM Microorganism Terminology,Enterobacter cancerogenus,0
21628,CDISC Questionnaire ADCS-ADL Severe Dementia Test Name Terminology,ADCS-ADL Severe Dementia - Description of Highest Performance of Telephone Use,0
21629,CDISC SDTM Country Terminology,Finland,0
21630,Pediatric Nephrology Terminology,Refluxing Obstructed Megaureter,0
21631,CDISC SDTM Relationship to Subject Terminology,organ donor,0
21632,CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Name Terminology,C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Since Study Start),0
21633,Clinical Data Interchange Standards Consortium Terminology,Percent Recovered Over Dosing Interval Normalized by Body Mass Index,0
21634,CDISC SEND Terminology,Mean Residence Time to Last Nonzero Concentration by Intravascular Dose,0
21635,NCIt Neoplasm Core Terminology,Digestive System Neuroendocrine Tumor G2,0
21636,Clinical Data Interchange Standards Consortium Terminology,Kidney Injury Molecule-1 Measurement,0
21637,Neonatal Research Network Terminology,Phenylalanine/tyrosine ratio measurement,0
21638,CTRP Terminology,Bone Marrow Ablation with Stem Cell Support,0
21639,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Thiothixene,0
21640,CTRP Agent Terminology,Acetylcysteine,0
21641,CDISC SDTM Terminology,Antithrombin Antigen Measurement,0
21642,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Fenoldopam Mesylate,0
21643,NCIt Neoplasm Core Terminology,Hybrid nerve sheath tumor,0
21644,CDISC SDTM Pharmaceutical Dosage Form Terminology,Gel,0
21645,Behavior Rating Inventory of Executive Function,Emotional Control Scale,0
21646,CTRP Disease Terminology,Seizures,0
21647,Clinical Data Interchange Standards Consortium Terminology,RDQ - Appetite is Not Very Good,0
21648,CDISC Questionnaire EQ-5D-3L Test Code Terminology,EQ-5D-3L - Pain or Discomfort,0
21649,NCIt Antineoplastic Agent Terminology,Green Tea Extract-based Antioxidant Supplement,0
21650,US Counties Terminology,"Taylor County, TX",0
21651,CDISC SDTM Terminology,Aggregate QT Interval,0
21652,CDISC SDTM ECG Test Terminology by Code,Aggregate QT Interval,0
21653,National Health Interview Survey,Primary Sampling Unit,0
21654,Clinical Data Interchange Standards Consortium Terminology,CDISC SDTM Drug Resistance Status Terminology,0
21655,CDISC Questionnaire C-SSRS Children's Since Last Visit Test Name Terminology,C-SSRS Children's Since Last Visit - Non-Specific Active Suicidal Thoughts,0
21656,Clinical Data Interchange Standards Consortium Terminology,Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire,0
21657,FDA CDRH GUDID Terminology,Ozone Sterilization,0
21658,Patient Problem Codes FDA CDRH,Upper Respiratory Infections,0
21659,Pediatric Infectious Disease Terminology,Upper Respiratory Infections,0
21660,FDA Individual Case Safety Report Terminology,Quantity Exactness,0
21661,Clinical Data Interchange Standards Consortium Terminology,SOWS Subjective (Handelsman) - I Feel Restless,0
21662,CDISC SDTM Route of Administration Terminology,Intradural Route of Administration,0
21663,FACT-G Questionnaire,Losing Hope Against Illness,0
21664,CDISC SDTM Terminology,Epiglottis structure,0
21665,US Counties Terminology,"Garfield County, WA",0
21666,CDISC Functional Test Terminology,Nine-Hole Peg Functional Test,0
21667,FDA Device Component Code Hierarchy,Endoscopes,0
21668,CDISC SDTM Laboratory Test Terminology by Name,Methylmalonic Acid Measurement,0
21669,FDA Established Names and Unique Ingredient Identifier Codes Terminology,penclomedine,0
21670,Clinical Data Interchange Standards Consortium Terminology,Prealbumin measurement,0
21671,CDISC Variable Terminology,Exposure End Date,0
21672,Clinical Data Interchange Standards Consortium Terminology,Beta-2 Glycoprotein Antibody Measurement,0
21673,CDISC SEND Terminology,Uveal melanoma,0
21674,CDISC Questionnaire EPIC-26 Test Name Terminology,EPIC-26 - Dripping or Leaking Urine,0
21675,CDISC Questionnaire ADCS-ADL Severe Dementia Test Code Terminology,ADCS-ADL Severe Dementia - Talk About TV Content While Watching,0
21676,Clinical Data Interchange Standards Consortium Terminology,Ultrasonography,0
21677,Pediatric Terminology,Ultrasonography,0
21678,Pediatric Terminology,Fryns syndrome,0
21679,CDISC SDTM Terminology,FACIT-F Version 4 - Losing Hope Against Illness,0
21680,CDISC SEND Laboratory Animal Strain Terminology,CB6F1-TgN (RasH2),0
21681,CDISC Questionnaire Terminology,C-SSRS Since Last Visit - Non-Specific Suicidal Thought,0
21682,US Counties Terminology,"Prentiss County, MS",0
21683,Clinical Data Interchange Standards Consortium Terminology,Apolipoprotein E4 Measurement,0
21684,integrated Cancer Repository for Cancer Research,"Helpers, Construction Trades",0
21685,US Counties Terminology,"Warren County, IN",0
21686,Clinical Data Interchange Standards Consortium Terminology,"UPDRS - Symptomatic Orthostasis: Pulse, Standing",0
21687,CDISC SDTM Microorganism Terminology,Candida pulcherrima,0
21688,PROMIS Parent Proxy Short Form - Pain Interference,Child Had Trouble Walking One Block When in Pain,0
21689,CTRP Terminology,Polyvalent Antigen-KLH Conjugate Vaccine,0
21690,FDA Established Names and Unique Ingredient Identifier Codes Terminology,clotiazepam,0
21691,CDISC Clinical Classification PANSS Test Name Terminology,PANSS - Tension,0
21692,CDISC SDTM Terminology,Proximal Interphalangeal Joint 4 of the Hand,0
21693,Clinical Data Interchange Standards Consortium Terminology,Yersinia <bacteria>,0
21694,CDISC SEND Terminology,Vitamin E to Cholesterol Ratio Measurement,0
21695,Neonatal Research Network Terminology,Heterotaxy Syndrome,0
21696,CDISC QRS Terminology,NPI - Say That He/She is Worried About Planned Events,0
21697,US Counties Terminology,"Accomack County, VA",0
21698,Pediatric Rheumatology Terminology,Immunologic Deficiency Syndromes,0
21699,CDISC SDTM Laboratory Test Terminology by Name,Beta Amyloid 42 Measurement,0
21700,Clinical Data Interchange Standards Consortium Terminology,Annular a' Velocity,0
21701,FDA Device Component Code Hierarchy,Probes,0
21702,CDISC SEND Biospecimens Terminology,Peritoneal Cavity,0
21703,NCIt Antineoplastic Agent Terminology,bendamustine,0
21704,CDISC SEND Terminology,Homocysteine measurement,0
21705,CDISC SDTM Terminology,D-Dimer Measurement,0
21706,CDISC QRS Terminology,UPDRS - Schwab and England % ADL (With Dyskinesia),0
21707,"Geopolitical Entities, Names, and Codes Terminology","Midway Islands, UM",0
21708,CDISC SEND Terminology,Microgram per Milliliter,0
21709,CDISC SDTM Terminology,Minute Times Nanomole per Liter per Kilogram per Meter Squared,0
21710,Decisional Conflict Scale,Know the Benefits of Each Option,0
21711,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Etibendazole,0
21712,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Methaqualone Hydrochloride,0
21713,FDA Established Names and Unique Ingredient Identifier Codes Terminology,cedar elm pollen extract,0
21714,US Counties Terminology,"Mason County, WV",0
21715,NCIt Antineoplastic Agent Terminology,Eflornithine Hydrochloride,0
21716,Pediatric Adverse Events Terminology,Pleocytosis,0
21717,FDA Established Names and Unique Ingredient Identifier Codes Terminology,Cocaine Hydrochloride,0
21718,CDISC QRS Terminology,PANSS - Motor Retardation,0
21719,CDISC Questionnaire C-SSRS Since Last Visit Test Code Terminology,C-SSRS Since Last Visit - Description of Ideation With Plan and Intent,0
21720,CDISC SEND Terminology,Oxygen saturation measurement,0
21721,CDISC SDTM Vital Sign Terminology by Name,Oxygen saturation measurement,0
21722,CTRP Terminology,Childhood Acute Lymphoblastic Leukemia in Remission,0
21723,CDISC SEND Terminology,Hydrorhachis,0
21724,CDISC QRS Terminology,CDISC Questionnaire ASEX-Male Version Test Name Terminology,0
21725,CTRP Agent Terminology,Golotimod,0
21726,CDISC SDTM Canadian Cardiovascular Society Classification Terminology,Canadian Cardiovascular Society Grading Scale Class II,0
21727,Patient Problem Codes FDA CDRH,Cephalhematoma due to birth trauma,0
21728,CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology,Minute Times Picogram per Milliliter per Kilogram per Meter Squared,0
21729,MD Anderson Symptom Inventory - Spine Tumor,Weakness in Arms and/or Legs at its Worst,0
21730,CDISC SDTM Method Terminology,Particle-Enhanced Turbidimetric Immunoassay,0
21731,FDA Established Names and Unique Ingredient Identifier Codes Terminology,remogliflozin etabonate,0
21732,DICOM Terminology,Age Started,0
21733,Neonatal Research Network Terminology,Hereditary Factor V Deficiency,0
21734,GAIA Terminology,GAIA Level 1 Major External Structural Defect,0
21735,Exophytic Papillary Lesion,Subglottic Verrucous Carcinoma,1
21736,Locally Aggressive Lesion,Prostate Stromal Proliferation of Uncertain Malignant Potential,1
21737,Hyperplastic Epithelial Tissue Present,Intraductal Breast Myoepitheliosis,1
21738,Malignant Cellular Infiltrate,Recurrent Mediastinal Lymphoma,1
21739,Acanthosis,Condyloma acuminata of vulva,1
21740,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
21741,Epithelial Component Present,Hilar Cholangiocarcinoma by AJCC v8 Stage,1
21742,Benign Cellular Infiltrate,Polyp of esophagus,1
21743,Malignant Cellular Infiltrate,Malignant mastocytosis,1
21744,Osseous Differentiation,Extraskeletal osteosarcoma metastatic,1
21745,Epithelial Component Present,keratoacanthoma,1
21746,Epithelial Component Present,Stage II Rectal Cancer AJCC v7,1
21747,Epithelial Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
21748,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
21749,Carcinomatous Component Present,Vaginal Small Cell Carcinoma,1
21750,Lytic lesion,"Bone Cysts, Aneurysmal",1
21751,In Situ Lesion,Cervical Adenocarcinoma In Situ,1
21752,Neuroendocrine Differentiation,Malignant Paraganglionic Neoplasm,1
21753,Diffuse Lesion,Nonencapsulated sclerosing tumor,1
21754,Malignant Cellular Infiltrate,Malignant neoplasm of spleen,1
21755,Epithelial Component Present,Adenocarcinoma of Accessory Sinus,1
21756,Neuroendocrine Differentiation,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
21757,Pseudopapillary Pattern,Ovarian Embryonal Carcinoma,1
21758,Tissue Differentiation Uncertain,Unresectable Synovial Sarcoma,1
21759,Malignant Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v6,1
21760,Childhood Lesion,Childhood Favorable Prognosis Hodgkin Lymphoma,1
21761,Malignant Cellular Infiltrate,Stage III Urethral Cancer AJCC v8,1
21762,Indolent Clinical Course,Chondroma,1
21763,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vagina,1
21764,Malignant Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Carcinoma,1
21765,Lymphoplasmacytic Infiltrate,Childhood Central Nervous System Germinoma,1
21766,Serrated Glandular Architecture,Colon Sessile Serrated Adenoma/Polyp,1
21767,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma,1
21768,Malignant Germinomatous Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
21769,Malignant Cellular Infiltrate,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",1
21770,Malignant Cellular Infiltrate,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
21771,Edematous Stroma Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
21772,Carcinomatous Component Present,Adenocarcinoma with squamous metaplasia,1
21773,Osseous Differentiation,Osteosarcoma recurrent,1
21774,Malignant Cellular Infiltrate,Gallbladder adenocarcinoma,1
21775,Malignant Cellular Infiltrate,Carcinoma Metastatic to the Skin,1
21776,Recurrent disease,Recurrent Subsequent Malignant Neoplasm,1
21777,Malignant Cellular Infiltrate,Chromophobe Renal Cell Carcinoma,1
21778,Indolent Clinical Course,Intravascular fasciitis,1
21779,Malignant Cellular Infiltrate,Refractory Female Reproductive System Carcinoma,1
21780,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma,1
21781,Metastatic Lesion,Locally Advanced Chordoma,1
21782,Epithelial Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v8,1
21783,More than 10 Mitoses per 10HPF,Small cell lung cancer recurrent,1
21784,Well-Circumscribed Lesion,Aldosterone-Producing Adrenal Cortex Adenoma,1
21785,Malignant Cellular Infiltrate,"Adenocarcinoma, Oxyphilic",1
21786,Malignant Cellular Infiltrate,Alveolar soft part sarcoma non-metastatic,1
21787,Carcinomatous Component Present,Breast Carcinoma by Gene Expression Profile,1
21788,Epithelial Component Present,Grade 3 Clear Cell Renal Cell Carcinoma,1
21789,Neoplastic Plasma Cells Present in Bone Marrow,DS Stage III Plasma Cell Myeloma,1
21790,Epithelial Component Present,External Ear Squamous Cell Carcinoma,1
21791,Cutaneous Involvement,Type D Lymphomatoid Papulosis,1
21792,Well-Circumscribed Lesion,"Phyllodes tumor, benign",1
21793,Chronic lymphocytic inflammation,"Thymoma, type B1",1
21794,Acanthosis,Lower Gingival Verrucous Carcinoma,1
21795,Epithelial Component Present,Ovarian Clear Cell Adenofibroma,1
21796,Well-Circumscribed Lesion,Rectal polyp,1
21797,Keratin pearl formation,External Ear Squamous Cell Carcinoma,1
21798,Malignant Cellular Infiltrate,Stage 0 Colorectal Cancer AJCC v6 and v7,1
21799,Malignant Cellular Infiltrate,Bartholin Gland Adenocarcinoma,1
21800,Metaplasia,Bladder squamous cell carcinoma stage II,1
21801,Malignant Cellular Infiltrate,Adult Acute Monocytic Leukemia,1
21802,Primary Lesion,Adult Brain Glioblastoma,1
21803,Carcinomatous Component Present,Combined Lung Small Cell and Squamous Cell Carcinoma,1
21804,Epithelial Component Present,Colorectal Sessile Serrated Adenoma/Polyp,1
21805,Solid Growth Pattern,Skin Nodular Solid Basal Cell Carcinoma,1
21806,Hyaline Cartilage Differentiation,Grade II Chondrosarcoma,1
21807,Diffuse Pattern,Recurrent Childhood Gemistocytic Astrocytoma,1
21808,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
21809,Epithelial Component Present,Malignant Cystosarcoma Phyllodes,1
21810,Diffuse Pattern,Plasmablastic Lymphoma of the Oral Mucosa,1
21811,Malignant Cellular Infiltrate,Stage IIIB Esophageal Cancer AJCC v7,1
21812,Diffuse Pattern,Childhood Diffuse Large B-Cell Lymphoma,1
21813,Cutaneous Involvement,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
21814,Carcinomatous Component Present,Bladder adenocarcinoma stage II,1
21815,Neuroendocrine Differentiation,Stage IA Lung Small Cell Carcinoma AJCC v7,1
21816,Carcinomatous Component Present,Stage IIIB Ovarian Cancer AJCC v8,1
21817,Immunologic Deficiency Syndromes,Chronic graft-versus-host disease,1
21818,Malignant Cellular Infiltrate,Stage 0is Ureter Cancer AJCC v7,1
21819,Carcinomatous Component Present,Vagina Carcinoma,1
21820,Unifocal Lesion,Pulmonary Histiocytosis X,1
21821,Carcinomatous Component Present,Advanced Laryngeal Squamous Cell Carcinoma,1
21822,Malignant Cellular Infiltrate,epithelial-myoepithelial carcinoma of lung,1
21823,Carcinomatous Component Present,Stage IIB Small Intestinal Adenocarcinoma AJCC v8,1
21824,Mixed Cellular Population,Infiltrating duct and lobular carcinoma,1
21825,Immunologic Deficiency Syndromes,AIDS-Related Malignant Neoplasm,1
21826,Low Mitotic Activity,Advanced Pancreatic Neuroendocrine Tumor,1
21827,High Mitotic Activity,"Leydig cell tumor, malignant",1
21828,Sarcomatous Component Present,Parotid Gland Carcinosarcoma,1
21829,Carcinomatous Component Present,Stage IV Oropharyngeal Carcinoma AJCC v7,1
21830,Recurrent disease,Recurrent Head and Neck Carcinoma,1
21831,Epithelial Component Present,Histiocytoid Breast Carcinoma,1
21832,Therapy-Related Toxicity,Transplant-Related Carcinoma,1
21833,Carcinomatous Component Present,Intestinal-Type Sinonasal Adenocarcinoma,1
21834,Malignant Cellular Infiltrate,"Leiomyosarcoma, Epithelioid",1
21835,Nuclear Grooves,Recurrent Thyroid Gland Papillary Carcinoma,1
21836,Epithelial Component Present,Stage IV Ampulla of Vater Cancer AJCC v8,1
21837,Carcinomatous Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
21838,Acanthosis,Condylomata Acuminata,1
21839,Encapsulated Mass,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
21840,Carcinomatous Component Present,Stage III Ovarian Cancer AJCC v8,1
21841,Villous Pattern,Colorectal Villous Adenoma,1
21842,CD56-Positive Neoplastic Cells Present,Refractory Aggressive NK-Cell Leukemia,1
21843,Epithelial Component Present,Low Grade Squamous Intraepithelial Neoplasia,1
21844,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with inv(X)(p11;q12),1
21845,Necrotic changes (finding),"Liposarcoma, Dedifferentiated",1
21846,High Mitotic Activity,Thymic Small Cell Carcinoma,1
21847,atypia morphology,Primary ameloblastic carcinoma,1
21848,Malignant Cellular Infiltrate,Cutaneous Lymphomatoid Granulomatosis,1
21849,Recurrent disease,Recurrent Endometrial Undifferentiated Carcinoma,1
21850,Carcinomatous Component Present,Major Salivary Gland Adenoid Cystic Carcinoma,1
21851,Multinodular Mass,Metastatic Dermatofibrosarcoma Protuberans,1
21852,Malignant Cellular Infiltrate,Lung Adenocarcinoma In Situ,1
21853,Myxoid Stroma Formation,Sellar Dedifferentiated Chordoma,1
21854,Benign Cellular Infiltrate,Benign neoplasm of retina,1
21855,Epithelial Component Present,Bladder papilloma,1
21856,Epithelial Component Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
21857,Carcinomatous Component Present,Small intestine carcinoma stage III,1
21858,Chronic lymphocytic inflammation,Eccrine spiradenoma,1
21859,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v7,1
21860,Nuclear Atypia,Epithelioid glioblastoma,1
21861,Carcinomatous Component Present,Stage IIIA Eyelid Carcinoma AJCC v7,1
21862,Juvenile Lesion,Juvenile cataract,1
21863,Carcinomatous Component Present,"Transitional cell carcinoma, micropapillary",1
21864,Nerve palsy,Acquired Facial Nerve Palsy,1
21865,Cellular Pleomorphism,"Perivascular epithelioid tumor, malignant",1
21866,Cartilaginous Differentiation,Dedifferentiated chondrosarcoma,1
21867,Poorly Differentiated Lesion,Large cell lung cancer stage II,1
21868,Regional Disease,Locally Advanced Bile Duct Carcinoma,1
21869,Well Differentiated Lesion,Grade I Chondrosarcoma,1
21870,Malignant Cellular Infiltrate,Stage III Intrahepatic Cholangiocarcinoma AJCC v8,1
21871,Dysplasia,Foveolar-Type Adenoma,1
21872,Diffuse Pattern,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
21873,Compartmentalized Pattern,Senile Sebaceous Hyperplasia,1
21874,Malignant Cellular Infiltrate,Refractory Hodgkin Lymphoma,1
21875,Solitary mass,Bronchioloalveolar Adenocarcinoma,1
21876,Primary Lesion,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
21877,Above the Diaphragm Disease,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
21878,Malignant Cellular Infiltrate,Unresectable Hepatocellular Carcinoma,1
21879,Epithelial Component Present,Epithelial-myoepithelial carcinoma,1
21880,Malignant Cellular Infiltrate,Platinum-Resistant Urothelial Carcinoma,1
21881,In Situ Lesion,Carcinoma in situ in a polyp,1
21882,Malignant Cellular Infiltrate,Infiltrating Urothelial Carcinoma,1
21883,Benign Cellular Infiltrate,Metanephric stromal tumor,1
21884,Nuclear Atypia,Multifocal Glioblastomas,1
21885,Well-Circumscribed Lesion,Ovarian Cystadenoma,1
21886,Malignant Cellular Infiltrate,Paget Disease of the Anus,1
21887,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of lung,1
21888,Malignant Cellular Infiltrate,Childhood Burkitt Leukemia,1
21889,Blasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic-Myeloproliferative Diseases,1
21890,Biphasic Pattern,Borderline Ovarian Endometrioid Cystadenofibroma,1
21891,Carcinomatous Component Present,Metastatic Prostate Small Cell Carcinoma,1
21892,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
21893,Locally Aggressive Lesion,Composite hemangioendothelioma,1
21894,Malignant Cellular Infiltrate,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
21895,Carcinomatous Component Present,Adenocarcinoma with neuroendocrine differentiation,1
21896,Tissue of Mullerian Origin Present,Malignant Mixed Mesodermal (Mullerian) Tumor,1
21897,Recurrent disease,Recurrent Metastatic Malignant Neoplasm,1
21898,Malignant Cellular Infiltrate,Corneal Melanoma,1
21899,Low Mitotic Activity,Gastric Neuroendocrine Tumor G2,1
21900,Malignant Cellular Infiltrate,Adult Acute Monocytic Leukemia,1
21901,Pain,Childhood Mesenchymal Chondrosarcoma,1
21902,Well Differentiated Lesion,Plantar Verrucous Skin Carcinoma,1
21903,Diffuse Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
21904,Duct-Like Structures Present,Adenoameloblastoma,1
21905,Malignant Cellular Infiltrate,Contralateral Breast Carcinoma,1
21906,Epithelial Component Present,Vaginal Villous Adenoma,1
21907,Fibrotic Stroma Formation,Borderline Ovarian Serous Cystadenofibroma,1
21908,Carcinomatous Component Present,Recurrent Paranasal Sinus Squamous Cell Carcinoma,1
21909,Epithelial Component Present,Stage III Thymoma AJCC v8,1
21910,HMB-45-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, malignant",1
21911,Adulthood Lesion,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma,1
21912,Nodular lesions,Thyroid Gland Lipoadenoma,1
21913,Exophytic Polypoid Lesion,Gastric Non-Neoplastic Polyp,1
21914,Primary Lesion,Adult Brain Glioblastoma,1
21915,Cutaneous Involvement,Mycosis fungoides recurrent,1
21916,Benign Cellular Infiltrate,Benign Reproductive System Neoplasm,1
21917,Malignant Cellular Infiltrate,Stage IIA Uveal Melanoma AJCC v7,1
21918,Cellular Pleomorphism,Adult Undifferentiated Pleomorphic Sarcoma,1
21919,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
21920,High Grade Lesion,Stage IB Lung Small Cell Carcinoma AJCC v7,1
21921,Epithelial Component Present,adenocarcinoma of breast with squamous metaplasia,1
21922,Necrotic changes (finding),MGMT-Unmethylated Glioblastoma,1
21923,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v8,1
21924,Epithelial Component Present,Unresectable Transitional Cell Carcinoma,1
21925,Mixed Cellular Population,Atypical polypoid adenomyoma,1
21926,Indolent Clinical Course,Benign Extraskeletal Cartilaginous and Osseous Neoplasm,1
21927,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,1
21928,In Situ Lesion,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
21929,Immunosuppression-Related Post-Transplant Toxicity,New Onset Diabetes After Transplant,1
21930,CD30-Positive Neoplastic Cells Present,Stage III Anaplastic Large Cell Lymphoma,1
21931,Glandular Pattern,Somatostatinoma,1
21932,Hyperplastic Tissue Present,Benign Prostatic Hyperplasia,1
21933,Epithelial Component Present,Malignant Cystosarcoma Phyllodes,1
21934,Somatostatin Positive Neoplastic Cells Present,Somatostatinoma,1
21935,Benign Cellular Infiltrate,Lung Mixed Squamous Cell and Glandular Papilloma,1
21936,Cavernous Lymphatic Space Formation,Cavernous lymphangioma,1
21937,Papillary Pattern,inverted ductal papilloma of salivary gland,1
21938,Epithelial Component Present,Recurrent Chromophobe Renal Cell Carcinoma,1
21939,Cellular Pleomorphism,Classic Type Atypical Fibroxanthoma,1
21940,Malignant Cellular Infiltrate,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
21941,Childhood Lesion,Hepatoblastoma recurrent,1
21942,Malignant Cellular Infiltrate,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8,1
21943,Carcinomatous Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
21944,Well-Circumscribed Lesion,Polyp of gallbladder,1
21945,Biphasic Pattern,Pleural Biphasic Synovial Sarcoma,1
21946,Severe dysplasia,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,1
21947,Well-Circumscribed Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
21948,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile ganglioglioma,1
21949,Metastatic Lesion,Metastatic Lung Adenosquamous Carcinoma,1
21950,Recurrent disease,Recurrent Adult Lymphoblastic Lymphoma,1
21951,Metastatic Lesion,Malignant Ameloblastoma,1
21952,Secondary Lesion,Metastatic Carcinoma in the Adrenal Cortex,1
21953,Thyroglobulin Positive Neoplastic Cells Present,Poorly Differentiated Thyroid Carcinoma,1
21954,Pain,Central Nervous System Mesenchymal Chondrosarcoma,1
21955,Malignant Cellular Infiltrate,Thymic Basaloid Carcinoma,1
21956,Lytic lesion,Desmoplastic fibroma,1
21957,Benign Cellular Infiltrate,Intramuscular lipoma,1
21958,Primary Lesion,BCLC Stage D Hepatocellular Carcinoma,1
21959,Malignant Cellular Infiltrate,Erythroid Neoplasm,1
21960,Epithelial Component Present,Metastatic Pancreatic Neuroendocrine Carcinoma,1
21961,Therapy-Related Toxicity,Cutaneous Radiation-Related Angiosarcoma,1
21962,Biphasic Pattern,Malignant Vulvar Phyllodes Tumor,1
21963,Carcinomatous Component Present,Adenocarcinoma of anal glands,1
21964,Malignant Cellular Infiltrate,Stage IA Bone Cancer AJCC v8,1
21965,Malignant Cellular Infiltrate,Advanced Digestive System Neuroendocrine Neoplasm,1
21966,Epithelial Component Present,Esophageal carcinoma,1
21967,Diffuse Pattern,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
21968,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v7,1
21969,Malignant Cellular Infiltrate,Ureteric cancer regional,1
21970,Poorly Differentiated Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,1
21971,Epithelial Component Present,Resectable Renal Cell Carcinoma,1
21972,Metastatic Lesion,Metastatic Malignant Genitourinary System Neoplasm,1
21973,Edematous Stroma Formation,Vaginal Angiomyofibroblastoma,1
21974,In Situ Lesion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
21975,Carcinomatous Component Present,Stage II Esophageal Adenocarcinoma AJCC v7,1
21976,Rimming of Adipose Tissue Cells Present,Subcutaneous panniculitis-like T-cell lymphoma,1
21977,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",1
21978,Epithelial Component Present,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
21979,Epithelial Component Present,Hormone Receptor Positive Breast Carcinoma,1
21980,Multinodular Mass,"Dermatofibrosarcoma Protuberans, Myxoid",1
21981,Well Differentiated Neuroendocrine Lesion,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,1
21982,Carcinomatous Component Present,Skin Clear Cell Basal Cell Carcinoma,1
21983,Fibrotic Stroma Formation,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
21984,Malignant Cellular Infiltrate,Metastatic Squamous Cell Breast Carcinoma,1
21985,Malignant Cellular Infiltrate,Tibial adamantinoma,1
21986,Papillary Pattern,Frontal Sinus Schneiderian Papilloma,1
21987,Hyperplastic Tissue Present,Cervical Mesonephric Remnants and Hyperplasia,1
21988,Epithelial Component Present,High Grade Mucoepidermoid Breast Carcinoma,1
21989,Malignant Cellular Infiltrate,Borderline Resectable Pancreatic Carcinoma,1
21990,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of appendix,1
21991,Breast Microcalcification,Oligodendroglioma of spinal cord,1
21992,Carcinomatous Component Present,Locally Advanced Unresectable Cervical Adenocarcinoma,1
21993,Carcinomatous Component Present,Stage IIB Appendix Carcinoma AJCC v8,1
21994,Malignant Cellular Infiltrate,Secondary malignant neoplasm of retina,1
21995,Carcinomatous Component Present,Villous adenocarcinoma,1
21996,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v7,1
21997,Carcinomatous Component Present,Breast Carcinoma,1
21998,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone,1
21999,'Starry-sky' pattern,Colon Burkitt Lymphoma,1
22000,Well-Circumscribed Lesion,Breast Phyllodes Tumor,1
22001,Epithelial Component Present,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
22002,Neuroendocrine Differentiation,Vaginal Neuroendocrine Carcinoma,1
22003,Malignant Cellular Infiltrate,Uterine Corpus Cancer,1
22004,Carcinomatous Component Present,mucoepidermoid carcinoma of lung,1
22005,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v7,1
22006,Increased Cellularity Present,Peripheral neuroblastoma,1
22007,Refractory Disease,Refractory Urothelial Carcinoma,1
22008,Primary Lesion,Primary Peritoneal Cancer by AJCC v7 Stage,1
22009,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Polyembryoma AJCC v6 and v7,1
22010,Malignant Cellular Infiltrate,Prognostic Stage IB Breast Cancer AJCC v8,1
22011,Malignant Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v6 and v7,1
22012,Malignant Cellular Infiltrate,Adult Immunoblastic Lymphoma,1
22013,Hyaline Cartilage Differentiation,Chondrosarcoma recurrent,1
22014,Malignant Cellular Infiltrate,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
22015,Malignant Cellular Infiltrate,Stage II Eyelid Carcinoma AJCC v7,1
22016,Schwannian Stroma Predominant Component of the Tumor Volume,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
22017,Multifocal Lesion,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
22018,Metastatic Lesion,Metastatic basal cell carcinoma,1
22019,Benign Cellular Infiltrate,Ovarian Myxoma,1
22020,Secondary Lesion,Secondary malignant neoplasm of vagina,1
22021,Cutaneous Involvement,Cutaneous Precursor Lymphoid Neoplasm,1
22022,Benign Cellular Infiltrate,Grade 1 Ovarian Teratoma,1
22023,Carcinomatous Component Present,Diffuse Gastric Adenocarcinoma,1
22024,Peripheral Nuclear Palisading,Basaloid squamous cell carcinoma,1
22025,Pseudopapillary Pattern,Adult Papillary Meningioma,1
22026,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
22027,Cystic Change,Anal Papillary Hidradenoma,1
22028,Malignant Cellular Infiltrate,alk-positive anaplastic large cell lymphoma,1
22029,Well-Circumscribed Lesion,Ovarian Cystadenoma,1
22030,Epithelial Component Present,Adenocarcinoma in situ in villous adenoma,1
22031,Neuroendocrine Differentiation,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
22032,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer,1
22033,Carcinomatous Component Present,Stage IV Pancreatic Cancer AJCC v8,1
22034,Low Grade Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1,1
22035,High Mitotic Activity,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
22036,High Mitotic Activity,Stage IV Lung Small Cell Carcinoma AJCC v7,1
22037,Carcinomatous Component Present,Stage IV Pancreatic Cancer AJCC v6 and v7,1
22038,Oligodendroglial Component Present,Recurrent Anaplastic Oligodendroglioma,1
22039,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
22040,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
22041,Malignant Cellular Infiltrate,Prognostic Stage 0 Breast Cancer AJCC v8,1
22042,Collagenous Stroma Formation,Fibromatosis colli,1
22043,Proliferation of Small Ducts Present,Intrahepatic Bile Duct Microcystic Adenoma,1
22044,Microcystic Change,Microcystic adnexal carcinoma,1
22045,Malignant Cellular Infiltrate,Carcinoma of upper gum,1
22046,Metastatic Lesion,Prostate Carcinoma Metastatic in the Bone,1
22047,Malignant Cellular Infiltrate,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
22048,Diffuse Pattern,Stage III Adult Immunoblastic Lymphoma,1
22049,"Undifferentiated ""Fetal-Type"" Tissues Present",Pineal Region Immature Teratoma,1
22050,Malignant Cellular Infiltrate,Childhood Central Nervous System Mixed Germ Cell Tumor,1
22051,Anaplasia,Metastatic Sarcomatoid Renal Cell Carcinoma,1
22052,Cutaneous Involvement,"lymphomatoid papulosis, type A",1
22053,Mucoid Stroma Formation,Small Intestinal Mucinous Adenocarcinoma,1
22054,Recurrent disease,Adenoid cystic carcinoma of the oral cavity recurrent,1
22055,Mixed Cellular Population,Malignant Parotid Gland Mixed Tumor,1
22056,Epithelial Component Present,Stage IA Cervical Cancer AJCC v6 and v7,1
22057,Poorly Differentiated Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
22058,Perineural spread,Major Salivary Gland Adenoid Cystic Carcinoma,1
22059,Malignant Cellular Infiltrate,Ann Arbor Stage IV Grade 3 Follicular Lymphoma,1
22060,Epithelial Component Present,papillary carcinoma of penis,1
22061,Carcinomatous Component Present,carcinosarcoma of liver,1
22062,Epithelial Component Present,Colorectal Adenomatous Polyp,1
22063,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with FLT3/ITD Mutation,1
22064,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
22065,Carcinomatous Component Present,Clear Cell Intrahepatic Cholangiocarcinoma,1
22066,Childhood Lesion,Refractory Childhood Acute Lymphoblastic Leukemia,1
22067,Slit-Like Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
22068,Carcinomatous Component Present,Papillary adenocarcinoma,1
22069,Malignant Cellular Infiltrate,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,1
22070,Benign Cellular Infiltrate,Spinal Cord Neurofibroma,1
22071,Malignant Cellular Infiltrate,Abdominal Rhabdomyosarcoma,1
22072,Carcinomatous Component Present,Recurrent Adrenal Cortex Carcinoma,1
22073,Epithelial Component Present,Cystic basal cell carcinoma,1
22074,Neuroendocrine Differentiation,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
22075,Acanthosis,Urethral Verrucous Carcinoma,1
22076,Cutaneous Involvement,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
22077,Favorable Clinical Outcome,Ganglioneuroma of mediastinum,1
22078,Childhood Lesion,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
22079,Epithelial Component Present,Atypical adenoma,1
22080,Indolent Clinical Course,Cervical Rhabdomyoma,1
22081,Carcinomatous Component Present,Platinum-Resistant Ovarian Carcinoma,1
22082,Nuclear Atypia,Childhood Anaplastic Oligoastrocytoma,1
22083,Increased Cellularity Present,Peripheral neuroblastoma,1
22084,Anaplasia,Classical Glioblastoma,1
22085,Malignant Cellular Infiltrate,Malignant tumor of minor salivary gland,1
22086,Indolent Clinical Course,Endobronchial Leiomyoma,1
22087,Epithelial Component Present,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
22088,Regional Disease,Locally Advanced Pancreatic Adenocarcinoma,1
22089,Metastatic Lesion,Metastatic Unresectable Basal Cell Carcinoma,1
22090,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v8,1
22091,Transformed Phase of Disease,Non-Hodgkin's lymphoma transformed recurrent,1
22092,Malignant Cellular Infiltrate,Malignant mastocytosis,1
22093,Malignant Cellular Infiltrate,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
22094,Malignant Cellular Infiltrate,Cervical Cancer by AJCC v8 Stage,1
22095,CD1a-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
22096,Increased Cellularity Present,Recurrent Childhood Anaplastic Oligoastrocytoma,1
22097,'Starry-sky' pattern,Childhood Burkitt Lymphoma,1
22098,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage III,1
22099,Malignant Cellular Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,1
22100,Jaw Keratocyst,Basal Cell Nevus Syndrome,1
22101,Diffuse Pattern,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
22102,Neuroendocrine Differentiation,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
22103,Epithelial Component Present,Parathyroid Gland Oncocytic Adenoma,1
22104,Epithelial Component Present,Pancreatic Intraductal Papillary Mucinous Neoplasm,1
22105,High Grade Lesion,Childhood Embryonal Rhabdomyosarcoma,1
22106,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v7,1
22107,Malignant Cellular Infiltrate,Spindle Cell Type A Uveal Melanoma,1
22108,Malignant Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
22109,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
22110,Epithelial Component Present,Orbit Paraganglioma,1
22111,Secondary Lesion,Secondary malignant neoplasm of eye,1
22112,Malignant Cellular Infiltrate,atypical medullary carcinoma of breast,1
22113,Anaplasia,MGMT-Unmethylated Glioblastoma,1
22114,Nuclear Atypia,Anaplastic astrocytoma,1
22115,Malignant Cellular Infiltrate,Stage IVC Rectal Cancer AJCC v8,1
22116,Refractory Disease,T-cell lymphoma refractory,1
22117,Malignant Cellular Infiltrate,"NK-Cell Lymphoma, Unclassifiable",1
22118,Tubular Structures Present,Ovarian Sertoli Cell Tumor with Lipid Storage,1
22119,Locally Aggressive Lesion,Recurrent Desmoid-Type Fibromatosis,1
22120,Malignant Cellular Infiltrate,Stage IVA Bone Sarcoma AJCC v7,1
22121,Malignant Cellular Infiltrate,Locally Advanced Unresectable Cervical Carcinoma,1
22122,Mixed Cellular Population,Ovarian Clear Cell Adenofibroma,1
22123,Poorly Differentiated Lesion,"Lung Large Cell Carcinoma, Clear Cell Variant",1
22124,Epithelial Component Present,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
22125,Exophytic Polypoid Lesion,Peutz Jehgers polyp,1
22126,Metastatic Lesion,Secondary malignant neoplasm of bone marrow,1
22127,Refractory Disease,Refractory Myxoid Liposarcoma,1
22128,Cutaneous Involvement,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
22129,Epithelial Component Present,Stage IB1 Cervical Cancer AJCC v8,1
22130,Epithelial Component Present,"Adenoma, Microcystic",1
22131,Severe dysplasia,Pleomorphic lobular carcinoma in situ of breast,1
22132,Extraocular Dissemination of Disease,Extraocular retinoblastoma,1
22133,Clinical TNM Finding,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
22134,Indolent Clinical Course,Endometrial Polyp,1
22135,Malignant Cellular Infiltrate,Small cell carcinoma of ovary,1
22136,Mesenchymal Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
22137,Indolent Clinical Course,benign fibrous histiocytoma of bone,1
22138,Malignant Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage III,1
22139,Epithelial Component Present,"Malignant Mixed Tumor, Not Otherwise Specified",1
22140,Malignant Cellular Infiltrate,Acral Lentiginous Malignant Melanoma,1
22141,Epithelial Component Present,Gastric Papillary Adenocarcinoma,1
22142,Primary Lesion,Brain Glioblastoma,1
22143,Carcinomatous Component Present,Stage III Merkel Cell Carcinoma AJCC v7,1
22144,Ineffective hematopoiesis,Refractory anaemia with excess blasts,1
22145,Carcinomatous Component Present,Recurrent Urethral Cancer,1
22146,Cutaneous Involvement,Dermatitis,1
22147,Immunologic Deficiency Syndromes,AIDS-Related Hodgkin Lymphoma,1
22148,Pseudoalveolar Pattern,Vulvar Alveolar Soft Part Sarcoma,1
22149,Poorly Cohesive Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric,1
22150,Malignant Cellular Infiltrate,Nonestrogen-Dependent Malignant Neoplasm,1
22151,More than 10 Mitoses per 10HPF,Stage II Lung Small Cell Carcinoma AJCC v7,1
22152,Intermediate Grade Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G2,1
22153,Carcinomatous Component Present,Recurrent Vulvar Carcinoma,1
22154,Benign Cellular Infiltrate,Benign neoplasm of respiratory tract,1
22155,Apocrine Differentiation,apocrine adenocarcinoma of vulva,1
22156,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
22157,Fascicles of Spindly Tumor Cells Present,Tanycytic ependymoma,1
22158,Carcinomatous Component Present,squamous cell carcinoma of urethra,1
22159,Cutaneous Involvement,Pilomatrix carcinoma of skin,1
22160,Hyperkeratosis,Vulvar Inverted Follicular Keratosis,1
22161,Malignant Cellular Infiltrate,Eccrine porocarcinoma,1
22162,Cystic Change,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
22163,Complete Spontaneous Regression,"lymphomatoid papulosis, type A",1
22164,Carcinomatous Component Present,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
22165,Increased Cellularity Present,Childhood Cerebral Anaplastic Astrocytoma,1
22166,Malignant Cellular Infiltrate,Burkitt Lymphoma with Plasmacytoid Differentiation,1
22167,Adulthood Lesion,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
22168,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
22169,Malignant Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
22170,Epithelial Component Present,Stage IIIB Esophageal Cancer AJCC v7,1
22171,Regional Disease,Locally Advanced Chordoma,1
22172,Tissue Differentiation Uncertain,Nonossifying Fibromyxoid Tumor,1
22173,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Tumor G2,1
22174,Exophytic Polypoid Lesion,Vulvar Fibroepithelial Stromal Polyp,1
22175,Ependymal Differentiation,Angiocentric glioma,1
22176,Well-Circumscribed Lesion,Non-Functioning Adrenal Cortex Adenoma,1
22177,Chromogranin A Positive Neoplastic Cells Present,Testicular Carcinoid Tumor,1
22178,Carcinomatous Component Present,Lung Basaloid Large Cell Carcinoma,1
22179,Recurrent disease,Recurrent Childhood Gemistocytic Astrocytoma,1
22180,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I,1
22181,Secondary Lesion,Disseminated adenocarcinoma,1
22182,Benign Cellular Infiltrate,Inverting papilloma of the paranasal sinus,1
22183,Infantile Lesion,"Neuroectodermal Tumor, Melanotic",1
22184,Recurrent disease,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
22185,Primary Lesion,Aggressive Systemic Mastocytosis,1
22186,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
22187,Microcystic Change,Serous cystadenoma of pancreas,1
22188,Secondary Lesion,Metastatic Squamous Cell Breast Carcinoma,1
22189,Malignant Cellular Infiltrate,Refractory Uterine Corpus Carcinosarcoma,1
22190,Recurrent disease,Recurrent Anterior Pituitary Gland Neoplasm,1
22191,Cutaneous Involvement,Harlequin Fetus,1
22192,High Mitotic Activity,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
22193,Secondary Lesion,Transitional cell cancer of renal pelvis and ureter metastatic,1
22194,Epidermotropic Lymphocytic Infiltrate,Stage IB Mycosis Fungoides AJCC v7,1
22195,Hereditary Lesion,Adenomatous Polyposis Coli,1
22196,Malignant Cellular Infiltrate,Chondroblastic osteosarcoma,1
22197,Carcinomatous Component Present,Bladder squamous cell carcinoma stage II,1
22198,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Thyroid,1
22199,Primary Lesion,Stage IIB Primary Peritoneal Cancer AJCC v8,1
22200,Epithelial Component Present,Adenocarcinoma of the rete testis,1
22201,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v7,1
22202,Carcinomatous Component Present,FIGO Stage IC3 Ovarian Cancer,1
22203,Sarcomatous Component Present,carcinosarcoma of extrahepatic bile duct,1
22204,Carcinomatous Component Present,Alcohol-Related Carcinoma,1
22205,Myxoid Stroma Formation,Myxoid chondrosarcoma,1
22206,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
22207,Metastatic Lesion,Disseminated carcinoma,1
22208,Epithelial Component Present,Advanced Oral Cavity Squamous Cell Carcinoma,1
22209,Lobulated Growth Pattern,Salivary Gland Myoepithelial Carcinoma,1
22210,Epithelial Component Present,Clinical Stage IIA Gastric Cancer AJCC v8,1
22211,Low Mitotic Activity,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,1
22212,Carcinomatous Component Present,Stage IVC Laryngeal Cancer AJCC v8,1
22213,Duct-Like Structures Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
22214,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",1
22215,Malignant Cellular Infiltrate,Schneiderian carcinoma,1
22216,Malignant Cellular Infiltrate,Malignant neoplasm of soft tissue,1
22217,Epithelial Component Present,Ovarian Sex Cord Tumor with Annular Tubules,1
22218,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
22219,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
22220,Lobulated Growth Pattern,Primary chondrosarcoma of bone,1
22221,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage II,1
22222,Hereditary Lesion,Hereditary clear cell renal cell carcinoma,1
22223,Osteoid formation,Secondary osteosarcoma,1
22224,Metastatic Lesion,Metastatic Bladder Squamous Cell Carcinoma,1
22225,Thick-Walled Hyalinized Vessels Present,Ureter Schwannoma,1
22226,Cartilaginous Component Present,Chondroblastic osteosarcoma,1
22227,Superficial Lesion,Superficial fibromatosis,1
22228,Cutaneous Involvement,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin,1
22229,Cutaneous Involvement,Contact Dermatitis,1
22230,Epithelial Component Present,Metastatic Lung Small Cell Carcinoma,1
22231,Tubular Structures Present,Sertoli Cell Tumor,1
22232,Malignant Cellular Infiltrate,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
22233,Nodular Pattern,Ann Arbor Stage II Follicular Lymphoma,1
22234,Slow Growing Mass,Medullary Hemangioblastoma,1
22235,Malignant Cellular Infiltrate,Exocervical Carcinoma,1
22236,Well Differentiated Neuroendocrine Lesion,Stage I Appendix Neuroendocrine Tumor AJCC v7,1
22237,Epithelial Component Present,Histiocytoid Breast Carcinoma,1
22238,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
22239,Malignant Cellular Infiltrate,Metastatic Breast Carcinoid Tumor,1
22240,Neuroectodermal Differentiation,Disseminated neuroblastoma,1
22241,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
22242,Increased Cellularity Present,Resectable Neuroblastoma,1
22243,Cutaneous Involvement,Acrodermatitis,1
22244,Anaplasia,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,1
22245,Epithelial Component Present,Recurrent Extrahepatic Bile Duct Carcinoma,1
22246,Malignant Cellular Infiltrate,Recurrent Minor Salivary Gland Adenocarcinoma,1
22247,Epithelial Component Present,Testicular Thecoma,1
22248,Carcinomatous Component Present,Stage I Vulvar Carcinoma,1
22249,Osseous Differentiation,Stage IIA Osteosarcoma AJCC v7,1
22250,Malignant Cellular Infiltrate,carcinoma of pancreas with osteoclast-like giant cells,1
22251,Cutaneous Involvement,Clear cell squamous cell carcinoma of skin,1
22252,Absence of Invasion,Adenocarcinoma in situ in adenomatous polyp,1
22253,Benign Cellular Infiltrate,Subungual exostoses,1
22254,Epithelial Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
22255,Malignant Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
22256,Malignant Cellular Infiltrate,Sarcomatoid Mesothelioma,1
22257,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Erythroid Leukemia,1
22258,Mass of body structure,Monoblastic Sarcoma,1
22259,Epithelial Component Present,High Grade Esophageal Glandular Intraepithelial Neoplasia,1
22260,Cutaneous Involvement,Malignant Breast Eccrine Spiradenoma,1
22261,Bone marrow depression,Hypocellular Myelodysplastic Syndrome,1
22262,Carcinomatous Component Present,Stage IIIB Vulvar Cancer AJCC v8,1
22263,Lobulated Growth Pattern,Pyogenic granuloma of skin and subcutaneous tissue,1
22264,Carcinomatous Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
22265,Systemic disease,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative",1
22266,Benign Cellular Infiltrate,Epithelioid hemangioma of skin,1
22267,Tubular Pattern,tubulopapillary adenoma of gallbladder,1
22268,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Ganglioneuroblastoma, Intermixed",1
22269,Malignant Cellular Infiltrate,Transitional cell carcinoma of bladder,1
22270,Malignant Cellular Infiltrate,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
22271,Indolent Clinical Course,Spindle cell hemangioma,1
22272,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myeloid leukemia with abnormal marrow eosinophils,1
22273,Malignant Cellular Infiltrate,Stage IV Intrahepatic Bile Duct Cancer AJCC v8,1
22274,Intraductal Lesion,Intraductal Cribriform Breast Adenocarcinoma,1
22275,Invasive Lesion,Inflammatory carcinoma of breast stage III,1
22276,Vascular Channel Formation,Angiosarcoma of the breast,1
22277,Malignant Cellular Infiltrate,Low Grade Malignant Peripheral Nerve Sheath Tumor,1
22278,High Grade Lesion,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
22279,Childhood Lesion,Recurrent Childhood Kidney Neoplasm,1
22280,Immunologic Deficiency Syndromes,AIDS-Related Lymphoblastic Lymphoma,1
22281,Malignant Cellular Infiltrate,Unresectable Malignant Neoplasm,1
22282,Secondary Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
22283,Refractory Disease,Refractory Colorectal Carcinoma,1
22284,Malignant Cellular Infiltrate,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
22285,Precise Histogenesis Unknown,Central Nervous System Hemangioblastoma,1
22286,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum,1
22287,Carcinomatous Component Present,Stage IV Esophageal Adenocarcinoma AJCC v7,1
22288,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
22289,In Situ Lesion,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
22290,Microcystic Change,Pilocytic Astrocytoma,1
22291,Rapidly Enlarging Mass,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
22292,Carcinomatous Component Present,carcinosarcoma of lung,1
22293,Malignant Cellular Infiltrate,Recurrent Carcinoma of Unknown Primary,1
22294,Recurrent disease,"Recurrent Medulloblastoma, SHH-Activated",1
22295,Epithelial Component Present,Benign neoplasm of sweat gland,1
22296,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,1
22297,Malignant Cellular Infiltrate,AIDS-Related Cervical Kaposi Sarcoma,1
22298,Lesion with Diameter of 10mm or Less,Pituitary Gland Microadenoma,1
22299,Mixed Cellular Population,Cystadenofibroma of fallopian tube,1
22300,Malignant Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor,1
22301,Epithelial Component Present,Locally Advanced Digestive System Carcinoma,1
22302,Epithelial Component Present,Adenoma of lung,1
22303,Malignant Cellular Infiltrate,Desmoplastic mesothelioma,1
22304,Vascular Channel Formation,Myxoma,1
22305,Mixed Cellular Population,Cystadenofibroma,1
22306,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
22307,Well-Circumscribed Lesion,Adenomatous polyp of colon,1
22308,Severe dysplasia,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
22309,Malignant Cellular Infiltrate,Childhood Classic Hodgkin Lymphoma,1
22310,Chronic lymphocytic inflammation,"Thymoma, type B1, malignant",1
22311,Childhood Lesion,Recurrent Childhood Lymphoblastic Lymphoma,1
22312,Malignant Cellular Infiltrate,Pleural mesothelioma malignant advanced,1
22313,Hyperkeratosis,Laryngeal verrucous carcinoma,1
22314,Malignant Cellular Infiltrate,bilateral breast cancer,1
22315,Epithelial Component Present,papillary carcinoma of penis,1
22316,Epithelial Component Present,Colorectal Adenoma with Moderate Dysplasia,1
22317,Hereditary Lesion,Hereditary benign intraepithelial dyskeratosis,1
22318,Secondary Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
22319,Benign Cellular Infiltrate,Capillary hemangioma of retina,1
22320,Secondary Lesion,Metastatic Lung Non-Small Cell Carcinoma,1
22321,Well-Circumscribed Lesion,Benign Prostate Phyllodes Tumor,1
22322,Malignant Cellular Infiltrate,Refractory Dedifferentiated Liposarcoma,1
22323,Malignant Cellular Infiltrate,Cutaneous Mature B-Cell Neoplasm,1
22324,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
22325,Carcinomatous Component Present,Platinum-Resistant Primary Peritoneal Carcinoma,1
22326,Epithelial Component Present,Adenoid cystic breast carcinoma,1
22327,Carcinomatous Component Present,Stage IIA Ampulla of Vater Cancer AJCC v7,1
22328,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
22329,Recurrent disease,Diffuse large B-cell lymphoma recurrent,1
22330,Malignant Cellular Infiltrate,Pericardial Synovial Sarcoma,1
22331,Diffuse Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,1
22332,Metastatic/Recurrent Disease,Conventional Extraskeletal Myxoid Chondrosarcoma,1
22333,Secondary Lesion,Uveal Melanoma Metastatic in the Liver,1
22334,Carcinomatous Component Present,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7,1
22335,Well-Circumscribed Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
22336,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer,1
22337,Malignant Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v7,1
22338,Chronic Inflammatory Infiltrate,benign fibrous histiocytoma of bone,1
22339,Psammoma Body Formation,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
22340,Nerve palsy,Progressive bulbar palsy,1
22341,Lymphatic Spread,Inflammatory carcinoma of breast stage III,1
22342,Malignant Cellular Infiltrate,Gastrointestinal carcinoma in situ,1
22343,Epithelial Component Present,Juvenile Type Testicular Granulosa Cell Tumor,1
22344,Mixed Cellular Population,Malignant Mixed Tumor,1
22345,Malignant Cellular Infiltrate,Alcohol-Related Laryngeal Carcinoma,1
22346,Childhood Lesion,Childhood Acute Lymphoblastic Leukemia,1
22347,Epithelial Component Present,squamous cell carcinoma of the thyroid gland,1
22348,Nuclear pleomorphism,Childhood Pleomorphic Rhabdomyosarcoma,1
22349,Epithelial Component Present,Benign Apocrine Neoplasm,1
22350,Papillary Pattern,Choroid Plexus Papilloma,1
22351,Deep Lesion,Deep Hemangioma,1
22352,Necrotic changes (finding),Vulvar Large Cell Neuroendocrine Carcinoma,1
22353,Carcinomatous Component Present,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
22354,Epithelial Component Present,Metastatic Hypopharyngeal Carcinoma,1
22355,Malignant Cellular Infiltrate,Tibial adamantinoma,1
22356,Dilated Vascular Space Formation,Glomangioma of skin,1
22357,Malignant Cellular Infiltrate,Uveal Melanoma Metastatic in the Liver,1
22358,Nuclear Atypia,Temporal Lobe Anaplastic Astrocytoma,1
22359,Epithelial Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
22360,Recurrent disease,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
22361,Papillary Pattern,Papilloma of nasal vestibule,1
22362,Epithelial Component Present,Stage 0 Vulvar Carcinoma,1
22363,Stromal Invasion,Stage IV Ovarian Cancer AJCC v8,1
22364,Epithelial Component Present,Adenoma of the nipple,1
22365,Carcinomatous Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
22366,Malignant Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
22367,Angiocentric Pattern,Pulmonary Lymphomatoid Granulomatosis,1
22368,Childhood Lesion,Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8,1
22369,Primary Lesion,Gastric T-Cell Non-Hodgkin Lymphoma,1
22370,Syncytial Pattern,Nasopharyngeal lymphoepithelioma stage I,1
22371,Epithelial Component Present,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
22372,Well Differentiated Hyaline Cartilage Present,Childhood Mesenchymal Chondrosarcoma,1
22373,Exophytic Polypoid Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,1
22374,Hyperplastic Tissue Present,Focal Epithelial Hyperplasia,1
22375,Necrotic changes (finding),"Ovarian Small Cell Carcinoma, Pulmonary Type",1
22376,Malignant Cellular Infiltrate,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,1
22377,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage IV,1
22378,Absence of Invasion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
22379,Carcinomatous Component Present,Stage 0 Gastric Cancer AJCC v6 and v7,1
22380,Epithelial Component Present,clear cell adenocarcinoma of gallbladder,1
22381,Tricholemmal Differentiation,Classic Type Trichilemmoma,1
22382,Adulthood Lesion,Adult Type Ovarian Granulosa Cell Tumor,1
22383,Malignant Cellular Infiltrate,Acute Megakaryocytic Leukemias,1
22384,Malignant Cellular Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis,1
22385,Monophasic Pattern,"Synovial sarcoma, spindle cell",1
22386,Epithelial Component Present,lymphoepithelial squamous cell carcinoma of salivary gland,1
22387,Low Mitotic Activity,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
22388,Benign Cellular Infiltrate,Breast Pleomorphic Adenoma,1
22389,Epithelial Component Present,Pancreatic Medullary Carcinoma,1
22390,Malignant Cellular Infiltrate,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
22391,Epithelial Component Present,Metastatic Salivary Gland Carcinoma,1
22392,Chronic Inflammatory Infiltrate,Cutaneous Lymphomatoid Granulomatosis,1
22393,Local disease,Lumbosacral Lipoma,1
22394,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Cervical Endometrioid Adenocarcinoma,1
22395,Metastatic/Recurrent Disease,Extraskeletal Myxoid Chondrosarcoma,1
22396,Metastatic Lesion,Transitional cell carcinoma metastatic,1
22397,Malignant Cellular Infiltrate,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
22398,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
22399,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II,1
22400,Encapsulated Mass,Benign cystic nephroma,1
22401,Epithelial Component Present,Gonadotroph adenoma,1
22402,Necrotic changes (finding),Colorectal Small Cell Neuroendocrine Carcinoma,1
22403,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,lipid-rich carcinoma of breast,1
22404,Cutaneous Involvement,Microcystic adnexal carcinoma,1
22405,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage II,1
22406,Non Lipogenic Sarcomatous Stroma Present,Unresectable Dedifferentiated Liposarcoma,1
22407,Monoclonal Eosinophils Present,Adult Acute Eosinophilic Leukemia,1
22408,Recurrent disease,Laryngeal verrucous carcinoma recurrent,1
22409,Malignant Cellular Infiltrate,Refractory Dedifferentiated Liposarcoma,1
22410,Tubular Pattern,Ampulla of Vater Tubulovillous Adenoma,1
22411,Epithelial Component Present,Multiple Endocrine Neoplasia Type 1,1
22412,"Undifferentiated ""Fetal-Type"" Tissues Present",Extragonadal primary malignant teratoma,1
22413,Pautrier-Like Microabscess Present,Acute Adult T-Cell Leukemia/Lymphoma,1
22414,Severe dysplasia,Papillary carcinoma in situ,1
22415,Malignant Cellular Infiltrate,Endometrioid adenocarcinoma recurrent,1
22416,New bone formation (morphologic abnormality),Giant Cell Lesion of Small Bones,1
22417,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
22418,Epithelial Component Present,basaloid squamous cell carcinoma of floor of mouth,1
22419,Mitotic Activity,Endodermal sinus tumor of ovary,1
22420,Malignant Cellular Infiltrate,Lymphoma of retina,1
22421,Malignant Cellular Infiltrate,Clitoral Carcinoma,1
22422,Carcinomatous Component Present,Type II Endometrial Adenocarcinoma,1
22423,Carcinomatous Component Present,Refractory Primary Peritoneal Carcinoma,1
22424,Carcinomatous Component Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
22425,Malignant Cellular Infiltrate,Metastatic Malignant Pancreatic Neoplasm,1
22426,Primary Lesion,Childhood Infratentorial Ependymoma,1
22427,Malignant Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v8,1
22428,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage III,1
22429,Epithelial Component Present,Stage III Adrenal Cortex Carcinoma AJCC v8,1
22430,Recurrent disease,Recurrent Childhood Cerebellar Astrocytoma,1
22431,Solitary mass,Minimally Invasive Mucinous Lung Adenocarcinoma,1
22432,Glandular Pattern,"Somatostatinoma, malignant",1
22433,Epithelial Component Present,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8",1
22434,High Grade Lesion,Anaplastic Hemispheric Astrocytoma,1
22435,Rapidly Enlarging Mass,Rhabdomyosarcoma,1
22436,Epithelial Component Present,Stage II Bladder Cancer AJCC v8,1
22437,Recurrent disease,Recurrent Grade II Lymphomatoid Granulomatosis,1
22438,High Mitotic Activity,Anal Canal Small Cell Neuroendocrine Carcinoma,1
22439,Malignant Cellular Infiltrate,Tibial adamantinoma,1
22440,Benign Cellular Infiltrate,Vulvar Superficial Myofibroblastoma,1
22441,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
22442,Benign Cellular Infiltrate,Ovarian Cellular Fibroma,1
22443,Malignant Cellular Infiltrate,Ann Arbor Stage IV AIDS-Related Lymphoma,1
22444,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
22445,Carcinomatous Component Present,Stage IIIB Fallopian Tube Cancer AJCC v7,1
22446,Epithelial Component Present,Grade 3 Colon Adenocarcinoma,1
22447,Malignant Cellular Infiltrate,Childhood Giant Cell Glioblastoma,1
22448,Carcinomatous Component Present,Poorly Differentiated Hepatocellular Carcinoma,1
22449,Indolent Clinical Course,Benign fibrohistiocytic neoplasm of skin,1
22450,Carcinomatous Component Present,Stage IA Pancreatic Cancer AJCC v8,1
22451,Malignant Cellular Infiltrate,Cervical Cancer by AJCC v8 Stage,1
22452,Regional Disease,Crohn Disease,1
22453,Neuroectodermal Differentiation,"Adrenal Gland Ganglioneuroblastoma, Intermixed",1
22454,S-100-Positive Neoplastic Cells Present,Lung PEComa,1
22455,Malignant Cellular Infiltrate,Metastatic Urethral Urothelial Carcinoma,1
22456,In Situ Lesion,Intraepithelial Squamous Cell Carcinoma,1
22457,Malignant Cellular Infiltrate,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
22458,Tissue of Mullerian Origin Present,Adenomyoma,1
22459,Secondary Lesion,Secondary Supratentorial Anaplastic Astrocytoma,1
22460,Malignant Cellular Infiltrate,Anaplastic (Malignant) Intraspinal Meningioma,1
22461,Extensive Stage Lesion,Mesothelioma malignant advanced,1
22462,Malignant Cellular Infiltrate,Postcricoid cancer,1
22463,Carcinomatous Component Present,Paranasal Sinus Cancer,1
22464,Malignant Cellular Infiltrate,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",1
22465,Epithelial Component Present,Cervical Basaloid Carcinoma,1
22466,Cold Nodule,Thyroid Angiosarcoma,1
22467,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v8 Stage,1
22468,Neuroectodermal Differentiation,Neuroblastic tumors,1
22469,Carcinomatous Component Present,Unresectable Bladder Urothelial Carcinoma,1
22470,Neuroendocrine Differentiation,Digestive System Neuroendocrine Neoplasm,1
22471,Hyperplastic Tissue Present,Lobular Endocervical Glandular Hyperplasia,1
22472,Indolent Clinical Course,Kidney Fibroma,1
22473,Dysplasia,Grade II Prostatic Intraepithelial Neoplasia,1
22474,Malignant Cellular Infiltrate,Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
22475,Epithelial Component Present,Colorectal Filiform Serrated Adenoma,1
22476,Carcinomatous Component Present,Distal Bile Duct Carcinoma,1
22477,Low Mitotic Activity,Somatostatinoma,1
22478,Slow Growing Mass,Peripheral Hemangioblastoma,1
22479,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Fetal Lung Adenocarcinoma,1
22480,Exophytic Papillary Lesion,Cervical Papillary Squamous Cell Carcinoma,1
22481,Metastatic/Recurrent Disease,Refractory Synovial Sarcoma,1
22482,Epithelial Component Present,Stage III Breast Cancer AJCC v6,1
22483,Cartilaginous Differentiation,Chondroblastic osteosarcoma,1
22484,Refractory Disease,"Refractory Medulloblastoma, SHH-Activated",1
22485,Epithelial Component Present,signet ring cell carcinoma of breast,1
22486,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v7,1
22487,Bone Marrow and Blood Involvement,Burkitt Leukemia,1
22488,Neuroendocrine Differentiation,Stage IA Merkel Cell Carcinoma AJCC v7,1
22489,Cutaneous Involvement,Spindle cell squamous cell carcinoma,1
22490,Well-Circumscribed Lesion,Juxtaglomerular tumor,1
22491,Fibrotic Stroma Formation,Cystadenofibroma,1
22492,Refractory Disease,Refractory Malignant Female Reproductive System Neoplasm,1
22493,Pathologic TNM Finding,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
22494,Epithelial Component Present,Benign Ovarian Mucinous Tumor,1
22495,Malignant Cellular Infiltrate,Stage I Ovarian Cancer AJCC v8,1
22496,Carcinomatous Component Present,Pathologic Stage 0 Gastric Cancer AJCC v8,1
22497,Epithelial Component Present,Paget Disease of the Scrotum,1
22498,Epithelial Component Present,Tonsillar Carcinoma,1
22499,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Small Cell Variant",1
22500,Malignant Cellular Infiltrate,Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8,1
22501,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
22502,Malignant Cellular Infiltrate,Thymic Mucoepidermoid Carcinoma,1
22503,Epithelial Component Present,Desmoplastic trichoepithelioma,1
22504,Nested Pattern,Clear Cell Sarcoma of Soft Tissue,1
22505,Neuroendocrine Differentiation,small cell carcinoma of extrahepatic bile duct,1
22506,Malignant Cellular Infiltrate,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
22507,Mesenchymal Component Present,Borderline Breast Phyllodes Tumor,1
22508,Carcinomatous Component Present,Barrett's Adenocarcinoma,1
22509,Cutaneous Involvement,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
22510,Therapy-Related Toxicity,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,1
22511,Indolent Clinical Course,Ameloblastic fibrodentinoma,1
22512,Intraductal Lesion,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
22513,Epithelial Component Present,Grade II Prostatic Intraepithelial Neoplasia,1
22514,Carcinomatous Component Present,Renal Pelvis Cancer by AJCC v7 Stage,1
22515,Benign Cellular Infiltrate,Infiltrating Intramuscular Lipoma,1
22516,Slowly Progressive Clinical Course,Smoldering Systemic Mastocytosis,1
22517,Epithelial Component Present,Apudoma,1
22518,Abundance of Small Lymphocytes,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
22519,Anaplasia,Sarcomatoid Carcinoma of the Penis,1
22520,Acanthosis,Upper Gingival Verrucous Carcinoma,1
22521,Carcinomatous Component Present,Tubular breast carcinoma,1
22522,Absence of Invasion,Atypical Lobular Breast Hyperplasia,1
22523,Papillary Pattern,Sphenoid Sinus Inverted Papilloma,1
22524,Heterologous Elements Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
22525,Microvascular Proliferation,Recurrent Gliosarcoma,1
22526,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of gallbladder,1
22527,Myxoid Stroma Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
22528,Well Differentiated Neuroendocrine Lesion,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
22529,Epithelial Component Present,Intraductal Cribriform Breast Adenocarcinoma,1
22530,Carcinomatous Component Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",1
22531,Epithelial Component Present,Stage IV Intrahepatic Bile Duct Cancer AJCC v8,1
22532,Plasma cell inflammation,Gastric Inflammatory Myofibroblastic Tumor,1
22533,Malignant Cellular Infiltrate,Refractory Colon Carcinoma,1
22534,Epithelial Component Present,Stage III Colon Cancer AJCC v8,1
22535,Carcinomatous Component Present,undifferentiated carcinoma of anal canal,1
22536,Fibrotic Stroma Formation,Ovarian Serous Adenofibroma,1
22537,Cutaneous Involvement,Cutaneous Angioimmunoblastic T-Cell Lymphoma,1
22538,Absence of Invasion,Bladder adenocarcinoma stage 0,1
22539,Epithelial Component Present,Widely Invasive Thymoma,1
22540,Papillary Pattern,Syringocystadenoma Papilliferum,1
22541,Desmoplastic Stroma Formation,Desmoplastic Neurotropic Melanoma,1
22542,Malignant Cellular Infiltrate,Primary Bone Osteosarcoma,1
22543,Malignant Cellular Infiltrate,EBV-Related Hodgkin Lymphoma,1
22544,Malignant Cellular Infiltrate,Adult Epithelioid Hemangioendothelioma,1
22545,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
22546,Immunologic Deficiency Syndromes,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,1
22547,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v8,1
22548,Intermediate Grade Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor G2,1
22549,Anaplasia,Childhood Brain Glioblastoma,1
22550,Neuroendocrine Differentiation,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
22551,Invasive Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
22552,Carcinomatous Component Present,Breast Carcinoma Metastatic in Lymph Node,1
22553,Secondary Lesion,Secondary Neoplasm,1
22554,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage 0,1
22555,In Situ Lesion,Carcinoma in situ of ampulla of Vater,1
22556,Tubular Pattern,Syringoma,1
22557,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Diffuse Leiomyomatosis,1
22558,Refractory Disease,Refractory cancer,1
22559,Malignant Cellular Infiltrate,Parotid Gland Carcinosarcoma,1
22560,Exophytic Polypoid Lesion,Gallbladder adenoma,1
22561,Carcinomatous Component Present,Laryngeal verrucous carcinoma,1
22562,Carcinomatous Component Present,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
22563,Epithelial Component Present,Stage II Carcinoma of Penis,1
22564,Malignant Cellular Infiltrate,Stage IV Bone Cancer AJCC v7,1
22565,Carcinomatous Component Present,Stage I Esophageal Cancer,1
22566,Cellular Pleomorphism,Malignant fibrous histiocytoma recurrent,1
22567,Carcinomatous Component Present,Thyroid carcinoma,1
22568,Carcinomatous Component Present,Adult Hepatocellular Carcinoma,1
22569,Primary Lesion,Gastric T-Cell Non-Hodgkin Lymphoma,1
22570,Somatostatin Positive Neoplastic Cells Present,Pancreatic Somatostatinoma,1
22571,Slow Growing Painless Mass,Palisaded encapsulated neuroma,1
22572,Malignant Cellular Infiltrate,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
22573,'Starry-sky' pattern,Recurrent Adult Burkitt Lymphoma,1
22574,Lymphoplasmacytic Infiltrate,Nasopharyngeal Nonkeratinizing Carcinoma,1
22575,Epithelial Component Present,Thyroid Gland Hyperfunctioning Adenoma,1
22576,Epithelial Component Present,undifferentiated carcinoma of salivary gland,1
22577,Epithelial Component Present,Fibroepithelioma of Pinkus,1
22578,Epithelial Component Present,adenoid cystic carcinoma of floor of mouth,1
22579,Epithelial Component Present,Mild epithelial dysplasia,1
22580,Sebaceous Differentiation,Eyelid Sebaceous Gland Carcinoma,1
22581,Undifferentiated Lesion,Undifferentiated Stromal Sarcoma,1
22582,Well-Circumscribed Lesion,Adult Pineocytoma,1
22583,Lobulated Growth Pattern,Apocrine adenoma,1
22584,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,1
22585,Well Differentiated Neuroendocrine Lesion,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,1
22586,Carcinomatous Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
22587,Benign Cellular Infiltrate,Central Nervous System Hibernoma,1
22588,Indolent Clinical Course,chondroma of lung,1
22589,Carcinomatous Component Present,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
22590,Metastatic/Recurrent Disease,Distal-Type Epithelioid Sarcoma,1
22591,Cutaneous Involvement,Ocular Sebaceous Carcinoma,1
22592,Malignant Cellular Infiltrate,Non-small cell lung cancer stage I,1
22593,Carcinomatous Component Present,Colorectal Cancer by AJCC v6 Stage,1
22594,Well-Circumscribed Lesion,Gastric Non-Neoplastic Polyp,1
22595,Recurrent disease,Recurrent Childhood Glioblastoma,1
22596,Malignant Cellular Infiltrate,Invasive Ductal and Lobular Carcinoma,1
22597,Mixed Cellular Population,Malignant Vulvar Phyllodes Tumor,1
22598,Bone Marrow Dysplasia Present,"Leukemia, Myelomonocytic, Chronic",1
22599,Myxoid Stroma Formation,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation,1
22600,Indolent Clinical Course,"Mixed Tumor, Not Otherwise Specified",1
22601,Myxoid Stroma Formation,Juxta-Articular Myxoma,1
22602,Papillary Pattern,Intraductal papillary breast neoplasm,1
22603,Benign Cellular Infiltrate,Benign neoplasm of epicardium,1
22604,Benign Cellular Infiltrate,Trigeminal schwannoma,1
22605,Tubular Pattern,Tubular adenoma of breast,1
22606,Epithelial Component Present,Lung Typical Carcinoid Tumor,1
22607,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Advanced Uterine Corpus Carcinosarcoma,1
22608,Local disease,Inner Ear Lipoma,1
22609,Hypercellular bone marrow,Juvenile Myelomonocytic Leukemia,1
22610,Primary Lesion,Brain Ependymoma,1
22611,Primary Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7,1
22612,Neuroendocrine Differentiation,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
22613,Epithelial Component Present,Stage III Colon Cancer,1
22614,Malignant Cellular Infiltrate,Stage IIA Uterine Sarcoma AJCC v7,1
22615,Epithelial Component Present,Traditional Serrated Adenoma,1
22616,Malignant Cellular Infiltrate,Stage IVB Primary Peritoneal Cancer AJCC v8,1
22617,Ventricular Involvement Only,Lateral Ventricle Ependymal Tumor,1
22618,Recurrent disease,Recurrent Malignant Central Nervous System Neoplasm,1
22619,Angiodestructive Pattern,Recurrent Childhood Lymphomatoid Granulomatosis,1
22620,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
22621,Clinical TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,1
22622,Carcinomatous Component Present,Squamous cell carcinoma of vagina,1
22623,Pseudopapillary Pattern,Childhood Ovarian Embryonal Carcinoma,1
22624,Refractory Disease,Refractory Ewing Sarcoma,1
22625,Carcinomatous Component Present,Bartholin Gland Transitional Cell Carcinoma,1
22626,Moderately Differentiated Lesion,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
22627,Cutaneous Involvement,Dedifferentiated Dermatofibrosarcoma Protuberans,1
22628,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor G1,1
22629,Superficial Lesion,Superficial angiomyxoma,1
22630,Insular Pattern,Malignant Pancreatic Somatostatinoma,1
22631,Ground Glass Nuclear Inclusion,Childhood Thyroid Gland Papillary Carcinoma,1
22632,Malignant Cellular Infiltrate,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
22633,Malignant Cellular Infiltrate,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
22634,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,1
22635,Anaplasia,Anaplastic Brain Stem Glioma,1
22636,Carcinomatous Component Present,Stage 0is Renal Pelvis Cancer AJCC v8,1
22637,Perivascular Pseudorosette Formation,Adult Anaplastic Ependymoma,1
22638,Benign Cellular Infiltrate,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
22639,In Situ Lesion,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7,1
22640,High Grade Lesion,Alveolar soft part sarcoma metastatic,1
22641,Carcinomatous Component Present,Adenocarcinoma of ampulla of Vater,1
22642,Single Cell Necrosis,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
22643,Hyperplastic Epithelial Tissue Present,Atypical Ductal Breast Hyperplasia,1
22644,Numerous Stromal Mast Cells Present,Breast Myofibroblastoma,1
22645,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v8,1
22646,Local disease,Intramuscular lipoma,1
22647,Metastatic Lesion,Secondary malignant neoplasm of stomach,1
22648,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma,1
22649,Secondary Lesion,Secondary malignant neoplasm of liver,1
22650,Neuroendocrine Differentiation,Esophageal Neuroendocrine Neoplasm,1
22651,Low Mitotic Activity,Stage II Ileal Neuroendocrine Tumor AJCC v8,1
22652,Epithelial Component Present,Stage IV Renal Cell Cancer AJCC v7,1
22653,Epithelial Component Present,Appendix Traditional Serrated Adenoma,1
22654,In Situ Lesion,Stage 0 Rectal Cancer AJCC v8,1
22655,Epithelial Component Present,Stage I Esophageal Squamous Cell Carcinoma AJCC v7,1
22656,Infiltrating Tumor Margins Present,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
22657,Carcinomatous Component Present,Stage I Prostate Cancer AJCC v7,1
22658,Malignant Cellular Infiltrate,Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,1
22659,Epithelial Component Present,Small Intestinal Signet Ring Cell Carcinoma,1
22660,Desmoplastic Stroma Formation,Desmoplastic trichilemmoma,1
22661,Carcinomatous Component Present,Stage IIC Colorectal Cancer AJCC v8,1
22662,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Cystadenocarcinoma of kidney,1
22663,Severe dysplasia,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
22664,Malignant Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v7,1
22665,Large Spaces Filled with Blood Present,"Bone Cysts, Aneurysmal",1
22666,Epithelial Component Present,"Uterine Carcinosarcoma, Heterologous Type",1
22667,Platinum Resistance,Platinum-Resistant Lung Small Cell Carcinoma,1
22668,Carcinomatous Component Present,Adenocarcinoma in situ in a polyp,1
22669,Epithelial Component Present,Stage IIIB Eyelid Carcinoma AJCC v8,1
22670,Epithelial Component Present,Exophytic Schneiderian Papilloma,1
22671,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Adult Acute Monocytic Leukemia,1
22672,Exophytic Polypoid Lesion,Sessile Serrated Adenoma/Polyp,1
22673,Carcinomatous Component Present,Carcinoma ex pleomorphic adenoma of parotid gland,1
22674,Non-Malignant Cellular Infiltrate,Chronic Lymphoproliferative Disorder of NK-Cells,1
22675,Carcinomatous Component Present,Laryngeal verrucous carcinoma,1
22676,Benign Cellular Infiltrate,Subglottic Hemangioma,1
22677,High Mitotic Activity,"Perivascular epithelioid tumor, malignant",1
22678,Malignant Cellular Infiltrate,Stage II Merkel Cell Carcinoma AJCC v7,1
22679,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
22680,Benign Cellular Infiltrate,Ethmoid Sinus Schneiderian Papilloma,1
22681,Malignant Cellular Infiltrate,squamous cell carcinoma of middle ear,1
22682,Absence of Invasion,Stage 0 Vulvar Cancer,1
22683,Calcitonin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
22684,Epithelial Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v7,1
22685,Malignant Cellular Infiltrate,Adult Undifferentiated Pleomorphic Sarcoma,1
22686,Benign Cellular Infiltrate,Trichoepithelioma,1
22687,Clinical TNM Finding,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
22688,Neuroendocrine Differentiation,Malignant Intrathoracic Paravertebral Paraganglioma,1
22689,Benign Cellular Infiltrate,Syringoma,1
22690,Malignant Cellular Infiltrate,Diffuse malignant mesothelioma,1
22691,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage II,1
22692,Malignant Cellular Infiltrate,Stage II Hilar Cholangiocarcinoma AJCC v8,1
22693,Malignant Cellular Infiltrate,Metastatic Thyroid Gland Papillary Carcinoma,1
22694,Microvascular Proliferation,Neural Glioblastoma,1
22695,Cutaneous Involvement,"Dermatitis, Allergic Contact",1
22696,Malignant Cellular Infiltrate,"Dendritic Cell Sarcoma, Interdigitating",1
22697,Epithelial Component Present,Benign Testicular Sertoli Cell Tumor,1
22698,Indolent Clinical Course,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
22699,Adulthood Lesion,Adult Unfavorable Prognosis Hodgkin Lymphoma,1
22700,Cutaneous plaque,"Basal cell carcinoma, micronodular",1
22701,Benign Cellular Infiltrate,Soft tissue chondroma,1
22702,Vascular Channel Formation,Bone Epithelioid Hemangioma,1
22703,Epithelial Component Present,Malignant Vulvar Phyllodes Tumor,1
22704,Carcinomatous Component Present,"Adenocarcinoma, Oxyphilic",1
22705,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Isolated del(5q),1
22706,Malignant Cellular Infiltrate,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
22707,Hereditary Lesion,Ataxia Telangiectasia,1
22708,Malignant Cellular Infiltrate,Stage IV Urethral Cancer AJCC v8,1
22709,Carcinomatous Component Present,Pseudomyxoma Peritonei,1
22710,Widely Invasive Lesion,Widely Invasive Thymoma,1
22711,Mesenchymal Metaplasia,Adenocarcinoma with cartilaginous metaplasia,1
22712,Secondary Lesion,Secondary malignant neoplasm of sternum,1
22713,Malignant Cellular Infiltrate,Transitional cell carcinoma of ureter,1
22714,Mucoid Stroma Formation,Primary Cutaneous Mucinous Carcinoma,1
22715,Cutaneous Involvement,Tinea,1
22716,Epithelial Component Present,Stage III Adult Liver Cancer AJCC v7,1
22717,Tissue Differentiation Uncertain,Clear-Cell Myomelanocytic Tumors,1
22718,Multinodular Mass,Adult Angiosarcoma,1
22719,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v8 Stage,1
22720,High Grade Lesion,Childhood Alveolar Rhabdomyosarcoma,1
22721,Refractory Disease,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
22722,Carcinomatous Component Present,BRCA-Mutated Ovarian Carcinoma,1
22723,Biphasic Pattern,Borderline Ovarian Endometrioid Adenofibroma,1
22724,Malignant Cellular Infiltrate,Recurrent Endometrial Cancer,1
22725,Low Grade Lesion,Cardiac Epithelioid Hemangioendothelioma,1
22726,Papillary Pattern,Cervical Warty Carcinoma,1
22727,Exophytic Polypoid Lesion,adenomatous polyp of stomach,1
22728,High Mitotic Activity,Stage IIC Merkel Cell Carcinoma AJCC v7,1
22729,Carcinomatous Component Present,Submandibular Gland Acinic Cell Carcinoma,1
22730,Poorly Differentiated Lesion,Stage IA Lung Large Cell Carcinoma AJCC v7,1
22731,Chronic Inflammatory Infiltrate,Non-Ossifying Fibroma,1
22732,Carcinomatous Component Present,Ovarian Transitional Cell Carcinoma,1
22733,Polymorphic Cellular Infiltrate,Thyroid Gland Langerhans Cell Histiocytosis,1
22734,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v7,1
22735,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v6,1
22736,Pathologic TNM Finding,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
22737,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
22738,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(11;17)(q13;q21),1
22739,Epithelial Component Present,Stage IA Cervical Cancer AJCC v8,1
22740,Invasive Lesion,"Squamous cell carcinoma, microinvasive",1
22741,Splenomegaly,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
22742,Malignant Cellular Infiltrate,Endometrioid carcinoma ovary,1
22743,Infiltrative Growth Pattern,Dupuytren Contracture,1
22744,Malignant Cellular Infiltrate,Refractory Paranasal Sinus Squamous Cell Carcinoma,1
22745,Benign Cellular Infiltrate,Histiocytoma,1
22746,Low Mitotic Activity,Stage I Jejunal Neuroendocrine Tumor AJCC v8,1
22747,Epithelial Component Present,Tongue Carcinoma,1
22748,Primary Lesion,Primary serous papillary carcinoma of peritoneum,1
22749,Monomorphic Cellular Infiltrate,"Adenoma, Basal Cell",1
22750,Malignant Cellular Infiltrate,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,1
22751,Malignant Cellular Infiltrate,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
22752,Epithelial Component Present,Bladder Papillary Clear Cell Adenocarcinoma,1
22753,Epithelial Component Present,Gallbladder Goblet Cell Carcinoid,1
22754,Malignant Cellular Infiltrate,Third Ventricle Germinoma,1
22755,Malignant Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,1
22756,Malignant Cellular Infiltrate,Refractory Primary Effusion Lymphoma,1
22757,Malignant Cellular Infiltrate,Stage IV Pancreatic Cancer AJCC v6 and v7,1
22758,Malignant Cellular Infiltrate,de novo Myelodysplastic Syndrome,1
22759,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Larynx,1
22760,Carcinomatous Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
22761,Epithelial Component Present,Recurrent Parotid Gland Carcinoma,1
22762,Keratin pearl formation,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
22763,Serrated Glandular Architecture,Filiform Serrated Adenoma,1
22764,Epithelial Component Present,Ovarian Trabecular Carcinoid Tumor,1
22765,Undifferentiated Lesion,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
22766,Cavernous Vascular Space Formation,Cavernous hemangioma of the face,1
22767,Epithelial Component Present,Ovarian Insular Carcinoid Tumor,1
22768,Malignant Germinomatous Cellular Infiltrate,Recurrent Extragonadal Seminoma,1
22769,Islands of Odontogenic Epithelium Present,Central odontogenic fibroma,1
22770,Carcinomatous Component Present,Stage IV Bladder Cancer AJCC v6,1
22771,Epithelial Component Present,Lipid-rich carcinoma,1
22772,Benign Cellular Infiltrate,Acoustic Neuroma,1
22773,Well-Circumscribed Lesion,Pancreatic Solid Serous Adenoma,1
22774,Benign Cellular Infiltrate,Fetal rhabdomyoma,1
22775,Perivascular Arrangement of Tumor Cells,Bone Glomus Tumor,1
22776,Epithelial Component Present,Metastatic Bladder Urothelial Carcinoma,1
22777,No Identifiable Line of Differentiation,Childhood Undifferentiated Pleomorphic Sarcoma,1
22778,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma AJCC v7,1
22779,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor,1
22780,Epithelial Component Present,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
22781,Carcinomatous Component Present,Metastatic Lung Non-Small Cell Squamous Carcinoma,1
22782,Absence of Invasion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
22783,Epithelial Component Present,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
22784,Malignant Cellular Infiltrate,Stage II Indolent Adult Non-Hodgkin Lymphoma,1
22785,Epithelial Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
22786,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Adult Lymphoma AJCC v8,1
22787,Carcinomatous Component Present,Carcinosarcoma of ovary,1
22788,Rapidly Enlarging Mass,Rhabdomyosarcoma,1
22789,Carcinomatous Component Present,Colorectal Neuroendocrine Carcinoma,1
22790,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage III,1
22791,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v8,1
22792,Malignant Cellular Infiltrate,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
22793,Malignant Cellular Infiltrate,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
22794,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,1
22795,Cystic Change,Fundic gland polyp,1
22796,Therapy-Related Toxicity,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder,1
22797,Absence of Invasion,Cervical Squamous Cell Carcinoma In Situ,1
22798,Carcinomatous Component Present,Stage II Vulvar Cancer AJCC v8,1
22799,Rapidly Enlarging Mass,embryonal rhabdomyosarcoma of prostate,1
22800,Malignant Cellular Infiltrate,"Medulloblastoma, SHH-Activated",1
22801,Anaplasia,Infratentorial Glioblastoma,1
22802,Malignant Cellular Infiltrate,Lung Small Cell Carcinoma by AJCC v7 Stage,1
22803,Epithelial Component Present,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,1
22804,Infiltrative Growth Pattern,Infratentorial Glioblastoma,1
22805,Chronic lymphocytic inflammation,Micronodular thymoma with lymphoid stroma,1
22806,Microsatellite Stable,Metastatic Microsatellite Stable Colorectal Carcinoma,1
22807,Epithelial Component Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,1
22808,Cutaneous Involvement,Scrotal Sarcoma,1
22809,Epithelial Component Present,Stage III Colon Cancer AJCC v7,1
22810,Well Differentiated Neuroendocrine Lesion,Stage III Ileal Neuroendocrine Tumor AJCC v8,1
22811,Cutaneous Involvement,Primary Cutaneous Intravascular Large B-Cell Lymphoma,1
22812,Metastatic Lesion,Prostate Carcinoma Metastatic in the Soft Tissue,1
22813,Perivascular Arrangement of Tumor Cells,Gastric Glomus Tumor,1
22814,Vascular Channel Formation,Central Nervous System Epithelioid Hemangioendothelioma,1
22815,Childhood Lesion,Stage IV Childhood Burkitt Lymphoma,1
22816,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor G2,1
22817,Dysplasia,Noninfiltrating Intraductal Carcinoma,1
22818,Vascular proliferation,Giant Cell Tumor of Soft Tissue,1
22819,Dysplasia,Appendix Mucinous Cystadenoma,1
22820,Epithelial Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,1
22821,Carcinomatous Component Present,Stage IB Ovarian Cancer AJCC v8,1
22822,Epithelial Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
22823,Neuroendocrine Differentiation,Atrial Paraganglioma,1
22824,Slow Growing Mass,Kadish Stage A Olfactory Neuroblastoma,1
22825,Malignant Cellular Infiltrate,Recurrent Indolent Adult Non-Hodgkin Lymphoma,1
22826,High Mitotic Activity,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
22827,Microvascular Proliferation,Recurrent Glioblastoma,1
22828,Neuroendocrine Differentiation,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
22829,Epithelial Component Present,Stage IIIA Small Intestinal Cancer AJCC v7,1
22830,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
22831,Malignant Cellular Infiltrate,Stage III Vaginal Cancer AJCC v6 and v7,1
22832,High Mitotic Activity,Metastatic Bladder Small Cell Carcinoma,1
22833,Malignant Cellular Infiltrate,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
22834,Neuroendocrine Differentiation,Malignant Intrathoracic Paravertebral Paraganglioma,1
22835,Malignant Cellular Infiltrate,Adult Alveolar Soft Part Sarcoma,1
22836,High Mitotic Activity,Primary hepatic neuroendocrine carcinoma,1
22837,Vascular Channel Formation,Post-Radiotherapy Breast Angiosarcoma,1
22838,Lobulated Growth Pattern,Juxta-Articular Myxoma,1
22839,Benign Cellular Infiltrate,Dartoic myoma,1
22840,Lobulated Growth Pattern,Chordoma of clivus,1
22841,Malignant Cellular Infiltrate,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
22842,Neuroendocrine Differentiation,Malignant Intrathoracic Paravertebral Paraganglioma,1
22843,Carcinomatous Component Present,squamous cell carcinoma of renal pelvis,1
22844,Favorable Clinical Outcome,Type D Lymphomatoid Papulosis,1
22845,Malignant Cellular Infiltrate,Stage II Pharynx Carcinoma,1
22846,Epithelial Component Present,Prognostic Stage IIB Breast Cancer AJCC v8,1
22847,Carcinomatous Component Present,Stage IV Nasal Cavity Carcinoma AJCC v7,1
22848,Peripheral Nuclear Palisading,Small cell lung cancer extensive stage,1
22849,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Solid Variant",1
22850,Mesenchymal Component Present,"Phyllodes tumor, benign",1
22851,Malignant Cellular Infiltrate,Non-Hematologic Malignancy,1
22852,Carcinomatous Component Present,Stage II Colon Cancer,1
22853,Malignant Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v6 and v7,1
22854,Epithelial Component Present,Anal Verrucous Carcinoma,1
22855,Cellular Pleomorphism,Cardiac Malignant Fibrous Histiocytoma,1
22856,Vascular Channel Formation,Hemangioma,1
22857,Hyalinized Vessels Present,Pilocytic Astrocytoma,1
22858,Malignant Cellular Infiltrate,Malignant retroperitoneal tumor,1
22859,Bone Marrow Dysplasia Present,Refractory anemia with ringed sideroblasts,1
22860,Carcinomatous Component Present,Stage II Colorectal Cancer AJCC v8,1
22861,Borderline Resectable Mass,Borderline Resectable Pancreatic Adenocarcinoma,1
22862,Epithelial Component Present,Recurrent respiratory papillomatosis,1
22863,Stromal Invasion,Stage IB Ovarian Cancer AJCC v6 and v7,1
22864,Malignant Cellular Infiltrate,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
22865,Indolent Clinical Course,Breast Epithelioid Hemangioma,1
22866,Lobulated Growth Pattern,Chondroid chordoma,1
22867,Epithelial Component Present,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7,1
22868,Malignant Cellular Infiltrate,Synovial sarcoma recurrent,1
22869,Geographic Necrosis,Extragonadal primary embryonal carcinoma,1
22870,Endometrial Type Glands and Stroma Present,"Cervical Adenomyoma, Endometrial Type",1
22871,Malignant Cellular Infiltrate,Sweat gland carcinoma,1
22872,Adnexal Differentiation,Malignant eccrine spiradenoma,1
22873,Anaplasia,Recurrent Childhood Gliosarcoma,1
22874,Malignant Cellular Infiltrate,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
22875,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v6,1
22876,Neuroendocrine Differentiation,Pancreatic Somatostatinoma,1
22877,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
22878,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v6 Stage,1
22879,Epithelial Component Present,Laryngeal Giant Cell Carcinoma,1
22880,Carcinomatous Component Present,Recurrent Head and Neck Carcinoma,1
22881,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8,1
22882,Microvascular Proliferation,Childhood Gliosarcoma,1
22883,Malignant Cellular Infiltrate,Stage 0 Renal Pelvis Cancer AJCC v7,1
22884,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma recurrent,1
22885,Hereditary Lesion,Bloom Syndrome,1
22886,Benign Cellular Infiltrate,Vaginal Dermoid Cyst,1
22887,Infiltrative Growth Pattern,Recurrent Gliosarcoma,1
22888,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation,1
22889,Cystic Change,Ovarian Mucinous Cystadenofibroma,1
22890,Nuclear Pseudoinclusion,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
22891,Malignant Cellular Infiltrate,Stage IIC Colon Cancer AJCC v7,1
22892,Malignant Cellular Infiltrate,Activated B-cell type diffuse large B-cell lymphoma,1
22893,Childhood Lesion,Childhood Malignant Liver Neoplasm,1
22894,Carcinomatous Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v8,1
22895,Monoclonal Gammapathies,Monoclonal Gammopathy of Undetermined Significance,1
22896,Carcinomatous Component Present,Stage II Rectal Cancer AJCC v8,1
22897,Solid Growth Pattern,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
22898,Cutaneous Involvement,Stage IIC Merkel Cell Carcinoma AJCC v7,1
22899,Cutaneous Involvement,Cutaneous schistosomiasis,1
22900,Malignant Cellular Infiltrate,Malignant Uveal Neoplasm,1
22901,Urine phosphorous concentration above normal,Oncogenic osteomalacia,1
22902,Low Mitotic Activity,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
22903,Secondary Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,1
22904,Carcinomatous Component Present,Stage II Rectosigmoid Cancer AJCC v7,1
22905,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8,1
22906,Hemorrhagic,Anaplastic adrenocortical carcinoma,1
22907,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,1
22908,Non-Invasive Lesion,Ureter Inverted Papilloma,1
22909,Follicular Differentiation,Pilomatrixoma,1
22910,Malignant Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v8 Stage,1
22911,Well-Circumscribed Lesion,Solid Angioleiomyoma,1
22912,Tissue of Mullerian Origin Present,serous adenocarcinofibroma of ovary,1
22913,Epithelial Component Present,"Pancreatic carcinoma, familial",1
22914,Tissue of Mullerian Origin Present,Ovarian Mucinous Cystadenofibroma,1
22915,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v6 and v7,1
22916,Epithelial Component Present,Benign Ovarian Clear Cell Tumor,1
22917,Tissue Differentiation Uncertain,Pleural Monophasic Synovial Sarcoma,1
22918,Carcinomatous Component Present,Localized Gallbladder Carcinoma,1
22919,Childhood Lesion,Childhood Testicular Embryonal Carcinoma,1
22920,Stromal Invasion,Undifferentiated carcinoma of ovary,1
22921,Benign Cellular Infiltrate,Vulvar Trichoepithelioma,1
22922,Hereditary Lesion,Neurofibromatosis 2,1
22923,Neuroendocrine Differentiation,Low Grade Lung Neuroendocrine Neoplasm,1
22924,Exophytic Polypoid Lesion,Juvenile polyp,1
22925,Metastatic Lesion,Metastatic Breast Neuroendocrine Neoplasm,1
22926,Tissue of Mullerian Origin Present,Cystadenofibroma,1
22927,Immunologic Deficiency Syndromes,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
22928,Malignant Cellular Infiltrate,Endometrial Mucinous Adenocarcinoma,1
22929,Diffuse Pattern,Childhood Malignant Peripheral Nerve Sheath Tumor,1
22930,Malignant Cellular Infiltrate,Necrotic intraocular melanoma,1
22931,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
22932,Exophytic Papillary Lesion,Condyloma acuminata of cervix,1
22933,Collagenous Stroma Formation,Desmoplastic fibroblastoma,1
22934,Epithelial Component Present,Acantholytic acanthoma,1
22935,Hyalinized Stroma Formation,Pleural Epithelioid Hemangioendothelioma,1
22936,Childhood Lesion,Childhood B Acute Lymphoblastic Leukemia,1
22937,Epithelial Component Present,Stage I Laryngeal Cancer AJCC v8,1
22938,Antoni A Pattern,Benign Mediastinal Psammomatous Schwannoma,1
22939,Well-Circumscribed Lesion,Polyp of ethmoidal sinus,1
22940,Epithelial Component Present,Postcricoid cancer,1
22941,Childhood Lesion,Childhood Immature Teratoma,1
22942,Adulthood Lesion,Indolent Adult Non-Hodgkin Lymphoma,1
22943,Neuroendocrine Differentiation,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
22944,Malignant Cellular Infiltrate,Childhood Cerebellar Anaplastic Astrocytoma,1
22945,Fibrotic Stroma Formation,Adenocarcinofibroma,1
22946,Malignant Cellular Infiltrate,Hypergranular promyelocytic leukemia,1
22947,Epithelial Component Present,Maxillary Sinus Inverted Papilloma,1
22948,Primary Site Unknown,Squamous Cell Carcinoma of Unknown Primary,1
22949,Benign Cellular Infiltrate,Dartoic myoma,1
22950,Epithelial Component Present,Colorectal Intraepithelial Neoplasia,1
22951,Cutaneous Involvement,Invasive Cutaneous Melanoma,1
22952,Malignant Cellular Infiltrate,Resectable Extrahepatic Bile Duct Adenocarcinoma,1
22953,Carcinomatous Component Present,Pathologic Stage I Gastric Cancer AJCC v8,1
22954,Malignant Cellular Infiltrate,Refractory Uterine Corpus Carcinoma,1
22955,Epithelial Component Present,Stage IVA Colorectal Cancer AJCC v8,1
22956,Carcinomatous Component Present,Urothelial carcinoma recurrent,1
22957,Necrotic changes (finding),small cell carcinoma of appendix,1
22958,Malignant Cellular Infiltrate,Asynchronous Multifocal Osteosarcoma,1
22959,High Grade Lesion,Resectable Dedifferentiated Liposarcoma,1
22960,Malignant Cellular Infiltrate,Childhood Malignant Testicular Germ Cell Tumor,1
22961,Immunosuppression-Related Post-Transplant Toxicity,Chronic graft-versus-host disease,1
22962,Malignant Cellular Infiltrate,Acute Promyelocytic Leukemia,1
22963,Malignant Cellular Infiltrate,adenosquamous carcinoma of esophagus,1
22964,Unresectable Mass,Metastatic Unresectable Sarcoma,1
22965,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory anemias,1
22966,Pseudopapillary Pattern,Childhood Testicular Embryonal Carcinoma,1
22967,Epithelial Component Present,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
22968,Malignant Cellular Infiltrate,Pericardial Synovial Sarcoma,1
22969,Inflammatory infiltrate,Inflammatory Leiomyosarcoma,1
22970,Neuronal Differentiation,Pituitary Gland Gangliocytoma,1
22971,Recurrent disease,Recurrent Childhood Cerebellar Astrocytoma,1
22972,Malignant Cellular Infiltrate,Colorectal Burkitt Lymphoma,1
22973,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v8,1
22974,Diffuse Pattern,Diffuse large B-cell lymphoma refractory,1
22975,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Hurthle Cell Carcinoma,1
22976,Carcinomatous Component Present,Locally Advanced Small Intestinal Carcinoma,1
22977,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage I,1
22978,Well-Circumscribed Lesion,Colorectal Adenomatous Polyp,1
22979,Nuclear Atypia,"Glioblastoma, IDH-Mutant",1
22980,Epithelial Component Present,Colon Micropapillary Adenocarcinoma,1
22981,Angiodestructive Pattern,Recurrent Lymphomatoid Granulomatosis,1
22982,Malignant Cellular Infiltrate,Thyroid Gland Mucoepidermoid Carcinoma,1
22983,Chromogranin A Positive Neoplastic Cells Present,Metastatic Breast Carcinoid Tumor,1
22984,Benign Cellular Infiltrate,Intracystic papillary adenoma,1
22985,Primary Lesion,Brain Stem Glioma,1
22986,Carcinomatous Component Present,Malignant neoplasm of stomach stage II,1
22987,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
22988,Pregnancy Complications,Cesarean Scar Pregnancy,1
22989,Solitary mass,Sacral Chordoma,1
22990,Poorly Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
22991,Malignant Cellular Infiltrate,Anal cancer recurrent,1
22992,Malignant Cellular Infiltrate,Gastric Large Cell Neuroendocrine Carcinoma,1
22993,High Mitotic Activity,Metastatic Digestive System Neuroendocrine Carcinoma,1
22994,Tricholemmal Differentiation,Trichilemmoma,1
22995,Well-Circumscribed Lesion,Soft tissue perineurioma,1
22996,Increased Cellularity Present,Resectable Neuroblastoma,1
22997,Malignant Cellular Infiltrate,Advanced Synovial Sarcoma,1
22998,Malignant Cellular Infiltrate,Squamous cell carcinoma of colon,1
22999,Malignant Cellular Infiltrate,Adult Diffuse Large B-Cell Lymphoma,1
23000,Slow Growing Mass,Benign Intracranial Meningioma,1
23001,Hereditary Lesion,Hereditary Multiple Exostoses,1
23002,No Identifiable Line of Differentiation,Adult Undifferentiated Pleomorphic Sarcoma,1
23003,Ganglioneuroma Component Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
23004,Malignant Cellular Infiltrate,"Acute myeloid leukemia, t(8;21) (q22;q22)",1
23005,Epithelial Component Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
23006,Hemorrhagic,Superior Vena Cava Angiosarcoma,1
23007,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx recurrent,1
23008,Pseudopapillary Pattern,teratocarcinoma of mediastinum,1
23009,Malignant Cellular Infiltrate,Stage I Lip Carcinoma,1
23010,Cutaneous Involvement,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
23011,Collagenous Stroma Formation,"Fibromatosis, Aggressive",1
23012,High Grade Lesion,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
23013,Malignant Cellular Infiltrate,Small cell osteosarcoma,1
23014,Calcitonin serum level increased,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
23015,Carcinomatous Component Present,Urethral Cancer by AJCC v8 Stage,1
23016,Carcinomatous Component Present,Neuroendocrine carcinoma of the bladder,1
23017,High Grade Lesion,High Grade Lung Neuroendocrine Neoplasm,1
23018,Benign Cellular Infiltrate,Central Nervous System Myofibroblastoma,1
23019,Exophytic Polypoid Lesion,Appendix Tubular Adenoma,1
23020,Epithelial Component Present,Stage III Nasopharyngeal Carcinoma AJCC v7,1
23021,Malignant Cellular Infiltrate,Kaposi Sarcoma,1
23022,Indolent Clinical Course,Intravenous leiomyomatosis,1
23023,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor G2,1
23024,Malignant Cellular Infiltrate,Parotid Gland Acinic Cell Carcinoma,1
23025,Carcinomatous Component Present,Bladder transitional cell carcinoma stage IV,1
23026,Malignant Cellular Infiltrate,Esophageal Spindle Cell Carcinoma,1
23027,Polarization of Nuclei Towards the Glandular Lumen,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",1
23028,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
23029,Malignant Cellular Infiltrate,Low grade appendiceal mucinous neoplasm,1
23030,Pseudoencapsulated Mass,"Perineurioma, malignant",1
23031,Cutaneous Involvement,Cutaneous myxoma,1
23032,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage I,1
23033,Nuclear pleomorphism,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
23034,Ganglion Cell-Like Elements Present,Intestinal Gangliocytic Paraganglioma,1
23035,Diffuse Pattern,Anaplastic astrocytoma,1
23036,Koilocytotic atypia,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
23037,Low Mitotic Activity,Rectal Neuroendocrine Tumor by AJCC v8 Stage,1
23038,Carcinomatous Component Present,squamous cell carcinoma of middle ear,1
23039,Epithelial Component Present,Intraductal Cribriform Breast Adenocarcinoma,1
23040,Malignant Cellular Infiltrate,Acute monocytic/monoblastic leukemia,1
23041,Nuclear pleomorphism,Salivary duct carcinoma,1
23042,Malignant Cellular Infiltrate,sarcoma of small intestine,1
23043,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
23044,Carcinomatous Component Present,Advanced Neuroendocrine Carcinoma,1
23045,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v7,1
23046,Carcinomatous Component Present,Esophageal squamous cell carcinoma recurrent,1
23047,Malignant Cellular Infiltrate,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
23048,Carcinomatous Component Present,Stage 0 Anal Cancer AJCC v8,1
23049,Malignant Cellular Infiltrate,Stage IIIB Uveal Melanoma AJCC v7,1
23050,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
23051,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders,1
23052,Hyperplastic Tissue Present,Papillary Urothelial Hyperplasia,1
23053,Severe dysplasia,Stage 0 Major Salivary Gland Cancer AJCC v8,1
23054,Epithelial Component Present,Anal Adenocarcinoma within Anorectal Fistula,1
23055,Benign Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyoma,1
23056,Epithelial Component Present,Endocervical polyp,1
23057,Malignant Cellular Infiltrate,Fibrosarcoma of bone,1
23058,Nuclear Molding,large cell neuroendocrine carcinoma of lung,1
23059,Malignant Cellular Infiltrate,Stage II Testicular Cancer AJCC v6 and v7,1
23060,Carcinomatous Component Present,Stage I Gastric Carcinoma,1
23061,High Mitotic Activity,Gastric Neuroendocrine Carcinoma,1
23062,Anaplasia,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
23063,Well-Circumscribed Lesion,Anal Inflammatory Cloacogenic Polyp,1
23064,Carcinomatous Component Present,Adenocarcinoid tumor,1
23065,Locally Aggressive Lesion,Intermediate Fibrohistiocytic Neoplasm,1
23066,Neuroendocrine Differentiation,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
23067,Stromal Invasion,Ovarian epithelial cancer stage II,1
23068,Benign Cellular Infiltrate,Lipomatosis of Nerve,1
23069,Epithelial Component Present,Stage III Bladder Cancer AJCC v8,1
23070,Non-Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
23071,Mild dysplasia,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,1
23072,Epithelial Component Present,Parotid Gland Acinic Cell Carcinoma,1
23073,Exophytic Polypoid Lesion,Giant Fibrovascular Esophageal Polyp,1
23074,Benign Cellular Infiltrate,Ganglioneuroma,1
23075,Perivascular Arrangement of Tumor Cells,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
23076,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma non-metastatic,1
23077,Epithelial Component Present,Thoracic NUT Carcinoma,1
23078,Indolent Clinical Course,Vulvar Leiomyoma,1
23079,Carcinomatous Component Present,Secondary carcinoma,1
23080,Cystic Change,Malignant ovarian cyst,1
23081,Tissue of Mullerian Origin Present,Cystadenofibroma,1
23082,Malignant Cellular Infiltrate,Pathologic Stage IIIC Gastric Cancer AJCC v8,1
23083,Epithelial Component Present,Refractory Female Reproductive System Carcinoma,1
23084,Epithelial Component Present,Adenocarcinoma in tubular adenoma,1
23085,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
23086,Carcinomatous Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
23087,Malignant Cellular Infiltrate,AIDS with Kaposi's sarcoma,1
23088,Malignant Cellular Infiltrate,Intrahepatic cholangiocarcinoma recurrent,1
23089,Epithelial Component Present,Stage III Primary Peritoneal Cancer AJCC v7,1
23090,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7,1
23091,Aggressive Clinical Course,"Thymoma, type B2, malignant",1
23092,Epithelial Component Present,Colorectal High Grade Intraepithelial Neoplasia,1
23093,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage IV,1
23094,Diffuse Pattern,Immunoblastic lymphoma associated with AIDS,1
23095,Invasive Lesion,Acinic Cell Breast Carcinoma,1
23096,Malignant Cellular Infiltrate,Stage IIIA Testicular Cancer AJCC v8,1
23097,Malignant Cellular Infiltrate,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
23098,Vascular Channel Formation,Thyroid Gland Benign Vascular Neoplasm,1
23099,Malignant Cellular Infiltrate,Solid carcinoma,1
23100,Secondary Lesion,Metastatic Malignant Neoplasm in the Iris,1
23101,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in Lymph Node,1
23102,Carcinomatous Component Present,Barrett's Adenocarcinoma,1
23103,Neuroendocrine Differentiation,Gastric Small Cell Carcinoma,1
23104,Childhood Lesion,Childhood Central Nervous System Neuroblastoma,1
23105,Papillary Pattern,verrucous carcinoma of esophagus,1
23106,Pagetoid Proliferation,Stage III Superficial Spreading Melanoma AJCC v7,1
23107,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of extrahepatic bile duct,1
23108,Mature Neutrophils Present,Differentiated Granulocytic Sarcoma,1
23109,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
23110,Malignant Cellular Infiltrate,Stage II Adult Lymphoblastic Lymphoma,1
23111,Cutaneous Involvement,Benign Apocrine Neoplasm,1
23112,Carcinomatous Component Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,1
23113,Epithelial Component Present,Gastric Cancer by AJCC v6 Stage,1
23114,Metastatic Lesion,Stage IV Skin Melanoma,1
23115,atypia morphology,Borderline Fallopian Tube Neoplasm,1
23116,Osseous Differentiation,Asynchronous Multifocal Osteosarcoma,1
23117,Secondary Lesion,Adenocarcinoma of the prostate stage IV,1
23118,Well-Circumscribed Lesion,Polyp of small intestine,1
23119,Geographic Necrosis,Adult Central Nervous System Embryonal Carcinoma,1
23120,Epithelial Component Present,Refractory Endometrial Endometrioid Adenocarcinoma,1
23121,Malignant Cellular Infiltrate,Urothelial carcinoma ureter recurrent,1
23122,Calcinosis,Dentinogenic Ghost Cell Tumor,1
23123,Epithelial Component Present,Breast Cancer by AJCC v7 Stage,1
23124,Metastatic Lesion,Metastatic Hypopharyngeal Carcinoma,1
23125,Carcinomatous Component Present,Ameloblastic Carcinoma,1
23126,Epithelial Component Present,Paget Disease of the Breast with Invasive Ductal Carcinoma,1
23127,Metastatic Lesion,Metastatic Neoplasm,1
23128,Carcinomatous Component Present,Stage IIA Colon Cancer AJCC v8,1
23129,Prominent Squamous Eddies Present,Vulvar Inverted Follicular Keratosis,1
23130,Malignant Cellular Infiltrate,Fibromyxosarcoma,1
23131,Borderline Lesion,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
23132,Skin Red Dot,Angioma serpiginosum,1
23133,Absence of Invasion,Stage 0 Gallbladder Cancer AJCC v6 and v7,1
23134,Childhood Lesion,Childhood Brain Stem Gliosarcoma,1
23135,Vascular Channel Formation,Angiomatous Meningioma,1
23136,More than 10 Mitoses per 10HPF,Metastatic Prostate Small Cell Carcinoma,1
23137,Invasive Lesion,Metastatic Prostate Small Cell Carcinoma,1
23138,Recurrent disease,Recurrent Prostate Acinar Adenocarcinoma,1
23139,Unclassifiable Lesion,"Peripheral T-Cell Lymphoma, Unclassifiable",1
23140,Malignant Cellular Infiltrate,Stage I Anal Cancer AJCC v8,1
23141,Well-Circumscribed Lesion,villous adenoma of stomach,1
23142,Malignant Cellular Infiltrate,Childhood Acute Monoblastic Leukemia,1
23143,Hyperplastic Tissue Present,Parathyroid hyperplasia,1
23144,Malignant Cellular Infiltrate,atypical medullary carcinoma of breast,1
23145,Malignant Cellular Infiltrate,Myelodysplastic-Myeloproliferative Diseases,1
23146,Carcinomatous Component Present,Stage IIA Appendix Carcinoma AJCC v7,1
23147,Schwannian Stroma More than 50 Percent of the Tumor Volume,Central Nervous System Ganglioneuroblastoma,1
23148,Benign Cellular Infiltrate,Vulvar Fibrolipoma,1
23149,Benign Cellular Infiltrate,Retinoma,1
23150,Mitotic Activity,"Testicular Yolk Sac Tumor, Papillary Pattern",1
23151,Epithelial Component Present,Stage IIIA Eyelid Carcinoma AJCC v8,1
23152,Microcystic Change,Ovarian Microcystic Stromal Tumor,1
23153,Pseudoglandular Pattern,Sellar Embryonal Carcinoma,1
23154,Carcinomatous Component Present,Stage IV Major Salivary Gland Cancer AJCC v7,1
23155,High Grade Lesion,Fibroblastic osteosarcoma,1
23156,High Grade Lesion,Intracortical osteosarcoma,1
23157,Malignant Cellular Infiltrate,Stage 0 Urethral Cancer AJCC v7,1
23158,Malignant Cellular Infiltrate,Grade 1 Colon Adenocarcinoma,1
23159,Hereditary Lesion,Sturge-Weber Syndrome,1
23160,Diffuse Pattern,Plasmablastic lymphoma,1
23161,Epithelial Component Present,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
23162,Refractory Disease,Refractory Lymphoblastic Lymphoma,1
23163,Pseudoglandular Pattern,Testicular embryonal carcinoma,1
23164,Malignant Cellular Infiltrate,Duodenal Extraskeletal Osteosarcoma,1
23165,Secondary Lesion,Metastatic Vulvar Carcinoma,1
23166,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
23167,Ground Glass Nuclear Inclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
23168,Malignant Cellular Infiltrate,Infiltrating papillary adenocarcinoma,1
23169,Adulthood Lesion,Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma,1
23170,Epithelial Component Present,Stage IIA Anal Cancer AJCC v8,1
23171,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q,1
23172,Swelling,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,1
23173,Congenital Abnormality,Vulvar Congenital Melanocytic Nevus,1
23174,Epithelial Component Present,Prostate Carcinoma Metastatic in the Lung,1
23175,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v7,1
23176,Malignant Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v7,1
23177,Malignant Cellular Infiltrate,Fibroblastic osteosarcoma,1
23178,Borderline Lesion,Borderline Ovarian Serous Cystadenofibroma,1
23179,Metastatic/Recurrent Disease,Proximal-Type Epithelioid Sarcoma,1
23180,Recurrent disease,Recurrent Aggressive NK-Cell Leukemia,1
23181,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Cancer AJCC v7,1
23182,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Neutropenia,1
23183,Epithelial Component Present,Stage IB Fallopian Tube Cancer AJCC v8,1
23184,Benign Cellular Infiltrate,Benign tumor of endocrine gland,1
23185,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Tumor G1,1
23186,Carcinomatous Component Present,Nodulo-ulcerative basal cell carcinoma,1
23187,Epithelial Component Present,Recurrent Ureter Carcinoma,1
23188,Carcinomatous Component Present,Stage III Nasal Cavity Cancer AJCC v6 and v7,1
23189,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Fallopian Tube Endometrioid Tumor,1
23190,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v7,1
23191,Epithelial Component Present,Metastatic Thyroid Gland Follicular Carcinoma,1
23192,Epithelial Component Present,Unclassified Hepatocellular Adenoma,1
23193,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma,1
23194,High Grade Lesion,Cardiac Synovial Sarcoma,1
23195,Epithelial Component Present,cystadenocarcinoma of intrahepatic bile duct,1
23196,Indolent Clinical Course,Laryngeal Leiomyoma,1
23197,Malignant Cellular Infiltrate,Stage IIIC Ovarian Cancer,1
23198,Malignant Cellular Infiltrate,Adult Anaplastic Oligodendroglioma,1
23199,Tubular Structures Present,Tubular breast carcinoma,1
23200,Malignant Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
23201,Severe cytologic atypia,Anal Canal Small Cell Neuroendocrine Carcinoma,1
23202,Epithelial Component Present,Atypical Breast Papilloma,1
23203,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage III,1
23204,Deep Lesion,Tendon Sheath Lipoma,1
23205,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v8,1
23206,Malignant Cellular Infiltrate,Endometrial Transitional Cell Carcinoma,1
23207,Exophytic Polypoid Lesion,Colorectal Peutz-Jeghers Polyp,1
23208,High Grade Lesion,Embryonal Rhabdomyosarcoma,1
23209,Carcinomatous Component Present,Cervical Warty Carcinoma,1
23210,Carcinomatous Component Present,Locally Advanced Cervical Carcinoma,1
23211,Malignant Cellular Infiltrate,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
23212,Monomorphic Cellular Infiltrate,Adult Oligodendroglioma,1
23213,Epithelial Component Present,Submucosal Invasive Colon Adenocarcinoma,1
23214,Neuroendocrine Differentiation,Unresectable Adrenal Gland Pheochromocytoma,1
23215,Malignant Cellular Infiltrate,Carcinoma of lower gum,1
23216,Carcinomatous Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
23217,Epithelial Component Present,Bladder Urachal Adenocarcinoma,1
23218,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
23219,Mixed Cellular Population,Anaplastic Oligoastrocytoma,1
23220,Adulthood Lesion,Stage III Adult Hodgkin Lymphoma,1
23221,Dysplasia,Anal Intraepithelial Neoplasia 2,1
23222,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
23223,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
23224,Epithelial Component Present,Stage III Nasopharyngeal Carcinoma AJCC v8,1
23225,Malignant Cellular Infiltrate,Non-squamous non-small cell lung cancer,1
23226,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v6 Stage,1
23227,Neuroendocrine Differentiation,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
23228,Unresectable Mass,Unresectable Head and Neck Squamous Cell Carcinoma,1
23229,Childhood Lesion,Childhood Ovarian Germ Cell Tumor,1
23230,'Starry-sky' pattern,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma,1
23231,Malignant Cellular Infiltrate,Uterine Corpus High Grade Endometrial Stromal Sarcoma,1
23232,Malignant Cellular Infiltrate,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
23233,Neuroendocrine Differentiation,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
23234,Mitotic Activity,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
23235,Malignant Cellular Infiltrate,Breast Carcinoma by Gene Expression Profile,1
23236,Malignant Cellular Infiltrate,Advanced Renal Cell Carcinoma,1
23237,Hereditary Lesion,Hereditary Malignant Neoplasm,1
23238,Carcinomatous Component Present,Childhood Hepatocellular Carcinoma,1
23239,Epithelial Component Present,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
23240,Neoplastic Plasma Cells Present in Bone Marrow,Smoldering myeloma,1
23241,Benign Cellular Infiltrate,Dartoic myoma,1
23242,Well-Circumscribed Lesion,Rectal Adenoma with Severe Dysplasia,1
23243,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma metastatic,1
23244,Benign Cellular Infiltrate,"Acanthoma, Clear Cell",1
23245,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(5;17)(q35;q21),1
23246,Cutaneous Involvement,Locally Advanced Skin Squamous Cell Carcinoma,1
23247,Malignant Cellular Infiltrate,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,1
23248,Malignant Cellular Infiltrate,Stage IIIA Colorectal Cancer AJCC v7,1
23249,Cystic Change,Pancreatic Intraductal Tubulopapillary Neoplasm,1
23250,Epithelial Component Present,Colon cancer recurrent,1
23251,Epithelial Component Present,Thymic Sarcomatoid Carcinoma,1
23252,Generalized Dysplasia,Colon Traditional Serrated Adenoma,1
23253,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Glycogen-rich carcinoma,1
23254,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
23255,Malignant Cellular Infiltrate,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,1
23256,Adulthood Lesion,Adult Liposarcoma,1
23257,Malignant Cellular Infiltrate,Myxoid/Round Cell Liposarcoma,1
23258,Malignant Cellular Infiltrate,Small cell carcinoma of prostate,1
23259,Immunosuppression-Related Post-Transplant Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
23260,Indolent Clinical Course,"Synovioma, benign",1
23261,Epithelial Component Present,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
23262,Nerve palsy,Abducens Nerve Palsy,1
23263,Acanthosis,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
23264,Neuroendocrine Differentiation,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
23265,Malignant Cellular Infiltrate,Splenic Manifestation of Prolymphocytic Leukemia,1
23266,Refractory Disease,Refractory T-Cell Prolymphocytic Leukemia,1
23267,Malignant Cellular Infiltrate,Secondary Central Nervous System Hodgkin Lymphoma,1
23268,Lytic lesion,Malignant Giant Cell Tumor of Bone,1
23269,Carcinomatous Component Present,Metastatic Renal Pelvis Urothelial Carcinoma,1
23270,Cutaneous Involvement,Verrucous epidermal nevus,1
23271,Recurrent disease,Breast cancer recurrent,1
23272,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Teratoma,1
23273,Anaplasia,Anaplastic small cell lymphoma,1
23274,Epithelial Component Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
23275,Epithelial Component Present,"Leydig cell tumor, benign",1
23276,Malignant Cellular Infiltrate,Recurrent Urinary System Carcinoma,1
23277,Carcinomatous Component Present,Platinum-Resistant Fallopian Tube Carcinoma,1
23278,Childhood Lesion,Childhood Giant Cell Glioblastoma,1
23279,High Mitotic Activity,"Leydig cell tumor, malignant",1
23280,Cystic Change,Cystadenocarcinoma of pancreas,1
23281,Exophytic Polypoid Lesion,Cervical Microglandular Polyp,1
23282,Mild cytologic atypia,Verrucous carcinoma of penis,1
23283,Ineffective hematopoiesis,MYELODYSPLASTIC SYNDROME,1
23284,Epithelial Component Present,Posterior Tongue Adenoid Cystic Carcinoma,1
23285,Thick-Walled Vessels Present,Angiomyolipoma,1
23286,Carcinomatous Component Present,Stage III Cervical Cancer AJCC v6 and v7,1
23287,Epithelial Component Present,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
23288,Epithelial Component Present,Stage I Fallopian Tube Cancer AJCC v8,1
23289,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of intestine,1
23290,HMB-45-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis of skin,1
23291,Hereditary Lesion,Von Hippel-Lindau Syndrome,1
23292,High Grade Lesion,Cardiac Monophasic Synovial Sarcoma,1
23293,Hyalinized Vessels Present,Recurrent Childhood Pilocytic Astrocytoma,1
23294,Indolent Clinical Course,Appendix Leiomyoma,1
23295,Refractory Disease,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
23296,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma,1
23297,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Tumor,1
23298,Carcinomatous Component Present,Posterior Tongue Squamous Cell Carcinoma,1
23299,Hereditary Lesion,Von Hippel-Lindau Syndrome,1
23300,Pathologic TNM Finding,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
23301,Cutaneous Involvement,Eccrine Sweat Gland Hamartoma,1
23302,Pregnancy Complications,Stage I Gestational Trophoblastic Tumor AJCC v7,1
23303,Malignant Cellular Infiltrate,Secondary malignant neoplasm of anus,1
23304,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
23305,Carcinomatous Component Present,Stage IIIC Hepatocellular Carcinoma AJCC v7,1
23306,Malignant Cellular Infiltrate,Minor Salivary Gland Adenocarcinoma,1
23307,Hot Nodule,Thyroid Gland Hyperfunctioning Adenoma,1
23308,Malignant Cellular Infiltrate,Myeloid leukemia associated with Down Syndrome,1
23309,Exophytic Polypoid Lesion,Precancerous Polyp,1
23310,Tissue Differentiation Uncertain,Malignant Soft Tissue Tumor of Uncertain Differentiation,1
23311,Necrotic changes (finding),Occult Lung Small Cell Carcinoma,1
23312,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v7,1
23313,Pseudo-Psammoma Body Formation,Secretory meningioma,1
23314,Malignant Cellular Infiltrate,Lymphoma by AJCC v8 Stage,1
23315,Trabecular Pattern,Well Differentiated Hepatocellular Carcinoma,1
23316,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity recurrent,1
23317,Absence of Invasion,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7,1
23318,Malignant Cellular Infiltrate,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7,1
23319,Malignant Cellular Infiltrate,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
23320,Skin Papule,Sebaceoma,1
23321,Adulthood Lesion,Adult Unfavorable Prognosis Hodgkin Lymphoma,1
23322,Perivascular Arrangement of Tumor Cells,Hereditary Glomangioma,1
23323,Metastatic Lesion,Castration-Naive Prostate Carcinoma,1
23324,Malignant Cellular Infiltrate,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
23325,Honeycomb Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
23326,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of nasal cavity,1
23327,Myxoid Stroma Formation,Vertebral chordoma,1
23328,Recurrent disease,Recurrent Ampulla of Vater Adenocarcinoma,1
23329,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Placental Choriocarcinoma,1
23330,Hyperkeratosis,Seborrheic keratosis of eyelid,1
23331,Osteoid formation,Radiation-Related Osteosarcoma,1
23332,Macule,Stage III Acral Lentiginous Melanoma AJCC v7,1
23333,Osseous Differentiation,Childhood Conventional Osteosarcoma,1
23334,Tissue of Mullerian Origin Present,Broad Ligament Serous Cystadenofibroma,1
23335,Malignant Cellular Infiltrate,Stage II Colon Cancer,1
23336,Secondary Lesion,Extraskeletal osteosarcoma metastatic,1
23337,Carcinomatous Component Present,Pericardial Carcinomatosis,1
23338,Epithelial Component Present,signet ring cell carcinoma of gallbladder,1
23339,Malignant Cellular Infiltrate,Prostatic Urethra Urothelial Carcinoma,1
23340,Immunologic Deficiency Syndromes,Lymphoproliferative disorder caused by methotrexate,1
23341,Malignant Germinomatous Cellular Infiltrate,Germinomatous Germ Cell Tumor,1
23342,Monocytosis,Juvenile Myelomonocytic Leukemia,1
23343,Epithelial Component Present,Primary Carcinoma Unspecified Site,1
23344,Absence of Invasion,Intraductal carcinoma and lobular carcinoma in situ,1
23345,Childhood Lesion,Childhood Malignant Solid Neoplasm,1
23346,Nuclear pleomorphism,Cardiac Myxofibrosarcoma,1
23347,Stromal Invasion,Stage IB Ovarian Cancer AJCC v6 and v7,1
23348,High Grade Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
23349,Carcinomatous Component Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",1
23350,Carcinomatous Component Present,Pathologic Stage IIIC Gastric Cancer AJCC v8,1
23351,Carcinomatous Component Present,Duodenal Cancer,1
23352,Malignant Cellular Infiltrate,Thymic Basaloid Carcinoma,1
23353,Malignant Cellular Infiltrate,Anaplastic Oligoastrocytoma,1
23354,Refractory Disease,Refractory Bile Duct Carcinoma,1
23355,Ineffective hematopoiesis,Recurrent Myelodysplastic Syndrome,1
23356,Multifocal Lesion,"Langerhans Cell Histiocytosis, Polystotic",1
23357,Diffuse Lesion,Melanomatosis,1
23358,Resectable Mass,Resectable Digestive System Carcinoma,1
23359,Adulthood Lesion,Stage IIA Adult Soft Tissue Sarcoma AJCC v7,1
23360,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
23361,Epithelial Component Present,Stage I Major Salivary Gland Cancer AJCC v8,1
23362,Epithelial Component Present,Small Cell Adenocarcinoma,1
23363,Malignant Cellular Infiltrate,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
23364,Epithelial Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
23365,Benign Cellular Infiltrate,Pyogenic granuloma,1
23366,Epithelial Component Present,"Carcinoma, Granular Cell",1
23367,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor G1,1
23368,Rapidly Enlarging Mass,Anaplastic Embryonal Rhabdomyosarcoma,1
23369,Indolent Clinical Course,chondroma of lung,1
23370,Myxoid Stroma Formation,Chordoma of clivus,1
23371,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage III Immature Testicular Teratoma AJCC v6 and v7,1
23372,Papillary Pattern,Sclerosing Breast Papilloma,1
23373,Cutaneous Involvement,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
23374,Infiltrative Growth Pattern,Childhood Giant Cell Glioblastoma,1
23375,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Refractory Cytopenia of Childhood,1
23376,Mediastinal mass,Mediastinal T Acute Lymphoblastic Leukemia,1
23377,Diffuse Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma,1
23378,Benign Cellular Infiltrate,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
23379,Malignant Cellular Infiltrate,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",1
23380,Malignant Cellular Infiltrate,Ampulla of Vater Mucinous Adenocarcinoma,1
23381,Intraosseous Lesion,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
23382,Malignant Cellular Infiltrate,Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
23383,Carcinomatous Component Present,Recurrent Adenoid Cystic Carcinoma,1
23384,Epithelial Component Present,Stage III Oral Cavity Cancer AJCC v6 and v7,1
23385,Low Mitotic Activity,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
23386,Metaplasia,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
23387,Infiltrative Growth Pattern,"Glioblastoma, IDH-Wildtype",1
23388,Benign Cellular Infiltrate,Lipoma of external auditory meatus,1
23389,Anaplasia,Infratentorial Glioblastoma,1
23390,Carcinomatous Component Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
23391,Dense Collagenized Tissue Present,Syringoma,1
23392,Poorly Differentiated Lesion,Skin Sarcomatoid Basal Cell Carcinoma,1
23393,Carcinomatous Component Present,Prostate carcinoma,1
23394,Malignant Germinomatous Cellular Infiltrate,Childhood Central Nervous System Germinoma,1
23395,Malignant Cellular Infiltrate,Stage II Ureter Cancer AJCC v7,1
23396,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
23397,Carcinomatous Component Present,Squamous cell carcinoma of vulva,1
23398,Malignant Cellular Infiltrate,BCLC Stage D Adult Hepatocellular Carcinoma,1
23399,Malignant Cellular Infiltrate,Locally Recurrent Malignant Neoplasm,1
23400,Malignant Cellular Infiltrate,ROSE Cluster 4,1
23401,Tissue of Mullerian Origin Present,Cystadenofibroma of fallopian tube,1
23402,Carcinomatous Component Present,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
23403,Epithelial Component Present,Adenoma,1
23404,Adnexal Differentiation,Sebaceoma,1
23405,CD30-Positive Neoplastic Cells Present,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
23406,Epithelial Component Present,adenosquamous carcinoma of breast,1
23407,Cutaneous Involvement,External Ear Basal Cell Carcinoma,1
23408,Metastatic Lesion,Carcinomatosis,1
23409,Epithelial Component Present,Locally Advanced Thymic Carcinoma,1
23410,Cutaneous Involvement,Xeroderma Pigmentosum,1
23411,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
23412,Carcinomatous Component Present,Stage IV Ovarian Cancer AJCC v8,1
23413,Malignant Cellular Infiltrate,Unresectable Rhabdomyosarcoma,1
23414,Recurrent disease,Extra-osseous Ewing's sarcoma recurrent,1
23415,Mucoid Stroma Formation,mucinous adenocarcinoma of rectum,1
23416,Dysplasia,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
23417,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Adenocarcinoma,1
23418,Systemic disease,Aggressive Systemic Mastocytosis,1
23419,Well-Circumscribed Lesion,Gallbladder adenoma,1
23420,Dysplasia,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
23421,Borderline Lesion,Borderline Ovarian Transitional Cell Tumor,1
23422,Malignant Cellular Infiltrate,Stage IIC Colon Cancer AJCC v7,1
23423,Multifocal Lesion,Recurrent respiratory papillomatosis,1
23424,Storiform Growth Pattern,"Dendritic Cell Sarcoma, Interdigitating",1
23425,Stromal Invasion,Serous cystadenocarcinoma ovary,1
23426,Mitotic Activity,Tufted angioma of skin,1
23427,Benign Cellular Infiltrate,Thyroid Gland Black Follicular Adenoma,1
23428,Malignant Cellular Infiltrate,Malignant odontogenic tumor,1
23429,Severe dysplasia,Stage 0is Ureter Cancer AJCC v8,1
23430,Malignant Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia,1
23431,Malignant Cellular Infiltrate,Sporadic Burkitt's lymphoma,1
23432,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Central Nervous System,1
23433,Malignant Cellular Infiltrate,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
23434,Indolent Clinical Course,Solitary Osteochondroma,1
23435,Adulthood Lesion,Stage IIIA Adult Liver Cancer AJCC v7,1
23436,Reactive Germinal Centers Present,Pulmonary nodular lymphoid hyperplasia,1
23437,Malignant Cellular Infiltrate,Squamous cell carcinoma of vulva,1
23438,Papillary Pattern,"Cystadenocarcinoma, Papillary",1
23439,Low Mitotic Activity,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,1
23440,Childhood Lesion,Childhood Embryonal Carcinoma,1
23441,Childhood Lesion,Childhood Infratentorial Neoplasm,1
23442,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Pseudoglandular Variant",1
23443,Carcinomatous Component Present,Carcinoma Arising from Craniopharyngioma,1
23444,Benign Cellular Infiltrate,Benign Uveal Neoplasm,1
23445,Pain,Osteoid osteoma,1
23446,Epithelial Component Present,Metastatic Gastric Neuroendocrine Carcinoma,1
23447,Vascular Channel Formation,Skin Cavernous Hemangioma,1
23448,Epithelial Component Present,Ampulla of Vater Neuroendocrine Tumor G1,1
23449,Osseous Differentiation,Intracortical osteosarcoma,1
23450,Keratin pearl formation,keratinizing squamous cell carcinoma of vulva,1
23451,Epithelial Component Present,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7,1
23452,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of appendix,1
23453,Mixed Cellular Population,Prostate Phyllodes Tumor,1
23454,Malignant Cellular Infiltrate,Intraductal carcinoma and lobular carcinoma in situ,1
23455,Multifocal Lesion,Erdheim-Chester Disease,1
23456,Tissue of Mullerian Origin Present,Stage III Uterine Corpus Adenosarcoma AJCC v8,1
23457,Carcinomatous Component Present,Stage IV Eyelid Carcinoma AJCC v8,1
23458,Carcinomatous Component Present,Bile duct mucinous adenocarcinoma,1
23459,Carcinomatous Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
23460,Malignant Cellular Infiltrate,Carcinoma ex Eccrine Spiradenoma,1
23461,Malignant Cellular Infiltrate,Childhood Synovial Sarcoma,1
23462,Lobulated Growth Pattern,Primary myoepithelial carcinoma of lung,1
23463,Malignant Cellular Infiltrate,Advanced Gastric Neuroendocrine Carcinoma,1
23464,Neoplastic Cells with TFH Cell Phenotype Present,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
23465,Malignant Cellular Infiltrate,malignant lymphoma of pancreatic lymph nodes,1
23466,Mixed Cellular Population,Borderline Ovarian Clear Cell Cystadenofibroma,1
23467,Mixed Cellular Population,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
23468,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage III,1
23469,Malignant Cellular Infiltrate,Nodular Sclerosis Classical Hodgkin Lymphoma,1
23470,Malignant Cellular Infiltrate,Bronchioloalveolar Adenocarcinoma,1
23471,Heterologous Elements Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
23472,Immunologic Deficiency Syndromes,AIDS-Related Retinopathy,1
23473,Epithelial Component Present,Stage 0a Bladder Cancer AJCC v8,1
23474,Carcinomatous Component Present,Distal Bile Duct Cancer by AJCC v7 Stage,1
23475,Adulthood Lesion,Adult Grade II Meningioma,1
23476,Vascular Channel Formation,Transplant-Related Kaposi Sarcoma,1
23477,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
23478,Carcinomatous Component Present,Recurrent Paget Disease of the Breast,1
23479,Malignant Cellular Infiltrate,BCLC Stage B Hepatocellular Carcinoma,1
23480,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
23481,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma metastatic,1
23482,Invasive Lesion,Invasive Ductal Breast Carcinoma,1
23483,S-100-Positive Neoplastic Cells Present,Eosinophilic Granuloma,1
23484,Childhood Lesion,"Childhood Ganglioneuroblastoma, Intermixed",1
23485,Urine phosphorous concentration above normal,Oncogenic osteomalacia,1
23486,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
23487,Benign Cellular Infiltrate,Benign neoplasm of fallopian tube,1
23488,Epithelial Component Present,Esophageal Spindle Cell Carcinoma,1
23489,Malignant Cellular Infiltrate,Uterine Ligament Serous Adenocarcinoma,1
23490,Neuroendocrine Differentiation,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
23491,Efferent Arteriolar Hyalinosis,Diabetic Nephropathy,1
23492,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Microcystic Pattern",1
23493,Biphasic Pattern,carcinosarcoma of salivary gland,1
23494,Eccrine Differentiation,Eccrine Neoplasm,1
23495,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
23496,Epithelial Component Present,Esophageal Cancer by AJCC v7 Stage,1
23497,Epithelial Component Present,Nasopharyngeal Papillary Adenocarcinoma,1
23498,Epithelial Component Present,Stage IVA Vulvar Cancer AJCC v8,1
23499,Malignant Cellular Infiltrate,Stage IVA Gallbladder Carcinoma,1
23500,Malignant Cellular Infiltrate,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
23501,Malignant Cellular Infiltrate,Ameloblastic fibrosarcoma,1
23502,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
23503,Recurrent disease,Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
23504,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
23505,Malignant Cellular Infiltrate,Stage I Anal Canal Cancer AJCC v6 and v7,1
23506,Prominent Keratin Formation,Esophageal Well Differentiated Squamous Cell Carcinoma,1
23507,Malignant Cellular Infiltrate,Carcinomatosis of peritoneal cavity,1
23508,Carcinomatous Component Present,squamous cell carcinoma of middle ear,1
23509,Carcinomatous Component Present,Stage IIIA Lung Cancer AJCC v7,1
23510,Low Mitotic Activity,Stage I Colon Neuroendocrine Tumor AJCC v8,1
23511,Carcinomatous Component Present,Stage III Colorectal Cancer AJCC v8,1
23512,Exophytic Polypoid Lesion,Intrahepatic Bile Duct Microcystic Adenoma,1
23513,Carcinomatous Component Present,Endometrial Dedifferentiated Carcinoma,1
23514,Malignant Cellular Infiltrate,Mediastinal Granulocytic Sarcoma,1
23515,Carcinomatous Component Present,Bladder transitional cell carcinoma stage III,1
23516,Epithelial Component Present,Well Differentiated Hepatocellular Carcinoma,1
23517,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Cystadenofibroma,1
23518,Epithelial Component Present,Vaginal Adenosquamous Carcinoma,1
23519,Malignant Cellular Infiltrate,Childhood Acute Erythroid Leukemia,1
23520,Carcinomatous Component Present,Stage II Rectosigmoid Cancer AJCC v7,1
23521,Tissue Differentiation Uncertain,Nonossifying Fibromyxoid Tumor,1
23522,Malignant Cellular Infiltrate,Stage II Renal Pelvis Cancer AJCC v8,1
23523,Epithelial Component Present,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
23524,Cutaneous Involvement,Dedifferentiated Dermatofibrosarcoma Protuberans,1
23525,Malignant Cellular Infiltrate,Choroid Spindle Cell Type B Melanoma,1
23526,Childhood Lesion,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
23527,Mast Cells 10 Percent or More of Peripheral Blood White Cells,"Leukemia, Mast-Cell",1
23528,Carcinomatous Component Present,Mucinous cystadenocarcinoma of ovary,1
23529,Carcinomatous Component Present,malignant myoepithelioma of breast,1
23530,Malignant Cellular Infiltrate,Human Papillomavirus-Related Verrucous Carcinoma,1
23531,Metastatic Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
23532,Epithelial Component Present,Stage 0 Cervical Cancer AJCC v6,1
23533,Epithelial Component Present,Adenocarcinoma of ampulla of Vater,1
23534,Poorly Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Carcinoma,1
23535,Mixed Cellular Population,Uterine Corpus Adenosarcoma by AJCC v8 Stage,1
23536,Polymorphic Cellular Infiltrate,Cutaneous Angioimmunoblastic T-Cell Lymphoma,1
23537,Epithelial Component Present,Undifferentiated carcinoma of nasopharynx,1
23538,Well-Circumscribed Lesion,Anaplastic Kidney Wilms Tumor,1
23539,Malignant Cellular Infiltrate,Conventional Extraskeletal Myxoid Chondrosarcoma,1
23540,Malignant Cellular Infiltrate,Prognostic Stage IV Breast Cancer AJCC v8,1
23541,Primary Lesion,Recurrent Olfactory Neuroblastoma,1
23542,Micropapillary Pattern,Colorectal Micropapillary Adenocarcinoma,1
23543,Splenomegaly,Blast Phase,1
23544,Lesion Less than 10mm in Diameter,Sporadic Thyroid Gland Micromedullary Carcinoma,1
23545,Extracutaneous Dissemination of Disease,Mycosis fungoides stage II,1
23546,Refractory Disease,Refractory Malignant Thyroid Gland Neoplasm,1
23547,Malignant Cellular Infiltrate,Vulvar Alveolar Rhabdomyosarcoma,1
23548,Epithelial Component Present,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
23549,Dense Collagenized Tissue Present,Syringoma,1
23550,Cutaneous Involvement,"Dermatitis, Occupational",1
23551,Benign Cellular Infiltrate,Bone Epithelioid Hemangioma,1
23552,Epithelial Component Present,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,1
23553,Low Mitotic Activity,malignant gastrinoma of pancreas,1
23554,Indolent Clinical Course,Skin Cavernous Hemangioma,1
23555,Malignant Cellular Infiltrate,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid,1
23556,Epithelial Component Present,Stage IV Bladder Cancer AJCC v6,1
23557,Metastatic Lesion,Locally Advanced Bile Duct Carcinoma,1
23558,Recurrent disease,Marginal zone lymphoma recurrent,1
23559,Necrotic changes (finding),Colorectal Large Cell Neuroendocrine Carcinoma,1
23560,Malignant Cellular Infiltrate,T-Cell Lymphoma,1
23561,Childhood Lesion,Recurrent Childhood Cerebral Astrocytoma,1
23562,Malignant Cellular Infiltrate,Adult Central Nervous System Germinoma,1
23563,Malignant Cellular Infiltrate,Metastatic Human Papillomavirus-Related Malignant Neoplasm,1
23564,Malignant Cellular Infiltrate,Hereditary Nonpolyposis Colorectal Cancer,1
23565,Benign Cellular Infiltrate,Desmoplastic trichoepithelioma,1
23566,Malignant Cellular Infiltrate,Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and 7,1
23567,Perivascular Pseudorosette Formation,Astroblastoma,1
23568,Epithelial Component Present,CARCINOMA OF VULVA,1
23569,Slow Growing Mass,Cerebral Hemangioblastoma,1
23570,Rosenthal Fibers Present,Rosette-forming glioneuronal neoplasm,1
23571,Carcinomatous Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
23572,Epithelial Component Present,Stage I Vaginal Cancer AJCC v6 and v7,1
23573,Recurrent disease,Recurrent Ovarian Germ Cell Tumor,1
23574,More than 10 Mitoses per 10HPF,Lung Small Cell Carcinoma by AJCC v7 Stage,1
23575,Epithelial Component Present,Locally Advanced Cervical Carcinoma,1
23576,Papillary Pattern,Fallopian Tube Papillary Adenocarcinoma,1
23577,Malignant Cellular Infiltrate,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,1
23578,Encapsulated Mass,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
23579,Epithelial Component Present,Rectal Medullary Carcinoma,1
23580,Malignant Cellular Infiltrate,Advanced Unfavorable Hodgkin Lymphoma,1
23581,Rapidly Enlarging Mass,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
23582,High Grade Lesion,Adult Glioblastoma,1
23583,Malignant Cellular Infiltrate,Localized Gastric Carcinoma,1
23584,Epithelial Component Present,Stage IB2 Cervical Cancer AJCC v8,1
23585,Adnexal Differentiation,Benign Eccrine Neoplasm,1
23586,Mixed Cellular Population,Mixed Cell Type Kidney Wilms Tumor,1
23587,Regional Disease,Locally Advanced Head and Neck Carcinoma,1
23588,Epithelial Component Present,Stage II Rectal Cancer AJCC v7,1
23589,Malignant Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v7,1
23590,Epithelial Component Present,Human Papillomavirus-Related Squamous Cell Carcinoma,1
23591,Epithelial Component Present,Stage IIB Prostate Cancer AJCC v8,1
23592,Carcinomatous Component Present,Adenocarcinoma of anal canal,1
23593,Benign Cellular Infiltrate,Ovarian Sclerosing Stromal Tumor,1
23594,Benign Cellular Infiltrate,Leiomyomatosis peritonealis disseminata,1
23595,Encapsulated Mass,Recurrent Thyroid Gland Follicular Carcinoma,1
23596,Refractory Disease,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
23597,Malignant Cellular Infiltrate,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
23598,Well-Circumscribed Lesion,Benign neoplasm of mesothelial tissue of pleura,1
23599,Diffuse Pattern,Grade 2 Diffuse Follicular Lymphoma,1
23600,Benign Cellular Infiltrate,Adenoameloblastoma,1
23601,Malignant Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis,1
23602,Epithelial Component Present,Stage I Duodenal Neuroendocrine Tumor AJCC v8,1
23603,Perineural spread,Adenoid Cystic Carcinoma,1
23604,Carcinomatous Component Present,large cell neuroendocrine carcinoma of gallbladder,1
23605,Hyalinized Stroma Formation,Pericardial Solitary Fibrous Tumor,1
23606,Favorable Clinical Outcome,Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm,1
23607,Epithelial Component Present,Lung squamous cell carcinoma stage III,1
23608,Carcinomatous Component Present,Colorectal Cancer by AJCC v7 Stage,1
23609,Epithelial Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
23610,Malignant Cellular Infiltrate,Glottis Verrucous Carcinoma,1
23611,Hemorrhagic,Central Nervous System Angiosarcoma,1
23612,Stromal Invasion,Stage IIB Ovarian Cancer AJCC v8,1
23613,No Identifiable Line of Differentiation,Central Nervous System Undifferentiated Pleomorphic Sarcoma,1
23614,Epithelial Component Present,Stage IIIB Colorectal Cancer AJCC v8,1
23615,Nuclear Pseudoinclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
23616,Malignant Cellular Infiltrate,Colorectal Angiosarcoma,1
23617,Malignant Cellular Infiltrate,Metastatic Digestive System Carcinoma,1
23618,Multifocal Lesion,Multiple Endocrine Neoplasia Type 2a,1
23619,Carcinomatous Component Present,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
23620,Malignant Cellular Infiltrate,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
23621,Adulthood Lesion,Adult Epithelioid Hemangioendothelioma,1
23622,Primary Lesion,Pineal Gland Astrocytoma,1
23623,Benign Cellular Infiltrate,Paraganglioma-Like Dermal Melanocytic Tumor,1
23624,Epithelial Component Present,Blepharal carcinoma,1
23625,Local disease,Tonsillar Lipoma,1
23626,Mixed Cellular Population,Anaplastic Kidney Wilms Tumor,1
23627,Nodular Pattern,Ann Arbor Stage IV Grade 2 Follicular Lymphoma,1
23628,Microvascular Proliferation,Recurrent Glioblastoma,1
23629,Diffuse Lesion,Angiomatosis,1
23630,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
23631,Malignant Cellular Infiltrate,Recurrent Malignant Germ Cell Tumor,1
23632,Secondary Lesion,Locally Advanced Prostate Adenocarcinoma,1
23633,Micropapillary Pattern,intraductal micropapillary carcinoma of breast,1
23634,Dysplasia,High Grade Corneal Intraepithelial Neoplasia,1
23635,Malignant Cellular Infiltrate,Papillary Eccrine Carcinoma,1
23636,Carcinomatous Component Present,Submandibular Gland Adenocarcinoma,1
23637,Localized Lesion,Plasmacytoma,1
23638,Epithelial Component Present,Ampulla of Vater Mucinous Adenocarcinoma,1
23639,Epithelial Component Present,Stage IVA Major Salivary Gland Cancer AJCC v7,1
23640,Well-Circumscribed Lesion,Giant Fibrovascular Esophageal Polyp,1
23641,Clinical TNM Finding,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
23642,Fibrotic Stroma Formation,Tubulocystic renal cell carcinoma,1
23643,Carcinomatous Component Present,Bladder Urachal Carcinoma,1
23644,Carcinomatous Component Present,Advanced Oral Cavity Squamous Cell Carcinoma,1
23645,Edematous Stroma Formation,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
23646,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma metastatic,1
23647,Diffuse Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
23648,Fibrous Septa Present,Childhood Ovarian Dysgerminoma,1
23649,Epithelial Component Present,"Acanthoma, Clear Cell",1
23650,Adulthood Lesion,Adult Myelodysplastic Syndrome,1
23651,Severe dysplasia,Stage 0 Lip Carcinoma,1
23652,Malignant Cellular Infiltrate,Methotrexate-Associated Lymphoma,1
23653,Epithelial Component Present,Endometrial Dedifferentiated Carcinoma,1
23654,Malignant Cellular Infiltrate,Ampulla of Vater Mucinous Adenocarcinoma,1
23655,Malignant Cellular Infiltrate,"Basal cell carcinoma, micronodular",1
23656,Childhood Lesion,Childhood Colorectal Carcinoma,1
23657,High Mitotic Activity,Bartholin Gland Small Cell Carcinoma,1
23658,Carcinomatous Component Present,Bladder Mixed Adenocarcinoma,1
23659,Absence of Stromal Invasion,Borderline Ovarian Endometrioid Cystadenofibroma,1
23660,Carcinomatous Component Present,Stage I Lip and Oral Cavity Cancer AJCC v8,1
23661,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
23662,Malignant Cellular Infiltrate,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
23663,Epithelial Component Present,Undifferentiated carcinoma of esophagus,1
23664,Regional Disease,Locally Advanced Head and Neck Carcinoma,1
23665,Infiltrative Growth Pattern,Glioblastoma multiforme of spinal cord,1
23666,Immunosuppression-Related Post-Transplant Toxicity,Infectious mononucleosis-like post-transplant lymphoproliferative disorder,1
23667,Ground Glass Nuclear Inclusion,Recurrent Thyroid Gland Papillary Carcinoma,1
23668,Malignant Cellular Infiltrate,Metastatic Bladder Small Cell Carcinoma,1
23669,Cutaneous Involvement,"Keratoderma, Palmoplantar",1
23670,Unresectable Mass,Unresectable Ureter Urothelial Carcinoma,1
23671,Cutaneous Involvement,Cutaneous Chronic Lymphocytic Leukemia,1
23672,Indolent Clinical Course,Lumbosacral Lipoma,1
23673,Epithelial Component Present,Stage III Lung Cancer AJCC v7,1
23674,Epithelial Component Present,Ethmoid Sinus Adenocarcinoma,1
23675,Malignant Cellular Infiltrate,Recurrent Primitive Neuroectodermal Tumor,1
23676,Well-Circumscribed Lesion,Frontal sinus polyp,1
23677,Malignant Cellular Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
23678,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v8,1
23679,Adulthood Lesion,Adult Lymphoblastic Lymphoma,1
23680,Capillary Sized Vascular Channel Formation,Senile angioma,1
23681,Tissue of Mullerian Origin Present,Uterine Corpus Carcinosarcoma,1
23682,Biphasic Pattern,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
23683,Epithelial Component Present,Refractory Endometrial Endometrioid Adenocarcinoma,1
23684,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
23685,Alternative Fascicle (Bundle) Pattern,Urethral Leiomyoma,1
23686,Epithelial Component Present,Renal cell carcinoma recurrent,1
23687,Perineural spread,Adenoid cystic carcinoma of the oral cavity recurrent,1
23688,Malignant Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v6 and v7,1
23689,Epithelial Component Present,Papillary Breast Neoplasm,1
23690,Malignant Cellular Infiltrate,Grade 3 Colon Adenocarcinoma,1
23691,Carcinomatous Component Present,Bladder Urachal Adenocarcinoma,1
23692,Diffuse Pattern,BN2 Diffuse Large B-Cell Lymphoma,1
23693,Extensive Stage Lesion,Advanced Carcinoma,1
23694,Benign Cellular Infiltrate,Lung Glandular Papilloma,1
23695,Dysplasia,Duodenal Adenoma,1
23696,Immunologic Deficiency Syndromes,AIDS-Related Vulvovaginal Candidiasis,1
23697,Epithelial Component Present,Endocervical Carcinoma,1
23698,Oligodendroglial Component Present,Adult Brain Oligodendroglioma,1
23699,Malignant Cellular Infiltrate,Vulvar Adenocarcinoma of Sweat Gland Type,1
23700,Malignant Cellular Infiltrate,Cerebral Non-Hodgkin Lymphoma,1
23701,Severe dysplasia,Bowen's Disease,1
23702,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
23703,Carcinomatous Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
23704,Carcinomatous Component Present,Squamous cell carcinoma of lip,1
23705,Malignant Cellular Infiltrate,Stage II Hilar Cholangiocarcinoma AJCC v7,1
23706,Malignant Cellular Infiltrate,Malignant neoplasm of abdominal part of esophagus,1
23707,Recurrent disease,Recurrent Skin Angiosarcoma,1
23708,Epithelial Component Present,Stage II Vaginal Cancer AJCC v8,1
23709,Malignant Component Present,Dermoid cyst with secondary tumor,1
23710,Tissue Differentiation Uncertain,Pulmonary lymphangioleiomyomatosis,1
23711,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic eosinophilic leukemia,1
23712,Malignant Cellular Infiltrate,Granulocytic Sarcoma,1
23713,Malignant Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
23714,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma,1
23715,Locally Aggressive Lesion,"Fibromatosis, Aggressive",1
23716,Cutaneous Involvement,Verrucous keratotic hemangioma,1
23717,Unresectable Mass,Unresectable Desmoid-Type Fibromatosis,1
23718,Carcinomatous Component Present,recurrent gastric cancer,1
23719,Secondary Lesion,Locally Advanced Squamous Cell Carcinoma,1
23720,Carcinomatous Component Present,Vaginal Non-Keratinizing Squamous Cell Carcinoma,1
23721,Epithelial Component Present,Intrahepatic Bile Duct Papillary Neoplasm,1
23722,Epithelial Component Present,Laryngeal Cancer by AJCC v7 Stage,1
23723,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8,1
23724,Cartilaginous Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
23725,Low Cellularity Present,Protoplasmic astrocytoma,1
23726,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage I,1
23727,Epithelial Component Present,Broad Ligament Serous Adenocarcinoma,1
23728,High Mitotic Activity,Recurrent Salivary Duct Carcinoma,1
23729,Carcinomatous Component Present,Stage IV Ampulla of Vater Cancer AJCC v7,1
23730,Cutaneous Involvement,Dermatitis,1
23731,atypia morphology,Borderline Ovarian Clear Cell Adenofibroma,1
23732,Exophytic Polypoid Lesion,Multiple adenomatous polyps,1
23733,Malignant Cellular Infiltrate,Adult Anaplastic Ependymoma,1
23734,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
23735,Malignant Cellular Infiltrate,Bile duct carcinoma,1
23736,Thyroglobulin Positive Neoplastic Cells Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
23737,Malignant Cellular Infiltrate,Gastric Synovial Sarcoma,1
23738,Epithelial Component Present,"Papillary mucinous cystadenoma, borderline malignancy",1
23739,Benign Cellular Infiltrate,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
23740,Epithelial Component Present,Disseminated carcinoma,1
23741,Refractory Disease,Platinum-Resistant Urothelial Carcinoma,1
23742,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity recurrent,1
23743,Epithelial Component Present,Stage IIA Colon Cancer AJCC v8,1
23744,Carcinomatous Component Present,Upper Gingival Squamous Cell Carcinoma,1
23745,Well-Circumscribed Lesion,Bile duct adenoma,1
23746,Multifocal Lesion,Multifocal superficial basal cell carcinoma,1
23747,Malignant Cellular Infiltrate,Advanced Neuroendocrine Carcinoma,1
23748,Malignant Cellular Infiltrate,Unresectable Pancreatic Neuroendocrine Carcinoma,1
23749,Carcinomatous Component Present,Stage IVB Rectal Cancer AJCC v7,1
23750,Low Grade Lesion,Classic Congenital Mesoblastic Nephroma,1
23751,Epithelial Component Present,Invasive papillary breast carcinoma,1
23752,Perivascular Arrangement of Tumor Cells,Glomangioma of skin,1
23753,Malignant Cellular Infiltrate,Recurrent Childhood Medulloblastoma,1
23754,Cutaneous Involvement,Benign Apocrine Neoplasm,1
23755,Malignant Cellular Infiltrate,Stage IB Soft Tissue Sarcoma AJCC v7,1
23756,Malignant Cellular Infiltrate,lymphoepithelial squamous cell carcinoma of salivary gland,1
23757,Dense Intercellular Reticulin Network Present,Childhood Pleomorphic Xanthoastrocytoma,1
23758,Necrotic changes (finding),Metastatic Prostate Small Cell Carcinoma,1
23759,Malignant Cellular Infiltrate,Localized Resectable Neuroblastoma,1
23760,Hypercellular bone marrow,Acute panmyelosis with myelofibrosis,1
23761,Resectable Mass,Hepatoblastoma resectable,1
23762,Papillary Pattern,Papillary carcinoma of the breast,1
23763,Necrotic changes (finding),Stage IIB Lung Small Cell Carcinoma AJCC v7,1
23764,Malignant Cellular Infiltrate,Osteosclerotic Plasma Cell Myeloma,1
23765,Epithelial Component Present,Renal cell carcinoma recurrent,1
23766,Cartilaginous Component Present,Bizarre parosteal osteochondromatous proliferation,1
23767,Extensive Stage Lesion,Advanced Melanoma,1
23768,Therapy-Related Toxicity,Radiation-Related Sarcoma,1
23769,Primary Lesion,Gastric T-Cell Non-Hodgkin Lymphoma,1
23770,Blasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
23771,Absence of Invasion,Adenocarcinoma in situ in tubulovillous adenoma,1
23772,Malignant Cellular Infiltrate,Malignant Peritoneal Germ Cell Tumor,1
23773,HMB-45-Positive Neoplastic Cells Present,Sclerosing PEComa,1
23774,Invasive Lesion,Invasive Mucinous Lung Adenocarcinoma,1
23775,Malignant Cellular Infiltrate,Sarcoma of kidney,1
23776,Epithelial Component Present,Stage IV Thymoma AJCC v8,1
23777,Squamous metaplasia of bladder,Bladder Squamous Cell Carcinoma,1
23778,Epithelial Component Present,"Adenoma, Basal Cell",1
23779,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
23780,Malignant Cellular Infiltrate,Stage II Ureter Cancer AJCC v8,1
23781,Cribriform Pattern,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
23782,Malignant Cellular Infiltrate,Bulbomembranous Urethral Malignant Neoplasm,1
23783,Metastatic/Recurrent Disease,Adult Synovial Sarcoma,1
23784,Epithelial Component Present,Endometrial Undifferentiated Carcinoma,1
23785,Carcinomatous Component Present,Extrapulmonary Small Cell Carcinoma,1
23786,Dysplasia,Moderate pancreatic duct dysplasia,1
23787,Malignant Cellular Infiltrate,Basal cell carcinoma - adenoid,1
23788,Chronic Inflammatory Infiltrate,Diffuse large B-cell lymphoma associated with chronic inflammation,1
23789,Immunosuppression-Related Post-Transplant Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
23790,Recurrent disease,Marginal zone lymphoma recurrent,1
23791,Mild cytologic atypia,Pancreatic Intraepithelial Neoplasia-1,1
23792,Mitotic Activity,Testicular yolk sac tumor,1
23793,Mass of pleura,Pyothorax-Associated Lymphoma,1
23794,Well Differentiated Lesion,Pleural Well Differentiated Papillary Mesothelioma,1
23795,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
23796,Neuroendocrine Differentiation,Stage II Gastric Neuroendocrine Tumor AJCC v8,1
23797,Hyaline Cartilage Differentiation,chondroma of lung,1
23798,Malignant Cellular Infiltrate,Stage IV Small Intestinal Adenocarcinoma AJCC v8,1
23799,Intestinal metaplasia,Ampulla of Vater Intestinal-Type Adenocarcinoma,1
23800,Carcinomatous Component Present,Carcinoma of the Appendix,1
23801,Exophytic Polypoid Lesion,Foveolar-Type Adenoma,1
23802,Carcinomatous Component Present,Pyriform Fossa Squamous Cell Carcinoma,1
23803,Epithelial Component Present,High Grade Anal Canal Squamous Intraepithelial Neoplasia,1
23804,Malignant Cellular Infiltrate,"Testicular Intratubular Germ Cell Neoplasia, Unclassified",1
23805,Geographic Necrosis,Teratocarcinoma,1
23806,Epithelial Component Present,Cervical Squamous Neoplasm,1
23807,Calcinosis,Testicular Large Cell Calcifying Sertoli Cell Tumor,1
23808,Intermediate Grade Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor G2,1
23809,Well-Circumscribed Lesion,Sessile Serrated Adenoma/Polyp,1
23810,Mesenchymal Metaplasia of Malignant Cells Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
23811,Malignant Cellular Infiltrate,Adenocarcinoma of large intestine,1
23812,Mucoid Stroma Formation,Ampulla of Vater Mucinous Adenocarcinoma,1
23813,Microinvasive tumor,"Squamous cell carcinoma, microinvasive",1
23814,Therapy-Related Toxicity,Treatment related leukaemia,1
23815,Malignant Cellular Infiltrate,Stage IA2 Lung Cancer AJCC v8,1
23816,Malignant Cellular Infiltrate,Papillary mucinous cystadenocarcinoma,1
23817,Papillary Pattern,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
23818,Childhood Lesion,Recurrent Childhood Acute Lymphoblastic Leukemia,1
23819,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Primary amyloidosis,1
23820,Tubular Pattern,tubular adenoma of extrahepatic bile duct,1
23821,Carcinomatous Component Present,Large cell lung cancer stage III,1
23822,Epithelial Component Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
23823,Carcinomatous Component Present,Anterior Tongue Mucoepidermoid Carcinoma,1
23824,Carcinomatous Component Present,Mixed Ductal-Endocrine Carcinoma,1
23825,Malignant Cellular Infiltrate,mucinous adenocarcinoma of gallbladder,1
23826,Malignant Cellular Infiltrate,Solid pseudopapillary tumor of the pancreas,1
23827,Biphasic Pattern,Recurrent Childhood Pilocytic Astrocytoma,1
23828,Malignant Cellular Infiltrate,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,1
23829,Absence of Invasion,Stage 0 Vaginal Cancer AJCC v7,1
23830,Nodular Pattern,Nodulo-ulcerative basal cell carcinoma,1
23831,Malignant Cellular Infiltrate,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
23832,In Situ Lesion,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
23833,Epithelial Component Present,Stage 0 Bladder Carcinoma,1
23834,Well Differentiated Neuroendocrine Lesion,Gastro-enteropancreatic neuroendocrine tumor,1
23835,More than 5 Mitoses per 50HPF,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
23836,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Carcinosarcoma,1
23837,Well-Circumscribed Lesion,Pleomorphic Lipoma,1
23838,Benign Cellular Infiltrate,Ameloblastic fibroma,1
23839,Apocrine Differentiation,apocrine adenocarcinoma of vulva,1
23840,Chromogranin A Positive Neoplastic Cells Present,Gastrointestinal Carcinoid Tumor,1
23841,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Carcinoma,1
23842,Epithelial Component Present,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
23843,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Seminoma,1
23844,Cutaneous Involvement,Deep Penetrating Nevus,1
23845,Primary Lesion,Adult Giant Cell Glioblastoma,1
23846,Anaplasia,Childhood Anaplastic Oligodendroglioma,1
23847,Malignant Cellular Infiltrate,Epithelioid sarcoma recurrent,1
23848,Pregnancy Complications,Placenta Disorders,1
23849,Infiltrative Growth Pattern,Childhood Gliosarcoma,1
23850,Malignant Cellular Infiltrate,Pathologic Stage IIIC Gastric Cancer AJCC v8,1
23851,Neuronal Differentiation,Cerebellar Neuronal and Mixed Neuronal-Glial Tumor,1
23852,Malignant Cellular Infiltrate,Ewings sarcoma-primitive neuroectodermal tumor (PNET),1
23853,Non-Invasive Lesion,Low-grade intraurothelial neoplasia,1
23854,Absence of Invasion,Adenocarcinoma in situ in tubulovillous adenoma,1
23855,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyp,1
23856,Generalized illness,Disseminated squamous cell carcinoma,1
23857,Cutaneous Involvement,Skin Cavernous Hemangioma,1
23858,Absence of Stromal Invasion,Fallopian Tube Metaplastic Papillary Tumor,1
23859,Storiform Growth Pattern,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
23860,Recurrent disease,Recurrent Pancreatic Ductal Adenocarcinoma,1
23861,Low Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
23862,High Mitotic Activity,High Grade Ovarian Serous Adenocarcinoma,1
23863,Epithelial Component Present,Large cell neuroendocrine carcinoma,1
23864,Diffuse Lesion,Diffuse leptomeningeal glioneuronal neoplasm,1
23865,Nuclear Atypia,Childhood Cerebellar Anaplastic Astrocytoma,1
23866,Papillary Pattern,sialadenoma papilliferum of salivary gland,1
23867,Epithelial Component Present,Squamous Cell Carcinoma of Unknown Primary,1
23868,Malignant Cellular Infiltrate,Adult T Acute Lymphoblastic Leukemia,1
23869,Epithelial Component Present,Lung Mucinous Adenocarcinoma In Situ,1
23870,Low Mitotic Activity,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
23871,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic Lymphadenopathy,1
23872,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v8,1
23873,Malignant Cellular Infiltrate,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin,1
23874,Metastatic Lesion,Metastatic Carcinoma in the Adrenal Medulla,1
23875,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage I,1
23876,Benign Cellular Infiltrate,Adenoma of lung,1
23877,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v8 Stage,1
23878,Multinodular Pattern,Ancell-Spiegler cylindromas,1
23879,Epithelial Component Present,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
23880,Epithelial Component Present,Stage IVB Laryngeal Cancer AJCC v7,1
23881,Deep Lesion,Recurrent Desmoid-Type Fibromatosis,1
23882,Carcinomatous Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
23883,Epithelial Component Present,Stage IIA Appendix Carcinoma AJCC v7,1
23884,Mild dysplasia,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia,1
23885,Pathologic TNM Finding,Pathologic Stage IA Cutaneous Melanoma AJCC v8,1
23886,Metastatic Lesion,Advanced Unfavorable Hodgkin Lymphoma,1
23887,Carcinomatous Component Present,"Uterine Carcinosarcoma, Homologous Type",1
23888,Epithelial Component Present,Basal-Like Prostate Carcinoma,1
23889,Non-Hereditary Lesion,Helicobacter Pylori-Related Gastric Adenocarcinoma,1
23890,Epithelial Component Present,Prostate Acinar Adenocarcinoma,1
23891,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of lacrimal gland,1
23892,Lobulated Growth Pattern,Chondromyxoid fibroma,1
23893,Benign Cellular Infiltrate,Fallopian Tube Adenomatoid Tumor,1
23894,Carcinomatous Component Present,Prostate Cancer by AJCC v6 Stage,1
23895,Epithelial Component Present,Pleomorphic carcinoma,1
23896,Infiltrating Tumor Margins Present,Malignant phyllodes tumor of breast,1
23897,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis recurrent,1
23898,Epithelial Component Present,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
23899,Epithelial Component Present,Gastric Cardia Squamous Cell Carcinoma,1
23900,Malignant Cellular Infiltrate,Occult Lung Large Cell Carcinoma,1
23901,Stromal Invasion,FIGO Stage III Ovarian Cancer,1
23902,Malignant Cellular Infiltrate,Acute Megakaryocytic Leukemias,1
23903,Well-Circumscribed Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,1
23904,Malignant Cellular Infiltrate,Adult Acute Lymphocytic Leukemia,1
23905,Cutaneous Involvement,Contact dermatitis due to solar radiation,1
23906,Recurrent disease,Recurrent tumors of the Ewing's family,1
23907,Refractory Disease,Refractory Spinal Cord Neoplasm,1
23908,Epithelial Component Present,Stage III Primary Peritoneal Cancer AJCC v7,1
23909,Rapidly Enlarging Mass,Refractory Rhabdomyosarcoma,1
23910,Malignant Cellular Infiltrate,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
23911,Malignant Cellular Infiltrate,lymphoepithelial squamous cell carcinoma of salivary gland,1
23912,Epithelial Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
23913,Malignant Cellular Infiltrate,Refractory Lymphoma,1
23914,Slit-Like Stromal Retraction Present,Multifocal superficial basal cell carcinoma,1
23915,Epithelial Component Present,Bladder Urachal Squamous Cell Carcinoma,1
23916,Insular Pattern,Malignant Pancreatic Somatostatinoma,1
23917,Papillary Pattern,Condylomata Acuminata,1
23918,Diffuse Pattern,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
23919,Malignant Cellular Infiltrate,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
23920,Drug Exposure,Alkylating Agent-Related Acute Myeloid Leukemia,1
23921,Malignant Cellular Infiltrate,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
23922,Secondary Lesion,Secondary malignant neoplasm of retina,1
23923,Epithelial Component Present,Lip basal cell carcinoma,1
23924,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage III,1
23925,Carcinomatous Component Present,Primary solid type intraosseous squamous cell carcinoma,1
23926,Vascular Channel Formation,Solid Angioleiomyoma,1
23927,Benign Cellular Infiltrate,"Mixed Tumor, Not Otherwise Specified",1
23928,Stromal Invasion,large cell neuroendocrine carcinoma of ovary,1
23929,Mixed Cellular Population,Infiltrating duct and lobular carcinoma,1
23930,Malignant Cellular Infiltrate,Squamous cell carcinoma of esophagus,1
23931,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Juvenile Myelomonocytic Leukemia,1
23932,Cutaneous Involvement,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
23933,Recurrent disease,Recurrent Kaposi Sarcoma,1
23934,Chromogranin A Positive Neoplastic Cells Present,Extrahepatic Bile Duct Carcinoid Tumor,1
23935,Primary Lesion,BCLC Stage B Adult Hepatocellular Carcinoma,1
23936,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
23937,Cartilaginous Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
23938,Carcinomatous Component Present,adenocarcinoma of breast with squamous metaplasia,1
23939,Deep Lesion,Chest Wall Fibromatosis,1
23940,Benign Cellular Infiltrate,Benign Adult Cerebellar Neoplasm,1
23941,Adulthood Lesion,Adult Type Ovarian Granulosa Cell Tumor,1
23942,Dermal Involvement,Fibrous Hamartoma of Infancy,1
23943,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
23944,Carcinomatous Component Present,Endometrial Carcinoma,1
23945,Hyperplastic Tissue Present,Bronchial Epithelial Hyperplasia,1
23946,Pale Eosinophilic Stroma Formation,Dysembryoplastic neuroepithelial tumor,1
23947,Organoid Pattern,Tongue Alveolar Soft Part Sarcoma',1
23948,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,1
23949,Epithelial Component Present,Squamous cell carcinoma of prostate,1
23950,Refractory Disease,Refractory Hormone Receptor Positive Breast Carcinoma,1
23951,Chronic Inflammatory Infiltrate,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
23952,Secondary Lesion,Metastatic Bladder Urothelial Carcinoma,1
23953,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v7,1
23954,Epithelial Component Present,Borderline epithelial tumor of ovary,1
23955,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor,1
23956,Recurrent disease,Recurrent Acute Megakaryoblastic Leukemia,1
23957,Primary Lesion,Stage IB Osteosarcoma AJCC v7,1
23958,Epithelial Component Present,Stage II Colorectal Cancer AJCC v8,1
23959,Epithelial Component Present,Gastric Cancer by AJCC v6 Stage,1
23960,Chronic Inflammatory Infiltrate,Grade I Lymphomatoid Granulomatosis,1
23961,Low Grade Lesion,Mixed Congenital Mesoblastic Nephroma,1
23962,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor,1
23963,Benign Cellular Infiltrate,Mediastinal Chondroma,1
23964,Papillary Pattern,"Transitional cell carcinoma, micropapillary",1
23965,Epithelial Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7,1
23966,Mixed Cellular Population,Female Reproductive System Adenofibroma,1
23967,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia,1
23968,Malignant Cellular Infiltrate,Clinical Stage IB Cutaneous Melanoma AJCC v8,1
23969,Epithelial Component Present,Squamous Papilloma of the Nasopharynx,1
23970,Malignant Cellular Infiltrate,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
23971,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage II",1
23972,Carcinomatous Component Present,Refractory Bile Duct Carcinoma,1
23973,Local disease,Localized Gastroesophageal Junction Adenocarcinoma,1
23974,Malignant Cellular Infiltrate,Stage I Retroperitoneal Sarcoma AJCC v8,1
23975,Malignant Cellular Infiltrate,Stage III Appendix Carcinoma AJCC v8,1
23976,In Situ Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
23977,Epithelial Component Present,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
23978,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma,1
23979,Syncytial Pattern,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion",1
23980,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage II,1
23981,Epithelial Component Present,Transplant-Related Hepatocellular Carcinoma,1
23982,Villous Pattern,Villous adenoma of duodenum,1
23983,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of vulva,1
23984,Cutaneous Involvement,Kaposi's sarcoma of skin,1
23985,Malignant Cellular Infiltrate,Carcinoma,1
23986,C19MC Amplification,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
23987,Primary Lesion,Intraosseous well differentiated osteosarcoma,1
23988,Slow Growing Mass,Papillary ependymoma,1
23989,Nuclear Pseudoinclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
23990,atypia morphology,Malignant Testicular Leydig Cell Tumor,1
23991,Carcinomatous Component Present,Stage IA Vulvar Cancer AJCC v7,1
23992,Biphasic Pattern,Adenocarcinofibroma,1
23993,Childhood Lesion,Benign Childhood Cerebral Neoplasm,1
23994,Carcinomatous Component Present,Carcinoma Metastatic to the Skin,1
23995,Severe dysplasia,Carcinoma in situ of fallopian tube,1
23996,Epithelial Component Present,Meckel Diverticulum Neuroendocrine Tumor G1,1
23997,Carcinomatous Component Present,large cell neuroendocrine carcinoma of appendix,1
23998,Absence of Invasion,Stage 0 Rectal Cancer AJCC v6 and v7,1
23999,Vascular Channel Formation,Multiple Lobular Capillary Hemangiomas,1
24000,Nuclear Atypia,"Anaplastic Astrocytoma, IDH-Wildtype",1
24001,Malignant Cellular Infiltrate,Malignant neoplasm of fallopian tube,1
24002,Cysts Containing Proteinaceous Fluid Present,Serous cystadenoma of pancreas,1
24003,Malignant Cellular Infiltrate,leiomyosarcoma of vulva,1
24004,Secondary Lesion,Lung Carcinoma Metastatic in the Bone,1
24005,Recurrent Lymphoma,African Burkitt's lymphoma,1
24006,Benign Cellular Infiltrate,Benign Thalamic Neoplasm,1
24007,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Pulmonary Blastoma,1
24008,Junctional Proliferation,Epithelioid and spindle cell nevus,1
24009,Epithelial Component Present,Localized Adrenal Gland Pheochromocytoma,1
24010,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,1
24011,Well-Circumscribed Lesion,Pseudopolyposis of colon,1
24012,Benign Cellular Infiltrate,Vaginal Mullerian Papilloma,1
24013,Local disease,Mesothelioma malignant localized,1
24014,Clinical TNM Finding,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
24015,Malignant Cellular Infiltrate,Metastatic Parathyroid Gland Carcinoma,1
24016,Carcinomatous Component Present,large cell neuroendocrine carcinoma of breast,1
24017,Malignant Germinomatous Cellular Infiltrate,germinoma of brain,1
24018,Epithelial Component Present,"Adenocarcinoma of lung, stage II",1
24019,Malignant Cellular Infiltrate,Cervical Adenocarcinoma,1
24020,Microvascular Proliferation,Acinar cell carcinoma of pancreas,1
24021,Nodular Pattern,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",1
24022,Neuroendocrine Differentiation,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
24023,Metastatic Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
24024,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
24025,Absence of Invasion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
24026,Carcinomatous Component Present,Carcinoma in situ in a polyp,1
24027,Dysplasia,Bladder transitional cell carcinoma stage 0,1
24028,Solitary mass,Unresectable Chordoma,1
24029,Diffuse Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,1
24030,Precise Histogenesis Unknown,Cerebellar hemangioblastoma,1
24031,Recurrent disease,Hodgkin's disease lymphocyte depletion type recurrent,1
24032,Necrotic changes (finding),Necrotic intraocular melanoma,1
24033,Epithelial Component Present,Multifocal superficial basal cell carcinoma,1
24034,Malignant Cellular Infiltrate,Urothelial carcinoma recurrent,1
24035,Malignant Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v7 Stage,1
24036,Sarcomatous Component Present,Parotid Gland Carcinosarcoma,1
24037,Well-Circumscribed Lesion,Cystadenocarcinoma of kidney,1
24038,Eosinophilic inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
24039,Unresectable Mass,Unresectable Paraganglioma,1
24040,Tissue Differentiation Uncertain,Extraskeletal Myxoid Chondrosarcoma,1
24041,Rapidly Enlarging Mass,Gallbladder Rhabdomyosarcoma,1
24042,Epithelial Component Present,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
24043,Immunosuppression-Related Post-Transplant Toxicity,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,1
24044,High Mitotic Activity,Combined Lung Small Cell and Squamous Cell Carcinoma,1
24045,Cutaneous Involvement,Pilomatrixoma,1
24046,Diffuse Lesion,Papillomatosis,1
24047,Malignant Cellular Infiltrate,Malignant medulloepithelioma of ciliary body,1
24048,Epithelial Component Present,Large cell lung cancer stage III,1
24049,Early Stromal Invasion Present,Early Invasive Cervical Adenocarcinoma,1
24050,Malignant Cellular Infiltrate,Cervical Clear Cell Adenocarcinoma,1
24051,Malignant Cellular Infiltrate,Scrotal Sarcoma,1
24052,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic syndrome, no ICD-O subtype",1
24053,Metastatic Lesion,Metastatic Malignant Neoplasm to the Cervix,1
24054,Malignant Cellular Infiltrate,Stage IA Adult Soft Tissue Sarcoma AJCC v7,1
24055,Benign Cellular Infiltrate,Exophytic Schneiderian Papilloma,1
24056,Cutaneous Involvement,basal cell carcinoma of penis,1
24057,Epithelial Component Present,Stage I Vulvar Cancer,1
24058,Lytic lesion,Giant Cell Lesion of Small Bones,1
24059,Carcinomatous Component Present,Stage II Hypopharyngeal Carcinoma AJCC v8,1
24060,Diffuse Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
24061,Epithelial Component Present,Villous adenoma of colon,1
24062,Malignant Cellular Infiltrate,Gastric Kaposi's Sarcoma,1
24063,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage III,1
24064,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Cancer AJCC v7,1
24065,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
24066,Secondary Lesion,Alkylating Agent-Related Myelodysplastic Syndrome,1
24067,Cytoplasmic Membrane-Bound Granules Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
24068,Epithelial Component Present,Alcohol-Related Laryngeal Carcinoma,1
24069,Malignant Cellular Infiltrate,Grade 3 Malignant Neoplasm,1
24070,Primary Lesion,Recurrent Childhood Anaplastic Oligoastrocytoma,1
24071,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,1
24072,Vascular Channel Formation,Post-Radiotherapy Breast Angiosarcoma,1
24073,Cysts Containing Proteinaceous Fluid Present,Papillary serous cystadenoma,1
24074,Vascular Channel Formation,Small Intestinal Angiosarcoma,1
24075,Benign Cellular Infiltrate,Benign Cutaneous Fibroblastic Neoplasm,1
24076,Oligodendroglial Component Present,Recurrent Childhood Anaplastic Oligodendroglioma,1
24077,Secondary Lesion,Metastatic Lip Squamous Cell Carcinoma,1
24078,Cystic Change,Ovarian Endometrioid Cystadenofibroma,1
24079,Postneoadjuvant Therapy Pathologic TNM Finding,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
24080,Malignant Cellular Infiltrate,Papillary squamous cell carcinoma,1
24081,Neuronal Differentiation,Pituitary Gland Gangliocytoma,1
24082,Carcinomatous Component Present,adenoid cystic carcinoma of accessory sinus,1
24083,Glomeruloid Vessels Present,Pilocytic Astrocytoma,1
24084,Epithelial Component Present,Pancreatic adenocarcinoma resectable,1
24085,Malignant Cellular Infiltrate,Carcinoma of apocrine gland,1
24086,Lobulated Growth Pattern,Left atrial myxoma,1
24087,Malignant Cellular Infiltrate,Cancer of Ear,1
24088,Necrotic changes (finding),pleomorphic carcinoma of breast,1
24089,Cutaneous Involvement,Acute Generalized Exanthematous Pustulosis,1
24090,Epithelial Component Present,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
24091,Epithelial Component Present,Stage IC Ovarian Cancer AJCC v8,1
24092,Benign Cellular Infiltrate,Mediastinal Leiomyoma,1
24093,Epithelial Component Present,Low-grade intraurothelial neoplasia,1
24094,Secondary Lesion,Locally Advanced Small Intestinal Carcinoma,1
24095,Malignant Cellular Infiltrate,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
24096,Malignant Cellular Infiltrate,Activated B-cell type diffuse large B-cell lymphoma,1
24097,More than 5 Mitoses per 50HPF,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
24098,Hyperkeratosis,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
24099,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
24100,Malignant Cellular Infiltrate,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
24101,Non-Invasive Lesion,Bladder Urothelial Carcinoma in Situ,1
24102,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of spleen,1
24103,Carcinomatous Component Present,Major Salivary Gland Adenoid Cystic Carcinoma,1
24104,Malignant Cellular Infiltrate,Carcinoma of supraglottis,1
24105,Childhood Lesion,Stage I Childhood Anaplastic Large Cell Lymphoma,1
24106,Osteoid formation,Secondary osteosarcoma,1
24107,Immunologic Deficiency Syndromes,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,1
24108,Malignant Cellular Infiltrate,Resectable Dedifferentiated Liposarcoma,1
24109,Malignant Cellular Infiltrate,Childhood Medulloblastoma,1
24110,Storiform Growth Pattern,"Histiocytoma, Benign Fibrous",1
24111,Carcinomatous Component Present,Lung Acinar Adenocarcinoma,1
24112,Malignant Cellular Infiltrate,Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma,1
24113,Epithelial Component Present,Cervical Adenocarcinoma In Situ,1
24114,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage IV,1
24115,Thick-Walled Hyalinized Vessels Present,Sympathetic Schwannoma,1
24116,Dysplasia,Intraductal Cribriform Breast Adenocarcinoma,1
24117,Juvenile Lesion,Juvenile rheumatoid arthritis,1
24118,Malignant Cellular Infiltrate,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
24119,Cystic Change,"Cystadenoma, Serous",1
24120,Absence of a Hormonal Syndrome,Pituitary Gland Oncocytic Adenoma,1
24121,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of lung,1
24122,Malignant Cellular Infiltrate,Recurrent Endometrial Mixed Cell Adenocarcinoma,1
24123,Stromal Invasion,FIGO Stage IC2 Ovarian Cancer,1
24124,Diffuse Pattern,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,1
24125,Severe dysplasia,Stage 0 Vulvar Cancer,1
24126,Indolent Clinical Course,Lipoma of external auditory meatus,1
24127,Malignant Cellular Infiltrate,Prostatic Duct Urothelial Carcinoma,1
24128,Epithelial Component Present,Ovarian Transitional Cell Tumor,1
24129,Delicate Vascular Network Formation,Recurrent Clear Cell Renal Cell Carcinoma,1
24130,Carcinomatous Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
24131,Childhood Lesion,Childhood Supratentorial Ependymoma,1
24132,Malignant Cellular Infiltrate,Methotrexate-Associated Hodgkin Lymphoma,1
24133,Carcinomatous Component Present,Acinar Prostate Mucinous Adenocarcinoma,1
24134,Cysts Containing Proteinaceous Fluid Present,Serous cystadenocarcinoma of pancreas,1
24135,Malignant Cellular Infiltrate,"Lymphoma, Mixed-Cell, Follicular",1
24136,Exophytic Polypoid Lesion,Ampulla of Vater Tubulovillous Adenoma,1
24137,Carcinomatous Component Present,Trichilemmocarcinoma,1
24138,Secondary Lesion,Metastatic Parathyroid Gland Carcinoma,1
24139,Perivascular Arrangement of Tumor Cells,Benign Glomus Tumor,1
24140,Extensive Stage Lesion,Advanced B-Cell Neoplasm,1
24141,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Oropharynx,1
24142,Childhood Lesion,Childhood Choroid Plexus Carcinoma,1
24143,Chronic Inflammatory Infiltrate,Grade III Lymphomatoid Granulomatosis,1
24144,Absence of Invasion,Stage 0 Breast Cancer AJCC v6 and v7,1
24145,Nodular Pattern,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma,1
24146,Indolent Clinical Course,Fibrofolliculoma,1
24147,Recurrent disease,Small intestine carcinoma recurrent,1
24148,Multinodular Pattern,Proximal-Type Epithelioid Sarcoma,1
24149,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1
24150,Neuroendocrine Differentiation,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
24151,Epithelial Component Present,Grade II Penile Intraepithelial Neoplasia,1
24152,Microsatellite Stable,Advanced Microsatellite Stable Colorectal Carcinoma,1
24153,Malignant Cellular Infiltrate,Stage II Colorectal Cancer AJCC v7,1
24154,Malignant Cellular Infiltrate,basaloid carcinoma of penis,1
24155,More than 5 Mitoses per 50HPF,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
24156,Carcinomatous Component Present,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
24157,Immunologic Deficiency Syndromes,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
24158,Epithelial Component Present,Paget Disease Extramammary,1
24159,Cavernous Vascular Space Formation,"Hemangioma, Cavernous, Central Nervous System",1
24160,Benign Cellular Infiltrate,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
24161,High Grade Lesion,Combined Lung Carcinoma,1
24162,Congenital Lesion,GIANT PIGMENTED HAIRY NEVUS,1
24163,Antoni A Pattern,Sternal Intraosseous Schwannoma,1
24164,Carcinomatous Component Present,Stage IIA1 Cervical Cancer AJCC v8,1
24165,Metastatic Lesion,Metastatic Carcinoma in the Lung,1
24166,Tissue Differentiation Uncertain,Kidney Epithelioid Type Angiomyolipoma,1
24167,Metaplasia,Bladder squamous cell carcinoma stage II,1
24168,Metastatic Lesion,Metastatic Neoplasm to the Placenta,1
24169,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Fetal Lung Adenocarcinoma,1
24170,Carcinomatous Component Present,Breast Carcinoma with Choriocarcinomatous Features,1
24171,Epithelial Component Present,Stage 0 Esophageal Cancer AJCC v6,1
24172,Carcinomatous Component Present,Superior Sulcus Lung Carcinoma,1
24173,Juvenile Lesion,Juvenile cataract,1
24174,Neuroectodermal Differentiation,Kadish Stage A Olfactory Neuroblastoma,1
24175,High Mitotic Activity,small cell carcinoma of ureter,1
24176,Carcinomatous Component Present,Primary solid type intraosseous squamous cell carcinoma,1
24177,Metastatic Lesion,Metastatic basal cell carcinoma,1
24178,Immunologic Deficiency Syndromes,Transplant-Related Squamous Cell Carcinoma,1
24179,Neuroendocrine Differentiation,Prostate Neuroendocrine Neoplasm,1
24180,Childhood Lesion,Childhood Thyroid Gland Follicular Carcinoma,1
24181,Childhood Lesion,Postsurgical Stage III Hepatoblastoma,1
24182,Epithelial Component Present,basaloid squamous cell carcinoma of floor of mouth,1
24183,Malignant Cellular Infiltrate,Metastatic Endometrial Carcinoma,1
24184,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,1
24185,Epithelial Component Present,Stage 0 Lung Cancer AJCC v8,1
24186,Childhood Lesion,Childhood Brain Stem Astrocytoma,1
24187,Multilocular Lesion,Cystadenocarcinoma of kidney,1
24188,Epithelial Component Present,Soft Palate Pleomorphic Adenoma,1
24189,Malignant Cellular Infiltrate,Testicular embryonal carcinoma,1
24190,Malignant Cellular Infiltrate,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
24191,Neuroendocrine Differentiation,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
24192,Epithelial Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v7,1
24193,Macrofollicular Structures Present,Juvenile type ovarian granulosa cell tumor,1
24194,Epithelial Component Present,Adenocarcinoma of the prostate stage III,1
24195,Epithelial Component Present,Penile Cancer by AJCC v8 Stage,1
24196,Carcinomatous Component Present,Hepatocellular Carcinoma by AJCC v7 Stage,1
24197,Epithelial Component Present,Stage I Renal Pelvis Cancer AJCC v7,1
24198,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v7,1
24199,Malignant Cellular Infiltrate,AIDS-Related Anal Canal Carcinoma,1
24200,Carcinomatous Component Present,Bile duct cancer resectable,1
24201,Malignant Cellular Infiltrate,Paranasal Sinus Lymphoma,1
24202,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v7,1
24203,Epithelial Component Present,Bladder transitional cell carcinoma stage III,1
24204,Biphasic Pattern,Benign Prostate Phyllodes Tumor,1
24205,Epithelial Component Present,Lung Pleomorphic Adenoma,1
24206,Carcinomatous Component Present,Stage IIB Gallbladder Cancer AJCC v8,1
24207,Childhood Lesion,Childhood Malignant Solid Neoplasm,1
24208,Monoclonal Cellular Population Present,Thyroid Gland Follicular Adenoma,1
24209,High Mitotic Activity,Intestinal Neuroendocrine Carcinoma,1
24210,Malignant Cellular Infiltrate,Adult Mixed Cellularity Classical Hodgkin Lymphoma,1
24211,Epithelial Component Present,Digital papillary eccrine carcinoma of skin,1
24212,Malignant Cellular Infiltrate,Refractory Classic Hodgkin Lymphoma,1
24213,Carcinomatous Component Present,Mucoepidermoid carcinoma of parotid gland,1
24214,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
24215,Well Differentiated Lesion,Vulvar Warty Carcinoma,1
24216,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
24217,Epithelial Component Present,BCLC Stage D Adult Hepatocellular Carcinoma,1
24218,Invasive Lesion,Growth Hormone-Producing Pituitary Gland Carcinoma,1
24219,Carcinomatous Component Present,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
24220,Epithelial Component Present,Benign Ovarian Seromucinous Tumor,1
24221,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma refractory,1
24222,Papillary Pattern,verrucous carcinoma of esophagus,1
24223,Glandular Pattern,Pancreatic Somatostatinoma,1
24224,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
24225,Epithelial Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7,1
24226,Epithelial Component Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
24227,Malignant Cellular Infiltrate,Carcinoma Arising from Craniopharyngioma,1
24228,Lobulated Growth Pattern,Clivus Chondroid Chordoma,1
24229,Malignant Cellular Infiltrate,Urethral Verrucous Carcinoma,1
24230,Tissue Differentiation Uncertain,Adult Extraskeletal Myxoid Chondrosarcoma,1
24231,Fibrotic Stroma Formation,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,1
24232,Malignant Cellular Infiltrate,Papillary squamous cell carcinoma,1
24233,Benign Cellular Infiltrate,Parathyroid Gland Lipoadenoma,1
24234,Moderate dysplasia,Anal Intraepithelial Neoplasia 2,1
24235,Epithelial Component Present,Vaginal Carcinosarcoma,1
24236,Benign Cellular Infiltrate,Schneiderian papilloma,1
24237,Carcinomatous Component Present,Prognostic Stage 0 Breast Cancer AJCC v8,1
24238,Malignant Cellular Infiltrate,Pineal Region Yolk Sac Tumor,1
24239,Nuclear Grooves,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
24240,Benign Cellular Infiltrate,Skin appendage adenoma,1
24241,Malignant Cellular Infiltrate,Invasive Ductal and Lobular Carcinoma,1
24242,Malignant Cellular Infiltrate,Stage IIA Testicular Cancer AJCC v6 and v7,1
24243,Biphasic Pattern,Thymus Lipofibroadenoma,1
24244,Malignant Cellular Infiltrate,Epithelioid Sarcoma NCI Grade 2,1
24245,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma AJCC v7,1
24246,Benign Cellular Infiltrate,Cerebral hemangioma,1
24247,Intramucosal Lesion,Intramucosal Adenocarcinoma,1
24248,Malignant Cellular Infiltrate,AIDS-Related Cervical Carcinoma,1
24249,Recurrent disease,Recurrent Kidney Wilms Tumor,1
24250,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Mature Teratoma,1
24251,Primary Lesion,Extra-osseous Ewing's sarcoma recurrent,1
24252,Hereditary Lesion,Schwannomatosis,1
24253,Osseous Differentiation,Extraskeletal osteosarcoma non-metastatic,1
24254,Neuroendocrine Differentiation,Pancreatic Small Cell Neuroendocrine Carcinoma,1
24255,Well Differentiated Lesion,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
24256,Malignant Cellular Infiltrate,Distal Bile Duct Carcinoma,1
24257,Benign Cellular Infiltrate,Intramuscular lipoma,1
24258,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
24259,Locally Aggressive Lesion,Aggressive osteoblastoma,1
24260,Malignant Cellular Infiltrate,Malignant tumor of base of tongue,1
24261,Carcinomatous Component Present,Sweat Gland Tubular Carcinoma,1
24262,Malignant Cellular Infiltrate,Breast Lymphoma,1
24263,Diffuse Pattern,Supratentorial Glioblastoma,1
24264,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Primary Systemic Amyloidosis,1
24265,High Grade Lesion,"Synovial sarcoma, epithelioid cell",1
24266,Metastatic/Recurrent Disease,Liver Synovial Sarcoma,1
24267,Increased Cellularity Present,Recurrent Anaplastic Astrocytoma,1
24268,Epithelial Component Present,Follicular thyroid carcinoma,1
24269,Malignant Cellular Infiltrate,Luminal A Prostate Carcinoma,1
24270,Calcitonin Positive Neoplastic Cells Present,Familial medullary thyroid carcinoma,1
24271,Epithelial Component Present,Cervical Intraepithelial Neoplasia Grade 2/3,1
24272,Malignant Cellular Infiltrate,basaloid carcinoma of anus,1
24273,Exophytic Polypoid Lesion,Colorectal hyperplastic polyp,1
24274,Malignant Cellular Infiltrate,Ampulla of Vater Hepatoid Adenocarcinoma,1
24275,Well-Circumscribed Lesion,Cyst of Skene's duct,1
24276,Malignant Cellular Infiltrate,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
24277,Infiltrative Growth Pattern,"Perivascular epithelioid tumor, malignant",1
24278,Monoclonal Cellular Population Present,Aggressive Systemic Mastocytosis,1
24279,Malignant Cellular Infiltrate,Secondary malignant neoplasm of axilla,1
24280,Benign Cellular Infiltrate,leiomyoma of trachea,1
24281,Carcinomatous Component Present,Stage 0 Rectal Cancer AJCC v8,1
24282,Neuroendocrine Differentiation,Intermediate Grade Lung Neuroendocrine Neoplasm,1
24283,Carcinomatous Component Present,Bladder squamous cell carcinoma stage IV,1
24284,Carcinomatous Component Present,Papillary carcinoma of the breast,1
24285,Carcinomatous Component Present,Stage IIIB Eyelid Carcinoma AJCC v7,1
24286,Malignant Cellular Infiltrate,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
24287,Carcinomatous Component Present,Endometrial Transitional Cell Carcinoma,1
24288,Follicular Cell Differentiation,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8,1
24289,Malignant Cellular Infiltrate,adenosquamous carcinoma of ovary,1
24290,S-100-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
24291,Regional Disease,Locally Advanced Carcinoma,1
24292,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v8,1
24293,Cystic Lesion,Adamantinous Craniopharyngioma,1
24294,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
24295,Epithelial Component Present,Stage III Ampulla of Vater Cancer AJCC v8,1
24296,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
24297,Papillary Pattern,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
24298,Carcinomatous Component Present,Stage IA Gastric Carcinoma,1
24299,Borderline Resectable Mass,Borderline Resectable Carcinoma,1
24300,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
24301,Pseudolobular Pattern,Ovarian Sclerosing Stromal Tumor,1
24302,Benign Cellular Infiltrate,Fibroid Tumor,1
24303,Immunologic Deficiency Syndromes,Monomorphic Post-Transplant Lymphoproliferative Disorder,1
24304,Metastatic Lesion,Distantly Metastatic Malignant Neoplasm,1
24305,Primary Lesion,Peripheral neuroepithelioma of bone recurrent,1
24306,Epithelial Component Present,Mammary Analog Secretory Carcinoma of Salivary Gland,1
24307,Malignant Cellular Infiltrate,Pathologic Stage IIC Cutaneous Melanoma AJCC v8,1
24308,Hereditary Lesion,Carney Complex,1
24309,Epithelial Component Present,Breast Mucinous Cystadenocarcinoma,1
24310,Carcinomatous Component Present,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
24311,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage II,1
24312,Endophytic Tumor Growth,Cervical Verrucous Carcinoma,1
24313,Invasive Lesion,Squamous cell breast carcinoma,1
24314,Epithelial Component Present,"Carcinoma, Small Cell",1
24315,Non-Invasive Lesion,Stage 0is Ureter Cancer AJCC v7,1
24316,Epithelial Component Present,Skin squamous cell carcinoma metastatic,1
24317,Neuroendocrine Differentiation,Stage I Jejunal Neuroendocrine Tumor AJCC v8,1
24318,Epithelial Component Present,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
24319,High Mitotic Activity,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
24320,Malignant Cellular Infiltrate,"Chondrosarcoma, Clear Cell",1
24321,Mesenchymal Component Present,Breast Pleomorphic Adenoma,1
24322,Epithelial Component Present,Type I Endometrial Adenocarcinoma,1
24323,Carcinomatous Component Present,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
24324,Monophasic Pattern,Cardiac Monophasic Synovial Sarcoma,1
24325,"Fully Differentiated ""Adult-Type"" Tissues Present","Teratoma, Malignant",1
24326,Indolent Clinical Course,Pigmented villonodular synovitis,1
24327,Malignant Cellular Infiltrate,Nipple Duct Carcinoma,1
24328,Carcinomatous Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
24329,Cystic Change,Testicular Dermoid Cyst,1
24330,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
24331,Somatostatin Positive Neoplastic Cells Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
24332,Epithelial Component Present,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
24333,Pregnancy Complications,Non-Metastatic Gestational Trophoblastic Tumor,1
24334,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity recurrent,1
24335,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma of the Oropharynx,1
24336,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma,1
24337,Carcinomatous Component Present,Stage I Small Intestinal Adenocarcinoma AJCC v8,1
24338,Malignant Cellular Infiltrate,Undifferentiated round cell sarcoma,1
24339,Malignant Cellular Infiltrate,Minor Salivary Gland Adenocarcinoma,1
24340,Malignant Cellular Infiltrate,Stage IA Ampulla of Vater Cancer AJCC v8,1
24341,Malignant Cellular Infiltrate,Adenocarcinoma of anal canal,1
24342,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,1
24343,Diffuse Pattern,Centroblastic Lymphoma by Ann Arbor Stage,1
24344,Clinical TNM Finding,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,1
24345,Tissue Differentiation Uncertain,Epithelioid Type Angiomyolipoma,1
24346,Moderate dysplasia,Grade II Prostatic Intraepithelial Neoplasia,1
24347,"Amorphus, Eosinophilic, and Acellular Deposit",Senile cardiac amyloidosis,1
24348,Carcinomatous Component Present,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
24349,Childhood Lesion,Childhood Acute Basophilic Leukemia,1
24350,Malignant Cellular Infiltrate,Stage IV Colon Carcinoma,1
24351,Malignant Cellular Infiltrate,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
24352,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),1
24353,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma,1
24354,Malignant Cellular Infiltrate,carcinoma of gingiva,1
24355,Sebaceous Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
24356,Nuclear Atypia,MGMT-Methylated Glioblastoma,1
24357,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
24358,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v7,1
24359,Malignant Cellular Infiltrate,yolk sac tumor of mediastinum,1
24360,Malignant Cellular Infiltrate,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
24361,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma recurrent,1
24362,Epithelial Component Present,Rectal Serrated Adenocarcinoma,1
24363,Epithelial Component Present,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
24364,Chronic lymphocytic inflammation,Parotid Gland Sebaceous Lymphadenoma,1
24365,Well Differentiated Neuroendocrine Lesion,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
24366,Refractory Disease,Precursor T-lymphoblastic lymphoma/leukemia refractory,1
24367,Cystic Change,Mucoepidermoid carcinoma of the oral cavity stage III,1
24368,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage I,1
24369,Hemorrhagic,Solid pseudopapillary tumor of the pancreas,1
24370,Abundance of Small Lymphocytes,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
24371,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
24372,Adulthood Lesion,Stage IV Adult Non-Hodgkin Lymphoma,1
24373,Secondary Lesion,Metastatic Malignant Neoplasm to the Cervix,1
24374,Secondary Lesion,Secondary malignant neoplasm of pituitary gland,1
24375,Malignant Cellular Infiltrate,Metastatic Colon Carcinoma,1
24376,Cytoplasmic Membrane-Bound Granules Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
24377,Infiltrative Growth Pattern,"Fibromatosis, Abdominal",1
24378,Clinical TNM Finding,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
24379,Primary Lesion,Stage IVB Primary Peritoneal Cancer AJCC v8,1
24380,Secondary Lesion,Metastatic Thyroid Gland Follicular Carcinoma,1
24381,Carcinomatous Component Present,Lobular carcinoma in situ of breast,1
24382,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Seminoma,1
24383,Immunologic Deficiency Syndromes,Plasmacytic Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
24384,Malignant Cellular Infiltrate,Pericardial mesothelioma malignant recurrent,1
24385,Well-Circumscribed Lesion,Colorectal hyperplastic polyp,1
24386,Adulthood Lesion,Adult Epithelioid Hemangioendothelioma,1
24387,Refractory Disease,Refractory Primary Lymphoma of Bone,1
24388,Malignant Cellular Infiltrate,Recurrent Childhood Rhabdomyosarcoma,1
24389,Fibrotic Stroma Formation,Malignant Brenner Tumor,1
24390,Bone Marrow and Blood Involvement,Burkitt Leukemia,1
24391,Neuroendocrine Differentiation,Superior and Inferior Paraaortic Paraganglioma,1
24392,Unresectable Mass,Metastatic Unresectable Carcinoma,1
24393,Nuclear Atypia,Childhood Anaplastic Oligoastrocytoma,1
24394,Epithelial Component Present,Stage IVC Appendix Carcinoma AJCC v8,1
24395,Carcinomatous Component Present,Metastatic Endometrial Carcinoma,1
24396,Hyaline Cartilage Differentiation,Chondrosarcoma recurrent,1
24397,Antoni A Pattern,Pleural Schwannoma,1
24398,Pseudoglandular Pattern,Sellar Embryonal Carcinoma,1
24399,Carcinomatous Component Present,Clear cell odontogenic carcinoma,1
24400,Malignant Component Present,Ovarian Dermoid Cyst with Secondary Carcinoma,1
24401,Epithelial Component Present,Cervical intraepithelial neoplasia grade 2,1
24402,Malignant Cellular Infiltrate,Stage IVB Gallbladder Carcinoma,1
24403,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
24404,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v6 Stage,1
24405,Carcinomatous Component Present,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
24406,Epithelial Component Present,Major Salivary Gland Cancer by AJCC v8 Stage,1
24407,Malignant Cellular Infiltrate,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
24408,Carcinomatous Component Present,Sporadic Breast Carcinoma,1
24409,Carcinomatous Component Present,Breast Carcinoma by Gene Expression Profile,1
24410,Epithelial Component Present,Localized Gastroesophageal Junction Adenocarcinoma,1
24411,Carcinomatous Component Present,Paget Disease Extramammary,1
24412,Primary Lesion,Recurrent Primary Effusion Lymphoma,1
24413,Cystic Change,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
24414,Severe dysplasia,Stage 0 Rectal Cancer AJCC v6 and v7,1
24415,Immunologic Deficiency Syndromes,Neoplastic Post-Transplant Lymphoproliferative Disorder,1
24416,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6,1
24417,Malignant Cellular Infiltrate,Meningeal Lymphoma,1
24418,Carcinomatous Component Present,Stage III Prostate Cancer AJCC v8,1
24419,Carcinomatous Component Present,Grade 2 Endometrial Endometrioid Adenocarcinoma,1
24420,Mixture of Germ Cell Neoplastic Components Present,Adult Central Nervous System Mixed Germ Cell Tumor,1
24421,Mixed Cellular Population,Invasive Mixed Breast Carcinoma,1
24422,Carcinomatous Component Present,Ethmoid Sinus Squamous Cell Carcinoma,1
24423,Intraductal Lesion,Intrahepatic Bile Duct Papillary Neoplasm,1
24424,High Grade Lesion,Sellar Dedifferentiated Chordoma,1
24425,Benign Cellular Infiltrate,Angiomatosis,1
24426,Myofibroblastic Differentiation,Dermatofibrosarcoma protuberans with myoid differentiation,1
24427,Malignant Cellular Infiltrate,Cecum Carcinoma,1
24428,Cystic Change,Borderline Ovarian Serous Cystadenofibroma,1
24429,Malignant Cellular Infiltrate,Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8,1
24430,Epithelial Component Present,Ovarian Granulosa-Stromal Cell Tumor,1
24431,Carcinomatous Component Present,Cervical Squamous Cell Carcinoma In Situ,1
24432,Non-Specific Glandular Pattern,Bladder Adenocarcinoma,1
24433,Malignant Cellular Infiltrate,Stage II Non-Hodgkin Lymphoma,1
24434,Nuclear Atypia,Brain Stem Glioblastoma,1
24435,Malignant Cellular Infiltrate,Malignant Adrenal Gland Composite Pheochromocytoma,1
24436,Intraosseous Lesion,Odontogenic myxofibroma,1
24437,Mild dysplasia,Low-grade intraurothelial neoplasia,1
24438,Tissue Differentiation Uncertain,Orbital Alveolar Soft Part Sarcoma,1
24439,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,1
24440,Carcinomatous Component Present,Lung Cancer by AJCC v6 Stage,1
24441,Epithelial Component Present,Anal squamous cell carcinoma,1
24442,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G1,1
24443,Carcinomatous Component Present,Glottic Squamous Cell Carcinoma,1
24444,Chronic lymphocytic inflammation,Follicular Bronchitis/Bronchiolitis,1
24445,Malignant Cellular Infiltrate,Malignant neoplasm of glottis,1
24446,Malignant Cellular Infiltrate,Ann Arbor Stage IIIA Hodgkin Lymphoma,1
24447,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,1
24448,Epithelial Component Present,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,1
24449,Adulthood Lesion,Stage I Indolent Adult Non-Hodgkin Lymphoma,1
24450,Unresectable Mass,Metastatic Unresectable Sarcoma,1
24451,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Brain,1
24452,Generalized illness,Leiomyomatosis peritonealis disseminata,1
24453,High Grade Lesion,Stage IA Lung Small Cell Carcinoma AJCC v7,1
24454,Mild dysplasia,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
24455,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Acute Myelomonocytic Leukemia,1
24456,Neuroendocrine Differentiation,Metastatic Adrenal Gland Pheochromocytoma,1
24457,Cutaneous Involvement,Cellular Blue Nevus,1
24458,Refractory Disease,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
24459,Malignant Cellular Infiltrate,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,1
24460,Well Differentiated Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1,1
24461,Osseous Differentiation,Osteosarcoma recurrent,1
24462,Childhood Lesion,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,1
24463,Carcinomatous Component Present,carcinosarcoma of extrahepatic bile duct,1
24464,Refractory Disease,Refractory Malignant Testicular Germ Cell Tumor,1
24465,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
24466,Malignant Cellular Infiltrate,Corneal Melanoma,1
24467,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v8,1
24468,Severe cytologic atypia,Vaginal Undifferentiated Sarcoma,1
24469,Epithelial Component Present,Stage II Colon Cancer AJCC v8,1
24470,Carcinomatous Component Present,Locally Advanced Basal Cell Carcinoma,1
24471,Epithelial Component Present,Malignant Phyllodes Tumor of Prostate,1
24472,Epithelial Component Present,Occult Lung Non-Small Cell Carcinoma,1
24473,Epithelial Component Present,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
24474,Well Differentiated Neuroendocrine Lesion,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
24475,Epithelial Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8,1
24476,Malignant Cellular Infiltrate,Fibrolamellar Hepatocellular Carcinoma,1
24477,Well-Circumscribed Lesion,Rectal Tubular Adenoma,1
24478,Secondary Lesion,Metastatic Lung Non-Small Cell Carcinoma,1
24479,Benign Cellular Infiltrate,Frontal Sinus Schneiderian Papilloma,1
24480,Recurrent disease,Recurrent Male Reproductive System Carcinoma,1
24481,Malignant Cellular Infiltrate,Malignant Bone Neoplasm,1
24482,Rapidly Enlarging Mass,rhabdomyosarcoma of mediastinum,1
24483,Epithelial Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
24484,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,Recurrent High Risk Myelodysplastic Syndrome,1
24485,Well-Circumscribed Lesion,Sessile Serrated Adenoma/Polyp,1
24486,Metastatic Lesion,Medulloblastoma with Leptomeningeal Spread,1
24487,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of the cecum,1
24488,Epithelial Component Present,Refractory Colon Carcinoma,1
24489,Epithelial Component Present,Stage I Rectosigmoid Cancer AJCC v6 and v7,1
24490,Papillary Pattern,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
24491,Epithelial Component Present,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,1
24492,Malignant Cellular Infiltrate,Adult B Acute Lymphoblastic Leukemia,1
24493,Secondary Lesion,Carcinoma Metastatic to the Skin,1
24494,Metastatic/Recurrent Disease,"Sarcoma, Epithelioid",1
24495,Benign Cellular Infiltrate,Rectal Lipoma,1
24496,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with Minimal Differentiation,1
24497,Undifferentiated Lesion,"Endometrial stromal sarcoma, high grade",1
24498,Serrated Glandular Architecture,Rectal Serrated Adenocarcinoma,1
24499,Stromal Invasion,Stage IC Ovarian Cancer AJCC v8,1
24500,Epithelial Component Present,Mucinous adenocarcinoma of colon,1
24501,Ineffective hematopoiesis,Refractory Cytopenia of Childhood,1
24502,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage II,1
24503,Metastatic Lesion,Pleural mesothelioma malignant advanced,1
24504,Hyperkeratosis,Supraglottic Verrucous Carcinoma,1
24505,Benign Cellular Infiltrate,Glomerulosa Cell Adrenal Cortical Adenoma,1
24506,Childhood Lesion,Childhood Pilomyxoid Astrocytoma,1
24507,Metastatic Lesion,Metastasizing Chondroblastoma,1
24508,Epithelial Component Present,Stage 0 Oropharyngeal Carcinoma,1
24509,High Mitotic Activity,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
24510,Nuclear Pseudoinclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
24511,Dysplasia,Colorectal Filiform Serrated Adenoma,1
24512,Nuclear Grooves,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
24513,Epithelial Component Present,Stage IB1 Cervical Cancer AJCC v8,1
24514,Nuclear Atypia,Recurrent Childhood Glioblastoma,1
24515,Malignant Cellular Infiltrate,Recurrent Plasmablastic Lymphoma,1
24516,Lobulated Growth Pattern,Apocrine adenoma,1
24517,Carcinomatous Component Present,Esophageal Mixed Adenoneuroendocrine Carcinoma,1
24518,Malignant Cellular Infiltrate,Infiltrating Cervical Carcinoma,1
24519,Carcinomatous Component Present,Stage II Vaginal Cancer AJCC v8,1
24520,Recurrent disease,Recurrent Primary Effusion Lymphoma,1
24521,Epithelial Component Present,Uterine Ligament Clear Cell Adenocarcinoma,1
24522,Secondary Lesion,Metastatic Unresectable Sarcoma,1
24523,Invasive Lesion,High Grade Mucoepidermoid Breast Carcinoma,1
24524,Calcitonin serum level increased,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
24525,Neuroendocrine Differentiation,Small cell lung cancer extensive stage,1
24526,Carcinomatous Component Present,Stage IIA Lung Large Cell Carcinoma AJCC v7,1
24527,Thin-Walled Branching Vascular Pattern,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
24528,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
24529,Vascular Channel Formation,Aggressive angiomyxoma,1
24530,Malignant Cellular Infiltrate,Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage,1
24531,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
24532,Platinum Resistance,Platinum-Resistant Primary Peritoneal Carcinoma,1
24533,Malignant Cellular Infiltrate,Metastatic Lung Neuroendocrine Neoplasm,1
24534,Well-Circumscribed Lesion,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
24535,Carcinomatous Component Present,Stage II Oral Cavity Cancer AJCC v6 and v7,1
24536,Malignant Cellular Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,1
24537,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v7,1
24538,Intracellular Accumulation of Lipids,Temporal Lobe Pleomorphic Xanthoastrocytoma,1
24539,Epithelial Component Present,"Papillomatosis, glandular",1
24540,Malignant Cellular Infiltrate,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
24541,High Mitotic Activity,Endometrial Large Cell Neuroendocrine Carcinoma,1
24542,Bone marrow reticulin fibrosis,Hairy Cell Leukemia,1
24543,Epithelial Component Present,Pancreatic Delta Cell Neoplasm,1
24544,Nested Pattern,Sclerosing Epithelioid Fibrosarcoma,1
24545,Low Mitotic Activity,Esophageal Neuroendocrine Tumor,1
24546,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v7,1
24547,Carcinomatous Component Present,Pleural Carcinomatosis,1
24548,Anaplasia,Systemic Anaplastic Large Cell Lymphoma,1
24549,Carcinomatous Component Present,Resectable Pancreatic Acinar Cell Carcinoma,1
24550,Carcinomatous Component Present,Colorectal Sarcomatoid Carcinoma,1
24551,Oligodendroglial Component Present,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
24552,Epithelial Component Present,Stage IIIb Penile Cancer AJCC v7,1
24553,In Situ Lesion,Adenocarcinoma in situ in a polyp,1
24554,Mixed Cellular Population,Anaplastic Oligoastrocytoma,1
24555,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone metastatic,1
24556,Poorly Differentiated Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
24557,Metastatic/Recurrent Disease,Pulmonary Artery Intimal Sarcoma,1
24558,Malignant Cellular Infiltrate,Squamous cell carcinoma of vulva,1
24559,Poorly Differentiated Lesion,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
24560,Cystic Change,sialadenoma papilliferum of salivary gland,1
24561,Refractory Disease,Refractory Colon Carcinoma,1
24562,Metastatic Lesion,Metastatic Epithelioid Hemangioendothelioma,1
24563,Neuroectodermal Differentiation,Familial Neuroblastoma,1
24564,Carcinomatous Component Present,Carcinoma of subglottis,1
24565,High Grade Lesion,Recurrent Childhood Glioblastoma,1
24566,Refractory Disease,Refractory Kaposi Sarcoma,1
24567,Severe cytologic atypia,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
24568,Lobulated Growth Pattern,Vertebral chordoma,1
24569,Epithelial Component Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
24570,Necrotic changes (finding),Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
24571,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
24572,Cutaneous Involvement,Stage III Lentigo Maligna Melanoma AJCC v7,1
24573,Secondary Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,1
24574,Carcinomatous Component Present,Anatomic Stage 0 Breast Cancer AJCC v8,1
24575,Immunosuppression-Related Post-Transplant Toxicity,Acute humoral allograft nephropathy,1
24576,Malignant Cellular Infiltrate,B-cell lymphoma recurrent,1
24577,Carcinomatous Component Present,Transitional cell cancer of the renal pelvis and ureter localized,1
24578,Biphasic Pattern,Vulvar Ectopic Fibroadenoma,1
24579,Clinical TNM Finding,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
24580,Malignant Cellular Infiltrate,Infant Acute Undifferentiated Leukemia,1
24581,Well Differentiated Neuroendocrine Lesion,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
24582,Myxoid Stroma Formation,Ovarian Myxoma,1
24583,Epithelial Component Present,Recurrent Thyroid Gland Papillary Carcinoma,1
24584,Myxoid Stroma Formation,Epithelioid hemangioendothelioma of lung,1
24585,Epithelial Component Present,Oropharyngeal lymphepithelioma,1
24586,Hereditary Lesion,"Optic Atrophies, Hereditary",1
24587,Cutaneous Involvement,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
24588,Childhood Lesion,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8,1
24589,Carcinomatous Component Present,Stage IIIB Ampulla of Vater Cancer AJCC v8,1
24590,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
24591,Severe dysplasia,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
24592,Lymphoplasmacytic Infiltrate,Tonsillar Undifferentiated Carcinoma,1
24593,Mitotic Activity,Childhood Giant Cell Glioblastoma,1
24594,Malignant Cellular Infiltrate,Invasive Cutaneous Melanoma,1
24595,Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia,1
24596,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8,1
24597,Malignant Cellular Infiltrate,Early Hepatocellular Carcinoma,1
24598,Cutaneous Involvement,Rosacea,1
24599,Malignant Cellular Infiltrate,Pathologic Stage IV Cutaneous Melanoma AJCC v8,1
24600,Refractory Disease,Refractory Adult Spinal Cord Neoplasm,1
24601,Neuroendocrine Differentiation,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
24602,Congenital Lesion,Congenital aphakia,1
24603,Malignant Cellular Infiltrate,Stage II Childhood Lymphoblastic Lymphoma,1
24604,Well-Circumscribed Lesion,Adrenal Cortex Oncocytic Adenoma,1
24605,Mild cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
24606,Malignant Cellular Infiltrate,Stage IIIC Ovarian Cancer AJCC v8,1
24607,Epithelial Component Present,Anatomic Stage III Breast Cancer AJCC v8,1
24608,Thin-Walled Branching Vascular Pattern,Epidural Spinal Canal Angiolipoma,1
24609,Mitotic Activity,Teratocarcinoma,1
24610,Lobulated Growth Pattern,Chordoma of clivus,1
24611,Cellular Pleomorphism,Classic Type Atypical Fibroxanthoma,1
24612,Diffuse Pattern,Grade III Lymphomatoid Granulomatosis,1
24613,Malignant Cellular Infiltrate,mantle cell lymphoma of stomach,1
24614,Fibromuscular Stroma Formation,Bartholin Gland Adenomyoma,1
24615,Malignant Cellular Infiltrate,Recurrent Ovarian Cystadenocarcinoma,1
24616,Malignant Cellular Infiltrate,Stage III Hodgkin Lymphoma,1
24617,Epithelial Component Present,Stage I Carcinoma of Bladder,1
24618,atypia morphology,Borderline Ovarian Clear Cell Cystadenofibroma,1
24619,Epithelial Component Present,Gastric Fundus Carcinoma,1
24620,Well Differentiated Neuroendocrine Lesion,Non functioning pancreatic endocrine tumor,1
24621,Cystic Change,Mucoepidermoid carcinoma of parotid gland,1
24622,Epithelial Component Present,Squamous cell breast carcinoma,1
24623,Malignant Cellular Infiltrate,Stage IIIB Rectal Cancer AJCC v8,1
24624,High Mitotic Activity,neuroendocrine carcinoma of anal canal,1
24625,Malignant Cellular Infiltrate,Primary Childhood Soft Tissue Sarcoma,1
24626,Malignant Cellular Infiltrate,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
24627,Carcinomatous Component Present,Stage IVA Cervical Cancer AJCC v8,1
24628,Malignant Cellular Infiltrate,Trabecular adenocarcinoma,1
24629,Carcinomatous Component Present,Mesonephroma,1
24630,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Cystadenocarcinoma of kidney,1
24631,Fibrous Septa Present,Childhood Ovarian Dysgerminoma,1
24632,Primary Lesion,Stage IV Primary Peritoneal Cancer AJCC v7,1
24633,Metastatic/Recurrent Disease,"Synovial sarcoma, epithelioid cell",1
24634,Epithelial Component Present,Stage IA Ovarian Cancer,1
24635,Solitary mass,Cardiac Epithelioid Hemangioendothelioma,1
24636,Malignant Cellular Infiltrate,Malignant tumor of epididymis,1
24637,Borderline Lesion,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
24638,Carcinomatous Component Present,Stage IB Ovarian Cancer AJCC v8,1
24639,Epithelial Component Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
24640,Benign Cellular Infiltrate,Benign Carotid Body Paraganglioma,1
24641,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity recurrent,1
24642,Neuroendocrine Differentiation,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
24643,Birbeck Granules Present,Letterer-Siwe Disease,1
24644,Malignant Cellular Infiltrate,Stage III Lung Cancer AJCC v7,1
24645,High Grade Lesion,Kidney Synovial Sarcoma,1
24646,Indolent Clinical Course,Vulvar Lipoma,1
24647,Focal dysplasia,Colon Sessile Serrated Adenoma/Polyp,1
24648,Hyperkeratosis,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
24649,Papillary Pattern,Cervical Squamotransitional Carcinoma,1
24650,Cutaneous Involvement,Carcinoma in situ of skin,1
24651,Malignant Cellular Infiltrate,Acantholytic squamous cell carcinoma,1
24652,Fibrotic Stroma Formation,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
24653,Malignant Cellular Infiltrate,Platinum-Resistant Urothelial Carcinoma,1
24654,Jaw Keratocyst,Basal Cell Nevus Syndrome,1
24655,Vascular Channel Formation,Lymphangiomatosis,1
24656,Malignant Cellular Infiltrate,Stage IVC Lip Cancer AJCC v6 and v7,1
24657,High Grade Lesion,Alveolar soft part sarcoma non-metastatic,1
24658,Cutaneous Involvement,Senile hemangioma of lip,1
24659,Inflammatory infiltrate,Nodular tenosynovitis,1
24660,Low Grade Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
24661,Intracanalicular Growth Pattern,Malignant Cystosarcoma Phyllodes,1
24662,Pushing Tumor Margin,Verrucous carcinoma,1
24663,Carcinomatous Component Present,Gastric Intramucosal Adenocarcinoma,1
24664,Carcinomatous Component Present,Stage I Adrenal Cortex Carcinoma AJCC v8,1
24665,Exophytic Polypoid Lesion,Fibrous polyp,1
24666,Malignant Cellular Infiltrate,Stage III Childhood Non-Hodgkin Lymphoma,1
24667,Epithelial Component Present,Ovarian Cancer by AJCC v6 and v7 Stage,1
24668,Cystic Change,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,1
24669,Necrotic changes (finding),Metastatic Lung Small Cell Carcinoma,1
24670,Malignant Cellular Infiltrate,Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
24671,Invasive Lesion,Secretory breast carcinoma,1
24672,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
24673,Immunoglobulin Deposition,Primary amyloidosis,1
24674,Slow Growing Mass,Recurrent Craniopharyngioma,1
24675,Malignant Cellular Infiltrate,Secondary malignant neoplasm of choroid,1
24676,Rapidly Enlarging Mass,Adult Rhabdomyosarcoma,1
24677,Refractory Disease,Refractory Hepatoblastoma,1
24678,Mesenchymal Component Present,Mixed Salivary Gland Tumor,1
24679,Regional Disease,Locally Advanced Bile Duct Carcinoma,1
24680,Epithelial Component Present,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
24681,Radiation Sickness,Radiation-Related Sarcoma,1
24682,Metastatic Lesion,Metastatic leiomyosarcoma,1
24683,Capillary Sized Vascular Channel Formation,Senile hemangioma of lip,1
24684,Malignant Cellular Infiltrate,malignant neoplasm of large intestine stage IV,1
24685,Malignant Cellular Infiltrate,Childhood T Acute Lymphoblastic Leukemia,1
24686,Malignant Cellular Infiltrate,"Perivascular epithelioid tumor, malignant",1
24687,Malignant Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v8 Stage,1
24688,Mixed Cellular Population,Benign Prostate Phyllodes Tumor,1
24689,Epithelial Component Present,Occult Lung Large Cell Carcinoma,1
24690,Non-Invasive Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
24691,Epithelial Component Present,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7,1
24692,Epithelial Component Present,Vaginal cancer recurrent,1
24693,Papillary Pattern,Adult Myxopapillary Ependymoma,1
24694,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, SHH-Activated, TP53-Wildtype",1
24695,Carcinomatous Component Present,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
24696,Malignant Cellular Infiltrate,Primary Vitreoretinal Lymphoma,1
24697,Recurrent disease,Recurrent Skin Angiosarcoma,1
24698,Epithelial Component Present,Thymic Adenosquamous Carcinoma,1
24699,Whorling Growth Pattern,Classical Low Grade Fibromyxoid Sarcoma,1
24700,Immunologic Deficiency Syndromes,AIDS-Related Pneumocystis Pneumonia,1
24701,Refractory Disease,Refractory Chronic Leukemia,1
24702,Epithelial Component Present,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
24703,Malignant Cellular Infiltrate,Thymic Undifferentiated Carcinoma,1
24704,Intestinal metaplasia,Barrett's Adenocarcinoma,1
24705,Fibrotic Stroma Formation,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
24706,Malignant Cellular Infiltrate,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
24707,Non-Hereditary Lesion,Mucinous adenocarcinoma gastric,1
24708,Malignant Cellular Infiltrate,Chronic myeloproliferative disorder,1
24709,Secondary Lesion,Breast Carcinoma Metastatic in the Bone,1
24710,Anaplasia,Anaplastic Sarcoma of the Kidney,1
24711,Secondary Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
24712,Recurrent disease,Recurrent Kidney Wilms Tumor,1
24713,Carcinomatous Component Present,Stage II Adult Liver Cancer AJCC v7,1
24714,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
24715,Carcinomatous Component Present,Cervical Adenoid Cystic Carcinoma,1
24716,Mixed Cellular Population,Uterine Corpus Carcinofibroma,1
24717,Nodular lesions,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
24718,Mitotic Activity,"Testicular Yolk Sac Tumor, Papillary Pattern",1
24719,Epithelial Component Present,Adenosquamous Bile Duct Carcinoma,1
24720,Malignant Cellular Infiltrate,Lymphohistiocytoid Mesothelioma,1
24721,Glial Differentiation,Anaplastic ganglioglioma,1
24722,Malignant Cellular Infiltrate,Stage IVB Liver Cancer,1
24723,Epithelial Component Present,Advanced Microsatellite Stable Colorectal Carcinoma,1
24724,Malignant Cellular Infiltrate,Squamous cell carcinoma of prostate,1
24725,Slow Growing Mass,Elastofibroma,1
24726,Nuclear Atypia,Infratentorial Glioblastoma,1
24727,Epithelial Component Present,Localized Adrenal Gland Pheochromocytoma,1
24728,Malignant Cellular Infiltrate,Metastatic Neoplasm to the Gallbladder,1
24729,Necrotic changes (finding),Colorectal Large Cell Neuroendocrine Carcinoma,1
24730,Anaplasia,High grade surface osteosarcoma,1
24731,Papillary Pattern,serous surface papillary carcinoma of ovary,1
24732,atypia morphology,Cutaneous Leiomyosarcoma,1
24733,Metastatic Lesion,Secondary malignant neoplasm of vulva,1
24734,High Grade Lesion,Pleural Synovial Sarcoma,1
24735,Tissue of Mullerian Origin Present,Ovarian Endometrioid Cystadenofibroma,1
24736,Malignant Cellular Infiltrate,Invasive Mixed Breast Carcinoma,1
24737,Malignant Cellular Infiltrate,Stage IIA Lung Adenocarcinoma AJCC v7,1
24738,Tissue Differentiation Uncertain,Distal-Type Epithelioid Sarcoma,1
24739,Malignant Cellular Infiltrate,Stage IB Gastric Carcinoma,1
24740,Low Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor G2,1
24741,Vascular Channel Formation,Radiation-Related Angiosarcoma,1
24742,Benign Cellular Infiltrate,Grade 1 Ovarian Teratoma,1
24743,Malignant Cellular Infiltrate,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion",1
24744,Epithelial Component Present,Stage IV Oral Cavity Cancer AJCC v6 and v7,1
24745,Radiation Sickness,"Leukemia, Radiation-Induced",1
24746,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
24747,Nodular Pattern,Medulloblastoma with extensive nodularity,1
24748,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
24749,Malignant Cellular Infiltrate,Colon Cribriform Comedo-Type Adenocarcinoma,1
24750,Malignant Cellular Infiltrate,carcinosarcoma of gallbladder,1
24751,Benign Cellular Infiltrate,Pilomatrixoma,1
24752,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
24753,Storiform Growth Pattern,Resectable Undifferentiated Pleomorphic Sarcoma,1
24754,Immunologic Deficiency Syndromes,AIDS-Related Cervical Kaposi Sarcoma,1
24755,Malignant Cellular Infiltrate,Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8,1
24756,Carcinomatous Component Present,Advanced Adult Hepatocellular Carcinoma,1
24757,Epithelial Component Present,Stage I Anal Canal Cancer AJCC v6 and v7,1
24758,Cystic Change,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
24759,Malignant Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v8,1
24760,Epithelial Component Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
24761,Indolent Clinical Course,Cavernous lymphangioma,1
24762,Papillary Pattern,Bladder Papillary Clear Cell Adenocarcinoma,1
24763,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8,1
24764,Acinar Cell Differentiation,Pancreatic Acinar Cell Neoplasm,1
24765,Epithelial Component Present,Hereditary Diffuse Gastric Adenocarcinoma,1
24766,Cystic Change,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
24767,Malignant Cellular Infiltrate,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
24768,Recurrent disease,Acute lymphoblastic leukemia recurrent,1
24769,Epithelial Component Present,Gallbladder Papillomatosis,1
24770,In Situ Lesion,Carcinoma in situ of ampulla of Vater,1
24771,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Clinical Stage,1
24772,Malignant Cellular Infiltrate,Secondary Prostate Urothelial Carcinoma,1
24773,Carcinomatous Component Present,Squamous Cell Bile Duct Carcinoma,1
24774,Malignant Cellular Infiltrate,Stage II Nasal Cavity Cancer AJCC v6 and v7,1
24775,Alternative Fascicle (Bundle) Pattern,Gastric Leiomyoma,1
24776,Carcinomatous Component Present,Pancreatic Cancer by AJCC v8 Stage,1
24777,Perivascular Arrangement of Tumor Cells,Glomangioma of skin,1
24778,Malignant Cellular Infiltrate,sarcoma of lung,1
24779,Carcinomatous Component Present,Squamous cell carcinoma in situ with questionable stromal invasion,1
24780,Epithelial Component Present,Serous adenofibroma,1
24781,Malignant Cellular Infiltrate,Stage 0 Major Salivary Gland Cancer AJCC v8,1
24782,Epithelial Component Present,Non-Small Cell Lung Carcinoma,1
24783,Carcinomatous Component Present,Squamous cell carcinoma of trachea,1
24784,Local disease,Epidural Spinal Canal Angiolipoma,1
24785,Tissue Differentiation Uncertain,Vulvar Superficial Angiomyxoma,1
24786,Diffuse Pattern,Recurrent Childhood Fibrillary Astrocytoma,1
24787,Contiguous Disease,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
24788,Malignant Cellular Infiltrate,Recurrent Non-Hodgkin Lymphoma,1
24789,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Reactive systemic amyloidosis,1
24790,Enterochromaffin-Like Type Granules Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
24791,Carcinomatous Component Present,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
24792,Malignant Cellular Infiltrate,Advanced Cutaneous Melanoma of the Extremity,1
24793,Secondary Lesion,Metastatic Adrenal Cortex Carcinoma,1
24794,Recurrent disease,Recurrent Fallopian Tube Carcinoma,1
24795,Carcinomatous Component Present,Locally Advanced Microsatellite Stable Colorectal Carcinoma,1
24796,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v7,1
24797,Biphasic Pattern,Ovarian Clear Cell Adenofibroma,1
24798,High Mitotic Activity,Ampulla of Vater Neuroendocrine Carcinoma,1
24799,Epithelial Component Present,Breast adenoma,1
24800,Pseudopapillary Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
24801,Malignant Cellular Infiltrate,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
24802,Immunologic Deficiency Syndromes,AIDS-Related Lymphoblastic Lymphoma,1
24803,Malignant Cellular Infiltrate,Clear cell odontogenic carcinoma,1
24804,Thyroglobulin Positive Neoplastic Cells Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
24805,Chromogranin A Positive Neoplastic Cells Present,Uterine Corpus Carcinoid Tumor,1
24806,Carcinomatous Component Present,"Lung Large Cell Carcinoma, Clear Cell Variant",1
24807,Epithelial Component Present,Borderline Ovarian Endometrioid Adenofibroma,1
24808,Systemic disease,Adult Systemic Anaplastic Large Cell Lymphoma,1
24809,Benign Cellular Infiltrate,Colon Ganglioneuroma,1
24810,Cutaneous Involvement,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
24811,Malignant Cellular Infiltrate,Hairy Cell Leukemia,1
24812,Malignant Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia,1
24813,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Clinical Stage,1
24814,"Amorphus, Eosinophilic, and Acellular Deposit",Recurrent Primary Amyloidosis,1
24815,Malignant Cellular Infiltrate,leiomyosarcoma of anus,1
24816,Cutaneous Involvement,"Xeroderma pigmentosum, group B",1
24817,Malignant Cellular Infiltrate,Stage 0 Pancreatic Cancer AJCC v8,1
24818,Carcinomatous Component Present,Hepatic cancer metastatic,1
24819,Malignant Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
24820,Epithelial Component Present,Malignant Pancreatic Vipoma,1
24821,Well-Circumscribed Lesion,Osteoid osteoma,1
24822,Nerve palsy,Abducens Nerve Palsy,1
24823,Epithelial Component Present,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,1
24824,Malignant Cellular Infiltrate,Grade 2 Clear Cell Renal Cell Carcinoma,1
24825,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Stage,1
24826,Malignant Cellular Infiltrate,Stage I Bone Cancer AJCC v7,1
24827,Collagenous Stroma Formation,Vaginal Myofibroblastoma,1
24828,Absence of Invasion,Carcinoma in situ of middle ear,1
24829,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
24830,More than 10 Mitoses per 10HPF,Platinum-Resistant Lung Small Cell Carcinoma,1
24831,Thin Bands of Collagen Present,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
24832,Carcinomatous Component Present,Oncocytic Breast Carcinoma,1
24833,Malignant Cellular Infiltrate,EZB Diffuse Large B-Cell Lymphoma,1
24834,Premalignant Lesion,Pulmonary Lymphomatoid Granulomatosis,1
24835,Lesion with Diameter Less than 11mm,Small Size Posterior Uveal Melanoma,1
24836,Poorly Differentiated Lesion,Oropharyngeal Poorly Differentiated Carcinoma,1
24837,Cutaneous Involvement,Trichofolliculoma,1
24838,Neuroendocrine Differentiation,Unresectable Carcinoid Tumor,1
24839,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
24840,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Polystotic",1
24841,Mucoid Stroma Formation,Mucinous carcinoma of breast,1
24842,Mucoid Stroma Formation,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
24843,Diffuse Pattern,MCD Diffuse Large B-Cell Lymphoma,1
24844,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
24845,Osseous Differentiation,Primary Bone Osteosarcoma,1
24846,Anaplasia,Rectal Sarcomatoid Carcinoma,1
24847,Papillary Pattern,Cervical Squamotransitional Carcinoma,1
24848,Low Mitotic Activity,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
24849,Microvascular Proliferation,Brain Glioblastoma,1
24850,Nuclear pleomorphism,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
24851,Dysplasia,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
24852,Multinodular Mass,"Dermatofibrosarcoma Protuberans, Myxoid",1
24853,Carcinomatous Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7,1
24854,Carcinomatous Component Present,Maxillary Sinus Adenoid Cystic Carcinoma,1
24855,Absence of Invasion,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7,1
24856,Multifocal Lesion,Vestibular Micropapillomatosis,1
24857,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Pulmonary Artery Choriocarcinoma,1
24858,Epithelial Component Present,Breast Carcinoma with Choriocarcinomatous Features,1
24859,Chronic lymphocytic inflammation,Inflammatory pseudotumor of liver,1
24860,Chromogranin A Positive Neoplastic Cells Present,Gastric Carcinoid Tumor,1
24861,Cystic Change,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,1
24862,High Mitotic Activity,Stage IB Merkel Cell Carcinoma AJCC v7,1
24863,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8,1
24864,Secondary Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,1
24865,Neuroendocrine Differentiation,Stage II Lung Small Cell Carcinoma AJCC v7,1
24866,Well Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor G2,1
24867,Carcinomatous Component Present,Breast Cancer by AJCC v7 Stage,1
24868,Carcinomatous Component Present,Stage I Skin Cancer,1
24869,Neuroendocrine Differentiation,Minor Salivary Gland Small Cell Carcinoma,1
24870,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v7,1
24871,Monomorphic Cellular Infiltrate,Adult Brain Oligodendroglioma,1
24872,Syncytial Pattern,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
24873,Benign Cellular Infiltrate,Angioma serpiginosum,1
24874,Childhood Lesion,Pediatric nodal marginal zone lymphoma,1
24875,Epithelial Component Present,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
24876,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma recurrent,1
24877,Nuclear Grooves,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
24878,Ineffective hematopoiesis,Refractory Thrombocytopenia,1
24879,Unfavorable Clinical Outcome,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",1
24880,Single Cell Necrosis,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
24881,Malignant Cellular Infiltrate,Mesenchymal Chondrosarcoma,1
24882,Tubular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
24883,Severe dysplasia,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,1
24884,Lobulated Growth Pattern,Pyogenic granuloma of skin and subcutaneous tissue,1
24885,Hormonal resistance,Hormone-Resistant Prostate Carcinoma,1
24886,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Cancer AJCC v8,1
24887,Benign Cellular Infiltrate,Benign neoplasm of pleura,1
24888,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Skin,1
24889,Carcinomatous Component Present,Disseminated squamous cell carcinoma,1
24890,Epithelial Component Present,Appendix Tubular Carcinoid,1
24891,Honeycomb Pattern,Brain Oligodendroglioma,1
24892,Epithelial Component Present,Tumor of the Thecoma/Fibroma Group,1
24893,Cutaneous Involvement,Malignant tumor of epidermal appendage,1
24894,Malignant Cellular Infiltrate,FIGO Stage IIIA1(i) Ovarian Cancer,1
24895,Rapidly Enlarging Mass,Childhood Embryonal Rhabdomyosarcoma,1
24896,Epithelial Component Present,Glomerulosa Cell Adrenal Cortical Adenoma,1
24897,Malignant Cellular Infiltrate,Laryngeal Basaloid Carcinoma,1
24898,Primary Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
24899,Malignant Cellular Infiltrate,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
24900,Thick-Walled Hyalinized Vessels Present,Gastric Schwannoma,1
24901,Mixed Cellular Population,Mixed epithelial tumor of ovary,1
24902,Carcinomatous Component Present,squamous cell carcinoma of ovary,1
24903,Epithelial Component Present,Cervical Esophagus Squamous Cell Carcinoma,1
24904,Malignant Cellular Infiltrate,sarcoma of trachea,1
24905,Malignant Cellular Infiltrate,Stage III Skin Cancer,1
24906,High Grade Lesion,Pleomorphic Rhabdomyosarcoma,1
24907,Malignant Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
24908,Malignant Cellular Infiltrate,"Intraocular melanoma, spindle cell",1
24909,Severe cytologic atypia,Metastatic Gastric Neuroendocrine Carcinoma,1
24910,Malignant Cellular Infiltrate,Stage IB Vulvar Carcinoma AJCC v6,1
24911,Osseous Differentiation,Stage II Osteosarcoma AJCC v7,1
24912,Cutaneous Involvement,Unresectable Skin Squamous Cell Carcinoma,1
24913,Malignant Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v7 Stage,1
24914,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2,1
24915,Benign Cellular Infiltrate,Benign Apocrine Neoplasm,1
24916,Epithelial Component Present,Carcinoid tumor of the liver,1
24917,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Poorly Differentiated Neuroblastoma,1
24918,Hyalinized Stroma Formation,Cardiac Epithelioid Hemangioendothelioma,1
24919,Epithelial Component Present,Small intestine carcinoma metastatic,1
24920,Well Differentiated Neuroendocrine Lesion,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
24921,Carcinomatous Component Present,Pancreatic adenocarcinoma recurrent,1
24922,Malignant Cellular Infiltrate,Stage IIIA Gastric Carcinoma,1
24923,Fibrotic Stroma Formation,Classical Low Grade Fibromyxoid Sarcoma,1
24924,Malignant Cellular Infiltrate,Adenocarcinoma of rete ovarii,1
24925,Epithelial Component Present,Small cell lung cancer extensive stage,1
24926,Cystic Change,Mucinous cystadenofibroma,1
24927,Epithelial Component Present,Stage I Hepatocellular Carcinoma AJCC v6 and v7,1
24928,Indolent Clinical Course,Cardiac Cavernous Hemangioma,1
24929,Metastatic Lesion,Secondary Heart Lymphoma,1
24930,Carcinomatous Component Present,Pancreatic Medullary Carcinoma,1
24931,Diffuse Pattern,Stage I Adult Immunoblastic Lymphoma,1
24932,Lobulated Growth Pattern,Chordoma of clivus,1
24933,Epithelial Component Present,Stage II Thymoma AJCC v8,1
24934,Malignant Cellular Infiltrate,Smoldering myeloma,1
24935,Cystic Change,Benign cystic nephroma,1
24936,Hyperplastic Tissue Present,Parathyroid Clear Cell Hyperplasia,1
24937,Low Mitotic Activity,Stage III Jejunal Neuroendocrine Tumor AJCC v8,1
24938,Carcinomatous Component Present,Recurrent Adult Hepatocellular Carcinoma,1
24939,Refractory Disease,Chronic lymphocytic leukemia refractory,1
24940,Below the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,1
24941,Metastatic Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
24942,Primary Lesion,Lentigo maligna recurrent,1
24943,Malignant Cellular Infiltrate,CIC-DUX Sarcoma,1
24944,Malignant Cellular Infiltrate,Skin Squamous Cell Carcinoma In Situ,1
24945,Stromal Invasion,Ovarian mixed epithelial carcinoma,1
24946,Carcinomatous Component Present,Basal-Like Prostate Carcinoma,1
24947,Epithelial Component Present,Stage I Prostate Carcinoma,1
24948,Below the Diaphragm Disease,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
24949,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Gene Mutation,1
24950,Benign Cellular Infiltrate,Cardiac hemangioma,1
24951,Carcinomatous Component Present,Metastatic Adenoid Cystic Carcinoma,1
24952,Malignant Cellular Infiltrate,Smoldering myeloma,1
24953,Malignant Cellular Infiltrate,Refractory anemia with excess blasts II,1
24954,Adulthood Lesion,Lugano Classification Adult Lymphoma by AJCC v8 Stage,1
24955,Carcinomatous Component Present,Vaginal Adenoid Cystic Carcinoma,1
24956,Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells,Non-IgM Monoclonal Gammopathy of Undetermined Significance,1
24957,Carcinomatous Component Present,Colorectal Signet Ring Cell Carcinoma,1
24958,High Mitotic Activity,Platinum-Sensitive Lung Small Cell Carcinoma,1
24959,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage IV,1
24960,Well Differentiated Neuroendocrine Lesion,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
24961,Malignant Cellular Infiltrate,Malignant neoplasm of soft palate,1
24962,Epithelial Component Present,Gastric Pylorus Carcinoma,1
24963,Malignant Cellular Infiltrate,"Carcinoma, Granular Cell",1
24964,Carcinomatous Component Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
24965,Cutaneous Involvement,Cutaneous sarcoidosis,1
24966,Indolent Clinical Course,Fibrous Hamartoma of Infancy,1
24967,Dysplasia,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
24968,Necrotic changes (finding),large cell neuroendocrine carcinoma of thymus,1
24969,Adulthood Lesion,Adult Choroid Plexus Neoplasm,1
24970,Retiform Structures Comprise 90% or More of the Tumor,Ovarian Retiform Sertoli-Leydig Cell Tumor,1
24971,Refractory Disease,Refractory Neurofibromatosis Type 1,1
24972,Epithelial Component Present,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma,1
24973,Microcystic Change,Sclerosing Polycystic Adenosis,1
24974,Well-Circumscribed Lesion,Central Nervous System Rhabdomyoma,1
24975,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v8,1
24976,Malignant Cellular Infiltrate,Anaplastic Brain Stem Glioma,1
24977,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
24978,Stromal Invasion,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
24979,Steatohepatitis,Inflammatory Hepatocellular Adenoma,1
24980,Metastatic Lesion,Advanced Cutaneous Melanoma of the Extremity,1
24981,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,1
24982,Vascular Channel Formation,Intracortical osteosarcoma,1
24983,Epithelial Component Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
24984,Epithelial Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v8,1
24985,Benign Cellular Infiltrate,Maxillary Sinus Inverted Papilloma,1
24986,Anaplasia,Chondroblastic osteosarcoma,1
24987,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
24988,Invasive Lesion,Breast Carcinoma with Osseous Metaplasia,1
24989,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides refractory,1
24990,Poorly Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Carcinoma,1
24991,High Mitotic Activity,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
24992,Malignant Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma of the Cervix,1
24993,Metastatic Lesion,Colon Carcinoma Metastatic in the Liver,1
24994,Epithelial Component Present,Hidroacanthoma simplex,1
24995,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck by AJCC v7 Stage,1
24996,Epithelial Component Present,Childhood Small Intestinal Carcinoma,1
24997,Villous Pattern,Cervical Villoglandular Adenocarcinoma,1
24998,Vascular Channel Formation,Cardiac hemangioma,1
24999,Pseudostratified Tumor Cells Present,"Endocervical Adenocarcinoma, Usual Type",1
25000,Carcinomatous Component Present,Recurrent Pancreatic Ductal Adenocarcinoma,1
25001,Increased Cellularity Present,Ependymoblastoma,1
25002,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,1
25003,Carcinomatous Component Present,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,1
25004,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v7,1
25005,Unresectable Mass,Unresectable Renal Pelvis Urothelial Carcinoma,1
25006,Rapidly Enlarging Mass,Sclerosing rhabdomyosarcoma,1
25007,Malignant Cellular Infiltrate,small cell carcinoma of ureter,1
25008,Carcinomatous Component Present,Colorectal Sarcomatoid Carcinoma,1
25009,Malignant Cellular Infiltrate,Metaplastic carcinoma of breast,1
25010,Benign Cellular Infiltrate,Soft tissue chondroma,1
25011,Biphasic Pattern,Malignant Vulvar Phyllodes Tumor,1
25012,Malignant Cellular Infiltrate,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
25013,Recurrent disease,Recurrent Digestive System Carcinoma,1
25014,Refractory Disease,Refractory Primary Cutaneous Lymphoma,1
25015,Hyalinized Vessels Present,Juvenile Pilocytic Astrocytoma,1
25016,Recurrent disease,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
25017,Human Papillomavirus Negative,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
25018,Increased Cellularity Present,Juvenile fibroadenoma of breast,1
25019,Malignant Cellular Infiltrate,Anaplastic adrenocortical carcinoma,1
25020,Mild dysplasia,"Glandular intraepithelial neoplasia, low grade",1
25021,Benign Cellular Infiltrate,Multiple Lobular Capillary Hemangiomas,1
25022,Cutaneous Involvement,Glomus tumor of skin,1
25023,Primary Lesion,Early Hepatocellular Carcinoma,1
25024,Malignant Cellular Infiltrate,Testicular embryonal carcinoma,1
25025,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma recurrent,1
25026,Cutaneous Involvement,Primary cutaneous diffuse large cell B-cell lymphoma,1
25027,In Situ Lesion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
25028,Malignant Cellular Infiltrate,Asynchronous Multifocal Osteosarcoma,1
25029,Benign Cellular Infiltrate,Parathyroid transitional clear cell adenoma,1
25030,Cutaneous Involvement,Stage III Lip Basal Cell Carcinoma,1
25031,Diffuse Pattern,Central Nervous System Intravascular Large B-Cell Lymphoma,1
25032,Vascular Channel Formation,Vulvar Superficial Angiomyxoma,1
25033,Malignant Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v7,1
25034,Diffuse Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,1
25035,Carcinomatous Component Present,Parotid Gland Undifferentiated Carcinoma,1
25036,Encapsulated Mass,Thyroid Gland Oncocytic Adenoma,1
25037,Malignant Cellular Infiltrate,Stage II Malignant Mediastinal Germ Cell Tumor,1
25038,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Accelerated Phase",1
25039,Argentaffin Positive Neoplastic Cells Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
25040,Neuroendocrine Differentiation,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
25041,Malignant Cellular Infiltrate,Stage I Liver Carcinoma,1
25042,Diffuse Pattern,Recurrent Childhood Protoplasmic Astrocytoma,1
25043,Tissue of Mullerian Origin Present,Ovarian Mucinous Adenofibroma,1
25044,Cutaneous Involvement,Corn of toe,1
25045,Pushing Tumor Margin,Anal Verrucous Carcinoma,1
25046,Intraductal Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",1
25047,Malignant Cellular Infiltrate,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
25048,Malignant Cellular Infiltrate,Small Intestinal B-Cell Non-Hodgkin Lymphoma,1
25049,Malignant Cellular Infiltrate,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
25050,Fibrosis,Breast Sclerosing Adenosis,1
25051,Infiltrative Growth Pattern,Mesenchymal Glioblastoma,1
25052,Gastrin Positive Neoplastic Cells Present,"Gastrinoma, malignant",1
25053,Indolent Clinical Course,Rhabdomyoma,1
25054,Intracanalicular Growth Pattern,Intracanalicular fibroadenoma,1
25055,Malignant Cellular Infiltrate,Anatomic Stage IA Breast Cancer AJCC v8,1
25056,Necrotic changes (finding),Small cell carcinoma of the cervix,1
25057,Epithelial Component Present,Acinar Cell Carcinoma,1
25058,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,1
25059,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum,1
25060,Epithelial Component Present,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
25061,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Smoldering myeloma,1
25062,Carcinomatous Component Present,Stage III Renal Pelvis Cancer AJCC v7,1
25063,Regional Disease,Locally Advanced Microsatellite Stable Colorectal Carcinoma,1
25064,Peripheral Blood Involvement,Sezary Syndrome,1
25065,Benign Cellular Infiltrate,Benign phyllodes neoplasm of breast,1
25066,Malignant Cellular Infiltrate,Gallbladder Neuroendocrine Carcinoma,1
25067,Primary Lesion,Refractory Primary Effusion Lymphoma,1
25068,Diffuse Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,1
25069,Carcinomatous Component Present,Ear carcinoma,1
25070,Adulthood Lesion,Adult Systemic Anaplastic Large Cell Lymphoma,1
25071,Carcinomatous Component Present,Stage III Small Intestinal Adenocarcinoma AJCC v8,1
25072,Lymphadenopathy,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
25073,Neuroendocrine Differentiation,Regional Adrenal Gland Pheochromocytoma,1
25074,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH,1
25075,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage II,1
25076,CD56-Positive Neoplastic Cells Present,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,1
25077,Necrotic changes (finding),Digestive System Large Cell Neuroendocrine Carcinoma,1
25078,Recurrent disease,Recurrent Childhood Acute Lymphoblastic Leukemia,1
25079,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
25080,Malignant Cellular Infiltrate,Eccrine ductal carcinoma,1
25081,Metastatic Lesion,Metastatic Pharyngeal Carcinoma,1
25082,Indolent Clinical Course,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,1
25083,Neuroendocrine Differentiation,Superior and Inferior Paraaortic Paraganglioma,1
25084,Malignant Cellular Infiltrate,PNET of bone localized,1
25085,Mixed Cellular Population,Fallopian Tube Adenosarcoma,1
25086,Epithelial Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
25087,Malignant Cellular Infiltrate,Carcinoma of Male Breast,1
25088,Peripheral Nuclear Palisading,Metastatic Lung Small Cell Carcinoma,1
25089,Epithelial Component Present,Squamous intraepithelial lesion,1
25090,Dysplasia,adenoma of intrahepatic bile duct,1
25091,Malignant Cellular Infiltrate,Vulvar Adenocarcinoma of Mammary Gland Type,1
25092,Malignant Cellular Infiltrate,Classic medulloblastoma,1
25093,Indolent Clinical Course,Oral Cavity Monomorphic Adenoma,1
25094,Myxoid Stroma Formation,Ameloblastic fibroma,1
25095,Carcinomatous Component Present,Vulvar Adenocarcinoma of Mammary Gland Type,1
25096,Malignant Cellular Infiltrate,Bladder Papillary Urothelial Carcinoma,1
25097,Carcinomatous Component Present,Tubular breast carcinoma,1
25098,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma,1
25099,Well-Circumscribed Lesion,Colonic Polyps,1
25100,Malignant Cellular Infiltrate,Renal Pelvis Cancer by AJCC v7 Stage,1
25101,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
25102,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Neutropenia,1
25103,Diffuse Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,1
25104,Malignant Cellular Infiltrate,Malignant Cystosarcoma Phyllodes,1
25105,Metastatic Lesion,Locally Advanced Digestive System Carcinoma,1
25106,Benign Cellular Infiltrate,Vulvar Leiomyoma,1
25107,Mitotic Activity,Adult Brain Stem Gliosarcoma,1
25108,Nodular lesions,Thyroid Gland Lipoadenoma,1
25109,Tissue Differentiation Uncertain,Childhood Synovial Sarcoma,1
25110,Lobulated Growth Pattern,Mediastinal Chondroma,1
25111,Epithelial Component Present,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
25112,Epithelial Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
25113,Recurrent disease,Recurrent Male Reproductive System Carcinoma,1
25114,Vascular Channel Formation,Deep Hemangioma,1
25115,Cutaneous Involvement,Vulvar Blue Nevus,1
25116,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Somatotroph/Lactotroph Adenoma,1
25117,CD1a-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
25118,Benign Cellular Infiltrate,Mature Gastric Teratoma,1
25119,Diffuse Pattern,Recurrent Grade III Lymphomatoid Granulomatosis,1
25120,Carcinomatous Component Present,Gastric Small Cell Carcinoma,1
25121,Cutaneous Involvement,Skin squamous cell carcinoma recurrent,1
25122,Unresectable Mass,Unresectable Liposarcoma,1
25123,Mixed Cellular Population,Mucinous adenofibroma,1
25124,Malignant Cellular Infiltrate,Refractory High Risk Myelodysplastic Syndrome,1
25125,Localized Lesion,Chondrosarcoma localised,1
25126,Carcinomatous Component Present,"Malignant Mixed Tumor, Not Otherwise Specified",1
25127,Indolent Clinical Course,Trichodiscoma,1
25128,Neuroendocrine Differentiation,small cell carcinoma of appendix,1
25129,Anaplasia,Childhood Gliosarcoma,1
25130,Precise Histogenesis Unknown,Peripheral Hemangioblastoma,1
25131,Angiocentric Pattern,Recurrent Grade III Lymphomatoid Granulomatosis,1
25132,Epithelial Component Present,Stage IV Ureter Cancer AJCC v7,1
25133,Adulthood Lesion,Indolent Adult Non-Hodgkin Lymphoma,1
25134,Non-Invasive Lesion,Low-grade intraurothelial neoplasia,1
25135,Malignant Cellular Infiltrate,Dedifferentiated Solitary Fibrous Tumor,1
25136,Recurrent disease,Recurrent Acute Leukemia,1
25137,Intraductal Lesion,Intraductal Breast Papillomatosis,1
25138,Invasive Lesion,Bladder transitional cell carcinoma stage III,1
25139,Diffuse Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,1
25140,Secondary Lesion,"Glioblastoma, IDH-Mutant",1
25141,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v8,1
25142,Epithelial Component Present,Carcinoma of lower gum,1
25143,Slow Growing Mass,Dedifferentiated chordoma,1
25144,Immature Myeloid Cells Increased in Bone Marrow,Benzene-Related Acute Myeloid Leukemia,1
25145,Hemorrhagic,Ovarian Angiosarcoma,1
25146,Benign Cellular Infiltrate,Ovarian Fibromata,1
25147,Epithelial Component Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
25148,Chronic Inflammatory Infiltrate,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
25149,Collagenous Stroma Formation,Vulvar Superficial Myofibroblastoma,1
25150,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Columnar Cell Change of the Breast,1
25151,Epithelial Component Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
25152,Epithelial Component Present,Testicular Thecoma,1
25153,Microvascular Proliferation,Mesenchymal Glioblastoma,1
25154,Malignant Cellular Infiltrate,Stage IIIB Testicular Cancer AJCC v8,1
25155,Sarcomatous Component Present,Carcinosarcoma,1
25156,Malignant Cellular Infiltrate,Refractory Malignant Endocrine Neoplasm,1
25157,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v8,1
25158,Cutaneous Involvement,Diaper candidiasis,1
25159,Epithelial Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
25160,Clinical TNM Finding,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
25161,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma,1
25162,Proliferation of Small Ducts Present,adenoma of intrahepatic bile duct,1
25163,Malignant Cellular Infiltrate,Ki-1+ Anaplastic Large Cell Lymphoma,1
25164,Low Grade Lesion,Congenital Mesoblastic Nephroma,1
25165,Infantile Lesion,Infant Acute Undifferentiated Leukemia,1
25166,Intraductal Lesion,Intrahepatic Bile Duct Papillary Neoplasm,1
25167,Clinical TNM Finding,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
25168,Malignant Cellular Infiltrate,Stage 1 Neuroblastoma,1
25169,Benign Cellular Infiltrate,Oral Cavity Leiomyoma,1
25170,Epithelial Component Present,Bile duct clear cell adenocarcinoma,1
25171,Mucoid Stroma Formation,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
25172,Malignant Cellular Infiltrate,Stage II Vaginal Cancer AJCC v6 and v7,1
25173,Exophytic Polypoid Lesion,Uterine Polyp,1
25174,In Situ Lesion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
25175,Peripheral Nuclear Palisading,combined small cell carcinoma of lung,1
25176,Carcinomatous Component Present,Stage IVA Appendix Carcinoma AJCC v8,1
25177,Non-Invasive Lesion,Papillary transitional cell neoplasm of low malignant potential,1
25178,Prominent Stromal Reaction,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
25179,Well Differentiated Lesion,Cervical Squamotransitional Carcinoma,1
25180,Epithelial Component Present,Ampulla of Vater Cancer by AJCC v7 Stage,1
25181,Anaplasia,Multifocal Glioblastomas,1
25182,Multifocal Lesion,Lipoblastomatosis,1
25183,Mixed Cellular Population,Mixed Oligodendroglioma-Astrocytoma,1
25184,Epithelial Component Present,Cervical intraepithelial neoplasia grade 1,1
25185,Well Differentiated Neuroendocrine Lesion,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
25186,Benign Cellular Infiltrate,Pericardial Leiomyoma,1
25187,Childhood Lesion,Childhood Ovarian Choriocarcinoma,1
25188,Epithelial Component Present,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,1
25189,Epithelial Component Present,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
25190,Primary Lesion,Ethmoid Sinus Primary Ectopic Meningioma,1
25191,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Ganglioneuroblastoma, Intermixed",1
25192,Epithelial Component Present,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
25193,Malignant Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
25194,Primary Lesion,Refractory Primary Effusion Lymphoma,1
25195,Malignant Cellular Infiltrate,Malignant neoplasm of bronchus,1
25196,Secondary Lesion,Testicular cancer metastatic,1
25197,Vascular Channel Formation,Vulvar Superficial Angiomyxoma,1
25198,Nodules of Compact Keratin Present,Adamantinous Craniopharyngioma,1
25199,Epithelial Component Present,Colorectal Medullary Carcinoma,1
25200,Refractory Disease,Refractory Malignant Thymoma,1
25201,Severe dysplasia,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",1
25202,Vascular Channel Formation,Cardiac Intramuscular Hemangioma,1
25203,Carcinomatous Component Present,Throat cancer,1
25204,Cutaneous Involvement,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8,1
25205,Malignant Cellular Infiltrate,Testicular Monophasic Choriocarcinoma,1
25206,Malignant Cellular Infiltrate,Malignant Parotid Gland Mixed Tumor,1
25207,Malignant Cellular Infiltrate,Oropharyngeal Carcinoma by AJCC v7 Stage,1
25208,Intraocular Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
25209,Epithelial Component Present,Intraepithelial Squamous Cell Carcinoma,1
25210,Carcinomatous Component Present,Carcinoma of glottis,1
25211,Malignant Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v7,1
25212,Carcinomatous Component Present,Recurrent Uterine Corpus Carcinosarcoma,1
25213,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,choriocarcinoma of mediastinum,1
25214,Invasive Lesion,Bladder transitional cell carcinoma stage IV,1
25215,Fibrotic Stroma Formation,Nasopharyngeal Angiofibroma,1
25216,Carcinomatous Component Present,Basal-Like Prostate Carcinoma,1
25217,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage III,1
25218,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
25219,Metastatic Lesion,Metastatic Genitourinary System Carcinoma,1
25220,Vascular Channel Formation,Vascular neoplasm of skin,1
25221,Splenomegaly,"Leukemia, Myeloid, Chronic-Phase",1
25222,Carcinomatous Component Present,Primary Peritoneal High Grade Serous Adenocarcinoma,1
25223,Collagenous Stroma Formation,Vulvar Angiomyofibroblastoma,1
25224,Radiation Sickness,Radiation-Induced Intracranial Meningioma,1
25225,Malignant Cellular Infiltrate,Malignant Head and Neck Neoplasm,1
25226,Severe dysplasia,Stage 0 Vulvar Cancer,1
25227,Adnexal Differentiation,Vulvar Neoplasm of Skin Appendage Origin,1
25228,Lymphoplasmacytic Infiltrate,Oropharyngeal lymphoepithelioma stage III,1
25229,Malignant Cellular Infiltrate,Squamous cell carcinoma of nasopharynx,1
25230,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
25231,Pregnancy Complications,Stage IV Gestational Trophoblastic Tumor AJCC v7,1
25232,Cutaneous Involvement,Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage,1
25233,Malignant Cellular Infiltrate,Rhabdomyosarcoma of cervix uteri,1
25234,Carcinomatous Component Present,Recurrent Submandibular Gland Carcinoma,1
25235,Cutaneous Involvement,Hemangioendothelioma of skin,1
25236,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma,1
25237,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of breast,1
25238,Childhood Lesion,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement,1
25239,Malignant Cellular Infiltrate,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
25240,Malignant Cellular Infiltrate,Colon Sarcoma,1
25241,Epithelial Component Present,Stage IIIB Anal Cancer AJCC v8,1
25242,Severe cytologic atypia,Gallbladder Neuroendocrine Carcinoma,1
25243,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage III,1
25244,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Carcinosarcoma,1
25245,Epithelial Component Present,Non-squamous non-small cell lung cancer,1
25246,Carcinomatous Component Present,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
25247,Metastatic Lesion,Metastatic Benign Neoplasm,1
25248,Well-Circumscribed Lesion,Calcifying Fibrous Pseudotumor,1
25249,Malignant Cellular Infiltrate,Renal cell carcinoma recurrent,1
25250,Malignant Cellular Infiltrate,Plantar Verrucous Skin Carcinoma,1
25251,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
25252,Malignant Cellular Infiltrate,Malignant tumor of external ear,1
25253,Cutaneous Involvement,Minimal Deviation Melanoma,1
25254,Neuroendocrine Differentiation,Small Intestinal VIP-Producing Neuroendocrine Tumor,1
25255,Epithelial Component Present,Hard Palate Pleomorphic Adenoma,1
25256,Benign Cellular Infiltrate,Senile hemangioma of lip,1
25257,Epithelial Component Present,Localized Unresectable Adult Hepatocellular Carcinoma,1
25258,Malignant Cellular Infiltrate,Metastatic Colon Carcinoma,1
25259,Acanthosis,Condyloma anal,1
25260,Seizures,Dysembryoplastic neuroepithelial tumor,1
25261,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
25262,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern",1
25263,Benign Cellular Infiltrate,benign mature teratoma of pancreas,1
25264,Epithelial Component Present,Benign Basal Cell Neoplasm,1
25265,Indolent Clinical Course,Solitary Adult Fibroma,1
25266,Childhood Lesion,Refractory Cytopenia of Childhood,1
25267,Adulthood Lesion,Adult Penile Carcinoma,1
25268,Malignant Cellular Infiltrate,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
25269,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
25270,Malignant Cellular Infiltrate,Recurrent Liver Carcinoma,1
25271,Infiltrative Growth Pattern,Childhood Cerebellar Anaplastic Astrocytoma,1
25272,Absence of Invasion,Carcinoma in situ in a polyp,1
25273,Epithelial Component Present,Resectable Renal Cell Carcinoma,1
25274,Malignant Cellular Infiltrate,Grade 2 Endometrial Endometrioid Adenocarcinoma,1
25275,Malignant Cellular Infiltrate,Stage IVC Colorectal Cancer AJCC v8,1
25276,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma of parotid gland,1
25277,Malignant Cellular Infiltrate,Stage IIIC Eyelid Carcinoma AJCC v7,1
25278,Secondary Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
25279,Epithelial Component Present,Metastatic Pharyngeal Carcinoma,1
25280,Diffuse Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
25281,Eccrine Differentiation,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
25282,High Mitotic Activity,Childhood Anaplastic Oligodendroglioma,1
25283,Malignant Cellular Infiltrate,Squamous cell carcinoma of floor of mouth,1
25284,Geographic Necrosis,Childhood Central Nervous System Embryonal Carcinoma,1
25285,Invasive Lesion,lipid-rich carcinoma of breast,1
25286,Stromal Invasion,Clear cell adenocarcinoma of ovary,1
25287,Epithelial Component Present,Anal Canal Small Cell Neuroendocrine Carcinoma,1
25288,Deep Lesion,Cardiac Intramuscular Hemangioma,1
25289,Carcinomatous Component Present,Fallopian Tube Gestational Choriocarcinoma,1
25290,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,1
25291,Malignant Cellular Infiltrate,Papillary serous cystadenocarcinoma,1
25292,High Mitotic Activity,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7,1
25293,Epithelial Component Present,Stage I Bladder Cancer AJCC v8,1
25294,Carcinomatous Component Present,Cervical Serous Adenocarcinoma,1
25295,Malignant Cellular Infiltrate,Stage 0 Ureter Cancer AJCC v7,1
25296,Cutaneous Involvement,Contact dermatitis due to acid,1
25297,Well-Circumscribed Lesion,Polyp of esophagus,1
25298,Dysplasia,Noninfiltrating Intraductal Carcinoma,1
25299,Mitotic Activity,"Anaplastic Astrocytoma, IDH-Mutant",1
25300,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
25301,Carcinomatous Component Present,"Papillary renal cell carcinoma, sporadic",1
25302,Infiltrative Growth Pattern,Grade III Childhood Astrocytoma,1
25303,Malignant Cellular Infiltrate,Testicular Typical Seminoma,1
25304,Somatostatin Positive Neoplastic Cells Present,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
25305,Syncytial Pattern,Nasopharyngeal lymphoepithelioma stage I,1
25306,Malignant Cellular Infiltrate,"Phosphaturic mesenchymal tumor, malignant",1
25307,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,carcinosarcoma of fallopian tube,1
25308,Epithelial Component Present,Ampulla of Vater Neuroendocrine Tumor G2,1
25309,Epithelial Component Present,Stage IIIC Rectal Cancer AJCC v8,1
25310,Slow Growing Mass,Adult Craniopharyngioma,1
25311,Congenital Lesion,Congenital hemangioma,1
25312,Benign Cellular Infiltrate,Melanoacanthoma,1
25313,Diarrhea,Pancreatic Vipoma,1
25314,Thick-Walled Vessels Present,Angiomyolipoma,1
25315,Malignant Cellular Infiltrate,Cervical Squamotransitional Carcinoma,1
25316,Neuroendocrine Differentiation,Superior and Inferior Paraaortic Paraganglioma,1
25317,Follicular Cell Differentiation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
25318,Metastatic Lesion,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
25319,Rapidly Enlarging Mass,Sclerosing rhabdomyosarcoma,1
25320,Edematous Stroma Formation,Vulvar Angiomyxoma,1
25321,Carcinomatous Component Present,Mixed Acinar-Ductal Carcinoma of the Pancreas,1
25322,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma,1
25323,Tissue Differentiation Uncertain,Liver Synovial Sarcoma,1
25324,Cystic Change,Cystic teratoma,1
25325,Carcinomatous Component Present,Carcinoma in situ of ampulla of Vater,1
25326,Malignant Cellular Infiltrate,"Carcinoma, Giant Cell",1
25327,Well Differentiated Lesion,Verrucous carcinoma of penis,1
25328,Bone Marrow Eosinophilia,"Acute myeloid leukemia, inv(16)(p13q22)",1
25329,Epithelial Component Present,Adenocarcinoma of the prostate metastatic,1
25330,Malignant Cellular Infiltrate,leiomyosarcoma of bone,1
25331,Epithelial Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
25332,Tubular Pattern,Apocrine adenoma,1
25333,Carcinomatous Component Present,Stage IVB Rectal Cancer AJCC v7,1
25334,Diffuse Pattern,oligodendroglioma,1
25335,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
25336,Eosinophilic inflammation,Histiocytoid hemangioma,1
25337,Epithelial Component Present,Childhood Carcinoid Tumor,1
25338,Malignant Cellular Infiltrate,Prostate Basal Cell Carcinoma,1
25339,Dystrophic calcification,Adamantinous Craniopharyngioma,1
25340,Pseudopapillary Pattern,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
25341,CD56-Positive Neoplastic Cells Present,Monomorphic epitheliotropic intestinal T-cell lymphoma,1
25342,Malignant Cellular Infiltrate,Leiomyosarcoma NCI Grade 3,1
25343,Vascular Channel Formation,Capillary hemangioma of retina,1
25344,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Cystadenofibroma,1
25345,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
25346,Epithelial Component Present,Refractory Digestive System Neuroendocrine Carcinoma,1
25347,Osseous Differentiation,Stage II Osteosarcoma AJCC v7,1
25348,Metastatic Lesion,Advanced Kaposi Sarcoma,1
25349,Malignant Cellular Infiltrate,Recurrent Digestive System Carcinoma,1
25350,Epithelial Component Present,Malignant Brenner Tumor,1
25351,Invasive Lesion,Scirrhous carcinoma of breast,1
25352,Follicular Cell Differentiation,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
25353,Indolent Clinical Course,benign myoepithelioma of salivary gland,1
25354,Papillary Pattern,Laryngeal verrucous carcinoma recurrent,1
25355,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
25356,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage I,1
25357,In Situ Lesion,Adenocarcinoma in situ in villous adenoma,1
25358,Epithelial Component Present,Stage I Vulvar Cancer AJCC v8,1
25359,Absence of Invasion,Stage 0 Breast Cancer AJCC v6 and v7,1
25360,More than 10 Mitoses per 10HPF,Small cell carcinoma of lung,1
25361,Malignant Cellular Infiltrate,Refractory Bile Duct Carcinoma,1
25362,Diffuse Lesion,Kasabach-Merritt syndrome,1
25363,Unresectable Mass,Unresectable Lymphoma,1
25364,Malignant Cellular Infiltrate,Cervical Warty Carcinoma,1
25365,Crystal deposition,Bladder Alveolar Soft Part Sarcoma,1
25366,Hyperkeratosis,Buccal Mucosa Verrucous Carcinoma,1
25367,Epithelial Component Present,Hepatocellular Carcinoma by BCLC Stage,1
25368,Nuclear Expression of STAT6 Protein,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
25369,Malignant Cellular Infiltrate,Malignant tumor of palate,1
25370,Malignant Cellular Infiltrate,"Squamous cell carcinoma, large cell, nonkeratinizing",1
25371,Refractory Disease,Refractory Adult Acute Lymphoblastic Leukemia,1
25372,Malignant Cellular Infiltrate,Metastatic Vaginal Carcinoma,1
25373,High Mitotic Activity,Testicular embryonal carcinoma stage II,1
25374,Refractory Disease,Intestinal T-cell lymphoma refractory,1
25375,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v7 Stage,1
25376,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
25377,Malignant Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v8,1
25378,Carcinomatous Component Present,Squamous cell carcinoma of head and neck metastatic,1
25379,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,1
25380,Fibrotic Stroma Formation,Resectable Pancreatic Ductal Adenocarcinoma,1
25381,Malignant Cellular Infiltrate,Stage IV Ovarian Carcinoma,1
25382,Carcinomatous Component Present,Grade 2 Rectal Adenocarcinoma,1
25383,Ganglion Cell-Like Elements Present,Ampulla of Vater Gangliocytic Paraganglioma,1
25384,Carcinomatous Component Present,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
25385,Malignant Cellular Infiltrate,Secondary malignant neoplasm of kidney,1
25386,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,1
25387,Somatostatin Positive Neoplastic Cells Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
25388,Malignant Cellular Infiltrate,Asynchronous Multifocal Osteosarcoma,1
25389,Epithelial Component Present,Ductal Breast Carcinoma,1
25390,Koilocytotic atypia,Human Papillomavirus-Related Verrucous Carcinoma,1
25391,Carcinomatous Component Present,Stage 0a Renal Pelvis Cancer AJCC v7,1
25392,Carcinomatous Component Present,Cervical Serous Adenocarcinoma,1
25393,Malignant Cellular Infiltrate,Malignant tumor of rectosigmoid junction,1
25394,Recurrent disease,Recurrent Childhood Astrocytic Tumor,1
25395,Solid Growth Pattern,Pleuropulmonary blastoma type III,1
25396,Epithelial Component Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8,1
25397,Deep Lesion,Infiltrating Intramuscular Lipoma,1
25398,Malignant Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v8,1
25399,Malignant Cellular Infiltrate,Cutaneous Follicular Lymphoma,1
25400,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage II,1
25401,Mixed Cellular Population,Malignant Submandibular Gland Mixed Tumor,1
25402,Epithelial Component Present,Carcinoma of lung,1
25403,Absence of Invasion,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
25404,Well-Circumscribed Lesion,Serous cystadenoma of ovary,1
25405,Epithelial Component Present,Stage IA Eyelid Carcinoma AJCC v8,1
25406,Carcinomatous Component Present,Acinar cell cystadenocarcinoma,1
25407,Malignant Cellular Infiltrate,Chordoma,1
25408,Recurrent disease,Recurrent Parotid Gland Undifferentiated Carcinoma,1
25409,Therapy-Related Toxicity,Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders,1
25410,Epithelial Component Present,Breast Carcinoma with Chondroid Metaplasia,1
25411,Severe dysplasia,Biliary Intraepithelial Neoplasia-3,1
25412,Microcystic Change,Subependymal Glioma,1
25413,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Adult Lymphoma AJCC v8,1
25414,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage II,1
25415,Poorly Differentiated Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
25416,Epithelial Component Present,Low Grade Fallopian Tube Serous Adenocarcinoma,1
25417,Low Mitotic Activity,Rectal Neuroendocrine Tumor,1
25418,Recurrent disease,Recurrent Fallopian Tube Serous Adenocarcinoma,1
25419,Villous Pattern,villous adenoma of stomach,1
25420,Cutaneous Involvement,Pityriasis Rubra Pilaris,1
25421,Diffuse Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
25422,Recurrent disease,Recurrent Extrahepatic Bile Duct Carcinoma,1
25423,Neuroendocrine Differentiation,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,1
25424,Epithelial Component Present,adenocarcinoma of oral cavity,1
25425,Capillary Sized Vascular Channel Formation,Solid Glomus Tumor,1
25426,Epithelial Component Present,Bladder transitional cell carcinoma stage IV,1
25427,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
25428,Tissue of Mullerian Origin Present,Mucinous cystadenofibroma,1
25429,Papillary Pattern,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
25430,Recurrent disease,Recurrent Adult Soft Tissue Sarcoma,1
25431,Benign Cellular Infiltrate,Elastofibroma,1
25432,Malignant Cellular Infiltrate,adenocarcinoma of middle ear,1
25433,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement,1
25434,Benign Cellular Infiltrate,intraductal papilloma of salivary gland,1
25435,Epithelial Component Present,Locally Advanced Squamous Cell Carcinoma,1
25436,Indolent Clinical Course,Chorioangioma,1
25437,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
25438,Pseudoglandular Pattern,Sellar Embryonal Carcinoma,1
25439,Well-Circumscribed Lesion,Mixed cell adenoma,1
25440,Severe dysplasia,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
25441,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Ligament Endometrioid Adenocarcinoma,1
25442,Malignant Cellular Infiltrate,Malignant Solitary Fibrous Tumor,1
25443,Smooth Muscle Component Present,Pulmonary lymphangioleiomyomatosis,1
25444,Malignant Cellular Infiltrate,Advanced Head and Neck Carcinoma,1
25445,Neuroendocrine Differentiation,Malignant Vipoma,1
25446,Metastatic Lesion,Locally Advanced Gastrointestinal Stromal Tumor,1
25447,Rapidly Enlarging Mass,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
25448,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Monodermal and Highly Specialized Teratoma,1
25449,Primary Lesion,Recurrent Adult Hepatocellular Carcinoma,1
25450,Nuclear Atypia,Grade III Childhood Astrocytoma,1
25451,'Starry-sky' pattern,Adult Burkitt Lymphoma,1
25452,High Grade Lesion,Mediastinal Synovial Sarcoma,1
25453,Malignant Cellular Infiltrate,follicular lymphoma of spleen,1
25454,Carcinomatous Component Present,Adenocarcinoma of the prostate stage IV,1
25455,Malignant Cellular Infiltrate,Superior Vena Cava Angiosarcoma,1
25456,Multifocal Lesion,Uterine Corpus Diffuse Leiomyomatosis,1
25457,Malignant Cellular Infiltrate,Pathologic Stage II Gastric Cancer AJCC v8,1
25458,High Grade Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,1
25459,Epithelial Component Present,Recurrent Anal Mucinous Adenocarcinoma,1
25460,Indolent Clinical Course,Cellular angiofibroma,1
25461,Tumor Vascular Invasion,Malignant Testicular Leydig Cell Tumor,1
25462,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage II,1
25463,Tissue of Mullerian Origin Present,Mucinous cystadenofibroma,1
25464,Neuroendocrine Differentiation,Platinum-Sensitive Lung Small Cell Carcinoma,1
25465,Benign Cellular Infiltrate,"Oncocytoma, renal",1
25466,Primary Lesion,Childhood Rhabdomyosarcoma,1
25467,Diffuse Pattern,Childhood Cerebral Anaplastic Astrocytoma,1
25468,High Grade Lesion,Cervical Alveolar Soft Part Sarcoma,1
25469,Nuclear pleomorphism,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
25470,Neuroendocrine Differentiation,Pancreatic Delta Cell Neoplasm,1
25471,Malignant Cellular Infiltrate,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
25472,Primary Lesion,Mycosis fungoides recurrent,1
25473,Follicular Cell Differentiation,Recurrent Thyroid Gland Papillary Carcinoma,1
25474,Metastatic Lesion,Pancreatic neuroendocrine tumor metastatic,1
25475,Malignant Cellular Infiltrate,Fascial fibrosarcoma,1
25476,Invasive Lesion,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
25477,Resectable Mass,Resectable Neuroblastoma,1
25478,Epithelial Component Present,"Cystadenocarcinoma, Papillary",1
25479,Indolent Clinical Course,Tendon Sheath Lipoma,1
25480,Favorable Clinical Outcome,Colorectal Ganglioneuroma,1
25481,More than 10 Mitoses per 10HPF,Childhood Lung Small Cell Carcinoma,1
25482,Epithelial Component Present,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
25483,Epithelial Component Present,Moderate epithelial dysplasia,1
25484,Epithelial Component Present,papillary carcinoma of renal pelvis,1
25485,Non-Invasive Lesion,Low-grade intraurothelial neoplasia,1
25486,Well Differentiated Neuroendocrine Lesion,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
25487,Papillary Pattern,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7,1
25488,Nuclear Atypia,Atypical neurofibroma,1
25489,Epithelial Component Present,Adenocarcinoma in situ in tubular adenoma,1
25490,Malignant Cellular Infiltrate,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
25491,Secondary Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
25492,Indolent Clinical Course,Hemangioma of choroid,1
25493,Enterochromaffin-Like Type Granules Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
25494,Well-Circumscribed Lesion,Non-Functioning Adrenal Cortex Adenoma,1
25495,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,adenosquamous carcinoma of ovary,1
25496,Childhood Lesion,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
25497,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
25498,Benign Cellular Infiltrate,Benign neoplasm of adrenal gland,1
25499,Epithelial Component Present,Metastatic Breast Carcinoid Tumor,1
25500,Carcinomatous Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
25501,Disease regression,regressing melanoma of skin,1
25502,Malignant Cellular Infiltrate,Stage III Pancreatic Cancer AJCC v6 and v7,1
25503,Epithelial Component Present,Anal Canal Neuroendocrine Tumor,1
25504,Aggressive Clinical Course,Adult Burkitt Leukemia,1
25505,Cutaneous Involvement,Skin Angiosarcoma,1
25506,Malignant Cellular Infiltrate,Pediatric follicular lymphoma,1
25507,Malignant Cellular Infiltrate,Gonadal Polyembryoma,1
25508,Carcinomatous Component Present,Basal cell carcinoma - adamantinoid,1
25509,Neuroendocrine Differentiation,Stage I Lung Small Cell Carcinoma AJCC v7,1
25510,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage II,1
25511,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma recurrent,1
25512,Malignant Cellular Infiltrate,Rectal Lymphoma,1
25513,Malignant Cellular Infiltrate,"Retinoblastoma, undifferentiated",1
25514,Primary Lesion,Fibrolamellar Hepatocellular Carcinoma,1
25515,Malignant Cellular Infiltrate,Pineal Region Yolk Sac Tumor,1
25516,Pregnancy Complications,Stage IVA Gestational Trophoblastic Tumor AJCC v7,1
25517,Benign Cellular Infiltrate,Esophageal hemangioma,1
25518,Carcinomatous Component Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,1
25519,Encapsulated Mass,minimally invasive follicular carcinoma of the thyroid gland,1
25520,Carcinomatous Component Present,Mediastinal/Thymic NUT Carcinoma,1
25521,Carcinomatous Component Present,Cecum Carcinoma,1
25522,Hemorrhagic,Angiosarcoma NCI Grade 3,1
25523,Thin-Walled Branching Vascular Pattern,Angiolipoma,1
25524,Epithelial Component Present,Superior Sulcus Lung Carcinoma,1
25525,Epithelial Component Present,Unresectable Intrahepatic Cholangiocarcinoma,1
25526,Pseudoglandular Pattern,Childhood Testicular Embryonal Carcinoma,1
25527,Epithelial Component Present,Squamous cell carcinoma of tonsil,1
25528,Encapsulated Mass,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
25529,Multilayered Rosette Formation,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified",1
25530,Cutaneous Involvement,Hidradenoma Papilliferum,1
25531,Therapy-Related Toxicity,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
25532,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
25533,Osseous Component Present,Multiple hamartoma of lung,1
25534,Metastatic Lesion,Advanced Kaposi Sarcoma,1
25535,More than 5 Mitoses per 50HPF,Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
25536,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck,1
25537,Epithelial Component Present,Rectosigmoid Cancer by AJCC v7 Stage,1
25538,Carcinomatous Component Present,Recurrent Childhood Hepatocellular Carcinoma,1
25539,Rapidly Enlarging Mass,rhabdomyosarcoma of testis,1
25540,Cutaneous Involvement,Sarcoma of skin,1
25541,Epithelial Component Present,Small Intestinal Undifferentiated Carcinoma,1
25542,Epithelial Component Present,Hard Palate Monomorphic Adenoma,1
25543,Benign Cellular Infiltrate,Thyroid Gland Spindle Cell Follicular Adenoma,1
25544,Primary Lesion,Recurrent Childhood Brain Stem Astrocytoma,1
25545,Malignant Cellular Infiltrate,Pathologic Stage IB Gastric Cancer AJCC v8,1
25546,Insular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
25547,Absence of Invasion,Carcinoma in situ of prostate,1
25548,Well-Circumscribed Lesion,Anal skin tag,1
25549,Papillary Pattern,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
25550,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,"Leukemia, Myeloid, Chronic-Phase",1
25551,Childhood Lesion,Childhood Acute Myeloid Leukemia with Maturation,1
25552,Malignant Cellular Infiltrate,"Malignant tumor, giant cell type",1
25553,Carcinomatous Component Present,Major Salivary Gland Cancer by AJCC v8 Stage,1
25554,Carcinomatous Component Present,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
25555,Benign Cellular Infiltrate,Genital rhabdomyoma,1
25556,Secondary Lesion,Epithelioid sarcoma metastatic,1
25557,Malignant Cellular Infiltrate,Hilar Cholangiocarcinoma by AJCC v8 Stage,1
25558,Malignant Cellular Infiltrate,Chest Wall Sarcoma,1
25559,Lymphoplasmacytic Infiltrate,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
25560,Malignant Cellular Infiltrate,Vulvar Eccrine Porocarcinoma,1
25561,Biphasic Pattern,"Cervical Adenomyoma, Endocervical Type",1
25562,Slow Growing Mass,Central Nervous System Hemangioblastoma,1
25563,Malignant Cellular Infiltrate,Squamous cell carcinoma in situ with questionable stromal invasion,1
25564,Borderline Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
25565,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
25566,Malignant Cellular Infiltrate,Refractory Thyroid Gland Carcinoma,1
25567,Low Grade Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1,1
25568,Non-Contiguous Disease,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
25569,Increased Cellularity Present,Stage 2B Neuroblastoma,1
25570,Malignant Cellular Infiltrate,Carcinoma of upper gum,1
25571,Tissue of Mullerian Origin Present,Papillary adenofibroma,1
25572,Chromogranin A Positive Neoplastic Cells Present,Lung Typical Carcinoid Tumor,1
25573,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v8,1
25574,atypia morphology,Atypical Lobular Breast Hyperplasia,1
25575,Metastatic Lesion,Locally Advanced Carcinoma,1
25576,Cutaneous Involvement,Malignant Breast Eccrine Spiradenoma,1
25577,Sebaceous Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
25578,Malignant Cellular Infiltrate,Skin-associated lymphoid tissue lymphoma,1
25579,Solar Radiation Toxicity,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
25580,Well-Circumscribed Lesion,Breast Ductal Adenoma,1
25581,Well-Circumscribed Lesion,adenoma of extrahepatic bile duct,1
25582,Epithelial Component Present,Malignant sex-cord stromal tumor,1
25583,Malignant Cellular Infiltrate,Cholangiolocellular Carcinoma,1
25584,Malignant Cellular Infiltrate,Vaginal Cancer by AJCC v7 Stage,1
25585,Malignant Cellular Infiltrate,Advanced Uveal Melanoma,1
25586,Benign Cellular Infiltrate,Thyroid Gland Benign Vascular Neoplasm,1
25587,Well-Circumscribed Lesion,Rectal Sessile Serrated Adenoma/Polyp,1
25588,Carcinomatous Component Present,Major Salivary Gland Carcinoma,1
25589,Malignant Cellular Infiltrate,Stage IIIB Breast Carcinoma,1
25590,Vascular Channel Formation,Cardiac hemangioma,1
25591,Malignant Cellular Infiltrate,Malignant Female Reproductive System Neoplasm,1
25592,Mixture of Germ Cell Neoplastic Components Present,Childhood Central Nervous System Mixed Germ Cell Tumor,1
25593,Carcinomatous Component Present,Stage III Eyelid Carcinoma AJCC v8,1
25594,Malignant Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
25595,Epithelial Component Present,Nasopharyngeal Carcinoma by AJCC v8 Stage,1
25596,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of gallbladder,1
25597,Anaplasia,Sarcomatoid Renal Cell Carcinoma,1
25598,Benign Cellular Infiltrate,Squamous cell papilloma of skin,1
25599,Malignant Cellular Infiltrate,Metastatic Fibrolamellar Carcinoma,1
25600,Defective Heavy Chain Present,gamma-Chain Disease,1
25601,Epithelial Component Present,Vaginal adenocarcinoma metastatic,1
25602,Vascular Channel Formation,Lymphangiomatosis,1
25603,Necrotic changes (finding),Malignant Lung PEComa,1
25604,Carcinomatous Component Present,Pharyngeal Carcinoma by AJCC v8 Stage,1
25605,Malignant Cellular Infiltrate,Stage IV Retroperitoneal Sarcoma AJCC v8,1
25606,Recurrent disease,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
25607,Adnexal Differentiation,Benign Pilar-Associated Mesenchyme Neoplasm,1
25608,Epithelial Component Present,Invasive Cribriform Breast Carcinoma,1
25609,Calcitonin serum level increased,Medullary carcinoma of thyroid,1
25610,Carcinomatous Component Present,adenosquamous carcinoma of ovary,1
25611,Biphasic Pattern,"Phyllodes tumor, benign",1
25612,Carcinomatous Component Present,Endometrial Large Cell Neuroendocrine Carcinoma,1
25613,Nuclear Clearing,Follicular Variant Thyroid Gland Papillary Carcinoma,1
25614,Severe dysplasia,Clinical Stage 0 Gastric Cancer AJCC v8,1
25615,Refractory Disease,Refractory Malignant Thyroid Gland Neoplasm,1
25616,Cutaneous Involvement,Porokeratosis,1
25617,High Mitotic Activity,Childhood Anaplastic Ependymoma,1
25618,Well-Circumscribed Lesion,Esophageal squamous papilloma,1
25619,Cutaneous Involvement,Dermatophytosis of scalp and beard,1
25620,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
25621,Malignant Cellular Infiltrate,Acute bilineal leukemia,1
25622,Malignant Cellular Infiltrate,High Grade Astrocytic Tumor,1
25623,Benign Cellular Infiltrate,Vaginal Dermoid Cyst,1
25624,Chromogranin A Positive Neoplastic Cells Present,Thymic Carcinoid Tumor,1
25625,Epithelial Component Present,Undifferentiated Carcinoma of Unknown Primary,1
25626,Epithelial Component Present,Laryngeal Cancer by AJCC v7 Stage,1
25627,Malignant Cellular Infiltrate,Cecum Non-Hodgkin Lymphoma,1
25628,Carcinomatous Component Present,Bladder Urachal Squamous Cell Carcinoma,1
25629,Metastatic Lesion,Breast Carcinoma Metastatic in the Skin,1
25630,Secondary Lesion,Lung Carcinoma Metastatic in the Central Nervous System,1
25631,Mitotic Activity,"Testicular Yolk Sac Tumor, Papillary Pattern",1
25632,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v7,1
25633,Radial Growth Phase,Stage III Superficial Spreading Melanoma AJCC v7,1
25634,Carcinomatous Component Present,Glottic Squamous Cell Carcinoma,1
25635,Malignant Cellular Infiltrate,Small Intestinal Medullary Carcinoma,1
25636,Tissue Differentiation Uncertain,Alveolar soft part sarcoma metastatic,1
25637,High Mitotic Activity,small cell carcinoma of salivary gland,1
25638,atypia morphology,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
25639,Neuroendocrine Differentiation,Childhood Carcinoid Tumor,1
25640,Carcinomatous Component Present,Stage IIIA Small Intestinal Cancer AJCC v7,1
25641,Peripheral Nuclear Palisading,Thymic Basaloid Carcinoma,1
25642,Antoni A Pattern,Sellar Schwannoma,1
25643,Low Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1,1
25644,Epithelial Component Present,Stage III Rectal Cancer AJCC v7,1
25645,Mesenchymal Differentiation,Stromal Predominant Kidney Wilms Tumor,1
25646,Cutaneous Involvement,basal cell carcinoma of scrotum,1
25647,Perivascular Arrangement of Tumor Cells,Malignant Pericytic Neoplasm,1
25648,Carcinomatous Component Present,External Ear Carcinoma,1
25649,Cutaneous Involvement,Trichofolliculoma,1
25650,Anaplasia,Anaplastic astrocytoma,1
25651,Pregnancy Complications,Remote Placental Infarction,1
25652,Papillary Pattern,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
25653,Refractory Disease,Refractory Malignant Bone Neoplasm,1
25654,Primary Lesion,Childhood Brain Stem Astrocytoma,1
25655,Epithelial Component Present,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
25656,Monomorphic Cellular Infiltrate,sebaceous adenoma of salivary gland,1
25657,Nuclear Molding,Occult Lung Small Cell Carcinoma,1
25658,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Seminoma,1
25659,Increased Cellularity Present,Childhood Anaplastic Oligoastrocytoma,1
25660,Epithelial Component Present,Stage IIIA Ovarian Cancer AJCC v6 and v7,1
25661,Epithelial Component Present,Mild epithelial dysplasia,1
25662,Childhood Lesion,Childhood Cerebral Ependymoma,1
25663,Encapsulated Mass,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
25664,Malignant Cellular Infiltrate,Early Favorable Hodgkin Lymphoma,1
25665,Indolent Clinical Course,Bizarre leiomyoma,1
25666,Low Mitotic Activity,Appendix Neuroendocrine Tumor,1
25667,Malignant Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia,1
25668,Cutaneous Involvement,Leukemic infiltration of skin,1
25669,Benign Cellular Infiltrate,Inverted papilloma of urinary bladder,1
25670,Malignant Cellular Infiltrate,Stage IV Bone Sarcoma AJCC v7,1
25671,Carcinomatous Component Present,Stage IIA Colon Cancer AJCC v7,1
25672,Pregnancy Complications,Stage IA Gestational Trophoblastic Tumor AJCC v7,1
25673,Malignant Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v6 and v7,1
25674,Epithelial Component Present,Mucinous Adenocarcinoma,1
25675,Benign Cellular Infiltrate,benign neoplasm of lymph nodes,1
25676,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
25677,Carcinomatous Component Present,Metastatic Unresectable Basal Cell Carcinoma,1
25678,Cytoplasmic Eosinophilic Globules Present,Undifferentiated (Embryonal) Sarcoma,1
25679,Carcinomatous Component Present,Cystadenocarcinoma of pancreas,1
25680,Multinodular Mass,Pulmonary Artery Angiosarcoma,1
25681,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
25682,Malignant Cellular Infiltrate,Vaginal cancer recurrent,1
25683,Malignant Cellular Infiltrate,Well Differentiated Fibrosarcoma,1
25684,Indolent Clinical Course,Lipoma of pleura,1
25685,Tissue of Mullerian Origin Present,Cystadenofibroma of fallopian tube,1
25686,Smooth Muscle Component Present,Lymphangioleiomyomatosis of skin,1
25687,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage I,1
25688,Malignant Cellular Infiltrate,Stage III Merkel Cell Carcinoma AJCC v7,1
25689,Malignant Cellular Infiltrate,Adult Pure Erythroid Leukemia,1
25690,Malignant Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v7,1
25691,Carcinomatous Component Present,Throat cancer,1
25692,Malignant Cellular Infiltrate,Gastric Hepatoid Adenocarcinoma,1
25693,Pathologic TNM Finding,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
25694,Villous Pattern,Villous adenoma of rectum,1
25695,Intraosseous Lesion,Odontogenic myxoma,1
25696,Epithelial Component Present,Stage IIA Ovarian Cancer AJCC v8,1
25697,Benign Cellular Infiltrate,Frontal Sinus Inverted Papilloma,1
25698,Neuronal Differentiation,Glioblastoma with Primitive Neuronal Component,1
25699,Benign Cellular Infiltrate,Frontal Sinus Inverted Papilloma,1
25700,Epithelial Component Present,Bilateral Carcinoma,1
25701,Microvascular Proliferation,Cerebellar Glioblastoma,1
25702,Secondary Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
25703,Nuclear pleomorphism,Pleomorphic Variant Mantle Cell Lymphoma,1
25704,Malignant Cellular Infiltrate,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
25705,Malignant Cellular Infiltrate,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
25706,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Clinical Stage,1
25707,Carcinomatous Component Present,undifferentiated carcinoma of cervix,1
25708,Squamous Metaplasia of Malignant Cells Present,Adenocarcinoma with squamous metaplasia,1
25709,Malignant Cellular Infiltrate,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,1
25710,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
25711,Eccrine Differentiation,Eccrine hidrocystoma,1
25712,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone,1
25713,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage IV,1
25714,Carcinomatous Component Present,Metastatic Digestive System Carcinoma,1
25715,Carcinomatous Component Present,Gastric Small Cell Carcinoma,1
25716,Childhood Lesion,Childhood Bladder Carcinoma,1
25717,Increased Cellularity Present,Cellular Myxoma,1
25718,S-100-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
25719,Malignant Cellular Infiltrate,Blastema Predominant Kidney Wilms Tumor,1
25720,Epithelial Component Present,Broad Ligament Serous Adenofibroma,1
25721,Carcinomatous Component Present,Stage II Colon Cancer,1
25722,Benign Cellular Infiltrate,Otic polyp,1
25723,Diffuse Pattern,Recurrent Childhood Fibrillary Astrocytoma,1
25724,Indolent Clinical Course,Gastric Plexiform Fibromyxoma,1
25725,Hyaline Cartilage Differentiation,Secondary Chondrosarcoma,1
25726,Benign Cellular Infiltrate,"Acanthoma, Pilar Sheath",1
25727,Secondary Lesion,Lymphangitis carcinomatosa,1
25728,Secondary Lesion,Secondary Central Chondrosarcoma,1
25729,Infiltrative Growth Pattern,Anaplastic Hemispheric Astrocytoma,1
25730,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v8,1
25731,atypia morphology,"Endometrioid adenoma, borderline malignancy",1
25732,Thick-Walled Hyalinized Vessels Present,Gastric Schwannoma,1
25733,Mesenchymal Component Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
25734,Epithelial Component Present,Poorly Differentiated Hepatocellular Carcinoma,1
25735,Human Papillomavirus Positive,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
25736,Epithelial Component Present,Anatomic Stage II Breast Cancer AJCC v8,1
25737,Storiform Growth Pattern,Non-Ossifying Fibroma,1
25738,Malignant Cellular Infiltrate,Refractory Malignant Brain Neoplasm,1
25739,Epithelial Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
25740,High Mitotic Activity,Refractory Lung Small Cell Carcinoma,1
25741,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2,1
25742,Comedo Necrosis,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
25743,Clinical TNM Finding,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,1
25744,Carcinomatous Component Present,Recurrent Childhood Hepatocellular Carcinoma,1
25745,Malignant Cellular Infiltrate,Secondary malignant neoplasm of liver,1
25746,Carcinomatous Component Present,Krukenberg Tumor,1
25747,Infiltrative Growth Pattern,Giant Cell Glioblastoma,1
25748,Well-Circumscribed Lesion,Pericardial Adenomatoid Tumor,1
25749,Antoni A Pattern,Schwannoma of the Twelfth Cranial Nerve,1
25750,Adnexal Differentiation,Malignant Sebaceous Neoplasm,1
25751,Monoclonal Gammapathies,Smoldering Waldenstrom Macroglobulinemia,1
25752,Recurrent disease,Recurrent Lip and Oral Cavity Carcinoma,1
25753,Epithelial Component Present,Colon Traditional Serrated Adenoma,1
25754,Infiltrating Tumor Margins Present,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
25755,Carcinomatous Component Present,Metastatic Ductal Breast Carcinoma,1
25756,Epithelial Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
25757,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma,1
25758,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
25759,Indolent Clinical Course,Mediastinal Chondroma,1
25760,Malignant Cellular Infiltrate,Diffuse Gastric Adenocarcinoma,1
25761,Chromogranin A Positive Neoplastic Cells Present,Thymic Atypical Carcinoid Tumor,1
25762,Carcinomatous Component Present,Stage IVB Colorectal Cancer AJCC v7,1
25763,Neuroendocrine Differentiation,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,1
25764,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
25765,Trabecular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
25766,In Situ Lesion,Bladder Urothelial Carcinoma in Situ,1
25767,Papillary Pattern,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
25768,Monoclonal Paraproteinemia,Indolent multiple myeloma,1
25769,Low Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
25770,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage II subdiaphragmatic,1
25771,Epithelial Component Present,Prostate Phyllodes Tumor,1
25772,Hyperplastic Epithelial Tissue Present,Atypical Breast Myoepitheliosis,1
25773,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
25774,Recurrent disease,Recurrent tumors of the Ewing's family,1
25775,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type",1
25776,Absence of Invasion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
25777,Epithelial Component Present,Carcinoid tumor of the prostate,1
25778,Epithelial Component Present,Mucinous Adenocarcinoma,1
25779,Epithelial Component Present,Carcinoma in Situ,1
25780,Neuroendocrine Differentiation,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
25781,More than 10 Mitoses per 10HPF,Small cell carcinoma of lung,1
25782,Nerve palsy,Congenital facial nerve palsy,1
25783,Malignant Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Solid Pattern",1
25784,Adnexal Differentiation,Eyelid Sebaceous Gland Carcinoma,1
25785,Benign Cellular Infiltrate,Benign squamous cell tumor,1
25786,Benign Cellular Infiltrate,Colon Lipoma,1
25787,Recurrent disease,Recurrent Parotid Gland Undifferentiated Carcinoma,1
25788,Epithelial Component Present,Stage IA Ovarian Cancer AJCC v8,1
25789,Papillary Pattern,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
25790,Benign Cellular Infiltrate,Benign Vaginal Mixed Tumor,1
25791,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
25792,Intestinal metaplasia of gastric mucosa,adenomatous polyp of stomach,1
25793,Burn injury,Old Burn Scar-Related Cutaneous Melanoma,1
25794,Myxoid Stroma Formation,Ventricular myxoma,1
25795,Chromogranin A Positive Neoplastic Cells Present,Pancreatic Neuroendocrine Tumor G1,1
25796,Epithelial Component Present,Stage III Jejunal Neuroendocrine Tumor AJCC v8,1
25797,Malignant Cellular Infiltrate,Posterior Tongue Squamous Cell Carcinoma,1
25798,Well Differentiated Lesion,Well Differentiated Hepatocellular Carcinoma,1
25799,Single Cell Necrosis,Vulvar Merkel Cell Carcinoma,1
25800,Nuclear pleomorphism,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
25801,Malignant Cellular Infiltrate,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
25802,Adnexal Differentiation,Carcinoma ex Eccrine Spiradenoma,1
25803,Hypercellular bone marrow,Philadelphia chromosome negative chronic myelogenous leukemia,1
25804,Epithelial Component Present,Compact Cell Adrenal Cortical Adenoma,1
25805,In Situ Lesion,Adenocarcinoma in situ in tubular adenoma,1
25806,Endophytic Tumor Growth,Laryngeal verrucous carcinoma,1
25807,Non-Invasive Lesion,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7,1
25808,Malignant Cellular Infiltrate,Bilateral Malignant Neoplasm,1
25809,Secondary Lesion,Advanced Synovial Sarcoma,1
25810,Carcinomatous Component Present,Stage IC Ovarian Cancer AJCC v6 and v7,1
25811,Islands of Odontogenic Epithelium Present,Peripheral Odontogenic Fibroma,1
25812,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
25813,Stromal Invasion,squamous cell carcinoma of ovary,1
25814,Cutaneous Involvement,Malignant Cutaneous Granular Cell Tumor,1
25815,Malignant Cellular Infiltrate,Metastatic Lip Carcinoma,1
25816,Malignant Cellular Infiltrate,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
25817,Monomorphic Cellular Infiltrate,oligodendroglioma,1
25818,Diffuse Pattern,Centroblastic lymphoma stage III,1
25819,Epithelial Component Present,Anal Canal Neuroendocrine Tumor,1
25820,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Heterologous Type",1
25821,Diffuse Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,1
25822,Childhood Lesion,Cystic Partially Differentiated Nephroblastoma,1
25823,Metastatic Lesion,Metastatic hepatocellular carcinoma,1
25824,Cutaneous Involvement,Primary Cutaneous Hodgkin Lymphoma,1
25825,Necrotic changes (finding),Refractory Extensive Stage Lung Small Cell Carcinoma,1
25826,Adulthood Lesion,Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma,1
25827,Indolent Clinical Course,Intravenous leiomyomatosis,1
25828,More than 10 Mitoses per 10HPF,Platinum-Sensitive Lung Small Cell Carcinoma,1
25829,Malignant Cellular Infiltrate,Small Intestinal Adenosquamous Carcinoma,1
25830,Infiltrative Growth Pattern,Anaplastic Diencephalic Astrocytoma,1
25831,Malignant Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v8,1
25832,Cutaneous Involvement,Glomus tumor of skin,1
25833,Malignant Cellular Infiltrate,Cardiac Yolk Sac Tumor,1
25834,Carcinomatous Component Present,Stage I Skin Cancer,1
25835,Immunologic Deficiency Syndromes,AIDS-Related Herpes Zoster,1
25836,Benign Cellular Infiltrate,Childhood Central Nervous System Mature Teratoma,1
25837,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Recurrent B-Cell Prolymphocytic Leukemia,1
25838,Carcinomatous Component Present,Paget Disease of the Breast with Invasive Ductal Carcinoma,1
25839,Absence of Invasion,Intermediate Grade Ductal Breast Carcinoma In Situ,1
25840,Carcinomatous Component Present,Stage IA Cervical Cancer AJCC v8,1
25841,Cutaneous Involvement,Stage III Skin Cancer,1
25842,Epithelial Component Present,Prostate cancer stage D,1
25843,Neuroendocrine Differentiation,Lung Typical Carcinoid Tumor,1
25844,Nuclear pleomorphism,Hepatocellular Small Cell Change,1
25845,Carcinomatous Component Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8,1
25846,Metastatic Lesion,Metastatic Lung Small Cell Carcinoma,1
25847,Epithelial Component Present,malignant steroid cell tumor of ovary,1
25848,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage IV,1
25849,Malignant Cellular Infiltrate,Recurrent Childhood Gliomatosis Cerebri,1
25850,Carcinomatous Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
25851,Malignant Cellular Infiltrate,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion",1
25852,Malignant Cellular Infiltrate,Lymphoma of eye,1
25853,Benign Cellular Infiltrate,Non-Ossifying Fibroma,1
25854,Malignant Cellular Infiltrate,Recurrent Indolent Adult Non-Hodgkin Lymphoma,1
25855,Malignant Cellular Infiltrate,Stage I Cervical Cancer AJCC v6 and v7,1
25856,Epithelial Component Present,Stage IB Pancreatic Cancer AJCC v8,1
25857,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myeloid leukemia with abnormal marrow eosinophils,1
25858,Myxoid Stroma Formation,malignant epithelioid hemangioendothelioma of liver,1
25859,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis of skin,1
25860,Carcinomatous Component Present,malignant myoepithelioma of breast,1
25861,Diffuse Pattern,Refractory Malignant Peripheral Nerve Sheath Tumor,1
25862,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Choriocarcinoma,1
25863,Alternative Fascicle (Bundle) Pattern,Leiomyoma of esophagus,1
25864,Benign Cellular Infiltrate,Appendix Lipoma,1
25865,Benign Cellular Infiltrate,Benign neurologic neoplasms,1
25866,Malignant Cellular Infiltrate,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
25867,Epithelial Component Present,"Malignant Mixed Tumor, Not Otherwise Specified",1
25868,Malignant Cellular Infiltrate,Stage I Pleural Malignant Mesothelioma AJCC v8,1
25869,Carcinomatous Component Present,Vaginal Carcinosarcoma,1
25870,Malignant Cellular Infiltrate,Malignant neoplasm of urinary bladder,1
25871,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage I,1
25872,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
25873,Indolent Clinical Course,Cavernous hemangioma of orbit,1
25874,Biphasic Pattern,Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
25875,Carcinomatous Component Present,Stage IIA Lung Adenosquamous Carcinoma AJCC v7,1
25876,Carcinomatous Component Present,Advanced Carcinoma,1
25877,Carcinomatous Component Present,Metastatic Vulvar Carcinoma,1
25878,Malignant Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage I,1
25879,Biphasic Pattern,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
25880,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v7,1
25881,Carcinomatous Component Present,Posterior Tongue Adenoid Cystic Carcinoma,1
25882,Indolent Clinical Course,Endobronchial lipoma,1
25883,Glomerular Hypertrophy,"Focal Segmental Glomerulosclerosis, Not Otherwise Specified",1
25884,Metastatic Lesion,Secondary malignant neoplasm of pericardium,1
25885,Mesenchymal Differentiation,Stromal Predominant Kidney Wilms Tumor,1
25886,Anaplasia,Recurrent Anaplastic Oligodendroglioma,1
25887,Lymphoplasmacytic Infiltrate,HHV8-Positive Multicentric Castleman Disease,1
25888,Metaplasia,Bladder Squamous Cell Carcinoma,1
25889,Carcinomatous Component Present,Refractory Endometrial Carcinoma,1
25890,Hereditary Lesion,Hereditary sideroblastic anemia,1
25891,High Grade Lesion,Gallbladder Rhabdomyosarcoma,1
25892,Peripheral Nuclear Palisading,Basaloid squamous cell carcinoma,1
25893,Absence of Invasion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
25894,Secondary Lesion,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
25895,Well Differentiated Lesion,Verrucous carcinoma of the oral cavity recurrent,1
25896,Epithelial Component Present,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8,1
25897,Malignant Cellular Infiltrate,Small Intestinal Adenosquamous Carcinoma,1
25898,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Alkylating Agent-Related Myelodysplastic Syndrome,1
25899,Malignant Cellular Infiltrate,Lung Lymphoepithelioma-Like Carcinoma,1
25900,Infiltrative Growth Pattern,Pigmented villonodular synovitis,1
25901,Cutaneous Involvement,Stage 0 Cutaneous Melanoma AJCC v6 and v7,1
25902,Malignant Cellular Infiltrate,Oncocytic Breast Carcinoma,1
25903,Malignant Cellular Infiltrate,Stage IA Bone Sarcoma AJCC v7,1
25904,Carcinomatous Component Present,Paget Disease of the Scrotum,1
25905,Cystic Change,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
25906,Cutaneous Involvement,Common blue nevus of skin,1
25907,Malignant Cellular Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7,1
25908,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity stage III,1
25909,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
25910,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
25911,Epithelial Component Present,Malignant Intrathoracic Paravertebral Paraganglioma,1
25912,Epithelial Component Present,Intracanalicular fibroadenoma,1
25913,Epithelial Component Present,Squamous intraepithelial neoplasia grade 2,1
25914,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage I,1
25915,VIP Positive Neoplastic Cells Present,Malignant Pancreatic Vipoma,1
25916,Nodular Pattern,Pulmonary nodular lymphoid hyperplasia,1
25917,Cartilage-Like Elements Present,Chondroid chordoma,1
25918,Adulthood Lesion,Adult Extracardiac Rhabdomyoma,1
25919,Malignant Cellular Infiltrate,Prognostic Stage IIA Breast Cancer AJCC v8,1
25920,Indolent Clinical Course,Uterine Corpus Epithelioid Leiomyoma,1
25921,Splenomegaly,Philadelphia chromosome negative chronic myelogenous leukemia,1
25922,Malignant Cellular Infiltrate,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
25923,Squamoid Corpuscle,Pancreatoblastoma,1
25924,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
25925,Epithelial Component Present,Ampulla of Vater Neuroendocrine Tumor G1,1
25926,Low Mitotic Activity,Malignant Pancreatic Somatostatinoma,1
25927,Metastatic Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,1
25928,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Cancer AJCC v7,1
25929,Oligodendroglial Component Present,oligodendroglioma,1
25930,Tissues Derived from Two or Three Embryonic Layers Present,Grade 1 Ovarian Teratoma,1
25931,Malignant Cellular Infiltrate,Calcifying Nested Epithelial Stromal Tumor of the Liver,1
25932,Biphasic Pattern,Carcinosarcoma of ovary,1
25933,Epithelial Component Present,Adenocarcinoma of small intestine,1
25934,Malignant Cellular Infiltrate,Small Intestinal Squamous Cell Carcinoma,1
25935,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
25936,Epithelial Component Present,Stage IB2 Cervical Cancer AJCC v8,1
25937,atypia morphology,Borderline Ovarian Mucinous Adenofibroma,1
25938,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anaemia with excess blasts,1
25939,Monoclonal Langerhans Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
25940,Mitotic Activity,Recurrent Childhood Giant Cell Glioblastoma,1
25941,Malignant Cellular Infiltrate,Stage II Vulva Cancer AJCC v6,1
25942,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma recurrent,1
25943,Epithelial Component Present,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
25944,Non-Hereditary Lesion,"Papillary renal cell carcinoma, sporadic",1
25945,Carcinomatous Component Present,Adenocarcinoma with spindle cell metaplasia,1
25946,Epithelial Component Present,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8,1
25947,Rapidly Enlarging Mass,Rhabdomyosarcoma,1
25948,Epithelial Component Present,Sex Hormone-Producing Adrenal Cortex Adenoma,1
25949,Fibrotic Stroma Formation,Broad Ligament Serous Cystadenofibroma,1
25950,Carcinomatous Component Present,Recurrent Submandibular Gland Carcinoma,1
25951,Epithelial Component Present,Esophageal Neuroendocrine Tumor,1
25952,Carcinomatous Component Present,Squamous cell breast carcinoma,1
25953,Carcinomatous Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
25954,Malignant Cellular Infiltrate,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage,1
25955,Childhood Lesion,Childhood Malignant Small Intestinal Neoplasm,1
25956,Carcinomatous Component Present,hepatoid adenocarcinoma of gallbladder,1
25957,Cystic Change,cystic mucinous tumor of pancreas with moderate dysplasia,1
25958,Carcinomatous Component Present,Stage IIA2 Cervical Cancer AJCC v8,1
25959,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
25960,Benign Cellular Infiltrate,Benign Gastric Soft Tissue Neoplasm,1
25961,Epithelial Component Present,Stage I Paranasal Sinus Cancer,1
25962,Indolent Clinical Course,Pleomorphic Lipoma,1
25963,Benign Cellular Infiltrate,Central Nervous System Chondroma,1
25964,Refractory Disease,Refractory Primary Amyloidosis,1
25965,Local disease,Spindle Cell/Pleomorphic Lipoma,1
25966,Infiltrative Growth Pattern,Fibromatosis colli,1
25967,Epithelial Component Present,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
25968,Vascular Channel Formation,Solid Angioleiomyoma,1
25969,Benign Cellular Infiltrate,Capillary hemangioma of retina,1
25970,Marked Bone Marrow Fibrosis,Overt Primary Myelofibrosis,1
25971,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor,1
25972,Intraluminal Tumor Growth,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
25973,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
25974,Staghorn Configuration,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
25975,Secondary Lesion,Metastatic Lip Squamous Cell Carcinoma,1
25976,Malignant Cellular Infiltrate,Type II Endometrial Adenocarcinoma,1
25977,Benign Cellular Infiltrate,Juvenile papillomatosis of breast,1
25978,Carcinomatous Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
25979,Malignant Cellular Infiltrate,"Acute myeloid leukemia, t(8;21) (q22;q22)",1
25980,Neuroendocrine Differentiation,Kidney Neuroendocrine Neoplasm,1
25981,Benign Cellular Infiltrate,Benign Accessory Urethral Gland Neoplasm,1
25982,Benign Cellular Infiltrate,Benign neoplasm of tonsil,1
25983,Childhood Lesion,Childhood Ovarian Teratoma,1
25984,Borderline Lesion,Type E Lymphomatoid Papulosis,1
25985,Malignant Cellular Infiltrate,Stage IV Pharynx Carcinoma,1
25986,Papillary Pattern,"Schneiderian papilloma, inverted",1
25987,Epithelial Component Present,Stage 0 Esophageal Cancer AJCC v7,1
25988,Carcinomatous Component Present,Acinar cell cystadenocarcinoma,1
25989,Malignant Cellular Infiltrate,Central Nervous System Choriocarcinoma,1
25990,Epithelial Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
25991,Negative Bone Marrow and Peripheral Blood,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder,1
25992,Secondary Lesion,Secondary malignant neoplasm of pituitary gland,1
25993,Solid Growth Pattern,Solid Lung Adenocarcinoma,1
25994,Malignant Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
25995,Malignant Cellular Infiltrate,Upper Gingival Squamous Cell Carcinoma,1
25996,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of pancreas,1
25997,Well-Circumscribed Lesion,Tubulovillous adenoma of rectum,1
25998,Childhood Lesion,Childhood Craniopharyngioma,1
25999,Secondary Lesion,Intermediate Atypical Prostate Carcinoma,1
26000,Malignant Cellular Infiltrate,Carcinoma,1
26001,Benign Cellular Infiltrate,Benign Parathyroid Gland Adenoma,1
26002,Malignant Cellular Infiltrate,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
26003,Malignant Cellular Infiltrate,Intraocular Malignant Peripheral Nerve Sheath Tumor,1
26004,Cutaneous Involvement,Cutaneous leiomyoma,1
26005,Malignant Cellular Infiltrate,adenosquamous carcinoma of pancreas,1
26006,Clinical TNM Finding,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
26007,Intracytoplasmic Eosinophilic Inclusion,Refractory Rhabdoid Tumor,1
26008,Carcinomatous Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
26009,Malignant Cellular Infiltrate,Stage I Hodgkin Lymphoma,1
26010,Malignant Cellular Infiltrate,Unfavorable Non-Hodgkin Lymphoma,1
26011,Cutaneous Involvement,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
26012,Epithelial Component Present,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
26013,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of extrahepatic bile duct,1
26014,Lymphoplasmacytic Infiltrate,Waldenstrom Macroglobulinemia,1
26015,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone,1
26016,Malignant Cellular Infiltrate,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
26017,Malignant Cellular Infiltrate,Adult Central Nervous System Mixed Germ Cell Tumor,1
26018,Thick-Walled Hyalinized Vessels Present,Degenerated Schwannoma,1
26019,Non-Malignant Cellular Infiltrate,Lymphadenitis,1
26020,Mitotic Activity,Testicular yolk sac tumor stage II,1
26021,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v7,1
26022,Hyalinized Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
26023,Focal dysplasia,Sessile Serrated Adenoma/Polyp,1
26024,Epithelial Component Present,Benign neoplasm of sebaceous gland,1
26025,Recurrent disease,Bladder adenocarcinoma recurrent,1
26026,Epithelial Component Present,Breast Papillomatosis,1
26027,Cord-Like Pattern,Syringoma,1
26028,Aggressive Clinical Course,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",1
26029,Malignant Cellular Infiltrate,Morpheic basal cell carcinoma,1
26030,Invasive Lesion,adenosquamous carcinoma of breast,1
26031,Recurrent disease,Recurrent Parotid Gland Squamous Cell Carcinoma,1
26032,Malignant Cellular Infiltrate,Stage IIB Appendix Carcinoma AJCC v7,1
26033,Localized Lesion,Solitary Myofibromatosis,1
26034,Epithelial Component Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
26035,Epithelial Component Present,Small Intestinal Intraepithelial Neoplasia,1
26036,Epithelial Component Present,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
26037,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,"Acute myeloid leukemia, inv(16)(p13q22)",1
26038,Severe dysplasia,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
26039,Epithelial Component Present,Stage IA Ovarian Cancer AJCC v8,1
26040,High Grade Lesion,High Grade Liver Dysplastic Nodule,1
26041,Carcinomatous Component Present,Small cell carcinoma of ovary,1
26042,Carcinomatous Component Present,Stage I Renal Cell Cancer AJCC v8,1
26043,Mass of body structure,Mediastinal Myeloid Sarcoma,1
26044,Malignant Cellular Infiltrate,Colloid Carcinoma of the Pancreas,1
26045,Carcinomatous Component Present,Transplant-Related Skin Squamous Cell Carcinoma,1
26046,Neuroendocrine Differentiation,Metastatic Gastric Neuroendocrine Carcinoma,1
26047,Malignant Cellular Infiltrate,Liver Fibrosarcoma,1
26048,Secondary Lesion,Metastatic Bladder Small Cell Carcinoma,1
26049,Malignant Cellular Infiltrate,"Adenocarcinoma, Scirrhous",1
26050,Malignant Cellular Infiltrate,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7,1
26051,Malignant Cellular Infiltrate,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
26052,Malignant Cellular Infiltrate,Gastrointestinal Stromal Sarcoma,1
26053,Recurrent disease,Recurrent Primary Vitreoretinal Lymphoma,1
26054,Benign Cellular Infiltrate,Leiomyoma of esophagus,1
26055,Carcinomatous Component Present,BRCA-Mutated Ovarian Carcinoma,1
26056,Malignant Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7,1
26057,Epithelial Component Present,Refractory Thyroid Gland Carcinoma,1
26058,Syncytial Pattern,Oropharyngeal lymphepithelioma,1
26059,Infantile Lesion,Fibrous Hamartoma of Infancy,1
26060,Secondary Lesion,Metastatic Malignant Neoplasm to the Thyroid,1
26061,Low Grade Lesion,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
26062,Cutaneous Involvement,Dermatologic disorders,1
26063,Epithelial Component Present,adenoid cystic carcinoma of esophagus,1
26064,Carcinomatous Component Present,Uterine Ligament Mucinous Adenocarcinoma,1
26065,Biphasic Pattern,Malignant Mixed Mesodermal (Mullerian) Tumor,1
26066,Benign Cellular Infiltrate,Bladder Urothelial Papilloma,1
26067,Primary Lesion,Central Nervous System T-Cell Non-Hodgkin Lymphoma,1
26068,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity recurrent,1
26069,Recurrent disease,Locally Recurrent Malignant Neoplasm,1
26070,Neuronal Differentiation,Ganglioneuroma,1
26071,Malignant Cellular Infiltrate,Stage IVB Colon Cancer AJCC v8,1
26072,Malignant Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7,1
26073,Malignant Cellular Infiltrate,Secondary carcinoma,1
26074,Adulthood Lesion,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma,1
26075,Cutaneous Involvement,Clinical Stage IIA Cutaneous Melanoma AJCC v8,1
26076,Epithelial Component Present,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
26077,Malignant Cellular Infiltrate,Refractory Cutaneous Melanoma,1
26078,Benign Cellular Infiltrate,Capillary hemangioma of orbit,1
26079,Carcinomatous Component Present,Adenocarcinoma of the prostate stage I,1
26080,Antoni A Pattern,Pleural Schwannoma,1
26081,Carcinomatous Component Present,Squamous cell carcinoma of tongue,1
26082,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor,1
26083,Benign Cellular Infiltrate,Hereditary Kidney Oncocytoma,1
26084,Malignant Cellular Infiltrate,Lymphoepithelial malignant thymoma,1
26085,Metastatic Lesion,Breast Carcinoma Metastatic in the Liver,1
26086,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
26087,Benign Cellular Infiltrate,Ganglioneuromatosis,1
26088,Malignant Cellular Infiltrate,Refractory Malignant Peripheral Nerve Sheath Tumor,1
26089,Well Differentiated Lesion,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
26090,Benign Cellular Infiltrate,Parathyroid mixed cell type adenoma,1
26091,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
26092,Collagenous Stroma Formation,Sclerosing PEComa,1
26093,Multinodular Pattern,Adult Extraskeletal Myxoid Chondrosarcoma,1
26094,Carcinomatous Component Present,Adenocarcinoma of cecum,1
26095,Childhood Lesion,Extrarenal Rhabdoid Tumor of the Liver,1
26096,Carcinomatous Component Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
26097,Malignant Cellular Infiltrate,Childhood Soft Tissue Sarcoma,1
26098,Recurrent disease,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
26099,Malignant Cellular Infiltrate,Cervical Cancer by AJCC v6 Stage,1
26100,Childhood Lesion,Stage I Childhood Burkitt Lymphoma,1
26101,Malignant Cellular Infiltrate,Warty Carcinoma of the Penis,1
26102,Infiltrating Tumor Margins Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
26103,Carcinomatous Component Present,undifferentiated carcinoma of cervix,1
26104,Follicular Structures Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
26105,Well-Circumscribed Lesion,Tubulovillous adenoma of rectum,1
26106,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis,1
26107,Solitary mass,Chondroid chordoma,1
26108,Primary Lesion,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",1
26109,Carcinomatous Component Present,"Papillary transitional cell carcinoma, non-invasive",1
26110,Carcinomatous Component Present,carcinosarcoma of liver,1
26111,Cutaneous Involvement,Skin carcinoma,1
26112,Acanthosis,Condyloma acuminata of cervix,1
26113,Unresectable Mass,Unresectable Carcinoma,1
26114,Radiation Sickness,Radiation Pneumonitis,1
26115,Epithelial Component Present,Ethmoid Sinus Squamous Cell Carcinoma,1
26116,Epithelial Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
26117,Stromal Invasion,Stage IVB Ovarian Cancer AJCC v8,1
26118,Malignant Cellular Infiltrate,Parotid Gland Sarcoma,1
26119,Indolent Clinical Course,Hemangioma of breast,1
26120,Carcinomatous Component Present,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
26121,Solitary mass,Central Nervous System Epithelioid Hemangioendothelioma,1
26122,Benign Cellular Infiltrate,Uterine Corpus Hydropic Leiomyoma,1
26123,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
26124,Poorly Differentiated Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
26125,Vascular Channel Formation,Capillary hemangioma of orbit,1
26126,Adulthood Lesion,Recurrent Adult Hodgkin Lymphoma,1
26127,Adnexal Differentiation,Hidroacanthoma simplex,1
26128,Epithelial Component Present,Papilloma of eyelid,1
26129,Neuroendocrine Differentiation,Endometrial Large Cell Neuroendocrine Carcinoma,1
26130,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v6 Stage,1
26131,Malignant Cellular Infiltrate,Recurrent Acute Myelomonocytic Leukemia,1
26132,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,1
26133,Primary Lesion,Metastatic hepatocellular carcinoma,1
26134,Epithelial Component Present,Bowenoid papulosis,1
26135,Carcinomatous Component Present,Stage IIC Appendix Carcinoma AJCC v8,1
26136,Epithelial Component Present,Colorectal Neuroendocrine Tumor G2,1
26137,Epithelial Component Present,Colorectal Carcinoma Metastatic in the Lung,1
26138,Malignant Cellular Infiltrate,Childhood Rectal Carcinoma,1
26139,Mixed Cellular Population,Mixed Salivary Gland Tumor,1
26140,Malignant Cellular Infiltrate,Locally Advanced Soft Tissue Sarcoma,1
26141,Myxoid Stroma Formation,Aggressive angiomyxoma,1
26142,Epithelial Component Present,Stage IIC Colon Cancer AJCC v7,1
26143,Childhood Lesion,Childhood Malignant Penile Neoplasm,1
26144,In Situ Lesion,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",1
26145,Dysplasia,Small Intestinal Low Grade Intraepithelial Neoplasia,1
26146,Severe dysplasia,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
26147,Malignant Cellular Infiltrate,Adenocarcinoid tumor,1
26148,Malignant Cellular Infiltrate,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
26149,High Grade Lesion,Childhood Rhabdomyosarcoma,1
26150,Carcinomatous Component Present,Pancreatic Large Cell Neuroendocrine Carcinoma,1
26151,Malignant Cellular Infiltrate,Central Nervous System Intravascular Large B-Cell Lymphoma,1
26152,Malignant Cellular Infiltrate,Acute monocytic/monoblastic leukemia,1
26153,Multifocal Lesion,Multifocal superficial basal cell carcinoma,1
26154,Epithelial Component Present,Multiple Endocrine Neoplasia,1
26155,Carcinomatous Component Present,Stage IIA Rectal Cancer AJCC v7,1
26156,Primary Lesion,High grade surface osteosarcoma,1
26157,Pathologic TNM Finding,Pathologic Stage IV Cutaneous Melanoma AJCC v8,1
26158,Monomorphic Cellular Infiltrate,Angiocentric glioma,1
26159,Carcinomatous Component Present,Carcinoma of upper gum,1
26160,Carcinomatous Component Present,Stage IIIB Colon Cancer AJCC v8,1
26161,Epithelial Component Present,Ovarian Stromal-Leydig Cell Tumor,1
26162,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v8,1
26163,Cutaneous Involvement,Acne Keloid,1
26164,Infiltrating Tumor Margins Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
26165,Acantholysis,Laryngeal Acantholytic Squamous Cell Carcinoma,1
26166,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
26167,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of thymus,1
26168,Whorling Growth Pattern,Transitional Meningioma,1
26169,Immunologic Deficiency Syndromes,Ann Arbor Stage I AIDS-Related Lymphoma,1
26170,Well-Circumscribed Lesion,Filiform Serrated Adenoma,1
26171,Angiodestructive Pattern,Recurrent Grade II Lymphomatoid Granulomatosis,1
26172,Cutaneous Involvement,Acquired ichthyosis,1
26173,Malignant Cellular Infiltrate,Alcohol-Related Carcinoma,1
26174,Radiation Sickness,Radiation-Related Non-Neoplastic Disorder,1
26175,Epithelial Component Present,Unresectable Basal Cell Carcinoma,1
26176,Carcinomatous Component Present,Renal Pelvis Carcinoma,1
26177,Carcinomatous Component Present,Stage IIA Penile Cancer AJCC v8,1
26178,Cutaneous Involvement,Refractory Malignant Skin Neoplasm,1
26179,Malignant Cellular Infiltrate,Metastatic Urethral Urothelial Carcinoma,1
26180,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
26181,Diffuse Pattern,T-cell/histiocyte rich large B-cell lymphoma,1
26182,More than 10 Mitoses per 10HPF,Childhood Lung Small Cell Carcinoma,1
26183,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Adenofibroma,1
26184,Malignant Cellular Infiltrate,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,1
26185,Necrotic changes (finding),Pancreatic Small Cell Neuroendocrine Carcinoma,1
26186,Carcinomatous Component Present,Nipple Duct Carcinoma,1
26187,Epithelial Component Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
26188,Lobulated Growth Pattern,Sellar Chondroid Chordoma,1
26189,Malignant Cellular Infiltrate,Iris Spindle Cell Melanoma,1
26190,Carcinomatous Component Present,Biliary Tract Carcinoma,1
26191,Pregnancy Complications,Placental Choriocarcinoma,1
26192,Carcinomatous Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage,1
26193,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage II subdiaphragmatic,1
26194,Encapsulated Mass,Clear cell papillary renal cell carcinoma,1
26195,Epithelial Component Present,Recurrent Parathyroid Gland Carcinoma,1
26196,Epithelial Component Present,intraductal micropapillary carcinoma of breast,1
26197,Poorly Differentiated Lesion,Pleomorphic carcinoma,1
26198,Cutaneous Involvement,Familial benign pemphigus,1
26199,Poorly Differentiated Lesion,Large cell lung cancer stage III,1
26200,Epithelial Component Present,Stage I Ampulla of Vater Cancer AJCC v8,1
26201,Dysplasia,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
26202,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
26203,Cutaneous Involvement,Contact dermatitis due to dichromate,1
26204,Vascular Channel Formation,Capillary hemangioma of retina,1
26205,Increased Cellularity Present,Vulvar Cellular Angiofibroma,1
26206,Cytoplasmic Membrane-Bound Granules Present,Stage IV Merkel Cell Carcinoma AJCC v7,1
26207,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 3 Follicular Lymphoma,1
26208,Neuroendocrine Differentiation,Breast Neuroendocrine Neoplasm,1
26209,Carcinomatous Component Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
26210,Malignant Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
26211,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v7 Stage,1
26212,Poorly Differentiated Lesion,Skin Sarcomatoid Basal Cell Carcinoma,1
26213,Carcinomatous Component Present,Stage IIB Esophageal Carcinoma,1
26214,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
26215,Severe cytologic atypia,Extrahepatic Bile Duct Neuroendocrine Carcinoma,1
26216,Malignant Cellular Infiltrate,Colorectal Diffuse Large B-Cell Lymphoma,1
26217,Carcinomatous Component Present,Eyelid Carcinoma by AJCC v8 Stage,1
26218,Carcinomatous Component Present,Unresectable Skin Basal Cell Carcinoma,1
26219,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
26220,Malignant Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v6 and v7,1
26221,Malignant Cellular Infiltrate,Metastatic Lung Carcinoma,1
26222,Neuroendocrine Differentiation,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
26223,Low Mitotic Activity,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
26224,Metastatic Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
26225,Follicular Cell Differentiation,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
26226,Mild dysplasia,Mild esophageal dysplasia,1
26227,Childhood Lesion,Stage III Childhood Lymphoblastic Lymphoma,1
26228,Childhood Lesion,Childhood Unfavorable Prognosis Hodgkin Lymphoma,1
26229,Necrotic changes (finding),Esophageal Large Cell Neuroendocrine Carcinoma,1
26230,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v8,1
26231,Epithelial Component Present,Thyroid Gland Lipoadenoma,1
26232,Neuroendocrine Differentiation,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
26233,Well-Circumscribed Lesion,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
26234,Epithelial Component Present,Gingival Squamous Cell Carcinoma,1
26235,Papillary Pattern,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
26236,Invasive Lesion,"Hydatidiform Mole, Invasive",1
26237,Carcinomatous Component Present,Unresectable Basal Cell Carcinoma,1
26238,Well-Circumscribed Lesion,Appendix Traditional Serrated Adenoma,1
26239,Indolent Clinical Course,Conventional Lipoma,1
26240,Low Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v8,1
26241,Tissue Differentiation Uncertain,Monophasic Synovial Sarcoma,1
26242,Neuroendocrine Differentiation,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
26243,Mitotic Activity,"Testicular Yolk Sac Tumor, Hepatoid Pattern",1
26244,Malignant Cellular Infiltrate,Advanced Unfavorable Non-Hodgkin Lymphoma,1
26245,Epithelial Component Present,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
26246,Malignant Cellular Infiltrate,Alkylating Agent-Related Acute Myeloid Leukemia,1
26247,In Situ Lesion,Stage 0 Anal Cancer AJCC v8,1
26248,Adulthood Lesion,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma,1
26249,Indolent Clinical Course,Diffuse Lipomatosis,1
26250,Metastatic Lesion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
26251,Carcinomatous Component Present,Stage IIIB Vulvar Cancer AJCC v7,1
26252,Well-Circumscribed Lesion,Cerebellar hemangioblastoma,1
26253,Malignant Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8,1
26254,Invasive Lesion,Microinvasive Malignant Neoplasm,1
26255,Cutaneous Involvement,Type A Tylosis,1
26256,Cystic Change,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
26257,Malignant Cellular Infiltrate,Secondary malignant neoplasm of larynx,1
26258,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage IV,1
26259,Immunologic Deficiency Syndromes,Methotrexate-Associated Lymphoma,1
26260,Cutaneous Involvement,"Dermatitis, Occupational",1
26261,Benign Cellular Infiltrate,Plantar wart,1
26262,Poorly Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
26263,Epithelioid Component Present,Pleural Biphasic Synovial Sarcoma,1
26264,Malignant Cellular Infiltrate,Rectal Signet Ring Cell Adenocarcinoma,1
26265,Severe cytologic atypia,Digestive System Neuroendocrine Carcinoma,1
26266,Epithelial Component Present,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
26267,Carcinomatous Component Present,Stage IB Lung Small Cell Carcinoma AJCC v7,1
26268,Malignant Cellular Infiltrate,Stage III Colon Cancer AJCC v8,1
26269,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v7,1
26270,In Situ Lesion,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8",1
26271,Childhood Lesion,Childhood Testicular Neoplasm,1
26272,Vascular Channel Formation,Airway Hemangioma,1
26273,Radiation Sickness,Radiation damage to artery,1
26274,Necrotic changes (finding),Colon Small Cell Neuroendocrine Carcinoma,1
26275,Biphasic Pattern,Perineal Ectopic Fibroadenoma,1
26276,Epithelial Component Present,Occult Breast Carcinoma,1
26277,Epithelial Component Present,Stage II Penile Cancer AJCC v8,1
26278,Nuclear Atypia,MGMT-Methylated Glioblastoma,1
26279,Hyaline Cartilage Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
26280,Tissue Differentiation Uncertain,Extraskeletal Myxoid Chondrosarcoma,1
26281,Carcinomatous Component Present,Ovarian Cancer by FIGO Stage,1
26282,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage II,1
26283,Malignant Cellular Infiltrate,Gastrointestinal carcinoma,1
26284,Malignant Cellular Infiltrate,Pilomatrix carcinoma of skin,1
26285,Secondary Lesion,Metastatic Malignant Neoplasm in the Soft Tissues,1
26286,Increased Cellularity Present,Neuroblastoma,1
26287,Neuroendocrine Differentiation,Regional Adrenal Gland Pheochromocytoma,1
26288,Carcinomatous Component Present,Metastatic Signet Ring Cell Breast Carcinoma,1
26289,Epithelial Component Present,Penile Cancer by AJCC v6 Stage,1
26290,Epithelial Component Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
26291,Carcinomatous Component Present,Stage IV Laryngeal Cancer AJCC v8,1
26292,Nuclear Atypia,Anaplastic astrocytoma,1
26293,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Seminoma,1
26294,Benign Cellular Infiltrate,Benign neoplasm of brain stem,1
26295,Refractory Disease,Refractory Female Reproductive System Carcinoma,1
26296,Malignant Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v8,1
26297,Papillary Pattern,Urethral Verrucous Carcinoma,1
26298,Epithelial Component Present,Oral Cavity Adenoma,1
26299,Perivascular Arrangement of Tumor Cells,Angiomyoma,1
26300,Monomorphic Cellular Infiltrate,Ependymoma of brain stem,1
26301,Well-Circumscribed Lesion,Eccrine acrospiroma,1
26302,Carcinomatous Component Present,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,1
26303,Pseudoencapsulated Mass,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
26304,Neuroendocrine Differentiation,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,1
26305,Carcinomatous Component Present,Renal Pelvis Carcinoma,1
26306,Metastatic Lesion,Pleural Carcinomatosis,1
26307,Precise Histogenesis Unknown,Peripheral Hemangioblastoma,1
26308,Epithelial Component Present,malignant steroid cell tumor of ovary,1
26309,Carcinomatous Component Present,Childhood Lung Small Cell Carcinoma,1
26310,Epithelial Component Present,Stage I Nasopharyngeal Carcinoma AJCC v8,1
26311,Ground Glass Nuclear Inclusion,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
26312,Malignant Cellular Infiltrate,Recurrent Dedifferentiated Liposarcoma,1
26313,Well-Circumscribed Lesion,Heavily Pigmented Adrenal Cortical Adenoma,1
26314,Carcinomatous Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v7,1
26315,Malignant Cellular Infiltrate,BCLC Stage A Hepatocellular Carcinoma,1
26316,Osseous Differentiation,Bone Surface (Peripheral) Osteosarcoma,1
26317,Cutaneous Involvement,Precancerous melanosis,1
26318,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
26319,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Colon,1
26320,Superficial Lesion,Atypical Lipoma,1
26321,Hemorrhagic,Skin Angiosarcoma,1
26322,Epithelial Component Present,Cystadenofibroma of fallopian tube,1
26323,Diffuse Pattern,Childhood Brain Oligodendroglioma,1
26324,Tumor Vascular Invasion,Malignant Testicular Sex Cord-Stromal Tumor,1
26325,Cutaneous Involvement,"Xeroderma pigmentosum, group B",1
26326,Childhood Lesion,Childhood Yolk Sac Tumor,1
26327,Metaplasia of Malignant Cells Present,Adenocarcinoma with apocrine metaplasia,1
26328,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v8,1
26329,Epithelial Component Present,Stage IV Vulvar Cancer AJCC v7,1
26330,Carcinomatous Component Present,basal cell carcinoma of scrotum,1
26331,Recurrent disease,B-cell lymphoma recurrent,1
26332,Multinodular Mass,Angiosarcoma NCI Grade 2,1
26333,Dysplasia,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
26334,Unresectable Mass,Metastatic Unresectable Malignant Neoplasm,1
26335,Metastatic/Recurrent Disease,Cardiac Monophasic Synovial Sarcoma,1
26336,Malignant Cellular Infiltrate,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
26337,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
26338,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
26339,Benign Cellular Infiltrate,Adult Cardiac Cellular Rhabdomyoma,1
26340,Epithelial Component Present,Micronodular thymoma with lymphoid stroma,1
26341,Carcinomatous Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
26342,Malignant Cellular Infiltrate,Human Papillomavirus-Related Verrucous Carcinoma,1
26343,Malignant Cellular Infiltrate,Leukemic infiltration of skin,1
26344,Malignant Cellular Infiltrate,Marginal zone lymphoma stage I,1
26345,Borderline Lesion,Borderline Ovarian Clear Cell Cystadenofibroma,1
26346,Malignant Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8,1
26347,Carcinomatous Component Present,Trabecular adenocarcinoma,1
26348,Epithelial Component Present,Conjunctival intraepithelial neoplasia,1
26349,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Heterologous Type",1
26350,Malignant Cellular Infiltrate,Anal Extramucosal (Perianal) Adenocarcinoma,1
26351,Epithelial Component Present,Stage IVB Appendix Carcinoma AJCC v8,1
26352,Malignant Cellular Infiltrate,Recurrent Childhood Glioblastoma,1
26353,Benign Cellular Infiltrate,Junctional nevus,1
26354,atypia morphology,Atypical Mesothelial Hyperplasia,1
26355,Carcinomatous Component Present,Small Intestinal Mucinous Adenocarcinoma,1
26356,Epithelial Component Present,Metastatic Cervical Adenosquamous Carcinoma,1
26357,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx recurrent,1
26358,Epithelial Component Present,Squamous cell carcinoma of lip,1
26359,CD30-Positive Neoplastic Cells Present,Recurrent Childhood Anaplastic Large Cell Lymphoma,1
26360,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
26361,Epithelial Component Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
26362,Tissue Differentiation Uncertain,Juxta-Articular Myxoma,1
26363,Neuroendocrine Differentiation,Extra-Adrenal Retroperitoneal Paraganglioma,1
26364,Malignant Cellular Infiltrate,Cerebellar Glioblastoma,1
26365,Malignant Cellular Infiltrate,Recurrent Digestive System Carcinoma,1
26366,Mitotic Activity,Vaginal Yolk Sac Tumor,1
26367,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
26368,Epithelial Component Present,Superficial Epithelioma with Sebaceous Differentiation,1
26369,Cutaneous Involvement,Apocrine Sweat Gland Hamartoma,1
26370,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
26371,Microvascular Proliferation,Multifocal Glioblastomas,1
26372,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v6,1
26373,Malignant Cellular Infiltrate,Refractory Myxoid Liposarcoma,1
26374,Endophytic Tumor Growth,Anal Verrucous Carcinoma,1
26375,Malignant Cellular Infiltrate,Stage III Childhood Hodgkin Lymphoma,1
26376,Malignant Cellular Infiltrate,Philadelphia-Positive Myelogenous Leukemia,1
26377,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
26378,Neuroendocrine Differentiation,Cerebellar Paraganglioma,1
26379,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
26380,Malignant Cellular Infiltrate,Advanced Digestive System Neuroendocrine Neoplasm,1
26381,Keratin pearl formation,Lung Basaloid Squamous Cell Carcinoma,1
26382,Tissue Differentiation Uncertain,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
26383,Indolent Clinical Course,Benign myoepithelioma,1
26384,Follicular Cell Differentiation,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
26385,Benign Cellular Infiltrate,Benign neoplasm of respiratory tract,1
26386,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma,1
26387,Epithelial Component Present,Stage IB Eyelid Carcinoma AJCC v7,1
26388,Thin-Walled Branching Vascular Pattern,Epidural Spinal Canal Angiolipoma,1
26389,Malignant Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v6,1
26390,Breast Microcalcification,Childhood Brain Oligodendroglioma,1
26391,Refractory Disease,Refractory Primary Cutaneous Lymphoma,1
26392,Intraductal Lesion,Atypical Breast Papilloma,1
26393,Exophytic Polypoid Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
26394,Malignant Cellular Infiltrate,small cell carcinoma of appendix,1
26395,Cribriform Pattern,Invasive Cribriform Breast Carcinoma,1
26396,Malignant Cellular Infiltrate,Metastatic Parathyroid Gland Carcinoma,1
26397,Malignant Cellular Infiltrate,undifferentiated carcinoma of urethra,1
26398,Indolent Clinical Course,Benign Gastric Soft Tissue Neoplasm,1
26399,Metastatic Lesion,Secondary malignant neoplasm of liver,1
26400,Cutaneous Involvement,Paget's disease of vulva,1
26401,Vascular Channel Formation,Central Nervous System Hemangioma,1
26402,Fibrotic Stroma Formation,Rete Ovarii Cystadenofibroma,1
26403,Diffuse Pattern,Mixed Oligodendroglioma-Astrocytoma,1
26404,Neuroendocrine Differentiation,Pancreatic Endocrine Carcinoma,1
26405,Carcinomatous Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
26406,Carcinomatous Component Present,Adrenal Cortex Carcinoma by AJCC v8 Stage,1
26407,Epithelial Component Present,Mixed germ cell-sex cord-stromal tumor,1
26408,Metastatic Lesion,Secondary malignant neoplasm of anus,1
26409,Malignant Cellular Infiltrate,Stage IB Pancreatic Cancer AJCC v8,1
26410,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q),1
26411,Metastatic/Recurrent Disease,Liver Synovial Sarcoma,1
26412,Malignant Cellular Infiltrate,High Grade Salivary Gland Carcinoma,1
26413,Benign Cellular Infiltrate,Urethral Leiomyoma,1
26414,Birbeck Granules Present,"Langerhans cell histiocytosis, unifocal",1
26415,Endophytic Tumor Growth,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
26416,Non Lipogenic Sarcomatous Stroma Present,Refractory Dedifferentiated Liposarcoma,1
26417,Malignant Cellular Infiltrate,Stage III Nasal Cavity Cancer AJCC v6 and v7,1
26418,Anaplasia,Anaplastic (Malignant) Intraspinal Meningioma,1
26419,Angioinvasion,Type E Lymphomatoid Papulosis,1
26420,Well-Circumscribed Lesion,Angiomyofibroblastoma,1
26421,Cutaneous Involvement,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
26422,Epithelial Component Present,"Transitional cell papilloma, inverted",1
26423,Epithelial Component Present,Liver carcinoma,1
26424,Nodular Pattern,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
26425,Metastatic Lesion,Metastatic Chordoma,1
26426,Malignant Cellular Infiltrate,Stage IB1 Cervical Cancer,1
26427,Adnexal Differentiation,Vulvar Sebaceous Carcinoma,1
26428,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1,1
26429,Above the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
26430,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage I,1
26431,Malignant Cellular Infiltrate,Pancreatic carcinoma non-resectable,1
26432,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v8,1
26433,Malignant Cellular Infiltrate,Immunoblastic Large-Cell Lymphoma,1
26434,Malignant Cellular Infiltrate,Thymic Adenosquamous Carcinoma,1
26435,Epithelial Component Present,Laryngeal verrucous carcinoma,1
26436,Malignant Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor,1
26437,Infiltrative Growth Pattern,Adult Gliosarcoma,1
26438,Carcinomatous Component Present,apocrine adenocarcinoma of vulva,1
26439,Infiltrative Growth Pattern,Fibromatosis,1
26440,Well-Circumscribed Lesion,tubulovillous adenoma of stomach,1
26441,Malignant Cellular Infiltrate,Metastatic Pancreatic Neuroendocrine Carcinoma,1
26442,Mucoid Stroma Formation,Primary Cutaneous Mucinous Carcinoma,1
26443,Carcinomatous Component Present,Skin Pseudovascular Squamous Cell Carcinoma,1
26444,Plasma cell inflammation,Lung Inflammatory Myofibroblastic Tumor,1
26445,Microfollicular Structures Present,Microfollicular adenoma,1
26446,Metaplasia,Bladder squamous cell carcinoma stage 0,1
26447,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
26448,Lesion with Diameter Greater than 2cm,Osteoblastoma,1
26449,Epithelial Component Present,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
26450,Malignant Cellular Infiltrate,Regressing Non-Cutaneous Melanoma,1
26451,Slow Growing Mass,Ependymoma of spinal cord,1
26452,"Hyperkeratosis, Epidermolytic",Epidermolytic acanthoma,1
26453,Benign Cellular Infiltrate,Ethmoid Sinus Schneiderian Papilloma,1
26454,Metastatic Lesion,Locally Advanced Skin Squamous Cell Carcinoma,1
26455,Mild dysplasia,"Glandular intraepithelial neoplasia, low grade",1
26456,Malignant Cellular Infiltrate,Gallbladder adenocarcinoma,1
26457,More than 10 Mitoses per 10HPF,Metastatic Prostate Small Cell Carcinoma,1
26458,Local disease,Uterine Corpus Adenomatoid Tumor,1
26459,Malignant Cellular Infiltrate,Colorectal Adenocarcinoma Metastatic in the Liver,1
26460,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage I,1
26461,Intraductal Lesion,Biliary papillomatosis,1
26462,Intraductal Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
26463,Malignant Cellular Infiltrate,Stage IV Merkel Cell Carcinoma AJCC v7,1
26464,Malignant Cellular Infiltrate,Throat cancer,1
26465,Vascular Channel Formation,Soft Tissue Angiosarcoma,1
26466,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v6,1
26467,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
26468,Carcinomatous Component Present,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
26469,Lobulated Growth Pattern,Pyogenic granuloma of oral mucosa,1
26470,Malignant Cellular Infiltrate,Prognostic Stage III Breast Cancer AJCC v8,1
26471,Increased megakaryocytes (bone marrow),"Thrombocythemia, Essential",1
26472,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Adult Acute Myeloid Leukemia without Maturation,1
26473,Glandular Pattern,"Testicular Yolk Sac Tumor, Enteric Pattern",1
26474,Biphasic Pattern,sialadenoma papilliferum of salivary gland,1
26475,Mixed Cellular Population,Stage II Kidney Wilms Tumor,1
26476,Malignant Cellular Infiltrate,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
26477,Malignant Cellular Infiltrate,Anal canal squamous cell carcinoma,1
26478,effusion,Body Cavity Primary Effusion Lymphoma,1
26479,Malignant Cellular Infiltrate,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
26480,Epithelial Component Present,Lobular carcinoma in situ of breast,1
26481,Carcinomatous Component Present,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
26482,Dysplasia,Stage 0is Ureter Cancer AJCC v7,1
26483,Benign Cellular Infiltrate,Cellular fibroma,1
26484,Multinodular Mass,Ovarian Angiosarcoma,1
26485,Exophytic Polypoid Lesion,tubular adenoma of extrahepatic bile duct,1
26486,Benign Cellular Infiltrate,Fibrofolliculoma,1
26487,Exophytic Polypoid Lesion,Villous adenoma of rectum,1
26488,Monomorphic Cellular Infiltrate,sebaceous adenoma of salivary gland,1
26489,Favorable Clinical Outcome,Maturing Ganglioneuroma,1
26490,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v8,1
26491,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma,1
26492,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v6 Stage,1
26493,Myxoid Stroma Formation,Superficial angiomyxoma,1
26494,Malignant Cellular Infiltrate,Recurrent Hodgkin Lymphoma,1
26495,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",1
26496,Dysplasia,Bile Duct Biliary Intraepithelial Neoplasia,1
26497,Carcinomatous Component Present,Cervical Warty Carcinoma,1
26498,High Mitotic Activity,Vaginal Small Cell Carcinoma,1
26499,Carcinomatous Component Present,Stage IIIC Ovarian Cancer AJCC v8,1
26500,Epithelial Component Present,Adenomatous polyp of colon,1
26501,Benign Cellular Infiltrate,Inverted papilloma of urinary bladder,1
26502,Rapidly Enlarging Mass,Embryonal Rhabdomyosarcoma,1
26503,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q,1
26504,Carcinomatous Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v8,1
26505,Tissue of Mullerian Origin Present,Refractory Uterine Corpus Carcinosarcoma,1
26506,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Monodermal and Highly Specialized Teratoma,1
26507,Epithelial Component Present,Metastatic Thyroid Gland Carcinoma,1
26508,Malignant Cellular Infiltrate,ENSAT Stage II Adrenal Cortex Carcinoma,1
26509,Malignant Cellular Infiltrate,Refractory Aggressive Non-Hodgkin Lymphoma,1
26510,Malignant Cellular Infiltrate,Adenocarcinoma of salivary gland,1
26511,Storiform Growth Pattern,"Histiocytoma, Benign Fibrous",1
26512,Epithelial Component Present,Vulvar adenocarcinoma,1
26513,Hypercellular bone marrow,Acute panmyelosis with myelofibrosis,1
26514,Absence of Invasion,Bowenoid papulosis of penis,1
26515,Osseous Differentiation,Benign Osteogenic Neoplasm,1
26516,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage,1
26517,Malignant Cellular Infiltrate,Localized Extrahepatic Bile Duct Carcinoma,1
26518,Recurrent disease,Recurrent Childhood Protoplasmic Astrocytoma,1
26519,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
26520,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
26521,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v8,1
26522,Radiation Sickness,Radiation-Induced Intracranial Meningioma,1
26523,Unresectable Mass,Unresectable Skin Basal Cell Carcinoma,1
26524,Carcinomatous Component Present,Squamous cell carcinoma of nasopharynx,1
26525,Cutaneous Involvement,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
26526,Epithelial Component Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
26527,Carcinomatous Component Present,Stage 0 Gallbladder Cancer AJCC v8,1
26528,Malignant Cellular Infiltrate,Splenic Small Lymphocytic Lymphoma,1
26529,Perivascular Arrangement of Tumor Cells,Pulmonary lymphangioleiomyomatosis,1
26530,Well-Circumscribed Lesion,Vaginal Fibroepithelial Polyp,1
26531,Benign Cellular Infiltrate,Myofibroblastoma,1
26532,Mucoid Stroma Formation,Rectosigmoid Mucinous Adenocarcinoma,1
26533,Carcinomatous Component Present,Stage III Paranasal Sinus Cancer AJCC v6 and v7,1
26534,Severe cytologic atypia,small cell carcinoma of gallbladder,1
26535,Cysts Containing Proteinaceous Fluid Present,"Cystadenocarcinoma, Serous",1
26536,Epithelial Component Present,Gastric Cancer by AJCC v7 Stage,1
26537,Well Differentiated Lesion,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
26538,Human Papillomavirus Positive,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
26539,Juvenile Lesion,Juvenile cataract,1
26540,Malignant Cellular Infiltrate,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",1
26541,Exophytic Polypoid Lesion,tubulopapillary adenoma of gallbladder,1
26542,Malignant Cellular Infiltrate,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
26543,Malignant Cellular Infiltrate,Stage III Adrenal Cortex Carcinoma AJCC v7,1
26544,Well-Circumscribed Lesion,Anal skin tag,1
26545,Tissue of Mullerian Origin Present,Uterine Corpus Carcinosarcoma,1
26546,Hyaline Cartilage Differentiation,Adult Myxoid Chondrosarcoma,1
26547,Diffuse Lesion,Meningeal melanomatosis,1
26548,Malignant Cellular Infiltrate,Malignant melanoma in precancerous melanosis,1
26549,Cutaneous Involvement,Solar lentigo,1
26550,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx,1
26551,Malignant Cellular Infiltrate,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
26552,Single Type of Tissue Derived from One Embryonic Layer Present,"Struma ovarii, malignant",1
26553,Malignant Cellular Infiltrate,Malignant neoplasm of oropharynx,1
26554,Carcinomatous Component Present,Stage IVC Nasopharyngeal Carcinoma AJCC v7,1
26555,Benign Cellular Infiltrate,Uterine Corpus Atypical Polypoid Adenomyoma,1
26556,Increased Cellularity Present,Childhood Anaplastic Oligodendroglioma,1
26557,Severe dysplasia,Colorectal Adenoma with Severe Dysplasia,1
26558,Malignant Cellular Infiltrate,Vaginal adenocarcinoma,1
26559,Malignant Cellular Infiltrate,Stage IIIB Adult Liver Cancer AJCC v7,1
26560,Intraluminal Necrosis,Intermediate Grade Ductal Breast Carcinoma In Situ,1
26561,Carcinomatous Component Present,Metastatic Vulvar Carcinoma,1
26562,Carcinomatous Component Present,Uterine Ligament Endometrioid Adenocarcinoma,1
26563,Epithelial Component Present,Human Papillomavirus-Related Endocervical Adenocarcinoma,1
26564,Indolent Clinical Course,benign fibrous histiocytoma of bone,1
26565,Recurrent disease,Melanoma recurrent,1
26566,Papillary Pattern,"Transitional cell papilloma, benign",1
26567,Metaplasia,Bladder squamous cell carcinoma stage III,1
26568,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v7 Stage,1
26569,Epithelial Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
26570,Malignant Cellular Infiltrate,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7,1
26571,Epithelial Component Present,Unresectable Paraganglioma,1
26572,Human Papillomavirus Positive,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
26573,Thick-Walled Hyalinized Vessels Present,Schwannoma of the Twelfth Cranial Nerve,1
26574,Swelling,Central Nervous System Mesenchymal Chondrosarcoma,1
26575,Eccrine Differentiation,Vulvar Syringoma,1
26576,Epithelial Component Present,Biliary Intraepithelial Neoplasia-3,1
26577,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage IV,1
26578,Malignant Cellular Infiltrate,Intraductal papillary adenocarcinoma with invasion,1
26579,Neuroendocrine Differentiation,Recurrent Adrenal Gland Pheochromocytoma,1
26580,Diffuse Pattern,Diffuse large B-cell lymphoma recurrent,1
26581,Ground Glass Nuclear Inclusion,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
26582,Carcinomatous Component Present,"Carcinoma, Cribriform",1
26583,Invasive Lesion,Infiltrating duct and lobular carcinoma,1
26584,Carcinomatous Component Present,Localized Unresectable Adult Hepatocellular Carcinoma,1
26585,Epithelial Component Present,Bartholin Gland Adenosquamous Carcinoma,1
26586,Carcinomatous Component Present,Metastatic non-small cell lung cancer,1
26587,Malignant Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v8 Stage,1
26588,High Grade Lesion,Lung Biphasic Synovial Sarcoma,1
26589,Mitotic Activity,"Glioblastoma, IDH-Mutant",1
26590,Carcinomatous Component Present,Carcinoma of subglottis,1
26591,Benign Cellular Infiltrate,Sphenoid Sinus Schneiderian Papilloma,1
26592,Malignant Cellular Infiltrate,Stage IV Kidney Wilms Tumor,1
26593,Diffuse Pattern,Recurrent Anaplastic Oligoastrocytoma,1
26594,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v7,1
26595,Absence of Basal Cell Layer,Prostate Acinar Adenocarcinoma,1
26596,Cystic Change,Clear Cell Papillary Cystadenoma,1
26597,Exophytic Polypoid Lesion,Bladder Villous Adenoma,1
26598,Epithelial Component Present,Colorectal Carcinoma,1
26599,Neuroendocrine Differentiation,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
26600,Carcinomatous Component Present,Ampulla of Vater Undifferentiated Carcinoma,1
26601,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
26602,Malignant Cellular Infiltrate,Non-small cell carcinoma,1
26603,Splenomegaly,"Myeloid Leukemia, Chronic",1
26604,atypia morphology,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
26605,Cutaneous Involvement,Squamous Cell Carcinoma of Anal Margin,1
26606,Malignant Cellular Infiltrate,Stage 0 Ampulla of Vater Cancer AJCC v8,1
26607,Malignant Cellular Infiltrate,"Myeloproliferative Neoplasm, Unclassifiable",1
26608,Osteoid formation,Adult Extraskeletal Osteosarcoma,1
26609,Malignant Cellular Infiltrate,Recurrent Breast Lymphoma,1
26610,Deep Lesion,Intramuscular lipoma,1
26611,Chromogranin A Positive Neoplastic Cells Present,Regional Digestive System Neuroendocrine Tumor G1,1
26612,Metastatic Lesion,Locally Advanced Sarcoma,1
26613,Carcinomatous Component Present,Papillary Eccrine Carcinoma,1
26614,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma,1
26615,Dysplasia,Villous adenoma of rectum,1
26616,Apocrine Differentiation,Ceruminous adenocarcinoma,1
26617,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
26618,Malignant Cellular Infiltrate,Secondary malignant neoplasm of brain stem,1
26619,Carcinomatous Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8,1
26620,Malignant Cellular Infiltrate,sarcoma of extrahepatic bile duct,1
26621,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",1
26622,Carcinomatous Component Present,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7,1
26623,Malignant Cellular Infiltrate,Malignant Pericardial Germ Cell Tumor,1
26624,Carcinomatous Component Present,Secondary carcinoma,1
26625,Malignant Cellular Infiltrate,Biochemically Recurrent Prostate Carcinoma,1
26626,Cutaneous Involvement,Dermatologic disorders,1
26627,Metastatic Lesion,Mesothelioma malignant advanced,1
26628,Papillary Pattern,Nonencapsulated sclerosing tumor,1
26629,Hyperkeratosis,Upper Gingival Verrucous Carcinoma,1
26630,Carcinomatous Component Present,Locally Advanced Bile Duct Carcinoma,1
26631,Benign Cellular Infiltrate,Vulvar Nodular Hidradenoma,1
26632,High Mitotic Activity,Classic Type Atypical Fibroxanthoma,1
26633,Diffuse Pattern,Recurrent Anaplastic Astrocytoma,1
26634,Malignant Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8,1
26635,Malignant Cellular Infiltrate,Locally Advanced Salivary Gland Carcinoma,1
26636,Low Mitotic Activity,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
26637,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligoastrocytoma,1
26638,Malignant Cellular Infiltrate,Philadelphia chromosome negative chronic myelogenous leukemia,1
26639,Fibrosis,"Fibrocystic change, proliferative type with atypia",1
26640,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Clinical Stage,1
26641,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH,1
26642,Epithelial Component Present,Ureter Cancer by AJCC v7 Stage,1
26643,Tissue of Mullerian Origin Present,Adenosarcoma of cervix uteri,1
26644,Epithelial Component Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,1
26645,Childhood Lesion,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
26646,Well Differentiated Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Tumor G1,1
26647,Vascular Channel Formation,Conventional Angiosarcoma,1
26648,Malignant Cellular Infiltrate,Appendix Carcinoma by AJCC v8 Stage,1
26649,Sarcomatous or Carcinomatous Component Present,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,1
26650,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia,1
26651,Malignant Cellular Infiltrate,Plasmablastic lymphoma,1
26652,Malignant Cellular Infiltrate,Pituitary Gland Non-Hodgkin Lymphoma,1
26653,Metastatic Lesion,Metastatic Renal Pelvis Urothelial Carcinoma,1
26654,Refractory Disease,Refractory Rhabdoid Tumor,1
26655,Benign Cellular Infiltrate,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,1
26656,Glial Differentiation,Recurrent Gliosarcoma,1
26657,Malignant Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v8,1
26658,Calcitonin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
26659,Rapidly Enlarging Mass,Fusion-Negative Alveolar Rhabdomyosarcoma,1
26660,Carcinomatous Component Present,Intraductal Cribriform Breast Adenocarcinoma,1
26661,Defective Heavy Chain Present,mu-Chain Disease,1
26662,More than 10 Mitoses per 10HPF,Small cell carcinoma of prostate,1
26663,Anaplasia,Secondary Supratentorial Anaplastic Astrocytoma,1
26664,Malignant Cellular Infiltrate,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
26665,Indolent Clinical Course,Hemangioma of intra-abdominal structure,1
26666,Epithelial Component Present,Vaginal Neuroendocrine Carcinoma,1
26667,Carcinomatous Component Present,Carcinoma breast stage I,1
26668,Carcinomatous Component Present,lymphoepithelial squamous cell carcinoma of salivary gland,1
26669,Cutaneous Involvement,Regressing nevus,1
26670,Gyriform Trabecular Pattern,"Gastrinoma, malignant",1
26671,High Mitotic Activity,Recurrent Anaplastic Oligoastrocytoma,1
26672,Skin Papule,Lipoid dermatoarthritis,1
26673,Indolent Clinical Course,Hard Palate Pleomorphic Adenoma,1
26674,Epithelial Component Present,"Carcinoma, Lobular",1
26675,Slow Growing Mass,Adamantinous Craniopharyngioma,1
26676,Mesenchymal Component Present,Pericanalicular fibroadenoma,1
26677,Benign Cellular Infiltrate,Vulvar Superficial Angiomyxoma,1
26678,Carcinomatous Component Present,mucoepidermoid carcinoma of floor of mouth,1
26679,Malignant Cellular Infiltrate,Central Nervous System Embryonal Tumor with Rhabdoid Features,1
26680,Ischemia,Vascular insufficiency of intestine,1
26681,Follicular Cell Differentiation,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
26682,Recurrent disease,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
26683,Epithelial Component Present,Thymic Typical Carcinoid Tumor,1
26684,Malignant Cellular Infiltrate,Hypocellular Myelodysplastic Syndrome,1
26685,Carcinomatous Component Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
26686,Vascular Channel Formation,Breast Angiomatosis,1
26687,Unresectable Mass,Unresectable Urethral Urothelial Carcinoma,1
26688,Malignant Cellular Infiltrate,"Testicular Intratubular Germ Cell Neoplasia, Unclassified",1
26689,Epithelial Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,1
26690,Aggressive Clinical Course,Undifferentiated Stromal Sarcoma,1
26691,Anaplasia,Spindle cell squamous cell carcinoma,1
26692,Malignant Cellular Infiltrate,Primary myoepithelial carcinoma of lung,1
26693,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
26694,Nuclear Atypia,Recurrent Gliosarcoma,1
26695,Malignant Cellular Infiltrate,Intraocular retinoblastoma,1
26696,Calcitonin serum level increased,Sporadic Thyroid Gland Medullary Carcinoma,1
26697,Carcinomatous Component Present,undifferentiated carcinoma of anal canal,1
26698,Indolent Clinical Course,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
26699,Malignant Cellular Infiltrate,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8,1
26700,Malignant Cellular Infiltrate,Lymphocyte Rich Classical Hodgkin Lymphoma,1
26701,Epithelial Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,1
26702,Secondary Lesion,Secondary malignant neoplasm of prostate,1
26703,Epithelial Component Present,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
26704,Epithelial Component Present,Oropharyngeal squamous papilloma,1
26705,Malignant Cellular Infiltrate,Stage IV Appendix Carcinoma AJCC v8,1
26706,Nuclear pleomorphism,Lung Pleomorphic Carcinoma,1
26707,Epithelial Component Present,keratinizing squamous cell carcinoma of nasal cavity,1
26708,Diffuse Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
26709,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage IIIB,1
26710,"Adenocarcinoma, intestinal type",intestinal type adenocarcinoma of extrahepatic bile duct,1
26711,Papillary Pattern,Ureter Inverted Papilloma,1
26712,Epithelial Component Present,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
26713,Osteoid formation,Duodenal Extraskeletal Osteosarcoma,1
26714,Malignant Cellular Infiltrate,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
26715,Mitotic Activity,"Testicular Yolk Sac Tumor, Papillary Pattern",1
26716,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Basophilic Leukemia,1
26717,Thrombocytosis,"Thrombocythemia, Essential",1
26718,Anaplasia,Childhood Anaplastic Oligoastrocytoma,1
26719,Ground Glass Nuclear Inclusion,Follicular Variant Thyroid Gland Papillary Carcinoma,1
26720,Metastatic/Recurrent Disease,Refractory Synovial Sarcoma,1
26721,Thin Bands of Collagen Present,Hemangiopericytoma of meninges,1
26722,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Choriocarcinoma of ovary,1
26723,Malignant Cellular Infiltrate,Stage IIIC1 Uterine Corpus Cancer AJCC v7,1
26724,atypia morphology,Borderline Ovarian Endometrioid Adenofibroma,1
26725,Epithelial Component Present,Stage IIA Anal Cancer AJCC v8,1
26726,Malignant Cellular Infiltrate,Trilateral Retinoblastoma,1
26727,Immunosuppression-Related Post-Transplant Toxicity,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
26728,Crystal deposition,Alveolar soft part sarcoma metastatic,1
26729,Glandular Pattern,"Testicular Yolk Sac Tumor, Enteric Pattern",1
26730,'Starry-sky' pattern,Stage II Burkitt Lymphoma,1
26731,Adulthood Lesion,BCLC Stage A Adult Hepatocellular Carcinoma,1
26732,Indolent Clinical Course,Vulvar Leiomyoma,1
26733,Carcinomatous Component Present,Stage IIA Appendix Carcinoma AJCC v7,1
26734,Malignant Cellular Infiltrate,Urothelial carcinoma bladder recurrent,1
26735,Immunoglobulin Deposition,Heavy Chain Deposition Disease,1
26736,Benign Cellular Infiltrate,HIV lipodystrophy,1
26737,Mesenchymal Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
26738,Epithelial Component Present,Mucoepidermoid Breast Carcinoma,1
26739,Neuroendocrine Differentiation,Refractory Abdominal Neuroendocrine Neoplasm,1
26740,Well Differentiated Neuroendocrine Lesion,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
26741,Vascular Channel Formation,Metastatic angiosarcoma,1
26742,Malignant Cellular Infiltrate,Clear Cell Intrahepatic Cholangiocarcinoma,1
26743,Metastatic Lesion,Secondary malignant neoplasm of esophagus,1
26744,Stromal Invasion,Malignant Ovarian Serous Tumor,1
26745,Epithelial Component Present,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,1
26746,Severe cytologic atypia,Advanced Gastric Neuroendocrine Carcinoma,1
26747,Recurrent disease,Endometrioid adenocarcinoma recurrent,1
26748,Mesenchymal Differentiation,"Transitional cell carcinoma, spindle cell",1
26749,Neuroendocrine Differentiation,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
26750,Malignant Cellular Infiltrate,BCLC Stage C Hepatocellular Carcinoma,1
26751,Carcinomatous Component Present,Adenocarcinoma of appendix,1
26752,Malignant Cellular Infiltrate,Lung Pleomorphic Carcinoma,1
26753,Absence of Invasion,Carcinoma in situ of prostate,1
26754,Favorable Clinical Outcome,Cutaneous Mastocytosis,1
26755,Carcinomatous Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
26756,Epithelial Component Present,Stage 0 Colon Cancer AJCC v6 and v7,1
26757,Necrotic changes (finding),Colon Small Cell Neuroendocrine Carcinoma,1
26758,Postneoadjuvant Therapy Pathologic TNM Finding,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
26759,Epithelial Component Present,Skin Pseudovascular Squamous Cell Carcinoma,1
26760,Epithelial Component Present,Urethral Carcinoma,1
26761,Epithelial Component Present,Stage III Appendix Carcinoma AJCC v8,1
26762,Cutaneous Involvement,"Basal cell carcinoma, micronodular",1
26763,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Lymphoma AJCC v8,1
26764,Malignant Cellular Infiltrate,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,1
26765,Cutaneous Involvement,GIANT PIGMENTED HAIRY NEVUS,1
26766,Malignant Cellular Infiltrate,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
26767,Low Mitotic Activity,Stage I Gastric Neuroendocrine Tumor AJCC v8,1
26768,Epithelial Component Present,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
26769,Epithelial Component Present,Stage II Intrahepatic Bile Duct Cancer AJCC v8,1
26770,Epithelial Component Present,Undifferentiated carcinoma of esophagus,1
26771,Cutaneous Involvement,"Dermatitis, Irritant",1
26772,Poorly Differentiated Neuroendocrine Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,1
26773,Perivascular Arrangement of Tumor Cells,Adult Papillary Meningioma,1
26774,Malignant Cellular Infiltrate,Malignant tumor of pyriform fossa,1
26775,Well-Circumscribed Lesion,Genital rhabdomyoma,1
26776,Carcinomatous Component Present,Carcinoma of hard palate,1
26777,Carcinomatous Component Present,Stage III Colorectal Cancer AJCC v7,1
26778,Dysplasia,Intraductal carcinoma and lobular carcinoma in situ,1
26779,Indolent Clinical Course,Oral Cavity Lipoma,1
26780,Biphasic Pattern,serous adenocarcinofibroma of ovary,1
26781,Secondary Lesion,Metastatic Signet Ring Cell Breast Carcinoma,1
26782,Pregnancy Complications,Severe pre-eclampsia,1
26783,Storiform Growth Pattern,Adult Undifferentiated Pleomorphic Sarcoma,1
26784,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8,1
26785,Cutaneous Involvement,Refractory Malignant Skin Neoplasm,1
26786,Epithelial Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
26787,Benign Cellular Infiltrate,endometrioid adenofibroma of ovary,1
26788,Hyalinized Stroma Formation,Mediastinal Solitary Fibrous Tumor,1
26789,Well-Circumscribed Lesion,Cerebral Hemangioblastoma,1
26790,Carcinomatous Component Present,Stage IIIC Ovarian Cancer AJCC v8,1
26791,Malignant Cellular Infiltrate,Metastatic Pancreatic Neuroendocrine Carcinoma,1
26792,Carcinomatous Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,1
26793,Carcinomatous Component Present,mucinous adenocarcinoma of salivary gland,1
26794,Malignant Cellular Infiltrate,Head and Neck Basaloid Carcinoma,1
26795,Tissue Differentiation Uncertain,Synovial sarcoma recurrent,1
26796,Extracutaneous Dissemination of Disease,Mycosis fungoides stage IV,1
26797,Regional Disease,Locally Advanced Cervical Adenocarcinoma,1
26798,Cutaneous Involvement,Solar lentigo,1
26799,Epithelial Component Present,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
26800,Anaplasia,Sarcomatoid Renal Cell Carcinoma,1
26801,Epithelial Component Present,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
26802,Tissue Differentiation Uncertain,Cardiac Synovial Sarcoma,1
26803,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,1
26804,Poorly Differentiated Lesion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
26805,High Grade Lesion,Rhabdomyosarcoma of the orbit,1
26806,Perineural spread,Metastatic Adenoid Cystic Carcinoma,1
26807,Carcinomatous Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
26808,Malignant Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma of the Cervix,1
26809,Malignant Cellular Infiltrate,Nipple Duct Carcinoma,1
26810,Neuroectodermal Differentiation,neuroblastoma of spinal cord,1
26811,Metastatic Lesion,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,1
26812,Malignant Cellular Infiltrate,Neuroblastic tumors,1
26813,Epithelial Component Present,Cystadenocarcinoma of pancreas,1
26814,Minimal Invasion Present,Bronchioloalveolar Adenocarcinoma,1
26815,Dysplasia,Colorectal High Grade Intraepithelial Neoplasia,1
26816,Anaplasia,Recurrent Childhood Anaplastic Oligoastrocytoma,1
26817,Acinar Pattern,Pancreatoblastoma,1
26818,Epithelial Component Present,Mixed Squamous Cell Carcinoma of the Penis,1
26819,Epithelial Component Present,Small Intestinal VIP-Producing Neuroendocrine Tumor,1
26820,Malignant Cellular Infiltrate,Kidney Extraskeletal Osteosarcoma,1
26821,Indolent Clinical Course,Ovarian Cellular Fibroma,1
26822,Malignant Cellular Infiltrate,Metastatic Unresectable Gastric Adenocarcinoma,1
26823,Secondary Lesion,Secondary malignant neoplasm of small intestine,1
26824,Papillary Pattern,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
26825,Diffuse Pattern,Immunoblastic Large-Cell Lymphoma,1
26826,Intermediate Grade Neuroendocrine Lesion,Gastric Neuroendocrine Tumor G2,1
26827,Carcinomatous Component Present,Bilateral Carcinoma,1
26828,Epithelial Component Present,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
26829,Adnexal Differentiation,Fibrofolliculoma,1
26830,Carcinomatous Component Present,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
26831,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
26832,Cutaneous Involvement,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
26833,Benign Cellular Infiltrate,Mediastinal Neurofibroma,1
26834,Recurrent disease,Recurrent Ovarian Carcinosarcoma,1
26835,Cutaneous Involvement,Skin Cavernous Hemangioma,1
26836,Recurrent disease,Synovial sarcoma recurrent,1
26837,Carcinomatous Component Present,Stage IA Lung Adenosquamous Carcinoma AJCC v7,1
26838,Acinar Pattern,Pancreatoblastoma,1
26839,Malignant Cellular Infiltrate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,1
26840,Malignant Cellular Infiltrate,Carcinoma of anal canal,1
26841,Rapidly Enlarging Mass,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
26842,Neuroendocrine Differentiation,Pancreatic Somatostatinoma,1
26843,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
26844,Malignant Cellular Infiltrate,Centroblastic Lymphoma by Ann Arbor Stage,1
26845,Carcinomatous Component Present,Stage III Nasopharyngeal Carcinoma,1
26846,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma,1
26847,Childhood Lesion,Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8,1
26848,Cutaneous Involvement,Desmoplastic trichoepithelioma,1
26849,Malignant Cellular Infiltrate,Metastatic Bladder Squamous Cell Carcinoma,1
26850,Malignant Cellular Infiltrate,Post polycythaemia vera myelofibrosis,1
26851,Metastatic Lesion,"Squamous cell carcinoma, metastatic",1
26852,Increased Cellularity Present,Secondary Supratentorial Anaplastic Astrocytoma,1
26853,Fibrotic Stroma Formation,Ovarian serous cystadenofibroma,1
26854,Carcinomatous Component Present,Stage IVB Major Salivary Gland Cancer AJCC v7,1
26855,Malignant Cellular Infiltrate,Primary chondrosarcoma of bone,1
26856,Necrotic changes (finding),Anaplastic adrenocortical carcinoma,1
26857,Malignant Cellular Infiltrate,Refractory Diffuse Intrinsic Pontine Glioma,1
26858,Diffuse Pattern,AIDS-Related Primary Effusion Lymphoma,1
26859,Somatostatin Positive Neoplastic Cells Present,Malignant Pancreatic Somatostatinoma,1
26860,Adulthood Lesion,Adult Lymphoblastic Lymphoma,1
26861,Dysplasia,Pyloric Gland Adenoma,1
26862,Papillary Pattern,Maxillary Sinus Schneiderian Papilloma,1
26863,Malignant Cellular Infiltrate,small cell carcinoma of breast,1
26864,Benign Cellular Infiltrate,Hard Palate Monomorphic Adenoma,1
26865,Aggressive Clinical Course,Childhood Burkitt Leukemia,1
26866,Somatostatin Positive Neoplastic Cells Present,Pancreatic Somatostatinoma,1
26867,Collagenous Stroma Formation,Fibrous Meningioma,1
26868,Mild dysplasia,Colorectal Low Grade Intraepithelial Neoplasia,1
26869,Angiodestructive Pattern,Grade III Lymphomatoid Granulomatosis,1
26870,High Grade Lesion,Stage I Lung Small Cell Carcinoma AJCC v7,1
26871,Malignant Cellular Infiltrate,Malignant neoplasm of abdominal part of esophagus,1
26872,Severe cytologic atypia,Digestive System Neuroendocrine Carcinoma,1
26873,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, t(16;16)(p13;q22)",1
26874,Malignant Cellular Infiltrate,Stage IIB Small Intestinal Cancer AJCC v7,1
26875,Primary Lesion,Supratentorial Glioblastoma,1
26876,Cutaneous Involvement,Type A Tylosis,1
26877,Tissue Differentiation Uncertain,Conventional Extraskeletal Myxoid Chondrosarcoma,1
26878,Malignant Cellular Infiltrate,Malignant Accessory Urethral Gland Neoplasm,1
26879,Cutaneous Involvement,adenosquamous carcinoma of skin,1
26880,Nuclear Grooves,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
26881,Carcinomatous Component Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
26882,Epithelial Component Present,Anal Adenocarcinoma within Anorectal Fistula,1
26883,Malignant Germinomatous Cellular Infiltrate,Sellar Germinoma,1
26884,Malignant Cellular Infiltrate,Cerebral Glioblastoma,1
26885,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
26886,Carcinomatous Component Present,Stage IA Merkel Cell Carcinoma AJCC v7,1
26887,Malignant Cellular Infiltrate,solid type ductal carcinoma in situ of breast,1
26888,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7,1
26889,Low Grade Lesion,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
26890,Adnexal Differentiation,Trichodiscoma,1
26891,Cutaneous Involvement,Eczema,1
26892,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma recurrent,1
26893,Diffuse Pattern,Childhood Cerebral Anaplastic Astrocytoma,1
26894,Epithelial Component Present,Cauda Equina Paraganglioma,1
26895,Junctional Proliferation,"Nevus, Spindle Cell",1
26896,Fibrotic Stroma Formation,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
26897,Low Mitotic Activity,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
26898,Extensive Stage Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
26899,Dysplasia,Stage 0 Ureter Cancer AJCC v7,1
26900,Childhood Lesion,Recurrent Childhood Burkitt Lymphoma,1
26901,Epithelial Component Present,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
26902,Epithelial Component Present,Bladder Cancer by AJCC v8 Stage,1
26903,Epithelial Component Present,Recurrent Chromophobe Renal Cell Carcinoma,1
26904,Monomorphic Cellular Infiltrate,sebaceous adenoma of salivary gland,1
26905,Epithelial Component Present,Non functioning pancreatic endocrine tumor,1
26906,Carcinomatous Component Present,Stage 0 Pancreatic Cancer AJCC v6 and v7,1
26907,In Situ Lesion,Bowen's Disease,1
26908,Low Grade Lesion,Cardiac Epithelioid Hemangioendothelioma,1
26909,Epithelial Component Present,Colorectal Neuroendocrine Tumor,1
26910,Carcinomatous Component Present,Hepatic cancer metastatic,1
26911,Epithelial Component Present,Adenomatous polyp of colon,1
26912,Carcinomatous Component Present,Recurrent Anal Adenocarcinoma,1
26913,Malignant Cellular Infiltrate,Cystic Partially Differentiated Nephroblastoma,1
26914,Adulthood Lesion,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
26915,Low Mitotic Activity,Stage III Ileal Neuroendocrine Tumor AJCC v8,1
26916,Tissue Differentiation Uncertain,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
26917,Primary Lesion,Recurrent Childhood Brain Stem Glioma,1
26918,Malignant Cellular Infiltrate,Leukemic Nonnodal Mantle Cell Lymphoma,1
26919,Epithelial Component Present,"Neoplasms, Fibroepithelial",1
26920,Low Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1,1
26921,Epithelial Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
26922,Carcinomatous Component Present,Renal medullary carcinoma,1
26923,Malignant Cellular Infiltrate,Papillary renal cell carcinoma type 2,1
26924,Epithelial Component Present,Anatomic Stage 0 Breast Cancer AJCC v8,1
26925,Epithelial Component Present,Stage IIIB Lung Large Cell Carcinoma AJCC v7,1
26926,Collagenous Stroma Formation,Mammary-Type Myofibroblastoma,1
26927,Myxoid Stroma Formation,Ameloblastic fibroma,1
26928,Malignant Cellular Infiltrate,Systemic Anaplastic Large Cell Lymphoma,1
26929,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma recurrent,1
26930,"Undifferentiated ""Fetal-Type"" Tissues Present",Grade 1 Teratoma,1
26931,Birbeck Granules Present,Refractory Langerhans Cell Histiocytosis,1
26932,Malignant Cellular Infiltrate,Stage III Bladder Cancer AJCC v8,1
26933,Carcinomatous Component Present,Stage I Rectosigmoid Cancer AJCC v6 and v7,1
26934,Malignant Cellular Infiltrate,"Carcinoma, Large Cell",1
26935,Lymphoplasmacytic Infiltrate,Central Nervous System Germinoma,1
26936,Childhood Lesion,Childhood Cerebral Astrocytoma,1
26937,Epithelial Component Present,Masaoka-Koga Stage IIb,1
26938,Malignant Cellular Infiltrate,Malignant neoplasm of anus,1
26939,Malignant Component Present,Ovarian Dermoid Cyst with Melanoma,1
26940,Hyperplastic Tissue Present,Endometrial Hyperplasia,1
26941,Metastatic Lesion,Secondary malignant neoplasm of skin,1
26942,Indolent Clinical Course,Central Nervous System Hibernoma,1
26943,Cystic Change,Cystadenoma,1
26944,Perivascular Arrangement of Tumor Cells,Glomangioma,1
26945,Epithelial Component Present,Oncocytic Breast Carcinoma,1
26946,Well-Circumscribed Lesion,Gastric hyperplastic polyp,1
26947,Malignant Cellular Infiltrate,Undifferentiated Endocervical Sarcoma,1
26948,Benign Cellular Infiltrate,Balloon cell nevus,1
26949,Transformed Phase of Disease,Refractory Transformed Non-Hodgkin Lymphoma,1
26950,Mixed Cellular Population,Anaplastic Oligoastrocytoma,1
26951,Perineural spread,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
26952,Clinical TNM Finding,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8,1
26953,Malignant Cellular Infiltrate,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
26954,Malignant Cellular Infiltrate,Metastatic urothelial carcinoma,1
26955,Carcinomatous Component Present,Metastatic Carcinoma in the Adrenal Medulla,1
26956,Microvascular Proliferation,Juvenile Pilocytic Astrocytoma,1
26957,Syncytial Pattern,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
26958,Moderate cytologic atypia,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
26959,High Mitotic Activity,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7,1
26960,Malignant Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Neoplasm,1
26961,Malignant Cellular Infiltrate,Renal Vein Leiomyosarcoma,1
26962,Malignant Cellular Infiltrate,Refractory Malignant Urinary System Neoplasm,1
26963,Benign Cellular Infiltrate,Benign neoplasm of colon,1
26964,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,1
26965,Malignant Cellular Infiltrate,adenocarcinoma of ureter,1
26966,Epithelial Component Present,Adenocarcinoma of salivary gland,1
26967,Malignant Cellular Infiltrate,Grade 2 Cutaneous Follicular Lymphoma,1
26968,Severe dysplasia,Carcinoma in situ of trachea,1
26969,Malignant Cellular Infiltrate,Synovial sarcoma metastatic,1
26970,Mesenchymal Differentiation,"Transitional cell carcinoma, spindle cell",1
26971,Single Malignant Cells Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",1
26972,Malignant Cellular Infiltrate,mucinous adenocarcinoma of anus,1
26973,Secondary Lesion,Pleural Carcinomatosis,1
26974,Neuroendocrine Differentiation,Advanced Neuroendocrine Carcinoma,1
26975,Immunologic Deficiency Syndromes,AIDS-Related Malignant Cervical Neoplasm,1
26976,Rapidly Enlarging Mass,Central Nervous System Rhabdomyosarcoma,1
26977,Indolent Clinical Course,Soft Palate Pleomorphic Adenoma,1
26978,Carcinomatous Component Present,Stage IV Lip Basal Cell Carcinoma,1
26979,Superficial Lesion,Superficial angiomyxoma,1
26980,Epithelial Component Present,Alcohol-Related Laryngeal Carcinoma,1
26981,Malignant Cellular Infiltrate,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,1
26982,Biphasic Pattern,Adult Mesenchymal Chondrosarcoma,1
26983,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of parotid gland,1
26984,Carcinomatous Component Present,Refractory Primary Peritoneal Carcinoma,1
26985,Epithelial Component Present,Non functioning pancreatic endocrine tumor,1
26986,Mitotic Activity,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
26987,Cutaneous Involvement,Xeroderma,1
26988,Osseous Differentiation,Stage IA Osteosarcoma AJCC v7,1
26989,Cutaneous Involvement,Scrotal Hemangioma,1
26990,Nuclear Atypia,MGMT-Methylated Glioblastoma,1
26991,High Grade Lesion,Recurrent Dedifferentiated Liposarcoma,1
26992,Malignant Cellular Infiltrate,Stage IIIB Primary Peritoneal Cancer AJCC v7,1
26993,Pseudorosette Formation,"Gastrinoma, malignant",1
26994,Malignant Cellular Infiltrate,Unresectable Gastrointestinal Stromal Tumor,1
26995,Carcinomatous Component Present,Stage IVA Colorectal Cancer AJCC v7,1
26996,Immunologic Deficiency Syndromes,Post-transplant lymphoproliferative disorder,1
26997,atypia morphology,Borderline Ovarian Endometrioid Cystadenofibroma,1
26998,Chronic Inflammatory Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
26999,Childhood Lesion,Childhood Choroid Plexus Papilloma,1
27000,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,High Risk Myelodysplastic Syndrome,1
27001,Malignant Cellular Infiltrate,Gallbladder Cribriform Carcinoma,1
27002,Malignant Cellular Infiltrate,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
27003,Contiguous Disease,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
27004,Epithelial Component Present,Hard Palate Adenoid Cystic Carcinoma,1
27005,Epithelial Component Present,Stage III Vulvar Cancer AJCC v7,1
27006,Epithelial Component Present,Adenosquamous cell lung cancer stage I,1
27007,Epithelial Component Present,Retroperitoneal Carcinoma,1
27008,Malignant Cellular Infiltrate,"Acute myeloid leukemia, minimal differentiation",1
27009,Epithelial Component Present,Cervical Esophagus Adenocarcinoma,1
27010,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v7,1
27011,Epithelial Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
27012,Infiltrative Growth Pattern,Chest Wall Fibromatosis,1
27013,Malignant Cellular Infiltrate,Splenic Manifestation of Prolymphocytic Leukemia,1
27014,Refractory Disease,Non-Hodgkin's lymphoma refractory,1
27015,Papillary Pattern,Condyloma acuminata of cervix,1
27016,Well-Circumscribed Lesion,Vaginal Rhabdomyoma,1
27017,Childhood Lesion,Childhood Mixed Glioma,1
27018,Malignant Cellular Infiltrate,Ann Arbor Stage II AIDS-Related Lymphoma,1
27019,Recurrent disease,Recurrent Biliary Tract Carcinoma,1
27020,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myeloid Leukemia with Minimal Differentiation,1
27021,Vascular Channel Formation,Gastric Hemangioma,1
27022,Exophytic Polypoid Lesion,Gastric Non-Neoplastic Polyp,1
27023,Epithelial Component Present,Sporadic Diffuse Gastric Adenocarcinoma,1
27024,Osteoid formation,Aggressive osteoblastoma,1
27025,Neuroendocrine Differentiation,Recurrent Abdominal Neuroendocrine Neoplasm,1
27026,Multilineage Dysplasia Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
27027,Malignant Cellular Infiltrate,Stage II Uterine Corpus Leiomyosarcoma AJCC v8,1
27028,Neuroendocrine Differentiation,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
27029,Unresectable Mass,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
27030,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v7 Stage,1
27031,Metaplasia of Malignant Cells Present,adenocarcinoma of breast with squamous metaplasia,1
27032,Biphasic Pattern,Tibial adamantinoma,1
27033,Metastatic Lesion,Locally Advanced Digestive System Carcinoma,1
27034,"Undifferentiated ""Fetal-Type"" Tissues Present",Mediastinal Immature Teratoma,1
27035,Rapidly Enlarging Mass,Sclerosing rhabdomyosarcoma,1
27036,Malignant Cellular Infiltrate,Refractory Dedifferentiated Liposarcoma,1
27037,Indolent Clinical Course,Breast Angiomatosis,1
27038,Malignant Cellular Infiltrate,"Myeloid Leukemia, Chronic",1
27039,Epithelial Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage,1
27040,Malignant Cellular Infiltrate,Granular Cell Leiomyosarcoma,1
27041,Vascular Channel Formation,Childhood Angiosarcoma,1
27042,Childhood Lesion,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",1
27043,Well Differentiated Neuroendocrine Lesion,Stage IIB Colon Neuroendocrine Tumor AJCC v8,1
27044,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v7,1
27045,Benign Cellular Infiltrate,Infiltrating angiolipoma,1
27046,High Mitotic Activity,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
27047,Epithelial Component Present,Paget Disease of the Anus,1
27048,Hyaline Cartilage Differentiation,Juxtacortical chondroma,1
27049,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma,1
27050,Carcinomatous Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",1
27051,Metastatic Lesion,Metastatic Meningioma,1
27052,Carcinomatous Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v7,1
27053,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
27054,Malignant Cellular Infiltrate,Advanced cancer,1
27055,Follicular Cell Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
27056,Malignant Cellular Infiltrate,Metastatic Hypopharyngeal Carcinoma,1
27057,Cord-Like Pattern,Vaginal Adenoid Basal Carcinoma,1
27058,Childhood Lesion,Childhood Testicular Mature Teratoma,1
27059,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP B",1
27060,Malignant Cellular Infiltrate,Stage IA2 Cervical Cancer AJCC v8,1
27061,Malignant Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v7,1
27062,Malignant Cellular Infiltrate,Locally Advanced Small Intestinal Carcinoma,1
27063,Low Cellularity Present,Childhood Pilocytic Astrocytoma,1
27064,Malignant Cellular Infiltrate,Large cell lung cancer recurrent,1
27065,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
27066,Indolent Clinical Course,Fibroma of prostate,1
27067,Metastatic Lesion,Carcinoma Metastatic to the Skin,1
27068,Increased Cellularity Present,Neuroblastoma recurrent,1
27069,Non-Invasive Lesion,Ureter Inverted Papilloma,1
27070,Carcinomatous Component Present,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
27071,Refractory Disease,Refractory Lymphoproliferative Disorder,1
27072,Malignant Cellular Infiltrate,leiomyosarcoma of lung,1
27073,Epithelial Component Present,Stage IVA Oropharyngeal Carcinoma AJCC v7,1
27074,Carcinomatous Component Present,Keratinizing Paranasal Sinus Squamous Cell Carcinoma,1
27075,Benign Cellular Infiltrate,Benign neoplasm of cornea,1
27076,Malignant Cellular Infiltrate,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage,1
27077,Fibroblastoma-Like Differentiation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,1
27078,Metastatic Lesion,Metastatic malignant neoplasm to nasopharynx,1
27079,Vascular Channel Formation,Cardiac Kaposi's Sarcoma,1
27080,Extraosseous Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,1
27081,Malignant Cellular Infiltrate,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
27082,Malignant Component Present,Ovarian Dermoid Cyst with Secondary Carcinoma,1
27083,Biphasic Pattern,Phyllodes Tumor,1
27084,Recurrent disease,acute biphenotypic leukemia in relapse,1
27085,Anaplasia,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
27086,Childhood Lesion,Childhood Brain Germ Cell Tumor,1
27087,Secondary Lesion,Metastatic Breast Carcinoid Tumor,1
27088,Pathologic TNM Finding,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
27089,Epithelial Component Present,Basal cell carcinoma,1
27090,Malignant Cellular Infiltrate,Adenocarcinoma in adenomatous polyposis coli,1
27091,Hyalinized Vessels Present,Childhood Pilocytic Astrocytoma,1
27092,High Grade Lesion,Sellar Dedifferentiated Chordoma,1
27093,Tubular Pattern,Pancreatic Somatostatinoma,1
27094,Cystic Change,"Serous cystadenoma, borderline malignancy",1
27095,Malignant Cellular Infiltrate,Bartholin Gland Small Cell Carcinoma,1
27096,Primary Site Unknown,Melanoma of Unknown Primary,1
27097,Increased Cellularity Present,Childhood Pineoblastoma,1
27098,Stromal Invasion,Stage IA Ovarian Cancer,1
27099,Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia,1
27100,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,1
27101,Malignant Cellular Infiltrate,Cervical Villoglandular Adenocarcinoma,1
27102,Pushing Tumor Margin,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
27103,Epithelial Component Present,Colorectal Intraepithelial Neoplasia,1
27104,High Mitotic Activity,Pancreatic Endocrine Carcinoma,1
27105,Carcinomatous Component Present,Stage IIIA Lung Cancer AJCC v7,1
27106,Malignant Cellular Infiltrate,Stage IA Ampulla of Vater Cancer AJCC v8,1
27107,Low Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1,1
27108,Papillary Pattern,Vaginal Squamous Papilloma,1
27109,Benign Cellular Infiltrate,Pericardial Leiomyoma,1
27110,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia,1
27111,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma recurrent,1
27112,Cutaneous Involvement,Malignant Breast Eccrine Spiradenoma,1
27113,Malignant Cellular Infiltrate,Solid Papillary Breast Carcinoma,1
27114,Malignant Cellular Infiltrate,Carcinoma in situ in a polyp,1
27115,Malignant Cellular Infiltrate,Cerebral Non-Hodgkin Lymphoma,1
27116,Indolent Clinical Course,Mediastinal Leiomyoma,1
27117,Cutaneous Involvement,Warty dyskeratoma,1
27118,Epithelial Component Present,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
27119,Refractory Disease,Refractory Urothelial Carcinoma,1
27120,Malignant Cellular Infiltrate,Childhood Epithelioid Sarcoma,1
27121,Epithelial Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma,1
27122,Single Cell Necrosis,Stage IIA Merkel Cell Carcinoma AJCC v7,1
27123,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma non-metastatic,1
27124,Epithelial Component Present,Borderline Ovarian Clear Cell Cystadenofibroma,1
27125,Epithelial Component Present,Ampulla of Vater Adenosquamous Carcinoma,1
27126,Malignant Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v8,1
27127,Benign Cellular Infiltrate,Benign Mixed Tumor of the Vulva,1
27128,Carcinomatous Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
27129,Exophytic Polypoid Lesion,Oropharyngeal Polyp,1
27130,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma,1
27131,Favorable Clinical Outcome,Inflammatory Hepatocellular Adenoma,1
27132,Local disease,Localized Unresectable Neuroblastoma,1
27133,Borderline Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1
27134,Syncytial Pattern,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
27135,Nuclear Atypia,Childhood Brain Anaplastic Astrocytoma,1
27136,Carcinomatous Component Present,BCLC Stage D Hepatocellular Carcinoma,1
27137,Trabecular Pattern,Somatostatinoma,1
27138,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
27139,Malignant Cellular Infiltrate,Acute Erythroblastic Leukemia,1
27140,Malignant Cellular Infiltrate,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,1
27141,Localized Lesion,Solitary Osteochondroma,1
27142,Well-Circumscribed Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,1
27143,Recurrent disease,Recurrent Uveal Melanoma,1
27144,Invasive Lesion,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,1
27145,Malignant Cellular Infiltrate,Childhood Brain Anaplastic Astrocytoma,1
27146,Epithelial Component Present,Stage IIIA Thymoma AJCC v8,1
27147,Malignant Cellular Infiltrate,Prostate cancer stage B,1
27148,Epithelial Component Present,Bladder Non-Invasive Papillary Urothelial Neoplasm,1
27149,Epithelial Component Present,Rectal Medullary Carcinoma,1
27150,Epithelial Component Present,canalicular adenoma of salivary gland,1
27151,Aggressive Clinical Course,Burkitt Leukemia,1
27152,Epithelial Component Present,Hepatic cancer stage IVA,1
27153,Exophytic Papillary Lesion,papillary carcinoma of penis,1
27154,Extraosseous Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
27155,Malignant Cellular Infiltrate,Carcinoma Arising from Craniopharyngioma,1
27156,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,carcinosarcoma of fallopian tube,1
27157,Malignant Cellular Infiltrate,Recurrent Skin Angiosarcoma,1
27158,Secondary Lesion,Carcinoma ex Eccrine Spiradenoma,1
27159,Vascular Channel Formation,Adult Epithelioid Hemangioendothelioma,1
27160,Epithelial Component Present,Borderline Resectable Carcinoma,1
27161,Cutaneous Involvement,Scrotal Carcinoma,1
27162,Nuclear Grooves,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
27163,Mitotic Activity,Childhood Yolk Sac Tumor,1
27164,Malignant Germinomatous Cellular Infiltrate,Intracranial Germinoma,1
27165,Tissue Differentiation Uncertain,Cardiac Biphasic Synovial Sarcoma,1
27166,Carcinomatous Component Present,Stage III Hepatocellular Carcinoma AJCC v7,1
27167,Severe cytologic atypia,Colorectal Small Cell Neuroendocrine Carcinoma,1
27168,Malignant Cellular Infiltrate,Lung Enteric Adenocarcinoma,1
27169,Diffuse Pattern,Childhood Immunoblastic Lymphoma,1
27170,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
27171,Epithelial Component Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
27172,Benign Cellular Infiltrate,HIV lipodystrophy,1
27173,Malignant Cellular Infiltrate,melanoma,1
27174,Epithelial Component Present,Buccal Mucosa Verrucous Carcinoma,1
27175,Carcinomatous Component Present,Stage III Anal Cancer AJCC v8,1
27176,Diffuse Pattern,Adult Giant Cell Glioblastoma,1
27177,Primary Lesion,Primary leiomyosarcoma,1
27178,Pseudostratified Tumor Cells Present,"Endocervical Adenocarcinoma, Usual Type",1
27179,Peripheral Nuclear Palisading,basaloid carcinoma of anus,1
27180,Malignant Cellular Infiltrate,Ocular Sebaceous Carcinoma,1
27181,Carcinomatous Component Present,adenocarcinoma of urethra,1
27182,Epithelial Component Present,Locally Advanced Pancreatic Adenocarcinoma,1
27183,Rapidly Enlarging Mass,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
27184,Recurrent disease,Recurrent Adrenal Cortex Carcinoma,1
27185,Fibrotic Stroma Formation,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
27186,Mild cytologic atypia,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
27187,Monomorphic Cellular Infiltrate,Recurrent Childhood Oligodendroglioma,1
27188,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma,1
27189,Carcinomatous Component Present,Skin Basaloid Carcinoma,1
27190,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Alkylating Agent-Related Myelodysplastic Syndrome,1
27191,Absence of Stromal Invasion,Serous papillary cystic tumor of borderline malignancy,1
27192,Carcinomatous Component Present,Clinical Stage II Gastric Cancer AJCC v8,1
27193,Secondary Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,1
27194,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory Cytopenia of Childhood,1
27195,Thyroglobulin Positive Neoplastic Cells Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
27196,Epithelial Component Present,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
27197,Cutaneous Involvement,Cutaneous Lipomatous Neoplasm,1
27198,Pathologic TNM Finding,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
27199,Malignant Cellular Infiltrate,Hydroa vacciniforme-like lymphoma,1
27200,Malignant Cellular Infiltrate,Stage IA Hepatocellular Carcinoma AJCC v8,1
27201,Hemorrhagic,Solid pseudopapillary tumor of the pancreas,1
27202,Subcutaneous Involvement,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
27203,Hyaline Cartilage Differentiation,Myxoid chondrosarcoma,1
27204,Nodular Pattern,Distal-Type Epithelioid Sarcoma,1
27205,Malignant Cellular Infiltrate,"Cancer, Supratentorial",1
27206,Dysplasia,Ampulla of Vater Tubulovillous Adenoma,1
27207,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Teratoma,1
27208,Adnexal Differentiation,Neoplasm of skin with adnexal differentiation,1
27209,Lymphoplasmacytic Infiltrate,"Castleman Disease, Hyaline-Vascular Type",1
27210,Epithelial Component Present,Basaloid squamous cell carcinoma,1
27211,Benign Cellular Infiltrate,Benign neoplasm of sebaceous gland,1
27212,Malignant Cellular Infiltrate,Stage IIIC1 Uterine Corpus Cancer AJCC v7,1
27213,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with Neuroblastoma,1
27214,Anaplasia,Anaplastic Malignant Neoplasm,1
27215,Clinical TNM Finding,Clinical Stage IIB Gastric Cancer AJCC v8,1
27216,Malignant Cellular Infiltrate,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
27217,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma,1
27218,Cutaneous Involvement,Malignant Sebaceous Neoplasm,1
27219,Malignant Cellular Infiltrate,Cardiac Malignant Fibrous Histiocytoma,1
27220,Deep Lesion,Spindle cell liposarcoma,1
27221,Platinum Resistance,Platinum-Resistant Primary Peritoneal Carcinoma,1
27222,Cystic Change,"Cystadenocarcinoma, Papillary",1
27223,Carcinomatous Component Present,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
27224,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v8,1
27225,Neuroectodermal Differentiation,Stage 2B Neuroblastoma,1
27226,Carcinomatous Component Present,Pancreatic Mixed Adenoneuroendocrine Carcinoma,1
27227,Epithelial Component Present,Ceruminous adenocarcinoma,1
27228,Childhood Lesion,Recurrent Childhood Protoplasmic Astrocytoma,1
27229,Epithelial Component Present,Ovarian Sertoli-Stromal Cell Tumor,1
27230,Recurrent disease,Recurrent Pancreatic Acinar Cell Carcinoma,1
27231,Immunologic Deficiency Syndromes,AIDS-Related Gastric Kaposi Sarcoma,1
27232,Exophytic Polypoid Lesion,Ampulla of Vater Tubulovillous Adenoma,1
27233,Hyperplastic Tissue Present,Adrenal Medullary Hyperplasia,1
27234,Malignant Cellular Infiltrate,Stage IV Anal Cancer AJCC v8,1
27235,Benign Cellular Infiltrate,Proliferative fasciitis,1
27236,Epithelial Component Present,carcinosarcoma of fallopian tube,1
27237,Epithelial Component Present,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",1
27238,Primary Lesion,Indolent Systemic Mastocytosis,1
27239,Carcinomatous Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage,1
27240,Diffuse Lesion,Lymphangiomatosis,1
27241,Epithelial Component Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
27242,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
27243,Malignant Cellular Infiltrate,Lymphoid leukemia,1
27244,Epithelial Component Present,Benign Basal Cell Neoplasm,1
27245,Single Type of Tissue Derived from One Embryonic Layer Present,Monodermal teratoma,1
27246,Poorly Differentiated Lesion,Poorly Differentiated Angiosarcoma,1
27247,Cutaneous Involvement,Carcinoma Metastatic to the Skin,1
27248,Epithelial Component Present,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,1
27249,Carcinomatous Component Present,Advanced Head and Neck Carcinoma,1
27250,Painless Mass,Giant Cell Tumor of Soft Tissue,1
27251,Well-Circumscribed Lesion,Mixed Cell Adrenal Cortical Adenoma,1
27252,Carcinomatous Component Present,Breast cancer recurrent,1
27253,Solitary mass,"Bronchiolo-alveolar carcinoma, non-mucinous",1
27254,Hyperkeratosis,"Lung Squamous Cell Carcinoma, Papillary Variant",1
27255,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Columnar Cell Hyperplasia of the Breast,1
27256,Aggressive Clinical Course,Digital papillary eccrine carcinoma of skin,1
27257,Well-Circumscribed Lesion,"Polyposis, Gastric",1
27258,Unresectable Mass,Unresectable Urethral Urothelial Carcinoma,1
27259,Organoid Pattern,Bladder Alveolar Soft Part Sarcoma,1
27260,Malignant Cellular Infiltrate,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
27261,Well-Circumscribed Lesion,Colon adenoma,1
27262,More than 10 Mitoses per 10HPF,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
27263,Recurrent disease,Recurrent Childhood Ependymoma,1
27264,Malignant Cellular Infiltrate,Platinum-Resistant Ovarian Carcinoma,1
27265,Malignant Cellular Infiltrate,Recurrent Malignant Skin Neoplasm,1
27266,Papillary Pattern,Myxopapillary ependymoma,1
27267,Epithelial Component Present,Adenocarcinoma Of Esophagus,1
27268,Lobulated Growth Pattern,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1
27269,Carcinomatous Component Present,Metastatic thymic carcinoma,1
27270,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Adult Pure Erythroid Leukemia,1
27271,Epithelial Component Present,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
27272,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Microadenoma,1
27273,Carcinomatous Component Present,Primary Intraosseous Squamous Cell Carcinoma,1
27274,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma,1
27275,Well Differentiated Lesion,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
27276,Diffuse Pattern,Classical Glioblastoma,1
27277,Childhood Lesion,Childhood Soft Tissue Sarcoma,1
27278,Non-Hereditary Lesion,Gastric Papillary Adenocarcinoma,1
27279,Malignant Cellular Infiltrate,Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8,1
27280,Malignant Cellular Infiltrate,Carcinoma ex Eccrine Spiradenoma,1
27281,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,1
27282,Malignant Cellular Infiltrate,Esophageal Diffuse Large B-Cell Lymphoma,1
27283,Epithelial Component Present,Vulvar Seborrheic Keratosis,1
27284,Non-Invasive Lesion,Stage 0is Ureter Cancer AJCC v7,1
27285,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma,1
27286,Metastatic Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
27287,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Nodular amyloidosis,1
27288,Exophytic Polypoid Lesion,Villous adenoma of duodenum,1
27289,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
27290,Epithelial Component Present,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,1
27291,Adnexal Differentiation,Sebaceous Gland Neoplasms,1
27292,Villous Pattern,Villous adenoma of colon,1
27293,Microvascular Proliferation,gliosarcoma,1
27294,Malignant Cellular Infiltrate,Adult Lymphoblastic Lymphoma,1
27295,Childhood Lesion,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
27296,Carcinomatous Component Present,Low Grade Adenosquamous Breast Carcinoma,1
27297,Epithelial Component Present,High Grade Conjunctival Intraepithelial Neoplasia,1
27298,Malignant Cellular Infiltrate,Nodular melanoma,1
27299,Necrotic changes (finding),Refractory Extensive Stage Lung Small Cell Carcinoma,1
27300,Fibrosis,Fibrosclerosis of breast,1
27301,Myxoid Changes Present,Osteochondromyxoma,1
27302,Benign Cellular Infiltrate,Central Nervous System Dermoid Cyst,1
27303,Carcinomatous Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
27304,Epithelial Component Present,CARCINOMA OF VULVA,1
27305,Diffuse Pattern,Cardiac Malignant Peripheral Nerve Sheath Tumor,1
27306,Endobronchial Lesion,Lung Glandular Papilloma,1
27307,Cutaneous Involvement,Signet Ring Melanoma,1
27308,Benign Cellular Infiltrate,Benign neoplasm of oropharynx,1
27309,Carcinomatous Component Present,Pigmented Basal Cell Carcinoma,1
27310,Cellular Pleomorphism,Malignant Lung PEComa,1
27311,Carcinomatous Component Present,Stage II Ampulla of Vater Cancer AJCC v8,1
27312,Polymorphic Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
27313,Diffuse Pattern,Recurrent Childhood Diffuse Astrocytoma,1
27314,Non-Specific Glandular Pattern,Bladder Adenocarcinoma,1
27315,Childhood Lesion,Infant Leukemia,1
27316,Juvenile Lesion,Juvenile type ovarian granulosa cell tumor,1
27317,Fibrotic Stroma Formation,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
27318,Carcinomatous Component Present,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
27319,Trabecular Pattern,Well Differentiated Hepatocellular Carcinoma,1
27320,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v7 Stage,1
27321,Carcinomatous Component Present,Stage I Adrenal Cortex Carcinoma AJCC v8,1
27322,Intraductal Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
27323,Malignant Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,1
27324,Endocervical Type Epithelium Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
27325,Diffuse Pattern,Secondary Supratentorial Anaplastic Astrocytoma,1
27326,Recurrent disease,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
27327,Neuroendocrine Differentiation,Ovarian Neuroendocrine Neoplasm,1
27328,Carcinomatous Component Present,Prostate cancer stage B,1
27329,Epithelioid Component Present,Pleural Biphasic Synovial Sarcoma,1
27330,Cutaneous Involvement,Acne Keloid,1
27331,atypia morphology,Vulvar Dysplastic Melanocytic Nevus,1
27332,Immunologic Deficiency Syndromes,"Lymphoma, AIDS-Related",1
27333,Malignant Cellular Infiltrate,Small cell glioblastoma,1
27334,Epithelial Component Present,Stage IB Fallopian Tube Cancer AJCC v8,1
27335,Desmoplastic Stroma Formation,Childhood Desmoplastic Small Round Cell Tumor,1
27336,Malignant Cellular Infiltrate,Grade 2 Endometrial Mucinous Adenocarcinoma,1
27337,Carcinomatous Component Present,verrucous carcinoma of vagina,1
27338,Adnexal Differentiation,Eccrine acrospiroma,1
27339,Recurrent disease,Duodenal carcinoma recurrent,1
27340,Benign Cellular Infiltrate,Parathyroid mixed cell type adenoma,1
27341,Carcinomatous Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
27342,In Situ Lesion,Stage 0 Anal Cancer AJCC v8,1
27343,Epithelial Component Present,Serous cystadenocarcinoma ovary,1
27344,Cutaneous Involvement,Cutaneous neurofibroma,1
27345,Metastatic Lesion,Metastatic Carcinoma in the Adrenal Medulla,1
27346,Microvascular Proliferation,Classical Glioblastoma,1
27347,Koilocytotic atypia,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
27348,Solid Growth Pattern,Pancreatic Solid Serous Adenoma,1
27349,Above the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
27350,Thick-Walled Hyalinized Vessels Present,Gastric Schwannoma,1
27351,Malignant Cellular Infiltrate,Recurrent Malignant Ovarian Brenner Tumor,1
27352,Benign Cellular Infiltrate,Aldosterone-Producing Adrenal Cortex Adenoma,1
27353,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v8,1
27354,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",1
27355,Metastatic/Recurrent Disease,Malignant Lung PEComa,1
27356,Epithelial Component Present,Stage 0 Merkel Cell Carcinoma AJCC v7,1
27357,Carcinomatous Component Present,Primary hepatic neuroendocrine carcinoma,1
27358,Epithelial Component Present,Testicular Carcinoid Tumor,1
27359,Malignant Cellular Infiltrate,Monoblastic Sarcoma,1
27360,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia,1
27361,Primary Lesion,Primary Effusion Lymphoma,1
27362,Pushing Tumor Margin,Laryngeal verrucous carcinoma recurrent,1
27363,Cutaneous Involvement,Epithelial neoplasm of skin,1
27364,Lobulated Growth Pattern,malignant myoepithelioma of breast,1
27365,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Double expressor lymphoma,1
27366,Cutaneous Involvement,Diaper Rash,1
27367,Malignant Cellular Infiltrate,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
27368,Malignant Cellular Infiltrate,Cancer of Neck,1
27369,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage I,1
27370,Unresectable Mass,Locally Advanced Unresectable Bone Sarcoma,1
27371,Carcinomatous Component Present,Recurrent Endometrial Serous Adenocarcinoma,1
27372,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v7 Stage,1
27373,Intraosseous Lesion,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
27374,Malignant Cellular Infiltrate,Stage I Childhood Lymphoblastic Lymphoma,1
27375,Mitotic Activity,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor,1
27376,Indolent Clinical Course,Central odontogenic fibroma,1
27377,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
27378,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis of skin,1
27379,Thin Bands of Collagen Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
27380,Tissue Differentiation Uncertain,Clear Cell Sarcoma of Soft Tissue,1
27381,Benign Cellular Infiltrate,Colon Leiomyoma,1
27382,Secondary Lesion,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,1
27383,Malignant Cellular Infiltrate,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
27384,Absence of Invasion,Stage 0 Colon Cancer AJCC v6 and v7,1
27385,S-100-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Interdigitating",1
27386,Absence of Invasion,Adenocarcinoma in situ in adenomatous polyp,1
27387,Drug toxicity,Transplant-Related Kaposi Sarcoma,1
27388,Benign Cellular Infiltrate,Seborrheic keratosis of eyelid,1
27389,Vascular Channel Formation,Hemolymphangioma,1
27390,Necrotic changes (finding),Melanotic malignant nerve sheath tumor,1
27391,Fibrotic Stroma Formation,Borderline Ovarian Endometrioid Adenofibroma,1
27392,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
27393,Neuroendocrine Differentiation,Recurrent Digestive System Neuroendocrine Carcinoma,1
27394,Tissue of Mullerian Origin Present,Uterine Corpus Atypical Polypoid Adenomyoma,1
27395,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v6 Stage,1
27396,Mesenchymal Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
27397,Carcinomatous Component Present,Sphenoid Sinus Squamous Cell Carcinoma,1
27398,Acanthosis,Vaginal Warty Carcinoma,1
27399,Cutaneous Involvement,Non-Neoplastic Hair Disorder,1
27400,Malignant Cellular Infiltrate,Recurrent Acute Leukemia,1
27401,Carcinomatous Component Present,"Squamous Cell Carcinoma of the Penis, Usual Type",1
27402,High Grade Lesion,Radiation-Related Osteosarcoma,1
27403,Malignant Cellular Infiltrate,Anaplastic Carcinoma of the Rectum,1
27404,Malignant Cellular Infiltrate,Lobular carcinoma in situ of breast,1
27405,Epithelial Component Present,Paget's disease and intraductal carcinoma of breast,1
27406,Bilateral Disease,Bilateral Carcinoma,1
27407,Malignant Cellular Infiltrate,Paget's Disease of the Nipple,1
27408,Diffuse Pattern,Supratentorial Glioblastoma,1
27409,Indolent Clinical Course,Breast Epithelioid Hemangioma,1
27410,Primary Lesion,Childhood Gliosarcoma,1
27411,Recurrent disease,Recurrent Fallopian Tube Serous Adenocarcinoma,1
27412,Lobulated Growth Pattern,Sellar Chondroid Chordoma,1
27413,Epithelial Component Present,Prognostic Stage 0 Breast Cancer AJCC v8,1
27414,Carcinomatous Component Present,Mucinous adenocarcinoma of appendix,1
27415,Fibrotic Stroma Formation,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
27416,Cutaneous Involvement,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
27417,Locally Aggressive Lesion,Inflammatory Myofibroblastic Tumor,1
27418,Myxoid Stroma Formation,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
27419,Epithelial Component Present,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
27420,Malignant Cellular Infiltrate,Stage IIIA Anal Cancer AJCC v8,1
27421,Platinum Resistance,Platinum-Resistant Lung Small Cell Carcinoma,1
27422,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
27423,Hypercellular bone marrow,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
27424,Thick-Walled Hyalinized Vessels Present,Peripheral Nerve Schwannoma,1
27425,Chronic lymphocytic inflammation,Nonencapsulated sclerosing tumor,1
27426,Indolent Clinical Course,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",1
27427,Epithelial Component Present,Glomerulosa Cell Adrenal Cortical Adenoma,1
27428,Carcinomatous Component Present,Prostate Cancer by AJCC v6 Stage,1
27429,Epithelial Component Present,large cell neuroendocrine carcinoma of breast,1
27430,Nerve palsy,Glossopharyngeal nerve paralysis,1
27431,Epithelial Component Present,Gastric Carcinoid Tumor,1
27432,Epithelial Component Present,Clear cell papillary renal cell carcinoma,1
27433,Diffuse Pattern,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,1
27434,Carcinomatous Component Present,Stage IA1 Cervical Cancer,1
27435,Childhood Lesion,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
27436,Malignant Cellular Infiltrate,Refractory Central Nervous System Lymphoma,1
27437,Epithelial Component Present,"Thymoma, type B3",1
27438,Tissue Differentiation Uncertain,Childhood Kidney Angiomyolipoma,1
27439,Recurrent disease,Peritoneal mesothelioma malignant recurrent,1
27440,Papillary Pattern,Oncocytic Schneiderian papilloma,1
27441,Malignant Cellular Infiltrate,Liver Synovial Sarcoma,1
27442,High Grade Lesion,Metastatic Lung Small Cell Carcinoma,1
27443,Fibrotic Stroma Formation,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
27444,Benign Cellular Infiltrate,Ganglioneuroma of mediastinum,1
27445,Malignant Cellular Infiltrate,Squamous Cell Carcinoma of Unknown Primary,1
27446,Epithelial Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
27447,Epithelial Component Present,Borderline Ovarian Serous Adenofibroma,1
27448,Serotonin Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell",1
27449,Recurrent disease,Primary mediastinal large B-cell lymphoma recurrent,1
27450,Endophytic Tumor Growth,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
27451,Malignant Cellular Infiltrate,Stage III Testicular Seminoma AJCC v6 and v7,1
27452,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8,1
27453,Epithelial Component Present,Stage I Lung Small Cell Carcinoma AJCC v7,1
27454,Ineffective hematopoiesis,Myelodysplastic Syndrome with Isolated del(5q),1
27455,Dysplasia,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
27456,Carcinomatous Component Present,Stage I Renal Cell Cancer AJCC v8,1
27457,Recurrent disease,Recurrent Olfactory Neuroblastoma,1
27458,Benign Cellular Infiltrate,Benign Teratoma,1
27459,Primary Lesion,Fibrolamellar Hepatocellular Carcinoma,1
27460,Epithelial Component Present,Stage IVA Hepatocellular Carcinoma AJCC v7,1
27461,Malignant Cellular Infiltrate,Pericardial Yolk Sac Tumor,1
27462,Carcinomatous Component Present,Small Intestinal Squamous Cell Carcinoma,1
27463,Indolent Clinical Course,Colorectal Leiomyoma,1
27464,Exophytic Polypoid Lesion,Polyp of vulva,1
27465,Benign Cellular Infiltrate,Central Nervous System Leiomyoma,1
27466,Invasive Lesion,"Dermatofibrosarcoma Protuberans, Myxoid",1
27467,Anaplasia,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,1
27468,Malignant Cellular Infiltrate,Refractory Human Papillomavirus-Related Malignant Neoplasm,1
27469,Papillary Pattern,Condyloma Acuminatum with Dysplasia,1
27470,Invasive Lesion,Invasive Mixed Breast Carcinoma,1
27471,Benign Cellular Infiltrate,Plexiform Neurofibroma,1
27472,Neuroendocrine Differentiation,Pancreatic Delta Cell Neoplasm,1
27473,Epithelial Component Present,Breast Cancer by AJCC v8 Prognostic Stage,1
27474,Refractory Disease,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
27475,Severe cytologic atypia,"Endometrial stromal sarcoma, high grade",1
27476,Malignant Cellular Infiltrate,Primary malignant neoplasm of glomus jugulare,1
27477,Carcinomatous Component Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
27478,Malignant Cellular Infiltrate,sarcoma of trachea,1
27479,Refractory Disease,Refractory Cutaneous Melanoma,1
27480,Poorly Differentiated Lesion,Poorly Differentiated Hepatocellular Carcinoma,1
27481,Mixed Cellular Population,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,1
27482,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8,1
27483,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma refractory,1
27484,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
27485,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage III,1
27486,Rapidly Enlarging Mass,Adult Pleomorphic Rhabdomyosarcoma,1
27487,Refractory Disease,Refractory Glioblastoma,1
27488,Malignant Cellular Infiltrate,Histiocytoid Breast Carcinoma,1
27489,Malignant Cellular Infiltrate,Resectable Digestive System Carcinoma,1
27490,Malignant Cellular Infiltrate,Eccrine porocarcinoma,1
27491,Fibrotic Stroma Formation,clear cell adenocarcinofibroma of ovary,1
27492,Malignant Cellular Infiltrate,Stage IV Diffuse Large B-Cell Lymphoma,1
27493,Primary Lesion,Non-Hodgkin's lymphoma of central nervous system,1
27494,Follicular Cell Differentiation,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
27495,Perivascular Arrangement of Tumor Cells,Hereditary Glomangioma,1
27496,Negative Bone Marrow and Peripheral Blood,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder,1
27497,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
27498,Bone Marrow Lymphoplasmacytic Infiltrate,Waldenstrom Macroglobulinemia,1
27499,Refractory Disease,Mantle cell lymphoma refractory,1
27500,Insular Pattern,"Somatostatinoma, malignant",1
27501,Carcinomatous Component Present,Adenocarcinoma of the rete testis,1
27502,Adulthood Lesion,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8,1
27503,Vascular Channel Formation,Colon Cavernous Hemangioma,1
27504,Epithelial Component Present,Stage III Vulvar Cancer AJCC v8,1
27505,Lymphoplasmacytic Infiltrate,Central Nervous System Germinoma,1
27506,Epithelial Component Present,Stage IIB Prostate Cancer AJCC v7,1
27507,Low Grade Neuroendocrine Lesion,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
27508,Secondary Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
27509,Carcinomatous Component Present,Stage 0 Esophageal Cancer AJCC v7,1
27510,Vascular Channel Formation,Gastric Hemangioma,1
27511,Malignant Cellular Infiltrate,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
27512,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
27513,Epithelial Component Present,Low Grade Salivary Gland Mucoepidermoid Carcinoma,1
27514,Malignant Cellular Infiltrate,Childhood Non-Hodgkin Lymphoma,1
27515,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Endometrioid Tumor,1
27516,Hereditary Lesion,Hereditary Kidney Oncocytoma,1
27517,Neuroectodermal Differentiation,"Ganglioneuroblastoma, Nodular",1
27518,Hereditary Lesion,Multiple self-healing epithelioma of Ferguson-Smith,1
27519,Epithelial Component Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
27520,Hemorrhagic,Angiosarcoma of liver,1
27521,Invasive Lesion,Paget Disease of the Breast with Invasive Ductal Carcinoma,1
27522,Well Differentiated Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1,1
27523,Well-Circumscribed Lesion,Duodenal Adenoma,1
27524,Rapidly Enlarging Mass,Fusion-Negative Alveolar Rhabdomyosarcoma,1
27525,Malignant Cellular Infiltrate,Embryonal Rhabdomyosarcoma,1
27526,Malignant Cellular Infiltrate,Prostate Cancer by Whitmore-Jewett Stage,1
27527,Chronic lymphocytic inflammation,Salivary Gland Sebaceous Lymphadenoma,1
27528,Epithelial Component Present,Gastric Neuroendocrine Neoplasm,1
27529,Solitary mass,Chordoma,1
27530,Epithelial Component Present,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
27531,Epithelial Component Present,Pleomorphic Hepatocellular Carcinoma,1
27532,Malignant Cellular Infiltrate,Stage IIIB Fallopian Tube Cancer AJCC v8,1
27533,Malignant Cellular Infiltrate,Malignant neoplasm of cheek mucosa,1
27534,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage I,1
27535,Nuclear pleomorphism,Type D Lymphomatoid Papulosis,1
27536,Wheezing,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
27537,Carcinomatous Component Present,Oropharyngeal lymphepithelioma,1
27538,Carcinomatous Component Present,Mixed Acinar-Ductal Carcinoma of the Pancreas,1
27539,Malignant Cellular Infiltrate,Adenocarcinoma,1
27540,Epithelial Component Present,Benign Epithelioma,1
27541,Radial Growth Phase,Stage III Superficial Spreading Melanoma AJCC v7,1
27542,Malignant Cellular Infiltrate,Stage IV Ovarian Cancer AJCC v6 and v7,1
27543,Unclassifiable Lesion,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",1
27544,Malignant Cellular Infiltrate,Resectable Pancreatic Ductal Adenocarcinoma,1
27545,Malignant Cellular Infiltrate,Stage IIIA Appendix Carcinoma AJCC v8,1
27546,Benign Cellular Infiltrate,Hemangioma of gingiva,1
27547,Follicular Cell Differentiation,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
27548,Slow Growing Mass,Hemosiderotic Fibrolipomatous Tumor,1
27549,Malignant Cellular Infiltrate,Prostate Cancer by Whitmore-Jewett Stage,1
27550,Epithelial Component Present,Hard Palate Squamous Cell Carcinoma,1
27551,Pathologic TNM Finding,Pathologic Stage III Cutaneous Melanoma AJCC v8,1
27552,Epithelial Component Present,Stage IA Breast Cancer AJCC v7,1
27553,Carcinomatous Component Present,adenocarcinoma of urethra,1
27554,Malignant Cellular Infiltrate,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
27555,Glandular Pattern,Intestinal-Type Sinonasal Adenocarcinoma,1
27556,Villous Pattern,Ampulla of Vater Tubulovillous Adenoma,1
27557,High Grade Lesion,Metastatic Lung Small Cell Carcinoma,1
27558,Carcinomatous Component Present,"Lung Large Cell Carcinoma, Clear Cell Variant",1
27559,Benign Cellular Infiltrate,Benign neoplasm of mesothelial tissue of pleura,1
27560,Mixed Cellular Population,carcinosarcoma of lung,1
27561,Epithelial Component Present,Carcinoma of anal canal,1
27562,Adnexal Differentiation,Malignant Germinative Follicular Epithelium Neoplasm,1
27563,Malignant Cellular Infiltrate,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
27564,Biphasic Pattern,Pericanalicular fibroadenoma,1
27565,Epithelial Component Present,Ovarian Granulosa-Stromal Cell Tumor,1
27566,Intestinal metaplasia,Vaginal Tubular Adenoma,1
27567,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
27568,Epithelial Component Present,Biliary Intraepithelial Neoplasia-2,1
27569,atypia morphology,Borderline Ovarian Mucinous Tumor,1
27570,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Ligament Endometrioid Adenocarcinoma,1
27571,Clinical TNM Finding,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
27572,In Situ Lesion,Carcinoma in situ of ampulla of Vater,1
27573,Benign Cellular Infiltrate,Benign Ovarian Serous Tumor,1
27574,Epithelial Component Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,1
27575,Benign Cellular Infiltrate,Uterine Corpus Diffuse Leiomyomatosis,1
27576,Malignant Cellular Infiltrate,"Malignant Mixed Tumor, Not Otherwise Specified",1
27577,Malignant Cellular Infiltrate,Regressing Non-Cutaneous Melanoma,1
27578,Low Mitotic Activity,Stage II Gastric Neuroendocrine Tumor AJCC v8,1
27579,Benign Cellular Infiltrate,Maturing Ganglioneuroma,1
27580,Calcitonin serum level increased,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
27581,Malignant Cellular Infiltrate,Stage IVB Lung Cancer AJCC v8,1
27582,In Situ Lesion,Pleomorphic lobular carcinoma in situ of breast,1
27583,Malignant Cellular Infiltrate,synovial sarcoma,1
27584,No Evidence of Metastatic Disease,Non-Metastatic Childhood Soft Tissue Sarcoma,1
27585,Malignant Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis,1
27586,Benign Cellular Infiltrate,Ovarian Sclerosing Stromal Tumor,1
27587,Primary Lesion,Meningeal melanomatosis,1
27588,Carcinomatous Component Present,Metastatic Breast Carcinoma,1
27589,Malignant Cellular Infiltrate,Stage IIC Appendix Carcinoma AJCC v8,1
27590,Epithelial Component Present,Stage I Ureter Cancer AJCC v8,1
27591,Carcinomatous Component Present,Prostate carcinoma,1
27592,Childhood Lesion,Childhood Choroid Plexus Papilloma,1
27593,Recurrent disease,Pancreatic adenocarcinoma recurrent,1
27594,Epithelial Component Present,Papillary craniopharyngioma,1
27595,Epithelial Component Present,Fallopian Tube Endometrioid Tumor,1
27596,Malignant Cellular Infiltrate,Recurrent Lung Carcinoma Cell Type Unspecified,1
27597,Invasive Lesion,adenosquamous carcinoma of breast,1
27598,Recurrent disease,B-cell small lymphocytic lymphoma recurrent,1
27599,High Grade Lesion,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,1
27600,Comedo Necrosis,Rectal Cribriform Comedo-Type Adenocarcinoma,1
27601,Malignant Cellular Infiltrate,Stage IIB Uveal Melanoma AJCC v7,1
27602,Malignant Cellular Infiltrate,Locally Advanced Small Intestinal Carcinoma,1
27603,Primary Lesion,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
27604,Carcinomatous Component Present,Invasive papillary breast carcinoma,1
27605,Benign Cellular Infiltrate,Lipoma of spermatic cord,1
27606,Malignant Cellular Infiltrate,Malignant Phyllodes Tumor of Prostate,1
27607,Invasive Lesion,"Dermatofibrosarcoma Protuberans, Myxoid",1
27608,Low Grade Neuroendocrine Lesion,Gastric Carcinoid Tumor,1
27609,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma,1
27610,Non-Invasive Lesion,Stage 0a Ureter Cancer AJCC v7,1
27611,Edematous Stroma Formation,Spermatocytic seminoma,1
27612,Carcinomatous Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
27613,Epithelial Component Present,"Transitional cell carcinoma, micropapillary",1
27614,Epithelial Component Present,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
27615,Malignant Cellular Infiltrate,Stage IIC Prostate Cancer AJCC v8,1
27616,Epithelial Component Present,Stage I Colon Cancer AJCC v8,1
27617,Malignant Cellular Infiltrate,ISS Stage II Plasma Cell Myeloma,1
27618,Ground Glass Nuclear Inclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
27619,Benign Cellular Infiltrate,benign mature teratoma of pancreas,1
27620,Benign Cellular Infiltrate,Ovarian Clear Cell Cystadenofibroma,1
27621,Carcinomatous Component Present,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
27622,Recurrent disease,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,1
27623,Vascular Channel Formation,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
27624,Invasive Lesion,Breast Columnar Cell Mucinous Carcinoma,1
27625,Epithelial Component Present,tubulopapillary adenoma of gallbladder,1
27626,Rapidly Enlarging Mass,Anaplastic thyroid carcinoma,1
27627,Epithelial Component Present,Stage IV Penile Cancer AJCC v7,1
27628,Intraocular Lesion,Intraocular Lymphoma,1
27629,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v7,1
27630,Malignant Cellular Infiltrate,Stage III Renal Pelvis Cancer AJCC v8,1
27631,Malignant Cellular Infiltrate,Biochemically Recurrent Prostate Carcinoma,1
27632,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
27633,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma,1
27634,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
27635,Malignant Cellular Infiltrate,Anal margin Paget's disease,1
27636,Epithelial Component Present,Recurrent Male Reproductive System Carcinoma,1
27637,High Mitotic Activity,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
27638,Well-Circumscribed Lesion,"Leydig cell tumor, benign",1
27639,Solitary mass,Chordoma of clivus,1
27640,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v7 Stage,1
27641,Epithelial Component Present,Stage III Prostate Cancer AJCC v8,1
27642,Osteoid formation,Extraskeletal Osteosarcoma,1
27643,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v7,1
27644,Malignant Cellular Infiltrate,Rectal Small Cell Neuroendocrine Carcinoma,1
27645,Low Mitotic Activity,Gastric Gastrin-Producing Neuroendocrine Tumor,1
27646,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma metastatic,1
27647,Intestinal metaplasia,Vaginal Villous Adenoma,1
27648,Tubular Pattern,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma,1
27649,Epithelial Component Present,Stage I Vaginal Cancer AJCC v8,1
27650,Hemorrhagic,Angiosarcoma non-metastatic,1
27651,Lobulated Growth Pattern,Ventricular myxoma,1
27652,Invasive Lesion,Infiltrating duct and lobular carcinoma,1
27653,Complete Spontaneous Regression,Type D Lymphomatoid Papulosis,1
27654,Malignant Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v7,1
27655,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
27656,S-100-Positive Neoplastic Cells Present,Lung PEComa,1
27657,Malignant Cellular Infiltrate,Urothelial carcinoma bladder recurrent,1
27658,Malignant Cellular Infiltrate,Pharyngeal cancer stage I,1
27659,Carcinomatous Component Present,Advanced Lung Non-Small Cell Squamous Carcinoma,1
27660,Epithelial Component Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
27661,Malignant Cellular Infiltrate,Uveal Melanoma Metastatic in the Liver,1
27662,Epithelial Component Present,Urethral Urothelial Papilloma,1
27663,Epithelial Component Present,Signet-ring cell adenocarcinoma gastric,1
27664,Carcinomatous Component Present,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,1
27665,High Mitotic Activity,Gastric Neuroendocrine Carcinoma,1
27666,Tissue Differentiation Uncertain,Adult Alveolar Soft Part Sarcoma,1
27667,Necrotic changes (finding),Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
27668,Malignant Cellular Infiltrate,Refractory Gastric Carcinoma,1
27669,Precise Histogenesis Unknown,Central Nervous System Hemangioblastoma,1
27670,Hyperplastic Tissue Present,Sebaceous hyperplasia,1
27671,Epithelial Component Present,Stage 0 Gallbladder Cancer AJCC v6 and v7,1
27672,Stromal Invasion,Ovarian Cancer by AJCC v6 and v7 Stage,1
27673,Carcinomatous Component Present,Parotid Gland Adenocarcinoma,1
27674,Epithelial Component Present,Skin Clear Cell Basal Cell Carcinoma,1
27675,Extensive Stage Lesion,Advanced Digestive System Neuroendocrine Neoplasm,1
27676,Epithelial Component Present,Glucagonoma,1
27677,Malignant Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage,1
27678,Secondary Lesion,CNS metastases,1
27679,Metastatic Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
27680,Cutaneous Involvement,Cutaneous Fibrohistiocytic Neoplasm,1
27681,Papillary Pattern,Papillary carcinoma in situ,1
27682,Crystal deposition,Alveolar soft part sarcoma non-metastatic,1
27683,Secondary Lesion,Secondary Chondrosarcoma,1
27684,Benign Cellular Infiltrate,Lipoma of external auditory meatus,1
27685,Malignant Cellular Infiltrate,Central Nervous System Kaposi Sarcoma,1
27686,Malignant Cellular Infiltrate,Recurrent Olfactory Neuroblastoma,1
27687,Pathologic TNM Finding,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
27688,Epithelial Component Present,Adenocarcinoma of anal canal,1
27689,Malignant Cellular Infiltrate,Malignant neoplasm of bladder recurrent,1
27690,atypia morphology,Actinic keratosis,1
27691,Lesion with Diameter of 10mm or Less,Papillary Thyroid Microcarcinoma,1
27692,Regional Disease,Locally Advanced Pancreatic Ductal Adenocarcinoma,1
27693,Malignant Cellular Infiltrate,Refractory WHO Grade III Glioma,1
27694,atypia morphology,Malignant Ovarian Thecoma,1
27695,Malignant Cellular Infiltrate,verrucous carcinoma of vulva,1
27696,Biphasic Pattern,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
27697,Tubular Pattern,Colonic tubulovillous adenoma,1
27698,Absence of Stromal Invasion,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
27699,Malignant Cellular Infiltrate,Small intestine carcinoma recurrent,1
27700,Carcinomatous Component Present,Childhood Paranasal Sinus Carcinoma,1
27701,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
27702,Carcinomatous Component Present,Stage IA Lung Small Cell Carcinoma AJCC v7,1
27703,Carcinomatous Component Present,Carcinoma in a polyp,1
27704,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone marrow,1
27705,Mast Cells 10 Percent or More of Peripheral Blood White Cells,"Leukemia, Mast-Cell",1
27706,Postneoadjuvant Therapy Pathologic TNM Finding,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
27707,Endophytic Tumor Growth,Urethral Verrucous Carcinoma,1
27708,Radiation Sickness,Radiation-induced fibrous mediastinitis,1
27709,Macrofollicular Structures Present,Juvenile Type Testicular Granulosa Cell Tumor,1
27710,Recurrent disease,Recurrent Salivary Gland Cancer,1
27711,Malignant Cellular Infiltrate,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,1
27712,Well-Circumscribed Lesion,Lung Mucinous Cystadenoma,1
27713,Epithelial Component Present,Growth Hormone-Producing Pituitary Gland Neoplasm,1
27714,Spontaneous Regression,Vulvar Keratoacanthoma,1
27715,Cutaneous Involvement,Unresectable Skin Basal Cell Carcinoma,1
27716,Malignant Cellular Infiltrate,Stage IV Anal Canal Cancer AJCC v6 and v7,1
27717,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage,1
27718,Perivascular fibrosis,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage,1
27719,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
27720,Carcinomatous Component Present,Distal Bile Duct Carcinoma,1
27721,Nuclear Atypia,Cerebellar Glioblastoma,1
27722,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
27723,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214,1
27724,Glandular Pattern,Somatostatinoma,1
27725,Intracellular Accumulation of Lipids,Pleomorphic Xanthoastrocytoma,1
27726,Malignant Cellular Infiltrate,mucinous adenocarcinofibroma of ovary,1
27727,Recurrent disease,Recurrent Craniopharyngioma,1
27728,Steatohepatitis,HNF1alpha-Inactivated Hepatocellular Adenoma,1
27729,Intraosseous Lesion,Odontogenic myxofibroma,1
27730,Epithelial Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
27731,Malignant Cellular Infiltrate,Grade II Chondrosarcoma,1
27732,Malignant Cellular Infiltrate,Central Nervous System Embryonal Tumor with Rhabdoid Features,1
27733,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Lipid-rich carcinoma,1
27734,Unresectable Mass,Metastatic Unresectable Malignant Neoplasm,1
27735,Epithelial Component Present,undifferentiated carcinoma of appendix,1
27736,Morphologic Overlap,B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma,1
27737,Carcinomatous Component Present,Retroperitoneal Carcinoma,1
27738,Multifocal Lesion,Intraductal Breast Myoepitheliosis,1
27739,Malignant Cellular Infiltrate,Recurrent Childhood Rhabdomyosarcoma,1
27740,Epithelial Component Present,High Grade Anal Canal Squamous Intraepithelial Neoplasia,1
27741,Malignant Cellular Infiltrate,Colon Serrated Adenocarcinoma,1
27742,Cutaneous Involvement,Type D Lymphomatoid Papulosis,1
27743,Epithelial Component Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
27744,Fibrosis,Primary mediastinal large B-cell lymphoma refractory,1
27745,Multinodular Mass,Metastatic angiosarcoma,1
27746,Actinic Damage,Hutchinson's Melanotic Freckle,1
27747,Carcinomatous Component Present,Undifferentiated carcinoma of stomach,1
27748,Epithelial Component Present,Stage I Hepatocellular Carcinoma AJCC v6 and v7,1
27749,Myxoid Stroma Formation,Epithelioid hemangioendothelioma,1
27750,Malignant Cellular Infiltrate,Cigarette Smoking-Related Carcinoma,1
27751,Malignant Cellular Infiltrate,Squamous Cell Carcinoma of Unknown Primary,1
27752,Follicular Cell Differentiation,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
27753,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v8 Stage,1
27754,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v8,1
27755,Well Differentiated Lesion,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
27756,Malignant Cellular Infiltrate,Biliary Intraepithelial Neoplasia-3,1
27757,Metastatic/Recurrent Disease,Gastric Synovial Sarcoma,1
27758,Epithelial Component Present,Verrucous carcinoma of the oral cavity recurrent,1
27759,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
27760,Nuclear Molding,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
27761,Low Mitotic Activity,Ileal Neuroendocrine Tumor,1
27762,Malignant Cellular Infiltrate,Pathologic Stage IIB Cutaneous Melanoma AJCC v8,1
27763,Recurrent disease,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
27764,Epithelial Component Present,keratinizing squamous cell carcinoma of lung,1
27765,Malignant Cellular Infiltrate,Secondary malignant neoplasm of hypopharynx,1
27766,Well-Circumscribed Lesion,Cortisol-Producing Adrenal Cortex Adenoma,1
27767,Malignant Cellular Infiltrate,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,1
27768,Malignant Cellular Infiltrate,Bladder Adenocarcinoma,1
27769,"Fully Differentiated ""Adult-Type"" Tissues Present",Mediastinal Immature Teratoma,1
27770,Epithelial Component Present,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
27771,Epithelial Component Present,Extrahepatic Bile Duct Carcinoid Tumor,1
27772,Low Grade Neuroendocrine Lesion,Carcinoid tumor of the duodenum,1
27773,Storiform Growth Pattern,Non-Ossifying Fibroma,1
27774,Malignant Component Present,Testicular Teratoma with Somatic-Type Malignancy,1
27775,Locally Aggressive Lesion,Intermediate Osteogenic Neoplasm,1
27776,Intraocular Lesion,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
27777,Dysplasia,Appendix Sessile Serrated Adenoma/Polyp,1
27778,Malignant Cellular Infiltrate,Unresectable Intrahepatic Cholangiocarcinoma,1
27779,Malignant Cellular Infiltrate,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
27780,Syncytial Pattern,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
27781,CD4-Positive Neoplastic Cells Present,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
27782,Malignant Cellular Infiltrate,Renal carcinoma,1
27783,Carcinomatous Component Present,Transitional cell carcinoma urethra,1
27784,Multinodular and Vacuolated Pattern,Multinodular and Vacuolated Tumor of the Cerebrum,1
27785,Poorly Differentiated Lesion,Colorectal Sarcomatoid Carcinoma,1
27786,Invasive Lesion,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,1
27787,Epithelial Component Present,BCLC Stage A Hepatocellular Carcinoma,1
27788,Neuroendocrine Differentiation,Non functioning pancreatic endocrine tumor,1
27789,High Grade Lesion,High Grade Liver Dysplastic Nodule,1
27790,Extensive Stage Lesion,Pericardial mesothelioma malignant advanced,1
27791,Carcinomatous Component Present,Stage 0 Colon Cancer AJCC v8,1
27792,Clinical TNM Finding,Clinical Stage I Gastric Cancer AJCC v8,1
27793,Recurrent disease,Recurrent Desmoid-Type Fibromatosis,1
27794,Malignant Cellular Infiltrate,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7,1
27795,Neuroendocrine Differentiation,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
27796,Malignant Cellular Infiltrate,Metastatic Non-Cutaneous Melanoma,1
27797,Solar Radiation Toxicity,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
27798,Epithelial Component Present,mixed acinar-endocrine carcinoma of pancreas,1
27799,Malignant Cellular Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,1
27800,Well Differentiated Hyaline Cartilage Present,Adult Mesenchymal Chondrosarcoma,1
27801,Malignant Cellular Infiltrate,Secretory breast carcinoma,1
27802,Malignant Cellular Infiltrate,Ann Arbor Stage IIIB Hodgkin Lymphoma,1
27803,Malignant Cellular Infiltrate,Transplant-Related Hepatocellular Carcinoma,1
27804,Diffuse Pattern,Thyroid Diffuse Large B-Cell Lymphoma,1
27805,Cutaneous Involvement,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
27806,Solid Growth Pattern,Pleuropulmonary blastoma type III,1
27807,Nuclear Atypia,Childhood Cerebral Anaplastic Astrocytoma,1
27808,Pseudopapillary Pattern,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
27809,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v8 Stage,1
27810,Acinar Cell Differentiation,Recurrent Acinic Cell Breast Carcinoma,1
27811,Epithelial Component Present,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,1
27812,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Fallopian Tube Gestational Choriocarcinoma,1
27813,Chromogranin A Positive Neoplastic Cells Present,Gallbladder Goblet Cell Carcinoid,1
27814,Secondary Lesion,Secondary malignant neoplasm of colon,1
27815,Mild dysplasia,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
27816,High Mitotic Activity,Small cell lung cancer extensive stage,1
27817,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage III,1
27818,Malignant Cellular Infiltrate,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
27819,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Prolactin Secreting Adenoma,1
27820,Primary Lesion,Cerebellar Glioblastoma,1
27821,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
27822,Cutaneous Involvement,Lentigo maligna melanoma,1
27823,Carcinomatous Component Present,Stage 0a Ureter Cancer AJCC v8,1
27824,Cutaneous Involvement,"Nevus, Blue",1
27825,Rimming of Adipose Tissue Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
27826,Malignant Cellular Infiltrate,Recurrent Endometrial Serous Adenocarcinoma,1
27827,Low Grade Neuroendocrine Lesion,Carcinoid tumor of intestine,1
27828,Below the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,1
27829,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
27830,Epithelial Component Present,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
27831,Epithelial Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
27832,Epithelial Component Present,"Thymoma, type B2",1
27833,Deep Lesion,Aggressive angiomyxoma,1
27834,Carcinomatous Component Present,Stage IIIA Bladder Cancer AJCC v8,1
27835,Monoclonal Cellular Population Present,Thyroid Gland Lipoadenoma,1
27836,Malignant Cellular Infiltrate,T-Cell Large Granular Lymphocyte Leukemia,1
27837,Malignant Cellular Infiltrate,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
27838,Epithelial Component Present,Stage I Adrenal Cortex Carcinoma AJCC v7,1
27839,Epithelial Component Present,Stage IIA Colon Neuroendocrine Tumor AJCC v8,1
27840,Epithelial Component Present,Lung Pleomorphic Adenoma,1
27841,Papillary Pattern,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
27842,Recurrent disease,Recurrent Cancer of Gallbladder,1
27843,Presence of a Hormonal Syndrome,Malignant Pancreatic Vipoma,1
27844,Epithelial Component Present,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
27845,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
27846,Intracanalicular Growth Pattern,Malignant Cystosarcoma Phyllodes,1
27847,Carcinomatous Component Present,Prostate cancer stage B,1
27848,Epithelial Component Present,Stage IIIC Ovarian Cancer AJCC v8,1
27849,Tissues Derived from Two or Three Embryonic Layers Present,Childhood Ovarian Mature Teratoma,1
27850,Malignant Cellular Infiltrate,Human Papillomavirus-Related Endocervical Adenocarcinoma,1
27851,Malignant Cellular Infiltrate,Stage II Skin Cancer,1
27852,Carcinomatous Component Present,"Adenocarcinoma of lung, stage IV",1
27853,Epithelial Component Present,Recurrent Cancer of Gallbladder,1
27854,Malignant Cellular Infiltrate,Diffuse Intrinsic Pontine Glioma,1
27855,Antoni A Pattern,Sympathetic Schwannoma,1
27856,Absence of Invasion,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
27857,Malignant Cellular Infiltrate,Advanced Neuroendocrine Carcinoma,1
27858,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma,1
27859,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
27860,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor,1
27861,Dysplasia,Fundic gland polyp,1
27862,Cutaneous Involvement,Vulvar Adenocarcinoma of Sweat Gland Type,1
27863,Well Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
27864,Malignant Cellular Infiltrate,Stage II Appendix Carcinoma AJCC v8,1
27865,Mixed Cellular Population,Salivary Gland Pleomorphic Adenoma,1
27866,Regional Disease,Locally Advanced Bone Sarcoma,1
27867,Regional Disease,Locally Advanced Small Intestinal Carcinoma,1
27868,Metastatic Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
27869,Carcinomatous Component Present,Recurrent Chromophobe Renal Cell Carcinoma,1
27870,Carcinomatous Component Present,Recurrent Fallopian Tube Serous Adenocarcinoma,1
27871,Malignant Cellular Infiltrate,Malignant Cystosarcoma Phyllodes,1
27872,Refractory Disease,Anaplastic large cell lymphoma T- and null-cell types refractory,1
27873,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Alveolar Variant",1
27874,Diffuse Pattern,MGMT-Methylated Glioblastoma,1
27875,Epithelial Component Present,Pancreatic Neuroendocrine Microadenoma,1
27876,Epithelial Component Present,Syringoma,1
27877,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v6 Stage,1
27878,Carcinomatous Component Present,Stage II Renal Cell Cancer,1
27879,Mixed Cellular Population,Stage IC Uterine Corpus Adenosarcoma AJCC v8,1
27880,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma,1
27881,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Non-Gestational Ovarian Choriocarcinoma,1
27882,Immunologic Deficiency Syndromes,AIDS-Related Primary Central Nervous System Lymphoma,1
27883,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
27884,Malignant Cellular Infiltrate,Prostate Lymphoma,1
27885,Carcinomatous Component Present,epithelial-myoepithelial carcinoma of lung,1
27886,Gyriform Trabecular Pattern,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
27887,Dentin formation,"Fibro-odontoma, Ameloblastic",1
27888,Local disease,Lipoma of spinal cord,1
27889,Papillary Pattern,Condyloma anal,1
27890,Monomorphic Cellular Infiltrate,Ependymoma,1
27891,Unresectable Mass,Unresectable Craniopharyngioma,1
27892,Necrotic changes (finding),MGMT-Unmethylated Glioblastoma,1
27893,Non-Invasive Lesion,Inverted urothelial papilloma,1
27894,Indolent Clinical Course,Ameloblastic fibrodentinoma,1
27895,Epithelial Component Present,Pituitary Gland Macroadenoma,1
27896,Epithelial Component Present,Benign Ovarian Luteinized Thecoma,1
27897,Malignant Cellular Infiltrate,"Lung Large Cell Carcinoma, Clear Cell Variant",1
27898,Clinical TNM Finding,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
27899,Poorly Differentiated Lesion,Renal medullary carcinoma,1
27900,Stromal Invasion,FIGO Stage IVB Ovarian Cancer,1
27901,Epithelial Component Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
27902,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1B,1
27903,Poorly Differentiated Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
27904,Hyperplastic Tissue Present,Ductal Breast Hyperplasia,1
27905,Malignant Cellular Infiltrate,Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,1
27906,Severe dysplasia,Stage 0is Urethral Cancer AJCC v8,1
27907,Malignant Cellular Infiltrate,Recurrent Appendix Mucinous Adenocarcinoma,1
27908,Pseudopapillary Pattern,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,1
27909,Epithelial Component Present,Cervical intraepithelial neoplasia grade 2,1
27910,Malignant Cellular Infiltrate,Cervical Keratinizing Squamous Cell Carcinoma,1
27911,Myxoid Stroma Formation,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
27912,Epithelial Component Present,undifferentiated carcinoma of appendix,1
27913,Epithelial Component Present,Malignant Phyllodes Tumor of Prostate,1
27914,Neuroectodermal Differentiation,Stage 2 Neuroblastoma,1
27915,Infiltrative Growth Pattern,"Fibromatosis, Plantar",1
27916,Carcinomatous Component Present,Unresectable Skin Carcinoma,1
27917,atypia morphology,Borderline Ovarian Serous Adenofibroma,1
27918,Secondary Lesion,Metastatic Paraganglioma,1
27919,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8,1
27920,Microglandular Pattern,Cervical Microglandular Polyp,1
27921,Epithelial Component Present,Stage IIIA Gastric Carcinoma,1
27922,Malignant Cellular Infiltrate,Carcinoma Metastatic to the Skin,1
27923,Indolent Clinical Course,Benign Bone Schwannoma,1
27924,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
27925,Malignant Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type recurrent,1
27926,Indolent Clinical Course,Hemangioma of breast,1
27927,Carcinomatous Component Present,Stage 0 Vulvar Cancer,1
27928,Cystic Change,Melanoacanthoma,1
27929,Malignant Cellular Infiltrate,Stage III Primary Peritoneal Cancer AJCC v8,1
27930,Questionable Invasive Lesion,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,1
27931,Poorly Cohesive Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric,1
27932,Perivascular Pseudorosette Formation,Adult Anaplastic Ependymoma,1
27933,Stromal Invasion,Stage IIIC Ovarian Cancer,1
27934,Severe dysplasia,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
27935,Glomeruloid Vessels Present,Adult Pilocytic Astrocytoma,1
27936,Carcinomatous Component Present,Stage IVA Appendix Carcinoma AJCC v8,1
27937,Malignant Cellular Infiltrate,Localized Gallbladder Carcinoma,1
27938,Epithelial Component Present,Carcinoma of sublingual gland,1
27939,Malignant Cellular Infiltrate,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
27940,Lobulated Growth Pattern,Chordoma of clivus,1
27941,Cutaneous Involvement,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
27942,Benign Cellular Infiltrate,Benign vascular neoplasm,1
27943,Malignant Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v7 Stage,1
27944,Malignant Cellular Infiltrate,Stage I Acral Lentiginous Melanoma AJCC v7,1
27945,Immunologic Deficiency Syndromes,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
27946,Childhood Lesion,Childhood Atypical Choroid Plexus Papilloma,1
27947,Unresectable Mass,Metastatic Unresectable Malignant Neoplasm,1
27948,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Liver,1
27949,Epithelial Component Present,Thyroid stimulating hormone-producing pituitary tumor,1
27950,Epithelial Component Present,Parasympathetic paraganglioma,1
27951,Cartilaginous Differentiation,Chondroblastoma,1
27952,Cutaneous Involvement,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
27953,Malignant Cellular Infiltrate,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
27954,Neuroendocrine Differentiation,Intestinal Neuroendocrine Neoplasm,1
27955,Osseous Component Present,Endobronchial Hamartoma,1
27956,Epithelial Component Present,Papillary serous cystadenocarcinoma,1
27957,Metastatic Lesion,Metastatic Adenoid Cystic Carcinoma,1
27958,Carcinomatous Component Present,Stage IV Major Salivary Gland Cancer AJCC v8,1
27959,Epithelial Component Present,Pancreatic Macrocystic Serous Cystadenoma,1
27960,Malignant Cellular Infiltrate,Burkitt Lymphoma with Plasmacytoid Differentiation,1
27961,Secondary Lesion,Metastatic Neoplasm to the Gallbladder,1
27962,Recurrent disease,Recurrent Endometrial Serous Adenocarcinoma,1
27963,Well Differentiated Neuroendocrine Lesion,Pancreatic Somatostatinoma,1
27964,Carcinomatous Component Present,Scrotal Carcinoma,1
27965,Epithelial Component Present,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,1
27966,Moderate dysplasia,Grade II Penile Intraepithelial Neoplasia,1
27967,Severe dysplasia,Stage 0 Vulvar Cancer,1
27968,Hereditary Lesion,Hereditary Breast and Ovarian Cancer Syndrome,1
27969,Malignant Cellular Infiltrate,Secondary malignant neoplasm of brain stem,1
27970,Epithelial Component Present,Breast Carcinoma Metastatic in the Spine,1
27971,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
27972,Benign Cellular Infiltrate,Leiomyoma of ciliary body,1
27973,Secondary Lesion,Pseudomyxoma Peritonei,1
27974,High Grade Lesion,Diencephalic Glioblastoma,1
27975,Malignant Cellular Infiltrate,Lung adenocarcinoma recurrent,1
27976,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type I,1
27977,Carcinomatous Component Present,Colon Small Cell Neuroendocrine Carcinoma,1
27978,Epithelial Component Present,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
27979,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
27980,Epithelial Component Present,Refractory Malignant Thymoma,1
27981,Malignant Cellular Infiltrate,Brain Glioblastoma,1
27982,Malignant Cellular Infiltrate,Childhood Hodgkin Lymphoma by Ann Arbor Stage,1
27983,Hereditary Lesion,TUBEROUS SCLEROSIS 2 (disorder),1
27984,Epithelial Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
27985,Non-Invasive Lesion,Bladder Urothelial Carcinoma in Situ,1
27986,Severe dysplasia,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
27987,Carcinomatous Component Present,Recurrent Ovarian Serous Adenocarcinoma,1
27988,Malignant Cellular Infiltrate,Immunodeficiency-associated Burkitt's lymphoma,1
27989,Meckel Diverticulum,Meckel Diverticulum Neuroendocrine Tumor G1,1
27990,Cutaneous Involvement,"Carcinoma, Skin Appendage",1
27991,Malignant Cellular Infiltrate,Oropharyngeal cancer recurrent,1
27992,Malignant Cellular Infiltrate,Thymic Clear Cell Carcinoma,1
27993,Malignant Cellular Infiltrate,Choriocarcinoma combined with other germ cell elements,1
27994,Epithelial Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
27995,Malignant Cellular Infiltrate,Stage III Prostate Carcinoma,1
27996,Childhood Lesion,Childhood Non-Hodgkin Lymphoma,1
27997,Epithelial Component Present,Colon cancer recurrent,1
27998,Malignant Cellular Infiltrate,Malignant Hard Palate Neoplasm,1
27999,Papillary Pattern,Vaginal Mullerian Papilloma,1
28000,High Grade Lesion,Secondary osteosarcoma,1
28001,Benign Cellular Infiltrate,Female Reproductive System Adenofibroma,1
28002,Childhood Lesion,Childhood Brain Anaplastic Astrocytoma,1
28003,Cutaneous Involvement,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
28004,Thick-Walled Hyalinized Vessels Present,Ureter Schwannoma,1
28005,Immunologic Deficiency Syndromes,Transplant-Related Hepatocellular Carcinoma,1
28006,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
28007,Neuroendocrine Differentiation,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,1
28008,Malignant Cellular Infiltrate,Alkylating Agent-Related Myelodysplastic Syndrome,1
28009,Epithelial Component Present,Cervical Verrucous Carcinoma,1
28010,Stromal Invasion,Recurrent Ovarian Clear Cell Adenocarcinoma,1
28011,Poorly Differentiated Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma,1
28012,Two Separate Tumor Masses Present in the Same Organ,Pituitary Gland Double Adenomas,1
28013,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-2,1
28014,Recurrent disease,Recurrent Uterine Corpus Carcinoma,1
28015,Pseudopapillary Pattern,Childhood Ovarian Embryonal Carcinoma,1
28016,Neuroectodermal Differentiation,Neuroblastoma of brain,1
28017,Epithelial Component Present,Bladder Cancer by AJCC v8 Stage,1
28018,Benign Cellular Infiltrate,Cardiac fibroma,1
28019,Epithelial Component Present,Stage II Cervical Cancer AJCC v8,1
28020,Malignant Cellular Infiltrate,Pericardial Angiosarcoma,1
28021,Carcinomatous Component Present,"Malignant Mixed Tumor, Not Otherwise Specified",1
28022,Nodular Pattern,Grade 3 Cutaneous Follicular Lymphoma,1
28023,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Malignant Neoplasm,1
28024,Indolent Clinical Course,Cellular Myxoma,1
28025,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myeloid Leukemia with Maturation,1
28026,Epithelial Component Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
28027,Diffuse Lesion,Intraductal papillomatosis,1
28028,Bone Marrow Dysplasia Present,Recurrent Chronic Myelomonocytic Leukemia,1
28029,Benign Cellular Infiltrate,Trigeminal schwannoma,1
28030,S-100-Positive Neoplastic Cells Present,Lung Clear Cell Tumor,1
28031,Immature Granulocytes in Peripheral Blood Under 10 Percent,"Leukemia, Myelomonocytic, Chronic",1
28032,Well-Circumscribed Lesion,Rhabdomyoma,1
28033,Carcinomatous Component Present,malignant myoepithelioma of breast,1
28034,Cystic Change,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma,1
28035,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
28036,Secondary Lesion,Metastatic Adrenal Cortex Carcinoma,1
28037,Malignant Cellular Infiltrate,Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7,1
28038,Well Differentiated Lesion,Gastric Carcinoid Tumor,1
28039,Lymphoplasmacytic Infiltrate,Oropharyngeal lymphoepithelioma stage I,1
28040,Pushing Tumor Margin,Urethral Verrucous Carcinoma,1
28041,Malignant Cellular Infiltrate,Childhood Small Intestinal Carcinoma,1
28042,Malignant Cellular Infiltrate,AJCC Grade 1 Sarcoma,1
28043,High Grade Lesion,Stage IV Lung Small Cell Carcinoma AJCC v7,1
28044,Benign Cellular Infiltrate,Neurothekeoma,1
28045,Epithelial Component Present,Oncocytic Schneiderian papilloma,1
28046,Carcinomatous Component Present,Human Papillomavirus-Related Cervical Carcinoma,1
28047,Carcinomatous Component Present,Ovarian Cancer by FIGO Stage,1
28048,Epithelial Component Present,Squamous cell carcinoma of head and neck metastatic,1
28049,Papillary Pattern,Respiratory papilloma,1
28050,Malignant Cellular Infiltrate,Embryonal Carcinoma,1
28051,Diffuse Pattern,large B-cell diffuse lymphoma of accessory sinus,1
28052,Well Differentiated Neuroendocrine Lesion,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
28053,Neuroendocrine Differentiation,Malignant neoplasm of carotid body,1
28054,Epithelial Component Present,Pathologic Stage IV Gastric Cancer AJCC v8,1
28055,Malignant Cellular Infiltrate,Colorectal Medullary Carcinoma,1
28056,Benign Cellular Infiltrate,Juvenile Xanthogranuloma,1
28057,Intraductal Lesion,papillomatosis of extrahepatic bile duct,1
28058,Carcinomatous Component Present,Villous adenocarcinoma,1
28059,Cervical Glandular Dysplasia,Cervical Adenocarcinoma In Situ,1
28060,Malignant Cellular Infiltrate,Secondary malignant neoplasm of eye,1
28061,Secondary Lesion,Locally Advanced Angiosarcoma,1
28062,Diffuse Lesion,Carcinomatosis of peritoneal cavity,1
28063,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Alveolar Variant",1
28064,Papillary Pattern,Inverted urothelial papilloma,1
28065,Carcinomatous Component Present,Rectosigmoid cancer recurrent,1
28066,Epithelial Component Present,Stage II Fallopian Tube Cancer,1
28067,Collagenous Stroma Formation,Classic Congenital Mesoblastic Nephroma,1
28068,Epithelial Component Present,Solid carcinoma,1
28069,High Grade Lesion,Frontal Lobe Anaplastic Astrocytoma,1
28070,Squamous metaplasia of bladder,Bladder squamous cell carcinoma recurrent,1
28071,Indolent Clinical Course,Urethral Leiomyoma,1
28072,CD56-Positive Neoplastic Cells Present,adult nasal type extranodal NK/T-cell lymphoma,1
28073,Epithelial Component Present,Polymorphous low grade adenocarcinoma of salivary gland,1
28074,Epithelial Component Present,Esophageal Large Cell Neuroendocrine Carcinoma,1
28075,Microvascular Proliferation,Brain Stem Glioblastoma,1
28076,Dysplasia,Adenoma of ampulla of Vater,1
28077,Malignant Cellular Infiltrate,Duodenal-type follicular lymphoma,1
28078,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Tumor G2,1
28079,Malignant Cellular Infiltrate,Classical Glioblastoma,1
28080,Metastatic Lesion,Metastatic Cervical Carcinoma,1
28081,Adnexal Differentiation,Sweat Gland Neoplasms,1
28082,Malignant Cellular Infiltrate,Recurrent Childhood Central Nervous System Embryonal Neoplasm,1
28083,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of lacrimal gland,1
28084,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Columnar Cell Hyperplasia of the Breast,1
28085,Malignant Cellular Infiltrate,Orbital Melanoma,1
28086,Secondary Lesion,Metastatic Triple-Negative Breast Carcinoma,1
28087,Neuroendocrine Differentiation,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
28088,Nuclear Grooves,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
28089,Cutaneous Involvement,Pustulosis of Palms and Soles,1
28090,Antoni A Pattern,Benign Esophageal Schwannoma,1
28091,Malignant Cellular Infiltrate,Borderline Resectable Pancreatic Adenocarcinoma,1
28092,Diffuse Pattern,Pleural Epithelioid Mesothelioma,1
28093,Papillary Pattern,Ureter Inverted Papilloma,1
28094,Capillary Sized Vascular Channel Formation,Infantile hemangioma,1
28095,Nuclear Atypia,Adult Giant Cell Glioblastoma,1
28096,Malignant Cellular Infiltrate,Refractory cancer,1
28097,High Grade Lesion,Anaplastic Diencephalic Astrocytoma,1
28098,Malignant Cellular Infiltrate,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
28099,Dysplasia,"Vulvar Intraepithelial Neoplasia, Differentiated Type",1
28100,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,1
28101,Malignant Cellular Infiltrate,Polymorphous low grade adenocarcinoma of salivary gland,1
28102,Adulthood Lesion,Adult Anaplastic Astrocytoma,1
28103,Epithelial Component Present,Papillary serous endometrial carcinoma,1
28104,Malignant Cellular Infiltrate,"Squamous cell carcinoma, large cell, nonkeratinizing",1
28105,Neuroendocrine Differentiation,Breast Neuroendocrine Neoplasm,1
28106,Adulthood Lesion,Adult Grade I Meningioma,1
28107,Malignant Cellular Infiltrate,Retinoblastoma by AJCC v8 Stage,1
28108,Cutaneous Involvement,Granuloma Annulare,1
28109,High Grade Lesion,Angiosarcoma NCI Grade 3,1
28110,Malignant Cellular Infiltrate,Stage I Penile Cancer AJCC v6,1
28111,Epithelial Component Present,Vaginal Adenoid Basal Carcinoma,1
28112,Vertical Growth Phase,Nodular melanoma,1
28113,Papillary Pattern,Papillary Breast Neoplasm,1
28114,Cutaneous Involvement,Recurrent Primary Cutaneous Lymphoma,1
28115,Vascular Channel Formation,Hemangioma of skin,1
28116,Epithelial Component Present,Stage II Cervical Cancer AJCC v8,1
28117,Malignant Cellular Infiltrate,neuroendocrine carcinoma of anal canal,1
28118,Malignant Cellular Infiltrate,Atypical Teratoid Rhabdoid Tumor,1
28119,Well-Circumscribed Lesion,Recurrent Thyroid Gland Medullary Carcinoma,1
28120,Epithelial Component Present,Fallopian Tube Endometrioid Tumor,1
28121,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
28122,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
28123,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
28124,Papillary Pattern,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
28125,Epithelial Component Present,Anatomic Stage III Breast Cancer AJCC v8,1
28126,Epithelial Component Present,Basaloid carcinoma,1
28127,Malignant Cellular Infiltrate,Childhood Malignant Testicular Germ Cell Tumor,1
28128,Carcinomatous Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
28129,Malignant Cellular Infiltrate,Cutaneous Chronic Lymphocytic Leukemia,1
28130,Malignant Cellular Infiltrate,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension,1
28131,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8,1
28132,White blood cell count increased (lab result),"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
28133,Carcinomatous Component Present,Recurrent Ovarian Serous Adenocarcinoma,1
28134,Epithelial Component Present,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
28135,Malignant Cellular Infiltrate,Adenocarcinoma of nasal cavity,1
28136,Carcinomatous Component Present,Bladder adenocarcinoma stage III,1
28137,Adulthood Lesion,Lugano Classification Stage IIE Adult Lymphoma AJCC v8,1
28138,Transformed Phase of Disease,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,1
28139,Epithelial Component Present,Invasive Ductal Breast Carcinoma,1
28140,Carcinomatous Component Present,Salivary gland carcinoma,1
28141,Multifocal Lesion,"Lipomatosis, Multiple Symmetrical",1
28142,Primary Lesion,lymphoma of spinal cord,1
28143,Adulthood Lesion,Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma,1
28144,Swelling,Giant Cell Tumor of Bone,1
28145,High Grade Lesion,Childhood Pleomorphic Rhabdomyosarcoma,1
28146,Malignant Cellular Infiltrate,Secondary malignant neoplasm of female breast,1
28147,atypia morphology,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
28148,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
28149,Diffuse Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
28150,Malignant Cellular Infiltrate,Stage III Ureter Cancer AJCC v7,1
28151,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage I,1
28152,Secondary Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
28153,Nuclear Atypia,Anaplastic Hemispheric Astrocytoma,1
28154,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone recurrent,1
28155,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
28156,Neuroendocrine Differentiation,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
28157,Carcinomatous Component Present,Hepatic cancer metastatic,1
28158,Therapy-Related Toxicity,Kaposi Sarcoma Related to Immunosuppressive Treatment,1
28159,Tissue of Mullerian Origin Present,serous adenocarcinofibroma of ovary,1
28160,Secondary Lesion,Metastatic Malignant Genitourinary System Neoplasm,1
28161,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v8,1
28162,Neuroendocrine Differentiation,"Somatostatinoma, malignant",1
28163,Malignant Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v7,1
28164,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
28165,Invasive Lesion,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,1
28166,Malignant Cellular Infiltrate,Combined Lung Carcinoma,1
28167,Metastatic Lesion,Metastatic Paraganglioma,1
28168,Malignant Cellular Infiltrate,Recurrent Fibrosarcoma,1
28169,Adulthood Lesion,Adult Brain Stem Mixed Glioma,1
28170,Solid Growth Pattern,Solid Lung Adenocarcinoma,1
28171,Benign Cellular Infiltrate,Melanoacanthoma,1
28172,Cutaneous Involvement,Ichthyosis linearis circumflexa,1
28173,Carcinomatous Component Present,Recurrent Ovarian Adenocarcinoma,1
28174,Carcinomatous Component Present,Recurrent Adenoid Cystic Carcinoma,1
28175,Secondary Lesion,Secondary Central Nervous System Hodgkin Lymphoma,1
28176,Primary Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v7,1
28177,Carcinomatous Component Present,"Adenocarcinoma of lung, stage IV",1
28178,Malignant Cellular Infiltrate,Stage I Anaplastic Large Cell Lymphoma,1
28179,Carcinomatous Component Present,Stage III Lung Cancer AJCC v6,1
28180,Epithelial Component Present,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,1
28181,Monoclonal Eosinophils Present,"Leukemia, Eosinophilic, Acute",1
28182,Epithelial Component Present,Small intestine carcinoma stage IV,1
28183,High Mitotic Activity,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
28184,Vascular Channel Formation,Benign neoplasm of blood vessel,1
28185,Malignant Cellular Infiltrate,Adenocarcinoma of Accessory Sinus,1
28186,Primary Lesion,Recurrent tumors of the Ewing's family,1
28187,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia-2,1
28188,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
28189,Carcinomatous Component Present,Endometrial adenocarcinoma metastatic,1
28190,Diffuse Pattern,Recurrent Childhood Giant Cell Glioblastoma,1
28191,Carcinomatous Component Present,FIGO Stage II Ovarian Cancer,1
28192,Malignant Cellular Infiltrate,Stage IV Lip and Oral Cavity Cancer AJCC v8,1
28193,Absence of Invasion,Stage 0is Bladder Cancer AJCC v8,1
28194,Carcinomatous Component Present,Nasopharyngeal squamous cell carcinoma stage III,1
28195,Stromal Invasion,Ovarian mixed epithelial carcinoma,1
28196,High Mitotic Activity,Recurrent Salivary Duct Carcinoma,1
28197,Epithelial Component Present,Laryngeal squamous cell carcinoma recurrent,1
28198,Nuclear Atypia,Anaplastic astrocytoma,1
28199,Childhood Lesion,Postsurgical Stage I Hepatoblastoma,1
28200,Malignant Cellular Infiltrate,Malignant neoplasm of esophagus,1
28201,Carcinomatous Component Present,Stage IA Lung Large Cell Carcinoma AJCC v7,1
28202,Epithelial Component Present,Primary myoepithelial carcinoma of lung,1
28203,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8,1
28204,Refractory Disease,Refractory Plasma Cell Neoplasm,1
28205,Metaplasia of Malignant Cells Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
28206,Cutaneous Involvement,Pemphigus Vulgaris,1
28207,Dysplasia,Anal Intraepithelial Neoplasia 1,1
28208,Carcinomatous Component Present,Lobular carcinoma in situ of breast,1
28209,Malignant Cellular Infiltrate,Invasive Mixed Breast Carcinoma,1
28210,Regional Disease,Locally Advanced Unresectable Gastric Adenocarcinoma,1
28211,Epithelial Component Present,Clear cell squamous cell carcinoma of skin,1
28212,Reactive Germinal Centers Present,Pulmonary nodular lymphoid hyperplasia,1
28213,Non Lipogenic Sarcomatous Stroma Present,Resectable Dedifferentiated Liposarcoma,1
28214,Carcinomatous Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
28215,Carcinomatous Component Present,Small intestine carcinoma stage III,1
28216,Nuclear pleomorphism,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
28217,Edematous Stroma Formation,Vaginal Angiomyofibroblastoma,1
28218,Epithelial Component Present,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
28219,Severe cytologic atypia,Metastatic Digestive System Neuroendocrine Carcinoma,1
28220,Indolent Clinical Course,Ectopic hamartomatous thymoma,1
28221,Malignant Cellular Infiltrate,Pharyngeal cancer stage I,1
28222,Peripheral Nuclear Palisading,Stage IA Lung Small Cell Carcinoma AJCC v7,1
28223,Malignant Cellular Infiltrate,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,1
28224,Hyaline Cartilage Differentiation,Soft tissue chondroma,1
28225,Epithelial Component Present,squamous cell carcinoma of renal pelvis,1
28226,Malignant Cellular Infiltrate,malignant neoplasm of bone marrow,1
28227,Honeycomb Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
28228,Epithelial Component Present,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
28229,Carcinomatous Component Present,Stage IIA Esophageal Adenocarcinoma AJCC v7,1
28230,Malignant Cellular Infiltrate,Scirrhous carcinoma of breast,1
28231,Carcinomatous Component Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,1
28232,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage III,1
28233,High Grade Lesion,Embryonal Rhabdomyosarcoma,1
28234,Epithelial Component Present,Virus-Related Carcinoma,1
28235,Dysplasia,Stage 0 Vaginal Cancer AJCC v7,1
28236,Pathologic TNM Finding,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
28237,Neuroendocrine Differentiation,Refractory Abdominal Neuroendocrine Neoplasm,1
28238,Malignant Cellular Infiltrate,Adenocarcinoma of lung stage IIIB,1
28239,Borderline Lesion,Childhood Lymphomatoid Granulomatosis,1
28240,Deep Lesion,Deep histiocytoma,1
28241,Epithelial Component Present,BCLC Stage A Hepatocellular Carcinoma,1
28242,Anaplasia,Cerebral Glioblastoma,1
28243,Swelling,Central Nervous System Mesenchymal Chondrosarcoma,1
28244,Malignant Cellular Infiltrate,recurrent gastric cancer,1
28245,Immunologic Deficiency Syndromes,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
28246,Cystic Change,Gallbladder Mucinous Cystic Neoplasm,1
28247,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
28248,Recurrent disease,Recurrent Malignant Male Reproductive System Neoplasm,1
28249,Dysplasia,Anal Intraepithelial Neoplasia 3,1
28250,Malignant Cellular Infiltrate,Carcinoma of ampulla of Vater,1
28251,Carcinomatous Component Present,Hormone Receptor Positive Breast Carcinoma,1
28252,Malignant Cellular Infiltrate,"Adenocarcinoma, Tubular",1
28253,Tissue Differentiation Uncertain,Acral Fibromyxoma,1
28254,Indolent Clinical Course,Benign Lung PEComa,1
28255,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
28256,Malignant Cellular Infiltrate,Vaginal Adenosquamous Carcinoma,1
28257,Encapsulated Mass,Thyroid Gland Black Follicular Adenoma,1
28258,Carcinomatous Component Present,adenoid cystic carcinoma of esophagus,1
28259,Adulthood Lesion,Adult Oligodendroglioma,1
28260,Splenomegaly,Refractory Hepatosplenic T-Cell Lymphoma,1
28261,Human Papillomavirus Positive,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
28262,Neuroendocrine Differentiation,Neuroendocrine neoplasm of appendix,1
28263,Epithelial Component Present,Hereditary clear cell renal cell carcinoma,1
28264,Metastatic Lesion,Stage IV Laryngeal Carcinoma,1
28265,Secondary Lesion,Colorectal Carcinoma Metastatic in the Liver,1
28266,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Alkylating Agent-Related Myelodysplastic Syndrome,1
28267,Negative Peripheral Blood,Aleukemic Monocytic Leukemia Cutis,1
28268,Malignant Cellular Infiltrate,Malignant tumor of ethmoid sinus,1
28269,Epithelial Component Present,Stage II Esophageal Cancer AJCC v7,1
28270,Vascular Channel Formation,Hemangiosarcoma of heart,1
28271,Malignant Cellular Infiltrate,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
28272,Epithelial Component Present,Transplant-Related Hepatocellular Carcinoma,1
28273,Malignant Cellular Infiltrate,Prostate Lymphoma,1
28274,Epithelial Component Present,Middle Ear Paraganglioma,1
28275,Malignant Cellular Infiltrate,Malignant neoplasm of gallbladder localized,1
28276,Pseudopapillary Pattern,Childhood Ovarian Embryonal Carcinoma,1
28277,Elastophagocytosis,Granulomatous slack skin disease,1
28278,Malignant Cellular Infiltrate,Clinical Stage IB Cutaneous Melanoma AJCC v8,1
28279,Indolent Clinical Course,calcifying aponeurotic fibroma,1
28280,Lipomatous Component Present,Angiomyolipoma,1
28281,Vascular Channel Formation,Cardiac Cavernous Hemangioma,1
28282,Malignant Cellular Infiltrate,Stage IVB Laryngeal Cancer AJCC v7,1
28283,Malignant Cellular Infiltrate,Malignant Superior Vena Cava Neoplasm,1
28284,Cutaneous Involvement,Acanthoma,1
28285,Benign Cellular Infiltrate,Colorectal Ganglioneuroma,1
28286,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 1 Endometrial Endometrioid Adenocarcinoma,1
28287,Myxoid Stroma Formation,Epithelioid hemangioendothelioma,1
28288,Alternative Fascicle (Bundle) Pattern,Rectal Leiomyoma,1
28289,Carcinomatous Component Present,Stage IA Cervical Cancer AJCC v6 and v7,1
28290,Carcinomatous Component Present,Anterior Tongue Carcinoma,1
28291,Edematous Stroma Formation,Vulvar Angiomyxoma,1
28292,Follicular Cell Differentiation,Multicentric Thyroid Gland Papillary Carcinoma,1
28293,Primary Lesion,Recurrent Childhood Hepatocellular Carcinoma,1
28294,Primary Lesion,Metastatic hepatocellular carcinoma,1
28295,Lymphoplasmacytic Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
28296,Carcinomatous Component Present,Stage III Anal Cancer AJCC v8,1
28297,Delicate Arborizing Vascular Channel Formation,Ovarian Myxoid Liposarcoma,1
28298,Exophytic Polypoid Lesion,Foveolar-Type Adenoma,1
28299,Malignant Cellular Infiltrate,"Lymphoma, Non-Hodgkin",1
28300,Malignant Cellular Infiltrate,Refractory Pancreatic Carcinoma,1
28301,Metastatic Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
28302,Adnexal Differentiation,Benign Outer Hair Sheath and Infundibulum Neoplasm,1
28303,Unresectable Mass,Locally Advanced Unresectable Renal Cell Carcinoma,1
28304,Secondary Lesion,Secondary Prostate Urothelial Carcinoma,1
28305,Angiocentric Pattern,Pulmonary Lymphomatoid Granulomatosis,1
28306,Malignant Cellular Infiltrate,Desmoplastic Neurotropic Melanoma,1
28307,Well Differentiated Neuroendocrine Lesion,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
28308,Hyperplastic Tissue Present,Usual ductal hyperplasia of breast,1
28309,Malignant Cellular Infiltrate,Bladder Adenocarcinoma,1
28310,Hyalinized Stroma Formation,Chondroid lipoma,1
28311,Melanoma Cells Present,Breast Carcinoma with Melanotic Features,1
28312,Metastatic Lesion,Liposarcoma metastatic,1
28313,Tissue of Mullerian Origin Present,Stage I Uterine Corpus Adenosarcoma AJCC v8,1
28314,Thin Bands of Collagen Present,Thyroid Gland Solitary Fibrous Tumor,1
28315,Tartrate Resistant Acid Phosphatase Positive Cells Present,Splenic Manifestation of Hairy Cell Leukemia,1
28316,Malignant Cellular Infiltrate,Adult Desmoplastic Small Round Cell Tumor,1
28317,Fibrotic Stroma Formation,Nasopharyngeal Angiofibroma,1
28318,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
28319,Malignant Cellular Infiltrate,Stage I Bladder Cancer AJCC v8,1
28320,Mixed Cellular Population,Hereditary Kidney Wilms Tumor,1
28321,Malignant Cellular Infiltrate,"Paget's Disease, Mammary",1
28322,High Grade Lesion,Cervical Alveolar Soft Part Sarcoma,1
28323,Mesenchymal Component Present,Vulvar Ectopic Fibroadenoma,1
28324,Well-Circumscribed Lesion,Seminal Vesicle Cystadenoma,1
28325,Endophytic Tumor Growth,Frontal Sinus Inverted Papilloma,1
28326,atypia morphology,Malignant Ovarian Thecoma,1
28327,atypia morphology,Atypical adenomatous hyperplasia,1
28328,bone marrow fibrosis,"Leukemia, Mast-Cell",1
28329,Malignant Cellular Infiltrate,Malignant mesothelioma,1
28330,Low Grade Lesion,Cellular Congenital Mesoblastic Nephroma,1
28331,Benign Cellular Infiltrate,Leiomyomatosis peritonealis disseminata,1
28332,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Carcinosarcoma,1
28333,Malignant Cellular Infiltrate,Stage IA Hepatocellular Carcinoma AJCC v8,1
28334,Mucoid Stroma Formation,Rectosigmoid Mucinous Adenocarcinoma,1
28335,Mild dysplasia,Cervical Squamous Intraepithelial Neoplasia 1,1
28336,Malignant Cellular Infiltrate,"Basal cell carcinoma, infundibulocystic",1
28337,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with a Variant RARA Translocation,1
28338,Malignant Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
28339,Infiltrative Growth Pattern,Childhood Gliosarcoma,1
28340,Malignant Cellular Infiltrate,"Anaplastic large cell lymphoma, ALK negative",1
28341,Malignant Cellular Infiltrate,Adenocarcinoma in situ in tubulovillous adenoma,1
28342,Finding related to pregnancy,Non-Hodgkin Lymphoma During Pregnancy,1
28343,Clinical TNM Finding,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
28344,Lymphadenopathy,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage,1
28345,Malignant Cellular Infiltrate,Hereditary Nonpolyposis Colorectal Cancer,1
28346,Multinodular Mass,Angiosarcoma of the breast,1
28347,Nuclear Atypia,"Anaplastic Astrocytoma, IDH-Mutant",1
28348,Malignant Cellular Infiltrate,Stage II Bone Sarcoma AJCC v7,1
28349,Cutaneous Involvement,Stage II Merkel Cell Carcinoma AJCC v7,1
28350,Malignant Cellular Infiltrate,Malignant Intracranial Neoplasm,1
28351,Malignant Cellular Infiltrate,Stage IA Pleural Malignant Mesothelioma AJCC v7,1
28352,Unclassifiable Lesion,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",1
28353,Malignant Germinomatous Cellular Infiltrate,Sellar Germinoma,1
28354,Benign Cellular Infiltrate,Myxoma of the Endocardium,1
28355,Epithelial Component Present,Stage I Pancreatic Cancer AJCC v6 and v7,1
28356,Carcinomatous Component Present,Stage III Skin Cancer,1
28357,High Grade Lesion,Kidney Synovial Sarcoma,1
28358,Malignant Cellular Infiltrate,Vulvar adenocarcinoma,1
28359,Carcinomatous Component Present,Carcinoma of glottis,1
28360,Mixture of Germ Cell Neoplastic Components Present,Childhood Ovarian Mixed Germ Cell Tumor,1
28361,Papillary Pattern,Nonencapsulated sclerosing tumor,1
28362,Epithelial Component Present,Sphenoid Sinus Inverted Papilloma,1
28363,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage I,1
28364,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity refractory,1
28365,atypia morphology,Atypical Adenomatous Lung Hyperplasia,1
28366,Complex Glandular Pattern,Atypical polypoid adenomyoma,1
28367,Cutaneous Involvement,Benign fibrohistiocytic neoplasm of skin,1
28368,Carcinomatous Component Present,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
28369,Carcinomatous Component Present,Stage IV Renal Cell Cancer,1
28370,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v7,1
28371,Malignant Cellular Infiltrate,Stage IB Pancreatic Cancer AJCC v8,1
28372,Fibrotic Stroma Formation,Basal Cell Ameloblastoma,1
28373,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Medulla,1
28374,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-0,1
28375,Carcinomatous Component Present,Stage II Colorectal Cancer AJCC v8,1
28376,Benign Cellular Infiltrate,Ovarian Myxoma,1
28377,Severe cytologic atypia,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
28378,Well-Circumscribed Lesion,Gastric hyperplastic polyp,1
28379,Adulthood Lesion,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma,1
28380,Geographic Necrosis,Childhood Ovarian Embryonal Carcinoma,1
28381,Malignant Cellular Infiltrate,Small intestine carcinoma stage IV,1
28382,Epithelial Component Present,Non-small cell carcinoma,1
28383,Malignant Cellular Infiltrate,Clear Cell Intrahepatic Cholangiocarcinoma,1
28384,Epithelial Component Present,Vaginal Mesonephric Adenocarcinoma,1
28385,Epithelial Component Present,BCLC Stage D Hepatocellular Carcinoma,1
28386,High Grade Lesion,Secondary osteosarcoma,1
28387,Stromal Invasion,Stage IC Ovarian Cancer AJCC v8,1
28388,Two Separate Tumor Masses Present in the Same Organ,Pituitary Gland Double Adenomas,1
28389,Vascular Channel Formation,Cardiac Cavernous Hemangioma,1
28390,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma,1
28391,Malignant Cellular Infiltrate,Seminoma,1
28392,Diffuse Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor,1
28393,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
28394,Invasive Lesion,Bladder transitional cell carcinoma stage IV,1
28395,Malignant Cellular Infiltrate,squamous cell carcinoma of urethra,1
28396,Extensive Stage Lesion,Advanced Melanoma,1
28397,Pregnancy Complications,Placental polyp,1
28398,Necrotic changes (finding),Refractory Extensive Stage Lung Small Cell Carcinoma,1
28399,Ganglion Cell-Like Elements Present,Small Intestinal Gangliocytic Paraganglioma,1
28400,Angiodestructive Pattern,Adult Grade III Lymphomatoid Granulomatosis,1
28401,Malignant Cellular Infiltrate,Lymphoma of eye,1
28402,Nuclear Atypia,Adult Gliosarcoma,1
28403,Epithelial Component Present,Stage IV Renal Pelvis Cancer AJCC v8,1
28404,Low Mitotic Activity,Stage IV Appendix Neuroendocrine Tumor AJCC v8,1
28405,Poorly Differentiated Neuroendocrine Lesion,Gastric Small Cell Carcinoma,1
28406,Monomorphic Cellular Infiltrate,Thymic Basaloid Carcinoma,1
28407,Malignant Cellular Infiltrate,Acantholytic squamous cell carcinoma of skin,1
28408,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
28409,Immunologic Deficiency Syndromes,AIDS-Related Human Papillomavirus Infection,1
28410,Malignant Cellular Infiltrate,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
28411,Gastric-Type Epithelial Differentiation,"Cervical Mucinous Adenocarcinoma, Gastric Type",1
28412,Papillary Pattern,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
28413,Myxoid Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
28414,Borderline Lesion,Borderline Ovarian Clear Cell Cystadenofibroma,1
28415,Epithelial Component Present,Uterine Corpus Carcinosarcoma,1
28416,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
28417,Malignant Cellular Infiltrate,Esophageal Spindle Cell Carcinoma,1
28418,Epithelial Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
28419,Tubular Pattern,tubular adenoma of gallbladder,1
28420,Carcinomatous Component Present,Metastatic Lung Carcinoma,1
28421,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Carcinoma,1
28422,Osseous Differentiation,Chondroblastic osteosarcoma,1
28423,Secondary Lesion,Advanced Prostate Adenocarcinoma,1
28424,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage III,1
28425,Epithelial Component Present,Appendix Mucinous Cystadenoma,1
28426,Benign Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
28427,Malignant Cellular Infiltrate,Anatomic Stage IIIC Breast Cancer AJCC v8,1
28428,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor,1
28429,atypia morphology,Borderline Ovarian Clear Cell Adenofibroma,1
28430,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Pure Erythroid Leukemia,1
28431,Neuroendocrine Differentiation,Neuroendocrine Tumors,1
28432,Epithelial Component Present,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,1
28433,Epithelial Component Present,Lung squamous cell carcinoma stage I,1
28434,Malignant Cellular Infiltrate,"Endometrial stromal sarcoma, high grade",1
28435,Lesion with Diameter of 10mm or Less,Functioning Pituitary Gland Microadenoma,1
28436,Carcinomatous Component Present,Combined Lung Small Cell and Squamous Cell Carcinoma,1
28437,Morphologic Overlap,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
28438,Refractory Disease,Refractory Childhood Malignant Germ Cell Tumor,1
28439,Hyperkeratosis,Urethral Verrucous Carcinoma,1
28440,Increased Cellularity Present,Adult Pineoblastoma,1
28441,Benign Cellular Infiltrate,Polyp in nasopharynx,1
28442,Malignant Cellular Infiltrate,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
28443,High Mitotic Activity,small cell carcinoma of salivary gland,1
28444,Carcinomatous Component Present,Small Intestinal Squamous Cell Carcinoma,1
28445,Epithelial Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
28446,Metastatic Lesion,Prostate Carcinoma Metastatic in the Lung,1
28447,Carcinomatous Component Present,Invasive papillary breast carcinoma,1
28448,Malignant Cellular Infiltrate,Ann Arbor Stage IIB Hodgkin Lymphoma,1
28449,Villous Pattern,Small Intestinal Villous Adenoma,1
28450,Biphasic Pattern,Borderline Ovarian Endometrioid Adenofibroma,1
28451,Pseudorosette Formation,Rosette-forming glioneuronal tumor of the fourth ventricle,1
28452,Cutaneous Involvement,furuncle,1
28453,Malignant Cellular Infiltrate,Central Nervous System Germinoma,1
28454,Exophytic Papillary Lesion,Lower Gingival Verrucous Carcinoma,1
28455,Cysts Containing Proteinaceous Fluid Present,Serous cystadenoma of pancreas,1
28456,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
28457,Epithelial Component Present,Stage III Oral Cavity Cancer AJCC v6 and v7,1
28458,Whorling Growth Pattern,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
28459,Epithelial Component Present,Vulvar Trichoepithelioma,1
28460,Multifocal Lesion,Pelvic lipomatosis,1
28461,Papillary Pattern,Choroid Plexus Papilloma,1
28462,Childhood Lesion,Childhood Grade III Meningioma,1
28463,Epithelial Component Present,Pyloric Gland Adenoma,1
28464,Squamous metaplasia of bladder,Bladder Squamous Cell Carcinoma,1
28465,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v6 and v7,1
28466,Epithelial Component Present,Rectosigmoid cancer recurrent,1
28467,Malignant Cellular Infiltrate,Undifferentiated carcinoma of ovary,1
28468,Epithelial Component Present,Stage I Skin Cancer,1
28469,Benign Cellular Infiltrate,Desmoplastic fibroblastoma,1
28470,In Situ Lesion,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
28471,Macrocystic Change,"Lymphangioma, Cystic",1
28472,Well Differentiated Lesion,Verrucous carcinoma of oral cavity,1
28473,Refractory Disease,Marginal zone lymphoma refractory,1
28474,Immunologic Deficiency Syndromes,Bone Marrow Transplantation Nephropathy,1
28475,Epithelial Component Present,solid type ductal carcinoma in situ of breast,1
28476,Malignant Cellular Infiltrate,Adult Myxoid Chondrosarcoma,1
28477,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Tumor,1
28478,Cavernous Vascular Space Formation,"Hemangioma, Cavernous, Central Nervous System",1
28479,Dysplasia,Appendix High Grade Intraepithelial Neoplasia,1
28480,Nuclear Atypia,"Anaplastic Astrocytoma, IDH-Mutant",1
28481,Refractory Disease,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma,1
28482,Spindle Cell Osteo-Fibrous Component Present,Tibial adamantinoma,1
28483,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Gangliocytic Paraganglioma,1
28484,Benign Cellular Infiltrate,Cervical Adenofibroma,1
28485,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,1
28486,Mitotic Activity,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7,1
28487,Recurrent disease,Recurrent Breast Angiosarcoma,1
28488,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Adult Acute Monoblastic Leukemia,1
28489,Refractory Disease,Refractory Peripheral Primitive Neuroectodermal Tumor,1
28490,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
28491,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
28492,Childhood Lesion,Childhood Yolk Sac Tumor,1
28493,Recurrent disease,Recurrent tumors of the Ewing's family,1
28494,Benign Cellular Infiltrate,Benign neoplasm of stomach,1
28495,Epithelial Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
28496,Birbeck Granules Present,Recurrent Langerhans Cell Histiocytosis,1
28497,Absence of Invasion,Intraductal carcinoma and lobular carcinoma in situ,1
28498,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
28499,Carcinomatous Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
28500,Malignant Cellular Infiltrate,Stage I Esophageal Squamous Cell Carcinoma AJCC v7,1
28501,Cutaneous Involvement,Benign Hair Follicle Neoplasm,1
28502,Sinusoidal Growth Pattern,ALK positive large B-cell lymphoma,1
28503,Recurrent disease,Recurrent Anaplastic Large Cell Lymphoma,1
28504,Therapy-Related Toxicity,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
28505,Benign Cellular Infiltrate,Borderline Ovarian Mucinous Adenofibroma,1
28506,Malignant Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",1
28507,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage II,1
28508,Well-Circumscribed Lesion,Colorectal Adenoma with Mild Dysplasia,1
28509,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
28510,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Columnar Cell Change of the Breast with Atypia,1
28511,Hyperkeratosis,Classic Type Trichilemmoma,1
28512,Malignant Cellular Infiltrate,Carcinoma bone,1
28513,Epithelial Component Present,Stage II Esophageal Squamous Cell Carcinoma AJCC v7,1
28514,Malignant Cellular Infiltrate,Recurrent Chromophobe Renal Cell Carcinoma,1
28515,Epithelial Component Present,Metastatic Ureter Carcinoma,1
28516,Malignant Cellular Infiltrate,Malignant Rectal Neoplasm,1
28517,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage III Immature Testicular Teratoma AJCC v6 and v7,1
28518,Neuronal Differentiation,Adult Ganglioglioma,1
28519,Hemorrhagic,Hemangiosarcoma,1
28520,Recurrent disease,Adenoid cystic carcinoma of the oral cavity recurrent,1
28521,Secondary Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
28522,S-100-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma,1
28523,Refractory Disease,Refractory Colorectal Carcinoma,1
28524,Carcinomatous Component Present,Paget Disease of the Scrotum,1
28525,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
28526,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v7,1
28527,Chromogranin A Positive Neoplastic Cells Present,Laryngeal Carcinoid Tumor,1
28528,Malignant Cellular Infiltrate,Anatomic Stage IV Breast Cancer AJCC v8,1
28529,Primary Lesion,Primary serous papillary carcinoma of peritoneum,1
28530,Malignant Cellular Infiltrate,Malignant neoplasm of muscle,1
28531,Epithelial Component Present,ENSAT Stage II Adrenal Cortex Carcinoma,1
28532,Pseudoencapsulated Mass,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
28533,Epithelial Component Present,Vulvar Eccrine Porocarcinoma,1
28534,Epithelial Component Present,Small intestine carcinoma non-resectable,1
28535,Epithelial Component Present,Stage IIIA Colorectal Cancer AJCC v8,1
28536,Malignant Cellular Infiltrate,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
28537,Malignant Cellular Infiltrate,Recurrent Prostate Acinar Adenocarcinoma,1
28538,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma of lacrimal gland,1
28539,Sebaceous Differentiation,Superficial Epithelioma with Sebaceous Differentiation,1
28540,Biphasic Pattern,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
28541,Cutaneous Involvement,Malignant fibrous histiocytoma of skin,1
28542,Cutaneous Involvement,Actinic keratosis,1
28543,Necrotic changes (finding),Epithelioid glioblastoma,1
28544,Neuroendocrine Differentiation,Extra-Adrenal Paraganglioma,1
28545,Epithelial Component Present,Ovarian Granulosa-Stromal Cell Tumor,1
28546,Malignant Cellular Infiltrate,Lung Lymphoepithelioma-Like Carcinoma,1
28547,Malignant Cellular Infiltrate,Adrenal Gland Lymphoma,1
28548,Epithelial Component Present,Recurrent Carcinoma,1
28549,Indolent Clinical Course,Angiomyofibroblastoma,1
28550,Exophytic Polypoid Lesion,Colorectal Villous Adenoma,1
28551,Diffuse Pattern,Recurrent Primary Effusion Lymphoma,1
28552,Epithelial Component Present,Lung Mixed Squamous Cell and Glandular Papilloma,1
28553,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
28554,Cutaneous Involvement,Diaper candidiasis,1
28555,Epithelial Component Present,Pyriform Fossa Squamous Cell Carcinoma,1
28556,Malignant Cellular Infiltrate,Stage IIIA Penile Cancer AJCC v8,1
28557,Benign Cellular Infiltrate,Inverted urothelial papilloma,1
28558,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Cancer AJCC v8,1
28559,Epithelial Component Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
28560,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
28561,Epithelial Component Present,Stage III Breast Cancer AJCC v6,1
28562,High Mitotic Activity,Large Cell/Anaplastic Medulloblastoma,1
28563,Epithelial Component Present,High Grade Intraepithelial Neoplasia,1
28564,Carcinomatous Component Present,Stage IIIA Prostate Cancer AJCC v8,1
28565,Epithelial Component Present,"Adenocarcinoma, Tubular",1
28566,Metaplasia of Malignant Cells Present,Adenocarcinoma with apocrine metaplasia,1
28567,Malignant Cellular Infiltrate,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
28568,Cutaneous Involvement,Dermatophytosis of groin and perianal area,1
28569,Neuroectodermal Differentiation,Childhood Neuroblastoma,1
28570,Carcinomatous Component Present,Well Differentiated Prostate Adenocarcinoma,1
28571,Vascular Channel Formation,Angiomyoma,1
28572,Dysplasia,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
28573,Epithelial Component Present,Stage IIIB Anal Canal Cancer AJCC v6 and v7,1
28574,Pregnancy Complications,Poor Prognosis Metastatic Gestational Trophoblastic Tumor,1
28575,Epithelial Component Present,Grade 2 Endometrial Endometrioid Adenocarcinoma,1
28576,Absence of Invasion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
28577,Benign Cellular Infiltrate,Ureter Schwannoma,1
28578,Monomorphic Cellular Infiltrate,Childhood Infratentorial Ependymoma,1
28579,In Situ Lesion,In situ mantle cell neoplasia,1
28580,Carcinomatous Component Present,Stage IIIB Lung Cancer AJCC v7,1
28581,Epithelial Component Present,Bladder cancer recurrent,1
28582,Malignant Cellular Infiltrate,Refractory Childhood Hodgkin Lymphoma,1
28583,Malignant Cellular Infiltrate,Stage IVB Major Salivary Gland Cancer AJCC v8,1
28584,Epithelial Component Present,Laryngeal Paraganglioma,1
28585,Mixed Cellular Population,Vaginal Adenosarcoma,1
28586,Absence of Stromal Invasion,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
28587,atypia morphology,Neoplastic C-Cell Hyperplasia,1
28588,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
28589,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,adenosquamous carcinoma of ovary,1
28590,Cutaneous Involvement,Stage II Merkel Cell Carcinoma AJCC v7,1
28591,Epithelial Component Present,Refractory Nasopharyngeal Carcinoma,1
28592,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,"Acute Myeloid Leukemia, M1",1
28593,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Glycogen-rich carcinoma,1
28594,Primary Lesion,Recurrent Primary Malignant Neoplasm,1
28595,Lesion with Diameter of 10mm or Less,Functioning Pituitary Gland Microadenoma,1
28596,Cutaneous Involvement,Fibrous tissue neoplasm of skin,1
28597,Secondary Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
28598,High Grade Lesion,High Grade Broad Ligament Serous Adenocarcinoma,1
28599,Epithelial Component Present,Invasive Breast Carcinoma by Histologic Grade,1
28600,Malignant Cellular Infiltrate,Plasmablastic Lymphoma of the Oral Mucosa,1
28601,Epithelial Component Present,High-Grade Prostatic Intraepithelial Neoplasia,1
28602,Indolent Clinical Course,"Histiocytoma, Benign Fibrous",1
28603,Cystic Lesion,Recurrent Craniopharyngioma,1
28604,Vascular Channel Formation,Verrucous keratotic hemangioma,1
28605,Malignant Cellular Infiltrate,Amelanotic Skin Melanoma,1
28606,Cutaneous Involvement,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
28607,Malignant Cellular Infiltrate,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,1
28608,Carcinomatous Component Present,mucoepidermoid carcinoma of lung,1
28609,Indolent Clinical Course,Brain Hemangioma,1
28610,Secondary Lesion,Peritoneal mesothelioma malignant advanced,1
28611,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v8 Stage,1
28612,Cutaneous Involvement,keratoacanthoma,1
28613,Malignant Cellular Infiltrate,Malignant neoplasm of glottis,1
28614,Epithelial Component Present,Papillary tumor of renal pelvis,1
28615,Epithelial Component Present,Small cell carcinoma of lung,1
28616,Malignant Cellular Infiltrate,Squamous cell carcinoma of the parotid gland,1
28617,Malignant Cellular Infiltrate,Stage II Rectal Cancer AJCC v8,1
28618,Papillary Pattern,Serous papillary cystic tumor of borderline malignancy,1
28619,Primary Lesion,Hepatitis B Virus-Related Hepatocellular Carcinoma,1
28620,Hyperkeratosis,Plantar wart,1
28621,Solitary mass,Sellar Chordoma,1
28622,Local disease,Epicardial Lipoma,1
28623,Malignant Cellular Infiltrate,Duodenal Cancer,1
28624,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
28625,Well Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor G2,1
28626,Malignant Cellular Infiltrate,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension,1
28627,Dysplasia,Cervical Squamous Intraepithelial Neoplasia,1
28628,Malignant Cellular Infiltrate,Clinical Stage IIC Cutaneous Melanoma AJCC v8,1
28629,Malignant Cellular Infiltrate,Sebaceous Adenocarcinoma,1
28630,Malignant Cellular Infiltrate,Retinoblastoma unilateral,1
28631,Immunologic Deficiency Syndromes,Graft-vs-Host Disease,1
28632,Metastatic Lesion,Extraskeletal osteosarcoma metastatic,1
28633,Carcinomatous Component Present,Stage IVB Appendix Carcinoma AJCC v8,1
28634,Vascular Channel Formation,Metastatic angiosarcoma,1
28635,Increased Cellularity Present,Secondary Supratentorial Anaplastic Astrocytoma,1
28636,Carcinomatous Component Present,Stage IV Rectosigmoid Cancer AJCC v6,1
28637,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
28638,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v6,1
28639,Infiltrating Tumor Margins Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
28640,Ground Glass Nuclear Inclusion,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
28641,Nodular Pattern,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,1
28642,Cutaneous Involvement,Dermatologic disorders,1
28643,Childhood Lesion,Refractory Childhood Acute Lymphoblastic Leukemia,1
28644,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage I,1
28645,Lymphadenopathy,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
28646,Preserved Nuclear Polarity,Inverted urothelial papilloma,1
28647,Malignant Cellular Infiltrate,Anaplastic adrenocortical carcinoma,1
28648,Epithelial Component Present,Papilloma,1
28649,Carcinomatous Component Present,Stage 0 Pancreatic Cancer AJCC v8,1
28650,Clinical TNM Finding,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,1
28651,Epithelial Component Present,Acquired cystic disease associated renal cell carcinoma,1
28652,Malignant Cellular Infiltrate,Anaplastic large cell lymphoma T- and null-cell types refractory,1
28653,Indolent Clinical Course,Ossifying Fibroma,1
28654,Osteoid formation,Extraskeletal Osteosarcoma,1
28655,Cutaneous Involvement,Eccrine carcinoma of skin,1
28656,Carcinomatous Component Present,Minor Salivary Gland Adenoid Cystic Carcinoma,1
28657,Malignant Cellular Infiltrate,Primary cutaneous diffuse large cell B-cell lymphoma,1
28658,High Grade Lesion,MGMT-Methylated Glioblastoma,1
28659,Malignant Cellular Infiltrate,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
28660,Primary Lesion,Childhood Cerebral Ependymoma,1
28661,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
28662,Tissue of Mullerian Origin Present,Borderline Ovarian Serous Adenofibroma,1
28663,Papillary Pattern,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
28664,Papillary Pattern,Inverting papilloma of the nasal cavity,1
28665,Malignant Cellular Infiltrate,Localized Primitive Neuroectodermal Tumor,1
28666,Diffuse Pattern,Grade III Lymphomatoid Granulomatosis,1
28667,Carcinomatous Component Present,Stage 0a Renal Pelvis Cancer AJCC v8,1
28668,Malignant Cellular Infiltrate,Diffuse follicle center lymphoma,1
28669,Malignant Cellular Infiltrate,Clinical Stage IVA Gastric Cancer AJCC v8,1
28670,Nuclear Grooves,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
28671,Malignant Cellular Infiltrate,Primary Carcinoma,1
28672,Epithelial Component Present,Gastric Neuroendocrine Neoplasm,1
28673,Primary Lesion,Clear Cell Hepatocellular Carcinoma,1
28674,Carcinomatous Component Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
28675,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
28676,Infiltrative Growth Pattern,Infantile digital fibromatosis,1
28677,Cutaneous Involvement,Giant Cell Fibroblastoma,1
28678,Swelling,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,1
28679,Severe dysplasia,Intraductal Cribriform Breast Adenocarcinoma,1
28680,Epithelial Component Present,Stage IB Fallopian Tube Cancer AJCC v8,1
28681,Exophytic Polypoid Lesion,Ampulla of Vater Villous Adenoma,1
28682,Malignant Cellular Infiltrate,teratocarcinoma of mediastinum,1
28683,Acinar Cell Differentiation,Pancreatic Acinar Cell Cystadenoma,1
28684,Cutaneous Involvement,Carcinoma in situ of skin,1
28685,Epithelial Component Present,Refractory Oral Cavity Squamous Cell Carcinoma,1
28686,Small Aggregates of Tumor Cells Present,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
28687,Immunologic Deficiency Syndromes,Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders,1
28688,Cavernous Vascular Space Formation,Giant Hemangioma,1
28689,Benign Cellular Infiltrate,Serous cystadenoma of ovary,1
28690,Malignant Cellular Infiltrate,Malignant myoepithelioma,1
28691,Carcinomatous Component Present,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
28692,Low Grade Lesion,Recurrent Childhood Pilocytic Astrocytoma,1
28693,Well-Circumscribed Lesion,"Cystadenoma, Papillary",1
28694,Malignant Cellular Infiltrate,Follicular T-cell lymphoma,1
28695,Invasive Lesion,minimally invasive follicular carcinoma of the thyroid gland,1
28696,Cystic Change,Clear Cell Papillary Cystadenoma,1
28697,Increased Cellularity Present,Stage 2 Neuroblastoma,1
28698,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v8 Stage,1
28699,Epithelial Component Present,Lipid-rich carcinoma,1
28700,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
28701,Mesenchymal Component Present,carcinoma ex pleomorphic adenoma of salivary gland,1
28702,Recurrent disease,Large cell lung cancer recurrent,1
28703,Well Differentiated Lesion,verrucous carcinoma of esophagus,1
28704,Primary Lesion,Hepatitis B Virus-Related Hepatocellular Carcinoma,1
28705,Secondary Lesion,Metastases to adrenals,1
28706,Carcinomatous Component Present,Head and Neck Carcinoma,1
28707,Epithelial Component Present,Oxyphilic Adenoma,1
28708,White blood cell count increased (lab result),Acute promyelocytic leukemia - hypogranular variant,1
28709,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage,1
28710,Recurrent disease,Hodgkin's disease nodular sclerosis recurrent,1
28711,Malignant Cellular Infiltrate,Alcohol-Related Esophageal Squamous Cell Carcinoma,1
28712,Malignant Cellular Infiltrate,Childhood Parosteal Osteosarcoma,1
28713,Recurrent disease,Recurrent Childhood Spinal Cord Neoplasm,1
28714,Tissue Differentiation Uncertain,synovial sarcoma,1
28715,Epithelial Component Present,TSH-Producing Pituitary Gland Carcinoma,1
28716,Primary Lesion,Childhood Periosteal Osteosarcoma,1
28717,Malignant Cellular Infiltrate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,1
28718,Carcinomatous Component Present,Papillary Renal Cell Carcinoma,1
28719,Carcinomatous Component Present,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
28720,Calcinosis,Calcifying Odontogenic Cyst,1
28721,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,1
28722,Adnexal Differentiation,Germinative Follicular Epithelium Neoplasm,1
28723,Biphasic Pattern,Cervical Adenofibroma,1
28724,atypia morphology,Atypical adenoma,1
28725,Carcinomatous Component Present,Stage IV Urethral Cancer AJCC v7,1
28726,Epithelial Component Present,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
28727,Benign Cellular Infiltrate,Ivory Exostosis,1
28728,Malignant Cellular Infiltrate,Large B-cell lymphoma with IRF4 rearrangement,1
28729,Malignant Cellular Infiltrate,Secondary Myelodysplastic Syndrome,1
28730,Tissue of Mullerian Origin Present,Vaginal Carcinosarcoma,1
28731,Vascular Channel Formation,Hemangioma of spleen,1
28732,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
28733,Epithelial Component Present,Moderate pancreatic duct dysplasia,1
28734,Benign Cellular Infiltrate,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
28735,Malignant Cellular Infiltrate,Testicular choriocarcinoma stage I,1
28736,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Erythroleukemia (Erythroid/Myeloid),1
28737,Dysplasia,Anogenital papillomaviral intraepithelial neoplasia,1
28738,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
28739,Malignant Cellular Infiltrate,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
28740,Epithelial Component Present,Stage IIA Pancreatic Cancer AJCC v8,1
28741,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v8,1
28742,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
28743,Vascular Channel Formation,Adult Epithelioid Hemangioendothelioma,1
28744,Benign Cellular Infiltrate,Benign Adult Brain Stem Neoplasm,1
28745,Benign Cellular Infiltrate,Lumbosacral Lipoma,1
28746,Cutaneous Involvement,Pseudoporphyria,1
28747,Pushing Tumor Margin,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
28748,Nuclear Pseudoinclusion,Childhood Thyroid Gland Papillary Carcinoma,1
28749,Carcinomatous Component Present,Stage IIIC Fallopian Tube Cancer AJCC v8,1
28750,Malignant Cellular Infiltrate,Malignant Smooth Muscle Neoplasm,1
28751,Carcinomatous Component Present,Castration-Sensitive Prostate Carcinoma,1
28752,Epithelial Component Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
28753,Malignant Cellular Infiltrate,Stage IV Rectal Cancer AJCC v8,1
28754,Malignant Cellular Infiltrate,Pathologic Stage II Retinoblastoma AJCC v8,1
28755,Epithelial Component Present,Stage IIA Pancreatic Cancer AJCC v8,1
28756,Borderline Lesion,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
28757,Refractory Disease,Refractory Primary Peritoneal Carcinoma,1
28758,Malignant Cellular Infiltrate,"Papillary squamous cell carcinoma, non-invasive",1
28759,Dysplasia,Cervical intraepithelial neoplasia grade 1,1
28760,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor G1,1
28761,Metastatic/Recurrent Disease,Adult Alveolar Soft Part Sarcoma,1
28762,Adnexal Differentiation,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
28763,Benign Cellular Infiltrate,Angiomyoma,1
28764,Childhood Lesion,Childhood Acute Myelomonocytic Leukemia,1
28765,Epithelial Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
28766,Primary Lesion,Temporal Lobe Anaplastic Astrocytoma,1
28767,Monomorphic Cellular Infiltrate,Recurrent Ependymoma,1
28768,Epithelial Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,1
28769,Malignant Cellular Infiltrate,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,1
28770,Carcinomatous Component Present,"Squamous cell carcinoma, metastatic",1
28771,Carcinomatous Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,1
28772,Glomerular Hypertrophy,Obesity Related Glomerulopathy,1
28773,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
28774,Benign Cellular Infiltrate,Ovarian Cystadenoma,1
28775,Pushing Tumor Margin,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
28776,Adulthood Lesion,Adult Immunoblastic Lymphoma,1
28777,Carcinomatous Component Present,Stage IV Hepatocellular Carcinoma AJCC v6,1
28778,Rapidly Enlarging Mass,Vulvar Alveolar Rhabdomyosarcoma,1
28779,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage III,1
28780,Epithelial Component Present,Stage I Major Salivary Gland Cancer AJCC v7,1
28781,Indolent Clinical Course,Squamous odontogenic tumor,1
28782,Malignant Cellular Infiltrate,Small Intestinal Diffuse Large B-Cell Lymphoma,1
28783,Carcinomatous Component Present,Gastrointestinal carcinoma in situ,1
28784,Carcinomatous Component Present,Metastatic Thyroid Gland Carcinoma,1
28785,Malignant Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage,1
28786,Metastatic Lesion,Advanced cancer,1
28787,Epithelial Component Present,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
28788,Carcinomatous Component Present,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7,1
28789,Epithelial Component Present,Aldosterone-Producing Adrenal Cortex Adenoma,1
28790,Epithelial Component Present,Locally Advanced Adrenal Gland Pheochromocytoma,1
28791,Cartilaginous Differentiation,Childhood Myxoid Chondrosarcoma,1
28792,Malignant Cellular Infiltrate,Anaplastic adrenocortical carcinoma,1
28793,Follicular Cell Differentiation,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
28794,Childhood Lesion,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
28795,Diffuse Pattern,Adult Diffuse Large B-Cell Lymphoma,1
28796,Epithelial Component Present,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
28797,Malignant Cellular Infiltrate,Advanced B-Cell Neoplasm,1
28798,Malignant Cellular Infiltrate,Stage III Liver Cancer,1
28799,Carcinomatous Component Present,Clear cell adenocarcinoma of ovary,1
28800,High Grade Lesion,Radiation-Related Osteosarcoma,1
28801,Rapidly Enlarging Mass,Ovarian Rhabdomyosarcoma,1
28802,Regional Disease,Locally Advanced Sarcoma,1
28803,Cystic Change,Recurrent Ovarian Cystadenocarcinoma,1
28804,Epithelial Component Present,Vaginal Glandular Neoplasm,1
28805,High Grade Lesion,Childhood Spindle Cell Rhabdomyosarcoma,1
28806,Childhood Lesion,Infant Acute Biphenotypic Leukemia,1
28807,Epithelial Component Present,Carcinoma of sublingual gland,1
28808,Chromogranin A Positive Neoplastic Cells Present,Lung Typical Carcinoid Tumor,1
28809,Primary Lesion,Recurrent Childhood Glioblastoma,1
28810,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma,1
28811,Malignant Cellular Infiltrate,Neck Carcinoma,1
28812,Vascular Channel Formation,Parotid Gland Hemangioma,1
28813,Cellular Pseudostratification,cystic mucinous tumor of pancreas with moderate dysplasia,1
28814,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma AJCC v7,1
28815,Splenomegaly,"Leukemia, Myeloid, Accelerated Phase",1
28816,Benign Cellular Infiltrate,Intravascular Angioleiomyoma,1
28817,Severe dysplasia,Stage 0 Lung Cancer AJCC v6 and v7,1
28818,Hereditary Lesion,Familial medullary thyroid carcinoma,1
28819,Carcinomatous Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8,1
28820,Invasive Lesion,Invasive Prostate Carcinoma,1
28821,Dysplasia,Stage 0 Vaginal Cancer AJCC v7,1
28822,Tissue Differentiation Uncertain,Lung PEComa,1
28823,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma of central nervous system,1
28824,Well Differentiated Neuroendocrine Lesion,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,1
28825,Malignant Cellular Infiltrate,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
28826,High Mitotic Activity,Intestinal Neuroendocrine Carcinoma,1
28827,Primary Lesion,Adult Brain Stem Glioma,1
28828,Metastatic Lesion,Metastatic Extracranial Malignant Solid Neoplasm,1
28829,Collagenous Stroma Formation,Extra-abdominal fibromatosis,1
28830,High Grade Lesion,Lung Monophasic Synovial Sarcoma,1
28831,Ineffective hematopoiesis,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
28832,Epithelial Component Present,"Papilloma, Intraductal",1
28833,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma recurrent,1
28834,Carcinomatous Component Present,Stage IIIC Rectal Cancer AJCC v7,1
28835,Nuclear Atypia,Adult Brain Glioblastoma,1
28836,Pathologic TNM Finding,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
28837,Epithelial Component Present,Palate carcinoma,1
28838,Epithelial Component Present,Stage IVA Colon Cancer AJCC v8,1
28839,Invasive Lesion,Breast Carcinoma with Melanotic Features,1
28840,Malignant Cellular Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
28841,Absence of Invasion,Stage 0 Colon Cancer AJCC v6 and v7,1
28842,Malignant Cellular Infiltrate,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
28843,Malignant Cellular Infiltrate,signet ring cell carcinoma of gallbladder,1
28844,Epithelial Component Present,"Urinary bladder carcinoma stage I, with cancer in situ",1
28845,Diffuse Pattern,Adult Mixed Glioma,1
28846,Low Mitotic Activity,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,1
28847,Malignant Cellular Infiltrate,Refractory Malignant Endocrine Neoplasm,1
28848,Tubular Structures Present,Pyloric Gland Adenoma,1
28849,Malignant Cellular Infiltrate,Laryngeal Cancer by AJCC v6 Stage,1
28850,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
28851,Hyperplastic Tissue Present,C-cell hyperplasia of thyroid,1
28852,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Spine,1
28853,Epithelial Component Present,Renal Cell Carcinoma Associated with Neuroblastoma,1
28854,Metastatic Lesion,Metastatic melanoma,1
28855,Therapy-Related Toxicity,Cutaneous Radiation-Related Angiosarcoma,1
28856,Epithelial Component Present,Breast Cancer by AJCC v8 Prognostic Stage,1
28857,Malignant Cellular Infiltrate,T-cell lymphoma refractory,1
28858,Dysplasia,adenoma of extrahepatic bile duct,1
28859,Neuroendocrine Differentiation,Adrenal Gland Pheochromocytoma,1
28860,Mesenchymal Metaplasia of Malignant Cells Present,Breast Carcinoma with Osseous Metaplasia,1
28861,Secondary Lesion,Advanced Malignant Solid Neoplasm,1
28862,Epithelial Component Present,Stage III Renal Pelvis Cancer AJCC v7,1
28863,Malignant Cellular Infiltrate,"Ganglioneuroblastoma, Intermixed",1
28864,Abundance of Small Lymphocytes,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
28865,Bone Marrow Dysplasia Present,Refractory High Risk Myelodysplastic Syndrome,1
28866,Epithelial Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
28867,Adulthood Lesion,Stage IV Adult Burkitt Lymphoma,1
28868,Epithelial Component Present,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
28869,Childhood Lesion,Childhood Small Intestinal Carcinoma,1
28870,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma,1
28871,Refractory Disease,Refractory Indolent Adult Non-Hodgkin Lymphoma,1
28872,Poorly Differentiated Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,1
28873,Cutaneous Involvement,Vulvar Syringoma,1
28874,Secondary Lesion,Cholangiocarcinoma metastatic,1
28875,Epithelial Component Present,Ovarian Mucinous Adenofibroma,1
28876,Anaplasia,Stage III Anaplastic Large Cell Lymphoma,1
28877,Bone Marrow and Blood Involvement,Recurrent Burkitt Leukemia,1
28878,Malignant Cellular Infiltrate,Grade 1 Diffuse Follicular Lymphoma,1
28879,Epithelial Component Present,Stage IA Lung Squamous Cell Carcinoma AJCC v7,1
28880,Secondary Lesion,Secondary Central Nervous System Hodgkin Lymphoma,1
28881,Necrotic changes (finding),large cell neuroendocrine carcinoma of extrahepatic bile duct,1
28882,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1,1
28883,Neuroectodermal Differentiation,Peripheral Primitive Neuroectodermal Tumor of the Kidney,1
28884,Cutaneous Involvement,Grade 2 Cutaneous Follicular Lymphoma,1
28885,Malignant Cellular Infiltrate,"Malignant neoplasm of kidney, except pelvis",1
28886,Epithelial Component Present,Pleomorphic lobular carcinoma in situ of breast,1
28887,Carcinomatous Component Present,Advanced Cervical Adenocarcinoma,1
28888,Malignant Cellular Infiltrate,recurrent gastric cancer,1
28889,Mixture of Germ Cell Neoplastic Components Present,Central Nervous System Mixed Germ Cell Tumor,1
28890,Malignant Cellular Infiltrate,Ethmoid Sinus Squamous Cell Carcinoma,1
28891,Malignant Cellular Infiltrate,Intracranial Liposarcoma,1
28892,Nuclear Atypia,Epithelioid glioblastoma,1
28893,Malignant Cellular Infiltrate,Metastatic Microsatellite Stable Colorectal Carcinoma,1
28894,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Basophilic Leukemia,1
28895,Glucagon-Like Peptide Positive Neoplastic Cells Present,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
28896,Carcinomatous Component Present,Stage IIB Colon Cancer AJCC v7,1
28897,Lepidic Growth Pattern,"Bronchiolo-alveolar carcinoma, non-mucinous",1
28898,Rimming of Adipose Tissue Cells Present,Subcutaneous panniculitis-like T-cell lymphoma,1
28899,Metastatic Lesion,Locally Advanced Cervical Carcinoma,1
28900,Epithelial Component Present,Metastatic Digestive System Carcinoma,1
28901,Malignant Cellular Infiltrate,Recurrent WHO Grade III Glioma,1
28902,Epithelial Component Present,Collecting Duct Carcinoma of the Kidney,1
28903,Epithelial Component Present,Malignant Ovarian Sex Cord-Stromal Tumor,1
28904,Epithelial Component Present,Metastatic gastric adenocarcinoma,1
28905,Absence of Invasion,Ampulla of Vater Villous Adenoma,1
28906,Childhood Lesion,Childhood Testicular Embryonal Carcinoma,1
28907,Malignant Cellular Infiltrate,Secondary malignant neoplasm of kidney,1
28908,Glucagon-Like Peptide Positive Neoplastic Cells Present,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
28909,Fibrotic Stroma Formation,Ovarian Clear Cell Cystadenofibroma,1
28910,Poorly Differentiated Lesion,Refractory Pancreatic Neuroendocrine Carcinoma,1
28911,Benign Cellular Infiltrate,Mediastinal Neurofibroma,1
28912,Tissue Differentiation Uncertain,Myxoma,1
28913,Edematous Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
28914,Carcinomatous Component Present,Oral Cavity Carcinoma,1
28915,Benign Cellular Infiltrate,Ganglioneuroma,1
28916,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Carcinoma AJCC v7,1
28917,Epithelial Component Present,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
28918,Primary Lesion,Stage IB Osteosarcoma AJCC v7,1
28919,Epithelial Component Present,'Refractory Paraganglioma',1
28920,Florid Follicular Hyperplasia,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
28921,Indolent Clinical Course,Synovial Hemangioma,1
28922,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
28923,Epithelial Component Present,Stage IA Cervical Cancer AJCC v8,1
28924,Metastatic Lesion,Metastatic Cervical Adenosquamous Carcinoma,1
28925,Primary Lesion,Recurrent Childhood Gliomatosis Cerebri,1
28926,Epithelial Component Present,Adenocarcinoma of lung (disorder),1
28927,Malignant Cellular Infiltrate,Childhood Liposarcoma,1
28928,Malignant Cellular Infiltrate,Stage IV Osteosarcoma AJCC v7,1
28929,Malignant Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v8,1
28930,Mitotic Activity,Yolk Sac Tumor,1
28931,Lepidic Growth Pattern,"Bronchiolo-alveolar carcinoma, non-mucinous",1
28932,Epithelial Component Present,Tubular breast carcinoma,1
28933,Epithelial Component Present,Stage I Fallopian Tube Cancer AJCC v8,1
28934,Hyperplastic Tissue Present,Squamous Hyperplasia,1
28935,Malignant Cellular Infiltrate,Ovarian Lymphoma,1
28936,Follicular Structures Present,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
28937,Epithelial Component Present,FSH-Producing Gonadotroph Adenoma,1
28938,Carcinomatous Component Present,Refractory Bladder Carcinoma,1
28939,Epithelial Component Present,Stage I Gallbladder Cancer AJCC v8,1
28940,Epithelial Component Present,Invasive papillary breast carcinoma,1
28941,Cutaneous Involvement,Basal cell carcinoma of vulva,1
28942,Neuroendocrine Differentiation,Unresectable Pancreatic Neuroendocrine Carcinoma,1
28943,Malignant Cellular Infiltrate,Early Invasive Cervical Squamous Cell Carcinoma,1
28944,Epithelial Component Present,Minor Salivary Gland Adenoid Cystic Carcinoma,1
28945,Metastatic Lesion,Metastatic basal cell carcinoma,1
28946,Epithelial Component Present,Stage IB Breast Cancer AJCC v7,1
28947,Epithelial Component Present,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,1
28948,Malignant Cellular Infiltrate,Stage II Adrenal Cortex Carcinoma AJCC v7,1
28949,Therapy-Related Toxicity,Kaposi Sarcoma Related to Immunosuppressive Treatment,1
28950,Osteoid formation,Childhood Conventional Osteosarcoma,1
28951,Malignant Cellular Infiltrate,Recurrent Acinic Cell Breast Carcinoma,1
28952,Multifocal Lesion,Multiple endocrine neoplasia Type 2,1
28953,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",1
28954,Papillary Pattern,Bladder Papillary Clear Cell Adenocarcinoma,1
28955,Primary Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
28956,Slow Growing Mass,Adult Myxopapillary Ependymoma,1
28957,Carcinomatous Component Present,Stage IIB Vaginal Cancer AJCC v8,1
28958,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Microscopic Thymoma,1
28959,Adulthood Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
28960,Recurrent disease,Malignant neoplasm of duodenum recurrent,1
28961,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v6 Stage,1
28962,Diffuse Pattern,Refractory Diffuse Intrinsic Pontine Glioma,1
28963,Epithelial Component Present,Adult Liver Carcinoma,1
28964,Osseous Differentiation,Periosteal Osteosarcoma,1
28965,Severe dysplasia,Lung Mucinous Adenocarcinoma In Situ,1
28966,Malignant Cellular Infiltrate,melanoma,1
28967,Epithelial Component Present,Stage 0a Urethral Cancer AJCC v7,1
28968,Carcinomatous Component Present,Uterine Corpus Carcinosarcoma,1
28969,Metastatic Lesion,Breast Carcinoma Metastatic in the Liver,1
28970,Malignant Cellular Infiltrate,Metastatic Bladder Urothelial Carcinoma,1
28971,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma,1
28972,Peripheral Nuclear Palisading,Stage I Lung Small Cell Carcinoma AJCC v7,1
28973,More than 10 Mitoses per 10HPF,Small cell lung cancer extensive stage,1
28974,Malignant Cellular Infiltrate,Colorectal Large Cell Neuroendocrine Carcinoma,1
28975,Malignant Cellular Infiltrate,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
28976,Malignant Cellular Infiltrate,Colon Carcinoma Metastatic in the Lung,1
28977,Diffuse Pattern,"Diffuse Astrocytoma, IDH-Wildtype",1
28978,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage II,1
28979,Immunologic Deficiency Syndromes,AIDS-Related Cryptococcosis,1
28980,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP E",1
28981,Benign Cellular Infiltrate,Childhood Craniopharyngioma,1
28982,Epithelial Component Present,Submucosal Invasive Colon Adenocarcinoma,1
28983,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,1
28984,Epithelial Component Present,Inflammatory Breast Carcinoma,1
28985,Severe cytologic atypia,Rectal Small Cell Neuroendocrine Carcinoma,1
28986,Malignant Cellular Infiltrate,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
28987,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
28988,Hyperplastic Tissue Present,Sebaceous hyperplasia,1
28989,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Tumor G2,1
28990,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Tumor,1
28991,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
28992,Epithelial Component Present,Pancreatic Intraductal Papillary-Mucinous Adenoma,1
28993,Carcinomatous Component Present,Stage I Paranasal Sinus Cancer,1
28994,Neuroendocrine Differentiation,insulinoma,1
28995,Biphasic Pattern,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
28996,Monomorphic Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
28997,Epithelial Component Present,Stage II Vaginal Cancer AJCC v8,1
28998,Adulthood Lesion,Adult cystic teratoma,1
28999,Thin Bands of Collagen Present,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
29000,High Mitotic Activity,Metastatic Lung Small Cell Carcinoma,1
29001,Moderate dysplasia,Grade II Penile Intraepithelial Neoplasia,1
29002,Epithelial Component Present,adenoma of extrahepatic bile duct,1
29003,Primary Lesion,Primary Systemic Mastocytosis,1
29004,Malignant Cellular Infiltrate,Spindle cell liposarcoma,1
29005,Severe dysplasia,Stage 0 Gallbladder Cancer AJCC v8,1
29006,Carcinomatous Component Present,Tubulocystic renal cell carcinoma,1
29007,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),1
29008,Mucoid Stroma Formation,mucinous adenocarcinoma of anus,1
29009,Storiform Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
29010,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,choriocarcinoma of mediastinum,1
29011,Malignant Cellular Infiltrate,Testicular embryonal carcinoma,1
29012,Malignant Cellular Infiltrate,Stage IV Hilar Cholangiocarcinoma AJCC v8,1
29013,Well Differentiated Neuroendocrine Lesion,Stage IIB Colon Neuroendocrine Tumor AJCC v8,1
29014,Carcinomatous Component Present,Stage IVA Ovarian Cancer AJCC v8,1
29015,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8,1
29016,Vascular Channel Formation,Congenital Cystic Hygroma,1
29017,Epithelial Component Present,Thyroid Gland Mucinous Follicular Adenoma,1
29018,Stromal Invasion,Lepidic Predominant Adenocarcinoma,1
29019,Benign Cellular Infiltrate,Parotid Gland Lipoma,1
29020,Malignant Cellular Infiltrate,Clear Cell Sarcoma of Soft Tissue,1
29021,Nuclear pleomorphism,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
29022,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Carcinoma,1
29023,Pseudoalveolar Pattern,Bladder Alveolar Soft Part Sarcoma,1
29024,Indolent Clinical Course,Uterine Corpus Lipoleiomyoma,1
29025,Adnexal Differentiation,Classic Type Trichilemmoma,1
29026,Benign Cellular Infiltrate,Benign Eccrine Neoplasm,1
29027,Epithelial Component Present,Stage II Breast Cancer AJCC v6 and v7,1
29028,Intraductal Lesion,Intraductal papillary breast neoplasm,1
29029,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v8,1
29030,Malignant Cellular Infiltrate,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
29031,Epithelial Component Present,Stage IIIB Fallopian Tube Cancer AJCC v8,1
29032,Epithelial Component Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
29033,Carcinomatous Component Present,Colorectal Micropapillary Adenocarcinoma,1
29034,Malignant Cellular Infiltrate,Ovarian Cancer by FIGO Stage,1
29035,Well-Circumscribed Lesion,Small Intestinal Tubulovillous Adenoma,1
29036,Calcitonin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
29037,Childhood Lesion,Classic Congenital Mesoblastic Nephroma,1
29038,Well Differentiated Neuroendocrine Lesion,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
29039,Secondary Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
29040,Malignant Cellular Infiltrate,Cardiac Lymphoma,1
29041,Malignant Cellular Infiltrate,Stage IVB Prostate Cancer AJCC v8,1
29042,Chromogranin A Positive Neoplastic Cells Present,Uterine Corpus Carcinoid Tumor,1
29043,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
29044,Malignant Cellular Infiltrate,EBV-Related Non-Hodgkin Lymphoma,1
29045,High Grade Lesion,Gastric Synovial Sarcoma,1
29046,Carcinomatous Component Present,Pathologic Stage IIIC Gastric Cancer AJCC v8,1
29047,Primary Lesion,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
29048,Biphasic Pattern,Vulvar Ectopic Fibroadenoma,1
29049,S-100-Positive Neoplastic Cells Present,Pulmonary lymphangioleiomyomatosis,1
29050,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29051,Neoplastic Growth or Spread,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
29052,Malignant Cellular Infiltrate,Metastatic Kidney Medullary Carcinoma,1
29053,Carcinomatous Component Present,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29054,Low Mitotic Activity,Gastro-enteropancreatic neuroendocrine tumor,1
29055,Epithelial Component Present,Glomus vagale tumor,1
29056,Carcinomatous Component Present,Stage IIIB Anal Canal Cancer AJCC v6 and v7,1
29057,Epithelial Component Present,High Grade Penile Intraepithelial Neoplasia,1
29058,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
29059,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage IV,1
29060,Secondary Lesion,Advanced Neuroendocrine Neoplasm,1
29061,Chromogranin A Positive Neoplastic Cells Present,Testicular Carcinoid Tumor,1
29062,Mitotic Activity,Malignant Ovarian Luteinized Thecoma,1
29063,Malignant Cellular Infiltrate,Recurrent Uterine Corpus Carcinosarcoma,1
29064,Osseous Component Present,Endobronchial Hamartoma,1
29065,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
29066,High Grade Lesion,Radiation-Related Osteosarcoma,1
29067,Cutaneous Involvement,Mycosis Fungoides by AJCC v7 Stage,1
29068,Exophytic Polypoid Lesion,Esophageal Spindle Cell Carcinoma,1
29069,Carcinomatous Component Present,Early-Stage Breast Carcinoma,1
29070,Low Mitotic Activity,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
29071,Malignant Cellular Infiltrate,Ann Arbor Stage I Grade 2 Follicular Lymphoma,1
29072,Hypercellular bone marrow,Blast Phase,1
29073,More than 5 Mitoses per 50HPF,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
29074,Carcinomatous Component Present,Stage II Gastric Carcinoma,1
29075,Metastatic Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
29076,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
29077,Extensive Stage Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,1
29078,Clinical TNM Finding,Clinical Stage IIB Cutaneous Melanoma AJCC v8,1
29079,Primary Lesion,Meningeal melanomatosis,1
29080,Carcinomatous Component Present,Refractory Nasopharyngeal Carcinoma,1
29081,Honeycomb Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
29082,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myeloid leukemia with abnormal marrow eosinophils,1
29083,Malignant Cellular Infiltrate,Stage IVB Prostate Cancer AJCC v8,1
29084,Well-Circumscribed Lesion,Adenomatoid tumor of epididymis,1
29085,High Grade Lesion,Epithelioid Sarcoma NCI Grade 3,1
29086,Lesion with Diameter Greater than 15mm,Medium/Large Size Posterior Uveal Melanoma,1
29087,Metastatic Lesion,Metachronous Osteosarcoma,1
29088,Local disease,Infiltrating angiolipoma,1
29089,Increased Cellularity Present,Differentiating Neuroblastoma,1
29090,Somatostatin Positive Neoplastic Cells Present,Pancreatic Somatostatinoma,1
29091,Dysplasia,Biliary Intraepithelial Neoplasia-3,1
29092,Anaplasia,alk-positive anaplastic large cell lymphoma,1
29093,High Grade Lesion,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
29094,Carcinomatous Component Present,Lower Gingival Squamous Cell Carcinoma,1
29095,Thyroglobulin Positive Neoplastic Cells Present,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
29096,Malignant Cellular Infiltrate,Stage IV Bone Cancer AJCC v8,1
29097,Malignant Cellular Infiltrate,Medullomyoblastoma,1
29098,Necrotic changes (finding),Metastatic Lung Small Cell Carcinoma,1
29099,Malignant Cellular Infiltrate,Non-Small Cell Adenocarcinoma,1
29100,Increased Cellularity Present,Neuroblastoma,1
29101,Absence of Invasion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
29102,Chronic Inflammatory Infiltrate,Diffuse large B-cell lymphoma associated with chronic inflammation,1
29103,Adulthood Lesion,Advanced Adult Hepatocellular Carcinoma,1
29104,High Mitotic Activity,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
29105,Malignant Cellular Infiltrate,Metastatic Renal Pelvis Urothelial Carcinoma,1
29106,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",1
29107,Intracytoplasmic Eosinophilic Inclusion,Refractory Rhabdoid Tumor,1
29108,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
29109,Epithelial Component Present,Stage III Penile Cancer AJCC v8,1
29110,Well Differentiated Neuroendocrine Lesion,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
29111,Epithelial Component Present,Exocervical Carcinoma,1
29112,Endophytic Tumor Growth,inverted ductal papilloma of salivary gland,1
29113,Eccrine Differentiation,Eccrine hidrocystoma,1
29114,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v7,1
29115,Benign Cellular Infiltrate,Benign Uterine Corpus PEComa,1
29116,High Grade Lesion,Grade III Childhood Astrocytoma,1
29117,Neuroendocrine Differentiation,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
29118,Diffuse Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,1
29119,Cord-Like Pattern,Adenoid basal carcinoma of cervix uteri,1
29120,Carcinomatous Component Present,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
29121,Malignant Cellular Infiltrate,Gastric Liposarcoma,1
29122,Mild cytologic atypia,Cervical Verrucous Carcinoma,1
29123,Recurrent disease,Recurrent Indolent Adult Non-Hodgkin Lymphoma,1
29124,Epithelial Component Present,Stage IB Ampulla of Vater Cancer AJCC v8,1
29125,Childhood Lesion,Childhood Cerebellar Anaplastic Astrocytoma,1
29126,Thick-Walled Hyalinized Vessels Present,Ureter Schwannoma,1
29127,Mesenchymal Differentiation,Stromal Predominant Kidney Wilms Tumor,1
29128,Diffuse Lesion,Recurrent respiratory papillomatosis,1
29129,Well Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor G2,1
29130,Carcinomatous Component Present,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
29131,Lobulated Growth Pattern,Unresectable Chordoma,1
29132,Cystic Change,Vulvar Seborrheic Keratosis,1
29133,Below the Diaphragm Disease,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
29134,Infiltrative Growth Pattern,Supratentorial Glioblastoma,1
29135,Benign Cellular Infiltrate,Benign neoplasm of larynx,1
29136,Malignant Cellular Infiltrate,Sellar Chondroid Chordoma,1
29137,High Grade Lesion,Small cell glioblastoma,1
29138,Immunologic Deficiency Syndromes,AIDS related complication,1
29139,Malignant Cellular Infiltrate,Primary cutaneous lymphoma,1
29140,Epithelial Component Present,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
29141,Epithelial Component Present,Stage IIIA Rectal Cancer AJCC v7,1
29142,Borderline Lesion,Atypical follicular adenoma,1
29143,Epithelial Component Present,Type II Endometrial Adenocarcinoma,1
29144,Slow Growing Mass,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1
29145,Clinical TNM Finding,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
29146,Extensive Stage Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
29147,Childhood Lesion,Recurrent Childhood Medulloblastoma,1
29148,Rapidly Enlarging Mass,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma,1
29149,Malignant Cellular Infiltrate,Stage I Vulvar Carcinoma,1
29150,Benign Cellular Infiltrate,Pineal Region Mature Teratoma,1
29151,Carcinomatous Component Present,Stage IVB Cervical Cancer AJCC v8,1
29152,Malignant Cellular Infiltrate,Malignant Mixed Tumor,1
29153,BCR/ABL1 Fusion Negative,Ph-Like Acute Lymphoblastic Leukemia,1
29154,Papillary Pattern,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
29155,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma,1
29156,In Situ Lesion,"Urinary bladder carcinoma stage I, with cancer in situ",1
29157,Carcinomatous Component Present,Well Differentiated Prostate Adenocarcinoma,1
29158,Malignant Cellular Infiltrate,Clear Cell Hepatocellular Carcinoma,1
29159,Pseudorosette Formation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
29160,Papillary Pattern,Upper Gingival Verrucous Carcinoma,1
29161,Cutaneous Involvement,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,1
29162,Epithelial Component Present,Adenocarcinoma in adenomatous polyp,1
29163,Extraosseous Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,1
29164,Carcinomatous Component Present,squamous cell carcinoma of the thyroid gland,1
29165,Intraductal Lesion,Intracystic Papillary Breast Carcinoma,1
29166,Papillary Pattern,Bladder Squamous Papilloma,1
29167,Epithelial Component Present,Prognostic Stage IIA Breast Cancer AJCC v8,1
29168,Presence of a Hormonal Syndrome,Functioning Pituitary Gland Microadenoma,1
29169,Epithelial Component Present,Colon Adenoma with Severe Dysplasia,1
29170,Epithelial Component Present,Regional Digestive System Neuroendocrine Tumor G1,1
29171,Malignant Cellular Infiltrate,Recurrent Carcinoma of Unknown Primary,1
29172,Mild dysplasia,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
29173,Malignant Cellular Infiltrate,Stage I Lentigo Maligna Melanoma AJCC v7,1
29174,Malignant Cellular Infiltrate,Stage I Ovarian Polyembryoma AJCC v6 and v7,1
29175,Indolent Clinical Course,Thyroid Gland Benign Vascular Neoplasm,1
29176,Hemorrhagic,Solid pseudopapillary tumor of the pancreas,1
29177,Epithelial Component Present,Stage III Gallbladder Cancer AJCC v6,1
29178,Pregnancy Complications,Placenta Increta,1
29179,HMB-45-Positive Neoplastic Cells Present,Benign Lung PEComa,1
29180,Neuronal Differentiation,Anaplastic ganglioglioma,1
29181,Epithelial Component Present,Glomus Jugulare Tumor,1
29182,Carcinomatous Component Present,Hereditary Prostate Carcinoma,1
29183,Epithelial Component Present,Common wart,1
29184,Low Mitotic Activity,Stage IIB Colon Neuroendocrine Tumor AJCC v8,1
29185,Tumor Vascular Invasion,Malignant Testicular Sex Cord-Stromal Tumor,1
29186,Locally Aggressive Lesion,"Fibromatosis, Aggressive",1
29187,Benign Cellular Infiltrate,Ganglioneuroma of mediastinum,1
29188,Epithelial Component Present,Anaplastic thyroid carcinoma,1
29189,Epithelial Component Present,"Papillary renal cell carcinoma, sporadic",1
29190,Hereditary Lesion,Hereditary Nonpolyposis Colorectal Cancer,1
29191,Exophytic Papillary Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
29192,Recurrent disease,recurrent childhood acute myeloid leukemia,1
29193,Malignant Cellular Infiltrate,Central Nervous System Ganglioneuroblastoma,1
29194,Endophytic Tumor Growth,Glottis Verrucous Carcinoma,1
29195,Hereditary Lesion,"Neoplastic Syndromes, Hereditary",1
29196,Regional Disease,Locally Advanced Unresectable Carcinoma,1
29197,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
29198,Swelling,Bizarre parosteal osteochondromatous proliferation,1
29199,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v8 Stage,1
29200,Epithelial Component Present,Prolactin-Producing Pituitary Gland Carcinoma,1
29201,High Grade Lesion,Small cell carcinoma of lung,1
29202,Cutaneous Involvement,Erythema Multiforme,1
29203,Bilateral Disease,Synchronous Bilateral Breast Carcinoma,1
29204,Serum phosphate concentration below normal,Oncogenic osteomalacia,1
29205,Epithelial Component Present,Stage IIIA Eyelid Carcinoma AJCC v7,1
29206,Carcinomatous Component Present,Stage IIIA Anal Canal Cancer AJCC v6 and v7,1
29207,Childhood Lesion,Childhood Immunoblastic Lymphoma,1
29208,Refractory Disease,Refractory Osteosarcoma,1
29209,Dysplasia,Cervical Adenocarcinoma In Situ,1
29210,Necrotic changes (finding),large cell neuroendocrine carcinoma of gallbladder,1
29211,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage III,1
29212,Metastatic Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
29213,Non-Invasive Lesion,Bladder papilloma,1
29214,Malignant Cellular Infiltrate,Carcinoma in situ of cecum,1
29215,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
29216,Malignant Cellular Infiltrate,Small intestine carcinoma stage II,1
29217,Carcinomatous Component Present,Cholangiocarcinoma non-resectable,1
29218,Hereditary Lesion,Hereditary Ovarian Carcinoma,1
29219,Pain,Osteoclastic Giant Cell-Rich Tumor of Bone,1
29220,Indolent Clinical Course,Deep Hemangioma,1
29221,Thin Bands of Collagen Present,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
29222,Benign Cellular Infiltrate,Giant Fibrovascular Esophageal Polyp,1
29223,Epithelial Component Present,Papillary craniopharyngioma,1
29224,Malignant Cellular Infiltrate,small cell carcinoma of gallbladder,1
29225,Collagenous Stroma Formation,Vaginal Angiomyofibroblastoma,1
29226,Epithelial Component Present,Bladder Paraganglioma,1
29227,High Mitotic Activity,Occult Lung Small Cell Carcinoma,1
29228,Low Grade Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1,1
29229,Osteogenesis,Fibrodysplasia Ossificans Progressiva,1
29230,Severe dysplasia,Lung Adenocarcinoma In Situ,1
29231,Anaplasia,Giant cell carcinoma of lung,1
29232,Poorly Differentiated Neuroendocrine Lesion,Rectal Small Cell Neuroendocrine Carcinoma,1
29233,Secondary Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,1
29234,Neuroendocrine Differentiation,Malignant Paraganglionic Neoplasm,1
29235,Cavernous Lymphatic Space Formation,Cavernous lymphangioma,1
29236,Diffuse Pattern,Pleural Sarcomatoid Mesothelioma,1
29237,S-100-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
29238,Absence of Invasion,Stage 0 Pancreatic Cancer AJCC v6 and v7,1
29239,Papillary Pattern,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
29240,Malignant Cellular Infiltrate,Stage III Carcinoma of Stomach,1
29241,'Starry-sky' pattern,Gastric Burkitt Lymphoma,1
29242,Mitotic Activity,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
29243,Neuroectodermal Differentiation,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
29244,Malignant Cellular Infiltrate,Primary Non-Hodgkin Lymphoma of Bone,1
29245,Severe dysplasia,Stage 0 Lip Carcinoma,1
29246,Malignant Cellular Infiltrate,Medullomyoblastoma,1
29247,Immunologic Deficiency Syndromes,Transplant-Related Hepatocellular Carcinoma,1
29248,Benign Cellular Infiltrate,Soft tissue chondroma,1
29249,Borderline Lesion,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
29250,Cellular Pleomorphism,Refractory Undifferentiated Pleomorphic Sarcoma,1
29251,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
29252,Benign Cellular Infiltrate,Cardiac Cavernous Hemangioma,1
29253,Carcinomatous Component Present,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
29254,Monoclonal Cellular Population Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
29255,Malignant Cellular Infiltrate,follicular lymphoma of thyroid gland,1
29256,Unresectable Mass,Unresectable Leiomyosarcoma,1
29257,Severe cytologic atypia,Unresectable Pancreatic Neuroendocrine Carcinoma,1
29258,Well-Circumscribed Lesion,Hyperplastic Polyp,1
29259,Poorly Differentiated Lesion,Large cell carcinoma with rhabdoid phenotype,1
29260,Carcinomatous Component Present,Colorectal Medullary Carcinoma,1
29261,Malignant Cellular Infiltrate,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
29262,Cysts Containing Proteinaceous Fluid Present,Papillary serous cystadenocarcinoma,1
29263,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
29264,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
29265,Syncytial Pattern,Oropharyngeal lymphoepithelioma stage III,1
29266,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
29267,Alternative Fascicle (Bundle) Pattern,Leiomyomatosis peritonealis disseminata,1
29268,Carcinomatous Component Present,Minimally Invasive Mucinous Lung Adenocarcinoma,1
29269,Secondary Lesion,Refractory Metastatic Digestive System Carcinoma,1
29270,Benign Cellular Infiltrate,Childhood Ovarian Mature Teratoma,1
29271,Malignant Cellular Infiltrate,Stage III Choroidal and Ciliary Body Melanoma AJCC v8,1
29272,Alcohol Toxicity,Alcohol-Related Hepatocellular Carcinoma,1
29273,Follicular Structures Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
29274,Carcinomatous Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,1
29275,Epithelial Component Present,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,1
29276,Carcinomatous Component Present,Metastatic Digestive System Neuroendocrine Carcinoma,1
29277,Neuroendocrine Differentiation,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
29278,Malignant Cellular Infiltrate,sarcoma of mediastinum,1
29279,In Situ Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
29280,Immunologic Deficiency Syndromes,"Leukoplakia, Hairy",1
29281,Malignant Cellular Infiltrate,Pancreatic Small Cell Neuroendocrine Carcinoma,1
29282,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis,1
29283,Histiocytosis,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
29284,Metastatic Lesion,Metastatic malignant neoplasm to brain,1
29285,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v7,1
29286,Carcinomatous Component Present,Cholangiocarcinoma recurrent,1
29287,Well Differentiated Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
29288,Epithelial Component Present,Stage I Nasal Cavity Cancer AJCC v6 and v7,1
29289,Low Grade Neuroendocrine Lesion,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
29290,Villous Pattern,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
29291,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Teratoma,1
29292,Severe dysplasia,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
29293,Malignant Cellular Infiltrate,"Diffuse large B-cell lymphoma, unclassifiable, NOS",1
29294,Malignant Cellular Infiltrate,Familial Waldenstrom's Macroglobulinaemia,1
29295,Carcinomatous Component Present,Stage II Laryngeal Cancer AJCC v8,1
29296,Koilocytotic atypia,Vulvar Warty Carcinoma,1
29297,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,1
29298,Carcinomatous Component Present,Stage III Appendix Carcinoma AJCC v8,1
29299,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
29300,Carcinomatous Component Present,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
29301,Secondary Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
29302,Comedo Necrosis,High Grade Ductal Breast Carcinoma In Situ,1
29303,Childhood Lesion,PRETEXT Stage 3 Hepatoblastoma,1
29304,Widely Invasive Lesion,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
29305,Increased Cellularity Present,Adult Pineoblastoma,1
29306,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,1
29307,Malignant Cellular Infiltrate,Stage IIIC Ovarian Cancer,1
29308,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
29309,Secondary Lesion,Prostate Carcinoma Metastatic in the Lung,1
29310,Increased Cellularity Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
29311,Malignant Cellular Infiltrate,Skin Basaloid Carcinoma,1
29312,Malignant Cellular Infiltrate,Fallopian Tube Mucinous Adenocarcinoma,1
29313,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
29314,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
29315,Malignant Cellular Infiltrate,adenocarcinoma of breast with spindle cell metaplasia,1
29316,Carcinomatous Component Present,Low Grade Mucoepidermoid Breast Carcinoma,1
29317,Fibrotic Stroma Formation,Fallopian Tube Serous Adenofibroma,1
29318,Metastatic/Recurrent Disease,Distal-Type Epithelioid Sarcoma,1
29319,Metastatic Lesion,Secondary malignant neoplasm of ciliary body,1
29320,Epithelial Component Present,Adenolymphoma,1
29321,Malignant Cellular Infiltrate,Refractory cytopenia with unilineage dysplasia,1
29322,Locally Aggressive Lesion,Intermediate Bone Neoplasm,1
29323,Malignant Cellular Infiltrate,Epithelial-myoepithelial carcinoma,1
29324,Cutaneous Involvement,Primary Cutaneous Hodgkin Lymphoma,1
29325,Aggressive Clinical Course,Invasive micropapillary carcinoma of breast,1
29326,Epithelial Component Present,Grade 2 Rectal Adenocarcinoma,1
29327,Firm mass,Cervical Malignant Peripheral Nerve Sheath Tumor,1
29328,"Undifferentiated ""Fetal-Type"" Tissues Present",Malignant Ovarian Teratoma,1
29329,Carcinomatous Component Present,Prognostic Stage IIIC Breast Cancer AJCC v8,1
29330,Questionable Invasive Lesion,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,1
29331,Benign Cellular Infiltrate,Seborrheic keratosis,1
29332,Generalized illness,Letterer-Siwe Disease,1
29333,Cutaneous Involvement,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
29334,Fibrosis,Lipomatosis of Nerve,1
29335,Osteoid formation,Extraskeletal osteosarcoma recurrent,1
29336,Hyperplastic Tissue Present,Parathyroid Clear Cell Hyperplasia,1
29337,Malignant Cellular Infiltrate,"Liposarcoma, well differentiated",1
29338,Follicular Cell Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
29339,Epithelial Component Present,Cervical Squamous Cell Carcinoma,1
29340,Indolent Clinical Course,Periosteal fibroma,1
29341,Carcinomatous Component Present,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,1
29342,Epithelial Component Present,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
29343,Epithelial Component Present,Stage II Primary Peritoneal Cancer AJCC v8,1
29344,Metastatic Lesion,Locally Advanced Lung Carcinoma,1
29345,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
29346,Malignant Cellular Infiltrate,Malignant neoplasm of spinal cord,1
29347,Carcinomatous Component Present,carcinosarcoma of lung,1
29348,Cutaneous Involvement,Stage IIC Cutaneous Melanoma AJCC v6 and v7,1
29349,Malignant Cellular Infiltrate,Carcinoma,1
29350,Mixed Cellular Population,"Cervical Adenomyoma, Endometrial Type",1
29351,Transformed Phase of Disease,Refractory Transformed Chronic Lymphocytic Leukemia,1
29352,Malignant Cellular Infiltrate,"Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
29353,In Situ Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
29354,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Acute Monocytic Leukemia,1
29355,More than 10 Mitoses per 10HPF,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
29356,Indolent Clinical Course,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
29357,Secondary Lesion,"Squamous cell carcinoma, metastatic",1
29358,Osteoid formation,Childhood Conventional Osteosarcoma,1
29359,Hereditary Lesion,Gardner Syndrome,1
29360,High Grade Lesion,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
29361,Confluent Sheets of Anaplastic T-Lymphocytes Present,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
29362,Geographic Necrosis,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
29363,Malignant Cellular Infiltrate,Sarcomatoid Mesothelioma,1
29364,Malignant Cellular Infiltrate,Malignant Placental Neoplasm,1
29365,Thin-Walled Branching Vascular Pattern,Pericardial Solitary Fibrous Tumor,1
29366,Epithelial Component Present,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
29367,Recurrent disease,Recurrent Childhood Kidney Neoplasm,1
29368,Malignant Cellular Infiltrate,Stage I Esophageal Cancer AJCC v7,1
29369,Epithelial Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
29370,Cutaneous Involvement,Stage IV Skin Melanoma,1
29371,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Central Nervous System Choriocarcinoma,1
29372,Neuroendocrine Differentiation,Breast Solid Neuroendocrine Carcinoma,1
29373,Malignant Cellular Infiltrate,Submandibular Gland Acinic Cell Carcinoma,1
29374,Epithelial Component Present,Gallbladder Neuroendocrine Tumor G1,1
29375,Secondary Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
29376,Malignant Cellular Infiltrate,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
29377,Tissues Derived from Two or Three Embryonic Layers Present,Childhood Ovarian Mature Teratoma,1
29378,Malignant Cellular Infiltrate,Luminal B Breast Carcinoma,1
29379,Carcinomatous Component Present,Cervical carcinoma stage II AJCC v7,1
29380,Indolent Clinical Course,Glomangiomatosis,1
29381,Bone Marrow Dysplasia Present,Alkylating Agent-Related Myelodysplastic Syndrome,1
29382,Vascular Channel Formation,Spindle cell hemangioma,1
29383,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v6 and v7,1
29384,Malignant Cellular Infiltrate,Angiocentric lymphoma stage I,1
29385,Non-Invasive Lesion,Inverted urothelial papilloma,1
29386,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v8,1
29387,Mild cytologic atypia,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
29388,Monoclonal Cellular Population Present,Monoclonal B-Cell Lymphocytosis,1
29389,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
29390,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
29391,High Grade Lesion,Esophageal Rhabdomyosarcoma,1
29392,Indolent Clinical Course,Steroid Lipomatosis,1
29393,Microvascular Proliferation,Cerebral Glioblastoma,1
29394,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma During Pregnancy,1
29395,Lymphoplasmacytic Infiltrate,Laryngeal Lymphoepithelial Carcinoma,1
29396,Cutaneous Involvement,Syringoma,1
29397,Epithelial Component Present,Advanced Well Differentiated Neuroendocrine Neoplasm,1
29398,Carcinomatous Component Present,Endometrial Dedifferentiated Carcinoma,1
29399,Carcinomatous Component Present,Ampulla of Vater Mucinous Adenocarcinoma,1
29400,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage IV,1
29401,Malignant Cellular Infiltrate,Metastatic Lung Non-Small Cell Carcinoma,1
29402,Severe dysplasia,Stage 0 Ampulla of Vater Cancer AJCC v8,1
29403,Malignant Cellular Infiltrate,Recurrent Head and Neck Squamous Cell Carcinoma,1
29404,Tissue of Mullerian Origin Present,Atypical polypoid adenomyoma,1
29405,Indolent Clinical Course,Anal Leiomyoma,1
29406,Malignant Cellular Infiltrate,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,1
29407,Nuclear Atypia,Classical Glioblastoma,1
29408,High Mitotic Activity,Gallbladder Neuroendocrine Carcinoma,1
29409,Lymphadenopathy,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
29410,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage II,1
29411,Malignant Cellular Infiltrate,Secondary malignant neoplasm of stomach,1
29412,Malignant Cellular Infiltrate,Small Intestinal Follicular Lymphoma,1
29413,Malignant Cellular Infiltrate,Hereditary Prostate Carcinoma,1
29414,Necrotic changes (finding),Brain Stem Glioblastoma,1
29415,Vascular Channel Formation,Venous Angioleiomyoma,1
29416,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor G2,1
29417,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
29418,Epithelial Component Present,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
29419,Splenomegaly,Chronic Neutrophilic Leukemia,1
29420,Neuroendocrine Differentiation,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
29421,Malignant Cellular Infiltrate,Stage 0 Vulvar Carcinoma,1
29422,Malignant Cellular Infiltrate,Cardiac Fibrosarcoma,1
29423,Epithelial Component Present,Renal Pelvis and Ureter Cancer by AJCC v8 Stage,1
29424,Malignant Cellular Infiltrate,Metastases to abdominal cavity,1
29425,Benign Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,1
29426,Encapsulated Mass,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,1
29427,Epithelial Component Present,cloacogenic carcinoma of rectum,1
29428,Epithelial Component Present,Posterior Tongue Squamous Cell Carcinoma,1
29429,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with unilineage dysplasia,1
29430,Dysplasia,tubulopapillary adenoma of extrahepatic bile duct,1
29431,Epithelial Component Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
29432,Carcinomatous Component Present,Metastatic Lung Adenocarcinoma,1
29433,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I,1
29434,Malignant Cellular Infiltrate,High-Risk Neuroblastoma,1
29435,Cartilaginous Differentiation,mesenchymal chondrosarcoma of bone,1
29436,Myxoid Stroma Formation,Vulvar Superficial Angiomyxoma,1
29437,Cellular Pseudostratification,cystic mucinous tumor of pancreas with moderate dysplasia,1
29438,Malignant Cellular Infiltrate,Small Intestinal Follicular Lymphoma,1
29439,Neuroendocrine Differentiation,Refractory Digestive System Neuroendocrine Carcinoma,1
29440,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma,1
29441,Neuroendocrine Differentiation,Neoplasm of aortic body,1
29442,Intracellular Accumulation of Lipids,Anaplastic Pleomorphic Xanthoastrocytoma,1
29443,Well-Circumscribed Lesion,Retinal hemangioblastoma,1
29444,Hyperplastic Tissue Present,Endometrial cystic hyperplasia,1
29445,Well-Circumscribed Lesion,Breast Apocrine Adenoma,1
29446,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Seminoma,1
29447,Papillary Pattern,Human Papillomavirus-Related Verrucous Carcinoma,1
29448,Malignant Cellular Infiltrate,Malignant neoplasm of endocervix,1
29449,Low Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1,1
29450,Low Mitotic Activity,Intestinal Neuroendocrine Tumor,1
29451,Cutaneous Involvement,"Xeroderma pigmentosum, group F",1
29452,Epithelial Component Present,Paget disease of anal canal,1
29453,Malignant Cellular Infiltrate,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
29454,Carcinomatous Component Present,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
29455,Adnexal Differentiation,Primary Cutaneous Mucinous Carcinoma,1
29456,Well-Circumscribed Lesion,Spinal hemangioblastoma,1
29457,Vascular Channel Formation,Locally Advanced Epithelioid Hemangioendothelioma,1
29458,Cytoplasmic Membrane-Bound Granules Present,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
29459,Epithelial Component Present,Stage II Pancreatic Cancer AJCC v8,1
29460,Neuroendocrine Differentiation,Recurrent Neuroendocrine Neoplasm,1
29461,Hyalinized Stroma Formation,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
29462,Malignant Cellular Infiltrate,"Refractory Medulloblastoma, SHH-Activated",1
29463,Malignant Cellular Infiltrate,Locally Advanced Bile Duct Carcinoma,1
29464,Carcinomatous Component Present,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
29465,Malignant Cellular Infiltrate,Malignant tumor of pleura,1
29466,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
29467,Carcinomatous Component Present,Squamous cell carcinoma of vagina,1
29468,Diffuse Lesion,Angiomatosis,1
29469,Malignant Cellular Infiltrate,Unresectable Skin Basal Cell Carcinoma,1
29470,Exophytic Polypoid Lesion,Polyp of vulva,1
29471,Indolent Clinical Course,Benign myoepithelioma,1
29472,Carcinomatous Component Present,Liver and Intrahepatic Biliary Tract Carcinoma,1
29473,Macrocystic Change,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
29474,Angiodestructive Pattern,Recurrent Lymphomatoid Granulomatosis,1
29475,Extensive Stage Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,1
29476,Carcinomatous Component Present,Anal Verrucous Carcinoma,1
29477,Favorable Clinical Outcome,Beta-Catenin-Activated Hepatocellular Adenoma,1
29478,Macule,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,1
29479,CD56-Positive Neoplastic Cells Present,Nasal Type Extranodal NK/T-Cell Lymphoma,1
29480,Tobacco Chewing Toxicity,Tobacco Chewing-Related Carcinoma,1
29481,Malignant Cellular Infiltrate,Stage III Diffuse Large B-Cell Lymphoma,1
29482,Malignant Cellular Infiltrate,Kidney Synovial Sarcoma,1
29483,Carcinomatous Component Present,Stage IVB Oropharyngeal Carcinoma AJCC v7,1
29484,Severe dysplasia,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
29485,Childhood Lesion,Childhood Pleomorphic Xanthoastrocytoma,1
29486,Malignant Cellular Infiltrate,Malignant Vaginal Neoplasm,1
29487,Carcinomatous Component Present,Borderline Resectable Pancreatic Adenocarcinoma,1
29488,Carcinomatous Component Present,Recurrent Thyroid Gland Papillary Carcinoma,1
29489,Malignant Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v7,1
29490,Epithelial Component Present,Bladder Non-Invasive Papillary Urothelial Neoplasm,1
29491,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with hyperdiploidy,1
29492,Microcystic Change,Protoplasmic astrocytoma,1
29493,Tissue Differentiation Uncertain,Cervical Alveolar Soft Part Sarcoma,1
29494,Carcinomatous Component Present,Adenocarcinoma of large intestine,1
29495,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
29496,Carcinomatous Component Present,Stage IIIB Small Intestinal Cancer AJCC v7,1
29497,Malignant Cellular Infiltrate,Advanced Adult Hepatocellular Carcinoma,1
29498,Malignant Cellular Infiltrate,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29499,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v7,1
29500,Wheezing,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
29501,High Mitotic Activity,Small cell neuroendocrine carcinoma of bladder,1
29502,High Mitotic Activity,Large Cell/Anaplastic Medulloblastoma,1
29503,Malignant Cellular Infiltrate,Mantle cell lymphoma,1
29504,Locally Aggressive Lesion,Intermediate Osteogenic Neoplasm,1
29505,Epithelial Component Present,Stage III Rectal Cancer AJCC v6,1
29506,Malignant Cellular Infiltrate,"Carcinoma, Small Cell",1
29507,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma,1
29508,Carcinomatous Component Present,Stage IIIA Esophageal Cancer AJCC v7,1
29509,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
29510,Well-Circumscribed Lesion,Colon adenoma,1
29511,Malignant Cellular Infiltrate,Cholangiocarcinoma resectable,1
29512,Benign Cellular Infiltrate,Benign neoplasm of pineal gland,1
29513,Adulthood Lesion,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8,1
29514,Malignant Cellular Infiltrate,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8,1
29515,Benign Cellular Infiltrate,Sebaceoma,1
29516,Benign Cellular Infiltrate,Intravenous leiomyomatosis,1
29517,Epithelial Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
29518,Carcinomatous Component Present,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
29519,Hereditary Lesion,Ataxia Telangiectasia,1
29520,Malignant Cellular Infiltrate,Vulvar Small Cell Carcinoma,1
29521,Acinar Cell Differentiation,Recurrent Acinic Cell Breast Carcinoma,1
29522,Hyperplastic Tissue Present,Stromal hyperplasia,1
29523,Well-Circumscribed Lesion,Colorectal Adenoma with Mild Dysplasia,1
29524,Neuroendocrine Differentiation,Refractory Pancreatic Neuroendocrine Carcinoma,1
29525,Malignant Cellular Infiltrate,sarcoma of larynx,1
29526,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
29527,Childhood Lesion,Childhood Acute Megakaryoblastic Leukemia,1
29528,Malignant Cellular Infiltrate,Childhood Rectal Carcinoma,1
29529,Cartilaginous Differentiation,Childhood Mesenchymal Chondrosarcoma,1
29530,Neuroendocrine Differentiation,Carcinoid tumor of rectum,1
29531,Cutaneous Involvement,Solar lentigo,1
29532,Malignant Cellular Infiltrate,Pathologic Stage II Cutaneous Melanoma AJCC v8,1
29533,Epithelial Component Present,Gastric adenoma,1
29534,Carcinomatous Component Present,Gallbladder Carcinoma,1
29535,Carcinomatous Component Present,Squamous cell carcinoma of floor of mouth,1
29536,Splenomegaly,Splenic Manifestation of T-Cell Prolymphocytic Leukemia,1
29537,Malignant Cellular Infiltrate,Stage III Skin Cancer,1
29538,Carcinomatous Component Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
29539,Low Mitotic Activity,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
29540,Epithelial Component Present,Stage IA Fallopian Tube Cancer AJCC v8,1
29541,Malignant Cellular Infiltrate,Stage IV Indolent Adult Non-Hodgkin Lymphoma,1
29542,Skin nodule,Skin Nodular Basal Cell Carcinoma,1
29543,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v6 Stage,1
29544,Increased Cellularity Present,Frontal Lobe Anaplastic Oligodendroglioma,1
29545,Epithelial Component Present,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
29546,Benign Cellular Infiltrate,Disseminated Juvenile Xanthogranuloma,1
29547,Malignant Cellular Infiltrate,Squamous Cell Carcinoma of Unknown Primary,1
29548,Vascular Channel Formation,Infantile hemangioma of liver,1
29549,Epithelial Component Present,Stage III Urethral Cancer AJCC v8,1
29550,Childhood Lesion,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
29551,Epithelial Component Present,Fallopian Tube Papilloma,1
29552,Childhood Lesion,Childhood Parathyroid Gland Carcinoma,1
29553,Recurrent Genetic Abnormalities Present,"Acute myeloid leukemia, inv(16)(p13q22)",1
29554,Myxoid Stroma Formation,Botryoid-Type Embryonal Rhabdomyosarcoma,1
29555,Epithelial Component Present,signet ring cell carcinoma of breast,1
29556,Adulthood Lesion,Non-Hodgkin Lymphoma During Pregnancy,1
29557,Benign Cellular Infiltrate,Benign Vaginal Melanocytic Nevus,1
29558,Carcinomatous Component Present,adenocarcinoma of gallbladder with squamous metaplasia,1
29559,Carcinomatous Component Present,Stage IVA Vulvar Cancer AJCC v8,1
29560,Invasive Lesion,Adenocarcinoma of the prostate stage I,1
29561,Low Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
29562,Carcinomatous Component Present,Cervical Lymphoepithelioma-Like Carcinoma,1
29563,Malignant Cellular Infiltrate,Colorectal Angiosarcoma,1
29564,Polymorphic Cellular Infiltrate,Angiocentric immunoproliferative lesion grade 2,1
29565,Epithelial Component Present,Stage I Distal Bile Duct Cancer AJCC v8,1
29566,Mixed Cellular Population,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
29567,Indolent Clinical Course,Lymphangioendothelioma,1
29568,Childhood Lesion,Childhood Medulloblastoma,1
29569,Tubular Pattern,tubular adenoma of extrahepatic bile duct,1
29570,Refractory Disease,Refractory Urothelial Carcinoma,1
29571,Malignant Cellular Infiltrate,Breast Carcinoma with Choriocarcinomatous Features,1
29572,Hereditary Lesion,Recurrent BRCA-Mutated Ovarian Carcinoma,1
29573,Carcinomatous Component Present,Stage IVA Colon Cancer AJCC v7,1
29574,Epithelial Component Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
29575,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
29576,Diffuse Lesion,Intraductal papillomatosis,1
29577,Gastrin Positive Neoplastic Cells Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
29578,Carcinomatous Component Present,Stage IVB Rectal Cancer AJCC v8,1
29579,Bone Marrow Involvement,Waldenstrom's macroglobulinemia refractory,1
29580,Malignant Cellular Infiltrate,Giant Cell Glioblastoma,1
29581,Malignant Cellular Infiltrate,Recurrent Bone Ewing Sarcoma,1
29582,Malignant Cellular Infiltrate,Cervix carcinoma recurrent,1
29583,Epithelial Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
29584,Epithelial Component Present,Hepatitis C Virus-Related Hepatocellular Carcinoma,1
29585,Malignant Cellular Infiltrate,Posterior Pharyngeal Wall Squamous Cell Carcinoma,1
29586,Neuroendocrine Differentiation,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
29587,Neuroendocrine Differentiation,Stage III Jejunal Neuroendocrine Tumor AJCC v8,1
29588,Benign Cellular Infiltrate,Inverting papilloma of the paranasal sinus,1
29589,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma,1
29590,Malignant Cellular Infiltrate,Stage IIIA Lung Large Cell Carcinoma AJCC v7,1
29591,Carcinomatous Component Present,Anatomic Stage IIIB Breast Cancer AJCC v8,1
29592,Malignant Cellular Infiltrate,Basal-Like Breast Carcinoma,1
29593,Tissue Differentiation Uncertain,Alveolar soft part sarcoma recurrent,1
29594,Malignant Cellular Infiltrate,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
29595,Carcinomatous Component Present,Gallbladder Neuroendocrine Carcinoma,1
29596,Malignant Cellular Infiltrate,Early Invasive Cervical Adenocarcinoma,1
29597,Primary Lesion,Recurrent Anaplastic Oligodendroglioma,1
29598,Malignant Cellular Infiltrate,leiomyosarcoma of liver,1
29599,Borderline Lesion,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
29600,Rapidly Enlarging Mass,Alveolar rhabdomyosarcoma,1
29601,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type I,1
29602,Preserved Nuclear Polarity,Renal Pelvis Inverted Papilloma,1
29603,Malignant Cellular Infiltrate,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
29604,Epithelial Component Present,Colon Cancer by AJCC v8 Stage,1
29605,Malignant Cellular Infiltrate,Malignant Hard Palate Neoplasm,1
29606,Cutaneous Involvement,"Keratoderma, Palmoplantar, Epidermolytic",1
29607,Neuroendocrine Differentiation,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
29608,Carcinomatous Component Present,Carcinosarcoma,1
29609,Malignant Cellular Infiltrate,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",1
29610,Malignant Cellular Infiltrate,Barrett's Adenocarcinoma,1
29611,Malignant Cellular Infiltrate,Refractory Malignant Thyroid Gland Neoplasm,1
29612,Epithelial Component Present,Stage IIIB Cervical Cancer AJCC v8,1
29613,Benign Cellular Infiltrate,Solitary Myofibromatosis,1
29614,Malignant Cellular Infiltrate,Adenocarcinoma with metaplasia,1
29615,Epithelial Component Present,Adenosquamous cell lung cancer stage IIIB,1
29616,Benign Cellular Infiltrate,Cervical Microglandular Polyp,1
29617,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Disorder,1
29618,Epithelial Component Present,Adenoma of large intestine,1
29619,Carcinomatous Component Present,Pancreatic Mixed Adenoneuroendocrine Carcinoma,1
29620,Epithelial Component Present,Recurrent Neuroendocrine Neoplasm,1
29621,Recurrent disease,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
29622,Indolent Clinical Course,Hemangioma of gingiva,1
29623,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma,1
29624,Malignant Cellular Infiltrate,Ovarian Transitional Cell Carcinoma,1
29625,Epithelial Component Present,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
29626,Malignant Cellular Infiltrate,Recurrent Follicular Lymphoma,1
29627,Malignant Cellular Infiltrate,Stage IA Eyelid Carcinoma AJCC v8,1
29628,Metastatic Lesion,Metastatic basal cell carcinoma,1
29629,Cutaneous Involvement,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",1
29630,Malignant Cellular Infiltrate,Glioblastoma,1
29631,Nuclear Grooves,Nonencapsulated sclerosing tumor,1
29632,Malignant Cellular Infiltrate,Ureter Cancer by AJCC v7 Stage,1
29633,Cutaneous Involvement,Pustulosis of Palms and Soles,1
29634,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to oropharynx,1
29635,Epithelial Component Present,Proximal Urethral Carcinoma,1
29636,Epithelial Component Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
29637,Malignant Cellular Infiltrate,Oropharyngeal Basaloid Carcinoma,1
29638,Carcinomatous Component Present,Stage IIIA Ovarian Cancer AJCC v8,1
29639,Locally Aggressive Lesion,Kaposiform Hemangioendothelioma,1
29640,Argentaffin Positive Neoplastic Cells Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
29641,Borderline Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
29642,Epithelial Component Present,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
29643,Carcinomatous Component Present,Metastatic Vaginal Carcinoma,1
29644,Exophytic Polypoid Lesion,Small Intestinal Tubulovillous Adenoma,1
29645,Childhood Lesion,Benign Childhood Brain Neoplasm,1
29646,Carcinomatous Component Present,Lung Enteric Adenocarcinoma,1
29647,Malignant Cellular Infiltrate,Recurrent Hodgkin Lymphoma,1
29648,Malignant Cellular Infiltrate,Childhood Malignant Liver Neoplasm,1
29649,Malignant Cellular Infiltrate,Stage IVA Laryngeal Cancer AJCC v8,1
29650,Epithelial Component Present,Sex Cord-Stromal Tumor,1
29651,Villous Pattern,"Adenoma, Villous",1
29652,Malignant Cellular Infiltrate,Laryngeal Acantholytic Squamous Cell Carcinoma,1
29653,Exophytic Papillary Lesion,Vulvar Keratoacanthoma,1
29654,Anaplasia,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
29655,Malignant Cellular Infiltrate,Central Nervous System Kaposi Sarcoma,1
29656,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome refractory,1
29657,Neuroendocrine Differentiation,neuroendocrine carcinoma of anal canal,1
29658,Perivascular Arrangement of Tumor Cells,Cerebellar Papillary Meningioma,1
29659,Resectable Mass,Borderline Resectable Pancreatic Adenocarcinoma,1
29660,Malignant Cellular Infiltrate,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
29661,Cellular Pleomorphism,Cardiac Malignant Fibrous Histiocytoma,1
29662,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
29663,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
29664,Fibrotic Stroma Formation,Peripheral Odontogenic Fibroma,1
29665,Metastatic Lesion,Metastatic Gastrointestinal Stromal Tumor,1
29666,Cellular Changes Resembling Foveolar Epithelium Cells,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
29667,atypia morphology,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
29668,Diffuse Pattern,Adult Anaplastic Oligodendroglioma,1
29669,Pathologic TNM Finding,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
29670,High Mitotic Activity,Unresectable Pancreatic Neuroendocrine Carcinoma,1
29671,Primary Lesion,Stage I Hepatocellular Carcinoma AJCC v8,1
29672,Malignant Cellular Infiltrate,Extragonadal Seminoma,1
29673,Recurrent disease,Recurrent Digestive System Neuroendocrine Carcinoma,1
29674,Malignant Cellular Infiltrate,Small intestine carcinoma stage IV,1
29675,Recurrent Lymphoma,EBV-Related Hodgkin Lymphoma,1
29676,High Mitotic Activity,combined small cell carcinoma of lung,1
29677,High Mitotic Activity,Refractory Extensive Stage Lung Small Cell Carcinoma,1
29678,Carcinomatous Component Present,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
29679,Castration-Sensitive,Castration-Sensitive Prostate Carcinoma,1
29680,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyp,1
29681,Intracanalicular Growth Pattern,Benign phyllodes neoplasm of breast,1
29682,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
29683,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Secondary Myelodysplastic Syndrome,1
29684,Primary Lesion,Splenic marginal zone lymphoma recurrent,1
29685,Malignant Cellular Infiltrate,Malignant Hard Palate Neoplasm,1
29686,Anaplasia,Childhood Cerebellar Anaplastic Astrocytoma,1
29687,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor G1,1
29688,Malignant Cellular Infiltrate,Luminal A Prostate Carcinoma,1
29689,Intermediate Grade Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G2,1
29690,Epithelial Component Present,Bowenoid papulosis of penis,1
29691,Malignant Cellular Infiltrate,B-cell lymphoma recurrent,1
29692,Well-Circumscribed Lesion,Gastric Hamartoma,1
29693,Malignant Cellular Infiltrate,Maxillary Sinus Carcinoma,1
29694,Therapy-Related Toxicity,Monomorphic Post-Transplant Lymphoproliferative Disorder,1
29695,Cutaneous Involvement,Meyerson Nevus,1
29696,Adulthood Lesion,Adult Solid Neoplasm,1
29697,Increased Cellularity Present,Childhood Cerebellar Anaplastic Astrocytoma,1
29698,Metastatic Lesion,Secondary malignant neoplasm of ovary,1
29699,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma,1
29700,Perineural spread,adenoid cystic carcinoma of floor of mouth,1
29701,Malignant Cellular Infiltrate,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
29702,Well Differentiated Lesion,verrucous carcinoma of vulva,1
29703,Multifocal Lesion,Periductal Breast Myoepitheliosis,1
29704,Malignant Cellular Infiltrate,Malignant Sebaceous Neoplasm,1
29705,Malignant Cellular Infiltrate,Metastases to adrenals,1
29706,Huge Vascular Channel Formation,Telangiectatic Glomangioma,1
29707,Malignant Cellular Infiltrate,Stage 0 Anal Cancer AJCC v8,1
29708,Favorable Clinical Outcome,Type B Lymphomatoid Papulosis,1
29709,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v8,1
29710,Carcinomatous Component Present,Stage IIIC Rectal Cancer AJCC v7,1
29711,Epithelial Component Present,Squamous cell carcinoma of prostate,1
29712,Benign Cellular Infiltrate,Hard Palate Monomorphic Adenoma,1
29713,Malignant Germinomatous Cellular Infiltrate,"Seminoma, anaplastic",1
29714,Hyaline Cartilage Differentiation,Soft tissue chondroma,1
29715,Adulthood Lesion,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
29716,Malignant Cellular Infiltrate,Uterine Angiosarcoma,1
29717,Epithelial Component Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
29718,Epithelial Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
29719,Germinal Centers with Prominent Hyalinized Vessels Present,"Castleman Disease, Hyaline-Vascular Type",1
29720,Cutaneous Involvement,Nodular melanoma,1
29721,Benign Cellular Infiltrate,Laryngeal Leiomyoma,1
29722,Carcinomatous Component Present,Recurrent Oral Cavity Carcinoma,1
29723,Multifocal Lesion,"Lipomatosis, Multiple Symmetrical",1
29724,Well-Circumscribed Lesion,Lung Mucinous Cystadenoma,1
29725,Malignant Cellular Infiltrate,neuroblastoma of spinal cord,1
29726,Malignant Cellular Infiltrate,Stage III Lip Cancer AJCC v6 and v7,1
29727,Perineural spread,Lipomatosis of Nerve,1
29728,Cutaneous Involvement,Carcinoma of apocrine gland,1
29729,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage I,1
29730,Secondary Lesion,Metastatic Signet Ring Cell Breast Carcinoma,1
29731,Severe dysplasia,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,1
29732,Carcinomatous Component Present,Gastric Hepatoid Adenocarcinoma,1
29733,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
29734,Epithelial Component Present,Appendix Carcinoma by AJCC v8 Stage,1
29735,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v8,1
29736,Human Papillomavirus Negative,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
29737,Epithelial Component Present,Stage 0 Vulvar Carcinoma,1
29738,Epithelial Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
29739,High Mitotic Activity,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
29740,Carcinomatous Component Present,Colon Serrated Adenocarcinoma,1
29741,Epithelial Component Present,Eccrine spiradenoma,1
29742,Cord-Like Pattern,Vaginal Adenoid Basal Carcinoma,1
29743,Epithelial Component Present,Stage IVC Lip Cancer AJCC v6 and v7,1
29744,Epithelial Component Present,Refractory Small Intestinal Carcinoma,1
29745,Epithelial Component Present,Metastatic Endometrial Carcinoma,1
29746,Malignant Cellular Infiltrate,Rectal Lymphoma,1
29747,Recurrent disease,Recurrent Endometrial Clear Cell Adenocarcinoma,1
29748,Papillary Pattern,Papillary thyroid carcinoma,1
29749,Carcinomatous Component Present,large cell carcinoma of salivary gland,1
29750,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor,1
29751,Carcinomatous Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
29752,Intestinal metaplasia,Vaginal Villous Adenoma,1
29753,Malignant Cellular Infiltrate,Skin Metatypical Carcinoma,1
29754,Primary Lesion,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,1
29755,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma,1
29756,Secondary Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
29757,Anaplasia,Adult Brain Glioblastoma,1
29758,High Mitotic Activity,Combined Lung Large Cell Neuroendocrine Carcinoma,1
29759,Cutaneous Involvement,Classic Type Trichilemmoma,1
29760,Malignant Cellular Infiltrate,Recurrent Rectal Cancer,1
29761,Severe cytologic atypia,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
29762,High Grade Lesion,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
29763,Hereditary Lesion,Multiple self-healing epithelioma of Ferguson-Smith,1
29764,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Columnar Cell Change of the Breast,1
29765,Epithelial Component Present,Vaginal Large Cell Neuroendocrine Carcinoma,1
29766,Carcinomatous Component Present,signet ring cell carcinoma of appendix,1
29767,Osseous Differentiation,Parosteal Osteosarcoma,1
29768,Epithelial Component Present,Metastatic Carcinoma to the Uterine Cervix,1
29769,Recurrent disease,Recurrent Myxoid Liposarcoma,1
29770,Epithelial Component Present,Recurrent Malignant Ovarian Brenner Tumor,1
29771,Cutaneous Involvement,"Lichen Planus, Oral",1
29772,"Undifferentiated ""Fetal-Type"" Tissues Present",Extragonadal primary malignant teratoma,1
29773,Diffuse Pattern,Refractory Extranodal Diffuse Large B-cell Lymphoma,1
29774,Epithelial Component Present,Advanced Squamous Cell Carcinoma of the Oropharynx,1
29775,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v6,1
29776,Cutaneous Involvement,Cutaneous Mature T-Cell and NK-Cell Neoplasm,1
29777,Carcinomatous Component Present,Non-small cell lung cancer stage III,1
29778,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
29779,Epithelial Component Present,Carcinoma breast stage I,1
29780,Malignant Cellular Infiltrate,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
29781,Low Grade Lesion,Grade I Chondrosarcoma,1
29782,Mixed Cellular Population,Pleomorphic adenoma of lacrimal gland,1
29783,Secondary Lesion,Skin squamous cell carcinoma metastatic,1
29784,Micropapillary Pattern,"Transitional cell carcinoma, micropapillary",1
29785,Diffuse Pattern,"Glioblastoma, IDH-Wildtype",1
29786,Epithelial Component Present,Cortisol-Producing Adrenal Cortex Adenoma,1
29787,Metastatic Lesion,Metastatic Adrenal Cortex Carcinoma,1
29788,Fibrotic Stroma Formation,Fallopian Tube Serous Adenofibroma,1
29789,Severe cytologic atypia,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
29790,Epithelial Component Present,Gastrointestinal Carcinoid Tumor,1
29791,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of parotid gland,1
29792,Nuclear Molding,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
29793,Secondary Lesion,Advanced Prostate Carcinoma,1
29794,Follicular Cell Differentiation,minimally invasive follicular carcinoma of the thyroid gland,1
29795,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor,1
29796,Mesenchymal Component Present,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
29797,Malignant Cellular Infiltrate,Paget's disease of vulva,1
29798,Malignant Cellular Infiltrate,Stage IV Lip and Oral Cavity Cancer AJCC v8,1
29799,Indolent Clinical Course,Adult Cardiac Cellular Rhabdomyoma,1
29800,Malignant Cellular Infiltrate,Grade 3 Clear Cell Renal Cell Carcinoma,1
29801,Epithelial Component Present,Cervical Squamous Intraepithelial Neoplasia 1,1
29802,Epithelial Component Present,Stage IVC Paranasal Sinus Cancer AJCC v7,1
29803,Malignant Cellular Infiltrate,Ependymoblastoma,1
29804,Primary Lesion,Childhood Parosteal Osteosarcoma,1
29805,Malignant Cellular Infiltrate,Invasive Mucinous Lung Adenocarcinoma,1
29806,Carcinomatous Component Present,Breast Cancer by AJCC v7 Stage,1
29807,Metaplasia,Metaplastic carcinoma,1
29808,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage,1
29809,Dysplasia,Colorectal Adenoma with Severe Dysplasia,1
29810,In Situ Lesion,Gastric Fundus Carcinoma In Situ AJCC v6 and v7,1
29811,Antoni A Pattern,Microcystic/Reticular Schwannoma,1
29812,Malignant Cellular Infiltrate,mucosa-associated lymphoid tissue (MALT) lymphoma of breast,1
29813,Acanthosis,Seborrheic keratosis of eyelid,1
29814,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v8,1
29815,Malignant Cellular Infiltrate,ENSAT Stage II Adrenal Cortex Carcinoma,1
29816,Epithelial Component Present,Vulvar Non-Keratinizing Squamous Cell Carcinoma,1
29817,Malignant Cellular Infiltrate,Gastric Burkitt Lymphoma,1
29818,Recurrent disease,Pleural mesothelioma malignant recurrent,1
29819,Multifocal Lesion,Gardner Syndrome,1
29820,Microvascular Proliferation,Recurrent Pancreatic Acinar Cell Carcinoma,1
29821,Cutaneous Involvement,Stage III Cutaneous Melanoma AJCC v6,1
29822,Malignant Cellular Infiltrate,Mesenchymal Chondrosarcoma,1
29823,Malignant Cellular Infiltrate,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
29824,Epithelial Component Present,Prostate Neuroendocrine Neoplasm,1
29825,Acantholysis,Laryngeal Acantholytic Squamous Cell Carcinoma,1
29826,Epithelial Component Present,Hard Palate Squamous Cell Carcinoma,1
29827,Malignant Cellular Infiltrate,Stage III Immature Testicular Teratoma AJCC v6 and v7,1
29828,Cellular Pleomorphism,Refractory Undifferentiated Pleomorphic Sarcoma,1
29829,Epithelial Component Present,Stage IIB Gastric Cancer AJCC v7,1
29830,Malignant Cellular Infiltrate,Stage IV Uveal Melanoma AJCC v7,1
29831,Epithelial Component Present,Stage IIIB Fallopian Tube Cancer AJCC v8,1
29832,Alcohol Toxicity,Alcohol-Related Carcinoma,1
29833,Recurrent disease,Recurrent Follicular Lymphoma,1
29834,Carcinomatous Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v8,1
29835,Epithelial Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
29836,Well-Circumscribed Lesion,Giant Fibrovascular Esophageal Polyp,1
29837,Anaplasia,Sarcomatoid Renal Cell Carcinoma,1
29838,Epithelial Component Present,Intestinal Intraepithelial Neoplasia,1
29839,Malignant Cellular Infiltrate,Small Intestinal Lymphoma,1
29840,Epithelial Component Present,Atypical choroid plexus papilloma,1
29841,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v7,1
29842,Epithelial Component Present,Thymoma by AJCC v8 Stage,1
29843,Epithelial Component Present,Squamous cell carcinoma of scrotum,1
29844,Vascular Channel Formation,Solid Angioleiomyoma,1
29845,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage I,1
29846,Malignant Cellular Infiltrate,Stage II Adrenal Cortex Carcinoma AJCC v8,1
29847,Carcinomatous Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
29848,Epithelial Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
29849,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
29850,Well-Circumscribed Lesion,Rhabdomyoma,1
29851,Epithelial Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
29852,Epithelial Component Present,Bladder squamous cell carcinoma stage 0,1
29853,Malignant Cellular Infiltrate,Stage 2 Neuroblastoma,1
29854,S-100-Positive Neoplastic Cells Present,Eosinophilic Granuloma,1
29855,CD56-Positive Neoplastic Cells Present,Recurrent Aggressive NK-Cell Leukemia,1
29856,Epithelial Component Present,Intraepithelial Squamous Cell Carcinoma,1
29857,Epithelial Component Present,minimally invasive follicular carcinoma of the thyroid gland,1
29858,Epithelial Component Present,Non-Small Cell Adenocarcinoma,1
29859,Recurrent disease,Recurrent Malignant Female Reproductive System Neoplasm,1
29860,Cystic Change,mucoepidermoid carcinoma of lung,1
29861,Epithelial Component Present,Vestibular Papilloma,1
29862,Carcinomatous Component Present,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
29863,Malignant Cellular Infiltrate,"Testicular Intratubular Germ Cell Neoplasia, Unclassified",1
29864,Malignant Cellular Infiltrate,Stage IV Bone Cancer AJCC v7,1
29865,Well-Circumscribed Lesion,Fundic gland polyp,1
29866,Rarely Metastasizing Lesion,Retiform hemangioendothelioma,1
29867,Recurrent disease,Recurrent Visual Pathway Glioma,1
29868,Ground Glass Nuclear Inclusion,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
29869,Cystic Change,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
29870,Monoclonal Cellular Population Present,Thyroid Gland Hyperfunctioning Adenoma,1
29871,Malignant Cellular Infiltrate,Stage II Hypopharyngeal Carcinoma AJCC v6 and v7,1
29872,Somatostatin Positive Neoplastic Cells Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
29873,Malignant Cellular Infiltrate,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,1
29874,Borderline Resectable Mass,Borderline Resectable Pancreatic Adenocarcinoma,1
29875,Anaplasia,MGMT-Unmethylated Glioblastoma,1
29876,Secondary Lesion,Metastatic Bladder Urothelial Carcinoma,1
29877,Malignant Cellular Infiltrate,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7,1
29878,Carcinomatous Component Present,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
29879,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29880,Cutaneous Involvement,Type A Tylosis,1
29881,Malignant Cellular Infiltrate,fibrosarcoma of small intestine,1
29882,Metastatic Lesion,Secondary malignant neoplasm of colon,1
29883,Epithelial Component Present,Advanced Laryngeal Squamous Cell Carcinoma,1
29884,Sarcomatous Component Present,Recurrent Ovarian Carcinosarcoma,1
29885,High Mitotic Activity,Childhood Anaplastic Ependymoma,1
29886,Malignant Cellular Infiltrate,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
29887,Malignant Cellular Infiltrate,Thymic Mucoepidermoid Carcinoma,1
29888,Well-Circumscribed Lesion,Desmoplastic fibroblastoma,1
29889,Malignant Cellular Infiltrate,Pericardial mesothelioma malignant recurrent,1
29890,CD30-Positive Neoplastic Cells Present,Stage III Childhood Anaplastic Large Cell Lymphoma,1
29891,Indolent Clinical Course,Extracardiac Rhabdomyoma,1
29892,Melanosomes Present,Mediastinal Melanotic Schwannoma,1
29893,Malignant Cellular Infiltrate,Squamous cell carcinoma of vagina,1
29894,Osseous Differentiation,Childhood Extraskeletal Osteosarcoma,1
29895,Blasts Under 20 Percent of Peripheral Blood White Cells,Refractory Chronic Myelomonocytic Leukemia,1
29896,Epithelial Component Present,Resectable Renal Cell Carcinoma,1
29897,Malignant Cellular Infiltrate,Small Intestinal Adenosquamous Carcinoma,1
29898,Cutaneous Involvement,Sweat gland adenocarcinoma,1
29899,Cutaneous Involvement,Eccrine carcinoma of skin,1
29900,Local disease,Localized Adrenal Gland Pheochromocytoma,1
29901,Infiltrative Growth Pattern,Epithelioid glioblastoma,1
29902,Indolent Clinical Course,Mucous Membrane Hemangioma,1
29903,Malignant Cellular Infiltrate,Synchronous Bilateral Breast Carcinoma,1
29904,atypia morphology,Malignant Ovarian Thecoma,1
29905,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29906,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v7,1
29907,Primary Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7,1
29908,Unclassifiable Lesion,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
29909,Epithelial Component Present,Mucinous cystadenocarcinoma of ovary,1
29910,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
29911,Childhood Lesion,Hepatoblastoma non-resectable,1
29912,Epithelial Component Present,Unresectable Carcinoma,1
29913,Absence of Invasion,Adenocarcinoma in situ in tubulovillous adenoma,1
29914,Adulthood Lesion,Lugano Classification Stage III Adult Lymphoma AJCC v8,1
29915,Focal dysplasia,Rectal Sessile Serrated Adenoma/Polyp,1
29916,Malignant Cellular Infiltrate,Stage 0 Cutaneous Melanoma AJCC v6 and v7,1
29917,Refractory Disease,Refractory Pancreatic Carcinoma,1
29918,Angiodestructive Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
29919,Epithelial Component Present,Multiple Endocrine Neoplasia Type 2b,1
29920,Thick-Walled Vessels Present,Childhood Kidney Angiomyolipoma,1
29921,Carcinomatous Component Present,intraductal micropapillary carcinoma of breast,1
29922,Myomatous Stroma Formation,Cervical Atypical Polypoid Adenomyoma,1
29923,Epithelial Component Present,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
29924,Secondary Lesion,Synovial sarcoma metastatic,1
29925,Tissue of Mullerian Origin Present,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
29926,Carcinomatous Component Present,Squamous cell carcinoma of lip,1
29927,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Signet Ring Variant",1
29928,Invasive Lesion,Dermatofibrosarcoma protuberans with myoid differentiation,1
29929,Recurrent disease,Recurrent Adrenal Cortex Carcinoma,1
29930,Therapy-Related Toxicity,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,1
29931,Malignant Cellular Infiltrate,Pituitary Gland Non-Hodgkin Lymphoma,1
29932,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent High Risk Myelodysplastic Syndrome,1
29933,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Secretory breast carcinoma,1
29934,Epithelial Component Present,Squamous Papilloma of the Larynx,1
29935,Non-Malignant Cellular Infiltrate,Axillary lymphadenitis,1
29936,Cystic Change,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma,1
29937,Epithelial Component Present,Stage IV Esophageal Adenocarcinoma AJCC v7,1
29938,Carcinomatous Component Present,Papillary Eccrine Carcinoma,1
29939,Radial Growth Phase,Stage II Superficial Spreading Melanoma AJCC v6 and v7,1
29940,Malignant Cellular Infiltrate,Adrenal Cortex Carcinoma by AJCC v7 Stage,1
29941,Carcinomatous Component Present,Metastatic Signet Ring Cell Breast Carcinoma,1
29942,Carcinomatous Component Present,Metastatic Fibrolamellar Carcinoma,1
29943,Malignant Cellular Infiltrate,Frontal Lobe Anaplastic Oligodendroglioma,1
29944,Malignant Cellular Infiltrate,Stage IC Eyelid Carcinoma AJCC v7,1
29945,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
29946,Malignant Cellular Infiltrate,Melanoma Metastatic in the Central Nervous System,1
29947,Intraosseous Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
29948,Intraosseous Lesion,Intraosseous well differentiated osteosarcoma,1
29949,Serrated Glandular Architecture,Rectal Traditional Serrated Adenoma,1
29950,Mitotic Activity,Teratocarcinoma,1
29951,Epithelial Component Present,Carcinoma of Littre Glands,1
29952,Absence of Stromal Invasion,Borderline Uterine Ligament Neoplasm,1
29953,Poorly Differentiated Lesion,Large cell lung cancer stage I,1
29954,Secondary Lesion,Metachronous Osteosarcoma,1
29955,Anaplasia,Anaplastic Kidney Wilms Tumor,1
29956,Fibrotic Stroma Formation,carcinoma of pancreas with osteoclast-like giant cells,1
29957,Carcinomatous Component Present,small cell carcinoma of larynx,1
29958,Severe dysplasia,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
29959,Diffuse Pattern,Cardiac Malignant Peripheral Nerve Sheath Tumor,1
29960,Epithelial Component Present,Unresectable Renal Cell Carcinoma,1
29961,Malignant Cellular Infiltrate,Advanced Unfavorable Hodgkin Lymphoma,1
29962,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage I,1
29963,Necrotic changes (finding),Recurrent Glioblastoma,1
29964,Epithelial Component Present,Carcinoma of lung,1
29965,Dysplasia,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29966,Malignant Cellular Infiltrate,Lentigo maligna melanoma,1
29967,Nuclear Atypia,Brain Stem Glioblastoma,1
29968,Carcinomatous Component Present,Signet-ring cell adenocarcinoma gastric,1
29969,Hyperkeratosis,Vulvar Inverted Follicular Keratosis,1
29970,Edematous Stroma Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
29971,Cutaneous Involvement,Skin Sarcomatoid Basal Cell Carcinoma,1
29972,Spindle Cell Osteo-Fibrous Component Present,Adamantinoma,1
29973,Malignant Cellular Infiltrate,Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
29974,Malignant Cellular Infiltrate,Sphenoid Sinus Squamous Cell Carcinoma,1
29975,Carcinomatous Component Present,Transplant-Related Squamous Cell Carcinoma,1
29976,Moderate dysplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
29977,Malignant Cellular Infiltrate,Treatment related acute myeloid leukaemia,1
29978,Carcinomatous Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v7,1
29979,Epithelial Component Present,Solid carcinoma,1
29980,Childhood Lesion,Malignant Childhood Central Nervous System Neoplasm,1
29981,Malignant Cellular Infiltrate,Non-squamous non-small cell lung cancer,1
29982,Epithelial Component Present,Stage IIB Primary Peritoneal Cancer AJCC v8,1
29983,Malignant Cellular Infiltrate,Recurrent Soft Tissue Sarcoma,1
29984,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v8,1
29985,Epithelial Component Present,Ureter Cancer by AJCC v8 Stage,1
29986,Indolent Clinical Course,"Hemangioma, Cavernous",1
29987,Malignant Cellular Infiltrate,Primary ameloblastic carcinoma,1
29988,Papillary Pattern,Pedunculated conjunctival papilloma,1
29989,Cutaneous Involvement,Lymphangioma of skin,1
29990,Junctional Proliferation,Dysplastic Nevus,1
29991,Carcinomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,1
29992,Apocrine Differentiation,Benign Apocrine Neoplasm,1
29993,Invasive Lesion,Adenocarcinoma of the prostate stage III,1
29994,High Mitotic Activity,Stage 0 Merkel Cell Carcinoma AJCC v7,1
29995,Exophytic Polypoid Lesion,Gastric Cronkhite Canada Polyposis,1
29996,Lobulated Growth Pattern,Malignant myoepithelioma,1
29997,Malignant Cellular Infiltrate,Stage III Childhood Anaplastic Large Cell Lymphoma,1
29998,Epithelial Component Present,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
29999,Epithelial Component Present,Basaloid carcinoma,1
30000,Carcinomatous Component Present,Stage IVA Laryngeal Cancer AJCC v7,1
30001,Malignant Cellular Infiltrate,Stage III Bladder Cancer AJCC v8,1
30002,Epithelial Component Present,"Schneiderian papilloma, inverted",1
30003,Malignant Cellular Infiltrate,Vulvar Adenocarcinoma of Mammary Gland Type,1
30004,Malignant Cellular Infiltrate,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,1
30005,In Situ Lesion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
30006,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
30007,Epithelial Component Present,Schneiderian papilloma,1
30008,Carcinomatous Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
30009,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v7,1
30010,Mixed Cellular Population,Stage IVA Uterine Corpus Adenosarcoma AJCC v8,1
30011,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
30012,Epithelial Component Present,Breast Carcinoma Metastatic in the Skin,1
30013,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
30014,Extraosseous Lesion,Peripheral Odontogenic Fibroma,1
30015,Malignant Cellular Infiltrate,Lugano Classification Stage III Adult Lymphoma AJCC v8,1
30016,Malignant Cellular Infiltrate,Stage IVA Paranasal Sinus Cancer AJCC v7,1
30017,Mixed Cellular Population,Giant fibroadenoma of breast,1
30018,Benign Cellular Infiltrate,Lipomatosis of Nerve,1
30019,Immunologic Deficiency Syndromes,Bone Marrow Transplantation Nephropathy,1
30020,Recurrent disease,Recurrent Endometrial Endometrioid Adenocarcinoma,1
30021,Hereditary Lesion,Hereditary Diffuse Gastric Adenocarcinoma,1
30022,Malignant Cellular Infiltrate,"Carcinoma, Endometrioid",1
30023,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v8,1
30024,Malignant Cellular Infiltrate,Stage 0 Colorectal Cancer AJCC v6 and v7,1
30025,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia,1
30026,Benign Cellular Infiltrate,Hemangioma of intracranial structure,1
30027,High Mitotic Activity,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,1
30028,Metastatic/Recurrent Disease,Alveolar soft part sarcoma recurrent,1
30029,Benign Cellular Infiltrate,Colorectal Leiomyoma,1
30030,Polyvesicular Vitelline Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
30031,Epithelial Component Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
30032,Benign Cellular Infiltrate,Benign neoplasm of pharynx,1
30033,Parakeratosis,Common wart,1
30034,Benign Cellular Infiltrate,ductal papilloma of salivary gland,1
30035,Malignant Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v8,1
30036,Geographic Necrosis,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
30037,Epithelial Component Present,Thyroid Gland Black Follicular Adenoma,1
30038,Malignant Cellular Infiltrate,Refractory Malignant Head and Neck Neoplasm,1
30039,Angiocentric Pattern,Recurrent Grade II Lymphomatoid Granulomatosis,1
30040,Epithelial Component Present,Desmoplastic trichoepithelioma,1
30041,Hereditary Lesion,Hereditary corneal dystrophy,1
30042,Carcinomatous Component Present,Ocular Sebaceous Carcinoma,1
30043,Well-Circumscribed Lesion,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
30044,Low Cellularity Present,Childhood Protoplasmic Astrocytoma,1
30045,Mesenchymal Component Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
30046,Localized Lesion,Pleural Well Differentiated Papillary Mesothelioma,1
30047,Borderline Lesion,Borderline Uterine Ligament Neoplasm,1
30048,In Situ Lesion,Stage 0 Anal Cancer AJCC v8,1
30049,Immunosuppression-Related Post-Transplant Toxicity,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
30050,Epithelial Component Present,Adult Fibrolamellar Carcinoma,1
30051,Islands of Neuropil-Like Matrix Present,Glioneuronal Tumor with Neuropil-Like Islands,1
30052,Malignant Cellular Infiltrate,Metastatic Lobular Breast Carcinoma,1
30053,Tobacco Chewing Toxicity,Tobacco Chewing-Related Carcinoma,1
30054,Cartilaginous Differentiation,Secondary Central Chondrosarcoma,1
30055,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Bone,1
30056,Vascular Channel Formation,Benign vascular neoplasm,1
30057,Malignant Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v8,1
30058,Epithelial Component Present,Liver carcinoma,1
30059,Epithelial Component Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
30060,Metastatic Lesion,Carcinomatosis of peritoneal cavity,1
30061,Benign Cellular Infiltrate,Benign tumor of exocrine pancreas,1
30062,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12),1
30063,Metastatic Lesion,Locally Advanced Prostate Carcinoma,1
30064,Epithelial Component Present,Cervical carcinoma stage II AJCC v7,1
30065,Benign Cellular Infiltrate,Blue rubber bleb nevus syndrome,1
30066,Vascular Channel Formation,Endemic African Kaposi Sarcoma,1
30067,High Mitotic Activity,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
30068,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
30069,Malignant Cellular Infiltrate,Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma,1
30070,Malignant Cellular Infiltrate,Malignant neoplasm of spleen,1
30071,Refractory Disease,Refractory Spinal Cord Neoplasm,1
30072,Malignant Cellular Infiltrate,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",1
30073,Benign Cellular Infiltrate,Pancreatic Solid Serous Adenoma,1
30074,Childhood Lesion,Childhood Breast Carcinoma,1
30075,Cutaneous Involvement,Mycosis fungoides stage IV,1
30076,Epithelial Component Present,Non-small cell lung cancer stage III,1
30077,Neuroendocrine Differentiation,Stage IV Ileal Neuroendocrine Tumor AJCC v8,1
30078,Borderline Lesion,Borderline Ovarian Clear Cell Cystadenofibroma,1
30079,Carcinomatous Component Present,large cell neuroendocrine carcinoma of thymus,1
30080,Malignant Cellular Infiltrate,Glioblastoma,1
30081,Carcinomatous Component Present,Stage II Lung Cancer AJCC v6,1
30082,Secondary Lesion,Liposarcoma metastatic,1
30083,Epithelial Component Present,Malignant Cardiac Paraganglioma,1
30084,Carcinomatous Component Present,Recurrent Fallopian Tube Carcinoma,1
30085,Malignant Cellular Infiltrate,Invasive Breast Carcinoma by Histologic Grade,1
30086,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v7,1
30087,Malignant Cellular Infiltrate,papillary carcinoma of penis,1
30088,Carcinomatous Component Present,Grade 1 Colon Adenocarcinoma,1
30089,Metastatic/Recurrent Disease,Lung Synovial Sarcoma,1
30090,Malignant Cellular Infiltrate,signet ring cell carcinoma of pancreas,1
30091,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
30092,Malignant Cellular Infiltrate,Gestational Ovarian Choriocarcinoma,1
30093,Pathologic TNM Finding,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
30094,Resectable Mass,Hepatoma resectable,1
30095,Adnexal Differentiation,Eccrine acrospiroma,1
30096,High Grade Lesion,Pleural Biphasic Synovial Sarcoma,1
30097,Adnexal Differentiation,Eccrine ductal carcinoma,1
30098,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
30099,Well-Circumscribed Lesion,Large Bowel Juvenile Polyp,1
30100,Invasive Lesion,Adenocarcinoma of the prostate stage II,1
30101,Exophytic Polypoid Lesion,Cervical Fibroepithelial Polyp,1
30102,Epithelial Component Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
30103,Organoid Pattern,Alveolar soft part sarcoma non-metastatic,1
30104,Indolent Clinical Course,Benign neoplasm of tongue,1
30105,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 3 Follicular Lymphoma,1
30106,Malignant Cellular Infiltrate,Carcinoma duodenum resectable,1
30107,Epithelial Component Present,Adenoid cystic carcinoma of salivary gland,1
30108,Thin-Walled Branching Vascular Pattern,Central Nervous System Angiolipoma,1
30109,Cutaneous Involvement,Stage I Skin Cancer,1
30110,Nuclear Grooves,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
30111,Metastatic Lesion,"Squamous cell carcinoma, metastatic",1
30112,Papillary Pattern,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
30113,Necrotic changes (finding),small cell carcinoma of appendix,1
30114,Malignant Cellular Infiltrate,Childhood Small Intestinal Leiomyosarcoma,1
30115,Metastatic Lesion,Secondary malignant neoplasm of thymus,1
30116,Severe cytologic atypia,Pancreatic Small Cell Neuroendocrine Carcinoma,1
30117,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
30118,Malignant Cellular Infiltrate,Hodgkin Lymphoma During Pregnancy,1
30119,Nuclear Atypia,Childhood Brain Anaplastic Astrocytoma,1
30120,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,1
30121,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
30122,High Mitotic Activity,Malignant Solitary Fibrous Tumor,1
30123,Dysplasia,High Grade Esophageal Squamous Intraepithelial Neoplasia,1
30124,Malignant Cellular Infiltrate,Mucosal Melanoma,1
30125,Malignant Cellular Infiltrate,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
30126,Malignant Cellular Infiltrate,External Ear Basal Cell Carcinoma,1
30127,Carcinomatous Component Present,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
30128,Eosinophil count raised (finding),Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12),1
30129,Malignant Cellular Infiltrate,Thymic Atypical Carcinoid Tumor,1
30130,Malignant Cellular Infiltrate,Diffuse follicle center lymphoma,1
30131,Malignant Cellular Infiltrate,Stage II Uterine Corpus Leiomyosarcoma AJCC v8,1
30132,Carcinomatous Component Present,Rectal Carcinoma,1
30133,Cysts Containing Proteinaceous Fluid Present,Ovarian Papillary Cystadenoma,1
30134,Epithelial Component Present,ENSAT Stage IV Adrenal Cortex Carcinoma,1
30135,Epithelial Component Present,Ovarian Trabecular Carcinoid Tumor,1
30136,Neuroendocrine Differentiation,Advanced Neuroendocrine Neoplasm,1
30137,Epithelial Component Present,Skin Nodular Basal Cell Carcinoma,1
30138,Refractory Disease,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
30139,Vertical Growth Phase,Desmoplastic melanoma,1
30140,Stable Disease,Smoldering myeloma,1
30141,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma,1
30142,Epithelial Component Present,Ovarian Transitional Cell Tumor,1
30143,Well-Circumscribed Lesion,Lipoblastoma,1
30144,Malignant Cellular Infiltrate,solid type ductal carcinoma in situ of breast,1
30145,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Carcinoma,1
30146,Cutaneous Involvement,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
30147,Malignant Cellular Infiltrate,Gastric Hodgkin's Lymphoma,1
30148,S-100-Positive Neoplastic Cells Present,"Langerhans cell histiocytosis, unifocal",1
30149,Recurrent Lymphoma,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
30150,Epithelial Component Present,Multicentric Breast Carcinoma,1
30151,Mixed Cellular Population,Eccrine mixed tumor of skin,1
30152,Perineural spread,Recurrent Adenoid Cystic Carcinoma,1
30153,Diffuse Pattern,Childhood Fibrillary Astrocytoma,1
30154,Malignant Cellular Infiltrate,Common Variant Anaplastic Large Cell Lymphoma,1
30155,Cystic Change,Dermoid cyst of skin,1
30156,Well-Circumscribed Lesion,Benign Vaginal Mixed Tumor,1
30157,Epithelial Component Present,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
30158,Low Grade Neuroendocrine Lesion,Colon Neuroendocrine Tumor G1,1
30159,Alternative Fascicle (Bundle) Pattern,Intravenous leiomyomatosis,1
30160,Tissue of Mullerian Origin Present,Cervical Adenomyoma,1
30161,"Fully Differentiated ""Adult-Type"" Tissues Present",Vaginal Dermoid Cyst,1
30162,Epithelial Component Present,Ovarian Insular Carcinoid Tumor,1
30163,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma,1
30164,Dysplasia,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
30165,Adnexal Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
30166,Epithelial Component Present,Cervical Clear Cell Adenocarcinoma,1
30167,Secondary Lesion,Secondary malignant neoplasm of colon,1
30168,Carcinomatous Component Present,Gingival Squamous Cell Carcinoma,1
30169,Epithelial Component Present,Glucagonoma,1
30170,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
30171,Carcinomatous Component Present,Stage III Nasopharyngeal Carcinoma AJCC v8,1
30172,Dysplasia,Appendix Tubulovillous Adenoma,1
30173,Carcinomatous Component Present,Stage I Rectosigmoid Cancer AJCC v6 and v7,1
30174,Adulthood Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,1
30175,Metastatic Lesion,Advanced B-Cell Neoplasm,1
30176,Malignant Cellular Infiltrate,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
30177,Cartilaginous Differentiation,Adult Myxoid Chondrosarcoma,1
30178,Hyperkeratosis,Supraglottic Verrucous Carcinoma,1
30179,Carcinomatous Component Present,Liver and Intrahepatic Biliary Tract Carcinoma,1
30180,Bilateral Disease,Synchronous Bilateral Breast Carcinoma,1
30181,Malignant Cellular Infiltrate,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
30182,Cutaneous Involvement,Skin Clear Cell Basal Cell Carcinoma,1
30183,Malignant Cellular Infiltrate,Stage II Distal Bile Duct Cancer AJCC v8,1
30184,Carcinomatous Component Present,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,1
30185,Secondary Lesion,Hormone refractory prostate cancer,1
30186,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Disseminated",1
30187,Mesenchymal Component Present,Malignant Cystosarcoma Phyllodes,1
30188,Borderline Lesion,Lymphomatoid Granulomatosis,1
30189,Epithelial Component Present,Stage IIIB Gallbladder Cancer AJCC v8,1
30190,Secondary Lesion,Secondary malignant neoplasm of spinal cord,1
30191,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
30192,Acute inflammation,"lymphomatoid papulosis, type A",1
30193,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v8,1
30194,Malignant Cellular Infiltrate,AIDS-related anal cancer recurrent,1
30195,Malignant Cellular Infiltrate,Metastatic Urethral Urothelial Carcinoma,1
30196,Malignant Cellular Infiltrate,Malignant tumor of peritoneum,1
30197,Secondary Lesion,Advanced Head and Neck Carcinoma,1
30198,Mass of body structure,Differentiated Granulocytic Sarcoma,1
30199,Eccrine Differentiation,Syringoma,1
30200,Immunologic Deficiency Syndromes,Transplant-Related Bladder Urothelial Carcinoma,1
30201,Desmoplastic Stroma Formation,Desmoplastic ameloblastoma,1
30202,Epithelial Component Present,Refractory Thyroid Gland Carcinoma,1
30203,Dysplasia,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
30204,Borderline Lesion,"Endometrioid adenoma, borderline malignancy",1
30205,Acanthosis,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
30206,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage II,1
30207,Papillary Pattern,papillary carcinoma of renal pelvis,1
30208,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v8,1
30209,Pericanalicular Growth Pattern,Pericanalicular fibroadenoma,1
30210,Malignant Cellular Infiltrate,Rhabdoid meningioma,1
30211,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
30212,Epithelial Component Present,Refractory Endometrial Clear Cell Adenocarcinoma,1
30213,Increased Cellularity Present,Olfactory Neuroblastoma,1
30214,Carcinomatous Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v8,1
30215,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
30216,Malignant Cellular Infiltrate,Stage IVC Major Salivary Gland Cancer AJCC v8,1
30217,Childhood Lesion,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
30218,Malignant Cellular Infiltrate,Endometrial Adenosquamous Carcinoma,1
30219,Glial Differentiation,Adult Ganglioglioma,1
30220,Childhood Lesion,Childhood B Lymphoblastic Lymphoma,1
30221,Carcinomatous Component Present,Stage IA Lung Adenosquamous Carcinoma AJCC v7,1
30222,Epithelial Component Present,Lower Gingival Squamous Cell Carcinoma,1
30223,Diffuse Pattern,Plasmablastic Lymphoma of the Oral Mucosa,1
30224,Tubal Diverticulosis,Salpingitis isthmica nodosa,1
30225,Malignant Cellular Infiltrate,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,1
30226,Well Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
30227,Malignant Cellular Infiltrate,Refractory High Risk Myelodysplastic Syndrome,1
30228,Adnexal Differentiation,Perifollicular fibroma,1
30229,Neuroendocrine Differentiation,Stage II Gastric Neuroendocrine Tumor AJCC v8,1
30230,Single Cell Necrosis,Recurrent Merkel Cell Carcinoma,1
30231,Epithelial Component Present,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
30232,Hemorrhagic,Angiosarcoma NCI Grade 2,1
30233,Cystic Change,Pancreatic Acinar Cell Cystadenoma,1
30234,Malignant Cellular Infiltrate,Stage III Superficial Spreading Melanoma AJCC v7,1
30235,Ineffective hematopoiesis,Refractory High Risk Myelodysplastic Syndrome,1
30236,Cutaneous Involvement,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
30237,Carcinomatous Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
30238,Cutaneous Involvement,Mongolian Spot,1
30239,Fibrotic Stroma Formation,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,1
30240,Necrotic changes (finding),Small cell carcinoma of prostate,1
30241,Secondary Lesion,Metastatic Bladder Small Cell Carcinoma,1
30242,Secondary Lesion,Refractory Metastatic Digestive System Carcinoma,1
30243,Carcinomatous Component Present,Stage IIIB Lung Cancer AJCC v7,1
30244,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v7,1
30245,Epithelial Component Present,Locally Advanced Unresectable Basal Cell Carcinoma,1
30246,Keratin pearl formation,Spindle cell squamous cell carcinoma,1
30247,High Mitotic Activity,undifferentiated sarcoma of ovary,1
30248,Epithelial Component Present,Stage III Ileal Neuroendocrine Tumor AJCC v8,1
30249,Malignant Cellular Infiltrate,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
30250,Carcinomatous Component Present,Cervical Cancer by AJCC v8 Stage,1
30251,Benign Cellular Infiltrate,Lymphangioendothelioma,1
30252,Epithelial Component Present,Parotid Gland Undifferentiated Carcinoma,1
30253,Diffuse Pattern,Anaplastic Oligoastrocytoma,1
30254,Epithelial Component Present,Condylomata Acuminata,1
30255,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,1
30256,Epithelial Component Present,Thyroid Gland Black Follicular Adenoma,1
30257,Hyperchromatism,"Perineurioma, malignant",1
30258,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
30259,Neuroendocrine Differentiation,Glomus Tympanicum Tumor,1
30260,Malignant Cellular Infiltrate,Lugano Classification Stage I Hodgkin Lymphoma AJCC v8,1
30261,Recurrent disease,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
30262,Monomorphic Cellular Infiltrate,Cervical Basaloid Carcinoma,1
30263,Pregnancy Complications,"Pregnancy, Ovarian",1
30264,Benign Cellular Infiltrate,Hidrocystoma,1
30265,Biphasic Pattern,Recurrent Ovarian Carcinosarcoma,1
30266,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma,1
30267,Malignant Cellular Infiltrate,Ann Arbor Stage I Grade 1 Follicular Lymphoma,1
30268,Malignant Cellular Infiltrate,Childhood Malignant Peripheral Nerve Sheath Tumor,1
30269,Ventricular Involvement Only,Third Ventricle Ependymal Tumor,1
30270,High Grade Lesion,Osteosarcoma Arising in Paget Disease of Bone,1
30271,Epithelial Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
30272,Malignant Cellular Infiltrate,"Medulloblastoma, SHH-Activated, TP53-Mutant",1
30273,Epithelial Component Present,Unresectable Gallbladder Carcinoma,1
30274,Epithelial Component Present,Adenocarcinoma of lung stage IIIB,1
30275,Epithelial Component Present,Advanced Squamous Cell Carcinoma of the Oropharynx,1
30276,Malignant Cellular Infiltrate,Malignant Cystosarcoma Phyllodes,1
30277,Benign Cellular Infiltrate,Lung Glandular Papilloma,1
30278,Lobulated Growth Pattern,Locally Advanced Chordoma,1
30279,Secondary Lesion,Secondary malignant neoplasm of kidney,1
30280,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage II,1
30281,Benign Cellular Infiltrate,Adenoma of middle ear,1
30282,Carcinomatous Component Present,Apocrine Breast Carcinoma In Situ,1
30283,Multifocal Lesion,Multifocal breast carcinoma,1
30284,Vascular Channel Formation,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
30285,Adnexal Differentiation,Superficial Epithelioma with Sebaceous Differentiation,1
30286,Melanin Pigment Present,Melanoacanthoma,1
30287,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Mature Teratoma,1
30288,Malignant Cellular Infiltrate,Anaplastic Kidney Wilms Tumor,1
30289,Neuroendocrine Differentiation,"Pheochromocytoma, malignant",1
30290,Unmethylated MGMT Gene Promoter,MGMT-Unmethylated Glioblastoma,1
30291,Cysts Containing Proteinaceous Fluid Present,"Serous cystadenoma, borderline malignancy",1
30292,Vascular Channel Formation,Cavernous hemangioma of retina,1
30293,Carcinomatous Component Present,Rectal Sarcomatoid Carcinoma,1
30294,Malignant Cellular Infiltrate,Stage IVC Major Salivary Gland Cancer AJCC v8,1
30295,Metastatic Lesion,Melanoma Metastatic in the Central Nervous System,1
30296,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
30297,Secondary Lesion,Recurrent Metastatic Malignant Neoplasm,1
30298,Malignant Cellular Infiltrate,Metastatic Squamous Cell Breast Carcinoma,1
30299,Poorly Differentiated Lesion,Gingival Spindle Cell Carcinoma,1
30300,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
30301,Carcinomatous Component Present,Stage II Esophageal Cancer,1
30302,Epithelial Component Present,Stage IIIA Penile Cancer AJCC v8,1
30303,Malignant Cellular Infiltrate,Stage 0 Testicular Seminoma AJCC v6 and v7,1
30304,Increased Cellularity Present,Kadish Stage B Olfactory Neuroblastoma,1
30305,Benign Cellular Infiltrate,Cervical Adenofibroma,1
30306,Malignant Cellular Infiltrate,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,1
30307,Deep Lesion,"Fibromatosis, Abdominal",1
30308,Indolent Clinical Course,Lipoma of corpus callosum,1
30309,Pseudoalveolar Pattern,Alveolar soft part sarcoma metastatic,1
30310,Malignant Cellular Infiltrate,Splenic Lymphoblastic Lymphoma,1
30311,Indolent Clinical Course,Vaginal Myofibroblastoma,1
30312,Benign Cellular Infiltrate,Benign neoplasm of thorax,1
30313,Carcinomatous Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
30314,Diffuse Pattern,Pleural Desmoplastic Mesothelioma,1
30315,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v6,1
30316,Epithelial Component Present,Grade 2 Colorectal Adenocarcinoma,1
30317,Acanthosis,Verrucous carcinoma of the oral cavity recurrent,1
30318,Epithelial Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v8,1
30319,Secondary Lesion,Metastatic Lung Neuroendocrine Neoplasm,1
30320,High Mitotic Activity,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
30321,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Type B Melanoma,1
30322,Malignant Cellular Infiltrate,Stage II Intrahepatic Bile Duct Cancer AJCC v8,1
30323,Malignant Cellular Infiltrate,Refractory Malignant Neoplasm of Multiple Primary Sites,1
30324,Malignant Cellular Infiltrate,Secondary malignant neoplasm of parathyroid gland,1
30325,Carcinomatous Component Present,Choroid Plexus Carcinoma,1
30326,Malignant Cellular Infiltrate,Vaginal Neuroendocrine Carcinoma,1
30327,Necrotic changes (finding),small cell carcinoma of extrahepatic bile duct,1
30328,Indolent Clinical Course,Vaginal Rhabdomyoma,1
30329,Epithelial Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
30330,Tissue Differentiation Uncertain,Adult Synovial Sarcoma,1
30331,Monocytosis,Chronic Myelomonocytic Leukemia-2,1
30332,High Grade Lesion,Kidney Synovial Sarcoma,1
30333,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",1
30334,Mitotic Activity,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
30335,Malignant Cellular Infiltrate,Clinical Stage II Retinoblastoma AJCC v8,1
30336,Dilated Vascular Space Formation,Glomangioma of skin,1
30337,Encapsulated Mass,Thyroid Gland Oncocytic Adenoma,1
30338,"Fully Differentiated ""Adult-Type"" Tissues Present",Extragonadal primary malignant teratoma,1
30339,Low Grade Lesion,Low grade myofibroblastic sarcoma,1
30340,High Grade Lesion,Liver Synovial Sarcoma,1
30341,Adulthood Lesion,Adult Mixed Glioma,1
30342,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage IV,1
30343,Carcinomatous Component Present,Transitional cell carcinoma of bladder,1
30344,Plexiform Growth Pattern,Gastric Plexiform Fibromyxoma,1
30345,Ineffective hematopoiesis,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
30346,Locally Aggressive Lesion,Atypical fibroxanthoma of skin,1
30347,Malignant Cellular Infiltrate,Refractory Plasma Cell Neoplasm,1
30348,Epithelial Component Present,Submandibular Gland Undifferentiated Carcinoma,1
30349,Collagenous Stroma Formation,Sclerosing PEComa,1
30350,Non-Invasive Lesion,Papillary transitional cell neoplasm of low malignant potential,1
30351,Dysplasia,Low Grade Conjunctival Intraepithelial Neoplasia,1
30352,Low Mitotic Activity,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
30353,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Pulmonary Blastoma,1
30354,Epithelial Component Present,Subglottic Verrucous Carcinoma,1
30355,Recurrent disease,Recurrent Carcinoma of Unknown Primary,1
30356,Recurrent disease,Penis carcinoma recurrent,1
30357,Carcinomatous Component Present,Stage IIB Pancreatic Cancer AJCC v8,1
30358,Neuronal Differentiation,Ganglioglioma,1
30359,Vascular Channel Formation,Intracranial cavernous hemangioma,1
30360,Severe cytologic atypia,Unresectable Pancreatic Neuroendocrine Carcinoma,1
30361,Poorly Differentiated Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma,1
30362,Regional Disease,Locally Advanced Unresectable Carcinoma,1
30363,Carcinomatous Component Present,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
30364,Fibrotic Stroma Formation,Vulvar Fibrolipoma,1
30365,Malignant Cellular Infiltrate,Paranasal Sinus Cancer,1
30366,Papillary Pattern,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7,1
30367,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of pleura,1
30368,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Childhood Acute Myeloid Leukemia without Maturation,1
30369,Slow Growing Mass,Peripheral Hemangioblastoma,1
30370,Non-Hereditary Lesion,Gastric Cardia Adenocarcinoma,1
30371,Benign Cellular Infiltrate,Adrenal Gland Ganglioneuroma,1
30372,Exophytic Papillary Lesion,Condyloma acuminata of cervix,1
30373,Glomerular Hypertrophy,Focal glomerulosclerosis,1
30374,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
30375,Carcinomatous Component Present,Papillary Thyroid Microcarcinoma,1
30376,Epithelial Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
30377,Epithelial Component Present,Descending Colon Neuroendocrine Tumor G1,1
30378,Anaplasia,Breast implant-associated anaplastic large cell lymphoma,1
30379,Malignant Cellular Infiltrate,Adenocarcinoma in situ in villous adenoma,1
30380,Refractory Disease,Non-Hodgkin's lymphoma refractory,1
30381,Malignant Cellular Infiltrate,Recurrent T Acute Lymphoblastic Leukemia,1
30382,Malignant Cellular Infiltrate,Colorectal Lymphoma,1
30383,Metastatic Lesion,Metastatic Urethral Carcinoma,1
30384,Indolent Clinical Course,Benign vascular neoplasm,1
30385,Pushing Tumor Margin,Verrucous carcinoma of penis,1
30386,High Mitotic Activity,Digestive System Small Cell Neuroendocrine Carcinoma,1
30387,Dense Intercellular Reticulin Network Present,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
30388,Cutaneous Involvement,"Xeroderma pigmentosum, group B",1
30389,'Starry-sky' pattern,Burkitt Lymphoma by Ann Arbor Stage,1
30390,Bone Marrow Lymphoplasmacytic Infiltrate,Waldenstrom's macroglobulinemia refractory,1
30391,Endophytic Tumor Growth,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
30392,Malignant Cellular Infiltrate,Carcinoma in Situ,1
30393,Epithelial Component Present,Mild epithelial dysplasia,1
30394,Indolent Clinical Course,Atrial myxoma,1
30395,Mixed Cellular Population,Adenosarcoma of cervix uteri,1
30396,Malignant Cellular Infiltrate,Metastatic Fallopian Tube Carcinoma,1
30397,Unifocal Lesion,Eosinophilic Granuloma,1
30398,Malignant Cellular Infiltrate,Skin carcinoma,1
30399,Eccrine Differentiation,Malignant Eccrine Neoplasm,1
30400,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v6,1
30401,Tartrate Resistant Acid Phosphatase Positive Cells Present,Progressive Hairy Cell Leukemia Initial Treatment,1
30402,S-100-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis,1
30403,Microinvasive tumor,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension,1
30404,Epithelial Component Present,Esophageal adenocarcinoma recurrent,1
30405,Malignant Cellular Infiltrate,Stage III Bladder Cancer AJCC v6 and v7,1
30406,Sarcomatous Component Present,Ovarian Dermoid Cyst with Secondary Sarcoma,1
30407,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma recurrent,1
30408,Glomeruloid Vessels Present,Third Ventricle Pilocytic Astrocytoma,1
30409,Gyriform Trabecular Pattern,Gastric Gastrin-Producing Neuroendocrine Tumor,1
30410,Epithelial Component Present,Childhood Breast Carcinoma,1
30411,Malignant Cellular Infiltrate,Stage 0 Ampulla of Vater Cancer AJCC v8,1
30412,Polymorphic Cellular Infiltrate,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
30413,Vascular Channel Formation,"Hemangioma, Cavernous",1
30414,Carcinomatous Component Present,Refractory Head and Neck Carcinoma,1
30415,Carcinomatous Component Present,Carcinoma of lung,1
30416,Indolent Clinical Course,Juxtacortical chondroma,1
30417,Malignant Cellular Infiltrate,Cardiac Biphasic Synovial Sarcoma,1
30418,Malignant Cellular Infiltrate,Stage I Adult Liver Cancer AJCC v7,1
30419,Mixed Cellular Population,Malignant Phyllodes Tumor of Prostate,1
30420,Secondary Lesion,Metastatic Digestive System Carcinoma,1
30421,High Mitotic Activity,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
30422,Benign Cellular Infiltrate,Rete Testis Adenoma,1
30423,Pregnancy Complications,Acute Placental Infarction,1
30424,Pregnancy Complications,Stage I Gestational Trophoblastic Neoplasm AJCC v8,1
30425,Diffuse Lesion,Diffuse Intrinsic Pontine Glioma,1
30426,Nuclear Atypia,Atypical follicular adenoma,1
30427,Follicular Cell Differentiation,Atypical follicular adenoma,1
30428,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
30429,Myxoid Stroma Formation,Atrial myxoma,1
30430,Epithelial Component Present,fibroma of testis,1
30431,Severe cytologic atypia,Colorectal Large Cell Neuroendocrine Carcinoma,1
30432,Microvascular Proliferation,Childhood Brain Stem Gliosarcoma,1
30433,Anaplasia,Stage II Anaplastic Large Cell Lymphoma,1
30434,Stromal Invasion,FIGO Stage II Ovarian Cancer,1
30435,Bone Marrow Involvement,Waldenstrom's macroglobulinemia refractory,1
30436,Cutaneous Involvement,Acantholytic acanthoma,1
30437,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Germinoma,1
30438,Indolent Clinical Course,Oral Cavity Adenoma,1
30439,Lymphadenopathy,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
30440,Epithelial Component Present,Subglottic Squamous Cell Carcinoma,1
30441,Childhood Lesion,Childhood Myxoid Chondrosarcoma,1
30442,Carcinomatous Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
30443,Epithelial Component Present,Breast Cancer by AJCC v8 Prognostic Stage,1
30444,Severe dysplasia,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
30445,Dermal Involvement,Neuronevus,1
30446,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma,1
30447,Epithelial Component Present,Basaloid carcinoma,1
30448,Carcinomatous Component Present,Stage IIIA Ovarian Cancer AJCC v6 and v7,1
30449,Epithelial Component Present,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
30450,Malignant Cellular Infiltrate,Type II Endometrial Adenocarcinoma,1
30451,Aggressive Clinical Course,Childhood Burkitt Leukemia,1
30452,atypia morphology,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
30453,Microcystic Change,Lymphangioma circumscriptum,1
30454,Epithelial Component Present,Advanced Head and Neck Squamous Cell Carcinoma,1
30455,Nuclear Atypia,Childhood Anaplastic Oligoastrocytoma,1
30456,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8,1
30457,Mixture of Germ Cell Neoplastic Components Present,Ovarian germ cell tumor mixed,1
30458,Syncytial Pattern,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
30459,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage II,1
30460,Malignant Cellular Infiltrate,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant",1
30461,Aggressive Clinical Course,"Thymoma, type B2, malignant",1
30462,Carcinomatous Component Present,Recurrent Chromophobe Renal Cell Carcinoma,1
30463,Malignant Cellular Infiltrate,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",1
30464,Myxoid Stroma Formation,Recurrent Myxoid Liposarcoma,1
30465,Neuroendocrine Differentiation,Stage III Merkel Cell Carcinoma AJCC v7,1
30466,Carcinomatous Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
30467,Malignant Cellular Infiltrate,Platinum-Resistant Ovarian Carcinoma,1
30468,Localized Lesion,Benign cystic nephroma,1
30469,Benign Cellular Infiltrate,Benign Uveal Neoplasm,1
30470,Hyperkeratosis,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
30471,Papillary Pattern,Vestibular Papilloma,1
30472,Malignant Cellular Infiltrate,"Lung Large Cell Carcinoma, Clear Cell Variant",1
30473,Recurrent disease,Angiocentric lymphoma recurrent,1
30474,Malignant Cellular Infiltrate,Pathologic Stage I Retinoblastoma AJCC v8,1
30475,Malignant Cellular Infiltrate,Endometrial adenocarcinoma,1
30476,Carcinomatous Component Present,Maxillary Sinus Squamous Cell Carcinoma,1
30477,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
30478,Dysplasia,tubular adenoma of stomach,1
30479,Epithelial Component Present,Microcystic adnexal carcinoma,1
30480,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Differentiating Neuroblastoma,1
30481,Well-Circumscribed Lesion,cystadenoma of salivary gland,1
30482,Pathologic TNM Finding,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
30483,Secondary Lesion,Secondary malignant neoplasm of sternum,1
30484,Epithelial Component Present,Stage IIB Anal Cancer AJCC v8,1
30485,Malignant Primitive Cellular Infiltrate,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,1
30486,Malignant Cellular Infiltrate,Luminal A Breast Carcinoma,1
30487,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
30488,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Basophilic Leukemia,1
30489,Increased Cellularity Present,Kadish Stage C Olfactory Neuroblastoma,1
30490,Epineurial Invasion,Lipomatosis of Nerve,1
30491,Nodular lesions,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
30492,Severe dysplasia,Carcinoma in situ of skin,1
30493,Malignant Cellular Infiltrate,Splenic Manifestation of Chronic Lymphocytic Leukemia,1
30494,Malignant Cellular Infiltrate,Nonencapsulated sclerosing tumor,1
30495,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8,1
30496,Malignant Cellular Infiltrate,Primary cutaneous lymphoma,1
30497,Superficial Lesion,Atypical Lipoma,1
30498,Malignant Cellular Infiltrate,Malignant Mixed Mesodermal (Mullerian) Tumor,1
30499,Chromogranin A Positive Neoplastic Cells Present,Metastatic Breast Carcinoid Tumor,1
30500,Diffuse Pattern,Body Cavity Primary Effusion Lymphoma,1
30501,Hyperkeratosis,Common wart,1
30502,Refractory Disease,Refractory Malignant Skin Neoplasm,1
30503,Benign Cellular Infiltrate,Central Breast Papilloma,1
30504,Tissue Differentiation Uncertain,Atypical fibroxanthoma - spindle cell type,1
30505,Recurrent disease,Recurrent Glioblastoma,1
30506,Epithelial Component Present,Locally Advanced Urothelial Carcinoma,1
30507,Myxoid Stroma Formation,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
30508,Splenomegaly,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
30509,Malignant Cellular Infiltrate,Medulloblastoma with Leptomeningeal Spread,1
30510,Malignant Cellular Infiltrate,Recurrent Salivary Gland Cancer,1
30511,Secondary Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
30512,Severe cytologic atypia,Primary hepatic neuroendocrine carcinoma,1
30513,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
30514,Carcinomatous Component Present,Stage IV Esophageal Cancer AJCC v7,1
30515,Local disease,Localized tumors of the Ewing's family,1
30516,Epithelial Component Present,Rectosigmoid cancer,1
30517,Vascular Channel Formation,Anastomosing Hemangioma,1
30518,Epithelial Component Present,Stage IIA Merkel Cell Carcinoma AJCC v7,1
30519,Well-Circumscribed Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
30520,Epithelial Component Present,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
30521,Antoni A Pattern,Conventional Schwannoma,1
30522,Cutaneous Involvement,Exacerbation of acne,1
30523,Unclassifiable Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
30524,Adnexal Differentiation,Desmoplastic trichoepithelioma,1
30525,Carcinomatous Component Present,Stage II Vulva Cancer AJCC v6,1
30526,Adulthood Lesion,Adult Anaplastic Astrocytoma,1
30527,Lobulated Growth Pattern,Sellar Chordoma,1
30528,Malignant Cellular Infiltrate,Desmoplastic Small Round Cell Tumor,1
30529,Malignant Cellular Infiltrate,Esophageal Mixed Adenoneuroendocrine Carcinoma,1
30530,Metastatic Lesion,Metastatic Bone Sarcoma,1
30531,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
30532,Epithelial Component Present,Stage IIIC Rectal Cancer AJCC v7,1
30533,Papillary Pattern,Peripheral Breast Papilloma,1
30534,Carcinomatous Component Present,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
30535,Vascular Channel Formation,Hemangioma of intracranial structure,1
30536,Embryoid Bodies Present,Stage II Ovarian Polyembryoma AJCC v6 and v7,1
30537,Malignant Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
30538,Recurrent disease,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
30539,Capillary Sized Vascular Channel Formation,Cerebral Hemangioblastoma,1
30540,Epithelial Component Present,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
30541,Extensive Stage Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
30542,Cutaneous Involvement,Non-Neoplastic Skin Disorder,1
30543,Vascular Channel Formation,Recurrent Skin Angiosarcoma,1
30544,Malignant Cellular Infiltrate,Metastatic non-small cell lung cancer,1
30545,Malignant Cellular Infiltrate,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,1
30546,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
30547,Melanin-Forming Neuroepithelial Cells Present,"Neuroectodermal Tumor, Melanotic",1
30548,Malignant Cellular Infiltrate,Metastatic Unresectable Basal Cell Carcinoma,1
30549,Malignant Cellular Infiltrate,Malignant sex-cord stromal tumor,1
30550,Poorly Differentiated Lesion,Sarcomatoid Renal Cell Carcinoma,1
30551,Metastatic Lesion,Pericardial mesothelioma malignant advanced,1
30552,Hyalinized Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
30553,Increased Cellularity Present,Anaplastic Diencephalic Astrocytoma,1
30554,Regional Disease,Locally Advanced Unresectable Prostate Adenocarcinoma,1
30555,Myxoid Stroma Formation,Myxoma,1
30556,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Immature Teratoma,1
30557,Vascular Channel Formation,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,1
30558,Malignant Cellular Infiltrate,Sinonasal undifferentiated carcinoma,1
30559,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
30560,Metastatic/Recurrent Disease,Liver Synovial Sarcoma,1
30561,Malignant Cellular Infiltrate,Laryngeal Leiomyosarcoma,1
30562,Epithelial Component Present,Adenocarcinoma with spindle cell metaplasia,1
30563,Malignant Cellular Infiltrate,Lugano Classification Stage III Hodgkin Lymphoma AJCC v8,1
30564,Exophytic Papillary Lesion,Laryngeal verrucous carcinoma,1
30565,Epithelial Component Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
30566,Benign Cellular Infiltrate,ductal papilloma of salivary gland,1
30567,Melanin Pigment Present,Spindle cell nevus of Reed,1
30568,Malignant Cellular Infiltrate,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
30569,Dysplasia,Esophageal dysplasia,1
30570,Benign Cellular Infiltrate,Benign neoplasm of axilla,1
30571,Well-Circumscribed Lesion,Stage II Kidney Wilms Tumor,1
30572,Carcinomatous Component Present,Synchronous Bilateral Breast Carcinoma,1
30573,Hereditary Lesion,Constitutional Mismatch Repair Deficiency Syndrome,1
30574,In Situ Lesion,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
30575,Pregnancy Complications,"Pregnancy, Tubal",1
30576,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
30577,Benign Cellular Infiltrate,Inverted Papilloma,1
30578,Severe dysplasia,Biliary Intraepithelial Neoplasia-3,1
30579,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Tumor,1
30580,Malignant Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
30581,Collagenous Stroma Formation,Central Nervous System Myofibroblastoma,1
30582,S-100-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
30583,Benign Cellular Infiltrate,Borderline Ovarian Serous Adenofibroma,1
30584,Immunosuppression-Related Post-Transplant Toxicity,Engraftment syndrome,1
30585,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity recurrent,1
30586,Benign Cellular Infiltrate,Benign neoplasm of urethra,1
30587,Malignant Cellular Infiltrate,Extraskeletal Osteosarcoma,1
30588,Adulthood Lesion,Adult Intracranial Germ Cell Tumor,1
30589,Local disease,Appendix Lipoma,1
30590,Benign Cellular Infiltrate,Left atrial myxoma,1
30591,Immunologic Deficiency Syndromes,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,1
30592,Anaplasia,Stage I Anaplastic Large Cell Lymphoma,1
30593,Carcinomatous Component Present,Papillary Renal Cell Carcinoma,1
30594,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Immature Teratoma,1
30595,Dilated Thin-Walled Vascular Space Formation,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
30596,Poorly Differentiated Lesion,Sarcomatoid carcinoma of the lung,1
30597,Cystic Change,Dermoid Cyst of the Spinal Cord,1
30598,Epithelial Component Present,Oncocytic Breast Carcinoma,1
30599,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
30600,Benign Cellular Infiltrate,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
30601,Well-Circumscribed Lesion,Colorectal hyperplastic polyp,1
30602,Epithelial Component Present,Mesonephric tumor,1
30603,Severe dysplasia,Lung Adenocarcinoma In Situ,1
30604,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
30605,Fibrotic Stroma Formation,Ovarian Serous Adenofibroma,1
30606,Malignant Cellular Infiltrate,Hepatic lymphoma,1
30607,Malignant Cellular Infiltrate,Cecum Non-Hodgkin Lymphoma,1
30608,Mild cytologic atypia,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
30609,Multinodular Mass,Conventional Angiosarcoma,1
30610,Borderline Lesion,Borderline Fallopian Tube Endometrioid Tumor,1
30611,Malignant Cellular Infiltrate,Stage I Pancreatic Cancer AJCC v8,1
30612,Fibrosis,"Fibrocystic change, proliferative type with atypia",1
30613,Cytoplasmic Membrane-Bound Granules Present,Stage IIA Merkel Cell Carcinoma AJCC v7,1
30614,Indolent Clinical Course,Piloleiomyoma,1
30615,Well Differentiated Lesion,Supraglottic Verrucous Carcinoma,1
30616,Parakeratosis,Classic Type Trichilemmoma,1
30617,Benign Cellular Infiltrate,neurofibroma of esophagus,1
30618,Metastatic Lesion,Metastatic Adrenal Cortex Carcinoma,1
30619,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",1
30620,Well-Circumscribed Lesion,Peutz-Jeghers Polyp of the Stomach,1
30621,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage IV,1
30622,Benign Cellular Infiltrate,Myxoid leiomyoma,1
30623,Adulthood Lesion,Adult Rhabdomyosarcoma,1
30624,Carcinomatous Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
30625,Malignant Cellular Infiltrate,Thymic Mucoepidermoid Carcinoma,1
30626,Well-Circumscribed Lesion,Stage V Kidney Wilms Tumor,1
30627,Thick-Walled Hyalinized Vessels Present,Acoustic Neuroma,1
30628,Primary Lesion,Stage IVA Osteosarcoma AJCC v7,1
30629,Multinodular Mass,Cutaneous Radiation-Related Angiosarcoma,1
30630,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
30631,High Grade Lesion,Recurrent Anaplastic Astrocytoma,1
30632,Cutaneous Involvement,"Xeroderma Pigmentosum, Complementation Group D",1
30633,Neuroendocrine Differentiation,Stage IB Lung Small Cell Carcinoma AJCC v7,1
30634,Adnexal Differentiation,Malignant neoplasm of sweat gland,1
30635,Malignant Cellular Infiltrate,Small intestine carcinoma,1
30636,Secondary Lesion,Metastatic Malignant Neoplasm in the Soft Tissues,1
30637,Local disease,Infiltrating angiolipoma,1
30638,Carcinomatous Component Present,Minor Salivary Gland Adenocarcinoma,1
30639,Malignant Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v6 and v7,1
30640,Epithelial Component Present,Intrahepatic Bile Duct Microcystic Adenoma,1
30641,Epithelial Component Present,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8,1
30642,Recurrent disease,Recurrent Uterine Corpus Carcinoma,1
30643,Mixed Cellular Population,"Phyllodes tumor, borderline",1
30644,Malignant Cellular Infiltrate,Stage IV Intrahepatic Bile Duct Cancer AJCC v8,1
30645,Secondary Lesion,Advanced Bile Duct Carcinoma,1
30646,Fibromyxoid Stroma Formation,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
30647,Malignant Cellular Infiltrate,Colorectal Large Cell Neuroendocrine Carcinoma,1
30648,Hyperkeratosis,Verrucous carcinoma of the oral cavity recurrent,1
30649,High Mitotic Activity,neuroendocrine carcinoma of anal canal,1
30650,Carcinomatous Component Present,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
30651,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
30652,Cutaneous Involvement,Chronic Bullous Disease of Childhood,1
30653,Recurrent disease,Recurrent B Acute Lymphoblastic Leukemia,1
30654,Cutaneous Involvement,Pityriasis Rubra Pilaris,1
30655,Malignant Cellular Infiltrate,Metastatic Gastric Carcinoma,1
30656,Carcinomatous Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
30657,Malignant Cellular Infiltrate,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
30658,Epithelial Component Present,Lung Cancer by AJCC v7 Stage,1
30659,Metastatic/Recurrent Disease,Childhood Epithelioid Sarcoma,1
30660,Well Differentiated Neuroendocrine Lesion,Duodenal Neuroendocrine Tumor,1
30661,Neuronal Differentiation,Central Neurocytoma,1
30662,In Situ Lesion,Carcinoma in Situ,1
30663,Intraductal Lesion,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
30664,Absence of Invasion,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
30665,Childhood Lesion,Childhood Diffuse Large B-Cell Lymphoma,1
30666,Severe dysplasia,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8",1
30667,Epithelial Component Present,Stage IB Cervical Cancer AJCC v8,1
30668,Childhood Lesion,Childhood Pineal Parenchymal Cell Neoplasm,1
30669,Chronic lymphocytic inflammation,Gastric Carcinoma with Lymphoid Stroma,1
30670,Honeycomb Pattern,Adult Brain Oligodendroglioma,1
30671,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
30672,Perivascular Arrangement of Tumor Cells,Malignant Lung PEComa,1
30673,Primary Lesion,Adult Fibrolamellar Carcinoma,1
30674,Adulthood Lesion,Benign Adult Brain Neoplasm,1
30675,Malignant Cellular Infiltrate,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
30676,Carcinomatous Component Present,Stage IB Ampulla of Vater Cancer AJCC v7,1
30677,Primary Lesion,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
30678,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v8,1
30679,High Grade Lesion,Glioblastoma,1
30680,Vascular Channel Formation,Poorly Differentiated Angiosarcoma,1
30681,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
30682,Malignant Cellular Infiltrate,Minor Salivary Gland Squamous Cell Carcinoma,1
30683,Epithelial Component Present,Adenocarcinoma of the prostate stage II,1
30684,Cutaneous Involvement,Cervical Blue Nevus,1
30685,Malignant Cellular Infiltrate,undifferentiated carcinoma of cervix,1
30686,Indolent Clinical Course,Central Nervous System Myofibroblastoma,1
30687,atypia morphology,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
30688,Carcinomatous Component Present,Stage IIIC Prostate Cancer AJCC v8,1
30689,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
30690,Regional Disease,Locally Advanced Paraganglioma,1
30691,Cutaneous Involvement,"Nevus, Spindle Cell",1
30692,Malignant Cellular Infiltrate,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,1
30693,Chromogranin A Positive Neoplastic Cells Present,Thymic Carcinoid Tumor,1
30694,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage III,1
30695,Epithelial Component Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
30696,Carcinomatous Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
30697,Epithelial Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
30698,CD30-Positive Neoplastic Cells Present,Adult Systemic Anaplastic Large Cell Lymphoma,1
30699,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of lung,1
30700,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,1
30701,Malignant Cellular Infiltrate,malignant neoplasm of bone marrow,1
30702,Mixed Cellular Population,carcinosarcoma of extrahepatic bile duct,1
30703,Junctional Proliferation,"Nevus, Spindle Cell",1
30704,Benign Cellular Infiltrate,Myolipoma,1
30705,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
30706,Benign Cellular Infiltrate,Myxoma of the Endocardium,1
30707,Cutaneous Involvement,Skin carcinoma,1
30708,Epithelial Component Present,Large cell lung cancer stage III,1
30709,Junctional Proliferation,Junctional nevus,1
30710,Dysplasia,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
30711,Carcinomatous Component Present,Bladder squamous cell carcinoma stage 0,1
30712,Indolent Clinical Course,Lipoma of pleura,1
30713,Cutaneous Involvement,Nodulo-ulcerative basal cell carcinoma,1
30714,"Fully Differentiated ""Adult-Type"" Tissues Present",Sellar Immature Teratoma,1
30715,Cutaneous Involvement,Warty dyskeratoma,1
30716,Morphologic Overlap,"Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
30717,Diffuse Pattern,AIDS-Related Primary Effusion Lymphoma,1
30718,In Situ Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
30719,Cutaneous Involvement,Urticaria,1
30720,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
30721,Malignant Cellular Infiltrate,Acute Undifferentiated Leukemia,1
30722,Malignant Cellular Infiltrate,Stage IV Ovarian Carcinoma,1
30723,Malignant Cellular Infiltrate,Squamous cell carcinoma of the parotid gland,1
30724,Pathologic TNM Finding,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
30725,Malignant Cellular Infiltrate,Childhood Testicular Embryonal Carcinoma,1
30726,Malignant Cellular Infiltrate,Urothelial carcinoma bladder recurrent,1
30727,Radiation Sickness,Mucositis following radiation therapy,1
30728,Carcinomatous Component Present,Stage IIC Appendix Carcinoma AJCC v7,1
30729,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Lymphoma,1
30730,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
30731,Necrotic changes (finding),Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
30732,Secondary Lesion,Metastatic Lip Squamous Cell Carcinoma,1
30733,Dysplasia,Ampulla of Vater Villous Adenoma,1
30734,Solitary mass,Bronchioloalveolar Adenocarcinoma,1
30735,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",1
30736,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity recurrent,1
30737,Cutaneous Involvement,Actinic keratosis,1
30738,Nuclear Atypia,Diencephalic Glioblastoma,1
30739,Epithelial Component Present,Lung Basaloid Squamous Cell Carcinoma,1
30740,Dysplasia,Fundic gland polyp,1
30741,Pseudoencapsulated Mass,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
30742,Papillary Pattern,Urethral Condyloma Acuminatum,1
30743,Immunologic Deficiency Syndromes,Maternally Derived Graft Versus Host Disease,1
30744,Mitotic Activity,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor,1
30745,Trabecular Pattern,Microfollicular adenoma,1
30746,Adulthood Lesion,Stage III Adult Immunoblastic Lymphoma,1
30747,Epithelial Component Present,Metastatic Sarcomatoid Renal Cell Carcinoma,1
30748,Nuclear Pseudoinclusion,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
30749,Alternative Fascicle (Bundle) Pattern,Uterine Fibroids,1
30750,Myxoid Stroma Formation,Mediastinal Epithelioid Hemangioendothelioma,1
30751,Carcinomatous Component Present,Hormone refractory prostate cancer,1
30752,Poorly Differentiated Lesion,Sarcomatoid carcinoma of the lung,1
30753,Epithelial Component Present,Moderate pancreatic duct dysplasia,1
30754,Well-Circumscribed Lesion,Desmoplastic fibroblastoma,1
30755,Recurrent Lymphoma,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
30756,Congenital Lesion,Coloboma of eyelid,1
30757,Secondary Lesion,Locally Advanced Prostate Adenocarcinoma,1
30758,Intraductal Lesion,Peripheral Breast Papilloma,1
30759,Carcinomatous Component Present,Carcinomatosis,1
30760,Benign Cellular Infiltrate,Fibromatosis colli,1
30761,Epithelial Component Present,Gastric Body Carcinoma,1
30762,Malignant Cellular Infiltrate,Medulloblastoma with extensive nodularity,1
30763,Malignant Cellular Infiltrate,Mixed Hepatoblastoma with Teratoid Features,1
30764,Malignant Component Present,"Struma ovarii, malignant",1
30765,"Fully Differentiated ""Adult-Type"" Tissues Present",Central Nervous System Dermoid Cyst,1
30766,Immunologic Deficiency Syndromes,Bone Marrow Transplantation Nephropathy,1
30767,Radiation Sickness,Solar Radiation-Related Cutaneous Melanoma,1
30768,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
30769,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Sellar Region,1
30770,Carcinomatous Component Present,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
30771,Epithelial Component Present,Ovarian serous cystadenofibroma,1
30772,Epithelial Component Present,Skin carcinoma,1
30773,Malignant Cellular Infiltrate,Adenocarcinoma of appendix,1
30774,Cutaneous Involvement,Grade 1 Cutaneous Follicular Lymphoma,1
30775,Extensive Stage Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx,1
30776,Immunologic Deficiency Syndromes,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
30777,Malignant Cellular Infiltrate,Stage IIB Osteosarcoma AJCC v7,1
30778,Primary Lesion,Childhood Gliosarcoma,1
30779,Secondary Lesion,Secondary malignant neoplasm of retina,1
30780,Benign Cellular Infiltrate,Benign neoplasm of gallbladder,1
30781,Defective Heavy Chain Present,gamma-Chain Disease,1
30782,Malignant Cellular Infiltrate,hepatoid adenocarcinoma of gallbladder,1
30783,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma non-metastatic,1
30784,Metastatic Lesion,Metastatic Malignant Germ Cell Tumor,1
30785,Epithelial Component Present,Carcinoma,1
30786,Endophytic Tumor Growth,Laryngeal verrucous carcinoma recurrent,1
30787,Anaplasia,"Seminoma, anaplastic",1
30788,Malignant Cellular Infiltrate,leiomyosarcoma of extrahepatic bile duct,1
30789,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
30790,Locally Aggressive Lesion,Dermatofibrosarcoma protuberans with myoid differentiation,1
30791,Low Mitotic Activity,Stage I Duodenal Neuroendocrine Tumor AJCC v8,1
30792,Epithelial Component Present,Refractory Breast Carcinoma,1
30793,Neuroendocrine Differentiation,Small Intestinal Carcinoid Tumor,1
30794,Cutaneous Involvement,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
30795,Metastatic Lesion,Metastatic Malignant Neoplasm to the Cervix,1
30796,Carcinomatous Component Present,Large cell carcinoma of lung,1
30797,Recurrent disease,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
30798,Nodular lesions,Thyroid Nodule,1
30799,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
30800,Pseudopapillary Pattern,Testicular embryonal carcinoma stage III,1
30801,Neuroendocrine Differentiation,Gastric Neuroendocrine Carcinoma,1
30802,Lymphatic Spread,Inflammatory carcinoma of breast stage III,1
30803,Adnexal Differentiation,Pilomatrixoma,1
30804,Malignant Cellular Infiltrate,Metastatic Chordoma,1
30805,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8,1
30806,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v8,1
30807,Metastatic Lesion,Secondary malignant neoplasm of pancreas,1
30808,Malignant Cellular Infiltrate,Accessory Urethral Gland Carcinoma,1
30809,Carcinomatous Component Present,Adenocarcinoma of prostate,1
30810,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage II,1
30811,High Mitotic Activity,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
30812,Splenomegaly,Refractory B-Cell Prolymphocytic Leukemia,1
30813,Skin Red Dot,Angioma serpiginosum,1
30814,Hyperkeratosis,verrucous carcinoma of vulva,1
30815,Epithelial Component Present,Rectal Adenoma with Severe Dysplasia,1
30816,Rapidly Enlarging Mass,Anaplastic thyroid carcinoma,1
30817,Malignant Cellular Infiltrate,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
30818,Epithelial Component Present,Adenocarcinoma of the prostate metastatic,1
30819,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated RUNX1,1
30820,Insular Pattern,Pancreatic Somatostatinoma,1
30821,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor,1
30822,Malignant Cellular Infiltrate,Refractory Synovial Sarcoma,1
30823,Metastatic/Recurrent Disease,"Ossifying fibromyxoid tumor, malignant",1
30824,Lobulated Growth Pattern,Multiple Lobular Capillary Hemangiomas,1
30825,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor G2,1
30826,Perivascular Arrangement of Tumor Cells,Lymphangiomyoma,1
30827,Epithelial Component Present,Cervical Adenoid Cystic Carcinoma,1
30828,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline RUNX1 Mutation,1
30829,Epithelial Component Present,Water-clear cell adenoma,1
30830,Mitotic Activity,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
30831,Slow Growing Painless Mass,Nodular tenosynovitis,1
30832,Resectable Mass,Localized Resectable Adult Liver Carcinoma,1
30833,Antoni A Pattern,Peripheral Nerve Schwannoma,1
30834,Benign Cellular Infiltrate,Benign Apocrine Neoplasm,1
30835,Malignant Cellular Infiltrate,Malignant neoplasm of stomach recurrent,1
30836,Malignant Cellular Infiltrate,Parotid Gland Liposarcoma,1
30837,'Starry-sky' pattern,Immunodeficiency-associated Burkitt's lymphoma,1
30838,Carcinomatous Component Present,Gastric Intestinal-Type Adenocarcinoma,1
30839,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
30840,High Mitotic Activity,Pancreatic Large Cell Neuroendocrine Carcinoma,1
30841,Malignant Cellular Infiltrate,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
30842,In Situ Lesion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
30843,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
30844,Secondary Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
30845,Carcinomatous Component Present,Human Papillomavirus-Related Endocervical Adenocarcinoma,1
30846,Recurrent disease,Marginal zone lymphoma recurrent,1
30847,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
30848,Metastatic Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
30849,Epithelial Component Present,Recurrent Malignant Endocrine Neoplasm,1
30850,Cystic Change,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
30851,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
30852,Indolent Clinical Course,Angiomyofibroblastoma,1
30853,Carcinomatous Component Present,Stage IVA Gallbladder Cancer AJCC v8,1
30854,Malignant Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,1
30855,Extraosseous Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,1
30856,Malignant Cellular Infiltrate,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8,1
30857,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
30858,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma transformed recurrent,1
30859,Carcinomatous Component Present,pleomorphic carcinoma of breast,1
30860,Secondary Lesion,Krukenberg Tumor,1
30861,Malignant Cellular Infiltrate,Recurrent T-Cell Prolymphocytic Leukemia,1
30862,Chronic lymphocytic inflammation,Lymphoid interstitial pneumonia,1
30863,Refractory Disease,Refractory Malignant Pharyngeal Neoplasm,1
30864,Metastatic Lesion,Advanced Uterine Corpus Carcinosarcoma,1
30865,Trichoblastic Differentiation,Desmoplastic trichoepithelioma,1
30866,Epithelial Component Present,AIDS-related anal cancer recurrent,1
30867,Favorable Clinical Outcome,Beta-Catenin-Activated Hepatocellular Adenoma,1
30868,Carcinomatous Component Present,cloacogenic carcinoma of rectum,1
30869,Carcinomatous Component Present,Non-small cell lung cancer stage II,1
30870,Malignant Cellular Infiltrate,Advanced Cervical Adenocarcinoma,1
30871,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
30872,Mucoid Stroma Formation,Chordoid Glioma of the Third Ventricle,1
30873,No Identifiable Line of Differentiation,Malignant fibrous histiocytoma metastatic,1
30874,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
30875,Childhood Lesion,Childhood Thyroid Gland Medullary Carcinoma,1
30876,Well-Circumscribed Lesion,Childhood Kidney Wilms Tumor,1
30877,Recurrent disease,Recurrent Malignant Extragonadal Germ Cell Tumor,1
30878,Lymphoplasmacytic Infiltrate,Childhood Central Nervous System Germinoma,1
30879,Secondary Lesion,Secondary malignant neoplasm of colon,1
30880,Malignant Cellular Infiltrate,Stage IA Distal Bile Duct Cancer AJCC v7,1
30881,Epithelioid Component Present,"Synovial sarcoma, biphasic",1
30882,Skin Papule,Vulvar Trichoepithelioma,1
30883,Malignant Cellular Infiltrate,Colorectal cancer recurrent,1
30884,Epithelial Component Present,Esophageal Well Differentiated Squamous Cell Carcinoma,1
30885,Epithelial Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
30886,In Situ Lesion,Carcinoma in situ of trachea,1
30887,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Seminoma,1
30888,Epithelial Component Present,Skin Basaloid Carcinoma,1
30889,Chronic lymphocytic inflammation,Gastric Carcinoma with Lymphoid Stroma,1
30890,Cutaneous Involvement,Cockade nevus,1
30891,Carcinomatous Component Present,Endometrial adenocarcinoma,1
30892,Carcinomatous Component Present,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
30893,Epithelial Component Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
30894,Stromal Invasion,Stage II Ovarian Cancer AJCC v8,1
30895,Epithelial Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
30896,Dysplasia,Carcinoma in situ of fallopian tube,1
30897,Carcinomatous Component Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,1
30898,Myxoid Stroma Formation,Conventional Extraskeletal Myxoid Chondrosarcoma,1
30899,Epithelial Component Present,Stage IIIB Gastric Carcinoma,1
30900,Malignant Cellular Infiltrate,Stage I Ovarian Polyembryoma AJCC v6 and v7,1
30901,Unresectable Mass,Locally Advanced Unresectable Prostate Carcinoma,1
30902,Recurrent disease,Recurrent Carcinoma of Unknown Primary,1
30903,Rarely Metastasizing Lesion,Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm,1
30904,Malignant Cellular Infiltrate,Hyperdiploid B Acute Lymphoblastic Leukemia,1
30905,Epithelial Component Present,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,1
30906,Malignant Cellular Infiltrate,Distal-Type Epithelioid Sarcoma,1
30907,Tissue Differentiation Uncertain,Epithelioid Type Angiomyolipoma,1
30908,Absence of Stromal Invasion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
30909,Carcinomatous Component Present,Primary Peritoneal Low Grade Serous Adenocarcinoma,1
30910,Adnexal Differentiation,Tumor of follicular infundibulum,1
30911,Carcinomatous Component Present,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
30912,Carcinomatous Component Present,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8,1
30913,Malignant Cellular Infiltrate,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
30914,Epithelial Component Present,adenocarcinoma of extrahepatic bile duct,1
30915,Well Differentiated Neuroendocrine Lesion,Stage IIA Colon Neuroendocrine Tumor AJCC v8,1
30916,Epithelial Component Present,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
30917,Epithelial Component Present,Colon Carcinoma Metastatic in the Lung,1
30918,Thin Bands of Collagen Present,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
30919,Malignant Cellular Infiltrate,Conventional Leiomyosarcoma,1
30920,Benign Cellular Infiltrate,Intracranial Benign Fibrous Histiocytoma,1
30921,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma,1
30922,Enterochromaffin-Like Type Granules Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
30923,High Grade Lesion,Recurrent Childhood Glioblastoma,1
30924,Severe cytologic atypia,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
30925,Epithelial Component Present,Parathyroid mixed cell type adenoma,1
30926,Carcinomatous Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v8,1
30927,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Diffuse Leiomyomatosis,1
30928,Malignant Cellular Infiltrate,Vulvar Merkel Cell Carcinoma,1
30929,Malignant Cellular Infiltrate,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,1
30930,Epithelial Component Present,Locally Advanced Unresectable Cervical Carcinoma,1
30931,Carcinomatous Component Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
30932,Intermediate Grade Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2,1
30933,Epithelial Component Present,Gingival Squamous Cell Carcinoma,1
30934,Malignant Cellular Infiltrate,Secondary malignant neoplasm of choroid,1
30935,Macule,Stage III Acral Lentiginous Melanoma AJCC v7,1
30936,Fibrotic Stroma Formation,Pancreatic Hepatoid Adenocarcinoma,1
30937,Benign Cellular Infiltrate,Left atrial myxoma,1
30938,Collagenous Stroma Formation,Pelvic Fibromatosis,1
30939,Honeycomb Pattern,Brain Oligodendroglioma,1
30940,Lymphoplasmacytic Infiltrate,Familial Waldenstrom's Macroglobulinaemia,1
30941,Congenital Lesion,GIANT PIGMENTED HAIRY NEVUS,1
30942,Childhood Lesion,Childhood Brain Stem Gliosarcoma,1
30943,Malignant Cellular Infiltrate,Malignant melanoma of iris,1
30944,Indolent Clinical Course,Laryngeal Leiomyoma,1
30945,Malignant Cellular Infiltrate,"Glandular intraepithelial neoplasia, grade III",1
30946,Benign Cellular Infiltrate,"Hemangioma, Cavernous, Central Nervous System",1
30947,Malignant Cellular Infiltrate,Cervix carcinoma recurrent,1
30948,Epithelial Component Present,Stage II Lung Cancer AJCC v6,1
30949,Malignant Cellular Infiltrate,Uterine Corpus Myxoid Leiomyosarcoma,1
30950,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v7,1
30951,Malignant Cellular Infiltrate,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
30952,Multinodular Mass,Childhood Angiosarcoma,1
30953,Epithelial Component Present,adenoid cystic carcinoma of lung,1
30954,Borderline Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1
30955,Malignant Cellular Infiltrate,Acute Myeloid Leukemia (AML-M2),1
30956,Carcinomatous Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
30957,Recurrent disease,Recurrent Childhood Anaplastic Astrocytoma,1
30958,Nerve palsy,Acquired Facial Nerve Palsy,1
30959,Malignant Cellular Infiltrate,Stage I Uterine Corpus Cancer,1
30960,Hyaline Cartilage Differentiation,mesenchymal chondrosarcoma of bone,1
30961,Primary Lesion,Moderately Differentiated Hepatocellular Carcinoma,1
30962,Necrotic changes (finding),Cerebral Glioblastoma,1
30963,Malignant Cellular Infiltrate,Adult Cholangiocarcinoma,1
30964,Hyperplastic Tissue Present,Parathyroid Clear Cell Hyperplasia,1
30965,Childhood Lesion,Childhood Ovarian Embryonal Carcinoma,1
30966,Tissue of Mullerian Origin Present,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8,1
30967,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
30968,Primary Lesion,Recurrent Non-Cutaneous Melanoma,1
30969,Fibrotic Stroma Formation,Thyroid Gland Mucoepidermoid Carcinoma,1
30970,Refractory Disease,Refractory Acute Leukemia,1
30971,Malignant Cellular Infiltrate,Ann Arbor Stage IV Grade 3 Follicular Lymphoma,1
30972,Enterochromaffin Type Granules Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
30973,Carcinomatous Component Present,Epiglottic carcinoma,1
30974,Well-Circumscribed Lesion,Colorectal Hamartoma,1
30975,Cutaneous Involvement,Stage II Skin Cancer,1
30976,Carcinomatous Component Present,Advanced Small Intestinal Neuroendocrine Carcinoma,1
30977,Cystic Lesion,Unresectable Craniopharyngioma,1
30978,Nodular Pattern,Ann Arbor Stage IV Grade 3 Follicular Lymphoma,1
30979,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx,1
30980,Thick-Walled Hyalinized Vessels Present,Benign Intraocular Schwannoma,1
30981,Malignant Cellular Infiltrate,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
30982,Carcinomatous Component Present,Ovarian Cancer by FIGO Stage,1
30983,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Isolated del(5q),1
30984,Epithelial Component Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
30985,Benign Cellular Infiltrate,Intracranial lipoma,1
30986,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma,1
30987,Fibrotic Stroma Formation,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
30988,Papillary Pattern,Invasive micropapillary carcinoma of breast,1
30989,Carcinomatous Component Present,Stage IIIA1 Ovarian Cancer AJCC v8,1
30990,Well-Circumscribed Lesion,Rectal Traditional Serrated Adenoma,1
30991,Cystic Change,Benign Brenner Tumor,1
30992,Immunologic Deficiency Syndromes,Renal Allograft Thrombosis,1
30993,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
30994,Malignant Cellular Infiltrate,Recurrent Malignant Ovarian Transitional Cell Tumor,1
30995,bone marrow fibrosis,Post polycythaemia vera myelofibrosis,1
30996,Indolent Clinical Course,Parotid Gland Hemangioma,1
30997,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma,1
30998,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
30999,Radial Growth Phase,Stage I Superficial Spreading Melanoma AJCC v7,1
31000,Monoclonal Gammapathies,Monoclonal Gammopathy of Renal Significance,1
31001,Diffuse Pattern,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
31002,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage IV,1
31003,Malignant Cellular Infiltrate,Extraskeletal Osteosarcoma,1
31004,Monomorphic Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis,1
31005,Malignant Cellular Infiltrate,Malignant neoplasm of clitoris,1
31006,Epithelial Component Present,Stage IA Lung Adenosquamous Carcinoma AJCC v7,1
31007,Hemorrhagic,Ovarian Angiosarcoma,1
31008,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,1
31009,Invasive Lesion,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
31010,Benign Cellular Infiltrate,Hemangioma of skin,1
31011,Epithelial Component Present,Adenoma of rete ovarii,1
31012,Epithelial Component Present,Soft Palate Pleomorphic Adenoma,1
31013,Epithelial Component Present,Metastatic Carcinoma,1
31014,Malignant Cellular Infiltrate,Refractory Adult Acute Lymphoblastic Leukemia,1
31015,Hyperplastic Tissue Present,Basal cell hyperplasia,1
31016,Carcinomatous Component Present,NUT midline carcinoma,1
31017,Cervical lymphadenopathy,Sinus histiocytosis,1
31018,Malignant Cellular Infiltrate,Stage IB Fallopian Tube Cancer AJCC v6 and v7,1
31019,Benign Cellular Infiltrate,Choroid Plexus Papilloma,1
31020,Carcinomatous Component Present,Stage IVA Hepatocellular Carcinoma AJCC v7,1
31021,Diffuse Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
31022,Dysplasia,Colorectal Tubulovillous Adenoma,1
31023,HMB-45-Positive Neoplastic Cells Present,Sclerosing PEComa,1
31024,Epithelial Component Present,intraductal papilloma of salivary gland,1
31025,Vascular Channel Formation,Hemangioma of retina,1
31026,Epithelial Component Present,Urothelial cancer of renal pelvis,1
31027,Dysplasia,Colon Sessile Serrated Adenoma/Polyp,1
31028,Benign Cellular Infiltrate,Adenoma of the nipple,1
31029,Malignant Cellular Infiltrate,Laryngeal Leiomyosarcoma,1
31030,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v8,1
31031,Malignant Cellular Infiltrate,Non-small cell lung cancer stage III,1
31032,Malignant Cellular Infiltrate,Pathologic Stage IA Gastric Cancer AJCC v8,1
31033,Cutaneous Involvement,Toxic Epidermal Necrolysis,1
31034,Metastatic Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,1
31035,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,1
31036,Epithelial Component Present,Prostate Cancer by Whitmore-Jewett Stage,1
31037,Benign Cellular Infiltrate,Thyroid Gland Hyperfunctioning Adenoma,1
31038,Malignant Cellular Infiltrate,Salivary Gland Myoepithelial Carcinoma,1
31039,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of floor of mouth,1
31040,Regional Disease,Locally Advanced Carcinoma,1
31041,Monoclonal Cellular Population Present,Thyroid Gland Lipoadenoma,1
31042,Cord-Like Pattern,Clear cell sarcoma of kidney,1
31043,Absence of Invasion,Stage 0 Colon Cancer AJCC v8,1
31044,Malignant Cellular Infiltrate,Prostate Leiomyosarcoma,1
31045,Epithelial Component Present,undifferentiated carcinoma of extrahepatic bile duct,1
31046,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma,1
31047,Malignant Cellular Infiltrate,Hepatosplenic T-cell lymphoma,1
31048,Benign Cellular Infiltrate,Benign neuroendocrine tumor,1
31049,Pregnancy Complications,Hydatidiform Mole,1
31050,Cutaneous Involvement,Primary Cutaneous Hodgkin Lymphoma,1
31051,Epithelial Component Present,Transplant-Related Skin Squamous Cell Carcinoma,1
31052,Perivascular Arrangement of Tumor Cells,Hereditary Glomangioma,1
31053,Carcinomatous Component Present,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7,1
31054,Carcinomatous Component Present,Acinar cell carcinoma of pancreas,1
31055,Bone marrow reticulin fibrosis,Progressive Hairy Cell Leukemia Initial Treatment,1
31056,Malignant Cellular Infiltrate,Small intestine carcinoma non-resectable,1
31057,Multilocular Lesion,Juvenile granulosa cell tumor,1
31058,Malignant Germinomatous Cellular Infiltrate,"Seminoma, anaplastic",1
31059,Malignant Cellular Infiltrate,sarcoma of penis,1
31060,Splenomegaly,Splenic Manifestation of Prolymphocytic Leukemia,1
31061,Childhood Lesion,Childhood Lung Non-Small Cell Carcinoma,1
31062,Carcinomatous Component Present,Squamous cell carcinoma of floor of mouth,1
31063,Epithelial Component Present,Mild epithelial dysplasia,1
31064,Childhood Lesion,Childhood Brain Glioblastoma,1
31065,Epithelial Component Present,Grade 2 Colon Adenocarcinoma,1
31066,Carcinomatous Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v8,1
31067,Malignant Cellular Infiltrate,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,1
31068,Malignant Cellular Infiltrate,Malignant neoplasm of submandibular gland,1
31069,Mitotic Activity,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
31070,Duct-Like Structures Present,epithelial-myoepithelial carcinoma of salivary gland,1
31071,Well Differentiated Neuroendocrine Lesion,Stage I Digestive System Neuroendocrine Tumor AJCC v7,1
31072,Lymphatic Spread,Inflammatory carcinoma of breast stage IV,1
31073,Carcinomatous Component Present,Recurrent Ovarian Cystadenocarcinoma,1
31074,Malignant Cellular Infiltrate,squamous cell carcinoma of renal pelvis,1
31075,Malignant Cellular Infiltrate,Treatment related acute myeloid leukaemia,1
31076,Epithelial Component Present,Benign Parathyroid Gland Adenoma,1
31077,Primary Lesion,Recurrent WHO Grade III Glioma,1
31078,Cutaneous Involvement,Unresectable Skin Basal Cell Carcinoma,1
31079,Multinodular Mass,Conventional Angiosarcoma,1
31080,Rhabdomyosarcomatous Differentiation,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
31081,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage II,1
31082,Epithelial Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral",1
31083,Non-Invasive Lesion,Bladder Urothelial Papilloma,1
31084,Metastatic/Recurrent Disease,Peritoneal Desmoplastic Small Round Cell Tumor,1
31085,Carcinomatous Component Present,"Hepatocellular carcinoma, scirrhous",1
31086,Metastatic Lesion,Secondary malignant neoplasm of pericardium,1
31087,Epithelial Component Present,Atypical Ductal Breast Hyperplasia,1
31088,Epithelial Component Present,Stage II Renal Pelvis Cancer AJCC v7,1
31089,Indolent Clinical Course,Parotid Gland Hemangioma,1
31090,Epithelial Component Present,Stage II Fallopian Tube Cancer AJCC v8,1
31091,Epithelial Component Present,Laryngeal Cancer by AJCC v7 Stage,1
31092,Carcinomatous Component Present,Cervical Endometrioid Adenocarcinoma,1
31093,Epithelial Component Present,Stage IV Urethral Cancer AJCC v7,1
31094,Follicular Structures Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
31095,Epithelial Component Present,Stage IVC Laryngeal Cancer AJCC v8,1
31096,Perivascular Pseudorosette Formation,Anaplastic Astroblastoma,1
31097,Mixed Cellular Population,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
31098,Storiform Growth Pattern,Metastatic Dermatofibrosarcoma Protuberans,1
31099,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma refractory,1
31100,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma,1
31101,Epithelial Component Present,Stage IB2 Cervical Cancer AJCC v8,1
31102,Rapidly Enlarging Mass,Uterine Corpus Rhabdomyosarcoma,1
31103,Epithelial Component Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7,1
31104,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Halo nevus,1
31105,Malignant Cellular Infiltrate,Transplant-Related Squamous Cell Carcinoma,1
31106,Refractory Disease,Nodal marginal zone B-cell lymphoma refractory,1
31107,Recurrent disease,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma,1
31108,Malignant Cellular Infiltrate,adenocarcinoma of extrahepatic bile duct,1
31109,Well-Circumscribed Lesion,Fundic gland polyp,1
31110,Metastatic Lesion,Rectal Carcinoma Metastatic in the Liver,1
31111,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
31112,Epithelial Component Present,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
31113,Malignant Cellular Infiltrate,Mycosis Fungoides by AJCC v7 Stage,1
31114,Vascular Channel Formation,Hemolymphangioma,1
31115,Carcinomatous Component Present,Stage II Lung Small Cell Carcinoma AJCC v7,1
31116,Microcystic Change,Recurrent Childhood Pilocytic Astrocytoma,1
31117,Extraocular Dissemination of Disease,Ocular Melanoma with Extraocular Extension,1
31118,Dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8,1
31119,Epithelial Component Present,Lung squamous cell carcinoma recurrent,1
31120,Stromal Invasion,Malignant Ovarian Surface Epithelial-Stromal Tumor,1
31121,Secondary Lesion,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
31122,Rimming of Adipose Tissue Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
31123,Neuroendocrine Differentiation,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
31124,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v6 Stage,1
31125,Epithelial Component Present,Uterine Ligament Serous Adenocarcinoma,1
31126,Pseudoglandular Pattern,Testicular embryonal carcinoma stage III,1
31127,Benign Cellular Infiltrate,Soft Palate Pleomorphic Adenoma,1
31128,Tubular Pattern,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
31129,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,1
31130,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage IV,1
31131,Large Spaces Filled with Blood Present,"Bone Cysts, Aneurysmal",1
31132,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
31133,Malignant Cellular Infiltrate,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8,1
31134,Monoclonal Langerhans Cells Present,Pulmonary Histiocytosis X,1
31135,Epithelial Component Present,Lung Non-Keratinizing Squamous Cell Carcinoma,1
31136,Nodular Pattern,Glioblastoma with Primitive Neuronal Component,1
31137,Malignant Cellular Infiltrate,PRETEXT Stage 2 Hepatoblastoma,1
31138,Carcinomatous Component Present,Vulvar Warty Carcinoma,1
31139,Well-Circumscribed Lesion,Focal nodular hyperplasia of liver,1
31140,Carcinomatous Component Present,Vaginal Mesonephric Adenocarcinoma,1
31141,Cystic Change,Pleuropulmonary blastoma type I,1
31142,Malignant Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm,1
31143,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v8,1
31144,Neuroendocrine Differentiation,Uterine Corpus Neuroendocrine Neoplasm,1
31145,Carcinomatous Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
31146,Malignant Cellular Infiltrate,Vaginal adenocarcinoma metastatic,1
31147,High Mitotic Activity,Cutaneous Leiomyosarcoma,1
31148,Diffuse Pattern,Gliomatosis cerebri,1
31149,Carcinomatous Component Present,Metastatic Oral Cavity Carcinoma,1
31150,Malignant Cellular Infiltrate,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
31151,Benign Cellular Infiltrate,Bizarre parosteal osteochondromatous proliferation,1
31152,Benign Cellular Infiltrate,Benign neoplasm of glottis,1
31153,Epithelial Component Present,Unresectable Adrenal Cortex Carcinoma,1
31154,Malignant Cellular Infiltrate,Mucosal lentiginous melanoma,1
31155,Malignant Cellular Infiltrate,Follicular Variant Thyroid Gland Papillary Carcinoma,1
31156,Benign Cellular Infiltrate,Lipoma of breast,1
31157,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v7 Stage,1
31158,Carcinomatous Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
31159,Malignant Cellular Infiltrate,Malignant neoplasm of spinal cord,1
31160,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
31161,Malignant Cellular Infiltrate,Adult Epithelioid Sarcoma,1
31162,Tissue of Mullerian Origin Present,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
31163,Epithelial Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
31164,Epithelial Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,1
31165,Metastatic Lesion,Secondary malignant neoplasm of vagina,1
31166,Hyperkeratosis,verrucous carcinoma of bladder,1
31167,High Grade Lesion,Adult Rhabdomyosarcoma,1
31168,Dysplasia,Biliary Intraepithelial Neoplasia-2,1
31169,Epithelial Component Present,Mucoepidermoid carcinoma of submandibular gland,1
31170,Malignant Cellular Infiltrate,Advanced Squamous Cell Carcinoma of the Oropharynx,1
31171,Malignant Cellular Infiltrate,Hepatic lymphoma,1
31172,Epithelial Component Present,Multifocal superficial basal cell carcinoma,1
31173,Recurrent disease,Recurrent Burkitt Lymphoma,1
31174,Hyperkeratosis,Cervical Papillary Squamous Cell Carcinoma,1
31175,Epithelial Component Present,Cervical Basaloid Carcinoma,1
31176,Epithelial Component Present,Bladder Papillary Urothelial Neoplasm,1
31177,Recurrent disease,Recurrent Malignant Central Nervous System Neoplasm,1
31178,Epithelial Component Present,Squamous Cell Bile Duct Carcinoma,1
31179,Carcinomatous Component Present,Invasive Ductal Breast Carcinoma,1
31180,Malignant Cellular Infiltrate,Malignant Ovarian Germ Cell Neoplasm,1
31181,Benign Cellular Infiltrate,Ureter Schwannoma,1
31182,Malignant Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",1
31183,Malignant Cellular Infiltrate,Lung Non-Keratinizing Squamous Cell Carcinoma,1
31184,Transformed Phase of Disease,Transformed Non-Hodgkin Lymphoma,1
31185,Defective Heavy Chain Present,Heavy Chain Disease,1
31186,Carcinomatous Component Present,Stage IIIB Anal Canal Cancer AJCC v6 and v7,1
31187,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor G2,1
31188,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis,1
31189,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8,1
31190,Epithelial Component Present,Stage IVB Primary Peritoneal Cancer AJCC v8,1
31191,Epithelial Component Present,Malignant eccrine spiradenoma,1
31192,Malignant Cellular Infiltrate,"Carcinoma, Signet Ring Cell",1
31193,Hyaline Cartilage Differentiation,Primary chondrosarcoma of bone,1
31194,Exophytic Polypoid Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,1
31195,High Grade Lesion,Glioblastoma with Primitive Neuronal Component,1
31196,Unresectable Mass,Unresectable Skin Carcinoma,1
31197,Epithelial Component Present,Lung adenocarcinoma recurrent,1
31198,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
31199,Epithelial Component Present,Intestinal Neuroendocrine Tumor,1
31200,Splenomegaly,T-Cell Prolymphocytic Leukemia,1
31201,Epithelial Component Present,Breast Carcinoma Metastatic in the Liver,1
31202,Endophytic Tumor Growth,Upper Gingival Verrucous Carcinoma,1
31203,Carcinomatous Component Present,Bartholin Gland Squamous Cell Carcinoma,1
31204,Malignant Cellular Infiltrate,Lung Adenocarcinoma by AJCC v7 Stage,1
31205,'Starry-sky' pattern,Childhood Burkitt Lymphoma,1
31206,Secondary Lesion,Metastatic thymic carcinoma,1
31207,Malignant Cellular Infiltrate,Refractory Malignant Germ Cell Tumor,1
31208,Childhood Lesion,Childhood Atypical Choroid Plexus Papilloma,1
31209,Chronic Inflammatory Infiltrate,Lymphomatoid Granulomatosis,1
31210,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v7,1
31211,Nodular Pattern,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",1
31212,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of cervix uteri,1
31213,Carcinomatous Component Present,Stage III Hepatocellular Carcinoma AJCC v6,1
31214,Diffuse Pattern,Immunoblastic Large-Cell Lymphoma,1
31215,Epithelial Component Present,Parasympathetic paraganglioma,1
31216,Carcinomatous Component Present,carcinoma of middle ear,1
31217,Metastatic Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
31218,Malignant Cellular Infiltrate,Angiocentric lymphoma refractory,1
31219,Secondary Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
31220,Carcinomatous Component Present,epithelial-myoepithelial carcinoma of lung,1
31221,Malignant Cellular Infiltrate,RISS Stage III Plasma Cell Myeloma,1
31222,Severe dysplasia,Colorectal Adenoma with Severe Dysplasia,1
31223,Immunologic Deficiency Syndromes,"Post-transplant lymphoproliferative disorder, polymorphic",1
31224,Malignant Cellular Infiltrate,"Carcinoma, Papillary",1
31225,Malignant Cellular Infiltrate,Environment-Related Malignant Neoplasm,1
31226,Well-Circumscribed Lesion,Adenomatous polyp of rectum,1
31227,Carcinomatous Component Present,carcinoma of lacrimal gland,1
31228,High Mitotic Activity,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
31229,Invasive Lesion,Invasive Cribriform Breast Carcinoma,1
31230,Epithelial Component Present,Ureter Carcinoma,1
31231,Multifocal Lesion,Myofibromatosis,1
31232,Carcinomatous Component Present,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
31233,Malignant Cellular Infiltrate,primitive neuroectodermal tumor (PNET) of spinal cord,1
31234,Recurrent disease,Recurrent T-Cell Prolymphocytic Leukemia,1
31235,Carcinomatous Component Present,ACTH-Producing Pituitary Gland Carcinoma,1
31236,Carcinomatous Component Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
31237,Tissue Differentiation Uncertain,Recurrent Desmoplastic Small Round Cell Tumor,1
31238,Severe cytologic atypia,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
31239,Epithelial Component Present,Uterine Ligament Serous Adenocarcinoma,1
31240,Geographic Necrosis,Testicular embryonal carcinoma stage III,1
31241,Malignant Cellular Infiltrate,Pathologic Stage IIA Gastric Cancer AJCC v8,1
31242,Dysplasia,Cecum Villous Adenoma,1
31243,Carcinomatous Component Present,Appendix Mixed Adenoneuroendocrine Carcinoma,1
31244,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage III,1
31245,Malignant Cellular Infiltrate,Metastatic Malignant Pancreatic Neoplasm,1
31246,Bone Marrow Lymphoplasmacytic Infiltrate,Smoldering Waldenstrom Macroglobulinemia,1
31247,Hyaline Cartilage Differentiation,Mesenchymal Chondrosarcoma,1
31248,Epithelial Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
31249,Benign Cellular Infiltrate,Rete Ovarii Cystadenofibroma,1
31250,Malignant Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,1
31251,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
31252,Malignant Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
31253,Aggressive Clinical Course,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
31254,Epithelial Component Present,Colon Adenoma with Severe Dysplasia,1
31255,Carcinomatous Component Present,Choroid Plexus Carcinoma,1
31256,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
31257,Malignant Cellular Infiltrate,Advanced Prostate Adenocarcinoma,1
31258,Pseudoalveolar Pattern,Vulvar Alveolar Soft Part Sarcoma,1
31259,Malignant Cellular Infiltrate,Refractory Thyroid Gland Carcinoma,1
31260,Malignant Cellular Infiltrate,Stage I Lip and Oral Cavity Cancer AJCC v6 and v7,1
31261,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Tumor,1
31262,Follicular Cell Differentiation,Childhood Thyroid Gland Papillary Carcinoma,1
31263,Childhood Lesion,Childhood Malignant Kidney Neoplasm,1
31264,Recurrent disease,Recurrent Lymphoma,1
31265,Papillary Pattern,intraductal papilloma of salivary gland,1
31266,Malignant Cellular Infiltrate,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
31267,Cutaneous Involvement,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
31268,Carcinomatous Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,1
31269,Tissue Differentiation Uncertain,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
31270,Smooth Muscle Component Present,Epithelioid Type Angiomyolipoma,1
31271,Thyroglobulin Positive Neoplastic Cells Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
31272,Non Lipogenic Sarcomatous Stroma Present,Refractory Dedifferentiated Liposarcoma,1
31273,Angiocentric Pattern,Angiocentric glioma,1
31274,Malignant Cellular Infiltrate,Grade 2 Colon Adenocarcinoma,1
31275,Carcinomatous Component Present,Stage I Laryngeal Cancer AJCC v6 and v7,1
31276,Carcinomatous Component Present,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
31277,Oligodendroglial Component Present,Frontal Lobe Anaplastic Oligodendroglioma,1
31278,Malignant Cellular Infiltrate,Refractory Childhood Hodgkin Lymphoma,1
31279,Metaplasia of Malignant Cells Present,adenocarcinoma of breast with squamous metaplasia,1
31280,Absence of Invasion,Lung Non-Mucinous Adenocarcinoma In Situ,1
31281,Firm mass,Childhood Malignant Peripheral Nerve Sheath Tumor,1
31282,Neuroendocrine Differentiation,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
31283,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma recurrent,1
31284,Rapidly Enlarging Mass,Solid Alveolar Rhabdomyosarcoma,1
31285,Hyalinized Stroma Formation,Chondroid lipoma,1
31286,Indolent Clinical Course,Papilloma of buccal mucosa,1
31287,Well-Circumscribed Lesion,Central Nervous System Hibernoma,1
31288,Epithelial Component Present,Cecum Carcinoma,1
31289,atypia morphology,Atypical adenomatous hyperplasia,1
31290,Epithelial Component Present,Metastatic urothelial carcinoma,1
31291,Low Mitotic Activity,Regional Digestive System Neuroendocrine Tumor G1,1
31292,Dysplasia,Esophageal Glandular Intraepithelial Neoplasia,1
31293,Refractory Disease,Refractory Dedifferentiated Liposarcoma,1
31294,Cellular Stratification,Borderline Ovarian Mucinous Tumor,1
31295,Indolent Clinical Course,Perifollicular fibroma,1
31296,Primary Lesion,Childhood Pleomorphic Rhabdomyosarcoma,1
31297,Epithelial Component Present,squamous cell carcinoma of the thyroid gland,1
31298,Perivascular Arrangement of Tumor Cells,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
31299,Epithelial Component Present,Refractory Digestive System Neuroendocrine Carcinoma,1
31300,Benign Cellular Infiltrate,Renal Pelvis Urothelial Papilloma,1
31301,Rapidly Enlarging Mass,Rhabdomyosarcoma of cervix uteri,1
31302,Well Differentiated Neuroendocrine Lesion,Gastric Gastrin-Producing Neuroendocrine Tumor,1
31303,Well-Circumscribed Lesion,Soft tissue perineurioma,1
31304,Malignant Cellular Infiltrate,Secondary malignant neoplasm of eye,1
31305,Metastatic Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma,1
31306,Malignant Cellular Infiltrate,Undifferentiated (Embryonal) Sarcoma,1
31307,Osseous Differentiation,Secondary osteosarcoma,1
31308,Benign Cellular Infiltrate,Subungual exostoses,1
31309,Malignant Cellular Infiltrate,Parotid Gland Non-Hodgkin Lymphoma,1
31310,Poorly Differentiated Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
31311,Malignant Cellular Infiltrate,de novo Myelodysplastic Syndrome,1
31312,Vascular Channel Formation,Intracranial cavernous hemangioma,1
31313,Papillary Pattern,Childhood Myxopapillary Ependymoma,1
31314,'Starry-sky' pattern,Stage II Burkitt Lymphoma,1
31315,Malignant Cellular Infiltrate,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage,1
31316,Acanthosis,Laryngeal verrucous carcinoma stage IV,1
31317,Carcinomatous Component Present,"Adenocarcinoma of lung, stage I",1
31318,Refractory Disease,Refractory Ovarian Carcinoma,1
31319,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia-1,1
31320,Nuclear Expression of STAT6 Protein,Pericardial Solitary Fibrous Tumor,1
31321,Dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8,1
31322,Epithelial Component Present,Apocrine adenoma,1
31323,Epithelial Component Present,Stage III Ampulla of Vater Cancer AJCC v8,1
31324,Epithelial Component Present,Small Intestinal Carcinoid Tumor,1
31325,Secondary Lesion,Stage IV Skin Melanoma,1
31326,Malignant Cellular Infiltrate,Adenocarcinoma of Unknown Primary,1
31327,Recurrent disease,Recurrent Acinic Cell Breast Carcinoma,1
31328,Pathologic TNM Finding,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
31329,Malignant Cellular Infiltrate,Mediastinal (Thymic) Large B-Cell Lymphoma,1
31330,Carcinomatous Component Present,Vulvar Small Cell Carcinoma,1
31331,Borderline Resectable Mass,Borderline Resectable Pancreatic Carcinoma,1
31332,Osteoid formation,Osteoma,1
31333,Well-Circumscribed Lesion,Tubular adenoma of breast,1
31334,Carcinomatous Component Present,Stage IV Ovarian Cancer AJCC v6 and v7,1
31335,Carcinomatous Component Present,Minor Salivary Gland Adenocarcinoma,1
31336,Necrotic changes (finding),Childhood Malignant Peripheral Nerve Sheath Tumor,1
31337,Adulthood Lesion,Adult Ependymoma,1
31338,Carcinomatous Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7,1
31339,Carcinomatous Component Present,Recurrent Parotid Gland Adenoid Cystic Carcinoma,1
31340,Recurrent disease,Recurrent Ureter Carcinoma,1
31341,Epithelial Component Present,undifferentiated carcinoma of urethra,1
31342,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
31343,Carcinomatous Component Present,Extraocular Cutaneous Sebaceous Carcinoma,1
31344,Severe dysplasia,Carcinoma in situ of fallopian tube,1
31345,Epithelial Component Present,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
31346,Hyperkeratosis,Verrucous carcinoma of oral cavity,1
31347,Metastatic Lesion,Locally Advanced Unresectable Prostate Carcinoma,1
31348,Refractory Disease,Refractory Adult Spinal Cord Neoplasm,1
31349,Primary Lesion,Gastric T-Cell Non-Hodgkin Lymphoma,1
31350,Primary Lesion,Angiosarcoma non-metastatic,1
31351,Epithelial Component Present,Unresectable Extrahepatic Bile Duct Carcinoma,1
31352,Carcinomatous Component Present,Anal canal squamous cell carcinoma,1
31353,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma,1
31354,Epithelial Component Present,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
31355,Rapidly Enlarging Mass,Recurrent Rhabdomyosarcoma,1
31356,Adnexal Differentiation,Desmoplastic trichoepithelioma,1
31357,Carcinomatous Component Present,Adenocarcinoma of Skene Gland Origin,1
31358,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
31359,Carcinomatous Component Present,Unresectable Lung Non-Small Cell Carcinoma,1
31360,Malignant Cellular Infiltrate,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,1
31361,Endophytic Tumor Growth,Recurrent Inverted Schneiderian Papilloma,1
31362,Dysplasia,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
31363,Borderline Lesion,Recurrent Grade III Lymphomatoid Granulomatosis,1
31364,Malignant Cellular Infiltrate,Osteosarcoma Arising in Paget Disease of Bone,1
31365,Epithelial Component Present,Labia Minora Carcinoma,1
31366,Carcinomatous Component Present,Hypopharyngeal Carcinoma by AJCC v7 Stage,1
31367,Epithelial Component Present,Prostate Carcinoma by Gene Expression Profile,1
31368,Malignant Cellular Infiltrate,Advanced Renal Cell Carcinoma,1
31369,Malignant Cellular Infiltrate,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified",1
31370,Lobulated Growth Pattern,Meningothelial meningioma,1
31371,Malignant Cellular Infiltrate,Endometrial Clear Cell Adenocarcinoma,1
31372,Epithelial Component Present,Vulvar Inverted Follicular Keratosis,1
31373,Epithelial Component Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
31374,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma,1
31375,Thick-Walled Hyalinized Vessels Present,Schwannomatosis,1
31376,Epithelial Component Present,Stage I Hilar Cholangiocarcinoma AJCC v7,1
31377,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
31378,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
31379,Exophytic Papillary Lesion,Cervical Verrucous Carcinoma,1
31380,Carcinomatous Component Present,Stage IVC Appendix Carcinoma AJCC v8,1
31381,Malignant Cellular Infiltrate,Smoldering myeloma,1
31382,Prominent Intraductal Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,1
31383,No Identifiable Line of Differentiation,Unresectable Undifferentiated Pleomorphic Sarcoma,1
31384,Secondary Lesion,Disseminated adenocarcinoma,1
31385,Hyperplastic Tissue Present,Intraductal Breast Myoepitheliosis,1
31386,High Mitotic Activity,large cell neuroendocrine carcinoma of gallbladder,1
31387,Malignant Cellular Infiltrate,Grade 2 Colon Adenocarcinoma,1
31388,Secondary Lesion,Secondary malignant neoplasm of ureter,1
31389,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Brain,1
31390,Therapy-Related Toxicity,Lymphoproliferative disorder caused by methotrexate,1
31391,Malignant Cellular Infiltrate,Esophageal carcinoma recurrent,1
31392,Malignant Cellular Infiltrate,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7,1
31393,Nodular Pattern,Ann Arbor Stage III Grade 3 Follicular Lymphoma,1
31394,Hemorrhagic,Giant Cell Lesion of Small Bones,1
31395,Vascular Channel Formation,Cardiac Epithelioid Hemangioendothelioma,1
31396,Benign Cellular Infiltrate,Ganglioneuroma of skin,1
31397,Cutaneous Involvement,Cutaneous Melanoma by AJCC v6 Stage,1
31398,Epithelial Component Present,Tumor of the Thecoma/Fibroma Group,1
31399,Malignant Cellular Infiltrate,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7,1
31400,Malignant Cellular Infiltrate,Secondary malignant neoplasm of peritoneum,1
31401,Malignant Cellular Infiltrate,Childhood Brain Glioblastoma,1
31402,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
31403,Neuroendocrine Differentiation,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
31404,Pathologic TNM Finding,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
31405,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of parotid gland,1
31406,Cervical lymphadenopathy,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
31407,Malignant Cellular Infiltrate,Secondary malignant neoplasm of neck,1
31408,Carcinomatous Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
31409,Slow Growing Mass,Ganglioglioma,1
31410,Immunologic Deficiency Syndromes,HIV Encephalopathy,1
31411,Adulthood Lesion,Adult Soft Tissue Sarcoma,1
31412,Junctional Proliferation,Dysplastic Nevus,1
31413,Severe dysplasia,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,1
31414,Benign Cellular Infiltrate,Pyogenic granuloma of skin and subcutaneous tissue,1
31415,Malignant Cellular Infiltrate,High Risk Myelodysplastic Syndrome,1
31416,Epithelial Component Present,carcinosarcoma of extrahepatic bile duct,1
31417,Osseous Differentiation,Osteosarcoma localised,1
31418,Nerve palsy,Facial Nerve Palsy Related to Birth,1
31419,Malignant Cellular Infiltrate,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
31420,Mitotic Activity,Pericardial Yolk Sac Tumor,1
31421,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma stage I,1
31422,Mixed Cellular Population,Recurrent Childhood Anaplastic Oligoastrocytoma,1
31423,Rapidly Enlarging Mass,Proliferative fasciitis,1
31424,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Intermixed",1
31425,Cytoplasmic Membrane-Bound Granules Present,Stage 0 Merkel Cell Carcinoma AJCC v7,1
31426,Papillary Pattern,Papillary squamous cell carcinoma,1
31427,Edematous Stroma Formation,Spermatocytic seminoma,1
31428,Benign Cellular Infiltrate,Cavernous hemangioma of orbit,1
31429,Storiform Growth Pattern,Cardiac Malignant Fibrous Histiocytoma,1
31430,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
31431,Adulthood Lesion,Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage,1
31432,Vascular Channel Formation,Malignant Vascular Neoplasm,1
31433,Primary Lesion,Cerebellar and Fourth Ventricle Ependymal Tumor,1
31434,Epithelial Component Present,adenoid cystic carcinoma of accessory sinus,1
31435,Crystal deposition,Adult Alveolar Soft Part Sarcoma,1
31436,Malignant Cellular Infiltrate,Stage IIIB Anal Cancer AJCC v8,1
31437,Carcinomatous Component Present,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
31438,Carcinomatous Component Present,Stage II Rectal Cancer AJCC v8,1
31439,Malignant Cellular Infiltrate,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
31440,Multihormonal Immunoreactivity Present in a Single Cell Type,Monomorphous Plurihormonal Pituitary Gland Adenoma,1
31441,Adnexal Differentiation,Trichilemmocarcinoma,1
31442,Myxoid Stroma Formation,Odontogenic myxofibroma,1
31443,Malignant Cellular Infiltrate,Laryngeal Adenoid Cystic Carcinoma,1
31444,Mesenchymal Component Present,"Phyllodes tumor, borderline",1
31445,Exophytic Polypoid Lesion,papillary adenoma of extrahepatic bile duct,1
31446,Carcinomatous Component Present,Hard Palate Squamous Cell Carcinoma,1
31447,Malignant Cellular Infiltrate,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
31448,Secondary Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
31449,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
31450,Refractory Disease,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
31451,Refractory Disease,Refractory HIV-Associated Lymphoproliferative Disorder,1
31452,Monomorphic Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
31453,1p/19q Codeletion Status Unknown,Anaplastic Oligodendroglioma,1
31454,Congenital Abnormality,Vulvar Congenital Melanocytic Nevus,1
31455,Neuroendocrine Differentiation,Malignant Pancreatic Somatostatinoma,1
31456,Mild dysplasia,Low-grade intraurothelial neoplasia,1
31457,Metastatic/Recurrent Disease,Mediastinal Synovial Sarcoma,1
31458,Malignant Cellular Infiltrate,Metastatic Non-Cutaneous Melanoma,1
31459,Fibrotic Stroma Formation,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
31460,Trabecular Pattern,Ovarian Trabecular Carcinoid Tumor,1
31461,Carcinomatous Component Present,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
31462,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pancreas,1
31463,Malignant Cellular Infiltrate,Refractory Plasmablastic Lymphoma,1
31464,Malignant Cellular Infiltrate,Pathologic Stage II Cutaneous Melanoma AJCC v8,1
31465,Epithelial Component Present,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,1
31466,Well-Circumscribed Lesion,Preauricular skin tag,1
31467,Epithelial Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
31468,Osteoid formation,Duodenal Extraskeletal Osteosarcoma,1
31469,Secondary Lesion,Colon Carcinoma Metastatic in the Lung,1
31470,Benign Cellular Infiltrate,Vulvar Acquired Melanocytic Nevus,1
31471,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
31472,Indolent Clinical Course,Benign Osteogenic Neoplasm,1
31473,Benign Cellular Infiltrate,Benign neoplasm of epiglottis,1
31474,S-100-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
31475,Regional Disease,Locally Advanced Cervical Carcinoma,1
31476,Epithelial Component Present,High Grade Ductal Breast Carcinoma In Situ,1
31477,Therapy-Related Toxicity,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder,1
31478,Malignant Cellular Infiltrate,Stage II Colorectal Cancer,1
31479,Pseudopapillary Pattern,Papillary glioneuronal tumor,1
31480,Neuroendocrine Differentiation,Colorectal Neuroendocrine Carcinoma,1
31481,Epithelial Component Present,Stage II Prostate Carcinoma,1
31482,Malignant Cellular Infiltrate,Grade 1 Endometrial Endometrioid Adenocarcinoma,1
31483,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,1
31484,Metastatic Lesion,Locally Advanced Unresectable Sarcoma,1
31485,Malignant Cellular Infiltrate,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
31486,Epithelial Component Present,Accessory Urethral Gland Carcinoma,1
31487,Mitotic Activity,Cardiac Yolk Sac Tumor,1
31488,Epithelial Component Present,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
31489,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
31490,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,1
31491,Carcinomatous Component Present,Childhood Gastric Carcinoma,1
31492,Follicular Cell Differentiation,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
31493,Collagenous Stroma Formation,Vaginal Angiomyofibroblastoma,1
31494,Osseous Differentiation,Chondroblastic osteosarcoma,1
31495,Serrated Glandular Architecture,Filiform Serrated Adenoma,1
31496,Benign Cellular Infiltrate,Skin Cavernous Hemangioma,1
31497,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline RUNX1 Mutation,1
31498,Carcinomatous Component Present,undifferentiated carcinoma of ureter,1
31499,Malignant Cellular Infiltrate,Metastatic Neuroblastoma,1
31500,Malignant Cellular Infiltrate,Stage IIA2 Cervical Cancer AJCC v7,1
31501,Epithelial Component Present,Pathologic Stage IIIB Gastric Cancer AJCC v8,1
31502,Diffuse Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",1
31503,Carcinomatous Component Present,Major Salivary Gland Adenocarcinoma,1
31504,Recurrent disease,Recurrent Central Nervous System Neoplasm,1
31505,Adnexal Differentiation,Eccrine spiradenoma,1
31506,Malignant Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma,1
31507,Osseous Differentiation,Osteoblastoma,1
31508,Hypercellular bone marrow,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
31509,Anaplasia,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
31510,Carcinomatous Component Present,Labia Majora Carcinoma,1
31511,Sebaceous Differentiation,Eyelid Sebaceous Gland Carcinoma,1
31512,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
31513,Secondary Lesion,Secondary malignant neoplasm of nervous system,1
31514,Biphasic Pattern,Adamantinoma,1
31515,Recurrent disease,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
31516,Nuclear Grooves,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
31517,Malignant Cellular Infiltrate,Gallbladder Rhabdomyosarcoma,1
31518,Malignant Cellular Infiltrate,Epithelioid hemangioendothelioma of lung,1
31519,Malignant Cellular Infiltrate,Hepatitis C Virus-Related Hepatocellular Carcinoma,1
31520,Epithelial Component Present,Adenoma of rete ovarii,1
31521,Chronic Inflammatory Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,1
31522,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia-1,1
31523,Well Differentiated Neuroendocrine Lesion,Intestinal Gangliocytic Paraganglioma,1
31524,Necrotic changes (finding),Small cell carcinoma of esophagus,1
31525,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Yolk Sac Tumor,1
31526,Transformed Phase of Disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
31527,Epithelial Component Present,mucoepidermoid carcinoma of lung,1
31528,Therapy-Related Toxicity,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,1
31529,Malignant Cellular Infiltrate,Malignant neoplasm of nipple of female breast,1
31530,Epithelial Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
31531,Epithelial Component Present,Stage II Cervical Cancer AJCC v8,1
31532,Malignant Cellular Infiltrate,Childhood Malignant Liver Neoplasm,1
31533,Malignant Cellular Infiltrate,Endometrial Undifferentiated Carcinoma,1
31534,More than 10 Mitoses per 10HPF,Small cell lung cancer recurrent,1
31535,Hereditary Lesion,Hereditary hemorrhagic telangiectasia,1
31536,Epithelial Component Present,Carcinoma of extrahepatic bile duct,1
31537,Epithelial Component Present,Stage IIIC Gastric Cancer AJCC v7,1
31538,Malignant Cellular Infiltrate,Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8,1
31539,Paucicellular Stroma Present,canalicular adenoma of salivary gland,1
31540,Malignant Cellular Infiltrate,Colorectal Small Cell Neuroendocrine Carcinoma,1
31541,Mixed Cellular Population,"Cervical Adenomyoma, Endocervical Type",1
31542,Bone Marrow Eosinophilia,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
31543,Nuclear Atypia,Anaplastic astrocytoma,1
31544,Cutaneous Involvement,Subcutaneous Disorder,1
31545,Cystic Change,Recurrent Ovarian Cystadenocarcinoma,1
31546,Malignant Cellular Infiltrate,Squamous cell carcinoma of tongue,1
31547,Infiltrative Growth Pattern,MGMT-Methylated Glioblastoma,1
31548,Malignant Cellular Infiltrate,Malignant melanoma of conjunctiva,1
31549,Epithelial Component Present,Intraductal papillary breast neoplasm,1
31550,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
31551,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
31552,Epithelial Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
31553,Epithelial Component Present,Gallbladder Cancer by AJCC v8 Stage,1
31554,Carcinomatous Component Present,Fallopian Tube Mucinous Adenocarcinoma,1
31555,Mesenchymal Component Present,Giant fibroadenoma of breast,1
31556,Vascular Channel Formation,Hemangioma of skin,1
31557,Diffuse Pattern,"High Grade B-Cell Lymphoma, Not Otherwise Specified",1
31558,CD1a-Positive Neoplastic Cells Present,"Langerhans cell histiocytosis, unifocal",1
31559,Locally Aggressive Lesion,Atypical fibroxanthoma of skin,1
31560,Epithelial Component Present,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
31561,Necrotic changes (finding),Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
31562,Epithelial Component Present,Recurrent Skin Carcinoma,1
31563,Benign Cellular Infiltrate,Hemangioma of orbit,1
31564,Neuroendocrine Differentiation,Intra-Abdominal Paraganglioma,1
31565,Cutaneous Involvement,American cutaneous leishmaniasis,1
31566,Benign Cellular Infiltrate,"Gastrointestinal stromal tumor, benign",1
31567,Acanthosis,Buccal Mucosa Verrucous Carcinoma,1
31568,Malignant Cellular Infiltrate,"Carcinoma, Giant Cell",1
31569,Indolent Clinical Course,Central Nervous System Lipoma,1
31570,Unresectable Mass,Unresectable Melanoma,1
31571,Childhood Lesion,Childhood Medulloblastoma,1
31572,Malignant Cellular Infiltrate,Transformed Non-Hodgkin Lymphoma,1
31573,Pseudopapillary Pattern,Childhood Ovarian Embryonal Carcinoma,1
31574,Splenomegaly,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant",1
31575,Malignant Cellular Infiltrate,B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,1
31576,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II,1
31577,In Situ Lesion,Stage 0is Renal Pelvis Cancer AJCC v7,1
31578,Exophytic Polypoid Lesion,Vaginal Rhabdomyoma,1
31579,Recurrent disease,Recurrent Anaplastic Astrocytoma,1
31580,atypia morphology,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
31581,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Binet Staging System,1
31582,Malignant Cellular Infiltrate,Stage III Merkel Cell Carcinoma AJCC v7,1
31583,Osseous Differentiation,Stage I Osteosarcoma AJCC v7,1
31584,Biphasic Pattern,Uterine Corpus Atypical Polypoid Adenomyoma,1
31585,Pseudopapillary Pattern,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
31586,Dysplasia,Rectal Sessile Serrated Adenoma/Polyp,1
31587,High Grade Lesion,Osteosarcoma Arising in Paget Disease of Bone,1
31588,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx,1
31589,Epithelial Component Present,Glycogen-rich carcinoma,1
31590,Malignant Cellular Infiltrate,Grade I Nodular Sclerosis Hodgkin's Lymphoma,1
31591,Immunologic Deficiency Syndromes,Transplant-Related Bladder Urothelial Carcinoma,1
31592,Hypocellular Tissue,Intramuscular Myxoma,1
31593,Low Grade Lesion,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
31594,Carcinomatous Component Present,Tongue Carcinoma,1
31595,Recurrent disease,Non-Hodgkin's lymphoma transformed recurrent,1
31596,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
31597,Secondary Lesion,Secondary malignant neoplasm of female breast,1
31598,Malignant Cellular Infiltrate,Peritoneal mesothelioma malignant recurrent,1
31599,Epithelial Component Present,undifferentiated carcinoma of cervix,1
31600,Sonic Hedgehog/Patch Pathway Activated,"Recurrent Medulloblastoma, SHH-Activated",1
31601,Macrofollicular Structures Present,Macrofollicular adenoma,1
31602,Malignant Cellular Infiltrate,Cutaneous Lymphomatoid Granulomatosis,1
31603,Slow Growing Mass,Chordoma,1
31604,Zonal Pattern,Adamantinoma,1
31605,Papillary Pattern,Cervical Mullerian Papilloma,1
31606,Well Developed Rough Endoplasmic Reticulum Present,Densely Granulated Somatotroph Adenoma,1
31607,Exophytic Polypoid Lesion,Large Bowel Juvenile Polyp,1
31608,Carcinomatous Component Present,Locally Advanced Skin Squamous Cell Carcinoma,1
31609,Epithelial Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
31610,Carcinomatous Component Present,Solid Lung Adenocarcinoma,1
31611,Carcinomatous Component Present,Barrett's Adenocarcinoma,1
31612,S-100-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
31613,Perineural spread,Adenoid cystic carcinoma of salivary gland,1
31614,Clinical TNM Finding,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
31615,Malignant Cellular Infiltrate,Stage IA Breast Cancer AJCC v7,1
31616,Carcinomatous Component Present,Stage I Ovarian Cancer AJCC v8,1
31617,Carcinomatous Component Present,Stage IIB Pancreatic Cancer AJCC v6 and v7,1
31618,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v8,1
31619,Primary Lesion,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
31620,Secondary Lesion,Secondary malignant neoplasm of vagina,1
31621,CD30-Positive Neoplastic Cells Present,Stage I Childhood Anaplastic Large Cell Lymphoma,1
31622,Carcinomatous Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v7,1
31623,Carcinomatous Component Present,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
31624,Primary Lesion,Primary Childhood Soft Tissue Sarcoma,1
31625,Cutaneous Involvement,Epithelioid and spindle cell nevus,1
31626,Neuroendocrine Differentiation,Strumal carcinoid,1
31627,Refractory Disease,Refractory Primary Peritoneal Carcinoma,1
31628,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v8,1
31629,Malignant Cellular Infiltrate,Refractory cytopenia with unilineage dysplasia,1
31630,Locally Aggressive Lesion,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,1
31631,Malignant Cellular Infiltrate,Gallbladder adenosquamous carcinoma,1
31632,Schwannian Stroma Predominant Component of the Tumor Volume,Ganglioneuromatosis,1
31633,Carcinomatous Component Present,Stage III Paranasal Sinus Cancer AJCC v6 and v7,1
31634,Thin Bands of Collagen Present,Thyroid Gland Solitary Fibrous Tumor,1
31635,Eosinophilic inflammation,Breast Inflammatory Myofibroblastic Tumor,1
31636,Benign Cellular Infiltrate,Osteoid osteoma,1
31637,Neuroectodermal Differentiation,Stage 2A Neuroblastoma,1
31638,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma of prostate,1
31639,Non-Malignant Cellular Infiltrate,Suppurative lymphadenopathy,1
31640,Epithelial Component Present,Stage IIB Colon Cancer AJCC v8,1
31641,Low Mitotic Activity,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
31642,Increased Cellularity Present,Cellular leiomyoma,1
31643,Childhood Lesion,Recurrent Childhood Lymphoblastic Lymphoma,1
31644,Well Differentiated Neuroendocrine Lesion,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
31645,Exophytic Polypoid Lesion,Ampulla of Vater Tubular Adenoma,1
31646,Carcinomatous Component Present,Stage II Colon Cancer,1
31647,Epithelial Component Present,Anal Intraepithelial Neoplasia 3,1
31648,Sinusoidal Growth Pattern,ALK positive large B-cell lymphoma,1
31649,Thrombocytosis,"Thrombocythemia, Essential",1
31650,Epithelial Component Present,Recurrent Ovarian Mucinous Adenocarcinoma,1
31651,Diffuse Pattern,Adult Brain Oligodendroglioma,1
31652,Mesenchymal Component Present,Phyllodes Tumor,1
31653,Low Mitotic Activity,Glucagonoma,1
31654,Malignant Cellular Infiltrate,Type 1 Papillary Renal Cell Carcinoma,1
31655,Infiltrative Growth Pattern,Anaplastic Diencephalic Astrocytoma,1
31656,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,1
31657,Mild cytologic atypia,Plantar Verrucous Skin Carcinoma,1
31658,Epithelial Component Present,Intestinal Neuroendocrine Tumor G2,1
31659,Multinodular Mass,Uterine Angiosarcoma,1
31660,Intracytoplasmic Eosinophilic Inclusion,Atypical Teratoid Rhabdoid Tumor,1
31661,Gyriform Trabecular Pattern,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
31662,Dysplasia,tubulopapillary adenoma of gallbladder,1
31663,Carcinomatous Component Present,Stage IVC Oral Cavity Cancer AJCC v6 and v7,1
31664,Carcinomatous Component Present,Stage IIB Penile Cancer AJCC v8,1
31665,Malignant Cellular Infiltrate,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,1
31666,Smooth Muscle Component Present,Lymphangioleiomyomatosis,1
31667,Severe dysplasia,Stage 0is Bladder Cancer AJCC v8,1
31668,Epithelial Component Present,Jejunal Neuroendocrine Tumor,1
31669,Malignant Cellular Infiltrate,Infiltrating basal cell carcinoma,1
31670,Necrotic changes (finding),Esophageal Neuroendocrine Tumor G2,1
31671,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
31672,Monoclonal Langerhans Cells Present,"Langerhans cell histiocytosis, unifocal",1
31673,Malignant Cellular Infiltrate,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,1
31674,Monophasic Pattern,"Synovial sarcoma, spindle cell",1
31675,Malignant Cellular Infiltrate,Stage IV Malignant Mediastinal Germ Cell Tumor,1
31676,Intraductal Lesion,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
31677,Neuroendocrine Differentiation,Cervical Neuroendocrine Neoplasm,1
31678,Cutaneous Involvement,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,1
31679,Malignant Cellular Infiltrate,Recurrent Cancer of Gallbladder,1
31680,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v8,1
31681,Juvenile Lesion,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,1
31682,Cribriform Pattern,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
31683,Biphasic Pattern,sialadenoma papilliferum of salivary gland,1
31684,Malignant Cellular Infiltrate,Advanced Uterine Corpus Carcinosarcoma,1
31685,Papillary Pattern,Invasive micropapillary carcinoma of breast,1
31686,Mixture of Germ Cell Neoplastic Components Present,Adult Central Nervous System Mixed Germ Cell Tumor,1
31687,Recurrent disease,Recurrent Lip and Oral Cavity Carcinoma,1
31688,Carcinomatous Component Present,Advanced Oral Cavity Squamous Cell Carcinoma,1
31689,Malignant Cellular Infiltrate,Squamous cell carcinoma of trachea,1
31690,Papillary Pattern,Anal Canal Squamous Papilloma,1
31691,Malignant Cellular Infiltrate,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
31692,Papillary Pattern,Inverted Papilloma,1
31693,Malignant Cellular Infiltrate,Thymic Mucoepidermoid Carcinoma,1
31694,Well Differentiated Neuroendocrine Lesion,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,1
31695,Epithelial Component Present,Stage IIIC Colon Cancer AJCC v8,1
31696,Perineural spread,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
31697,Epithelial Component Present,Metastatic Unresectable Basal Cell Carcinoma,1
31698,Malignant Cellular Infiltrate,Retinoblastoma unilateral,1
31699,Multifocal Lesion,Myofibromatosis,1
31700,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
31701,Malignant Cellular Infiltrate,Malignant Giant Cell Tumor of Bone,1
31702,Epithelial Component Present,Digestive System Small Cell Neuroendocrine Carcinoma,1
31703,Alternative Fascicle (Bundle) Pattern,Oral Cavity Leiomyoma,1
31704,Carcinomatous Component Present,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
31705,Carcinomatous Component Present,Pleomorphic lobular carcinoma in situ of breast,1
31706,Recurrent disease,Recurrent Childhood Giant Cell Glioblastoma,1
31707,Indolent Clinical Course,"Uterine Corpus Leiomyoma, Mitotically Active Variant",1
31708,Extraosseous Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral",1
31709,Malignant Cellular Infiltrate,FIGO Stage IIIA1(ii) Ovarian Cancer,1
31710,Tissue of Mullerian Origin Present,Cystadenofibroma of fallopian tube,1
31711,Refractory Disease,Refractory Lung Small Cell Carcinoma,1
31712,Malignant Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
31713,High Grade Lesion,Lung Monophasic Synovial Sarcoma,1
31714,Childhood Lesion,Cystic Partially Differentiated Nephroblastoma,1
31715,Malignant Cellular Infiltrate,Metastatic Lung Non-Small Cell Squamous Carcinoma,1
31716,Malignant Cellular Infiltrate,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
31717,Refractory Disease,Refractory T-Cell Prolymphocytic Leukemia,1
31718,Epithelial Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
31719,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of gallbladder,1
31720,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
31721,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
31722,Epithelial Component Present,Ductal Carcinoma In Situ with Microinvasion,1
31723,Epithelial Component Present,Prostate Neuroendocrine Neoplasm,1
31724,Neuroendocrine Differentiation,Benign Carotid Body Paraganglioma,1
31725,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx,1
31726,Epithelial Component Present,Vaginal Large Cell Neuroendocrine Carcinoma,1
31727,Invasive Lesion,Bladder transitional cell carcinoma stage IV,1
31728,Carcinomatous Component Present,Childhood Thyroid Gland Follicular Carcinoma,1
31729,Secondary Lesion,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
31730,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,1
31731,Carcinomatous Component Present,Refractory Laryngeal Squamous Cell Carcinoma,1
31732,Malignant Cellular Infiltrate,Lymphoma of colon,1
31733,Carcinomatous Component Present,Stage II Rectal Cancer,1
31734,Slow Growing Mass,Peripheral Hemangioblastoma,1
31735,Adnexal Differentiation,Trichilemmoma,1
31736,Edematous Stroma Formation,Superficial angiomyxoma,1
31737,Embryoid Bodies Present,polyembryoma of ovary,1
31738,Carcinomatous Component Present,Recurrent Primary Peritoneal Carcinoma,1
31739,Local disease,Hibernoma,1
31740,Endobronchial Lesion,Lung Squamous Cell Papilloma,1
31741,Mixed Cellular Population,carcinosarcoma of fallopian tube,1
31742,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
31743,Alternative Fascicle (Bundle) Pattern,Vaginal Leiomyoma,1
31744,Mixed Cellular Population,Anaplastic Oligoastrocytoma,1
31745,Immunosuppression-Related Post-Transplant Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
31746,Malignant Cellular Infiltrate,Secondary osteosarcoma,1
31747,Neuroendocrine Differentiation,Stage IA Merkel Cell Carcinoma AJCC v7,1
31748,Therapy-Related Toxicity,Iatrogenic Kaposi Sarcoma,1
31749,Carcinomatous Component Present,Stage III Breast Cancer AJCC v6,1
31750,Benign Cellular Infiltrate,Central odontogenic fibroma,1
31751,Malignant Cellular Infiltrate,Stage IIA Esophagus Carcinoma,1
31752,Malignant Cellular Infiltrate,Minimally Invasive Mucinous Lung Adenocarcinoma,1
31753,Carcinomatous Component Present,Adenocarcinoma with osseous metaplasia,1
31754,Childhood Lesion,Childhood Central Nervous System Immature Teratoma,1
31755,CD1a-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X,1
31756,Storiform Growth Pattern,Abdominal Undifferentiated Pleomorphic Sarcoma,1
31757,Osseous Differentiation,Osteosarcoma of bone,1
31758,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Nasopharynx,1
31759,Malignant Cellular Infiltrate,Pediatric follicular lymphoma,1
31760,Rapidly Enlarging Mass,Alveolar rhabdomyosarcoma,1
31761,Malignant Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v7,1
31762,Carcinomatous Component Present,Stage II Liver Cancer,1
31763,Benign Cellular Infiltrate,Benign Ovarian Thecoma,1
31764,Epithelial Component Present,Localized Gallbladder Carcinoma,1
31765,Malignant Cellular Infiltrate,Stage IB1 Cervical Cancer,1
31766,Epithelial Component Present,Small intestine carcinoma metastatic,1
31767,Malignant Cellular Infiltrate,Disseminated adenocarcinoma,1
31768,High Grade Lesion,Fusion-Positive Alveolar Rhabdomyosarcoma,1
31769,Metastatic Lesion,Metastatic Adrenal Cortex Carcinoma,1
31770,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Stage,1
31771,Multinodular Mass,Post-Radiotherapy Breast Angiosarcoma,1
31772,Epithelial Component Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
31773,Multifocal Lesion,Multiple Endocrine Neoplasia,1
31774,Adulthood Lesion,Adult Central Nervous System Teratoma,1
31775,Nuclear Clearing,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
31776,Epithelial Component Present,Hepatoma resectable,1
31777,Recurrent disease,Recurrent B-Cell Prolymphocytic Leukemia,1
31778,Thyroglobulin Positive Neoplastic Cells Present,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
31779,Benign Cellular Infiltrate,Cardiac neurofibroma,1
31780,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia with abnormal eosinophils,1
31781,Epithelial Component Present,Ovarian Retiform Sertoli-Leydig Cell Tumor,1
31782,Secondary Lesion,Metastatic Thyroid Gland Follicular Carcinoma,1
31783,Papillary Pattern,Laryngeal verrucous carcinoma stage IV,1
31784,Epithelial Component Present,Stage II Esophageal Adenocarcinoma AJCC v7,1
31785,Cystic Change,cystadenocarcinoma of salivary gland,1
31786,In Situ Lesion,Pathologic Stage 0 Gastric Cancer AJCC v8,1
31787,Malignant Cellular Infiltrate,Refractory Primary Effusion Lymphoma,1
31788,Cutaneous Involvement,Stage IB Cutaneous Melanoma AJCC v7,1
31789,atypia morphology,Proliferating Brenner Tumor,1
31790,Slow Growing Mass,Brain Stem Hemangioblastoma,1
31791,Subcutaneous Involvement,"Histiocytoma, Angiomatoid Fibrous",1
31792,Fibrotic Stroma Formation,Ovarian Serous Adenofibroma,1
31793,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
31794,Rapidly Enlarging Mass,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
31795,Myxoid Stroma Formation,Low-grade fibromyxoid sarcoma,1
31796,Carcinomatous Component Present,"Papillary transitional cell carcinoma, non-invasive",1
31797,Fibrotic Stroma Formation,Adenocarcinofibroma,1
31798,Locally Aggressive Lesion,Chest Wall Fibromatosis,1
31799,Nodular lesions,Malignant carcinoid tumor of lung,1
31800,Metastatic Lesion,Advanced Prostate Adenocarcinoma,1
31801,Hyperkeratosis,verrucous carcinoma of bladder,1
31802,Pregnancy Complications,Stage IIB Gestational Trophoblastic Tumor AJCC v7,1
31803,Carcinomatous Component Present,Small Intestinal Signet Ring Cell Carcinoma,1
31804,Benign Cellular Infiltrate,Urethral Inverted Papilloma,1
31805,Unresectable Mass,Unresectable Paraganglioma,1
31806,Keratin pearl formation,Cervical Keratinizing Squamous Cell Carcinoma,1
31807,Intestinal metaplasia,Lung Enteric Adenocarcinoma,1
31808,Capillary Sized Vascular Channel Formation,Solid Glomus Tumor,1
31809,Multinodular Pattern,Conventional Extraskeletal Myxoid Chondrosarcoma,1
31810,Breast Microcalcification,oligodendroglioma,1
31811,Carcinomatous Component Present,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
31812,Benzene Exposure,Benzene-Related Acute Myeloid Leukemia,1
31813,Malignant Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v8,1
31814,Rapidly Enlarging Mass,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
31815,Well-Circumscribed Lesion,Gastric Juvenile Polyp,1
31816,Well-Circumscribed Lesion,Urethra Fibroepithelial Polyp,1
31817,Papillary Pattern,Noninfiltrating intraductal papillary adenocarcinoma,1
31818,Malignant Cellular Infiltrate,Pericardial Synovial Sarcoma,1
31819,Refractory Disease,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
31820,Epithelial Component Present,Stage IV Primary Peritoneal Cancer AJCC v7,1
31821,Fried-Egg Appearance of the Bone Marrow,Progressive Hairy Cell Leukemia Initial Treatment,1
31822,Malignant Cellular Infiltrate,Childhood Ganglioneuroblastoma,1
31823,Increased Cellularity Present,Anaplastic Oligoastrocytoma,1
31824,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage II,1
31825,Epithelial Component Present,"Adenoma, Sweat Gland",1
31826,Benign Cellular Infiltrate,Breast Ductal Adenoma,1
31827,Malignant Cellular Infiltrate,Gingival Spindle Cell Carcinoma,1
31828,Epithelial Component Present,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
31829,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Hypocellular Myelodysplastic Syndrome,1
31830,Nodular lesions,Microfollicular adenoma,1
31831,In Situ Lesion,Stage 0is Ureter Cancer AJCC v7,1
31832,Epithelial Component Present,Stage IVB Gallbladder Carcinoma,1
31833,Encapsulated Mass,Adenolymphoma,1
31834,Well Differentiated Neuroendocrine Lesion,insulinoma,1
31835,Epithelial Component Present,Recurrent Clear Cell Renal Cell Carcinoma,1
31836,Well-Circumscribed Lesion,Intrahepatic Bile Duct Microcystic Adenoma,1
31837,Neuronal Differentiation,Cerebellar Neuronal and Mixed Neuronal-Glial Tumor,1
31838,Polymorphic Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
31839,Mixed Cellular Population,Ovarian Mucinous Cystadenofibroma,1
31840,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
31841,Malignant Cellular Infiltrate,Small Intestinal Medullary Carcinoma,1
31842,Chromogranin A Positive Neoplastic Cells Present,Colon Neuroendocrine Tumor G1,1
31843,Neuroendocrine Differentiation,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
31844,Benign Cellular Infiltrate,Hemangioma of choroid,1
31845,Neuroendocrine Differentiation,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,1
31846,Epithelial Component Present,Pancreatic Serous Neoplasm,1
31847,Metastatic Lesion,Metastatic Malignant Neoplasm to the Cervix,1
31848,Monomorphic Cellular Infiltrate,Cervical Basaloid Carcinoma,1
31849,Benign Cellular Infiltrate,Benign Uterine Ligament Neoplasm,1
31850,Malignant Cellular Infiltrate,Childhood Mixed Germ Cell Tumor,1
31851,Malignant Cellular Infiltrate,Stage IIA Appendix Carcinoma AJCC v8,1
31852,Recurrent disease,Recurrent Non-Cutaneous Melanoma,1
31853,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor,1
31854,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Cystadenofibroma,1
31855,Epithelial Component Present,"Transitional cell papilloma, benign",1
31856,Malignant Cellular Infiltrate,Third Ventricle Germinoma,1
31857,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx recurrent,1
31858,Immunosuppression-Related Post-Transplant Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
31859,Epithelial Component Present,Uterine Corpus Carcinoid Tumor,1
31860,Epithelial Component Present,papillary carcinoma of renal pelvis,1
31861,Secondary Lesion,Metastatic Microsatellite Stable Colorectal Carcinoma,1
31862,Endophytic Tumor Growth,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
31863,Cutaneous Involvement,Acquired keratoderma,1
31864,Pseudoencapsulated Mass,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
31865,Epithelial Component Present,"Papillary squamous cell carcinoma, non-invasive",1
31866,Severe cytologic atypia,Extrahepatic Bile Duct Neuroendocrine Carcinoma,1
31867,Immunologic Deficiency Syndromes,AIDS-Related Primary Central Nervous System Lymphoma,1
31868,Secondary Lesion,Locally Advanced Unresectable Malignant Neoplasm,1
31869,Cutaneous Involvement,Hair nevus,1
31870,Well-Circumscribed Lesion,Colorectal Peutz-Jeghers Polyp,1
31871,Congenital Lesion,Congenital melanocytic nevus,1
31872,Carcinomatous Component Present,Penile Cancer by AJCC v8 Stage,1
31873,High Mitotic Activity,Stage IIB Merkel Cell Carcinoma AJCC v7,1
31874,Epithelial Component Present,Submandibular Gland Undifferentiated Carcinoma,1
31875,Necrotic changes (finding),Unresectable Dedifferentiated Liposarcoma,1
31876,Neuroendocrine Differentiation,Laryngeal Paraganglioma,1
31877,Immunologic Deficiency Syndromes,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
31878,Cutaneous Involvement,Psoriasis,1
31879,Epithelial Component Present,adenoid cystic carcinoma of floor of mouth,1
31880,Carcinomatous Component Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
31881,Carcinomatous Component Present,Stage III Renal Pelvis Cancer AJCC v8,1
31882,Human Papillomavirus Negative,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
31883,Pathologic TNM Finding,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
31884,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v8,1
31885,Necrotic changes (finding),Giant Cell Glioblastoma,1
31886,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Clinical Stage,1
31887,Myxoid Stroma Formation,Metastasizing Chondroblastoma,1
31888,Malignant Cellular Infiltrate,Advanced Adult Hepatocellular Carcinoma,1
31889,Recurrent disease,Recurrent Childhood Lymphoblastic Lymphoma,1
31890,Epithelial Component Present,Epithelial-myoepithelial carcinoma,1
31891,Edematous Stroma Formation,Microfollicular adenoma,1
31892,Cutaneous Involvement,Senile hemangioma of lip,1
31893,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
31894,Malignant Cellular Infiltrate,Malignant sex-cord stromal tumor,1
31895,Microvascular Proliferation,Adult Brain Glioblastoma,1
31896,Primary Lesion,Recurrent Adult Hepatocellular Carcinoma,1
31897,Malignant Cellular Infiltrate,Colorectal Burkitt Lymphoma,1
31898,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma,1
31899,Mixed Cellular Population,Malignant Mixed Tumor of the Minor Salivary Gland,1
31900,Carcinomatous Component Present,Basaloid squamous cell carcinoma,1
31901,Carcinomatous Component Present,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma,1
31902,Malignant Cellular Infiltrate,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,1
31903,Epithelial Component Present,mucinous adenocarcinoma of gallbladder,1
31904,Extraosseous Lesion,Extraskeletal osteosarcoma metastatic,1
31905,Absence of Invasion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
31906,Malignant Cellular Infiltrate,Refractory Primary Lymphoma of Bone,1
31907,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of gallbladder,1
31908,Papillary Pattern,Bladder Papillary Urothelial Neoplasm,1
31909,Epithelial Component Present,tubular adenoma of gallbladder,1
31910,Malignant Cellular Infiltrate,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
31911,Carcinomatous Component Present,Oropharyngeal Basaloid Carcinoma,1
31912,Epithelial Component Present,Clinical Stage IVA Gastric Cancer AJCC v8,1
31913,Fibrotic Stroma Formation,Fallopian Tube Serous Adenofibroma,1
31914,Epithelial Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
31915,Malignant Cellular Infiltrate,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
31916,Benign Cellular Infiltrate,Aggressive angiomyxoma,1
31917,Hyperplastic Tissue Present,Epithelial hyperplasia of skin,1
31918,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage I,1
31919,Adulthood Lesion,Adult Cerebellar Neoplasm,1
31920,Malignant Cellular Infiltrate,Stage II Penile Cancer AJCC v6,1
31921,Stromal Invasion,Small cell carcinoma of ovary,1
31922,Malignant Cellular Infiltrate,Childhood T Lymphoblastic Lymphoma,1
31923,Multinodular Mass,Central Nervous System Angiosarcoma,1
31924,Malignant Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
31925,Malignant Cellular Infiltrate,Major Salivary Gland Cancer by AJCC v8 Stage,1
31926,Refractory Disease,Refractory Malignant Bone Neoplasm,1
31927,Recurrent disease,Relapsed Hypopharynx Carcinoma,1
31928,Malignant Cellular Infiltrate,Grade I Nodular Sclerosis Hodgkin's Lymphoma,1
31929,Recurrent disease,Precursor T-lymphoblastic lymphoma/leukemia recurrent,1
31930,Epithelial Component Present,Colon Neuroendocrine Tumor,1
31931,Malignant Cellular Infiltrate,Refractory Laryngeal Squamous Cell Carcinoma,1
31932,Undifferentiated Lesion,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
31933,Cutaneous Involvement,Infestation by Phthirus pubis,1
31934,Trabecular Pattern,Pancreatic Somatostatinoma,1
31935,Malignant Cellular Infiltrate,Rectal Carcinoma,1
31936,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
31937,Lymphoplasmacytic Infiltrate,HHV8-Positive Multicentric Castleman Disease,1
31938,Diffuse Pattern,Recurrent Childhood Oligodendroglioma,1
31939,Carcinomatous Component Present,Stage IA Ovarian Cancer AJCC v8,1
31940,Epithelial Component Present,sialadenoma papilliferum of salivary gland,1
31941,Diffuse Pattern,Adult Oligodendroglioma,1
31942,Indolent Clinical Course,Cerebral Hemisphere Lipoma,1
31943,Carcinomatous Component Present,Ampulla of Vater Undifferentiated Carcinoma,1
31944,Adulthood Lesion,Benign Adult Brain Neoplasm,1
31945,Malignant Cellular Infiltrate,Stage IVC Hypopharyngeal Carcinoma AJCC v7,1
31946,Vascular Channel Formation,Recurrent Skin Angiosarcoma,1
31947,Epithelial Component Present,Stage I Jejunal Neuroendocrine Tumor AJCC v8,1
31948,Carcinomatous Component Present,Stage I Paranasal Sinus Cancer,1
31949,Papillary Pattern,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
31950,Biphasic Pattern,Recurrent Childhood Pilocytic Astrocytoma,1
31951,Epithelial Component Present,Pancreatic Somatostatinoma,1
31952,Malignant Cellular Infiltrate,Lymphadenopathic Kaposi Sarcoma,1
31953,Epithelial Component Present,Appendix Tubular Carcinoid,1
31954,Recurrent disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
31955,Congenital Lesion,Proliferative dermal lesion in congenital nevus,1
31956,Carcinomatous Component Present,Squamous cell carcinoma of lung,1
31957,Malignant Cellular Infiltrate,Stage I Appendix Carcinoma AJCC v7,1
31958,Epithelial Component Present,benign endometrioid tumor of ovary,1
31959,Epithelial Component Present,Squamous cell carcinoma of lung,1
31960,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
31961,Local disease,Kidney Lipoma,1
31962,Malignant Cellular Infiltrate,AIDS-Related Primary Central Nervous System Lymphoma,1
31963,Carcinomatous Component Present,Posterior Pharyngeal Wall Squamous Cell Carcinoma,1
31964,Malignant Cellular Infiltrate,basal cell adenocarcinoma of salivary gland,1
31965,Well Differentiated Neuroendocrine Lesion,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
31966,Above the Diaphragm Disease,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
31967,Malignant Cellular Infiltrate,Langerhans Cell Sarcoma,1
31968,Epithelial Component Present,Stage IIA Anal Cancer AJCC v8,1
31969,Primary Lesion,Recurrent Childhood Pineoblastoma,1
31970,Local disease,Cardiac Lipoma,1
31971,Mixed Cellular Population,Lung Mixed Squamous Cell and Glandular Papilloma,1
31972,Neuroendocrine Differentiation,Metastatic Gastric Neuroendocrine Carcinoma,1
31973,Exophytic Papillary Lesion,Subglottic Verrucous Carcinoma,1
31974,Malignant Cellular Infiltrate,Maxillary Sinus Adenoid Cystic Carcinoma,1
31975,Malignant Cellular Infiltrate,Thoracic Esophagus Adenocarcinoma,1
31976,Well-Circumscribed Lesion,Benign Vaginal Mixed Tumor,1
31977,Exophytic Papillary Lesion,Verrucous carcinoma of the oral cavity recurrent,1
31978,Carcinomatous Component Present,Prostate cancer stage B,1
31979,Adnexal Differentiation,Malignant Outer Hair Sheath and Infundibulum Neoplasm,1
31980,Epithelial Component Present,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,1
31981,Carcinomatous Component Present,Colorectal Carcinoma Metastatic in the Liver,1
31982,Epithelial Component Present,Anal Canal Squamous Papilloma,1
31983,Epithelial Component Present,Adenocarcinoma of the prostate stage I,1
31984,Epithelial Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
31985,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of intestine,1
31986,Epithelial Component Present,Prostate Carcinoma by Gene Expression Profile,1
31987,Exophytic Polypoid Lesion,Polyp of external auditory meatus,1
31988,Carcinomatous Component Present,"Adenocarcinoma of lung, stage II",1
31989,Malignant Cellular Infiltrate,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",1
31990,Carcinomatous Component Present,"Lung Squamous Cell Carcinoma, Small Cell Variant",1
31991,Epithelial Component Present,Fallopian Tube Serous Adenofibroma,1
31992,'Starry-sky' pattern,Burkitt Lymphoma,1
31993,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",1
31994,Infiltrative Growth Pattern,Malignant Uterine Corpus PEComa,1
31995,Severe cytologic atypia,Gastric Neuroendocrine Carcinoma,1
31996,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of cervix uteri,1
31997,Well-Circumscribed Lesion,Adult Pineocytoma,1
31998,Epithelial Component Present,Relapsed Hypopharynx Carcinoma,1
31999,Epithelial Component Present,Trichoadenoma,1
32000,Malignant Cellular Infiltrate,Squamous cell carcinoma of prostate,1
32001,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Carcinoma,1
32002,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pituitary gland,1
32003,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,1
32004,Cystic Change,Anterior Tongue Mucoepidermoid Carcinoma,1
32005,Keratin pearl formation,Skin Pseudovascular Squamous Cell Carcinoma,1
32006,Malignant Cellular Infiltrate,Recurrent Sarcoma of the Extremity,1
32007,Honeycomb Pattern,Brain Oligodendroglioma,1
32008,Well-Circumscribed Lesion,Myxoid liposarcoma metastatic,1
32009,Rapidly Enlarging Mass,Central Nervous System Rhabdomyosarcoma,1
32010,Malignant Cellular Infiltrate,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
32011,Malignant Cellular Infiltrate,Gallbladder Cribriform Carcinoma,1
32012,Malignant Cellular Infiltrate,Classical Hodgkin's Lymphoma,1
32013,Carcinomatous Component Present,Adenoid cystic carcinoma of oropharynx,1
32014,Severe cytologic atypia,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
32015,Alternative Fascicle (Bundle) Pattern,Oral Cavity Leiomyoma,1
32016,Epithelial Component Present,Small intestine carcinoma stage II,1
32017,Childhood Lesion,Childhood Mature Teratoma,1
32018,Benign Cellular Infiltrate,Vaginal Blue Nevus,1
32019,Primary Lesion,Recurrent Primary Effusion Lymphoma,1
32020,Malignant Cellular Infiltrate,Small Intestinal B-Cell Non-Hodgkin Lymphoma,1
32021,Clinical TNM Finding,Clinical Stage III Cutaneous Melanoma AJCC v8,1
32022,Epithelial Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,1
32023,Aflatoxins Toxicity,Aflatoxins-Related Hepatocellular Carcinoma,1
32024,Malignant Cellular Infiltrate,Parotid Gland Sarcoma,1
32025,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v7,1
32026,Breast Microcalcification,Recurrent Childhood Oligodendroglioma,1
32027,Benign Cellular Infiltrate,Lipoblastoma,1
32028,Epithelial Component Present,Stage IIIB Penile Cancer AJCC v8,1
32029,In Situ Lesion,Carcinoma in situ of trachea,1
32030,Metastatic/Recurrent Disease,Adult Desmoplastic Small Round Cell Tumor,1
32031,Hyperplastic Tissue Present,Follicular Lymph Node Hyperplasia,1
32032,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Type B Melanoma,1
32033,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Clinical Stage,1
32034,Nested Pattern,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
32035,Malignant Cellular Infiltrate,Osteosarcoma Arising in Paget Disease of Bone,1
32036,Malignant Cellular Infiltrate,Stage IIIC Esophageal Adenocarcinoma AJCC v7,1
32037,Neuroendocrine Differentiation,Carcinoid tumor of intestine,1
32038,Benign Cellular Infiltrate,Benign Ovarian Neoplasm,1
32039,Immunoglobulin Deposition,Immunoglobulin deposition disease,1
32040,Borderline Lesion,In situ follicular neoplasia,1
32041,Multilocular Lesion,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,1
32042,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,1
32043,Malignant Cellular Infiltrate,Recurrent Acute Megakaryoblastic Leukemia,1
32044,Mild cytologic atypia,Supraglottic Verrucous Carcinoma,1
32045,Cutaneous Involvement,Stage II Lentigo Maligna Melanoma AJCC v6 and v7,1
32046,Therapy-Related Toxicity,Transplant-Related Bladder Urothelial Carcinoma,1
32047,Malignant Cellular Infiltrate,Hypocellular Myelodysplastic Syndrome,1
32048,Carcinomatous Component Present,Sweat gland adenocarcinoma,1
32049,Malignant Cellular Infiltrate,Anal Intraepithelial Neoplasia 3,1
32050,Malignant Cellular Infiltrate,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
32051,Epithelial Component Present,Small intestine carcinoma non-resectable,1
32052,Malignant Cellular Infiltrate,Metastases to adrenals,1
32053,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
32054,Severe dysplasia,Carcinoma in Situ,1
32055,Epithelial Component Present,Malignant neoplasm of carotid body,1
32056,Non-Hereditary Lesion,"Papillary renal cell carcinoma, sporadic",1
32057,Tubular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
32058,Childhood Lesion,Childhood T Acute Lymphoblastic Leukemia,1
32059,Adnexal Differentiation,Eccrine Poroma,1
32060,Carcinomatous Component Present,undifferentiated carcinoma of appendix,1
32061,Low Mitotic Activity,Appendix Neuroendocrine Tumor G2,1
32062,Epithelial Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
32063,Indolent Clinical Course,Giant Cell Lesion of Small Bones,1
32064,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
32065,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor,1
32066,Cutaneous Involvement,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
32067,Malignant Cellular Infiltrate,Maxillary Sinus Carcinoma,1
32068,Malignant Cellular Infiltrate,Ann Arbor Stage IA Hodgkin Lymphoma,1
32069,Epithelial Component Present,Childhood Rectal Carcinoma,1
32070,Encapsulated Mass,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
32071,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Gastric Teratoma,1
32072,Epithelial Component Present,Pituitary Gland Paraganglioma,1
32073,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,1
32074,Well-Circumscribed Lesion,"Adenoma, Sweat Gland",1
32075,Malignant Cellular Infiltrate,Advanced Small Intestinal Neuroendocrine Carcinoma,1
32076,'Starry-sky' pattern,Methotrexate-Associated Burkitt Lymphoma,1
32077,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, SHH-Activated",1
32078,Malignant Cellular Infiltrate,Stage IVB Rectal Cancer AJCC v8,1
32079,High Mitotic Activity,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
32080,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Ovarian Endometrioid Adenocarcinoma,1
32081,Dysplasia,Colorectal Tubulovillous Adenoma,1
32082,Metastatic/Recurrent Disease,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
32083,Benign Cellular Infiltrate,Benign Breast Eccrine Spiradenoma,1
32084,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
32085,Carcinomatous Component Present,Stage IV Ureter Cancer AJCC v8,1
32086,Cutaneous Involvement,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
32087,Well-Circumscribed Lesion,Benign neoplasm of mesothelial tissue of pleura,1
32088,Nodular Pattern,Ann Arbor Stage I Follicular Lymphoma,1
32089,Chromogranin A Positive Neoplastic Cells Present,Metastatic carcinoid tumor,1
32090,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v6 and v7,1
32091,Epithelial Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
32092,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Childhood Acute Monoblastic Leukemia,1
32093,High Mitotic Activity,Childhood Choroid Plexus Carcinoma,1
32094,Malignant Cellular Infiltrate,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
32095,Epithelial Component Present,Grade 3 Rectal Adenocarcinoma,1
32096,Secondary Lesion,Metastatic Fibrolamellar Carcinoma,1
32097,Multinodular Mass,Prostate Angiosarcoma,1
32098,High Grade Lesion,Resectable Dedifferentiated Liposarcoma,1
32099,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage I Immature Testicular Teratoma AJCC v6 and v7,1
32100,Adulthood Lesion,Recurrent Adult Hodgkin Lymphoma,1
32101,Epithelial Component Present,Squamous cell carcinoma of vulva,1
32102,Epithelial Component Present,Hard Palate Monomorphic Adenoma,1
32103,Carcinomatous Component Present,"Papillary squamous cell carcinoma, non-invasive",1
32104,High Grade Lesion,rhabdomyosarcoma of liver,1
32105,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Endometrioid Cystadenoma,1
32106,Malignant Cellular Infiltrate,Childhood Choroid Plexus Carcinoma,1
32107,Malignant Cellular Infiltrate,Stage I Diffuse Large B-Cell Lymphoma,1
32108,Myxoid Stroma Formation,Myxoid chondrosarcoma,1
32109,Carcinomatous Component Present,Urothelial carcinoma bladder recurrent,1
32110,Metastatic Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,1
32111,Benign Cellular Infiltrate,Skin appendage adenoma,1
32112,Chronic lymphocytic inflammation,Gastric Inflammatory Myofibroblastic Tumor,1
32113,EBV-Positive Neoplastic Cells Present,Hydroa vacciniforme-like lymphoma,1
32114,Intraosseous Lesion,Primary Intraosseous Squamous Cell Carcinoma,1
32115,S-100-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis,1
32116,Carcinomatous Component Present,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
32117,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v8,1
32118,Adulthood Lesion,Adult Pineoblastoma,1
32119,Secondary Lesion,Locally Advanced Unresectable Malignant Neoplasm,1
32120,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8,1
32121,Epithelial Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma,1
32122,Antoni A Pattern,Sellar Schwannoma,1
32123,Malignant Cellular Infiltrate,"Carcinoma, Large Cell",1
32124,Lymphatic Spread,Lymphangitis carcinomatosa,1
32125,Childhood Lesion,Hepatoblastoma with Pure Fetal Epithelial Differentiation,1
32126,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of bladder,1
32127,Childhood Lesion,Recurrent Childhood Soft Tissue Sarcoma,1
32128,Regional Disease,Locally Advanced Salivary Gland Carcinoma,1
32129,Carcinomatous Component Present,Thoracic Esophagus Adenocarcinoma,1
32130,Localized Lesion,Plasmacytoma,1
32131,Absence of Invasion,Stage 0 Pharynx Carcinoma,1
32132,Cutaneous Involvement,Clear cell hidradenoma,1
32133,Diffuse Pattern,Breast Diffuse Large B-Cell Lymphoma,1
32134,Carcinomatous Component Present,Malignant neoplasm of stomach stage IV,1
32135,Mixed Cellular Population,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
32136,Well Developed Rough Endoplasmic Reticulum Present,Sparsely Granulated Lactotroph Adenoma,1
32137,Nuclear Expression of STAT6 Protein,Peritoneal Solitary Fibrous Tumor,1
32138,Malignant Cellular Infiltrate,Testicular Follicular Lymphoma,1
32139,Coughing,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
32140,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
32141,Malignant Cellular Infiltrate,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
32142,Epithelial Component Present,Anal Papillary Hidradenoma,1
32143,Nodular lesions,Thyroid Nodule,1
32144,Recurrent disease,Recurrent Lung Carcinoma Cell Type Unspecified,1
32145,Indolent Clinical Course,Cavernous lymphangioma,1
32146,Benign Cellular Infiltrate,Intracranial cavernous hemangioma,1
32147,Perivascular Arrangement of Tumor Cells,Glomangiomatosis,1
32148,Epithelial Component Present,"Hepatocellular carcinoma, scirrhous",1
32149,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
32150,Epithelial Component Present,Stage IVB Primary Peritoneal Cancer AJCC v8,1
32151,Malignant Cellular Infiltrate,Classical Low Grade Fibromyxoid Sarcoma,1
32152,Mixed Cellular Population,combined small cell carcinoma of lung,1
32153,Myxoid Stroma Formation,Adult Extraskeletal Myxoid Chondrosarcoma,1
32154,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity recurrent,1
32155,No Evidence of Metastatic Disease,Non-Metastatic Childhood Soft Tissue Sarcoma,1
32156,High Mitotic Activity,Pancreatic Endocrine Carcinoma,1
32157,Low Mitotic Activity,Stage IIB Colon Neuroendocrine Tumor AJCC v8,1
32158,Carcinomatous Component Present,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,1
32159,Epithelial Component Present,Stage IV Renal Cell Cancer AJCC v8,1
32160,Metastatic Lesion,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,1
32161,Nodular Pattern,"Lymphoma, Mixed-Cell, Follicular",1
32162,Well Differentiated Lesion,Subglottic Verrucous Carcinoma,1
32163,Carcinomatous Component Present,Colon Intramucosal Adenocarcinoma,1
32164,Carcinomatous Component Present,Stage IA Merkel Cell Carcinoma AJCC v7,1
32165,Carcinomatous Component Present,Stage IIIC Hepatocellular Carcinoma AJCC v7,1
32166,Malignant Cellular Infiltrate,Stage IIB Adult Soft Tissue Sarcoma AJCC v7,1
32167,Malignant Cellular Infiltrate,Metastatic carcinoid tumor,1
32168,Metaplasia,Ampulla of Vater Intestinal-Type Adenocarcinoma,1
32169,Malignant Cellular Infiltrate,Acinar cell cystadenocarcinoma,1
32170,Anaplasia,anaplastic large cell lymphoma of central nervous system,1
32171,Malignant Cellular Infiltrate,Ethmoid Sinus Squamous Cell Carcinoma,1
32172,Epithelial Component Present,Stage I Renal Pelvis Cancer AJCC v7,1
32173,Malignant Cellular Infiltrate,Drop Metastasis in the Spinal Cord,1
32174,Malignant Cellular Infiltrate,Metastatic Bone Ewing Sarcoma,1
32175,Solid Growth Pattern,Solid Papillary Breast Carcinoma,1
32176,Diffuse Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
32177,High Grade Lesion,Anaplastic Brain Stem Astrocytoma,1
32178,Malignant Cellular Infiltrate,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
32179,Carcinomatous Component Present,Throat cancer,1
32180,atypia morphology,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
32181,Epithelial Component Present,Upper Gingival Verrucous Carcinoma,1
32182,Epithelial Component Present,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
32183,Exophytic Polypoid Lesion,Filiform Serrated Adenoma,1
32184,Carcinomatous Component Present,Thymic Adenocarcinoma,1
32185,Malignant Cellular Infiltrate,Acute myelomonocytic leukemia with abnormal eosinophils,1
32186,Cartilage-Like Elements Present,Chondroid chordoma,1
32187,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
32188,Skin Erosion,Erosive Adenomatosis of the Nipple,1
32189,Indolent Clinical Course,Lipoblastoma,1
32190,Fibrotic Stroma Formation,Stage II Intrahepatic Cholangiocarcinoma AJCC v8,1
32191,Epithelial Component Present,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7,1
32192,Carcinomatous Component Present,Breast Cancer by AJCC v8 Anatomic Stage,1
32193,Cutaneous Involvement,Benign fibrohistiocytic neoplasm of skin,1
32194,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
32195,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
32196,Malignant Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v7,1
32197,Peripheral Nuclear Palisading,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
32198,Malignant Cellular Infiltrate,Sarcomatoid Hepatocellular Carcinoma,1
32199,Hyalinized Stroma Formation,Childhood Epithelioid Hemangioendothelioma,1
32200,Thick-Walled Hyalinized Vessels Present,Sellar Schwannoma,1
32201,Malignant Cellular Infiltrate,Retinoblastoma by AJCC v8 Stage,1
32202,Malignant Cellular Infiltrate,adenosquamous carcinoma of esophagus,1
32203,Malignant Cellular Infiltrate,Refractory Primary Peritoneal Carcinoma,1
32204,Epithelial Component Present,Adenocarcinoma of the prostate stage III,1
32205,Well Differentiated Lesion,Well Differentiated Fibrosarcoma,1
32206,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
32207,Recurrent disease,Recurrent Childhood Fibrillary Astrocytoma,1
32208,Malignant Cellular Infiltrate,Recurrent Hepatocellular Carcinoma,1
32209,Neuroectodermal Differentiation,Peripheral neuroblastoma,1
32210,Tissue Differentiation Uncertain,Unresectable Synovial Sarcoma,1
32211,Invasive Lesion,Endometrioid carcinoma of prostate,1
32212,Epithelial Component Present,Stage II Lung Cancer AJCC v7,1
32213,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v8,1
32214,Low Mitotic Activity,"Gastrinoma, malignant",1
32215,Carcinomatous Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage,1
32216,Primary Lesion,Stage IVB Primary Peritoneal Cancer AJCC v8,1
32217,Carcinomatous Component Present,Oral Cavity Carcinoma,1
32218,Stromal Invasion,Refractory Ovarian Carcinoma,1
32219,Curvilinear Thin-Walled Vascular Pattern,Fibromyxosarcoma,1
32220,Keratin pearl formation,Lung Basaloid Squamous Cell Carcinoma,1
32221,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage IV,1
32222,Infantile Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
32223,Hyperkeratosis,Desmoplastic trichilemmoma,1
32224,Glucagon-Like Peptide Positive Neoplastic Cells Present,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
32225,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
32226,Well Differentiated Lesion,Vulvar Warty Carcinoma,1
32227,Carcinomatous Component Present,Undifferentiated carcinoma of stomach,1
32228,Increased megakaryocytes (bone marrow),Overt Primary Myelofibrosis,1
32229,Malignant Cellular Infiltrate,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
32230,Malignant Cellular Infiltrate,Small cell lung cancer limited stage,1
32231,Tumor Vascular Invasion,"Somatostatinoma, malignant",1
32232,Malignant Cellular Infiltrate,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7,1
32233,Malignant Cellular Infiltrate,Intracranial Melanoma,1
32234,Epithelial Component Present,Ampulla of Vater Neuroendocrine Carcinoma,1
32235,Stromal Invasion,Carcinosarcoma of ovary,1
32236,Epithelial Component Present,Refractory Laryngeal Squamous Cell Carcinoma,1
32237,Carcinomatous Component Present,Sarcomatoid carcinoma of the lung,1
32238,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v7,1
32239,Malignant Cellular Infiltrate,Rectal Rhabdomyosarcoma,1
32240,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,1
32241,Malignant Cellular Infiltrate,Osteosclerotic Plasma Cell Myeloma,1
32242,Malignant Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v8 Stage,1
32243,Diffuse Pattern,Activated B-cell type diffuse large B-cell lymphoma,1
32244,Carcinomatous Component Present,Rectosigmoid cancer recurrent,1
32245,Indolent Clinical Course,Pelvic lipomatosis,1
32246,Monomorphic Cellular Infiltrate,Childhood Infratentorial Ependymoma,1
32247,Epithelial Component Present,Benign Basal Cell Neoplasm,1
32248,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v8,1
32249,Cystic Change,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
32250,Skin Red Dot,Angioma serpiginosum,1
32251,Childhood Lesion,Childhood Central Nervous System Yolk Sac Tumor,1
32252,Carcinomatous Component Present,Paget Disease of the Breast with Invasive Ductal Carcinoma,1
32253,Malignant Cellular Infiltrate,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
32254,Epithelial Component Present,Adenoid cystic carcinoma of salivary gland,1
32255,Secondary Lesion,Benzene-Related Acute Myeloid Leukemia,1
32256,Well Differentiated Neuroendocrine Lesion,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
32257,Malignant Cellular Infiltrate,hepatoid adenocarcinoma of bladder,1
32258,Cavernous Vascular Space Formation,Colon Cavernous Hemangioma,1
32259,Mixed Cellular Population,Invasive Mixed Breast Carcinoma,1
32260,Benign Cellular Infiltrate,Vaginal Dermoid Cyst,1
32261,Carcinomatous Component Present,Vulvar Adenocarcinoma of Sweat Gland Type,1
32262,Epithelial Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma,1
32263,Recurrent disease,Larynx carcinoma recurrent,1
32264,Bone Marrow Dysplasia Present,Refractory anemia with excess blasts I,1
32265,Stromal Invasion,"Carcinoma, Ovarian Epithelial",1
32266,Epithelial Component Present,Neuroendocrine neoplasm of lung,1
32267,Epithelial Component Present,"Carcinoma, Signet Ring Cell",1
32268,Benign Cellular Infiltrate,Benign Childhood Brain Neoplasm,1
32269,Clinical TNM Finding,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
32270,Cutaneous Involvement,Basal cell carcinoma - adenoid,1
32271,CD30-Positive Neoplastic Cells Present,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
32272,Malignant Cellular Infiltrate,Cutaneous Lymphomatoid Granulomatosis,1
32273,Epithelial Component Present,Undifferentiated carcinoma of stomach,1
32274,Microsatellite Stable,Advanced Microsatellite Stable Colorectal Carcinoma,1
32275,Vascular Channel Formation,Hobnail Hemangioma,1
32276,Epithelial Component Present,Stage IIIA Colon Cancer AJCC v7,1
32277,Benign Cellular Infiltrate,Disseminated Juvenile Xanthogranuloma,1
32278,Epithelial Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
32279,Single Type of Tissue Derived from One Embryonic Layer Present,Monodermal teratoma,1
32280,Pathologic TNM Finding,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
32281,Epithelial Component Present,Lung Cancer by AJCC v6 Stage,1
32282,Pregnancy Complications,Gestational Trophoblastic Tumor by AJCC v7 Stage,1
32283,Epithelial Component Present,Platinum-Resistant Ovarian Carcinoma,1
32284,Apocrine metaplasia,Breast Apocrine Adenoma,1
32285,Metastatic Lesion,Locally Advanced Cervical Carcinoma,1
32286,Exophytic Papillary Lesion,Subglottic Verrucous Carcinoma,1
32287,Low Mitotic Activity,Colon Neuroendocrine Tumor by AJCC v8 Stage,1
32288,Well-Circumscribed Lesion,Angiomyoma,1
32289,Infiltrative Growth Pattern,Childhood Fibrillary Astrocytoma,1
32290,Single Cell Necrosis,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
32291,Islands of Neuropil-Like Matrix Present,Glioneuronal Tumor with Neuropil-Like Islands,1
32292,Mild dysplasia,Low Grade Conjunctival Intraepithelial Neoplasia,1
32293,Carcinomatous Component Present,Cholangiocarcinoma metastatic,1
32294,Carcinomatous Component Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
32295,Malignant Cellular Infiltrate,Recurrent Grade 3 Follicular Lymphoma,1
32296,Malignant Cellular Infiltrate,Small Intestinal Lymphoma,1
32297,Unresectable Mass,Localized Unresectable Adult Hepatocellular Carcinoma,1
32298,Epithelial Component Present,Stage IB Breast Cancer AJCC v7,1
32299,Malignant Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage III,1
32300,Nuclear Atypia,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
32301,Mild cytologic atypia,verrucous carcinoma of vulva,1
32302,Malignant Cellular Infiltrate,Childhood Pleomorphic Rhabdomyosarcoma,1
32303,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v7,1
32304,Carcinomatous Component Present,Acinic Cell Breast Carcinoma,1
32305,Crystal deposition,Tongue Alveolar Soft Part Sarcoma',1
32306,Malignant Cellular Infiltrate,Gestational Ovarian Choriocarcinoma,1
32307,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
32308,Lymphoplasmacytic Infiltrate,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
32309,Malignant Cellular Infiltrate,Adult Central Nervous System Choriocarcinoma,1
32310,Exophytic Polypoid Lesion,Adenoma of ampulla of Vater,1
32311,Epithelial Component Present,Gastric Adenosquamous Carcinoma,1
32312,Epithelial Component Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
32313,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage II,1
32314,Carcinomatous Component Present,Refractory Carcinoma,1
32315,Epithelial Component Present,Urothelial carcinoma ureter metastatic,1
32316,Carcinomatous Component Present,Vaginal Mesonephric Adenocarcinoma,1
32317,Cutaneous Involvement,Urticaria Pigmentosa,1
32318,Epithelial Component Present,Stage IIC Prostate Cancer AJCC v8,1
32319,Peripheral Nuclear Palisading,Lung Small Cell Carcinoma by AJCC v7 Stage,1
32320,Benign Cellular Infiltrate,Benign neoplasm of uterine cervix,1
32321,Malignant Cellular Infiltrate,Locally Advanced Unresectable Sarcoma,1
32322,Carcinomatous Component Present,Growth Hormone-Producing Pituitary Gland Carcinoma,1
32323,Benign Cellular Infiltrate,Benign Cutaneous Fibroblastic Neoplasm,1
32324,Malignant Cellular Infiltrate,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
32325,Malignant Cellular Infiltrate,Stage IIC Merkel Cell Carcinoma AJCC v7,1
32326,Carcinomatous Component Present,adenosquamous carcinoma of pancreas,1
32327,Necrotic changes (finding),Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
32328,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell",1
32329,Epithelial Component Present,Adenocarcinoid tumor,1
32330,Epithelial Component Present,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
32331,Anaplasia,Proneural Glioblastoma,1
32332,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,1
32333,Malignant Cellular Infiltrate,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,1
32334,High Mitotic Activity,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
32335,Epithelial Component Present,Inflammatory Breast Carcinoma,1
32336,High Grade Lesion,"Anaplastic Astrocytoma, IDH-Wildtype",1
32337,Malignant Cellular Infiltrate,Adult Cholangiocarcinoma,1
32338,Adnexal Differentiation,"Adenoma, Sweat Gland",1
32339,Epithelial Component Present,Renal medullary carcinoma,1
32340,Organoid Pattern,Alveolar soft part sarcoma non-metastatic,1
32341,Epithelial Component Present,Blepharal carcinoma,1
32342,Epithelial Component Present,Bile duct adenocarcinoma,1
32343,Carcinomatous Component Present,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
32344,Carcinomatous Component Present,Esophageal carcinoma,1
32345,Secondary Lesion,Synovial sarcoma metastatic,1
32346,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myelomonocytic Leukemia,1
32347,Malignant Cellular Infiltrate,squamous cell carcinoma of ureter,1
32348,Follicular Cell Differentiation,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
32349,Malignant Cellular Infiltrate,Stage IIIB Colon Cancer AJCC v7,1
32350,Carcinomatous Component Present,Locally Advanced Digestive System Carcinoma,1
32351,Metastatic Lesion,Metastatic thymic carcinoma,1
32352,Epithelial Component Present,Cervical Adenocarcinoma In Situ,1
32353,Malignant Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",1
32354,Epithelial Component Present,Head and Neck Carcinoma,1
32355,Epithelial Component Present,Stage IIIB Fallopian Tube Cancer AJCC v8,1
32356,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,1
32357,Benign Cellular Infiltrate,Benign neoplasm of extrahepatic bile ducts,1
32358,Epithelial Component Present,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
32359,Carcinomatous Component Present,Cervical Squamous Cell Carcinoma,1
32360,Malignant Cellular Infiltrate,Stage IIB Bone Cancer AJCC v7,1
32361,Malignant Cellular Infiltrate,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
32362,Epithelial Component Present,carcinoma of pancreas with osteoclast-like giant cells,1
32363,Epithelial Component Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
32364,Resectable Mass,Borderline Resectable Malignant Neoplasm,1
32365,Epithelial Component Present,Vulvar Merkel Cell Carcinoma,1
32366,Endophytic Tumor Growth,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
32367,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gastric Choriocarcinoma,1
32368,Metastatic Lesion,Metastatic Triple-Negative Breast Carcinoma,1
32369,Epithelial Component Present,Stage IV Ureter Cancer AJCC v7,1
32370,Cystic Change,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
32371,Benign Cellular Infiltrate,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
32372,Malignant Cellular Infiltrate,Well Differentiated Fibrosarcoma,1
32373,Therapy-Related Toxicity,Treatment related secondary malignancy,1
32374,Malignant Cellular Infiltrate,Stage IIB Esophageal Adenocarcinoma AJCC v7,1
32375,Well-Circumscribed Lesion,Eccrine acrospiroma,1
32376,Hyperkeratosis,papillary squamous cell carcinoma of larynx,1
32377,Follicular Structures Present,Thyroid Gland Mucinous Follicular Adenoma,1
32378,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Tumor,1
32379,Epithelial Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
32380,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
32381,Epithelial Component Present,Paranasal Sinus Schneiderian Papilloma,1
32382,Benign Cellular Infiltrate,Benign tumor of iris,1
32383,Local disease,Pleomorphic Lipoma,1
32384,Glomerular Hypertrophy,Obesity Related Glomerulopathy,1
32385,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8,1
32386,Diffuse Pattern,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
32387,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage II,1
32388,Indolent Clinical Course,Cartilaginous exostosis,1
32389,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v7,1
32390,Epithelial Component Present,Advanced Lung Carcinoma,1
32391,Anaplasia,Recurrent Anaplastic Oligodendroglioma,1
32392,Vascular Channel Formation,Angiosarcoma Associated with Lymphedema,1
32393,Carcinomatous Component Present,Stage IIB Appendix Carcinoma AJCC v7,1
32394,Absence of Invasion,Noninfiltrating Intraductal Carcinoma,1
32395,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor,1
32396,Vascular Channel Formation,Capillary hemangioma of orbit,1
32397,Epithelial Component Present,Stage IIA Ovarian Cancer AJCC V6 and v7,1
32398,Carcinomatous Component Present,Stage IV Paranasal Sinus Cancer AJCC v7,1
32399,Malignant Cellular Infiltrate,Stage IVB Bone Cancer AJCC v7,1
32400,Chromogranin A Positive Neoplastic Cells Present,Carcinoid Tumor,1
32401,Epithelial Component Present,canalicular adenoma of salivary gland,1
32402,Locally Aggressive Lesion,Breast Inflammatory Myofibroblastic Tumor,1
32403,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage IV,1
32404,Epithelial Component Present,Stage II Esophageal Cancer AJCC v7,1
32405,Infantile Lesion,Fibrous Hamartoma of Infancy,1
32406,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
32407,Necrotic changes (finding),Recurrent Dedifferentiated Liposarcoma,1
32408,Carcinomatous Component Present,Endometrial Squamous Cell Carcinoma,1
32409,Carcinomatous Component Present,Stage IB Gastric Carcinoma,1
32410,Monoclonal Cellular Population Present,Mastocytosis,1
32411,Malignant Cellular Infiltrate,Non-Metastatic Childhood Soft Tissue Sarcoma,1
32412,Tissue of Mullerian Origin Present,Broad Ligament Serous Adenofibroma,1
32413,Malignant Germinomatous Cellular Infiltrate,"Seminoma, anaplastic",1
32414,Mixed Cellular Population,Uterine Corpus Carcinofibroma,1
32415,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
32416,Tissue of Mullerian Origin Present,Broad Ligament Serous Adenofibroma,1
32417,Favorable Clinical Outcome,Inflammatory Hepatocellular Adenoma,1
32418,Epithelial Component Present,Neuroendocrine neoplasm of appendix,1
32419,Blue Bone Formation,"Bone Cysts, Aneurysmal",1
32420,Malignant Cellular Infiltrate,Pleural Carcinomatosis,1
32421,Dilated Terminal Duct Lobular Units Present,Columnar Cell Change of the Breast,1
32422,Carcinomatous Component Present,Gastric Carcinoma with Lymphoid Stroma,1
32423,Poorly Differentiated Lesion,Renal medullary carcinoma,1
32424,Malignant Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,1
32425,Mixed Cellular Population,Malignant Submandibular Gland Mixed Tumor,1
32426,Adulthood Lesion,BCLC Stage D Adult Hepatocellular Carcinoma,1
32427,Nuclear pleomorphism,Recurrent Salivary Duct Carcinoma,1
32428,Carcinomatous Component Present,Squamous cell carcinoma of rectum,1
32429,Recurrent disease,Precursor T-lymphoblastic lymphoma/leukemia recurrent,1
32430,Mesenchymal Component Present,Breast Phyllodes Tumor,1
32431,Solid Growth Pattern,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
32432,Malignant Cellular Infiltrate,Stage III Kidney Wilms Tumor,1
32433,Well-Circumscribed Lesion,Spindle Cell/Pleomorphic Lipoma,1
32434,Carcinomatous Component Present,Maxillary Sinus Carcinoma,1
32435,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
32436,Neuroendocrine Differentiation,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
32437,Slow Growing Mass,Olfactory Neuroblastoma,1
32438,Refractory Disease,Refractory Mediastinal Lymphoma,1
32439,Dysplasia,"Glandular intraepithelial neoplasia, grade III",1
32440,Tissue Differentiation Uncertain,Epithelioid Type Angiomyolipoma,1
32441,Absence of Invasion,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
32442,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v7,1
32443,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
32444,Benign Cellular Infiltrate,Intraductal papilloma of breast,1
32445,Mixed Cellular Population,"Mixed Tumor, Not Otherwise Specified",1
32446,Cartilaginous Differentiation,Secondary Peripheral Chondrosarcoma,1
32447,Tubular Structures Present,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
32448,Epithelial Component Present,Acantholytic squamous cell carcinoma,1
32449,Severe dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
32450,Epithelial Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
32451,Malignant Cellular Infiltrate,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma,1
32452,Follicular Cell Differentiation,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,1
32453,S-100-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,1
32454,Adulthood Lesion,Adult Brain Stem Astrocytoma,1
32455,Tissue of Mullerian Origin Present,Uterine Corpus Adenomyoma,1
32456,Indolent Clinical Course,Dartoic myoma,1
32457,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Teratoma,1
32458,Argentaffin Positive Neoplastic Cells Present,Ovarian Insular Carcinoid Tumor,1
32459,Invasive Lesion,Endometrioid carcinoma of prostate,1
32460,Resectable Mass,Resectable Digestive System Carcinoma,1
32461,Ground Glass Nuclear Inclusion,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
32462,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v7,1
32463,Epithelial Component Present,Nasopharyngeal Nonkeratinizing Carcinoma,1
32464,Poorly Differentiated Neuroendocrine Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma,1
32465,Carcinomatous Component Present,Vaginal Papillary Carcinoma,1
32466,Malignant Cellular Infiltrate,Castration-Sensitive Prostate Carcinoma,1
32467,Malignant Cellular Infiltrate,Stage III Appendix Carcinoma AJCC v8,1
32468,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
32469,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma,1
32470,Malignant Cellular Infiltrate,Polycythemia Vera,1
32471,Malignant Cellular Infiltrate,Skin Clear Cell Basal Cell Carcinoma,1
32472,Primary Lesion,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
32473,Benign Cellular Infiltrate,Benign phyllodes neoplasm of breast,1
32474,Cutaneous Involvement,Senile nevus,1
32475,Carcinomatous Component Present,Carcinosarcoma of ovary,1
32476,Pregnancy Complications,Funisitis (disorder),1
32477,Epithelial Component Present,Stage IIIA Rectal Cancer AJCC v7,1
32478,Mixed Cellular Population,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
32479,Malignant Cellular Infiltrate,Parosteal Osteosarcoma,1
32480,Epithelial Component Present,Stage IIIB Appendix Carcinoma AJCC v8,1
32481,Metastatic Lesion,Myxoid liposarcoma metastatic,1
32482,High Mitotic Activity,Recurrent Anaplastic Oligodendroglioma,1
32483,atypia morphology,Borderline Ovarian Serous Tumor with Microinvasion,1
32484,In Situ Lesion,Noninfiltrating Intraductal Carcinoma,1
32485,High Mitotic Activity,Childhood Lung Small Cell Carcinoma,1
32486,Actinic Damage,Hutchinson's Melanotic Freckle,1
32487,Carcinomatous Component Present,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
32488,Epithelial Component Present,Rectal Serrated Adenocarcinoma,1
32489,Sarcomatous Component Present,carcinosarcoma of liver,1
32490,Primary Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
32491,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",1
32492,Unresectable Mass,Locally Advanced Unresectable Carcinoma,1
32493,Intraocular Lesion,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
32494,Indolent Clinical Course,Osteoid osteoma,1
32495,Local disease,Localized Non-Resectable Adult Liver Carcinoma,1
32496,Microvascular Proliferation,Recurrent Childhood Giant Cell Glioblastoma,1
32497,Vascular Channel Formation,Kaposi's sarcoma classical type,1
32498,Malignant Cellular Infiltrate,Metaplastic carcinoma,1
32499,High Grade Lesion,"Anaplastic Astrocytoma, IDH-Mutant",1
32500,Indolent Clinical Course,Liver Cavernous Hemangioma,1
32501,Malignant Cellular Infiltrate,Large cell lung cancer stage IV,1
32502,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis,1
32503,Recurrent disease,Recurrent Sarcoma of the Extremity,1
32504,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,1
32505,Dysplasia,Squamous intraepithelial neoplasia grade 2,1
32506,Malignant Cellular Infiltrate,"Adenocarcinoma, Tubular",1
32507,Adulthood Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
32508,Benign Cellular Infiltrate,Benign neoplasm of gallbladder,1
32509,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Neoplasm,1
32510,Well-Circumscribed Lesion,"Phyllodes tumor, benign",1
32511,Therapy-Related Toxicity,Transplant-Related Hepatocellular Carcinoma,1
32512,Epithelial Component Present,Recurrent Adrenal Gland Pheochromocytoma,1
32513,Adnexal Differentiation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
32514,Metastatic Lesion,Advanced Sarcoma,1
32515,Invasive Lesion,small cell carcinoma of breast,1
32516,Malignant Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
32517,Biphasic Pattern,"Transitional cell carcinoma, spindle cell",1
32518,Malignant Cellular Infiltrate,neuroendocrine carcinoma of anal canal,1
32519,Adnexal Differentiation,Pilar-Associated Mesenchyme Neoplasm,1
32520,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Oropharynx,1
32521,Local disease,Lipoma of pleura,1
32522,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
32523,Refractory Disease,Plasma cell myeloma refractory,1
32524,Intraosseous Lesion,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
32525,Epithelial Component Present,Transitional cell carcinoma of ureter,1
32526,Malignant Cellular Infiltrate,Stage I Oropharyngeal Carcinoma,1
32527,Cartilaginous Differentiation,Cartilaginous exostosis,1
32528,Chemotherapeutic Agent Toxicity,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
32529,Malignant Cellular Infiltrate,Penile Cancer by AJCC v8 Stage,1
32530,'Starry-sky' pattern,Stage III Adult Burkitt Lymphoma,1
32531,Low Mitotic Activity,Pancreatic Somatostatinoma,1
32532,Bone Marrow Dysplasia Present,"Myelodysplastic syndrome, no ICD-O subtype",1
32533,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
32534,Extraosseous Lesion,Adult Extraskeletal Osteosarcoma,1
32535,Ineffective hematopoiesis,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,1
32536,Capillary Sized Vascular Channel Formation,Capillary hemangioma of eyelid,1
32537,Epithelial Component Present,Serous cystadenocarcinoma ovary,1
32538,Increased Cellularity Present,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System,1
32539,Secondary Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
32540,Above the Diaphragm Disease,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,1
32541,Hyperplastic Epithelial Tissue Present,Columnar Cell Hyperplasia of the Breast,1
32542,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,1
32543,Malignant Cellular Infiltrate,Ovarian Clear Cell Cystadenocarcinoma,1
32544,Immunologic Deficiency Syndromes,Allograft Thrombosis,1
32545,Cutaneous Involvement,Malignant Sebaceous Neoplasm,1
32546,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Tumor G2,1
32547,Tissue Differentiation Uncertain,Benign Soft Tissue Tumor of Uncertain Differentiation,1
32548,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
32549,Diffuse Pattern,MGMT-Methylated Glioblastoma,1
32550,Fibrotic Stroma Formation,Stage III Intrahepatic Cholangiocarcinoma AJCC v8,1
32551,Mixed Cellular Population,Benign Prostate Phyllodes Tumor,1
32552,Invasive Lesion,Poorly Differentiated Prostate Adenocarcinoma,1
32553,Malignant Cellular Infiltrate,Invasive Cribriform Breast Carcinoma,1
32554,Vascular Channel Formation,Gallbladder Kaposi's Sarcoma,1
32555,Malignant Cellular Infiltrate,Postcricoid Squamous Cell Carcinoma,1
32556,Malignant Cellular Infiltrate,Stage II Merkel Cell Carcinoma AJCC v7,1
32557,Malignant Germinomatous Cellular Infiltrate,Testicular Typical Seminoma,1
32558,Heterologous Elements Present,Intraocular Teratoid Medulloepithelioma,1
32559,Neuroendocrine Differentiation,Carcinoid tumor of intestine,1
32560,Malignant Cellular Infiltrate,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,1
32561,More than 5 Mitoses per 50HPF,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
32562,Well Differentiated Neuroendocrine Lesion,Intestinal Gangliocytic Paraganglioma,1
32563,Malignant Cellular Infiltrate,Metastatic Gastric Neuroendocrine Carcinoma,1
32564,Well Differentiated Neuroendocrine Lesion,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
32565,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Disseminated",1
32566,Mitotic Activity,Recurrent Childhood Pilomyxoid Astrocytoma,1
32567,Neuroendocrine Differentiation,Ovarian Trabecular Carcinoid Tumor,1
32568,Malignant Cellular Infiltrate,Recurrent Dedifferentiated Liposarcoma,1
32569,Epithelial Component Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
32570,Fibrotic Stroma Formation,Stage II Intrahepatic Cholangiocarcinoma AJCC v7,1
32571,Carcinomatous Component Present,Intestinal-Type Sinonasal Adenocarcinoma,1
32572,Chronic lymphocytic inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
32573,Absence of Invasion,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
32574,Neuroendocrine Differentiation,Refractory Extensive Stage Lung Small Cell Carcinoma,1
32575,Epithelial Component Present,Colon Carcinoma,1
32576,Epithelial Component Present,Papillary serous cystadenocarcinoma,1
32577,Metastatic Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,1
32578,Primary Lesion,Parosteal Osteosarcoma,1
32579,Diffuse Pattern,Childhood Mixed Glioma,1
32580,CD30-Positive Neoplastic Cells Present,"Anaplastic large cell lymphoma, ALK negative",1
32581,Anaplasia,Lung Pleomorphic Carcinoma,1
32582,Carcinomatous Component Present,Stage 0is Renal Pelvis Cancer AJCC v8,1
32583,Epithelial Component Present,Mucinous adenocarcinoma of colon,1
32584,Follicular Cell Differentiation,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
32585,Epithelial Component Present,Metastatic Signet Ring Cell Breast Carcinoma,1
32586,Epithelial Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
32587,Dysplasia,Low Grade Conjunctival Intraepithelial Neoplasia,1
32588,Nuclear Pseudoinclusion,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
32589,Malignant Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v7,1
32590,Malignant Cellular Infiltrate,Malignant neoplasm of ovary,1
32591,Carcinomatous Component Present,Stage IA3 Lung Cancer AJCC v8,1
32592,Epithelial Component Present,Ampulla of Vater Undifferentiated Carcinoma,1
32593,Malignant Cellular Infiltrate,Squamous cell carcinoma of rectum,1
32594,Carcinomatous Component Present,Stage IVB Colorectal Cancer AJCC v7,1
32595,Epithelial Component Present,Ductal Breast Carcinoma with Squamous Metaplasia,1
32596,Malignant Cellular Infiltrate,Fallopian Tube Mucinous Adenocarcinoma,1
32597,Malignant Cellular Infiltrate,Hepatoblastoma recurrent,1
32598,Malignant Cellular Infiltrate,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
32599,Carcinomatous Component Present,Pathologic Stage IA Gastric Cancer AJCC v8,1
32600,Well-Circumscribed Lesion,Pancreatic Macrocystic Serous Cystadenoma,1
32601,Malignant Cellular Infiltrate,Stage 0 Colon Cancer AJCC v8,1
32602,'Starry-sky' pattern,Immunodeficiency-associated Burkitt's lymphoma,1
32603,Malignant Cellular Infiltrate,Stage I Pleural Malignant Mesothelioma AJCC v7,1
32604,Lytic lesion,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,1
32605,Cord-Like Pattern,Clear cell sarcoma of kidney,1
32606,Childhood Lesion,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
32607,Cutaneous Involvement,Trichilemmoma,1
32608,Invasive Lesion,Advanced Prostate Adenocarcinoma,1
32609,Low Grade Neuroendocrine Lesion,Carcinoid tumor of the cecum,1
32610,Recurrent disease,Recurrent Digestive System Neuroendocrine Carcinoma,1
32611,Regional Disease,Locally Advanced Bile Duct Carcinoma,1
32612,Childhood Lesion,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
32613,Malignant Cellular Infiltrate,Stage I Small Intestinal Adenocarcinoma AJCC v8,1
32614,Malignant Cellular Infiltrate,Unfavorable Hodgkin Lymphoma,1
32615,Malignant Cellular Infiltrate,Plasmablastic lymphoma,1
32616,Malignant Cellular Infiltrate,Recurrent Acute Megakaryoblastic Leukemia,1
32617,Malignant Cellular Infiltrate,Adult Systemic Anaplastic Large Cell Lymphoma,1
32618,Peau d'orange surface of breast,Inflammatory carcinoma of breast recurrent,1
32619,Carcinomatous Component Present,Urothelial carcinoma ureter recurrent,1
32620,Carcinomatous Component Present,Recurrent Endometrial Undifferentiated Carcinoma,1
32621,High Mitotic Activity,small cell carcinoma of salivary gland,1
32622,Breast Microcalcification,Oligodendroglioma of spinal cord,1
32623,Malignant Cellular Infiltrate,Stage 0is Penile Cancer AJCC v8,1
32624,Carcinomatous Component Present,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
32625,Non-Invasive Lesion,Bladder Non-Invasive Urothelial Neoplasm,1
32626,Carcinomatous Component Present,Breast Cancer by AJCC v8 Prognostic Stage,1
32627,Malignant Cellular Infiltrate,Cardiac Synovial Sarcoma,1
32628,Islands of Odontogenic Epithelium Present,Basal Cell Ameloblastoma,1
32629,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma of skin,1
32630,Secondary Lesion,Secondary malignant neoplasm of small intestine,1
32631,Exophytic Papillary Lesion,Buccal Mucosa Verrucous Carcinoma,1
32632,Malignant Cellular Infiltrate,Angiocentric lymphoma recurrent,1
32633,Malignant Cellular Infiltrate,Thymic Adenosquamous Carcinoma,1
32634,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
32635,Malignant Cellular Infiltrate,Stage IIIA Colon Cancer AJCC v7,1
32636,Indolent Clinical Course,Solid Angioleiomyoma,1
32637,Malignant Cellular Infiltrate,Broad Ligament Serous Adenocarcinoma,1
32638,Epithelial Component Present,Parotid Gland Undifferentiated Carcinoma,1
32639,Dysplasia,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
32640,Severe dysplasia,Bladder adenocarcinoma stage 0,1
32641,Malignant Cellular Infiltrate,Central Nervous System Embryonal Neoplasm,1
32642,Malignant Cellular Infiltrate,Squamous cell carcinoma of the paranasal sinus,1
32643,Dermal Involvement,Vaginal Blue Nevus,1
32644,Malignant Cellular Infiltrate,Vaginal Mucinous Adenocarcinoma,1
32645,Diffuse Pattern,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
32646,Epithelial Component Present,Stage 0 Colon Cancer AJCC v6 and v7,1
32647,Micropapillary Pattern,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
32648,Epithelial Component Present,Gonadotroph adenoma,1
32649,Jaw Keratocyst,Basal Cell Nevus Syndrome,1
32650,Malignant Cellular Infiltrate,Hormone Receptor Positive Breast Carcinoma,1
32651,Cutaneous Involvement,Non-Neoplastic Skin Disorder,1
32652,Absence of Invasion,Lobular Neoplasia,1
32653,Papillary Pattern,Bladder Papillary Urothelial Carcinoma,1
32654,Malignant Cellular Infiltrate,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
32655,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
32656,Malignant Cellular Infiltrate,Stage III Esophageal Adenocarcinoma AJCC v7,1
32657,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma non-metastatic,1
32658,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
32659,Extensive Stage Lesion,Advanced Uveal Melanoma,1
32660,Benign Cellular Infiltrate,Lipoma of axilla,1
32661,Hyperplastic Tissue Present,Drug-induced gingival hyperplasia,1
32662,Necrotic changes (finding),large cell neuroendocrine carcinoma of lung,1
32663,Lesion with Diameter of 10mm or Less,Functioning Pituitary Gland Microadenoma,1
32664,Villous Pattern,Villous adenoma of rectum,1
32665,Neuroendocrine Differentiation,Laryngeal Carcinoid Tumor,1
32666,Nodular lesions,Thyroid Gland Oncocytic Adenoma,1
32667,Epithelial Component Present,Locally Advanced Unresectable Renal Cell Carcinoma,1
32668,Malignant Cellular Infiltrate,Stage I Bladder Cancer AJCC v8,1
32669,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone recurrent,1
32670,Benign Cellular Infiltrate,Benign Fibroblastic Neoplasm,1
32671,Perivascular Arrangement of Tumor Cells,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
32672,Epithelial Component Present,"Endometrioid adenoma, borderline malignancy",1
32673,Epithelial Component Present,Breast Carcinoma Metastatic in the Brain,1
32674,Carcinomatous Component Present,Stage IIA Rectal Cancer AJCC v8,1
32675,Metastatic Lesion,Locally Advanced Basal Cell Carcinoma,1
32676,Carcinomatous Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
32677,Malignant Cellular Infiltrate,Retinoblastoma,1
32678,Epithelial Component Present,mixed acinar-endocrine carcinoma of pancreas,1
32679,Malignant Cellular Infiltrate,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma,1
32680,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor G1,1
32681,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pancreas,1
32682,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage IV,1
32683,Benign Cellular Infiltrate,Pigmented villonodular synovitis,1
32684,Malignant Cellular Infiltrate,Stage III Oral Cavity Cancer AJCC v6 and v7,1
32685,Cutaneous Involvement,Epidermolysis Bullosa Dystrophica,1
32686,Chemotherapeutic Agent Toxicity,Alkylating Agent-Related Myelodysplastic Syndrome,1
32687,Malignant Cellular Infiltrate,"Carcinoma, Neuroendocrine",1
32688,Epithelial Component Present,"Papillomatosis, glandular",1
32689,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Central Nervous System,1
32690,Cutaneous Involvement,Digital papillary eccrine carcinoma of skin,1
32691,Malignant Cellular Infiltrate,Childhood Testicular Embryonal Carcinoma,1
32692,Carcinomatous Component Present,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
32693,Childhood Lesion,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
32694,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma,1
32695,Immunoglobulin Light Chain Deposition,Light chain disease,1
32696,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
32697,Carcinomatous Component Present,Pancreatic Small Cell Neuroendocrine Carcinoma,1
32698,Recurrent disease,Recurrent Childhood Rhabdomyosarcoma,1
32699,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV,1
32700,Refractory Disease,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
32701,Benign Cellular Infiltrate,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,1
32702,Neuroendocrine Differentiation,Gastric Neuroendocrine Neoplasm,1
32703,Exophytic Polypoid Lesion,Ampulla of Vater Tubulovillous Adenoma,1
32704,Clinical TNM Finding,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
32705,Acanthosis,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
32706,Preserved Nuclear Polarity,Bladder Urothelial Papilloma,1
32707,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v7,1
32708,Epithelial Component Present,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
32709,Capillary Sized Vascular Channel Formation,Trichodiscoma,1
32710,Malignant Cellular Infiltrate,Transplant-Related Malignant Neoplasm,1
32711,Malignant Cellular Infiltrate,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8,1
32712,Malignant Cellular Infiltrate,Ewings sarcoma-primitive neuroectodermal tumor (PNET),1
32713,Complete Spontaneous Regression,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement,1
32714,Carcinomatous Component Present,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1
32715,Plasma cell inflammation,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
32716,Multifocal Lesion,mediastinal lipomatosis,1
32717,Metastatic Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,1
32718,Childhood Lesion,Recurrent Childhood Ependymoma,1
32719,Diffuse Pattern,Immunoblastic lymphoma associated with AIDS,1
32720,Therapy-Related Toxicity,Transplant-Related Lung Carcinoma,1
32721,Childhood Lesion,Childhood Testicular Non-Seminomatous Germ Cell Tumor,1
32722,Slow Growing Painless Mass,Palisaded encapsulated neuroma,1
32723,High Grade Lesion,Glioblastoma multiforme of spinal cord,1
32724,"Amorphus, Eosinophilic, and Acellular Deposit",Recurrent Primary Amyloidosis,1
32725,Malignant Cellular Infiltrate,Oropharyngeal lymphepithelioma,1
32726,Benign Cellular Infiltrate,Benign neoplasm of intestinal tract,1
32727,Carcinomatous Component Present,Localized Gallbladder Carcinoma,1
32728,Metastatic Lesion,Carcinoma bone,1
32729,Epithelial Component Present,Differentiated Thyroid Gland Carcinoma,1
32730,Malignant Cellular Infiltrate,Angiocentric lymphoma recurrent,1
32731,Eccrine Differentiation,Benign Eccrine Neoplasm,1
32732,Malignant Cellular Infiltrate,Plasma cell myeloma refractory,1
32733,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Erythroleukemia (Erythroid/Myeloid),1
32734,Benign Cellular Infiltrate,Chest Wall Fibromatosis,1
32735,Malignant Cellular Infiltrate,Childhood Extragonadal Malignant Germ Cell Tumor,1
32736,Biphasic Pattern,"Neoplasms, Fibroepithelial",1
32737,Epithelial Component Present,Primary Carcinoma Unspecified Site,1
32738,Carcinomatous Component Present,Oropharyngeal lymphepithelioma,1
32739,Epithelial Component Present,Stage III Breast Cancer AJCC v7,1
32740,Cystic Change,Melanoacanthoma,1
32741,Decreased platelet count,Myeloid Neoplasms with Germline ETV6 Mutation,1
32742,Chronic Inflammatory Infiltrate,Deep histiocytoma,1
32743,Perineural spread,adenoid cystic carcinoma of pharynx,1
32744,Epithelial Component Present,Stage IV Esophageal Adenocarcinoma AJCC v7,1
32745,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vagina,1
32746,Epithelial Component Present,endometrioid adenofibroma of ovary,1
32747,Cutaneous Involvement,Paget Disease of the Scrotum,1
32748,In Situ Lesion,Stage 0 Rectal Cancer AJCC v6 and v7,1
32749,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v6,1
32750,Carcinomatous Component Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
32751,Benign Cellular Infiltrate,Frontal Sinus Inverted Papilloma,1
32752,Benign Cellular Infiltrate,"Nevus, Spindle Cell",1
32753,Bilateral Disease,Bilateral Carcinoma,1
32754,Adulthood Lesion,Adult T-Cell Lymphoma/Leukemia,1
32755,Hyperkeratosis,Urethral Verrucous Carcinoma,1
32756,Nuclear Expression of STAT6 Protein,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
32757,Carcinomatous Component Present,Pancreatic Ductal Adenocarcinoma,1
32758,Indolent Clinical Course,Lymphangioma circumscriptum,1
32759,Carcinomatous Component Present,Localized Parathyroid Gland Carcinoma,1
32760,Calcitonin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
32761,Plasma cell inflammation,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
32762,Low Cellularity Present,Pilocytic Astrocytoma,1
32763,Indolent Clinical Course,Gastric Plexiform Fibromyxoma,1
32764,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1,1
32765,Malignant Cellular Infiltrate,T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,1
32766,Recurrent disease,Recurrent Primary Amyloidosis,1
32767,Malignant Cellular Infiltrate,"Endometrial stromal sarcoma, high grade",1
32768,Refractory Disease,Refractory Visual Pathway Glioma,1
32769,Eosinophil count raised (finding),B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH,1
32770,Epithelial Component Present,Stage IIIA Colorectal Cancer AJCC v7,1
32771,Carcinomatous Component Present,"Carcinoma, Signet Ring Cell",1
32772,Vascular Channel Formation,Hemangioma of subcutaneous tissue,1
32773,Unresectable Mass,Unresectable Hepatocellular Carcinoma,1
32774,Malignant Cellular Infiltrate,Stage II Cervical Cancer AJCC v8,1
32775,More than 5 Mitoses per 50HPF,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage",1
32776,Carcinomatous Component Present,Grade 4 Clear Cell Renal Cell Carcinoma,1
32777,Neuroendocrine Differentiation,small cell carcinoma of appendix,1
32778,Malignant Cellular Infiltrate,Localized Unresectable Neuroblastoma,1
32779,Epithelial Component Present,Papilloma of eyelid,1
32780,Stromal Invasion,mucinous adenocarcinoma of ovary,1
32781,Epithelial Component Present,Stage IVB Lung Cancer AJCC v8,1
32782,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage III,1
32783,Low Mitotic Activity,Carcinoid tumor of the cecum,1
32784,Mixed Cellular Population,Prostate Phyllodes Tumor,1
32785,Papillary Pattern,Papillary mucinous cystadenocarcinoma,1
32786,Vascular Channel Formation,Subglottic Hemangioma,1
32787,Low Cellularity Present,Recurrent Childhood Protoplasmic Astrocytoma,1
32788,Human Papillomavirus Positive,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
32789,Primary Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
32790,Carcinomatous Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
32791,Carcinomatous Component Present,Adult Salivary Gland Carcinoma,1
32792,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v8,1
32793,Recurrent disease,Recurrent Biliary Tract Carcinoma,1
32794,Cutaneous Involvement,Monilethrix,1
32795,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v6,1
32796,Monoclonal Langerhans Cells Present,"Langerhans Cell Histiocytosis, Polystotic",1
32797,Cutaneous Involvement,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
32798,Lobulated Growth Pattern,malignant myoepithelioma of breast,1
32799,CD1a-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis,1
32800,Primary Lesion,Adult Primary Melanocytic Lesion of Meninges,1
32801,Vascular Channel Formation,Digestive System Hemangioma,1
32802,Angiocentric Pattern,Angiocentric glioma,1
32803,Malignant Cellular Infiltrate,Refractory Melanoma,1
32804,Cutaneous Involvement,"Xeroderma pigmentosum, group B",1
32805,Mixed Cellular Population,Nephrogenic adenofibroma,1
32806,Epithelial Component Present,Glycogen-rich carcinoma,1
32807,Adulthood Lesion,Adult Extracardiac Rhabdomyoma,1
32808,Monomorphic Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,1
32809,Calcitonin Positive Neoplastic Cells Present,Childhood Thyroid Gland Medullary Carcinoma,1
32810,Malignant Cellular Infiltrate,Metastatic thymic carcinoma,1
32811,Alternative Fascicle (Bundle) Pattern,Leiomyoma of ciliary body,1
32812,Extensive Stage Lesion,Advanced Lung Carcinoma,1
32813,Mixed Cellular Population,Mixed Salivary Gland Tumor,1
32814,Recurrent disease,Recurrent Lip Basal Cell Carcinoma,1
32815,Benign Cellular Infiltrate,Angiomyoma,1
32816,Epithelial Component Present,Recurrent Invasive Ductal Breast Carcinoma,1
32817,Malignant Cellular Infiltrate,Unresectable Skin Carcinoma,1
32818,Malignant Cellular Infiltrate,Recurrent Acute Megakaryoblastic Leukemia,1
32819,Nuclear Atypia,Recurrent Childhood Glioblastoma,1
32820,Carcinomatous Component Present,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
32821,Regional Disease,Regional Adrenal Gland Pheochromocytoma,1
32822,Philadelphia chromosome negative,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
32823,Cystic Change,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,1
32824,Calcinosis,"Retinoblastoma, spontaneously regressed",1
32825,Cutaneous Involvement,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
32826,Epithelial Component Present,Bladder adenocarcinoma stage II,1
32827,Low Grade Lesion,Mediastinal Epithelioid Hemangioendothelioma,1
32828,High Grade Lesion,Pleural Synovial Sarcoma,1
32829,Anaplasia,Metastatic Sarcomatoid Renal Cell Carcinoma,1
32830,Hereditary Lesion,Familial Testicular Germ Cell Tumor,1
32831,Eccrine Differentiation,Vulvar Syringoma,1
32832,Epithelial Component Present,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
32833,Carcinomatous Component Present,Metastatic Lung Adenocarcinoma,1
32834,Increased Cellularity Present,Grade III Childhood Astrocytoma,1
32835,Primary Lesion,Recurrent Primary Peritoneal Carcinoma,1
32836,Neuroendocrine Differentiation,Familial Adrenal Gland Pheochromocytoma,1
32837,Congenital Lesion,GIANT PIGMENTED HAIRY NEVUS,1
32838,Heterologous Elements Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,1
32839,Cutaneous Involvement,Vulvar Trichoepithelioma,1
32840,Secondary Lesion,Locally Advanced Unresectable Renal Cell Carcinoma,1
32841,Indolent Clinical Course,chondroma of lung,1
32842,Malignant Cellular Infiltrate,Uterine Corpus Adenosarcoma,1
32843,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G2,1
32844,Benign Cellular Infiltrate,Benign Dermal Neoplasm,1
32845,Neuroendocrine Differentiation,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
32846,Malignant Cellular Infiltrate,Gastrointestinal Stromal Sarcoma,1
32847,Biphasic Pattern,Breast Fibroepithelial Neoplasm,1
32848,Adulthood Lesion,BCLC Stage D Adult Hepatocellular Carcinoma,1
32849,Indolent Clinical Course,Vulvar Superficial Myofibroblastoma,1
32850,Hyperkeratosis,verrucous carcinoma of vagina,1
32851,Benign Cellular Infiltrate,Benign Glomus Tumor,1
32852,Monomorphic Cellular Infiltrate,Low Grade Ductal Breast Carcinoma In Situ,1
32853,Adulthood Lesion,Adult Papillary Meningioma,1
32854,Unresectable Mass,Locally Advanced Unresectable Sarcoma,1
32855,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent,1
32856,Carcinomatous Component Present,Recurrent BRCA-Mutated Ovarian Carcinoma,1
32857,High Mitotic Activity,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
32858,Multifocal Lesion,"Histiocytosis, Langerhans-Cell",1
32859,Metastatic Lesion,Advanced Carcinoma,1
32860,Epithelial Component Present,Metastatic gastric adenocarcinoma,1
32861,Malignant Cellular Infiltrate,Recurrent Childhood Burkitt Lymphoma,1
32862,Cartilaginous Differentiation,Bizarre parosteal osteochondromatous proliferation,1
32863,Carcinomatous Component Present,Recurrent Parotid Gland Carcinoma,1
32864,Epithelial Component Present,Stage IIC Prostate Cancer AJCC v8,1
32865,Dysplasia,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
32866,Clinical TNM Finding,Clinical Stage II Esophageal Adenocarcinoma AJCC v8,1
32867,Epithelial Component Present,undifferentiated carcinoma of gallbladder,1
32868,Malignant Cellular Infiltrate,Recurrent Skin Angiosarcoma,1
32869,Biphasic Pattern,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,1
32870,Malignant Cellular Infiltrate,Hypocellular Myelodysplastic Syndrome,1
32871,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage III,1
32872,Neuroendocrine Differentiation,Ovarian Trabecular Carcinoid Tumor,1
32873,Locally Aggressive Lesion,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
32874,Carcinomatous Component Present,Epithelial-myoepithelial carcinoma,1
32875,Severe dysplasia,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
32876,Epithelial Component Present,Basal-Like Breast Carcinoma,1
32877,Hyalinized Stroma Formation,Thyroid Hyalinizing Trabecular Adenoma,1
32878,Infiltrative Growth Pattern,Fibrillary Astrocytoma,1
32879,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
32880,Epithelial Component Present,Advanced Bile Duct Carcinoma,1
32881,Polymorphic Cellular Infiltrate,Central Nervous System Langerhans Cell Histiocytosis,1
32882,Papillary Pattern,Papilloma,1
32883,Malignant Cellular Infiltrate,Osteosarcoma Arising in Paget Disease of Bone,1
32884,Epithelial Component Present,Squamous intraepithelial lesion,1
32885,Tumor Vascular Invasion,Malignant Pancreatic Somatostatinoma,1
32886,Benign Cellular Infiltrate,lipoma of large intestine,1
32887,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans,1
32888,Lymphoplasmacytic Infiltrate,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
32889,Malignant Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v6,1
32890,High Grade Lesion,Stage II Lung Small Cell Carcinoma AJCC v7,1
32891,Malignant Cellular Infiltrate,Advanced Well Differentiated Neuroendocrine Neoplasm,1
32892,Epithelial Component Present,Recurrent Oral Cavity Carcinoma,1
32893,Malignant Cellular Infiltrate,Stage III Hypopharyngeal Carcinoma AJCC v7,1
32894,High Grade Lesion,Childhood Brain Anaplastic Astrocytoma,1
32895,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
32896,Neuroendocrine Differentiation,Lung Small Cell Carcinoma by AJCC v7 Stage,1
32897,Epithelial Component Present,Stage IV Lung Cancer AJCC v8,1
32898,Malignant Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v8,1
32899,Benign Cellular Infiltrate,Aggressive angiomyxoma,1
32900,Malignant Cellular Infiltrate,Primary ameloblastic carcinoma,1
32901,Malignant Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v7,1
32902,Pregnancy Complications,Hydatidiform Mole,1
32903,CD30-Positive Neoplastic Cells Present,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
32904,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
32905,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
32906,Nuclear Atypia,Adult Brain Stem Gliosarcoma,1
32907,Malignant Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v6 and v7,1
32908,Increased Cellularity Present,Kadish Stage A Olfactory Neuroblastoma,1
32909,Absence of Stromal Invasion,Borderline epithelial tumor of ovary,1
32910,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Basophilic Leukemia,1
32911,Chronic Inflammatory Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
32912,Malignant Cellular Infiltrate,Multifocal breast carcinoma,1
32913,Negative Peripheral Blood,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
32914,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ureter,1
32915,Childhood Lesion,Childhood Ovarian Germ Cell Tumor,1
32916,Malignant Cellular Infiltrate,Stage 0 Esophageal Cancer AJCC v6,1
32917,Cystic Change,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
32918,Secondary Lesion,Adenocarcinoma of Unknown Primary,1
32919,Low Mitotic Activity,Carcinoid tumor of intestine,1
32920,CD30-Positive Neoplastic Cells Present,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
32921,Malignant Cellular Infiltrate,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
32922,Diffuse Lesion,Papillomatosis,1
32923,Recurrent disease,Recurrent Childhood Oligodendroglioma,1
32924,Cystic Change,Trichoadenoma,1
32925,Carcinomatous Component Present,Ovarian Dermoid Cyst with Adenocarcinoma,1
32926,Carcinomatous Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
32927,Well-Circumscribed Lesion,Spindle Cell/Pleomorphic Lipoma,1
32928,Epithelial Component Present,Extraocular Cutaneous Sebaceous Carcinoma,1
32929,Secondary Lesion,Secondary carcinoma,1
32930,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(5;17)(q35;q21),1
32931,Vascular Channel Formation,Polymorphus Hemangioendothelioma,1
32932,Malignant Cellular Infiltrate,Osteoblastic Osteosarcoma,1
32933,Carcinomatous Component Present,Stage IVA Paranasal Sinus Cancer AJCC v7,1
32934,Adulthood Lesion,Adult Teratoma,1
32935,Anaplasia,Thymic Sarcomatoid Carcinoma,1
32936,Carcinomatous Component Present,Pancreatic adenocarcinoma metastatic,1
32937,Malignant Cellular Infiltrate,Ethmoid Sinus Adenocarcinoma,1
32938,Epithelial Component Present,Testicular Brenner Tumor,1
32939,Biphasic Pattern,Vulvar Ectopic Fibroadenoma,1
32940,Epithelial Component Present,Carcinosarcoma of ovary,1
32941,Koilocytotic atypia,Warty Carcinoma of the Penis,1
32942,Recurrent disease,Recurrent B-Cell Prolymphocytic Leukemia,1
32943,Preserved Nuclear Polarity,Ureter Inverted Papilloma,1
32944,Recurrent disease,Recurrent Appendix Carcinoma,1
32945,atypia morphology,Borderline Fallopian Tube Neoplasm,1
32946,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Renal Cell Carcinoma,1
32947,Malignant Cellular Infiltrate,Central Nervous System Epithelioid Hemangioendothelioma,1
32948,Malignant Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma,1
32949,Epithelial Component Present,Papillary squamous cell carcinoma,1
32950,Malignant Cellular Infiltrate,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8,1
32951,Rapidly Enlarging Mass,Abdominal Rhabdomyosarcoma,1
32952,Heterologous Elements Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
32953,Malignant Cellular Infiltrate,Recurrent Transformed B-cell Non-Hodgkin Lymphoma,1
32954,Epithelial Component Present,Disseminated squamous cell carcinoma,1
32955,Mixed Cellular Population,Stage III Kidney Wilms Tumor,1
32956,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v6 and v7,1
32957,Exophytic Polypoid Lesion,Rectal Sessile Serrated Adenoma/Polyp,1
32958,Nuclear Grooves,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
32959,Malignant Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v7,1
32960,More than 10 Mitoses per 10HPF,Small cell lung cancer limited stage,1
32961,Alternative Fascicle (Bundle) Pattern,Vaginal Leiomyoma,1
32962,Low Grade Lesion,Multinodular and Vacuolated Tumor of the Cerebrum,1
32963,Non-Malignant Cellular Infiltrate,Histiocytic Necrotizing Lymphadenitis,1
32964,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Gene Mutation,1
32965,Carcinomatous Component Present,Hepatoid adenocarcinoma,1
32966,Epithelial Component Present,Small cell carcinoma of prostate,1
32967,Fibrotic Stroma Formation,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
32968,Secondary Lesion,Stage IV Esophageal Adenocarcinoma,1
32969,Malignant Cellular Infiltrate,Refractory Malignant Glioma,1
32970,Childhood Lesion,Childhood Soft Tissue Sarcoma,1
32971,Stromal Invasion,Ovarian Clear Cell Cystadenocarcinoma,1
32972,Biphasic Pattern,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
32973,Severe dysplasia,Prognostic Stage 0 Breast Cancer AJCC v8,1
32974,Thin-Walled Branching Vascular Pattern,Mediastinal Solitary Fibrous Tumor,1
32975,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma,1
32976,Hypercellular bone marrow,"Polycythemia Vera, Polycythemic Phase",1
32977,Indolent Clinical Course,Hemolymphangioma,1
32978,Epithelial Component Present,Gastric Squamous Cell Carcinoma,1
32979,Decreased platelet count,Myeloid Neoplasms with Germline ANKRD26 Mutation,1
32980,Follicular Structures Present,Atypical follicular adenoma,1
32981,Childhood Lesion,Malignant Childhood Central Nervous System Neoplasm,1
32982,High Mitotic Activity,Recurrent Merkel Cell Carcinoma,1
32983,Malignant Cellular Infiltrate,Bladder Urothelial Carcinoma in Situ,1
32984,Carcinomatous Component Present,Stage IIIA Adult Liver Cancer AJCC v7,1
32985,Carcinomatous Component Present,Non-small cell lung cancer stage III,1
32986,Benign Cellular Infiltrate,Mature Ovarian Teratoma,1
32987,Immunosuppression-Related Post-Transplant Toxicity,Bone Marrow Transplantation Nephropathy,1
32988,Multilineage Dysplasia Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
32989,Carcinomatous Component Present,Appendix Carcinoma by AJCC v8 Stage,1
32990,Malignant Cellular Infiltrate,Stage 0 Esophageal Cancer AJCC v6,1
32991,Epithelial Component Present,Adenosquamous cell lung cancer stage III,1
32992,Benign Cellular Infiltrate,Sex Hormone-Producing Adrenal Cortex Adenoma,1
32993,Epithelial Component Present,"Adenocarcinoma of lung, stage III",1
32994,Epithelial Component Present,Borderline Ovarian Clear Cell Cystadenofibroma,1
32995,Benign Cellular Infiltrate,Lipoma of the tongue,1
32996,Recurrent disease,Recurrent Spinal Cord Neoplasm,1
32997,Cutaneous Involvement,Adenoid cystic eccrine carcinoma,1
32998,Carcinomatous Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
32999,Epithelial Component Present,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
33000,Malignant Cellular Infiltrate,Vulvar Clear Cell Hidradenocarcinoma,1
33001,Malignant Cellular Infiltrate,Stage I Childhood Anaplastic Large Cell Lymphoma,1
33002,Malignant Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
33003,Precise Histogenesis Unknown,Medullary Hemangioblastoma,1
33004,Carcinomatous Component Present,carcinoma of eye,1
33005,Tubular Structures Present,Sertoli Cell Tumor,1
33006,Refractory Disease,Refractory Childhood Hodgkin Lymphoma,1
33007,Carcinomatous Component Present,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
33008,Adnexal Differentiation,Benign Germinative Follicular Epithelium Neoplasm,1
33009,Malignant Cellular Infiltrate,Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma,1
33010,Epithelial Component Present,Malignant Testicular Leydig Cell Tumor,1
33011,Malignant Cellular Infiltrate,M5b Acute differentiated monocytic leukemia,1
33012,Recurrent disease,Recurrent Acute Leukemia,1
33013,Severe dysplasia,Adenocarcinoma in situ in a polyp,1
33014,Carcinomatous Component Present,Hormone refractory prostate cancer,1
33015,Recurrent disease,Recurrent Endometrial Serous Adenocarcinoma,1
33016,Recurrent disease,Recurrent Childhood Soft Tissue Sarcoma,1
33017,Malignant Cellular Infiltrate,Adult Brain Medulloblastoma,1
33018,Secondary Lesion,Secondary malignant neoplasm of skin,1
33019,Increased Cellularity Present,Childhood Brain Anaplastic Astrocytoma,1
33020,Aggressive Clinical Course,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
33021,Benign Cellular Infiltrate,Testicular Large Cell Calcifying Sertoli Cell Tumor,1
33022,Polymorphic Cellular Infiltrate,Thyroid Gland Langerhans Cell Histiocytosis,1
33023,Neuroendocrine Differentiation,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
33024,Malignant Cellular Infiltrate,Stage III Adrenal Cortex Carcinoma AJCC v7,1
33025,Slowly Progressive Clinical Course,Smoldering Systemic Mastocytosis,1
33026,Hyperplastic Tissue Present,Papillary Ductal Breast Hyperplasia,1
33027,'Starry-sky' pattern,Colon Burkitt Lymphoma,1
33028,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
33029,Microvascular Proliferation,Diencephalic Glioblastoma,1
33030,High Grade Lesion,Synovial sarcoma recurrent,1
33031,Carcinomatous Component Present,Metastatic Penile Cancer,1
33032,Nodular Pattern,Ann Arbor Stage IV Grade 1 Follicular Lymphoma,1
33033,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1B,1
33034,Secondary Lesion,Locally Advanced Malignant Neoplasm,1
33035,Diffuse Cellular Infiltrate,"Carcinoma, diffuse type",1
33036,Carcinomatous Component Present,Metastatic Carcinoma in the Lung,1
33037,Unresectable Mass,Unresectable Low Grade Glioma,1
33038,Sebaceous Differentiation,Sebaceous Gland Neoplasms,1
33039,Metastatic/Recurrent Disease,Bladder Alveolar Soft Part Sarcoma,1
33040,Carcinomatous Component Present,Small intestine carcinoma recurrent,1
33041,Malignant Cellular Infiltrate,Colorectal Burkitt Lymphoma,1
33042,Mesenchymal Metaplasia,Adenocarcinoma with cartilaginous and osseous metaplasia,1
33043,Cafe-au-Lait Spots,McCune-Albright Syndrome,1
33044,Carcinomatous Component Present,Endometrial Undifferentiated Carcinoma,1
33045,Carcinomatous Component Present,Prognostic Stage IIIA Breast Cancer AJCC v8,1
33046,Epithelial Component Present,Vulvar Glandular Neoplasm,1
33047,Epithelial Component Present,"Transitional cell carcinoma, spindle cell",1
33048,Malignant Cellular Infiltrate,Recurrent Parotid Gland Adenoid Cystic Carcinoma,1
33049,Epithelial Component Present,Gallbladder Cancer by AJCC v8 Stage,1
33050,Malignant Cellular Infiltrate,Prostate cancer recurrent,1
33051,Epithelial Component Present,Inverted Papilloma,1
33052,Monoclonal Gammapathies,Waldenstrom's macroglobulinemia recurrent,1
33053,Well-Circumscribed Lesion,Appendix adenoma,1
33054,Exophytic Polypoid Lesion,Malignant lymphomatous polyposis,1
33055,Malignant Cellular Infiltrate,Basal-Like Breast Carcinoma,1
33056,Carcinomatous Component Present,Morpheic basal cell carcinoma,1
33057,Adulthood Lesion,Adult Acute Promyelocytic Leukemia with PML-RARA,1
33058,Malignant Cellular Infiltrate,Stage II Oropharyngeal Carcinoma,1
33059,Nuclear Atypia,Infratentorial Glioblastoma,1
33060,Fibrotic Stroma Formation,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
33061,Cutaneous Involvement,Stage II Lentigo Maligna Melanoma AJCC v6 and v7,1
33062,Malignant Cellular Infiltrate,Refractory Head and Neck Squamous Cell Carcinoma,1
33063,Hyperplastic Epithelial Tissue Present,Columnar Cell Hyperplasia of the Breast,1
33064,Tubular Structures Present,Sertoli Cell Tumor,1
33065,Well Differentiated Neuroendocrine Lesion,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
33066,Malignant Cellular Infiltrate,Recurrent Pancreatic Neuroendocrine Carcinoma,1
33067,Epithelial Component Present,Gastric Cancer by AJCC v8 Pathologic Stage,1
33068,Hyperkeratosis,Vulvar Warty Carcinoma,1
33069,Secondary Lesion,Carcinomatosis,1
33070,Benign Cellular Infiltrate,Benign Childhood Central Nervous System Neoplasm,1
33071,Carcinomatous Component Present,small cell carcinoma of salivary gland,1
33072,Carcinomatous Component Present,Exocervical Carcinoma,1
33073,Carcinomatous Component Present,Thoracic NUT Carcinoma,1
33074,Necrotic changes (finding),Recurrent Dedifferentiated Liposarcoma,1
33075,Carcinomatous Component Present,Metastatic Unresectable Gastric Adenocarcinoma,1
33076,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
33077,Nodular lesions,Lung Typical Carcinoid Tumor,1
33078,Necrotic changes (finding),Recurrent Childhood Giant Cell Glioblastoma,1
33079,Recurrent disease,Recurrent Endometrial Endometrioid Adenocarcinoma,1
33080,Extraosseous Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
33081,Increased Cellularity Present,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System,1
33082,Benign Cellular Infiltrate,Lipoma of skin,1
33083,Malignant Cellular Infiltrate,Malignant tumor of minor salivary gland,1
33084,Necrotic changes (finding),Platinum-Sensitive Lung Small Cell Carcinoma,1
33085,Epithelial Component Present,Recurrent Salivary Duct Carcinoma,1
33086,Hyperkeratosis,Subglottic Verrucous Carcinoma,1
33087,Malignant Cellular Infiltrate,"Carcinoma, Papillary",1
33088,Carcinomatous Component Present,Pilomatrix carcinoma of skin,1
33089,Carcinomatous Component Present,Perihilar Intrahepatic Cholangiocarcinoma,1
33090,High Grade Lesion,Rhabdomyosarcoma of the orbit,1
33091,Lobulated Growth Pattern,Sellar Dedifferentiated Chordoma,1
33092,Local disease,Inner Ear Lipoma,1
33093,Infiltrative Growth Pattern,Infiltrating basal cell carcinoma,1
33094,S-100-Positive Neoplastic Cells Present,Benign Lung PEComa,1
33095,Primary Site Unknown,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,1
33096,Epithelial Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
33097,Epithelial Component Present,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,1
33098,Malignant Cellular Infiltrate,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
33099,Malignant Cellular Infiltrate,Stage IIIC Appendix Carcinoma AJCC v7,1
33100,Immunologic Deficiency Syndromes,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
33101,Epithelial Component Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
33102,Myxoid Stroma Formation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
33103,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IIIB,1
33104,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
33105,Diffuse Pattern,Refractory Intravascular Large B-Cell Lymphoma,1
33106,Malignant Cellular Infiltrate,Malignant lymphoma of spleen,1
33107,Malignant Germinomatous Cellular Infiltrate,Childhood Seminoma,1
33108,Epithelial Component Present,Gastroesophageal Junction Neuroendocrine Carcinoma,1
33109,Malignant Cellular Infiltrate,Uterine Corpus High Grade Endometrial Stromal Sarcoma,1
33110,Recurrent disease,Recurrent Prostate Acinar Adenocarcinoma,1
33111,Anaplasia,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
33112,Metastatic Lesion,Recurrent Carcinoma of Unknown Primary,1
33113,Carcinomatous Component Present,Stage IV Anal Canal Cancer AJCC v6 and v7,1
33114,Malignant Cellular Infiltrate,Mediastinal Epithelioid Hemangioendothelioma,1
33115,Carcinomatous Component Present,"Lung Squamous Cell Carcinoma, Small Cell Variant",1
33116,Malignant Cellular Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,1
33117,Edematous Stroma Formation,Vulvar Angiomyxoma,1
33118,Malignant Cellular Infiltrate,Sarcoma by NCI Grade,1
33119,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
33120,Epithelial Component Present,Stage II Pancreatic Cancer AJCC v6 and v7,1
33121,Well Differentiated Lesion,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
33122,Secondary Lesion,Metastatic Gastric Neuroendocrine Carcinoma,1
33123,Malignant Cellular Infiltrate,Stage IIIA1 Ovarian Cancer AJCC v8,1
33124,Intraductal Lesion,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
33125,Malignant Cellular Infiltrate,Anaplastic Carcinoma of the Rectum,1
33126,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma refractory,1
33127,Carcinomatous Component Present,Recurrent Ovarian Carcinosarcoma,1
33128,Malignant Cellular Infiltrate,Lung Hilum Carcinoma,1
33129,Secondary Lesion,Stage IV Nasopharyngeal Carcinoma,1
33130,Osseous Differentiation,Metastatic osteosarcoma,1
33131,Malignant Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor,1
33132,Epithelial Component Present,Gastric Cancer by AJCC v8 Clinical Stage,1
33133,Primary Lesion,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
33134,Primary Lesion,Childhood Cerebral Ependymoma,1
33135,Carcinomatous Component Present,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,1
33136,Malignant Cellular Infiltrate,"Basal cell carcinoma, infundibulocystic",1
33137,Carcinomatous Component Present,Ampulla of Vater Adenosquamous Carcinoma,1
33138,Secondary Lesion,Squamous Cell Carcinoma of Unknown Primary,1
33139,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic syndrome, no ICD-O subtype",1
33140,Severe dysplasia,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
33141,Necrotic changes (finding),large cell neuroendocrine carcinoma of extrahepatic bile duct,1
33142,Carcinomatous Component Present,Ampulla of Vater Neuroendocrine Carcinoma,1
33143,Primary Lesion,Recurrent Non-Cutaneous Melanoma,1
33144,Papillary Pattern,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
33145,Recurrent disease,Recurrent Mediastinal Lymphoma,1
33146,Malignant Cellular Infiltrate,Uterine Corpus Adenosarcoma by AJCC v8 Stage,1
33147,Epithelial Component Present,Stage IV Intrahepatic Bile Duct Cancer AJCC v8,1
33148,Nuclear Atypia,Childhood Cerebral Anaplastic Astrocytoma,1
33149,Mild dysplasia,Small Intestinal Low Grade Intraepithelial Neoplasia,1
33150,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
33151,Pseudopapillary Pattern,Papillary glioneuronal tumor,1
33152,Metastatic/Recurrent Disease,Gastric Synovial Sarcoma,1
33153,Epithelial Component Present,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas,1
33154,Carcinomatous Component Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
33155,Secondary Lesion,Secondary malignant neoplasm of choroid,1
33156,Cutaneous Involvement,Stage IIB Cutaneous Melanoma AJCC v6 and v7,1
33157,Invasive Lesion,Adenocarcinoma of the prostate metastatic,1
33158,Acanthosis,Vulvar Inverted Follicular Keratosis,1
33159,Carcinomatous Component Present,Rectosigmoid cancer,1
33160,Secondary Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
33161,Rapidly Enlarging Mass,Vaginal Rhabdomyosarcoma,1
33162,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Soft Tissue,1
33163,Absence of Invasion,Stage 0 Ampulla of Vater Cancer AJCC v8,1
33164,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,1
33165,Primary Lesion,Childhood Meningeal Melanoma,1
33166,Hyperkeratosis,Verrucous carcinoma of oral cavity,1
33167,Serotonin Positive Neoplastic Cells Present,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
33168,Malignant Cellular Infiltrate,Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8,1
33169,Tissue Differentiation Uncertain,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
33170,Malignant Cellular Infiltrate,Recurrent Endometrial Serous Adenocarcinoma,1
33171,Malignant Cellular Infiltrate,Distal Urethral Carcinoma,1
33172,Malignant Cellular Infiltrate,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
33173,Carcinomatous Component Present,Early Invasive Cervical Squamous Cell Carcinoma,1
33174,Epithelial Component Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
33175,Malignant Cellular Infiltrate,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
33176,Epithelial Component Present,Adenocarcinoma gastric recurrent,1
33177,Malignant Cellular Infiltrate,Stage I Choroidal and Ciliary Body Melanoma AJCC v8,1
33178,Malignant Cellular Infiltrate,EBV-Related Lymphoma,1
33179,Locally Aggressive Lesion,Lung Inflammatory Myofibroblastic Tumor,1
33180,Childhood Lesion,Stage IV Childhood Lymphoblastic Lymphoma,1
33181,Well Differentiated Lesion,Cervical Warty Carcinoma,1
33182,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v8,1
33183,Carcinomatous Component Present,Metastatic Lip Squamous Cell Carcinoma,1
33184,Low Mitotic Activity,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,1
33185,Malignant Cellular Infiltrate,Refractory Endometrial Carcinoma,1
33186,Malignant Cellular Infiltrate,Childhood Anaplastic Large Cell Lymphoma,1
33187,Carcinomatous Component Present,Bladder squamous cell carcinoma stage III,1
33188,Sarcomatoid Features,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
33189,Epithelial Component Present,Rectal Sessile Serrated Adenoma/Polyp,1
33190,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
33191,Intermediate Grade Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor G2,1
33192,Epithelial Component Present,Unresectable Digestive System Adenocarcinoma,1
33193,Metastatic/Recurrent Disease,Childhood Alveolar Soft Part Sarcoma,1
33194,Carcinomatous Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7,1
33195,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
33196,Carcinomatous Component Present,Stage IIIC Hilar Cholangiocarcinoma AJCC v8,1
33197,Therapy-Related Toxicity,Radiation-Related Osteosarcoma,1
33198,Firm mass,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
33199,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anaemia with excess blasts,1
33200,Malignant Cellular Infiltrate,Hard Palate Adenoid Cystic Carcinoma,1
33201,Cutaneous Involvement,Infiltrating basal cell carcinoma,1
33202,Epithelial Component Present,Stage IIB Breast Carcinoma,1
33203,Local disease,Localized Bone Ewing Sarcoma,1
33204,Malignant Cellular Infiltrate,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
33205,Epithelial Component Present,Periampullary Adenocarcinoma,1
33206,Trabecular Pattern,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
33207,Epithelial Component Present,Cervical Squamous Papilloma,1
33208,High Mitotic Activity,Childhood Choroid Plexus Carcinoma,1
33209,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
33210,Neuroendocrine Differentiation,Middle Ear Paraganglioma,1
33211,Benign Cellular Infiltrate,Testicular Dermoid Cyst,1
33212,Carcinomatous Component Present,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
33213,Carcinomatous Component Present,Stage III Penile Cancer AJCC v8,1
33214,Necrotic changes (finding),Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
33215,Ineffective hematopoiesis,Myelodysplastic Syndrome with Isolated del(5q),1
33216,Carcinomatous Component Present,large cell neuroendocrine carcinoma of breast,1
33217,Adulthood Lesion,Stage I Adult Immunoblastic Lymphoma,1
33218,Monomorphic Cellular Infiltrate,Ependymoma of brain stem,1
33219,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
33220,Epithelial Component Present,Colorectal Neuroendocrine Carcinoma,1
33221,Malignant Cellular Infiltrate,Stage IIB Ovarian Cancer AJCC v6 and v7,1
33222,Human Papillomavirus Positive,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
33223,Malignant Cellular Infiltrate,Stage III Lung Cancer AJCC v7,1
33224,Well-Circumscribed Lesion,Preauricular skin tag,1
33225,Malignant Cellular Infiltrate,Clinical Stage 0 Cutaneous Melanoma AJCC v8,1
33226,Anaplasia,Recurrent Childhood Anaplastic Astrocytoma,1
33227,Tissue Differentiation Uncertain,"Histiocytoma, Angiomatoid Fibrous",1
33228,Thick-Walled Hyalinized Vessels Present,Cellular Schwannoma,1
33229,Malignant Cellular Infiltrate,Locally Advanced Bone Sarcoma,1
33230,Malignant Cellular Infiltrate,Abdominal Undifferentiated Pleomorphic Sarcoma,1
33231,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v7,1
33232,Anaplasia,Anaplastic small cell lymphoma,1
33233,Increased Cellularity Present,Recurrent Anaplastic Oligoastrocytoma,1
33234,Hereditary Lesion,Myeloid Neoplasms with Germline RUNX1 Mutation,1
33235,Carcinomatous Component Present,Distal 1/3 of the Common Bile Duct Adenocarcinoma,1
33236,Inflammatory infiltrate,Fibrous histiocytoma of tendon sheath,1
33237,Multinodular Pattern,Vulvar Proximal-Type Epithelioid Sarcoma,1
33238,Malignant Cellular Infiltrate,Stage IB Eyelid Carcinoma AJCC v8,1
33239,Malignant Cellular Infiltrate,Apocrine Breast Carcinoma In Situ,1
33240,Carcinomatous Component Present,Vulvar Merkel Cell Carcinoma,1
33241,Recurrent disease,Recurrent Grade I Lymphomatoid Granulomatosis,1
33242,Cervical lymphadenopathy,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,1
33243,Malignant Cellular Infiltrate,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
33244,Neuroendocrine Differentiation,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
33245,Malignant Cellular Infiltrate,Peripheral Intraneural Angiosarcoma,1
33246,Pseudopapillary Pattern,Cerebellar Papillary Meningioma,1
33247,Nuclear Molding,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
33248,Carcinomatous Component Present,Low Grade Salivary Gland Carcinoma,1
33249,Epithelial Component Present,FIGO Stage IIIA1(i) Ovarian Cancer,1
33250,Recurrent disease,Malignant neoplasm of hypopharynx recurrent,1
33251,Infiltrating Tumor Margins Present,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
33252,Benign Cellular Infiltrate,Benign Uterine Corpus PEComa,1
33253,Indolent Clinical Course,Spindle Cell/Pleomorphic Lipoma,1
33254,Cutaneous Involvement,Benign Cutaneous Fibroblastic Neoplasm,1
33255,Well Differentiated Neuroendocrine Lesion,Malignant Vipoma,1
33256,Malignant Cellular Infiltrate,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1
33257,Malignant Cellular Infiltrate,Childhood Myxoid Chondrosarcoma,1
33258,Carcinomatous Component Present,Neuroendocrine carcinoma of the bladder,1
33259,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
33260,Malignant Cellular Infiltrate,"Lymphoma, Follicular",1
33261,Adnexal Differentiation,Benign Pilar-Associated Mesenchyme Neoplasm,1
33262,Epithelial Component Present,Serous cystadenoma of ovary,1
33263,Micropapillary Pattern,Colon Micropapillary Adenocarcinoma,1
33264,Infiltrative Growth Pattern,Recurrent Desmoid-Type Fibromatosis,1
33265,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v8,1
33266,Mixed Cellular Population,Metachronous Wilms Tumor,1
33267,Carcinomatous Component Present,Small cell carcinoma of the cervix,1
33268,Cutaneous Involvement,Compound nevus of skin,1
33269,Malignant Cellular Infiltrate,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
33270,Papillary Pattern,Serous papillary cystic tumor of borderline malignancy,1
33271,Epithelial Component Present,Recurrent Thyroid Carcinoma,1
33272,Diffuse Pattern,Adult Gliosarcoma,1
33273,Epithelial Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
33274,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
33275,Pseudoencapsulated Mass,Intraocular Malignant Peripheral Nerve Sheath Tumor,1
33276,Geographic Necrosis,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
33277,Erythema,Inflammatory carcinoma of breast stage III,1
33278,Bone Marrow Dysplasia Present,Chronic Myelomonocytic Leukemia with Eosinophilia,1
33279,Malignant Cellular Infiltrate,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
33280,Benign Cellular Infiltrate,Benign neoplasm of pyriform sinus,1
33281,Solitary mass,Bone Epithelioid Hemangioendothelioma,1
33282,Diffuse Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
33283,In Situ Lesion,Stage 0 Pharynx Carcinoma,1
33284,Childhood Lesion,Childhood Leukemia,1
33285,Malignant Cellular Infiltrate,Recurrent Aggressive NK-Cell Leukemia,1
33286,Malignant Cellular Infiltrate,Refractory Malignant Glioma,1
33287,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",1
33288,Epithelial Component Present,Carcinoma of the Floor of the Mouth,1
33289,Collagenous Stroma Formation,Vaginal Myofibroblastoma,1
33290,Cartilaginous metaplasia,Adenocarcinoma with cartilaginous metaplasia,1
33291,Malignant Cellular Infiltrate,Stage III Intrahepatic Cholangiocarcinoma AJCC v7,1
33292,Secondary Lesion,Breast Carcinoma Metastatic in the Central Nervous System,1
33293,Monomorphic Cellular Infiltrate,Adult Brain Oligodendroglioma,1
33294,Carcinomatous Component Present,Chromophobe Renal Cell Carcinoma,1
33295,Benign Cellular Infiltrate,Craniopharyngioma,1
33296,Mixed Cellular Population,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,1
33297,Malignant Cellular Infiltrate,Squamous Cell Carcinoma In Situ of the Nipple,1
33298,Dysplasia,Colorectal Adenoma with Mild Dysplasia,1
33299,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
33300,Neuroendocrine Differentiation,Extrapulmonary Small Cell Carcinoma,1
33301,Epithelial Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
33302,Epithelial Component Present,Hormone refractory breast cancer,1
33303,Keratin pearl formation,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
33304,Primary Lesion,Central Nervous System Intravascular Large B-Cell Lymphoma,1
33305,Malignant Cellular Infiltrate,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
33306,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v7,1
33307,Benign Cellular Infiltrate,"Acanthoma, Clear Cell",1
33308,Poorly Differentiated Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,1
33309,Malignant Cellular Infiltrate,Squamous cell carcinoma with horn formation,1
33310,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Colon,1
33311,Benign Cellular Infiltrate,Intra-Abdominal Lymphangioma,1
33312,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Lymphoma AJCC v8,1
33313,Epithelial Component Present,Stage III Eyelid Carcinoma AJCC v8,1
33314,In Situ Lesion,Stage 0 Appendix Carcinoma AJCC v7,1
33315,Cauliflower-Like Mass,Choroid Plexus Papilloma,1
33316,Carcinomatous Component Present,Grade 4 Clear Cell Renal Cell Carcinoma,1
33317,Malignant Cellular Infiltrate,"Basal cell carcinoma, micronodular",1
33318,Microinvasive tumor,Microinvasive Malignant Neoplasm,1
33319,Malignant Cellular Infiltrate,Stage III Liver Cancer,1
33320,Carcinomatous Component Present,Stage I Colon Cancer AJCC v8,1
33321,Carcinomatous Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
33322,Absence of Invasion,Atypical Lobular Breast Hyperplasia,1
33323,Malignant Cellular Infiltrate,Childhood Mesenchymal Chondrosarcoma,1
33324,Carcinomatous Component Present,High Grade Fallopian Tube Serous Adenocarcinoma,1
33325,Malignant Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v7,1
33326,Neuroendocrine Differentiation,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
33327,Carcinomatous Component Present,Laryngeal Cancer by AJCC v6 Stage,1
33328,CD1a-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
33329,Carcinomatous Component Present,Stage IV Eyelid Carcinoma AJCC v8,1
33330,Malignant Cellular Infiltrate,Penis carcinoma recurrent,1
33331,Epithelial Component Present,Stage I Carcinoma of Bladder,1
33332,Epithelial Component Present,Serous surface papillary carcinoma,1
33333,High Mitotic Activity,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
33334,Lytic lesion,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,1
33335,Recurrent disease,Recurrent Malignant Pharyngeal Neoplasm,1
33336,Secondary Lesion,Secondary malignant neoplasm of bone,1
33337,Osteoid formation,Adult Extraskeletal Osteosarcoma,1
33338,Carcinomatous Component Present,Non-small cell carcinoma,1
33339,Splenomegaly,"Leukemia, Myeloid, Accelerated Phase",1
33340,Childhood Lesion,Childhood Paranasal Sinus Carcinoma,1
33341,Metastatic Lesion,Peripheral neuroepithelioma of bone metastatic,1
33342,Neuronal Differentiation,Pituitary Gland Gangliocytoma,1
33343,Carcinomatous Component Present,Pharyngeal Carcinoma by AJCC v6 Stage,1
33344,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
33345,Antoni A Pattern,Plexiform Schwannoma,1
33346,Malignant Cellular Infiltrate,alveolar rhabdomyosarcoma of orbit,1
33347,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant",1
33348,Malignant Cellular Infiltrate,Vaginal Mucinous Adenocarcinoma,1
33349,Malignant Cellular Infiltrate,Mediastinal Neuroblastoma,1
33350,Capillary Sized Vascular Channel Formation,Peripheral Hemangioblastoma,1
33351,Epithelial Component Present,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
33352,Epithelial Component Present,Sparsely Granulated Lactotroph Adenoma,1
33353,Malignant Cellular Infiltrate,Childhood Gastric Carcinoma,1
33354,Epithelial Component Present,Recurrent Adrenal Gland Pheochromocytoma,1
33355,Epithelial Component Present,clear cell adenocarcinoma of urethra,1
33356,Well-Circumscribed Lesion,Rectal Traditional Serrated Adenoma,1
33357,Carcinomatous Component Present,Hormone refractory breast cancer,1
33358,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",1
33359,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
33360,Epithelial Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
33361,Indolent Clinical Course,Mediastinal Leiomyoma,1
33362,Malignant Cellular Infiltrate,Distal 1/3 of the Common Bile Duct Adenocarcinoma,1
33363,Fibrotic Stroma Formation,Peripheral Odontogenic Fibroma,1
33364,Malignant Cellular Infiltrate,Choriocarcinoma combined with other germ cell elements,1
33365,Swelling,Central Nervous System Mesenchymal Chondrosarcoma,1
33366,Bone Marrow Dysplasia Present,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
33367,Carcinomatous Component Present,Stage III Hepatocellular Carcinoma AJCC v8,1
33368,Malignant Cellular Infiltrate,Metastatic Salivary Gland Carcinoma,1
33369,Hyperkeratosis,Vaginal Warty Carcinoma,1
33370,Indolent Clinical Course,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
33371,Myxoid Stroma Formation,Juxta-Articular Myxoma,1
33372,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Prolymphocytic Leukemia,1
33373,Epithelial Component Present,Stage IVA Laryngeal Cancer AJCC v7,1
33374,Epithelial Component Present,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
33375,Malignant Cellular Infiltrate,Paget's disease of penis,1
33376,Mixed Cellular Population,"Uterine Carcinosarcoma, Heterologous Type",1
33377,Diffuse Pattern,Adult Diffuse Astrocytoma,1
33378,Systemic disease,Langerhans Cell Sarcoma,1
33379,Recurrent disease,Recurrent Skin Angiosarcoma,1
33380,Epithelial Component Present,verrucous carcinoma of vulva,1
33381,Oligodendroglial Component Present,Brain Oligodendroglioma,1
33382,Malignant Cellular Infiltrate,Stage III Uveal Melanoma AJCC v7,1
33383,Childhood Lesion,Recurrent Childhood Soft Tissue Sarcoma,1
33384,Carcinomatous Component Present,Stage II Lip Basal Cell Carcinoma,1
33385,Malignant Cellular Infiltrate,Acute bilineal leukemia,1
33386,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Alveolar Variant",1
33387,Carcinomatous Component Present,Spindle cell squamous cell carcinoma,1
33388,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v8,1
33389,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Adenocarcinoma, endocervical type",1
33390,Malignant Cellular Infiltrate,Melanotic malignant nerve sheath tumor,1
33391,Carcinomatous Component Present,Refractory Anal Carcinoma,1
33392,Extensive Stage Lesion,Advanced Carcinoma,1
33393,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v7,1
33394,Pathologic TNM Finding,Pathologic Stage I Cutaneous Melanoma AJCC v8,1
33395,Keratin Horn Pearls Formation,Squamous cell carcinoma with horn formation,1
33396,Malignant Cellular Infiltrate,Ann Arbor Stage II AIDS-Related Lymphoma,1
33397,Cutaneous Involvement,furuncle,1
33398,Carcinomatous Component Present,Colon Adenosquamous Carcinoma,1
33399,Epithelial Component Present,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage,1
33400,Clinical TNM Finding,Clinical Stage IIB Cutaneous Melanoma AJCC v8,1
33401,Carcinomatous Component Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
33402,Secondary Lesion,Secondary malignant neoplasm of pancreas,1
33403,Carcinomatous Component Present,Carcinoma of lung,1
33404,Hyperplastic Tissue Present,Diffuse Laminar Endocervical Hyperplasia,1
33405,Malignant Cellular Infiltrate,Gastric Intramucosal Adenocarcinoma,1
33406,Malignant Cellular Infiltrate,Locally Advanced Prostate Carcinoma,1
33407,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
33408,Benign Cellular Infiltrate,Benign Hair Follicle Neoplasm,1
33409,Malignant Component Present,Central Nervous System Teratoma with Malignant Transformation,1
33410,Malignant Cellular Infiltrate,Small Cell Undifferentiated Hepatoblastoma,1
33411,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7,1
33412,Carcinomatous Component Present,basal cell adenocarcinoma of salivary gland,1
33413,Benign Cellular Infiltrate,Ameloblastic fibrodentinoma,1
33414,Well Differentiated Neuroendocrine Lesion,Rectal Neuroendocrine Tumor by AJCC v8 Stage,1
33415,Benign Cellular Infiltrate,Mediastinal Rhabdomyoma,1
33416,Malignant Cellular Infiltrate,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,1
33417,Poorly Differentiated Lesion,Poorly Differentiated Fibrosarcoma,1
33418,Epithelial Component Present,Unresectable Lung Non-Small Cell Carcinoma,1
33419,Epithelial Component Present,Malignant Paraganglionic Neoplasm,1
33420,Malignant Cellular Infiltrate,Brain Stem Glioblastoma,1
33421,Papillary Pattern,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
33422,Malignant Cellular Infiltrate,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7,1
33423,Well-Circumscribed Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
33424,Well-Circumscribed Lesion,Pyloric Gland Adenoma,1
33425,Carcinomatous Component Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,1
33426,Increased Cellularity Present,Adult Anaplastic Oligodendroglioma,1
33427,Metastatic Lesion,Advanced Carcinoma,1
33428,Secondary Lesion,Locally Advanced Head and Neck Carcinoma,1
33429,Malignant Cellular Infiltrate,Crohn Disease-Associated Colorectal Adenocarcinoma,1
33430,Carcinomatous Component Present,Carcinoma in situ of skin,1
33431,Malignant Cellular Infiltrate,Orbital lymphoma,1
33432,Increased Cellularity Present,Kadish Stage B Olfactory Neuroblastoma,1
33433,Carcinomatous Component Present,Cloacogenic carcinoma,1
33434,Epithelial Component Present,Stage IA Ovarian Cancer AJCC v8,1
33435,Tissue Differentiation Uncertain,Mediastinal Synovial Sarcoma,1
33436,Malignant Cellular Infiltrate,Hereditary Leiomyomatosis and Renal Cell Cancer,1
33437,Lymphatic Spread,Lymphangitis carcinomatosa,1
33438,Benign Cellular Infiltrate,Cartilaginous exostosis,1
33439,Papillary Pattern,Squamous cell papilloma of skin,1
33440,Malignant Cellular Infiltrate,Advanced Carcinoma,1
33441,Epithelial Component Present,Stage III Intrahepatic Bile Duct Cancer AJCC v8,1
33442,Tissues Derived from Two or Three Embryonic Layers Present,Dermoid cyst of ovary,1
33443,Benign Cellular Infiltrate,Fibroid Tumor,1
33444,Secondary Lesion,Metastatic Lung Neuroendocrine Neoplasm,1
33445,Metastatic Lesion,Metastatic Carcinoma in the Lung,1
33446,Oligodendroglial Component Present,Oligodendroglioma of spinal cord,1
33447,atypia morphology,Borderline Uterine Ligament Neoplasm,1
33448,Drug Exposure,Chemotherapy-Related Leukemia,1
33449,Epithelial Component Present,Stage IIB Breast Carcinoma,1
33450,Absence of Invasion,Intraductal carcinoma and lobular carcinoma in situ,1
33451,Primary Lesion,Childhood Supratentorial Ependymoma,1
33452,Malignant Cellular Infiltrate,Supraglottic Verrucous Carcinoma,1
33453,Malignant Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
33454,Epithelial Component Present,Colon Cribriform Comedo-Type Adenocarcinoma,1
33455,Exophytic Polypoid Lesion,Colon Hyperplastic Polyp,1
33456,Malignant Cellular Infiltrate,Stage IVB Laryngeal Cancer AJCC v7,1
33457,Necrotic changes (finding),"Glioblastoma, IDH-Wildtype",1
33458,Intraductal Lesion,intraductal papilloma of salivary gland,1
33459,Severe cytologic atypia,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
33460,Carcinomatous Component Present,Carcinoma of ampulla of Vater,1
33461,Malignant Cellular Infiltrate,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,1
33462,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
33463,Epithelial Component Present,Buccal Mucosa Verrucous Carcinoma,1
33464,Malignant Cellular Infiltrate,Recurrent Gastroesophageal Junction Adenocarcinoma,1
33465,Carcinomatous Component Present,Vulvar Cancer by AJCC v6 Stage,1
33466,Neuroendocrine Differentiation,Neuroendocrine neoplasm of lung,1
33467,Adulthood Lesion,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage,1
33468,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v7,1
33469,Childhood Lesion,Childhood Cerebellar Neoplasm,1
33470,Hyalinized Stroma Formation,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
33471,Recurrent disease,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
33472,Benign Cellular Infiltrate,Cerebellopontine Angle Schwannoma,1
33473,Recurrent disease,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
33474,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline ETV6 Mutation,1
33475,Malignant Cellular Infiltrate,atypical medullary carcinoma of breast,1
33476,Primary Lesion,Synovial sarcoma non-metastatic,1
33477,Benign Cellular Infiltrate,Benign Connective and Soft Tissue Neoplasm,1
33478,Melanosomes Present,Melanotic Schwannoma,1
33479,Carcinomatous Component Present,Bartholin's gland carcinoma,1
33480,Adulthood Lesion,Adult Central Nervous System Immature Teratoma,1
33481,Malignant Cellular Infiltrate,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
33482,Malignant Cellular Infiltrate,Unresectable Skin Squamous Cell Carcinoma,1
33483,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
33484,Childhood Lesion,Recurrent Childhood Liver Cancer,1
33485,Desmoplastic Stroma Formation,Childhood Desmoplastic Small Round Cell Tumor,1
33486,Malignant Cellular Infiltrate,Stage II Primary Peritoneal Cancer AJCC v8,1
33487,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v6,1
33488,Childhood Lesion,Childhood Central Nervous System Germ Cell Tumor,1
33489,Malignant Cellular Infiltrate,Testicular cancer metastatic,1
33490,Sarcomatous Component Present,carcinosarcoma of lung,1
33491,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",1
33492,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
33493,Malignant Cellular Infiltrate,Stage IIIA Lung Large Cell Carcinoma AJCC v7,1
33494,Epithelial Component Present,Stage III Primary Peritoneal Cancer AJCC v8,1
33495,Epithelial Component Present,Regional Digestive System Neuroendocrine Tumor G1,1
33496,Malignant Cellular Infiltrate,Malignant Ovarian Endometrioid Tumor,1
33497,Hyperkeratosis,Trichilemmoma,1
33498,Malignant Cellular Infiltrate,Desmoplastic Medulloblastoma,1
33499,Malignant Cellular Infiltrate,Secondary Peripheral Chondrosarcoma,1
33500,Angiocentric Pattern,Recurrent Lymphomatoid Granulomatosis,1
33501,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
33502,Secondary Lesion,Advanced Sarcoma,1
33503,atypia morphology,Pre-Malignant Skin Epithelial Lesion,1
33504,High Mitotic Activity,Stage IB Lung Small Cell Carcinoma AJCC v7,1
33505,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage I Immature Testicular Teratoma AJCC v6 and v7,1
33506,Epithelial Component Present,Appendix Neuroendocrine Tumor,1
33507,Infiltrative Growth Pattern,Cerebral Glioblastoma,1
33508,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, SHH-Activated, TP53-Wildtype",1
33509,Malignant Cellular Infiltrate,Apocrine Breast Carcinoma In Situ,1
33510,Malignant Cellular Infiltrate,Refractory Adult Acute Lymphoblastic Leukemia,1
33511,Carcinomatous Component Present,Bladder Cancer by AJCC v8 Stage,1
33512,Carcinomatous Component Present,Diffuse Gastric Adenocarcinoma,1
33513,Epithelial Component Present,"Squamous Cell Carcinoma of the Penis, Usual Type",1
33514,Unclassifiable Lesion,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
33515,Severe dysplasia,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
33516,Malignant Cellular Infiltrate,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
33517,Carcinomatous Component Present,Pancreatic Hepatoid Adenocarcinoma,1
33518,Carcinomatous Component Present,Anatomic Stage 0 Breast Cancer AJCC v8,1
33519,Hydropic degeneration,Uterine Corpus Hydropic Leiomyoma,1
33520,Benign Cellular Infiltrate,Non-Functioning Adrenal Cortex Adenoma,1
33521,Malignant Cellular Infiltrate,Hard Palate Mucoepidermoid Carcinoma,1
33522,Carcinomatous Component Present,mucinous adenocarcinoma of gallbladder,1
33523,Spindle Cell Metaplasia,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
33524,In Situ Lesion,Cervical Adenocarcinoma In Situ,1
33525,Infiltrative Growth Pattern,Childhood Cerebral Diffuse Astrocytoma,1
33526,Benign Cellular Infiltrate,Central Nervous System Rhabdomyoma,1
33527,Epithelial Component Present,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
33528,Necrotic changes (finding),Infratentorial Glioblastoma,1
33529,Local disease,Lipoma of spinal cord,1
33530,Carcinomatous Component Present,Ameloblastic Carcinoma Derived From Odontogenic Cyst,1
33531,Tissue Differentiation Uncertain,Superficial angiomyxoma,1
33532,Mixed Cellular Population,Benign Prostate Phyllodes Tumor,1
33533,Vascular Channel Formation,Capillary hemangioma of eyelid,1
33534,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2,1
33535,Malignant Cellular Infiltrate,Cardiac Rhabdomyosarcoma,1
33536,Pregnancy Complications,"Placenta, Retained",1
33537,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of parotid gland,1
33538,Childhood Lesion,Childhood Central Nervous System Germinoma,1
33539,No Identifiable Line of Differentiation,Childhood Undifferentiated Pleomorphic Sarcoma,1
33540,Epithelial Component Present,insulinoma,1
33541,Mucoid Stroma Formation,Pancreatic Intraductal Papillary-Mucinous Adenoma,1
33542,Malignant Cellular Infiltrate,Recurrent Parathyroid Gland Carcinoma,1
33543,Malignant Cellular Infiltrate,Stage IIIA Esophageal Cancer AJCC v7,1
33544,Fibrotic Stroma Formation,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
33545,Epithelial Component Present,Recurrent Abdominal Neuroendocrine Neoplasm,1
33546,Necrotic changes (finding),Platinum-Sensitive Lung Small Cell Carcinoma,1
33547,Hemorrhagic,Recurrent Skin Angiosarcoma,1
33548,Nodular Pattern,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,1
33549,Secondary Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
33550,Benign Cellular Infiltrate,Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm,1
33551,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
33552,Invasive Lesion,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
33553,Malignant Cellular Infiltrate,Cardiac Monophasic Synovial Sarcoma,1
33554,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to oropharynx,1
33555,Stromal Invasion,FIGO Stage III Ovarian Cancer,1
33556,Malignant Cellular Infiltrate,Malignant neoplasm of skin,1
33557,Infiltrative Growth Pattern,Anaplastic astrocytoma,1
33558,Primary Lesion,Meningeal melanomatosis,1
33559,Mixed Cellular Population,Borderline Breast Phyllodes Tumor,1
33560,Malignant Cellular Infiltrate,Stage IIB Primary Peritoneal Cancer AJCC v8,1
33561,Benign Cellular Infiltrate,Compact Cell Adrenal Cortical Adenoma,1
33562,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
33563,In Situ Lesion,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
33564,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,1
33565,Epithelial Component Present,Stage 0is Renal Pelvis Cancer AJCC v7,1
33566,Malignant Cellular Infiltrate,Esophageal Basaloid Carcinoma,1
33567,Prominent Keratin Formation,Esophageal Well Differentiated Squamous Cell Carcinoma,1
33568,Borderline Lesion,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,1
33569,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v6,1
33570,Carcinomatous Component Present,Colorectal Squamous Cell Carcinoma,1
33571,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
33572,Hyperplastic Tissue Present,Simple Endometrial Hyperplasia with Atypia,1
33573,Neuroendocrine Differentiation,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
33574,Malignant Cellular Infiltrate,Adult Liposarcoma,1
33575,Well Differentiated Neuroendocrine Lesion,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
33576,Necrotic changes (finding),Recurrent Giant Cell Glioblastoma,1
33577,Cutaneous Involvement,Desmoplastic Nevus,1
33578,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Cystadenofibroma,1
33579,Secondary Lesion,Metastatic leiomyosarcoma,1
33580,Carcinomatous Component Present,Grade 1 Colon Adenocarcinoma,1
33581,Benign Cellular Infiltrate,Periosteal fibroma,1
33582,Carcinomatous Component Present,Extraocular Cutaneous Sebaceous Carcinoma,1
33583,Honeycomb Pattern,Well Differentiated Oligodendroglioma,1
33584,Vertical Growth Phase,Desmoplastic Neurotropic Melanoma,1
33585,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia-2,1
33586,Recurrent disease,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
33587,Epithelial Component Present,CARCINOMA OF VULVA,1
33588,Malignant Cellular Infiltrate,Vulvar Cancer by AJCC v7 Stage,1
33589,Malignant Cellular Infiltrate,Immunodeficiency-associated Burkitt's lymphoma,1
33590,Carcinomatous Component Present,Stage II Pancreatic Cancer AJCC v6 and v7,1
33591,Malignant Cellular Infiltrate,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214,1
33592,Well Differentiated Lesion,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
33593,Metastatic Lesion,Pericardial mesothelioma malignant advanced,1
33594,Metastatic Lesion,Locally Advanced Gastrointestinal Stromal Tumor,1
33595,Epithelial Component Present,Gallbladder Neuroendocrine Tumor G2,1
33596,Adnexal Differentiation,Eccrine spiradenoma,1
33597,Poorly Differentiated Lesion,Colorectal Sarcomatoid Carcinoma,1
33598,Follicular Cell Differentiation,Follicular thyroid carcinoma,1
33599,Epithelial Component Present,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
33600,Secondary Lesion,Advanced Head and Neck Carcinoma,1
33601,Well-Circumscribed Lesion,Pleomorphic Rhabdomyosarcoma,1
33602,Malignant Cellular Infiltrate,Hepatic cancer stage IVA,1
33603,Deep Lesion,Central Nervous System Desmoid-Type Fibromatosis,1
33604,Nodular Pattern,Nodular Sclerosis Classical Hodgkin Lymphoma,1
33605,Monoclonal Cellular Population Present,"Leukemia, Mast-Cell",1
33606,Refractory Disease,Refractory Female Reproductive System Carcinoma,1
33607,Cutaneous Involvement,Flexural Skin Nevus,1
33608,Metastatic Lesion,Metastatic Unresectable Malignant Neoplasm,1
33609,Stromal Invasion,serous surface papillary carcinoma of ovary,1
33610,Malignant Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",1
33611,Epithelial Component Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
33612,Chronic lymphocytic inflammation,Breast Epithelioid Hemangioma,1
33613,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
33614,Carcinomatous Component Present,Stage IV Lip Cancer AJCC v6 and v7,1
33615,Epithelial Component Present,High Grade Gastric Intraepithelial Neoplasia,1
33616,Malignant Cellular Infiltrate,Stage IIB Anal Cancer AJCC v8,1
33617,Favorable Clinical Outcome,Biliary Adenofibroma,1
33618,Carcinomatous Component Present,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,1
33619,Childhood Lesion,Childhood Systemic Anaplastic Large Cell Lymphoma,1
33620,Carcinomatous Component Present,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7,1
33621,Benign Cellular Infiltrate,Benign Skeletal Muscle Neoplasm,1
33622,Anaplasia,Cerebellar Glioblastoma,1
33623,Osseous Differentiation,Osteosarcoma by AJCC v7 Stage,1
33624,Low Grade Lesion,Classic Congenital Mesoblastic Nephroma,1
33625,Benign Cellular Infiltrate,cystadenoma of salivary gland,1
33626,Epithelial Component Present,Stage IA Vaginal Cancer AJCC v8,1
33627,Malignant Cellular Infiltrate,Stage IVA Major Salivary Gland Cancer AJCC v7,1
33628,Malignant Cellular Infiltrate,Primary Non-Hodgkin Lymphoma of Bone,1
33629,Refractory Disease,Refractory Endometrial Serous Adenocarcinoma,1
33630,Mixed Cellular Population,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
33631,Well-Circumscribed Lesion,Pituicytoma,1
33632,Carcinomatous Component Present,Advanced Adult Hepatocellular Carcinoma,1
33633,Benign Cellular Infiltrate,Craniopharyngioma,1
33634,Pushing Tumor Margin,Laryngeal verrucous carcinoma stage IV,1
33635,Mixed Cellular Population,Childhood Mixed Glioma,1
33636,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myeloid Leukemia with Minimal Differentiation,1
33637,Stromal Invasion,FIGO Stage IIIA1(i) Ovarian Cancer,1
33638,Benign Cellular Infiltrate,Schwannoma of the Twelfth Cranial Nerve,1
33639,Malignant Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v7,1
33640,Malignant Cellular Infiltrate,Ampulla of Vater Clear Cell Adenocarcinoma,1
33641,Carcinomatous Component Present,Pancreatic Mixed Adenoneuroendocrine Carcinoma,1
33642,BRAF V600E Mutation Present,Splenic Manifestation of Hairy Cell Leukemia,1
33643,Carcinomatous Component Present,Scrotal Carcinoma,1
33644,Malignant Cellular Infiltrate,Prostate cancer recurrent,1
33645,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Adenofibroma,1
33646,Recurrent disease,Rectosigmoid cancer recurrent,1
33647,Epithelial Component Present,Grade 2 Invasive Breast Carcinoma,1
33648,Refractory Disease,Refractory Adrenal Gland Pheochromocytoma,1
33649,Mitotic Activity,Yolk Sac Tumor,1
33650,Monomorphic Cellular Infiltrate,Papillary ependymoma,1
33651,CD30-Positive Neoplastic Cells Present,alk-positive anaplastic large cell lymphoma,1
33652,Benign Cellular Infiltrate,Cardiac hemangioma,1
33653,Invasive Lesion,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,1
33654,Cutaneous Involvement,Atypical Spitz Nevus,1
33655,Epithelial Component Present,Vulvar Warty Carcinoma,1
33656,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma recurrent,1
33657,Severe dysplasia,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
33658,Epithelial Component Present,Pancreatic Delta Cell Neoplasm,1
33659,Carcinomatous Component Present,Stage III Nasopharyngeal Carcinoma,1
33660,Well Differentiated Lesion,papillary squamous cell carcinoma of larynx,1
33661,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v7,1
33662,Cutaneous Involvement,Nodulo-ulcerative basal cell carcinoma,1
33663,Malignant Cellular Infiltrate,Transplant-Related Bladder Urothelial Carcinoma,1
33664,Epithelial Component Present,Pyriform Fossa Carcinoma,1
33665,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage I,1
33666,Malignant Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
33667,Vascular Channel Formation,Senile angioma,1
33668,Epithelial Component Present,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
33669,Metastatic Lesion,Locally Advanced Malignant Neoplasm,1
33670,Epithelial Component Present,Colon Neuroendocrine Tumor,1
33671,Primary Lesion,Synovial sarcoma non-metastatic,1
33672,Encapsulated Mass,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
33673,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma recurrent,1
33674,Malignant Cellular Infiltrate,carcinoma of middle ear,1
33675,Epithelial Component Present,Recurrent Ovarian Serous Adenocarcinoma,1
33676,Carcinomatous Component Present,Skin Nodular Solid Basal Cell Carcinoma,1
33677,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",1
33678,Vascular Channel Formation,Hemangioma of liver,1
33679,Secondary Lesion,Metastatic Penile Cancer,1
33680,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
33681,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Cervical Endometrioid Adenocarcinoma,1
33682,Carcinomatous Component Present,Carcinoma of subglottis,1
33683,Epithelial Component Present,Glottis Verrucous Carcinoma,1
33684,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
33685,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
33686,Epithelial Component Present,undifferentiated carcinoma of salivary gland,1
33687,Recurrent disease,acute biphenotypic leukemia in relapse,1
33688,Epithelial Component Present,Minor Salivary Gland Adenocarcinoma,1
33689,Epithelial Component Present,Ovarian Mucinous Cystic Tumor with Mural Nodules,1
33690,Malignant Cellular Infiltrate,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
33691,Malignant Cellular Infiltrate,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
33692,Malignant Cellular Infiltrate,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
33693,Epithelial Component Present,Squamous cell carcinoma of mouth,1
33694,Malignant Cellular Infiltrate,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8,1
33695,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
33696,Epithelial Component Present,Adenocarcinoma with cartilaginous metaplasia,1
33697,Low Grade Lesion,Childhood Pilocytic Astrocytoma,1
33698,Lobulated Growth Pattern,Unresectable Chordoma,1
33699,Hyperplastic Tissue Present,Hyperplasia of Brunner glands of duodenum,1
33700,Carcinomatous Component Present,Squamous cell carcinoma of lung,1
33701,Severe dysplasia,Stage 0is Bladder Cancer AJCC v8,1
33702,In Situ Lesion,Bladder squamous cell carcinoma stage 0,1
33703,Tumor Vascular Invasion,"Leydig cell tumor, malignant",1
33704,Malignant Cellular Infiltrate,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
33705,Nuclear Clearing,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
33706,Mixed Cellular Population,Oral Cavity Pleomorphic Adenoma,1
33707,Benign Cellular Infiltrate,Borderline Ovarian Serous Cystadenofibroma,1
33708,Indolent Clinical Course,Fibrofolliculoma,1
33709,Refractory Disease,Acute myeloid leukemia refractory,1
33710,Epithelial Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
33711,Malignant Cellular Infiltrate,Malignant tumor of colon,1
33712,Lesion Less than 10mm in Diameter,Sporadic Thyroid Gland Micromedullary Carcinoma,1
33713,Malignant Cellular Infiltrate,Therapy-related myelodysplastic syndrome,1
33714,Recurrent disease,Recurrent tumors of the Ewing's family,1
33715,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic eosinophilic leukemia,1
33716,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,1
33717,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
33718,Adulthood Lesion,Benign Adult Brain Stem Neoplasm,1
33719,Refractory Disease,Refractory Lung Carcinoma,1
33720,Epithelial Component Present,Stage IVC Appendix Carcinoma AJCC v8,1
33721,Recurrent disease,Recurrent Adult Acute Lymphoblastic Leukemia,1
33722,Nuclear Pseudoinclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
33723,Carcinomatous Component Present,Squamous Cell Bile Duct Carcinoma,1
33724,Malignant Cellular Infiltrate,Hereditary Papillary Renal Carcinoma,1
33725,Malignant Cellular Infiltrate,Grade 1 Colorectal Adenocarcinoma,1
33726,Malignant Cellular Infiltrate,Metastatic Ductal Breast Carcinoma,1
33727,Oligodendroglial Component Present,Recurrent Childhood Oligoastrocytoma,1
33728,atypia morphology,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,1
33729,Stromal Invasion,Ovarian Cancer by FIGO Stage,1
33730,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
33731,Primary Lesion,Refractory Diffuse Intrinsic Pontine Glioma,1
33732,Benign Cellular Infiltrate,Ganglioneuromatosis,1
33733,Malignant Cellular Infiltrate,Nonestrogen-Dependent Malignant Neoplasm,1
33734,Benign Cellular Infiltrate,Benign tumor of iris,1
33735,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
33736,Severe dysplasia,Lung Squamous Cell Carcinoma In Situ,1
33737,Low Grade Neuroendocrine Lesion,Carcinoid tumor of intestine,1
33738,Epithelial Component Present,Fallopian Tube Gestational Choriocarcinoma,1
33739,Malignant Cellular Infiltrate,Gastric Large Cell Neuroendocrine Carcinoma,1
33740,Malignant Cellular Infiltrate,AIDS-Related Anal Non-Hodgkin Lymphoma,1
33741,Childhood Lesion,Childhood Malignant Testicular Germ Cell Tumor,1
33742,Carcinomatous Component Present,Stage IV Gallbladder Cancer AJCC v7,1
33743,Childhood Lesion,Childhood Brain Stem Gliosarcoma,1
33744,Malignant Cellular Infiltrate,Grade 3 Endometrial Mucinous Adenocarcinoma,1
33745,Carcinomatous Component Present,Recurrent Female Reproductive System Carcinoma,1
33746,Malignant Cellular Infiltrate,carcinosarcoma of fallopian tube,1
33747,Adulthood Lesion,Adult Nodular Sclerosis Classical Hodgkin Lymphoma,1
33748,Malignant Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v7,1
33749,Epithelial Component Present,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
33750,Epithelial Component Present,clear cell adenocarcinoma of bladder,1
33751,Fenestrating Pattern,Fibroepithelioma of Pinkus,1
33752,Epithelial Component Present,Stage IVC Colorectal Cancer AJCC v8,1
33753,Systemic disease,Primary Systemic Mastocytosis,1
33754,Malignant Germinomatous Cellular Infiltrate,Intracranial Germinoma,1
33755,Absence of Invasion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
33756,Carcinomatous Component Present,Stage 0is Urethral Cancer AJCC v7,1
33757,Malignant Cellular Infiltrate,Recurrent Subsequent Malignant Neoplasm,1
33758,Malignant Cellular Infiltrate,leiomyosarcoma of retroperitoneum,1
33759,Malignant Cellular Infiltrate,Stage I Esophageal Cancer,1
33760,Epithelial Component Present,Carcinoma in situ in a polyp,1
33761,Epithelial Component Present,Stage IV Prostate Cancer AJCC v7,1
33762,Vascular Channel Formation,Kasabach-Merritt syndrome,1
33763,Well Differentiated Neuroendocrine Lesion,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
33764,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v8,1
33765,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
33766,Malignant Cellular Infiltrate,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,1
33767,Tissue of Mullerian Origin Present,Rete Ovarii Cystadenofibroma,1
33768,Carcinomatous Component Present,Stage III Fallopian Tube Cancer AJCC v8,1
33769,Primary Lesion,Pilocytic astrocytoma of cerebellum,1
33770,Epithelial Component Present,Stage IA Lung Cancer AJCC v7,1
33771,Secondary Lesion,Metastatic osteosarcoma,1
33772,Carcinomatous Component Present,Anal squamous cell carcinoma,1
33773,Carcinomatous Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
33774,Glandular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
33775,Low Mitotic Activity,Stage III Ileal Neuroendocrine Tumor AJCC v8,1
33776,Secondary Lesion,Colorectal Carcinoma Metastatic in the Liver,1
33777,Benign Cellular Infiltrate,Benign neoplasm of sphenoidal sinus,1
33778,Malignant Cellular Infiltrate,Primary Peritoneal Low Grade Serous Adenocarcinoma,1
33779,Malignant Cellular Infiltrate,Stage IVB Appendix Carcinoma AJCC v7,1
33780,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma,1
33781,Malignant Cellular Infiltrate,Stage IIIB Lung Large Cell Carcinoma AJCC v7,1
33782,Absence of Invasion,Stage 0 Major Salivary Gland Cancer AJCC v8,1
33783,Lobulated Growth Pattern,Malignant myoepithelioma,1
33784,Epithelial Component Present,Thymic Sarcomatoid Carcinoma,1
33785,Well-Circumscribed Lesion,Breast Phyllodes Tumor,1
33786,Absence of Invasion,Biliary Intraepithelial Neoplasia-3,1
33787,Carcinomatous Component Present,Stage II Appendix Carcinoma AJCC v8,1
33788,BRAF V600E Mutation Present,Recurrent Hairy Cell Leukemia,1
33789,Carcinomatous Component Present,Stage II Lip and Oral Cavity Cancer AJCC v8,1
33790,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage II,1
33791,Carcinomatous Component Present,mixed acinar-endocrine carcinoma of pancreas,1
33792,Epithelial Component Present,Transitional cell carcinoma of ureter,1
33793,Epithelial Component Present,Inflammatory Hepatocellular Adenoma,1
33794,Malignant Cellular Infiltrate,Childhood Myelodysplastic Syndrome,1
33795,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
33796,Cutaneous Involvement,Benign Dermal Schwannoma,1
33797,Malignant Cellular Infiltrate,Spindle Cell Type A Uveal Melanoma,1
33798,Thin-Walled Branching Vascular Pattern,Central Nervous System Angiolipoma,1
33799,Recurrent disease,Recurrent Dedifferentiated Liposarcoma,1
33800,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma recurrent,1
33801,Malignant Cellular Infiltrate,Refractory Burkitt Leukemia,1
33802,Malignant Cellular Infiltrate,Locally Advanced Unresectable Cervical Adenocarcinoma,1
33803,In Situ Lesion,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
33804,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v8,1
33805,Exophytic Polypoid Lesion,Polyp of vulva,1
33806,Dysplasia,Perianal Squamous Intraepithelial Neoplasia,1
33807,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
33808,Malignant Cellular Infiltrate,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,1
33809,Epithelial Component Present,Prostate Adenosquamous Carcinoma,1
33810,Intracanalicular Growth Pattern,Phyllodes Tumor,1
33811,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
33812,Microcystic Change,Childhood Pilocytic Astrocytoma,1
33813,Unresectable Mass,Unresectable Solid Neoplasm,1
33814,Intraductal Lesion,Intrahepatic Bile Duct Papillary Neoplasm,1
33815,Carcinomatous Component Present,Recurrent Biliary Tract Carcinoma,1
33816,Cutaneous Involvement,Cutaneous Melanoma,1
33817,Benign Cellular Infiltrate,Benign Fibroblastic Neoplasm,1
33818,Multinodular Mass,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
33819,Recurrent disease,Recurrent Childhood Liver Cancer,1
33820,Hyperplastic Tissue Present,Tubal Epithelial Hyperplasia,1
33821,Malignant Cellular Infiltrate,"Carcinoma, Small Cell",1
33822,Secondary Lesion,Metastatic Prostate Carcinoma,1
33823,Indolent Clinical Course,Cutaneous leiomyoma,1
33824,Epithelial Component Present,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,1
33825,Epithelial Component Present,Stage IV Colorectal Cancer AJCC v8,1
33826,Malignant Cellular Infiltrate,Leiomyosarcoma recurrent,1
33827,Absence of Invasion,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
33828,Local disease,Gastric Lipoma,1
33829,Cutaneous Involvement,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8,1
33830,Epithelial Component Present,Recurrent Primary Peritoneal Carcinoma,1
33831,Carcinomatous Component Present,Recurrent Gastroesophageal Junction Adenocarcinoma,1
33832,Epithelial Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
33833,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
33834,Cutaneous Involvement,Keratoderma,1
33835,Metaplasia,Metastatic Bladder Squamous Cell Carcinoma,1
33836,Epithelial Component Present,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
33837,Hereditary Lesion,Rothmund-Thomson syndrome,1
33838,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage II,1
33839,Carcinomatous Component Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,1
33840,Carcinomatous Component Present,Distal Bile Duct Cancer by AJCC v8 Stage,1
33841,Benign Cellular Infiltrate,Non-Functioning Adrenal Cortex Adenoma,1
33842,Invasive Lesion,Metaplastic carcinoma of breast,1
33843,Epithelial Component Present,Stage IVA Hepatocellular Carcinoma AJCC v8,1
33844,Malignant Cellular Infiltrate,Carcinoma ex Eccrine Spiradenoma,1
33845,Cervical lymphadenopathy,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,1
33846,Malignant Cellular Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
33847,Malignant Cellular Infiltrate,Clinical Stage IIA Gastric Cancer AJCC v8,1
33848,Epithelial Component Present,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
33849,Epithelial Component Present,Metastatic Genitourinary System Carcinoma,1
33850,Malignant Cellular Infiltrate,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
33851,Malignant Cellular Infiltrate,Stage IVB Ovarian Cancer AJCC v8,1
33852,Chromogranin A Positive Neoplastic Cells Present,Ascending Colon Neuroendocrine Tumor G1,1
33853,Epithelial Component Present,Metastatic Fibrolamellar Carcinoma,1
33854,Epithelial Component Present,Ovarian Transitional Cell Tumor,1
33855,Increased Cellularity Present,Childhood Anaplastic Ependymoma,1
33856,Fibrotic Stroma Formation,Low Grade Mucoepidermoid Breast Carcinoma,1
33857,Malignant Cellular Infiltrate,Malignant Central Nervous System Germ Cell Tumor,1
33858,Diffuse Pattern,Giant Cell Glioblastoma,1
33859,Malignant Cellular Infiltrate,Recurrent Retinoblastoma,1
33860,Malignant Cellular Infiltrate,Rectal Carcinoma Metastatic in the Liver,1
33861,Epithelial Component Present,Lung Cancer by AJCC v8 Stage,1
33862,Thyroglobulin Positive Neoplastic Cells Present,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
33863,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v6,1
33864,Benign Cellular Infiltrate,Benign neoplasm of cecum,1
33865,Anaplasia,Malignant Meningioma,1
33866,Carcinomatous Component Present,Stage IIIB Anal Canal Cancer AJCC v6 and v7,1
33867,Malignant Cellular Infiltrate,Primary cerebral lymphoma,1
33868,Adulthood Lesion,Adult Cerebellar Neoplasm,1
33869,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Acute Megakaryocytic Leukemias,1
33870,Secondary Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
33871,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant",1
33872,Multilayered Rosette Formation,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
33873,Malignant Cellular Infiltrate,Stage IA Ampulla of Vater Cancer AJCC v8,1
33874,Carcinomatous Component Present,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
33875,Carcinomatous Component Present,Recurrent Pancreatic Acinar Cell Carcinoma,1
33876,Microinvasive tumor,Ductal Carcinoma In Situ with Microinvasion,1
33877,Malignant Cellular Infiltrate,Stage II Oropharyngeal Carcinoma,1
33878,Malignant Cellular Infiltrate,Lung squamous cell carcinoma stage I,1
33879,Glandular Differentiation,Gallbladder Goblet Cell Carcinoid,1
33880,Hyperplastic Epithelial Tissue Present,Intraductal Breast Myoepitheliosis,1
33881,Malignant Cellular Infiltrate,Oropharyngeal cancer recurrent,1
33882,Perivascular Arrangement of Tumor Cells,Glomangioma of skin,1
33883,Nested Pattern,Sclerosing Epithelioid Fibrosarcoma,1
33884,Carcinomatous Component Present,Stage I Penile Cancer AJCC v6,1
33885,Epithelial Component Present,Pancreatic adenocarcinoma resectable,1
33886,Immunosuppression-Related Post-Transplant Toxicity,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
33887,Neuroendocrine Differentiation,Localized Digestive System Neuroendocrine Tumor G1,1
33888,Congenital Lesion,Congenital Epulides,1
33889,Malignant Cellular Infiltrate,Malignant neoplasm of gastrointestinal tract,1
33890,Carcinomatous Component Present,Stage I Lung Small Cell Carcinoma AJCC v7,1
33891,Epithelial Component Present,"Serous cystadenoma, borderline malignancy",1
33892,Carcinomatous Component Present,Krukenberg Tumor,1
33893,Carcinomatous Component Present,Prostate Cancer by AJCC v7 Stage,1
33894,Immunologic Deficiency Syndromes,AIDS-Related Human Papillomavirus Infection,1
33895,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v6 Stage,1
33896,Malignant Cellular Infiltrate,Prolactin-Producing Pituitary Gland Carcinoma,1
33897,Malignant Cellular Infiltrate,mucinous adenocarcinofibroma of ovary,1
33898,Sarcomatous Component Present,carcinosarcoma of fallopian tube,1
33899,Benign Cellular Infiltrate,Juxta-Articular Myxoma,1
33900,Papillary Pattern,Bladder papilloma,1
33901,Refractory Disease,Refractory Transformed Chronic Lymphocytic Leukemia,1
33902,Carcinomatous Component Present,Stage 0is Ureter Cancer AJCC v8,1
33903,Recurrent disease,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,1
33904,Mitotic Activity,Glioblastoma multiforme of spinal cord,1
33905,Epithelial Component Present,Stage II Duodenal Neuroendocrine Tumor AJCC v8,1
33906,Malignant Cellular Infiltrate,Digestive System Hodgkin Lymphoma,1
33907,Malignant Cellular Infiltrate,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
33908,Concentric Perivascular Arrangement of Tumor Cells,Giant Cell Angioblastoma,1
33909,Epithelial Component Present,Stage IA Ovarian Cancer AJCC v8,1
33910,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v6 and v7,1
33911,Neuronal Differentiation,Dysembryoplastic neuroepithelial tumor,1
33912,Skin Papule,Vulvar Trichoepithelioma,1
33913,Papillary Pattern,"Papillary cystadenoma, borderline malignancy",1
33914,Schwannian Stroma Predominant Component of the Tumor Volume,Maturing Ganglioneuroma,1
33915,Childhood Lesion,Stage IV Childhood Lymphoblastic Lymphoma,1
33916,Diffuse Pattern,Diffuse large B-cell lymphoma associated with chronic inflammation,1
33917,Epithelial Component Present,Benign Apocrine Neoplasm,1
33918,Adulthood Lesion,Stage IV Adult Hodgkin Lymphoma,1
33919,Malignant Cellular Infiltrate,Thyroid carcinoma,1
33920,Locally Aggressive Lesion,Lipofibromatosis,1
33921,Slow Growing Mass,Childhood Supratentorial Ependymoma,1
33922,Malignant Cellular Infiltrate,Childhood Central Nervous System Yolk Sac Tumor,1
33923,Benign Cellular Infiltrate,Benign Mediastinal Psammomatous Schwannoma,1
33924,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
33925,Carcinomatous Component Present,Unresectable Transitional Cell Carcinoma,1
33926,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Adenocarcinoma,1
33927,Low Mitotic Activity,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
33928,Carcinomatous Component Present,Adenocarcinoma with osseous metaplasia,1
33929,Hereditary Lesion,Turcot Syndrome Type 1,1
33930,Encapsulated Mass,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
33931,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
33932,Carcinomatous Component Present,Small Intestinal Adenocarcinoma by AJCC v8 Stage,1
33933,BCR/ABL1 Fusion Negative,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
33934,Poorly Differentiated Lesion,Pancreatic Endocrine Carcinoma,1
33935,Exophytic Polypoid Lesion,Anal Canal Squamous Papilloma,1
33936,Inclusion-Like Nucleoli,Myxoinflammatory fibroblastic sarcoma,1
33937,Carcinomatous Component Present,Recurrent Salivary Gland Cancer,1
33938,Malignant Cellular Infiltrate,Osteoblastic Osteosarcoma,1
33939,Epithelial Component Present,Stage I Pancreatic Cancer AJCC v6 and v7,1
33940,Recurrent disease,Vaginal cancer recurrent,1
33941,Well-Circumscribed Lesion,Anaplastic Kidney Wilms Tumor,1
33942,Epithelial Component Present,Metastatic Lip and Oral Cavity Carcinoma,1
33943,Epithelial Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
33944,Absence of Invasion,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
33945,Epithelial Component Present,Merkel cell carcinoma,1
33946,Cutaneous Involvement,Pruritus,1
33947,Capillary Sized Vascular Channel Formation,Cardiac Capillary Hemangioma,1
33948,Follicular Cell Differentiation,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
33949,Malignant Cellular Infiltrate,Cerebellar Glioblastoma,1
33950,Stromal Invasion,Carcinosarcoma of ovary,1
33951,Cutaneous Involvement,Seborrheic keratosis,1
33952,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
33953,Pregnancy Complications,Infection of amniotic cavity,1
33954,Well-Circumscribed Lesion,Recurrent Myxoid Liposarcoma,1
33955,Recurrent disease,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
33956,Carcinomatous Component Present,keratinizing squamous cell carcinoma of nasal cavity,1
33957,Carcinomatous Component Present,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
33958,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v7,1
33959,Anaplasia,Glioblastoma,1
33960,Fibrosis,Breast Blunt Duct Adenosis,1
33961,Epithelial Component Present,Metastatic Lobular Breast Carcinoma,1
33962,Fetiform Mass,Ovarian Fetiform Teratoma,1
33963,Malignant Cellular Infiltrate,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
33964,Pseudoangiomatoid Space Formation,"Histiocytoma, Angiomatoid Fibrous",1
33965,Primary Lesion,Supratentorial Ependymal Tumor,1
33966,In Situ Lesion,Carcinoma in situ of fallopian tube,1
33967,Malignant Cellular Infiltrate,Malignant neoplasm of epicardium,1
33968,Epithelial Component Present,Carcinoma breast stage I,1
33969,Malignant Cellular Infiltrate,Malignant neoplasm of soft tissue,1
33970,Neuroendocrine Differentiation,Gastric Neuroendocrine Neoplasm,1
33971,Benign Cellular Infiltrate,Adenoma of rete ovarii,1
33972,Papillary Pattern,Verrucous carcinoma of the oral cavity recurrent,1
33973,Malignant Cellular Infiltrate,Recurrent Head and Neck Carcinoma,1
33974,Fibrosis,"Breast Fibrocystic Change, Proliferative Type",1
33975,Low Cellularity Present,Third Ventricle Pilocytic Astrocytoma,1
33976,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
33977,Well-Circumscribed Lesion,Blastema Predominant Kidney Wilms Tumor,1
33978,Malignant Cellular Infiltrate,Angiosarcoma of liver,1
33979,Papillary Pattern,Papillary tumor of the pineal region,1
33980,Cutaneous Involvement,Hidroacanthoma simplex,1
33981,Epithelial Component Present,Borderline Resectable Pancreatic Adenocarcinoma,1
33982,Mitotic Activity,Vulvar Yolk Sac Tumor,1
33983,Increased Cellularity Present,Neuroblastoma of brain,1
33984,Borderline Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
33985,Increased Cellularity Present,Childhood Brain Anaplastic Astrocytoma,1
33986,Malignant Cellular Infiltrate,Stage IIB Gallbladder Cancer AJCC v8,1
33987,Well-Circumscribed Lesion,"Histiocytoma, Angiomatoid Fibrous",1
33988,Local disease,Malignant neoplasm of gallbladder localized,1
33989,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Adult Myelodysplastic Syndrome,1
33990,Alternative Fascicle (Bundle) Pattern,Gastric Leiomyoma,1
33991,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract,1
33992,Malignant Cellular Infiltrate,DS Stage I Plasma Cell Myeloma,1
33993,Malignant Cellular Infiltrate,Grade 3b Follicular Lymphoma,1
33994,Metastatic/Recurrent Disease,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
33995,Regional Disease,Locally Advanced Bile Duct Carcinoma,1
33996,Malignant Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
33997,Epithelial Component Present,Adenocarcinoma in multiple adenomatous polyps,1
33998,Malignant Cellular Infiltrate,Stage I Hodgkin Lymphoma,1
33999,Carcinomatous Component Present,Stage IIIA Vulvar Cancer AJCC v7,1
34000,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
34001,Mitotic Activity,Metastasizing Chondroblastoma,1
34002,Epithelial Component Present,"Carcinoma, Basal Cell",1
34003,Epithelial Component Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
34004,Metaplasia,intestinal type adenocarcinoma of gallbladder,1
34005,Benign Cellular Infiltrate,Cervical Blue Nevus,1
34006,Malignant Cellular Infiltrate,Childhood Leiomyosarcoma,1
34007,High Grade Lesion,Refractory Dedifferentiated Liposarcoma,1
34008,Vascular Channel Formation,Small Intestinal Angiosarcoma,1
34009,Carcinomatous Component Present,Posterior Tongue Adenoid Cystic Carcinoma,1
34010,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Endocrine Carcinoma,1
34011,Recurrent disease,Recurrent Adult Spinal Cord Neoplasm,1
34012,Monomorphic Cellular Infiltrate,Small cell glioblastoma,1
34013,Benign Cellular Infiltrate,Benign Reproductive System Neoplasm,1
34014,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
34015,Benign Cellular Infiltrate,Infiltrating Intramuscular Lipoma,1
34016,Carcinomatous Component Present,Prolactin-Producing Pituitary Gland Carcinoma,1
34017,Epithelial Component Present,Esophageal carcinoma,1
34018,Recurrent disease,Leiomyosarcoma recurrent,1
34019,Epithelial Component Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
34020,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
34021,Malignant Cellular Infiltrate,Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8,1
34022,Secondary Lesion,Locally Advanced Angiosarcoma,1
34023,Cutaneous Involvement,"Adenoma, Sweat Gland",1
34024,Immunologic Deficiency Syndromes,HIV Encephalopathy,1
34025,Carcinomatous Component Present,Carcinoma in situ of prostate,1
34026,Malignant Cellular Infiltrate,Advanced Unresectable Gastric Adenocarcinoma,1
34027,Benign Cellular Infiltrate,Vaginal Rhabdomyoma,1
34028,Carcinomatous Component Present,Stage 0 Hilar Cholangiocarcinoma AJCC v8,1
34029,Clinical TNM Finding,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
34030,Malignant Cellular Infiltrate,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7,1
34031,Carcinomatous Component Present,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
34032,Acanthosis,Subglottic Verrucous Carcinoma,1
34033,Epithelial Component Present,Adenocarcinoma in situ in tubular adenoma,1
34034,Myxoid Stroma Formation,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
34035,Malignant Cellular Infiltrate,"Leukemia, Prolymphocytic, B-Cell",1
34036,Exophytic Papillary Lesion,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
34037,Benign Cellular Infiltrate,Benign neoplasm of buccal mucosa,1
34038,Cutaneous Involvement,Psoriasis,1
34039,Secondary Lesion,Locally Advanced Bone Sarcoma,1
34040,Dual Population of Bone Marrow Blasts Present,Acute bilineal leukemia,1
34041,Indolent Clinical Course,Cervical Leiomyoma,1
34042,Epithelial Component Present,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
34043,Increased Cellularity Present,Undifferentiated Neuroblastoma,1
34044,Malignant Cellular Infiltrate,Adult Anaplastic (Malignant) Meningioma,1
34045,Hyperplastic Tissue Present,Adenomatous hyperplasia,1
34046,Epithelial Component Present,Carcinoma of supraglottis,1
34047,Perivascular Arrangement of Tumor Cells,Benign Lung PEComa,1
34048,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
34049,Cavernous Vascular Space Formation,Cavernous hemangioma of orbit,1
34050,Metastatic Lesion,Advanced Cutaneous Melanoma of the Extremity,1
34051,Malignant Cellular Infiltrate,Testicular yolk sac tumor stage I,1
34052,Alternative Fascicle (Bundle) Pattern,Gastric Leiomyoma,1
34053,Benign Cellular Infiltrate,Superficial angiomyxoma,1
34054,Primary Lesion,Stage IIB Osteosarcoma AJCC v7,1
34055,Secondary Lesion,Metastatic Extracranial Malignant Solid Neoplasm,1
34056,Indolent Clinical Course,Benign Cutaneous Vascular Neoplasm,1
34057,Adulthood Lesion,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
34058,HMB-45-Positive Neoplastic Cells Present,Sclerosing PEComa,1
34059,Malignant Cellular Infiltrate,Anal Cancer by AJCC v8 Stage,1
34060,Carcinomatous Component Present,Infiltrating Bladder Carcinoma,1
34061,Vascular Channel Formation,Thyroid Gland Cavernous Hemangioma,1
34062,Malignant Cellular Infiltrate,Stage IIIC Appendix Carcinoma AJCC v8,1
34063,Carcinomatous Component Present,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
34064,Solid Growth Pattern,Solid Alveolar Rhabdomyosarcoma,1
34065,Carcinomatous Component Present,Stage IVB Colorectal Cancer AJCC v8,1
34066,Childhood Lesion,Stage IV Childhood Burkitt Lymphoma,1
34067,Diffuse Pattern,Glioblastoma by Gene Expression Profile,1
34068,Favorable Clinical Outcome,Good Prognosis Metastatic Gestational Trophoblastic Tumor,1
34069,Desmoplastic Stroma Formation,Desmoplastic trichilemmoma,1
34070,Carcinomatous Component Present,Unresectable Urethral Urothelial Carcinoma,1
34071,Epithelial Component Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
34072,Malignant Cellular Infiltrate,Colon Cancer by AJCC v8 Stage,1
34073,Malignant Cellular Infiltrate,Clear Cell Sarcoma of Soft Tissue,1
34074,Necrotic changes (finding),Pancreatic Small Cell Neuroendocrine Carcinoma,1
34075,High Mitotic Activity,Childhood Lung Small Cell Carcinoma,1
34076,Refractory Disease,Refractory Malignant Thymoma,1
34077,Biphasic Pattern,Uterine Corpus Carcinosarcoma,1
34078,Dysplasia,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
34079,Epithelial Component Present,signet ring cell carcinoma of gallbladder,1
34080,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
34081,Indolent Clinical Course,Sternal Chondromyxoid Fibroma,1
34082,Malignant Cellular Infiltrate,Fallopian Tube Adenosarcoma,1
34083,Vascular Channel Formation,Gastric Kaposi's Sarcoma,1
34084,In Situ Lesion,Intraductal Cribriform Breast Adenocarcinoma,1
34085,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,1
34086,Carcinomatous Component Present,Penis carcinoma,1
34087,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Adult Brain,1
34088,Osseous Differentiation,Bone island,1
34089,Bone Marrow Dysplasia Present,Adult Myelodysplastic Syndrome,1
34090,atypia morphology,Complex Endometrial Hyperplasia with Atypia,1
34091,Mixed Cellular Population,Anaplastic Oligoastrocytoma,1
34092,Epithelial Component Present,Pancreatic Neuroendocrine Tumor G1,1
34093,Epithelial Component Present,Eyelid Carcinoma by AJCC v8 Stage,1
34094,Cutaneous Involvement,Skin Abnormalities,1
34095,Refractory Disease,Angioimmunoblastic T-cell lymphoma refractory,1
34096,Infundibular-Like Structures Present,"Basal cell carcinoma, infundibulocystic",1
34097,Epithelial Component Present,Malignant Thymoma,1
34098,High Grade Lesion,Rhabdomyosarcoma with ganglionic differentiation,1
34099,Epithelial Component Present,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
34100,Hereditary Lesion,Neurofibromatosis 2,1
34101,Malignant Cellular Infiltrate,Stage III Ovarian Cancer AJCC v8,1
34102,Extensive Stage Lesion,Advanced Lymphoma,1
34103,Malignant Cellular Infiltrate,Refractory Classic Hodgkin Lymphoma,1
34104,Malignant Cellular Infiltrate,Adult T Lymphoblastic Lymphoma,1
34105,Squamous metaplasia of bladder,Bladder Urachal Squamous Cell Carcinoma,1
34106,Complete Spontaneous Regression,Lymphomatoid Papulosis,1
34107,Malignant Cellular Infiltrate,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8,1
34108,Benign Cellular Infiltrate,Hidradenoma Papilliferum,1
34109,Malignant Cellular Infiltrate,Stage IS Testicular Cancer AJCC v6 and v7,1
34110,Carcinomatous Component Present,ENSAT Stage III Adrenal Cortex Carcinoma,1
34111,Malignant Cellular Infiltrate,Adenoid cystic breast carcinoma,1
34112,Malignant Cellular Infiltrate,Malignant melanoma of breast,1
34113,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
34114,Malignant Cellular Infiltrate,Gastric Burkitt Lymphoma,1
34115,Epithelial Component Present,Stage IIB Ovarian Cancer AJCC v8,1
34116,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v8,1
34117,Recurrent disease,Recurrent Childhood Glioblastoma,1
34118,Malignant Cellular Infiltrate,Parotid Gland Acinic Cell Carcinoma,1
34119,Hyperplastic Tissue Present,Cervical Mesonephric Remnants and Hyperplasia,1
34120,Refractory Disease,Refractory Ovarian Carcinoma,1
34121,Epithelial Component Present,Platinum-Resistant Primary Peritoneal Carcinoma,1
34122,Mucoid Stroma Formation,Bile duct mucinous adenocarcinoma,1
34123,Monomorphic Cellular Infiltrate,Basaloid carcinoma,1
34124,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v7,1
34125,Thin-Walled Branching Vascular Pattern,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
34126,Malignant Cellular Infiltrate,Melanoma recurrent,1
34127,Cystic Change,Borderline Ovarian Serous Cystadenofibroma,1
34128,Primary Lesion,Primary Peritoneal Cancer by AJCC v8 Stage,1
34129,Vascular Channel Formation,Pulmonary Artery Angiosarcoma,1
34130,Epithelial Component Present,Eyelid Sebaceous Gland Carcinoma,1
34131,Myxoid Stroma Formation,Myxoma of the Endocardium,1
34132,Primary Lesion,Stage I Hepatocellular Carcinoma AJCC v8,1
34133,Neuroendocrine Differentiation,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
34134,Indolent Clinical Course,Hemangioma of spleen,1
34135,Bilateral Disease,Retinoblastoma bilateral,1
34136,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
34137,Refractory Disease,Anaplastic large cell lymphoma T- and null-cell types refractory,1
34138,Carcinomatous Component Present,Stage IB2 Cervical Cancer AJCC v8,1
34139,Honeycomb Pattern,Oligodendroglioma of spinal cord,1
34140,Malignant Cellular Infiltrate,Malignant neoplasm of pineal gland,1
34141,Epithelial Component Present,Minor Salivary Gland Squamous Cell Carcinoma,1
34142,Malignant Cellular Infiltrate,Recurrent Ovarian Adenocarcinoma,1
34143,Absence of Invasion,Stage 0 Major Salivary Gland Cancer AJCC v8,1
34144,Malignant Cellular Infiltrate,Submandibular Gland Squamous Cell Carcinoma,1
34145,Hyperplastic Tissue Present,Utricle-Associated Mucosal Gland Hyperplasia,1
34146,Low Mitotic Activity,Gastrinoma,1
34147,Carcinomatous Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
34148,Anaplasia,Lung Pleomorphic Carcinoma,1
34149,Primary Lesion,Diffuse melanocytosis,1
34150,Fibrotic Stroma Formation,Proliferating Brenner Tumor,1
34151,Tissue Differentiation Uncertain,Adult Alveolar Soft Part Sarcoma,1
34152,Cartilaginous Differentiation,Childhood Myxoid Chondrosarcoma,1
34153,Malignant Cellular Infiltrate,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
34154,Primary Lesion,Cerebral Glioblastoma,1
34155,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage,1
34156,Malignant Cellular Infiltrate,Cervical carcinoma stage II AJCC v7,1
34157,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1
34158,Poorly Differentiated Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
34159,Carcinomatous Component Present,Adenocarcinoma with neuroendocrine differentiation,1
34160,Invasive Lesion,Infiltrating Bladder Carcinoma,1
34161,Folliculotropic Lymphocytic Infiltrate,Follicular mycosis fungoides,1
34162,Malignant Cellular Infiltrate,Stage IVB Ovarian Cancer AJCC v8,1
34163,Carcinomatous Component Present,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
34164,Neuroendocrine Differentiation,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
34165,Carcinomatous Component Present,Grade 2 Clear Cell Renal Cell Carcinoma,1
34166,Neuroendocrine Differentiation,small cell carcinoma of ureter,1
34167,Refractory Disease,Refractory Rhabdoid Tumor,1
34168,Malignant Cellular Infiltrate,Testicular Typical Seminoma,1
34169,Syncytial Pattern,Lymphoepithelial carcinoma,1
34170,Malignant Cellular Infiltrate,cystadenocarcinoma of intrahepatic bile duct,1
34171,Malignant Cellular Infiltrate,Rectal Rhabdomyosarcoma,1
34172,High Mitotic Activity,Blastoid Variant Mantle Cell Lymphoma,1
34173,Cutaneous Involvement,Malignant Cutaneous Granular Cell Tumor,1
34174,Refractory Disease,Platinum-Resistant Ovarian Carcinoma,1
34175,Metastatic Lesion,Metastatic Unresectable Malignant Neoplasm,1
34176,Cutaneous Involvement,Xeroderma,1
34177,Malignant Cellular Infiltrate,Unresectable Digestive System Carcinoma,1
34178,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Non-Hilar Type",1
34179,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
34180,Malignant Cellular Infiltrate,Intraductal Non-Comedo Breast Adenocarcinoma,1
34181,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8,1
34182,Fibrotic Stroma Formation,Sarcomatoid Intrahepatic Cholangiocarcinoma,1
34183,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Hydropic Leiomyoma,1
34184,Carcinomatous Component Present,Refractory Liver Carcinoma,1
34185,Tumor Vascular Invasion,"Leydig cell tumor, malignant",1
34186,Tissue Differentiation Uncertain,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
34187,Carcinomatous Component Present,Skin Basaloid Carcinoma,1
34188,Monoclonal Cellular Population Present,Macrofollicular adenoma,1
34189,Epithelial Component Present,Squamous cell carcinoma of the parotid gland,1
34190,Borderline Lesion,"Serous cystadenoma, borderline malignancy",1
34191,Epithelial Component Present,Exocervical Carcinoma,1
34192,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
34193,Diffuse Pattern,Stage III Adult Immunoblastic Lymphoma,1
34194,Infiltrating Tumor Margins Present,Malignant phyllodes tumor of breast,1
34195,Epithelial Component Present,neuroendocrine carcinoma of anal canal,1
34196,Psammoma Body Formation,Benign Mediastinal Psammomatous Schwannoma,1
34197,Malignant Cellular Infiltrate,Stage III Renal Pelvis Cancer AJCC v8,1
34198,Well-Circumscribed Lesion,Classic Rhabdomyoma,1
34199,Malignant Cellular Infiltrate,Stage I Liver Carcinoma,1
34200,Carcinomatous Component Present,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
34201,Malignant Cellular Infiltrate,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
34202,Carcinomatous Component Present,Adenocarcinoma in situ in tubulovillous adenoma,1
34203,Multinodular Mass,Recurrent Skin Angiosarcoma,1
34204,Epithelial Component Present,Stage IB Cervical Cancer AJCC v8,1
34205,Epithelial Component Present,Small Intestinal Tubulovillous Adenoma,1
34206,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
34207,Lymphoplasmacytic Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
34208,Carcinomatous Component Present,Stage II Merkel Cell Carcinoma AJCC v7,1
34209,Indolent Clinical Course,Kasabach-Merritt syndrome,1
34210,Immunosuppression-Related Post-Transplant Toxicity,Renal transplant rejection,1
34211,Childhood Lesion,Childhood Malignant Testicular Germ Cell Tumor,1
34212,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage II,1
34213,Lymphoplasmacytic Infiltrate,Oropharyngeal lymphoepithelioma stage III,1
34214,No Evidence of Metastatic Disease,Benign pheochromocytoma of adrenal gland,1
34215,Malignant Cellular Infiltrate,Hereditary Papillary Renal Carcinoma,1
34216,Primary Lesion,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
34217,Malignant Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v6 and v7,1
34218,Malignant Cellular Infiltrate,Vaginal cancer recurrent,1
34219,Multinodular Mass,Gallbladder Angiosarcoma,1
34220,Malignant Cellular Infiltrate,Malignant tumor of peritoneum,1
34221,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
34222,Benign Cellular Infiltrate,Benign myoepithelioma,1
34223,Malignant Cellular Infiltrate,Growth Hormone-Producing Pituitary Gland Carcinoma,1
34224,Adulthood Lesion,Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8,1
34225,Neuroendocrine Differentiation,Orbit Paraganglioma,1
34226,Recurrent disease,Recurrent Malignant Soft Tissue Neoplasm,1
34227,Carcinomatous Component Present,Resectable Carcinoma,1
34228,Epithelial Component Present,Laryngeal Basaloid Carcinoma,1
34229,Cutaneous Involvement,Malignant Cutaneous Granular Cell Tumor,1
34230,Adulthood Lesion,Stage II Adult Soft Tissue Sarcoma AJCC v7,1
34231,Carcinomatous Component Present,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,1
34232,Epithelial Component Present,Anal cancer metastatic,1
34233,Perivascular fibrosis,Hodgkin's disease nodular sclerosis recurrent,1
34234,Adnexal Differentiation,Invasive Apocrine Breast Carcinoma,1
34235,Epithelial Component Present,Stage III Liver Cancer,1
34236,Epithelial Component Present,Stage IVB Basal Cell Lip Carcinoma,1
34237,Local disease,lipoma of extrahepatic bile duct,1
34238,Malignant Cellular Infiltrate,Recurrent Liver Carcinoma,1
34239,Epithelial Component Present,Stage IIIA Thymoma AJCC v8,1
34240,Neuronal Differentiation,Medulloblastoma with extensive nodularity,1
34241,Epithelial Component Present,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",1
34242,Intracellular Accumulation of Lipids,Childhood Pleomorphic Xanthoastrocytoma,1
34243,Borderline Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,1
34244,Pushing Tumor Margin,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
34245,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
34246,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
34247,Primary Lesion,Synchronous Multifocal Osteosarcoma,1
34248,Malignant Cellular Infiltrate,mantle cell lymphoma of small intestine,1
34249,Multifocal Lesion,Multiple Endocrine Neoplasia Type 2a,1
34250,Cutaneous Involvement,Hepatoerythropoietic Porphyria,1
34251,Malignant Cellular Infiltrate,Unresectable Cutaneous Melanoma,1
34252,'Starry-sky' pattern,Stage IV Childhood Burkitt Lymphoma,1
34253,Plexiform Vasculature Present,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
34254,Lesion with Diameter Greater than 2cm,Cementoma,1
34255,Metastatic Lesion,Melanoma Metastatic in the Central Nervous System,1
34256,Secondary Lesion,Metastatic Kidney Carcinoma,1
34257,Malignant Cellular Infiltrate,adenocarcinoma of breast with spindle cell metaplasia,1
34258,Low Grade Lesion,Third Ventricle Pilocytic Astrocytoma,1
34259,Dermal Involvement,Cervical Blue Nevus,1
34260,Carcinomatous Component Present,Ovarian cancer stage III,1
34261,Villous Projections of the Neoplastic Epithelium Present,Filiform Serrated Adenoma,1
34262,Malignant Cellular Infiltrate,Anterior Urethral Malignant Neoplasm,1
34263,Carcinomatous Component Present,Major Salivary Gland Adenoid Cystic Carcinoma,1
34264,Crystal deposition,Tongue Alveolar Soft Part Sarcoma',1
34265,Neuroendocrine Differentiation,Carotid Body Paraganglioma,1
34266,Carcinomatous Component Present,Metastatic Unresectable Carcinoma,1
34267,Splenomegaly,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
34268,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Mature Teratoma,1
34269,Cutaneous Involvement,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
34270,Carcinomatous Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
34271,Epithelial Component Present,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
34272,Primary Lesion,Recurrent Giant Cell Glioblastoma,1
34273,Vascular Channel Formation,Metastatic Epithelioid Hemangioendothelioma,1
34274,Carcinomatous Component Present,Occult Lung Adenocarcinoma,1
34275,Pregnancy Complications,Abruptio Placentae,1
34276,Recurrent disease,Recurrent Hairy Cell Leukemia,1
34277,Epithelial Component Present,Cervical Endometrioid Adenocarcinoma,1
34278,Malignant Cellular Infiltrate,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,1
34279,Benign Cellular Infiltrate,Common wart,1
34280,Malignant Cellular Infiltrate,Nonestrogen-Dependent Malignant Neoplasm,1
34281,Malignant Cellular Infiltrate,Colon Hodgkin Lymphoma,1
34282,Nuclear Grooves,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
34283,Carcinomatous Component Present,Urothelial cancer of renal pelvis,1
34284,Indolent Clinical Course,Lymphangioendothelioma,1
34285,Papillary Pattern,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
34286,Benign Cellular Infiltrate,Benign neoplasm of cecum,1
34287,Carcinomatous Component Present,"Squamous cell carcinoma, clear cell type",1
34288,Hyalinized Stroma Formation,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
34289,Dysplasia,Colonic tubulovillous adenoma,1
34290,Well-Circumscribed Lesion,Precancerous Polyp,1
34291,Neuroendocrine Differentiation,Colorectal Neuroendocrine Neoplasm,1
34292,Carcinomatous Component Present,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
34293,Stromal Invasion,large cell neuroendocrine carcinoma of ovary,1
34294,atypia morphology,Classic Type Atypical Fibroxanthoma,1
34295,Benign Cellular Infiltrate,Proliferative fasciitis,1
34296,Cystic Change,mucoepidermoid carcinoma of lung,1
34297,Diffuse Pattern,Mediastinal (Thymic) Large B-Cell Lymphoma,1
34298,Epithelial Component Present,Glucagonoma,1
34299,Malignant Cellular Infiltrate,Small intestine carcinoma resectable,1
34300,Recurrent disease,Leiomyosarcoma recurrent,1
34301,Primary Lesion,Cerebellar and Brain Stem Ependymal Tumor,1
34302,Malignant Cellular Infiltrate,Localized Gastroesophageal Junction Adenocarcinoma,1
34303,Carcinomatous Component Present,Ovarian cancer stage III,1
34304,Childhood Lesion,Recurrent Childhood Central Nervous System Neoplasm,1
34305,Malignant Cellular Infiltrate,Unresectable Urethral Urothelial Carcinoma,1
34306,Malignant Cellular Infiltrate,Hodgkin Lymphoma by Ann Arbor Stage,1
34307,Pseudostratified Columnar Tumor Cells Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
34308,atypia morphology,Classic Type Atypical Fibroxanthoma,1
34309,Pathologic TNM Finding,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
34310,Malignant Cellular Infiltrate,Refractory Malignant Peripheral Nerve Sheath Tumor,1
34311,Carcinomatous Component Present,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
34312,Nuclear Molding,Combined Lung Large Cell Neuroendocrine Carcinoma,1
34313,Carcinomatous Component Present,Gallbladder papillary adenocarcinoma,1
34314,Malignant Cellular Infiltrate,Malignant neoplasm of penis,1
34315,Malignant Cellular Infiltrate,Prognostic Stage IIA Breast Cancer AJCC v8,1
34316,Recurrent disease,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
34317,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,1
34318,Nuclear pleomorphism,Choroid Plexus Carcinoma,1
34319,atypia morphology,Proliferating Brenner Tumor,1
34320,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,1
34321,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with Minimal Differentiation,1
34322,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Hypocellular Myelodysplastic Syndrome,1
34323,Malignant Cellular Infiltrate,Childhood Systemic Anaplastic Large Cell Lymphoma,1
34324,Bone Marrow Lymphoplasmacytic Infiltrate,Waldenstrom's macroglobulinemia recurrent,1
34325,Malignant Cellular Infiltrate,Anterior Tongue Adenoid Cystic Carcinoma,1
34326,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v8,1
34327,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v8,1
34328,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
34329,Malignant Cellular Infiltrate,Recurrent Malignant Endocervical Neoplasm,1
34330,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Mixed Somatotroph and Lactotroph Adenoma,1
34331,Malignant Cellular Infiltrate,Stage I Gastric Carcinoma,1
34332,Hyperkeratosis,verrucous carcinoma of esophagus,1
34333,Carcinomatous Component Present,Vagina Carcinoma,1
34334,Regional Disease,Locally Advanced Prostate Adenocarcinoma,1
34335,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
34336,Malignant Cellular Infiltrate,Minor Salivary Gland Adenocarcinoma,1
34337,Epithelial Component Present,Breast Complex Fibroadenoma,1
34338,Slow Growing Mass,Venous Angioleiomyoma,1
34339,Epithelial Component Present,Carcinoma of submandibular gland,1
34340,"Fully Differentiated ""Adult-Type"" Tissues Present",Sellar Mature Teratoma,1
34341,Epithelial Component Present,"Phyllodes tumor, benign",1
34342,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic-Phase",1
34343,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
34344,Neuroendocrine Differentiation,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,1
34345,Epithelial Component Present,Bladder Adenocarcinoma,1
34346,Epithelial Component Present,Recurrent Fallopian Tube Serous Adenocarcinoma,1
34347,Diffuse Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
34348,Dilated Vascular Space Formation,Hereditary Glomangioma,1
34349,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8,1
34350,Epithelial Component Present,Recurrent Lip Basal Cell Carcinoma,1
34351,Malignant Cellular Infiltrate,Malignant neoplasm of hypopharynx recurrent,1
34352,Ganglioneuroma Component Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
34353,Cutaneous Involvement,Eccrine Poroma,1
34354,Epithelial Component Present,Early-Stage Breast Carcinoma,1
34355,Dysplasia,Gallbladder Biliary Intraepithelial Neoplasia,1
34356,Dysplasia,Vulval intraepithelial neoplasia,1
34357,Fibrotic Stroma Formation,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
34358,Malignant Cellular Infiltrate,St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8,1
34359,Malignant Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma,1
34360,Metastatic Lesion,Secondary malignant neoplasm of chest wall,1
34361,Primary Lesion,Cerebellar and Fourth Ventricle Ependymal Tumor,1
34362,Well-Circumscribed Lesion,Lung Mucinous Cystadenoma,1
34363,Thick-Walled Hyalinized Vessels Present,Jugular Foramen Schwannoma,1
34364,Malignant Cellular Infiltrate,Acute Leukemia of Ambiguous Lineage,1
34365,Epithelial Component Present,"Thymoma, type A, malignant",1
34366,Recurrent disease,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,1
34367,Neuroendocrine Differentiation,Advanced Small Intestinal Neuroendocrine Carcinoma,1
34368,Immunologic Deficiency Syndromes,Plasmacytic Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
34369,Epithelial Component Present,Cholangiocarcinoma non-resectable,1
34370,Epithelial Component Present,Bilateral Carcinoma,1
34371,Juvenile Lesion,Juvenile papillomatosis of breast,1
34372,Epithelial Component Present,Urothelial carcinoma bladder recurrent,1
34373,Mucoid Stroma Formation,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
34374,Nuclear Pseudoinclusion,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
34375,Anaplasia,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
34376,Metastatic Lesion,Metastatic Salivary Gland Carcinoma,1
34377,Carcinomatous Component Present,Platinum-Resistant Ovarian Carcinoma,1
34378,Malignant Cellular Infiltrate,Villous adenocarcinoma,1
34379,Carcinomatous Component Present,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
34380,Carcinomatous Component Present,Stage IV Major Salivary Gland Carcinoma with Metastasis,1
34381,Solitary mass,Dedifferentiated chordoma,1
34382,Carcinomatous Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
34383,Firm mass,High Grade Malignant Peripheral Nerve Sheath Tumor,1
34384,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
34385,Neuroendocrine Differentiation,Gastric Neuroendocrine Tumor G2,1
34386,Thick-Walled Vessels Present,Kidney Epithelioid Type Angiomyolipoma,1
34387,Nodular Pattern,Skin Nodular Solid Basal Cell Carcinoma,1
34388,Childhood Lesion,Childhood Parathyroid Gland Carcinoma,1
34389,Chronic lymphocytic inflammation,Follicular Bronchitis/Bronchiolitis,1
34390,In Situ Lesion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
34391,Aggressive Clinical Course,Thoracic NUT Carcinoma,1
34392,Malignant Cellular Infiltrate,Locally Advanced Unresectable Pancreatic Adenocarcinoma,1
34393,Cutaneous Involvement,Porokeratotic eccrine ostial and dermal duct nevus,1
34394,Epithelial Component Present,Bile duct mucinous adenocarcinoma,1
34395,Epithelial Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v8,1
34396,Severe cytologic atypia,small cell carcinoma of appendix,1
34397,Intraluminal Tumor Growth,Pulmonary Artery Intimal Sarcoma,1
34398,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum,1
34399,Fibrotic Stroma Formation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
34400,Epithelial Component Present,Spindle cell squamous cell carcinoma,1
34401,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
34402,Well Differentiated Neuroendocrine Lesion,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
34403,Cutaneous Involvement,Metastatic Dermatofibrosarcoma Protuberans,1
34404,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Nodular amyloidosis,1
34405,Childhood Lesion,Childhood Central Nervous System Neoplasm,1
34406,Cutaneous Involvement,Scrotal Liposarcoma,1
34407,Congenital Lesion,Congenital hemangioma,1
34408,Nuclear Atypia,Glioblastoma,1
34409,Malignant Cellular Infiltrate,Type II Endometrial Adenocarcinoma,1
34410,Malignant Cellular Infiltrate,"Myelodysplastic syndrome, no ICD-O subtype",1
34411,Malignant Cellular Infiltrate,liposarcoma,1
34412,Cutaneous Involvement,"Keratoderma, Palmoplantar, Epidermolytic",1
34413,Epithelial Component Present,Stage III Rectal Cancer AJCC v7,1
34414,Epithelial Component Present,Ovarian Granulosa-Stromal Cell Tumor,1
34415,Immunologic Deficiency Syndromes,AIDS-Related Lymphoblastic Lymphoma,1
34416,Indolent Clinical Course,Chondromatosis,1
34417,Clinical TNM Finding,Clinical Stage IIA Cutaneous Melanoma AJCC v8,1
34418,Follicular Cell Differentiation,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
34419,Hypercellular bone marrow,"Myeloid Leukemia, Chronic",1
34420,Nodular Pattern,Ann Arbor Stage II Grade 1 Follicular Lymphoma,1
34421,Immature Granulocytes in Peripheral Blood Increased,Juvenile Myelomonocytic Leukemia,1
34422,Recurrent disease,Recurrent Childhood Oligodendroglioma,1
34423,Intraocular Lesion,Recurrent Primary Vitreoretinal Lymphoma,1
34424,Malignant Cellular Infiltrate,Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage,1
34425,Crooke Hyaline Change,Crooke Cell Adenoma,1
34426,Carcinomatous Component Present,Laryngeal verrucous carcinoma stage IV,1
34427,Malignant Cellular Infiltrate,Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7,1
34428,High Grade Lesion,Fusion-Positive Rhabdomyosarcoma,1
34429,Bilateral Disease,Synchronous Bilateral Breast Carcinoma,1
34430,Malignant Cellular Infiltrate,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
34431,Malignant Cellular Infiltrate,basaloid squamous cell carcinoma of vulva,1
34432,Epithelial Component Present,Borderline Ovarian Mucinous Tumor,1
34433,Malignant Cellular Infiltrate,Grade 1 Colorectal Adenocarcinoma,1
34434,Diffuse Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
34435,Follicular Structures Present,Thyroid Gland Mucinous Follicular Adenoma,1
34436,Lymphoplasmacytic Infiltrate,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
34437,Neuronal Differentiation,Central Neurocytoma,1
34438,Intraductal Lesion,Central Breast Papilloma,1
34439,Epithelial Component Present,Large cell lung cancer stage III,1
34440,Low Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
34441,Malignant Cellular Infiltrate,Carcinoma of soft palate,1
34442,Malignant Cellular Infiltrate,Mediastinal Synovial Sarcoma,1
34443,Malignant Cellular Infiltrate,"Lymphoma, Large-Cell, Follicular",1
34444,Low Mitotic Activity,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
34445,Malignant Cellular Infiltrate,Fallopian Tube Papillary Adenocarcinoma,1
34446,Exophytic Papillary Lesion,Laryngeal verrucous carcinoma,1
34447,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
34448,Severe dysplasia,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
34449,Malignant Cellular Infiltrate,Rhabdomyosarcoma of cervix uteri,1
34450,Organoid Pattern,Vulvar Alveolar Soft Part Sarcoma,1
34451,Adulthood Lesion,Adult Brain Stem Gliosarcoma,1
34452,Malignant Cellular Infiltrate,Mantle cell lymphoma,1
34453,Neuroendocrine Differentiation,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
34454,Papillary Pattern,Epididymal Papillary Cystadenoma,1
34455,Malignant Cellular Infiltrate,leiomyosarcoma of anus,1
34456,Metastatic Lesion,Metastatic Salivary Gland Carcinoma,1
34457,Tissue Differentiation Uncertain,Intramuscular Myxoma,1
34458,Malignant Cellular Infiltrate,Metastatic Kidney Carcinoma,1
34459,Malignant Cellular Infiltrate,Luminal B Breast Carcinoma,1
34460,Thick-Walled Hyalinized Vessels Present,Colorectal Schwannoma,1
34461,Malignant Cellular Infiltrate,Unresectable Ewing Sarcoma,1
34462,Cystic Change,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
34463,Multinodular Mass,hemangioendothelial sarcoma of bone,1
34464,Severe cytologic atypia,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
34465,Malignant Cellular Infiltrate,Gastric Adenosquamous Carcinoma,1
34466,Malignant Cellular Infiltrate,Refractory Endometrial Endometrioid Adenocarcinoma,1
34467,Neuroendocrine Differentiation,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
34468,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated NPM1,1
34469,Well-Circumscribed Lesion,Uterine Polyp,1
34470,Multihormonal Immunoreactivity Present,Plurihormonal Pituitary Gland Adenoma,1
34471,Necrotic changes (finding),Stage III Lung Small Cell Carcinoma AJCC v7,1
34472,Malignant Cellular Infiltrate,Localized Primitive Neuroectodermal Tumor,1
34473,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-0,1
34474,Epithelial Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
34475,Mixed Cellular Population,Hard Palate Pleomorphic Adenoma,1
34476,Malignant Cellular Infiltrate,Recurrent Dedifferentiated Liposarcoma,1
34477,Carcinomatous Component Present,Stage IB Cervical Cancer AJCC v6 and v7,1
34478,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of appendix,1
34479,Benign Cellular Infiltrate,Oral Cavity Adenoma,1
34480,Transformed Phase of Disease,Non-Hodgkin's lymphoma transformed recurrent,1
34481,Carcinomatous Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
34482,Malignant Cellular Infiltrate,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
34483,Epithelial Component Present,Gallbladder Cribriform Carcinoma,1
34484,Epithelial Component Present,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
34485,Unresectable Mass,Unresectable Renal Pelvis Urothelial Carcinoma,1
34486,Invasive Lesion,Breast Carcinoma with Melanotic Features,1
34487,Multinodular Mass,Pericardial Angiosarcoma,1
34488,Secondary Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
34489,Malignant Cellular Infiltrate,Advanced Digestive System Carcinoma,1
34490,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v6 Stage,1
34491,Immunologic Deficiency Syndromes,Transplant-Related Kaposi Sarcoma,1
34492,Encapsulated Mass,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
34493,Malignant Cellular Infiltrate,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
34494,Carcinomatous Component Present,Stage IIIA Lung Cancer AJCC v7,1
34495,Epithelial Component Present,Thymic Clear Cell Carcinoma,1
34496,Glandular Pattern,"Vulvar Adenocarcinoma, Intestinal-Type",1
34497,Benign Cellular Infiltrate,Subungual exostoses,1
34498,Epithelial Component Present,Gastric Pylorus Carcinoma,1
34499,Myxoid Stroma Formation,Odontogenic myxoma,1
34500,Monoclonal Cellular Population Present,Skin Mastocytoma,1
34501,Epithelial Component Present,Stage I Colorectal Cancer AJCC v6 and v7,1
34502,Capillary Sized Vascular Channel Formation,Capillary hemangioma of eyelid,1
34503,Malignant Cellular Infiltrate,Grade 1 Malignant Neoplasm,1
34504,Epithelial Component Present,Stage IIIC Adult Liver Cancer AJCC v7,1
34505,Unifocal Lesion,Pulmonary Histiocytosis X,1
34506,Malignant Cellular Infiltrate,Paranasal Sinus Cancer,1
34507,Absence of Invasion,Stage 0 Colon Cancer AJCC v8,1
34508,Slow Growing Mass,Central Nervous System Hemangioblastoma,1
34509,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Larynx,1
34510,Epithelial Component Present,Malignant neoplasm of stomach stage I,1
34511,Carcinomatous Component Present,Adenocarcinoma of Skene Gland Origin,1
34512,Carcinomatous Component Present,Lung Adenocarcinoma In Situ,1
34513,Malignant Cellular Infiltrate,Clitoral Carcinoma,1
34514,Indolent Clinical Course,Endometrial Polyp,1
34515,Cellular Pleomorphism,Malignant Lung PEComa,1
34516,Malignant Cellular Infiltrate,Sellar Yolk Sac Tumor,1
34517,Nodular Pattern,Recurrent Grade 3 Follicular Lymphoma,1
34518,Malignant Cellular Infiltrate,Lung Adenocarcinoma by AJCC v7 Stage,1
34519,Malignant Cellular Infiltrate,Recurrent Atypical Teratoid/Rhabdoid Tumor,1
34520,Well Differentiated Neuroendocrine Lesion,"Somatostatinoma, malignant",1
34521,Borderline Lesion,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
34522,Carcinomatous Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
34523,Indolent Clinical Course,Soft tissue chondroma,1
34524,Carcinomatous Component Present,High Grade Appendix Mucinous Adenocarcinoma,1
34525,Epithelial Component Present,Low Grade Ductal Breast Carcinoma In Situ,1
34526,Malignant Cellular Infiltrate,Double-Hit Lymphoma,1
34527,Carcinomatous Component Present,Endometrial adenocarcinoma metastatic,1
34528,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 3,1
34529,Malignant Cellular Infiltrate,Recurrent Malignant Soft Tissue Neoplasm,1
34530,Epithelial Component Present,Borderline Ovarian Endometrioid Cystadenofibroma,1
34531,Infiltrative Growth Pattern,Childhood Fibrillary Astrocytoma,1
34532,Fibrotic Stroma Formation,Nonencapsulated sclerosing tumor,1
34533,Microinvasive tumor,"Squamous cell carcinoma, microinvasive",1
34534,Dilated Terminal Duct Lobular Units Present,Columnar Cell Lesion of the Breast,1
34535,Malignant Cellular Infiltrate,Pancreatic Large Cell Neuroendocrine Carcinoma,1
34536,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type III,1
34537,Indolent Clinical Course,Intravenous leiomyomatosis,1
34538,Tissue Differentiation Uncertain,Ovarian Myxoma,1
34539,Well-Circumscribed Lesion,"Phyllodes tumor, borderline",1
34540,High Grade Lesion,Refractory Dedifferentiated Liposarcoma,1
34541,Transformed Phase of Disease,Refractory Transformed B-cell Non-Hodgkin Lymphoma,1
34542,Epithelial Component Present,Pancreatic Neuroendocrine Microadenoma,1
34543,Malignant Cellular Infiltrate,Luminal B Breast Carcinoma,1
34544,Malignant Cellular Infiltrate,Stage III Esophageal Adenocarcinoma AJCC v7,1
34545,Dysplasia,High Grade Cervical Intraepithelial Neoplasia,1
34546,Pathologic TNM Finding,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
34547,Carcinomatous Component Present,Gastric Hepatoid Adenocarcinoma,1
34548,Metastatic/Recurrent Disease,Pleural Synovial Sarcoma,1
34549,Secondary Lesion,Melanoma of Unknown Primary,1
34550,Malignant Cellular Infiltrate,Recurrent Metastatic Digestive System Carcinoma,1
34551,Malignant Cellular Infiltrate,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
34552,Calcitonin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
34553,Malignant Cellular Infiltrate,Stage IB Vulvar Cancer AJCC v7,1
34554,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
34555,atypia morphology,Atypical fibroxanthoma of skin,1
34556,Malignant Cellular Infiltrate,Parotid Gland Carcinoma,1
34557,Well-Circumscribed Lesion,Colon Adenoma with Severe Dysplasia,1
34558,Well-Circumscribed Lesion,Ovarian Adenomatoid Tumor,1
34559,Carcinomatous Component Present,Pancreatic adenocarcinoma resectable,1
34560,Chromogranin A Positive Neoplastic Cells Present,Thymic Atypical Carcinoid Tumor,1
34561,S-100-Positive Neoplastic Cells Present,Angiomyolipoma of kidney,1
34562,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
34563,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
34564,Malignant Cellular Infiltrate,Carcinoma Arising in Nasal Papillomatosis,1
34565,Carcinomatous Component Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,1
34566,Koilocytotic atypia,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
34567,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1,1
34568,Tubular Pattern,Clear cell papillary renal cell carcinoma,1
34569,Aggressive Clinical Course,"Thymoma, type A, malignant",1
34570,Malignant Cellular Infiltrate,rhabdomyosarcoma of testis,1
34571,Neuroendocrine Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma,1
34572,Epithelial Component Present,Hurthle Cell Tumor,1
34573,Fibrotic Stroma Formation,Ovarian Clear Cell Adenofibroma,1
34574,Skin Red Dot,Angioma serpiginosum,1
34575,In Situ Lesion,Stage 0 Major Salivary Gland Cancer AJCC v8,1
34576,Malignant Cellular Infiltrate,adenosquamous carcinoma of salivary gland,1
34577,Slow Growing Mass,Adult Ependymoma,1
34578,High Mitotic Activity,Anaplastic Pleomorphic Xanthoastrocytoma,1
34579,Dysplasia,Cervical Intraepithelial Neoplasia,1
34580,Metastatic Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,1
34581,Malignant Cellular Infiltrate,Adenoid cystic eccrine carcinoma,1
34582,Epithelial Component Present,Grade 1 Endometrial Mucinous Adenocarcinoma,1
34583,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v7 Stage,1
34584,Benign Cellular Infiltrate,Benign neoplasm of mesothelial tissue of pleura,1
34585,Epithelial Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
34586,Inflammation,Inflammatory Hepatocellular Adenoma,1
34587,Malignant Cellular Infiltrate,small cell carcinoma of salivary gland,1
34588,Epithelial Component Present,Villous adenocarcinoma,1
34589,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
34590,Florid Follicular Hyperplasia,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
34591,Ventricular Involvement Only,Ventricular Ependymal Tumor,1
34592,Malignant Cellular Infiltrate,Malignant Cervical Soft Tissue Neoplasm,1
34593,Malignant Cellular Infiltrate,Ductal Breast Carcinoma with Squamous Metaplasia,1
34594,Malignant Cellular Infiltrate,Colorectal Leiomyosarcoma,1
34595,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity recurrent,1
34596,Nodular Pattern,Ann Arbor Stage IV Grade 2 Follicular Lymphoma,1
34597,Hyperplastic Tissue Present,Diffuse hyperplasia,1
34598,Neuroendocrine Differentiation,Carcinoid tumor of rectum,1
34599,Well-Circumscribed Lesion,Stromal Predominant Kidney Wilms Tumor,1
34600,Thick-Walled Vessels Present,Childhood Kidney Angiomyolipoma,1
34601,Early Stromal Invasion Present,Early Invasive Cervical Squamous Cell Carcinoma,1
34602,Severe dysplasia,Stage 0is Ureter Cancer AJCC v7,1
34603,Carcinomatous Component Present,Vulvar Large Cell Neuroendocrine Carcinoma,1
34604,Calcinosis,Ossifying fibromyxoid tumor,1
34605,Adulthood Lesion,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,1
34606,Clusters and Cords of GFAP Positive Epithelioid Tumor Cells Present,Chordoid Glioma of the Third Ventricle,1
34607,Malignant Cellular Infiltrate,Inflammatory liposarcoma,1
34608,Epithelial Component Present,Gastric Cardia Squamous Cell Carcinoma,1
34609,High Grade Lesion,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
34610,Carcinomatous Component Present,Stage II Oral Cavity Cancer AJCC v6 and v7,1
34611,Chronic Inflammatory Infiltrate,Pulmonary Lymphomatoid Granulomatosis,1
34612,Malignant Cellular Infiltrate,Differentiating Neuroblastoma,1
34613,Childhood Lesion,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",1
34614,Malignant Cellular Infiltrate,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
34615,Neuroendocrine Differentiation,Thymic Small Cell Carcinoma,1
34616,Diffuse Pattern,Lymphohistiocytoid Mesothelioma,1
34617,Malignant Cellular Infiltrate,Colorectal Adenocarcinoma Metastatic in the Liver,1
34618,Malignant Cellular Infiltrate,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7,1
34619,Pathologic TNM Finding,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
34620,Epithelial Component Present,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
34621,Unresectable Mass,Unresectable Bone Sarcoma,1
34622,Carcinomatous Component Present,undifferentiated carcinoma of liver,1
34623,Poorly Differentiated Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
34624,Papillary Pattern,Recurrent Inverted Schneiderian Papilloma,1
34625,Osteoid formation,Breast Extraskeletal Osteosarcoma,1
34626,Diffuse Lesion,Nonencapsulated sclerosing tumor,1
34627,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Pericardial Teratoma,1
34628,Adnexal Differentiation,Hidradenoma Papilliferum,1
34629,Adulthood Lesion,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
34630,Nuclear Atypia,Fibrillary Astrocytoma,1
34631,Childhood Lesion,Childhood Acute Monoblastic Leukemia,1
34632,Malignant Cellular Infiltrate,Parotid Gland Adenocarcinoma,1
34633,Carcinomatous Component Present,Stage IVC Pharyngeal Carcinoma,1
34634,High Mitotic Activity,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
34635,Vascular Channel Formation,hemangioma of mediastinum,1
34636,Childhood Lesion,Stage I Childhood Burkitt Lymphoma,1
34637,Epithelial Component Present,Primary Peritoneal High Grade Serous Adenocarcinoma,1
34638,Carcinomatous Component Present,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
34639,Mixture of Germ Cell Neoplastic Components Present,Choriocarcinoma combined with other germ cell elements,1
34640,Carcinomatous Component Present,Salivary gland carcinoma,1
34641,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis,1
34642,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma by RISS Stage,1
34643,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v7 Stage,1
34644,Primary Lesion,Stage IVA Hepatocellular Carcinoma AJCC v8,1
34645,Sebaceous Differentiation,Sebaceous Breast Carcinoma,1
34646,Neuroendocrine Differentiation,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
34647,Keratin pearl formation,"Lung Squamous Cell Carcinoma, Clear Cell Variant",1
34648,Dysplasia,Cervical intraepithelial neoplasia grade 2,1
34649,Well Differentiated Neuroendocrine Lesion,malignant gastrinoma of pancreas,1
34650,Cystic Change,Cystic Partially Differentiated Nephroblastoma,1
34651,Indolent Clinical Course,Digestive System Hemangioma,1
34652,Epithelial Component Present,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8,1
34653,Cutaneous Involvement,Skin Neoplasms,1
34654,CD56-Positive Neoplastic Cells Present,"Refractory NK-Cell Lymphoma, Unclassifiable",1
34655,Primary Lesion,Childhood Brain Stem Astrocytoma,1
34656,Benign Cellular Infiltrate,Benign neoplasm of lung,1
34657,Epithelial Component Present,Stage 0is Bladder Cancer AJCC v8,1
34658,More than 10 Mitoses per 10HPF,Small cell lung cancer recurrent,1
34659,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
34660,Rapidly Enlarging Mass,Cranial Nodular Fasciitis,1
34661,Absence of Stromal Invasion,Borderline Ovarian Transitional Cell Tumor,1
34662,Malignant Cellular Infiltrate,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
34663,In Situ Lesion,Carcinoma in situ of fallopian tube,1
34664,Refractory Disease,Refractory Alveolar Rhabdomyosarcoma,1
34665,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Medulla,1
34666,Childhood Lesion,Childhood Ovarian Dysgerminoma,1
34667,Cutaneous Involvement,Clear cell hidradenoma,1
34668,Cervical lymphadenopathy,Sinus histiocytosis,1
34669,Recurrent disease,Relapsed Hypopharynx Carcinoma,1
34670,Benign Cellular Infiltrate,Endobronchial lipoma,1
34671,Epithelial Component Present,carcinosarcoma of liver,1
34672,Epithelial Component Present,Stage IA Breast Cancer AJCC v7,1
34673,Epithelial Component Present,Stage IA Esophageal Adenocarcinoma AJCC v7,1
34674,Immunologic Deficiency Syndromes,Burkitt lymphoma associated with AIDS,1
34675,Benign Cellular Infiltrate,Vulvar Acquired Melanocytic Nevus,1
34676,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia T/myeloid,1
34677,Carcinomatous Component Present,Lip basal cell carcinoma,1
34678,Epithelial Component Present,Stage IA Esophageal Adenocarcinoma AJCC v7,1
34679,Hypercellular bone marrow,Chronic eosinophilic leukemia,1
34680,Malignant Cellular Infiltrate,T-Cell Lymphoma,1
34681,Papillary Pattern,"Transitional cell papilloma, inverted",1
34682,Metastatic/Recurrent Disease,Lung Biphasic Synovial Sarcoma,1
34683,Pregnancy Complications,Recurrent Gestational Trophoblastic Tumor,1
34684,Carcinomatous Component Present,Anaplastic thyroid carcinoma,1
34685,Secondary Lesion,Metastatic Carcinoma in the Adrenal Medulla,1
34686,Thyroglobulin Positive Neoplastic Cells Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
34687,Low Grade Lesion,Childhood Subependymal Giant Cell Astrocytoma,1
34688,Vascular Channel Formation,Hemangioma of skin,1
34689,Benign Cellular Infiltrate,Benign neoplasm of adrenal medulla,1
34690,Tubular Pattern,tubulopapillary adenoma of extrahepatic bile duct,1
34691,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
34692,Epithelial Component Present,Metastatic Salivary Gland Carcinoma,1
34693,Recurrent disease,Recurrent Acute Monoblastic and Monocytic Leukemia,1
34694,Malignant Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v8,1
34695,Epithelial Component Present,Jejunal Neuroendocrine Tumor G1,1
34696,Epithelial Component Present,Stage 0 Rectal Cancer AJCC v8,1
34697,Indolent Clinical Course,Benign Lung PEComa,1
34698,Anaplasia,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
34699,Infiltrative Growth Pattern,Adult Brain Stem Gliosarcoma,1
34700,Absence of Invasion,Stage 0 Lung Cancer AJCC v6 and v7,1
34701,Bone Marrow Dysplasia Present,Refractory High Risk Myelodysplastic Syndrome,1
34702,Carcinomatous Component Present,Refractory Digestive System Neuroendocrine Carcinoma,1
34703,Epithelial Component Present,"Thymoma, type AB, malignant",1
34704,Epithelial Component Present,Urethral Inverted Papilloma,1
34705,Metastatic Lesion,Secondary malignant neoplasm of pharynx,1
34706,Epithelial Component Present,"Phyllodes tumor, benign",1
34707,Benign Cellular Infiltrate,Ovarian Sclerosing Stromal Tumor,1
34708,Follicular Structures Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
34709,Low Grade Lesion,Childhood Epithelioid Hemangioendothelioma,1
34710,Carcinomatous Component Present,Stage IIA Eyelid Carcinoma AJCC v8,1
34711,Mixed Cellular Population,Stage IV Kidney Wilms Tumor,1
34712,Childhood Lesion,Childhood Hodgkin Lymphoma by Ann Arbor Stage,1
34713,Epithelial Component Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,1
34714,Malignant Cellular Infiltrate,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
34715,Benign Cellular Infiltrate,Giant Cell Lesion of Small Bones,1
34716,Epithelial Component Present,lymphoepithelial squamous cell carcinoma of salivary gland,1
34717,Well-Circumscribed Lesion,Metaplastic thymoma,1
34718,Cutaneous Involvement,Cutaneous Chronic Lymphocytic Leukemia,1
34719,Epithelial Component Present,Gingival Squamous Cell Carcinoma,1
34720,Low Mitotic Activity,"Glucagonoma, malignant",1
34721,Metastatic Lesion,Carcinomatosis of peritoneal cavity,1
34722,Hydropic Villous Change,Hydatidiform Mole,1
34723,Malignant Cellular Infiltrate,Dedifferentiated Solitary Fibrous Tumor,1
34724,Malignant Cellular Infiltrate,Colon Micropapillary Adenocarcinoma,1
34725,Malignant Cellular Infiltrate,Thyroid Lymphoma,1
34726,Well Differentiated Lesion,Laryngeal verrucous carcinoma stage IV,1
34727,Adulthood Lesion,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8,1
34728,Malignant Cellular Infiltrate,Recurrent Pancreatic Neuroendocrine Carcinoma,1
34729,Malignant Germinomatous Cellular Infiltrate,Intracranial Germinoma,1
34730,Carcinomatous Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
34731,Epithelial Component Present,Cervical Large Cell Neuroendocrine Carcinoma,1
34732,Malignant Cellular Infiltrate,Testicular Follicular Lymphoma,1
34733,Biphasic Pattern,Juvenile Pilocytic Astrocytoma,1
34734,Indolent Clinical Course,Juvenile Xanthogranuloma,1
34735,Cutaneous Involvement,Acute Generalized Exanthematous Pustulosis,1
34736,Epithelial Component Present,Adenoid cystic carcinoma of trachea,1
34737,Necrotic changes (finding),Combined Lung Small Cell and Squamous Cell Carcinoma,1
34738,Carcinomatous Component Present,Gastric Papillary Adenocarcinoma,1
34739,Malignant Cellular Infiltrate,Adult Burkitt Leukemia,1
34740,Eosinophilic inflammation,Gastric Inflammatory Myofibroblastic Tumor,1
34741,Malignant Cellular Infiltrate,Stage I Ovarian Cancer AJCC v6 and v7,1
34742,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Serous",1
34743,Cutaneous Involvement,Intermediate Cutaneous Fibrohistiocytic Neoplasm,1
34744,Epithelial Component Present,Stage IV Primary Peritoneal Cancer AJCC v8,1
34745,Fibrotic Stroma Formation,Ovarian Mucinous Cystadenofibroma,1
34746,Epithelial Component Present,Classic Type Trichilemmoma,1
34747,Carcinomatous Component Present,Digital papillary eccrine carcinoma of skin,1
34748,Malignant Cellular Infiltrate,eccrine adenocarcinoma of vulva,1
34749,Clinical TNM Finding,Clinical Stage IIC Cutaneous Melanoma AJCC v8,1
34750,Lobulated Growth Pattern,Ventricular myxoma,1
34751,Malignant Cellular Infiltrate,Recurrent Prostate Acinar Adenocarcinoma,1
34752,Malignant Cellular Infiltrate,Aleukemic Lymphoid Leukemia,1
34753,Ganglioneuroblastoma Component Present,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
34754,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v8,1
34755,Vascular Channel Formation,Parotid Gland Hemangioma,1
34756,Moderate dysplasia,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
34757,Epithelial Component Present,Functioning Pancreatic Neuroendocrine Tumor G2,1
34758,Malignant Cellular Infiltrate,Plasma Cell Myeloma by DS Stage,1
34759,Malignant Cellular Infiltrate,Childhood Parosteal Osteosarcoma,1
34760,In Situ Lesion,Carcinoma in situ of cecum,1
34761,Refractory Disease,Refractory Malignant Neoplasm of Multiple Primary Sites,1
34762,Cutaneous Involvement,Clear cell hidradenoma,1
34763,Epithelial Component Present,Dermal Duct Tumor,1
34764,Cutaneous Involvement,Stage IIIA Cutaneous Melanoma AJCC v7,1
34765,Carcinomatous Component Present,Stage III Childhood Hepatocellular Carcinoma AJCC v7,1
34766,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Soft Tissues,1
34767,Regional Disease,Locally Advanced Bile Duct Carcinoma,1
34768,Mitotic Activity,Frontal Lobe Anaplastic Astrocytoma,1
34769,Carcinomatous Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
34770,Single Type of Tissue Derived from One Embryonic Layer Present,Benign Struma Ovarii,1
34771,Malignant Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia,1
34772,Fibrotic Stroma Formation,Tubulocystic renal cell carcinoma,1
34773,High Mitotic Activity,Gastroesophageal Junction Neuroendocrine Carcinoma,1
34774,Malignant Cellular Infiltrate,"Synovial sarcoma, epithelioid cell",1
34775,Metastatic Lesion,Anal cancer metastatic,1
34776,Carcinomatous Component Present,Endometrial Carcinoma,1
34777,Carcinomatous Component Present,Platinum-Sensitive Lung Small Cell Carcinoma,1
34778,Epithelial Component Present,Invasive Breast Carcinoma by Histologic Grade,1
34779,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v6,1
34780,Malignant Cellular Infiltrate,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
34781,Glial Differentiation,Adult Gliosarcoma,1
34782,Exophytic Polypoid Lesion,Rectal Adenoma with Severe Dysplasia,1
34783,Childhood Lesion,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
34784,Carcinomatous Component Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
34785,Carcinomatous Component Present,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
34786,Benign Cellular Infiltrate,Benign phyllodes neoplasm of breast,1
34787,Epithelial Component Present,Breast Carcinoma Metastatic in the Bone,1
34788,Vascular Channel Formation,Angiomatous Meningioma,1
34789,Malignant Cellular Infiltrate,Mucoepidermoid Breast Carcinoma,1
34790,Rapidly Enlarging Mass,Fusion-Positive Rhabdomyosarcoma,1
34791,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
34792,Primary Lesion,Stage III Primary Peritoneal Cancer AJCC v8,1
34793,Malignant Cellular Infiltrate,adenocarcinoma of oral cavity,1
34794,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,Refractory High Risk Myelodysplastic Syndrome,1
34795,Gastrin Positive Neoplastic Cells Present,malignant gastrinoma of pancreas,1
34796,Epithelial Component Present,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
34797,Malignant Cellular Infiltrate,Stage II Hilar Cholangiocarcinoma AJCC v8,1
34798,Malignant Cellular Infiltrate,"Uterine Carcinosarcoma, Heterologous Type",1
34799,Exophytic Papillary Lesion,Warty Carcinoma of the Penis,1
34800,Adulthood Lesion,Stage II Adult Lymphoblastic Lymphoma,1
34801,Epithelial Component Present,Lung Typical Carcinoid Tumor,1
34802,Cutaneous Involvement,Skin disorder arising from mental factors,1
34803,Complete Spontaneous Regression,Type E Lymphomatoid Papulosis,1
34804,Fibrotic Stroma Formation,Biliary Adenofibroma,1
34805,Low Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v8,1
34806,Carcinomatous Component Present,Paget Disease Extramammary,1
34807,Pseudoglandular Pattern,Laryngeal Acantholytic Squamous Cell Carcinoma,1
34808,Nodular lesions,Focal nodular hyperplasia of liver,1
34809,Chronic Inflammatory Infiltrate,Adult Grade III Lymphomatoid Granulomatosis,1
34810,Epithelial Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
34811,Carcinomatous Component Present,Stage IIIC Fallopian Tube Cancer AJCC v7,1
34812,Diffuse Pattern,Recurrent Plasmablastic Lymphoma,1
34813,Biphasic Pattern,Third Ventricle Pilocytic Astrocytoma,1
34814,Alternative Fascicle (Bundle) Pattern,Laryngeal Leiomyoma,1
34815,Epithelial Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
34816,Carcinomatous Component Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,1
34817,Reinke Crystals Formation,Ovarian Stromal-Leydig Cell Tumor,1
34818,In Situ Lesion,Cervical Squamous Cell Carcinoma In Situ,1
34819,Epithelial Component Present,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
34820,Invasive Lesion,Squamous cell breast carcinoma,1
34821,Malignant Cellular Infiltrate,Stage III Acral Lentiginous Melanoma AJCC v7,1
34822,Epithelial Component Present,Stage III Colorectal Cancer,1
34823,Fibrotic Stroma Formation,Mucoepidermoid Breast Carcinoma,1
34824,Carcinomatous Component Present,Combined Lung Large Cell Neuroendocrine Carcinoma,1
34825,Intermediate Grade Neuroendocrine Lesion,Gastric Neuroendocrine Tumor G2,1
34826,Carcinomatous Component Present,intestinal type adenocarcinoma of gallbladder,1
34827,Cutaneous Involvement,Paget Disease of the Scrotum,1
34828,Well Differentiated Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
34829,Epithelial Component Present,Invasive Lobular Breast Carcinoma,1
34830,Epithelial Component Present,Metastatic Pancreatic Neuroendocrine Carcinoma,1
34831,Malignant Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v8,1
34832,Tissue Differentiation Uncertain,Malignant Uterine Corpus PEComa,1
34833,Chronic lymphocytic inflammation,Cardiac Inflammatory Myofibroblastic Tumor,1
34834,Indolent Clinical Course,Angiofibroma,1
34835,Epithelial Component Present,Stage II Oropharyngeal Carcinoma,1
34836,Benign Cellular Infiltrate,Breast Leiomyoma,1
34837,Carcinomatous Component Present,Refractory Carcinoma,1
34838,Recurrent disease,Precursor B-lymphoblastic lymphoma recurrent,1
34839,Epithelial Component Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
34840,Neuroendocrine Differentiation,Esophageal Neuroendocrine Neoplasm,1
34841,Jaw Keratocyst,Basal Cell Nevus Syndrome,1
34842,Monomorphic Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis,1
34843,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v6,1
34844,Tubular Structures Present,Benign mixed epithelial and stromal tumor of kidney,1
34845,Fibrotic Stroma Formation,endometrioid adenofibroma of ovary,1
34846,Increased Cellularity Present,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
34847,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
34848,Malignant Cellular Infiltrate,Stage IA Distal Bile Duct Cancer AJCC v7,1
34849,Peripheral Nuclear Palisading,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
34850,Immunologic Deficiency Syndromes,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
34851,Malignant Cellular Infiltrate,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
34852,Malignant Cellular Infiltrate,"Carcinoma, Small Cell",1
34853,Angiodestructive Pattern,Angiocentric immunoproliferative lesion grade 2,1
34854,Epithelial Component Present,Lymphoepithelial malignant thymoma,1
34855,Epithelial Component Present,Squamous intraepithelial lesion,1
34856,Malignant Cellular Infiltrate,Erythroleukemia (Erythroid/Myeloid),1
34857,Malignant Cellular Infiltrate,Childhood Lymphoma,1
34858,Epithelial Component Present,Minimally Invasive Mucinous Lung Adenocarcinoma,1
34859,Recurrent disease,Recurrent Primary Peritoneal Carcinoma,1
34860,Benign Cellular Infiltrate,Benign neoplasm of pharynx,1
34861,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage I,1
34862,Metastatic Lesion,Secondary Prostate Urothelial Carcinoma,1
34863,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
34864,Benign Cellular Infiltrate,Oral Cavity Lipoma,1
34865,Recurrent disease,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
34866,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7,1
34867,Epithelial Component Present,Testicular Thecoma,1
34868,Malignant Cellular Infiltrate,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
34869,Malignant Cellular Infiltrate,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
34870,Malignant Cellular Infiltrate,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,1
34871,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
34872,Neuroectodermal Differentiation,Localized Askin Tumor,1
34873,Nuclear Atypia,Small cell glioblastoma,1
34874,Perineural spread,Adenoid cystic carcinoma of submandibular gland,1
34875,Immunosuppression-Related Post-Transplant Toxicity,Graft-vs-Host Disease,1
34876,Epithelial Component Present,Recurrent Adrenal Cortex Carcinoma,1
34877,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v8,1
34878,Mitotic Activity,Childhood Pilomyxoid Astrocytoma,1
34879,Malignant Cellular Infiltrate,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7,1
34880,Cutaneous Involvement,Squamous Cell Carcinoma of Anal Margin,1
34881,Dermal Involvement,Vaginal Blue Nevus,1
34882,Malignant Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,1
34883,Epithelial Component Present,Gastric Large Cell Neuroendocrine Carcinoma,1
34884,Low Mitotic Activity,Metastatic Digestive System Neuroendocrine Tumor G1,1
34885,Pain,Mesenchymal Chondrosarcoma,1
34886,Cartilaginous Differentiation,Solitary Osteochondroma,1
34887,IDH Gene Family Mutation Status Unknown,oligodendroglioma,1
34888,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 4,1
34889,Increased Cellularity Present,Vulvar Cellular Angiofibroma,1
34890,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant",1
34891,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile ganglioglioma,1
34892,Malignant Cellular Infiltrate,Inflammatory carcinoma of breast stage IV,1
34893,Malignant Cellular Infiltrate,Rectal Adenosquamous Carcinoma,1
34894,Exophytic Polypoid Lesion,Polyp of middle ear,1
34895,Carcinomatous Component Present,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
34896,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,1
34897,Cutaneous Involvement,Diaper Rash,1
34898,Anaplasia,Anaplastic Diencephalic Astrocytoma,1
34899,Metastatic Lesion,Urothelial carcinoma ureter metastatic,1
34900,Epithelial Component Present,Childhood Laryngeal Carcinoma,1
34901,Malignant Cellular Infiltrate,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
34902,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
34903,Epithelial Component Present,Squamous non-small cell lung cancer,1
34904,Rapidly Enlarging Mass,"Myositis, Proliferative",1
34905,Ineffective hematopoiesis,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,1
34906,Papillary Pattern,ductal papilloma of salivary gland,1
34907,Epithelial Component Present,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
34908,Lymphadenopathy,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
34909,Benign Cellular Infiltrate,inverted ductal papilloma of salivary gland,1
34910,Malignant Cellular Infiltrate,Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8,1
34911,Peripheral Blood Involvement,Smoldering Adult T-Cell Leukemia/Lymphoma,1
34912,Malignant Cellular Infiltrate,Nipple Duct Carcinoma,1
34913,More than 10 Mitoses per 10HPF,Stage I Lung Small Cell Carcinoma AJCC v7,1
34914,Epithelial Component Present,Seminal Vesicle Cystadenoma,1
34915,Indolent Clinical Course,Synovial Hemangioma,1
34916,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Immature Teratoma,1
34917,Benign Cellular Infiltrate,Benign neoplasm of peritoneum,1
34918,Carcinomatous Component Present,Adenosquamous cell lung cancer stage III,1
34919,Recurrent disease,Oropharyngeal squamous cell carcinoma recurrent,1
34920,Malignant Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",1
34921,High Mitotic Activity,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
34922,Exophytic Polypoid Lesion,Cervical Fibroepithelial Polyp,1
34923,Secondary Lesion,Metastatic Carcinoma,1
34924,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of breast,1
34925,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Central Nervous System,1
34926,Epithelial Component Present,Anatomic Stage IV Breast Cancer AJCC v8,1
34927,Thick-Walled Hyalinized Vessels Present,Acoustic Neuroma,1
34928,Mitotic Activity,Adult Giant Cell Glioblastoma,1
34929,Malignant Cellular Infiltrate,Vaginal Large Cell Neuroendocrine Carcinoma,1
34930,Fibrotic Stroma Formation,Resectable Intrahepatic Cholangiocarcinoma,1
34931,Benign Cellular Infiltrate,Colorectal Ganglioneuroma,1
34932,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,1
34933,Exophytic Papillary Lesion,"Papillary squamous cell carcinoma, non-invasive",1
34934,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v8,1
34935,Epithelial Component Present,Bladder adenocarcinoma stage I,1
34936,Plasma cell inflammation,Inflammatory pseudotumor of liver,1
34937,Carcinomatous Component Present,Stage I Colon Cancer AJCC v6 and v7,1
34938,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of anal canal,1
34939,Exophytic Papillary Lesion,Papillary squamous cell carcinoma,1
34940,Mixed Cellular Population,Hybrid nerve sheath tumor,1
34941,Cutaneous Involvement,"Mucinosis, Follicular",1
34942,Exophytic Polypoid Lesion,Colorectal Tubulovillous Adenoma,1
34943,Poorly Differentiated Lesion,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
34944,Cystic Change,Broad Ligament Serous Cystadenoma,1
34945,Recurrent disease,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
34946,Collagenous Stroma Formation,Pelvic Fibromatosis,1
34947,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
34948,Rapidly Enlarging Mass,Vaginal Rhabdomyosarcoma,1
34949,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
34950,Diffuse Lesion,Meningeal Carcinomatosis,1
34951,Epithelial Component Present,Brenner Tumor,1
34952,Malignant Cellular Infiltrate,Solid Lung Adenocarcinoma,1
34953,Malignant Cellular Infiltrate,sarcoma of testis,1
34954,High Mitotic Activity,Vulvar Small Cell Carcinoma,1
34955,Adulthood Lesion,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8,1
34956,Osteoid formation,Cardiac Extraskeletal Osteosarcoma,1
34957,Adulthood Lesion,Adult Extracardiac Rhabdomyoma,1
34958,Malignant Cellular Infiltrate,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
34959,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
34960,Malignant Cellular Infiltrate,Myelodysplastic-Myeloproliferative Diseases,1
34961,Carcinomatous Component Present,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
34962,Carcinomatous Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma,1
34963,Epithelial Component Present,Stage III Lung Cancer AJCC v6,1
34964,Epithelial Component Present,Masaoka-Koga Stage I,1
34965,Low Mitotic Activity,Anal Canal Neuroendocrine Tumor G1,1
34966,Primary Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v8,1
34967,Epithelial Component Present,Metastatic Sarcomatoid Renal Cell Carcinoma,1
34968,Tissue Differentiation Uncertain,"Synovial sarcoma, epithelioid cell",1
34969,Metastatic/Recurrent Disease,Conventional Extraskeletal Myxoid Chondrosarcoma,1
34970,Cutaneous Involvement,Dermatitis acneiform,1
34971,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
34972,Metastatic Lesion,Krukenberg Tumor,1
34973,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1,1
34974,Microvascular Proliferation,Adult Brain Glioblastoma,1
34975,Carcinomatous Component Present,Stage I Laryngeal Cancer AJCC v6 and v7,1
34976,Neuroendocrine Differentiation,"Extra-adrenal paraganglioma, malignant",1
34977,Epithelial Component Present,Stage IVA Colorectal Cancer AJCC v7,1
34978,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
34979,Carcinomatous Component Present,Stage IV Paranasal Sinus Cancer AJCC v7,1
34980,Cystic Change,Rete Ovarii Cystadenofibroma,1
34981,Malignant Cellular Infiltrate,Stage III Childhood Hodgkin Lymphoma,1
34982,Adnexal Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
34983,Benign Cellular Infiltrate,Myxoid leiomyoma,1
34984,Absence of Muscle Invasion,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
34985,Biphasic Pattern,Ovarian Seromucinous Adenofibroma,1
34986,Biphasic Pattern,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
34987,Adulthood Lesion,Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8,1
34988,Unresectable Mass,Unresectable Pleural Malignant Mesothelioma,1
34989,Non-Malignant Cellular Infiltrate,Submandibular lymphadenitis,1
34990,Well-Circumscribed Lesion,External Auditory Canal Ceruminous Adenoma,1
34991,Recurrent disease,Recurrent Dedifferentiated Liposarcoma,1
34992,Biphasic Pattern,Atypical polypoid adenomyoma,1
34993,Malignant Cellular Infiltrate,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
34994,Malignant Cellular Infiltrate,CIC-DUX Sarcoma,1
34995,Dysplasia,Endometrial intraepithelial neoplasia,1
34996,Malignant Cellular Infiltrate,Contralateral Breast Carcinoma,1
34997,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v8,1
34998,Epithelial Component Present,Thymic Carcinoma,1
34999,Adulthood Lesion,Adult T-Cell Lymphoma/Leukemia,1
35000,Childhood Lesion,Childhood Anaplastic Large Cell Lymphoma,1
35001,Benign Cellular Infiltrate,Solid Angioleiomyoma,1
35002,Malignant Cellular Infiltrate,Synchronous Multifocal Osteosarcoma,1
35003,Secondary Lesion,Secondary malignant neoplasm of vagina,1
35004,Malignant Cellular Infiltrate,Sarcoma by NCI Grade,1
35005,Increased Cellularity Present,Childhood Anaplastic Ependymoma,1
35006,Invasive Lesion,Endometrioid carcinoma of prostate,1
35007,Epithelial Component Present,Stage II Vaginal Cancer AJCC v8,1
35008,'Starry-sky' pattern,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,1
35009,Epithelial Component Present,papillary adenoma of extrahepatic bile duct,1
35010,Epithelial Component Present,Stage IIIA Ampulla of Vater Cancer AJCC v8,1
35011,Carcinomatous Component Present,Pharyngeal Carcinoma by AJCC v8 Stage,1
35012,Encapsulated Mass,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
35013,Malignant Cellular Infiltrate,Cerebral Glioblastoma,1
35014,Malignant Cellular Infiltrate,Malignant Synovial Neoplasm,1
35015,Carcinomatous Component Present,Lymphoepithelial carcinoma,1
35016,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,1
35017,Malignant Cellular Infiltrate,Chondrosarcoma recurrent,1
35018,Slow Growing Painless Mass,Nodular tenosynovitis,1
35019,Dysplasia,Intestinal Intraepithelial Neoplasia,1
35020,Malignant Cellular Infiltrate,RISS Stage I Plasma Cell Myeloma,1
35021,Malignant Cellular Infiltrate,Aortic Angiosarcoma,1
35022,Non-Invasive Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
35023,Malignant Cellular Infiltrate,Carcinoma of larynx,1
35024,Presence of a Hormonal Syndrome,Pancreatic Somatostatinoma,1
35025,Adulthood Lesion,Lugano Classification Limited Stage Adult Lymphoma AJCC v8,1
35026,Epithelial Component Present,Chromophobe Renal Cell Carcinoma,1
35027,Fascicular Pattern,Clear Cell Sarcoma of Soft Tissue,1
35028,Chronic Inflammatory Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
35029,Nuclear Atypia,Multifocal Glioblastomas,1
35030,Malignant Cellular Infiltrate,Rectal Cribriform Comedo-Type Adenocarcinoma,1
35031,Erythema,Inflammatory carcinoma of breast stage IV,1
35032,Neuroendocrine Differentiation,Ovarian Carcinoid Tumor,1
35033,Malignant Cellular Infiltrate,"Liposarcoma, well differentiated",1
35034,Benign Cellular Infiltrate,Ethmoid Sinus Schneiderian Papilloma,1
35035,Malignant Cellular Infiltrate,Stage IVB Hilar Cholangiocarcinoma AJCC v8,1
35036,Epithelial Component Present,Mixed Somatotroph and Lactotroph Adenoma,1
35037,Secondary Lesion,Locally Advanced Malignant Neoplasm,1
35038,Epithelial Component Present,Stage 0 Urethral Cancer AJCC v7,1
35039,Malignant Cellular Infiltrate,Stage I Adult Lymphoblastic Lymphoma,1
35040,Epithelial Component Present,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
35041,Carcinomatous Component Present,Squamous cell carcinoma of scrotum,1
35042,Recurrent Lymphoma,EBV-Related Hodgkin Lymphoma,1
35043,Infiltrating Tumor Margins Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
35044,Intermediate Grade Lesion,Periosteal Osteosarcoma,1
35045,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Neoplasm,1
35046,Malignant Cellular Infiltrate,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
35047,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
35048,Perivascular Arrangement of Tumor Cells,Pulmonary lymphangioleiomyomatosis,1
35049,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
35050,Indolent Clinical Course,Benign Metastasizing Leiomyoma of the Uterine Corpus,1
35051,Malignant Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v8,1
35052,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
35053,Rapidly Enlarging Mass,Proliferative fasciitis,1
35054,Malignant Cellular Infiltrate,"Kaposi's sarcoma, metastatic",1
35055,Tissue Differentiation Uncertain,Synovial sarcoma recurrent,1
35056,Localized Lesion,Plasmacytoma anaplastic,1
35057,Malignant Cellular Infiltrate,serous adenocarcinofibroma of ovary,1
35058,Malignant Cellular Infiltrate,Testicular Teratoma with Somatic-Type Malignancy,1
35059,Epithelial Component Present,Prostatic Urethra Urothelial Carcinoma,1
35060,Carcinomatous Component Present,Gastric Cancer by AJCC v7 Stage,1
35061,Malignant Cellular Infiltrate,Advanced Small Intestinal Neuroendocrine Carcinoma,1
35062,Malignant Cellular Infiltrate,PRETEXT Stage 1 Hepatoblastoma,1
35063,Epithelial Component Present,Locally Advanced Salivary Gland Carcinoma,1
35064,Epithelial Component Present,Recurrent Cervical Adenosquamous Carcinoma,1
35065,Neuroendocrine Differentiation,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
35066,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor,1
35067,Epithelial Component Present,Oropharyngeal Carcinoma,1
35068,Carcinomatous Component Present,Ovarian Cystadenocarcinoma,1
35069,Malignant Cellular Infiltrate,African Burkitt's lymphoma,1
35070,Necrotic changes (finding),Small cell lung cancer limited stage,1
35071,Chronic Inflammatory Infiltrate,Childhood Lymphomatoid Granulomatosis,1
35072,Malignant Cellular Infiltrate,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
35073,Malignant Cellular Infiltrate,Unresectable Ewing Sarcoma,1
35074,Carcinomatous Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
35075,Hyperkeratosis,Verrucous carcinoma of the oral cavity recurrent,1
35076,Nuclear Grooves,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
35077,Carcinomatous Component Present,Bladder adenocarcinoma stage III,1
35078,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Central Nervous System,1
35079,Epithelial Component Present,Skin Clear Cell Basal Cell Carcinoma,1
35080,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Tumor G2,1
35081,Diffuse Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,1
35082,Epithelial Component Present,Stage II Anal Cancer AJCC v8,1
35083,Malignant Cellular Infiltrate,Stage IV Prostate Cancer AJCC v7,1
35084,Perivascular fibrosis,Hodgkin's disease nodular sclerosis recurrent,1
35085,Malignant Cellular Infiltrate,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
35086,Epithelial Component Present,Colorectal cancer recurrent,1
35087,Encapsulated Mass,Thyroid Gland Spindle Cell Follicular Adenoma,1
35088,Aflatoxins Toxicity,Aflatoxins-Related Hepatocellular Carcinoma,1
35089,'Starry-sky' pattern,African Burkitt's lymphoma,1
35090,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC V6 and v7,1
35091,Malignant Cellular Infiltrate,Malignant neoplasm of retina,1
35092,Invasive Lesion,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,1
35093,Malignant Cellular Infiltrate,Neuroendocrine carcinoma of the bladder,1
35094,Malignant Cellular Infiltrate,Stage IIIB Adult Liver Cancer AJCC v7,1
35095,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage IV,1
35096,Epithelial Component Present,Carcinoma of ampulla of Vater,1
35097,Carcinomatous Component Present,Stage I Esophageal Cancer AJCC v7,1
35098,Malignant Cellular Infiltrate,Stage I Skin Cancer,1
35099,Metastatic Lesion,Metastatic Breast Carcinoma,1
35100,Epithelial Component Present,Breast Fibroepithelial Neoplasm,1
35101,Refractory Disease,Refractory Malignant Neoplasm of Multiple Primary Sites,1
35102,Epithelial Component Present,Gastric Cardia Adenocarcinoma,1
35103,Papillary Pattern,Recurrent respiratory papillomatosis,1
35104,Malignant Cellular Infiltrate,Refractory Hairy Cell Leukemia,1
35105,Malignant Cellular Infiltrate,Squamous cell carcinoma of esophagus,1
35106,Malignant Cellular Infiltrate,Stage II Bone Sarcoma AJCC v7,1
35107,Benign Cellular Infiltrate,Capillary hemangioma of eyelid,1
35108,Neuroendocrine Differentiation,Gallbladder Goblet Cell Carcinoid,1
35109,Epithelial Component Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,1
35110,Severe dysplasia,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
35111,Tubular Pattern,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
35112,Synchronous Lesion,Synchronous Multifocal Osteosarcoma,1
35113,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
35114,Epithelial Component Present,Stage IVB Lung Cancer AJCC v8,1
35115,Benign Cellular Infiltrate,Benign Extragonadal Germ Cell Tumor,1
35116,Carcinomatous Component Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
35117,Well-Circumscribed Lesion,Colon Adenoma with Severe Dysplasia,1
35118,Dysplasia,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
35119,Splenomegaly,"Leukemia, Myeloid, Chronic-Phase",1
35120,Epithelial Component Present,Stage IIIC Fallopian Tube Cancer AJCC v7,1
35121,Pseudopapillary Pattern,Cerebellar Papillary Meningioma,1
35122,Carcinomatous Component Present,Stage III Esophageal Adenocarcinoma AJCC v7,1
35123,Pregnancy Complications,Stage IB Gestational Trophoblastic Tumor AJCC v7,1
35124,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v8,1
35125,Malignant Cellular Infiltrate,Colorectal Carcinoma Metastatic in the Lung,1
35126,Carcinomatous Component Present,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
35127,atypia morphology,Malignant Ovarian Thecoma,1
35128,Low Mitotic Activity,Colorectal Neuroendocrine Tumor,1
35129,Childhood Lesion,Recurrent Childhood Acute Lymphoblastic Leukemia,1
35130,Malignant Cellular Infiltrate,Malignant neoplasm of respiratory system,1
35131,Indolent Clinical Course,Congenital Cystic Hygroma,1
35132,Epithelial Component Present,Stage II Ampulla of Vater Cancer AJCC v7,1
35133,Malignant Cellular Infiltrate,Stage II Vulva Cancer AJCC v6,1
35134,Cutaneous Involvement,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
35135,Glomerular Hypertrophy,Secondary Focal Segmental Glomerulosclerosis,1
35136,Malignant Cellular Infiltrate,BCLC Stage D Adult Hepatocellular Carcinoma,1
35137,Malignant Cellular Infiltrate,Kadish Stage A Olfactory Neuroblastoma,1
35138,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
35139,Cartilaginous Differentiation,Mesenchymal Chondrosarcoma,1
35140,Malignant Cellular Infiltrate,Marginal zone lymphoma stage II,1
35141,Primary Lesion,Recurrent Medulloblastoma,1
35142,Absence of Invasion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
35143,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer,1
35144,Regional Disease,Ureteric cancer regional,1
35145,Exophytic Papillary Lesion,Vaginal Warty Carcinoma,1
35146,Diffuse Pattern,Double-Hit Lymphoma,1
35147,Cutaneous Involvement,Cutaneous diphtheria,1
35148,Carcinomatous Component Present,Endometrial adenocarcinoma,1
35149,Well Differentiated Lesion,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
35150,Malignant Cellular Infiltrate,Stage IIA2 Cervical Cancer AJCC v8,1
35151,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage IV,1
35152,Indolent Clinical Course,"Hemangioma, Cavernous",1
35153,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Clinical Stage,1
35154,Carcinomatous Component Present,Growth Hormone-Producing Pituitary Gland Carcinoma,1
35155,Carcinomatous Component Present,Recurrent Female Reproductive System Carcinoma,1
35156,Birbeck Granules Present,Adult Langerhans Cell Histiocytosis,1
35157,Carcinomatous Component Present,Bronchioloalveolar Adenocarcinoma,1
35158,Recurrent disease,Penis carcinoma recurrent,1
35159,Low Grade Neuroendocrine Lesion,Carcinoid tumor of intestine,1
35160,Intraductal Lesion,Noninfiltrating Intraductal Carcinoma,1
35161,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage III,1
35162,Cutaneous Involvement,Unresectable Cutaneous Melanoma,1
35163,Glandular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
35164,Epithelial Component Present,Stage IIIB Rectal Cancer AJCC v8,1
35165,Vascular Channel Formation,Lymphangioendothelioma,1
35166,Neuroendocrine Differentiation,Malignant Pancreatic Vipoma,1
35167,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1
35168,Pregnancy Complications,Placental Site Nodule or Plaque,1
35169,Metastatic Lesion,Metastatic Neoplasm to the Placenta,1
35170,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7,1
35171,Epithelial Component Present,Bladder Enteric Type Adenocarcinoma,1
35172,Carcinomatous Component Present,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7,1
35173,Recurrent disease,Recurrent Childhood Fibrillary Astrocytoma,1
35174,Malignant Cellular Infiltrate,MCD Diffuse Large B-Cell Lymphoma,1
35175,Low Grade Lesion,Subependymal Giant Cell Astrocytoma,1
35176,Well Differentiated Lesion,Verrucous carcinoma of the oral cavity recurrent,1
35177,Epithelial Component Present,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
35178,Secondary Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
35179,Malignant Cellular Infiltrate,Childhood Refractory Malignant Solid Neoplasm,1
35180,Malignant Cellular Infiltrate,Ear carcinoma,1
35181,Epithelial Component Present,Metastatic Kidney Carcinoma,1
35182,Hyalinized Vessels Present,Adult Pilocytic Astrocytoma,1
35183,Low Mitotic Activity,Anal Canal Neuroendocrine Tumor G1,1
35184,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v8,1
35185,Papillary Pattern,Urethral Verrucous Carcinoma,1
35186,Malignant Cellular Infiltrate,Primary peritoneal carcinoma,1
35187,Malignant Cellular Infiltrate,Pagetoid reticulosis,1
35188,Carcinomatous Component Present,Vulvar Small Cell Carcinoma,1
35189,Keratin pearl formation,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,1
35190,Malignant Cellular Infiltrate,Colorectal Signet Ring Cell Carcinoma,1
35191,Acinar Cell Differentiation,Recurrent Pancreatic Acinar Cell Carcinoma,1
35192,Carcinomatous Component Present,Parotid Gland Carcinosarcoma,1
35193,Malignant Cellular Infiltrate,Stage IIB Eyelid Carcinoma AJCC v8,1
35194,Epithelial Component Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
35195,Carcinomatous Component Present,cloacogenic carcinoma of rectum,1
35196,High Grade Lesion,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
35197,Carcinomatous Component Present,Stage 0 Oropharyngeal Carcinoma,1
35198,Malignant Cellular Infiltrate,Squamous Cell Carcinoma of Anal Margin,1
35199,Subcutaneous nodule,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
35200,Epithelial Component Present,Locally Advanced Prostate Adenocarcinoma,1
35201,Microvascular Proliferation,Neural Glioblastoma,1
35202,Monoclonal Cellular Population Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
35203,Epithelial Component Present,Localized Resectable Adult Liver Carcinoma,1
35204,Epithelial Component Present,Stage I Distal Bile Duct Cancer AJCC v8,1
35205,Indolent Clinical Course,Angiomatosis,1
35206,Malignant Cellular Infiltrate,High-Risk Neuroblastoma,1
35207,Necrotic changes (finding),"Glioblastoma, IDH-Mutant",1
35208,Cutaneous Involvement,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
35209,Carcinomatous Component Present,Grade 3 Invasive Breast Carcinoma,1
35210,Low Mitotic Activity,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
35211,Malignant Cellular Infiltrate,Lung adenocarcinoma recurrent,1
35212,Cutaneous Involvement,Common blue nevus of skin,1
35213,Epithelial Component Present,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
35214,Epithelial Component Present,Choroid Plexus Papilloma,1
35215,Carcinomatous Component Present,Paget's disease and intraductal carcinoma of breast,1
35216,Thyroglobulin Positive Neoplastic Cells Present,Papillary Thyroid Microcarcinoma,1
35217,Benign Cellular Infiltrate,Benign Ovarian Seromucinous Tumor,1
35218,Calcitonin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
35219,Cutaneous Involvement,Atrophic condition of skin,1
35220,Cystic Change,Thymic Mucoepidermoid Carcinoma,1
35221,Epithelial Component Present,Stage IVA Basal Cell Lip Carcinoma,1
35222,Malignant Cellular Infiltrate,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
35223,Swelling,Adamantinoma,1
35224,Endophytic Tumor Growth,verrucous carcinoma of vulva,1
35225,Osseous Differentiation,Intermediate Osteogenic Neoplasm,1
35226,Exophytic Polypoid Lesion,Esophageal squamous papilloma,1
35227,Carcinomatous Component Present,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
35228,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
35229,Metastatic Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,1
35230,Epithelial Component Present,Familial Paraganglioma,1
35231,Koilocytotic atypia,Vaginal Warty Carcinoma,1
35232,Epithelial Component Present,tubular adenoma of gallbladder,1
35233,Epithelial Component Present,Transitional cell carcinoma metastatic,1
35234,Oligodendroglial Component Present,Recurrent Anaplastic Oligodendroglioma,1
35235,Malignant Cellular Infiltrate,Adult Anaplastic (Malignant) Meningioma,1
35236,Metaplasia,Nephrogenic metaplasia,1
35237,Edematous Stroma Formation,Superficial angiomyxoma,1
35238,Adulthood Lesion,Stage III Adult Hodgkin Lymphoma,1
35239,Epithelial Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
35240,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
35241,Primary Lesion,Recurrent Medulloblastoma,1
35242,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis,1
35243,Severe dysplasia,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
35244,Epithelial Component Present,Primary Peritoneal Cancer by AJCC v7 Stage,1
35245,Malignant Cellular Infiltrate,Squamous cell carcinoma of skin,1
35246,Carcinomatous Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
35247,Carcinomatous Component Present,Refractory Liver Carcinoma,1
35248,High Mitotic Activity,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
35249,Metastatic Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
35250,Carcinomatous Component Present,Stage IIIA2 Fallopian Tube Cancer AJCC v8,1
35251,Papillary Pattern,Ethmoid Sinus Inverted Papilloma,1
35252,Recurrent disease,Adult T-cell lymphoma/leukemia recurrent,1
35253,Multifocal Lesion,Erdheim-Chester Disease,1
35254,Mild cytologic atypia,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
35255,Carcinomatous Component Present,Unresectable Lung Carcinoma,1
35256,Indolent Clinical Course,Intracranial lipoma,1
35257,Malignant Cellular Infiltrate,Recurrent Subsequent Malignant Neoplasm,1
35258,Malignant Cellular Infiltrate,Prolactin-Producing Pituitary Gland Carcinoma,1
35259,Epithelial Component Present,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
35260,Infiltrating Tumor Margins Present,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
35261,Congenital Lesion,Congenital Epulides,1
35262,Malignant Cellular Infiltrate,Secondary malignant neoplasm of large intestine,1
35263,Carcinomatous Component Present,Stage IIA Pancreatic Cancer AJCC v6 and v7,1
35264,Metastatic Lesion,Locally Advanced Squamous Cell Carcinoma,1
35265,Malignant Cellular Infiltrate,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
35266,Malignant Cellular Infiltrate,Unresectable Skin Carcinoma,1
35267,Dysplasia,Vaginal high grade squamous intraepithelial lesion,1
35268,Epithelial Component Present,Stage II Vulvar Cancer AJCC v8,1
35269,Malignant Cellular Infiltrate,Advanced Prostate Carcinoma,1
35270,Diffuse Pattern,Recurrent Childhood Diffuse Astrocytoma,1
35271,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage III,1
35272,Carcinomatous Component Present,Stage IVB Appendix Carcinoma AJCC v8,1
35273,Primary Lesion,Childhood Cerebral Diffuse Astrocytoma,1
35274,Malignant Cellular Infiltrate,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
35275,Refractory Disease,Refractory Head and Neck Carcinoma,1
35276,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
35277,Malignant Cellular Infiltrate,Gastric Synovial Sarcoma,1
35278,Abnormal Eosinophilic Granules Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
35279,Epithelial Component Present,High Grade Appendix Mucinous Adenocarcinoma,1
35280,Monoclonal Cellular Population Present,Clonal Hematopoiesis of Indeterminate Potential,1
35281,Malignant Cellular Infiltrate,Lip and Oral Cavity Carcinoma,1
35282,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
35283,Malignant Cellular Infiltrate,Colorectal Sarcoma,1
35284,Hyperplastic Tissue Present,Hyperplasia of Brunner glands of duodenum,1
35285,Stromal Invasion,Malignant Ovarian Endometrioid Tumor,1
35286,Monoclonal Cellular Population Present,Cutaneous Mastocytosis,1
35287,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v7,1
35288,Epithelial Component Present,Refractory Liver Carcinoma,1
35289,Epithelial Component Present,Poorly Differentiated Hepatocellular Carcinoma,1
35290,Malignant Cellular Infiltrate,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
35291,Benign Cellular Infiltrate,Apocrine adenoma,1
35292,Syncytial Pattern,Nasopharyngeal lymphoepithelioma recurrent,1
35293,Macrofollicular Structures Present,Juvenile type ovarian granulosa cell tumor,1
35294,Cartilaginous Differentiation,Benign chondrogenic neoplasm,1
35295,Primary Lesion,Small cell osteosarcoma,1
35296,Multinodular Mass,Uterine Angiosarcoma,1
35297,Malignant Cellular Infiltrate,Labia Minora Carcinoma,1
35298,Tissue Differentiation Uncertain,Aggressive angiomyxoma,1
35299,Invasive Lesion,Small cell carcinoma of prostate,1
35300,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Megakaryoblastic Leukemia,1
35301,Malignant Cellular Infiltrate,Laryngeal Mucoepidermoid Carcinoma,1
35302,Lytic lesion,Osteolytic Neoplasm,1
35303,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v7,1
35304,Vascular Channel Formation,Cardiac Capillary Hemangioma,1
35305,atypia morphology,High Grade Liver Dysplastic Nodule,1
35306,Carcinomatous Component Present,Ethmoid Sinus Adenocarcinoma,1
35307,Thyroglobulin Positive Neoplastic Cells Present,Multicentric Thyroid Gland Papillary Carcinoma,1
35308,Epithelial Component Present,Fibroepithelioma of Pinkus,1
35309,Carcinomatous Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
35310,Malignant Cellular Infiltrate,Stage IVB Prostate Cancer AJCC v8,1
35311,Human Papillomavirus Negative,Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
35312,Malignant Cellular Infiltrate,Lung Adenosquamous Carcinoma by AJCC v7 Stage,1
35313,Epithelial Component Present,Recurrent Merkel Cell Carcinoma,1
35314,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
35315,Lymphadenopathy,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
35316,Multifocal Lesion,Refractory Malignant Neoplasm of Multiple Primary Sites,1
35317,Benign Cellular Infiltrate,"Fibro-odontoma, Ameloblastic",1
35318,HMB-45-Positive Neoplastic Cells Present,Benign Uterine Corpus PEComa,1
35319,Eosinophil count raised (finding),Chronic Myelomonocytic Leukemia with Eosinophilia,1
35320,Intraductal Lesion,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
35321,Malignant Cellular Infiltrate,Frontal Lobe Anaplastic Astrocytoma,1
35322,atypia morphology,Dysplastic Nevus,1
35323,More than 10 Mitoses per 10HPF,Occult Lung Small Cell Carcinoma,1
35324,Cystic Change,Vaginal Dermoid Cyst,1
35325,Epithelial Component Present,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
35326,Malignant Cellular Infiltrate,Adenocarcinoma of large intestine,1
35327,Metastatic Lesion,Metastatic Childhood Soft Tissue Sarcoma,1
35328,Ground Glass Nuclear Inclusion,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
35329,Epithelial Component Present,Adenoma of large intestine,1
35330,Secondary Lesion,Distantly Metastatic Malignant Neoplasm,1
35331,Benign Cellular Infiltrate,Gastric Hemangioma,1
35332,Epithelial Component Present,Uterine Corpus Carcinosarcoma,1
35333,Malignant Cellular Infiltrate,Eccrine carcinoma of skin,1
35334,Carcinomatous Component Present,Metastatic Lung Adenocarcinoma,1
35335,High Grade Lesion,Recurrent Dedifferentiated Liposarcoma,1
35336,Epithelial Component Present,Adult Type Granulosa Cell Tumor,1
35337,Neuroendocrine Differentiation,Uterine Corpus Carcinoid Tumor,1
35338,High Mitotic Activity,Childhood Ovarian Embryonal Carcinoma,1
35339,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage IV,1
35340,Dysplasia,Rectal Sessile Serrated Adenoma/Polyp,1
35341,Local disease,Lipoma of the tongue,1
35342,Malignant Cellular Infiltrate,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
35343,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
35344,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I,1
35345,Malignant Cellular Infiltrate,Sellar Dedifferentiated Chordoma,1
35346,Necrotic changes (finding),Small cell carcinoma of esophagus,1
35347,Epithelial Component Present,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
35348,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Immature Teratoma,1
35349,Biphasic Pattern,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,1
35350,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v8,1
35351,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
35352,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,1
35353,Malignant Cellular Infiltrate,Old Burn Scar-Related Skin Squamous Cell Carcinoma,1
35354,Epithelial Component Present,Stage IV Vulvar Cancer AJCC v7,1
35355,Malignant Cellular Infiltrate,Non-Resectable Malignant Liver Neoplasm,1
35356,Malignant Cellular Infiltrate,Testicular yolk sac tumor stage I,1
35357,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage I,1
35358,Alternative Fascicle (Bundle) Pattern,Degeneration of uterine fibroid,1
35359,Refractory Disease,Refractory Desmoplastic Small Round Cell Tumor,1
35360,Infiltrative Growth Pattern,Peyronie Disease,1
35361,Malignant Cellular Infiltrate,Stage IV Malignant Mediastinal Germ Cell Tumor,1
35362,Necrotic changes (finding),Melanotic malignant nerve sheath tumor,1
35363,Absence of Invasion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
35364,Metastatic Lesion,Metastatic Lung Adenocarcinoma,1
35365,Mitotic Activity,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
35366,Mallory Bodies,Acute alcoholic liver disease,1
35367,Anaplasia,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
35368,Vascular Channel Formation,Intravascular Angioleiomyoma,1
35369,Slow Growing Mass,Hemangioblastoma,1
35370,More than 5 Mitoses per 50HPF,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
35371,Malignant Cellular Infiltrate,Advanced Pancreatic Neuroendocrine Tumor,1
35372,Malignant Cellular Infiltrate,Stage IA Breast Cancer AJCC v7,1
35373,In Situ Lesion,Stage 0 Rectal Cancer AJCC v8,1
35374,Benign Cellular Infiltrate,Apocrine adenoma,1
35375,Multilocular Lesion,"Mesothelioma, Cystic",1
35376,Carcinomatous Component Present,Bladder squamous cell carcinoma stage 0,1
35377,Primary Lesion,Primary serous papillary carcinoma of peritoneum,1
35378,Malignant Cellular Infiltrate,Recurrent Childhood Burkitt Lymphoma,1
35379,Secondary Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
35380,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage I,1
35381,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adult Subependymoma,1
35382,Adulthood Lesion,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
35383,Malignant Cellular Infiltrate,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,1
35384,Benign Cellular Infiltrate,Pancreatic Solid Serous Adenoma,1
35385,Epithelial Component Present,Stage IVA Rectal Cancer AJCC v7,1
35386,Carcinomatous Component Present,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
35387,Neuroendocrine Differentiation,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
35388,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
35389,Refractory Disease,Refractory Liposarcoma,1
35390,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
35391,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
35392,Malignant Cellular Infiltrate,leiomyosarcoma of mediastinum,1
35393,Adulthood Lesion,Adult Grade II Meningioma,1
35394,Primary Lesion,Fourth Ventricle and Brain Stem Ependymal Tumor,1
35395,Clinical TNM Finding,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
35396,Biphasic Pattern,Broad Ligament Serous Adenofibroma,1
35397,Malignant Cellular Infiltrate,Stage IIIB Lung Large Cell Carcinoma AJCC v7,1
35398,Malignant Cellular Infiltrate,Squamous Cell Carcinoma of Unknown Primary,1
35399,Epithelial Component Present,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
35400,Malignant Cellular Infiltrate,PRETEXT Stage 2 Hepatoblastoma,1
35401,Malignant Cellular Infiltrate,Lipid-rich carcinoma,1
35402,Malignant Cellular Infiltrate,signet ring cell carcinoma of pancreas,1
35403,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
35404,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
35405,Necrotic changes (finding),Small cell lung cancer limited stage,1
35406,Pseudostratified Tumor Cells Present,"Endocervical Adenocarcinoma, Usual Type",1
35407,Malignant Cellular Infiltrate,Refractory Thyroid Gland Carcinoma,1
35408,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
35409,Myomatous Stroma Formation,Uterine Corpus Atypical Polypoid Adenomyoma,1
35410,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v7 Stage,1
35411,Cutaneous Involvement,Basal cell carcinoma - follicular,1
35412,Invasive Lesion,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
35413,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
35414,Dysplasia,Appendix Sessile Serrated Adenoma/Polyp,1
35415,Low Mitotic Activity,Appendix Neuroendocrine Tumor G2,1
35416,Cutaneous Involvement,Mycosis fungoides stage IV,1
35417,Benign Cellular Infiltrate,Heavily Pigmented Adrenal Cortical Adenoma,1
35418,Neuroendocrine Differentiation,Stage IIB Merkel Cell Carcinoma AJCC v7,1
35419,Epithelial Component Present,Cerebellar Paraganglioma,1
35420,Malignant Cellular Infiltrate,Stage II Urethral Cancer AJCC v7,1
35421,Malignant Cellular Infiltrate,Clinical Stage II Esophageal Adenocarcinoma AJCC v8,1
35422,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
35423,Metastatic Lesion,Metastatic Lung Neuroendocrine Neoplasm,1
35424,Adulthood Lesion,Adult Acute Monoblastic and Monocytic Leukemia,1
35425,Malignant Cellular Infiltrate,Hereditary Prostate Carcinoma,1
35426,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Neoplasm,1
35427,Carcinomatous Component Present,undifferentiated carcinoma of liver,1
35428,Malignant Cellular Infiltrate,Medium/Large Size Posterior Uveal Melanoma,1
35429,Carcinomatous Component Present,Sphenoid Sinus Squamous Cell Carcinoma,1
35430,Nuclear pleomorphism,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
35431,Well-Circumscribed Lesion,Central Nervous System Hibernoma,1
35432,Whorling Growth Pattern,"Dendritic Cell Sarcoma, Follicular",1
35433,Refractory Disease,Refractory Primary Peritoneal Carcinoma,1
35434,Exophytic Polypoid Lesion,tubulopapillary adenoma of gallbladder,1
35435,Indolent Clinical Course,Benign neoplasm of spleen,1
35436,Malignant Cellular Infiltrate,Stage II Adult Hodgkin Lymphoma,1
35437,Nuclear Pseudoinclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
35438,Benign Cellular Infiltrate,Appendix Leiomyoma,1
35439,Benign Cellular Infiltrate,Perineal Ectopic Fibroadenoma,1
35440,Carcinomatous Component Present,Ampulla of Vater Squamous Cell Carcinoma,1
35441,Carcinomatous Component Present,Recurrent Submandibular Gland Squamous Cell Carcinoma,1
35442,Malignant Cellular Infiltrate,Stage IIA Anal Cancer AJCC v8,1
35443,Mesenchymal Component Present,Giant fibroadenoma of breast,1
35444,Childhood Lesion,Childhood Brain Anaplastic Astrocytoma,1
35445,Mixed Cellular Population,Nephroblastoma,1
35446,Childhood Lesion,Recurrent Childhood Acute Lymphoblastic Leukemia,1
35447,Tissue Differentiation Uncertain,Extrarenal rhabdoid tumor,1
35448,Malignant Cellular Infiltrate,Recurrent Olfactory Neuroblastoma,1
35449,Carcinomatous Component Present,Transplant-Related Squamous Cell Carcinoma,1
35450,Antoni A Pattern,Adrenal Gland Schwannoma,1
35451,Poorly Differentiated Lesion,Spindle cell squamous cell carcinoma,1
35452,Hyperplastic Tissue Present,Mesothelial hyperplasia,1
35453,New bone formation (morphologic abnormality),Giant Cell Lesion of Small Bones,1
35454,Mesenchymal Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
35455,Recurrent disease,recurrent adult acute myeloid leukemia,1
35456,Multinodular Mass,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
35457,Secondary Lesion,Metastatic Unresectable Basal Cell Carcinoma,1
35458,Endophytic Tumor Growth,verrucous carcinoma of bladder,1
35459,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,1
35460,Primary Lesion,Temporal Lobe Ependymal Tumor,1
35461,Cutaneous Involvement,Malignant neoplasm of sweat gland,1
35462,Epithelial Component Present,Stage IV Thymus Epithelial Neoplasm AJCC v8,1
35463,Monocytosis,Chronic Myelomonocytic Leukemia with Eosinophilia,1
35464,Malignant Cellular Infiltrate,Ameloblastic Carcinoma,1
35465,Hereditary Lesion,Hereditary hemorrhagic telangiectasia,1
35466,Pseudorosette Formation,Gastric Gastrin-Producing Neuroendocrine Tumor,1
35467,Secondary Lesion,Skin squamous cell carcinoma metastatic,1
35468,Tubular Pattern,tubulovillous adenoma of stomach,1
35469,Clinical TNM Finding,Clinical Stage IVB Gastric Cancer AJCC v8,1
35470,Crystal deposition,Alveolar soft part sarcoma metastatic,1
35471,Diffuse Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,1
35472,Chronic lymphocytic inflammation,Bone Epithelioid Hemangioma,1
35473,Malignant Cellular Infiltrate,Adenocarcinoma in adenomatous polyposis coli,1
35474,Perineural spread,adenoid cystic carcinoma of lung,1
35475,Epithelial Component Present,Stage IIA Merkel Cell Carcinoma AJCC v7,1
35476,Cystic Change,Pancreatic Intraductal Tubulopapillary Neoplasm,1
35477,Invasive Lesion,Locally Advanced Prostate Adenocarcinoma,1
35478,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage III,1
35479,Thin Bands of Collagen Present,Thymus Solitary Fibrous Tumor,1
35480,Primary Lesion,Poorly Differentiated Hepatocellular Carcinoma,1
35481,Dysplasia,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
35482,Adulthood Lesion,Adult T-cell lymphoma/leukemia recurrent,1
35483,Benign Cellular Infiltrate,Palisaded encapsulated neuroma,1
35484,Metastatic Lesion,Breast Carcinoma Metastatic in the Bone,1
35485,Malignant Cellular Infiltrate,Immature Granulocytic Sarcoma,1
35486,Nuclear Expression of STAT6 Protein,Thyroid Gland Solitary Fibrous Tumor,1
35487,Malignant Cellular Infiltrate,Pineal Region Choriocarcinoma,1
35488,Diffuse Pattern,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
35489,Well-Circumscribed Lesion,Recurrent Myxoid Liposarcoma,1
35490,Benign Cellular Infiltrate,Benign neoplasm of breast,1
35491,Epithelial Component Present,Prostate cancer stage B,1
35492,Epithelial Component Present,Minor Salivary Gland Mucoepidermoid Carcinoma,1
35493,Fibrotic Stroma Formation,Laryngeal Mucoepidermoid Carcinoma,1
35494,Pseudopapillary Pattern,embryonal carcinoma of mediastinum,1
35495,Mixed Cellular Population,carcinosarcoma of gallbladder,1
35496,Pathologic TNM Finding,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8,1
35497,Hyaline Cartilage Differentiation,Secondary Chondrosarcoma,1
35498,Locally Aggressive Lesion,Abdominal Inflammatory Myofibroblastic Tumor,1
35499,Benign Cellular Infiltrate,Benign Childhood Brain Neoplasm,1
35500,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage I,1
35501,Epithelial Component Present,"Endometrioid adenoma, borderline malignancy",1
35502,Tissue of Mullerian Origin Present,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
35503,Tubular Structures Present,Ovarian Sertoli Cell Tumor with Lipid Storage,1
35504,Well Differentiated Lesion,Upper Gingival Verrucous Carcinoma,1
35505,Well-Circumscribed Lesion,Oropharyngeal Polyp,1
35506,Malignant Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v8,1
35507,Malignant Cellular Infiltrate,Sarcoma of liver,1
35508,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage IV,1
35509,Chronic lymphocytic inflammation,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
35510,Local disease,Localized Gastroesophageal Junction Adenocarcinoma,1
35511,Dysplasia,"Gastric Adenoma, Gastric-Type",1
35512,Primary Lesion,Ethmoid Sinus Primary Ectopic Meningioma,1
35513,Malignant Cellular Infiltrate,Stage IV Ovarian Teratoma AJCC v6 and v7,1
35514,Vascular Channel Formation,Hemangiosarcoma,1
35515,Myxoid Stroma Formation,Follicular Myxoma,1
35516,Metastatic Lesion,Metastatic Digestive System Carcinoma,1
35517,Malignant Cellular Infiltrate,Malignant neoplasm of penis,1
35518,Mixed Cellular Population,Mixed astrocytoma-ependymoma,1
35519,Carcinomatous Component Present,Stage IA Esophageal Adenocarcinoma AJCC v7,1
35520,Peripheral Nuclear Palisading,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
35521,Aberrant Thyroid Tissue Present,Struma Ovarii,1
35522,Carcinomatous Component Present,Cervical Lymphoepithelioma-Like Carcinoma,1
35523,Metastatic Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,1
35524,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia recurrent,1
35525,Oligodendroglial Component Present,Recurrent Childhood Anaplastic Oligoastrocytoma,1
35526,Rapidly Enlarging Mass,Uterine Corpus Rhabdomyosarcoma,1
35527,Malignant Cellular Infiltrate,Synovial sarcoma recurrent,1
35528,In Situ Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
35529,Well-Circumscribed Lesion,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,1
35530,Carcinomatous Component Present,Adenocarcinoma of small intestine,1
35531,Recurrent disease,Recurrent T Acute Lymphoblastic Leukemia,1
35532,Cutaneous Involvement,Tufted angioma of skin,1
35533,Endocervical Type Epithelium Present,"Cervical Adenomyoma, Endocervical Type",1
35534,Severe cytologic atypia,Metastatic Pancreatic Neuroendocrine Carcinoma,1
35535,Hyalinized Stroma Formation,Solitary fibrous tumor,1
35536,Indolent Clinical Course,Benign neoplasm of body of uterus,1
35537,Malignant Cellular Infiltrate,Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8,1
35538,Neuroendocrine Differentiation,Stage III Lung Small Cell Carcinoma AJCC v7,1
35539,S-100-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
35540,Epithelial Component Present,Localized Non-Resectable Adult Liver Carcinoma,1
35541,Clinical TNM Finding,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
35542,Malignant Cellular Infiltrate,Recurrent Primary Malignant Neoplasm,1
35543,Well Differentiated Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1,1
35544,Malignant Cellular Infiltrate,Refractory Pancreatic Carcinoma,1
35545,Glial Differentiation,Childhood Gliosarcoma,1
35546,In Situ Lesion,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
35547,Intraductal Lesion,Intraductal papillary breast neoplasm,1
35548,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma of central nervous system,1
35549,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II,1
35550,Cutaneous Involvement,Skin Angiosarcoma,1
35551,Childhood Lesion,Childhood Malignant Small Intestinal Neoplasm,1
35552,Benign Cellular Infiltrate,Lymphangioma circumscriptum,1
35553,Carcinomatous Component Present,Bladder Enteric Type Adenocarcinoma,1
35554,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v7,1
35555,Refractory Disease,Refractory Synovial Sarcoma,1
35556,Recurrent disease,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma,1
35557,Epithelial Component Present,Carcinoid tumor of ileum,1
35558,Carcinomatous Component Present,Breast Cancer by AJCC v8 Stage,1
35559,Carcinomatous Component Present,Fallopian Tube Transitional Cell Carcinoma,1
35560,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
35561,Malignant Cellular Infiltrate,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
35562,Subcutaneous nodule,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
35563,Cystic Change,Cystadenoma of pancreas,1
35564,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma of parotid gland,1
35565,Epithelial Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
35566,Pregnancy Complications,Poor Prognosis Metastatic Gestational Trophoblastic Tumor,1
35567,Polyvesicular Vitelline Pattern,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
35568,Mixed Cellular Population,Pituitary Gland Mixed Gangliocytoma-Adenoma,1
35569,Epithelial Component Present,Classical Poroma,1
35570,Junctional Proliferation,Epithelioid cell nevus,1
35571,Metastatic Lesion,Metastatic Squamous Cell Carcinoma of the Nasopharynx,1
35572,Cutaneous Involvement,Sebaceous Breast Carcinoma,1
35573,Neuroendocrine Differentiation,"Carcinoma, Small Cell",1
35574,Malignant Cellular Infiltrate,Secondary malignant neoplasm of rectum,1
35575,Lesion Less than 10mm in Diameter,Sporadic Thyroid Gland Micromedullary Carcinoma,1
35576,Well-Circumscribed Lesion,Refractory Myxoid Liposarcoma,1
35577,Nuclear pleomorphism,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
35578,Carcinomatous Component Present,Stage 0a Urethral Cancer AJCC v8,1
35579,Well-Circumscribed Lesion,Rectal Tubular Adenoma,1
35580,Therapy-Related Toxicity,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
35581,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8,1
35582,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
35583,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis,1
35584,Malignant Cellular Infiltrate,Adenosquamous carcinoma,1
35585,Well-Circumscribed Lesion,Villous adenoma of colon,1
35586,Malignant Cellular Infiltrate,Nipple Carcinoma,1
35587,Carcinomatous Component Present,"Adenocarcinoma of lung, stage II",1
35588,Epithelial Component Present,Distal Esophagus Squamous Cell Carcinoma,1
35589,Adulthood Lesion,Adult Germ Cell Tumor,1
35590,Pathologic TNM Finding,Pathologic Stage III Cutaneous Melanoma AJCC v8,1
35591,Delicate Vascular Network Formation,Grade 4 Clear Cell Renal Cell Carcinoma,1
35592,Carcinomatous Component Present,Recurrent Thyroid Gland Follicular Carcinoma,1
35593,Osteoid formation,Bone island,1
35594,Mitotic Activity,Anaplastic astrocytoma,1
35595,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of rectum,1
35596,Locally Aggressive Lesion,Ossifying fibromyxoid tumor,1
35597,Hyperplastic Tissue Present,Utricle-Associated Mucosal Gland Hyperplasia,1
35598,Benign Cellular Infiltrate,Ancell-Spiegler cylindromas,1
35599,Hyalinized Stroma Formation,Chondroid lipoma,1
35600,Malignant Cellular Infiltrate,Metastatic signet ring cell carcinoma,1
35601,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma refractory,1
35602,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Cystic Teratoma,1
35603,Epithelial Component Present,Stage IV Lung Cancer AJCC v6,1
35604,Carcinomatous Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
35605,Benign Cellular Infiltrate,"Hemangioma, Cavernous, Central Nervous System",1
35606,Adulthood Lesion,Adult Brain Glioblastoma,1
35607,Secondary Lesion,Locally Advanced Small Intestinal Carcinoma,1
35608,Exophytic Polypoid Lesion,villous adenoma of stomach,1
35609,Sarcomatous Component Present,carcinosarcoma of salivary gland,1
35610,Carcinomatous Component Present,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
35611,Secondary Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,1
35612,Epithelial Component Present,Stage IV Nasal Cavity Carcinoma AJCC v7,1
35613,Necrotic changes (finding),Childhood Gliosarcoma,1
35614,Epithelial Component Present,Refractory Thymic Carcinoma,1
35615,Severe cytologic atypia,Esophageal Large Cell Neuroendocrine Carcinoma,1
35616,Cutaneous Involvement,American cutaneous leishmaniasis,1
35617,Carcinomatous Component Present,Bladder Urachal Urothelial Carcinoma,1
35618,Neuroendocrine Differentiation,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
35619,Indolent Clinical Course,Chorioangioma,1
35620,Mitotic Activity,teratocarcinoma of mediastinum,1
35621,Biphasic Pattern,Anal Ectopic Fibroadenoma,1
35622,Erythroid hyperplasia,"Polycythemia Vera, Polycythemic Phase",1
35623,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral",1
35624,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
35625,Malignant Cellular Infiltrate,Well Differentiated Hepatocellular Carcinoma,1
35626,Malignant Cellular Infiltrate,Pleural mesothelioma malignant advanced,1
35627,Benign Cellular Infiltrate,Benign Uterine Ligament Neoplasm,1
35628,Diffuse Pattern,Proneural Glioblastoma,1
35629,Diffuse Pattern,Gliomatosis Cerebri Type I,1
35630,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v7,1
35631,Malignant Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v8,1
35632,Whorling Growth Pattern,"Dendritic Cell Sarcoma, Interdigitating",1
35633,Epithelial Component Present,Carcinoma bone,1
35634,Recurrent disease,Recurrent Adenoid Cystic Carcinoma,1
35635,Biphasic Pattern,Recurrent Childhood Pilocytic Astrocytoma,1
35636,Follicular Cell Differentiation,Nonencapsulated sclerosing tumor,1
35637,Epithelial Component Present,Mixed Somatotroph and Lactotroph Adenoma,1
35638,Recurrent disease,Recurrent Langerhans Cell Histiocytosis,1
35639,Malignant Cellular Infiltrate,Stage III Ovarian Teratoma AJCC v6 and v7,1
35640,Well-Circumscribed Lesion,polyps,1
35641,Malignant Cellular Infiltrate,Stage IA Eyelid Carcinoma AJCC v7,1
35642,Secondary Lesion,Radiation-Related Osteosarcoma,1
35643,Papillary Pattern,Bladder Squamous Papilloma,1
35644,Secondary Lesion,Radiation-Related Osteosarcoma,1
35645,Malignant Cellular Infiltrate,Fusion-Positive Rhabdomyosarcoma,1
35646,Malignant Cellular Infiltrate,Squamous cell carcinoma of prostate,1
35647,Malignant Cellular Infiltrate,Stage IVB Fallopian Tube Cancer AJCC v8,1
35648,Cutaneous Involvement,Stage IV Merkel Cell Carcinoma AJCC v7,1
35649,Exophytic Polypoid Lesion,Rectal Traditional Serrated Adenoma,1
35650,Malignant Cellular Infiltrate,Rare Childhood Malignant Neoplasm,1
35651,High Grade Lesion,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
35652,Carcinomatous Component Present,Stage IB Eyelid Carcinoma AJCC v7,1
35653,Benign Cellular Infiltrate,Acral Fibromyxoma,1
35654,Slow Growing Mass,Sellar Dedifferentiated Chordoma,1
35655,Epithelial Component Present,Gastric Neuroendocrine Tumor,1
35656,Malignant Cellular Infiltrate,Platinum-Sensitive Lung Small Cell Carcinoma,1
35657,Regional Disease,Locally Advanced Chordoma,1
35658,Diffuse Pattern,Grade 1 Diffuse Follicular Lymphoma,1
35659,Epithelial Component Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,1
35660,Lymphadenopathy,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage,1
35661,Epithelial Component Present,Borderline epithelial tumor of ovary,1
35662,Low Mitotic Activity,Intestinal Neuroendocrine Tumor,1
35663,Storiform Growth Pattern,Cutaneous Fibrous Histiocytoma,1
35664,Secondary Lesion,Locally Advanced Prostate Adenocarcinoma,1
35665,Metastatic Lesion,Metastatic carcinoid tumor,1
35666,Cutaneous Involvement,Lymphangioleiomyomatosis of skin,1
35667,Carcinomatous Component Present,small cell carcinoma of breast,1
35668,Epithelial Component Present,Stage IIIB Colorectal Cancer AJCC v8,1
35669,Childhood Lesion,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
35670,Epithelial Component Present,Intraductal Cribriform Breast Adenocarcinoma,1
35671,Malignant Cellular Infiltrate,Uterine Corpus Rhabdomyosarcoma,1
35672,Epithelial Component Present,Platinum-Sensitive Lung Small Cell Carcinoma,1
35673,Local disease,Localized tumors of the Ewing's family,1
35674,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",1
35675,Cystic Change,Cystic Partially Differentiated Nephroblastoma,1
35676,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
35677,Mixed Cellular Population,Stage I Kidney Wilms Tumor,1
35678,Malignant Cellular Infiltrate,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
35679,Local disease,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
35680,Childhood Lesion,Childhood Ovarian Yolk Sac Tumor,1
35681,Malignant Cellular Infiltrate,Stage IIA Esophagus Carcinoma,1
35682,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
35683,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity refractory,1
35684,Malignant Cellular Infiltrate,Stage IIA Small Intestinal Cancer AJCC v7,1
35685,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of lung,1
35686,Epithelial Component Present,Sweat Gland Tubular Carcinoma,1
35687,Refractory Disease,Refractory Testicular Lymphoma,1
35688,In Situ Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
35689,Epithelial Component Present,"Acanthoma, Clear Cell",1
35690,Diffuse Pattern,Small cell glioblastoma,1
35691,Primary Lesion,Moderately Differentiated Hepatocellular Carcinoma,1
35692,Carcinomatous Component Present,Medullary carcinoma of breast,1
35693,Primary Lesion,Recurrent tumors of the Ewing's family,1
35694,Anaplasia,"Glioblastoma, IDH-Wildtype",1
35695,Melanin-Forming Neuroepithelial Cells Present,Melanotic medulloblastoma,1
35696,Biphasic Pattern,Ovarian Mucinous Cystadenofibroma,1
35697,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor,1
35698,Non-Invasive Lesion,Ampulla of Vater Tubulovillous Adenoma,1
35699,Malignant Cellular Infiltrate,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,1
35700,Mixed Cellular Population,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
35701,Low Grade Lesion,Extracutaneous Mastocytoma,1
35702,Malignant Cellular Infiltrate,Stage IV Renal Pelvis Cancer AJCC v8,1
35703,Low Mitotic Activity,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,1
35704,Borderline Lesion,Monoclonal Gammopathy of Undetermined Significance,1
35705,Regional Disease,Locally Advanced Unresectable Prostate Carcinoma,1
35706,Acanthosis,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
35707,Mixed Cellular Population,Malignant Mixed Tumor of the Minor Salivary Gland,1
35708,Well-Circumscribed Lesion,Gallbladder adenoma,1
35709,Malignant Cellular Infiltrate,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
35710,Non-Hereditary Lesion,Sporadic Thyroid Gland Micromedullary Carcinoma,1
35711,Tissue of Mullerian Origin Present,Borderline Ovarian Serous Cystadenofibroma,1
35712,Regional Disease,Locally Advanced Sarcoma,1
35713,Malignant Cellular Infiltrate,Ovarian Adenosarcoma,1
35714,Epithelial Component Present,Stage IV Renal Pelvis Cancer AJCC v8,1
35715,Birbeck Granules Present,Recurrent Langerhans Cell Histiocytosis,1
35716,Carcinomatous Component Present,Luminal B Breast Carcinoma,1
35717,Aggressive Clinical Course,Malignant mastocytosis,1
35718,Epithelial Component Present,"Carcinoid, Goblet Cell",1
35719,High Mitotic Activity,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
35720,High Mitotic Activity,Medulloepithelioma,1
35721,Microvascular Proliferation,Recurrent Childhood Gliosarcoma,1
35722,High Mitotic Activity,Gastric Neuroendocrine Carcinoma,1
35723,Metastatic Lesion,Metastatic Microsatellite Stable Colorectal Carcinoma,1
35724,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma of lung,1
35725,High Mitotic Activity,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
35726,Recurrent Lymphoma,EBV-Related Hodgkin Lymphoma,1
35727,Pathologic TNM Finding,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
35728,'Starry-sky' pattern,Colorectal Burkitt Lymphoma,1
35729,Two Separate Tumor Masses Present in the Same Organ,Pituitary Gland Double Adenomas,1
35730,Benign Cellular Infiltrate,Cervical Squamous Papilloma,1
35731,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Myelomonocytic Leukemia,1
35732,Malignant Cellular Infiltrate,Platinum-Sensitive Lung Small Cell Carcinoma,1
35733,Epithelial Component Present,Ovarian Cancer by AJCC v6 and v7 Stage,1
35734,Malignant Cellular Infiltrate,Gallbladder Cancer by AJCC v6 Stage,1
35735,Infiltrative Growth Pattern,"Glioblastoma, IDH-Mutant",1
35736,Well-Circumscribed Lesion,Breast adenoma,1
35737,Cystic Change,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
35738,Carcinomatous Component Present,Stage IB1 Cervical Cancer AJCC v8,1
35739,Epithelial Component Present,Benign Ovarian Transitional Cell Tumor,1
35740,Malignant Cellular Infiltrate,Unresectable Gastroesophageal Junction Adenocarcinoma,1
35741,Calcitonin Positive Neoplastic Cells Present,Familial medullary thyroid carcinoma,1
35742,Epithelial Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",1
35743,Swelling,mesenchymal chondrosarcoma of bone,1
35744,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I,1
35745,Collagenous Stroma Formation,Nuchal-type fibroma,1
35746,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor G2,1
35747,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with unilineage dysplasia,1
35748,Pain,Juxtacortical chondrosarcoma,1
35749,Locally Aggressive Lesion,Intermediate Lipomatous Neoplasm,1
35750,Neuroectodermal Differentiation,Neuroblastoma recurrent,1
35751,Benign Cellular Infiltrate,Benign neoplasm of thyroid gland,1
35752,atypia morphology,"Endometrioid adenoma, borderline malignancy",1
35753,Microcystic Change,Recurrent Childhood Protoplasmic Astrocytoma,1
35754,Malignant Cellular Infiltrate,Moderately Differentiated Hepatocellular Carcinoma,1
35755,Low Mitotic Activity,Gastric Gastrin-Producing Neuroendocrine Tumor,1
35756,Malignant Cellular Infiltrate,Locally Advanced Unresectable Cervical Adenocarcinoma,1
35757,Exophytic Polypoid Lesion,Otic polyp,1
35758,Rapidly Enlarging Mass,Recurrent Alveolar Rhabdomyosarcoma,1
35759,Biphasic Pattern,Pericanalicular fibroadenoma,1
35760,Cutaneous Involvement,Erythematosquamous dermatosis,1
35761,Carcinomatous Component Present,Stage IVB Colon Cancer AJCC v8,1
35762,Epithelial Component Present,Schneiderian papilloma,1
35763,Primary Lesion,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
35764,Malignant Cellular Infiltrate,AIDS-Related Cervical Kaposi Sarcoma,1
35765,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
35766,Mild cytologic atypia,Pancreatic Intraepithelial Neoplasia-1,1
35767,Epithelial Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v8,1
35768,Malignant Cellular Infiltrate,Carcinoma of the Appendix,1
35769,Epithelial Component Present,Mammary Analog Secretory Carcinoma of Salivary Gland,1
35770,Well-Circumscribed Lesion,Sporadic Thyroid Gland Medullary Carcinoma,1
35771,Papillary Pattern,Clear Cell Papillary Cystadenoma,1
35772,Carcinomatous Component Present,"Neuroendocrine carcinoma, metastatic",1
35773,Malignant Cellular Infiltrate,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
35774,Hemorrhagic,Angiosarcoma of liver,1
35775,Malignant Cellular Infiltrate,"Acute Myeloid Leukemia, M1",1
35776,Epithelial Component Present,Stage IIIA Ovarian Cancer AJCC v8,1
35777,Malignant Cellular Infiltrate,Resectable Neuroblastoma,1
35778,Cartilaginous Differentiation,Chondrogenic Neoplasm,1
35779,Endophytic Tumor Growth,Supraglottic Verrucous Carcinoma,1
35780,Malignant Cellular Infiltrate,Gastric Small Cell Carcinoma,1
35781,Low Mitotic Activity,Transverse Colon Neuroendocrine Tumor G1,1
35782,Mesenchymal Differentiation,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
35783,Congenital Lesion,Congenital aphakia,1
35784,Childhood Lesion,Stage I Childhood Lymphoblastic Lymphoma,1
35785,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v7,1
35786,Cystic Change,mucoepidermoid carcinoma of accessory sinus,1
35787,Malignant Cellular Infiltrate,Stage I Ovarian Cancer AJCC v8,1
35788,Epithelial Component Present,Pancreatic Cancer by AJCC v6 and v7 Stage,1
35789,Malignant Cellular Infiltrate,Lymphadenopathic Kaposi Sarcoma,1
35790,Malignant Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
35791,Diffuse Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
35792,Carcinomatous Component Present,Laryngeal verrucous carcinoma stage IV,1
35793,Carcinomatous Component Present,Colorectal Carcinoma Metastatic in the Lung,1
35794,Tissue Differentiation Uncertain,Follicular Myxoma,1
35795,Epithelial Component Present,Glomus vagale tumor,1
35796,Nuclear Pseudoinclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
35797,Epithelial Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
35798,Cholesterolosis,Adamantinous Craniopharyngioma,1
35799,Malignant Cellular Infiltrate,Fusion-Negative Alveolar Rhabdomyosarcoma,1
35800,Carcinomatous Component Present,Metastatic Genitourinary System Carcinoma,1
35801,Absence of Invasion,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
35802,Epithelial Component Present,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
35803,Severe dysplasia,Colorectal Adenoma with Severe Dysplasia,1
35804,Extensive Stage Lesion,Advanced Prostate Adenocarcinoma,1
35805,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v7,1
35806,Angiodestructive Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
35807,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v8,1
35808,Absence of Invasion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
35809,Low Mitotic Activity,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
35810,Well Differentiated Lesion,Well Differentiated Ovarian Steroid Cell Tumor,1
35811,Systemic disease,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
35812,Epithelial Component Present,Scrotal Carcinoma,1
35813,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
35814,Recurrent Lymphoma,EBV-Related Non-Hodgkin Lymphoma,1
35815,Carcinomatous Component Present,Prostate cancer stage A,1
35816,Well-Circumscribed Lesion,Uterine Polyp,1
35817,Epithelial Component Present,Stage IIIB Colorectal Cancer AJCC v7,1
35818,Low Mitotic Activity,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,1
35819,In Situ Lesion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
35820,Well-Circumscribed Lesion,estrogen-producing adrenal cortical adenoma,1
35821,Abundance of Small Lymphocytes,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
35822,Malignant Cellular Infiltrate,Stage IIA Pancreatic Cancer AJCC v8,1
35823,Hyaline Cartilage Differentiation,mesenchymal chondrosarcoma of bone,1
35824,Primary Lesion,Stage IIA Osteosarcoma AJCC v7,1
35825,Pregnancy Complications,Placental Site Nodule or Plaque,1
35826,Infiltrative Growth Pattern,Epithelioid glioblastoma,1
35827,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
35828,High Mitotic Activity,Anaplastic Oligodendroglioma,1
35829,Non-Hereditary Lesion,"Papillary renal cell carcinoma, sporadic",1
35830,Epithelial Component Present,Locally Advanced Cervical Adenocarcinoma,1
35831,Malignant Cellular Infiltrate,Bladder Lymphoma,1
35832,Epithelial Component Present,Acinic Cell Breast Carcinoma,1
35833,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v7,1
35834,Malignant Cellular Infiltrate,Stage IA2 Cervical Cancer AJCC v8,1
35835,Malignant Cellular Infiltrate,"Lymphoma, Non-Hodgkin",1
35836,Infiltrative Growth Pattern,"Glioblastoma, IDH-Mutant",1
35837,Papillary Pattern,Pancreatic Intraductal Papillary-Mucinous Adenoma,1
35838,Cutaneous Involvement,Desmoplastic Nevus,1
35839,Absence of Invasion,Bladder adenocarcinoma stage 0,1
35840,Benign Cellular Infiltrate,Hemangioma of intracranial structure,1
35841,Well-Circumscribed Lesion,Mixed Cell Type Kidney Wilms Tumor,1
35842,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
35843,Malignant Cellular Infiltrate,"Uterine Carcinosarcoma, Heterologous Type",1
35844,Fibrotic Stroma Formation,Fibrolipoma,1
35845,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
35846,Below the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,1
35847,Malignant Cellular Infiltrate,Secondary Supratentorial Anaplastic Astrocytoma,1
35848,Recurrent disease,Recurrent Appendix Carcinoma,1
35849,Malignant Cellular Infiltrate,Stage IV Adult Immunoblastic Lymphoma,1
35850,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
35851,Benign Cellular Infiltrate,Hidroacanthoma simplex,1
35852,bone marrow fibrosis,"Leukemia, Mast-Cell",1
35853,Carcinomatous Component Present,Eccrine ductal carcinoma,1
35854,Malignant Cellular Infiltrate,Stage I Vulvar Cancer AJCC v8,1
35855,Mitotic Activity,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
35856,Increased Cellularity Present,Cellular fibroma,1
35857,Metastatic Lesion,Breast Carcinoma Metastatic in the Lung,1
35858,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Cancer AJCC v8,1
35859,Malignant Cellular Infiltrate,Prognostic Stage I Breast Cancer AJCC v8,1
35860,Malignant Cellular Infiltrate,Small Intestinal Mixed Adenoneuroendocrine Carcinoma,1
35861,Perivascular Pseudorosette Formation,Anaplastic Astroblastoma,1
35862,Non-Invasive Lesion,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
35863,Malignant Cellular Infiltrate,Desmoplastic Neurotropic Melanoma,1
35864,Localized Lesion,Peritoneal Well Differentiated Papillary Mesothelioma,1
35865,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
35866,Therapy-Related Toxicity,Transplant-Related Hepatocellular Carcinoma,1
35867,Extraosseous Lesion,Breast Extraskeletal Osteosarcoma,1
35868,Papillary Pattern,Papillary adenofibroma,1
35869,Well-Circumscribed Lesion,"Gastric Adenoma, Gastric-Type",1
35870,Tissue of Mullerian Origin Present,Vaginal Adenosarcoma,1
35871,Benign Cellular Infiltrate,Meyerson Nevus,1
35872,Malignant Cellular Infiltrate,Childhood Immunoblastic Lymphoma,1
35873,Epithelial Component Present,Squamous cell carcinoma of tongue,1
35874,Indolent Clinical Course,Benign Extrahepatic Bile Duct Soft Tissue Neoplasm,1
35875,Malignant Cellular Infiltrate,"Lymphoma, Follicular, Grade 1",1
35876,Epithelial Component Present,Minor Salivary Gland Undifferentiated Carcinoma,1
35877,Cutaneous Involvement,"Carcinoma, Basosquamous",1
35878,Villous Pattern,Villous adenoma of colon,1
35879,Nuclear Atypia,Adult Glioblastoma,1
35880,Malignant Cellular Infiltrate,Childhood Gliosarcoma,1
35881,Malignant Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v8,1
35882,Storiform Growth Pattern,Inflammatory malignant fibrous histiocytoma,1
35883,Carcinomatous Component Present,Localized Parathyroid Gland Carcinoma,1
35884,Malignant Cellular Infiltrate,Unresectable Chordoma,1
35885,Recurrent disease,Recurrent Primitive Neuroectodermal Tumor,1
35886,High Grade Lesion,Advanced Synovial Sarcoma,1
35887,Acanthosis,Condylomata Acuminata,1
35888,Carcinomatous Component Present,Esophageal adenocarcinoma recurrent,1
35889,Immunologic Deficiency Syndromes,AIDS-Related Isosporiasis,1
35890,Collagenous Stroma Formation,Unresectable Desmoid-Type Fibromatosis,1
35891,Osseous Differentiation,Radiation-Related Osteosarcoma,1
35892,Benign Cellular Infiltrate,Benign tumor of penis,1
35893,Refractory Disease,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
35894,Primary Lesion,BCLC Stage A Adult Hepatocellular Carcinoma,1
35895,Epithelial Component Present,Stage IVB Paranasal Sinus Cancer AJCC v7,1
35896,Malignant Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v8,1
35897,Dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
35898,Vascular Channel Formation,AIDS with Kaposi's sarcoma,1
35899,Absence of Invasion,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
35900,Malignant Cellular Infiltrate,Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
35901,Vascular Channel Formation,Parotid Gland Kaposi Sarcoma,1
35902,Ineffective hematopoiesis,Refractory anemias,1
35903,Malignant Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v7,1
35904,Glomerular Hypertrophy,Chronic rejection of renal transplant,1
35905,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis of skin,1
35906,Cutaneous Involvement,Hair Diseases,1
35907,Well Differentiated Lesion,verrucous carcinoma of esophagus,1
35908,Invasive Lesion,signet ring cell carcinoma of breast,1
35909,Varicosity,Disorder of vein,1
35910,Severe cytologic atypia,Gallbladder Neuroendocrine Carcinoma,1
35911,Malignant Cellular Infiltrate,Adrenal neuroblastoma,1
35912,Epithelial Component Present,Adenocarcinoma Of Esophagus,1
35913,Malignant Cellular Infiltrate,Gastric Fundus Carcinoma,1
35914,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Isolated del(5q),1
35915,Absence of a Hormonal Syndrome,Non-Functioning Corticotroph Adenoma,1
35916,Malignant Cellular Infiltrate,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
35917,Epithelial Component Present,Stage IV Distal Bile Duct Cancer AJCC v8,1
35918,Monocytosis,Juvenile Myelomonocytic Leukemia,1
35919,Mixed Cellular Population,combined small cell carcinoma of lung,1
35920,Malignant Cellular Infiltrate,Nasal cavity carcinoma,1
35921,Necrotic changes (finding),Adult Brain Glioblastoma,1
35922,Nodular lesions,Thyroid Nodule,1
35923,Mesenchymal Component Present,Juvenile fibroadenoma of breast,1
35924,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,1
35925,Local disease,lipoma of esophagus,1
35926,Malignant Cellular Infiltrate,Malignant tumor of palate,1
35927,Malignant Cellular Infiltrate,Pathologic Stage III Gastric Cancer AJCC v8,1
35928,Epithelial Component Present,Ovarian Carcinoid Tumor,1
35929,Myxoid Stroma Formation,Myxoinflammatory fibroblastic sarcoma,1
35930,Intestinal metaplasia,Gastric Mixed Adenocarcinoma,1
35931,Cutaneous Involvement,Stage IIC Cutaneous Melanoma AJCC v6 and v7,1
35932,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell",1
35933,Osteoid formation,Intracortical osteosarcoma,1
35934,Indolent Clinical Course,Intermediate Rhabdomyoma,1
35935,Epithelial Component Present,Endometrial adenocarcinoma metastatic,1
35936,Neuroendocrine Differentiation,Localized Digestive System Neuroendocrine Tumor G1,1
35937,Epithelial Component Present,Stage IV Skin Cancer,1
35938,Malignant Cellular Infiltrate,Malignant Mixed Tumor of the Major Salivary Gland,1
35939,Storiform Growth Pattern,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
35940,Malignant Cellular Infiltrate,Breast Solid Neuroendocrine Carcinoma,1
35941,Immunoglobulin Deposition,Refractory Primary Amyloidosis,1
35942,Epithelial Component Present,Gastric Intramucosal Adenocarcinoma,1
35943,Epithelial Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
35944,Malignant Cellular Infiltrate,Esophageal Large Cell Neuroendocrine Carcinoma,1
35945,Cystic Change,Dermoid cyst of ovary,1
35946,Benign Cellular Infiltrate,Sporadic Cylindroma,1
35947,Carcinomatous Component Present,Stage II Small Intestinal Adenocarcinoma AJCC v8,1
35948,Endophytic Tumor Growth,Urethral Verrucous Carcinoma,1
35949,Carcinomatous Component Present,adenocarcinoma of middle ear,1
35950,Malignant Cellular Infiltrate,Luminal B Prostate Carcinoma,1
35951,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
35952,Indolent Clinical Course,Benign Anterior Tongue Neoplasm,1
35953,Osteoid formation,Telangiectatic osteosarcoma,1
35954,High Mitotic Activity,Gastroesophageal Junction Neuroendocrine Carcinoma,1
35955,Carcinomatous Component Present,Stage IV Esophageal Cancer AJCC v7,1
35956,Carcinomatous Component Present,Unresectable Digestive System Adenocarcinoma,1
35957,Epithelial Component Present,squamous cell carcinoma of ureter,1
35958,Ground Glass Nuclear Inclusion,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
35959,Mucoid Stroma Formation,mucinous adenocarcinoma of lung,1
35960,Malignant Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia,1
35961,Epithelial Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
35962,Malignant Cellular Infiltrate,Sezary Syndrome,1
35963,Malignant Cellular Infiltrate,Melanoma Metastatic in the Central Nervous System,1
35964,Epithelial Component Present,Parathyroid Gland Adenocarcinoma,1
35965,Malignant Cellular Infiltrate,Stage I Uterine Corpus Cancer AJCC v8,1
35966,Malignant Cellular Infiltrate,Metastatic Fallopian Tube Carcinoma,1
35967,Carcinomatous Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
35968,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with Variant MLL Translocations,1
35969,Malignant Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7,1
35970,No Identifiable Line of Differentiation,Childhood Undifferentiated Pleomorphic Sarcoma,1
35971,Diffuse Pattern,Fibrillary Astrocytoma,1
35972,Cystic Change,cystadenoma of salivary gland,1
35973,Melanin Pigment Present,GIANT PIGMENTED HAIRY NEVUS,1
35974,Papillary Pattern,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
35975,Lipomatous Component Present,Ectopic hamartomatous thymoma,1
35976,Cutaneous Involvement,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
35977,Epithelial Component Present,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
35978,Carcinomatous Component Present,Stage I Rectal Cancer AJCC v6 and v7,1
35979,Carcinomatous Component Present,Stage IV Esophageal Adenocarcinoma AJCC v7,1
35980,Platinum Resistance,Platinum-Resistant Fallopian Tube Carcinoma,1
35981,Micropapillary Pattern,Rectal Micropapillary Adenocarcinoma,1
35982,Carcinomatous Component Present,Stage II Lip Cancer AJCC v6 and v7,1
35983,Neuroectodermal Differentiation,Peripheral Ganglioneuroblastoma,1
35984,Carcinomatous Component Present,Stage IV Oropharyngeal Carcinoma,1
35985,Carcinomatous Component Present,Recurrent Uterine Corpus Carcinosarcoma,1
35986,Hemorrhagic,Pulmonary Artery Angiosarcoma,1
35987,Malignant Cellular Infiltrate,Carcinoma in situ of vagina,1
35988,Myxoid Stroma Formation,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation,1
35989,Borderline Lesion,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
35990,Benign Cellular Infiltrate,Ovarian Mucinous Cystadenofibroma,1
35991,Hyperplastic Tissue Present,Simple Endometrial Hyperplasia,1
35992,Carcinomatous Component Present,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
35993,Malignant Cellular Infiltrate,Intestinal-Type Sinonasal Adenocarcinoma,1
35994,Epithelial Component Present,Stage IVA Paranasal Sinus Cancer AJCC v7,1
35995,Increased Cellularity Present,Cellular Neurofibroma,1
35996,Papillary Pattern,Papillary adenoma,1
35997,Neuroendocrine Differentiation,Uterine Corpus Carcinoid Tumor,1
35998,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Columnar Cell Hyperplasia of the Breast,1
35999,Biphasic Pattern,Childhood Brain Stem Gliosarcoma,1
36000,Chromogranin A Positive Neoplastic Cells Present,Gallbladder Goblet Cell Carcinoid,1
36001,Cystic Lesion,Recurrent Craniopharyngioma,1
36002,Malignant Cellular Infiltrate,Malignant Esophageal Neoplasm by Topographic Region,1
36003,Epithelial Component Present,Submandibular Gland Acinic Cell Carcinoma,1
36004,Exophytic Polypoid Lesion,Colorectal hyperplastic polyp,1
36005,High Grade Lesion,Anaplastic astrocytoma,1
36006,Malignant Cellular Infiltrate,Gallbladder Cancer by AJCC v6 Stage,1
36007,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma,1
36008,Epithelial Component Present,Ureter Cancer by AJCC v7 Stage,1
36009,Epithelial Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
36010,'Starry-sky' pattern,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
36011,Mitotic Activity,Anaplastic Hemispheric Astrocytoma,1
36012,Carcinomatous Component Present,Laryngeal Giant Cell Carcinoma,1
36013,Epithelial Component Present,Localized Resectable Adult Hepatocellular Carcinoma,1
36014,Benign Cellular Infiltrate,Anal Canal Squamous Papilloma,1
36015,'Starry-sky' pattern,Immunodeficiency-associated Burkitt's lymphoma,1
36016,Malignant Cellular Infiltrate,Malignant neoplasm of thyroid,1
36017,Vascular Channel Formation,Congenital hemangioma,1
36018,Malignant Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v8,1
36019,Cutaneous Involvement,Stage I Merkel Cell Carcinoma AJCC v7,1
36020,Malignant Cellular Infiltrate,Recurrent Head and Neck Squamous Cell Carcinoma,1
36021,Epithelial Component Present,Stage IV Ovarian Cancer AJCC v6 and v7,1
36022,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v6,1
36023,Cartilaginous Differentiation,Secondary Peripheral Chondrosarcoma,1
36024,Malignant Cellular Infiltrate,Hereditary Ovarian Carcinoma,1
36025,Epithelial Component Present,Serous adenofibroma,1
36026,Malignant Cellular Infiltrate,undifferentiated sarcoma of soft tissue,1
36027,Malignant Cellular Infiltrate,Recurrent Ovarian Cystadenocarcinoma,1
36028,Aggressive Clinical Course,Adult Burkitt Leukemia,1
36029,Childhood Lesion,Childhood Leiomyosarcoma,1
36030,Malignant Cellular Infiltrate,Malignant Cystosarcoma Phyllodes,1
36031,Epithelial Component Present,Clinical Stage III Gastric Cancer AJCC v8,1
36032,Carcinomatous Component Present,Clinical Stage II Gastric Cancer AJCC v8,1
36033,Carcinomatous Component Present,Fallopian Tube Adenocarcinoma,1
36034,Malignant Cellular Infiltrate,Immunoglobulin deposition disease,1
36035,Epithelial Component Present,BCLC Stage D Hepatocellular Carcinoma,1
36036,Carcinomatous Component Present,Metaplastic carcinoma of breast,1
36037,Malignant Cellular Infiltrate,Grade 3 Clear Cell Renal Cell Carcinoma,1
36038,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
36039,Carcinomatous Component Present,Adenosquamous cell lung cancer,1
36040,Benign Cellular Infiltrate,Ameloblastic fibroma,1
36041,Malignant Cellular Infiltrate,Recurrent Oral Cavity Carcinoma,1
36042,Carcinomatous Component Present,Metastatic Pancreatic Neuroendocrine Carcinoma,1
36043,Papillary Pattern,Gallbladder Papillomatosis,1
36044,Malignant Cellular Infiltrate,Recurrent Anaplastic Oligodendroglioma,1
36045,Diffuse Pattern,Desmoplastic mesothelioma,1
36046,Pathologic TNM Finding,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
36047,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
36048,Malignant Cellular Infiltrate,Cervical Endometrioid Adenocarcinoma,1
36049,Diffuse Lesion,Pigmented villonodular synovitis,1
36050,Epithelial Component Present,Stage III Carcinoma of Penis,1
36051,Malignant Cellular Infiltrate,Pure Erythroid Leukemia,1
36052,Indolent Clinical Course,Gardner Fibroma,1
36053,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid carcinoma ovary,1
36054,Pain,Childhood Mesenchymal Chondrosarcoma,1
36055,Malignant Cellular Infiltrate,Hormone refractory breast cancer,1
36056,Secondary Lesion,Endometrioid adenocarcinoma metastatic,1
36057,Carcinomatous Component Present,Lepidic Predominant Adenocarcinoma,1
36058,Epithelial Component Present,Esophageal adenocarcinoma recurrent,1
36059,Epithelial Component Present,Squamous non-small cell lung cancer,1
36060,Invasive Lesion,Infiltrating angiolipoma,1
36061,Diffuse Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
36062,Epithelial Component Present,"Carcinoma, Lobular",1
36063,Epithelial Component Present,Low Grade Conjunctival Intraepithelial Neoplasia,1
36064,Indolent Clinical Course,Lipoma of spermatic cord,1
36065,Carcinomatous Component Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
36066,Carcinomatous Component Present,Adenocarcinoma in situ in a polyp,1
36067,Carcinomatous Component Present,Cervical Villoglandular Adenocarcinoma,1
36068,Cellular Changes Resembling Foveolar Epithelium Cells,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",1
36069,Tissue of Mullerian Origin Present,Ovarian Mucinous Adenofibroma,1
36070,Benign Cellular Infiltrate,Ovarian Adenomatoid Tumor,1
36071,Diffuse Pattern,Brain Stem Glioblastoma,1
36072,Locally Aggressive Lesion,Cardiac Inflammatory Myofibroblastic Tumor,1
36073,Well-Circumscribed Lesion,Stage V Kidney Wilms Tumor,1
36074,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
36075,Epithelial Component Present,Stage I Fallopian Tube Cancer AJCC v8,1
36076,Malignant Cellular Infiltrate,ROSE Cluster 4,1
36077,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v7 Stage,1
36078,Thick-Walled Hyalinized Vessels Present,Benign Esophageal Schwannoma,1
36079,Platinum Resistance,Platinum-Resistant Urothelial Carcinoma,1
36080,Epithelial Component Present,Thymoma malignant invasive,1
36081,Carcinomatous Component Present,Colon Cancer by AJCC v8 Stage,1
36082,Metastatic Lesion,Stage IV Esophageal Adenocarcinoma,1
36083,Metastatic Lesion,Metastatic leiomyosarcoma,1
36084,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type III,1
36085,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,1
36086,Malignant Cellular Infiltrate,Locally Advanced Thymic Carcinoma,1
36087,High Grade Lesion,Conventional Alveolar Rhabdomyosarcoma,1
36088,Malignant Cellular Infiltrate,Buccal Mucosa Verrucous Carcinoma,1
36089,Benign Cellular Infiltrate,"Hemangioma, Cavernous",1
36090,Malignant Cellular Infiltrate,Marginal Zone B-Cell Lymphoma,1
36091,Neuroendocrine Differentiation,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
36092,Cystic Change,Borderline Ovarian Endometrioid Cystadenofibroma,1
36093,Malignant Cellular Infiltrate,Mixed epithelioid and spindle cell melanoma,1
36094,Syncytial Pattern,Oropharyngeal lymphoepithelioma stage III,1
36095,Thick-Walled Hyalinized Vessels Present,Plexiform Schwannoma,1
36096,Childhood Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7,1
36097,Anaplasia,Recurrent Anaplastic Oligoastrocytoma,1
36098,Epithelial Component Present,Papillary cystic tumor,1
36099,Cutaneous Involvement,Parapsoriasis,1
36100,Epithelial Component Present,Duodenal Cancer,1
36101,Lymphadenopathy,Sezary Syndrome,1
36102,Carcinomatous Component Present,undifferentiated carcinoma of larynx,1
36103,Refractory Disease,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
36104,Malignant Cellular Infiltrate,Lung Spindle Cell Carcinoma,1
36105,Presence of a Hormonal Syndrome,Hormone secreting pituitary neoplasms,1
36106,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
36107,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
36108,Malignant Cellular Infiltrate,Class 1 Uveal Melanoma,1
36109,Neuroendocrine Differentiation,Childhood Adrenal Gland Pheochromocytoma,1
36110,High Grade Lesion,Recurrent Glioblastoma,1
36111,Gastrin Positive Neoplastic Cells Present,Gastric Gastrin-Producing Neuroendocrine Tumor,1
36112,Nuclear Atypia,Childhood Cerebellar Anaplastic Astrocytoma,1
36113,Severe dysplasia,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
36114,Well-Circumscribed Lesion,adenomatous polyp of stomach,1
36115,Monocytosis,Chronic Myelomonocytic Leukemia-0,1
36116,High Grade Lesion,Fusion-Positive Rhabdomyosarcoma,1
36117,Indolent Clinical Course,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
36118,Secondary Lesion,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,1
36119,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
36120,High Mitotic Activity,Undifferentiated Endocervical Sarcoma,1
36121,Oligodendroglial Component Present,Adult Oligodendroglioma,1
36122,Carcinomatous Component Present,Stage IIIB Anal Cancer AJCC v8,1
36123,Recurrent disease,Recurrent Malignant Neoplasm of Salivary Gland,1
36124,Malignant Cellular Infiltrate,Sellar Choriocarcinoma,1
36125,Malignant Cellular Infiltrate,Stage IV Rectal Carcinoma,1
36126,Severe cytologic atypia,Unresectable Digestive System Neuroendocrine Carcinoma,1
36127,Benign Cellular Infiltrate,Squamous cell papilloma of skin,1
36128,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage IV,1
36129,Recurrent disease,Diffuse large B-cell lymphoma recurrent,1
36130,Malignant Cellular Infiltrate,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
36131,Indolent Clinical Course,Digestive System Hemangioma,1
36132,Anaplasia,Spindle cell squamous cell carcinoma,1
36133,Carcinomatous Component Present,Anatomic Stage IIIA Breast Cancer AJCC v8,1
36134,Malignant Cellular Infiltrate,Stage III Eyelid Carcinoma AJCC v8,1
36135,Secondary Lesion,Advanced Favorable Hodgkin Lymphoma,1
36136,Well Differentiated Neuroendocrine Lesion,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
36137,High Mitotic Activity,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
36138,Vascular Channel Formation,Kaposi's sarcoma of cornea,1
36139,Mitotic Activity,Glioblastoma,1
36140,Malignant Cellular Infiltrate,Hereditary Renal Cell Carcinoma,1
36141,Indolent Clinical Course,Central Nervous System Hemangioma,1
36142,Myxoid Stroma Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
36143,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
36144,Epithelial Component Present,Anal Cancer by AJCC v8 Stage,1
36145,Carcinomatous Component Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,1
36146,Epithelial Component Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
36147,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v8,1
36148,High Mitotic Activity,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
36149,Severe cytologic atypia,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
36150,Malignant Cellular Infiltrate,Rectal Lymphoma,1
36151,Tissue Differentiation Uncertain,Vulvar Proximal-Type Epithelioid Sarcoma,1
36152,Cutaneous Involvement,Stage IV Lip Basal Cell Carcinoma,1
36153,Cutaneous Involvement,Eccrine ductal carcinoma,1
36154,Carcinomatous Component Present,Non-small cell lung cancer recurrent,1
36155,Local disease,Localized Non-Resectable Adult Liver Carcinoma,1
36156,Nerve palsy,Acquired Facial Nerve Palsy,1
36157,Carcinomatous Component Present,Grade 2 Invasive Breast Carcinoma,1
36158,Epithelial Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
36159,Mixed Cellular Population,Carcinosarcoma of ovary,1
36160,Secondary Lesion,Metastatic Colon Carcinoma,1
36161,Severe dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
36162,Local disease,Localized Malignant Neoplasm,1
36163,Epithelial Component Present,Glomus Tympanicum Tumor,1
36164,Neuroendocrine Differentiation,Bladder Neuroendocrine Neoplasm,1
36165,Epithelial Component Present,Metastatic Squamous Cell Breast Carcinoma,1
36166,Cutaneous Involvement,Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage,1
36167,Gastrin Positive Neoplastic Cells Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
36168,Epithelial Component Present,Ameloblastic Carcinoma,1
36169,Carcinomatous Component Present,Hereditary Renal Cell Carcinoma,1
36170,High Grade Lesion,Vulvar Alveolar Soft Part Sarcoma,1
36171,Thin Bands of Collagen Present,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
36172,Malignant Cellular Infiltrate,Stage IV Pharynx Carcinoma,1
36173,Malignant Cellular Infiltrate,Unresectable Skin Carcinoma,1
36174,Follicular Structures Present,Macrofollicular adenoma,1
36175,Hyperplastic Tissue Present,Columnar Cell Hyperplasia of the Breast with Atypia,1
36176,Malignant Cellular Infiltrate,Refractory Malignant Skin Neoplasm,1
36177,Indolent Clinical Course,Peripheral Odontogenic Fibroma,1
36178,Cystic Change,"Cystadenocarcinoma, Papillary",1
36179,Well Differentiated Lesion,"Retinoblastoma, differentiated",1
36180,Apocrine Differentiation,Ceruminous Neoplasm,1
36181,Biphasic Pattern,endometrioid adenofibroma of ovary,1
36182,Epithelial Component Present,Stage IIA Appendix Carcinoma AJCC v8,1
36183,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
36184,Malignant Cellular Infiltrate,Adenocarcinoma of duodenum,1
36185,Malignant Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v8,1
36186,Cutaneous Involvement,"Xeroderma pigmentosum, group F",1
36187,Perivascular Arrangement of Tumor Cells,Intravascular Angioleiomyoma,1
36188,Inconspicuous Syncytiotrophoblastic Cell Component,Testicular Monophasic Choriocarcinoma,1
36189,Low Grade Lesion,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
36190,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma recurrent,1
36191,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor,1
36192,Cellular Stratification,Nasopharyngeal Differentiated Carcinoma,1
36193,Low Grade Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant",1
36194,Immunologic Deficiency Syndromes,Monomorphic Post-Transplant Lymphoproliferative Disorder,1
36195,Carcinomatous Component Present,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
36196,Complex Glandular Pattern,Uterine Corpus Atypical Polypoid Adenomyoma,1
36197,Metastatic Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,1
36198,Epithelial Component Present,Bronchial adenoma,1
36199,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of the duodenum,1
36200,Papillary Pattern,Papillary Eccrine Carcinoma,1
36201,Carcinomatous Component Present,Primary Prostate Urothelial Carcinoma,1
36202,Secondary Lesion,Advanced Sarcoma of the Extremity,1
36203,Malignant Cellular Infiltrate,Recurrent Lymphomatoid Granulomatosis,1
36204,Multifocal Lesion,Bowenoid papulosis,1
36205,Benign Cellular Infiltrate,Benign neoplasm of retroperitoneum,1
36206,Blasts Under 5 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1,1
36207,Indolent Clinical Course,Lymphangioma,1
36208,Epithelial Component Present,Cervical Atypical Carcinoid Tumor,1
36209,Malignant Cellular Infiltrate,Primary malignant neoplasm,1
36210,Malignant Cellular Infiltrate,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
36211,Primary Lesion,Stage I Hepatocellular Carcinoma AJCC v6 and v7,1
36212,Vascular Channel Formation,Angiosarcoma NCI Grade 3,1
36213,Crystal deposition,Alveolar soft part sarcoma recurrent,1
36214,Nodular Pattern,Ann Arbor Stage I Follicular Lymphoma,1
36215,Endophytic Tumor Growth,Sphenoid Sinus Inverted Papilloma,1
36216,Benign Cellular Infiltrate,Hard Palate Monomorphic Adenoma,1
36217,Low Mitotic Activity,Gastrinoma,1
36218,Bone Marrow Dysplasia Present,Refractory Thrombocytopenia,1
36219,Sarcomatous Component Present,Carcinosarcoma of ovary,1
36220,Malignant Cellular Infiltrate,Stage II Rectal Cancer AJCC v8,1
36221,Thick-Walled Hyalinized Vessels Present,Colorectal Schwannoma,1
36222,Carcinomatous Component Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
36223,Carcinomatous Component Present,Hepatocellular Carcinoma by AJCC v7 Stage,1
36224,Carcinomatous Component Present,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
36225,Local disease,Fibrolipoma,1
36226,Geographic Necrosis,Embryonal Carcinoma,1
36227,Malignant Cellular Infiltrate,Stage IIA Ovarian Cancer AJCC V6 and v7,1
36228,Malignant Cellular Infiltrate,Stage I Appendix Carcinoma AJCC v7,1
36229,Malignant Cellular Infiltrate,Stage IB Testicular Cancer AJCC v8,1
36230,Therapy-Related Toxicity,Alkylating Agent-Related Myelodysplastic Syndrome,1
36231,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent,1
36232,Primary Lesion,Childhood Alveolar Rhabdomyosarcoma,1
36233,Vascular Channel Formation,Prostate Kaposi Sarcoma,1
36234,Epithelial Component Present,Follicular Variant Thyroid Gland Papillary Carcinoma,1
36235,Carcinomatous Component Present,Anatomic Stage IIA Breast Cancer AJCC v8,1
36236,Malignant Cellular Infiltrate,Rhabdomyosarcoma,1
36237,Epithelial Component Present,Large cell lung cancer recurrent,1
36238,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
36239,Cutaneous Involvement,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
36240,Epithelial Component Present,Bilateral Synchronous Sporadic Renal Cell Carcinoma,1
36241,Multinodular Mass,Recurrent Breast Angiosarcoma,1
36242,Synchronous Lesion,Synchronous Bilateral Breast Carcinoma,1
36243,Malignant Cellular Infiltrate,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,1
36244,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage,1
36245,Carcinomatous Component Present,intestinal type adenocarcinoma of extrahepatic bile duct,1
36246,Unresectable Mass,Locally Advanced Unresectable Prostate Adenocarcinoma,1
36247,Malignant Cellular Infiltrate,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
36248,Malignant Cellular Infiltrate,Pilomatrix carcinoma of skin,1
36249,Malignant Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v7,1
36250,In Situ Lesion,Stage 0 Pancreatic Cancer AJCC v8,1
36251,Clinical TNM Finding,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
36252,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome refractory,1
36253,Monomorphic Cellular Infiltrate,Skin Basaloid Carcinoma,1
36254,Epithelial Component Present,Breast Cancer by AJCC v7 Stage,1
36255,High Grade Lesion,Childhood Synovial Sarcoma,1
36256,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
36257,Radiation Sickness,Cataract associated with radiation,1
36258,Well-Circumscribed Lesion,Ovarian Papillary Cystadenoma,1
36259,Carcinomatous Component Present,Serous Tubal Intraepithelial Carcinoma,1
36260,Hormone Receptor Positive,Refractory Hormone Receptor Positive Breast Carcinoma,1
36261,Immunosuppression-Related Post-Transplant Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
36262,Well-Circumscribed Lesion,Intermediate Rhabdomyoma,1
36263,Benign Cellular Infiltrate,Heavily Pigmented Adrenal Cortical Adenoma,1
36264,Primary Lesion,"Recurrent Medulloblastoma, SHH-Activated",1
36265,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,1
36266,Benign Cellular Infiltrate,Lymphangioma,1
36267,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia,1
36268,Indolent Clinical Course,Leiomyoma of ciliary body,1
36269,Malignant Cellular Infiltrate,Refractory Malignant Female Reproductive System Neoplasm,1
36270,Benign Cellular Infiltrate,Thyroid Gland Mucinous Follicular Adenoma,1
36271,Epithelial Component Present,Pilomatrix carcinoma of skin,1
36272,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 4,1
36273,Carcinomatous Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7,1
36274,Malignant Cellular Infiltrate,Stage II Eyelid Carcinoma AJCC v7,1
36275,Low Mitotic Activity,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
36276,Low Grade Lesion,Low Grade Lung Neuroendocrine Neoplasm,1
36277,Malignant Cellular Infiltrate,Cholangiocarcinoma resectable,1
36278,Benign Cellular Infiltrate,Acoustic Neuroma,1
36279,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
36280,Epithelial Component Present,Adenoma of Minor Vestibular Glands,1
36281,Epithelial Component Present,Transitional cell carcinoma of bladder,1
36282,Malignant Cellular Infiltrate,Ductal Carcinoma In Situ with Microinvasion,1
36283,Gastrointestinal Type Epithelium Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
36284,Malignant Cellular Infiltrate,Pathologic Stage IIB Gastric Cancer AJCC v8,1
36285,Mixed Cellular Population,Ovarian Endometrioid Cystadenofibroma,1
36286,Neuroendocrine Differentiation,Ileal Neuroendocrine Tumor,1
36287,Tubular Pattern,Cholangiolocellular Carcinoma,1
36288,Malignant Cellular Infiltrate,Malignant Cutaneous Granular Cell Tumor,1
36289,Exophytic Polypoid Lesion,"Polyposis, Gastric",1
36290,Metastatic Lesion,Locally Advanced Unresectable Malignant Neoplasm,1
36291,Epithelial Component Present,Vulvar adenocarcinoma,1
36292,Hyperkeratosis,Warty Carcinoma of the Penis,1
36293,Malignant Cellular Infiltrate,melanoma of scrotum,1
36294,Benign Cellular Infiltrate,Fallopian Tube Papilloma,1
36295,Increased Cellularity Present,Disseminated neuroblastoma,1
36296,Bone Marrow Dysplasia Present,Childhood Myelodysplastic Syndrome,1
36297,Neuroectodermal Differentiation,Recurrent Olfactory Neuroblastoma,1
36298,Recurrent disease,Recurrent Childhood Hepatocellular Carcinoma,1
36299,Primary Site Unknown,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
36300,Epithelial Component Present,Small intestine carcinoma non-resectable,1
36301,Indolent Clinical Course,Endobronchial Leiomyoma,1
36302,Tissue of Mullerian Origin Present,Broad Ligament Serous Cystadenofibroma,1
36303,High Grade Lesion,Alveolar soft part sarcoma recurrent,1
36304,Ineffective hematopoiesis,Refractory anemias,1
36305,Pathologic TNM Finding,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
36306,Tissue Differentiation Uncertain,Childhood Alveolar Soft Part Sarcoma,1
36307,Nuclear Grooves,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
36308,Immunologic Deficiency Syndromes,AIDS-Related Diffuse Large B-cell Lymphoma,1
36309,Adnexal Differentiation,Pilomatrix carcinoma of skin,1
36310,Benign Cellular Infiltrate,Peripheral Odontogenic Fibroma,1
36311,Epithelial Component Present,Stage III Colorectal Cancer AJCC v8,1
36312,Pathologic TNM Finding,Retinoblastoma by AJCC v8 Pathologic Stage,1
36313,Morphologic Overlap,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
36314,Malignant Cellular Infiltrate,Malignant Childhood Central Nervous System Neoplasm,1
36315,Carcinomatous Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8,1
36316,Epithelial Component Present,Stage IIIA2 Fallopian Tube Cancer AJCC v8,1
36317,Secondary Lesion,Metastatic hepatocellular carcinoma,1
36318,Diffuse Pattern,Recurrent Childhood Diffuse Astrocytoma,1
36319,Epithelial Component Present,Flat Ductal Epithelial Atypia of the Breast,1
36320,Gastric-Type Epithelial Differentiation,Pyloric Gland Adenoma,1
36321,Neuroendocrine Differentiation,Metastatic Neuroendocrine Neoplasm,1
36322,Malignant Germinomatous Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7,1
36323,Carcinomatous Component Present,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
36324,Malignant Cellular Infiltrate,Pathologic Stage IB Cutaneous Melanoma AJCC v8,1
36325,Neuroendocrine Differentiation,Glucagonoma,1
36326,Slow Growing Mass,Adamantinous Craniopharyngioma,1
36327,Polymorphic Cellular Infiltrate,Eosinophilic Granuloma,1
36328,Secondary Lesion,Secondary malignant neoplasm of vulva,1
36329,Cribriform Pattern,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
36330,Infiltrative Growth Pattern,Mesenchymal Glioblastoma,1
36331,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
36332,Epidermal Involvement,Compound nevus of skin,1
36333,Malignant Cellular Infiltrate,Malignant Ovarian Surface Epithelial-Stromal Tumor,1
36334,Neuronal Differentiation,Pituitary Gland Mixed Gangliocytoma-Adenoma,1
36335,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
36336,Carcinomatous Component Present,Familial Nonmedullary Thyroid Gland Carcinoma,1
36337,Neuroectodermal Differentiation,Ewings sarcoma-primitive neuroectodermal tumor (PNET),1
36338,Malignant Cellular Infiltrate,Solid Alveolar Rhabdomyosarcoma,1
36339,Capillary Sized Vascular Channel Formation,Breast Capillary Hemangioma,1
36340,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage III,1
36341,Epithelial Component Present,Papillary thyroid carcinoma,1
36342,Cutaneous Involvement,Desmoplastic melanoma,1
36343,Adnexal Differentiation,Pilar tumor,1
36344,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
36345,Low Mitotic Activity,Esophageal Well Differentiated Squamous Cell Carcinoma,1
36346,Biphasic Pattern,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
36347,Low Mitotic Activity,Stage I Appendix Neuroendocrine Tumor AJCC v8,1
36348,Malignant Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v7,1
36349,Adulthood Lesion,Adult Meningeal Melanoma,1
36350,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
36351,Papillary Pattern,Cervical Warty Carcinoma,1
36352,Carcinomatous Component Present,Stage IIIC Rectal Cancer AJCC v8,1
36353,Adnexal Differentiation,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
36354,Cutaneous Involvement,Acute Adult T-Cell Leukemia/Lymphoma,1
36355,Epithelial Component Present,Inverted Squamous Cell Papilloma,1
36356,Secondary Lesion,Secondary malignant neoplasm of stomach,1
36357,Adnexal Differentiation,Eccrine mixed tumor of skin,1
36358,Carcinomatous Component Present,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
36359,Infiltrative Growth Pattern,Superficial fibromatosis,1
36360,Primary Lesion,Diffuse Intrinsic Pontine Glioma,1
36361,Necrotic changes (finding),"Glioblastoma, IDH-Wildtype",1
36362,Fibrotic Stroma Formation,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8,1
36363,Extraosseous Lesion,Childhood Extraskeletal Osteosarcoma,1
36364,Carcinomatous Component Present,Prostatic Duct Urothelial Carcinoma,1
36365,Epithelial Component Present,Cervical Glandular Neoplasm,1
36366,Precise Histogenesis Unknown,Hemangioblastoma,1
36367,Cartilaginous metaplasia,Adenocarcinoma with cartilaginous metaplasia,1
36368,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
36369,Malignant Cellular Infiltrate,Angiocentric lymphoma recurrent,1
36370,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
36371,Epithelial Component Present,Advanced Lung Non-Small Cell Squamous Carcinoma,1
36372,Blasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic-Myeloproliferative Diseases,1
36373,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v7,1
36374,Secondary Lesion,Meningeal Carcinomatosis,1
36375,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8,1
36376,Alternative Fascicle (Bundle) Pattern,Appendix Leiomyoma,1
36377,Carcinomatous Component Present,Refractory Ovarian Carcinoma,1
36378,Malignant Cellular Infiltrate,Stage IIB Penile Cancer AJCC v8,1
36379,Extraosseous Lesion,Extraskeletal osteosarcoma recurrent,1
36380,Pregnancy Complications,Stage IVB Gestational Trophoblastic Tumor AJCC v7,1
36381,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v8,1
36382,Carcinomatous Component Present,Metastatic Prostate Small Cell Carcinoma,1
36383,Epithelial Component Present,Low Grade Salivary Gland Carcinoma,1
36384,Mixed Cellular Population,Testicular gonadoblastoma,1
36385,Multifocal Lesion,Multiple polyps,1
36386,Dysplasia,tubulovillous adenoma of stomach,1
36387,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
36388,Epithelial Component Present,Stage IV Laryngeal Cancer AJCC v6,1
36389,Carcinomatous Component Present,Metastatic Gastroesophageal Junction Adenocarcinoma,1
36390,Carcinomatous Component Present,Invasive Ductal and Invasive Lobular Breast Carcinoma,1
36391,Epithelial Component Present,Undifferentiated carcinoma of stomach,1
36392,Tissue Differentiation Uncertain,Tongue Alveolar Soft Part Sarcoma',1
36393,Lymphoplasmacytic Infiltrate,Splenic Lymphoplasmacytic Lymphoma,1
36394,Malignant Cellular Infiltrate,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
36395,Malignant Cellular Infiltrate,Recurrent Malignant Central Nervous System Neoplasm,1
36396,Mesenchymal Component Present,Cellular Pleomorphic Adenoma,1
36397,Well-Circumscribed Lesion,Appendix Tubulovillous Adenoma,1
36398,Mitotic Activity,Yolk Sac Tumor,1
36399,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
36400,Primary Lesion,Childhood Brain Stem Mixed Glioma,1
36401,Malignant Cellular Infiltrate,Adenoma of the Colon with Intramucosal Adenocarcinoma,1
36402,Carcinomatous Component Present,Recurrent Urinary System Carcinoma,1
36403,Neuroendocrine Differentiation,Adrenal Gland Pheochromocytoma,1
36404,Epithelial Component Present,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
36405,Resectable Mass,Resectable Pancreatic Ductal Adenocarcinoma,1
36406,Vascular Channel Formation,Senile hemangioma of lip,1
36407,Mixture of Embryonal and Alveolar Features Present,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
36408,Benign Cellular Infiltrate,Adenoameloblastoma,1
36409,Benign Cellular Infiltrate,Hemangioma of skin,1
36410,Benign Cellular Infiltrate,Benign Mediastinal Germ Cell Tumor,1
36411,Malignant Cellular Infiltrate,Infiltrating Urothelial Carcinoma,1
36412,Fibrosis,Breast Apocrine Adenosis,1
36413,Carcinomatous Component Present,Rectal Sarcomatoid Carcinoma,1
36414,Hyperplastic Epithelial Tissue Present,Atypical Breast Myoepitheliosis,1
36415,Low Grade Lesion,Central Nervous System Epithelioid Hemangioendothelioma,1
36416,Progressive Clinical Course,Progressive Hairy Cell Leukemia Initial Treatment,1
36417,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
36418,Epithelial Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
36419,Malignant Cellular Infiltrate,Recurrent Retinoblastoma,1
36420,Unresectable Mass,Locally Advanced Unresectable Gastric Adenocarcinoma,1
36421,Malignant Cellular Infiltrate,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
36422,Malignant Cellular Infiltrate,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
36423,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
36424,Favorable Clinical Outcome,Hepatocellular Adenoma,1
36425,Malignant Cellular Infiltrate,Penile Cancer by AJCC v8 Stage,1
36426,Lesion with Diameter of 4mm or More,Vulvar Dysplastic Melanocytic Nevus,1
36427,Indolent Clinical Course,Cardiac Lipoma,1
36428,In Situ Lesion,Noninfiltrating Intraductal Carcinoma,1
36429,Exophytic Papillary Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
36430,Recurrent disease,Recurrent Malignant Skin Neoplasm,1
36431,Carcinomatous Component Present,Rectal Carcinoma,1
36432,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Larynx,1
36433,Presence of a Hormonal Syndrome,Hormone secreting pituitary neoplasms,1
36434,Non-Malignant Cellular Infiltrate,Lymphadenitis,1
36435,Cutaneous Involvement,Malignant vascular tumor of skin,1
36436,Epithelial Component Present,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
36437,Malignant Cellular Infiltrate,"Refractory NK-Cell Lymphoma, Unclassifiable",1
36438,Benign Cellular Infiltrate,Cervical Adenofibroma,1
36439,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v6 Stage,1
36440,Cutaneous Involvement,Malignant neoplasm of scrotum,1
36441,Malignant Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis,1
36442,Benign Cellular Infiltrate,Epithelioid hemangioma of skin,1
36443,Unresectable Mass,Unresectable Digestive System Adenocarcinoma,1
36444,Neuroectodermal Differentiation,Localized Unresectable Neuroblastoma,1
36445,Epithelial Component Present,Stage III Laryngeal Cancer AJCC v6 and v7,1
36446,Malignant Cellular Infiltrate,Desmoplastic mesothelioma,1
36447,Nodular lesions,Carcinoid tumor of lung,1
36448,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
36449,Cervical lymphadenopathy,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
36450,Chronic lymphocytic inflammation,Epithelioid hemangioma of skin,1
36451,Benign Cellular Infiltrate,"Lymphangioma, Cystic",1
36452,Malignant Cellular Infiltrate,Gallbladder Neuroendocrine Carcinoma,1
36453,Recurrent disease,Recurrent Childhood Acute Lymphoblastic Leukemia,1
36454,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,1
36455,Well-Circumscribed Lesion,Colorectal Adenomatous Polyp,1
36456,Malignant Cellular Infiltrate,Stage I Laryngeal Cancer AJCC v6 and v7,1
36457,Immature Myeloid Cells Increased in Bone Marrow,Benzene-Related Acute Myeloid Leukemia,1
36458,Secondary Lesion,Anal cancer metastatic,1
36459,Malignant Cellular Infiltrate,"Splenic B-Cell Lymphoma/Leukemia, Unclassifiable",1
36460,Carcinomatous Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7,1
36461,Childhood Lesion,Infant Acute Biphenotypic Leukemia,1
36462,Indolent Clinical Course,"Hemangioma, Intramuscular",1
36463,Epithelial Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
36464,Carcinomatous Component Present,Stage IIIB Cervical Cancer AJCC v8,1
36465,Oligodendroglial Component Present,Anaplastic Oligodendroglioma,1
36466,Benign Cellular Infiltrate,Benign neoplasm of frontal sinus,1
36467,Carcinomatous Component Present,adenoid cystic carcinoma of lung,1
36468,Well-Circumscribed Lesion,Phyllodes Tumor,1
36469,Epithelial Component Present,Stage IV Anal Cancer AJCC v8,1
36470,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
36471,Malignant Cellular Infiltrate,Duodenal Cancer,1
36472,Epithelial Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
36473,Carcinomatous Component Present,Childhood Thyroid Gland Follicular Carcinoma,1
36474,High Grade Lesion,High Grade Fallopian Tube Serous Adenocarcinoma,1
36475,Benign Cellular Infiltrate,Kidney Lipoma,1
36476,Unmethylated MGMT Gene Promoter,MGMT-Unmethylated Glioblastoma,1
36477,Therapy-Related Toxicity,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
36478,Severe dysplasia,Stage 0 Gallbladder Cancer AJCC v8,1
36479,Epithelial Component Present,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
36480,Epithelial Component Present,Stage IV Oral Cavity Cancer AJCC v6 and v7,1
36481,Fibrotic Stroma Formation,Low-grade fibromyxoid sarcoma,1
36482,Epithelial Component Present,Pleomorphic Hepatocellular Carcinoma,1
36483,Invasive Lesion,Recurrent Prostate Acinar Adenocarcinoma,1
36484,Primary Lesion,Hepatocellular Carcinoma by AJCC v6 Stage,1
36485,Cutaneous Involvement,Hamartoma of skin appendage,1
36486,Neuroectodermal Differentiation,Stage 2 Neuroblastoma,1
36487,Benign Cellular Infiltrate,Vulvar Ectopic Fibroadenoma,1
36488,Ground Glass Nuclear Inclusion,Childhood Thyroid Gland Papillary Carcinoma,1
36489,Carcinomatous Component Present,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
36490,Benign Cellular Infiltrate,Testicular Large Cell Calcifying Sertoli Cell Tumor,1
36491,Malignant Cellular Infiltrate,HPV positive oropharyngeal squamous cell carcinoma,1
36492,Primary Lesion,Stage IIA Primary Peritoneal Cancer AJCC v8,1
36493,Adulthood Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
36494,Exophytic Polypoid Lesion,Fallopian Tube Endometrioid Polyp,1
36495,Malignant Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v7,1
36496,Secondary Lesion,Secondary Myelodysplastic Syndrome,1
36497,Epithelial Component Present,Intermediate Grade Lung Neuroendocrine Neoplasm,1
36498,Vascular Channel Formation,Pulmonary Artery Angiosarcoma,1
36499,Slow Growing Mass,Benign Intracranial Meningioma,1
36500,Malignant Cellular Infiltrate,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",1
36501,Refractory Disease,Refractory Myelodysplastic Syndrome,1
36502,Carcinomatous Component Present,Advanced Urothelial Carcinoma,1
36503,Epithelial Component Present,Malignant Ovarian Luteinized Thecoma,1
36504,Benign Cellular Infiltrate,Venous Angioleiomyoma,1
36505,Diffuse Pattern,Adult Diffuse Astrocytoma,1
36506,Biphasic Pattern,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
36507,Carcinomatous Component Present,Adenocarcinoma with metaplasia,1
36508,Primary Lesion,Cerebral Hodgkin Lymphoma,1
36509,Benign Cellular Infiltrate,Rete Ovarii Cystadenofibroma,1
36510,Metastatic Lesion,Castration-Sensitive Prostate Carcinoma,1
36511,Epithelial Component Present,Small intestine carcinoma recurrent,1
36512,Small Lesion,Small Congenital Melanocytic Nevus,1
36513,Indolent Clinical Course,Pyogenic granuloma of skin and subcutaneous tissue,1
36514,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1
36515,Cutaneous Involvement,Benign neoplasm of scrotum,1
36516,Cellular Pleomorphism,Malignant fibrous histiocytoma metastatic,1
36517,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome recurrent,1
36518,Borderline Lesion,Cutaneous Lymphomatoid Granulomatosis,1
36519,Increased Cellularity Present,Kadish Stage B Olfactory Neuroblastoma,1
36520,Malignant Primitive Cellular Infiltrate,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,1
36521,Calcitonin serum level increased,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
36522,Extraosseous Lesion,Extraskeletal Osteosarcoma,1
36523,Malignant Cellular Infiltrate,Human Papillomavirus-Related Verrucous Carcinoma,1
36524,Cutaneous Involvement,Harlequin Fetus,1
36525,Recurrent disease,Recurrent Spindle Cell Sarcoma,1
36526,Favorable Clinical Outcome,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement,1
36527,Malignant Cellular Infiltrate,Malignant germ cell neoplasm,1
36528,Extensive Stage Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,1
36529,Malignant Cellular Infiltrate,Stage IV Colon Cancer AJCC v8,1
36530,Epithelial Component Present,Skin squamous cell carcinoma recurrent,1
36531,Vascular Channel Formation,Cavernous lymphangioma,1
36532,Benign Cellular Infiltrate,Childhood Mature Teratoma,1
36533,Malignant Cellular Infiltrate,Carcinoma of supraglottis,1
36534,Lipomatous Component Present,Kidney Epithelioid Type Angiomyolipoma,1
36535,Dysplasia,Colorectal Villous Adenoma,1
36536,Epithelial Component Present,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
36537,Clinical TNM Finding,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
36538,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
36539,Unmethylated MGMT Gene Promoter,MGMT-Unmethylated Glioblastoma,1
36540,Epithelial Component Present,Parathyroid Adenoma,1
36541,Cutaneous Involvement,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
36542,High Mitotic Activity,Malignant Lung PEComa,1
36543,Malignant Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage,1
36544,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
36545,Epithelial Component Present,Sebaceous Adenocarcinoma,1
36546,Fibrotic Stroma Formation,Classical Low Grade Fibromyxoid Sarcoma,1
36547,Malignant Cellular Infiltrate,Cystadenocarcinoma,1
36548,In Situ Lesion,Stage 0 Vaginal Cancer AJCC v7,1
36549,Well Differentiated Neuroendocrine Lesion,Gastrointestinal Carcinoid Tumor,1
36550,Carcinomatous Component Present,Cervical Keratinizing Squamous Cell Carcinoma,1
36551,Carcinomatous Component Present,"Adenocarcinoma, Clear Cell",1
36552,Epithelial Component Present,Stage I Nasopharyngeal Carcinoma AJCC v7,1
36553,Hyperplastic Tissue Present,Atypical Adenomatous Lung Hyperplasia,1
36554,'Starry-sky' pattern,Burkitt's lymphoma refractory,1
36555,Rapidly Enlarging Mass,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
36556,Epithelial Component Present,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
36557,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
36558,Carcinomatous Component Present,Stage IIIA Ovarian Carcinoma,1
36559,Hypercellular bone marrow,Philadelphia chromosome negative chronic myelogenous leukemia,1
36560,Epithelial Component Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
36561,Carcinomatous Component Present,Stage IIIB Breast Carcinoma,1
36562,Perivascular Arrangement of Tumor Cells,Malignant Pericytic Neoplasm,1
36563,Metastatic Lesion,Metastatic Hypopharyngeal Carcinoma,1
36564,Invasive Lesion,Recurrent Prostate Acinar Adenocarcinoma,1
36565,Carcinomatous Component Present,Mucinous cystadenocarcinoma appendix,1
36566,Epithelial Component Present,Tubulovillous adenoma,1
36567,Malignant Cellular Infiltrate,Carcinomatosis of peritoneal cavity,1
36568,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
36569,Vascular Channel Formation,Pericardial Angiosarcoma,1
36570,Malignant Cellular Infiltrate,Refractory Small Intestinal Carcinoma,1
36571,Low Mitotic Activity,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
36572,High Mitotic Activity,Testicular embryonal carcinoma stage I,1
36573,Therapy-Related Toxicity,Transplant-Related Carcinoma,1
36574,High Grade Lesion,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
36575,Perivascular fibrosis,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma,1
36576,Tissue Differentiation Uncertain,Pulmonary Artery Intimal Sarcoma,1
36577,Geographic Necrosis,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
36578,Epithelial Component Present,Seminal Vesicle Adenocarcinoma,1
36579,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
36580,Carcinomatous Component Present,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
36581,CD1a-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic",1
36582,Human Papillomavirus Positive,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
36583,Secondary Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,1
36584,Necrotic changes (finding),large cell neuroendocrine carcinoma of breast,1
36585,Primary Lesion,Recurrent Childhood Anaplastic Oligodendroglioma,1
36586,Secondary Lesion,Metastatic Adrenal Gland Pheochromocytoma,1
36587,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor,1
36588,Malignant Cellular Infiltrate,Stage IIIB Vulvar Cancer AJCC v7,1
36589,Carcinomatous Component Present,Posterior Tongue Adenoid Cystic Carcinoma,1
36590,Malignant Cellular Infiltrate,Childhood Mesenchymal Chondrosarcoma,1
36591,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,"Myelodysplastic syndrome, no ICD-O subtype",1
36592,Cutaneous Involvement,Eccrine acrospiroma,1
36593,Carcinomatous Component Present,carcinosarcoma of salivary gland,1
36594,Increased Cellularity Present,pineoblastoma,1
36595,Malignant Cellular Infiltrate,Advanced Squamous Cell Carcinoma of the Oropharynx,1
36596,Epithelial Component Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8,1
36597,Exophytic Polypoid Lesion,Endometrial Polyp,1
36598,Malignant Cellular Infiltrate,Stage I Lung Cancer AJCC v8,1
36599,Vascular Channel Formation,Prostate Kaposi Sarcoma,1
36600,Well-Circumscribed Lesion,Anaplastic Kidney Wilms Tumor,1
36601,Antoni A Pattern,Trigeminal schwannoma,1
36602,Alternative Fascicle (Bundle) Pattern,Piloleiomyoma,1
36603,Malignant Cellular Infiltrate,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
36604,Cutaneous Involvement,Malignant eccrine spiradenoma,1
36605,Epithelial Component Present,Cervical Lymphoepithelioma-Like Carcinoma,1
36606,Nuclear Atypia,Pineal parenchymal tumor of intermediate differentiation,1
36607,Benign Cellular Infiltrate,Endometrial stromal nodule,1
36608,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
36609,Benign Cellular Infiltrate,Compound nevus of skin,1
36610,Epithelial Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
36611,Epithelial Component Present,Stage IVA Major Salivary Gland Cancer AJCC v7,1
36612,Epithelial Component Present,Low Grade Esophageal Glandular Intraepithelial Neoplasia,1
36613,Well Differentiated Lesion,Esophageal Well Differentiated Squamous Cell Carcinoma,1
36614,Carcinomatous Component Present,Localized Non-Resectable Adult Liver Carcinoma,1
36615,Indolent Clinical Course,Sternal Chondromyxoid Fibroma,1
36616,Malignant Cellular Infiltrate,Stage IV Renal Pelvis Cancer AJCC v8,1
36617,Thick-Walled Hyalinized Vessels Present,Benign Cardiac Schwannoma,1
36618,Whorling Growth Pattern,Classical Low Grade Fibromyxoid Sarcoma,1
36619,Carcinomatous Component Present,Bladder transitional cell carcinoma stage 0,1
36620,Epithelial Component Present,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
36621,Mixed Cellular Population,Serous adenofibroma,1
36622,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor,1
36623,Malignant Cellular Infiltrate,undifferentiated carcinoma of pancreas,1
36624,Borderline Lesion,Borderline serous tumor of ovary,1
36625,Carcinomatous Component Present,Stage II Oropharyngeal Carcinoma,1
36626,Carcinomatous Component Present,Adenocarcinoma of the gastroesophageal junction,1
36627,Malignant Cellular Infiltrate,Malignant neoplasm of heart,1
36628,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
36629,Cutaneous Involvement,Furunculosis,1
36630,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma,1
36631,"Amorphus, Eosinophilic, and Acellular Deposit",Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
36632,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G1,1
36633,Lymphadenopathy,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
36634,Epithelial Component Present,Stage II Distal Bile Duct Cancer AJCC v8,1
36635,Micropapillary Pattern,"Transitional cell carcinoma, micropapillary",1
36636,Cutaneous Involvement,Kaposi's sarcoma classical type,1
36637,Cutaneous Involvement,Solar Radiation-Related Cutaneous Melanoma,1
36638,Cutaneous Involvement,regressing melanoma of skin,1
36639,Epithelial Component Present,Stage IV Anal Canal Cancer AJCC v6 and v7,1
36640,Primary Lesion,Ependymoma of brain,1
36641,Cutaneous Involvement,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8,1
36642,"Fully Differentiated ""Adult-Type"" Tissues Present","Teratoma, Malignant",1
36643,Exophytic Polypoid Lesion,Epulides,1
36644,Malignant Cellular Infiltrate,Stage IIIB Anal Cancer AJCC v8,1
36645,Malignant Cellular Infiltrate,Stage III Urethral Cancer AJCC v8,1
36646,Reactive Germinal Centers Present,Pulmonary nodular lymphoid hyperplasia,1
36647,Malignant Cellular Infiltrate,Colorectal Carcinoma,1
36648,Indolent Clinical Course,Pleomorphic Lipoma,1
36649,High Mitotic Activity,Testicular embryonal carcinoma stage I,1
36650,Primary Lesion,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
36651,Primary Lesion,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
36652,Malignant Cellular Infiltrate,Epithelioid Cell Melanoma,1
36653,Epithelial Component Present,Pancreatic Cancer by AJCC v6 and v7 Stage,1
36654,Malignant Cellular Infiltrate,Locally Advanced Bile Duct Carcinoma,1
36655,Hyperkeratosis,Laryngeal verrucous carcinoma,1
36656,Locally Aggressive Lesion,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
36657,Malignant Cellular Infiltrate,Gallbladder Cancer by AJCC v7 Stage,1
36658,Eccrine Differentiation,Benign Eccrine Neoplasm,1
36659,Carcinomatous Component Present,Advanced Gastric Neuroendocrine Carcinoma,1
36660,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21,1
36661,High Grade Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
36662,Refractory Disease,Refractory Hematologic Malignancy,1
36663,Malignant Cellular Infiltrate,fibrosarcoma of small intestine,1
36664,Epithelial Component Present,High Grade Cervical Intraepithelial Neoplasia,1
36665,Cutaneous Involvement,Stage III Acral Lentiginous Melanoma AJCC v7,1
36666,Carcinomatous Component Present,Gastric Mixed Adenoneuroendocrine Carcinoma,1
36667,Diffuse Lesion,Liver Lymphangiomatosis,1
36668,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
36669,Anaplasia,Childhood Cerebral Anaplastic Astrocytoma,1
36670,Malignant Cellular Infiltrate,Metastatic Chordoma,1
36671,Pathologic TNM Finding,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
36672,Poorly Differentiated Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
36673,Recurrent disease,Recurrent Extrahepatic Bile Duct Carcinoma,1
36674,Nodular Pattern,Benign Breast Eccrine Spiradenoma,1
36675,Abnormal alveolar pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",1
36676,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
36677,Perineural spread,adenoid cystic carcinoma of pharynx,1
36678,Malignant Cellular Infiltrate,Malignant neoplasm of duodenum,1
36679,Sarcomatous or Carcinomatous Component Present,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,1
36680,Spindle Cell Osteo-Fibrous Component Present,Adamantinoma,1
36681,High Grade Lesion,Mediastinal Synovial Sarcoma,1
36682,Epithelial Component Present,Anal Canal Squamous Intraepithelial Neoplasia,1
36683,Nuclear Grooves,Multicentric Thyroid Gland Papillary Carcinoma,1
36684,Adulthood Lesion,BCLC Stage D Adult Hepatocellular Carcinoma,1
36685,Epithelial Component Present,Submandibular Gland Adenocarcinoma,1
36686,Malignant Cellular Infiltrate,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",1
36687,In Situ Lesion,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
36688,Carcinomatous Component Present,Stage IV Renal Cell Cancer,1
36689,Carcinomatous Component Present,Paget's disease of vulva,1
36690,Carcinomatous Component Present,Cervical carcinoma stage II AJCC v7,1
36691,Epithelial Component Present,Benign neoplasm of sweat gland,1
36692,Primary Lesion,Multifocal osteosarcoma,1
36693,Low Mitotic Activity,Descending Colon Neuroendocrine Tumor G1,1
36694,Epithelial Component Present,Papillary tumor of renal pelvis,1
36695,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
36696,Nuclear Expression of STAT6 Protein,benign fibroma of liver,1
36697,Syncytial Pattern,Pancreatic Medullary Carcinoma,1
36698,Epithelial Component Present,Breast Carcinoma,1
36699,Well-Circumscribed Lesion,Pleomorphic Rhabdomyosarcoma,1
36700,Metastatic Lesion,Fibrosarcoma metastatic,1
36701,Indolent Clinical Course,Osteochondromyxoma,1
36702,Benign Cellular Infiltrate,Solid Angioleiomyoma,1
36703,Neuroendocrine Differentiation,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,1
36704,Vascular Channel Formation,Cardiac hemangioma,1
36705,Malignant Cellular Infiltrate,Adult Desmoplastic Small Round Cell Tumor,1
36706,Hypercellular bone marrow,"Polycythemia Vera, Polycythemic Phase",1
36707,Cutaneous Involvement,Cutaneous neurofibroma,1
36708,Well-Circumscribed Lesion,Sebaceoma,1
36709,Epithelial Component Present,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
36710,Carcinomatous Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
36711,Slow Growing Mass,Cerebellar hemangioblastoma,1
36712,atypia morphology,Atypical fibroxanthoma - spindle cell type,1
36713,Dysplasia,Intestinal Intraepithelial Neoplasia,1
36714,Malignant Cellular Infiltrate,Prefibrotic/Early Primary Myelofibrosis,1
36715,Well-Circumscribed Lesion,Stage IV Kidney Wilms Tumor,1
36716,Pregnancy Complications,Morbidly adherent placenta (disorder),1
36717,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Central Nervous System,1
36718,Indolent Clinical Course,Odontogenic myxoma,1
36719,Epithelial Component Present,Anatomic Stage II Breast Cancer AJCC v8,1
36720,Invasive Lesion,Breast Carcinoma with Osteoclastic Giant Cells,1
36721,Cystic Change,Clear Cell Papillary Cystadenoma,1
36722,Malignant Cellular Infiltrate,T-cell lymphoma recurrent,1
36723,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage II,1
36724,Carcinomatous Component Present,adenocarcinoma of middle ear,1
36725,Benign Cellular Infiltrate,benign myoepithelioma of salivary gland,1
36726,Syncytial Pattern,Metastatic Nasopharyngeal Undifferentiated Carcinoma,1
36727,Epithelial Component Present,clear cell adenocarcinoma of bladder,1
36728,Malignant Cellular Infiltrate,Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma,1
36729,Malignant Cellular Infiltrate,Small cell lung cancer recurrent,1
36730,Well Differentiated Neuroendocrine Lesion,Pancreatic Delta Cell Neoplasm,1
36731,Epithelial Component Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
36732,Trabecular Pattern,Malignant Pancreatic Somatostatinoma,1
36733,Cutaneous Involvement,Skin Neoplasms,1
36734,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,1
36735,Benign Cellular Infiltrate,Benign Pericytic Neoplasm,1
36736,Carcinomatous Component Present,Childhood Thyroid Gland Carcinoma,1
36737,Benign Cellular Infiltrate,Adenoma of the nipple,1
36738,Refractory Disease,Refractory Malignant Thymoma,1
36739,Malignant Cellular Infiltrate,Adult Acute Monoblastic and Monocytic Leukemia,1
36740,Low Mitotic Activity,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
36741,Carcinomatous Component Present,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
36742,Storiform Growth Pattern,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
36743,Benign Cellular Infiltrate,Benign neoplasm of spleen,1
36744,Carcinomatous Component Present,Stage I Lung Cancer AJCC v6,1
36745,Malignant Cellular Infiltrate,Ampulla of Vater Intestinal-Type Adenocarcinoma,1
36746,Epithelial Component Present,Stage III Fallopian Tube Cancer AJCC v8,1
36747,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma,1
36748,Epithelial Component Present,Penis carcinoma recurrent,1
36749,"Amorphus, Eosinophilic, and Acellular Deposit",Soft Tissue Amyloid Neoplasm,1
36750,Perivascular Arrangement of Tumor Cells,Malignant Pericytic Neoplasm,1
36751,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
36752,Low Cellularity Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1",1
36753,Malignant Cellular Infiltrate,Clinical Stage IIB Gastric Cancer AJCC v8,1
36754,Indolent Clinical Course,Chondroblastoma,1
36755,Malignant Cellular Infiltrate,Neck Carcinoma,1
36756,Malignant Cellular Infiltrate,"Adrenal Gland Ganglioneuroblastoma, Intermixed",1
36757,Increased Cellularity Present,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
36758,Epithelial Component Present,Metastatic Kidney Medullary Carcinoma,1
36759,Well-Circumscribed Lesion,Ovarian Seromucinous Cystadenoma,1
36760,Malignant Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,1
36761,Malignant Cellular Infiltrate,Recurrent Grade 3a Follicular Lymphoma,1
36762,Malignant Cellular Infiltrate,Unresectable Urothelial Carcinoma,1
36763,Epithelial Component Present,Hepatitis B Virus-Related Hepatocellular Carcinoma,1
36764,Cutaneous Involvement,Sezary Syndrome,1
36765,Epithelial Component Present,Unresectable Ureter Urothelial Carcinoma,1
36766,Malignant Cellular Infiltrate,Noninfiltrating intraductal papillary adenocarcinoma,1
36767,Malignant Cellular Infiltrate,Locally Advanced Unresectable Malignant Neoplasm,1
36768,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
36769,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
36770,Well-Circumscribed Lesion,Colorectal Adenoma with Mild Dysplasia,1
36771,Numerous Stromal Mast Cells Present,Angiomyofibroblastoma,1
36772,Well Differentiated Neuroendocrine Lesion,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
36773,Epithelial Component Present,Adenomatous Polyps,1
36774,Anaplasia,Giant cell carcinoma of lung,1
36775,Childhood Lesion,Recurrent Childhood Oligoastrocytoma,1
36776,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
36777,Malignant Cellular Infiltrate,AJCC Grade 1 Sarcoma,1
36778,Epithelial Component Present,Stage II Adrenal Cortex Carcinoma AJCC v8,1
36779,Carcinomatous Component Present,Hormone Receptor Positive Breast Carcinoma,1
36780,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma recurrent,1
36781,High Grade Lesion,Alveolar soft part sarcoma non-metastatic,1
36782,Carcinomatous Component Present,Primary Peritoneal High Grade Serous Adenocarcinoma,1
36783,Solitary mass,Epithelioid hemangioendothelioma,1
36784,Carcinomatous Component Present,Colon Carcinoma Metastatic in the Lung,1
36785,Malignant Cellular Infiltrate,AJCC Grade 4 Sarcoma,1
36786,Severe cytologic atypia,Metastatic Digestive System Neuroendocrine Carcinoma,1
36787,Epithelial Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
36788,Carcinomatous Component Present,Metastatic Unresectable Basal Cell Carcinoma,1
36789,Carcinomatous Component Present,Unresectable Adrenal Cortex Carcinoma,1
36790,Secondary Lesion,Adenocarcinoma of the prostate metastatic,1
36791,Malignant Cellular Infiltrate,Secondary malignant neoplasm of female breast,1
36792,Exophytic Papillary Lesion,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
36793,Primary Lesion,Aggressive Systemic Mastocytosis,1
36794,Mesenchymal Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
36795,Recurrent disease,Angiocentric lymphoma recurrent,1
36796,Extraosseous Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
36797,Malignant Cellular Infiltrate,Stage III Urethral Cancer AJCC v8,1
36798,Malignant Cellular Infiltrate,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
36799,S-100-Positive Neoplastic Cells Present,Letterer-Siwe Disease,1
36800,Malignant Cellular Infiltrate,Malignant neoplasm of brain,1
36801,Tumor Droplets Present,Adenoameloblastoma,1
36802,Malignant Cellular Infiltrate,Stage IIIA Breast Carcinoma,1
36803,Epithelial Component Present,Advanced Lung Non-Small Cell Squamous Carcinoma,1
36804,Annular Tubules Present,Ovarian Sex Cord Tumor with Annular Tubules,1
36805,Carcinomatous Component Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
36806,Epithelial Component Present,Anaplastic adrenocortical carcinoma,1
36807,High Grade Lesion,Burkitt-like lymphoma with 11q aberration,1
36808,Apocrine Differentiation,Malignant Apocrine Neoplasm,1
36809,Cutaneous Involvement,Hemangioma of skin,1
36810,Diffuse Pattern,"Diffuse Astrocytoma, IDH-Mutant",1
36811,Perineural spread,Lipomatosis of Nerve,1
36812,Epithelial Component Present,Stage IIIB Small Intestinal Cancer AJCC v7,1
36813,Follicular Cell Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
36814,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
36815,Clinical TNM Finding,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
36816,Cutaneous Involvement,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
36817,Blasts Under 20 Percent of Peripheral Blood White Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
36818,Epithelial Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
36819,High Mitotic Activity,Malignant Lung PEComa,1
36820,Multifocal Lesion,Refractory Malignant Neoplasm of Multiple Primary Sites,1
36821,Malignant Cellular Infiltrate,Mixed Cellularity Hodgkin Lymphoma,1
36822,Invasive Lesion,Minimally Invasive Thymoma,1
36823,Benign Cellular Infiltrate,Gastric Lymphangioma,1
36824,Malignant Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
36825,Secondary Lesion,Reactive systemic amyloidosis,1
36826,Keratin pearl formation,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
36827,Malignant Cellular Infiltrate,recurrent childhood acute myeloid leukemia,1
36828,Epithelial Component Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,1
36829,Benign Cellular Infiltrate,Paraganglioma-Like Dermal Melanocytic Tumor,1
36830,Unresectable Mass,Unresectable Solid Neoplasm,1
36831,Mitotic Activity,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
36832,Malignant Cellular Infiltrate,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
36833,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
36834,Malignant Cellular Infiltrate,Stage III Vulvar Cancer AJCC v6,1
36835,Myxoid Stroma Formation,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
36836,Cartilage-Like Elements Present,Sellar Chondroid Chordoma,1
36837,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage II,1
36838,Cystic Lesion,Unresectable Craniopharyngioma,1
36839,Primary Lesion,Intracortical osteosarcoma,1
36840,Epithelial Component Present,Ameloblastic Carcinoma Derived From Odontogenic Cyst,1
36841,Vascular Channel Formation,Angiosarcoma of liver,1
36842,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v8,1
36843,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v7 Stage,1
36844,Carcinomatous Component Present,Clinical Stage I Gastric Cancer AJCC v8,1
36845,Carcinomatous Component Present,Stage I Fallopian Tube Cancer AJCC v8,1
36846,Benign Cellular Infiltrate,Lymphangioendothelioma,1
36847,Epithelial Component Present,Metastatic Kidney Medullary Carcinoma,1
36848,Malignant Cellular Infiltrate,Adenocarcinoma of prostate,1
36849,Epithelial Component Present,Sclerosing thymoma,1
36850,Epithelial Component Present,Solid Lung Adenocarcinoma,1
36851,High Mitotic Activity,Small cell carcinoma of lung,1
36852,High Grade Lesion,Childhood Spindle Cell Rhabdomyosarcoma,1
36853,Malignant Cellular Infiltrate,Refractory Fallopian Tube Carcinoma,1
36854,Transformed Phase of Disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
36855,High Mitotic Activity,"Perineurioma, malignant",1
36856,Childhood Lesion,Childhood Malignant Kidney Neoplasm,1
36857,Secondary Lesion,Benzene-Related Acute Myeloid Leukemia,1
36858,Carcinomatous Component Present,"Carcinoma, Skin Appendage",1
36859,Papillary Pattern,serous surface papillary carcinoma of ovary,1
36860,Carcinomatous Component Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
36861,Epithelial Component Present,Metastatic Microsatellite Stable Colorectal Carcinoma,1
36862,Malignant Cellular Infiltrate,Stage IV Colon Carcinoma,1
36863,Epithelial Component Present,lipid-rich carcinoma of breast,1
36864,Cervical Glandular Dysplasia,intraepithelial glandular neoplasia of cervix,1
36865,Malignant Cellular Infiltrate,Occult Lung Squamous Cell Carcinoma,1
36866,Desmoplastic Stroma Formation,Desmoplastic infantile ganglioglioma,1
36867,Epithelial Component Present,Stage IC Eyelid Carcinoma AJCC v7,1
36868,Epithelial Component Present,Appendix Tubular Adenoma,1
36869,Malignant Cellular Infiltrate,Resectable Malignant Neoplasm,1
36870,CD56-Positive Neoplastic Cells Present,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,1
36871,Malignant Cellular Infiltrate,Malignant tumor of base of tongue,1
36872,S-100-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, malignant",1
36873,Malignant Cellular Infiltrate,Vaginal Endometrioid Adenocarcinoma,1
36874,"Fully Differentiated ""Adult-Type"" Tissues Present",Benign Teratoma,1
36875,Malignant Cellular Infiltrate,Cutaneous Mature B-Cell Neoplasm,1
36876,Invasive Lesion,Prostate Acinar Adenocarcinoma,1
36877,Malignant Cellular Infiltrate,Malignant nipple neoplasm,1
36878,Moderately Differentiated Lesion,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
36879,Infiltrative Growth Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",1
36880,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
36881,Biphasic Pattern,"Synovial sarcoma, biphasic",1
36882,Malignant Cellular Infiltrate,Human Papillomavirus-Related Adenosquamous Carcinoma,1
36883,Tissues Derived from Two or Three Embryonic Layers Present,Childhood Ovarian Immature Teratoma,1
36884,Recurrent disease,Urothelial carcinoma urethra recurrent,1
36885,Malignant Cellular Infiltrate,Pigmented Basal Cell Carcinoma,1
36886,Neuroendocrine Differentiation,Stage IV Lung Small Cell Carcinoma AJCC v7,1
36887,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v7,1
36888,Encapsulated Mass,Parotid Gland Warthin Tumor,1
36889,Mitotic Activity,Anaplastic astrocytoma,1
36890,Epithelial Component Present,Non-small cell lung cancer stage IIIB,1
36891,Epithelial Component Present,Laryngeal Cancer by AJCC v6 Stage,1
36892,Epithelial Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
36893,Multifocal Lesion,Bowenoid papulosis of penis,1
36894,Papillary Pattern,Condyloma Acuminatum with Dysplasia,1
36895,Sebaceous Differentiation,Sebaceous Adenocarcinoma,1
36896,Malignant Cellular Infiltrate,epithelial-myoepithelial carcinoma of salivary gland,1
36897,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
36898,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Solid Variant",1
36899,Well Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor,1
36900,Absence of Invasion,Actinic keratosis,1
36901,Absence of Invasion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
36902,Epithelial Component Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,1
36903,Mild cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
36904,Carcinomatous Component Present,Nipple Duct Carcinoma,1
36905,Epithelial Component Present,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
36906,Epithelial Component Present,Syringoma,1
36907,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity,1
36908,Malignant Cellular Infiltrate,Grade 3 Clear Cell Renal Cell Carcinoma,1
36909,Epithelial Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
36910,Carcinomatous Component Present,Stage IA Intrahepatic Bile Duct Cancer AJCC v8,1
36911,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
36912,Chromogranin A Positive Neoplastic Cells Present,Extrahepatic Bile Duct Carcinoid Tumor,1
36913,Capillary Sized Vascular Channel Formation,Capillary hemangioma of retina,1
36914,Malignant Cellular Infiltrate,Secondary malignant neoplasm of nervous system,1
36915,Epithelial Component Present,Carcinoma of lower gum,1
36916,Recurrent disease,Recurrent Fibrolamellar Carcinoma,1
36917,Carcinomatous Component Present,Stage IIIC Hepatocellular Carcinoma AJCC v7,1
36918,Epithelial Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
36919,Cutaneous Involvement,Urticaria,1
36920,Malignant Cellular Infiltrate,Sarcomatosis,1
36921,Diffuse Pattern,AIDS-Related Primary Effusion Lymphoma,1
36922,Adulthood Lesion,Adult Pineoblastoma,1
36923,Childhood Lesion,Childhood Laryngeal Carcinoma,1
36924,Recurrent disease,Recurrent Childhood Liver Cancer,1
36925,Epithelial Component Present,Metastatic Lung Adenosquamous Carcinoma,1
36926,Intraluminal Tumor Growth,Gallbladder Papillomatosis,1
36927,Mature Schwannian Stroma Present,Mature Ganglioneuroma,1
36928,Carcinomatous Component Present,Advanced Renal Cell Carcinoma,1
36929,Epithelial Component Present,Adenocarcinoma in Situ,1
36930,Intraosseous Lesion,Ossifying Fibroma,1
36931,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma,1
36932,Well-Circumscribed Lesion,Colon Traditional Serrated Adenoma,1
36933,Carcinomatous Component Present,Stage IIIC Lung Cancer AJCC v8,1
36934,Malignant Cellular Infiltrate,Recurrent Malignant Ovarian Brenner Tumor,1
36935,Benign Cellular Infiltrate,Hemangioma,1
36936,Biphasic Pattern,Adult Pilocytic Astrocytoma,1
36937,Malignant Cellular Infiltrate,Parotid Gland Non-Hodgkin Lymphoma,1
36938,Epithelial Component Present,Ampulla of Vater Gangliocytic Paraganglioma,1
36939,Eccrine Differentiation,Eccrine Neoplasm,1
36940,Carcinomatous Component Present,Gastric Body Carcinoma,1
36941,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Cancer AJCC v8,1
36942,Epithelial Component Present,Stage IIA Distal Bile Duct Cancer AJCC v7,1
36943,Epithelial Component Present,Recurrent Parotid Gland Undifferentiated Carcinoma,1
36944,Neuroendocrine Differentiation,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
36945,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v8,1
36946,Malignant Cellular Infiltrate,Sezary Syndrome,1
36947,Malignant Cellular Infiltrate,Kaposi Sarcoma,1
36948,Recurrent disease,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",1
36949,Acanthosis,Laryngeal verrucous carcinoma recurrent,1
36950,Immunosuppression-Related Post-Transplant Toxicity,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder,1
36951,Malignant Cellular Infiltrate,sarcoma of larynx,1
36952,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
36953,Carcinomatous Component Present,adenocarcinoma of gallbladder with squamous metaplasia,1
36954,Malignant Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
36955,Recurrent disease,Large cell lung cancer recurrent,1
36956,Epithelial Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
36957,Carcinomatous Component Present,Stage IVB Hepatocellular Carcinoma AJCC v7,1
36958,Superficial Lesion,Vulvar Superficial Angiomyxoma,1
36959,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern",1
36960,Diffuse Pattern,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
36961,Neuroectodermal Differentiation,Adrenal neuroblastoma,1
36962,Malignant Cellular Infiltrate,Adult Acute Basophilic Leukemia,1
36963,Diffuse Lesion,Melanomatosis,1
36964,Cutaneous Involvement,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
36965,Cutaneous Involvement,Cutaneous Mantle Cell Lymphoma,1
36966,Pathologic TNM Finding,Pathologic Stage IV Cutaneous Melanoma AJCC v8,1
36967,Adulthood Lesion,Adult Anaplastic (Malignant) Meningioma,1
36968,Malignant Cellular Infiltrate,Metastatic Carcinoma in the Adrenal Cortex,1
36969,Exophytic Polypoid Lesion,Colon Sessile Serrated Adenoma/Polyp,1
36970,Epithelial Component Present,Stage IIA Distal Bile Duct Cancer AJCC v7,1
36971,Malignant Cellular Infiltrate,mucinous adenocarcinoma of rectum,1
36972,Metastatic Lesion,Metastatic Bone Ewing Sarcoma,1
36973,Malignant Cellular Infiltrate,Mantle cell lymphoma stage IV,1
36974,Osseous Differentiation,Mediastinal Extraskeletal Osteosarcoma,1
36975,Carcinomatous Component Present,Stage II Skin Cancer,1
36976,Malignant Cellular Infiltrate,Malignant Esophageal Neoplasm by Anatomic Region,1
36977,Cutaneous Involvement,Lichen Sclerosus et Atrophicus,1
36978,Malignant Cellular Infiltrate,Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
36979,Well-Circumscribed Lesion,Adenomatoid tumor of epididymis,1
36980,Epithelial Component Present,Pericardial Carcinomatosis,1
36981,Metastatic/Recurrent Disease,Conventional Extraskeletal Myxoid Chondrosarcoma,1
36982,Primary Site Unknown,Undifferentiated Carcinoma of Unknown Primary,1
36983,Carcinomatous Component Present,Growth Hormone-Producing Pituitary Gland Carcinoma,1
36984,Epithelial Component Present,Stromal tumor of ovary,1
36985,Epithelial Component Present,Prognostic Stage IV Breast Cancer AJCC v8,1
36986,Severe dysplasia,Squamous Cell Carcinoma In Situ of the Nipple,1
36987,Carcinomatous Component Present,Vulvar Non-Keratinizing Squamous Cell Carcinoma,1
36988,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v8,1
36989,Cystic Change,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,1
36990,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of gallbladder,1
36991,Benign Cellular Infiltrate,Benign Ovarian Seromucinous Tumor,1
36992,Recurrent disease,Recurrent Childhood Cerebral Astrocytoma,1
36993,Carcinomatous Component Present,Prognostic Stage I Breast Cancer AJCC v8,1
36994,Epithelial Component Present,Stage II Hypopharyngeal Carcinoma AJCC v8,1
36995,Metastatic Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma,1
36996,Carcinomatous Component Present,Lymphoepithelial malignant thymoma,1
36997,Carcinomatous Component Present,Minor Salivary Gland Undifferentiated Carcinoma,1
36998,Benign Cellular Infiltrate,Pleomorphic adenoma of lacrimal gland,1
36999,Anaplasia,Supratentorial Glioblastoma,1
37000,Mucinous degeneration,Childhood Protoplasmic Astrocytoma,1
37001,Malignant Cellular Infiltrate,Stage III Merkel Cell Carcinoma AJCC v7,1
37002,Carcinomatous Component Present,Small Intestinal Squamous Cell Carcinoma,1
37003,Malignant Cellular Infiltrate,Malignant neoplasm of endocervix,1
37004,Unclassifiable Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
37005,Epithelial Component Present,Skin squamous cell carcinoma recurrent,1
37006,Apocrine Differentiation,Invasive Apocrine Breast Carcinoma,1
37007,Diffuse Pattern,Primary Effusion Lymphoma,1
37008,Villous Pattern,Villous adenocarcinoma,1
37009,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
37010,Malignant Cellular Infiltrate,Grade 1 Colorectal Adenocarcinoma,1
37011,Malignant Cellular Infiltrate,Kaposi Sarcoma NCI Grade 3,1
37012,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Tumor G1,1
37013,Epithelial Component Present,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,1
37014,Nodular lesions,Thyroid Gland Clear Cell Follicular Adenoma,1
37015,Malignant Cellular Infiltrate,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
37016,Malignant Cellular Infiltrate,"Vulvar Adenocarcinoma, Intestinal-Type",1
37017,Refractory Disease,Refractory Plasma Cell Neoplasm,1
37018,Stromal Invasion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
37019,Recurrent disease,Skin squamous cell carcinoma recurrent,1
37020,Malignant Cellular Infiltrate,"Dendritic Cell Sarcoma, Interdigitating",1
37021,Malignant Cellular Infiltrate,Vertebral chordoma,1
37022,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v7,1
37023,Malignant Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant",1
37024,Well-Circumscribed Lesion,Choroid Plexus Papilloma,1
37025,Epithelial Component Present,Carcinoma of upper gum,1
37026,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Insulinoma,1
37027,Plasma cell inflammation,Syringocystadenoma Papilliferum,1
37028,Neuroendocrine Differentiation,Refractory Digestive System Neuroendocrine Carcinoma,1
37029,Malignant Cellular Infiltrate,Secondary malignant neoplasm of extrahepatic bile ducts,1
37030,Carcinomatous Component Present,Occult Lung Carcinoma,1
37031,Well Differentiated Neuroendocrine Lesion,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,1
37032,Low Mitotic Activity,Carcinoid tumor of ileum,1
37033,Benign Cellular Infiltrate,Ganglioneuroma of mediastinum,1
37034,Malignant Cellular Infiltrate,Extramedullary Plasmacytoma,1
37035,Hemorrhagic,Angiosarcoma recurrent,1
37036,Epithelial Component Present,Stage IIB Ampulla of Vater Cancer AJCC v7,1
37037,Childhood Lesion,Childhood Rectal Carcinoma,1
37038,Invasive Lesion,malignant myoepithelioma of breast,1
37039,Metastatic/Recurrent Disease,Peritoneal Desmoplastic Small Round Cell Tumor,1
37040,Epithelial Component Present,Urinary System Paraganglioma,1
37041,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
37042,Low Grade Lesion,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
37043,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage I,1
37044,Epithelial Component Present,Stage IIIA Vulvar Cancer AJCC v7,1
37045,Cutaneous Involvement,Scrotal Infection,1
37046,Borderline Lesion,"Papillary cystadenoma, borderline malignancy",1
37047,Multifocal Lesion,Encephalocraniocutaneous lipomatosis,1
37048,Severe dysplasia,Clinical Stage 0 Gastric Cancer AJCC v8,1
37049,Poorly Differentiated Lesion,Large cell lung cancer stage III,1
37050,More than 5 Mitoses per 50HPF,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
37051,Epithelial Component Present,Clinical Stage IIA Gastric Cancer AJCC v8,1
37052,Bone Marrow Eosinophilia,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
37053,Epithelial Component Present,Eccrine porocarcinoma,1
37054,Benign Cellular Infiltrate,Syringofibroadenoma,1
37055,Carcinomatous Component Present,eccrine adenocarcinoma of vulva,1
37056,"Fully Differentiated ""Adult-Type"" Tissues Present",Central Nervous System Dermoid Cyst,1
37057,Diffuse Pattern,Lymphohistiocytoid Mesothelioma,1
37058,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
37059,Adulthood Lesion,Recurrent Adult Acute Lymphoblastic Leukemia,1
37060,Epithelial Component Present,Clear cell odontogenic carcinoma,1
37061,Epithelial Component Present,Thymic Basaloid Carcinoma,1
37062,Cutaneous Involvement,Leukemic infiltration of skin,1
37063,Human Papillomavirus Positive,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
37064,Malignant Cellular Infiltrate,Malignant neoplasm of sublingual gland,1
37065,Low Mitotic Activity,Intestinal Gangliocytic Paraganglioma,1
37066,Borderline Resectable Mass,Borderline Resectable Pancreatic Carcinoma,1
37067,Malignant Cellular Infiltrate,Locally Advanced Unresectable Malignant Neoplasm,1
37068,Neuroendocrine Differentiation,Stage I Gastric Neuroendocrine Tumor AJCC v8,1
37069,Hyperkeratosis,"Papillary squamous cell carcinoma, non-invasive",1
37070,Epithelial Component Present,"Gallbladder Adenocarcinoma, Biliary Type",1
37071,Mixed Cellular Population,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
37072,Locally Aggressive Lesion,Plexiform fibrohistiocytic tumor,1
37073,Osseous Differentiation,Stage IVA Osteosarcoma AJCC v7,1
37074,Stromal Invasion,Malignant Ovarian Mucinous Tumor,1
37075,No Identifiable Line of Differentiation,Resectable Undifferentiated Pleomorphic Sarcoma,1
37076,Tissue of Mullerian Origin Present,"Uterine Carcinosarcoma, Homologous Type",1
37077,Neuroendocrine Differentiation,combined small cell carcinoma of lung,1
37078,Epithelial Component Present,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
37079,Malignant Cellular Infiltrate,Leukemic Phase of Non-Hodgkin's Lymphoma,1
37080,Cutaneous Involvement,Merkel cell carcinoma,1
37081,Benign Cellular Infiltrate,Benign neoplasm of peritoneum,1
37082,Hyperkeratosis,Anal Verrucous Carcinoma,1
37083,Carcinomatous Component Present,Stage IV Breast Cancer AJCC v6 and v7,1
37084,Nuclear Molding,Refractory Lung Small Cell Carcinoma,1
37085,Malignant Cellular Infiltrate,Recurrent Ovarian Clear Cell Adenocarcinoma,1
37086,Low Mitotic Activity,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
37087,Malignant Cellular Infiltrate,Recurrent Olfactory Neuroblastoma,1
37088,Nuclear Pseudoinclusion,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
37089,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
37090,Nuclear Atypia,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,1
37091,Primary Lesion,Stage IVB Hepatocellular Carcinoma AJCC v7,1
37092,Cutaneous Involvement,Stage III Lentigo Maligna Melanoma AJCC v7,1
37093,Benign Cellular Infiltrate,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
37094,Epithelial Component Present,Ovarian Seromucinous Adenofibroma,1
37095,Well Differentiated Neuroendocrine Lesion,Stage I Appendix Neuroendocrine Tumor AJCC v7,1
37096,Hyperkeratosis,Human Papillomavirus-Related Verrucous Carcinoma,1
37097,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Superficial basal cell carcinoma,1
37098,Neuroendocrine Differentiation,small cell carcinoma of gallbladder,1
37099,Glial Differentiation,gliosarcoma,1
37100,Adulthood Lesion,Stage I Adult Immunoblastic Lymphoma,1
37101,Absence of Invasion,Stage 0 Appendix Carcinoma AJCC v8,1
37102,Recurrent disease,Recurrent Anaplastic Oligoastrocytoma,1
37103,Glandular metaplasia,Urethral Glandular Metaplasia,1
37104,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v7,1
37105,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
37106,Malignant Cellular Infiltrate,Pleural Monophasic Synovial Sarcoma,1
37107,Malignant Cellular Infiltrate,Sarcoma of ovary,1
37108,Epithelial Component Present,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
37109,Malignant Cellular Infiltrate,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage,1
37110,More than 10 Mitoses per 10HPF,large cell neuroendocrine carcinoma of lung,1
37111,Indolent Clinical Course,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
37112,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma associated with chronic inflammation,1
37113,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
37114,Epithelial Component Present,squamous cell carcinoma of the thyroid gland,1
37115,Tricholemmal Differentiation,Classic Type Trichilemmoma,1
37116,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Gene Mutation,1
37117,Unresectable Mass,Locally Advanced Unresectable Gastric Adenocarcinoma,1
37118,Epithelial Component Present,Meningeal Carcinomatosis,1
37119,Epithelial Component Present,Stage I Urethral Cancer AJCC v7,1
37120,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v6 Stage,1
37121,Well Differentiated Neuroendocrine Lesion,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
37122,Malignant Cellular Infiltrate,FIGO Stage IC3 Ovarian Cancer,1
37123,Carcinomatous Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma,1
37124,Mild dysplasia,Low grade cervical glandular intraepithelial neoplasia,1
37125,Benign Cellular Infiltrate,Angiomyofibroblastoma,1
37126,Malignant Cellular Infiltrate,Grade 3a Malignant Neoplasm,1
37127,Epithelial Component Present,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
37128,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
37129,Epithelial Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
37130,Epithelial Component Present,Adult Hepatocellular Carcinoma,1
37131,Malignant Cellular Infiltrate,Undifferentiated Endocervical Sarcoma,1
37132,Myxoid Stroma Formation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
37133,Metastatic Lesion,Metastatic Squamous Cell Breast Carcinoma,1
37134,Epithelial Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v7,1
37135,Carcinomatous Component Present,Stage I Lung Cancer AJCC v7,1
37136,Chromogranin A Positive Neoplastic Cells Present,Ovarian Carcinoid Tumor,1
37137,Malignant Cellular Infiltrate,Stage I Immature Testicular Teratoma AJCC v6 and v7,1
37138,Epithelial Component Present,Alcohol-Related Hepatocellular Carcinoma,1
37139,Increased Cellularity Present,Adult Pineoblastoma,1
37140,Recurrent disease,Non-small cell lung cancer recurrent,1
37141,Osseous Differentiation,Osteoblastic Osteosarcoma,1
37142,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of pancreas,1
37143,Malignant Cellular Infiltrate,Thymic Hodgkin Lymphoma,1
37144,Nuclear Pseudoinclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
37145,Lymphoplasmacytic Infiltrate,"Castleman Disease, Plasma Cell Type",1
37146,Epithelial Component Present,Malignant Vipoma,1
37147,Cystic Change,mucoepidermoid carcinoma of lacrimal gland,1
37148,Neuroendocrine Differentiation,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
37149,Malignant Cellular Infiltrate,Squamous cell carcinoma of lip,1
37150,Perivascular Arrangement of Tumor Cells,Venous Angioleiomyoma,1
37151,Malignant Cellular Infiltrate,Stage IVB Primary Peritoneal Cancer AJCC v8,1
37152,Carcinomatous Component Present,Eccrine porocarcinoma,1
37153,Cutaneous Involvement,Chest Wall Plexiform Fibrohistiocytic Neoplasm,1
37154,Secondary Lesion,Stage IV Esophageal Adenocarcinoma,1
37155,Moderate dysplasia,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
37156,Malignant Cellular Infiltrate,Metastatic Oral Cavity Adenoid Cystic Carcinoma,1
37157,S-100-Positive Neoplastic Cells Present,Lung PEComa,1
37158,Malignant Cellular Infiltrate,Stage II Esophageal Adenocarcinoma AJCC v7,1
37159,Unresectable Mass,Unresectable Renal Cell Carcinoma,1
37160,Epithelial Component Present,Adenoma of rete ovarii,1
37161,Primary Lesion,Recurrent Anaplastic Astrocytoma,1
37162,Carcinomatous Component Present,Locally Advanced Unresectable Gastric Adenocarcinoma,1
37163,Neuroendocrine Differentiation,Middle Ear Paraganglioma,1
37164,High Mitotic Activity,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
37165,Epithelial Component Present,Salivary Gland Myoepithelial Carcinoma,1
37166,Epithelial Component Present,Hard Palate Squamous Cell Carcinoma,1
37167,Malignant Cellular Infiltrate,Spindle cell liposarcoma,1
37168,Carcinomatous Component Present,Posterior Pharyngeal Wall Squamous Cell Carcinoma,1
37169,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Germinoma,1
37170,Carcinomatous Component Present,Minor Salivary Gland Adenocarcinoma,1
37171,Malignant Cellular Infiltrate,Anaplastic Oligoastrocytoma,1
37172,IDH Gene Family Mutation Status Unknown,Anaplastic Oligoastrocytoma,1
37173,Mitotic Activity,Testicular yolk sac tumor,1
37174,Primary Lesion,Recurrent tumors of the Ewing's family,1
37175,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides AJCC v7,1
37176,Epithelial Component Present,Cystic basal cell carcinoma,1
37177,Collagenous Stroma Formation,Pelvic Fibromatosis,1
37178,Vascular Channel Formation,Cardiac Capillary Hemangioma,1
37179,Anaplasia,Grade III Childhood Astrocytoma,1
37180,Carcinomatous Component Present,Cervical Adenosquamous Carcinoma,1
37181,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
37182,High Grade Lesion,"Synovial sarcoma, epithelioid cell",1
37183,Carcinomatous Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
37184,Refractory Disease,Refractory Malignant Germ Cell Tumor,1
37185,Malignant Cellular Infiltrate,Stage A Chronic Lymphocytic Leukemia,1
37186,Epithelial Component Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
37187,Carcinomatous Component Present,Adenosquamous cell lung cancer recurrent,1
37188,Malignant Cellular Infiltrate,Meningeal Leukemia,1
37189,Epithelial Component Present,Stage 0is Bladder Cancer AJCC v8,1
37190,Malignant Cellular Infiltrate,Infantile fibrosarcoma,1
37191,Benign Cellular Infiltrate,Recurrent Craniopharyngioma,1
37192,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",1
37193,Secondary Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
37194,Epithelial Component Present,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8,1
37195,Mitotic Activity,Cervical Yolk Sac Tumor,1
37196,Carcinomatous Component Present,Cervical Basaloid Carcinoma,1
37197,Anaplasia,Anaplastic (Malignant) Intracranial Meningioma,1
37198,Tubular Pattern,Tubular adenoma,1
37199,Malignant Cellular Infiltrate,Methotrexate-Associated Peripheral T-Cell Lymphoma,1
37200,Well-Circumscribed Lesion,Multiple polyps,1
37201,Epithelial Component Present,Bladder cancer recurrent,1
37202,Epithelial Component Present,Major Salivary Gland Adenocarcinoma,1
37203,Carcinomatous Component Present,Uterine Ligament Clear Cell Adenocarcinoma,1
37204,Tubular Pattern,tubulopapillary adenoma of extrahepatic bile duct,1
37205,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma refractory,1
37206,Secondary Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,1
37207,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
37208,Fibrosis,Lipomatosis of Nerve,1
37209,Resectable Mass,Bile duct cancer resectable,1
37210,Cutaneous Involvement,Malignant Eccrine Neoplasm,1
37211,Epithelial Component Present,Advanced Cervical Adenocarcinoma,1
37212,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
37213,Well-Circumscribed Lesion,Adenomatous Polyposis Coli,1
37214,Epithelial Component Present,Pathologic Stage IIB Gastric Cancer AJCC v8,1
37215,Benign Cellular Infiltrate,Schwannomatosis,1
37216,Well-Circumscribed Lesion,Uterine Polyp,1
37217,Epithelial Component Present,Colon Serrated Adenocarcinoma,1
37218,Malignant Cellular Infiltrate,Intraductal Non-Comedo Breast Adenocarcinoma,1
37219,Malignant Cellular Infiltrate,Keratinizing Paranasal Sinus Squamous Cell Carcinoma,1
37220,Malignant Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage,1
37221,More than 10 Mitoses per 10HPF,Metastatic Lung Small Cell Carcinoma,1
37222,Adulthood Lesion,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
37223,Epithelial Component Present,Anal canal squamous cell carcinoma,1
37224,Epithelial Component Present,Stage III Colon Cancer,1
37225,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
37226,Cutaneous Involvement,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
37227,Immunologic Deficiency Syndromes,AIDS-Related Idiopathic Thrombocytopenic Purpura,1
37228,Carcinomatous Component Present,Minor Salivary Gland Undifferentiated Carcinoma,1
37229,Nuclear Molding,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
37230,Benign Cellular Infiltrate,Benign tumor of nasopharynx,1
37231,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v7 Stage,1
37232,Malignant Cellular Infiltrate,Pleural Desmoplastic Mesothelioma,1
37233,Epithelial Component Present,Gastric adenoma,1
37234,Hyaline Cartilage Differentiation,Central Nervous System Chondroma,1
37235,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v7 Stage,1
37236,Lymphoplasmacytic Infiltrate,Oropharyngeal lymphoepithelioma stage III,1
37237,Malignant Cellular Infiltrate,Stage IVB Osteosarcoma AJCC v7,1
37238,Epithelial Component Present,Villous adenoma of duodenum,1
37239,Necrotic changes (finding),Recurrent Dedifferentiated Liposarcoma,1
37240,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
37241,Benign Cellular Infiltrate,Giant Fibrovascular Esophageal Polyp,1
37242,Carcinomatous Component Present,Recurrent ovarian cancer,1
37243,Epithelial Component Present,Childhood Paranasal Sinus Carcinoma,1
37244,Bilateral Disease,Bilateral Carcinoma,1
37245,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
37246,Compartmentalized Pattern,Sebaceous adenoma,1
37247,Carcinomatous Component Present,Adenoid cystic carcinoma of lacrimal gland,1
37248,atypia morphology,Malignant Solitary Fibrous Tumor,1
37249,Absence of Malignant Features,Benign tumor of choroid plexus,1
37250,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage I,1
37251,Malignant Cellular Infiltrate,BAP1-Mutant Clear Cell Renal Cell Carcinoma,1
37252,Carcinomatous Component Present,Stage 0 Gastric Cancer AJCC v6 and v7,1
37253,Epithelial Component Present,Thymoma malignant noninvasive,1
37254,Carcinomatous Component Present,Bladder Urachal Carcinoma,1
37255,Mixed Cellular Population,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
37256,Carcinomatous Component Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
37257,Follicular Differentiation,Trichofolliculoma,1
37258,Epithelial Component Present,Resectable Head and Neck Squamous Cell Carcinoma,1
37259,Exophytic Papillary Lesion,papillary squamous cell carcinoma of larynx,1
37260,Epithelial Component Present,Pericardial Carcinomatosis,1
37261,Lesion with Diameter of 4mm or More,Vulvar Dysplastic Melanocytic Nevus,1
37262,More than 10 Mitoses per 10HPF,Small cell carcinoma of prostate,1
37263,Neuroendocrine Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma,1
37264,Carcinomatous Component Present,Neuroendocrine carcinoma of appendix,1
37265,Childhood Lesion,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
37266,Human Papillomavirus Negative,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
37267,Postneoadjuvant Therapy Pathologic TNM Finding,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
37268,Carcinomatous Component Present,Vulvar Non-Keratinizing Squamous Cell Carcinoma,1
37269,Adulthood Lesion,Adult Brain Stem Astrocytoma,1
37270,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
37271,Squamous metaplasia,Adenolymphoma,1
37272,Below the Diaphragm Disease,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb,1
37273,Benign Cellular Infiltrate,Benign Intraocular Schwannoma,1
37274,Carcinomatous Component Present,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
37275,Anaplasia,Neural Glioblastoma,1
37276,Epithelial Component Present,Stage I Vulvar Cancer AJCC v8,1
37277,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Refractory B-Cell Prolymphocytic Leukemia,1
37278,Carcinomatous Component Present,Colorectal Signet Ring Cell Carcinoma,1
37279,Epithelial Component Present,Recurrent Fallopian Tube Carcinoma,1
37280,Primary Lesion,Ewing's sarcoma recurrent,1
37281,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
37282,Cutaneous Involvement,basal cell carcinoma of penis,1
37283,Malignant Cellular Infiltrate,leiomyosarcoma of vagina,1
37284,Malignant Cellular Infiltrate,Rectosigmoid Mucinous Adenocarcinoma,1
37285,Malignant Cellular Infiltrate,Stage IA Testicular Cancer AJCC v8,1
37286,Malignant Cellular Infiltrate,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
37287,Submucosal Lesion,Submucosal Invasive Colon Adenocarcinoma,1
37288,Calcitonin serum level increased,Recurrent Thyroid Gland Medullary Carcinoma,1
37289,Epithelial Component Present,Growth Hormone-Secreting Pituitary Adenoma,1
37290,Malignant Cellular Infiltrate,Cecum Lymphoma,1
37291,Benign Cellular Infiltrate,Eccrine acrospiroma,1
37292,Malignant Cellular Infiltrate,Pericardial Yolk Sac Tumor,1
37293,Epithelial Component Present,Non-small cell lung cancer stage II,1
37294,Malignant Cellular Infiltrate,Iris Spindle Cell Melanoma,1
37295,No Identifiable Line of Differentiation,Undifferentiated round cell sarcoma,1
37296,Cutaneous Involvement,Basal cell carcinoma of vulva,1
37297,Malignant Cellular Infiltrate,Rhabdomyosarcoma of cervix uteri,1
37298,Indolent Clinical Course,Rhabdomyoma,1
37299,Tissue Differentiation Uncertain,Lung Clear Cell Tumor,1
37300,atypia morphology,Atypical Type A Thymoma,1
37301,Sinusoidal Infiltration,Refractory Hepatosplenic T-Cell Lymphoma,1
37302,Alternative Fascicle (Bundle) Pattern,Liver Leiomyoma,1
37303,Malignant Cellular Infiltrate,Childhood B Lymphoblastic Lymphoma,1
37304,Epithelial Component Present,Multifocal superficial basal cell carcinoma,1
37305,Epithelial Component Present,Recurrent Primary Peritoneal Serous Adenocarcinoma,1
37306,Recurrent disease,Recurrent Grade I Lymphomatoid Granulomatosis,1
37307,Exophytic Papillary Lesion,Verrucous carcinoma,1
37308,Cafe-au-Lait Spots,Recurrent Neurofibromatosis Type 1,1
37309,Malignant Cellular Infiltrate,Gingival Spindle Cell Carcinoma,1
37310,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage IV,1
37311,Malignant Cellular Infiltrate,Colon Hodgkin Lymphoma,1
37312,Thin-Walled Branching Vascular Pattern,Malignant Solitary Fibrous Tumor,1
37313,Metastatic Lesion,Testicular cancer metastatic,1
37314,Epithelial Component Present,Stage IB Ampulla of Vater Cancer AJCC v7,1
37315,Well-Circumscribed Lesion,Angiofibroma,1
37316,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
37317,Metastatic Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
37318,Well-Circumscribed Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
37319,Carcinomatous Component Present,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
37320,Epithelial Component Present,Occult Lung Small Cell Carcinoma,1
37321,Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
37322,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma,1
37323,Cutaneous Involvement,Dermatofibrosarcoma Protuberans,1
37324,Epithelial Component Present,Ovarian Sex Cord Tumor with Annular Tubules,1
37325,Well-Circumscribed Lesion,"Phyllodes tumor, borderline",1
37326,Solid Growth Pattern,Solid Lung Adenocarcinoma,1
37327,Metastatic Lesion,Secondary malignant neoplasm of urethra,1
37328,Hemorrhagic,Locally Advanced Angiosarcoma,1
37329,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage I,1
37330,Epithelial Component Present,Stage II Skin Cancer,1
37331,Secondary Lesion,Locally Advanced Digestive System Carcinoma,1
37332,Epithelial Component Present,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
37333,Malignant Cellular Infiltrate,Bladder Adenocarcinoma,1
37334,High Grade Lesion,Refractory Synovial Sarcoma,1
37335,Cartilaginous Differentiation,Chondroblastoma,1
37336,In Situ Lesion,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,1
37337,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type",1
37338,Cutaneous Involvement,Clinical Stage 0 Cutaneous Melanoma AJCC v8,1
37339,Epithelial Component Present,Stage II Lung Cancer AJCC v8,1
37340,Well-Circumscribed Lesion,Malignant Vulvar Phyllodes Tumor,1
37341,Therapy-Related Toxicity,Treatment related leukaemia,1
37342,Moderate dysplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
37343,Carcinomatous Component Present,Stage I Pancreatic Cancer AJCC v8,1
37344,Primary Lesion,Anaplastic Diencephalic Astrocytoma,1
37345,Epithelial Component Present,Intracanalicular fibroadenoma,1
37346,Melanin Pigment Present,Melanotic neurofibroma,1
37347,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage,1
37348,Malignant Cellular Infiltrate,Uterine Corpus Adenosarcoma by AJCC v8 Stage,1
37349,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia,1
37350,Epithelial Component Present,Lung Carcinoma Metastatic in the Liver,1
37351,Well Differentiated Lesion,Warty Carcinoma of the Penis,1
37352,Invasive Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
37353,Carcinomatous Component Present,Recurrent Renal Pelvis Urothelial Carcinoma,1
37354,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage II,1
37355,High Mitotic Activity,Central Nervous System Embryonal Carcinoma,1
37356,Malignant Cellular Infiltrate,Stage I Retroperitoneal Sarcoma AJCC v8,1
37357,Epithelial Component Present,Stage III Anal Canal Cancer AJCC v6 and v7,1
37358,Neuroendocrine Differentiation,Intestinal Neuroendocrine Neoplasm,1
37359,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
37360,Malignant Cellular Infiltrate,Osteoblastic Osteosarcoma,1
37361,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Homologous Type",1
37362,Diffuse Pattern,Glioblastoma,1
37363,Malignant Cellular Infiltrate,Cervical carcinoma stage II AJCC v7,1
37364,Encapsulated Mass,Thyroid Gland Spindle Cell Follicular Adenoma,1
37365,Recurrent disease,Primary mediastinal large B-cell lymphoma recurrent,1
37366,Malignant Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
37367,Poorly Differentiated Lesion,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
37368,Cribriform Pattern,Cribriform Neuroepithelial Tumor,1
37369,Carcinomatous Component Present,Recurrent Thyroid Gland Medullary Carcinoma,1
37370,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of gallbladder,1
37371,Dysplasia,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
37372,Benign Cellular Infiltrate,"Lymphangioma, Cystic",1
37373,Carcinomatous Component Present,Stage III Nasal Cavity Cancer AJCC v6 and v7,1
37374,Carcinomatous Component Present,basaloid squamous cell carcinoma of floor of mouth,1
37375,Childhood Lesion,Recurrent Childhood Soft Tissue Sarcoma,1
37376,Malignant Cellular Infiltrate,Recurrent Hematologic Malignancy,1
37377,Hyaline Cartilage Differentiation,Mesenchymal Chondrosarcoma,1
37378,Epithelial Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,1
37379,Recurrent disease,Recurrent Anaplastic Oligodendroglioma,1
37380,Cervical lymphadenopathy,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
37381,Refractory Disease,Refractory Barrett Esophagus,1
37382,Primary Lesion,Metastatic hepatocellular carcinoma,1
37383,Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells,Non-IgM Monoclonal Gammopathy of Undetermined Significance,1
37384,Primary Lesion,Aflatoxins-Related Hepatocellular Carcinoma,1
37385,Non-Hereditary Lesion,Sporadic Breast Carcinoma,1
37386,Resectable Mass,Resectable Liposarcoma,1
37387,Anaplasia,"Carcinoma, Spindle-Cell",1
37388,High Grade Lesion,Liver Synovial Sarcoma,1
37389,Carcinomatous Component Present,Stage IV Breast Cancer AJCC v6 and v7,1
37390,Carcinomatous Component Present,Prognostic Stage I Breast Cancer AJCC v8,1
37391,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Pseudoglandular Variant",1
37392,Dysplasia,Anal Intraepithelial Neoplasia 3,1
37393,Secondary Lesion,Secondary malignant neoplasm of liver,1
37394,Malignant Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
37395,Childhood Lesion,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
37396,Benign Cellular Infiltrate,Benign neoplasm of endocardium,1
37397,Epithelial Component Present,Stage I Major Salivary Gland Cancer AJCC v7,1
37398,Low Mitotic Activity,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
37399,Childhood Lesion,Childhood Testicular Embryonal Carcinoma,1
37400,Cutaneous Involvement,Skin Pigmentation Disorder,1
37401,Lymphadenopathy,Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
37402,Carcinomatous Component Present,Invasive carcinoma of breast,1
37403,Malignant Cellular Infiltrate,Stage IV Pleural Malignant Mesothelioma AJCC v7,1
37404,Hereditary Lesion,Neurocutaneous Syndromes,1
37405,Metastatic/Recurrent Disease,Childhood Synovial Sarcoma,1
37406,Ground Glass Nuclear Inclusion,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
37407,Well Differentiated Lesion,mucinous adenocarcinoma of lung,1
37408,Indolent Clinical Course,Lung Myolipoma,1
37409,Benign Cellular Infiltrate,Cutaneous leiomyoma,1
37410,Local disease,Lipoma of spermatic cord,1
37411,Epithelial Component Present,Basal-Like Prostate Carcinoma,1
37412,Metastatic Lesion,Secondary malignant neoplasm of retina,1
37413,Malignant Cellular Infiltrate,Stage IA Esophageal Adenocarcinoma AJCC v7,1
37414,Epithelial Component Present,HPV positive oropharyngeal squamous cell carcinoma,1
37415,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
37416,Antoni A Pattern,Benign Esophageal Schwannoma,1
37417,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP J",1
37418,Cysts Containing Proteinaceous Fluid Present,Serous papillary cystic tumor of borderline malignancy,1
37419,Well-Circumscribed Lesion,Myxoid liposarcoma metastatic,1
37420,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v6 Stage,1
37421,Epithelial Component Present,Densely Granulated Non-Functioning Corticotroph Adenoma,1
37422,Hyperkeratosis,Plantar wart,1
37423,Cutaneous Involvement,Blastic plasmacytoid dendritic cell neoplasm,1
37424,Intraductal Lesion,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
37425,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
37426,Metaplasia,Bladder squamous cell carcinoma stage IV,1
37427,Carcinomatous Component Present,Localized Gastric Carcinoma,1
37428,Lytic lesion,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,1
37429,"Fully Differentiated ""Adult-Type"" Tissues Present",Immature Ovarian Teratoma,1
37430,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC v8,1
37431,Mitotic Activity,Temporal Lobe Anaplastic Astrocytoma,1
37432,Pathologic TNM Finding,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
37433,Childhood Lesion,Stage II Childhood Burkitt Lymphoma,1
37434,Epithelial Component Present,High Grade Intraepithelial Neoplasia,1
37435,atypia morphology,Malignant Ovarian Thecoma,1
37436,Epithelial Component Present,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
37437,Epithelial Component Present,Prognostic Stage II Breast Cancer AJCC v8,1
37438,Malignant Cellular Infiltrate,"Carcinoma, Small Cell",1
37439,Malignant Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v8,1
37440,Epithelial Component Present,adenocarcinoma of renal pelvis,1
37441,Skin Papule,Sebaceoma,1
37442,Malignant Cellular Infiltrate,Stage IIA Lung Large Cell Carcinoma AJCC v7,1
37443,"Amorphus, Eosinophilic, and Acellular Deposit",Soft Tissue Amyloid Neoplasm,1
37444,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
37445,Carcinomatous Component Present,Bladder squamous cell carcinoma recurrent,1
37446,Epithelial Component Present,Metastatic Bladder Squamous Cell Carcinoma,1
37447,Epithelial Component Present,Stage IIB Anal Cancer AJCC v8,1
37448,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
37449,Primary Lesion,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
37450,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1B,1
37451,Therapy-Related Toxicity,Treatment related secondary malignancy,1
37452,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Stage,1
37453,Antoni A Pattern,Conventional Schwannoma,1
37454,Invasive Lesion,signet ring cell carcinoma of breast,1
37455,Carcinomatous Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
37456,Secondary Lesion,Colorectal Carcinoma Metastatic in the Lung,1
37457,Thin-Walled Branching Vascular Pattern,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
37458,Malignant Cellular Infiltrate,Stage 0 Vulvar Cancer,1
37459,Carcinomatous Component Present,Colorectal Signet Ring Cell Carcinoma,1
37460,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
37461,Malignant Cellular Infiltrate,Infant T Acute Lymphoblastic Leukemia,1
37462,Malignant Cellular Infiltrate,"Hepatocellular carcinoma, scirrhous",1
37463,Epithelial Component Present,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
37464,Carcinomatous Component Present,Lung Squamous Cell Carcinoma In Situ,1
37465,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,1
37466,Malignant Cellular Infiltrate,Malignant neoplasm of skin,1
37467,Secondary Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma,1
37468,High Mitotic Activity,Malignant Uterine Corpus PEComa,1
37469,Tissue Differentiation Uncertain,Lymphangiomyoma,1
37470,Adulthood Lesion,Lugano Classification Stage II Adult Lymphoma AJCC v8,1
37471,Carcinomatous Component Present,Laryngeal verrucous carcinoma,1
37472,Epithelial Component Present,adenocarcinoma of oral cavity,1
37473,Epithelial Component Present,Rectal Neuroendocrine Tumor,1
37474,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
37475,Carcinomatous Component Present,"Squamous cell carcinoma, keratinizing",1
37476,Cutaneous Involvement,Clear cell squamous cell carcinoma of skin,1
37477,Steatohepatitis,HNF1alpha-Inactivated Hepatocellular Adenoma,1
37478,Malignant Cellular Infiltrate,Ann Arbor Stage IVA Hodgkin Lymphoma,1
37479,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell",1
37480,Malignant Cellular Infiltrate,Primary Effusion Lymphoma,1
37481,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),1
37482,Regional Disease,Locally Advanced Unresectable Sarcoma,1
37483,Primary Lesion,Stage IIIB Primary Peritoneal Cancer AJCC v7,1
37484,Infiltrative Growth Pattern,"Fibromatosis, Abdominal",1
37485,Refractory Disease,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
37486,Primary Lesion,Refractory Central Nervous System Non-Hodgkin Lymphoma,1
37487,Zonal Pattern,Adamantinoma,1
37488,Cutaneous Involvement,Epidermolysis Bullosa Acquisita,1
37489,Severe cytologic atypia,Digestive System Large Cell Neuroendocrine Carcinoma,1
37490,Moderate dysplasia,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
37491,Malignant Cellular Infiltrate,Cervical Mesonephric Adenocarcinoma,1
37492,Mesenchymal Differentiation,Metaplastic meningioma,1
37493,Epithelial Component Present,Oncocytic Schneiderian papilloma,1
37494,Lipomatous Component Present,Ectopic hamartomatous thymoma,1
37495,Papillary Pattern,Verrucous carcinoma of penis,1
37496,Carcinomatous Component Present,Stage I Cervical Cancer AJCC v8,1
37497,Absence of Stromal Invasion,Borderline Ovarian Transitional Cell Tumor,1
37498,Primary Site Unspecified,Primary Carcinoma Unspecified Site,1
37499,Neuroendocrine Differentiation,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
37500,Capillary Sized Vascular Channel Formation,Capillary hemangioma of orbit,1
37501,Unresectable Mass,Unresectable Pleural Malignant Mesothelioma,1
37502,Stromal Invasion,High Grade Ovarian Serous Adenocarcinoma,1
37503,Tubular Structures Present,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",1
37504,Tissue of Mullerian Origin Present,Stage IB Uterine Corpus Adenosarcoma AJCC v8,1
37505,Hyperplastic Tissue Present,Atypical Adenomatous Lung Hyperplasia,1
37506,Tissues Derived from Two or Three Embryonic Layers Present,Mature Ovarian Teratoma,1
37507,Fibrotic Stroma Formation,Minor Salivary Gland Mucoepidermoid Carcinoma,1
37508,Epithelial Component Present,Adenosquamous cell lung cancer,1
37509,Carcinomatous Component Present,Stage I Lip Basal Cell Carcinoma,1
37510,Intermediate Filaments Present,Recurrent Rhabdoid Tumor,1
37511,Malignant Cellular Infiltrate,Childhood Epithelioid Hemangioendothelioma,1
37512,Juvenile Lesion,Disseminated Juvenile Xanthogranuloma,1
37513,atypia morphology,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
37514,Monomorphic Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis,1
37515,Cutaneous Involvement,Dermatitis due to substances taken internally,1
37516,Dysplasia,Cecum Villous Adenoma,1
37517,Monomorphic Cellular Infiltrate,Sellar Ependymoma,1
37518,Carcinomatous Component Present,Anal margin Paget's disease,1
37519,Malignant Cellular Infiltrate,Old Burn Scar-Related Skin Squamous Cell Carcinoma,1
37520,Malignant Cellular Infiltrate,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
37521,Epithelial Component Present,Colon Small Cell Neuroendocrine Carcinoma,1
37522,Epithelial Component Present,tubulovillous adenoma of stomach,1
37523,Mucoid Stroma Formation,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
37524,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal tumor of soft tissue,1
37525,Carcinomatous Component Present,Stage IV Skin Cancer,1
37526,Carcinomatous Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v8,1
37527,Pseudoglandular Pattern,Central Nervous System Embryonal Carcinoma,1
37528,Adulthood Lesion,Recurrent Adult Burkitt Lymphoma,1
37529,Malignant Cellular Infiltrate,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,1
37530,Recurrent disease,Hepatoblastoma recurrent,1
37531,Vascular Channel Formation,Parotid Gland Lymphangioma,1
37532,Malignant Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v7,1
37533,Hormonal resistance,Hormone refractory breast cancer,1
37534,Childhood Lesion,Childhood Classic Hodgkin Lymphoma,1
37535,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
37536,Malignant Cellular Infiltrate,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",1
37537,Hyperplastic Epithelial Tissue Present,Atypical Breast Myoepitheliosis,1
37538,Secondary Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,1
37539,Epithelial Component Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
37540,Well-Circumscribed Lesion,adenoma of intrahepatic bile duct,1
37541,"Fully Differentiated ""Adult-Type"" Tissues Present",Dermoid cyst of ovary,1
37542,Recurrent disease,Recurrent Aggressive Non-Hodgkin Lymphoma,1
37543,Cutaneous Involvement,Palmoplantar keratoderma with leukoplakia,1
37544,Malignant Cellular Infiltrate,Childhood Conventional Osteosarcoma,1
37545,Tissue Differentiation Uncertain,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
37546,Carcinomatous Component Present,Stage I Lung Cancer AJCC v8,1
37547,Malignant Cellular Infiltrate,Acute myeloid leukemia with recurrent genetic abnormality,1
37548,Adulthood Lesion,Recurrent Adult Brain Neoplasm,1
37549,Childhood Lesion,Childhood Brain Neoplasm,1
37550,Carcinomatous Component Present,"Lung Large Cell Carcinoma, Clear Cell Variant",1
37551,Benign Cellular Infiltrate,Breast Myofibroblastoma,1
37552,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
37553,Nuclear Atypia,Cerebellar Glioblastoma,1
37554,Presence of a Hormonal Syndrome,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
37555,Malignant Cellular Infiltrate,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
37556,Absence of Invasion,Pre-Malignant Skin Epithelial Lesion,1
37557,Malignant Cellular Infiltrate,Recurrent Childhood Medulloblastoma,1
37558,Childhood Lesion,Grade III Childhood Astrocytoma,1
37559,Extraosseous Lesion,Extraskeletal osteosarcoma non-metastatic,1
37560,Extensive Stage Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
37561,Neuroendocrine Differentiation,Stage I Colon Neuroendocrine Tumor AJCC v8,1
37562,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v8,1
37563,Vascular Channel Formation,Kaposi's sarcoma of liver,1
37564,Malignant Cellular Infiltrate,Colorectal Diffuse Large B-Cell Lymphoma,1
37565,Adulthood Lesion,Refractory Adult Acute Lymphoblastic Leukemia,1
37566,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
37567,Carcinomatous Component Present,Stage IVB Vaginal Cancer AJCC v8,1
37568,Local disease,Endobronchial lipoma,1
37569,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,"Leukemia, Mast-Cell",1
37570,Malignant Cellular Infiltrate,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
37571,Immunosuppression-Related Post-Transplant Toxicity,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder,1
37572,Carcinomatous Component Present,Stage IVB Liver Cancer,1
37573,Carcinomatous Component Present,Pharyngeal Carcinoma,1
37574,Invasive Lesion,Microinvasive Malignant Neoplasm,1
37575,Cutaneous Involvement,Glomus tumor of skin,1
37576,Cutaneous Involvement,Atrophic lichen planus,1
37577,Metastatic Lesion,Prostate Carcinoma Metastatic in the Bone,1
37578,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
37579,Chronic lymphocytic inflammation,Halo nevus,1
37580,Epithelial Component Present,Advanced Carcinoid Tumor,1
37581,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
37582,Epithelial Component Present,Distal Esophagus Squamous Cell Carcinoma,1
37583,Epithelial Component Present,Pituitary Gland Multiple Adenomas,1
37584,Neuroendocrine Differentiation,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
37585,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP F",1
37586,Malignant Cellular Infiltrate,fibrosarcoma of kidney,1
37587,Carcinomatous Component Present,Endometrial Dedifferentiated Carcinoma,1
37588,Malignant Cellular Infiltrate,FIGO Stage IC1 Ovarian Cancer,1
37589,Epithelial Component Present,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
37590,Indolent Clinical Course,Juxtacortical chondroma,1
37591,Carcinomatous Component Present,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
37592,Exophytic Polypoid Lesion,Adenoma of ampulla of Vater,1
37593,Secondary Lesion,Secondary Acute Myeloid Leukemia,1
37594,Carcinomatous Component Present,Sarcomatoid Renal Cell Carcinoma,1
37595,Malignant Cellular Infiltrate,"Pheochromocytoma, malignant",1
37596,Malignant Cellular Infiltrate,Anaplastic (Malignant) Intraspinal Meningioma,1
37597,Monomorphic Cellular Infiltrate,basaloid squamous cell carcinoma of vulva,1
37598,Epithelial Component Present,Small Intestinal Signet Ring Cell Carcinoma,1
37599,Minimal Invasion Present,"Bronchiolo-alveolar carcinoma, non-mucinous",1
37600,Malignant Cellular Infiltrate,Recurrent Male Reproductive System Carcinoma,1
37601,Hyperkeratosis,Lower Gingival Verrucous Carcinoma,1
37602,Epithelial Component Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
37603,Malignant Cellular Infiltrate,Epithelioid Cell Uveal Melanoma,1
37604,Malignant Cellular Infiltrate,Malignant Testicular Non-Seminomatous Germ Cell Tumor,1
37605,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Minimal Differentiation,1
37606,Epithelial Component Present,Endolymphatic sac tumor,1
37607,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
37608,Diffuse Pattern,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
37609,Epithelial Component Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",1
37610,Well-Circumscribed Lesion,External Auditory Canal Ceruminous Adenoma,1
37611,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
37612,Carcinomatous Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
37613,Malignant Cellular Infiltrate,Metastatic Non-Cutaneous Melanoma,1
37614,Diffuse Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
37615,Epithelial Component Present,Recurrent BRCA-Mutated Ovarian Carcinoma,1
37616,Localized Lesion,Plasmacytoma,1
37617,Malignant Cellular Infiltrate,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
37618,Malignant Cellular Infiltrate,Nasopharyngeal cancer recurrent,1
37619,Neuroendocrine Differentiation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
37620,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Uterine Corpus Carcinosarcoma,1
37621,Adnexal Differentiation,Paget's disease of vulva,1
37622,Metastatic Lesion,Metastatic Hypopharyngeal Carcinoma,1
37623,Malignant Cellular Infiltrate,cystadenocarcinoma of salivary gland,1
37624,Benign Cellular Infiltrate,Female Reproductive System Adenofibroma,1
37625,Pseudoglandular Pattern,Ovarian Embryonal Carcinoma,1
37626,Epithelial Component Present,Intracanalicular fibroadenoma,1
37627,Thyroglobulin Positive Neoplastic Cells Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
37628,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor,1
37629,Malignant Cellular Infiltrate,Stage III Major Salivary Gland Cancer AJCC v8,1
37630,Cutaneous Involvement,Ocular Cicatricial Pemphigoid,1
37631,Epithelial Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v7,1
37632,Malignant Cellular Infiltrate,Malignant Mediastinal Soft Tissue Neoplasm,1
37633,Carcinomatous Component Present,Metastatic Digestive System Carcinoma,1
37634,Carcinomatous Component Present,Small intestine carcinoma stage IV,1
37635,Osseous Differentiation,Osteosarcoma by AJCC v7 Stage,1
37636,Epithelial Component Present,High Grade Appendix Mucinous Adenocarcinoma,1
37637,Hyperplastic Tissue Present,Parathyroid chief-cell hyperplasia,1
37638,Carcinomatous Component Present,Stage IIB Ovarian Cancer AJCC v8,1
37639,Follicular Cell Differentiation,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
37640,Epithelial Component Present,adenocarcinoma of extrahepatic bile duct,1
37641,Adulthood Lesion,Stage I Adult Burkitt Lymphoma,1
37642,Epithelial Component Present,Densely Granulated Non-Functioning Corticotroph Adenoma,1
37643,Malignant Cellular Infiltrate,Askin's tumor,1
37644,Tissue Differentiation Uncertain,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
37645,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v8 Stage,1
37646,Papillary Pattern,Renal Pelvis Urothelial Papilloma,1
37647,Malignant Cellular Infiltrate,Malignant neoplasm of cerebellum,1
37648,Epithelial Component Present,Mixed cell adenoma,1
37649,Adnexal Differentiation,Desmoplastic trichoepithelioma,1
37650,Radiation Sickness,"Leukemia, Radiation-Induced",1
37651,Malignant Cellular Infiltrate,Refractory Malignant Oral Neoplasm,1
37652,Carcinomatous Component Present,Stage I Bladder Cancer AJCC v8,1
37653,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v8,1
37654,Malignant Cellular Infiltrate,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
37655,Secondary Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,1
37656,Carcinomatous Component Present,Resectable Extrahepatic Bile Duct Adenocarcinoma,1
37657,Epithelial Component Present,Stage IV Lung Cancer AJCC v6,1
37658,Adulthood Lesion,Adult Solid Neoplasm,1
37659,Carcinomatous Component Present,Uterine Ligament Clear Cell Adenocarcinoma,1
37660,Vascular Channel Formation,vascular neoplasm of bone,1
37661,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Leptomeninges,1
37662,Epithelial Component Present,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
37663,Epithelial Component Present,Intraepithelial Neoplasia in Barrett Esophagus,1
37664,Epithelial Component Present,Fibroepithelioma of Pinkus,1
37665,Lepidic Growth Pattern,Lung Adenocarcinoma In Situ,1
37666,Malignant Cellular Infiltrate,Grade 1 Cutaneous Follicular Lymphoma,1
37667,Tubular Structures Present,Testicular Sclerosing Sertoli Cell Tumor,1
37668,Primary Lesion,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease",1
37669,Malignant Cellular Infiltrate,Melanoma Metastatic in the Central Nervous System,1
37670,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma recurrent,1
37671,Indolent Clinical Course,Myxoma,1
37672,Adulthood Lesion,Adult Central Nervous System Immature Teratoma,1
37673,Malignant Cellular Infiltrate,Malignant neoplasm of conjunctiva,1
37674,Extraosseous Lesion,Extramedullary Plasmacytoma,1
37675,Low Grade Lesion,Low Grade Liver Dysplastic Nodule,1
37676,Polarization of Nuclei Towards the Glandular Lumen,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",1
37677,Adulthood Lesion,Recurrent Adult Hepatocellular Carcinoma,1
37678,Primary Lesion,Recurrent Childhood Cerebral Astrocytoma,1
37679,Tissue of Mullerian Origin Present,Ovarian Seromucinous Adenofibroma,1
37680,Primary Lesion,Recurrent Childhood Pineoblastoma,1
37681,Vascular Channel Formation,Small Intestinal Angiosarcoma,1
37682,Carcinomatous Component Present,Stage IVC Basal Cell Lip Carcinoma,1
37683,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
37684,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,"Acute myeloid leukemia, t(16;16)(p13;q22)",1
37685,Malignant Cellular Infiltrate,Colon Hodgkin Lymphoma,1
37686,Carcinomatous Component Present,Vaginal Adenoid Cystic Carcinoma,1
37687,Exophytic Papillary Lesion,sialadenoma papilliferum of salivary gland,1
37688,Epithelial Component Present,Stage IV Laryngeal Carcinoma,1
37689,Metastatic Lesion,Locally Advanced Carcinoma,1
37690,Malignant Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,1
37691,Primary Lesion,BCLC Stage C Adult Hepatocellular Carcinoma,1
37692,Malignant Cellular Infiltrate,Recurrent T-Cell Prolymphocytic Leukemia,1
37693,Carcinomatous Component Present,Mucinous adenocarcinoma gastric,1
37694,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
37695,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Soft Tissues,1
37696,Malignant Cellular Infiltrate,Cardiac Malignant Peripheral Nerve Sheath Tumor,1
37697,Well-Circumscribed Lesion,Lipoblastoma,1
37698,High Mitotic Activity,Lung Small Cell Carcinoma by AJCC v7 Stage,1
37699,Increased Cellularity Present,Childhood Anaplastic Oligoastrocytoma,1
37700,Carcinomatous Component Present,Well Differentiated Prostate Adenocarcinoma,1
37701,Epithelial Component Present,Frontal Sinus Squamous Cell Carcinoma,1
37702,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8,1
37703,Exophytic Polypoid Lesion,Tubulovillous adenoma of rectum,1
37704,Vascular Channel Formation,Thyroid Gland Lymphangioma,1
37705,Malignant Cellular Infiltrate,Ovarian Myxoid Liposarcoma,1
37706,Infiltrative Growth Pattern,Extra-abdominal fibromatosis,1
37707,Mesenchymal Component Present,Lung Adenofibroma,1
37708,Childhood Lesion,Childhood Malignant Solid Neoplasm,1
37709,Childhood Lesion,Childhood Mesenchymal Chondrosarcoma,1
37710,Carcinomatous Component Present,Acquired cystic disease associated renal cell carcinoma,1
37711,Carcinomatous Component Present,Clinical Stage I Gastric Cancer AJCC v8,1
37712,Fibrotic Stroma Formation,mucinous adenocarcinofibroma of ovary,1
37713,Mitotic Activity,"Testicular Yolk Sac Tumor, Microcystic Pattern",1
37714,Malignant Cellular Infiltrate,Colorectal Hodgkin Lymphoma,1
37715,Multifocal Lesion,Bowenoid papulosis of penis,1
37716,Childhood Lesion,Childhood Grade I Meningioma,1
37717,Carcinomatous Component Present,Stage I Vulvar Carcinoma,1
37718,Perivascular Arrangement of Tumor Cells,Malignant Lung PEComa,1
37719,Cystic Change,Eccrine hidrocystoma,1
37720,Malignant Cellular Infiltrate,Malignant tumor of choroid plexus,1
37721,Epithelial Component Present,Tibial adamantinoma,1
37722,Papillary Pattern,Sclerosing Breast Papilloma,1
37723,Malignant Cellular Infiltrate,Clinical Stage 0 Gastric Cancer AJCC v8,1
37724,Epithelial Component Present,Bladder papilloma,1
37725,Microvascular Proliferation,Adult Glioblastoma,1
37726,Locally Aggressive Lesion,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
37727,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma refractory,1
37728,Malignant Cellular Infiltrate,Immunoblastic lymphoma associated with AIDS,1
37729,Cutaneous Involvement,Bowen's Disease,1
37730,Hereditary Lesion,PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,1
37731,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Myelodysplastic Syndrome,1
37732,Malignant Cellular Infiltrate,Malignant neoplasm of spinal cord,1
37733,Adnexal Differentiation,Syringocystadenoma Papilliferum,1
37734,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
37735,Cytoplasmic Membrane-Bound Granules Present,Stage IIA Merkel Cell Carcinoma AJCC v7,1
37736,Malignant Cellular Infiltrate,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
37737,Heterologous Elements Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
37738,Neuroendocrine Differentiation,Carcinoid tumor of appendix,1
37739,Carcinomatous Component Present,basaloid squamous cell carcinoma of floor of mouth,1
37740,Immunologic Deficiency Syndromes,AIDS-Related Anal Canal Carcinoma,1
37741,Pancreatobiliary-Type Malignant Cells Present,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,1
37742,Well-Circumscribed Lesion,Cystic Partially Differentiated Nephroblastoma,1
37743,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor,1
37744,Local disease,Chondroid lipoma,1
37745,Hyperplastic Tissue Present,Diffuse hyperplasia,1
37746,Malignant Cellular Infiltrate,Differentiated Granulocytic Sarcoma,1
37747,Platinum Resistance,Platinum-Resistant Fallopian Tube Carcinoma,1
37748,Diffuse Pattern,Pleural Epithelioid Mesothelioma,1
37749,Carcinomatous Component Present,Stage II Fallopian Tube Cancer AJCC v8,1
37750,Childhood Lesion,Childhood Gliosarcoma,1
37751,Epithelial Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage,1
37752,Malignant Cellular Infiltrate,Stage IA Intrahepatic Bile Duct Cancer AJCC v8,1
37753,Epithelial Component Present,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
37754,Proliferation of Small Ducts Present,adenoma of intrahepatic bile duct,1
37755,Benign Cellular Infiltrate,Schwannomatosis,1
37756,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor G1,1
37757,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,Refractory High Risk Myelodysplastic Syndrome,1
37758,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Heterologous Type",1
37759,Epithelial Component Present,Colorectal Tubulovillous Adenoma,1
37760,Indolent Clinical Course,Soft Palate Pleomorphic Adenoma,1
37761,High Mitotic Activity,Combined Lung Small Cell and Squamous Cell Carcinoma,1
37762,Epithelial Component Present,Benign Apocrine Neoplasm,1
37763,Apocrine Differentiation,Benign Apocrine Neoplasm,1
37764,Confluent Sheets of Anaplastic T-Lymphocytes Present,"lymphomatoid papulosis, type C",1
37765,Malignant Cellular Infiltrate,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
37766,Carcinomatous Component Present,Early Invasive Cervical Adenocarcinoma,1
37767,Malignant Cellular Infiltrate,"Chondrosarcoma, Clear Cell",1
37768,Mitotic Activity,Central Nervous System Yolk Sac Tumor,1
37769,Epithelial Component Present,"Transitional cell carcinoma, micropapillary",1
37770,Carcinomatous Component Present,Bile duct adenocarcinoma resectable,1
37771,Malignant Cellular Infiltrate,Acute Megakaryoblastic Leukemia with NUP98-KDM5A,1
37772,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage I Plasma Cell Myeloma,1
37773,Carcinomatous Component Present,Recurrent Ovarian Carcinosarcoma,1
37774,Vascular Channel Formation,Histiocytoid hemangioma,1
37775,High Mitotic Activity,Colon Small Cell Neuroendocrine Carcinoma,1
37776,Carcinomatous Component Present,Cholangiolocellular Carcinoma,1
37777,Macrocystic Change,Pancreatic Macrocystic Serous Cystadenoma,1
37778,Secondary Lesion,Osteosarcoma Arising in Paget Disease of Bone,1
37779,Nuclear Pseudoinclusion,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
37780,Nuclear Expression of STAT6 Protein,Dedifferentiated Solitary Fibrous Tumor,1
37781,Malignant Cellular Infiltrate,Stage IA Lung Cancer AJCC v7,1
37782,Primary Lesion,Recurrent tumors of the Ewing's family,1
37783,Childhood Lesion,Childhood Central Nervous System Germinoma,1
37784,Malignant Cellular Infiltrate,Acute panmyelosis with myelofibrosis,1
37785,Epithelial Component Present,Stage IV Oropharyngeal Carcinoma AJCC v7,1
37786,Cutaneous Involvement,External Ear Actinic Keratosis,1
37787,Carcinomatous Component Present,Stage I Penile Cancer AJCC v6,1
37788,Malignant Cellular Infiltrate,Advanced Adult Hepatocellular Carcinoma,1
37789,Epithelial Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
37790,Dysplasia,Oral Intraepithelial Neoplasia,1
37791,Malignant Cellular Infiltrate,Stage III Liver Cancer,1
37792,Metastatic Lesion,Meningeal Carcinomatosis,1
37793,Epithelial Component Present,Cervical Glandular Neoplasm,1
37794,Ischemia,Acute vascular insufficiency of intestine (disorder),1
37795,Dysplasia,Colorectal Adenoma with Mild Dysplasia,1
37796,Intraductal Lesion,Intraductal Cribriform Breast Adenocarcinoma,1
37797,Low Mitotic Activity,Carcinoid tumor of intestine,1
37798,Childhood Lesion,Recurrent Childhood Non-Hodgkin Lymphoma,1
37799,Insular Pattern,"Somatostatinoma, malignant",1
37800,Necrotic changes (finding),Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
37801,Malignant Cellular Infiltrate,Follicular thyroid carcinoma,1
37802,Poorly Differentiated Lesion,Poorly Differentiated Hepatocellular Carcinoma,1
37803,Malignant Cellular Infiltrate,Localized Resectable Adult Liver Carcinoma,1
37804,Refractory Disease,Refractory Small Intestinal Carcinoma,1
37805,Malignant Cellular Infiltrate,Spindle cell rhabdomyosarcoma,1
37806,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
37807,Adulthood Lesion,Adult Germ Cell Tumor,1
37808,Neuroectodermal Differentiation,Localized Askin Tumor,1
37809,Carcinomatous Component Present,Stage IV Bladder Cancer AJCC v8,1
37810,Low Grade Lesion,Low grade myofibroblastic sarcoma,1
37811,Hyperkeratosis,Melanoacanthoma,1
37812,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
37813,Thyroglobulin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Follicular Carcinoma,1
37814,Malignant Cellular Infiltrate,Basal cell carcinoma - adamantinoid,1
37815,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8,1
37816,Well Differentiated Neuroendocrine Lesion,Stage I Rectal Neuroendocrine Tumor AJCC v8,1
37817,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
37818,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma,1
37819,Cutaneous Involvement,Unresectable Skin Carcinoma,1
37820,Recurrent disease,Recurrent BRCA-Mutated Ovarian Carcinoma,1
37821,Carcinomatous Component Present,Stage 0 Gallbladder Cancer AJCC v6 and v7,1
37822,Locally Aggressive Lesion,Atypical Lipoma,1
37823,Malignant Cellular Infiltrate,Stage II Lentigo Maligna Melanoma AJCC v6 and v7,1
37824,Glandular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
37825,Epithelial Component Present,Eccrine hidrocystoma,1
37826,Fibrotic Stroma Formation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
37827,Immunologic Deficiency Syndromes,AIDS related complication,1
37828,Epithelial Component Present,Thymic Papillary Adenocarcinoma,1
37829,Epithelial Component Present,Helicobacter Pylori-Related Gastric Adenocarcinoma,1
37830,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
37831,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v6,1
37832,Malignant Cellular Infiltrate,Childhood Embryonal Rhabdomyosarcoma,1
37833,Carcinomatous Component Present,Nipple Carcinoma,1
37834,Epithelial Component Present,Serous surface papillary carcinoma,1
37835,Absence of Stromal Invasion,Borderline Fallopian Tube Mucinous Tumor,1
37836,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage II,1
37837,Benign Cellular Infiltrate,Benign Childhood Germ Cell Tumor,1
37838,Malignant Cellular Infiltrate,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
37839,Mitotic Activity,Chondroblastoma,1
37840,High Mitotic Activity,Adult Central Nervous System Embryonal Carcinoma,1
37841,Borderline Lesion,cystic mucinous tumor of pancreas with moderate dysplasia,1
37842,Cystic Change,mucoepidermoid carcinoma of floor of mouth,1
37843,Carcinomatous Component Present,Stage IV Prostate Carcinoma,1
37844,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
37845,Glandular Pattern,Glandular malignant peripheral nerve sheath tumor,1
37846,Gyriform Trabecular Pattern,"Gastrinoma, malignant",1
37847,Papillary Pattern,Atypical Breast Papilloma,1
37848,Malignant Cellular Infiltrate,Refractory Desmoplastic Small Round Cell Tumor,1
37849,Malignant Cellular Infiltrate,Sarcomatoid carcinoma of the lung,1
37850,Anaplasia,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
37851,Increased Cellularity Present,Childhood Cerebellar Anaplastic Astrocytoma,1
37852,Cervical Glandular Dysplasia,intraepithelial glandular neoplasia of cervix,1
37853,Secondary Lesion,Locally Advanced Unresectable Prostate Carcinoma,1
37854,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v8,1
37855,Neuroectodermal Differentiation,Kadish Stage A Olfactory Neuroblastoma,1
37856,Vascular Channel Formation,Angiosarcoma non-metastatic,1
37857,Monocytosis,Refractory Chronic Myelomonocytic Leukemia,1
37858,Malignant Cellular Infiltrate,Diffuse malignant mesothelioma,1
37859,Epithelial Component Present,Testicular Tumor of the Thecoma/Fibroma Group,1
37860,Capillary Sized Vascular Channel Formation,Pyogenic granuloma of oral mucosa,1
37861,Cribriform Pattern,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
37862,Childhood Lesion,Childhood Angiosarcoma,1
37863,Low Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
37864,Epithelial Component Present,Stage IIB Appendix Carcinoma AJCC v8,1
37865,Malignant Cellular Infiltrate,Adult Classical Hodgkin Lymphoma,1
37866,Carcinomatous Component Present,Childhood Lung Non-Small Cell Carcinoma,1
37867,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,1
37868,Eosinophilic inflammation,Breast Epithelioid Hemangioma,1
37869,Pseudopapillary Pattern,Cerebellar Papillary Meningioma,1
37870,Mesenchymal Metaplasia,Adenocarcinoma with cartilaginous metaplasia,1
37871,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-1B,1
37872,Malignant Cellular Infiltrate,sarcoma of lung,1
37873,Malignant Cellular Infiltrate,Carcinoma,1
37874,Epithelial Component Present,Stage II Colorectal Cancer AJCC v8,1
37875,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
37876,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage II,1
37877,Epithelial Component Present,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
37878,Malignant Cellular Infiltrate,sarcoma of vagina,1
37879,Carcinomatous Component Present,Carcinoma of the Floor of the Mouth,1
37880,WNT Pathway Activated,"Medulloblastoma, WNT-Activated",1
37881,HMB-45-Positive Neoplastic Cells Present,Perivascular Epithelioid Cell Neoplasms,1
37882,Primary Lesion,Frontal Lobe Ependymal Tumor,1
37883,Nuclear Atypia,Glioblastoma,1
37884,Malignant Cellular Infiltrate,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
37885,Papillary Pattern,Ureter Urothelial Papilloma,1
37886,Epithelial Component Present,Stage I Rectal Cancer AJCC v6 and v7,1
37887,Malignant Cellular Infiltrate,Skin Signet Ring Cell Basal Cell Carcinoma,1
37888,Well-Circumscribed Lesion,Breast adenoma,1
37889,Malignant Cellular Infiltrate,Stage IV Distal Bile Duct Cancer AJCC v8,1
37890,Epithelial Component Present,Stage IA Esophageal Cancer AJCC v7,1
37891,Invasive Lesion,Dermatofibrosarcoma protuberans with myoid differentiation,1
37892,Malignant Cellular Infiltrate,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
37893,Concentric Aggregates of Intermediate Filaments Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
37894,Mild cytologic atypia,Pancreatic Intraepithelial Neoplasia-1,1
37895,Malignant Cellular Infiltrate,Secondary malignant neoplasm of spinal cord,1
37896,Neuroectodermal Differentiation,Kadish Stage C Olfactory Neuroblastoma,1
37897,In Situ Lesion,Carcinoma in situ in a polyp,1
37898,In Situ Lesion,Stage 0 Ampulla of Vater Cancer AJCC v8,1
37899,Carcinomatous Component Present,Uterine Ligament Adenocarcinoma,1
37900,Multifocal Lesion,Recurrent respiratory papillomatosis,1
37901,Diffuse Pattern,Childhood Glioblastoma,1
37902,Well-Circumscribed Lesion,Traditional Serrated Adenoma,1
37903,Malignant Cellular Infiltrate,Cervical Verrucous Carcinoma,1
37904,Hereditary Lesion,Familial Colorectal Cancer Type X,1
37905,Malignant Cellular Infiltrate,Sarcoma of kidney,1
37906,Intraocular Lesion,Recurrent Primary Vitreoretinal Lymphoma,1
37907,Nuclear Pseudoinclusion,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
37908,Breast Microcalcification,Childhood Brain Oligodendroglioma,1
37909,Malignant Cellular Infiltrate,Adenocarcinoma in situ in tubulovillous adenoma,1
37910,Biphasic Pattern,Ovarian Clear Cell Cystadenofibroma,1
37911,Malignant Cellular Infiltrate,Stage II Lip Cancer AJCC v6 and v7,1
37912,Carcinomatous Component Present,Stage IA1 Cervical Cancer AJCC v8,1
37913,Pseudoencapsulated Mass,Low Grade Malignant Peripheral Nerve Sheath Tumor,1
37914,Cutaneous Involvement,"Mastocytosis, Diffuse Cutaneous",1
37915,Unilineage Dysplasia Present,Refractory cytopenia with unilineage dysplasia,1
37916,Follicular Structures Present,Microfollicular adenoma,1
37917,Nuclear Atypia,Proneural Glioblastoma,1
37918,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G2,1
37919,Epithelial Component Present,Growth Hormone-Secreting Pituitary Adenoma,1
37920,Carcinomatous Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v7,1
37921,Malignant Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
37922,Serrated Glandular Architecture,Appendix Sessile Serrated Adenoma/Polyp,1
37923,Epithelial Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
37924,Monoclonal Cellular Population Present,Thyroid Gland Clear Cell Follicular Adenoma,1
37925,Malignant Cellular Infiltrate,Sarcoma NCI Grade 2,1
37926,Epithelial Component Present,Malignant neoplasm of carotid body,1
37927,Nuclear Atypia,Childhood Gliosarcoma,1
37928,Pregnancy Complications,Stage I Gestational Trophoblastic Neoplasm AJCC v8,1
37929,Malignant Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v6 and v7,1
37930,Malignant Cellular Infiltrate,Medulloblastoma with extensive nodularity,1
37931,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v8,1
37932,In Situ Lesion,Biliary Intraepithelial Neoplasia-3,1
37933,Malignant Cellular Infiltrate,Gastric lymphoma,1
37934,Epithelial Component Present,Colon Cancer by AJCC v7 Stage,1
37935,Cutaneous Involvement,Porokeratotic eccrine ostial and dermal duct nevus,1
37936,Indolent Clinical Course,Indolent Systemic Mastocytosis,1
37937,Cystic Change,Pancreatic Intraductal Papillary Mucinous Neoplasm,1
37938,Epithelial Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
37939,Carcinomatous Component Present,Nasopharyngeal squamous cell carcinoma stage III,1
37940,Mixture of Morphologic Patterns,Mixed Squamous Cell Carcinoma of the Penis,1
37941,Epithelial Component Present,Broad Ligament Serous Adenocarcinoma,1
37942,Primary Lesion,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
37943,Abundance of Small Lymphocytes,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma,1
37944,Secondary Lesion,Secondary malignant neoplasm of parathyroid gland,1
37945,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Solid Variant",1
37946,Well Differentiated Neuroendocrine Lesion,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
37947,Bone Marrow Dysplasia Present,"Myelodysplastic syndrome, no ICD-O subtype",1
37948,'Starry-sky' pattern,Colon Burkitt Lymphoma,1
37949,Secondary Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
37950,CD30-Positive Neoplastic Cells Present,Anaplastic small cell lymphoma,1
37951,Nuclear pleomorphism,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
37952,Carcinomatous Component Present,Ear carcinoma,1
37953,Nuclear pleomorphism,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
37954,Benign Cellular Infiltrate,Microfollicular adenoma,1
37955,Pre-existing condition,Myeloid Neoplasms with Germline GATA2 Mutation,1
37956,Malignant Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm,1
37957,Carcinomatous Component Present,Stage IVA Pharyngeal Carcinoma,1
37958,Primary Lesion,Recurrent Medulloblastoma,1
37959,Benign Cellular Infiltrate,Respiratory papilloma,1
37960,Low Mitotic Activity,Colorectal Neuroendocrine Tumor G2,1
37961,Primary Lesion,Stage III Hepatocellular Carcinoma AJCC v7,1
37962,Carcinomatous Component Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma,1
37963,Malignant Cellular Infiltrate,Stage IVC Nasopharyngeal Carcinoma AJCC v7,1
37964,Myxoid Stroma Formation,Mediastinal Epithelioid Hemangioendothelioma,1
37965,Rosenthal Fibers Present,Rosette-forming glioneuronal neoplasm,1
37966,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v7,1
37967,Adulthood Lesion,Adult Mixed Glioma,1
37968,Locally Aggressive Lesion,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,1
37969,Benign Cellular Infiltrate,Hemangioma,1
37970,Malignant Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",1
37971,Anaplasia,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",1
37972,Epithelial Component Present,Stage IB Lung Cancer AJCC v8,1
37973,Refractory Disease,Refractory Malignant Solid Neoplasm,1
37974,Indolent Clinical Course,Calcifying Odontogenic Cyst,1
37975,Malignant Cellular Infiltrate,Grade 4 Clear Cell Renal Cell Carcinoma,1
37976,Epithelial Component Present,Epithelioma,1
37977,Malignant Cellular Infiltrate,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,1
37978,Ganglion Cell-Like Elements Present,Intestinal Gangliocytic Paraganglioma,1
37979,Childhood Lesion,Childhood Pilocytic Astrocytoma,1
37980,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v7,1
37981,Adnexal Differentiation,Trichoepithelioma,1
37982,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
37983,Epithelial Component Present,Stage IVA Colorectal Cancer AJCC v7,1
37984,Malignant Cellular Infiltrate,Stage IVA Primary Peritoneal Cancer AJCC v8,1
37985,Perivascular Arrangement of Tumor Cells,Glomangiomatosis,1
37986,Malignant Cellular Infiltrate,Hereditary Renal Cell Carcinoma,1
37987,Thick-Walled Hyalinized Vessels Present,Benign Cardiac Schwannoma,1
37988,Malignant Cellular Infiltrate,Diffuse malignant mesothelioma,1
37989,Severe cytologic atypia,Pancreatic Small Cell Neuroendocrine Carcinoma,1
37990,Benign Cellular Infiltrate,Trigeminal schwannoma,1
37991,Recurrent disease,Recurrent T Acute Lymphoblastic Leukemia,1
37992,Benign Cellular Infiltrate,Synovial Hemangioma,1
37993,Epithelial Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v7,1
37994,Refractory Disease,Refractory Plasmablastic Lymphoma,1
37995,Indolent Clinical Course,Follicular Myxoma,1
37996,Secondary Lesion,Metastatic malignant neoplasm to oropharynx,1
37997,Malignant Cellular Infiltrate,AIDS with Kaposi's sarcoma,1
37998,Malignant Cellular Infiltrate,Adenocarcinoma of anal glands,1
37999,Epithelial Component Present,Anal cancer metastatic,1
38000,Malignant Cellular Infiltrate,Postsurgical Stage III Hepatoblastoma,1
38001,Epithelial Component Present,Refractory Hormone Receptor Positive Breast Carcinoma,1
38002,Malignant Cellular Infiltrate,"Synovial sarcoma, epithelioid cell",1
38003,Mixed Cellular Population,Recurrent Ovarian Carcinosarcoma,1
38004,Malignant Cellular Infiltrate,Mixed Germ Cell Tumor,1
38005,Epithelial Component Present,Malignant phyllodes tumor of breast,1
38006,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma,1
38007,Malignant Cellular Infiltrate,Differentiated Granulocytic Sarcoma,1
38008,Malignant Cellular Infiltrate,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
38009,Mesenchymal Component Present,Salivary Gland Pleomorphic Adenoma,1
38010,Epithelial Component Present,Erosive Adenomatosis of the Nipple,1
38011,Low Mitotic Activity,Carcinoid tumor of the cecum,1
38012,Tissue Differentiation Uncertain,Cardiac Synovial Sarcoma,1
38013,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis,1
38014,Mitotic Activity,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7,1
38015,Hereditary Lesion,"Amyloidosis, Familial",1
38016,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
38017,Biphasic Pattern,Atypical polypoid adenomyoma,1
38018,Malignant Cellular Infiltrate,Squamous cell carcinoma of mouth,1
38019,Neuroendocrine Differentiation,Combined Lung Small Cell and Squamous Cell Carcinoma,1
38020,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma,1
38021,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
38022,Malignant Cellular Infiltrate,Malignant Cardiac Germ Cell Tumor,1
38023,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
38024,Epithelial Component Present,Stage I Ampulla of Vater Cancer AJCC v8,1
38025,Invasive Lesion,Invasive Ductal and Invasive Lobular Breast Carcinoma,1
38026,High Mitotic Activity,Large cell neuroendocrine carcinoma,1
38027,Severe dysplasia,Carcinoma in situ in a polyp,1
38028,Malignant Cellular Infiltrate,Stage IV Merkel Cell Carcinoma AJCC v7,1
38029,Malignant Cellular Infiltrate,Recurrent Endometrial Cancer,1
38030,Epithelial Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
38031,Tissue of Mullerian Origin Present,Cystadenofibroma,1
38032,Benign Cellular Infiltrate,Jugular Foramen Schwannoma,1
38033,Pregnancy Complications,Stage IIIB Gestational Trophoblastic Tumor AJCC v7,1
38034,Benign Cellular Infiltrate,Myofibromatosis,1
38035,Severe dysplasia,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
38036,Recurrent disease,Oral neoplasm malignant recurrent,1
38037,Malignant Cellular Infiltrate,Carcinoma of the Floor of the Mouth,1
38038,Secondary Lesion,Metastatic Carcinoma,1
38039,Wheezing,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
38040,Diffuse Pattern,Recurrent Glioblastoma,1
38041,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v7,1
38042,Epithelial Component Present,"Cystadenocarcinoma, Serous",1
38043,Well-Circumscribed Lesion,Osteoid osteoma,1
38044,Neuroendocrine Differentiation,Unresectable Pancreatic Neuroendocrine Carcinoma,1
38045,Epithelial Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
38046,Epithelial Component Present,Non-Functioning Pituitary Gland Neoplasm,1
38047,Mitotic Activity,Adult Anaplastic Astrocytoma,1
38048,Epithelial Component Present,Atypical Pituitary Gland Adenoma,1
38049,Malignant Cellular Infiltrate,Stage II Adult Liver Cancer AJCC v7,1
38050,Carcinomatous Component Present,Metastatic Hypopharyngeal Carcinoma,1
38051,Epithelial Component Present,Ethmoid Sinus Adenoid Cystic Carcinoma,1
38052,Mitotic Activity,"Testicular Yolk Sac Tumor, Solid Pattern",1
38053,Diffuse Pattern,Glioblastoma multiforme of spinal cord,1
38054,Mesenchymal Differentiation,gliosarcoma,1
38055,Low Mitotic Activity,Carcinoid tumor of pancreas,1
38056,Epithelial Component Present,Borderline Ovarian Mucinous Adenofibroma,1
38057,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
38058,Epithelial Component Present,Stage IIIA Eyelid Carcinoma AJCC v8,1
38059,Recurrent disease,Angiocentric lymphoma recurrent,1
38060,Malignant Cellular Infiltrate,Stage IB1 Cervical Cancer,1
38061,Poorly Differentiated Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,1
38062,Secondary Lesion,Secondary malignant neoplasm of lip,1
38063,Malignant Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
38064,Focal dysplasia,Appendix Sessile Serrated Adenoma/Polyp,1
38065,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
38066,Malignant Cellular Infiltrate,Sarcoma NCI Grade 2,1
38067,Benign Cellular Infiltrate,Recurrent Nevus,1
38068,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
38069,Epithelial Component Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,1
38070,Epithelial Component Present,keratinizing squamous cell carcinoma of vulva,1
38071,Malignant Cellular Infiltrate,Metastatic Carcinoma,1
38072,Malignant Cellular Infiltrate,Urothelial Carcinoma,1
38073,Hereditary Lesion,Hereditary corneal dystrophy,1
38074,Fibrous Septa Present,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
38075,Metastatic Lesion,Peripheral neuroepithelioma of bone metastatic,1
38076,Follicular Cell Differentiation,Multicentric Thyroid Gland Papillary Carcinoma,1
38077,Cartilaginous Differentiation,Chondroblastic osteosarcoma,1
38078,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage II,1
38079,Epithelial Component Present,Chromophobe Renal Cell Carcinoma,1
38080,Malignant Cellular Infiltrate,Familial Neuroblastoma,1
38081,Cutaneous Involvement,Malignant Breast Eccrine Spiradenoma,1
38082,Malignant Cellular Infiltrate,Stage IVB Lip Cancer AJCC v6 and v7,1
38083,Epithelial Component Present,Pancreatic Vipoma,1
38084,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
38085,Cystic Change,"Cystadenoma, Serous",1
38086,Cutaneous Involvement,Pityriasis Rubra Pilaris,1
38087,Secondary Lesion,Metastatic leiomyosarcoma,1
38088,Carcinomatous Component Present,Pathologic Stage IIIB Gastric Cancer AJCC v8,1
38089,CD1a-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
38090,Malignant Cellular Infiltrate,Anaplastic Brain Stem Glioma,1
38091,Indolent Clinical Course,Benign neoplasm of body of uterus,1
38092,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type II,1
38093,Lamellar Pattern,Fibrolamellar Hepatocellular Carcinoma,1
38094,Cutaneous Involvement,Eczema,1
38095,Malignant Germinomatous Cellular Infiltrate,Pineal germinoma,1
38096,Carcinomatous Component Present,Urothelial cancer of renal pelvis,1
38097,Carcinomatous Component Present,Stage IVC Appendix Carcinoma AJCC v8,1
38098,Cutaneous Involvement,Non-Neoplastic Skin Disorder,1
38099,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma metastatic,1
38100,Epithelial Component Present,Recurrent Clear Cell Renal Cell Carcinoma,1
38101,Malignant Cellular Infiltrate,Stage IIIA1 Fallopian Tube Cancer AJCC v8,1
38102,Childhood Lesion,Childhood Seminoma,1
38103,Cutaneous Involvement,Abscess of skin AND/OR subcutaneous tissue,1
38104,Childhood Lesion,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8,1
38105,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Tumor,1
38106,Carcinomatous Component Present,"Squamous cell carcinoma, metastatic",1
38107,Recurrent disease,Laryngeal papillomatosis,1
38108,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP C",1
38109,Tissue of Mullerian Origin Present,Uterine Corpus Adenofibroma,1
38110,Malignant Cellular Infiltrate,Stage IIIB Appendix Carcinoma AJCC v7,1
38111,Epithelial Component Present,LH-Producing Gonadotroph Adenoma,1
38112,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v7 Stage,1
38113,Epithelial Component Present,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
38114,CD30-Positive Neoplastic Cells Present,Childhood Systemic Anaplastic Large Cell Lymphoma,1
38115,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
38116,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
38117,Neuroendocrine Differentiation,Glomus Tympanicum Tumor,1
38118,Recurrent disease,Recurrent Primary Vitreoretinal Lymphoma,1
38119,Malignant Cellular Infiltrate,Metastatic Lip Carcinoma,1
38120,Benign Cellular Infiltrate,mediastinal lipomatosis,1
38121,Recurrent disease,Thymoma malignant recurrent,1
38122,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
38123,Well Differentiated Neuroendocrine Lesion,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
38124,Malignant Cellular Infiltrate,Anaplastic adrenocortical carcinoma,1
38125,Metastatic Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,1
38126,Mesenchymal Component Present,Intracanalicular fibroadenoma,1
38127,Cutaneous Involvement,Benign neoplasm of sebaceous gland,1
38128,Malignant Germinomatous Cellular Infiltrate,Pineal germinoma,1
38129,Carcinomatous Component Present,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
38130,Epithelial Component Present,Refractory Lung Small Cell Carcinoma,1
38131,Slow Growing Mass,Vertebral chordoma,1
38132,Exophytic Polypoid Lesion,Villous adenoma of rectum,1
38133,Benign Cellular Infiltrate,Vestibular Papilloma,1
38134,Fibrotic Stroma Formation,Stage III Intrahepatic Cholangiocarcinoma AJCC v7,1
38135,Childhood Lesion,"Childhood Ganglioneuroblastoma, Nodular",1
38136,Vascular proliferation,Nasopharyngeal Angiofibroma,1
38137,Epithelial Component Present,Oncocytic Breast Carcinoma,1
38138,Desmoplastic Stroma Formation,Desmoplastic Neurotropic Melanoma,1
38139,Cutaneous Involvement,Tufted angioma of skin,1
38140,Cutaneous Involvement,Eccrine acrospiroma,1
38141,Adulthood Lesion,Adult Acute Myeloid Leukemia with Maturation,1
38142,Malignant Cellular Infiltrate,Metastatic Malignant Germ Cell Tumor,1
38143,Epithelial Component Present,Adult Type Ovarian Granulosa Cell Tumor,1
38144,Ground Glass Nuclear Inclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
38145,Tissue Differentiation Uncertain,Follicular Myxoma,1
38146,Splenomegaly,Recurrent T-Cell Prolymphocytic Leukemia,1
38147,Malignant Cellular Infiltrate,FIGO Stage IIIA1(i) Ovarian Cancer,1
38148,Malignant Cellular Infiltrate,Adult Brain Medulloblastoma,1
38149,High Grade Lesion,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
38150,Neuroendocrine Differentiation,Stage IIA Colon Neuroendocrine Tumor AJCC v8,1
38151,Malignant Cellular Infiltrate,Stage IVC Nasopharyngeal Carcinoma AJCC v7,1
38152,Metastatic Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
38153,Cutaneous Involvement,Ocular Cicatricial Pemphigoid,1
38154,Glandular Pattern,Gastric Intestinal-Type Adenocarcinoma,1
38155,Lymphadenopathy,Chronic Adult T-Cell Leukemia/Lymphoma,1
38156,Carcinomatous Component Present,Stage II Lung Cancer AJCC v6,1
38157,Myxoid Stroma Formation,"Testicular Yolk Sac Tumor, Myxomatous Pattern",1
38158,Carcinomatous Component Present,Lipid-rich carcinoma,1
38159,Epithelial Component Present,Anatomic Stage IIB Breast Cancer AJCC v8,1
38160,Benign Cellular Infiltrate,Oral Cavity Leiomyoma,1
38161,Non-Invasive Lesion,Ampulla of Vater Tubular Adenoma,1
38162,Epithelial Component Present,Malignant sex-cord stromal tumor,1
38163,Cystic Change,Dermoid Cyst,1
38164,Basal Cells with Pale Cytoplasm Present,"Acanthoma, Clear Cell",1
38165,Neuroendocrine Differentiation,Gastrointestinal Carcinoid Tumor,1
38166,Childhood Lesion,St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8,1
38167,Diffuse Lesion,Meningeal Carcinomatosis,1
38168,Benign Cellular Infiltrate,Seminal Vesicle Cystadenoma,1
38169,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
38170,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
38171,Carcinomatous Component Present,Infiltrating Urothelial Carcinoma,1
38172,Papillary Pattern,papillary carcinoma of penis,1
38173,Benign Cellular Infiltrate,Squamous odontogenic tumor,1
38174,Epithelial Component Present,Stage III Gallbladder Cancer AJCC v8,1
38175,Secondary Lesion,Locally Advanced Skin Squamous Cell Carcinoma,1
38176,Necrotic changes (finding),Vulvar Large Cell Neuroendocrine Carcinoma,1
38177,Tubular Pattern,Ampulla of Vater Tubulovillous Adenoma,1
38178,Epithelial Component Present,Cauda Equina Paraganglioma,1
38179,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile astrocytoma,1
38180,Pregnancy Complications,Placental Non-Neoplastic Disorder,1
38181,Adulthood Lesion,Stage IV Adult Lymphoblastic Lymphoma,1
38182,Unilineage Dysplasia Present,Refractory anemias,1
38183,Secondary Lesion,Chemotherapy-Related Leukemia,1
38184,Desmoplastic Stroma Formation,Desmoplastic Nevus,1
38185,Increased Cellularity Present,Stage 3 Neuroblastoma,1
38186,Malignant Cellular Infiltrate,Stage IVA Basal Cell Lip Carcinoma,1
38187,Carcinomatous Component Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
38188,Malignant Cellular Infiltrate,Recurrent Intravascular Large B-Cell Lymphoma,1
38189,Fibrotic Stroma Formation,Thymic Mucoepidermoid Carcinoma,1
38190,Benign Cellular Infiltrate,Heavily Pigmented Adrenal Cortical Adenoma,1
38191,Recurrent Lymphoma,Recurrent Grade III Lymphomatoid Granulomatosis,1
38192,Low Mitotic Activity,Stage II Gastric Neuroendocrine Tumor AJCC v8,1
38193,Well-Circumscribed Lesion,Adult Cardiac Cellular Rhabdomyoma,1
38194,Malignant Cellular Infiltrate,Primary Cutaneous Mucinous Carcinoma,1
38195,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
38196,Non-Invasive Lesion,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
38197,Diffuse Lesion,Papillomatosis,1
38198,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Teratoma,1
38199,Pathologic TNM Finding,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,1
38200,Alcohol Toxicity,Alcohol-Related Carcinoma,1
38201,Epithelial Component Present,Hereditary Prostate Carcinoma,1
38202,Alternative Fascicle (Bundle) Pattern,Bone Leiomyoma,1
38203,Lesion with Diameter Less than 11mm,Small Size Posterior Uveal Melanoma,1
38204,Epithelial Component Present,Low Grade Salivary Gland Carcinoma,1
38205,CD30-Positive Neoplastic Cells Present,Adult Anaplastic Large Cell Lymphoma,1
38206,Epithelial Component Present,"Mesonephroma, benign",1
38207,Malignant Cellular Infiltrate,Recurrent Adult Lymphoblastic Lymphoma,1
38208,Anaplasia,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
38209,Papillary Pattern,Renal Pelvis Inverted Papilloma,1
38210,Low Grade Neuroendocrine Lesion,Carcinoid tumor of appendix,1
38211,Carcinomatous Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma,1
38212,Epithelial Component Present,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
38213,Carcinomatous Component Present,Stage IIIA Ovarian Carcinoma,1
38214,Malignant Cellular Infiltrate,Cancer of lymph node,1
38215,Lobulated Growth Pattern,Soft tissue chondroma,1
38216,Invasive Lesion,Oncocytic Breast Carcinoma,1
38217,Metastatic Lesion,Advanced Uterine Corpus Carcinosarcoma,1
38218,Pregnancy Complications,"Trophoblastic tumor, epithelioid",1
38219,Benign Cellular Infiltrate,Chief cell adenoma,1
38220,Biphasic Pattern,Uterine Corpus Carcinofibroma,1
38221,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma,1
38222,Epithelial Component Present,Unresectable Intrahepatic Cholangiocarcinoma,1
38223,Cutaneous Involvement,Stage IIC Cutaneous Melanoma AJCC v6 and v7,1
38224,atypia morphology,Grade III Lymphomatoid Granulomatosis,1
38225,Malignant Cellular Infiltrate,adenoid cystic carcinoma of pharynx,1
38226,Malignant Cellular Infiltrate,Stage IIIB Bladder Cancer AJCC v8,1
38227,Epithelial Component Present,Vulvar Adenocarcinoma of Mammary Gland Type,1
38228,Recurrent disease,Large cell lung cancer recurrent,1
38229,More than 5 Mitoses per 50HPF,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
38230,Comedo Necrosis,High Grade Ductal Breast Carcinoma In Situ,1
38231,Papillary Pattern,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
38232,Carcinomatous Component Present,Stage IIB Lung Cancer AJCC v7,1
38233,Cutaneous Involvement,Malignant Breast Eccrine Spiradenoma,1
38234,Carcinomatous Component Present,Vulvar Warty Carcinoma,1
38235,Well Differentiated Lesion,Well-differentiated papillary mesothelioma,1
38236,S-100-Positive Neoplastic Cells Present,Indeterminate dendritic cell tumor,1
38237,Metastatic/Recurrent Disease,Unresectable Synovial Sarcoma,1
38238,Cellular Pleomorphism,Giant Cell Fibrous Histiocytoma,1
38239,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage III,1
38240,Lesion with Diameter Less than 11mm,Small Size Posterior Uveal Melanoma,1
38241,Epithelial Component Present,Borderline Fallopian Tube Endometrioid Tumor,1
38242,High Mitotic Activity,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
38243,Malignant Cellular Infiltrate,Bartholin Gland Adenocarcinoma,1
38244,Malignant Cellular Infiltrate,Stage IIC Rectal Cancer AJCC v7,1
38245,High Mitotic Activity,Combined Lung Large Cell Neuroendocrine Carcinoma,1
38246,Epithelial Component Present,Vaginal Villous Adenoma,1
38247,Malignant Cellular Infiltrate,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma,1
38248,Carcinomatous Component Present,Stage IIB Ovarian Cancer AJCC v6 and v7,1
38249,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage II,1
38250,Epithelial Component Present,Locally Advanced Unresectable Carcinoma,1
38251,Multifocal Lesion,Multiple Endocrine Neoplasia Type 2b,1
38252,Increased megakaryocytes (bone marrow),Overt Primary Myelofibrosis,1
38253,Carcinomatous Component Present,Metastatic Gastric Neuroendocrine Carcinoma,1
38254,Hereditary Lesion,"Anemia, Hemolytic, Congenital",1
38255,Epithelial Component Present,Small Intestinal Squamous Cell Carcinoma,1
38256,Epithelial Component Present,Stage III Lung Cancer AJCC v8,1
38257,Epithelial Component Present,Anaplastic thyroid carcinoma,1
38258,Cutaneous Involvement,Clinical Stage I Cutaneous Melanoma AJCC v8,1
38259,Epithelial Component Present,Appendix Neuroendocrine Tumor G2,1
38260,Malignant Cellular Infiltrate,carcinosarcoma of salivary gland,1
38261,Abnormal Eosinophilic Granules Present,"Acute myeloid leukemia, inv(16)(p13q22)",1
38262,Malignant Cellular Infiltrate,Nasopharyngeal cancer recurrent,1
38263,Vascular Channel Formation,Cardiac Intramuscular Hemangioma,1
38264,Carcinomatous Component Present,Clear cell squamous cell carcinoma of skin,1
38265,Chromogranin A Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell",1
38266,Acute inflammation,Myxoinflammatory fibroblastic sarcoma,1
38267,Malignant Cellular Infiltrate,Refractory Breast Lymphoma,1
38268,Malignant Cellular Infiltrate,Stage IV Adrenal Cortex Carcinoma AJCC v7,1
38269,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Carcinoma AJCC v7,1
38270,Nested Pattern,Clear Cell Sarcoma of Soft Tissue,1
38271,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8,1
38272,Carcinomatous Component Present,Metastatic Bladder Squamous Cell Carcinoma,1
38273,Carcinomatous Component Present,adenocarcinoma of urethra,1
38274,Well Differentiated Lesion,Well Differentiated Ovarian Steroid Cell Tumor,1
38275,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
38276,Carcinomatous Component Present,Stage IVB Rectal Cancer AJCC v8,1
38277,Mixed Cellular Population,Lung Adenofibroma,1
38278,Diffuse Pattern,Gliomatosis Cerebri Type I,1
38279,Secondary Lesion,Metastatic Bladder Urothelial Carcinoma,1
38280,Benign Cellular Infiltrate,Esophageal hemangioma,1
38281,Invasive Lesion,Squamous cell carcinoma of prostate,1
38282,Stromal Invasion,Recurrent Ovarian Endometrioid Adenocarcinoma,1
38283,Malignant Cellular Infiltrate,Metastases to adrenals,1
38284,Malignant Cellular Infiltrate,Oropharyngeal lymphepithelioma,1
38285,Malignant Germinomatous Cellular Infiltrate,"Seminoma, anaplastic",1
38286,Malignant Cellular Infiltrate,Borderline Resectable Malignant Neoplasm,1
38287,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
38288,Peribronchial Proliferation of Neoplastic Cells Present,tumor miofibroblástico peribronquial congénito,1
38289,Carcinomatous Component Present,Small cell lung cancer limited stage,1
38290,Childhood Lesion,Childhood Brain Oligodendroglioma,1
38291,Epithelial Component Present,Carcinoid tumor of appendix,1
38292,Hereditary Lesion,Bloom Syndrome,1
38293,Malignant Cellular Infiltrate,Ear carcinoma,1
38294,Adulthood Lesion,Stage IV Adult Lymphoblastic Lymphoma,1
38295,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v8,1
38296,Childhood Lesion,Childhood Ovarian Teratoma,1
38297,Cutaneous Involvement,Congenital hypotrichia,1
38298,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",1
38299,Local disease,Oral Cavity Lipoma,1
38300,Neuroendocrine Differentiation,Metastatic Lung Neuroendocrine Neoplasm,1
38301,Hyaline Cartilage Differentiation,chondroma of lung,1
38302,Carcinomatous Component Present,Rectal Sarcomatoid Carcinoma,1
38303,Primary Lesion,Brain Stem Hemangioblastoma,1
38304,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
38305,Epithelial Component Present,Ovarian cancer stage III,1
38306,Neuroendocrine Differentiation,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
38307,Thyroglobulin Positive Neoplastic Cells Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
38308,Invasive Lesion,Recurrent Invasive Ductal Breast Carcinoma,1
38309,Carcinomatous Component Present,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8,1
38310,Anaplasia,Childhood Brain Glioblastoma,1
38311,Carcinomatous Component Present,"Adenocarcinoma, metastatic",1
38312,Carcinomatous Component Present,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
38313,Hereditary Lesion,Hereditary spherocytosis,1
38314,Indolent Clinical Course,Fibroma of tendon sheath,1
38315,Malignant Cellular Infiltrate,Fibrolamellar Hepatocellular Carcinoma,1
38316,Refractory Disease,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
38317,Malignant Cellular Infiltrate,Plasma Cell Myeloma by RISS Stage,1
38318,Papillary Pattern,Invasive micropapillary carcinoma of breast,1
38319,Carcinomatous Component Present,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,1
38320,Diffuse Pattern,Giant Cell Glioblastoma,1
38321,Recurrent disease,Recurrent Clear Cell Renal Cell Carcinoma,1
38322,Childhood Lesion,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
38323,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligoastrocytoma,1
38324,Benign Cellular Infiltrate,Vulvar Cellular Angiofibroma,1
38325,Malignant Cellular Infiltrate,Stage I Uterine Corpus Leiomyosarcoma AJCC v8,1
38326,Epithelial Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v8,1
38327,Absence of Invasion,Stage 0is Renal Pelvis Cancer AJCC v7,1
38328,Carcinomatous Component Present,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
38329,Stromal Invasion,Refractory Ovarian Endometrioid Adenocarcinoma,1
38330,Hyaline Cartilage Differentiation,Childhood Myxoid Chondrosarcoma,1
38331,Epithelial Component Present,Stage IIA Distal Bile Duct Cancer AJCC v7,1
38332,Epidermotropic Lymphocytic Infiltrate,Mycosis Fungoides,1
38333,Well-Circumscribed Lesion,Colon Traditional Serrated Adenoma,1
38334,Indolent Clinical Course,Benign Fibroblastic Neoplasm,1
38335,Systemic disease,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
38336,Secondary Lesion,Metastatic osteosarcoma,1
38337,Epithelial Component Present,Stage IVB Rectal Cancer AJCC v8,1
38338,Mixed Cellular Population,Stage III Kidney Wilms Tumor,1
38339,Nodular Pattern,Adenoameloblastoma,1
38340,Cutaneous Involvement,Nevus of Ota,1
38341,High Mitotic Activity,Stage II Lung Small Cell Carcinoma AJCC v7,1
38342,Malignant Cellular Infiltrate,Stage C Chronic Lymphocytic Leukemia,1
38343,Malignant Cellular Infiltrate,Hypocellular Myelodysplastic Syndrome,1
38344,Indolent Clinical Course,Hemangioma of retina,1
38345,Carcinomatous Component Present,External Ear Carcinoma,1
38346,Non-Invasive Lesion,cystic mucinous tumor of pancreas with moderate dysplasia,1
38347,Epithelial Component Present,Anal Intraepithelial Neoplasia 2,1
38348,Endophytic Tumor Growth,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
38349,Cutaneous Involvement,Hutchinson's Melanotic Freckle,1
38350,Malignant Cellular Infiltrate,Malignant tumor of renal pelvis,1
38351,Borderline Lesion,In situ mantle cell neoplasia,1
38352,Carcinomatous Component Present,Larynx carcinoma recurrent,1
38353,Malignant Cellular Infiltrate,Grade 3 Invasive Breast Carcinoma,1
38354,Epithelial Component Present,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,1
38355,Secondary Lesion,Breast Carcinoma Metastatic in the Brain,1
38356,Recurrent disease,Recurrent Pancreatic Cystadenocarcinoma,1
38357,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
38358,Malignant Cellular Infiltrate,Skin squamous cell carcinoma metastatic,1
38359,Glucagon-Like Peptide Positive Neoplastic Cells Present,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
38360,Carcinomatous Component Present,Stage IVB Gallbladder Cancer AJCC v8,1
38361,Primary Lesion,Alcohol-Related Hepatocellular Carcinoma,1
38362,Neuronal Differentiation,Ganglioglioma,1
38363,Lymphoplasmacytic Infiltrate,Nasopharyngeal Differentiated Carcinoma,1
38364,Malignant Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,1
38365,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v8,1
38366,Carcinomatous Component Present,Stage IIIA1 Ovarian Cancer AJCC v8,1
38367,Epithelial Component Present,Recurrent Parotid Gland Acinic Cell Carcinoma,1
38368,Epithelial Component Present,Carcinoid tumor of the liver,1
38369,Malignant Cellular Infiltrate,Mixed Hepatoblastoma with Teratoid Features,1
38370,Mixed Cellular Population,Nephroblastoma,1
38371,Indolent Clinical Course,Histiocytoid hemangioma,1
38372,Perineural spread,adenoid cystic carcinoma of lung,1
38373,Carcinomatous Component Present,Resectable Pancreatic Acinar Cell Carcinoma,1
38374,Malignant Cellular Infiltrate,Stage I Distal Bile Duct Cancer AJCC v8,1
38375,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,1
38376,Epithelial Component Present,Vaginal cancer recurrent,1
38377,Microfollicular Structures Present,Ovarian gynandroblastoma,1
38378,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ciliary body,1
38379,Indolent Clinical Course,Lung Myoepithelioma,1
38380,Benign Cellular Infiltrate,Benign digestive system neoplasms,1
38381,Cutaneous Involvement,Lymphangioleiomyomatosis of skin,1
38382,Epithelial Component Present,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
38383,Epithelial Component Present,Intestinal Neuroendocrine Neoplasm,1
38384,Epithelial Component Present,large cell neuroendocrine carcinoma of lung,1
38385,Severe dysplasia,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
38386,Carcinomatous Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7,1
38387,Carcinomatous Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
38388,Childhood Lesion,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
38389,Carcinomatous Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
38390,Multihormonal Immunoreactivity Present,Monomorphous Plurihormonal Pituitary Gland Adenoma,1
38391,Malignant Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v7,1
38392,Papillary Pattern,Ethmoid Sinus Schneiderian Papilloma,1
38393,Bone Marrow and Blood Involvement,Refractory Burkitt Leukemia,1
38394,Epithelial Component Present,clear cell adenocarcinoma of urethra,1
38395,Metastatic Lesion,Metastatic malignant neoplasm to brain,1
38396,Rapidly Enlarging Mass,Vulvar Keratoacanthoma,1
38397,Dilated Terminal Duct Lobular Units Present,Columnar Cell Hyperplasia of the Breast,1
38398,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
38399,Mixed Cellular Population,Malignant Vulvar Phyllodes Tumor,1
38400,Recurrent disease,Recurrent Grade 2 Follicular Lymphoma,1
38401,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,1
38402,Epithelial Component Present,Stage IIIA Gastric Carcinoma,1
38403,Malignant Cellular Infiltrate,Secondary malignant neoplasm of prostate,1
38404,Carcinomatous Component Present,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
38405,Indolent Clinical Course,Uterine Fibroids,1
38406,Epithelial Component Present,Cloacogenic carcinoma,1
38407,Localized Lesion,Solitary Osseous Plasmacytoma,1
38408,Childhood Lesion,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement,1
38409,Ground Glass Nuclear Inclusion,Atypical follicular adenoma,1
38410,Papillary Pattern,Squamous Papilloma of the Larynx,1
38411,Eccrine Differentiation,Malignant Eccrine Neoplasm,1
38412,Carcinomatous Component Present,Stage III Lung Cancer AJCC v8,1
38413,Desmoplastic Stroma Formation,Recurrent Desmoplastic Small Round Cell Tumor,1
38414,Cutaneous Involvement,basal cell carcinoma of scrotum,1
38415,Malignant Cellular Infiltrate,Sarcoma of skin,1
38416,Prominent Intraductal Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,1
38417,Epithelial Component Present,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
38418,Neuroendocrine Differentiation,Sympathetic paraganglioma,1
38419,Osseous Differentiation,Stage IA Osteosarcoma AJCC v7,1
38420,Benign Cellular Infiltrate,Vulvar Angiomyxoma,1
38421,Malignant Cellular Infiltrate,Stage IVB Colon Cancer AJCC v7,1
38422,Schwannian Stroma More than 50 Percent of the Tumor Volume,Childhood Ganglioneuroblastoma,1
38423,Perivascular fibrosis,Grade I Nodular Sclerosis Hodgkin's Lymphoma,1
38424,Carcinomatous Component Present,Stage IVC Rectal Cancer AJCC v8,1
38425,Chromogranin A Positive Neoplastic Cells Present,Carcinoid Tumor,1
38426,Epithelial Component Present,Anatomic Stage IIA Breast Cancer AJCC v8,1
38427,Intermediate Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2,1
38428,Epithelial Component Present,Stage III Adrenal Cortex Carcinoma AJCC v7,1
38429,Increased Cellularity Present,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
38430,Cutaneous Involvement,Primary Cutaneous Intravascular Large B-Cell Lymphoma,1
38431,Benign Cellular Infiltrate,Benign neoplasm of oropharynx,1
38432,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v8 Stage,1
38433,atypia morphology,Atypical adenomatous hyperplasia,1
38434,Thin-Walled Branching Vascular Pattern,Thyroid Gland Solitary Fibrous Tumor,1
38435,Epithelial Component Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
38436,Localized Lesion,Chest Wall Solitary Plasmacytoma,1
38437,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia,1
38438,Carcinomatous Component Present,Adenocarcinoma of appendix,1
38439,Indolent Clinical Course,Bizarre parosteal osteochondromatous proliferation,1
38440,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage IV,1
38441,Neuroendocrine Differentiation,Primary malignant neoplasm of glomus jugulare,1
38442,Necrotic changes (finding),Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
38443,Well-Circumscribed Lesion,Hemangioblastoma,1
38444,Cutaneous Involvement,Hidroacanthoma simplex,1
38445,Recurrent disease,Recurrent Childhood Fibrillary Astrocytoma,1
38446,Low Mitotic Activity,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
38447,Recurrent disease,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",1
38448,Cystic Change,Telangiectatic osteosarcoma,1
38449,Well-Circumscribed Lesion,Large Bowel Juvenile Polyp,1
38450,Malignant Cellular Infiltrate,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
38451,Epithelial Component Present,canalicular adenoma of salivary gland,1
38452,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma stage II,1
38453,Epithelial Component Present,Metastatic Breast Carcinoma,1
38454,Malignant Cellular Infiltrate,Salivary Gland Myoepithelial Carcinoma,1
38455,Low Grade Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,1
38456,Invasive Lesion,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
38457,Fibrotic Stroma Formation,Stage III Intrahepatic Cholangiocarcinoma AJCC v8,1
38458,Childhood Lesion,Extrarenal Rhabdoid Tumor of the Liver,1
38459,Clinical TNM Finding,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
38460,Carcinomatous Component Present,Duodenal carcinoma recurrent,1
38461,High Grade Lesion,Adult Glioblastoma,1
38462,Malignant Cellular Infiltrate,Stage II Bone Sarcoma AJCC v7,1
38463,Adulthood Lesion,Refractory Indolent Adult Non-Hodgkin Lymphoma,1
38464,Refractory Disease,Refractory Anal Carcinoma,1
38465,Capillary Sized Vascular Channel Formation,Histiocytoid hemangioma,1
38466,Epithelial Component Present,Stage II Lip Basal Cell Carcinoma,1
38467,Benign Cellular Infiltrate,Inverting papilloma of the nasal cavity,1
38468,Low Mitotic Activity,Glucagonoma,1
38469,Neuroendocrine Differentiation,Neuroendocrine neoplasm of gallbladder,1
38470,Benign Cellular Infiltrate,Atypical polypoid adenomyoma,1
38471,Carcinomatous Component Present,Crohn Disease-Associated Colorectal Adenocarcinoma,1
38472,Breast Microcalcification,Recurrent Childhood Oligodendroglioma,1
38473,Carcinomatous Component Present,Metastatic Esophageal Carcinoma,1
38474,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I,1
38475,Epithelial Component Present,Biliary Intraepithelial Neoplasia-1,1
38476,Favorable Clinical Outcome,Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm,1
38477,Well-Circumscribed Lesion,Flat adenoma,1
38478,Epithelial Component Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",1
38479,Epithelial Component Present,Mixed epithelial tumor of ovary,1
38480,Castration Resistance,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
38481,Intravascular Fibrin Thrombus Formation,Angiolipoma,1
38482,Dysplasia,High Grade Ductal Breast Carcinoma In Situ,1
38483,Histiocytosis,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
38484,Epithelial Component Present,Bowen's Disease,1
38485,Neuroendocrine Differentiation,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,1
38486,Carcinomatous Component Present,Stage IVB Vulvar Cancer AJCC v8,1
38487,Hyperplastic Tissue Present,Mesonephric Hyperplasia,1
38488,Malignant Cellular Infiltrate,Distal Esophagus Squamous Cell Carcinoma,1
38489,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Ductal Adenocarcinoma,1
38490,Malignant Cellular Infiltrate,Stage IIA Bone Sarcoma AJCC v7,1
38491,Benign Cellular Infiltrate,Intravascular fasciitis,1
38492,Benign Cellular Infiltrate,Juxtaglomerular tumor,1
38493,Neuroendocrine Differentiation,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
38494,Malignant Cellular Infiltrate,Unresectable Leiomyosarcoma,1
38495,Tubular Pattern,Lactating adenoma,1
38496,Epithelial Component Present,Carcinoma of subglottis,1
38497,Recurrent disease,Recurrent Childhood Giant Cell Glioblastoma,1
38498,Malignant Cellular Infiltrate,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
38499,Cystic Change,Pancreatic Acinar Cell Cystadenoma,1
38500,Pseudoencapsulated Mass,High Grade Malignant Peripheral Nerve Sheath Tumor,1
38501,Malignant Cellular Infiltrate,Intermediate Cell Type Uveal Melanoma,1
38502,Malignant Cellular Infiltrate,Acute myeloid leukemia refractory,1
38503,Malignant Cellular Infiltrate,Metastatic Rectal Carcinoma,1
38504,Epithelial Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v8,1
38505,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage IV,1
38506,Cartilaginous Differentiation,Childhood Mesenchymal Chondrosarcoma,1
38507,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
38508,Secondary Lesion,Metastatic Ewing's Sarcoma,1
38509,Epithelial Component Present,Adenocarcinoma in adenomatous polyposis coli,1
38510,Metastatic/Recurrent Disease,Malignant Lung PEComa,1
38511,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Chronic Neutrophilic Leukemia,1
38512,Carcinomatous Component Present,Human Papillomavirus-Related Carcinoma,1
38513,Hemorrhagic,Ovarian Angiosarcoma,1
38514,Hemorrhagic,Recurrent Breast Angiosarcoma,1
38515,Malignant Cellular Infiltrate,Locally Recurrent Malignant Neoplasm,1
38516,Regional Disease,Locally Advanced Urothelial Carcinoma,1
38517,Malignant Cellular Infiltrate,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
38518,Epithelial Component Present,Synchronous Bilateral Breast Carcinoma,1
38519,Malignant Cellular Infiltrate,Basal cell carcinoma,1
38520,Exophytic Polypoid Lesion,Gastric Hamartoma,1
38521,Cutaneous Involvement,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
38522,Carcinomatous Component Present,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
38523,Epithelial Component Present,Cervical Esophagus Squamous Cell Carcinoma,1
38524,Carcinomatous Component Present,Anal squamous cell carcinoma,1
38525,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma,1
38526,Malignant Cellular Infiltrate,Stage IV Childhood Non-Hodgkin Lymphoma,1
38527,Papillary Pattern,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
38528,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Adenocarcinoma, endocervical type",1
38529,Fever,Multi-centric Castleman's Disease,1
38530,Epithelial Component Present,Bladder squamous cell carcinoma stage I,1
38531,Malignant Cellular Infiltrate,Refractory Melanoma,1
38532,Metastatic Lesion,Metastatic Renal Cell Carcinoma,1
38533,Malignant Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
38534,Osseous Differentiation,Breast Extraskeletal Osteosarcoma,1
38535,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
38536,Severe dysplasia,Intraductal Cribriform Breast Adenocarcinoma,1
38537,Malignant Cellular Infiltrate,Labia Minora Carcinoma,1
38538,Malignant Cellular Infiltrate,Fallopian Tube Serous Adenocarcinoma,1
38539,Carcinomatous Component Present,undifferentiated carcinoma of larynx,1
38540,Malignant Cellular Infiltrate,Refractory Malignant Testicular Germ Cell Tumor,1
38541,Epithelial Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
38542,Carcinomatous Component Present,Cervical Squamotransitional Carcinoma,1
38543,Recurrent disease,Recurrent Primary Peritoneal Serous Adenocarcinoma,1
38544,Metastatic/Recurrent Disease,Lung Biphasic Synovial Sarcoma,1
38545,Epithelial Component Present,Adenoma of small intestine,1
38546,Indolent Clinical Course,Thyroid Gland Cavernous Hemangioma,1
38547,Infiltrating Tumor Margins Present,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
38548,Malignant Cellular Infiltrate,Granulomatous slack skin disease,1
38549,Carcinomatous Component Present,Anterior Tongue Squamous Cell Carcinoma,1
38550,Secondary Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
38551,Malignant Cellular Infiltrate,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
38552,Low Mitotic Activity,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,1
38553,Malignant Cellular Infiltrate,Stage IA2 Cervical Cancer AJCC v8,1
38554,White blood cell count increased (lab result),"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
38555,Epithelial Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
38556,Malignant Cellular Infiltrate,Sarcoma of soft tissue,1
38557,Malignant Cellular Infiltrate,Stage I Carcinoma of Penis,1
38558,Malignant Cellular Infiltrate,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
38559,Malignant Cellular Infiltrate,Solid Lung Adenocarcinoma,1
38560,Cutaneous Involvement,Ceruminous Neoplasm,1
38561,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
38562,Epithelial Component Present,Early gastric cancer,1
38563,Low Mitotic Activity,Recurrent Digestive System Neuroendocrine Tumor G1,1
38564,Cutaneous Involvement,Radiation-Recall Dermatitis,1
38565,Carcinomatous Component Present,Lung Lymphoepithelioma-Like Carcinoma,1
38566,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
38567,Epithelial Component Present,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
38568,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
38569,Glandular Pattern,Lung Enteric Adenocarcinoma,1
38570,Single Cell Necrosis,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
38571,Extensive Stage Lesion,Uveal Melanoma Metastatic in the Liver,1
38572,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction,1
38573,CD30-Positive Neoplastic Cells Present,Stage III Anaplastic Large Cell Lymphoma,1
38574,Epithelial Component Present,Distal Esophagus Adenocarcinoma,1
38575,Childhood Lesion,Childhood Yolk Sac Tumor,1
38576,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v8,1
38577,Malignant Cellular Infiltrate,Refractory High Risk Myelodysplastic Syndrome,1
38578,Carcinomatous Component Present,Prostate cancer stage A,1
38579,Well-Circumscribed Lesion,Villous adenoma of colon,1
38580,Vascular Channel Formation,Mediastinal Lymphangioma,1
38581,Cutaneous Involvement,Dermatophytosis,1
38582,Secondary Lesion,carcinoma ex pleomorphic adenoma of salivary gland,1
38583,Recurrent disease,Recurrent Childhood Lymphomatoid Granulomatosis,1
38584,Multinodular Mass,Conventional Angiosarcoma,1
38585,Cutaneous Involvement,Pilar-Associated Mesenchyme Neoplasm,1
38586,Benign Cellular Infiltrate,Benign neoplasm of oropharynx,1
38587,Metastatic Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
38588,Vascular Channel Formation,Infantile hemangioma,1
38589,Hypercellular bone marrow,Chronic eosinophilic leukemia,1
38590,Refractory Disease,Refractory Neuroblastoma,1
38591,Tall Papillae Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",1
38592,Chromogranin A Positive Neoplastic Cells Present,Transverse Colon Neuroendocrine Tumor G1,1
38593,Dysplasia,Low Grade Esophageal Squamous Intraepithelial Neoplasia,1
38594,Dysplasia,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
38595,Epithelial Component Present,NUT midline carcinoma,1
38596,Mixed Cellular Population,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
38597,Pseudoglandular Pattern,Childhood Central Nervous System Embryonal Carcinoma,1
38598,Metastatic Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
38599,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v8 Stage,1
38600,Finding related to pregnancy,Hodgkin Lymphoma During Pregnancy,1
38601,Hyperkeratosis,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
38602,Epithelial Component Present,Stage IB Breast Cancer AJCC v7,1
38603,Carcinomatous Component Present,basaloid carcinoma of anus,1
38604,Cutaneous Involvement,Melanocytic tumor of skin,1
38605,Vascular Channel Formation with Muscular Walls,Glomangiomyoma,1
38606,Epithelial Component Present,Carcinoma of submandibular gland,1
38607,Calcitonin Positive Neoplastic Cells Present,Medullary carcinoma of thyroid,1
38608,Epithelial Component Present,Recurrent Thyroid Gland Follicular Carcinoma,1
38609,Dysplasia,Pancreatic intraepithelial neoplasia,1
38610,Malignant Cellular Infiltrate,Anatomic Stage III Breast Cancer AJCC v8,1
38611,Infiltrative Growth Pattern,Diffuse Astrocytoma,1
38612,Carcinomatous Component Present,Acinar cell carcinoma of pancreas,1
38613,Malignant Cellular Infiltrate,Liposarcoma non-metastatic,1
38614,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma,1
38615,Malignant Cellular Infiltrate,Malignant tumor of palate,1
38616,Carcinomatous Component Present,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
38617,Malignant Cellular Infiltrate,Stage IV Adult Liver Cancer AJCC v7,1
38618,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage III,1
38619,Unresectable Mass,Small intestine carcinoma non-resectable,1
38620,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
38621,Malignant Cellular Infiltrate,Endometrioid carcinoma ovary,1
38622,Cutaneous Involvement,Bullous pemphigoid,1
38623,Nuclear pleomorphism,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
38624,Low Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
38625,Pseudoencapsulated Mass,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
38626,Epithelial Component Present,Metastatic Vulvar Carcinoma,1
38627,Intermediate Grade Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor G2,1
38628,Pathologic TNM Finding,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
38629,Malignant Cellular Infiltrate,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
38630,Epithelial Component Present,Breast Carcinoma with Osteoclastic Giant Cells,1
38631,Malignant Cellular Infiltrate,MGMT-Unmethylated Glioblastoma,1
38632,Intraductal Lesion,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
38633,Metastatic Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
38634,Well Differentiated Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
38635,Secondary Lesion,Locally Advanced Unresectable Sarcoma,1
38636,Mild cytologic atypia,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
38637,Anaplasia,Glioblastoma by Gene Expression Profile,1
38638,Neuroendocrine Differentiation,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
38639,Carcinomatous Component Present,Stage II Ampulla of Vater Cancer AJCC v8,1
38640,Epithelial Component Present,Childhood Choroid Plexus Neoplasm,1
38641,Syncytial Pattern,Medullary carcinoma of breast,1
38642,Solitary mass,Childhood Epithelioid Hemangioendothelioma,1
38643,Vascular Channel Formation,Lymphangioma,1
38644,Vascular Channel Formation,Hemangioma of liver,1
38645,Metastatic Lesion,Pancreatic adenocarcinoma metastatic,1
38646,Epithelial Component Present,Grade II Glandular Intraepithelial Neoplasia,1
38647,Mitotic Activity,Proneural Glioblastoma,1
38648,Benign Cellular Infiltrate,Cavernous hemangioma of retina,1
38649,Diffuse Pattern,Recurrent Giant Cell Glioblastoma,1
38650,Secondary Lesion,Pseudomyxoma Peritonei,1
38651,Cutaneous Involvement,Vulvar Merkel Cell Carcinoma,1
38652,Malignant Cellular Infiltrate,Adenocarcinoma of rectum,1
38653,Lymphoplasmacytic Infiltrate,Cervical Lymphoepithelioma-Like Carcinoma,1
38654,Tissue Differentiation Uncertain,Extrarenal Rhabdoid Tumor of the Liver,1
38655,Thin-Walled Branching Vascular Pattern,Thyroid Gland Solitary Fibrous Tumor,1
38656,Oligodendroglial Component Present,Childhood Anaplastic Oligoastrocytoma,1
38657,Malignant Cellular Infiltrate,Thymic Small Cell Carcinoma,1
38658,Neuroectodermal Differentiation,Sellar Neuroblastoma,1
38659,Local disease,Tonsillar Lipoma,1
38660,No Identifiable Line of Differentiation,Malignant Fibrous Histiocytoma,1
38661,Pregnancy Complications,Gestational Trophoblastic Tumor by AJCC v7 Stage,1
38662,Malignant Cellular Infiltrate,Cutaneous Follicular Lymphoma,1
38663,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage III,1
38664,Carcinomatous Component Present,Pathologic Stage IIA Gastric Cancer AJCC v8,1
38665,Indolent Clinical Course,Myoma,1
38666,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
38667,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Ovarian Immature Teratoma,1
38668,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
38669,Epithelial Component Present,Ovarian Tumor of the Thecoma/Fibroma Group,1
38670,Epithelial Component Present,Breast Pleomorphic Adenoma,1
38671,Collagenous Stroma Formation,Desmoplastic fibroma,1
38672,Malignant Cellular Infiltrate,Stage I Immature Testicular Teratoma AJCC v6 and v7,1
38673,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Acute Monocytic Leukemia,1
38674,Malignant Cellular Infiltrate,Occult Lung Adenocarcinoma,1
38675,Malignant Cellular Infiltrate,Refractory Hematologic Malignancy,1
38676,Encapsulated Mass,Clear cell papillary renal cell carcinoma,1
38677,Epithelial Component Present,Stage IA Eyelid Carcinoma AJCC v8,1
38678,Malignant Cellular Infiltrate,Ameloblastic fibrosarcoma,1
38679,Multilocular Lesion,Peritoneal cystic mesothelioma,1
38680,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,1
38681,Malignant Cellular Infiltrate,Osteosarcoma localised,1
38682,Malignant Cellular Infiltrate,"Mucinous adenocarcinoma, endocervical type",1
38683,Malignant Cellular Infiltrate,Small intestine carcinoma metastatic,1
38684,Epithelial Component Present,Stage IV Major Salivary Gland Carcinoma with Metastasis,1
38685,Carcinomatous Component Present,cloacogenic carcinoma of rectum,1
38686,Malignant Cellular Infiltrate,adenocarcinoma of middle ear,1
38687,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Yolk Sac Tumor,1
38688,Cystic Change,Cystic Neoplasm,1
38689,Adnexal Differentiation,Follicular Myxoma,1
38690,Lymphoplasmacytic Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
38691,Diffuse Pattern,Adult Glioblastoma,1
38692,Malignant Cellular Infiltrate,small cell carcinoma of gallbladder,1
38693,Single Cell Necrosis,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
38694,Unresectable Mass,Unresectable Gastric Adenocarcinoma,1
38695,Benign Cellular Infiltrate,Benign Fibroblastic Neoplasm,1
38696,Epithelial Component Present,Breast Columnar Cell Mucinous Carcinoma,1
38697,Well Differentiated Lesion,"Retinoblastoma, differentiated",1
38698,Mixed Cellular Population,Malignant Phyllodes Tumor of Prostate,1
38699,Intraosseous Lesion,Odontogenic myxoma,1
38700,Epithelial Component Present,Stage III Gallbladder Cancer AJCC v7,1
38701,Epithelial Component Present,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
38702,Adulthood Lesion,Recurrent Adult Soft Tissue Sarcoma,1
38703,Osseous Differentiation,Metastatic osteosarcoma,1
38704,Malignant Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
38705,Tissue Differentiation Uncertain,Synovial sarcoma recurrent,1
38706,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
38707,Anaplasia,alk-positive anaplastic large cell lymphoma,1
38708,Refractory Disease,Refractory Erdheim-Chester Disease,1
38709,Cutaneous Involvement,Skin Signet Ring Cell Basal Cell Carcinoma,1
38710,Cystic Change,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
38711,Recurrent disease,Recurrent Fibrosarcoma,1
38712,Lobulated Growth Pattern,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
38713,Carcinomatous Component Present,Stage IIIA Lung Cancer AJCC v7,1
38714,Indolent Clinical Course,Cerebral Hemisphere Lipoma,1
38715,Epithelial Component Present,Thyrotroph adenoma,1
38716,Malignant Cellular Infiltrate,Sarcoma NCI Grade 2,1
38717,Epithelial Component Present,Anaplastic adrenocortical carcinoma,1
38718,Metastatic Lesion,Prostate Carcinoma Metastatic in the Lung,1
38719,Malignant Cellular Infiltrate,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
38720,Epithelial Component Present,Transplant-Related Hepatocellular Carcinoma,1
38721,Chromogranin A Positive Neoplastic Cells Present,Metastatic Breast Carcinoid Tumor,1
38722,Carcinomatous Component Present,Large cell lung cancer stage IV,1
38723,Primary Lesion,Alveolar soft part sarcoma non-metastatic,1
38724,Absence of Stromal Invasion,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
38725,Low Mitotic Activity,Glucagonoma,1
38726,Cutaneous Involvement,"Connective tissue nevus, NOS",1
38727,Malignant Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v7,1
38728,Carcinomatous Component Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,1
38729,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with excess blasts II,1
38730,Absence of Invasion,Biliary Intraepithelial Neoplasia-3,1
38731,Malignant Cellular Infiltrate,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
38732,Malignant Cellular Infiltrate,Uterine Corpus Choriocarcinoma,1
38733,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v7,1
38734,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage IV,1
38735,Epithelial Component Present,"Carcinoma, Granular Cell",1
38736,Malignant Cellular Infiltrate,Grade 1 Endometrial Mucinous Adenocarcinoma,1
38737,Carcinomatous Component Present,Pathologic Stage IIIA Gastric Cancer AJCC v8,1
38738,Endophytic Tumor Growth,Laryngeal verrucous carcinoma recurrent,1
38739,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis,1
38740,Epithelial Component Present,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
38741,Recurrent disease,Recurrent Childhood Gemistocytic Astrocytoma,1
38742,Childhood Lesion,Recurrent Childhood Lymphoblastic Lymphoma,1
38743,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Skin Squamous Cell Carcinoma,1
38744,Cutaneous Involvement,Apocrine adenoma,1
38745,Benign Cellular Infiltrate,Fallopian tube leiomyoma,1
38746,Malignant Cellular Infiltrate,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
38747,Malignant Cellular Infiltrate,adenocarcinoma of extrahepatic bile duct,1
38748,Keratin pearl formation,Clear cell squamous cell carcinoma of skin,1
38749,Papillary Pattern,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
38750,Bone Marrow Dysplasia Present,Refractory anemia with excess blasts II,1
38751,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v8,1
38752,Cutaneous Involvement,Hepatoerythropoietic Porphyria,1
38753,Malignant Cellular Infiltrate,Parotid Gland Adenocarcinoma,1
38754,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
38755,Malignant Cellular Infiltrate,Breast Columnar Cell Mucinous Carcinoma,1
38756,Secondary Lesion,Metastatic Lung Adenocarcinoma,1
38757,Vascular Channel Formation,Mediastinal Angiosarcoma,1
38758,Extensive Stage Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
38759,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Polyembryoma AJCC v6 and v7,1
38760,Severe dysplasia,Stage 0is Ureter Cancer AJCC v7,1
38761,Cutaneous Involvement,Diaper candidiasis,1
38762,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage IV,1
38763,Well-Circumscribed Lesion,Fundic gland polyp,1
38764,Carcinomatous Component Present,Hepatic cancer metastatic,1
38765,Inflammatory infiltrate,Fibrous histiocytoma of tendon sheath,1
38766,Epithelial Component Present,Recurrent Pancreatic Cystadenocarcinoma,1
38767,Carcinomatous Component Present,Locally Advanced Unresectable Basal Cell Carcinoma,1
38768,Malignant Cellular Infiltrate,Prostate cancer stage B,1
38769,Adnexal Differentiation,Apocrine cystadenoma,1
38770,Acral Lesion,Primary cutaneous acral CD8 positive T-cell lymphoma,1
38771,Carcinomatous Component Present,Mucinous carcinoma of breast,1
38772,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",1
38773,Epithelial Component Present,"Adenocarcinoma, metastatic",1
38774,Malignant Cellular Infiltrate,Colon Serrated Adenocarcinoma,1
38775,Cutaneous Involvement,Eccrine hidrocystoma,1
38776,Dysplasia,Filiform Serrated Adenoma,1
38777,Malignant Cellular Infiltrate,Bladder Enteric Type Adenocarcinoma,1
38778,"Fully Differentiated ""Adult-Type"" Tissues Present",Testicular Dermoid Cyst,1
38779,Childhood Lesion,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,1
38780,Malignant Cellular Infiltrate,Unresectable Digestive System Adenocarcinoma,1
38781,Thick-Walled Hyalinized Vessels Present,Sellar Schwannoma,1
38782,Storiform Growth Pattern,"Histiocytoma, Benign Fibrous",1
38783,In Situ Lesion,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
38784,Necrotic changes (finding),"Perineurioma, malignant",1
38785,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis,1
38786,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma,1
38787,Neuroendocrine Differentiation,Pancreatic Small Cell Neuroendocrine Carcinoma,1
38788,Nodular Pattern,Ovarian Myxoid Liposarcoma,1
38789,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
38790,Carcinomatous Component Present,Stage III Bladder Cancer AJCC v8,1
38791,Malignant Cellular Infiltrate,Laryngeal Basaloid Carcinoma,1
38792,Multifocal Lesion,Lymphangioleiomyomatosis,1
38793,Epithelial Component Present,Recurrent Thyroid Gland Follicular Carcinoma,1
38794,Cribriform Pattern,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
38795,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
38796,Malignant Cellular Infiltrate,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
38797,Malignant Cellular Infiltrate,Extraskeletal Myxoid Chondrosarcoma,1
38798,Recurrent disease,Recurrent tumors of the Ewing's family,1
38799,Benign Cellular Infiltrate,Parathyroid Gland Lipoadenoma,1
38800,Epithelial Component Present,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,1
38801,Cutaneous Involvement,Locally Advanced Skin Squamous Cell Carcinoma,1
38802,Diffuse Pattern,Centroblastic lymphoma refractory,1
38803,Malignant Cellular Infiltrate,Colorectal Leiomyosarcoma,1
38804,Chromogranin A Positive Neoplastic Cells Present,Laryngeal Carcinoid Tumor,1
38805,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,1
38806,Malignant Cellular Infiltrate,Stage IIIB Gallbladder Cancer AJCC v8,1
38807,Increased Cellularity Present,Childhood Anaplastic Oligoastrocytoma,1
38808,Perineural spread,Desmoplastic Neurotropic Melanoma,1
38809,Human Papillomavirus Negative,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
38810,Recurrent disease,Recurrent Neurofibromatosis Type 1,1
38811,More than 10 Mitoses per 10HPF,Stage III Lung Small Cell Carcinoma AJCC v7,1
38812,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
38813,Epithelial Component Present,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
38814,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
38815,Carcinomatous Component Present,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8,1
38816,Well-Circumscribed Lesion,Cervical Fibroepithelial Polyp,1
38817,Carcinomatous Component Present,Stage IIIB Adult Liver Cancer AJCC v7,1
38818,S-100-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis of skin,1
38819,Benign Cellular Infiltrate,Gingival Angiofibroma,1
38820,Malignant Cellular Infiltrate,Intermediate Cell Type Uveal Melanoma,1
38821,Malignant Cellular Infiltrate,Malignant Mediastinal Soft Tissue Neoplasm,1
38822,Increased Cellularity Present,Kadish Stage C Olfactory Neuroblastoma,1
38823,Epithelial Component Present,Ovarian Serous Adenocarcinoma,1
38824,Epithelial Component Present,Neuroendocrine Tumors,1
38825,Carcinomatous Component Present,Tubulocystic renal cell carcinoma,1
38826,Blasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
38827,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
38828,Indolent Clinical Course,Senile angioma,1
38829,Stromal Invasion,Malignant Ovarian Serous Tumor,1
38830,Carcinomatous Component Present,Acinar Prostate Mucinous Adenocarcinoma,1
38831,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
38832,Secondary Lesion,Secondary malignant neoplasm of bone,1
38833,Low Mitotic Activity,Small Intestinal VIP-Producing Neuroendocrine Tumor,1
38834,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Adult Acute Monocytic Leukemia,1
38835,Diffuse Pattern,Diffuse Large B-Cell Lymphoma,1
38836,Primary Lesion,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
38837,Metastatic Lesion,Secondary Heart Lymphoma,1
38838,Cutaneous Involvement,Skin Signet Ring Cell Basal Cell Carcinoma,1
38839,Nuclear Molding,Stage IB Lung Small Cell Carcinoma AJCC v7,1
38840,Childhood Lesion,Hepatoblastoma non-resectable,1
38841,Benign Cellular Infiltrate,Benign neoplasm of bladder,1
38842,Exophytic Polypoid Lesion,Vaginal Villous Adenoma,1
38843,Epithelial Component Present,Hepatic cancer metastatic,1
38844,Malignant Cellular Infiltrate,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
38845,Epithelial Component Present,Non-Invasive Urothelial Neoplasm,1
38846,Carcinomatous Component Present,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7,1
38847,Hyperkeratosis,Verrucous carcinoma of oral cavity,1
38848,Neuroendocrine Differentiation,Foregut Carcinoid Tumor,1
38849,Carcinomatous Component Present,Metastatic Thyroid Gland Follicular Carcinoma,1
38850,Nuclear Molding,Stage IA Lung Small Cell Carcinoma AJCC v7,1
38851,Mixed Cellular Population,Stage IV Kidney Wilms Tumor,1
38852,Cysts Containing Proteinaceous Fluid Present,"Cystadenocarcinoma, Serous",1
38853,Severe cytologic atypia,Anaplastic Embryonal Rhabdomyosarcoma,1
38854,Malignant Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma,1
38855,Malignant Cellular Infiltrate,Renal medullary carcinoma,1
38856,Borderline Lesion,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
38857,Well-Circumscribed Lesion,Mediastinal Chondroma,1
38858,Antoni A Pattern,Schwannomatosis,1
38859,Monoclonal Paraproteinemia,Indolent multiple myeloma,1
38860,Malignant Cellular Infiltrate,Metastatic Genitourinary System Carcinoma,1
38861,Carcinomatous Component Present,"Transitional cell carcinoma, spindle cell",1
38862,Neuroectodermal Differentiation,Olfactory Neuroblastoma,1
38863,Secondary Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
38864,Local disease,Rectal Lipoma,1
38865,Indolent Clinical Course,Squamous odontogenic tumor,1
38866,Benign Cellular Infiltrate,"Nevus, Spindle Cell",1
38867,High Mitotic Activity,Endometrial Small Cell Carcinoma,1
38868,Carcinomatous Component Present,Bladder adenocarcinoma recurrent,1
38869,Malignant Cellular Infiltrate,Childhood Malignant Liver Neoplasm,1
38870,Extraocular Dissemination of Disease,Ocular Melanoma with Extraocular Extension,1
38871,Benign Cellular Infiltrate,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
38872,Malignant Cellular Infiltrate,Bile duct adenocarcinoma resectable,1
38873,Epithelial Component Present,Stage IVC Paranasal Sinus Cancer AJCC v7,1
38874,Well-Circumscribed Lesion,Mucinous cystadenoma of ovary,1
38875,Indolent Clinical Course,Benign neoplasm of oral cavity,1
38876,Epithelial Component Present,Prostatic Urethra Urothelial Carcinoma,1
38877,Epithelial Component Present,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7,1
38878,Well Differentiated Lesion,"Lung Squamous Cell Carcinoma, Papillary Variant",1
38879,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Neoplasm,1
38880,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
38881,Epithelial Component Present,Refractory Thyroid Gland Carcinoma,1
38882,Immunologic Deficiency Syndromes,Steroid Refractory Graft Versus Host Disease,1
38883,Stromal Invasion,FIGO Stage III Ovarian Cancer,1
38884,Malignant Cellular Infiltrate,High Grade Salivary Gland Carcinoma,1
38885,Hemorrhagic,Metastatic angiosarcoma,1
38886,Malignant Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia,1
38887,Thick-Walled Hyalinized Vessels Present,Benign Cardiac Schwannoma,1
38888,Indolent Clinical Course,Kidney Fibroma,1
38889,Carcinomatous Component Present,Stage I Pancreatic Cancer AJCC v6 and v7,1
38890,Severe dysplasia,Carcinoma in situ of prostate,1
38891,Lobulated Growth Pattern,Sellar Chondroid Chordoma,1
38892,Recurrent disease,Recurrent Pancreatic Ductal Adenocarcinoma,1
38893,Epithelial Component Present,Hormone Receptor Positive Breast Carcinoma,1
38894,Recurrent disease,Adult T-cell lymphoma/leukemia recurrent,1
38895,Epithelial Component Present,Metastatic Cervical Carcinoma,1
38896,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Mixed Germ Cell Tumor,1
38897,Malignant Cellular Infiltrate,Locally Advanced Gastrointestinal Stromal Tumor,1
38898,Myxoid Stroma Formation,Conventional Extraskeletal Myxoid Chondrosarcoma,1
38899,Epithelial Component Present,Bladder adenocarcinoma recurrent,1
38900,Malignant Cellular Infiltrate,Invasive Breast Carcinoma by Histologic Grade,1
38901,Diffuse Pattern,Glioblastoma multiforme of spinal cord,1
38902,Childhood Lesion,Recurrent Childhood Gliomatosis Cerebri,1
38903,Indolent Clinical Course,Esophageal hemangioma,1
38904,Hyperkeratosis,inverted follicular keratosis,1
38905,Well-Circumscribed Lesion,Phyllodes Tumor,1
38906,Primary Lesion,Hepatocellular Carcinoma by AJCC v8 Stage,1
38907,Carcinomatous Component Present,Colorectal Undifferentiated Carcinoma,1
38908,Indolent Clinical Course,Vaginal Myofibroblastoma,1
38909,Malignant Cellular Infiltrate,pineoblastoma,1
38910,Cellular Pleomorphism,Malignant fibrous histiocytoma metastatic,1
38911,Focal dysplasia,Rectal Sessile Serrated Adenoma/Polyp,1
38912,Malignant Cellular Infiltrate,Secondary malignant neoplasm of parathyroid gland,1
38913,Benign Cellular Infiltrate,mediastinal lipomatosis,1
38914,Well Differentiated Neuroendocrine Lesion,Ileal Neuroendocrine Tumor by AJCC v8 Stage,1
38915,Malignant Cellular Infiltrate,Carcinosarcoma of cervix uteri,1
38916,Tissue of Mullerian Origin Present,Ovarian Adenosarcoma,1
38917,Well Differentiated Hyaline Cartilage Present,Adult Mesenchymal Chondrosarcoma,1
38918,atypia morphology,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
38919,Childhood Lesion,Childhood Alveolar Rhabdomyosarcoma,1
38920,Malignant Cellular Infiltrate,"Hepatocellular carcinoma, scirrhous",1
38921,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
38922,Epithelial Component Present,Stage IVC Pharyngeal Carcinoma,1
38923,Capillary Sized Vascular Channel Formation,Histiocytoid hemangioma,1
38924,Exophytic Polypoid Lesion,Polyp of vocal cord,1
38925,Moderate dysplasia,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
38926,Carcinomatous Component Present,Rectal Micropapillary Adenocarcinoma,1
38927,Epithelial Component Present,Carcinoma of lower gum,1
38928,Indolent Clinical Course,Hemangioma of subcutaneous tissue,1
38929,Carcinomatous Component Present,Breast Carcinoma with Osteoclastic Giant Cells,1
38930,Cutaneous Involvement,Non-Neoplastic Skin Disorder,1
38931,Nested Pattern,Childhood Clear Cell Sarcoma of Soft Parts,1
38932,Carcinomatous Component Present,Bladder squamous cell carcinoma recurrent,1
38933,Perivascular fibrosis,Nodular Sclerosis Classical Hodgkin Lymphoma,1
38934,Carcinomatous Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
38935,Secondary Lesion,Stage IV Esophageal Adenocarcinoma,1
38936,Malignant Cellular Infiltrate,Gastric Cardia Squamous Cell Carcinoma,1
38937,Epithelial Component Present,Adenosquamous cell lung cancer stage IV,1
38938,Carcinomatous Component Present,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
38939,Apocrine metaplasia,Breast Apocrine Adenoma,1
38940,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
38941,Diffuse Pattern,Glioblastoma by Gene Expression Profile,1
38942,Epithelial Component Present,Sex cord stromal tumor of testis,1
38943,Malignant Cellular Infiltrate,Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,1
38944,Recurrent disease,Recurrent Appendix Mucinous Adenocarcinoma,1
38945,In Situ Lesion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
38946,Secondary Lesion,Pancreatic neuroendocrine tumor metastatic,1
38947,Multifocal Lesion,Osteochondromatosis,1
38948,Carcinomatous Component Present,Stage IVA Colorectal Cancer AJCC v7,1
38949,Non-Contiguous Disease,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,1
38950,Epithelial Component Present,Rectal Cancer by AJCC v7 Stage,1
38951,Adnexal Differentiation,Clear cell hidradenoma,1
38952,Mild cytologic atypia,Lower Gingival Verrucous Carcinoma,1
38953,Secondary Lesion,Secondary malignant neoplasm of pericardium,1
38954,Exophytic Polypoid Lesion,Gastric hyperplastic polyp,1
38955,Carcinomatous Component Present,Adenocarcinoma of appendix,1
38956,Increased Cellularity Present,Cellular Ependymoma,1
38957,Malignant Cellular Infiltrate,Stage III Skin Cancer,1
38958,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v7,1
38959,Borderline Lesion,Borderline Ovarian Transitional Cell Tumor,1
38960,Mesenchymal Component Present,Malignant Cystosarcoma Phyllodes,1
38961,Malignant Cellular Infiltrate,Recurrent Aggressive Non-Hodgkin Lymphoma,1
38962,Carcinomatous Component Present,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
38963,Neuroectodermal Differentiation,Stage 2B Neuroblastoma,1
38964,Endophytic Tumor Growth,Plantar Verrucous Skin Carcinoma,1
38965,Absence of Stromal Invasion,Proliferating Brenner Tumor,1
38966,Invasive Lesion,malignant myoepithelioma of breast,1
38967,Tissue Differentiation Uncertain,Clear-Cell Myomelanocytic Tumors,1
38968,Malignant Cellular Infiltrate,"Leukemia, Myelomonocytic, Chronic",1
38969,Epithelial Component Present,Biliary Intraepithelial Neoplasia-1,1
38970,Vascular Channel Formation,Cardiac Kaposi's Sarcoma,1
38971,Malignant Cellular Infiltrate,Pathologic Stage IV Gastric Cancer AJCC v8,1
38972,Neuroendocrine Differentiation,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,1
38973,Recurrent Lymphoma,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
38974,Epithelial Component Present,Skin Basaloid Carcinoma,1
38975,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of lacrimal gland,1
38976,Local disease,Localized Ewing Sarcoma,1
38977,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage II,1
38978,Hereditary Lesion,Gardner Syndrome,1
38979,Papillary Pattern,Inverted Papilloma,1
38980,Syncytial Pattern,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion",1
38981,Childhood Lesion,Childhood Burkitt Lymphoma,1
38982,Nodular Pattern,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
38983,Malignant Cellular Infiltrate,Malignant Skeletal Muscle Neoplasm,1
38984,Carcinomatous Component Present,keratinizing squamous cell carcinoma of nasal cavity,1
38985,Malignant Cellular Infiltrate,Stage IB Lung Cancer AJCC v8,1
38986,Cutaneous Involvement,Unresectable Head and Neck Squamous Cell Carcinoma,1
38987,Monocytosis,Chronic Myelomonocytic Leukemia-1,1
38988,Malignant Cellular Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
38989,Malignant Cellular Infiltrate,Childhood Leiomyosarcoma,1
38990,Tubular Pattern,Colonic tubulovillous adenoma,1
38991,Benign Cellular Infiltrate,Craniopharyngioma,1
38992,Nodular lesions,Giant Cell Tumor of Soft Tissue,1
38993,Mucoid Stroma Formation,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
38994,Villous Pattern,Ampulla of Vater Tubulovillous Adenoma,1
38995,Mixed Cellular Population,Adenosarcoma of cervix uteri,1
38996,Organoid Pattern,Alveolar soft part sarcoma non-metastatic,1
38997,Exophytic Papillary Lesion,Cervical Verrucous Carcinoma,1
38998,Benign Cellular Infiltrate,Benign Anal Granular Cell Tumor,1
38999,Adnexal Differentiation,Trichodiscoma,1
39000,More than 5 Mitoses per 50HPF,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
39001,Malignant Cellular Infiltrate,Childhood Brain Germinoma,1
39002,Epithelial Component Present,Stage IIIB Ampulla of Vater Cancer AJCC v8,1
39003,Monomorphic Cellular Infiltrate,Oropharyngeal Basaloid Carcinoma,1
39004,Antoni B Pattern,Acoustic Neuroma,1
39005,Epithelial Component Present,Squamous cell carcinoma of the parotid gland,1
39006,Carcinomatous Component Present,Anal margin basal cell carcinoma,1
39007,Infiltrative Growth Pattern,Glioblastoma multiforme of spinal cord,1
39008,Epithelial Component Present,Thymoma malignant invasive,1
39009,Epithelial Component Present,Stage II Rectal Cancer AJCC v7,1
39010,Malignant Cellular Infiltrate,Neuroblastic tumors,1
39011,Primary Lesion,Infratentorial Glioblastoma,1
39012,Epithelial Component Present,Schneiderian carcinoma,1
39013,Malignant Cellular Infiltrate,Luminal A Breast Carcinoma,1
39014,Childhood Lesion,Childhood Ovarian Choriocarcinoma,1
39015,Epithelial Component Present,"Papilloma, Squamous Cell",1
39016,Borderline Lesion,Borderline Breast Phyllodes Tumor,1
39017,Malignant Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v7,1
39018,Epithelial Component Present,Recurrent Paraganglioma,1
39019,Primary Lesion,Recurrent Childhood Liver Cancer,1
39020,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,1
39021,Necrotic changes (finding),pleomorphic carcinoma of breast,1
39022,Well-Circumscribed Lesion,Stage IV Kidney Wilms Tumor,1
39023,Epithelial Component Present,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage,1
39024,Well Differentiated Neuroendocrine Lesion,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,1
39025,Malignant Cellular Infiltrate,Malignant Gastric Gastrointestinal Stromal Tumor,1
39026,Carcinomatous Component Present,Cervical Basaloid Carcinoma,1
39027,Epithelial Component Present,Stage IVC Basal Cell Lip Carcinoma,1
39028,Malignant Cellular Infiltrate,Stage II Childhood Burkitt Lymphoma,1
39029,Fibrosis,"Breast Fibrocystic Change, Proliferative Type",1
39030,Monomorphic Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma,1
39031,Epithelial Component Present,Papillary craniopharyngioma,1
39032,Carcinomatous Component Present,Gastric Cancer by AJCC v7 Stage,1
39033,Carcinomatous Component Present,Human Papillomavirus-Related Squamous Cell Carcinoma,1
39034,Rapidly Enlarging Mass,Botryoid-Type Embryonal Rhabdomyosarcoma,1
39035,Benign Cellular Infiltrate,Benign tumor of endocrine gland,1
39036,Adulthood Lesion,Adult Immunoblastic Lymphoma,1
39037,Fibrotic Stroma Formation,Borderline Ovarian Endometrioid Adenofibroma,1
39038,Childhood Lesion,PRETEXT Stage 3 Hepatoblastoma,1
39039,Diffuse Pattern,Refractory Plasmablastic Lymphoma,1
39040,Malignant Cellular Infiltrate,Stage I Skin Cancer,1
39041,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v8,1
39042,Malignant Cellular Infiltrate,Central Nervous System Carcinoma,1
39043,Clinical TNM Finding,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
39044,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Choriocarcinoma,1
39045,Cystic Change,cystadenoma of extrahepatic bile duct,1
39046,Increased Cellularity Present,Sellar Neuroblastoma,1
39047,Epithelial Component Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
39048,Malignant Cellular Infiltrate,ROSE Cluster 1,1
39049,Moderate dysplasia,Squamous intraepithelial neoplasia grade 2,1
39050,Unresectable Mass,Unresectable Lymphoma,1
39051,Stromal Invasion,squamous cell carcinoma of ovary,1
39052,Epithelial Component Present,Carcinoma of bladder,1
39053,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
39054,Benign Cellular Infiltrate,"Acanthoma, Pilar Sheath",1
39055,Increased Cellularity Present,Secondary Supratentorial Anaplastic Astrocytoma,1
39056,Dysplasia,Vulval intraepithelial neoplasia grade 2,1
39057,Malignant Cellular Infiltrate,Stage IIC Fallopian Tube Cancer AJCC v6 and v7,1
39058,Hypercellular bone marrow,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
39059,Severe dysplasia,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
39060,Carcinomatous Component Present,Colon Micropapillary Adenocarcinoma,1
39061,Indolent Clinical Course,Soft Palate Pleomorphic Adenoma,1
39062,Carcinomatous Component Present,Stage I Eyelid Carcinoma AJCC v8,1
39063,Malignant Cellular Infiltrate,Stage IB1 Cervical Cancer,1
39064,Well-Circumscribed Lesion,Colorectal Adenomatous Polyp,1
39065,Cutaneous Involvement,Spindle cell squamous cell carcinoma,1
39066,Neuroendocrine Differentiation,Cauda Equina Paraganglioma,1
39067,Carcinomatous Component Present,Prostate carcinoma,1
39068,Papillary Pattern,Recurrent respiratory papillomatosis,1
39069,More than 5 Mitoses per 50HPF,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
39070,Malignant Cellular Infiltrate,Breast implant-associated anaplastic large cell lymphoma,1
39071,Well-Circumscribed Lesion,Myxoid liposarcoma metastatic,1
39072,Carcinomatous Component Present,Stage IV Penile Cancer AJCC v7,1
39073,Carcinomatous Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
39074,Malignant Cellular Infiltrate,Hepatoblastoma with Pure Fetal Epithelial Differentiation,1
39075,Carcinomatous Component Present,Histiocytoid Breast Carcinoma,1
39076,Childhood Lesion,Childhood Supratentorial Neoplasm,1
39077,Regional Disease,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
39078,Epithelial Component Present,Stage II Major Salivary Gland Cancer AJCC v8,1
39079,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
39080,atypia morphology,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
39081,Carcinomatous Component Present,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
39082,Tissue Differentiation Uncertain,Kidney Synovial Sarcoma,1
39083,Tissue Differentiation Uncertain,Adult Epithelioid Sarcoma,1
39084,Severe dysplasia,Low Grade Ductal Breast Carcinoma In Situ,1
39085,Mixed Cellular Population,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
39086,Syncytial Pattern,Undifferentiated carcinoma of nasopharynx,1
39087,Malignant Cellular Infiltrate,"Carcinoma, diffuse type",1
39088,Epithelial Component Present,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
39089,Epithelial Differentiation,"Transitional cell carcinoma, spindle cell",1
39090,Cystic Change,Syringocystadenoma Papilliferum,1
39091,Epithelial Component Present,Vaginal Tubulovillous Adenoma,1
39092,Ground Glass Nuclear Inclusion,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
39093,Carcinomatous Component Present,Stage III Urethral Cancer AJCC v7,1
39094,Tissue of Mullerian Origin Present,Uterine Carcinosarcoma,1
39095,S-100-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
39096,Adnexal Differentiation,Sebaceous Gland Neoplasms,1
39097,Pregnancy Complications,"Pregnancy, Ovarian",1
39098,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer recurrent,1
39099,Mixed Cellular Population,Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
39100,Diffuse Pattern,Refractory Glioblastoma,1
39101,Alcohol Toxicity,Alcohol-Related Esophageal Squamous Cell Carcinoma,1
39102,Epithelial Component Present,Stage 0 Esophageal Cancer AJCC v7,1
39103,Nuclear pleomorphism,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
39104,Malignant Cellular Infiltrate,Pathologic Stage IA Gastric Cancer AJCC v8,1
39105,Epithelial Component Present,Unresectable Skin Basal Cell Carcinoma,1
39106,Pseudorosette Formation,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
39107,Cystic Change,Pancreatic Intraductal Papillary Mucinous Neoplasm,1
39108,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Carcinoma,1
39109,Intraosseous Lesion,Odontogenic myxofibroma,1
39110,Malignant Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7,1
39111,Mitotic Activity,Malignant Ovarian Luteinized Thecoma,1
39112,Carcinomatous Component Present,Unresectable Renal Cell Carcinoma,1
39113,Tubular Pattern,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
39114,Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,1
39115,Slow Growing Mass,Childhood Supratentorial Ependymoma,1
39116,Cystic Change,Papillary serous cystadenoma,1
39117,Exophytic Polypoid Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
39118,Hyperplastic Tissue Present,Tubal Hyperplasia,1
39119,Necrotic changes (finding),Small cell lung cancer limited stage,1
39120,Carcinomatous Component Present,small cell carcinoma of larynx,1
39121,Malignant Cellular Infiltrate,Adenocarcinoma of salivary gland,1
39122,Neuroendocrine Differentiation,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
39123,Secondary Lesion,Metastatic Lung Small Cell Carcinoma,1
39124,Indolent Clinical Course,Oral Cavity Benign Granular Cell Tumor,1
39125,Cutaneous Involvement,Seborrheic keratosis of eyelid,1
39126,Superficial Lesion,"Fibromatosis, Plantar",1
39127,Carcinomatous Component Present,Vaginal Neuroendocrine Carcinoma,1
39128,Favorable Clinical Outcome,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
39129,Metastatic Lesion,Locally Advanced Skin Squamous Cell Carcinoma,1
39130,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),1
39131,Secondary Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
39132,Diffuse Pattern,Adult Mixed Glioma,1
39133,Childhood Lesion,Childhood Angiosarcoma,1
39134,Intraosseous Lesion,Primary Intraosseous Squamous Cell Carcinoma,1
39135,Malignant Cellular Infiltrate,Stage I Vaginal Cancer AJCC v8,1
39136,Malignant Cellular Infiltrate,Refractory Malignant Mesothelioma,1
39137,Well-Circumscribed Lesion,Clear Cell Adrenal Cortical Adenoma,1
39138,Carcinomatous Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage,1
39139,Recurrent disease,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,1
39140,Whorling Growth Pattern,follicular dendritic cell sarcoma of thyroid gland,1
39141,Well-Circumscribed Lesion,Peripheral Hemangioblastoma,1
39142,Malignant Cellular Infiltrate,Recurrent Rectal Cancer,1
39143,Carcinomatous Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,1
39144,Malignant Cellular Infiltrate,Malignant neoplasm of cornea,1
39145,Malignant Cellular Infiltrate,External Ear Squamous Cell Carcinoma,1
39146,Carcinomatous Component Present,Platinum-Resistant Primary Peritoneal Carcinoma,1
39147,Vascular Channel Formation,Breast Capillary Hemangioma,1
39148,Carcinomatous Component Present,Postcricoid Squamous Cell Carcinoma,1
39149,More than 10 Mitoses per 10HPF,Small cell lung cancer recurrent,1
39150,Benign Cellular Infiltrate,Acoustic Neuroma,1
39151,Perineural spread,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
39152,Neuroendocrine Differentiation,Metastatic Breast Neuroendocrine Neoplasm,1
39153,Childhood Lesion,Childhood Neuroblastoma,1
39154,Low Cellularity Present,Recurrent Childhood Pilocytic Astrocytoma,1
39155,Malignant Cellular Infiltrate,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
39156,Epithelial Component Present,Colorectal Undifferentiated Carcinoma,1
39157,Cutaneous Involvement,Cutaneous Precursor Lymphoid Neoplasm,1
39158,Epithelial Component Present,Stage 0 Penile Cancer AJCC v8,1
39159,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
39160,Malignant Cellular Infiltrate,Metastatic Bone Ewing Sarcoma,1
39161,Indolent Clinical Course,Synovial Hemangioma,1
39162,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation,1
39163,Low Mitotic Activity,Appendix Neuroendocrine Tumor G2,1
39164,Carcinomatous Component Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,1
39165,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v7,1
39166,Mitotic Activity,Cervical Yolk Sac Tumor,1
39167,Epithelial Component Present,Endometrial Carcinoma,1
39168,Malignant Cellular Infiltrate,Plasmacytoma,1
39169,Increased Cellularity Present,Childhood Anaplastic Oligoastrocytoma,1
39170,Nuclear Molding,Small cell lung cancer limited stage,1
39171,Malignant Cellular Infiltrate,Central Nervous System Embryonal Neoplasm,1
39172,Epithelial Component Present,Stage IVC Nasopharyngeal Carcinoma AJCC v7,1
39173,Secondary Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma,1
39174,Well Differentiated Lesion,Well Differentiated Leiomyosarcoma,1
39175,Numerous Stromal Mast Cells Present,Vulvar Superficial Myofibroblastoma,1
39176,Benzene Exposure,Benzene-Related Acute Myeloid Leukemia,1
39177,Refractory Disease,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
39178,Malignant Cellular Infiltrate,Small cell neuroendocrine carcinoma of bladder,1
39179,Malignant Cellular Infiltrate,Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,1
39180,Mild cytologic atypia,Buccal Mucosa Verrucous Carcinoma,1
39181,Benign Cellular Infiltrate,benign myoepithelioma of salivary gland,1
39182,Adulthood Lesion,Stage I Adult Non-Hodgkin Lymphoma,1
39183,Epithelial Component Present,Undifferentiated carcinoma of nasopharynx,1
39184,Multifocal Lesion,Osteochondromatosis,1
39185,Canalicular Pattern,canalicular adenoma of salivary gland,1
39186,Carcinomatous Component Present,Vaginal Papillary Carcinoma,1
39187,Malignant Cellular Infiltrate,Platinum-Resistant Lung Small Cell Carcinoma,1
39188,Mitotic Activity,Proneural Glioblastoma,1
39189,Malignant Cellular Infiltrate,Stage III Childhood Hodgkin Lymphoma,1
39190,Metastatic/Recurrent Disease,Alveolar soft part sarcoma metastatic,1
39191,Mixed Cellular Population,Childhood Anaplastic Oligoastrocytoma,1
39192,Splenomegaly,Recurrent Hepatosplenic T-Cell Lymphoma,1
39193,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage I,1
39194,Metastatic Lesion,Advanced Cervical Adenocarcinoma,1
39195,High Grade Lesion,rhabdomyosarcoma of prostate,1
39196,Intermediate Grade Neuroendocrine Lesion,Malignant Pancreatic Vipoma,1
39197,Epithelial Component Present,Pancreatic intraepithelial neoplasia,1
39198,Benign Cellular Infiltrate,Benign neoplasm of endometrium,1
39199,Malignant Cellular Infiltrate,Familial Waldenstrom's Macroglobulinaemia,1
39200,Neuroendocrine Differentiation,Cardiac Paraganglioma,1
39201,Severe dysplasia,Stage 0 Oropharyngeal Carcinoma,1
39202,Multinodular Mass,Uterine Angiosarcoma,1
39203,Epithelial Component Present,"Somatostatinoma, malignant",1
39204,Unifocal Disease,Extracutaneous Mastocytoma,1
39205,CD4-Positive Neoplastic Cells Present,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
39206,Refractory Disease,Refractory Central Nervous System Non-Hodgkin Lymphoma,1
39207,Malignant Cellular Infiltrate,Refractory Myxoid Liposarcoma,1
39208,Carcinomatous Component Present,Stage IVC Rectal Cancer AJCC v8,1
39209,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,"Acute myeloid leukemia, inv(16)(p13q22)",1
39210,Systemic disease,Lipoid dermatoarthritis,1
39211,Secondary Lesion,Metastatic Breast Neuroendocrine Neoplasm,1
39212,Secondary Lesion,Advanced Melanoma,1
39213,Severe dysplasia,Stage 0 Colorectal Cancer AJCC v8,1
39214,Carcinomatous Component Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
39215,Well-Circumscribed Lesion,Esophageal squamous papilloma,1
39216,Well Differentiated Lesion,Laryngeal verrucous carcinoma,1
39217,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
39218,Vascular Channel Formation,Kaposi Sarcoma Related to Immunosuppressive Treatment,1
39219,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
39220,Decreased platelet count,Kasabach-Merritt syndrome,1
39221,Pseudoglandular Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
39222,Epithelial Component Present,Skin Nodular Basal Cell Carcinoma,1
39223,Carcinomatous Component Present,Adult Salivary Gland Carcinoma,1
39224,Exophytic Polypoid Lesion,Rectal Tubular Adenoma,1
39225,Malignant Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v8,1
39226,Childhood Lesion,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,1
39227,Carcinomatous Component Present,Adenocarcinoma in multiple adenomatous polyps,1
39228,Metastatic Lesion,Metastatic Gastrointestinal Stromal Tumor,1
39229,Fibrotic Stroma Formation,clear cell adenocarcinofibroma of ovary,1
39230,Epithelial Component Present,Thymic Basaloid Carcinoma,1
39231,Epithelial Component Present,eccrine adenocarcinoma of vulva,1
39232,Malignant Cellular Infiltrate,Malignant Testicular Non-Seminomatous Germ Cell Tumor,1
39233,Low Grade Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,1
39234,Epithelial Component Present,Metastatic Lung Non-Small Cell Carcinoma,1
39235,Malignant Cellular Infiltrate,Colorectal Mucinous Adenocarcinoma,1
39236,Malignant Cellular Infiltrate,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
39237,Epithelial Component Present,Major Salivary Gland Adenocarcinoma,1
39238,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
39239,Malignant Cellular Infiltrate,Stage IV Anaplastic Large Cell Lymphoma,1
39240,Recurrent disease,Recurrent Malignant Brain Neoplasm,1
39241,Transformed Phase of Disease,Refractory Transformed B-cell Non-Hodgkin Lymphoma,1
39242,Neuroendocrine Differentiation,Neuroendocrine neoplasm of appendix,1
39243,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,1
39244,Epithelial Component Present,Leydig cell neoplasm of testis,1
39245,Carcinomatous Component Present,Colon Cancer by AJCC v6 Stage,1
39246,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v8,1
39247,Carcinomatous Component Present,Stage IVA Colorectal Cancer AJCC v8,1
39248,Painless Mass,Soft tissue chondroma,1
39249,Sarcomatous Component Present,Pleuropulmonary blastoma type II,1
39250,Multinodular Mass,Adult Angiosarcoma,1
39251,Epithelial Component Present,Squamous Papilloma of the Larynx,1
39252,Myxoid Stroma Formation,Chordoma of clivus,1
39253,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage III,1
39254,Encapsulated Mass,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
39255,Malignant Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v8,1
39256,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma,1
39257,Neuroendocrine Differentiation,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
39258,Metastatic Lesion,Stage IV adult soft tissue sarcoma,1
39259,Nuclear Atypia,gliosarcoma,1
39260,Epithelial Component Present,Invasive Mucinous Lung Adenocarcinoma,1
39261,Carcinomatous Component Present,Submandibular Gland Adenocarcinoma,1
39262,Non-Invasive Lesion,Ureter Urothelial Papilloma,1
39263,Malignant Cellular Infiltrate,Metastatic Breast Carcinoid Tumor,1
39264,Carcinomatous Component Present,Acinar Prostate Mucinous Adenocarcinoma,1
39265,Carcinomatous Component Present,Adenocarcinoma in villous adenoma,1
39266,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage I,1
39267,Refractory Disease,Refractory Primary Lymphoma of Bone,1
39268,In Situ Lesion,Stage 0is Ureter Cancer AJCC v8,1
39269,Malignant Cellular Infiltrate,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
39270,Epithelial Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
39271,Follicular Cell Differentiation,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
39272,Solitary mass,Recurrent Chordoma,1
39273,Carcinomatous Component Present,Refractory Paranasal Sinus Squamous Cell Carcinoma,1
39274,Well Differentiated Neuroendocrine Lesion,Stage I Colon Neuroendocrine Tumor AJCC v8,1
39275,Malignant Cellular Infiltrate,"Cranial Nerve Neoplasms, Malignant",1
39276,Adulthood Lesion,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
39277,Vascular Channel Formation,Adult Epithelioid Hemangioendothelioma,1
39278,Epithelial Component Present,Rectal Cancer by AJCC v8 Stage,1
39279,Benign Cellular Infiltrate,Colorectal Benign Granular Cell Tumor,1
39280,Carcinomatous Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
39281,Recurrent disease,Recurrent tumors of the Ewing's family,1
39282,Intracanalicular Growth Pattern,Benign phyllodes neoplasm of breast,1
39283,Mesenchymal Component Present,Giant fibroadenoma of breast,1
39284,Epithelial Component Present,Low Grade Corneal Intraepithelial Neoplasia,1
39285,Carcinomatous Component Present,Lung Non-Keratinizing Squamous Cell Carcinoma,1
39286,Microcystic Change,Childhood Protoplasmic Astrocytoma,1
39287,Cutaneous Involvement,Stage I Superficial Spreading Melanoma AJCC v7,1
39288,Primary Lesion,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor",1
39289,Epithelial Component Present,Breast Carcinoma with Choriocarcinomatous Features,1
39290,Myxoid Stroma Formation,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
39291,Storiform Growth Pattern,Malignant fibrous histiocytoma recurrent,1
39292,Papillary Pattern,Bronchial adenoma,1
39293,Childhood Lesion,Childhood Ovarian Immature Teratoma,1
39294,Childhood Lesion,Stage IV Childhood Lymphoblastic Lymphoma,1
39295,Acantholysis,Acantholytic acanthoma,1
39296,Tissue of Mullerian Origin Present,endometrioid adenofibroma of ovary,1
39297,Secondary Lesion,Locally Advanced Digestive System Carcinoma,1
39298,Chronic lymphocytic inflammation,Adenolymphoma,1
39299,Well-Circumscribed Lesion,Appendix Sessile Serrated Adenoma/Polyp,1
39300,Epithelial Component Present,Anatomic Stage IIIC Breast Cancer AJCC v8,1
39301,Breast Microcalcification,Adult Brain Oligodendroglioma,1
39302,Necrotic changes (finding),Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
39303,Carcinomatous Component Present,Carcinoma of anal margin,1
39304,Carcinomatous Component Present,Fallopian Tube Gestational Choriocarcinoma,1
39305,Dysplasia,Appendix Sessile Serrated Adenoma/Polyp,1
39306,Childhood Lesion,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
39307,Absence of Invasion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
39308,Epithelial Component Present,Poorly Cohesive Gastric Carcinoma,1
39309,Malignant Cellular Infiltrate,Advanced Uveal Melanoma,1
39310,Necrotic changes (finding),Intraocular Malignant Peripheral Nerve Sheath Tumor,1
39311,Slow Growing Mass,Ependymoma,1
39312,Cystic Change,Ovarian Clear Cell Cystadenofibroma,1
39313,Hyperplastic Tissue Present,Ductal Breast Hyperplasia,1
39314,Metastatic/Recurrent Disease,Cardiac Biphasic Synovial Sarcoma,1
39315,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,1
39316,Human Papillomavirus Negative,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
39317,Tissue Differentiation Uncertain,Epithelioid Type Angiomyolipoma,1
39318,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
39319,Malignant Cellular Infiltrate,Stage IV Ureter Cancer AJCC v8,1
39320,Malignant Cellular Infiltrate,"Sarcoma, metastatic",1
39321,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
39322,Epithelial Component Present,Rectal Signet Ring Cell Adenocarcinoma,1
39323,Encapsulated Mass,Thyroid Gland Lipoadenoma,1
39324,Epithelial Component Present,ENSAT Stage II Adrenal Cortex Carcinoma,1
39325,Nodular lesions,Liver Dysplastic Nodule,1
39326,Indolent Clinical Course,Cellular Myxoma,1
39327,Benign Cellular Infiltrate,Airway Hemangioma,1
39328,Thin Bands of Collagen Present,Solitary fibrous tumor,1
39329,Epithelial Component Present,Strumal carcinoid,1
39330,Fibrotic Stroma Formation,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
39331,Single Cell Necrosis,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
39332,Infiltrative Growth Pattern,Protoplasmic astrocytoma,1
39333,Adulthood Lesion,Adult Atypical Meningioma,1
39334,Dilated Terminal Duct Lobular Units Present,Columnar Cell Change of the Breast,1
39335,Adulthood Lesion,Adult Choroid Plexus Neoplasm,1
39336,Edematous Stroma Formation,Aggressive angiomyxoma,1
39337,Carcinomatous Component Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
39338,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma,1
39339,Antoni A Pattern,Sternal Intraosseous Schwannoma,1
39340,Hemorrhagic,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
39341,Proliferation of High Endothelial Venules Present,Angioimmunoblastic Lymphadenopathy,1
39342,Epithelial Component Present,Stage IB Cervical Cancer AJCC v6 and v7,1
39343,Malignant Cellular Infiltrate,BCLC Stage D Adult Hepatocellular Carcinoma,1
39344,Malignant Cellular Infiltrate,Testicular yolk sac tumor stage II,1
39345,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
39346,Epithelial Component Present,Uterine Corpus Carcinoid Tumor,1
39347,Benign Cellular Infiltrate,Central Nervous System Mature Teratoma,1
39348,Malignant Cellular Infiltrate,Recurrent Lymphoma,1
39349,Necrotic changes (finding),large cell neuroendocrine carcinoma of anal canal,1
39350,Fibrotic Stroma Formation,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
39351,Benign Cellular Infiltrate,"Myositis, Proliferative",1
39352,Well Differentiated Neuroendocrine Lesion,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
39353,Diffuse Pattern,Adult Anaplastic Oligodendroglioma,1
39354,Argentaffin Positive Neoplastic Cells Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
39355,Tissue Differentiation Uncertain,Cardiac Synovial Sarcoma,1
39356,Nuclear Atypia,Pineal parenchymal tumor of intermediate differentiation,1
39357,Malignant Cellular Infiltrate,Prostate Carcinoma Metastatic in the Lung,1
39358,Single Malignant Cells Present,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
39359,Neonatal Lesion,Neonatal leukemia,1
39360,Benign Cellular Infiltrate,Palisaded Lymph Node Myofibroblastoma,1
39361,Malignant Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v8,1
39362,Malignant Cellular Infiltrate,Infant T Acute Lymphoblastic Leukemia,1
39363,Mesenchymal Component Present,Breast Phyllodes Tumor,1
39364,Epithelial Component Present,Stage III Gallbladder Cancer AJCC v7,1
39365,Neuroendocrine Differentiation,Gastrinoma,1
39366,Dysplasia,Esophageal High Grade Intraepithelial Neoplasia,1
39367,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligodendroglioma,1
39368,Epithelial Component Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
39369,Malignant Germinomatous Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7,1
39370,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage III,1
39371,Diffuse Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
39372,Mitotic Activity,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7,1
39373,Nodular Pattern,Skin Nodular Solid Basal Cell Carcinoma,1
39374,Monoclonal Gammapathies,Monoclonal Gammopathy of Undetermined Significance,1
39375,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor by AJCC v8 Stage,1
39376,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Cancer AJCC v7,1
39377,Carcinomatous Component Present,Broad Ligament Serous Adenocarcinoma,1
39378,Well-Circumscribed Lesion,Pituicytoma,1
39379,Insular Pattern,Ovarian Insular Carcinoid Tumor,1
39380,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
39381,Carcinomatous Component Present,Minor Salivary Gland Carcinoma,1
39382,Malignant Cellular Infiltrate,Central Nervous System Rhabdomyosarcoma,1
39383,Neuroendocrine Differentiation,Sporadic Thyroid Gland Medullary Carcinoma,1
39384,Neuroendocrine Differentiation,Malignant carcinoid tumor of lung,1
39385,Hereditary Lesion,Hereditary Multiple Exostoses,1
39386,Angiodestructive Pattern,Recurrent Lymphomatoid Granulomatosis,1
39387,Epithelial Component Present,Adenocarcinoma of the prostate stage I,1
39388,Monomorphic Cellular Infiltrate,Refractory Ependymoma,1
39389,Non-Hereditary Lesion,Sporadic Retinoblastoma,1
39390,High Mitotic Activity,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
39391,Biphasic Pattern,Adenocarcinofibroma,1
39392,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Thyroid,1
39393,Recurrent disease,Recurrent Merkel Cell Carcinoma,1
39394,Malignant Cellular Infiltrate,Adult Acute Lymphocytic Leukemia,1
39395,Malignant Cellular Infiltrate,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
39396,High Mitotic Activity,Primary hepatic neuroendocrine carcinoma,1
39397,Mitotic Activity,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,1
39398,Epithelial Component Present,Gallbladder Flat Biliary Intraepithelial Neoplasia,1
39399,Increased Cellularity Present,Familial Neuroblastoma,1
39400,Malignant Cellular Infiltrate,Stage II Vulvar Cancer AJCC v8,1
39401,Cutaneous Involvement,Balloon cell malignant melanoma,1
39402,Carcinomatous Component Present,Squamous cell carcinoma of prostate,1
39403,Carcinomatous Component Present,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,1
39404,Cutaneous Involvement,Aplasia Cutis Congenita,1
39405,Benign Cellular Infiltrate,Adult Extracardiac Rhabdomyoma,1
39406,Slow Growing Mass,Chordoma,1
39407,Solid Growth Pattern,Breast Columnar Cell Mucinous Carcinoma,1
39408,Malignant Cellular Infiltrate,Unresectable Bladder Urothelial Carcinoma,1
39409,"Fully Differentiated ""Adult-Type"" Tissues Present","Teratoma, Malignant",1
39410,Cutaneous Involvement,Merkel cell carcinoma,1
39411,Malignant Cellular Infiltrate,Blastic Granulocytic Sarcoma,1
39412,Malignant Cellular Infiltrate,Central Nervous System B-Cell Non-Hodgkin Lymphoma,1
39413,Malignant Cellular Infiltrate,Primary Cutaneous Hodgkin Lymphoma,1
39414,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma stage III,1
39415,Carcinomatous Component Present,Stage IV Major Salivary Gland Cancer AJCC v8,1
39416,Malignant Cellular Infiltrate,Stage III Uveal Melanoma AJCC v7,1
39417,Epithelial Component Present,Nipple Carcinoma,1
39418,Metastatic Lesion,Advanced Carcinoma,1
39419,Malignant Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v8,1
39420,Malignant Cellular Infiltrate,Unresectable Bladder Urothelial Carcinoma,1
39421,Papillary Pattern,Biliary papillomatosis,1
39422,Childhood Lesion,Childhood Ovarian Embryonal Carcinoma,1
39423,Primary Lesion,BCLC Stage A Adult Hepatocellular Carcinoma,1
39424,Epithelial Component Present,Stage III Adrenal Cortex Carcinoma AJCC v8,1
39425,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",1
39426,Carcinomatous Component Present,Stage IV Adult Liver Cancer AJCC v7,1
39427,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Immature Teratoma,1
39428,Malignant Cellular Infiltrate,Parietal cell carcinoma,1
39429,Micropapillary Pattern,intraductal micropapillary carcinoma of breast,1
39430,Desmoplastic Stroma Formation,Desmoplastic trichilemmoma,1
39431,Koilocytotic atypia,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,1
39432,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v7,1
39433,Childhood Lesion,Childhood Brain Meningioma,1
39434,Epithelial Component Present,Metastatic Fibrolamellar Carcinoma,1
39435,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Colon,1
39436,Monomorphic Cellular Infiltrate,oligodendroglioma,1
39437,Malignant Cellular Infiltrate,Sclerosing rhabdomyosarcoma,1
39438,Malignant Cellular Infiltrate,Chondrosarcoma recurrent,1
39439,Vascular Channel Formation,Subglottic Hemangioma,1
39440,Cutaneous Involvement,Cutaneous Fibrohistiocytic Neoplasm,1
39441,Koilocytotic atypia,Cervical Papillary Squamous Cell Carcinoma,1
39442,Benign Cellular Infiltrate,Benign neoplasm of pharynx,1
39443,Biphasic Pattern,carcinosarcoma of liver,1
39444,Carcinomatous Component Present,Stage III Oropharyngeal Carcinoma AJCC v6,1
39445,Clinical TNM Finding,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,1
39446,Epithelial Component Present,Stage II Bladder Cancer AJCC v8,1
39447,Malignant Cellular Infiltrate,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,1
39448,Biphasic Pattern,Benign mixed epithelial and stromal tumor of kidney,1
39449,Ground Glass Nuclear Inclusion,Childhood Thyroid Gland Papillary Carcinoma,1
39450,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
39451,Pathologic TNM Finding,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,1
39452,Chromogranin A Positive Neoplastic Cells Present,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
39453,Neuroendocrine Differentiation,Primary hepatic neuroendocrine carcinoma,1
39454,Metastatic Lesion,Uveal Melanoma Metastatic in the Liver,1
39455,Epithelial Component Present,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,1
39456,Regional Disease,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
39457,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
39458,Nuclear pleomorphism,carcinoma of pancreas with osteoclast-like giant cells,1
39459,Epithelial Component Present,Ovarian Endometrioid Cystadenofibroma,1
39460,Childhood Lesion,Childhood Glioblastoma,1
39461,Nuclear Atypia,Atypical follicular adenoma,1
39462,Epithelial Component Present,epithelial-myoepithelial carcinoma of lung,1
39463,In Situ Lesion,Adenocarcinoma in Situ,1
39464,Malignant Cellular Infiltrate,"Glomus tumor, malignant",1
39465,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Leiomyosarcoma,1
39466,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Skin Squamous Cell Carcinoma,1
39467,Adnexal Differentiation,Trichoadenoma,1
39468,Well Differentiated Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1,1
39469,Absence of a Hormonal Syndrome,Non-Functioning Pituitary Gland Neoplasm,1
39470,Childhood Lesion,"Optic Nerve Glioma, Childhood",1
39471,Epithelial Component Present,Stage IV Esophageal Squamous Cell Carcinoma,1
39472,Absence of Invasion,Cervical Adenocarcinoma In Situ,1
39473,Epithelial Component Present,Ovarian Clear Cell Cystadenocarcinoma,1
39474,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
39475,Epithelial Component Present,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8,1
39476,Benign Cellular Infiltrate,Fibroma of prostate,1
39477,Skin nodule,Skin Nodular Basal Cell Carcinoma,1
39478,Low Mitotic Activity,Appendix Neuroendocrine Tumor,1
39479,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1,1
39480,Epithelial Component Present,Unresectable Skin Basal Cell Carcinoma,1
39481,Severe dysplasia,Pathologic Stage 0 Gastric Cancer AJCC v8,1
39482,Cystic Change,Brenner Tumor,1
39483,Indolent Clinical Course,Lymphangioendothelioma,1
39484,Malignant Cellular Infiltrate,"Sarcoma, Myeloid",1
39485,Malignant Cellular Infiltrate,Childhood Rectal Carcinoma,1
39486,Skin Papule,Desmoplastic trichoepithelioma,1
39487,Follicular Structures Present,Thyroid Gland Follicular Adenoma,1
39488,Epithelial Component Present,Sessile Serrated Adenoma/Polyp,1
39489,Malignant Cellular Infiltrate,Stage II Laryngeal Cancer AJCC v6 and v7,1
39490,Osseous Differentiation,Stage IVA Osteosarcoma AJCC v7,1
39491,Exophytic Papillary Lesion,Common wart,1
39492,Epithelial Component Present,Solid Papillary Breast Carcinoma,1
39493,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
39494,Malignant Cellular Infiltrate,Childhood Small Intestinal Leiomyosarcoma,1
39495,Malignant Cellular Infiltrate,Ciliary Body Mixed Cell Melanoma,1
39496,Malignant Cellular Infiltrate,Mesothelioma malignant recurrent,1
39497,Glucagon-Like Peptide Positive Neoplastic Cells Present,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
39498,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
39499,Primary Lesion,Childhood Cerebral Ependymoma,1
39500,Recurrent disease,Recurrent Primary Effusion Lymphoma,1
39501,Malignant Cellular Infiltrate,Basal cell carcinoma - keratotic,1
39502,Epithelial Component Present,Gastric carcinoma stage IV,1
39503,Epithelial Component Present,Vaginal intraepithelial neoplasia grade 2,1
39504,Unresectable Mass,Unresectable Soft Tissue Sarcoma,1
39505,Epithelial Component Present,Nasopharyngeal carcinoma,1
39506,Eosinophil count raised (finding),"Leukemia, Eosinophilic, Acute",1
39507,Hemorrhagic,Poorly Differentiated Angiosarcoma,1
39508,Epithelial Component Present,Appendix Intraepithelial Neoplasia,1
39509,Follicular Structures Present,Thyroid Gland Mucinous Follicular Adenoma,1
39510,Malignant Cellular Infiltrate,Stage II Bone Cancer AJCC v8,1
39511,Malignant Cellular Infiltrate,Clivus Chondroid Chordoma,1
39512,Malignant Cellular Infiltrate,Fallopian Tube Endometrioid Adenocarcinoma,1
39513,Monoclonal Paraproteinemia Present in Lower than Myeloma Levels,Non-IgM Monoclonal Gammopathy of Undetermined Significance,1
39514,Low Grade Lesion,Pilocytic astrocytoma of cerebellum,1
39515,Primary Lesion,Recurrent Diffuse Intrinsic Pontine Glioma,1
39516,Malignant Cellular Infiltrate,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
39517,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
39518,Carcinomatous Component Present,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
39519,Epithelial Component Present,Alcohol-Related Carcinoma,1
39520,Cystic Change,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
39521,Epithelial Component Present,Stage III Appendix Carcinoma AJCC v8,1
39522,Carcinomatous Component Present,Stage I Lung Cancer AJCC v6,1
39523,Stromal Invasion,Serous cystadenocarcinoma ovary,1
39524,Lamellar Pattern,Recurrent Fibrolamellar Carcinoma,1
39525,Well Differentiated Neuroendocrine Lesion,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
39526,Radiation Sickness,Radiation-Induced Intracranial Meningioma,1
39527,Carcinomatous Component Present,Large cell carcinoma with rhabdoid phenotype,1
39528,Slow Growing Mass,Papillary ependymoma,1
39529,Malignant Cellular Infiltrate,Stromal Predominant Kidney Wilms Tumor,1
39530,Dysplasia,Biliary Intraepithelial Neoplasia,1
39531,Biphasic Pattern,Uterine Corpus Adenosarcoma by AJCC v8 Stage,1
39532,Moderate dysplasia,Grade II Glandular Intraepithelial Neoplasia,1
39533,Epithelial Component Present,Pancreatic Endocrine Carcinoma,1
39534,Epithelial Component Present,Intraductal papilloma of breast,1
39535,Epithelial Component Present,Stage III Colorectal Cancer AJCC v8,1
39536,Epithelial Component Present,Prolactin-producing pituitary tumor,1
39537,Epithelial Component Present,Pancreatic adenocarcinoma metastatic,1
39538,Cutaneous Involvement,Cutaneous Mature T-Cell and NK-Cell Neoplasm,1
39539,Malignant Cellular Infiltrate,Recurrent Kidney Wilms Tumor,1
39540,Malignant Cellular Infiltrate,Locally Advanced Unresectable Gastric Adenocarcinoma,1
39541,Epithelial Component Present,Stage IC Ovarian Cancer AJCC v6 and v7,1
39542,Epithelial Component Present,Rectal Cribriform Comedo-Type Adenocarcinoma,1
39543,Carcinomatous Component Present,Locally Advanced Unresectable Cervical Adenocarcinoma,1
39544,Giant Mitochondria Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
39545,Large Spaces Filled with Blood Present,Telangiectatic osteosarcoma,1
39546,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v8,1
39547,HMB-45-Positive Neoplastic Cells Present,Lung Clear Cell Tumor,1
39548,Indolent Clinical Course,benign neoplasm of lymph nodes,1
39549,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Clinical Stage,1
39550,Peau d'orange surface of breast,Inflammatory carcinoma of breast recurrent,1
39551,Malignant Cellular Infiltrate,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,1
39552,Epithelial Component Present,Stage 0 Gallbladder Cancer AJCC v6 and v7,1
39553,Dysplasia,Intestinal Intraepithelial Neoplasia,1
39554,Poorly Differentiated Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
39555,Chromogranin A Positive Neoplastic Cells Present,Thymic Typical Carcinoid Tumor,1
39556,Intermediate Filaments Present,Rhabdoid Tumor,1
39557,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
39558,Epithelial Component Present,Early Hepatocellular Carcinoma,1
39559,Papillary Pattern,Juvenile papillomatosis of breast,1
39560,Low Mitotic Activity,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,1
39561,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of peritoneum,1
39562,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v7,1
39563,Cutaneous Involvement,Dermatitis Herpetiformis,1
39564,Moderate dysplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
39565,Adulthood Lesion,Adult Anaplastic Astrocytoma,1
39566,Pain,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,1
39567,Carcinomatous Component Present,Sporadic Diffuse Gastric Adenocarcinoma,1
39568,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma,1
39569,Low Mitotic Activity,Stage IV Rectal Neuroendocrine Tumor AJCC v8,1
39570,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma,1
39571,Malignant Cellular Infiltrate,Stage IA3 Lung Cancer AJCC v8,1
39572,Malignant Cellular Infiltrate,Metastatic Unresectable Sarcoma,1
39573,Diffuse Pattern,Adult Anaplastic Oligodendroglioma,1
39574,Malignant Cellular Infiltrate,Leukemia recurrent,1
39575,Schwannian Stroma More than 50 Percent of the Tumor Volume,Peripheral Ganglioneuroblastoma,1
39576,Fibrotic Stroma Formation,Proliferating Brenner Tumor,1
39577,In Situ Lesion,Intraepithelial Squamous Cell Carcinoma,1
39578,Malignant Cellular Infiltrate,Lung Cancer by AJCC v7 Stage,1
39579,Epithelial Component Present,Prostate cancer stage A,1
39580,Epithelial Component Present,"Urinary bladder carcinoma stage I, with cancer in situ",1
39581,Dysplasia,adenomatous polyp of stomach,1
39582,Increased Cellularity Present,Recurrent Childhood Anaplastic Astrocytoma,1
39583,Dysplasia,Large Cell Dysplasia,1
39584,Epithelial Component Present,Carcinoma of submandibular gland,1
39585,Carcinomatous Component Present,Metastatic Ureter Carcinoma,1
39586,Malignant Cellular Infiltrate,Anal Canal Mixed Adenoneuroendocrine Carcinoma,1
39587,Carcinomatous Component Present,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
39588,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor,1
39589,Cutaneous Involvement,Mucoepidermoid carcinoma of skin,1
39590,Hyalinized Stroma Formation,Hemangiopericytoma of meninges,1
39591,Epithelial Component Present,Colon Cancer by AJCC v8 Stage,1
39592,Invasive Lesion,Secretory breast carcinoma,1
39593,High Mitotic Activity,Small Intestinal Neuroendocrine Carcinoma,1
39594,Benign Cellular Infiltrate,Oral Cavity Leiomyoma,1
39595,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
39596,Aggravated Disease,Neurofibromatosis aggravated,1
39597,Unclassifiable Lesion,"Intracranial Embryonal Tumor, Not Otherwise Specified",1
39598,In Situ Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
39599,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma,1
39600,Malignant Cellular Infiltrate,Recurrent Thyroid Carcinoma,1
39601,Benign Cellular Infiltrate,Trichilemmoma,1
39602,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v8,1
39603,Increased Cellularity Present,Anaplastic Brain Stem Astrocytoma,1
39604,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
39605,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
39606,Carcinomatous Component Present,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
39607,Benign Cellular Infiltrate,Bladder Urothelial Papilloma,1
39608,Tissue Differentiation Uncertain,Cardiac Biphasic Synovial Sarcoma,1
39609,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
39610,Endophytic Tumor Growth,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
39611,Neuroendocrine Differentiation,Refractory Digestive System Neuroendocrine Neoplasm,1
39612,Epithelial Component Present,squamous cell carcinoma of lacrimal gland,1
39613,Epithelial Component Present,Gonadoblastoma,1
39614,Carcinomatous Component Present,Stage IVA Laryngeal Cancer AJCC v8,1
39615,Epithelial Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
39616,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage III,1
39617,Carcinomatous Component Present,Stage IIIA Penile Cancer AJCC v8,1
39618,Benign Cellular Infiltrate,Thyroid Gland Leiomyoma,1
39619,Nerve palsy,Facial Nerve Palsy Related to Trauma,1
39620,Pseudoglandular Pattern,Childhood Central Nervous System Embryonal Carcinoma,1
39621,Plasma cell inflammation,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,1
39622,Malignant Cellular Infiltrate,Stage II Bladder Cancer AJCC v8,1
39623,Local disease,lipoma of mediastinum,1
39624,Carcinomatous Component Present,Stage IV Colorectal Cancer,1
39625,Immature Granulocytes in Peripheral Blood Under 10 Percent,Refractory Chronic Myelomonocytic Leukemia,1
39626,Metaplasia,intestinal type adenocarcinoma of gallbladder,1
39627,Epithelial Component Present,malignant neoplasm of breast stage I,1
39628,Childhood Lesion,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
39629,Epithelial Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
39630,Biphasic Pattern,Benign phyllodes neoplasm of breast,1
39631,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage I,1
39632,Malignant Cellular Infiltrate,Lung Large Cell Carcinoma by AJCC v7 Stage,1
39633,Vascular Channel Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
39634,Malignant Cellular Infiltrate,Ethmoid Sinus Adenoid Cystic Carcinoma,1
39635,Local disease,Lipoma of external auditory meatus,1
39636,Cutaneous Involvement,Carcinoma in situ of skin,1
39637,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Polyembryoma AJCC v6 and v7,1
39638,Malignant Cellular Infiltrate,Malignant eccrine spiradenoma,1
39639,Multifocal Lesion,"Chondromatosis, Synovial",1
39640,Well-Circumscribed Lesion,Androgen-Producing Adrenal Cortex Adenoma,1
39641,Tissue Differentiation Uncertain,Conventional Extraskeletal Myxoid Chondrosarcoma,1
39642,Recurrent disease,Recurrent Ependymal Tumor,1
39643,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
39644,Secondary Lesion,Metastatic Endometrial Carcinoma,1
39645,Malignant Cellular Infiltrate,Recurrent Grade 2 Follicular Lymphoma,1
39646,Epithelial Component Present,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
39647,Poorly Differentiated Lesion,Pulmonary Blastoma,1
39648,Carcinomatous Component Present,Grade 2 Endometrial Mucinous Adenocarcinoma,1
39649,Carcinomatous Component Present,Squamous cell carcinoma of colon,1
39650,Metastatic/Recurrent Disease,Alveolar soft part sarcoma non-metastatic,1
39651,Epithelial Component Present,Sclerosing thymoma,1
39652,Smooth Muscle Component Present,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,1
39653,Fibrotic Stroma Formation,Fallopian Tube Serous Adenofibroma,1
39654,Diffuse Cellular Infiltrate,Diffuse Gastric Adenocarcinoma,1
39655,Adulthood Lesion,Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8,1
39656,Cutaneous Involvement,Tumor of dermis,1
39657,Malignant Cellular Infiltrate,Grade I Chondrosarcoma,1
39658,Immunologic Deficiency Syndromes,Post-transplant lymphoproliferative disorder,1
39659,Myxoid Stroma Formation,Bone Epithelioid Hemangioendothelioma,1
39660,Malignant Cellular Infiltrate,Carcinoma Arising in Nasal Papillomatosis,1
39661,Endophytic Tumor Growth,Subglottic Verrucous Carcinoma,1
39662,Absence of Invasion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
39663,Malignant Cellular Infiltrate,Metastatic gastric adenocarcinoma,1
39664,Cystic Change,Ovarian serous cystadenofibroma,1
39665,Hyalinized Stroma Formation,Cardiac Epithelioid Hemangioendothelioma,1
39666,Epithelial Component Present,Stage II Hilar Cholangiocarcinoma AJCC v8,1
39667,Malignant Cellular Infiltrate,Lymphoma by Site,1
39668,Metastatic Lesion,Locally Advanced Cervical Carcinoma,1
39669,Refractory Disease,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
39670,Indolent Clinical Course,Vulvar Superficial Angiomyxoma,1
39671,Epithelial Component Present,Metastatic Paraganglioma,1
39672,Absence of Invasion of the Muscularis Externa,Early gastric cancer,1
39673,Nuclear Atypia,Childhood Brain Anaplastic Astrocytoma,1
39674,Malignant Cellular Infiltrate,Metastatic Oral Cavity Squamous Cell Carcinoma,1
39675,Non-Malignant Cellular Infiltrate,Axillary lymphadenitis,1
39676,Malignant Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
39677,Epithelial Component Present,Large cell lung cancer stage III,1
39678,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
39679,Malignant Cellular Infiltrate,Intraductal papillary adenocarcinoma with invasion,1
39680,Epithelial Component Present,small cell carcinoma of kidney,1
39681,Carcinomatous Component Present,"Malignant Mixed Tumor, Not Otherwise Specified",1
39682,Hyaline Cartilage Differentiation,Dedifferentiated chondrosarcoma,1
39683,Epithelial Component Present,Serous cystadenocarcinoma ovary,1
39684,Malignant Cellular Infiltrate,Ureter Cancer by AJCC v7 Stage,1
39685,Metastatic Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
39686,Malignant Cellular Infiltrate,Stage IV Adult Hodgkin Lymphoma,1
39687,Vascular Channel Formation,Conventional Angiosarcoma,1
39688,Malignant Cellular Infiltrate,Malignant germ cell neoplasm,1
39689,Carcinomatous Component Present,Stage I Anal Canal Cancer AJCC v6 and v7,1
39690,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",1
39691,Thick-Walled Hyalinized Vessels Present,Pleural Schwannoma,1
39692,Diffuse Pattern,AIDS-Related Primary Effusion Lymphoma,1
39693,Carcinomatous Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
39694,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v6 and v7,1
39695,Carcinomatous Component Present,signet ring cell carcinoma of breast,1
39696,Exophytic Polypoid Lesion,Adenoma of ampulla of Vater,1
39697,Papillary Pattern,Stage 0a Ureter Cancer AJCC v7,1
39698,Cutaneous Involvement,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7,1
39699,Calcitonin serum level increased,Familial medullary thyroid carcinoma,1
39700,Epithelial Component Present,Non-small cell carcinoma,1
39701,Local disease,Cerebral Hemisphere Lipoma,1
39702,Adnexal Differentiation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
39703,Malignant Cellular Infiltrate,Classic medulloblastoma,1
39704,Red Papular Lesion,Senile angioma,1
39705,Benign Cellular Infiltrate,Hidroacanthoma simplex,1
39706,Epithelial Component Present,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
39707,Carcinomatous Component Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
39708,Epithelial Component Present,Small intestine carcinoma resectable,1
39709,Epithelial Component Present,Anal Verrucous Carcinoma,1
39710,Bone Marrow Dysplasia Present,Recurrent Myelodysplastic Syndrome,1
39711,Carcinomatous Component Present,Stage IIIA Ovarian Cancer AJCC v8,1
39712,Epithelial Component Present,Stage IIB Colorectal Cancer AJCC v8,1
39713,Benign Cellular Infiltrate,Gastric Leiomyoma,1
39714,Malignant Cellular Infiltrate,Parasite-Related Carcinoma,1
39715,Secondary Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma,1
39716,Mixed Cellular Population,Adult Brain Stem Mixed Glioma,1
39717,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
39718,Hyperkeratosis,External Ear Actinic Keratosis,1
39719,Carcinomatous Component Present,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8,1
39720,Malignant Cellular Infiltrate,Refractory Liposarcoma,1
39721,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage III,1
39722,Carcinomatous Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
39723,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,1
39724,Malignant Cellular Infiltrate,Small Intestinal Signet Ring Cell Carcinoma,1
39725,Refractory Disease,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder,1
39726,Osteoid formation,Ossifying Renal Tumor of Infancy,1
39727,Carcinomatous Component Present,large cell neuroendocrine carcinoma of gallbladder,1
39728,Acanthosis,Laryngeal verrucous carcinoma,1
39729,Carcinomatous Component Present,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7,1
39730,Diffuse Pattern,Stage II Diffuse Large B-Cell Lymphoma,1
39731,Vascular Channel Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
39732,Fibrotic Stroma Formation,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
39733,Indolent Clinical Course,Gingival Angiofibroma,1
39734,Carcinomatous Component Present,Recurrent Carcinoma of Unknown Primary,1
39735,Malignant Cellular Infiltrate,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
39736,Epithelial Component Present,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,1
39737,Malignant Cellular Infiltrate,Post polycythaemia vera myelofibrosis,1
39738,Mucoid Stroma Formation,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
39739,Epithelial Component Present,Laryngeal Cancer by AJCC v7 Stage,1
39740,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
39741,Dermal Involvement,Eccrine porocarcinoma,1
39742,Cutaneous Involvement,Fibrous tissue neoplasm of skin,1
39743,Indolent Clinical Course,Squamous odontogenic tumor,1
39744,Carcinomatous Component Present,Appendix Mixed Adenoneuroendocrine Carcinoma,1
39745,Multifocal Lesion,Multiple endocrine neoplasia Type 2,1
39746,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,1
39747,Epithelial Component Present,Skin appendage adenoma,1
39748,Epithelial Component Present,villous adenoma of stomach,1
39749,Epithelial Component Present,Cervical high grade squamous intraepithelial lesion,1
39750,Malignant Cellular Infiltrate,Malignant neoplasm of lung,1
39751,Epithelial Component Present,Cervical Squamous Intraepithelial Neoplasia 1,1
39752,More than 10 Mitoses per 10HPF,Small cell carcinoma of lung,1
39753,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
39754,Malignant Cellular Infiltrate,Locally Advanced Thymic Carcinoma,1
39755,Myxoid Stroma Formation,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
39756,Malignant Cellular Infiltrate,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,1
39757,Biphasic Pattern,Borderline Breast Phyllodes Tumor,1
39758,Epithelial Component Present,Breast adenoma,1
39759,Epithelial Component Present,Vaginal Cancer by AJCC v6 Stage,1
39760,Malignant Cellular Infiltrate,adenoid cystic carcinoma of accessory sinus,1
39761,Epithelial Component Present,Gastric Adenocarcinoma,1
39762,Neuroendocrine Differentiation,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
39763,Capillary Sized Vascular Channel Formation,Histiocytoid hemangioma,1
39764,Malignant Cellular Infiltrate,Malignant Extragonadal Germ Cell Tumor,1
39765,Diffuse Pattern,Centroblastic lymphoma stage II,1
39766,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
39767,Benign Cellular Infiltrate,chondroma of lung,1
39768,High Mitotic Activity,Pancreatic Small Cell Neuroendocrine Carcinoma,1
39769,Annular Tubules Present,Ovarian Sex Cord Tumor with Annular Tubules,1
39770,High Grade Lesion,Childhood Brain Glioblastoma,1
39771,Indolent Clinical Course,Adenomatoid Tumor,1
39772,Malignant Cellular Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,1
39773,Acinar Cell Differentiation,Recurrent Acinic Cell Breast Carcinoma,1
39774,Epithelial Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
39775,Radiation Sickness,Radiation-induced fibrous mediastinitis,1
39776,Epithelial Component Present,Unresectable Thyroid Gland Carcinoma,1
39777,Malignant Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,1
39778,Ground Glass Nuclear Inclusion,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
39779,High Grade Lesion,rhabdomyosarcoma of extrahepatic bile duct,1
39780,Recurrent Lymphoma,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
39781,Cutaneous Involvement,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
39782,Skin nodule,Fibroepithelioma of Pinkus,1
39783,Malignant Component Present,Ovarian Dermoid Cyst with Melanoma,1
39784,Cribriform Pattern,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
39785,Neuroectodermal Differentiation,Childhood Neuroblastoma,1
39786,Therapy-Related Toxicity,Methotrexate-Associated Hodgkin Lymphoma,1
39787,Aggressive Clinical Course,Thoracic NUT Carcinoma,1
39788,Malignant Cellular Infiltrate,Refractory Bile Duct Carcinoma,1
39789,Epithelial Component Present,Fallopian Tube Serous Adenocarcinoma,1
39790,Mucoid Stroma Formation,Chordoid Glioma of the Third Ventricle,1
39791,More than 10 Mitoses per 10HPF,Stage III Lung Small Cell Carcinoma AJCC v7,1
39792,Storiform Growth Pattern,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
39793,Cystic Change,Testicular Brenner Tumor,1
39794,Malignant Cellular Infiltrate,Metastatic Lung Small Cell Carcinoma,1
39795,Absence of Invasion,Stage 0 Vulvar Cancer,1
39796,Ionizing Radiation Toxicity,Ionizing Radiation-Related Malignant Neoplasm,1
39797,In Situ Lesion,Bladder adenocarcinoma stage 0,1
39798,Primary Lesion,Metastatic hepatocellular carcinoma,1
39799,Recurrent disease,Thymoma malignant recurrent,1
39800,Indolent Clinical Course,Benign neoplasm of hard palate,1
39801,Dysplasia,Adenoma of rectum,1
39802,Benign Cellular Infiltrate,Childhood Ovarian Mature Teratoma,1
39803,Tissue Differentiation Uncertain,Lung Clear Cell Tumor,1
39804,Chromogranin A Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell",1
39805,Epithelial Component Present,Synchronous Bilateral Breast Carcinoma,1
39806,Polymorphic Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
39807,Immunologic Deficiency Syndromes,AIDS-Related Malignant Anal Neoplasm,1
39808,Childhood Lesion,Childhood Central Nervous System Mature Teratoma,1
39809,Tissue Differentiation Uncertain,Intimal sarcoma,1
39810,Local disease,Pleomorphic Lipoma,1
39811,Perineural spread,Adenoid cystic breast carcinoma,1
39812,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
39813,Single Cell Necrosis,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
39814,Carcinomatous Component Present,Unresectable Renal Pelvis Urothelial Carcinoma,1
39815,Epithelial Component Present,Stage IIIA Penile Cancer AJCC v8,1
39816,Malignant Cellular Infiltrate,Stage II Esophageal Squamous Cell Carcinoma AJCC v7,1
39817,Borderline Lesion,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
39818,Cutaneous Involvement,Skin Mastocytoma,1
39819,Metastatic/Recurrent Disease,Pulmonary Artery Intimal Sarcoma,1
39820,Chronic lymphocytic inflammation,Gastric Carcinoma with Lymphoid Stroma,1
39821,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Unknown Primary,1
39822,Epithelial Component Present,Stage II Ampulla of Vater Cancer AJCC v8,1
39823,Malignant Cellular Infiltrate,synovial sarcoma,1
39824,Benign Cellular Infiltrate,Leiomyoma of small intestine,1
39825,Low Mitotic Activity,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
39826,Tissue Differentiation Uncertain,Peritoneal Desmoplastic Small Round Cell Tumor,1
39827,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
39828,Diffuse Pattern,oligodendroglioma,1
39829,Chromogranin A Positive Neoplastic Cells Present,Midgut Carcinoid Tumor,1
39830,Epithelial Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
39831,Intraductal Lesion,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
39832,Malignant Cellular Infiltrate,Appendix Carcinoma by AJCC v7 Stage,1
39833,Malignant Cellular Infiltrate,Ovarian Adenosarcoma,1
39834,Malignant Cellular Infiltrate,Stage I Vaginal Cancer AJCC v6 and v7,1
39835,Neuroendocrine Differentiation,Foregut Carcinoid Tumor,1
39836,Adulthood Lesion,Aggressive Adult Non-Hodgkin Lymphoma,1
39837,Well Differentiated Neuroendocrine Lesion,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
39838,Cavernous Vascular Space Formation,Intracranial cavernous hemangioma,1
39839,High Mitotic Activity,Stage II Merkel Cell Carcinoma AJCC v7,1
39840,Cutaneous Involvement,Cutaneous Fibrous Histiocytoma,1
39841,Epithelial Component Present,Refractory Paranasal Sinus Squamous Cell Carcinoma,1
39842,Absence of Stromal Invasion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
39843,Monoclonal Cellular Population Present,Thyroid Gland Clear Cell Follicular Adenoma,1
39844,Sarcomatous Component Present,Uterine Corpus Carcinosarcoma,1
39845,In Situ Lesion,Intraductal carcinoma and lobular carcinoma in situ,1
39846,Malignant Cellular Infiltrate,Stage III Lung Cancer AJCC v6,1
39847,Carcinomatous Component Present,Refractory Bladder Carcinoma,1
39848,Carcinomatous Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
39849,Perineural spread,Adenoid cystic carcinoma of the oral cavity recurrent,1
39850,Immunosuppression-Related Post-Transplant Toxicity,Renal transplant rejection,1
39851,High Grade Lesion,Refractory Dedifferentiated Liposarcoma,1
39852,Malignant Cellular Infiltrate,Skin squamous cell carcinoma metastatic,1
39853,Malignant Cellular Infiltrate,Unresectable Ewing Sarcoma,1
39854,Malignant Cellular Infiltrate,"Carcinoma, Giant Cell",1
39855,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
39856,Benign Cellular Infiltrate,Bladder Leiomyoma,1
39857,Malignant Cellular Infiltrate,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
39858,Cutaneous Involvement,Malignant blue nevus of skin,1
39859,High Grade Lesion,Recurrent Childhood Glioblastoma,1
39860,Severe dysplasia,Stage 0 Major Salivary Gland Cancer AJCC v8,1
39861,Epithelial Component Present,Squamous cell carcinoma of buccal mucosa,1
39862,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
39863,Carcinomatous Component Present,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
39864,Carcinomatous Component Present,Metastatic Carcinoma in the Adrenal Cortex,1
39865,Malignant Cellular Infiltrate,Warty Carcinoma of the Penis,1
39866,Lymphadenopathy,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage,1
39867,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm of Salivary Gland,1
39868,Carcinomatous Component Present,Carcinoma in a polyp,1
39869,Multihormonal Immunoreactivity Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma,1
39870,Metastatic Lesion,Metastatic Fibrolamellar Carcinoma,1
39871,Malignant Cellular Infiltrate,Pancreatic carcinoma,1
39872,Malignant Cellular Infiltrate,Anatomic Stage IIB Breast Cancer AJCC v8,1
39873,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v8,1
39874,Perivascular Arrangement of Tumor Cells,Lung Clear Cell Tumor,1
39875,Broad Fibrous Bands Formation,Parathyroid Gland Atypical Adenoma,1
39876,Epithelial Component Present,Prostate Carcinoma by Gene Expression Profile,1
39877,Epithelial Component Present,Stage II Lung Small Cell Carcinoma AJCC v7,1
39878,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2,1
39879,Malignant Cellular Infiltrate,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
39880,Epithelial Component Present,undifferentiated carcinoma of larynx,1
39881,Epithelial Component Present,undifferentiated carcinoma of extrahepatic bile duct,1
39882,Carcinomatous Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v7,1
39883,Malignant Cellular Infiltrate,Lymphangitis carcinomatosa,1
39884,Malignant Cellular Infiltrate,Acral Lentiginous Malignant Melanoma,1
39885,Malignant Cellular Infiltrate,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
39886,Malignant Cellular Infiltrate,Rhabdoid meningioma,1
39887,Malignant Cellular Infiltrate,small cell carcinoma of kidney,1
39888,Cutaneous Involvement,Hair nevus,1
39889,Carcinomatous Component Present,Prostate Cancer by AJCC v8 Stage,1
39890,Malignant Cellular Infiltrate,Epithelioid hemangioendothelioma,1
39891,Carcinomatous Component Present,Stage II Bladder Cancer AJCC v8,1
39892,Epithelial Component Present,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
39893,Epithelial Component Present,Gallbladder Papillomatosis,1
39894,Above the Diaphragm Disease,Hodgkin's disease mixed cellularity stage I supradiaphragmatic,1
39895,Severe dysplasia,Noninfiltrating Intraductal Carcinoma,1
39896,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage III,1
39897,Diffuse Lesion,Diffuse Pulmonary Lymphangiomatosis,1
39898,Low Mitotic Activity,Localized Digestive System Neuroendocrine Tumor G1,1
39899,Benign Cellular Infiltrate,Degeneration of uterine fibroid,1
39900,Carcinomatous Component Present,Stage I Carcinoma of Bladder,1
39901,Malignant Cellular Infiltrate,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
39902,Epithelial Component Present,Stage IIA Colorectal Cancer AJCC v7,1
39903,Increased Cellularity Present,Recurrent Childhood Anaplastic Oligodendroglioma,1
39904,Primary Lesion,Recurrent Anaplastic Oligodendroglioma,1
39905,Antoni A Pattern,Adrenal Gland Schwannoma,1
39906,Papillary Pattern,"Papilloma, Squamous Cell",1
39907,Cutaneous Involvement,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
39908,Low Grade Neuroendocrine Lesion,Localized Digestive System Neuroendocrine Tumor G1,1
39909,Childhood Lesion,Childhood Malignant Penile Neoplasm,1
39910,Keratin pearl formation,keratinizing squamous cell carcinoma of nasal cavity,1
39911,Epithelial Component Present,Malignant basal cell tumor,1
39912,Epithelial Component Present,Tumor of the Thecoma/Fibroma Group,1
39913,Recurrent disease,Recurrent Ampulla of Vater Adenocarcinoma,1
39914,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of appendix,1
39915,Carcinomatous Component Present,Prognostic Stage IIIC Breast Cancer AJCC v8,1
39916,Serotonin Positive Neoplastic Cells Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
39917,Carcinomatous Component Present,Inflammatory carcinoma of breast stage IV,1
39918,Carcinomatous Component Present,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
39919,Hyperplastic Tissue Present,Benign Prostatic Hyperplasia,1
39920,Epithelial Component Present,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
39921,Malignant Cellular Infiltrate,Solid Lung Adenocarcinoma,1
39922,Epithelial Component Present,Metastatic Renal Cell Carcinoma,1
39923,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1
39924,Epithelial Component Present,Stage IA Fallopian Tube Cancer AJCC v6 and v7,1
39925,Malignant Cellular Infiltrate,Leiomyosarcoma of Deep Soft Tissue,1
39926,Preserved Nuclear Polarity,Urethral Urothelial Papilloma,1
39927,Refractory Disease,Refractory Thymic Carcinoma,1
39928,Lobulated Growth Pattern,Unresectable Chordoma,1
39929,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Adult Acute Myeloid Leukemia without Maturation,1
39930,Diffuse Pattern,Diffuse Intrinsic Pontine Glioma,1
39931,Indolent Clinical Course,Cervical Rhabdomyoma,1
39932,atypia morphology,Atypical fibroxanthoma - spindle cell type,1
39933,Malignant Cellular Infiltrate,Choriocarcinoma of the Testis,1
39934,Recurrent disease,Recurrent Intravascular Large B-Cell Lymphoma,1
39935,Malignant Cellular Infiltrate,Refractory Mixed Phenotype Acute Leukemia,1
39936,Carcinomatous Component Present,Stage 0is Penile Cancer AJCC v8,1
39937,Monoclonal Cellular Population Present,Urticaria Pigmentosa,1
39938,Collagenous Stroma Formation,Vaginal Angiomyofibroblastoma,1
39939,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
39940,Epithelial Component Present,Stage IV Renal Cell Cancer AJCC v7,1
39941,Malignant Cellular Infiltrate,Carcinoma in situ of small intestine,1
39942,Peripheral Nuclear Palisading,basaloid carcinoma of anus,1
39943,Adnexal Differentiation,Trichoepithelioma,1
39944,Necrotic changes (finding),Malignant Lung PEComa,1
39945,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Grade 1 Endometrial Endometrioid Adenocarcinoma,1
39946,Recurrent disease,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
39947,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
39948,More than 10 Mitoses per 10HPF,Small cell lung cancer extensive stage,1
39949,Epithelial Component Present,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
39950,Malignant Cellular Infiltrate,Intermediate Cell Type Ciliary Body Melanoma,1
39951,Capillary Sized Vascular Channel Formation,Infantile hemangioma of liver,1
39952,Epithelial Component Present,Vaginal intraepithelial neoplasia,1
39953,Adulthood Lesion,Stage II Adult Hodgkin Lymphoma,1
39954,Recurrent disease,Recurrent Central Nervous System Non-Hodgkin Lymphoma,1
39955,Papillary Pattern,"Papillary mucinous cystadenoma, borderline malignancy",1
39956,Malignant Cellular Infiltrate,Refractory Aggressive Non-Hodgkin Lymphoma,1
39957,Malignant Cellular Infiltrate,Malignant tumor of choroid plexus,1
39958,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
39959,Adulthood Lesion,Adult Acute Myeloid Leukemia with Maturation,1
39960,Mixed Cellular Population,"Phyllodes tumor, benign",1
39961,Vascular Channel Formation,Parotid Gland Kaposi Sarcoma,1
39962,Hyaline Cartilage Differentiation,chondroma of lung,1
39963,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Aleukemic Monocytic Leukemia Cutis,1
39964,Well-Circumscribed Lesion,"Adenoma, Sweat Gland",1
39965,Malignant Cellular Infiltrate,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
39966,Epithelial Component Present,Stage II Esophageal Cancer AJCC v7,1
39967,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage I,1
39968,Epithelial Component Present,Carcinoma Metastatic to the Skin,1
39969,Cutaneous Involvement,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
39970,Fibrotic Stroma Formation,Major Salivary Gland Mucoepidermoid Carcinoma,1
39971,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v6,1
39972,Carcinomatous Component Present,combined small cell carcinoma of lung,1
39973,Pseudorosette Formation,"Gastrinoma, malignant",1
39974,Carcinomatous Component Present,Cholangiocarcinoma,1
39975,Indolent Clinical Course,Liver Cavernous Hemangioma,1
39976,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline DDX41 Mutation,1
39977,Increased Cellularity Present,Resectable Neuroblastoma,1
39978,Epithelial Component Present,Bladder Cancer by AJCC v6 Stage,1
39979,Tissue Differentiation Uncertain,Pulmonary Artery Intimal Sarcoma,1
39980,Clinical TNM Finding,Clinical Stage IVB Gastric Cancer AJCC v8,1
39981,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage II,1
39982,Well-Circumscribed Lesion,Juvenile Polyp of the Small Intestine,1
39983,Clinical TNM Finding,Clinical Stage IIA Gastric Cancer AJCC v8,1
39984,Carcinomatous Component Present,Stage I Renal Pelvis Cancer AJCC v7,1
39985,Immunoglobulin Deposition,Refractory Primary Amyloidosis,1
39986,Malignant Cellular Infiltrate,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
39987,Carcinomatous Component Present,Ampulla of Vater Hepatoid Adenocarcinoma,1
39988,atypia morphology,Borderline Ovarian Clear Cell Tumor,1
39989,Papillary Pattern,Frontal Sinus Schneiderian Papilloma,1
39990,Carcinomatous Component Present,Breast Mucinous Cystadenocarcinoma,1
39991,Non-Invasive Lesion,Papillary transitional cell neoplasm of low malignant potential,1
39992,Benign Cellular Infiltrate,Benign Mastocytoma,1
39993,Benign Cellular Infiltrate,Benign neoplasm of middle ear,1
39994,Bone marrow reticulin fibrosis,Hairy Cell Leukemia,1
39995,Malignant Cellular Infiltrate,"Mucinous adenocarcinoma, endocervical type",1
39996,Malignant Cellular Infiltrate,Cervical Villoglandular Adenocarcinoma,1
39997,Malignant Cellular Infiltrate,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
39998,atypia morphology,Borderline Ovarian Endometrioid Cystadenofibroma,1
39999,Malignant Cellular Infiltrate,Resectable Pancreatic Ductal Adenocarcinoma,1
40000,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Acute Myeloid Leukemia (AML-M2),1
40001,Pseudorosette Formation,"Gastrinoma, malignant",1
40002,Local disease,Intracranial lipoma,1
40003,Benign Cellular Infiltrate,Hemangioma of subcutaneous tissue,1
40004,Well-Circumscribed Lesion,polyps,1
40005,Cystic Lesion,Adult Craniopharyngioma,1
40006,Immunologic Deficiency Syndromes,Bone Marrow Transplantation Nephropathy,1
40007,Diffuse Pattern,Anaplastic Diencephalic Astrocytoma,1
40008,Secondary Lesion,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
40009,Indolent Clinical Course,Central Nervous System Hemangioma,1
40010,Malignant Cellular Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7,1
40011,Papillary Pattern,serous surface papillary carcinoma of ovary,1
40012,Primary Lesion,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,1
40013,Recurrent disease,Recurrent Adult Acute Lymphoblastic Leukemia,1
40014,Carcinomatous Component Present,Epithelial-myoepithelial carcinoma,1
40015,Epithelial Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v7,1
40016,Poorly Differentiated Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
40017,Childhood Lesion,Stage IV Childhood Lymphoblastic Lymphoma,1
40018,Carcinomatous Component Present,Lung Acinar Adenocarcinoma,1
40019,Adulthood Lesion,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8,1
40020,Invasive Lesion,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
40021,Tobacco Toxicity,Cigarette Smoking-Related Carcinoma,1
40022,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
40023,Malignant Cellular Infiltrate,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
40024,Indolent Clinical Course,Uterine Corpus Bizarre Leiomyoma,1
40025,Refractory Disease,Refractory Myxoid Liposarcoma,1
40026,Epithelial Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
40027,Cutaneous Involvement,Primary cutaneous lymphoma,1
40028,Keratin pearl formation,keratinizing squamous cell carcinoma of vulva,1
40029,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Mucinous",1
40030,Well-Circumscribed Lesion,Colon Traditional Serrated Adenoma,1
40031,Refractory Disease,Refractory Primary Peritoneal Carcinoma,1
40032,Nodular Pattern,Ann Arbor Stage IV Grade 2 Follicular Lymphoma,1
40033,Epithelial Component Present,Thyroid Gland Mucinous Carcinoma,1
40034,Pseudoencapsulated Mass,Refractory Malignant Peripheral Nerve Sheath Tumor,1
40035,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
40036,Adulthood Lesion,Adult Acute Basophilic Leukemia,1
40037,Non-Invasive Lesion,Bladder Non-Invasive Urothelial Neoplasm,1
40038,Carcinomatous Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8,1
40039,Epithelial Component Present,Colorectal Cancer by AJCC v8 Stage,1
40040,Childhood Lesion,Recurrent Childhood Optic Nerve Glioma,1
40041,Malignant Cellular Infiltrate,Stage IIB Esophageal Carcinoma,1
40042,Cutaneous Involvement,Morpheic basal cell carcinoma,1
40043,Low Mitotic Activity,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
40044,Carcinomatous Component Present,Stage III renal cell cancer,1
40045,Malignant Cellular Infiltrate,Philadelphia-Positive Myelogenous Leukemia,1
40046,Perivascular Arrangement of Tumor Cells,Solid Angioleiomyoma,1
40047,Childhood Lesion,Lugano Classification Advanced Stage Childhood Hodgkin Lymphoma AJCC v8,1
40048,Epithelial Component Present,Stage IC Ovarian Cancer AJCC v8,1
40049,Epithelial Component Present,Stage I Gastric Carcinoma,1
40050,Dysplasia,Cervical Intraepithelial Neoplasia Grade 2/3,1
40051,Anaplasia,Anaplastic Hemispheric Astrocytoma,1
40052,Epithelial Component Present,Anaplastic adrenocortical carcinoma,1
40053,Malignant Cellular Infiltrate,Overt Primary Myelofibrosis,1
40054,Carcinomatous Component Present,Mucinous cystadenocarcinoma of ovary,1
40055,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma recurrent,1
40056,Benign Cellular Infiltrate,Non-Functioning Adrenal Cortex Adenoma,1
40057,Carcinomatous Component Present,Pancreatic Small Cell Neuroendocrine Carcinoma,1
40058,Malignant Cellular Infiltrate,Unresectable Osteosarcoma,1
40059,Thin-Walled Branching Vascular Pattern,Pericardial Solitary Fibrous Tumor,1
40060,S-100-Positive Neoplastic Cells Present,Pulmonary lymphangioleiomyomatosis,1
40061,Metastatic Lesion,Secondary malignant neoplasm of liver,1
40062,Above the Diaphragm Disease,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
40063,Metastatic/Recurrent Disease,Cardiac Monophasic Synovial Sarcoma,1
40064,Multinodular Pattern,Eccrine dermal cylindroma,1
40065,Epithelial Component Present,Metastatic Bile Duct Carcinoma,1
40066,Refractory Disease,Anaplastic large cell lymphoma T- and null-cell types refractory,1
40067,Malignant Cellular Infiltrate,Endometrial Stromal Sarcoma,1
40068,Vascular Channel Formation,Metastatic Epithelioid Hemangioendothelioma,1
40069,Malignant Cellular Infiltrate,"T-Cell Prolymphocytic Leukemia, Small Cell Variant",1
40070,Carcinomatous Component Present,verrucous carcinoma of vulva,1
40071,Composite Lesion,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
40072,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
40073,Carcinomatous Component Present,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
40074,Epithelial Component Present,Stage IIB Esophageal Adenocarcinoma AJCC v7,1
40075,Malignant Cellular Infiltrate,Metastatic Esophageal Carcinoma,1
40076,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma by ISS Stage,1
40077,Stromal Invasion,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
40078,Benign Cellular Infiltrate,Frontal Sinus Schneiderian Papilloma,1
40079,Malignant Cellular Infiltrate,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
40080,Carcinomatous Component Present,Apocrine Breast Carcinoma In Situ,1
40081,Papillary Pattern,Syringocystadenoma Papilliferum,1
40082,Malignant Cellular Infiltrate,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,1
40083,Malignant Cellular Infiltrate,Refractory Thymic Carcinoma,1
40084,Childhood Lesion,Benign Childhood Supratentorial Neoplasm,1
40085,Carcinomatous Component Present,Stage IIC Colorectal Cancer AJCC v8,1
40086,Osseous Differentiation,Stage IV Osteosarcoma AJCC v7,1
40087,Adnexal Differentiation,Sebaceous Breast Carcinoma,1
40088,Benign Cellular Infiltrate,Scrotal Hemangioma,1
40089,Eosinophil count raised (finding),Childhood Acute Eosinophilic Leukemia,1
40090,Carcinomatous Component Present,Anterior Tongue Squamous Cell Carcinoma,1
40091,Carcinomatous Component Present,Ghost Cell Odontogenic Carcinoma,1
40092,Carcinomatous Component Present,Stage IA Merkel Cell Carcinoma AJCC v7,1
40093,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage III,1
40094,Epithelial Component Present,"Squamous cell carcinoma, clear cell type",1
40095,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
40096,Radiation Sickness,Cataract associated with radiation,1
40097,Malignant Cellular Infiltrate,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood,1
40098,Neuroendocrine Differentiation,Malignant Intrathoracic Paravertebral Paraganglioma,1
40099,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1,1
40100,Benign Cellular Infiltrate,Nasopharyngeal Angiofibroma,1
40101,Exophytic Polypoid Lesion,Polyp of vagina,1
40102,Neuroendocrine Differentiation,Intestinal Gangliocytic Paraganglioma,1
40103,Malignant Cellular Infiltrate,Mucosa-Associated Lymphoid Tissue Lymphoma,1
40104,Epithelial Component Present,"Gastric Adenoma, Gastric-Type",1
40105,Unresectable Mass,Unresectable Lung Carcinoma,1
40106,Epithelial Component Present,adenoma of extrahepatic bile duct,1
40107,Carcinomatous Component Present,Early Hepatocellular Carcinoma,1
40108,Hereditary Lesion,"Optic Atrophies, Hereditary",1
40109,Malignant Cellular Infiltrate,Stage IVA Bone Sarcoma AJCC v7,1
40110,Multinodular Pattern,Sporadic Cylindroma,1
40111,Malignant Cellular Infiltrate,Recurrent Combined Thymic Epithelial Neoplasm,1
40112,Malignant Cellular Infiltrate,Locally Advanced Carcinoma,1
40113,Carcinomatous Component Present,Unresectable Urethral Urothelial Carcinoma,1
40114,Hemorrhagic,Hemangiosarcoma,1
40115,Epithelial Component Present,Serous Endometrial Intraepithelial Carcinoma,1
40116,Epithelial Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
40117,Cutaneous Involvement,Clear cell hidradenoma,1
40118,Epithelial Differentiation,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
40119,Malignant Cellular Infiltrate,Gastric Small Cell Carcinoma,1
40120,Pathologic TNM Finding,Pathologic Stage IIC Cutaneous Melanoma AJCC v8,1
40121,Epithelial Component Present,Grade II Glandular Intraepithelial Neoplasia,1
40122,Carcinomatous Component Present,Undifferentiated carcinoma of stomach,1
40123,Malignant Cellular Infiltrate,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,1
40124,Epithelial Component Present,Bladder squamous cell carcinoma stage III,1
40125,Carcinomatous Component Present,Stage IVA Paranasal Sinus Cancer AJCC v7,1
40126,Pathologic TNM Finding,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
40127,Biphasic Pattern,Lung Biphasic Synovial Sarcoma,1
40128,High Grade Lesion,Adult Pleomorphic Rhabdomyosarcoma,1
40129,Epithelial Component Present,Laryngeal papillomatosis,1
40130,Low Mitotic Activity,Carcinoid tumor of pancreas,1
40131,Desmoplastic Stroma Formation,Adult Desmoplastic Small Round Cell Tumor,1
40132,Carcinomatous Component Present,Duodenal Cancer,1
40133,Malignant Cellular Infiltrate,malignant neoplasm of skull,1
40134,Epithelial Component Present,Colon Carcinoma Metastatic in the Liver,1
40135,Intraosseous Lesion,Basal Cell Ameloblastoma,1
40136,Malignant Cellular Infiltrate,Recurrent Chromophobe Renal Cell Carcinoma,1
40137,Increased Cellularity Present,Anaplastic astrocytoma,1
40138,Thyroglobulin Positive Neoplastic Cells Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
40139,Well-Circumscribed Lesion,Foveolar-Type Adenoma,1
40140,Intramucosal Lesion,Adenoma of the Colon with Intramucosal Adenocarcinoma,1
40141,Carcinomatous Component Present,mucoepidermoid carcinoma of esophagus,1
40142,Adulthood Lesion,Stage II Adult Soft Tissue Sarcoma AJCC v7,1
40143,Carcinomatous Component Present,Hormone-Resistant Prostate Carcinoma,1
40144,Carcinomatous Component Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
40145,Carcinomatous Component Present,Stage IIA1 Cervical Cancer AJCC v7,1
40146,Regional Disease,Locally Advanced Sarcoma,1
40147,Well Differentiated Neuroendocrine Lesion,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
40148,Absence of Muscle Invasion,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
40149,Nuclear Pseudoinclusion,Papillary Thyroid Microcarcinoma,1
40150,Malignant Cellular Infiltrate,AJCC Grade 3 Sarcoma,1
40151,Malignant Cellular Infiltrate,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
40152,Multinodular Pattern,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
40153,Malignant Cellular Infiltrate,Pathologic Stage IIB Cutaneous Melanoma AJCC v8,1
40154,Recurrent disease,Recurrent Childhood Oligoastrocytoma,1
40155,Intracanalicular Growth Pattern,Benign phyllodes neoplasm of breast,1
40156,Malignant Cellular Infiltrate,small cell carcinoma of salivary gland,1
40157,Epithelial Component Present,Anal margin Paget's disease,1
40158,Dysplasia,Vaginal Tubulovillous Adenoma,1
40159,Malignant Cellular Infiltrate,Colorectal Mantle Cell Lymphoma,1
40160,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
40161,Epithelial Component Present,Invasive papillary breast carcinoma,1
40162,Carcinomatous Component Present,adenocarcinoma of oral cavity,1
40163,Epithelial Component Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
40164,Carcinomatous Component Present,BRCA-Mutated Ovarian Carcinoma,1
40165,Slow Growing Mass,Adult Myxopapillary Ependymoma,1
40166,Malignant Cellular Infiltrate,Breast Rhabdomyosarcoma,1
40167,Unresectable Mass,Unresectable Solid Neoplasm,1
40168,Cutaneous Involvement,Porokeratosis,1
40169,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
40170,Epithelial Component Present,Trichilemmoma,1
40171,Epithelial Component Present,Ampulla of Vater Intestinal-Type Adenocarcinoma,1
40172,Malignant Cellular Infiltrate,Undifferentiated Endocervical Sarcoma,1
40173,Collagenous Stroma Formation,"Fibromatosis, Abdominal",1
40174,Diffuse Pattern,Brain Stem Glioblastoma,1
40175,Cutaneous Involvement,Skin Cavernous Hemangioma,1
40176,Epithelial Component Present,Stage IV Colorectal Cancer,1
40177,Papillary Pattern,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
40178,Thin Bands of Collagen Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
40179,Organoid Pattern,Orbital Alveolar Soft Part Sarcoma,1
40180,Well-Circumscribed Lesion,Preauricular skin tag,1
40181,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
40182,Malignant Cellular Infiltrate,Stage IA2 Cervical Cancer,1
40183,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,1
40184,Fibrotic Stroma Formation,Acanthomatous ameloblastoma,1
40185,Carcinomatous Component Present,Stage II Lip Cancer AJCC v6 and v7,1
40186,Polymorphic Cellular Infiltrate,Pulmonary Histiocytosis X,1
40187,Biphasic Pattern,Recurrent Ovarian Carcinosarcoma,1
40188,Epithelial Component Present,Recurrent Adult Hepatocellular Carcinoma,1
40189,Epithelial Component Present,Stage IA1 Cervical Cancer,1
40190,Radiation Sickness,Radiation-induced fibrous mediastinitis,1
40191,In Situ Lesion,Stage 0 Gallbladder Cancer AJCC v8,1
40192,Adulthood Lesion,Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8,1
40193,Malignant Cellular Infiltrate,Stage IVA Hepatocellular Carcinoma AJCC v7,1
40194,Indolent Clinical Course,Lung Myoepithelioma,1
40195,Epithelial Component Present,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,1
40196,Hyperplastic Tissue Present,Verumontanum Mucosal Gland Hyperplasia,1
40197,Defective Gamma Heavy Chain Present,gamma-Chain Disease,1
40198,Benign Cellular Infiltrate,Gastric Plexiform Fibromyxoma,1
40199,Locally Aggressive Lesion,Atypical fibroxanthoma of skin,1
40200,Infiltrative Growth Pattern,Adult Diffuse Astrocytoma,1
40201,Recurrent disease,Esophageal adenocarcinoma recurrent,1
40202,Malignant Cellular Infiltrate,Small cell carcinoma of ovary,1
40203,Malignant Cellular Infiltrate,Mucoepidermoid Carcinoma,1
40204,Necrotic changes (finding),Gastric Small Cell Carcinoma,1
40205,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of gallbladder,1
40206,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
40207,Epithelial Component Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,1
40208,Benign Cellular Infiltrate,Uterine Corpus Hydropic Leiomyoma,1
40209,Cutaneous Involvement,Vascular neoplasm of skin,1
40210,Malignant Cellular Infiltrate,Meningeal melanomatosis,1
40211,Neuroendocrine Differentiation,Rectal Neuroendocrine Neoplasm,1
40212,Malignant Cellular Infiltrate,Stage I Non-Hodgkin Lymphoma,1
40213,Neuroendocrine Differentiation,Locally Advanced Paraganglioma,1
40214,Primary Lesion,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
40215,Carcinomatous Component Present,Vulvar adenocarcinoma,1
40216,Absence of Invasion,Bowenoid papulosis,1
40217,VIP Positive Neoplastic Cells Present,Malignant Pancreatic Vipoma,1
40218,Decreased platelet count,Kasabach-Merritt syndrome,1
40219,Carcinomatous Component Present,Proximal Urethral Carcinoma,1
40220,Carcinomatous Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v8,1
40221,Epithelial Component Present,Masaoka-Koga Stage II,1
40222,Nested Pattern,Calcifying Nested Epithelial Stromal Tumor of the Liver,1
40223,Epithelial Component Present,Choroid Plexus Papilloma,1
40224,Epithelial Component Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
40225,Adulthood Lesion,Stage I Adult Hodgkin Lymphoma,1
40226,Dilated Terminal Duct Lobular Units Present,Columnar Cell Hyperplasia of the Breast,1
40227,Carcinomatous Component Present,"Basal cell carcinoma, micronodular",1
40228,Benign Cellular Infiltrate,Pedunculated conjunctival papilloma,1
40229,Epithelial Component Present,Carcinoma bone,1
40230,Cutaneous Involvement,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
40231,Malignant Cellular Infiltrate,Stage IIIB Appendix Carcinoma AJCC v8,1
40232,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
40233,Recurrent Lymphoma,EBV-Related Lymphoma,1
40234,Infiltrative Growth Pattern,"Fibromatosis, Plantar",1
40235,Anaplasia,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",1
40236,Desmoplastic Stroma Formation,Malignant Proliferating Pilar Tumor,1
40237,Epithelial Component Present,Ocular Sebaceous Carcinoma,1
40238,Benign Cellular Infiltrate,Benign Mediastinal Soft Tissue Neoplasm,1
40239,Immunologic Deficiency Syndromes,AIDS-Related Human Papillomavirus Infection,1
40240,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v8,1
40241,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Fetiform Teratoma,1
40242,Malignant Cellular Infiltrate,Adult Gliosarcoma,1
40243,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
40244,Refractory Disease,Refractory Desmoplastic Small Round Cell Tumor,1
40245,Metastatic Lesion,Cholangiocarcinoma metastatic,1
40246,Primary Lesion,Meningeal melanocytoma,1
40247,Secondary Lesion,Breast Carcinoma Metastatic in the Skin,1
40248,Necrotic changes (finding),Glandular malignant peripheral nerve sheath tumor,1
40249,Cutaneous Involvement,Stage III Merkel Cell Carcinoma AJCC v7,1
40250,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyposis coli,1
40251,Malignant Cellular Infiltrate,Prolactin-Producing Pituitary Gland Carcinoma,1
40252,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v7,1
40253,Smooth Muscle Component Present,Hamartoma of lung,1
40254,Epithelial Component Present,Glottic Squamous Cell Carcinoma,1
40255,Secondary Lesion,Advanced Urothelial Carcinoma,1
40256,Cystic Change,Ovarian Papillary Cystadenoma,1
40257,Well Differentiated Lesion,Verrucous carcinoma of penis,1
40258,Cutaneous Involvement,Herpes simplex dermatitis,1
40259,Multinodular Mass,Hemangiosarcoma,1
40260,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",1
40261,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
40262,Carcinomatous Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
40263,Carcinomatous Component Present,Stage III Bladder Cancer AJCC v6 and v7,1
40264,Malignant Cellular Infiltrate,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,1
40265,Nerve palsy,Cranial nerve palsies,1
40266,Multifocal Lesion,Chondromatosis,1
40267,Fibrotic Stroma Formation,Mucoepidermoid Carcinoma,1
40268,Borderline Resectable Mass,Borderline Resectable Carcinoma,1
40269,Malignant Cellular Infiltrate,Malignant Adrenal Gland Composite Pheochromocytoma,1
40270,Diffuse Pattern,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
40271,Well-Circumscribed Lesion,Unclassified Hepatocellular Adenoma,1
40272,Histiocytosis haematophagic,Secondary haemophagocytic lymphohistiocytosis,1
40273,Recurrent disease,Recurrent Malignant Head and Neck Neoplasm,1
40274,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
40275,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Gene Mutation,1
40276,Neuroendocrine Differentiation,Neoplasm of aortic body,1
40277,Epithelial Component Present,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
40278,Benign Cellular Infiltrate,Benign neoplasm of cornea,1
40279,Carcinomatous Component Present,Recurrent Digestive System Neuroendocrine Carcinoma,1
40280,Invasive Lesion,ACTH-Producing Pituitary Gland Carcinoma,1
40281,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v6 and v7,1
40282,Carcinomatous Component Present,Childhood Salivary Gland Carcinoma,1
40283,Malignant Cellular Infiltrate,Malignant Peritoneal and Retroperitoneal Neoplasm,1
40284,Malignant Cellular Infiltrate,Adenocarcinoma of salivary gland,1
40285,Childhood Lesion,Recurrent Childhood Brain Neoplasm,1
40286,Malignant Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor,1
40287,Well-Circumscribed Lesion,Ampulla of Vater Villous Adenoma,1
40288,Benign Cellular Infiltrate,Fibroma of prostate,1
40289,High Grade Lesion,Vaginal Rhabdomyosarcoma,1
40290,Benign Cellular Infiltrate,Pericardial Leiomyoma,1
40291,Refractory Disease,Refractory Soft Tissue Sarcoma,1
40292,Refractory Disease,Refractory Malignant Bone Neoplasm,1
40293,Absence of Invasion,Stage 0 Rectal Cancer AJCC v6 and v7,1
40294,Epithelial Component Present,Cervical Intraepithelial Neoplasia Grade 2/3,1
40295,Well-Circumscribed Lesion,Stage I Kidney Wilms Tumor,1
40296,Epithelial Component Present,Colorectal Neuroendocrine Tumor G2,1
40297,Malignant Cellular Infiltrate,Primary Malignant Liver Neoplasm,1
40298,Neuroendocrine Differentiation,Regional Digestive System Neuroendocrine Tumor G1,1
40299,Trabecular Pattern,Well Differentiated Hepatocellular Carcinoma,1
40300,Carcinomatous Component Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
40301,High Mitotic Activity,Anaplastic Oligoastrocytoma,1
40302,Primary Lesion,Recurrent tumors of the Ewing's family,1
40303,Epithelial Component Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
40304,Deep Lesion,Central Nervous System Desmoid-Type Fibromatosis,1
40305,Hereditary Lesion,Familial medullary thyroid carcinoma,1
40306,High Mitotic Activity,Central Nervous System Embryonal Carcinoma,1
40307,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Refractory anemia with excess blasts I,1
40308,Epithelial Component Present,Ovarian Surface Papilloma,1
40309,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
40310,Carcinomatous Component Present,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma,1
40311,Exophytic Polypoid Lesion,Duodenal Adenoma,1
40312,Malignant Cellular Infiltrate,Stage III Colorectal Cancer,1
40313,Intraosseous Lesion,Odontogenic myxoma,1
40314,Arborising Network of Cords of Basaloid Cells Present,Fibroepithelioma of Pinkus,1
40315,Biphasic Pattern,Intracanalicular fibroadenoma,1
40316,Nuclear Pseudoinclusion,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
40317,Malignant Germinomatous Cellular Infiltrate,Pineal germinoma,1
40318,Hypoglycemia,Malignant Pancreatic Insulinoma,1
40319,Mitotic Activity,High Grade Ductal Breast Carcinoma In Situ,1
40320,Malignant Cellular Infiltrate,Sarcoma,1
40321,Recurrent disease,Recurrent Thyroid Gland Papillary Carcinoma,1
40322,Secondary Lesion,Advanced Synovial Sarcoma,1
40323,Oligodendroglial Component Present,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
40324,Malignant Cellular Infiltrate,Locally Advanced Unresectable Soft Tissue Sarcoma,1
40325,Microvascular Proliferation,Childhood Brain Stem Gliosarcoma,1
40326,Well-Circumscribed Lesion,Ovarian Myxoid Liposarcoma,1
40327,Cutaneous Involvement,Dermatitis Herpetiformis,1
40328,Epithelial Component Present,Perineal Ectopic Fibroadenoma,1
40329,atypia morphology,Grade III Lymphomatoid Granulomatosis,1
40330,Indolent Clinical Course,"Lymphangioma, Cystic",1
40331,Carcinomatous Component Present,Asbestos-Related Lung Carcinoma,1
40332,In Situ Lesion,Adenocarcinoma in situ in tubulovillous adenoma,1
40333,Epithelial Component Present,Recurrent Endometrial Serous Adenocarcinoma,1
40334,Carcinomatous Component Present,Refractory Pancreatic Neuroendocrine Carcinoma,1
40335,Benign Cellular Infiltrate,Acral Fibromyxoma,1
40336,Secondary Lesion,Metastatic Uveal Melanoma,1
40337,Nodular Pattern,Nodulo-ulcerative basal cell carcinoma,1
40338,Diffuse Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
40339,S-100-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
40340,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma of the Nasopharynx,1
40341,Secondary Lesion,Metastatic Prostate Carcinoma,1
40342,Childhood Lesion,Childhood Supratentorial Neoplasm,1
40343,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
40344,Malignant Cellular Infiltrate,Stage IIB Uveal Melanoma AJCC v7,1
40345,Metastatic Lesion,Secondary malignant neoplasm of pituitary gland,1
40346,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
40347,Primary Lesion,Unresectable Hepatocellular Carcinoma,1
40348,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
40349,Carcinomatous Component Present,Head and Neck Basaloid Carcinoma,1
40350,Epithelial Component Present,Lung Squamous Cell Papilloma,1
40351,Malignant Cellular Infiltrate,Stage IV Skin Melanoma,1
40352,Epithelial Component Present,Pancreatic Neuroendocrine Tumor G2,1
40353,Childhood Lesion,Childhood Conventional Osteosarcoma,1
40354,Carcinomatous Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
40355,Secondary Lesion,Metastases to adrenals,1
40356,Adulthood Lesion,Adult Fibrolamellar Carcinoma,1
40357,Primary Lesion,Recurrent Childhood Anaplastic Oligoastrocytoma,1
40358,Epithelial Component Present,Oropharyngeal Carcinoma by AJCC v7 Stage,1
40359,Mixed Cellular Population,Juvenile fibroadenoma of breast,1
40360,Carcinomatous Component Present,Colon Cribriform Comedo-Type Adenocarcinoma,1
40361,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Liver,1
40362,Thick-Walled Hyalinized Vessels Present,Benign Esophageal Schwannoma,1
40363,Carcinomatous Component Present,FIGO Stage IIIC Ovarian Cancer,1
40364,Malignant Cellular Infiltrate,small cell carcinoma of breast,1
40365,Microvascular Proliferation,Adult Glioblastoma,1
40366,Benign Cellular Infiltrate,Thyroid Gland Benign Vascular Neoplasm,1
40367,Tissue of Mullerian Origin Present,Atypical polypoid adenomyoma,1
40368,No Identifiable Line of Differentiation,Undifferentiated spindle cell sarcoma,1
40369,Mixed Cellular Population,Infiltrating duct and lobular carcinoma,1
40370,Recurrent disease,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
40371,'Starry-sky' pattern,Burkitt's lymphoma of small intestine,1
40372,Epithelial Component Present,Stage IIB Lung Cancer AJCC v7,1
40373,Benign Cellular Infiltrate,Genital rhabdomyoma,1
40374,Insular Pattern,Malignant Pancreatic Somatostatinoma,1
40375,Malignant Cellular Infiltrate,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
40376,Secondary Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
40377,Borderline Lesion,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
40378,Epithelial Component Present,Stage IVA Lip Cancer AJCC v6 and v7,1
40379,Epithelial Component Present,Maxillary Sinus Carcinoma,1
40380,Recurrent disease,Larynx carcinoma recurrent,1
40381,Malignant Cellular Infiltrate,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",1
40382,Epithelial Component Present,Ampulla of Vater Tubulovillous Adenoma,1
40383,Malignant Cellular Infiltrate,Clear Cell Intrahepatic Cholangiocarcinoma,1
40384,Carcinomatous Component Present,Serous cystadenocarcinoma of pancreas,1
40385,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1",1
40386,Primary Site Unknown,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
40387,Malignant Cellular Infiltrate,Recurrent Pancreatic Ductal Adenocarcinoma,1
40388,Epithelial Component Present,Stage II Esophageal Adenocarcinoma AJCC v7,1
40389,Malignant Cellular Infiltrate,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
40390,Carcinomatous Component Present,Bladder adenocarcinoma recurrent,1
40391,Malignant Cellular Infiltrate,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
40392,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma,1
40393,Lobulated Growth Pattern,Locally Advanced Chordoma,1
40394,Hereditary Lesion,Peutz-Jeghers Syndrome,1
40395,Epithelial Component Present,Stage IVA Major Salivary Gland Cancer AJCC v7,1
40396,Epithelial Component Present,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
40397,Cutaneous Involvement,Vulvar Lichen Sclerosus,1
40398,Hyperplastic Tissue Present,Diffuse C-Cell Hyperplasia,1
40399,Carcinomatous Component Present,Penile Cancer by AJCC v8 Stage,1
40400,Malignant Cellular Infiltrate,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma,1
40401,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Carcinosarcoma,1
40402,Malignant Cellular Infiltrate,Squamous cell carcinoma of conjunctiva,1
40403,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Collapsing Variant,1
40404,Malignant Cellular Infiltrate,Stage IIIA Retroperitoneal Sarcoma AJCC v8,1
40405,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1A,1
40406,Glomerular Hypertrophy,Chronic rejection of renal transplant,1
40407,Epithelial Component Present,Metastatic Bile Duct Carcinoma,1
40408,Intestinal metaplasia,Gastric Mixed Adenocarcinoma,1
40409,Dysplasia,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
40410,Neuroendocrine Differentiation,Rectal Neuroendocrine Tumor,1
40411,Invasive Lesion,Widely Invasive Thymoma,1
40412,Juvenile Lesion,Juvenile type ovarian granulosa cell tumor,1
40413,Cutaneous Involvement,External Ear Actinic Keratosis,1
40414,Malignant Cellular Infiltrate,Advanced Cervical Carcinoma,1
40415,Epithelial Component Present,Fallopian Tube Adenocarcinoma,1
40416,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
40417,Hydropic Villous Change,"Hydatidiform Mole, Partial",1
40418,Low Mitotic Activity,Jejunal Neuroendocrine Tumor G1,1
40419,Squamous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
40420,Metastatic Lesion,Secondary Central Nervous System Lymphoma,1
40421,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
40422,Malignant Cellular Infiltrate,Stage IA Lung Adenosquamous Carcinoma AJCC v7,1
40423,Childhood Lesion,Childhood Unfavorable Prognosis Hodgkin Lymphoma,1
40424,Epithelial Component Present,Stage II Prostate Carcinoma,1
40425,Nodular Pattern,Medulloblastoma with extensive nodularity,1
40426,Epithelial Component Present,Collecting Duct Carcinoma of the Kidney,1
40427,Adulthood Lesion,Adult Epithelioid Hemangioendothelioma,1
40428,Carcinomatous Component Present,Stage I Anal Canal Cancer AJCC v6 and v7,1
40429,Carcinomatous Component Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
40430,Malignant Cellular Infiltrate,Metastatic Unresectable Malignant Neoplasm,1
40431,Benign Cellular Infiltrate,Enchondromatosis,1
40432,Infiltrating Tumor Margins Present,Malignant Cystosarcoma Phyllodes,1
40433,Epithelial Component Present,Recurrent Head and Neck Carcinoma,1
40434,Epithelial Component Present,Breast Carcinoma Metastatic in the Bone,1
40435,Cutaneous Involvement,Skin Nodular Solid Basal Cell Carcinoma,1
40436,Epithelial Component Present,Stage IV Ovarian Cancer AJCC v8,1
40437,Malignant Cellular Infiltrate,Larynx carcinoma recurrent,1
40438,Invasive Lesion,Dermatofibrosarcoma protuberans with myoid differentiation,1
40439,Neuropil Present,Differentiating Neuroblastoma,1
40440,Primary Lesion,Childhood Brain Stem Gliosarcoma,1
40441,Malignant Cellular Infiltrate,Acute myeloid leukemia with multilineage dysplasia,1
40442,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma,1
40443,Epithelial Component Present,Stage II Esophageal Cancer,1
40444,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v8,1
40445,Epithelial Component Present,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
40446,Therapy-Related Toxicity,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
40447,Therapy-Related Toxicity,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
40448,Anaplasia,Lung Pleomorphic Carcinoma,1
40449,Malignant Cellular Infiltrate,Stage IV Cervical Cancer AJCC v8,1
40450,Local disease,Vulvar Fibrolipoma,1
40451,Lymphoplasmacytic Infiltrate,Lung Spindle Cell Carcinoma,1
40452,Carcinomatous Component Present,Stage I Lung Cancer AJCC v8,1
40453,Cutaneous Involvement,Aleukemic Leukemia Cutis,1
40454,Primary Lesion,Adult Pleomorphic Hepatocellular Carcinoma,1
40455,Epithelial Component Present,"Carcinoma, Signet Ring Cell",1
40456,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of parotid gland,1
40457,Malignant Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage I,1
40458,Childhood Lesion,St. Jude Stage III Childhood Non-Hodgkin Lymphoma AJCC v8,1
40459,Malignant Cellular Infiltrate,Low Grade Endometrial Stromal Sarcoma,1
40460,Carcinomatous Component Present,Uterine Ligament Mucinous Adenocarcinoma,1
40461,Antoni A Pattern,Benign Cardiac Schwannoma,1
40462,Pushing Tumor Margin,Supraglottic Verrucous Carcinoma,1
40463,Extensive Stage Lesion,Advanced Uveal Melanoma,1
40464,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v7 Stage,1
40465,Malignant Cellular Infiltrate,follicular malignant lymphoma of breast,1
40466,High Grade Lesion,Childhood Cerebellar Anaplastic Astrocytoma,1
40467,Malignant Cellular Infiltrate,Refractory Chronic Myelomonocytic Leukemia,1
40468,Benign Cellular Infiltrate,Colorectal Perineurioma,1
40469,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP F",1
40470,Indolent Clinical Course,Lung Clear Cell Tumor,1
40471,Intravascular Spread,Intravascular fasciitis,1
40472,Massive Sinusoidal Histiocytic Infiltrate,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,1
40473,Bone Marrow Dysplasia Present,"Myelodysplastic syndrome, no ICD-O subtype",1
40474,Benign Cellular Infiltrate,"Adenoma, Sweat Gland",1
40475,Well-Circumscribed Lesion,Benign neoplasm of mesothelial tissue of peritoneum,1
40476,Malignant Cellular Infiltrate,Stage IIA Bone Cancer AJCC v8,1
40477,Epithelial Component Present,Stage III Primary Peritoneal Cancer AJCC v7,1
40478,Mitotic Activity,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,1
40479,Extraosseous Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,1
40480,Neuroendocrine Differentiation,Gallbladder Neuroendocrine Tumor G2,1
40481,Exophytic Polypoid Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
40482,Carcinomatous Component Present,Prognostic Stage I Breast Cancer AJCC v8,1
40483,Mild cytologic atypia,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
40484,Epithelial Component Present,Anal cancer recurrent,1
40485,Carcinomatous Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7,1
40486,Adulthood Lesion,Adult Teratoma,1
40487,High Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Carcinoma,1
40488,Metastatic Lesion,Drop Metastasis in the Spinal Cord,1
40489,Benign Cellular Infiltrate,Benign neoplasm of pituitary gland,1
40490,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma,1
40491,Well-Circumscribed Lesion,Adenoma of rectum,1
40492,Chronic Inflammatory Infiltrate,Mixed Cellularity Hodgkin Lymphoma,1
40493,Malignant Cellular Infiltrate,FIGO Stage IC1 Ovarian Cancer,1
40494,Nuclear Atypia,Supratentorial Glioblastoma,1
40495,Epithelial Component Present,Adenocarcinoma,1
40496,Epithelial Component Present,mucoepidermoid carcinoma of esophagus,1
40497,Malignant Cellular Infiltrate,Stage II Renal Pelvis and Ureter Cancer AJCC v7,1
40498,Malignant Cellular Infiltrate,Chondrosarcoma localised,1
40499,Neuroendocrine Differentiation,Digestive System Neuroendocrine Carcinoma,1
40500,Vascular Channel Formation,Hemangioma of spleen,1
40501,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v7 Stage,1
40502,Stromal Invasion,Ovarian adenocarcinoma,1
40503,Intramucosal Lesion,"Carcinoma of urinary bladder, superficial",1
40504,Adulthood Lesion,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,1
40505,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
40506,Secondary Lesion,Osteosarcoma Arising in Paget Disease of Bone,1
40507,Necrotic changes (finding),Adult Giant Cell Glioblastoma,1
40508,Borderline Lesion,Borderline Fallopian Tube Mucinous Tumor,1
40509,Malignant Cellular Infiltrate,Cardiac Biphasic Synovial Sarcoma,1
40510,Tissue of Mullerian Origin Present,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8,1
40511,Generalized Dysplasia,Appendix Traditional Serrated Adenoma,1
40512,Secondary Lesion,Secondary malignant neoplasm of parathyroid gland,1
40513,Mixed Cellular Population,Pleomorphic adenoma of parotid gland,1
40514,Necrotic changes (finding),Pancreatic Small Cell Neuroendocrine Carcinoma,1
40515,Cutaneous Involvement,Scrotal Sarcoma,1
40516,Intracytoplasmic Eosinophilic Inclusion,Extrarenal Rhabdoid Tumor of the Liver,1
40517,Epithelial Component Present,Advanced Unresectable Gastric Adenocarcinoma,1
40518,Malignant Cellular Infiltrate,Cervical Yolk Sac Tumor,1
40519,Malignant Cellular Infiltrate,Vaginal Neuroendocrine Carcinoma,1
40520,Acanthosis,Vaginal Warty Carcinoma,1
40521,C19MC Amplification,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
40522,Carcinomatous Component Present,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8,1
40523,High Mitotic Activity,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
40524,Epithelial Component Present,Borderline Ovarian Transitional Cell Tumor,1
40525,High Mitotic Activity,Intestinal Neuroendocrine Carcinoma,1
40526,Carcinomatous Component Present,Stage IIIA1 Ovarian Cancer AJCC v8,1
40527,Lymphadenopathy,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
40528,Nodular lesions,Microfollicular adenoma,1
40529,Epithelial Component Present,Refractory Bladder Carcinoma,1
40530,Primary Lesion,Osteosarcoma by AJCC v7 Stage,1
40531,Extracutaneous Dissemination of Disease,Disseminated Juvenile Xanthogranuloma,1
40532,Carcinomatous Component Present,Tobacco-Related Carcinoma,1
40533,Recurrent disease,Recurrent Childhood Visual Pathway Glioma,1
40534,Carcinomatous Component Present,Prognostic Stage I Breast Cancer AJCC v8,1
40535,Pseudopapillary Pattern,Testicular embryonal carcinoma stage II,1
40536,Epithelial Component Present,Adenomatous Polyps,1
40537,Indolent Clinical Course,Vaginal Leiomyoma,1
40538,Cutaneous Involvement,Preauricular skin tag,1
40539,Benign Cellular Infiltrate,Benign Adrenal Gland Composite Pheochromocytoma,1
40540,Tumor Vascular Invasion,"Glucagonoma, malignant",1
40541,Epithelial Component Present,Intraductal Cribriform Breast Adenocarcinoma,1
40542,Epithelial Component Present,Dermal Duct Tumor,1
40543,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Melanocytic Nevus,1
40544,Malignant Cellular Infiltrate,Transitional cell cancer of renal pelvis and ureter metastatic,1
40545,Malignant Cellular Infiltrate,"Mesothelioma, biphasic, malignant",1
40546,Burn injury,Old Burn Scar-Related Skin Squamous Cell Carcinoma,1
40547,Primary Lesion,Adult Brain Stem Gliosarcoma,1
40548,Carcinomatous Component Present,Stage 0a Penile Cancer AJCC v8,1
40549,Pseudopapillary Pattern,Adult Papillary Meningioma,1
40550,Localized Lesion,Extramedullary Plasmacytoma,1
40551,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage,1
40552,Unresectable Mass,Unresectable Extrahepatic Bile Duct Carcinoma,1
40553,Absence of Stromal Invasion,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,1
40554,Papillary Pattern,Papillary adenofibroma,1
40555,Malignant Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v8,1
40556,Hyalinized Stroma Formation,Peritoneal Solitary Fibrous Tumor,1
40557,Villous Pattern,"Adenoma, Villous",1
40558,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
40559,Biphasic Pattern,Cystadenofibroma,1
40560,Gastric dysplasia,adenomatous polyp of stomach,1
40561,"Amorphus, Eosinophilic, and Acellular Deposit",Reactive systemic amyloidosis,1
40562,Perivascular Arrangement of Tumor Cells,Clear-Cell Myomelanocytic Tumors,1
40563,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma,1
40564,Alternative Fascicle (Bundle) Pattern,Endobronchial Leiomyoma,1
40565,Benign Cellular Infiltrate,Benign neoplasm of thorax,1
40566,Carcinomatous Component Present,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
40567,Carcinomatous Component Present,Stage IV Anal Cancer AJCC v8,1
40568,Malignant Cellular Infiltrate,Stage II Adult Soft Tissue Sarcoma AJCC v7,1
40569,Carcinomatous Component Present,Bladder Papillary Clear Cell Adenocarcinoma,1
40570,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV,1
40571,Tissue Differentiation Uncertain,Lung Monophasic Synovial Sarcoma,1
40572,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
40573,Primary Lesion,Recurrent Primary Effusion Lymphoma,1
40574,Slow Growing Mass,Childhood Ganglioglioma,1
40575,Indolent Clinical Course,Ventricular myxoma,1
40576,Pathologic TNM Finding,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
40577,Carcinomatous Component Present,Stage IIB Anal Cancer AJCC v8,1
40578,Mediastinal mass,Thymic Hodgkin Lymphoma,1
40579,Increased Cellularity Present,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System,1
40580,Melanin Pigment Present,Common blue nevus of skin,1
40581,Epithelial Component Present,Anterior Tongue Carcinoma,1
40582,Recurrent disease,Recurrent Adult Lymphoblastic Lymphoma,1
40583,Secondary Lesion,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
40584,Villous Pattern,Vaginal Tubulovillous Adenoma,1
40585,Bone Marrow Dysplasia Present,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
40586,Epithelial Component Present,Fallopian Tube Cancer by AJCC v7 Stage,1
40587,Low Grade Neuroendocrine Lesion,Carcinoid tumor of ileum,1
40588,Malignant Cellular Infiltrate,Clear Cell Sarcoma of Soft Tissue,1
40589,Stromal Invasion,squamous cell carcinoma of ovary,1
40590,Capillary Sized Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
40591,Carcinomatous Component Present,Human Papillomavirus-Related Cervical Carcinoma,1
40592,Malignant Cellular Infiltrate,Uterine Corpus Myxoid Leiomyosarcoma,1
40593,Malignant Cellular Infiltrate,BALT lymphoma,1
40594,Dysplasia,Low Grade Cervical Squamous Intraepithelial Neoplasia,1
40595,Recurrent disease,Recurrent Anaplastic Oligoastrocytoma,1
40596,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-1,1
40597,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,1
40598,Malignant Cellular Infiltrate,Malignant tumor of small intestine,1
40599,Epithelial Component Present,Metastatic Unresectable Basal Cell Carcinoma,1
40600,Epithelial Component Present,Stage II Liver Cancer,1
40601,Exophytic Polypoid Lesion,Anal polyp,1
40602,Malignant Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v7,1
40603,Nodular Pattern,"Hodgkin lymphoma, nodular sclerosis, cellular phase",1
40604,More than 5 Mitoses per 50HPF,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
40605,Malignant Cellular Infiltrate,Localized Ewing Sarcoma,1
40606,Exophytic Polypoid Lesion,Colorectal Microvesicular Hyperplastic Polyp,1
40607,High Mitotic Activity,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
40608,Low Grade Lesion,Gastric Carcinoid Tumor,1
40609,Well-Circumscribed Lesion,Colonic Polyps,1
40610,Malignant Cellular Infiltrate,"Carcinoma, Basal Cell",1
40611,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia,1
40612,Low Mitotic Activity,Low Grade Ovarian Serous Adenocarcinoma,1
40613,Epithelial Component Present,Minimally Invasive Mucinous Lung Adenocarcinoma,1
40614,Malignant Cellular Infiltrate,Gallbladder Angiosarcoma,1
40615,Recurrent disease,Recurrent Thymic Carcinoma,1
40616,Tissue of Mullerian Origin Present,Ovarian Clear Cell Cystadenofibroma,1
40617,Malignant Cellular Infiltrate,Malignant neoplasm of thymus,1
40618,Recurrent disease,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
40619,Malignant Cellular Infiltrate,Cervical Yolk Sac Tumor,1
40620,Indolent Clinical Course,Central Nervous System Myofibroblastoma,1
40621,Malignant Cellular Infiltrate,Centroblastic lymphoma refractory,1
40622,Malignant Cellular Infiltrate,Adult Acute Monocytic Leukemia,1
40623,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v6,1
40624,Carcinomatous Component Present,Carcinoma in situ of skin,1
40625,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Signet Ring Variant",1
40626,Vascular Channel Formation,Angiomatous Meningioma,1
40627,Pathologic TNM Finding,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
40628,Cutaneous Involvement,Malignant fibrous histiocytoma of skin,1
40629,Carcinomatous Component Present,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type",1
40630,Anaplasia,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
40631,Adnexal Differentiation,Apocrine cystadenoma,1
40632,Epithelial Component Present,Recurrent Metastatic Digestive System Carcinoma,1
40633,Epithelial Component Present,Extrahepatic Bile Duct Carcinoid Tumor,1
40634,Mucoid Stroma Formation,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
40635,Secondary Lesion,stage IV pancreatic cancer,1
40636,Neuroendocrine Differentiation,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
40637,Epithelial Component Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
40638,Borderline Lesion,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,1
40639,Immunosuppression-Related Post-Transplant Toxicity,Bone Marrow Transplantation Nephropathy,1
40640,Cutaneous Involvement,regressing melanoma of skin,1
40641,Epithelial Component Present,BCLC Stage B Hepatocellular Carcinoma,1
40642,Carcinomatous Component Present,Small cell carcinoma of prostate,1
40643,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma,1
40644,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
40645,Adnexal Differentiation,Pilomatrix carcinoma of skin,1
40646,Epithelial Component Present,High Grade Intraepithelial Neoplasia,1
40647,Spindle Cell Osteo-Fibrous Component Present,Tibial adamantinoma,1
40648,Locally Aggressive Lesion,Intermediate Vascular Neoplasm,1
40649,Well Differentiated Neuroendocrine Lesion,Pancreatic Delta Cell Neoplasm,1
40650,Epithelial Component Present,Resectable Intrahepatic Cholangiocarcinoma,1
40651,Malignant Cellular Infiltrate,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8,1
40652,Benign Cellular Infiltrate,Benign Gastric Soft Tissue Neoplasm,1
40653,Secondary Lesion,Secondary Central Nervous System Lymphoma,1
40654,Malignant Cellular Infiltrate,mucinous adenocarcinoma of anus,1
40655,Malignant Cellular Infiltrate,Recurrent Adult Soft Tissue Sarcoma,1
40656,Benign Cellular Infiltrate,Central Nervous System Rhabdomyoma,1
40657,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage III,1
40658,Nerve palsy,Facial Nerve Palsy Related to Birth,1
40659,Exophytic Papillary Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
40660,Spindle Cell Component Present,Pleural Biphasic Synovial Sarcoma,1
40661,Vascular Channel Formation,Cervical Angiosarcoma,1
40662,Malignant Cellular Infiltrate,Lentigo maligna melanoma,1
40663,Benign Cellular Infiltrate,Esophageal hemangioma,1
40664,Cutaneous Involvement,Stage II Lip Basal Cell Carcinoma,1
40665,Congenital Lesion,Congenital melanocytic nevus,1
40666,Primary Lesion,BCLC Stage B Adult Hepatocellular Carcinoma,1
40667,More than 10 Mitoses per 10HPF,Platinum-Resistant Lung Small Cell Carcinoma,1
40668,Epithelial Component Present,Stage IVA Basal Cell Lip Carcinoma,1
40669,Epithelial Component Present,Small cell neuroendocrine carcinoma of bladder,1
40670,Childhood Lesion,Childhood Immature Teratoma,1
40671,Vascular Channel Formation,Kaposi's sarcoma of lung,1
40672,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
40673,Metastatic Lesion,Prostate Carcinoma Metastatic in the Bone,1
40674,Benign Cellular Infiltrate,Benign epithelial tumor of ovary,1
40675,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage IV,1
40676,High Grade Lesion,Fusion-Positive Alveolar Rhabdomyosarcoma,1
40677,Intraductal Lesion,Intraductal breast neoplasm,1
40678,Spindle Cell Component Present,Pleural Biphasic Synovial Sarcoma,1
40679,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity stage I,1
40680,Carcinomatous Component Present,Mucinous adenocarcinoma of appendix,1
40681,Childhood Lesion,Childhood Brain Stem Mixed Glioma,1
40682,Eosinophil count raised (finding),Chronic eosinophilic leukemia,1
40683,Carcinomatous Component Present,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
40684,Malignant Cellular Infiltrate,Stage III Major Salivary Gland Cancer AJCC v8,1
40685,Questionable Invasive Lesion,Atypical follicular adenoma,1
40686,Malignant Cellular Infiltrate,Ovarian Cancer by AJCC v8 Stage,1
40687,Primary Lesion,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
40688,Stromal Invasion,serous adenocarcinofibroma of ovary,1
40689,Carcinomatous Component Present,Occult Lung Carcinoma,1
40690,Pseudoglandular Pattern,Childhood Embryonal Carcinoma,1
40691,atypia morphology,Primary ameloblastic carcinoma,1
40692,Carcinomatous Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
40693,Cutaneous Involvement,Xeroderma Pigmentosum,1
40694,CD56-Positive Neoplastic Cells Present,"NK-Cell Lymphoma, Unclassifiable",1
40695,Secondary Lesion,Lung Carcinoma Metastatic in the Brain,1
40696,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma,1
40697,Hereditary Lesion,MUTYH-Associate Polyposis,1
40698,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage I,1
40699,Malignant Cellular Infiltrate,Ewings sarcoma-primitive neuroectodermal tumor (PNET),1
40700,Epithelial Component Present,Papillary tumor of renal pelvis,1
40701,Indolent Clinical Course,Lipoma of pleura,1
40702,Malignant Cellular Infiltrate,ROSE Cluster 6,1
40703,Follicular Differentiation,"Acanthoma, Pilar Sheath",1
40704,Malignant Cellular Infiltrate,Renal Vein Leiomyosarcoma,1
40705,Malignant Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v8,1
40706,Papillary Pattern,Vestibular Micropapillomatosis,1
40707,Neuroendocrine Differentiation,Transverse Colon Neuroendocrine Tumor G1,1
40708,Absence of Invasion,solid type ductal carcinoma in situ of breast,1
40709,Borderline Lesion,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
40710,Malignant Cellular Infiltrate,Lugano Classification Stage II Hodgkin Lymphoma AJCC v8,1
40711,Immunologic Deficiency Syndromes,Lymphoproliferative Disease Associated with Primary Immune Disorder,1
40712,Epithelial Component Present,Stage III Thymoma AJCC v8,1
40713,Rapidly Enlarging Mass,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
40714,Capillary Sized Vascular Channel Formation,Spinal hemangioblastoma,1
40715,Perivascular Pseudorosette Formation,Adult Anaplastic Ependymoma,1
40716,Childhood Lesion,"Optic Nerve Glioma, Childhood",1
40717,Malignant Cellular Infiltrate,Malignant Solid Neoplasm,1
40718,Well Differentiated Neuroendocrine Lesion,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
40719,Malignant Cellular Infiltrate,Metastatic Uveal Melanoma,1
40720,Malignant Cellular Infiltrate,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,1
40721,Malignant Cellular Infiltrate,Carcinoma breast stage I,1
40722,Epithelial Component Present,Benign Breast Adenomyoepithelioma,1
40723,Primary Lesion,Primary Effusion Lymphoma,1
40724,Chronic Inflammatory Infiltrate,Chronic lymphadenitis,1
40725,Adnexal Differentiation,Benign Breast Eccrine Spiradenoma,1
40726,Malignant Cellular Infiltrate,Recurrent Skin Angiosarcoma,1
40727,High Mitotic Activity,Dedifferentiated Solitary Fibrous Tumor,1
40728,Intravascular Spread,Intravascular fasciitis,1
40729,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
40730,Childhood Lesion,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
40731,Nodular Pattern,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma,1
40732,atypia morphology,Atypical adenoma,1
40733,Intermediate Grade Lesion,Intermediate Grade Lung Neuroendocrine Neoplasm,1
40734,Malignant Cellular Infiltrate,Localized Non-Resectable Adult Liver Carcinoma,1
40735,Tissue Differentiation Uncertain,"Phosphaturic mesenchymal tumor, benign",1
40736,Malignant Cellular Infiltrate,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
40737,Recurrent Genetic Abnormalities Present,Acute promyelocytic leukemia - hypogranular variant,1
40738,Tissue Differentiation Uncertain,Alveolar soft part sarcoma non-metastatic,1
40739,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v8,1
40740,Epithelial Component Present,Cervical Glandular Neoplasm,1
40741,Secondary Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
40742,Well-Circumscribed Lesion,adenoma of extrahepatic bile duct,1
40743,Exophytic Papillary Lesion,Upper Gingival Verrucous Carcinoma,1
40744,Malignant Cellular Infiltrate,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
40745,Indolent Clinical Course,Vulvar Superficial Myofibroblastoma,1
40746,Malignant Cellular Infiltrate,Perihilar Intrahepatic Cholangiocarcinoma,1
40747,Multilocular Lesion,Juvenile Type Testicular Granulosa Cell Tumor,1
40748,Delicate Vascular Network Formation,Grade 1 Clear Cell Renal Cell Carcinoma,1
40749,Bone Marrow Involvement,Hepatosplenic T-cell lymphoma,1
40750,Neuroendocrine Differentiation,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
40751,High Grade Lesion,Conventional Alveolar Rhabdomyosarcoma,1
40752,Epithelial Component Present,Thyroid Gland Clear Cell Follicular Adenoma,1
40753,Childhood Lesion,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
40754,Indolent Clinical Course,Benign Extrahepatic Bile Duct Soft Tissue Neoplasm,1
40755,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v7 Stage,1
40756,Epithelial Component Present,verrucous carcinoma of bladder,1
40757,Infiltrative Growth Pattern,Childhood Cerebellar Anaplastic Astrocytoma,1
40758,Epithelial Component Present,Pancreatic Acinar Cell Cystadenoma,1
40759,Nodular Pattern,Refractory Follicular Lymphoma,1
40760,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
40761,Exophytic Polypoid Lesion,Polyp of vulva,1
40762,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
40763,Papillary Pattern,Verrucous carcinoma of penis,1
40764,Malignant Cellular Infiltrate,Recurrent Renal Pelvis Urothelial Carcinoma,1
40765,Epithelial Component Present,Well Differentiated Pancreatic Endocrine Tumor,1
40766,Benign Cellular Infiltrate,Colorectal Leiomyoma,1
40767,Neuroendocrine Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
40768,Mediastinal mass,Thymic Hodgkin Lymphoma,1
40769,Perivascular Pseudorosette Formation,Anaplastic Astroblastoma,1
40770,Benign Cellular Infiltrate,Schneiderian papilloma,1
40771,Malignant Cellular Infiltrate,Uterine Corpus Adenosarcoma by AJCC v8 Stage,1
40772,Metastatic Lesion,Locally Advanced Soft Tissue Sarcoma,1
40773,Indolent Clinical Course,Gastric Lymphangioma,1
40774,Malignant Cellular Infiltrate,Metastatic Lip Carcinoma,1
40775,Benign Cellular Infiltrate,"Adenoma, Monomorphic",1
40776,Epithelial Component Present,Squamous cell carcinoma of the parotid gland,1
40777,Malignant Cellular Infiltrate,Gastric Cardia Squamous Cell Carcinoma,1
40778,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Cystadenofibroma,1
40779,Malignant Cellular Infiltrate,B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,1
40780,Malignant Cellular Infiltrate,Liver and Intrahepatic Bile Duct Malignant Non-Epithelial Neoplasm,1
40781,Low Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor,1
40782,Adulthood Lesion,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
40783,Malignant Cellular Infiltrate,Fallopian Tube Gestational Choriocarcinoma,1
40784,Low Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
40785,Sarcomatous Component Present,Ovarian Dermoid Cyst with Leiomyosarcoma,1
40786,Pseudorosette Formation,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
40787,Malignant Cellular Infiltrate,Stage III Colorectal Cancer,1
40788,Malignant Cellular Infiltrate,Ann Arbor Stage I Grade 3 Follicular Lymphoma,1
40789,Well-Circumscribed Lesion,adenoma of intrahepatic bile duct,1
40790,Anaplasia,Skin Sarcomatoid Basal Cell Carcinoma,1
40791,Malignant Cellular Infiltrate,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8,1
40792,Well Differentiated Neuroendocrine Lesion,Glucagonoma,1
40793,Ground Glass Nuclear Inclusion,Multicentric Thyroid Gland Papillary Carcinoma,1
40794,Glomerular Hypertrophy,Focal glomerulosclerosis,1
40795,Papillary Pattern,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
40796,Metastatic Lesion,Secondary malignant neoplasm of pituitary gland,1
40797,Invasive Lesion,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension,1
40798,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
40799,Composite Lesion,Recurrent Combined Thymic Epithelial Neoplasm,1
40800,Childhood Lesion,Childhood Ovarian Teratoma,1
40801,Intermediate Filaments Present,Childhood Atypical Teratoid/Rhabdoid Tumor,1
40802,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
40803,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage II,1
40804,Carcinomatous Component Present,Stage II Skin Cancer,1
40805,Neuronal Differentiation,Plexosarcoma,1
40806,Malignant Cellular Infiltrate,Digestive System Non-Hodgkin Lymphoma,1
40807,Diffuse Pattern,Diffuse large B-cell lymphoma recurrent,1
40808,Carcinomatous Component Present,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
40809,Endophytic Tumor Growth,verrucous carcinoma of esophagus,1
40810,Carcinomatous Component Present,Metastatic gastric adenocarcinoma,1
40811,Cutaneous Involvement,Pilomatrix carcinoma of skin,1
40812,Perineural spread,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
40813,Epithelial Component Present,Advanced Lung Carcinoma,1
40814,Well-Circumscribed Lesion,Hemangioblastoma,1
40815,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Lipid-rich carcinoma,1
40816,Peripheral Nuclear Palisading,Lung Small Cell Carcinoma by AJCC v7 Stage,1
40817,Immunologic Deficiency Syndromes,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,1
40818,Carcinomatous Component Present,Metastatic Microsatellite Stable Colorectal Carcinoma,1
40819,Epithelial Component Present,Sparsely Granulated Corticotroph Adenoma,1
40820,Multinodular Mass,Skin Angiosarcoma,1
40821,Epithelial Component Present,Esophageal Neuroendocrine Tumor,1
40822,Malignant Cellular Infiltrate,Childhood Brain Glioblastoma,1
40823,Increased Cellularity Present,Cellular neurothekeoma,1
40824,Diffuse Pattern,Childhood Immunoblastic Lymphoma,1
40825,Malignant Cellular Infiltrate,Plasmacytoma,1
40826,Malignant Cellular Infiltrate,Peripheral primitive neuroectodermal tumor of soft tissue,1
40827,Vascular Channel Formation,Gastric Lymphangioma,1
40828,Rapidly Enlarging Mass,Childhood Embryonal Rhabdomyosarcoma,1
40829,Pathologic TNM Finding,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
40830,Carcinomatous Component Present,Cloacogenic carcinoma,1
40831,Carcinomatous Component Present,Stage IV Breast Cancer AJCC v6 and v7,1
40832,Epithelial Component Present,Benign Ovarian Clear Cell Tumor,1
40833,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1,1
40834,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
40835,Acquired Lesion,Hemangioma acquired,1
40836,Malignant Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v7,1
40837,Carcinomatous Component Present,Metastatic signet ring cell carcinoma,1
40838,Benign Cellular Infiltrate,Atrial myxoma,1
40839,Malignant Cellular Infiltrate,Recurrent Paget Disease of the Anal Canal,1
40840,Dilated Cystic Spaces Present,Tubulocystic renal cell carcinoma,1
40841,Carcinomatous Component Present,Refractory Endometrial Mixed Cell Adenocarcinoma,1
40842,Malignant Cellular Infiltrate,Malignant neoplasm of bronchus,1
40843,Malignant Cellular Infiltrate,Metastatic Malignant Pancreatic Neoplasm,1
40844,Vascular Channel Formation,Senile hemangioma of lip,1
40845,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1A,1
40846,Metastatic/Recurrent Disease,Childhood Desmoplastic Small Round Cell Tumor,1
40847,Secondary Lesion,Secondary Heart Lymphoma,1
40848,Estrogen receptor negative,Metastatic Triple-Negative Breast Carcinoma,1
40849,Secondary Lesion,Pancreatic neuroendocrine tumor metastatic,1
40850,High Grade Lesion,High Grade Fallopian Tube Serous Adenocarcinoma,1
40851,Malignant Cellular Infiltrate,Mixed Hepatoblastoma with Teratoid Features,1
40852,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor,1
40853,Papillary Pattern,Condyloma acuminata of vagina,1
40854,Epithelial Component Present,Stage II Rectal Cancer,1
40855,Malignant Cellular Infiltrate,Locally Advanced Unresectable Renal Cell Carcinoma,1
40856,Radiation Sickness,Radiation-Induced Cerebritis,1
40857,Therapy-Related Toxicity,Cutaneous Radiation-Related Angiosarcoma,1
40858,Carcinomatous Component Present,Stage IIIC Adult Liver Cancer AJCC v7,1
40859,Absence of Invasion,Carcinoma in situ of ampulla of Vater,1
40860,Malignant Cellular Infiltrate,Stage IV Rectosigmoid Cancer AJCC v7,1
40861,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Childhood Acute Monocytic Leukemia,1
40862,Unresectable Mass,Unresectable Craniopharyngioma,1
40863,Malignant Cellular Infiltrate,Stage I Ovarian Germ Cell Tumor AJCC v6 and v7,1
40864,Neuroendocrine Differentiation,Liver Neuroendocrine Neoplasm,1
40865,Epithelial Component Present,"Carcinoma, Lobular",1
40866,Malignant Cellular Infiltrate,Adrenal Gland Lymphoma,1
40867,Multifocal Lesion,Encephalocraniocutaneous lipomatosis,1
40868,Malignant Cellular Infiltrate,Pancreatic Non-Hodgkin Lymphoma,1
40869,Epithelial Component Present,Refractory Head and Neck Carcinoma,1
40870,Local disease,Malignant neoplasm of gallbladder localized,1
40871,Tubular Pattern,Colorectal Tubular Adenoma,1
40872,Carcinomatous Component Present,Mucin-producing adenocarcinoma,1
40873,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
40874,Delicate Vascular Network Formation,Grade 4 Clear Cell Renal Cell Carcinoma,1
40875,Cutaneous Involvement,Paraganglioma-Like Dermal Melanocytic Tumor,1
40876,Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
40877,HER2/Neu Negative,Metastatic Triple-Negative Breast Carcinoma,1
40878,Malignant Cellular Infiltrate,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
40879,Benign Cellular Infiltrate,Serous cystadenoma of pancreas,1
40880,Recurrent disease,Recurrent Thyroid Gland Anaplastic Carcinoma,1
40881,Chronic Inflammatory Infiltrate,Lymphomatoid Granulomatosis,1
40882,EBV-Positive Neoplastic Cells Present,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
40883,Angiodestructive Pattern,Lymphomatoid Granulomatosis,1
40884,Prominent Squamous Eddies Present,inverted follicular keratosis,1
40885,Childhood Lesion,Childhood Mature Teratoma,1
40886,Adulthood Lesion,Stage I Indolent Adult Non-Hodgkin Lymphoma,1
40887,Epithelial Component Present,Stage IVA Vaginal Cancer AJCC v6 and v7,1
40888,Matrical Differentiation,Basal cell carcinoma - follicular,1
40889,Multifocal Lesion,Synchronous Multifocal Osteosarcoma,1
40890,Presence of a Hormonal Syndrome,Malignant Pancreatic Insulinoma,1
40891,Indolent Clinical Course,Anastomosing Hemangioma,1
40892,Malignant Cellular Infiltrate,Childhood Diffuse Large B-Cell Lymphoma,1
40893,Epithelial Component Present,Bartholin's gland carcinoma,1
40894,Tissue of Mullerian Origin Present,Ovarian Seromucinous Adenofibroma,1
40895,Monomorphic Cellular Infiltrate,Oropharyngeal Basaloid Carcinoma,1
40896,Duct-Like Structures Present,Epithelial-myoepithelial carcinoma,1
40897,Stromal Invasion,Malignant Ovarian Endometrioid Tumor,1
40898,Indolent Clinical Course,Leiomyomatosis,1
40899,Secondary Lesion,Metastatic Breast Neuroendocrine Neoplasm,1
40900,Childhood Lesion,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement,1
40901,Benign Cellular Infiltrate,Atrial myxoma,1
40902,Epithelial Component Present,Vaginal Tubulovillous Adenoma,1
40903,Secondary Lesion,Advanced Unresectable Gastric Adenocarcinoma,1
40904,Epithelial Component Present,Ectopic Thyroid Gland Thymoma,1
40905,Cutaneous Involvement,Scabies <infestation>,1
40906,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage I Plasma Cell Myeloma,1
40907,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v7,1
40908,Malignant Cellular Infiltrate,Stage IV Anal Cancer AJCC v8,1
40909,Epithelial Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
40910,High Plasma Renin Activity,Juxtaglomerular tumor,1
40911,Primary Lesion,Childhood Infratentorial Ependymoma,1
40912,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I,1
40913,Malignant Cellular Infiltrate,Hard Palate Squamous Cell Carcinoma,1
40914,Malignant Cellular Infiltrate,Childhood Yolk Sac Tumor,1
40915,Unresectable Mass,Unresectable Lung Carcinoma,1
40916,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
40917,Oligodendroglial Component Present,Oligodendroglial Neoplasm,1
40918,Cutaneous Involvement,Ichthyosis Bullosa of Siemens,1
40919,Epithelial Component Present,keratinizing squamous cell carcinoma of nasal cavity,1
40920,Invasive Lesion,Bladder transitional cell carcinoma stage IV,1
40921,Epithelial Component Present,Ethmoid Sinus Schneiderian Papilloma,1
40922,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v8,1
40923,Metastatic Lesion,Metastatic Pharyngeal Carcinoma,1
40924,Malignant Cellular Infiltrate,Refractory Rhabdoid Tumor,1
40925,Carcinomatous Component Present,Childhood Colorectal Carcinoma,1
40926,Malignant Cellular Infiltrate,Advanced Carcinoid Tumor,1
40927,Malignant Cellular Infiltrate,Childhood Central Nervous System Ganglioneuroblastoma,1
40928,Below the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,1
40929,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
40930,Breast Microcalcification,oligodendroglioma,1
40931,Well Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
40932,Necrotic changes (finding),Dedifferentiated Solitary Fibrous Tumor,1
40933,Tissue Differentiation Uncertain,Ventricular myxoma,1
40934,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage I Plasma Cell Myeloma,1
40935,Epithelial Component Present,Esophageal Cancer by AJCC v8 Stage,1
40936,Mesenchymal Differentiation,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
40937,Malignant Cellular Infiltrate,Stage III Colon Cancer AJCC v7,1
40938,Ischemia,Acute vascular insufficiency of intestine (disorder),1
40939,Carcinomatous Component Present,Anaplastic adrenocortical carcinoma,1
40940,Dysplasia,Cervical Squamous Intraepithelial Neoplasia,1
40941,Oligodendroglial Component Present,Anaplastic Oligoastrocytoma,1
40942,Increased Cellularity Present,Anaplastic astrocytoma,1
40943,Carcinomatous Component Present,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
40944,Carcinomatous Component Present,Carcinoma of hard palate,1
40945,Malignant Cellular Infiltrate,Anal margin Paget's disease,1
40946,Indolent Clinical Course,Benign Osteogenic Neoplasm,1
40947,Fibrosis,"Breast Fibrocystic Change, Proliferative Type",1
40948,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic Lymphadenopathy,1
40949,Secondary Lesion,carcinoma ex pleomorphic adenoma of salivary gland,1
40950,Epithelial Component Present,adenosquamous carcinoma of pancreas,1
40951,Malignant Cellular Infiltrate,Childhood Seminoma,1
40952,Epithelial Component Present,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
40953,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v7,1
40954,Malignant Cellular Infiltrate,Centroblastic lymphoma recurrent,1
40955,Malignant Cellular Infiltrate,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
40956,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
40957,Malignant Cellular Infiltrate,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
40958,Cutaneous Involvement,Bullous lichen planus,1
40959,Regional Disease,Ureteric cancer regional,1
40960,Hyperkeratosis,Upper Gingival Verrucous Carcinoma,1
40961,Osteoid formation,Aggressive osteoblastoma,1
40962,Malignant Cellular Infiltrate,Stage IVB Cervical Cancer AJCC v8,1
40963,Low Grade Lesion,Myxoinflammatory fibroblastic sarcoma,1
40964,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
40965,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell",1
40966,Non-Invasive Lesion,Renal Pelvis Urothelial Papilloma,1
40967,Malignant Germinomatous Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
40968,Epithelial Component Present,Intracystic Papillary Breast Carcinoma,1
40969,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Seminoma,1
40970,Chronic Inflammatory Infiltrate,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage,1
40971,Recurrent disease,Recurrent Malignant Endocrine Neoplasm,1
40972,Benign Cellular Infiltrate,Inverted Papilloma,1
40973,Mitotic Activity,Cardiac Yolk Sac Tumor,1
40974,Carcinomatous Component Present,Clinical Stage III Gastric Cancer AJCC v8,1
40975,Epithelial Component Present,Endometrial Undifferentiated Carcinoma,1
40976,Epithelial Component Present,Primary serous papillary carcinoma of peritoneum,1
40977,Deep Lesion,Unresectable Desmoid-Type Fibromatosis,1
40978,S-100-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, malignant",1
40979,Epithelial Component Present,Fallopian Tube Squamous Cell Carcinoma,1
40980,Benign Cellular Infiltrate,Benign Female Reproductive System Neoplasm,1
40981,More than 10 Mitoses per 10HPF,Metastatic Lung Small Cell Carcinoma,1
40982,atypia morphology,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
40983,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8,1
40984,Benign Cellular Infiltrate,Grade 1 Ovarian Teratoma,1
40985,MGMT Gene Promoter Methylation,MGMT-Methylated Glioblastoma,1
40986,Carcinomatous Component Present,Submandibular Gland Squamous Cell Carcinoma,1
40987,Slow Growing Mass,Adult Myxopapillary Ependymoma,1
40988,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage I,1
40989,Indolent Clinical Course,Intramuscular lipoma,1
40990,Indolent Clinical Course,Mediastinal Leiomyoma,1
40991,Increased Cellularity Present,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
40992,Tubular Structures Present,Benign mixed epithelial and stromal tumor of kidney,1
40993,Malignant Cellular Infiltrate,Serous surface papillary carcinoma,1
40994,Crystal deposition,Orbital Alveolar Soft Part Sarcoma,1
40995,Neuroendocrine Differentiation,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
40996,Malignant Component Present,Ovarian Dermoid Cyst with Secondary Sarcoma,1
40997,Non-Malignant Cellular Infiltrate,Pulmonary nodular lymphoid hyperplasia,1
40998,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
40999,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis recurrent,1
41000,Mucoid Stroma Formation,Myxopapillary ependymoma,1
41001,Malignant Cellular Infiltrate,Superficial spreading malignant melanoma of skin,1
41002,More than 10 Mitoses per 10HPF,Platinum-Resistant Lung Small Cell Carcinoma,1
41003,Malignant Cellular Infiltrate,Anaplastic Hemispheric Astrocytoma,1
41004,Malignant Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v7,1
41005,Epithelial Component Present,Recurrent Merkel Cell Carcinoma,1
41006,Cutaneous Involvement,Vulvar Lichen Sclerosus,1
41007,Malignant Cellular Infiltrate,Malignant Mixed Tumor of the Minor Salivary Gland,1
41008,Therapy-Related Toxicity,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
41009,Epithelial Component Present,Low Grade Squamous Intraepithelial Neoplasia,1
41010,Dysplasia,Colorectal Tubulovillous Adenoma,1
41011,High Grade Lesion,Osteoblastic Osteosarcoma,1
41012,Primary Lesion,Primary Melanocytic Lesion of Meninges,1
41013,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Carcinoma,1
41014,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v8,1
41015,Metastatic/Recurrent Disease,Synovial sarcoma non-metastatic,1
41016,Perineural spread,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
41017,Pseudopapillary Pattern,Teratocarcinoma,1
41018,Carcinomatous Component Present,Undifferentiated Carcinoma of Unknown Primary,1
41019,Exophytic Papillary Lesion,Upper Gingival Verrucous Carcinoma,1
41020,Neuroendocrine Differentiation,Ascending Colon Neuroendocrine Tumor G1,1
41021,Malignant Cellular Infiltrate,Bilateral Synchronous Sporadic Renal Cell Carcinoma,1
41022,Biphasic Pattern,Prostate Phyllodes Tumor,1
41023,Epithelial Component Present,Gastrointestinal tract adenoma,1
41024,Malignant Cellular Infiltrate,Stage IV Pancreatic Cancer AJCC v6 and v7,1
41025,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Hyalinizing Trabecular Adenoma,1
41026,Nodular Pattern,Ann Arbor Stage I Grade 3 Follicular Lymphoma,1
41027,Mitotic Activity,cystic mucinous tumor of pancreas with moderate dysplasia,1
41028,Fibromyxoid Stroma Formation,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
41029,Epithelial Component Present,Intraepithelial Squamous Cell Carcinoma,1
41030,Epithelial Component Present,Esophageal carcinoma,1
41031,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1A,1
41032,Exophytic Papillary Lesion,Condyloma Acuminatum with Dysplasia,1
41033,Carcinomatous Component Present,Tubular breast carcinoma,1
41034,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage IV,1
41035,Carcinomatous Component Present,Fallopian Tube Gestational Choriocarcinoma,1
41036,Mixed Cellular Population,Anal Ectopic Fibroadenoma,1
41037,Neuroendocrine Differentiation,Prostate Neuroendocrine Neoplasm,1
41038,Adulthood Lesion,Recurrent Indolent Adult Non-Hodgkin Lymphoma,1
41039,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma,1
41040,Epithelial Component Present,"Hepatocellular carcinoma, scirrhous",1
41041,Encapsulated Mass,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
41042,Malignant Cellular Infiltrate,Solid Alveolar Rhabdomyosarcoma,1
41043,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma,1
41044,Hydropic Villous Change,"Hydatidiform Mole, Invasive",1
41045,Tissue Differentiation Uncertain,Childhood Kidney Angiomyolipoma,1
41046,Secondary Lesion,Metastatic signet ring cell carcinoma,1
41047,Malignant Cellular Infiltrate,Stage IV Kidney Wilms Tumor,1
41048,Cutaneous Involvement,Lentigo,1
41049,Thyroglobulin Positive Neoplastic Cells Present,Microfollicular adenoma,1
41050,Carcinomatous Component Present,Ovarian Cancer by AJCC v6 and v7 Stage,1
41051,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
41052,Localized Lesion,Plasmacytoma anaplastic,1
41053,Immunologic Deficiency Syndromes,AIDS-Related Cryptococcosis,1
41054,Nodular Pattern,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",1
41055,Pathologic TNM Finding,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
41056,S-100-Positive Neoplastic Cells Present,Pulmonary lymphangioleiomyomatosis,1
41057,Carcinomatous Component Present,Vaginal Non-Keratinizing Squamous Cell Carcinoma,1
41058,"Amorphus, Eosinophilic, and Acellular Deposit",Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
41059,Syncytial Pattern,Cervical Lymphoepithelioma-Like Carcinoma,1
41060,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v8,1
41061,Epithelial Component Present,Skin Sarcomatoid Basal Cell Carcinoma,1
41062,Immunosuppression-Related Post-Transplant Toxicity,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
41063,Benign Cellular Infiltrate,Benign neoplasm of maxillary sinus,1
41064,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Cytopenia of Childhood,1
41065,Malignant Cellular Infiltrate,"Neuroectodermal Tumor, Primitive",1
41066,Non-Hereditary Lesion,Sporadic Retinoblastoma,1
41067,Malignant Cellular Infiltrate,Stage IVC Colorectal Cancer AJCC v8,1
41068,Nuclear Pseudoinclusion,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
41069,Hemorrhagic,Uterine Angiosarcoma,1
41070,Carcinomatous Component Present,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
41071,Benign Cellular Infiltrate,Leiomyoma of esophagus,1
41072,Epithelial Component Present,neuroendocrine carcinoma of anal canal,1
41073,Cystic Change,Intracystic Papillary Breast Carcinoma,1
41074,Hyperplastic Tissue Present,Hyperplasia,1
41075,Epithelial Component Present,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
41076,Childhood Lesion,Recurrent Childhood Gliomatosis Cerebri,1
41077,Epithelial Component Present,Hard Palate Pleomorphic Adenoma,1
41078,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
41079,Malignant Cellular Infiltrate,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
41080,Malignant Cellular Infiltrate,Clinical Stage IB Cutaneous Melanoma AJCC v8,1
41081,Carcinomatous Component Present,Stage II Colon Cancer,1
41082,Biphasic Pattern,Ovarian Mucinous Cystadenofibroma,1
41083,Vascular Channel Formation,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
41084,Epithelial Component Present,Stage IIB Esophageal Adenocarcinoma AJCC v7,1
41085,Malignant Cellular Infiltrate,Multifocal breast carcinoma,1
41086,Malignant Cellular Infiltrate,Metastatic Bone Ewing Sarcoma,1
41087,Metastatic/Recurrent Disease,Orbital Alveolar Soft Part Sarcoma,1
41088,Malignant Cellular Infiltrate,Pancreatic Large Cell Neuroendocrine Carcinoma,1
41089,Systemic disease,Aggressive Systemic Mastocytosis,1
41090,Hyperplastic Tissue Present,Lobular Endocervical Glandular Hyperplasia,1
41091,Carcinomatous Component Present,Synchronous Bilateral Breast Carcinoma,1
41092,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
41093,Epithelial Component Present,Fibroadenoma of breast,1
41094,Unresectable Mass,Unresectable Head and Neck Squamous Cell Carcinoma,1
41095,Refractory Disease,Refractory Transformed Chronic Lymphocytic Leukemia,1
41096,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
41097,Epithelial Component Present,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
41098,Absence of Invasion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
41099,Adulthood Lesion,Lugano Classification Limited Stage Adult Lymphoma AJCC v8,1
41100,Malignant Cellular Infiltrate,High grade B-cell lymphoma,1
41101,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage II,1
41102,Metastatic Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,1
41103,Intraocular Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
41104,Intermediate Filaments Present,Rhabdoid Tumor,1
41105,Perineural spread,Metastatic Adenoid Cystic Carcinoma,1
41106,Cartilaginous Differentiation,Osteochondromatosis,1
41107,Malignant Cellular Infiltrate,Secondary Central Nervous System Non-Hodgkin Lymphoma,1
41108,Epithelial Component Present,Stage IVA Colorectal Cancer AJCC v8,1
41109,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v6 and v7,1
41110,Malignant Cellular Infiltrate,Bartholin Gland Transitional Cell Carcinoma,1
41111,Villous Pattern,"Adenoma, Villous",1
41112,Refractory Disease,Refractory Small Intestinal Carcinoma,1
41113,Carcinomatous Component Present,Metastatic Bladder Squamous Cell Carcinoma,1
41114,Epithelial Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
41115,Pathologic TNM Finding,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8,1
41116,Epithelial Component Present,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
41117,Metaplasia,Nephrogenic metaplasia,1
41118,Carcinomatous Component Present,Parotid Gland Carcinoma,1
41119,Severe dysplasia,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
41120,Malignant Cellular Infiltrate,Basal cell carcinoma - follicular,1
41121,Cutaneous Involvement,Dedifferentiated Dermatofibrosarcoma Protuberans,1
41122,Epithelial Component Present,Pancreatic Intraductal Papillary-Mucinous Adenoma,1
41123,Malignant Cellular Infiltrate,Carcinoma in situ of cecum,1
41124,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma metastatic,1
41125,Epithelial Component Present,Gastric adenoma,1
41126,Well-Circumscribed Lesion,Gastric hyperplastic polyp,1
41127,Indolent Clinical Course,Lipoma of chest wall,1
41128,Plexiform Growth Pattern,Chest Wall Plexiform Fibrohistiocytic Neoplasm,1
41129,Severe cytologic atypia,Refractory Pancreatic Neuroendocrine Carcinoma,1
41130,Microinvasive tumor,Borderline Ovarian Serous Tumor with Microinvasion,1
41131,Intracanalicular Growth Pattern,Malignant Phyllodes Tumor of Prostate,1
41132,Locally Aggressive Lesion,"Phosphaturic mesenchymal tumor, benign",1
41133,Human Papillomavirus Positive,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
41134,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
41135,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1
41136,Diffuse Pattern,Adult Immunoblastic Lymphoma,1
41137,Nuclear Molding,Small cell lung cancer extensive stage,1
41138,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Cytopenia of Childhood,1
41139,Exophytic Polypoid Lesion,Villous adenoma of colon,1
41140,Acquired Lesion,Acquired kyphosis,1
41141,Epithelial Component Present,Grade 3 Colon Adenocarcinoma,1
41142,Cartilaginous Differentiation,Childhood Mesenchymal Chondrosarcoma,1
41143,Carcinomatous Component Present,Lung Micropapillary Adenocarcinoma,1
41144,Carcinomatous Component Present,"Adenocarcinoma of lung, stage I",1
41145,Malignant Cellular Infiltrate,Rectosigmoid Mucinous Adenocarcinoma,1
41146,Biphasic Pattern,Childhood Gliosarcoma,1
41147,Carcinomatous Component Present,Stage IIB Lung Adenocarcinoma AJCC v7,1
41148,Neuroendocrine Differentiation,Central Nervous System Paraganglioma,1
41149,Malignant Cellular Infiltrate,Cardiac Yolk Sac Tumor,1
41150,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis,1
41151,Epithelial Component Present,Carcinoma of upper gum,1
41152,Benign Cellular Infiltrate,Benign neoplasm of gallbladder,1
41153,Infiltrating Tumor Margins Present,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
41154,Secondary Lesion,Breast Carcinoma Metastatic in the Skin,1
41155,Malignant Cellular Infiltrate,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
41156,Birbeck Granules Present,Langerhans Cell Sarcoma,1
41157,Well Differentiated Lesion,Supraglottic Verrucous Carcinoma,1
41158,Epithelial Component Present,High Grade Broad Ligament Serous Adenocarcinoma,1
41159,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
41160,Epithelial Component Present,Advanced Laryngeal Squamous Cell Carcinoma,1
41161,Epithelial Component Present,Metastatic Renal Pelvis Urothelial Carcinoma,1
41162,Malignant Cellular Infiltrate,Endemic African Kaposi Sarcoma,1
41163,Carcinomatous Component Present,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
41164,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
41165,Well-Circumscribed Lesion,Breast Myofibroblastoma,1
41166,Malignant Cellular Infiltrate,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
41167,Primary Lesion,Recurrent Childhood Cerebral Astrocytoma,1
41168,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
41169,Plexiform Growth Pattern,Plexiform fibrohistiocytic tumor,1
41170,Carcinomatous Component Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
41171,Myxoid Stroma Formation,Central Nervous System Epithelioid Hemangioendothelioma,1
41172,Carcinomatous Component Present,Vulvar Neuroendocrine Carcinoma,1
41173,Diffuse Pattern,Recurrent Childhood Anaplastic Oligodendroglioma,1
41174,Benign Cellular Infiltrate,Renal Pelvis Urothelial Papilloma,1
41175,Epithelial Component Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
41176,Mixed Cellular Population,Recurrent Childhood Oligoastrocytoma,1
41177,Anaplasia,Anaplastic Oligoastrocytoma,1
41178,Primary Lesion,Adult Brain Medulloblastoma,1
41179,Recurrent disease,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
41180,Epithelial Component Present,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
41181,Extensive Stage Lesion,Advanced Adult Hepatocellular Carcinoma,1
41182,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma,1
41183,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
41184,Malignant Cellular Infiltrate,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas,1
41185,Preserved Nuclear Polarity,"Transitional cell papilloma, benign",1
41186,Nodular Pattern,Benign Breast Eccrine Spiradenoma,1
41187,Favorable Clinical Outcome,Ganglioneuroma of skin,1
41188,Carcinomatous Component Present,Bladder Papillary Urothelial Carcinoma,1
41189,Epithelial Component Present,External Auditory Canal Ceruminous Adenoma,1
41190,Cutaneous Involvement,Cystic basal cell carcinoma,1
41191,Epithelial Component Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
41192,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 3 Follicular Lymphoma,1
41193,Malignant Cellular Infiltrate,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
41194,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
41195,Infiltrating Tumor Margins Present,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
41196,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
41197,Stromal Invasion,Stage IA Ovarian Cancer,1
41198,Absence of Invasion,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
41199,Benign Cellular Infiltrate,Bone Leiomyoma,1
41200,Pregnancy Complications,Gestational Trophoblastic Neoplasms,1
41201,Decreased platelet count,Kasabach-Merritt syndrome,1
41202,Deep Lesion,Inflammatory liposarcoma,1
41203,Epithelial Component Present,adenocarcinoma of breast with spindle cell metaplasia,1
41204,Malignant Cellular Infiltrate,Glioblastoma,1
41205,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
41206,Benign Cellular Infiltrate,Ureter Leiomyoma,1
41207,Carcinomatous Component Present,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
41208,Pseudoglandular Pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",1
41209,Unresectable Mass,Unresectable Intrahepatic Cholangiocarcinoma,1
41210,Carcinomatous Component Present,Malignant Breast Eccrine Spiradenoma,1
41211,Carcinomatous Component Present,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
41212,Benign Cellular Infiltrate,Benign Smooth Muscle Neoplasm,1
41213,Carcinomatous Component Present,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
41214,Epithelial Component Present,'Refractory Paraganglioma',1
41215,Eccrine Differentiation,Malignant Eccrine Neoplasm,1
41216,Epithelial Component Present,Stage IVB Vaginal Cancer AJCC v8,1
41217,Epithelial Component Present,Colorectal Neuroendocrine Carcinoma,1
41218,Malignant Cellular Infiltrate,Lugano Classification Adult Lymphoma by AJCC v8 Stage,1
41219,Epithelial Component Present,"Pheochromocytoma, malignant",1
41220,Malignant Cellular Infiltrate,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
41221,Low Mitotic Activity,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,1
41222,Epithelial Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
41223,Nodular Pattern,Ann Arbor Stage I Follicular Lymphoma,1
41224,Indolent Clinical Course,Follicular Myxoma,1
41225,Nuclear Molding,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
41226,Recurrent disease,Recurrent Malignant Endocrine Neoplasm,1
41227,Carcinomatous Component Present,Pseudomyxoma Peritonei,1
41228,Diffuse Pattern,Pleural Desmoplastic Mesothelioma,1
41229,Epithelial Component Present,"Transitional cell carcinoma, spindle cell",1
41230,Well Differentiated Neuroendocrine Lesion,Localized Digestive System Neuroendocrine Tumor G1,1
41231,Acinar Pattern,Lung Acinar Adenocarcinoma,1
41232,Carcinomatous Component Present,Superficial basal cell carcinoma,1
41233,Childhood Lesion,Stage III Childhood Hodgkin Lymphoma,1
41234,Cutaneous Involvement,Circumscribed storiform collagenoma,1
41235,Cystic Change,Vulvar Inverted Follicular Keratosis,1
41236,Secondary Lesion,Secondary malignant neoplasm of retina,1
41237,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage II,1
41238,Acanthosis,Laryngeal verrucous carcinoma,1
41239,Low Mitotic Activity,Intermediate Atypical Prostate Carcinoma,1
41240,Epithelial Component Present,Thoracic Esophagus Squamous Cell Carcinoma,1
41241,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
41242,Well-Circumscribed Lesion,Renal Pelvis Fibroepithelial Polyp,1
41243,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v6,1
41244,Malignant Cellular Infiltrate,Stage III Immature Testicular Teratoma AJCC v6 and v7,1
41245,Low Mitotic Activity,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,1
41246,Malignant Germinomatous Cellular Infiltrate,Extragonadal Seminoma,1
41247,Carcinomatous Component Present,Squamous cell carcinoma of nasopharynx,1
41248,Carcinomatous Component Present,Stage III Anal Cancer AJCC v8,1
41249,Nodular lesions,Nodular amyloidosis,1
41250,Secondary Lesion,Ameloblastic Carcinoma Derived From Odontogenic Cyst,1
41251,Epithelial Component Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
41252,Epithelial Component Present,large cell carcinoma of salivary gland,1
41253,Malignant Cellular Infiltrate,Refractory Malignant Thymoma,1
41254,Pathologic TNM Finding,Pathologic Stage IIIB Gastric Cancer AJCC v8,1
41255,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v8,1
41256,Malignant Cellular Infiltrate,Stage IIA Prostate Cancer AJCC v7,1
41257,Extensive Stage Lesion,Advanced Neuroendocrine Neoplasm,1
41258,Malignant Cellular Infiltrate,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
41259,Carcinomatous Component Present,Refractory Ovarian Endometrioid Adenocarcinoma,1
41260,Myxoid Stroma Formation,Vulvar Superficial Angiomyxoma,1
41261,Malignant Cellular Infiltrate,Drop Metastasis in the Spinal Cord,1
41262,Malignant Cellular Infiltrate,Recurrent Childhood Burkitt Lymphoma,1
41263,Diffuse Pattern,"Glioblastoma, IDH-Wildtype",1
41264,Malignant Cellular Infiltrate,Endocervical Carcinoma,1
41265,Well-Circumscribed Lesion,Juvenile Polyp of the Small Intestine,1
41266,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
41267,Infiltrative Growth Pattern,Infratentorial Glioblastoma,1
41268,Non-Hereditary Lesion,Sporadic Retinoblastoma,1
41269,Epithelial Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
41270,Nuclear Molding,Combined Lung Small Cell and Squamous Cell Carcinoma,1
41271,Carcinomatous Component Present,Renal Cell Carcinoma,1
41272,Well Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
41273,Epithelial Component Present,Hereditary Prostate Carcinoma,1
41274,Malignant Cellular Infiltrate,Stage IIA Ampulla of Vater Cancer AJCC v8,1
41275,Tissue Differentiation Uncertain,Extraskeletal Myxoid Chondrosarcoma,1
41276,Indolent Clinical Course,Atrial myxoma,1
41277,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
41278,Slow Growing Mass,Brain Ependymoma,1
41279,Malignant Cellular Infiltrate,Stage I Ampulla of Vater Cancer AJCC v7,1
41280,Malignant Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma,1
41281,Epithelial Component Present,Unresectable Hepatocellular Carcinoma,1
41282,Benign Cellular Infiltrate,Hemangioma of Peripheral Nerve,1
41283,Malignant Cellular Infiltrate,Renal Pelvis Cancer by AJCC v7 Stage,1
41284,Rhabdomyosarcomatous Differentiation,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
41285,Epithelial Component Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
41286,Primary Lesion,Childhood Cerebral Diffuse Astrocytoma,1
41287,Benign Cellular Infiltrate,Vulvar Cellular Angiofibroma,1
41288,Nuclear pleomorphism,Salivary duct carcinoma,1
41289,Epithelial Component Present,Lymphangitis carcinomatosa,1
41290,Well-Circumscribed Lesion,Small Intestinal Tubulovillous Adenoma,1
41291,Mixed Cellular Population,Vaginal Carcinosarcoma,1
41292,Epithelial Component Present,Stage IV Renal Cell Cancer,1
41293,Epithelial Component Present,Intraepithelial Neoplasia,1
41294,Cutaneous Involvement,"Dermatitis, Occupational",1
41295,Diffuse Pattern,MGMT-Unmethylated Glioblastoma,1
41296,Infiltrative Growth Pattern,Adult Gliosarcoma,1
41297,Carcinomatous Component Present,Malignant neoplasm of stomach stage I,1
41298,Malignant Cellular Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis,1
41299,Carcinomatous Component Present,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
41300,Generalized illness,Leiomyomatosis peritonealis disseminata,1
41301,Mesenchymal Component Present,Pleomorphic adenoma of lacrimal gland,1
41302,Malignant Cellular Infiltrate,Malignant neoplasm of conjunctiva,1
41303,Epithelial Component Present,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,1
41304,Carcinomatous Component Present,Stage IIIA Gastric Carcinoma,1
41305,Adnexal Differentiation,Apocrine breast carcinoma,1
41306,Epithelial Component Present,Unresectable Hepatocellular Carcinoma,1
41307,Well-Circumscribed Lesion,villous adenoma of stomach,1
41308,Malignant Cellular Infiltrate,Stage IIA Breast Carcinoma,1
41309,Pathologic TNM Finding,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
41310,Carcinomatous Component Present,Adenocarcinoma in tubulovillous adenoma,1
41311,Recurrent disease,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
41312,Solitary mass,Sellar Chondroid Chordoma,1
41313,Sinusoidal Infiltration,Refractory Hepatosplenic T-Cell Lymphoma,1
41314,Epithelial Component Present,Pancreatic Neuroendocrine Microadenoma,1
41315,Rimming of Adipose Tissue Cells Present,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
41316,Vascular Channel Formation,Thyroid Angiosarcoma,1
41317,Invasive Lesion,Infiltrating Intramuscular Lipoma,1
41318,Multifocal Lesion,"Lipomatosis, Multiple Symmetrical",1
41319,Cutaneous Involvement,Erythema toxicum neonatorum,1
41320,Tissue Differentiation Uncertain,Atrial myxoma,1
41321,Epithelial Component Present,keratoacanthoma,1
41322,Epithelial Component Present,Stage IB Vulvar Carcinoma AJCC v6,1
41323,Epithelial Component Present,Anal cancer metastatic,1
41324,Carcinomatous Component Present,Clinical Stage II Gastric Cancer AJCC v8,1
41325,Epithelial Component Present,Undifferentiated carcinoma of ovary,1
41326,Malignant Cellular Infiltrate,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,1
41327,Epithelial Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage,1
41328,CD1a-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis,1
41329,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage IV,1
41330,Indolent Clinical Course,Capillary hemangioma of orbit,1
41331,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage,1
41332,Benign Cellular Infiltrate,Benign Intraocular Medulloepithelioma,1
41333,Malignant Cellular Infiltrate,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
41334,Clinical TNM Finding,Clinical Stage IIC Cutaneous Melanoma AJCC v8,1
41335,Epithelial Component Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,1
41336,Extensive Stage Lesion,Advanced Uveal Melanoma,1
41337,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma,1
41338,Papillary Pattern,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
41339,High Mitotic Activity,Malignant tenosynovial giant cell tumor,1
41340,Tissue Differentiation Uncertain,Uterine Corpus PEComa,1
41341,Vascular Channel Formation,Hemangioma acquired,1
41342,Malignant Cellular Infiltrate,Thymic Adenosquamous Carcinoma,1
41343,Malignant Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v7,1
41344,Severe cytologic atypia,Pancreatic Large Cell Neuroendocrine Carcinoma,1
41345,Coughing,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
41346,Carcinomatous Component Present,Stage IA Intrahepatic Bile Duct Cancer AJCC v8,1
41347,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Adenofibroma,1
41348,Well-Circumscribed Lesion,Urethra Fibroepithelial Polyp,1
41349,Transformed Phase of Disease,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,1
41350,Malignant Cellular Infiltrate,Transitional cell cancer of renal pelvis and ureter metastatic,1
41351,Papillary Pattern,Laryngeal verrucous carcinoma stage IV,1
41352,Infiltrative Growth Pattern,Glioblastoma multiforme of spinal cord,1
41353,Malignant Cellular Infiltrate,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
41354,Immunologic Deficiency Syndromes,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
41355,Mesenchymal Differentiation,Metaplastic meningioma,1
41356,Epithelial Component Present,Carcinoma of Male Breast,1
41357,Increased Cellularity Present,Juxta-Articular Myxoma,1
41358,Carcinomatous Component Present,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
41359,Carcinomatous Component Present,Infiltrating Cervical Carcinoma,1
41360,Nuclear pleomorphism,Childhood Pleomorphic Rhabdomyosarcoma,1
41361,Epithelial Component Present,Hepatoma resectable,1
41362,Adulthood Lesion,Indolent Adult Non-Hodgkin Lymphoma,1
41363,Epithelial Component Present,Neck Carcinoma,1
41364,High Grade Lesion,Alveolar soft part sarcoma metastatic,1
41365,Stromal Invasion,Recurrent Ovarian Transitional Cell Carcinoma,1
41366,Severe dysplasia,Lung Squamous Cell Carcinoma In Situ,1
41367,Benign Cellular Infiltrate,Pleomorphic Lipoma,1
41368,Epithelial Component Present,Childhood Breast Carcinoma,1
41369,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Ovarian Endometrioid Adenocarcinoma,1
41370,High Grade Lesion,Alveolar soft part sarcoma metastatic,1
41371,Epithelial Component Present,Stage 0is Ureter Cancer AJCC v8,1
41372,Epithelial Component Present,Cervical Adenosquamous Carcinoma,1
41373,Mixed Cellular Population,Cervical Adenomyoma,1
41374,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia,1
41375,Epithelial Component Present,mucoepidermoid carcinoma of lacrimal gland,1
41376,Intraductal Lesion,High Grade Ductal Breast Carcinoma In Situ,1
41377,Benign Cellular Infiltrate,Bone island,1
41378,Primary Site Unknown,Undifferentiated Carcinoma of Unknown Primary,1
41379,Stromal Invasion,Malignant Ovarian Endometrioid Tumor,1
41380,Recurrent disease,Recurrent Adult Brain Neoplasm,1
41381,Pseudopapillary Pattern,Testicular embryonal carcinoma stage II,1
41382,Secondary Lesion,Extra-osseous Ewing's sarcoma metastatic,1
41383,Malignant Cellular Infiltrate,Parotid Gland Carcinosarcoma,1
41384,Anaplasia,Childhood Anaplastic Oligoastrocytoma,1
41385,Metastatic Lesion,Metastatic Meningioma,1
41386,Unclassifiable Lesion,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified",1
41387,Finding related to pregnancy,Hodgkin Lymphoma During Pregnancy,1
41388,Mesenchymal Component Present,Pleomorphic adenoma of parotid gland,1
41389,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v7,1
41390,Malignant Cellular Infiltrate,Stage II Colorectal Cancer,1
41391,Primary Lesion,Metastatic Fibrolamellar Carcinoma,1
41392,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
41393,Osseous Differentiation,Metastatic osteosarcoma,1
41394,Cutaneous Involvement,Basal cell carcinoma of vulva,1
41395,Cystic Change,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
41396,Tubular Structures Present,Gastric Tubular Adenocarcinoma,1
41397,Carcinomatous Component Present,Primary peritoneal carcinoma,1
41398,Nodular lesions,"Childhood Ganglioneuroblastoma, Nodular",1
41399,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v8,1
41400,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",1
41401,Malignant Cellular Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
41402,Malignant Cellular Infiltrate,Metastatic Unresectable Basal Cell Carcinoma,1
41403,Malignant Cellular Infiltrate,Recurrent Acute Myelomonocytic Leukemia,1
41404,Carcinomatous Component Present,Stage IVB Lung Cancer AJCC v8,1
41405,Exophytic Polypoid Lesion,Fallopian Tube Endometrioid Polyp,1
41406,Refractory Disease,Peripheral T-cell lymphoma unspecified refractory,1
41407,Malignant Cellular Infiltrate,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
41408,Necrotic changes (finding),large cell neuroendocrine carcinoma of gallbladder,1
41409,Firm mass,Cardiac Malignant Peripheral Nerve Sheath Tumor,1
41410,Malignant Cellular Infiltrate,Sweat gland carcinoma,1
41411,Adnexal Differentiation,Desmoplastic trichilemmoma,1
41412,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum,1
41413,Childhood Lesion,Childhood Nongerminomatous Germ Cell Tumor,1
41414,Monomorphic Cellular Infiltrate,Well Differentiated Oligodendroglioma,1
41415,Childhood Lesion,Recurrent Childhood Malignant Germ Cell Tumor,1
41416,Low Grade Lesion,Childhood Epithelioid Hemangioendothelioma,1
41417,Epithelial Component Present,Stage IV Laryngeal Cancer AJCC v6,1
41418,Malignant Cellular Infiltrate,Stage IA Bone Cancer AJCC v7,1
41419,Carcinomatous Component Present,Adenocarcinoma of anal canal,1
41420,Malignant Cellular Infiltrate,Malignant tumor of colon,1
41421,Gyriform Trabecular Pattern,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
41422,Anaplasia,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
41423,Hyperplastic Tissue Present,Atypical Mesothelial Hyperplasia,1
41424,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myeloid leukemia with multilineage dysplasia,1
41425,Vascular Channel Formation,Hemangiosarcoma,1
41426,Aggressive Clinical Course,Adult Burkitt Leukemia,1
41427,Cutaneous Involvement,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
41428,Carcinomatous Component Present,Recurrent Paranasal Sinus Squamous Cell Carcinoma,1
41429,Malignant Cellular Infiltrate,Prognostic Stage IIB Breast Cancer AJCC v8,1
41430,Epithelial Component Present,Low Grade Squamous Intraepithelial Neoplasia,1
41431,Malignant Cellular Infiltrate,Vulvar Large Cell Neuroendocrine Carcinoma,1
41432,Carcinomatous Component Present,Vaginal clear cell adenocarcinoma,1
41433,Secondary Lesion,Disseminated adenocarcinoma,1
41434,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
41435,Epithelial Component Present,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8,1
41436,Epithelial Component Present,Appendix High Grade Intraepithelial Neoplasia,1
41437,Carcinomatous Component Present,Squamous cell carcinoma of the nasal cavity,1
41438,Epithelial Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,1
41439,Chronic Inflammatory Infiltrate,Lymphomatoid Granulomatosis,1
41440,Epithelial Component Present,Stage IV Urethral Cancer AJCC v8,1
41441,Malignant Cellular Infiltrate,mucinous adenocarcinoma of rectum,1
41442,Malignant Cellular Infiltrate,Malignant Ovarian Transitional Cell Tumor,1
41443,High Mitotic Activity,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
41444,Epithelial Component Present,undifferentiated carcinoma of liver,1
41445,Epithelial Component Present,Vaginal Tubular Adenoma,1
41446,Malignant Cellular Infiltrate,CNS metastases,1
41447,Mesenchymal Component Present,Prostate Phyllodes Tumor,1
41448,Malignant Cellular Infiltrate,Anatomic Stage IIB Breast Cancer AJCC v8,1
41449,Non-Invasive Lesion,Stage 0is Renal Pelvis Cancer AJCC v7,1
41450,Epithelial Component Present,Stage IV Lung Squamous Cell Carcinoma AJCC v7,1
41451,Malignant Cellular Infiltrate,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7,1
41452,Epithelial Component Present,Malignant Breast Eccrine Spiradenoma,1
41453,Epithelial Component Present,Stage IV Pancreatic Cancer AJCC v6 and v7,1
41454,Sebaceous Differentiation,sebaceous adenoma of salivary gland,1
41455,Adulthood Lesion,Adult Pleomorphic Rhabdomyosarcoma,1
41456,Mitotic Activity,Adult Anaplastic Astrocytoma,1
41457,Storiform Growth Pattern,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
41458,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8,1
41459,Cystic Change,Mucoepidermoid carcinoma of submandibular gland,1
41460,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, t(16;16)(p13;q22)",1
41461,Diffuse Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
41462,CD4-Positive Neoplastic Cells Present,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
41463,Recurrent disease,Angiosarcoma recurrent,1
41464,Papillary Pattern,Condyloma anal,1
41465,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage II,1
41466,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage,1
41467,Anaplasia,MGMT-Unmethylated Glioblastoma,1
41468,Birbeck Granules Present,Tumors Derived from Langerhans Cells,1
41469,Bone Marrow Lymphoplasmacytic Infiltrate,Familial Waldenstrom's Macroglobulinaemia,1
41470,Mild dysplasia of colon,Colorectal Low Grade Intraepithelial Neoplasia,1
41471,Well Differentiated Lesion,Subglottic Verrucous Carcinoma,1
41472,Exophytic Polypoid Lesion,Vaginal Fibroepithelial Polyp,1
41473,Malignant Cellular Infiltrate,Refractory Central Nervous System Lymphoma,1
41474,Increased Cellularity Present,Frontal Lobe Anaplastic Oligodendroglioma,1
41475,Metastatic Lesion,Advanced Adult Hepatocellular Carcinoma,1
41476,Diffuse Pattern,Diffuse follicle center lymphoma,1
41477,Malignant Cellular Infiltrate,Submandibular Gland Acinic Cell Carcinoma,1
41478,Carcinomatous Component Present,Endometrial adenocarcinoma metastatic,1
41479,Malignant Cellular Infiltrate,Stage IVB Lip and Oral Cavity Cancer AJCC v8,1
41480,Malignant Cellular Infiltrate,Luminal B Breast Carcinoma,1
41481,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of cervix uteri,1
41482,Malignant Cellular Infiltrate,Squamous cell carcinoma of pharynx,1
41483,Carcinomatous Component Present,Appendix Mixed Adenoneuroendocrine Carcinoma,1
41484,Exophytic Polypoid Lesion,Frontal sinus polyp,1
41485,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligodendroglioma,1
41486,Malignant Cellular Infiltrate,Stage IIIC Lung Cancer AJCC v8,1
41487,Metastatic Lesion,Cholangiocarcinoma metastatic,1
41488,High Grade Lesion,Recurrent Gliosarcoma,1
41489,Malignant Cellular Infiltrate,Lymphoma stage III,1
41490,Epithelial Component Present,Recurrent Abdominal Neuroendocrine Neoplasm,1
41491,Carcinomatous Component Present,Vaginal Keratinizing Squamous Cell Carcinoma,1
41492,Epithelial Component Present,Carcinoma in situ of penis,1
41493,Metastatic Lesion,Metastatic Bladder Urothelial Carcinoma,1
41494,Carcinomatous Component Present,Parasite-Related Carcinoma,1
41495,Primary Lesion,Childhood Hepatocellular Carcinoma,1
41496,Osteoid formation,Aggressive osteoblastoma,1
41497,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myelomonocytic leukemia with abnormal eosinophils,1
41498,Low Mitotic Activity,Stage I Rectal Neuroendocrine Tumor AJCC v8,1
41499,Hemorrhagic,Uterine Angiosarcoma,1
41500,Extraosseous Lesion,Peripheral primitive neuroectodermal tumor of soft tissue,1
41501,Splenomegaly,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
41502,Epithelial Component Present,Appendix Carcinoma by AJCC v8 Stage,1
41503,Cutaneous Involvement,Stage IIB Cutaneous Melanoma AJCC v6 and v7,1
41504,Carcinomatous Component Present,Stage IIIC Fallopian Tube Cancer AJCC v7,1
41505,Malignant Cellular Infiltrate,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
41506,Epithelial Component Present,Recurrent Thymic Carcinoma,1
41507,Cutaneous Involvement,Stage IIA Cutaneous Melanoma AJCC v6 and v7,1
41508,Chromogranin A Positive Neoplastic Cells Present,Breast Carcinoid Tumor,1
41509,Epithelial Component Present,Vaginal Cancer by AJCC v8 Stage,1
41510,Single Cell Necrosis,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
41511,Indolent Clinical Course,Pyogenic granuloma of oral mucosa,1
41512,High Grade Lesion,"Synovial sarcoma, spindle cell",1
41513,Low Grade Lesion,Adamantinoma,1
41514,Malignant Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v8,1
41515,Benign Cellular Infiltrate,Paranasal Sinus Schneiderian Papilloma,1
41516,Cystic Change,Seborrheic keratosis of eyelid,1
41517,Carcinomatous Component Present,Stage IVB Gallbladder Cancer AJCC v8,1
41518,Childhood Lesion,Childhood Myxoid Chondrosarcoma,1
41519,Benign Cellular Infiltrate,Lymphangioma,1
41520,Malignant Cellular Infiltrate,Malignant Breast Adenomyoepithelioma,1
41521,Epithelial Component Present,Recurrent Craniopharyngioma,1
41522,Secondary Lesion,Secondary malignant neoplasm of axilla,1
41523,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
41524,Microcystic Change,Recurrent Childhood Protoplasmic Astrocytoma,1
41525,Cartilaginous Differentiation,Chondroblastic osteosarcoma,1
41526,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
41527,Primary Lesion,Meningeal melanomatosis,1
41528,Epithelial Component Present,Functioning Pancreatic Neuroendocrine Tumor G2,1
41529,Chronic Inflammatory Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,1
41530,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8,1
41531,Deep Lesion,Sclerosing liposarcoma,1
41532,Cystic Change,Pancreatic Macrocystic Serous Cystadenoma,1
41533,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v8,1
41534,Malignant Cellular Infiltrate,Primary amyloidosis,1
41535,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma,1
41536,Neuroendocrine Differentiation,Unresectable Carcinoid Tumor,1
41537,Diffuse Pattern,Malignant Peripheral Nerve Sheath Tumor,1
41538,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma recurrent,1
41539,Severe dysplasia,Pathologic Stage 0 Gastric Cancer AJCC v8,1
41540,Refractory Disease,Refractory Hairy Cell Leukemia,1
41541,Carcinomatous Component Present,Ear carcinoma,1
41542,Malignant Cellular Infiltrate,Secondary Central Nervous System Lymphoma,1
41543,Malignant Cellular Infiltrate,Lung Biphasic Synovial Sarcoma,1
41544,Vascular Channel Formation,Benign neoplasm of lymph vessels,1
41545,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
41546,Human Papillomavirus Negative,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
41547,Carcinomatous Component Present,Gastric Papillary Adenocarcinoma,1
41548,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Microadenoma,1
41549,Malignant Cellular Infiltrate,Clinical Stage II Esophageal Adenocarcinoma AJCC v8,1
41550,Carcinomatous Component Present,Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
41551,Carcinomatous Component Present,Sarcomatoid carcinoma of the lung,1
41552,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Differentiating Neuroblastoma,1
41553,Malignant Cellular Infiltrate,Adenocarcinoma in situ in villous adenoma,1
41554,Adulthood Lesion,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma,1
41555,Malignant Cellular Infiltrate,Refractory Peripheral Primitive Neuroectodermal Tumor,1
41556,Monocytosis,Chronic Myelomonocytic Leukemia-0,1
41557,Malignant Cellular Infiltrate,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
41558,Alternative Fascicle (Bundle) Pattern,Leiomyoma of Gallbladder,1
41559,Malignant Cellular Infiltrate,Metastatic Genitourinary System Carcinoma,1
41560,Epithelial Component Present,Prognostic Stage IA Breast Cancer AJCC v8,1
41561,Splenomegaly,Splenic marginal zone lymphoma refractory,1
41562,Carcinomatous Component Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
41563,Multifocal Lesion,mediastinal lipomatosis,1
41564,Vascular Channel Formation,Lymphangiomatosis,1
41565,Carcinomatous Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
41566,Osseous Differentiation,Central Nervous System Extraskeletal Osteosarcoma,1
41567,Malignant Cellular Infiltrate,Advanced Microsatellite Stable Colorectal Carcinoma,1
41568,Malignant Cellular Infiltrate,Secondary malignant neoplasm of neck,1
41569,Malignant Cellular Infiltrate,Adult Acute Erythroid Leukemia,1
41570,Epithelial Component Present,Epithelial tumor of ovary,1
41571,Epithelial Component Present,Stage I Prostate Cancer AJCC v8,1
41572,Papillary Pattern,Adult Myxopapillary Ependymoma,1
41573,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma refractory,1
41574,Metastatic Lesion,Secondary malignant neoplasm of heart,1
41575,Epithelial Component Present,Bladder Mixed Adenocarcinoma,1
41576,Malignant Cellular Infiltrate,Stage IV Adrenal Cortex Carcinoma AJCC v7,1
41577,Malignant Cellular Infiltrate,Malignant neoplasm of respiratory system,1
41578,Epithelial Component Present,"Transitional cell carcinoma, micropapillary",1
41579,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with abnormal marrow eosinophils,1
41580,Epithelial Component Present,Recurrent Liver Carcinoma,1
41581,Rapidly Enlarging Mass,Vulvar Alveolar Rhabdomyosarcoma,1
41582,Carcinomatous Component Present,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
41583,Epithelial Component Present,Prognostic Stage I Breast Cancer AJCC v8,1
41584,Carcinomatous Component Present,Metastatic Renal Cell Carcinoma,1
41585,Indolent Clinical Course,fibroma of testis,1
41586,Carcinomatous Component Present,Paget's Disease of the Nipple,1
41587,Adnexal Differentiation,Sebaceous Adenocarcinoma,1
41588,Perivascular Arrangement of Tumor Cells,Benign Pericytic Neoplasm,1
41589,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
41590,Slow Growing Mass,Unresectable Craniopharyngioma,1
41591,Carcinomatous Component Present,Mixed Squamous Cell Carcinoma of the Penis,1
41592,Immunosuppression-Related Post-Transplant Toxicity,New Onset Diabetes After Transplant,1
41593,Carcinomatous Component Present,Vaginal Small Cell Carcinoma,1
41594,Childhood Lesion,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
41595,Windblown Appearance of Atypical Keratinocytes,Bowen's Disease,1
41596,Carcinomatous Component Present,Stage IVA Hepatocellular Carcinoma AJCC v8,1
41597,Epithelial Component Present,Islet Cell Tumor,1
41598,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
41599,Tissue Differentiation Uncertain,Acral Fibromyxoma,1
41600,Epithelial Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
41601,Malignant Cellular Infiltrate,Colon Kaposi Sarcoma,1
41602,High Mitotic Activity,Unresectable Pancreatic Neuroendocrine Carcinoma,1
41603,Epithelial Component Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,1
41604,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of vulva,1
41605,Dermal Involvement,Vulvar Eccrine Porocarcinoma,1
41606,Carcinomatous Component Present,carcinosarcoma of salivary gland,1
41607,Metastatic Lesion,Rectal Carcinoma Metastatic in the Liver,1
41608,Carcinomatous Component Present,Stage IB Lung Large Cell Carcinoma AJCC v7,1
41609,Epithelial Component Present,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
41610,Malignant Cellular Infiltrate,Mucinous cystadenocarcinoma of ovary,1
41611,Epithelial Component Present,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
41612,Well Differentiated Lesion,verrucous carcinoma of vagina,1
41613,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Cystadenofibroma,1
41614,Epithelial Component Present,Lung Squamous Cell Papilloma,1
41615,Neuroendocrine Differentiation,Meckel Diverticulum Neuroendocrine Tumor G1,1
41616,No Identifiable Line of Differentiation,Adult Undifferentiated Pleomorphic Sarcoma,1
41617,Papillary Pattern,Supraglottic Verrucous Carcinoma,1
41618,Carcinomatous Component Present,Ovarian Transitional Cell Carcinoma,1
41619,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
41620,Childhood Lesion,Childhood Soft Tissue Sarcoma,1
41621,Malignant Cellular Infiltrate,Adult Acute Monoblastic and Monocytic Leukemia,1
41622,Alternative Fascicle (Bundle) Pattern,Leiomyomatosis,1
41623,Fibrotic Stroma Formation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
41624,Epithelial Component Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
41625,Microcystic Change,Lymphangioma circumscriptum,1
41626,Mitotic Activity,"Testicular Yolk Sac Tumor, Myxomatous Pattern",1
41627,Metastatic Lesion,Colon Carcinoma Metastatic in the Lung,1
41628,Malignant Cellular Infiltrate,Childhood Acute Lymphoblastic Leukemia,1
41629,Pathologic TNM Finding,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
41630,Radiation Sickness,Radiation-Induced Vascular Disease,1
41631,Malignant Cellular Infiltrate,Recurrent Rhabdomyosarcoma,1
41632,Negative Bone Marrow and Peripheral Blood,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,1
41633,Secondary Lesion,Advanced Head and Neck Carcinoma,1
41634,Malignant Cellular Infiltrate,Lung Non-Small Cell Cancer by AJCC v7 Stage,1
41635,Neuroendocrine Differentiation,Refractory Adrenal Gland Pheochromocytoma,1
41636,Malignant Cellular Infiltrate,Refractory Female Reproductive System Carcinoma,1
41637,Carcinomatous Component Present,Stage 0is Ureter Cancer AJCC v7,1
41638,Carcinomatous Component Present,Intramucosal Adenocarcinoma,1
41639,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
41640,Malignant Cellular Infiltrate,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
41641,Anaplasia,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
41642,Vascular Channel Formation,Central Nervous System Angiosarcoma,1
41643,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma,1
41644,Cystic Lesion,Craniopharyngioma,1
41645,Syncytial Pattern,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion",1
41646,Diffuse Pattern,Adult Diffuse Large B-Cell Lymphoma,1
41647,Carcinomatous Component Present,Squamous cell carcinoma,1
41648,Pseudoencapsulated Mass,High Grade Malignant Peripheral Nerve Sheath Tumor,1
41649,Malignant Cellular Infiltrate,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
41650,Metastatic/Recurrent Disease,Conventional Extraskeletal Myxoid Chondrosarcoma,1
41651,Epithelial Component Present,Secretory adenoma of pituitary,1
41652,Carcinomatous Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
41653,Epithelial Component Present,Non-squamous non-small cell lung cancer,1
41654,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
41655,Carcinomatous Component Present,Oropharyngeal Carcinoma by AJCC v6 Stage,1
41656,Malignant Cellular Infiltrate,Recurrent Merkel Cell Carcinoma,1
41657,Epithelial Component Present,Oral Intraepithelial Neoplasia,1
41658,Epithelial Component Present,Ovarian gonadoblastoma,1
41659,Benign Cellular Infiltrate,"Mixed Tumor, Not Otherwise Specified",1
41660,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyposis coli,1
41661,Polymorphic Cellular Infiltrate,Adult Langerhans Cell Histiocytosis,1
41662,Malignant Cellular Infiltrate,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
41663,Malignant Cellular Infiltrate,Stage IVA Lung Cancer AJCC v8,1
41664,Carcinomatous Component Present,Stage IV Nasal Cavity Carcinoma AJCC v7,1
41665,Malignant Cellular Infiltrate,Nephroblastoma,1
41666,Well-Circumscribed Lesion,Anal skin tag,1
41667,Recurrent disease,Recurrent Childhood Pilomyxoid Astrocytoma,1
41668,1p/19q Codeletion Status Unknown,oligodendroglioma,1
41669,Malignant Cellular Infiltrate,Stage IIA Testicular Cancer AJCC v6 and v7,1
41670,Recurrent disease,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
41671,Perivascular Arrangement of Tumor Cells,Gastric Glomus Tumor,1
41672,Epithelial Component Present,Adenosquamous carcinoma,1
41673,Malignant Cellular Infiltrate,Childhood Acute Megakaryoblastic Leukemia,1
41674,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",1
41675,Carcinomatous Component Present,Stage IV Skin Cancer,1
41676,Carcinomatous Component Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
41677,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Acute Myelomonocytic Leukemia,1
41678,Epithelial Component Present,Testicular Carcinoid Tumor,1
41679,Childhood Lesion,Childhood Lung Non-Small Cell Carcinoma,1
41680,In Situ Lesion,Stage 0 Colon Cancer AJCC v8,1
41681,Papillary Pattern,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
41682,Malignant Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm,1
41683,Vascular Channel Formation,"Kaposi's sarcoma, metastatic",1
41684,Primary Lesion,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,1
41685,Metaplasia of Malignant Cells Present,adenocarcinoma of breast with spindle cell metaplasia,1
41686,Adulthood Lesion,Adult Cholangiocarcinoma,1
41687,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Binet Staging System,1
41688,Epithelial Component Present,Cecum Carcinoma,1
41689,atypia morphology,Atypical hyperplasia of breast,1
41690,Nuclear Grooves,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
41691,Childhood Lesion,Childhood Gastric Carcinoma,1
41692,Necrotic changes (finding),Epithelioid glioblastoma,1
41693,Epithelial Component Present,Stage IIIA1 Ovarian Cancer AJCC v8,1
41694,Secondary Lesion,Synovial sarcoma metastatic,1
41695,Carcinomatous Component Present,Posterior Pharyngeal Wall Carcinoma,1
41696,Malignant Cellular Infiltrate,Metastatic Ewing's Sarcoma,1
41697,Clinical TNM Finding,Clinical Stage IIC Cutaneous Melanoma AJCC v8,1
41698,Multinodular Pattern,Gastric Plexiform Fibromyxoma,1
41699,Pseudoglandular Pattern,teratocarcinoma of mediastinum,1
41700,Malignant Cellular Infiltrate,Choriocarcinoma of ovary,1
41701,Malignant Cellular Infiltrate,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
41702,Mesenchymal Component Present,Breast Complex Fibroadenoma,1
41703,Necrotic changes (finding),Adult Malignant Peripheral Nerve Sheath Tumor,1
41704,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
41705,Hyperplastic Epithelial Tissue Present,Ductal Breast Hyperplasia,1
41706,Carcinomatous Component Present,Stage II Fallopian Tube Cancer,1
41707,Benign Cellular Infiltrate,Mature Teratoma,1
41708,Vascular Channel Formation,Airway Hemangioma,1
41709,Indolent Clinical Course,Oral Cavity Monomorphic Adenoma,1
41710,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
41711,In Situ Lesion,Carcinoma in situ of vagina,1
41712,Malignant Cellular Infiltrate,Grade 2 Endometrial Endometrioid Adenocarcinoma,1
41713,Carcinomatous Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,1
41714,Stromal Invasion,Recurrent Ovarian Mucinous Adenocarcinoma,1
41715,Hyperkeratosis,Verrucous carcinoma of the oral cavity recurrent,1
41716,Malignant Cellular Infiltrate,Stage II Diffuse Large B-Cell Lymphoma,1
41717,Epithelial Component Present,Pancreatic Serous Neoplasm,1
41718,Malignant Cellular Infiltrate,Adult Cholangiocarcinoma,1
41719,Malignant Cellular Infiltrate,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
41720,Carcinomatous Component Present,Carcinoma in situ of vagina,1
41721,Infiltrative Growth Pattern,"Diffuse Astrocytoma, IDH-Mutant",1
41722,Serrated Glandular Architecture,Traditional Serrated Adenoma,1
41723,Childhood Lesion,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7,1
41724,Epithelial Component Present,Stage IA Cervical Cancer AJCC v6 and v7,1
41725,Metastatic/Recurrent Disease,Epithelioid sarcoma non-metastatic,1
41726,Benign Cellular Infiltrate,Hidradenoma Papilliferum,1
41727,Carcinomatous Component Present,Clear cell odontogenic carcinoma,1
41728,Malignant Cellular Infiltrate,Stage IVA Colon Cancer AJCC v8,1
41729,Multinodular Mass,Angiosarcoma of spleen,1
41730,Recurrent disease,Recurrent Lip and Oral Cavity Carcinoma,1
41731,Epithelial Component Present,Stage IIIC Hilar Cholangiocarcinoma AJCC v8,1
41732,Epithelial Component Present,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
41733,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",1
41734,Carcinomatous Component Present,Medullary carcinoma of thyroid,1
41735,Epithelial Component Present,adenosquamous carcinoma of esophagus,1
41736,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma refractory,1
41737,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
41738,Epithelial Component Present,Ovarian gynandroblastoma,1
41739,Carcinomatous Component Present,Stage 0 Renal Pelvis Cancer AJCC v7,1
41740,Malignant Cellular Infiltrate,Grade 3 Invasive Breast Carcinoma,1
41741,Carcinomatous Component Present,cystadenocarcinoma of salivary gland,1
41742,Severe dysplasia,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,1
41743,Epithelial Component Present,Adenoid cystic eccrine carcinoma,1
41744,Refractory Disease,Angioimmunoblastic T-cell lymphoma refractory,1
41745,Carcinomatous Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
41746,Benign Cellular Infiltrate,Adenoma of lung,1
41747,Epithelial Component Present,Posterior Tongue Adenoid Cystic Carcinoma,1
41748,High Grade Lesion,Recurrent Glioblastoma,1
41749,Carcinomatous Component Present,Stage IVC Hypopharyngeal Carcinoma AJCC v8,1
41750,Epithelial Component Present,Stage IVA Vulvar Cancer AJCC v6,1
41751,Metastatic Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
41752,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
41753,Malignant Cellular Infiltrate,Cutaneous Malignant Melanoma 2,1
41754,Rapidly Enlarging Mass,Fusion-Negative Rhabdomyosarcoma,1
41755,Secondary Lesion,Secondary malignant neoplasm of lung,1
41756,Epithelial Component Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,1
41757,Carcinomatous Component Present,Childhood Gastric Carcinoma,1
41758,atypia morphology,Liver Dysplastic Nodule,1
41759,Epithelial Component Present,Bladder Urachal Urothelial Carcinoma,1
41760,Carcinomatous Component Present,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
41761,Malignant Cellular Infiltrate,Malignant odontogenic tumor,1
41762,Epithelial Component Present,Metastatic Lip Carcinoma,1
41763,Benign Cellular Infiltrate,Central Nervous System Myofibroblastoma,1
41764,Indolent Clinical Course,Nasopharyngeal Angiofibroma,1
41765,Malignant Cellular Infiltrate,Stage IB1 Cervical Cancer AJCC v8,1
41766,Absence of Stromal Invasion,Benign Brenner Tumor,1
41767,Carcinomatous Component Present,Colorectal Cancer by AJCC v8 Stage,1
41768,Exophytic Polypoid Lesion,Polyp of maxillary sinus,1
41769,Carcinomatous Component Present,Laryngeal Adenoid Cystic Carcinoma,1
41770,Epithelial Component Present,Hypopharyngeal Carcinoma,1
41771,Malignant Cellular Infiltrate,Juvenile Myelomonocytic Leukemia,1
41772,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v6,1
41773,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
41774,Fibrotic Stroma Formation,Perihilar Intrahepatic Cholangiocarcinoma,1
41775,Epithelial Component Present,Mild esophageal dysplasia,1
41776,S-100-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic",1
41777,Carcinomatous Component Present,Advanced Neuroendocrine Carcinoma,1
41778,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",1
41779,Stromal Invasion,Stage IB Ovarian Cancer AJCC v8,1
41780,Skin nodule,Pilomatrixoma,1
41781,Metastatic Lesion,"Squamous cell carcinoma, metastatic",1
41782,Epithelial Component Present,Childhood Atypical Choroid Plexus Papilloma,1
41783,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",1
41784,Perineural spread,adenoid cystic carcinoma of lung,1
41785,Neuroendocrine Differentiation,Intestinal Neuroendocrine Tumor,1
41786,Malignant Cellular Infiltrate,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,1
41787,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
41788,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
41789,Hereditary Lesion,Hereditary Kidney Oncocytoma,1
41790,Malignant Cellular Infiltrate,Refractory Hormone Receptor Positive Breast Carcinoma,1
41791,Hereditary Lesion,Turcot Syndrome Type 1,1
41792,atypia morphology,Low Grade Liver Dysplastic Nodule,1
41793,Malignant Cellular Infiltrate,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
41794,Osseous Differentiation,Bone Surface (Peripheral) Osteosarcoma,1
41795,Cutaneous Involvement,Locally Advanced Skin Squamous Cell Carcinoma,1
41796,Well-Circumscribed Lesion,"Polyposis, Gastric",1
41797,Secondary Lesion,Secondary malignant neoplasm of orbit,1
41798,Multinodular Pattern,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
41799,Epithelial Component Present,Carcinoid Tumor,1
41800,Carcinomatous Component Present,Metastatic Lung Carcinoma,1
41801,Well-Circumscribed Lesion,Pineocytoma,1
41802,Adulthood Lesion,Adult Cholangiocarcinoma,1
41803,Malignant Cellular Infiltrate,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
41804,Monomorphic Cellular Infiltrate,Childhood Cerebral Ependymoma,1
41805,Carcinomatous Component Present,carcinosarcoma of lung,1
41806,Epithelial Component Present,Jejunal Neuroendocrine Tumor G1,1
41807,Capillary Sized Vascular Channel Formation,Solid Glomus Tumor,1
41808,Anaplasia,Adult Anaplastic Ependymoma,1
41809,Carcinomatous Component Present,Endometrial Clear Cell Adenocarcinoma,1
41810,Epithelial Component Present,Bladder Urachal Squamous Cell Carcinoma,1
41811,Dysplasia,Gallbladder Papillary Biliary Intraepithelial Neoplasia,1
41812,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
41813,Primary Lesion,Well Differentiated Hepatocellular Carcinoma,1
41814,Well-Circumscribed Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
41815,Local disease,Localized Extrahepatic Bile Duct Carcinoma,1
41816,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
41817,Malignant Cellular Infiltrate,Frontal Lobe Anaplastic Oligodendroglioma,1
41818,Carcinomatous Component Present,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
41819,Exophytic Polypoid Lesion,Gastrointestinal polyps,1
41820,Carcinomatous Component Present,Serous Endometrial Intraepithelial Carcinoma,1
41821,CD30-Positive Neoplastic Cells Present,Stage I Anaplastic Large Cell Lymphoma,1
41822,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Immature Teratoma,1
41823,Malignant Cellular Infiltrate,Colon Leiomyosarcoma,1
41824,Mild cytologic atypia,Supraglottic Verrucous Carcinoma,1
41825,Hyperplastic Epithelial Tissue Present,Ductal Breast Hyperplasia,1
41826,Benign Cellular Infiltrate,Ovarian Fetiform Teratoma,1
41827,Neuroendocrine Differentiation,Well Differentiated Pancreatic Endocrine Tumor,1
41828,Childhood Lesion,Childhood Hematopoietic Neoplasm,1
41829,Malignant Cellular Infiltrate,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",1
41830,Low Mitotic Activity,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,1
41831,Malignant Cellular Infiltrate,Thyroid carcinoma,1
41832,Malignant Cellular Infiltrate,carcinoma of pancreas with osteoclast-like giant cells,1
41833,Malignant Cellular Infiltrate,Mixed Acinar-Ductal Carcinoma of the Pancreas,1
41834,Carcinomatous Component Present,Renal Cell Carcinoma Associated with Neuroblastoma,1
41835,Malignant Cellular Infiltrate,Recurrent Extragonadal Seminoma,1
41836,Mesenchymal Component Present,Benign Prostate Phyllodes Tumor,1
41837,Epithelial Component Present,Breast Pleomorphic Adenoma,1
41838,Neuroendocrine Differentiation,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,1
41839,Squamous metaplasia of bladder,verrucous carcinoma of bladder,1
41840,Well-Circumscribed Lesion,Mixed Cell Type Kidney Wilms Tumor,1
41841,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
41842,Exophytic Papillary Lesion,Buccal Mucosa Verrucous Carcinoma,1
41843,Primary Lesion,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
41844,Radiation Sickness,Radiation-Related Osteosarcoma,1
41845,More than 5 Mitoses per 50HPF,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
41846,Malignant Cellular Infiltrate,Primary leiomyosarcoma,1
41847,Epithelial Component Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
41848,Infiltrative Growth Pattern,Supratentorial Glioblastoma,1
41849,Carcinomatous Component Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
41850,Neuroendocrine Differentiation,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
41851,Vascular Channel Formation,Hemangioma acquired,1
41852,Hereditary Lesion,Hereditary corneal dystrophy,1
41853,Vascular Channel Formation,Refractory Kaposi Sarcoma,1
41854,Epithelial Component Present,Locally Advanced Digestive System Carcinoma,1
41855,Oligodendroglial Component Present,Anaplastic Oligoastrocytoma,1
41856,Malignant Cellular Infiltrate,Carcinoma of submandibular gland,1
41857,Vacuolated Plasma Cells in the Bone Marrow,mu-Chain Disease,1
41858,Childhood Lesion,Childhood Rectal Carcinoma,1
41859,Epithelial Component Present,Prognostic Stage IIIB Breast Cancer AJCC v8,1
41860,Recurrent disease,Recurrent Adult Soft Tissue Sarcoma,1
41861,Fibrosis,"Hepatocellular carcinoma, scirrhous",1
41862,Neuroendocrine Differentiation,Neuroendocrine Tumors,1
41863,Epithelial Component Present,Mixed Squamous Cell Carcinoma of the Penis,1
41864,Epithelial Component Present,CARCINOMA OF VULVA,1
41865,Alternative Fascicle (Bundle) Pattern,Cervical Leiomyoma,1
41866,Severe dysplasia,Stage 0is Bladder Cancer AJCC v8,1
41867,Peripheral Nuclear Palisading,basaloid squamous cell carcinoma of floor of mouth,1
41868,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
41869,Malignant Cellular Infiltrate,Stage IB Fallopian Tube Cancer AJCC v8,1
41870,High Mitotic Activity,Intestinal Neuroendocrine Carcinoma,1
41871,Secondary Lesion,Transitional cell cancer of renal pelvis and ureter metastatic,1
41872,Epithelial Component Present,Stage IVA Basal Cell Lip Carcinoma,1
41873,Epithelial Component Present,Large cell lung cancer stage II,1
41874,Malignant Cellular Infiltrate,Stage IV Superficial Spreading Melanoma AJCC v6 and v7,1
41875,Malignant Cellular Infiltrate,Adult Acute Monocytic Leukemia,1
41876,Mesenchymal Component Present,Oral Cavity Pleomorphic Adenoma,1
41877,Storiform Growth Pattern,Cutaneous Fibrous Histiocytoma,1
41878,Nodular lesions,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
41879,Malignant Cellular Infiltrate,Stage IIIB Breast Carcinoma,1
41880,Epithelial Component Present,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
41881,Epithelial Component Present,Ameloblastic Carcinoma,1
41882,Absence of Invasion,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
41883,Carcinomatous Component Present,Undifferentiated carcinoma of nasopharynx,1
41884,Benign Cellular Infiltrate,Benign neoplasm of anus,1
41885,Epithelial Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
41886,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Cancer AJCC v8,1
41887,Local disease,Infiltrating Intramuscular Lipoma,1
41888,Dysplasia,Cervical Adenocarcinoma In Situ,1
41889,Cutaneous Involvement,Vascular neoplasm of skin,1
41890,Lipomatous Differentiation,Cerebellar Liponeurocytoma,1
41891,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myeloid leukemia with abnormal marrow eosinophils,1
41892,Secondary Lesion,Locally Advanced Chordoma,1
41893,Oligodendroglial Component Present,Oligodendroglial Neoplasm,1
41894,Malignant Cellular Infiltrate,ISS Stage II Plasma Cell Myeloma,1
41895,Carcinomatous Component Present,Stage IV Paranasal Sinus Cancer AJCC v7,1
41896,Carcinomatous Component Present,Stage IIB Lung Cancer AJCC v7,1
41897,Indolent Clinical Course,Central Nervous System Leiomyoma,1
41898,Carcinomatous Component Present,Sarcomatoid carcinoma of the lung,1
41899,Malignant Cellular Infiltrate,Hereditary Male Breast Carcinoma,1
41900,Borderline Lesion,"Post-transplant lymphoproliferative disorder, polymorphic",1
41901,Epithelial Component Present,Non-Small Cell Adenocarcinoma,1
41902,Carcinomatous Component Present,Intrahepatic cholangiocarcinoma recurrent,1
41903,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
41904,Absence of Invasion,Atypical Lobular Breast Hyperplasia,1
41905,Well-Circumscribed Lesion,Hepatocellular Adenoma,1
41906,Childhood Lesion,Childhood Systemic Anaplastic Large Cell Lymphoma,1
41907,Epithelial Component Present,Ovarian gynandroblastoma,1
41908,Epithelial Component Present,Carcinoma bone,1
41909,Epithelial Component Present,Low grade appendiceal mucinous neoplasm,1
41910,Dysplasia,Vaginal intraepithelial neoplasia grade 1,1
41911,Malignant Cellular Infiltrate,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
41912,Carcinomatous Component Present,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8,1
41913,Malignant Cellular Infiltrate,Metastatic non-small cell lung cancer,1
41914,Adulthood Lesion,Adult Mesenchymal Chondrosarcoma,1
41915,Clinical TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,1
41916,Carcinomatous Component Present,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
41917,Malignant Cellular Infiltrate,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,1
41918,Immunologic Deficiency Syndromes,Engraftment syndrome,1
41919,Malignant Cellular Infiltrate,Helicobacter Pylori-Related Non-Hodgkin Lymphoma,1
41920,Carcinomatous Component Present,Locally Advanced Bile Duct Carcinoma,1
41921,Nuclear pleomorphism,Hepatocellular Small Cell Change,1
41922,Follicular Cell Differentiation,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
41923,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
41924,Papillary Pattern,Pancreatic Intraepithelial Neoplasia-1B,1
41925,Nuclear Pseudoinclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
41926,Absence of Stromal Invasion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
41927,Recurrent disease,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
41928,Epithelial Component Present,Malignant Vulvar Phyllodes Tumor,1
41929,atypia morphology,Borderline Fallopian Tube Neoplasm,1
41930,Malignant Cellular Infiltrate,Recurrent Pancreatic Acinar Cell Carcinoma,1
41931,Capsular Invasion,"Thymoma, type B1, malignant",1
41932,Epithelial Component Present,Stage IIB Fallopian Tube Cancer AJCC v8,1
41933,Metastatic Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,1
41934,Malignant Cellular Infiltrate,Anaplastic Sarcoma of the Kidney,1
41935,Adulthood Lesion,Adult Grade II Meningioma,1
41936,Malignant Cellular Infiltrate,Anaplastic Oligodendroglioma,1
41937,Malignant Cellular Infiltrate,Lugano Classification Hodgkin Lymphoma by AJCC v8 Stage,1
41938,Dysplasia,Gallbladder Papillary Biliary Intraepithelial Neoplasia,1
41939,Epithelial Component Present,Recurrent Lip and Oral Cavity Carcinoma,1
41940,Absence of a Hormonal Syndrome,Non-Functioning Pituitary Gland Macroadenoma,1
41941,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
41942,Malignant Cellular Infiltrate,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8,1
41943,Epithelial Differentiation,Papillary tumor of the pineal region,1
41944,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Oncocytic Adenoma,1
41945,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v8,1
41946,Blasts Under 20 Percent of Peripheral Blood White Cells,Refractory Chronic Myelomonocytic Leukemia,1
41947,Well-Circumscribed Lesion,Spinal hemangioblastoma,1
41948,Malignant Cellular Infiltrate,Childhood Alveolar Rhabdomyosarcoma,1
41949,Absence of Stromal Invasion,Fallopian Tube Metaplastic Papillary Tumor,1
41950,Vascular Channel Formation,Childhood Epithelioid Hemangioendothelioma,1
41951,Malignant Cellular Infiltrate,Refractory Extranodal Diffuse Large B-cell Lymphoma,1
41952,Recurrent disease,Recurrent Malignant Thyroid Gland Neoplasm,1
41953,Cystic Change,Vulvar Inverted Follicular Keratosis,1
41954,Biphasic Pattern,Malignant Vulvar Phyllodes Tumor,1
41955,Immunologic Deficiency Syndromes,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
41956,Edematous Stroma Formation,Myxoma,1
41957,Malignant Cellular Infiltrate,Prostate carcinoma,1
41958,Antoni A Pattern,Sellar Schwannoma,1
41959,Neuroendocrine Differentiation,Colorectal Small Cell Neuroendocrine Carcinoma,1
41960,Submucosal Lesion,Submucosal Invasive Colon Adenocarcinoma,1
41961,Epithelial Component Present,Recurrent Urethral Cancer,1
41962,Painless Mass,Giant Cell Tumor of Soft Tissue,1
41963,Increased Cellularity Present,"Anaplastic Astrocytoma, IDH-Wildtype",1
41964,Malignant Cellular Infiltrate,Recurrent Myxoid Liposarcoma,1
41965,Malignant Cellular Infiltrate,"Hodgkin lymphoma, nodular sclerosis, cellular phase",1
41966,Swelling,Central Nervous System Mesenchymal Chondrosarcoma,1
41967,Composite Lesion,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
41968,Necrotic changes (finding),Resectable Dedifferentiated Liposarcoma,1
41969,Preserved Nuclear Polarity,Ureter Inverted Papilloma,1
41970,Monomorphic Cellular Infiltrate,"Adenoma, Monomorphic",1
41971,Slow Growing Mass,Chondroid chordoma,1
41972,Carcinomatous Component Present,Stage IIIA Hepatocellular Carcinoma AJCC v8,1
41973,Refractory Disease,Intestinal T-cell lymphoma refractory,1
41974,Necrotic changes (finding),Low Grade Malignant Peripheral Nerve Sheath Tumor,1
41975,Benign Cellular Infiltrate,Benign neoplasm of lacrimal gland,1
41976,Low Grade Neuroendocrine Lesion,Carcinoid tumor of rectum,1
41977,Nuclear Atypia,Mesenchymal Glioblastoma,1
41978,Intestinal metaplasia,Intestinal-Type Sinonasal Adenocarcinoma,1
41979,Epithelial Component Present,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
41980,Epithelial Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
41981,Cutaneous Involvement,Vulvar Congenital Melanocytic Nevus,1
41982,High Mitotic Activity,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
41983,Carcinomatous Component Present,Recurrent Ovarian Clear Cell Adenocarcinoma,1
41984,High Mitotic Activity,Gallbladder Neuroendocrine Carcinoma,1
41985,Well Differentiated Neuroendocrine Lesion,Gastrinoma,1
41986,Carcinomatous Component Present,Synchronous Bilateral Breast Carcinoma,1
41987,Malignant Cellular Infiltrate,Immunoblastic Large-Cell Lymphoma,1
41988,Recurrent disease,Esophageal squamous cell carcinoma recurrent,1
41989,Primary Lesion,Childhood Hepatocellular Carcinoma,1
41990,Epithelial Component Present,Spindle Cell Oncocytoma of the Adenohypophysis,1
41991,Cutaneous Involvement,Necrobiosis Lipoidica,1
41992,Epithelial Component Present,Appendix Tubular Carcinoid,1
41993,Splenomegaly,T-Cell Large Granular Lymphocyte Leukemia,1
41994,High Mitotic Activity,Stage 0 Merkel Cell Carcinoma AJCC v7,1
41995,Radiation Sickness,Radiation sickness syndrome,1
41996,Malignant Cellular Infiltrate,Malignant tumor of epididymis,1
41997,Acanthosis,Subglottic Verrucous Carcinoma,1
41998,Carcinomatous Component Present,Gastric Neuroendocrine Carcinoma,1
41999,Cafe-au-Lait Spots,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas",1
42000,Recurrent disease,Recurrent Renal Pelvis Urothelial Carcinoma,1
42001,Necrotic changes (finding),Stage II Lung Small Cell Carcinoma AJCC v7,1
42002,Osseous Differentiation,Childhood Periosteal Osteosarcoma,1
42003,Mixed Cellular Population,Borderline Ovarian Endometrioid Adenofibroma,1
42004,Epithelial Component Present,Localized Unresectable Adult Hepatocellular Carcinoma,1
42005,Epithelial Component Present,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7,1
42006,Recurrent disease,Endometrioid adenocarcinoma recurrent,1
42007,Epithelial Component Present,Bladder squamous cell carcinoma recurrent,1
42008,Carcinomatous Component Present,Colon Carcinoma,1
42009,Indolent Clinical Course,Juvenile Xanthogranuloma,1
42010,Mediastinal mass,Mediastinal T Acute Lymphoblastic Leukemia,1
42011,Epithelial Component Present,Benign epithelial tumor of ovary,1
42012,Epithelial Component Present,Stage II Esophageal Cancer AJCC v7,1
42013,Primary Lesion,Pineal Gland Astrocytoma,1
42014,Hereditary Lesion,Familial Acute Myeloid Leukemia with Mutated Cebpa,1
42015,Nuclear Grooves,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
42016,Epithelial Component Present,Stage IIB Lung Cancer AJCC v7,1
42017,Lytic lesion,Chondroblastoma,1
42018,Presence of a Hormonal Syndrome,Functioning Pancreatic Neuroendocrine Tumor G2,1
42019,Neuroendocrine Differentiation,Familial Adrenal Gland Pheochromocytoma,1
42020,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
42021,Epithelial Component Present,Stage IIIA Vulvar Cancer AJCC v8,1
42022,Hemorrhagic,Uterine Angiosarcoma,1
42023,Dysplasia,High Grade Anal Canal Squamous Intraepithelial Neoplasia,1
42024,Malignant Cellular Infiltrate,"Adenocarcinoma, metastatic",1
42025,Generalized Hydropic Villous Change,Complete hydatidiform mole,1
42026,Metastatic Lesion,Pleural mesothelioma malignant advanced,1
42027,Regional Disease,Locally Advanced Unresectable Pancreatic Adenocarcinoma,1
42028,Carcinomatous Component Present,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type",1
42029,Carcinomatous Component Present,Bladder squamous cell carcinoma stage IV,1
42030,Metastatic Lesion,Metastatic leiomyosarcoma,1
42031,Macrofollicular Structures Present,Juvenile granulosa cell tumor,1
42032,Splenomegaly,T-Cell Prolymphocytic Leukemia,1
42033,Epithelial Component Present,Anal canal squamous cell carcinoma,1
42034,Malignant Cellular Infiltrate,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
42035,Synchronous Lesion,Bilateral Synchronous Sporadic Renal Cell Carcinoma,1
42036,Childhood Lesion,Recurrent Childhood Hodgkin Lymphoma,1
42037,Microvascular Proliferation,Adult Brain Stem Gliosarcoma,1
42038,S-100-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis,1
42039,Infiltrative Growth Pattern,Recurrent Anaplastic Astrocytoma,1
42040,Hereditary Lesion,"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)",1
42041,Epithelial Component Present,Stage IA Esophageal Adenocarcinoma AJCC v7,1
42042,Epithelial Component Present,Borderline Ovarian Clear Cell Cystadenofibroma,1
42043,Epithelial Component Present,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,1
42044,Malignant Cellular Infiltrate,Primary cutaneous acral CD8 positive T-cell lymphoma,1
42045,Childhood Lesion,Childhood Brain Oligodendroglioma,1
42046,Carcinomatous Component Present,Recurrent Ovarian Cystadenocarcinoma,1
42047,Epithelial Component Present,Urothelial carcinoma ureter recurrent,1
42048,Cystic Change,Cystadenocarcinoma,1
42049,Carcinomatous Component Present,Stage IC Eyelid Carcinoma AJCC v7,1
42050,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v8 Stage,1
42051,Benign Cellular Infiltrate,Tumorlet,1
42052,Epithelial Component Present,"Carcinoma, Endometrioid",1
42053,Osteoid formation,High grade surface osteosarcoma,1
42054,Papillary Pattern,Papillary thyroid carcinoma,1
42055,Malignant Cellular Infiltrate,Colon Leiomyosarcoma,1
42056,Vascular Channel Formation,Vascular Breast Neoplasm,1
42057,Cytoplasmic Membrane-Bound Granules Present,Merkel cell carcinoma,1
42058,Malignant Cellular Infiltrate,Ampulla of Vater Signet Ring Cell Carcinoma,1
42059,Malignant Cellular Infiltrate,Stage 0 Oropharyngeal Carcinoma,1
42060,Indolent Clinical Course,Benign Skeletal Muscle Neoplasm,1
42061,Malignant Cellular Infiltrate,Adenocarcinoma in adenomatous polyposis coli,1
42062,Mild dysplasia,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia,1
42063,Epithelial Component Present,Anal Intraepithelial Neoplasia 2,1
42064,Secondary Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
42065,Benign Cellular Infiltrate,Spindle cell lipoma,1
42066,Organoid Pattern,Alveolar soft part sarcoma metastatic,1
42067,Malignant Cellular Infiltrate,Squamous non-small cell lung cancer,1
42068,Malignant Cellular Infiltrate,Alcohol-Related Laryngeal Carcinoma,1
42069,Comedo Necrosis,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
42070,No Evidence of Radiologic Finding,Occult Breast Carcinoma,1
42071,Carcinomatous Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,1
42072,Carcinomatous Component Present,Locally Advanced Basal Cell Carcinoma,1
42073,Hyperkeratosis,Cervical Warty Carcinoma,1
42074,Severe dysplasia,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",1
42075,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myelomonocytic Leukemia,1
42076,Malignant Cellular Infiltrate,Stage IIB Uterine Sarcoma AJCC v7,1
42077,Well Differentiated Lesion,verrucous carcinoma of bladder,1
42078,Malignant Cellular Infiltrate,Ureter Cancer by AJCC v7 Stage,1
42079,Benign Cellular Infiltrate,Ureter Schwannoma,1
42080,Follicular Structures Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
42081,Epithelial Component Present,Recurrent Combined Thymic Epithelial Neoplasm,1
42082,Indolent Clinical Course,Endobronchial lipoma,1
42083,Poorly Differentiated Lesion,Stage IIB Lung Large Cell Carcinoma AJCC v7,1
42084,Recurrent Genetic Abnormalities Present,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities,1
42085,Epithelial Component Present,Stage II Intrahepatic Bile Duct Cancer AJCC v8,1
42086,Carcinomatous Component Present,Advanced Unresectable Gastric Adenocarcinoma,1
42087,Malignant Cellular Infiltrate,Stage I Lentigo Maligna Melanoma AJCC v7,1
42088,Cutaneous Involvement,Malignant neoplasm of scrotum,1
42089,Malignant Cellular Infiltrate,Asbestos-Related Lung Carcinoma,1
42090,Epithelial Component Present,Adenocarcinoma of lung stage IIIA,1
42091,Diffuse Pattern,Stage IV Diffuse Large B-Cell Lymphoma,1
42092,Cartilaginous Differentiation,Cartilaginous exostosis,1
42093,Malignant Cellular Infiltrate,"Mucinous adenocarcinoma, endocervical type",1
42094,Malignant Cellular Infiltrate,Kaposi's sarcoma of esophagus,1
42095,Well-Circumscribed Lesion,Pulmonary Sclerosing Hemangioma,1
42096,Recurrent disease,Recurrent Breast Angiosarcoma,1
42097,Malignant Cellular Infiltrate,Testicular yolk sac tumor stage III,1
42098,Well Differentiated Lesion,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
42099,Epithelial Component Present,Benign Ovarian Clear Cell Tumor,1
42100,Mitotic Activity,Pilomyxoid astrocytoma,1
42101,Carcinomatous Component Present,Bladder Adenocarcinoma,1
42102,Rapidly Enlarging Mass,Childhood Spindle Cell Rhabdomyosarcoma,1
42103,Recurrent disease,Recurrent Childhood Medulloblastoma,1
42104,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Microadenoma,1
42105,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IIIB,1
42106,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ganglioneuroblastoma,1
42107,Epithelial Component Present,Stage I Esophageal Cancer AJCC v7,1
42108,Malignant Cellular Infiltrate,Stage IV Adult Hodgkin Lymphoma,1
42109,Carcinomatous Component Present,Stage 0 Vaginal Cancer AJCC v7,1
42110,Benign Cellular Infiltrate,Uterine Corpus Diffuse Leiomyomatosis,1
42111,Necrotic changes (finding),Childhood Glioblastoma,1
42112,Borderline Lesion,Atypical Spitz Nevus,1
42113,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v8,1
42114,Benign Cellular Infiltrate,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
42115,Epithelial Component Present,Refractory Oropharyngeal Squamous Cell Carcinoma,1
42116,Epithelial Component Present,Carcinoma of unknown primary,1
42117,Tissue Differentiation Uncertain,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
42118,Malignant Cellular Infiltrate,Langerhans Cell Sarcoma,1
42119,Epithelial Component Present,Stage IV Appendix Carcinoma AJCC v8,1
42120,Malignant Cellular Infiltrate,"Urinary bladder carcinoma stage I, with cancer in situ",1
42121,Malignant Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
42122,Epithelial Component Present,Biochemically Recurrent Prostate Carcinoma,1
42123,Carcinomatous Component Present,small cell carcinoma of salivary gland,1
42124,Epithelial Component Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
42125,Carcinomatous Component Present,Invasive Ductal and Invasive Lobular Breast Carcinoma,1
42126,Epithelial Component Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",1
42127,Well Differentiated Lesion,Well Differentiated Ovarian Steroid Cell Tumor,1
42128,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
42129,Monomorphic Cellular Infiltrate,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
42130,Perivascular Arrangement of Tumor Cells,Benign Glomus Tumor,1
42131,Malignant Cellular Infiltrate,Low Grade Salivary Gland Carcinoma,1
42132,Acinar Cell Differentiation,Acinic Cell Breast Carcinoma,1
42133,Epithelial Component Present,Neuroendocrine neoplasm of larynx,1
42134,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
42135,Malignant Cellular Infiltrate,Lung Enteric Adenocarcinoma,1
42136,Malignant Cellular Infiltrate,Lung Small Cell Carcinoma by AJCC v7 Stage,1
42137,Benign Cellular Infiltrate,Cystadenofibroma of fallopian tube,1
42138,Invasive Lesion,Recurrent Invasive Ductal Breast Carcinoma,1
42139,Recurrent disease,Recurrent Childhood Anaplastic Oligodendroglioma,1
42140,Tissue Differentiation Uncertain,Orbital Alveolar Soft Part Sarcoma,1
42141,Pseudopapillary Pattern,teratocarcinoma of mediastinum,1
42142,Malignant Cellular Infiltrate,Undifferentiated (Embryonal) Sarcoma,1
42143,Epithelial Component Present,Squamous cell carcinoma of colon,1
42144,Malignant Cellular Infiltrate,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8,1
42145,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
42146,Secondary Lesion,Secondary Central Nervous System Lymphoma,1
42147,Cutaneous Involvement,Skin Clear Cell Basal Cell Carcinoma,1
42148,Malignant Cellular Infiltrate,Stage IIIB Esophageal Adenocarcinoma AJCC v7,1
42149,Carcinomatous Component Present,Lung Adenosquamous Carcinoma by AJCC v7 Stage,1
42150,Carcinomatous Component Present,Old Burn Scar-Related Skin Squamous Cell Carcinoma,1
42151,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v6 Stage,1
42152,Malignant Cellular Infiltrate,"Transitional cell carcinoma, micropapillary",1
42153,Benign Cellular Infiltrate,Periosteal fibroma,1
42154,Epithelial Component Present,Small Intestinal Adenosquamous Carcinoma,1
42155,Malignant Cellular Infiltrate,Recurrent Malignant Endocervical Neoplasm,1
42156,Splenomegaly,Recurrent B-Cell Prolymphocytic Leukemia,1
42157,Carcinomatous Component Present,Cervical Clear Cell Adenocarcinoma,1
42158,Carcinomatous Component Present,"Paget's Disease, Mammary",1
42159,Absence of Invasion,Low Grade Ductal Breast Carcinoma In Situ,1
42160,Malignant Cellular Infiltrate,Refractory T Acute Lymphoblastic Leukemia,1
42161,Recurrent disease,Recurrent Burkitt Lymphoma,1
42162,Benign Cellular Infiltrate,Benign neoplasm of cecum,1
42163,High Grade Lesion,Glioblastoma,1
42164,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Lung,1
42165,Macule,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,1
42166,Cystic Change,mucoepidermoid carcinoma of accessory sinus,1
42167,Malignant Cellular Infiltrate,Stage IA Lung Cancer AJCC v7,1
42168,Malignant Cellular Infiltrate,Angiosarcoma Associated with Lymphedema,1
42169,Malignant Cellular Infiltrate,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
42170,Malignant Cellular Infiltrate,Clinical Stage II Cutaneous Melanoma AJCC v8,1
42171,Malignant Cellular Infiltrate,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
42172,Intraductal Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
42173,Pale Eosinophilic Stroma Formation,Dysembryoplastic neuroepithelial tumor,1
42174,Recurrent disease,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
42175,Carcinomatous Component Present,Early Invasive Cervical Adenocarcinoma,1
42176,Malignant Cellular Infiltrate,Recurrent Cancer of Gallbladder,1
42177,Malignant Cellular Infiltrate,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
42178,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
42179,Hyperplastic Tissue Present,Bronchial Epithelial Hyperplasia,1
42180,Hereditary Lesion,Familial Paraganglioma-Pheochromocytoma Syndrome,1
42181,Malignant Cellular Infiltrate,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
42182,Immunologic Deficiency Syndromes,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,1
42183,Malignant Cellular Infiltrate,Major Salivary Gland Sarcoma,1
42184,Malignant Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
42185,Borderline Lesion,"Mesothelioma, Cystic",1
42186,Indolent Clinical Course,Ivory Exostosis,1
42187,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
42188,Epithelial Component Present,Appendix Carcinoma by AJCC v7 Stage,1
42189,Refractory Disease,Refractory Malignant Urinary System Neoplasm,1
42190,Malignant Cellular Infiltrate,"Liposarcoma, Dedifferentiated",1
42191,"Amorphus, Eosinophilic, and Acellular Deposit",Nodular amyloidosis,1
42192,Benign Cellular Infiltrate,Ureter Urothelial Papilloma,1
42193,Calcitonin serum level increased,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
42194,Biphasic Pattern,Papillary glioneuronal tumor,1
42195,Malignant Cellular Infiltrate,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
42196,Primary Lesion,Primary mediastinal large B-cell lymphoma recurrent,1
42197,Epithelial Component Present,Stage IVA Lip Cancer AJCC v6 and v7,1
42198,Secondary Lesion,Locally Advanced Bile Duct Carcinoma,1
42199,Malignant Cellular Infiltrate,Stage I Adult Burkitt Lymphoma,1
42200,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer AJCC v8,1
42201,Neuroendocrine Differentiation,Extra-Adrenal Paraganglioma,1
42202,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8,1
42203,Borderline Lesion,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
42204,Absence of Invasion,Anal Intraepithelial Neoplasia 3,1
42205,Epithelial Component Present,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
42206,Malignant Cellular Infiltrate,Pleural Biphasic Synovial Sarcoma,1
42207,Epithelial Component Present,HER2-positive carcinoma of breast,1
42208,Well-Circumscribed Lesion,Gallbladder adenoma,1
42209,Malignant Cellular Infiltrate,Stage IB Esophageal Cancer AJCC v7,1
42210,Malignant Cellular Infiltrate,Stage II Anal Canal Cancer AJCC v6 and v7,1
42211,Benign Cellular Infiltrate,Laryngeal Leiomyoma,1
42212,Intraductal Lesion,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
42213,Epithelial Component Present,Intestinal-Type Sinonasal Adenocarcinoma,1
42214,Carcinomatous Component Present,Minor Salivary Gland Carcinoma,1
42215,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,1
42216,High Mitotic Activity,Stage IA Merkel Cell Carcinoma AJCC v7,1
42217,Epithelial Component Present,"Papilloma, Squamous Cell",1
42218,Neuroectodermal Differentiation,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
42219,Carcinomatous Component Present,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
42220,Childhood Lesion,Childhood Gonadal Germ Cell Tumor,1
42221,Malignant Cellular Infiltrate,Refractory Leukemia,1
42222,Low Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1,1
42223,Malignant Cellular Infiltrate,Malignant neoplasm of larynx,1
42224,Borderline Lesion,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
42225,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
42226,Epithelial Component Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",1
42227,Adulthood Lesion,Adult Hodgkin Lymphoma,1
42228,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Gene Mutations,1
42229,Malignant Cellular Infiltrate,Sarcoma by FNCLCC Grade,1
42230,Secondary Lesion,Metastatic urothelial carcinoma,1
42231,Refractory Disease,Refractory Bladder Carcinoma,1
42232,Blastemal Pattern,Blastema Predominant Kidney Wilms Tumor,1
42233,Fibrotic Stroma Formation,Female Reproductive System Adenofibroma,1
42234,Secondary Lesion,Metastatic Unresectable Malignant Neoplasm,1
42235,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v6 Stage,1
42236,Rapidly Enlarging Mass,Fusion-Negative Rhabdomyosarcoma,1
42237,Epithelial Component Present,Minor Salivary Gland Adenoid Cystic Carcinoma,1
42238,Malignant Cellular Infiltrate,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7,1
42239,Epithelial Component Present,ACTH-Secreting Pituitary Adenoma,1
42240,Epithelial Component Present,Platinum-Resistant Urothelial Carcinoma,1
42241,Polymorphic Cellular Infiltrate,Thyroid Gland Langerhans Cell Histiocytosis,1
42242,Malignant Cellular Infiltrate,Malignant tumor of myocardium,1
42243,Mesenchymal Component Present,Malignant Phyllodes Tumor of Prostate,1
42244,Non-Hereditary Lesion,Parietal cell carcinoma,1
42245,Benign Cellular Infiltrate,Testicular Sclerosing Sertoli Cell Tumor,1
42246,Epithelial Component Present,Esophageal squamous papilloma,1
42247,Nodular Pattern,Methotrexate-Associated Follicular Lymphoma,1
42248,Mixed Cellular Population,Borderline Ovarian Mucinous Adenofibroma,1
42249,Well Differentiated Neuroendocrine Lesion,Pancreatic Vipoma,1
42250,Carcinomatous Component Present,FIGO Stage IIIC Ovarian Cancer,1
42251,Low Mitotic Activity,Stage I Colon Neuroendocrine Tumor AJCC v8,1
42252,Malignant Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v8,1
42253,Hyperplastic Tissue Present,Sebaceous hyperplasia,1
42254,Acanthosis,Cervical Warty Carcinoma,1
42255,Cystic Change,Parotid Gland Warthin Tumor,1
42256,Malignant Cellular Infiltrate,Postcricoid Squamous Cell Carcinoma,1
42257,Cutaneous Involvement,Exfoliative dermatitis,1
42258,Malignant Cellular Infiltrate,Recurrent Extranodal Diffuse Large B-cell Lymphoma,1
42259,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Ann Arbor Stage,1
42260,Mixed Cellular Population,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
42261,Carcinomatous Component Present,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
42262,Malignant Cellular Infiltrate,Stage II Immature Testicular Teratoma AJCC v6 and v7,1
42263,Benign Cellular Infiltrate,Fibroma of prostate,1
42264,Poorly Cohesive Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric,1
42265,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G2,1
42266,Carcinomatous Component Present,External Ear Squamous Cell Carcinoma,1
42267,Benign Cellular Infiltrate,Benign Adrenal Gland Composite Pheochromocytoma,1
42268,Hypercellular bone marrow,"Polycythemia Vera, Polycythemic Phase",1
42269,Metastatic/Recurrent Disease,Malignant Lung PEComa,1
42270,Tissue Differentiation Uncertain,Acral Fibromyxoma,1
42271,Recurrent disease,Alveolar soft part sarcoma recurrent,1
42272,Metastatic Lesion,Metastasizing Chondroblastoma,1
42273,Malignant Cellular Infiltrate,Renal Pelvis Cancer by AJCC v8 Stage,1
42274,Malignant Cellular Infiltrate,Malignant tumor of palate,1
42275,Epithelial Component Present,Colorectal Adenomatous Polyp,1
42276,Intraluminal Tumor Growth,Gallbladder Papillomatosis,1
42277,Malignant Cellular Infiltrate,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
42278,Epithelial Component Present,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
42279,Lesion with Diameter Greater than 10mm,Non-Functioning Pituitary Gland Macroadenoma,1
42280,Epithelial Component Present,Submandibular Gland Acinic Cell Carcinoma,1
42281,Malignant Cellular Infiltrate,Gastric Carcinoma with Lymphoid Stroma,1
42282,Neuroendocrine Differentiation,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
42283,Osseous Differentiation,Stage IIA Osteosarcoma AJCC v7,1
42284,Clinical TNM Finding,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
42285,Cutaneous Involvement,Apocrine cystadenoma,1
42286,Malignant Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
42287,Malignant Cellular Infiltrate,High Grade Ductal Breast Carcinoma In Situ,1
42288,Dilated Vascular Space Formation,Hobnail Hemangioma,1
42289,Secondary Lesion,Metastatic Malignant Neoplasm to the Thyroid,1
42290,Dysplasia,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
42291,Carcinomatous Component Present,Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7,1
42292,Carcinomatous Component Present,Stage III Rectosigmoid Cancer AJCC v7,1
42293,Tissue of Mullerian Origin Present,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
42294,Malignant Cellular Infiltrate,Clear Cell Hepatocellular Carcinoma,1
42295,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v7,1
42296,Oligodendroglial Component Present,Frontal Lobe Anaplastic Oligodendroglioma,1
42297,Carcinomatous Component Present,Fallopian Tube Gestational Choriocarcinoma,1
42298,Malignant Cellular Infiltrate,Refractory Mature B-Cell Non-Hodgkin Lymphoma,1
42299,Mixed Cellular Population,endometrioid adenofibroma of ovary,1
42300,Epithelial Component Present,Masaoka-Koga Stage I,1
42301,Eccrine Differentiation,Eccrine carcinoma of skin,1
42302,Well Differentiated Neuroendocrine Lesion,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,1
42303,Carcinomatous Component Present,Endometrioid adenocarcinoma metastatic,1
42304,Absence of Invasion,Carcinoma in Situ,1
42305,Severe dysplasia,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
42306,Follicular Cell Differentiation,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
42307,High Mitotic Activity,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
42308,Neuroendocrine Differentiation,Mediastinal Paraganglioma,1
42309,"Amorphus, Eosinophilic, and Acellular Deposit",Reactive systemic amyloidosis,1
42310,Pregnancy Complications,Stage III Gestational Trophoblastic Neoplasm AJCC v8,1
42311,Malignant Cellular Infiltrate,Stage I Rectosigmoid Cancer AJCC v6 and v7,1
42312,Exophytic Polypoid Lesion,Foveolar-Type Adenoma,1
42313,Borderline Lesion,Cystadenocarcinoma of kidney,1
42314,Epidermotropic Lymphocytic Infiltrate,Stage IA Mycosis Fungoides AJCC v7,1
42315,Epithelial Component Present,Small Intestinal Intraepithelial Neoplasia,1
42316,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx recurrent,1
42317,Intraocular Lesion,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
42318,Pseudoglandular Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
42319,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Choriocarcinoma,1
42320,"Undifferentiated ""Fetal-Type"" Tissues Present",Pineal Region Immature Teratoma,1
42321,Malignant Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v6 and v7,1
42322,Cutaneous Involvement,Herpes simplex dermatitis,1
42323,Epithelial Component Present,Pleomorphic lobular carcinoma in situ of breast,1
42324,Metastatic Lesion,Metastatic Rectal Carcinoma,1
42325,'Starry-sky' pattern,Stage I Childhood Burkitt Lymphoma,1
42326,Dysplasia,Colorectal Villous Adenoma,1
42327,Neuroendocrine Differentiation,Metastatic Lung Neuroendocrine Neoplasm,1
42328,Geographic Necrosis,Adult Central Nervous System Embryonal Carcinoma,1
42329,Epithelial Component Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
42330,Increased Cellularity Present,Cellular Neurofibroma,1
42331,Below the Diaphragm Disease,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb,1
42332,Diffuse Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
42333,Fibroblastoma-Like Differentiation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,1
42334,High Grade Lesion,Adult Synovial Sarcoma,1
42335,Neuroendocrine Differentiation,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
42336,Cutaneous Involvement,Chronic Adult T-Cell Leukemia/Lymphoma,1
42337,Epithelial Component Present,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
42338,Carcinomatous Component Present,Large cell lung cancer stage IV,1
42339,Cutaneous Involvement,Invasive Apocrine Breast Carcinoma,1
42340,Malignant Cellular Infiltrate,Rectal Serrated Adenocarcinoma,1
42341,Benign Cellular Infiltrate,Lipoblastomatosis,1
42342,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
42343,Malignant Cellular Infiltrate,Kaposi's sarcoma of liver,1
42344,Epithelial Component Present,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
42345,Carcinomatous Component Present,Stage IVB Fallopian Tube Cancer AJCC v8,1
42346,Epithelial Component Present,Inverted papilloma of urinary bladder,1
42347,Recurrent disease,Recurrent Childhood Anaplastic Oligoastrocytoma,1
42348,Neuroendocrine Differentiation,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
42349,Cartilaginous Differentiation,Chondromatosis,1
42350,Cutaneous Involvement,Cutis Laxa,1
42351,Malignant Cellular Infiltrate,Colon Carcinoma Metastatic in the Liver,1
42352,Indolent Clinical Course,Vulvar Angiomyxoma,1
42353,Pregnancy Complications,"Pregnancy, Ovarian",1
42354,Slit-Like Vascular Channel Formation,Solid Angioleiomyoma,1
42355,Stromal Invasion,Ovarian Transitional Cell Carcinoma,1
42356,Malignant Cellular Infiltrate,Paget Disease of the Scrotum,1
42357,Neoplastic Plasma Cells Present in Bone Marrow,Osteosclerotic Plasma Cell Myeloma,1
42358,Thyroglobulin Positive Neoplastic Cells Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
42359,Carcinomatous Component Present,Stage IV Vaginal Cancer AJCC v8,1
42360,Carcinomatous Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
42361,Carcinomatous Component Present,Stage I Major Salivary Gland Cancer AJCC v8,1
42362,Hyperplastic Tissue Present,Prostatic Atypical Adenomatous Hyperplasia,1
42363,Recurrent disease,Non-Hodgkin's lymphoma transformed recurrent,1
42364,Biphasic Pattern,Clear cell cystadenofibroma,1
42365,Epithelial Component Present,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
42366,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
42367,Recurrent disease,Recurrent Merkel Cell Carcinoma,1
42368,Malignant Cellular Infiltrate,Thyroid Lymphoma,1
42369,Epithelial Component Present,Common wart,1
42370,Malignant Cellular Infiltrate,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,1
42371,'Starry-sky' pattern,Adult Burkitt Lymphoma,1
42372,Refractory Disease,Refractory Malignant Urinary System Neoplasm,1
42373,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
42374,Carcinomatous Component Present,Adenocarcinoma gastric recurrent,1
42375,Diffuse Pattern,Childhood Gemistocytic Astrocytoma,1
42376,Recurrent disease,Recurrent Ovarian Endometrioid Adenocarcinoma,1
42377,Indolent Clinical Course,Pericardial Adenomatoid Tumor,1
42378,Epithelial Component Present,combined small cell carcinoma of lung,1
42379,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
42380,Malignant Cellular Infiltrate,Kadish Stage C Olfactory Neuroblastoma,1
42381,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
42382,Indolent Clinical Course,Spindle cell hemangioma,1
42383,Malignant Cellular Infiltrate,Immunoblastic Large-Cell Lymphoma,1
42384,Below the Diaphragm Disease,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
42385,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
42386,Exophytic Polypoid Lesion,Vaginal Tubulovillous Adenoma,1
42387,Epithelial Component Present,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
42388,Indolent Clinical Course,Soft Palate Pleomorphic Adenoma,1
42389,Epithelial Component Present,Refractory Nasopharyngeal Carcinoma,1
42390,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
42391,Invasive Lesion,Endometrioid carcinoma of prostate,1
42392,Villous Pattern,villous adenoma of stomach,1
42393,Benign Cellular Infiltrate,Vaginal Blue Nevus,1
42394,Neuroendocrine Differentiation,Stage IV Appendix Neuroendocrine Tumor AJCC v8,1
42395,Malignant Cellular Infiltrate,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,1
42396,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v8,1
42397,Necrotic changes (finding),Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
42398,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Aleukemic Monocytic Leukemia Cutis,1
42399,Adnexal Differentiation,Eccrine dermal cylindroma,1
42400,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
42401,S-100-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,1
42402,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v8 Stage,1
42403,Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells,Non-IgM Monoclonal Gammopathy of Undetermined Significance,1
42404,Increased Cellularity Present,Adrenal neuroblastoma,1
42405,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Adenocarcinoma,1
42406,Hyperkeratosis,Seborrheic keratosis of eyelid,1
42407,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
42408,Epithelial Component Present,Gastric Neuroendocrine Neoplasm,1
42409,Dysplasia,Villous adenoma of duodenum,1
42410,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Skin,1
42411,Epithelial Component Present,Unresectable Gastric Adenocarcinoma,1
42412,Epithelial Component Present,TSH-Producing Pituitary Gland Carcinoma,1
42413,Monoclonal Gammapathies,Waldenstrom's macroglobulinemia recurrent,1
42414,Malignant Cellular Infiltrate,Gliomatosis Cerebri Type I,1
42415,Epithelial Component Present,Regional Digestive System Neuroendocrine Tumor G1,1
42416,Invasive Lesion,Advanced Prostate Adenocarcinoma,1
42417,Chromogranin A Positive Neoplastic Cells Present,Ovarian Trabecular Carcinoid Tumor,1
42418,Malignant Cellular Infiltrate,Carcinoma of hard palate,1
42419,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v6 and v7,1
42420,Cartilaginous Differentiation,Enchondromatosis,1
42421,Malignant Cellular Infiltrate,"Sarcoma, Myeloid",1
42422,Fibrous Septa Present,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
42423,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
42424,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage IV,1
42425,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
42426,Malignant Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma AJCC v7,1
42427,Nuclear pleomorphism,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
42428,Severe dysplasia,Intraductal Non-Comedo Breast Adenocarcinoma,1
42429,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Flat Ductal Epithelial Atypia of the Breast,1
42430,Gastric-Type Epithelial Differentiation,"Gastric Adenoma, Gastric-Type",1
42431,Carcinomatous Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
42432,Carcinomatous Component Present,Colorectal Cancer by AJCC v6 Stage,1
42433,Malignant Cellular Infiltrate,Lymphoepithelioid lymphoma (clinical),1
42434,Carcinomatous Component Present,Localized Resectable Adult Liver Carcinoma,1
42435,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
42436,Epithelial Component Present,Stage I Colon Cancer AJCC v8,1
42437,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",1
42438,Secondary Lesion,Extra-osseous Ewing's sarcoma metastatic,1
42439,Epithelial Component Present,Alveolar adenoma,1
42440,Epithelial Component Present,Stage IB Hepatocellular Carcinoma AJCC v8,1
42441,Malignant Cellular Infiltrate,Digestive System Large Cell Neuroendocrine Carcinoma,1
42442,Calcitonin Positive Neoplastic Cells Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
42443,Epithelial Component Present,Brenner Tumor,1
42444,Malignant Cellular Infiltrate,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
42445,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
42446,Carcinomatous Component Present,Rectosigmoid cancer recurrent,1
42447,Cutaneous Involvement,Ceruminous Neoplasm,1
42448,Adnexal Differentiation,Benign neoplasm of sebaceous gland,1
42449,Cartilaginous Differentiation,Chondroma,1
42450,Benign Cellular Infiltrate,Benign Ovarian Neoplasm,1
42451,Carcinomatous Component Present,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
42452,Aberrant Thyroid Tissue Present,Struma Ovarii,1
42453,Exophytic Polypoid Lesion,tubulovillous adenoma of stomach,1
42454,Neoplastic Plasma Cells Present in Bone Marrow,Non-Secretory Plasma Cell Myeloma,1
42455,Gastric dysplasia,villous adenoma of stomach,1
42456,Pathologic TNM Finding,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
42457,Pushing Tumor Margin,Human Papillomavirus-Related Verrucous Carcinoma,1
42458,Malignant Cellular Infiltrate,lymphoepithelial squamous cell carcinoma of salivary gland,1
42459,Ground Glass Nuclear Inclusion,Atypical follicular adenoma,1
42460,Carcinomatous Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
42461,Anaplasia,Anaplastic astrocytoma,1
42462,Entrapped Respiratory Epithelium Present,Endobronchial Hamartoma,1
42463,Adnexal Differentiation,eccrine adenocarcinoma of vulva,1
42464,Borderline Lesion,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder,1
42465,Malignant Cellular Infiltrate,Lung Mucinous Adenocarcinoma In Situ,1
42466,Recurrent Genetic Abnormalities Present,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",1
42467,Malignant Cellular Infiltrate,germinoma of brain,1
42468,Primary Lesion,Peripheral neuroepithelioma of bone recurrent,1
42469,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,M5b Acute differentiated monocytic leukemia,1
42470,Epithelial Component Present,Hard Palate Pleomorphic Adenoma,1
42471,Epithelial Component Present,Recurrent Lung Carcinoma Cell Type Unspecified,1
42472,Papillary Pattern,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
42473,Epithelial Component Present,Stage IV Laryngeal Carcinoma,1
42474,Cartilaginous Component Present,Chondroblastic osteosarcoma,1
42475,Malignant Cellular Infiltrate,Granulocytic Sarcoma,1
42476,Secondary Lesion,Metastatic Malignant Neoplasm to the Cervix,1
42477,Benign Cellular Infiltrate,Angiolipoma,1
42478,Immunosuppression-Related Post-Transplant Toxicity,Maternally Derived Graft Versus Host Disease,1
42479,Malignant Cellular Infiltrate,Metastatic Malignant Pancreatic Neoplasm,1
42480,Cutaneous Involvement,Diaper candidiasis,1
42481,Vascular Channel Formation,Venous Angioleiomyoma,1
42482,Malignant Cellular Infiltrate,Non-Gestational Ovarian Choriocarcinoma,1
42483,Malignant Cellular Infiltrate,Stage I Vaginal Cancer AJCC v6 and v7,1
42484,Pathologic TNM Finding,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
42485,Intraosseous Lesion,Intraosseous well differentiated osteosarcoma,1
42486,Secondary Lesion,Recurrent Metastatic Digestive System Carcinoma,1
42487,Schwannian Stroma Predominant Component of the Tumor Volume,Colorectal Ganglioneuroma,1
42488,Malignant Cellular Infiltrate,Adenocarcinoma with squamous metaplasia,1
42489,Epithelial Component Present,Ovarian Mucinous Cystadenofibroma,1
42490,Complete Spontaneous Regression,"lymphomatoid papulosis, type A",1
42491,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
42492,Carcinomatous Component Present,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
42493,Carcinomatous Component Present,undifferentiated carcinoma of larynx,1
42494,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma,1
42495,Benign Cellular Infiltrate,Uterine Fibroids,1
42496,Carcinomatous Component Present,Laryngeal verrucous carcinoma,1
42497,Malignant Cellular Infiltrate,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
42498,Hyperplastic Tissue Present,Cervical Mesonephric Remnants and Hyperplasia,1
42499,Epithelial Component Present,Advanced Cervical Adenocarcinoma,1
42500,Benign Cellular Infiltrate,Ovarian Clear Cell Cystadenofibroma,1
42501,Epithelial Component Present,Locally Advanced Head and Neck Carcinoma,1
42502,Carcinomatous Component Present,Stage IIIA Fallopian Tube Cancer AJCC v8,1
42503,Malignant Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
42504,Dermal Involvement,Deep Penetrating Nevus,1
42505,Metastatic Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
42506,Epithelial Component Present,Appendix Low Grade Intraepithelial Neoplasia,1
42507,Carcinomatous Component Present,FIGO Stage IIIA1(ii) Ovarian Cancer,1
42508,Epithelial Component Present,Extrapulmonary Small Cell Carcinoma,1
42509,Malignant Cellular Infiltrate,Cecum Lymphoma,1
42510,Epithelial Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v7,1
42511,Malignant Cellular Infiltrate,Stage IIIA Adult Liver Cancer AJCC v7,1
42512,"Fully Differentiated ""Adult-Type"" Tissues Present",Malignant teratoma of testis,1
42513,Vascular Channel Formation,Pleural Epithelioid Hemangioendothelioma,1
42514,Benign Cellular Infiltrate,Childhood Choroid Plexus Papilloma,1
42515,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP J",1
42516,Carcinomatous Component Present,Laryngeal Giant Cell Carcinoma,1
42517,Carcinomatous Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
42518,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
42519,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma,1
42520,Epithelial Component Present,Colorectal Low Grade Intraepithelial Neoplasia,1
42521,Myxoid Stroma Formation,Recurrent Chordoma,1
42522,Carcinomatous Component Present,Bladder Squamous Cell Carcinoma,1
42523,Carcinomatous Component Present,Anaplastic Carcinoma of the Rectum,1
42524,Epithelial Component Present,Bladder Cancer by AJCC v6 Stage,1
42525,Malignant Cellular Infiltrate,Testicular cancer metastatic,1
42526,Malignant Cellular Infiltrate,Undifferentiated carcinoma of nasopharynx,1
42527,Cutaneous Involvement,Epithelioid cell nevus,1
42528,Malignant Cellular Infiltrate,Anal Canal Small Cell Neuroendocrine Carcinoma,1
42529,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v7,1
42530,Recurrent disease,Neuroblastoma recurrent,1
42531,Carcinomatous Component Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,1
42532,Cutaneous Involvement,Herpes zoster dermatitis of eyelid,1
42533,Villous Pattern,Colorectal Villous Adenoma,1
42534,Biphasic Pattern,Benign mixed epithelial and stromal tumor of kidney,1
42535,Enterochromaffin Type Granules Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
42536,Locally Aggressive Lesion,Giant Cell Fibroblastoma,1
42537,Malignant Cellular Infiltrate,Squamous cell carcinoma of pharynx,1
42538,Malignant Cellular Infiltrate,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
42539,Metaplasia,Pleomorphic adenoma of lacrimal gland,1
42540,Slow Growing Mass,Giant Cell Angioblastoma,1
42541,Epithelial Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,1
42542,Malignant Cellular Infiltrate,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
42543,Secondary Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
42544,Carcinomatous Component Present,"Endocervical Adenocarcinoma, Usual Type",1
42545,Hyalinized Stroma Formation,Locally Advanced Epithelioid Hemangioendothelioma,1
42546,Epithelial Component Present,Colon Cancer by AJCC v8 Stage,1
42547,Carcinomatous Component Present,Stage IA1 Cervical Cancer,1
42548,Monoclonal Gammapathies,Waldenstrom's macroglobulinemia refractory,1
42549,Thyroglobulin Positive Neoplastic Cells Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
42550,Carcinomatous Component Present,Ampulla of Vater Mucinous Adenocarcinoma,1
42551,Mild dysplasia,"Glandular intraepithelial neoplasia, low grade",1
42552,Nodular Pattern,Nodulo-ulcerative basal cell carcinoma,1
42553,Glandular Pattern,Lung Enteric Adenocarcinoma,1
42554,Malignant Cellular Infiltrate,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8,1
42555,Monomorphic Cellular Infiltrate,Childhood Supratentorial Ependymoma,1
42556,Malignant Cellular Infiltrate,Waldenstrom's macroglobulinemia refractory,1
42557,Hereditary Lesion,Hereditary Non-Polyposis Colon Cancer Type 2,1
42558,Refractory Disease,Refractory Chronic Leukemia,1
42559,Therapy-Related Toxicity,Transplant-Related Squamous Cell Carcinoma,1
42560,Intraductal Lesion,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
42561,Malignant Cellular Infiltrate,Refractory Melanoma,1
42562,Carcinomatous Component Present,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
42563,Intracytoplasmic Eosinophilic Inclusion,Childhood Atypical Teratoid/Rhabdoid Tumor,1
42564,Malignant Cellular Infiltrate,Childhood Medulloblastoma,1
42565,Carcinomatous Component Present,Parasite-Related Carcinoma,1
42566,Malignant Cellular Infiltrate,Vulvar adenocarcinoma,1
42567,Malignant Cellular Infiltrate,Stage I Oral Cavity Cancer AJCC v6 and v7,1
42568,Papillary Pattern,Anal Canal Squamous Papilloma,1
42569,Diffuse Pattern,"Epithelioid mesothelioma, malignant",1
42570,Carcinomatous Component Present,Recurrent Thyroid Gland Follicular Carcinoma,1
42571,Benign Cellular Infiltrate,lipoma of mediastinum,1
42572,Primary Lesion,Parosteal Osteosarcoma,1
42573,Carcinomatous Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
42574,Carcinomatous Component Present,Stage IV Vaginal Cancer AJCC v8,1
42575,Abundance of Small Lymphocytes,Lymphocyte Rich Classical Hodgkin Lymphoma,1
42576,Carcinomatous Component Present,Stage IB Breast Cancer AJCC v7,1
42577,Malignant Cellular Infiltrate,Recurrent Childhood Hodgkin Lymphoma,1
42578,Malignant Cellular Infiltrate,Recurrent Primary Effusion Lymphoma,1
42579,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
42580,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
42581,Malignant Cellular Infiltrate,"Intracranial Embryonal Tumor, Not Otherwise Specified",1
42582,Dysplasia,High grade cervical glandular intraepithelial neoplasia,1
42583,Mitotic Activity,Anaplastic Brain Stem Astrocytoma,1
42584,Carcinomatous Component Present,Breast Cancer by AJCC v8 Prognostic Stage,1
42585,Immunologic Deficiency Syndromes,Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma,1
42586,Neuroendocrine Differentiation,Regional Digestive System Neuroendocrine Tumor G1,1
42587,Malignant Cellular Infiltrate,Esophageal Non-Hodgkin Lymphoma,1
42588,Cutaneous Involvement,Fibrous Hamartoma of Infancy,1
42589,Enterochromaffin Type Granules Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
42590,Blasts Expressing CD56 and Immature T-Cell Markers Present,NK-lymphoblastic leukemia/lymphoma,1
42591,Cutaneous Involvement,"Carcinoma, Basal Cell",1
42592,Refractory Disease,Peripheral T-cell lymphoma unspecified refractory,1
42593,Epithelial Component Present,Liver Neuroendocrine Neoplasm,1
42594,Lytic lesion,Malignant Giant Cell Tumor of Bone,1
42595,Malignant Cellular Infiltrate,Combined Lung Large Cell Neuroendocrine Carcinoma,1
42596,Radiation Sickness,"Neoplasms, Radiation-Induced",1
42597,Carcinomatous Component Present,combined small cell carcinoma of lung,1
42598,Mucoid Stroma Formation,Bile duct mucinous adenocarcinoma,1
42599,Polymorphic Cellular Infiltrate,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
42600,Diffuse Pattern,Adult Glioblastoma,1
42601,Tissue of Mullerian Origin Present,"Uterine Carcinosarcoma, Homologous Type",1
42602,Carcinomatous Component Present,Stage IVA Pharyngeal Carcinoma,1
42603,Low Grade Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1,1
42604,Low Mitotic Activity,Colon Neuroendocrine Tumor G1,1
42605,Dysplasia,Pancreatic Intraepithelial Neoplasia-1,1
42606,Tubular Structures Present,Malignant Testicular Sertoli Cell Tumor,1
42607,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Neutrophilic Leukemia,1
42608,Mucoid Stroma Formation,Recurrent Appendix Mucinous Adenocarcinoma,1
42609,Adulthood Lesion,Adult Fibrolamellar Carcinoma,1
42610,Chronic Inflammatory Infiltrate,Mixed Cellularity Hodgkin Lymphoma,1
42611,Chromogranin A Positive Neoplastic Cells Present,Advanced Carcinoid Tumor,1
42612,Primary Lesion,Ventricular and Brain Stem Ependymal Tumor,1
42613,Malignant Cellular Infiltrate,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7,1
42614,Immunoglobulin Deposition,Primary amyloidosis,1
42615,Carcinomatous Component Present,Large cell neuroendocrine carcinoma,1
42616,Epithelial Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v8,1
42617,Epithelial Component Present,Tumor of follicular infundibulum,1
42618,Carcinomatous Component Present,cystadenocarcinoma of intrahepatic bile duct,1
42619,Dilated Thin-Walled Vascular Space Formation,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
42620,Childhood Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
42621,Neuroendocrine Differentiation,Carcinoid tumor of rectum,1
42622,Lymphoplasmacytic Infiltrate,Waldenstrom's macroglobulinemia refractory,1
42623,Vascular Channel Formation,"Hemangioma, Cavernous, Central Nervous System",1
42624,Malignant Cellular Infiltrate,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
42625,Metastatic/Recurrent Disease,Desmoplastic Small Round Cell Tumor,1
42626,Epithelial Component Present,Nipple Duct Carcinoma,1
42627,Cellular Stratification,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
42628,Malignant Cellular Infiltrate,Stage IA Lung Adenocarcinoma AJCC v7,1
42629,Follicular Structures Present,Thyroid Gland Mucinous Follicular Adenoma,1
42630,Solitary mass,Sellar Dedifferentiated Chordoma,1
42631,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Kaposi Sarcoma,1
42632,Malignant Cellular Infiltrate,Malignant lymphoma of testis,1
42633,Invasive Lesion,signet ring cell carcinoma of breast,1
42634,Carcinomatous Component Present,Stage IIIB Colon Cancer AJCC v7,1
42635,Epithelial Component Present,Adenosquamous cell lung cancer stage IV,1
42636,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
42637,Malignant Cellular Infiltrate,Localized Lymphoma,1
42638,Nodular Pattern,Skin Nodular Basal Cell Carcinoma,1
42639,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
42640,Severe dysplasia,High Grade Ductal Breast Carcinoma In Situ,1
42641,High Grade Lesion,Endometrial Dedifferentiated Carcinoma,1
42642,Foveolar-Type Epithelium Present,Foveolar-Type Adenoma,1
42643,Infiltrative Growth Pattern,Metastatic Kidney Medullary Carcinoma,1
42644,CD30-Positive Neoplastic Cells Present,Stage III Childhood Anaplastic Large Cell Lymphoma,1
42645,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v7 Stage,1
42646,Carcinomatous Component Present,BCLC Stage A Adult Hepatocellular Carcinoma,1
42647,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
42648,Favorable Clinical Outcome,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
42649,Malignant Cellular Infiltrate,Metastatic melanoma,1
42650,Epithelial Component Present,Stage I Liver Carcinoma,1
42651,Malignant Cellular Infiltrate,Metastatic Adrenal Cortex Carcinoma,1
42652,Rapidly Enlarging Mass,Esophageal Rhabdomyosarcoma,1
42653,Microvascular Proliferation,Brain Glioblastoma,1
42654,Malignant Cellular Infiltrate,Chemotherapy-Related Leukemia,1
42655,Carcinomatous Component Present,Anal cancer recurrent,1
42656,Diffuse Pattern,Diffuse follicle center lymphoma,1
42657,Metastatic Lesion,Metastatic Extracranial Malignant Solid Neoplasm,1
42658,Malignant Cellular Infiltrate,Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma,1
42659,Epithelial Component Present,Moderate pancreatic duct dysplasia,1
42660,Carcinomatous Component Present,Stage IIB Pancreatic Cancer AJCC v6 and v7,1
42661,Epithelial Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
42662,Acanthosis,Verrucous carcinoma,1
42663,Malignant Cellular Infiltrate,Microcystic adnexal carcinoma,1
42664,Carcinomatous Component Present,Gastric Fundus Carcinoma,1
42665,Bone Marrow Dysplasia Present,Alkylating Agent-Related Myelodysplastic Syndrome,1
42666,Hormonal resistance,Hormone refractory breast cancer,1
42667,Indolent Clinical Course,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
42668,Cutaneous Involvement,Apocrine Neoplasm,1
42669,Monoclonal Paraproteinemia Present in Lower than Myeloma Levels,Non-IgM Monoclonal Gammopathy of Undetermined Significance,1
42670,Primary Lesion,Childhood Infratentorial Ependymoma,1
42671,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v7,1
42672,Malignant Cellular Infiltrate,Squamous cell carcinoma of nasopharynx,1
42673,Papillary Pattern,Endolymphatic sac tumor,1
42674,Secondary Lesion,Metastatic malignant neoplasm to nasopharynx,1
42675,Malignant Cellular Infiltrate,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
42676,Aggressive Clinical Course,"Thymoma, type B2, malignant",1
42677,Carcinomatous Component Present,Stage II Rectosigmoid Cancer AJCC v7,1
42678,Keratin pearl formation,keratinizing squamous cell carcinoma of nasal cavity,1
42679,Malignant Cellular Infiltrate,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
42680,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
42681,Malignant Cellular Infiltrate,Stage II Rectal Cancer,1
42682,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
42683,Secondary Lesion,Breast Carcinoma Metastatic in the Central Nervous System,1
42684,Postneoadjuvant Therapy Pathologic TNM Finding,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
42685,Sarcomatous Component Present,carcinosarcoma of lung,1
42686,Cutaneous Involvement,"lymphomatoid papulosis, type A",1
42687,Malignant Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia,1
42688,Carcinomatous Component Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
42689,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Clinical Stage,1
42690,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Brain,1
42691,Primary Lesion,Recurrent Combined Thymic Epithelial Neoplasm,1
42692,CD1a-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X,1
42693,Absence of Stromal Invasion,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
42694,Neuroendocrine Differentiation,Stage III Lung Small Cell Carcinoma AJCC v7,1
42695,Carcinomatous Component Present,Stage IIIA Rectal Cancer AJCC v8,1
42696,Malignant Cellular Infiltrate,Stage IIIA Breast Carcinoma,1
42697,Childhood Lesion,Recurrent Childhood Lymphomatoid Granulomatosis,1
42698,Borderline Lesion,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
42699,Epithelial Component Present,Cervical intraepithelial neoplasia grade 1,1
42700,Malignant Cellular Infiltrate,Stage IIB Fallopian Tube Cancer AJCC v8,1
42701,Malignant Cellular Infiltrate,Stage I Urethral Cancer AJCC v8,1
42702,Malignant Cellular Infiltrate,Proximal Urethral Carcinoma,1
42703,Fibrotic Stroma Formation,Hard Palate Mucoepidermoid Carcinoma,1
42704,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
42705,Anaplasia,Anaplastic Oligoastrocytoma,1
42706,Diffuse Pattern,Small cell glioblastoma,1
42707,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma,1
42708,Epithelial Component Present,Seborrheic keratosis of eyelid,1
42709,Lytic lesion,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,1
42710,Biphasic Pattern,gliosarcoma,1
42711,atypia morphology,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
42712,Epithelial Component Present,Ureter Inverted Papilloma,1
42713,Hyperplastic Tissue Present,Circumferential Endothelial Hyperplasia,1
42714,Hyperplastic Epithelial Tissue Present,Papillary Ductal Breast Hyperplasia,1
42715,Cutaneous Involvement,Primary cutaneous lymphoma,1
42716,Indolent Clinical Course,Cutaneous leiomyoma,1
42717,Hepatomegaly,Post polycythaemia vera myelofibrosis,1
42718,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v7,1
42719,Adulthood Lesion,Adult Lymphoma,1
42720,Cutaneous Involvement,Stage IIB Merkel Cell Carcinoma AJCC v7,1
42721,Nuclear Atypia,Classical Glioblastoma,1
42722,Sarcomatous Component Present,carcinosarcoma of extrahepatic bile duct,1
42723,Indolent Clinical Course,Paratesticular Lipoma,1
42724,Epithelial Component Present,intraepithelial glandular neoplasia of cervix,1
42725,Malignant Cellular Infiltrate,Luminal A Breast Carcinoma,1
42726,Epithelial Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
42727,Malignant Cellular Infiltrate,High Grade Fallopian Tube Serous Adenocarcinoma,1
42728,Intestinal metaplasia,Vaginal Villous Adenoma,1
42729,Carcinomatous Component Present,Stage IIIB Appendix Carcinoma AJCC v8,1
42730,Exanthema,Rothmund-Thomson syndrome,1
42731,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
42732,Malignant Cellular Infiltrate,Stromal sarcoma,1
42733,Epithelial Component Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,1
42734,Collagenous Stroma Formation,Odontogenic myxofibroma,1
42735,Well-Circumscribed Lesion,Adenoma of ampulla of Vater,1
42736,Non-Invasive Lesion,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7,1
42737,Epithelial Component Present,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
42738,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,endometrioid adenofibroma of ovary,1
42739,Skin Erosion,Erosive Adenomatosis of the Nipple,1
42740,Cutaneous Involvement,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,1
42741,Chronic lymphocytic inflammation,Salivary Gland Sebaceous Lymphadenoma,1
42742,Blasts Under 5 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1,1
42743,Pseudoalveolar Pattern,Alveolar soft part sarcoma recurrent,1
42744,Malignant Cellular Infiltrate,BN2 Diffuse Large B-Cell Lymphoma,1
42745,Epithelial Component Present,Locally Advanced Unresectable Cervical Adenocarcinoma,1
42746,Diffuse Pattern,Desmoplastic mesothelioma,1
42747,Malignant Cellular Infiltrate,Malignant Accessory Urethral Gland Neoplasm,1
42748,Malignant Cellular Infiltrate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
42749,Carcinomatous Component Present,Bartholin Gland Squamous Cell Carcinoma,1
42750,Radiation Sickness,Radiation damage to artery,1
42751,Carcinomatous Component Present,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
42752,Composite Lesion,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
42753,Adnexal Differentiation,Hidroacanthoma simplex,1
42754,Epithelial Component Present,Primary Peritoneal Low Grade Serous Adenocarcinoma,1
42755,Chronic Inflammatory Infiltrate,Adult Grade III Lymphomatoid Granulomatosis,1
42756,Carcinomatous Component Present,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
42757,Intermediate Grade Neuroendocrine Lesion,Malignant Pancreatic Vipoma,1
42758,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
42759,Vascular Channel Formation,Tufted angioma of skin,1
42760,Indolent Clinical Course,Lipoma of axilla,1
42761,Malignant Cellular Infiltrate,Prognostic Stage IIA Breast Cancer AJCC v8,1
42762,Epithelial Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
42763,Clinical TNM Finding,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
42764,Carcinomatous Component Present,Prolactin-Producing Pituitary Gland Carcinoma,1
42765,Malignant Cellular Infiltrate,Prostate Basal Cell Carcinoma,1
42766,Carcinomatous Component Present,Stage II Lip Basal Cell Carcinoma,1
42767,Diffuse Cellular Infiltrate,"Carcinoma, diffuse type",1
42768,Low Mitotic Activity,Somatostatinoma,1
42769,Gastric dysplasia,adenomatous polyp of stomach,1
42770,Epithelial Component Present,Undifferentiated carcinoma of esophagus,1
42771,Carcinomatous Component Present,Serous Endometrial Intraepithelial Carcinoma,1
42772,Malignant Cellular Infiltrate,"Neoplasms, Unknown Primary",1
42773,Metastatic Lesion,Lung Carcinoma Metastatic in the Brain,1
42774,'Starry-sky' pattern,Stage I Burkitt Lymphoma,1
42775,Recurrent disease,Malignant neoplasm of stomach recurrent,1
42776,Carcinomatous Component Present,Well Differentiated Adrenal Cortex Carcinoma,1
42777,Bone Marrow Dysplasia Present,Hypocellular Myelodysplastic Syndrome,1
42778,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
42779,Non-Hereditary Lesion,Sporadic Gastric Adenocarcinoma,1
42780,Indolent Clinical Course,Lung Myoepithelioma,1
42781,Malignant Cellular Infiltrate,Well Differentiated Malignant Neoplasm,1
42782,Malignant Cellular Infiltrate,Mixed Ductal-Endocrine Carcinoma,1
42783,Necrotic changes (finding),Small cell neuroendocrine carcinoma of bladder,1
42784,Neuroectodermal Differentiation,Stage 4S neuroblastoma,1
42785,Fibrotic Stroma Formation,Testicular Brenner Tumor,1
42786,Epithelial Component Present,Breast Fibroepithelial Neoplasm,1
42787,Cutaneous Involvement,Neuronevus,1
42788,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
42789,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Cancer AJCC v7,1
42790,Malignant Cellular Infiltrate,Refractory Endometrial Mixed Cell Adenocarcinoma,1
42791,Epithelial Component Present,Urothelial Neoplasm,1
42792,Calcitonin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
42793,Indolent Clinical Course,Cranial Nodular Fasciitis,1
42794,Biphasic Pattern,Cystadenofibroma,1
42795,Malignant Cellular Infiltrate,Unresectable Cutaneous Melanoma,1
42796,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
42797,Epithelial Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
42798,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v7,1
42799,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v8,1
42800,Malignant Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,1
42801,Congenital Lesion,Congenital hemangioma,1
42802,Extensive Stage Lesion,Advanced Synovial Sarcoma,1
42803,Carcinomatous Component Present,Stage I Vulvar Cancer AJCC v8,1
42804,Adulthood Lesion,Stage II Adult Lymphoblastic Lymphoma,1
42805,Monoclonal Langerhans Cells Present,Central Nervous System Langerhans Cell Histiocytosis,1
42806,Epithelial Component Present,Bladder Papillary Urothelial Carcinoma,1
42807,Apocrine metaplasia,Breast Apocrine Adenoma,1
42808,Anaplasia,Recurrent Anaplastic Oligoastrocytoma,1
42809,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline DDX41 Mutation,1
42810,Epithelial Component Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,1
42811,Recurrent disease,Recurrent Extranodal Diffuse Large B-cell Lymphoma,1
42812,Localized Lesion,Well-differentiated papillary mesothelioma,1
42813,Epithelial Component Present,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
42814,Skin nodule,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,1
42815,Carcinomatous Component Present,Prognostic Stage III Breast Cancer AJCC v8,1
42816,Epithelial Component Present,Prostate Cancer by Whitmore-Jewett Stage,1
42817,Benign Cellular Infiltrate,Central Nervous System Lipoma,1
42818,Neuroendocrine Differentiation,Superior and Inferior Paraaortic Paraganglioma,1
42819,Malignant Cellular Infiltrate,Meningeal Lymphoma,1
42820,Malignant Cellular Infiltrate,Recurrent Primitive Neuroectodermal Tumor,1
42821,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
42822,Malignant Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,1
42823,Malignant Cellular Infiltrate,large cell carcinoma of salivary gland,1
42824,Well Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor,1
42825,Invasive Lesion,Prostate Basal Cell Carcinoma,1
42826,Malignant Cellular Infiltrate,Regressing Non-Cutaneous Melanoma,1
42827,Epithelial Component Present,Lipoadenoma,1
42828,High Grade Lesion,Alveolar Soft Part Sarcoma,1
42829,Malignant Cellular Infiltrate,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
42830,Indolent Clinical Course,Diffuse Lipomatosis,1
42831,Malignant Cellular Infiltrate,Malignant Adrenal Medulla Neoplasm,1
42832,Carcinomatous Component Present,Gastric Mixed Adenocarcinoma,1
42833,Absence of Invasion,Stage 0is Ureter Cancer AJCC v8,1
42834,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
42835,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
42836,Epithelial Component Present,Thymic epithelial tumor,1
42837,Malignant Cellular Infiltrate,Blast Phase,1
42838,Epithelial Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
42839,Infantile Lesion,Infant Acute Lymphoblastic Leukemia,1
42840,Cutaneous Involvement,Vulvar Inverted Follicular Keratosis,1
42841,Malignant Cellular Infiltrate,Stage III Renal Cell Cancer AJCC v8,1
42842,Malignant Cellular Infiltrate,Stage IV Burkitt Lymphoma,1
42843,Malignant Cellular Infiltrate,ROSE Cluster 6,1
42844,Endophytic Tumor Growth,Laryngeal verrucous carcinoma recurrent,1
42845,Carcinomatous Component Present,Rectal Cancer by AJCC v7 Stage,1
42846,Severe cytologic atypia,Metastatic Gastric Neuroendocrine Carcinoma,1
42847,Diffuse Pattern,Epithelioid glioblastoma,1
42848,Epithelial Component Present,Lung Mucous Gland Adenoma,1
42849,Perivascular fibrosis,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage,1
42850,Epithelial Component Present,Ovarian serous cystadenofibroma,1
42851,Malignant Cellular Infiltrate,Pancreatic Hepatoid Adenocarcinoma,1
42852,Severe dysplasia,Stage 0 Pancreatic Cancer AJCC v8,1
42853,Carcinomatous Component Present,Stage II Lung Cancer AJCC v7,1
42854,Pseudoglandular Pattern,Embryonal Carcinoma,1
42855,Immunosuppression-Related Post-Transplant Toxicity,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
42856,Carcinomatous Component Present,Papillary carcinoma of the breast,1
42857,Malignant Cellular Infiltrate,Refractory Lymphoma,1
42858,Malignant Cellular Infiltrate,Stage IB Merkel Cell Carcinoma AJCC v7,1
42859,Preserved Nuclear Polarity,Ureter Urothelial Papilloma,1
42860,Chronic Inflammatory Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis,1
42861,Primary Lesion,Recurrent Childhood Hepatocellular Carcinoma,1
42862,High Grade Lesion,Brain Stem Glioblastoma,1
42863,Serrated Glandular Architecture,Colorectal Sessile Serrated Adenoma/Polyp,1
42864,Osteoid formation,Extraskeletal osteosarcoma metastatic,1
42865,Biphasic Pattern,Cystadenofibroma,1
42866,Epithelial Component Present,clear cell neoplasm of ovary,1
42867,Carcinomatous Component Present,Cervical Cancer by AJCC v6 Stage,1
42868,Extensive Stage Lesion,Advanced Synovial Sarcoma,1
42869,Absence of Invasion,Carcinoma in situ of penis,1
42870,Low Grade Lesion,Epithelioid hemangioendothelioma of lung,1
42871,Epithelial Component Present,Recurrent Fibrolamellar Carcinoma,1
42872,Epithelial Component Present,Carcinoma,1
42873,Dysplasia,Colorectal Villous Adenoma,1
42874,Benign Cellular Infiltrate,Benign neoplasm of respiratory tract,1
42875,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Thrombocytopenia,1
42876,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
42877,Refractory Disease,Refractory T Acute Lymphoblastic Leukemia,1
42878,Monoclonal Cellular Population Present,Malignant mastocytosis,1
42879,Secondary Lesion,Metastatic Neoplasm to the Gallbladder,1
42880,Recurrent disease,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
42881,Severe dysplasia,Adenocarcinoma in situ in adenomatous polyp,1
42882,Epithelial Component Present,Refractory Adrenal Gland Pheochromocytoma,1
42883,Indolent Clinical Course,Congenital Cystic Hygroma,1
42884,Benign Cellular Infiltrate,Lung Squamous Cell Papilloma,1
42885,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,1
42886,Carcinomatous Component Present,Skin Metatypical Carcinoma,1
42887,Solitary mass,Pleural Epithelioid Hemangioendothelioma,1
42888,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v7,1
42889,Rapidly Enlarging Mass,embryonal rhabdomyosarcoma of orbit,1
42890,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v7,1
42891,Mural Nodule,Ovarian Mucinous Cystic Tumor with Mural Nodules,1
42892,Epithelial Component Present,Stage IB1 Cervical Cancer,1
42893,Acanthosis,Verrucous carcinoma,1
42894,Neuroendocrine Differentiation,Neuroendocrine neoplasm of larynx,1
42895,Epithelial Component Present,Stage IIIC Fallopian Tube Cancer AJCC v8,1
42896,Extracutaneous Dissemination of Disease,Mycosis fungoides stage IV,1
42897,Malignant Cellular Infiltrate,Subglottic Verrucous Carcinoma,1
42898,Fibrotic Stroma Formation,Classical Low Grade Fibromyxoid Sarcoma,1
42899,Malignant Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v6 and v7,1
42900,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of salivary gland,1
42901,Hemorrhagic,Angiosarcoma recurrent,1
42902,Monomorphic Cellular Infiltrate,Adult Grade III Lymphomatoid Granulomatosis,1
42903,Malignant Cellular Infiltrate,Epithelioid sarcoma metastatic,1
42904,Skin nodule,Proliferative dermal lesion in congenital nevus,1
42905,Epithelial Component Present,Carcinoma in situ of skin,1
42906,Epithelial Component Present,Breast adenoma,1
42907,Carcinomatous Component Present,Stage 0a Urethral Cancer AJCC v7,1
42908,Ground Glass Nuclear Inclusion,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
42909,Carcinomatous Component Present,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
42910,Well Differentiated Neuroendocrine Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,1
42911,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma,1
42912,Carcinomatous Component Present,Stage IIB Small Intestinal Adenocarcinoma AJCC v8,1
42913,Morphologic Overlap,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
42914,Malignant Cellular Infiltrate,Stage IB Eyelid Carcinoma AJCC v8,1
42915,Carcinomatous Component Present,Stage IV Hepatocellular Carcinoma AJCC v7,1
42916,Hyperplastic Tissue Present,Tubal Hyperplasia,1
42917,Primary Lesion,Cerebellar and Fourth Ventricle Ependymal Tumor,1
42918,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
42919,Epithelial Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
42920,Vascular Channel Formation,Osteoblastic Osteosarcoma,1
42921,Invasive Lesion,Tubular breast carcinoma,1
42922,Malignant Cellular Infiltrate,Thyroid Gland Mucinous Carcinoma,1
42923,Epithelial Component Present,Pancreatic Ductal Adenocarcinoma,1
42924,Anaplasia,Childhood Giant Cell Glioblastoma,1
42925,Malignant Cellular Infiltrate,Stage I Vulvar Carcinoma,1
42926,Epithelial Component Present,Urethral Condyloma Acuminatum,1
42927,Deep Lesion,"Hemangioma, Intramuscular",1
42928,Lytic lesion,Cranial Nodular Fasciitis,1
42929,Mitotic Activity,Glioblastoma multiforme of spinal cord,1
42930,Carcinomatous Component Present,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
42931,Benign Cellular Infiltrate,Childhood Mature Teratoma,1
42932,Invasive Lesion,Invasive papillary breast carcinoma,1
42933,Lymphadenopathy,HHV8-Positive Multicentric Castleman Disease,1
42934,Multifocal Lesion,Pelvic lipomatosis,1
42935,Epithelial Component Present,Mesonephric tumor,1
42936,Carcinomatous Component Present,Acantholytic squamous cell carcinoma,1
42937,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v8,1
42938,Epithelial Component Present,Thyroid Gland Adenocarcinoma,1
42939,Malignant Cellular Infiltrate,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,1
42940,Malignant Cellular Infiltrate,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
42941,Benign Cellular Infiltrate,Skin Papilloma,1
42942,Moderate dysplasia,Grade II Glandular Intraepithelial Neoplasia,1
42943,Epithelial Component Present,Malignant Germinative Follicular Epithelium Neoplasm,1
42944,Follicular Cell Differentiation,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
42945,Cutaneous Involvement,Breast Nevus,1
42946,Follicular Cell Differentiation,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
42947,Childhood Lesion,Childhood Grade III Meningioma,1
42948,Cystic Change,Cystadenofibroma of fallopian tube,1
42949,Carcinomatous Component Present,Adenocarcinoma of the gastroesophageal junction,1
42950,Chromogranin A Positive Neoplastic Cells Present,Ovarian Carcinoid Tumor,1
42951,Epithelial Component Present,Renal Cell Carcinoma Associated with Neuroblastoma,1
42952,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage II,1
42953,Malignant Cellular Infiltrate,Papillary squamous cell carcinoma,1
42954,Malignant Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
42955,Malignant Cellular Infiltrate,Anaplastic Hemispheric Astrocytoma,1
42956,Malignant Cellular Infiltrate,Recurrent Chronic Myelomonocytic Leukemia,1
42957,Carcinomatous Component Present,Stage III Liver Cancer,1
42958,Primary Lesion,Anaplastic Brain Stem Astrocytoma,1
42959,Epithelial Component Present,bilateral breast cancer,1
42960,Anaplasia,Anaplastic (Malignant) Intracranial Meningioma,1
42961,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Hodgkin Lymphoma AJCC v8,1
42962,Epithelial Component Present,Mediastinal/Thymic NUT Carcinoma,1
42963,Malignant Cellular Infiltrate,Adenosarcoma of cervix uteri,1
42964,Cystic Change,Brenner Tumor,1
42965,Intraductal Lesion,Pancreatic Intraductal Neoplasms,1
42966,Koilocytotic atypia,HPV positive oropharyngeal squamous cell carcinoma,1
42967,High Grade Lesion,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
42968,Well Differentiated Lesion,Human Papillomavirus-Related Verrucous Carcinoma,1
42969,Mixed Cellular Population,Mixed Oligodendroglioma-Astrocytoma,1
42970,Cellular Pleomorphism,Intracortical osteosarcoma,1
42971,Epithelial Component Present,Mild epithelial dysplasia,1
42972,Microvascular Proliferation,Cerebellar Glioblastoma,1
42973,Epithelial Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
42974,Malignant Cellular Infiltrate,Soft Tissue Angiosarcoma,1
42975,Pseudoglandular Pattern,Sellar Embryonal Carcinoma,1
42976,Neuroendocrine Differentiation,small cell carcinoma of gallbladder,1
42977,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma,1
42978,Malignant Cellular Infiltrate,Intraocular Malignant Peripheral Nerve Sheath Tumor,1
42979,Childhood Lesion,Refractory Diffuse Intrinsic Pontine Glioma,1
42980,Glandular Pattern,Ovarian Mucinous Carcinoid Tumor,1
42981,Metastatic Lesion,Malignant fibrous histiocytoma metastatic,1
42982,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Nodular amyloidosis,1
42983,Hyperkeratosis,Vaginal Warty Carcinoma,1
42984,Unresectable Mass,Unresectable Extrahepatic Bile Duct Carcinoma,1
42985,Metastatic Lesion,Locally Advanced Carcinoma,1
42986,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage IV,1
42987,Benign Cellular Infiltrate,Peripheral Breast Papilloma,1
42988,Malignant Cellular Infiltrate,leiomyosarcoma of lung,1
42989,Mixed Cellular Population,Mixed Salivary Gland Tumor,1
42990,Dysplasia,Pancreatic Intraepithelial Neoplasia-1A,1
42991,Childhood Lesion,Childhood Malignant Small Intestinal Neoplasm,1
42992,Smooth Muscle Component Present,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,1
42993,Tubular Pattern,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,1
42994,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Dysplastic Nevus,1
42995,Neuroendocrine Differentiation,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
42996,Dysplasia,adenoma of extrahepatic bile duct,1
42997,Carcinomatous Component Present,"Carcinoma, Lobular",1
42998,Metastatic/Recurrent Disease,Pleural Synovial Sarcoma,1
42999,Malignant Cellular Infiltrate,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",1
43000,Invasive Lesion,Infiltrating Bladder Carcinoma,1
43001,Intraductal Lesion,Pancreatic Intraductal Neoplasms,1
43002,Malignant Cellular Infiltrate,Retinoblastoma,1
43003,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
43004,Epithelial Component Present,Adult Salivary Gland Carcinoma,1
43005,Dysplasia,Small Intestinal Tubulovillous Adenoma,1
43006,Monomorphic Cellular Infiltrate,basaloid squamous cell carcinoma of floor of mouth,1
43007,Secondary Lesion,Breast Carcinoma Metastatic in the Spine,1
43008,Malignant Cellular Infiltrate,Malignant Giant Cell Tumor of Bone,1
43009,Encapsulated Mass,Thyroid Hurthle Cell Carcinoma,1
43010,Malignant Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
43011,Malignant Cellular Infiltrate,Malignant neoplasm of major salivary gland,1
43012,Metaplasia,Urethral Nephrogenic Adenoma,1
43013,Cutaneous Involvement,Vulvar Eccrine Porocarcinoma,1
43014,Benign Cellular Infiltrate,Cystic tumor of atrio-ventricular node,1
43015,Malignant Cellular Infiltrate,Stage IA Vulvar Carcinoma AJCC v6,1
43016,Low Mitotic Activity,Pancreatic Somatostatinoma,1
43017,Adulthood Lesion,Adult Epithelioid Hemangioendothelioma,1
43018,Malignant Cellular Infiltrate,Recurrent Classic Hodgkin Lymphoma,1
43019,Birbeck Granules Present,Eosinophilic Granuloma,1
43020,Malignant Cellular Infiltrate,Thymic Basaloid Carcinoma,1
43021,Malignant Cellular Infiltrate,FIGO Stage IIIA2 Ovarian Cancer,1
43022,Thyroglobulin Positive Neoplastic Cells Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
43023,Epithelial Component Present,Stage IV Lung Cancer AJCC v7,1
43024,Islands of Odontogenic Epithelium Present,Granular cell ameloblastoma,1
43025,Histiocytosis,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,1
43026,Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
43027,Childhood Lesion,Childhood Central Nervous System Neuroblastoma,1
43028,Thick-Walled Hyalinized Vessels Present,Trigeminal schwannoma,1
43029,Neuroendocrine Differentiation,Primary hepatic neuroendocrine carcinoma,1
43030,Regional Disease,Locally Advanced Malignant Neoplasm,1
43031,Epithelial Component Present,Urethral Cancer by AJCC v8 Stage,1
43032,Epithelial Component Present,Adenoid cystic breast carcinoma,1
43033,Nuclear pleomorphism,Choroid Plexus Carcinoma,1
43034,Malignant Cellular Infiltrate,Uterine Angiosarcoma,1
43035,Papillary Pattern,Verrucous carcinoma of penis,1
43036,Infiltrative Growth Pattern,Brain Glioblastoma,1
43037,Well Differentiated Neuroendocrine Lesion,Glucagonoma,1
43038,Low Mitotic Activity,Metastatic Digestive System Neuroendocrine Tumor G1,1
43039,Carcinomatous Component Present,Hypopharyngeal Carcinoma,1
43040,Epithelial Component Present,Ovarian Carcinoid Tumor,1
43041,Malignant Cellular Infiltrate,Bladder Urothelial Carcinoma in Situ,1
43042,Diffuse Pattern,Refractory Plasmablastic Lymphoma,1
43043,Invasive Lesion,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
43044,Carcinomatous Component Present,Stage IB2 Cervical Cancer,1
43045,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
43046,Microvascular Proliferation,Glioblastoma,1
43047,Epithelial Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v8,1
43048,Recurrent disease,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,1
43049,Poorly Differentiated Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
43050,Secondary Lesion,Extra-osseous Ewing's sarcoma metastatic,1
43051,Malignant Cellular Infiltrate,Stage III Adult Soft Tissue Sarcoma AJCC v7,1
43052,Malignant Cellular Infiltrate,Childhood Brain Anaplastic Astrocytoma,1
43053,Chronic lymphocytic inflammation,Abdominal Inflammatory Myofibroblastic Tumor,1
43054,Carcinomatous Component Present,Pleural Carcinomatosis,1
43055,Encapsulated Mass,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
43056,Papillary Pattern,Glandular papilloma,1
43057,Malignant Cellular Infiltrate,Malignant vascular tumor of skin,1
43058,Carcinomatous Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
43059,Epithelial Component Present,Cervix carcinoma,1
43060,Resectable Mass,Resectable Malignant Neoplasm,1
43061,Epithelial Component Present,Stage I Colon Neuroendocrine Tumor AJCC v8,1
43062,Local disease,Adenomatoid tumor of epididymis,1
43063,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma refractory,1
43064,Carcinomatous Component Present,Maxillary Sinus Carcinoma,1
43065,Epithelial Component Present,Metastatic Breast Carcinoid Tumor,1
43066,Mixed Cellular Population,Perineal Ectopic Fibroadenoma,1
43067,Malignant Cellular Infiltrate,Inferior Vena Cava Leiomyosarcoma,1
43068,Favorable Clinical Outcome,Duodenal-type follicular lymphoma,1
43069,Refractory Disease,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder,1
43070,Locally Aggressive Lesion,Gastric Inflammatory Myofibroblastic Tumor,1
43071,Recurrent disease,Hodgkin's disease mixed cellularity recurrent,1
43072,Malignant Cellular Infiltrate,Thymic Clear Cell Carcinoma,1
43073,Severe cytologic atypia,Pancreatic Endocrine Carcinoma,1
43074,Malignant Cellular Infiltrate,Stage IV Liver Cancer,1
43075,Benign Cellular Infiltrate,Pilomatrixoma,1
43076,Benign Cellular Infiltrate,Plexiform Schwannoma,1
43077,Benign Cellular Infiltrate,Clear cell cystadenofibroma,1
43078,Carcinomatous Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
43079,Malignant Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",1
43080,Epithelial Component Present,Hereditary clear cell renal cell carcinoma,1
43081,Local disease,Appendix Lipoma,1
43082,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma,1
43083,Cystic Change,Serous cystadenoma of ovary,1
43084,Mixed Cellular Population,Stage I Kidney Wilms Tumor,1
43085,1p/19q Codeletion Status Unknown,oligodendroglioma,1
43086,Epithelial Component Present,Breast Carcinoma with Melanotic Features,1
43087,Malignant Cellular Infiltrate,Recurrent Alveolar Rhabdomyosarcoma,1
43088,Storiform Growth Pattern,"Dendritic Cell Sarcoma, Follicular",1
43089,Recurrent disease,Splenic marginal zone lymphoma recurrent,1
43090,Malignant Cellular Infiltrate,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
43091,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v7,1
43092,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8,1
43093,Metastatic/Recurrent Disease,Lung Biphasic Synovial Sarcoma,1
43094,Well-Circumscribed Lesion,Skin tag,1
43095,Epithelial Component Present,Stage I Prostate Cancer AJCC v8,1
43096,Malignant Cellular Infiltrate,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma,1
43097,Neuroendocrine Differentiation,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
43098,Resectable Mass,Pancreatic adenocarcinoma resectable,1
43099,Secondary Lesion,Transitional cell carcinoma metastatic,1
43100,Epithelial Component Present,Hard Palate Monomorphic Adenoma,1
43101,Exophytic Polypoid Lesion,Nasal Polyps,1
43102,atypia morphology,Borderline Ovarian Clear Cell Adenofibroma,1
43103,Perivascular Arrangement of Tumor Cells,"Perivascular epithelioid tumor, malignant",1
43104,Carcinomatous Component Present,Adenocarcinoma of anal glands,1
43105,Malignant Cellular Infiltrate,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
43106,Malignant Cellular Infiltrate,Adult Penile Carcinoma,1
43107,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
43108,Malignant Germinomatous Cellular Infiltrate,Germinoma,1
43109,Malignant Cellular Infiltrate,Nasopharyngeal Papillary Adenocarcinoma,1
43110,Benign Cellular Infiltrate,Ovarian Fibromata,1
43111,Malignant Cellular Infiltrate,Radiation-Related Osteosarcoma,1
43112,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Type A Melanoma,1
43113,Benign Cellular Infiltrate,Benign neoplasm of testis,1
43114,Monomorphic Cellular Infiltrate,Adult Spinal Cord Ependymoma,1
43115,Malignant Cellular Infiltrate,Recurrent Bone Ewing Sarcoma,1
43116,Myxoid Stroma Formation,Sellar Dedifferentiated Chordoma,1
43117,Benign Cellular Infiltrate,Multiple Lobular Capillary Hemangiomas,1
43118,Chronic Inflammatory Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
43119,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
43120,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage I,1
43121,Carcinomatous Component Present,Fallopian Tube Gestational Choriocarcinoma,1
43122,Malignant Cellular Infiltrate,Thyroid Sarcoma,1
43123,Epithelial Component Present,ductal papilloma of salivary gland,1
43124,Carcinomatous Component Present,Stage IIIC Colorectal Cancer AJCC v8,1
43125,Indolent Clinical Course,Kidney Fibroma,1
43126,Malignant Cellular Infiltrate,Ewing's sarcoma of bone,1
43127,Malignant Cellular Infiltrate,Pericardial Synovial Sarcoma,1
43128,Epithelial Component Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
43129,Epithelial Component Present,Cervical Glandular Neoplasm,1
43130,Cutaneous Involvement,"Pemphigoid, Benign Mucous Membrane",1
43131,Intermediate Grade Neuroendocrine Lesion,Appendix Neuroendocrine Tumor G2,1
43132,Malignant Cellular Infiltrate,Malignant neoplasm of esophagus,1
43133,Mucoid Stroma Formation,Mucinous adenocarcinoma gastric,1
43134,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage II,1
43135,Epithelial Component Present,Metastatic Triple-Negative Breast Carcinoma,1
43136,Carcinomatous Component Present,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
43137,Indolent Clinical Course,Uterine Corpus Diffuse Leiomyomatosis,1
43138,Carcinomatous Component Present,Carcinoma of subglottis,1
43139,Malignant Cellular Infiltrate,liposarcoma of mediastinum,1
43140,Malignant Cellular Infiltrate,Transplant-Related Renal Cell Carcinoma,1
43141,Carcinomatous Component Present,Vaginal Neuroendocrine Carcinoma,1
43142,Carcinomatous Component Present,Stage IV Rectosigmoid Cancer AJCC v6,1
43143,Malignant Cellular Infiltrate,Recurrent Appendix Carcinoma,1
43144,Indolent Clinical Course,Chondroid lipoma,1
43145,Vascular Channel Formation,Histiocytoid hemangioma,1
43146,Epithelial Component Present,Mixed Somatotroph and Lactotroph Adenoma,1
43147,Carcinomatous Component Present,Stage IIB Fallopian Tube Cancer AJCC v8,1
43148,Epithelial Component Present,Gallbladder Cancer by AJCC v8 Stage,1
43149,High Mitotic Activity,Recurrent Pancreatic Neuroendocrine Carcinoma,1
43150,Refractory Disease,Refractory Neuroendocrine Neoplasm,1
43151,Epithelial Component Present,Penis carcinoma,1
43152,Osseous Differentiation,Fibroblastic osteosarcoma,1
43153,Malignant Cellular Infiltrate,High Grade Malignant Neoplasm,1
43154,Recurrent disease,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,1
43155,Adulthood Lesion,Adult Diffuse Large B-Cell Lymphoma,1
43156,Osseous Differentiation,Primary Bone Osteosarcoma,1
43157,Carcinomatous Component Present,Lung Pleomorphic Carcinoma,1
43158,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v8,1
43159,C19MC Amplification,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
43160,Cystic Change,Papillary cystic tumor,1
43161,Intraductal Lesion,solid type ductal carcinoma in situ of breast,1
43162,Indolent Clinical Course,Cavernous hemangioma of retina,1
43163,Recurrent disease,Recurrent Vulvar Carcinoma,1
43164,Oligodendroglial Component Present,Adult Brain Oligodendroglioma,1
43165,Epithelial Component Present,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
43166,Carcinomatous Component Present,Oropharyngeal Basaloid Carcinoma,1
43167,Metastatic Lesion,Breast Carcinoma Metastatic in the Brain,1
43168,Malignant Cellular Infiltrate,Ampulla of Vater Intestinal-Type Adenocarcinoma,1
43169,Indolent Clinical Course,lipoma of large intestine,1
43170,Biphasic Pattern,sialadenoma papilliferum of salivary gland,1
43171,Malignant Cellular Infiltrate,leiomyosarcoma of rectum,1
43172,Epithelial Component Present,Refractory Digestive System Neuroendocrine Neoplasm,1
43173,Epithelial Component Present,Glomus vagale tumor,1
43174,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Gastric Type",1
43175,Increased Cellularity Present,Adult Anaplastic Oligodendroglioma,1
43176,Multifocal Lesion,Multiple adenomatous polyps,1
43177,Capillary Sized Vascular Channel Formation,Cerebral Hemangioblastoma,1
43178,Malignant Cellular Infiltrate,Pyothorax-Associated Lymphoma,1
43179,Cartilaginous Differentiation,Central Nervous System Mesenchymal Chondrosarcoma,1
43180,Low Mitotic Activity,Carcinoid tumor of the cecum,1
43181,Follicular Cell Differentiation,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
43182,Bilateral Mass,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,1
43183,Nodular lesions,Macrofollicular adenoma,1
43184,Malignant Cellular Infiltrate,"Carcinoma, Signet Ring Cell",1
43185,Epithelial Component Present,Vaginal Carcinosarcoma,1
43186,Carcinomatous Component Present,Stage IA Intrahepatic Bile Duct Cancer AJCC v8,1
43187,Honeycomb Pattern,Childhood Brain Oligodendroglioma,1
43188,Radiation Sickness,Radiation-Related Angiosarcoma,1
43189,Malignant Cellular Infiltrate,Childhood Yolk Sac Tumor,1
43190,Malignant Cellular Infiltrate,Low Grade Mucoepidermoid Breast Carcinoma,1
43191,Malignant Cellular Infiltrate,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
43192,Epithelial Component Present,Metastatic Cervical Adenosquamous Carcinoma,1
43193,Syncytial Pattern,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
43194,Retiform Structures Comprise 90% or More of the Tumor,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
43195,Presence of a Hormonal Syndrome,Glucagonoma,1
43196,Primary Lesion,Childhood Cerebellar Anaplastic Astrocytoma,1
43197,Benign Cellular Infiltrate,Myxoma of the Endocardium,1
43198,Increased Cellularity Present,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
43199,Carcinomatous Component Present,Stage IIA Appendix Carcinoma AJCC v8,1
43200,Pathologic TNM Finding,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
43201,Malignant Cellular Infiltrate,Malignant Cutaneous Granular Cell Tumor,1
43202,Carcinomatous Component Present,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations,1
43203,Metastatic Lesion,Breast Carcinoma Metastatic in the Lung,1
43204,Epithelial Component Present,Cervical Adenocarcinoma,1
43205,Invasive Lesion,Mucinous carcinoma of breast,1
43206,Malignant Cellular Infiltrate,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
43207,Benign Cellular Infiltrate,Cavernous hemangioma of the face,1
43208,Intraductal Lesion,"Papilloma, Intraductal",1
43209,Slow Growing Mass,Adult Myxopapillary Ependymoma,1
43210,Malignant Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",1
43211,Epithelial Component Present,Stage IIA Breast Carcinoma,1
43212,Lymphoplasmacytic Infiltrate,HHV8-Positive Multicentric Castleman Disease,1
43213,Malignant Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma,1
43214,Infiltrative Growth Pattern,Cerebral Glioblastoma,1
43215,Malignant Cellular Infiltrate,Refractory anemia with ringed sideroblasts,1
43216,Benign Cellular Infiltrate,Benign Intraocular Medulloepithelioma,1
43217,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
43218,Hemorrhagic,Gallbladder Angiosarcoma,1
43219,Carcinomatous Component Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
43220,Carcinomatous Component Present,Childhood Renal Cell Carcinoma,1
43221,Carcinomatous Component Present,Laryngeal Adenoid Cystic Carcinoma,1
43222,Collagenous Stroma Formation,Benign mixed epithelial and stromal tumor of kidney,1
43223,Pregnancy Complications,Stage IIB Gestational Trophoblastic Tumor AJCC v7,1
43224,Rosenthal Fibers Present,Rosette-forming glioneuronal tumor of the fourth ventricle,1
43225,Unresectable Mass,Non-Resectable Malignant Liver Neoplasm,1
43226,Malignant Cellular Infiltrate,sarcoma of vagina,1
43227,Epithelial Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v8,1
43228,Extensive Stage Lesion,Advanced Gastric Neuroendocrine Carcinoma,1
43229,Indolent Clinical Course,Verrucous keratotic hemangioma,1
43230,Benign Cellular Infiltrate,Benign neoplasm of small intestine,1
43231,Invasive Lesion,Breast Carcinoma with Chondroid Metaplasia,1
43232,Childhood Lesion,Childhood Kidney Neoplasm,1
43233,Malignant Cellular Infiltrate,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
43234,In Situ Lesion,Carcinoma in situ of vagina,1
43235,Benign Cellular Infiltrate,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
43236,Cutaneous Involvement,"NEVUS, EPIDERMAL (disorder)",1
43237,Severe dysplasia,Lung Mucinous Adenocarcinoma In Situ,1
43238,Epithelial Component Present,"Papilloma, Squamous Cell",1
43239,Malignant Cellular Infiltrate,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,1
43240,Mild dysplasia,Low Grade Esophageal Squamous Intraepithelial Neoplasia,1
43241,Malignant Cellular Infiltrate,Stage I Adult Soft Tissue Sarcoma AJCC v7,1
43242,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage II,1
43243,Malignant Cellular Infiltrate,Ovarian Wilms Tumor,1
43244,Childhood Lesion,Childhood Ovarian Teratoma,1
43245,Epithelial Component Present,Stage IV Vaginal Cancer AJCC v6 and v7,1
43246,Carcinomatous Component Present,Vaginal Cancer by AJCC v6 Stage,1
43247,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Basophilic Leukemia,1
43248,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage,1
43249,Therapy-Related Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
43250,Tissue of Mullerian Origin Present,Ovarian Mucinous Cystadenofibroma,1
43251,Malignant Cellular Infiltrate,Cervical Squamous Cell Carcinoma In Situ,1
43252,Malignant Cellular Infiltrate,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
43253,Dysplasia,Rectal Sessile Serrated Adenoma/Polyp,1
43254,Malignant Cellular Infiltrate,Stage I Retroperitoneal Sarcoma AJCC v8,1
43255,Hyperkeratosis,Papillary squamous cell carcinoma,1
43256,Cutaneous Involvement,Acne Vulgaris,1
43257,High Grade Lesion,combined small cell carcinoma of lung,1
43258,Rapidly Enlarging Mass,Pleomorphic Rhabdomyosarcoma,1
43259,Hyalinized Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
43260,Malignant Cellular Infiltrate,Oncocytic Breast Carcinoma,1
43261,Geographic Necrosis,Testicular embryonal carcinoma stage III,1
43262,Atypical Lymphocytes Present in Peripheral Blood,Infectious Mononucleosis,1
43263,Malignant Cellular Infiltrate,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
43264,Anaplasia,Childhood Anaplastic Ependymoma,1
43265,Carcinomatous Component Present,Locally Advanced Prostate Adenocarcinoma,1
43266,Epithelial Component Present,Bile duct cancer recurrent,1
43267,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
43268,Carcinomatous Component Present,Well Differentiated Prostate Adenocarcinoma,1
43269,Aggressive Clinical Course,Recurrent High Risk Myelodysplastic Syndrome,1
43270,Malignant Cellular Infiltrate,Hemangiosarcoma of heart,1
43271,Recurrent disease,Recurrent WHO Grade III Glioma,1
43272,Carcinomatous Component Present,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,1
43273,Epithelial Component Present,Adenosquamous cell lung cancer stage III,1
43274,Papillary Pattern,Verrucous carcinoma,1
43275,Chromogranin A Positive Neoplastic Cells Present,Metastatic Breast Carcinoid Tumor,1
43276,Fibrotic Stroma Formation,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,1
43277,Mallory Bodies,"Hepatitis, Alcoholic",1
43278,Epithelial Component Present,Acquired cystic disease associated renal cell carcinoma,1
43279,Cutaneous Involvement,Perifollicular fibroma,1
43280,Carcinomatous Component Present,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
43281,Infantile Lesion,Neonatal leukemia,1
43282,Adnexal Differentiation,Neoplasm of skin with adnexal differentiation,1
43283,Metastatic Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
43284,Nodular Pattern,Hodgkin's disease nodular sclerosis recurrent,1
43285,Edematous Stroma Formation,Myxoma,1
43286,Severe cytologic atypia,small cell carcinoma of gallbladder,1
43287,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Cytopenia of Childhood,1
43288,Bilateral Disease,Retinoblastoma bilateral,1
43289,Epithelial Component Present,Colorectal Cancer by AJCC v7 Stage,1
43290,Carcinomatous Component Present,large cell neuroendocrine carcinoma of appendix,1
43291,Epithelial Component Present,Stage II Bladder Cancer AJCC v6 and v7,1
43292,Epithelial Component Present,"Basal cell carcinoma, infundibulocystic",1
43293,Mild cytologic atypia,Supraglottic Verrucous Carcinoma,1
43294,Acantholysis,Acantholytic squamous cell carcinoma of skin,1
43295,Malignant Cellular Infiltrate,Ovarian Clear Cell Cystadenocarcinoma,1
43296,Epithelial Component Present,Appendix Carcinoma by AJCC v7 Stage,1
43297,Secondary Lesion,Secondary malignant neoplasm of eye,1
43298,Malignant Cellular Infiltrate,Acute myeloid leukemia refractory,1
43299,Argentaffin Positive Neoplastic Cells Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
43300,Childhood Lesion,Hepatoblastoma resectable,1
43301,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
43302,CD56-Positive Neoplastic Cells Present,adult nasal type extranodal NK/T-cell lymphoma,1
43303,Malignant Cellular Infiltrate,Pathologic Stage III Gastric Cancer AJCC v8,1
43304,Extensive Stage Lesion,Advanced Pancreatic Neuroendocrine Tumor,1
43305,Benign Cellular Infiltrate,Retroperitoneal Ganglioneuroma,1
43306,Glial Differentiation,Childhood Gliosarcoma,1
43307,Epithelial Component Present,stage IV pancreatic cancer,1
43308,Cutaneous Involvement,Follicular mycosis fungoides,1
43309,Malignant Cellular Infiltrate,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
43310,Cutaneous Involvement,Unresectable Head and Neck Squamous Cell Carcinoma,1
43311,Carcinomatous Component Present,Small Intestinal Mucinous Adenocarcinoma,1
43312,High Grade Lesion,"Synovial sarcoma, epithelioid cell",1
43313,Carcinomatous Component Present,Stage IVC Appendix Carcinoma AJCC v8,1
43314,High Grade Lesion,Unresectable Rhabdomyosarcoma,1
43315,Benign Cellular Infiltrate,Benign neoplasm of rectum,1
43316,Epithelial Component Present,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
43317,Alternative Fascicle (Bundle) Pattern,Pericardial Leiomyoma,1
43318,Cutaneous Involvement,Plantar wart,1
43319,Sebaceous Differentiation,Superficial Epithelioma with Sebaceous Differentiation,1
43320,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma In Situ,1
43321,Carcinomatous Component Present,Malignant neoplasm of stomach stage II,1
43322,Carcinomatous Component Present,Comedocarcinoma,1
43323,Malignant Cellular Infiltrate,Metastatic Carcinoma,1
43324,Carcinomatous Component Present,Pleural Carcinomatosis,1
43325,Malignant Cellular Infiltrate,Glioblastoma multiforme of spinal cord,1
43326,Cutaneous Involvement,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
43327,Malignant Cellular Infiltrate,Urothelial carcinoma ureter metastatic,1
43328,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage I,1
43329,Well-Circumscribed Lesion,Vaginal Rhabdomyoma,1
43330,Malignant Cellular Infiltrate,Retinoblastoma by AJCC v8 Clinical Stage,1
43331,Unclassifiable Lesion,primitive neuroectodermal tumor (PNET) of spinal cord,1
43332,Carcinomatous Component Present,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
43333,Epithelial Component Present,Recurrent Pancreatic Neuroendocrine Carcinoma,1
43334,Cutaneous Involvement,"Lichen Planus, Oral",1
43335,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
43336,Multihormonal Immunoreactivity Present in Two or More Cell Types,Plurimorphous Plurihormonal Pituitary Gland Adenoma,1
43337,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Papillary Variant",1
43338,Diffuse Pattern,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",1
43339,Chromogranin A Positive Neoplastic Cells Present,Cervical Atypical Carcinoid Tumor,1
43340,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
43341,Carcinomatous Component Present,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
43342,Malignant Cellular Infiltrate,Stage IIIA Eyelid Carcinoma AJCC v7,1
43343,Malignant Cellular Infiltrate,cloacogenic carcinoma of rectum,1
43344,Epithelial Component Present,Stage I Merkel Cell Carcinoma AJCC v7,1
43345,Nuclear Pseudoinclusion,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
43346,Low Grade Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1,1
43347,Malignant Cellular Infiltrate,Oropharyngeal Carcinoma,1
43348,Perivascular Arrangement of Tumor Cells,Malignant Lung PEComa,1
43349,Epithelial Component Present,Stage IVB Major Salivary Gland Cancer AJCC v7,1
43350,Intraocular Lesion,Refractory Primary Vitreoretinal Lymphoma,1
43351,Recurrent disease,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
43352,Malignant Cellular Infiltrate,verrucous carcinoma of vagina,1
43353,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
43354,Low Mitotic Activity,Small Intestinal Neuroendocrine Tumor,1
43355,Carcinomatous Component Present,Laryngeal Basaloid Carcinoma,1
43356,Epithelial Component Present,Stage IIB Fallopian Tube Cancer AJCC v8,1
43357,Malignant Cellular Infiltrate,Stage IIIA Distal Bile Duct Cancer AJCC v8,1
43358,Therapy-Related Toxicity,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,1
43359,Cutaneous Involvement,Atrophoderma maculatum,1
43360,Myxoid Stroma Formation,Mediastinal Epithelioid Hemangioendothelioma,1
43361,Malignant Cellular Infiltrate,Methotrexate-Associated Hodgkin Lymphoma,1
43362,Epithelial Component Present,Metastatic Triple-Negative Breast Carcinoma,1
43363,Antoni A Pattern,Sternal Intraosseous Schwannoma,1
43364,Microvascular Proliferation,Supratentorial Glioblastoma,1
43365,Stromal Invasion,Small cell carcinoma of ovary,1
43366,Malignant Cellular Infiltrate,Stage IV Soft Tissue Sarcoma AJCC v7,1
43367,Chromogranin A Positive Neoplastic Cells Present,Unresectable Carcinoid Tumor,1
43368,Low Mitotic Activity,Recurrent Digestive System Neuroendocrine Tumor G1,1
43369,Childhood Lesion,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
43370,Malignant Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v7 Stage,1
43371,Malignant Cellular Infiltrate,solid type ductal carcinoma in situ of breast,1
43372,IDH Gene Family Mutation Status Unknown,Mixed Oligodendroglioma-Astrocytoma,1
43373,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,1
43374,Epithelial Component Present,Carcinoma of submandibular gland,1
43375,Malignant Cellular Infiltrate,Colorectal Carcinoma,1
43376,Cutaneous Involvement,Eczema,1
43377,Undifferentiated Lesion,Vaginal Undifferentiated Sarcoma,1
43378,Cystic Change,Benign Brenner Tumor,1
43379,Hereditary Lesion,Recurrent BRCA-Mutated Ovarian Carcinoma,1
43380,Vascular Channel Formation,Angiosarcoma NCI Grade 3,1
43381,High Grade Lesion,Synovial sarcoma non-metastatic,1
43382,Malignant Cellular Infiltrate,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,1
43383,Carcinomatous Component Present,Stage IVC Appendix Carcinoma AJCC v7,1
43384,Neuroendocrine Differentiation,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
43385,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Non-Gestational Ovarian Choriocarcinoma,1
43386,Carcinomatous Component Present,Recurrent Clear Cell Renal Cell Carcinoma,1
43387,Epithelial Component Present,Distal 1/3 of the Common Bile Duct Adenocarcinoma,1
43388,Multicentric Lesion,Multicentric Breast Carcinoma,1
43389,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
43390,Epithelial Component Present,Intracystic Papillary Breast Carcinoma,1
43391,Indolent Clinical Course,Infantile hemangioma,1
43392,Apocrine Differentiation,Invasive Apocrine Breast Carcinoma,1
43393,Microcystic Change,Subependymal Glioma,1
43394,Pericanalicular Growth Pattern,Pericanalicular fibroadenoma,1
43395,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Secretory breast carcinoma,1
43396,Pathologic TNM Finding,Pathologic Stage IV Retinoblastoma AJCC v8,1
43397,Cutaneous Involvement,Diaper Rash,1
43398,Malignant Cellular Infiltrate,Refractory Metastatic Digestive System Carcinoma,1
43399,Recurrent disease,Mantle cell lymphoma recurrent,1
43400,Cutaneous Involvement,Cutaneous pseudolymphoma,1
43401,Epithelial Component Present,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
43402,Lesion Less than 10mm in Diameter,Sporadic Thyroid Gland Micromedullary Carcinoma,1
43403,Neuroendocrine Differentiation,Recurrent Neuroendocrine Neoplasm,1
43404,Epithelial Component Present,Stage I Fallopian Tube Cancer,1
43405,Epithelial Component Present,Stage IVB Colorectal Cancer AJCC v7,1
43406,Carcinomatous Component Present,Nasopharyngeal Nonkeratinizing Carcinoma,1
43407,Storiform Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
43408,Malignant Cellular Infiltrate,Malignant Aortic Neoplasm,1
43409,Carcinomatous Component Present,Bladder Papillary Clear Cell Adenocarcinoma,1
43410,Malignant Cellular Infiltrate,Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8,1
43411,Endophytic Tumor Growth,Upper Gingival Verrucous Carcinoma,1
43412,Increased Cellularity Present,Stage 3 Neuroblastoma,1
43413,Epithelial Component Present,Bladder adenocarcinoma recurrent,1
43414,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v7 Stage,1
43415,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage,1
43416,Chromogranin A Positive Neoplastic Cells Present,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",1
43417,Chronic lymphocytic inflammation,"Thymoma, type AB",1
43418,High Grade Lesion,Rhabdomyosarcoma of the orbit,1
43419,Solitary mass,Chest Wall Solitary Plasmacytoma,1
43420,Absence of Invasion,Biliary Intraepithelial Neoplasia-3,1
43421,Malignant Cellular Infiltrate,Refractory Malignant Thyroid Gland Neoplasm,1
43422,Papillary Pattern,"Papillary renal cell carcinoma, sporadic",1
43423,Carcinomatous Component Present,Grade 2 Colorectal Adenocarcinoma,1
43424,Malignant Cellular Infiltrate,Malignant neoplasm of abdominal part of esophagus,1
43425,Epithelial Component Present,Basal cell carcinoma of vulva,1
43426,Malignant Cellular Infiltrate,Metastatic Carcinoma in the Adrenal Cortex,1
43427,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Fallopian Tube Endometrioid Tumor,1
43428,Locally Aggressive Lesion,Ossifying fibromyxoid tumor,1
43429,Thin Bands of Collagen Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
43430,Malignant Cellular Infiltrate,Glioblastoma,1
43431,More than 10 Mitoses per 10HPF,Platinum-Sensitive Lung Small Cell Carcinoma,1
43432,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts,1
43433,Secondary Lesion,Advanced Cutaneous Melanoma of the Extremity,1
43434,Pathologic TNM Finding,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
43435,Storiform Growth Pattern,Dermatofibrosarcoma Protuberans,1
43436,Metastatic Lesion,Locally Advanced Unresectable Bone Sarcoma,1
43437,Metastatic Lesion,Carcinomatosis,1
43438,Clinical TNM Finding,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
43439,Malignant Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v7,1
43440,Malignant Cellular Infiltrate,Nodulo-ulcerative basal cell carcinoma,1
43441,Epithelial Component Present,BCLC Stage 0 Hepatocellular Carcinoma,1
43442,Epithelial Component Present,basal cell adenocarcinoma of salivary gland,1
43443,Childhood Lesion,Refractory Hepatoblastoma,1
43444,Malignant Cellular Infiltrate,Malignant Adrenal Medulla Neoplasm,1
43445,Recurrent disease,Recurrent Chordoma,1
43446,Chronic Inflammatory Infiltrate,Pulmonary Lymphomatoid Granulomatosis,1
43447,Stromal Invasion,Stage IA Ovarian Cancer AJCC v8,1
43448,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,1
43449,Osseous Differentiation,Multifocal osteosarcoma,1
43450,Cutaneous Involvement,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
43451,Epithelial Component Present,Small cell neuroendocrine carcinoma of bladder,1
43452,Dual Population of Bone Marrow Blasts Present,Acute bilineal leukemia,1
43453,Carcinomatous Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
43454,Malignant Cellular Infiltrate,Splenic Lymphoplasmacytic Lymphoma,1
43455,Epithelial Component Present,Stage IA Eyelid Carcinoma AJCC v7,1
43456,Secondary Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
43457,Nodular Pattern,Ann Arbor Stage II Follicular Lymphoma,1
43458,Diffuse Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
43459,Multinodular Mass,Cervical Angiosarcoma,1
43460,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
43461,Carcinomatous Component Present,adenocarcinoma of renal pelvis,1
43462,Intracytoplasmic Eosinophilic Inclusion,Childhood Atypical Teratoid/Rhabdoid Tumor,1
43463,Neuroectodermal Differentiation,Neuroblastic tumors,1
43464,Recurrent disease,Laryngeal papillomatosis,1
43465,Malignant Cellular Infiltrate,Stage III Childhood Lymphoblastic Lymphoma,1
43466,Malignant Cellular Infiltrate,Iatrogenic Kaposi Sarcoma,1
43467,Recurrent disease,Hodgkin's disease nodular sclerosis recurrent,1
43468,Malignant Cellular Infiltrate,Unresectable Dedifferentiated Liposarcoma,1
43469,Biphasic Pattern,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,1
43470,Epithelial Component Present,Pseudomyxoma Peritonei,1
43471,Recurrent disease,Recurrent Ovarian Transitional Cell Carcinoma,1
43472,Endophytic Tumor Growth,Frontal Sinus Inverted Papilloma,1
43473,Epithelial Component Present,Stage II Rectal Cancer,1
43474,Carcinomatous Component Present,Stage II Gallbladder Cancer AJCC v7,1
43475,Cutaneous Involvement,Stage I Lip Basal Cell Carcinoma,1
43476,Carcinomatous Component Present,Colorectal Carcinoma Metastatic in the Lung,1
43477,Papillary Pattern,Glottis Verrucous Carcinoma,1
43478,Malignant Cellular Infiltrate,Fibrosarcoma,1
43479,Hyperplastic Tissue Present,Circumferential Endothelial Hyperplasia,1
43480,Epithelial Component Present,Stage IIA Vaginal Cancer AJCC v8,1
43481,Carcinomatous Component Present,Submucosal Invasive Colon Adenocarcinoma,1
43482,Carcinomatous Component Present,Stage I Lung Cancer AJCC v7,1
43483,Low Mitotic Activity,Colorectal Neuroendocrine Tumor G2,1
43484,Dysplasia,tubulovillous adenoma of stomach,1
43485,Malignant Cellular Infiltrate,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
43486,Well-Circumscribed Lesion,Rectal Sessile Serrated Adenoma/Polyp,1
43487,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v8,1
43488,Well-Circumscribed Lesion,Colon Serrated Polyposis,1
43489,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
43490,Low Mitotic Activity,Malignant Vipoma,1
43491,Epithelial Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",1
43492,Primary Lesion,Recurrent Central Nervous System Lymphoma,1
43493,Malignant Cellular Infiltrate,Intramucosal Adenocarcinoma,1
43494,Carcinomatous Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma,1
43495,Gastrin Positive Neoplastic Cells Present,malignant gastrinoma of pancreas,1
43496,Carcinomatous Component Present,Stage IV Lip Basal Cell Carcinoma,1
43497,Intraductal Lesion,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
43498,Histiocytoid Differentiation,Lymphohistiocytoid Mesothelioma,1
43499,Malignant Cellular Infiltrate,Stage I Vulvar Carcinoma,1
43500,Hemorrhagic,Uterine Angiosarcoma,1
43501,Cystic Change,Fundic gland polyp,1
43502,Pseudopapillary Pattern,embryonal carcinoma of mediastinum,1
43503,Neuroendocrine Differentiation,Gastric Neuroendocrine Tumor,1
43504,Acinar Cell Differentiation,Recurrent Pancreatic Acinar Cell Carcinoma,1
43505,Mitotic Activity,Adult Yolk Sac Tumor,1
43506,Epithelial Component Present,Stage I Pancreatic Cancer AJCC v6 and v7,1
43507,More than 5 Mitoses per 50HPF,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
43508,Anaplasia,Malignant Meningioma,1
43509,Epithelial Component Present,Subglottic Squamous Cell Carcinoma,1
43510,Tissue Differentiation Uncertain,Extrarenal rhabdoid tumor,1
43511,Well-Circumscribed Lesion,Polyp of esophagus,1
43512,Antoni A Pattern,Trigeminal schwannoma,1
43513,Malignant Cellular Infiltrate,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
43514,Well-Circumscribed Lesion,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
43515,Epithelial Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
43516,Unclassifiable Lesion,"Peripheral T-Cell Lymphoma, Unclassifiable",1
43517,Recurrent disease,Recurrent Childhood Giant Cell Glioblastoma,1
43518,Adulthood Lesion,Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage,1
43519,Carcinomatous Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
43520,Slow Growing Mass,Sellar Chordoma,1
43521,Exophytic Papillary Lesion,papillary squamous cell carcinoma of larynx,1
43522,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Clinical Course,1
43523,Carcinomatous Component Present,Stage I Renal Cell Carcinoma,1
43524,Malignant Cellular Infiltrate,ACTH-Producing Pituitary Gland Carcinoma,1
43525,Benign Cellular Infiltrate,Benign Cervical Soft Tissue Neoplasm,1
43526,Malignant Cellular Infiltrate,Recurrent Retinoblastoma,1
43527,Keratin pearl formation,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
43528,Somatostatin Positive Neoplastic Cells Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
43529,Carcinomatous Component Present,Platinum-Resistant Urothelial Carcinoma,1
43530,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma recurrent,1
43531,Epithelial Component Present,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
43532,Epithelial Component Present,Encapsulated Thymoma,1
43533,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage I,1
43534,Immunologic Deficiency Syndromes,HIV Encephalopathy,1
43535,S-100-Positive Neoplastic Cells Present,Benign Uterine Corpus PEComa,1
43536,Tubular Pattern,Vaginal Tubular Adenoma,1
43537,Malignant Cellular Infiltrate,Centroblastic lymphoma refractory,1
43538,Carcinomatous Component Present,Urothelial carcinoma ureter metastatic,1
43539,Carcinomatous Component Present,Adenoid cystic carcinoma of lacrimal gland,1
43540,Epithelial Component Present,lipid-rich carcinoma of breast,1
43541,Cutaneous Involvement,Pilomatrixoma,1
43542,Cutaneous Involvement,"Adenoma, Sweat Gland",1
43543,Adulthood Lesion,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1
43544,Epithelial Component Present,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,1
43545,Slow Growing Mass,Childhood Ganglioglioma,1
43546,Metastatic Lesion,Locally Advanced Malignant Solid Neoplasm,1
43547,Refractory Disease,Refractory Malignant Thyroid Gland Neoplasm,1
43548,Cutaneous Involvement,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin,1
43549,Epithelial Component Present,Lung Adenocarcinoma In Situ,1
43550,Epithelial Component Present,Digestive System Neuroendocrine Tumor G2,1
43551,Malignant Cellular Infiltrate,Sellar Embryonal Carcinoma,1
43552,Malignant Cellular Infiltrate,Recurrent Primary Effusion Lymphoma,1
43553,Necrotic changes (finding),small cell carcinoma of appendix,1
43554,Neuroendocrine Differentiation,Recurrent Paraganglioma,1
43555,Absence of Stromal Invasion,Fallopian Tube Metaplastic Papillary Tumor,1
43556,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction,1
43557,Mesenchymal Component Present,Eccrine mixed tumor of skin,1
43558,Malignant Cellular Infiltrate,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,1
43559,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
43560,Mixed Cellular Population,Cervical Atypical Polypoid Adenomyoma,1
43561,Indolent Clinical Course,Lipoma of the tongue,1
43562,Necrotic changes (finding),Refractory Glioblastoma,1
43563,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v8,1
43564,Epithelial Component Present,Ovarian cancer stage III,1
43565,Malignant Cellular Infiltrate,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
43566,Keratin pearl formation,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
43567,Childhood Lesion,Childhood Cerebral Diffuse Astrocytoma,1
43568,Malignant Cellular Infiltrate,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
43569,Tubular Pattern,Somatostatinoma,1
43570,Epithelial Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",1
43571,Borderline Lesion,Pulmonary Lymphomatoid Granulomatosis,1
43572,Neuroendocrine Differentiation,Combined Lung Large Cell Neuroendocrine Carcinoma,1
43573,Pregnancy Complications,Placenta Accreta,1
43574,Epithelial Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
43575,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v7,1
43576,Exophytic Polypoid Lesion,Small Intestinal Villous Adenoma,1
43577,Papillary Pattern,"Transitional cell papilloma, benign",1
43578,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1,1
43579,Epithelial Component Present,Vaginal Squamous Papilloma,1
43580,Refractory Disease,Platinum-Resistant Urothelial Carcinoma,1
43581,Malignant Cellular Infiltrate,Breast cancer recurrent,1
43582,Immunosuppression-Related Post-Transplant Toxicity,Neoplastic Post-Transplant Lymphoproliferative Disorder,1
43583,Indolent Clinical Course,Pleomorphic Lipoma,1
43584,Malignant Cellular Infiltrate,Metastatic Gastroesophageal Junction Adenocarcinoma,1
43585,Adnexal Differentiation,Sebaceoma,1
43586,Malignant Cellular Infiltrate,Stage IVB Cervical Cancer AJCC v8,1
43587,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
43588,Absence of a Hormonal Syndrome,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
43589,Intracellular Accumulation of Lipids,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
43590,Childhood Lesion,Childhood Brain Meningioma,1
43591,Borderline Lesion,Borderline Ovarian Endometrioid Cystadenofibroma,1
43592,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of floor of mouth,1
43593,Metastatic/Recurrent Disease,Alveolar Soft Part Sarcoma,1
43594,Carcinomatous Component Present,Refractory Ovarian Carcinoma,1
43595,Epithelial Component Present,Stage IIA Lung Squamous Cell Carcinoma AJCC v7,1
43596,Epithelial Component Present,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
43597,Deep Lesion,Recurrent Desmoid-Type Fibromatosis,1
43598,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
43599,Epithelial Component Present,tubular adenoma of stomach,1
43600,Epithelial Component Present,"Transitional cell papilloma, benign",1
43601,Malignant Cellular Infiltrate,High Grade Malignant Neoplasm,1
43602,Papillary Pattern,Borderline Ovarian Serous Adenofibroma,1
43603,Dysplasia,Tubular adenoma of colon,1
43604,Chronic Inflammatory Infiltrate,Cutaneous Lymphomatoid Granulomatosis,1
43605,Malignant Cellular Infiltrate,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
43606,S-100-Positive Neoplastic Cells Present,Lung PEComa,1
43607,Anaplasia,Anaplastic Diencephalic Astrocytoma,1
43608,Myomatous Stroma Formation,Adenomyoma,1
43609,Acanthosis,Bowen's Disease,1
43610,Malignant Cellular Infiltrate,Papillary Lung Adenocarcinoma,1
43611,Malignant Cellular Infiltrate,Stage III Testicular Seminoma AJCC v6 and v7,1
43612,Absence of Invasion,Carcinoma in situ of prostate,1
43613,Low Grade Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
43614,Malignant Cellular Infiltrate,Intimal sarcoma,1
43615,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage II,1
43616,Immunologic Deficiency Syndromes,Transplant-Related Carcinoma,1
43617,Epithelial Component Present,Familial Adrenal Gland Pheochromocytoma,1
43618,Carcinomatous Component Present,Stage II Skin Cancer,1
43619,Epithelial Component Present,Glomus vagale tumor,1
43620,Carcinomatous Component Present,Acquired cystic disease associated renal cell carcinoma,1
43621,Malignant Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
43622,Secondary Lesion,Locally Advanced Angiosarcoma,1
43623,Metastatic Lesion,Benign Metastasizing Leiomyoma of the Uterine Corpus,1
43624,Lymphoplasmacytic Infiltrate,Undifferentiated carcinoma of nasopharynx,1
43625,Infiltrative Growth Pattern,Proneural Glioblastoma,1
43626,Epithelial Component Present,Stage II Penile Cancer AJCC v6,1
43627,Neuroendocrine Differentiation,Gallbladder Goblet Cell Carcinoid,1
43628,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v7,1
43629,Pushing Tumor Margin,Benign Prostate Phyllodes Tumor,1
43630,Recurrent disease,Recurrent Childhood Astrocytic Tumor,1
43631,Cutaneous Involvement,Cutaneous Mature T-Cell and NK-Cell Neoplasm,1
43632,Low Mitotic Activity,Jejunal Neuroendocrine Tumor,1
43633,Childhood Lesion,Stage I Childhood Hodgkin Lymphoma,1
43634,Benign Cellular Infiltrate,Benign Breast Adenomyoepithelioma,1
43635,Malignant Cellular Infiltrate,Small Intestinal Cancer by AJCC v7 Stage,1
43636,Carcinomatous Component Present,Chromophobe Renal Cell Carcinoma,1
43637,Epithelial Component Present,Tumor of follicular infundibulum,1
43638,Carcinomatous Component Present,Stage IIB Rectal Cancer AJCC v8,1
43639,Mixed Cellular Population,Anaplastic Oligoastrocytoma,1
43640,Lepidic Growth Pattern,Minimally Invasive Mucinous Lung Adenocarcinoma,1
43641,Malignant Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v7 Stage,1
43642,Chromogranin A Positive Neoplastic Cells Present,Metastatic Digestive System Neuroendocrine Tumor G1,1
43643,Epithelial Component Present,Carcinoma in situ of middle ear,1
43644,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
43645,Recurrent Malignant Neoplasm,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
43646,Carcinomatous Component Present,Ampulla of Vater Squamous Cell Carcinoma,1
43647,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
43648,Malignant Cellular Infiltrate,Nevoid Melanoma,1
43649,Epithelial Component Present,Undifferentiated Fallopian Tube Carcinoma,1
43650,Metastatic Lesion,Metastatic Colon Carcinoma,1
43651,Clinical TNM Finding,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
43652,Carcinomatous Component Present,Stage IVA Hepatocellular Carcinoma AJCC v8,1
43653,Lobulated Growth Pattern,Left atrial myxoma,1
43654,Monoclonal Eosinophils Present,"Leukemia, Eosinophilic, Acute",1
43655,Nodular Pattern,Ann Arbor Stage IV Grade 2 Follicular Lymphoma,1
43656,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
43657,Pathologic TNM Finding,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
43658,Carcinomatous Component Present,Papillary Thyroid Microcarcinoma,1
43659,Epithelial Component Present,Stage I Colon Cancer AJCC v8,1
43660,Epithelial Component Present,Paget Disease Extramammary,1
43661,Malignant Cellular Infiltrate,Thyroid Hurthle Cell Carcinoma,1
43662,Carcinomatous Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma,1
43663,Nuclear Molding,Stage IV Lung Small Cell Carcinoma AJCC v7,1
43664,Childhood Lesion,Childhood Systemic Anaplastic Large Cell Lymphoma,1
43665,Carcinomatous Component Present,Advanced Digestive System Carcinoma,1
43666,Papillary Pattern,Hidradenoma Papilliferum,1
43667,Malignant Cellular Infiltrate,Recurrent Invasive Ductal Breast Carcinoma,1
43668,Primary Lesion,Localized Resectable Adult Hepatocellular Carcinoma,1
43669,Refractory Disease,Refractory Malignant Testicular Germ Cell Tumor,1
43670,Malignant Cellular Infiltrate,Clinical Stage IIB Cutaneous Melanoma AJCC v8,1
43671,Epithelial Component Present,Transitional cell carcinoma of bladder,1
43672,Neuroendocrine Differentiation,Esophageal Neuroendocrine Tumor G2,1
43673,Carcinomatous Component Present,Broad Ligament Serous Adenocarcinoma,1
43674,Malignant Cellular Infiltrate,Stage IA Adult Soft Tissue Sarcoma AJCC v7,1
43675,Stromal Invasion,Stage I Ovarian Cancer AJCC v6 and v7,1
43676,Primary Lesion,Childhood Parosteal Osteosarcoma,1
43677,Unresectable Mass,Unresectable Hepatocellular Carcinoma,1
43678,Solar Radiation Toxicity,Solar Radiation-Related Cutaneous Melanoma,1
43679,Cutaneous Involvement,Unresectable Skin Carcinoma,1
43680,Blasts Under 5 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1,1
43681,Carcinomatous Component Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
43682,Epithelial Component Present,Stage I Fallopian Tube Cancer,1
43683,Schwannian Stroma Predominant Component of the Tumor Volume,Mature Ganglioneuroma,1
43684,Carcinomatous Component Present,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
43685,Malignant Cellular Infiltrate,Vaginal Neuroendocrine Carcinoma,1
43686,Multinodular Mass,Colorectal Angiosarcoma,1
43687,Nuclear Clearing,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
43688,Severe cytologic atypia,Colorectal Large Cell Neuroendocrine Carcinoma,1
43689,Invasive Lesion,Breast Carcinoma with Osseous Metaplasia,1
43690,Epithelial Component Present,Villous adenocarcinoma,1
43691,Low Mitotic Activity,Gastric Neuroendocrine Tumor,1
43692,Blasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Chronic Myelomonocytic Leukemia,1
43693,Secondary Lesion,Secondary Central Nervous System Lymphoma,1
43694,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
43695,Neuroendocrine Differentiation,Digestive System Large Cell Neuroendocrine Carcinoma,1
43696,Severe cytologic atypia,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
43697,Epithelial Component Present,Ovarian Surface Papilloma,1
43698,Chromogranin A Positive Neoplastic Cells Present,Jejunal Neuroendocrine Tumor G1,1
43699,Malignant Cellular Infiltrate,High grade surface osteosarcoma,1
43700,Benign Cellular Infiltrate,Intra-Abdominal Lymphangioma,1
43701,Papillary Pattern,"Cystadenoma, Papillary",1
43702,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
43703,Decreased platelet count,Kasabach-Merritt syndrome,1
43704,Indolent Clinical Course,Liver Lipoma,1
43705,Malignant Cellular Infiltrate,Childhood Nasal Cavity Carcinoma,1
43706,Schwannian Stroma More than 50 Percent of the Tumor Volume,Peripheral Ganglioneuroblastoma,1
43707,Follicular Cell Differentiation,Childhood Thyroid Gland Papillary Carcinoma,1
43708,Cutaneous Involvement,Mycosis Fungoides,1
43709,Malignant Cellular Infiltrate,Hypopharyngeal Cancer,1
43710,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v8 Stage,1
43711,Epithelial Component Present,Malignant Brenner Tumor,1
43712,Lobulated Growth Pattern,Apocrine adenoma,1
43713,Absence of Invasion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
43714,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage I,1
43715,Well Differentiated Neuroendocrine Lesion,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
43716,Malignant Cellular Infiltrate,Recurrent Male Reproductive System Carcinoma,1
43717,Low Mitotic Activity,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
43718,Malignant Cellular Infiltrate,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
43719,Malignant Cellular Infiltrate,Philadelphia-Positive Myelogenous Leukemia,1
43720,Malignant Cellular Infiltrate,Frontal Sinus Squamous Cell Carcinoma,1
43721,Epithelial Component Present,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7,1
43722,Malignant Cellular Infiltrate,Chronic myeloproliferative disorder,1
43723,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
43724,Epithelial Component Present,Carcinoma of submandibular gland,1
43725,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Ovarian Choriocarcinoma,1
43726,Malignant Cellular Infiltrate,Metastatic Bone Ewing Sarcoma,1
43727,Mesenchymal Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
43728,Borderline Lesion,Childhood Lymphomatoid Granulomatosis,1
43729,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
43730,Malignant Cellular Infiltrate,Stage IV Ureter Cancer AJCC v7,1
43731,Epithelial Component Present,Adenoma of rectum,1
43732,Epithelial Component Present,Grade II Penile Intraepithelial Neoplasia,1
43733,Necrotic changes (finding),Refractory Glioblastoma,1
43734,Stromal Invasion,Ovarian mixed epithelial carcinoma,1
43735,Secondary Lesion,"Neuroendocrine carcinoma, metastatic",1
43736,Malignant Cellular Infiltrate,Transitional cell carcinoma metastatic,1
43737,Malignant Cellular Infiltrate,Esophageal carcinoma recurrent,1
43738,Mixed Cellular Population,Uterine Corpus Carcinofibroma,1
43739,Epithelial Component Present,Advanced Gastric Neuroendocrine Carcinoma,1
43740,Carcinomatous Component Present,Acinar Cell Carcinoma,1
43741,Malignant Cellular Infiltrate,Malignant neoplasm of respiratory system,1
43742,Carcinomatous Component Present,carcinosarcoma of liver,1
43743,Epithelial Component Present,Gastric Cardia Squamous Cell Carcinoma,1
43744,Cutaneous Involvement,Stage IIIC Cutaneous Melanoma AJCC v7,1
43745,Necrotic changes (finding),Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
43746,Hyaline Cartilage Differentiation,Enchondroma,1
43747,Carcinomatous Component Present,Adenoid cystic carcinoma of salivary gland,1
43748,Well-Circumscribed Lesion,Tubular adenoma of breast,1
43749,Exophytic Polypoid Lesion,Colorectal Microvesicular Hyperplastic Polyp,1
43750,Epithelial Component Present,Prostate Cancer by AJCC v8 Stage,1
43751,Painless Mass,Soft tissue chondroma,1
43752,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of parotid gland,1
43753,Capillary Sized Vascular Channel Formation,Senile angioma,1
43754,Neuroendocrine Differentiation,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
43755,Low Mitotic Activity,Gallbladder Tubular Carcinoid,1
43756,Carcinomatous Component Present,Lung Enteric Adenocarcinoma,1
43757,Epithelial Component Present,Functioning Endocrine Neoplasm,1
43758,Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric,1
43759,Refractory Disease,Peripheral T-cell lymphoma unspecified refractory,1
43760,Malignant Cellular Infiltrate,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
43761,Epithelial Component Present,Ceruminous adenocarcinoma,1
43762,Nodular Pattern,Medulloblastoma with extensive nodularity,1
43763,Nodular Pattern,Recurrent Follicular Lymphoma,1
43764,Malignant Cellular Infiltrate,Bartholin Gland Adenoid Cystic Carcinoma,1
43765,Nuclear Grooves,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
43766,Cutaneous Involvement,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
43767,Malignant Cellular Infiltrate,Malignant Female Reproductive System Neoplasm,1
43768,Epithelial Component Present,Unresectable Adrenal Gland Pheochromocytoma,1
43769,High Grade Lesion,Childhood Rhabdomyosarcoma,1
43770,Extramedullary Hematopoiesis (disorder),Post polycythaemia vera myelofibrosis,1
43771,Carcinomatous Component Present,ENSAT Stage II Adrenal Cortex Carcinoma,1
43772,Epithelial Component Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
43773,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal tumor of soft tissue,1
43774,Epithelial Component Present,Stage IIB Cervical Cancer AJCC v6 and v7,1
43775,Cutaneous Involvement,Stage I Lentigo Maligna Melanoma AJCC v7,1
43776,Chronic lymphocytic inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
43777,Cutaneous Involvement,Mucoepidermoid carcinoma of skin,1
43778,Borderline Lesion,Atypical Spitz Nevus,1
43779,Malignant Cellular Infiltrate,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
43780,Carcinomatous Component Present,Laryngeal Adenoid Cystic Carcinoma,1
43781,Refractory Disease,Lymphoplasmacytoid lymphoma/immunocytoma refractory,1
43782,Malignant Cellular Infiltrate,Childhood Melanoma,1
43783,Benign Cellular Infiltrate,Sebaceous adenoma,1
43784,Mixed Cellular Population,Adult Mixed Glioma,1
43785,Well-Circumscribed Lesion,Angiomyofibroblastoma,1
43786,Keratin pearl formation,"Lung Squamous Cell Carcinoma, Clear Cell Variant",1
43787,Pain,Adult Mesenchymal Chondrosarcoma,1
43788,Exophytic Polypoid Lesion,Polyp of nasal sinus,1
43789,Carcinomatous Component Present,Stage I Hilar Cholangiocarcinoma AJCC v8,1
43790,'Starry-sky' pattern,Recurrent Adult Burkitt Lymphoma,1
43791,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v7,1
43792,Adnexal Differentiation,Basal cell carcinoma - follicular,1
43793,Recurrent disease,Recurrent Malignant Female Reproductive System Neoplasm,1
43794,Papillary Pattern,Papillary mucinous cystadenocarcinoma,1
43795,Well-Circumscribed Lesion,Papillary serous cystadenoma,1
43796,Vascular Channel Formation,Angiosarcoma Associated with Lymphedema,1
43797,Mixed Cellular Population,Rete Ovarii Cystadenofibroma,1
43798,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Mature Teratoma,1
43799,Parakeratosis,Bowen's Disease,1
43800,Carcinomatous Component Present,Lung Cancer by AJCC v6 Stage,1
43801,Acanthosis,Verrucous carcinoma of oral cavity,1
43802,Malignant Cellular Infiltrate,Vaginal Adenoid Basal Carcinoma,1
43803,Malignant Cellular Infiltrate,Uterine Ligament Mucinous Adenocarcinoma,1
43804,Wedge-Shaped Growth Pattern,Deep Penetrating Nevus,1
43805,Carcinomatous Component Present,Endometrial Dedifferentiated Carcinoma,1
43806,Papillary Pattern,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
43807,Malignant Cellular Infiltrate,Extraocular Cutaneous Sebaceous Carcinoma,1
43808,Epithelial Component Present,Anatomic Stage II Breast Cancer AJCC v8,1
43809,Borderline Lesion,Borderline Uterine Ligament Neoplasm,1
43810,Neuroendocrine Differentiation,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,1
43811,Epithelial Component Present,Perihilar Intrahepatic Cholangiocarcinoma,1
43812,Poorly Differentiated Lesion,Renal medullary carcinoma,1
43813,Cystic Change,Vulvar Seborrheic Keratosis,1
43814,Vascular Channel Formation,Angiosarcoma NCI Grade 3,1
43815,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
43816,Heterologous Elements Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
43817,Malignant Cellular Infiltrate,Carcinoma of soft palate,1
43818,Carcinomatous Component Present,signet ring cell carcinoma of breast,1
43819,Epithelial Component Present,Collecting Duct Carcinoma of the Kidney,1
43820,Exophytic Polypoid Lesion,Rectal Juvenile Polyp,1
43821,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of skin,1
43822,Well Differentiated Neuroendocrine Lesion,Stage IIB Colon Neuroendocrine Tumor AJCC v8,1
43823,Lytic lesion,Giant Cell Lesion of Small Bones,1
43824,Odontogenic Cysts,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
43825,Ineffective hematopoiesis,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
43826,Anaplasia,Recurrent Childhood Anaplastic Astrocytoma,1
43827,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
43828,Malignant Cellular Infiltrate,Carcinosarcoma of ovary,1
43829,Clinical TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,1
43830,Vascular Channel Formation,Advanced Kaposi Sarcoma,1
43831,Histiocytosis,T-cell/histiocyte rich large B-cell lymphoma,1
43832,Cutaneous Involvement,Transplant-Related Skin Squamous Cell Carcinoma,1
43833,Trichoblastic Differentiation,Vulvar Trichoepithelioma,1
43834,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,1
43835,Epithelial Component Present,Bile duct carcinoma,1
43836,'Starry-sky' pattern,Stage III Burkitt Lymphoma,1
43837,Malignant Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
43838,Malignant Cellular Infiltrate,Ann Arbor Stage II Mantle Cell Lymphoma,1
43839,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of bladder,1
43840,Carcinomatous Component Present,Adenocarcinoma Of Esophagus,1
43841,Epithelial Component Present,"Adenocarcinoma of lung, stage II",1
43842,Rapidly Enlarging Mass,Unresectable Rhabdomyosarcoma,1
43843,Firm mass,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
43844,Recurrent disease,Neuroblastoma recurrent,1
43845,Immunologic Deficiency Syndromes,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
43846,Epidermotropic Lymphocytic Infiltrate,Stage IB Mycosis Fungoides AJCC v7,1
43847,Lobulated Growth Pattern,Dedifferentiated chordoma,1
43848,Cystic Change,Cystic teratoma,1
43849,Epithelial Component Present,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
43850,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,1
43851,Well Differentiated Lesion,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",1
43852,Carcinomatous Component Present,Stage IIB Lung Large Cell Carcinoma AJCC v7,1
43853,Malignant Cellular Infiltrate,Stage II Adult Soft Tissue Sarcoma AJCC v7,1
43854,Malignant Cellular Infiltrate,Childhood Acute Basophilic Leukemia,1
43855,atypia morphology,Fallopian Tube Metaplastic Papillary Tumor,1
43856,Intermediate Filaments Present,Recurrent Rhabdoid Tumor,1
43857,Numerous Stromal Mast Cells Present,Vaginal Myofibroblastoma,1
43858,Slow Growing Mass,Juvenile Pilocytic Astrocytoma,1
43859,Capillary Sized Vascular Channel Formation,Histiocytoid hemangioma,1
43860,Malignant Cellular Infiltrate,Malignant neoplasm of duodenum,1
43861,CD30-Positive Neoplastic Cells Present,Stage IV Anaplastic Large Cell Lymphoma,1
43862,Malignant Cellular Infiltrate,Chemotherapy-Related Leukemia,1
43863,Malignant Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",1
43864,Cutaneous Involvement,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8,1
43865,Carcinomatous Component Present,Recurrent Ovarian Carcinosarcoma,1
43866,Carcinomatous Component Present,Bronchioloalveolar Adenocarcinoma,1
43867,Epithelial Component Present,Recurrent Head and Neck Carcinoma,1
43868,Collagenous Stroma Formation,Pelvic Fibromatosis,1
43869,Syncytial Pattern,Undifferentiated carcinoma of nasopharynx,1
43870,Pain,Childhood Mesenchymal Chondrosarcoma,1
43871,Osseous Differentiation,Stage I Osteosarcoma AJCC v7,1
43872,Childhood Lesion,Recurrent Childhood Gemistocytic Astrocytoma,1
43873,Epithelial Component Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
43874,Mixed Cellular Population,combined small cell carcinoma of lung,1
43875,Epithelial Component Present,Metastatic Carcinoma in the Lung,1
43876,HER2/Neu Negative,Metastatic Triple-Negative Breast Carcinoma,1
43877,Malignant Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",1
43878,Malignant Cellular Infiltrate,Ocular Sebaceous Carcinoma,1
43879,Refractory Disease,Refractory Malignant Glioma,1
43880,Clinical TNM Finding,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
43881,Malignant Cellular Infiltrate,Body Cavity Primary Effusion Lymphoma,1
43882,Recurrent disease,Recurrent Malignant Thyroid Gland Neoplasm,1
43883,Childhood Lesion,Childhood Seminoma,1
43884,Papillary Pattern,Hereditary Papillary Renal Carcinoma,1
43885,Refractory Disease,Refractory WHO Grade III Glioma,1
43886,Benign Cellular Infiltrate,Benign neoplasm of accessory sinus,1
43887,Mixture of Germ Cell Neoplastic Components Present,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor,1
43888,Sebaceous Differentiation,Vulvar Sebaceous Carcinoma,1
43889,Carcinomatous Component Present,Small intestine adenocarcinoma metastatic NOS,1
43890,Malignant Cellular Infiltrate,Marginal zone lymphoma recurrent,1
43891,Carcinomatous Component Present,Adult Liver Carcinoma,1
43892,Syncytial Pattern,Nasopharyngeal lymphoepithelioma recurrent,1
43893,Malignant Cellular Infiltrate,mantle cell lymphoma of small intestine,1
43894,Carcinomatous Component Present,"Carcinoma, Basosquamous",1
43895,Fibrotic Stroma Formation,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
43896,Epithelial Component Present,Stage IIIA Breast Carcinoma,1
43897,Solitary mass,Sacral Chordoma,1
43898,Epithelial Component Present,Metastatic Oral Cavity Carcinoma,1
43899,Mitotic Activity,Chondroblastoma,1
43900,Carcinomatous Component Present,keratinizing squamous cell carcinoma of lung,1
43901,Indolent Clinical Course,Mediastinal Lymphangioma,1
43902,Carcinomatous Component Present,Carcinoma breast stage I,1
43903,Carcinomatous Component Present,Invasive Carcinoma,1
43904,Malignant Cellular Infiltrate,Childhood Ovarian Yolk Sac Tumor,1
43905,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm,1
43906,Malignant Cellular Infiltrate,Pilomatrix carcinoma of skin,1
43907,Epithelial Component Present,Epithelioma,1
43908,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma by ISS Stage,1
43909,Metastatic Lesion,Secondary malignant neoplasm of bone marrow,1
43910,Malignant Cellular Infiltrate,Locally Advanced Bile Duct Carcinoma,1
43911,Malignant Cellular Infiltrate,Carcinoma of subglottis,1
43912,Carcinomatous Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v7,1
43913,Epithelial Component Present,Renal medullary carcinoma,1
43914,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v8,1
43915,Primary Lesion,Primary Systemic Mastocytosis,1
43916,Epithelial Component Present,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
43917,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
43918,Carcinomatous Component Present,"Squamous Cell Carcinoma of the Penis, Usual Type",1
43919,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor,1
43920,Carcinomatous Component Present,Adenocarcinoma in situ in adenomatous polyp,1
43921,Neuroendocrine Differentiation,Stage I Merkel Cell Carcinoma AJCC v7,1
43922,Intraosseous Lesion,Granular cell ameloblastoma,1
43923,Refractory Disease,Refractory Undifferentiated Pleomorphic Sarcoma,1
43924,Malignant Cellular Infiltrate,Unresectable Ureter Urothelial Carcinoma,1
43925,Indolent Clinical Course,Bone island,1
43926,EBV-Positive Neoplastic Cells Present,Hydroa vacciniforme-like lymphoma,1
43927,Papillary Pattern,Papillary Ductal Breast Hyperplasia,1
43928,Peripheral Blood Involvement,Leukemic Nonnodal Mantle Cell Lymphoma,1
43929,Epithelial Component Present,Flat adenoma,1
43930,Mixed Cellular Population,Invasive Mixed Breast Carcinoma,1
43931,Carcinomatous Component Present,Stage I Hepatocellular Carcinoma AJCC v8,1
43932,Carcinomatous Component Present,Vulvar Cancer by AJCC v6 Stage,1
43933,Pathologic TNM Finding,Retinoblastoma by AJCC v8 Pathologic Stage,1
43934,Malignant Cellular Infiltrate,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant",1
43935,Carcinomatous Component Present,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
43936,Cutaneous Involvement,Mycosis fungoides stage III,1
43937,CD30-Positive Neoplastic Cells Present,alk-positive anaplastic large cell lymphoma,1
43938,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v8,1
43939,Follicular Cell Differentiation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
43940,Secondary Lesion,Locally Advanced Angiosarcoma,1
43941,Benign Cellular Infiltrate,Adrenal Cortical Adenoma,1
43942,Fibrotic Stroma Formation,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,1
43943,Malignant Cellular Infiltrate,Adult Acute Monoblastic and Monocytic Leukemia,1
43944,Malignant Cellular Infiltrate,Parotid Gland Sarcoma,1
43945,Malignant Cellular Infiltrate,Recurrent Paget Disease of the Anal Canal,1
43946,Epithelial Component Present,Squamous cell carcinoma of scrotum,1
43947,Rapidly Enlarging Mass,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
43948,Childhood Lesion,Childhood Brain Neoplasm,1
43949,Nuclear Molding,Small cell lung cancer recurrent,1
43950,Parakeratosis,Desmoplastic trichilemmoma,1
43951,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Small Cell Variant",1
43952,Malignant Cellular Infiltrate,Metastatic urothelial carcinoma,1
43953,Immunologic Deficiency Syndromes,Chronic Allograft Arteriopathy,1
43954,Nuclear Grooves,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
43955,Malignant Cellular Infiltrate,Prostate Acinar Adenocarcinoma,1
43956,Intestinal metaplasia,Vaginal Adenoma,1
43957,Epithelial Component Present,"Adenoma, Basal Cell",1
43958,Unresectable Mass,Unresectable Bone Sarcoma,1
43959,Malignant Cellular Infiltrate,Prostate Undifferentiated Carcinoma,1
43960,Recurrent disease,Recurrent Childhood Cerebellar Astrocytoma,1
43961,Malignant Cellular Infiltrate,Childhood Laryngeal Carcinoma,1
43962,Venous Type Vascular Channel Formation,Venous Angioleiomyoma,1
43963,Malignant Cellular Infiltrate,Non-Secretory Plasma Cell Myeloma,1
43964,Severe dysplasia,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
43965,Secondary Lesion,Treatment related acute myeloid leukaemia,1
43966,Microcystic Change,Protoplasmic astrocytoma,1
43967,Epithelial Component Present,Thymoma by AJCC v8 Stage,1
43968,Malignant Cellular Infiltrate,Stage II Anaplastic Large Cell Lymphoma,1
43969,Recurrent disease,Acute lymphoblastic leukemia recurrent,1
43970,Carcinomatous Component Present,Refractory Head and Neck Squamous Cell Carcinoma,1
43971,Malignant Cellular Infiltrate,ISS Stage I Plasma Cell Myeloma,1
43972,Malignant Cellular Infiltrate,Malignant hepatobiliary neoplasms,1
43973,Carcinomatous Component Present,Ceruminous adenocarcinoma,1
43974,Carcinomatous Component Present,Bladder Adenocarcinoma,1
43975,Epithelial Component Present,Multiple Endocrine Neoplasia Type 2b,1
43976,Favorable Clinical Outcome,Adrenal Gland Ganglioneuroma,1
43977,Carcinomatous Component Present,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
43978,Malignant Cellular Infiltrate,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,1
43979,Mixed Cellular Population,Cervical Adenofibroma,1
43980,Neuroendocrine Differentiation,Pancreatic Somatostatinoma,1
43981,Epithelial Component Present,Peripheral Breast Papilloma,1
43982,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v7,1
43983,Neuroectodermal Differentiation,Mediastinal Neuroblastoma,1
43984,Carcinomatous Component Present,Stage 0 Oropharyngeal Carcinoma,1
43985,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of extrahepatic bile duct,1
43986,Perivascular Arrangement of Tumor Cells,Glomus Tumor of Uncertain Malignant Potential,1
43987,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with Minimal Differentiation,1
43988,Osteoid formation,Extraskeletal osteosarcoma metastatic,1
43989,Epithelial Component Present,Esophageal Adenocarcinoma by AJCC v7 Stage,1
43990,Cellular Pleomorphism,Resectable Undifferentiated Pleomorphic Sarcoma,1
43991,Malignant Cellular Infiltrate,Familial medullary thyroid carcinoma,1
43992,Indolent Clinical Course,Bladder Leiomyoma,1
43993,Benign Cellular Infiltrate,Benign neoplasm of oropharynx,1
43994,Epithelial Component Present,Stage I Ovarian Cancer AJCC v8,1
43995,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v7,1
43996,Immunologic Deficiency Syndromes,Chronic graft-versus-host disease,1
43997,Extraosseous Lesion,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
43998,Low Grade Lesion,Childhood Parosteal Osteosarcoma,1
43999,Mixed Cellular Population,Borderline Ovarian Serous Adenofibroma,1
44000,Malignant Cellular Infiltrate,Stage A Chronic Lymphocytic Leukemia,1
44001,Carcinomatous Component Present,Barrett's Adenocarcinoma,1
44002,Diffuse Pattern,Central Nervous System Intravascular Large B-Cell Lymphoma,1
44003,Secondary Lesion,Secondary malignant neoplasm of prostate,1
44004,Lymphadenopathy,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
44005,Malignant Cellular Infiltrate,Clinical Stage IIA Cutaneous Melanoma AJCC v8,1
44006,Rarely Metastasizing Lesion,Composite hemangioendothelioma,1
44007,Malignant Cellular Infiltrate,Stage 0 Lip Carcinoma,1
44008,Malignant Cellular Infiltrate,Prognostic Stage IIIA Breast Cancer AJCC v8,1
44009,Therapy-Related Toxicity,Methotrexate-Associated Follicular Lymphoma,1
44010,Epithelial Component Present,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
44011,Antoni A Pattern,Jugular Foramen Schwannoma,1
44012,Epithelial Component Present,Human Papillomavirus-Related Cervical Carcinoma,1
44013,Epithelial Component Present,Endometrioid carcinoma of prostate,1
44014,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
44015,Biphasic Pattern,Cervical Atypical Polypoid Adenomyoma,1
44016,Malignant Cellular Infiltrate,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
44017,Epithelial Component Present,Metastatic Ductal Breast Carcinoma,1
44018,Malignant Cellular Infiltrate,Diencephalic Glioblastoma,1
44019,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
44020,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v8,1
44021,Malignant Cellular Infiltrate,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,1
44022,S-100-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
44023,Anaplasia,Cerebellar Glioblastoma,1
44024,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of lacrimal gland,1
44025,Epithelial Component Present,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
44026,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
44027,Severe cytologic atypia,large cell neuroendocrine carcinoma of appendix,1
44028,Epithelial Component Present,Bladder Papillary Clear Cell Adenocarcinoma,1
44029,Adulthood Lesion,Stage I Adult Hodgkin Lymphoma,1
44030,Malignant Cellular Infiltrate,Refractory B Acute Lymphoblastic Leukemia,1
44031,Benign Cellular Infiltrate,Squamous Papilloma of the Nasopharynx,1
44032,Epithelial Component Present,Carcinoma of upper gum,1
44033,Indolent Clinical Course,Cutaneous leiomyoma,1
44034,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
44035,Epithelial Component Present,"Carcinoma of urinary bladder, superficial",1
44036,Indolent Clinical Course,Lipomatosis of Nerve,1
44037,Epithelial Component Present,Vulvar Cancer by AJCC v7 Stage,1
44038,Epithelial Component Present,Skin Squamous Cell Carcinoma In Situ,1
44039,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
44040,Well-Circumscribed Lesion,villous adenoma of stomach,1
44041,Benign Cellular Infiltrate,Apocrine adenoma,1
44042,Epithelial Component Present,Recurrent Chromophobe Renal Cell Carcinoma,1
44043,Infiltrative Growth Pattern,"Fibromatosis, Abdominal",1
44044,Carcinomatous Component Present,Stage IVC Hypopharyngeal Carcinoma AJCC v7,1
44045,Malignant Cellular Infiltrate,Stage IV Kidney Wilms Tumor,1
44046,Local disease,Endobronchial lipoma,1
44047,Carcinomatous Component Present,Cervical Verrucous Carcinoma,1
44048,Low Mitotic Activity,Pancreatic Neuroendocrine Microadenoma,1
44049,Epithelial Component Present,Rectal Neuroendocrine Tumor,1
44050,Epithelial Component Present,Water-clear cell adenoma,1
44051,Malignant Cellular Infiltrate,Angiocentric lymphoma refractory,1
44052,No Evidence of Metastatic Disease,Benign Adrenal Gland Composite Pheochromocytoma,1
44053,Metastatic Lesion,Secondary malignant neoplasm of urethra,1
44054,Nodular lesions,Microfollicular adenoma,1
44055,Epithelial Component Present,Prostatic Duct Urothelial Carcinoma,1
44056,Malignant Cellular Infiltrate,Gastric Adenosquamous Carcinoma,1
44057,Epithelial Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7,1
44058,Epithelial Component Present,Stage IA Cervical Cancer AJCC v6 and v7,1
44059,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia with Eosinophilia,1
44060,Unresectable Mass,Unresectable Ewing Sarcoma,1
44061,Epithelial Component Present,Spindle Cell Oncocytoma of the Adenohypophysis,1
44062,Carcinomatous Component Present,mucinous adenocarcinoma of gallbladder,1
44063,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
44064,Dysplasia,Vaginal intraepithelial neoplasia grade 2,1
44065,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma,1
44066,No Identifiable Line of Differentiation,Malignant fibrous histiocytoma metastatic,1
44067,Organoid Pattern,Alveolar soft part sarcoma non-metastatic,1
44068,Recurrent disease,Recurrent Childhood Optic Nerve Astrocytoma,1
44069,Malignant Cellular Infiltrate,Extragonadal primary embryonal carcinoma,1
44070,Epithelial Component Present,Stage IB Lung Adenocarcinoma AJCC v7,1
44071,Papillary Pattern,Primary serous papillary carcinoma of peritoneum,1
44072,Invasive Lesion,Recurrent Prostate Acinar Adenocarcinoma,1
44073,Metastatic Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,1
44074,Epithelial Component Present,Parathyroid Gland Atypical Adenoma,1
44075,Hyperkeratosis,Upper Gingival Verrucous Carcinoma,1
44076,Carcinomatous Component Present,Stage II Vaginal Cancer AJCC v8,1
44077,Multilocular Lesion,Benign cystic nephroma,1
44078,Exophytic Polypoid Lesion,Polyp of maxillary sinus,1
44079,Epithelial Component Present,Gastric Mixed Adenocarcinoma,1
44080,Carcinomatous Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v7,1
44081,Carcinomatous Component Present,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
44082,Cavernous Vascular Space Formation,Cardiac Cavernous Hemangioma,1
44083,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
44084,Stromal Invasion,Stage IV Ovarian Cancer AJCC v8,1
44085,Neuroendocrine Differentiation,Pancreatic Large Cell Neuroendocrine Carcinoma,1
44086,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Viscera,1
44087,Misplaced Exocytosis Present,Sparsely Granulated Lactotroph Adenoma,1
44088,Malignant Cellular Infiltrate,Thymic Clear Cell Carcinoma,1
44089,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligoastrocytoma,1
44090,Malignant Cellular Infiltrate,Childhood Anaplastic Ependymoma,1
44091,Malignant Cellular Infiltrate,Digestive System Non-Hodgkin Lymphoma,1
44092,Malignant Cellular Infiltrate,Labia Minora Carcinoma,1
44093,Malignant Cellular Infiltrate,Malignant neoplasm of ureter,1
44094,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
44095,Malignant Cellular Infiltrate,Stage IB Soft Tissue Sarcoma AJCC v7,1
44096,Nodular Pattern,Skin Nodular Basal Cell Carcinoma,1
44097,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma,1
44098,Primary Lesion,Infratentorial Glioblastoma,1
44099,Carcinomatous Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v8,1
44100,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v7 Stage,1
44101,Carcinomatous Component Present,Transplant-Related Hepatocellular Carcinoma,1
44102,Secondary Lesion,Metastatic Human Papillomavirus-Related Malignant Neoplasm,1
44103,Benign Cellular Infiltrate,"Benign neoplasm of eye, unspecified",1
44104,Epithelial Component Present,Esophageal Well Differentiated Squamous Cell Carcinoma,1
44105,Benign Cellular Infiltrate,Ventricular myxoma,1
44106,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Bone,1
44107,Malignant Cellular Infiltrate,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma,1
44108,Adnexal Differentiation,Sebaceoma,1
44109,Malignant Cellular Infiltrate,Recurrent Pancreatic Cystadenocarcinoma,1
44110,Cystic Change,Testicular Dermoid Cyst,1
44111,Malignant Cellular Infiltrate,Askin's tumor,1
44112,Epithelial Component Present,Low Grade Broad Ligament Serous Adenocarcinoma,1
44113,Carcinomatous Component Present,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
44114,Epithelial Component Present,Stage IA Pancreatic Cancer AJCC v8,1
44115,Malignant Cellular Infiltrate,Recurrent Fallopian Tube Carcinoma,1
44116,Epithelial Component Present,Inflammatory Breast Carcinoma,1
44117,Endometrial Type Glands and Stroma Present,"Cervical Adenomyoma, Endometrial Type",1
44118,Carcinomatous Component Present,Localized Extrahepatic Bile Duct Carcinoma,1
44119,High Mitotic Activity,Childhood Embryonal Carcinoma,1
44120,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma,1
44121,Benign Cellular Infiltrate,Ectomesenchymal Chondromyxoid Tumor,1
44122,Single Cell Necrosis,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
44123,Benign Cellular Infiltrate,Benign neoplasm of bladder,1
44124,Cribriform Pattern,Cribriform Neuroepithelial Tumor,1
44125,Epithelial Component Present,Bladder adenocarcinoma stage I,1
44126,Cold Nodule,Thyroid Hyalinizing Trabecular Adenoma,1
44127,Malignant Cellular Infiltrate,Adenocarcinoma of duodenum,1
44128,Malignant Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v8,1
44129,Cutaneous Involvement,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
44130,Malignant Cellular Infiltrate,Stage III Anal Cancer AJCC v8,1
44131,Cutaneous Involvement,Dermatosis Papulosa Nigra,1
44132,Neuroendocrine Differentiation,Stage I Rectal Neuroendocrine Tumor AJCC v8,1
44133,Epithelial Component Present,Gastric Carcinoid Tumor,1
44134,More than 10 Mitoses per 10HPF,Small cell lung cancer recurrent,1
44135,Stromal Invasion,Ovarian Cystadenocarcinoma,1
44136,Glial Differentiation,Ganglioglioma,1
44137,Malignant Cellular Infiltrate,regressing melanoma of skin,1
44138,Malignant Cellular Infiltrate,Resectable Pancreatic Ductal Adenocarcinoma,1
44139,Malignant Cellular Infiltrate,"Medulloblastoma, SHH-Activated, TP53-Mutant",1
44140,Epithelial Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v7,1
44141,Malignant Cellular Infiltrate,Adenocarcinoma of lacrimal gland,1
44142,Tumor Vascular Invasion,malignant gastrinoma of pancreas,1
44143,Epithelial Component Present,Digestive System Small Cell Neuroendocrine Carcinoma,1
44144,Benign Cellular Infiltrate,Hemangioma of gingiva,1
44145,Epithelial Component Present,Ileal Neuroendocrine Tumor by AJCC v8 Stage,1
44146,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
44147,High Grade Lesion,Childhood Lung Small Cell Carcinoma,1
44148,Borderline Lesion,Borderline serous tumor of ovary,1
44149,Infiltrative Growth Pattern,Refractory Glioblastoma,1
44150,Indolent Clinical Course,Capillary hemangioma of eyelid,1
44151,Epithelial Component Present,Undifferentiated carcinoma of esophagus,1
44152,Malignant Cellular Infiltrate,Prostate Basal Cell Carcinoma,1
44153,Secondary Lesion,Metastatic gastric adenocarcinoma,1
44154,Serotonin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
44155,Metastatic Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
44156,Hereditary Lesion,Turcot Syndrome Type 1,1
44157,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
44158,Carcinomatous Component Present,Stage IIIA Penile Cancer AJCC v8,1
44159,Malignant Cellular Infiltrate,Alveolar soft part sarcoma non-metastatic,1
44160,Anaplasia,Giant Cell Glioblastoma,1
44161,Unresectable Mass,Unresectable Undifferentiated Pleomorphic Sarcoma,1
44162,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myeloid leukemia with abnormal marrow eosinophils,1
44163,Follicular Cell Differentiation,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
44164,Unresectable Mass,Unresectable Undifferentiated Pleomorphic Sarcoma,1
44165,Secondary Lesion,Secondary malignant neoplasm of larynx,1
44166,Biphasic Pattern,Vaginal Adenosarcoma,1
44167,Epithelial Component Present,Mild esophageal dysplasia,1
44168,Acinar Cell Differentiation,Recurrent Pancreatic Acinar Cell Carcinoma,1
44169,Secondary Lesion,Hormone refractory prostate cancer,1
44170,Spindle Cell Component Present,Metanephric stromal tumor,1
44171,Carcinomatous Component Present,Recurrent Lip and Oral Cavity Carcinoma,1
44172,Epithelial Component Present,Colorectal Neuroendocrine Tumor,1
44173,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
44174,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v7 Stage,1
44175,Epithelial Component Present,Refractory Anal Carcinoma,1
44176,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",1
44177,Carcinomatous Component Present,Esophageal squamous cell carcinoma recurrent,1
44178,Immunologic Deficiency Syndromes,AIDS-Related Herpes Zoster,1
44179,Mitotic Activity,"Testicular Yolk Sac Tumor, Myxomatous Pattern",1
44180,CD30-Positive Neoplastic Cells Present,"Anaplastic large cell lymphoma, ALK negative",1
44181,Carcinomatous Component Present,BCLC Stage B Adult Hepatocellular Carcinoma,1
44182,Childhood Lesion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
44183,Malignant Cellular Infiltrate,carcinoma ex pleomorphic adenoma of salivary gland,1
44184,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v8,1
44185,Papillary Pattern,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
44186,Cellular Stratification,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
44187,Alternative Fascicle (Bundle) Pattern,Intravenous leiomyomatosis,1
44188,Benign Cellular Infiltrate,Pelvic lipomatosis,1
44189,Carcinomatous Component Present,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
44190,Epithelial Component Present,Bartholin Gland Transitional Cell Carcinoma,1
44191,Malignant Cellular Infiltrate,Childhood Malignant Liver Neoplasm,1
44192,Hyperkeratosis,Cervical Verrucous Carcinoma,1
44193,Cartilaginous Differentiation,Chondrosarcoma recurrent,1
44194,Epithelial Component Present,Colorectal Cancer by AJCC v6 Stage,1
44195,Moderate dysplasia,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
44196,Exophytic Papillary Lesion,Verrucous carcinoma,1
44197,Myxoid Stroma Formation,Vulvar Superficial Angiomyxoma,1
44198,Squamous metaplasia of bladder,Bladder Urachal Squamous Cell Carcinoma,1
44199,Ventricular Involvement Only,Lateral Ventricle Ependymal Tumor,1
44200,Non-Hereditary Lesion,Sporadic Thyroid Gland Medullary Carcinoma,1
44201,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,1
44202,Cutaneous Involvement,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
44203,Vascular proliferation,Vulvar Cellular Angiofibroma,1
44204,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,1
44205,Chromogranin A Positive Neoplastic Cells Present,Meckel Diverticulum Neuroendocrine Tumor G1,1
44206,Stromal Invasion,Recurrent Ovarian Carcinosarcoma,1
44207,Epithelial Component Present,Atypical adenoma,1
44208,Malignant Cellular Infiltrate,Small cell osteosarcoma,1
44209,Epithelial Component Present,Anterior Tongue Carcinoma,1
44210,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
44211,Indolent Clinical Course,Solitary Osteochondroma,1
44212,Malignant Cellular Infiltrate,Hepatoblastoma recurrent,1
44213,Metastatic Lesion,Metastatic Kidney Carcinoma,1
44214,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",1
44215,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Childhood Ganglioneuroblastoma, Intermixed",1
44216,Perivascular Pseudorosette Formation,Adult Anaplastic Ependymoma,1
44217,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH,1
44218,Diffuse Pattern,"High Grade B-Cell Lymphoma, Not Otherwise Specified",1
44219,Primary Lesion,Giant Cell Glioblastoma,1
44220,Benign Cellular Infiltrate,Apocrine adenoma,1
44221,Secondary Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,1
44222,Carcinomatous Component Present,Stage I Esophageal Cancer,1
44223,Mixture of Embryonal and Alveolar Features Present,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
44224,Metastatic Lesion,Metastatic Neuroendocrine Neoplasm,1
44225,Metastatic Lesion,Pancreatic neuroendocrine tumor metastatic,1
44226,Peripheral Nuclear Palisading,Combined Lung Large Cell Neuroendocrine Carcinoma,1
44227,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
44228,Adulthood Lesion,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
44229,Malignant Cellular Infiltrate,basaloid carcinoma of penis,1
44230,Malignant Cellular Infiltrate,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
44231,Epithelial Component Present,Refractory Female Reproductive System Carcinoma,1
44232,Absence of Invasion,Adenoma of ampulla of Vater,1
44233,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia recurrent,1
44234,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma,1
44235,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myeloid leukemia with multilineage dysplasia,1
44236,Epithelial Component Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
44237,Malignant Cellular Infiltrate,Leiomyosarcoma of stomach,1
44238,Adulthood Lesion,Stage I Indolent Adult Non-Hodgkin Lymphoma,1
44239,Malignant Cellular Infiltrate,Malignant Lung PEComa,1
44240,Epithelial Component Present,Unresectable Digestive System Neuroendocrine Carcinoma,1
44241,Papillary Pattern,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
44242,Malignant Cellular Infiltrate,Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
44243,Pushing Tumor Margin,Subglottic Verrucous Carcinoma,1
44244,Metastatic Lesion,Metastatic Urethral Carcinoma,1
44245,Childhood Lesion,Hepatoblastoma recurrent,1
44246,Malignant Cellular Infiltrate,Adult Penile Carcinoma,1
44247,Indolent Clinical Course,Piloleiomyoma,1
44248,Multinodular Mass,Radiation-Related Angiosarcoma,1
44249,Perivascular Arrangement of Tumor Cells,Pulmonary lymphangioleiomyomatosis,1
44250,Epithelial Component Present,Stage I Adrenal Cortex Carcinoma AJCC v7,1
44251,High Mitotic Activity,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
44252,Malignant Cellular Infiltrate,Anatomic Stage 0 Breast Cancer AJCC v8,1
44253,Mitotic Activity,Anaplastic Hemispheric Astrocytoma,1
44254,Carcinomatous Component Present,Tubular breast carcinoma,1
44255,Malignant Cellular Infiltrate,Stage IV Uterine Sarcoma AJCC v7,1
44256,Malignant Cellular Infiltrate,Class 1a Uveal Melanoma,1
44257,Neuroectodermal Differentiation,malignant ganglioneuroblastoma of adrenal gland,1
44258,Neuronal Differentiation,Childhood Ganglioglioma,1
44259,Eosinophilic inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
44260,Cystic Change,Mucoepidermoid carcinoma of the oral cavity stage III,1
44261,Epithelial Component Present,Multifocal breast carcinoma,1
44262,Epithelial Component Present,Multicentric Thyroid Gland Papillary Carcinoma,1
44263,Malignant Cellular Infiltrate,Small Intestinal Undifferentiated Carcinoma,1
44264,Malignant Cellular Infiltrate,Liver carcinoma,1
44265,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Aleukemic Monocytic Leukemia Cutis,1
44266,Carcinomatous Component Present,Small Intestinal Mixed Adenoneuroendocrine Carcinoma,1
44267,Carcinomatous Component Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
44268,Resectable Mass,Resectable Carcinoma,1
44269,High Mitotic Activity,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
44270,Cutaneous Involvement,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8,1
44271,Carcinomatous Component Present,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant",1
44272,Cutaneous Involvement,Skin Squamous Cell Carcinoma In Situ,1
44273,Carcinomatous Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
44274,Epithelial Component Present,Malignant Ovarian Serous Tumor,1
44275,Well-Circumscribed Lesion,Gardner Syndrome,1
44276,High Mitotic Activity,Testicular embryonal carcinoma stage I,1
44277,Myxoid Stroma Formation,"Testicular Yolk Sac Tumor, Myxomatous Pattern",1
44278,Vascular Channel Formation,Thyroid Angiosarcoma,1
44279,Epithelial Component Present,Metastatic Parathyroid Gland Carcinoma,1
44280,Exophytic Polypoid Lesion,Ampulla of Vater Tubulovillous Adenoma,1
44281,Malignant Cellular Infiltrate,epithelial-myoepithelial carcinoma of salivary gland,1
44282,Epithelial Component Present,Metastatic Fibrolamellar Carcinoma,1
44283,Malignant Cellular Infiltrate,Splenic Lymphoblastic Lymphoma,1
44284,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
44285,Epithelial Component Present,Stage IIB Colon Cancer AJCC v7,1
44286,Non-Hereditary Lesion,Gastric Papillary Adenocarcinoma,1
44287,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma,1
44288,Rapidly Enlarging Mass,Botryoid-Type Embryonal Rhabdomyosarcoma,1
44289,Epithelial Component Present,"Oncocytoma, renal",1
44290,Mixed Cellular Population,Ovarian serous cystadenofibroma,1
44291,Malignant Cellular Infiltrate,Malignant tumor of pyriform fossa,1
44292,Malignant Cellular Infiltrate,Malignant tumor of eye,1
44293,Epithelial Component Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
44294,Benign Cellular Infiltrate,Neurothekeoma,1
44295,Metaplasia,Bladder squamous cell carcinoma stage 0,1
44296,Malignant Cellular Infiltrate,Locally Recurrent Malignant Neoplasm,1
44297,Malignant Cellular Infiltrate,Hydroa vacciniforme-like lymphoma,1
44298,Generalized illness,Letterer-Siwe Disease,1
44299,Epithelial Component Present,Sweat gland adenocarcinoma,1
44300,Unresectable Mass,Unresectable Skin Basal Cell Carcinoma,1
44301,Childhood Lesion,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
44302,Cystic Lesion,Papillary craniopharyngioma,1
44303,Malignant Cellular Infiltrate,Osteosarcoma of bone,1
44304,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
44305,Cutaneous Involvement,Recurrent Lip Basal Cell Carcinoma,1
44306,Refractory Disease,Refractory Barrett Esophagus,1
44307,Malignant Cellular Infiltrate,Stage 0 Uterine Corpus Cancer,1
44308,Epithelial Component Present,Pilomatrixoma,1
44309,Carcinomatous Component Present,"Carcinoma, Lobular",1
44310,Hemorrhagic,Mediastinal Angiosarcoma,1
44311,Epithelial Component Present,Intermediate Atypical Prostate Carcinoma,1
44312,Carcinomatous Component Present,NUT midline carcinoma,1
44313,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
44314,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma,1
44315,Benign Cellular Infiltrate,Squamous cell papilloma of eyelid,1
44316,Carcinomatous Component Present,Prolactin-Producing Pituitary Gland Carcinoma,1
44317,Schwannian Stroma Predominant Component of the Tumor Volume,Retroperitoneal Ganglioneuroma,1
44318,Benign Cellular Infiltrate,Desmoplastic trichilemmoma,1
44319,"Amorphus, Eosinophilic, and Acellular Deposit","Amyloidosis, Familial",1
44320,Epithelial Component Present,Luminal B Prostate Carcinoma,1
44321,Recurrent disease,Recurrent tumors of the Ewing's family,1
44322,Fibrotic Stroma Formation,Rete Ovarii Cystadenofibroma,1
44323,atypia morphology,Atypical hyperplasia,1
44324,Mild cytologic atypia,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
44325,Malignant Cellular Infiltrate,Asynchronous Multifocal Osteosarcoma,1
44326,Absence of Stromal Invasion,Borderline Fallopian Tube Mucinous Tumor,1
44327,Stromal Invasion,Malignant Ovarian Serous Tumor,1
44328,Erythema,Inflammatory carcinoma of breast stage III,1
44329,Malignant Cellular Infiltrate,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
44330,Adulthood Lesion,Adult Acute Monocytic Leukemia,1
44331,Carcinomatous Component Present,Fallopian Tube Carcinoma,1
44332,Cystic Change,Telangiectatic osteosarcoma,1
44333,Malignant Cellular Infiltrate,Mixed Ductal-Endocrine Carcinoma,1
44334,Cutaneous Involvement,Benign Outer Hair Sheath and Infundibulum Neoplasm,1
44335,Adulthood Lesion,Adult Medulloblastoma,1
44336,Well Differentiated Lesion,Anal Verrucous Carcinoma,1
44337,Adulthood Lesion,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
44338,Epithelial Component Present,Unresectable Digestive System Neuroendocrine Carcinoma,1
44339,Epithelial Component Present,Childhood Rectal Carcinoma,1
44340,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage III,1
44341,Vascular Channel Formation,Locally Advanced Epithelioid Hemangioendothelioma,1
44342,Tissue Differentiation Uncertain,Ventricular myxoma,1
44343,Malignant Cellular Infiltrate,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8",1
44344,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,1
44345,Malignant Cellular Infiltrate,ROSE Cluster 7,1
44346,Keratin pearl formation,External Ear Squamous Cell Carcinoma,1
44347,Epithelial Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
44348,Hereditary Lesion,Hereditary Melanoma,1
44349,Epithelial Component Present,Small intestine carcinoma recurrent,1
44350,Mild dysplasia,Vaginal intraepithelial neoplasia grade 1,1
44351,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Germinoma,1
44352,Absence of a Hormonal Syndrome,Non-Functioning Pituitary Gland Neoplasm,1
44353,Carcinomatous Component Present,Stage IV Eyelid Carcinoma AJCC v7,1
44354,Malignant Cellular Infiltrate,apocrine adenocarcinoma of vulva,1
44355,Malignant Cellular Infiltrate,Thymoma malignant noninvasive,1
44356,Melanin-Pigmented Dendritic Cells Present,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
44357,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma,1
44358,Epithelial Component Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,1
44359,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
44360,Epithelial Component Present,Squamous cell carcinoma of esophagus,1
44361,Benign Cellular Infiltrate,Lung Pleomorphic Adenoma,1
44362,Malignant Cellular Infiltrate,Epithelioid Sarcoma NCI Grade 2,1
44363,Malignant Cellular Infiltrate,Gastric Fundus Carcinoma,1
44364,Microcystic Change,Adult Subependymoma,1
44365,Adnexal Differentiation,Trichoadenoma,1
44366,'Starry-sky' pattern,Methotrexate-Associated Burkitt Lymphoma,1
44367,Malignant Cellular Infiltrate,Moderately Differentiated Prostate Adenocarcinoma,1
44368,Tubular Structures Present,Fetal Lung Adenocarcinoma,1
44369,Mixed Cellular Population,Malignant Parotid Gland Mixed Tumor,1
44370,Mesenchymal Differentiation,Childhood Gliosarcoma,1
44371,Adulthood Lesion,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
44372,More than 10 Mitoses per 10HPF,Platinum-Sensitive Lung Small Cell Carcinoma,1
44373,Epithelial Component Present,ACTH-producing pituitary tumor,1
44374,Malignant Cellular Infiltrate,sarcoma of larynx,1
44375,Malignant Cellular Infiltrate,Stage IV Adult Immunoblastic Lymphoma,1
44376,Necrotic changes (finding),large cell neuroendocrine carcinoma of anal canal,1
44377,Hemorrhagic,Radiation-Related Angiosarcoma,1
44378,Cutaneous Involvement,Stage 0 Merkel Cell Carcinoma AJCC v7,1
44379,Carcinomatous Component Present,Stage III Skin Cancer,1
44380,Epithelial Component Present,Stage III renal cell cancer,1
44381,Peripheral Nuclear Palisading,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
44382,Neuroendocrine Differentiation,Colon Neuroendocrine Neoplasm,1
44383,Neoplastic Plasma Cells Present in Bone Marrow,Plasma cell myeloma recurrent,1
44384,Secondary Lesion,Locally Advanced Small Intestinal Carcinoma,1
44385,Neuroendocrine Differentiation,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
44386,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts,1
44387,Indolent Clinical Course,Benign neoplasm of lymph vessels,1
44388,Myxoid Stroma Formation,Mediastinal Epithelioid Hemangioendothelioma,1
44389,Seminomatous Component Present,Mixed Germ Cell Tumor,1
44390,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Tumor,1
44391,Secondary Lesion,Stage IV Esophageal Adenocarcinoma,1
44392,Indolent Clinical Course,Endobronchial Leiomyoma,1
44393,Carcinomatous Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
44394,Childhood Lesion,Recurrent Childhood Central Nervous System Embryonal Neoplasm,1
44395,Epithelial Component Present,Ovarian mixed epithelial carcinoma,1
44396,Mixed Cellular Population,Breast Fibroepithelial Neoplasm,1
44397,Cutaneous Involvement,Nevus comedonicus,1
44398,Chromogranin A Positive Neoplastic Cells Present,Testicular Carcinoid Tumor,1
44399,Borderline Lesion,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
44400,Well-Circumscribed Lesion,Otic polyp,1
44401,Malignant Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
44402,Benign Cellular Infiltrate,Ancell-Spiegler cylindromas,1
44403,Secondary Lesion,Advanced Head and Neck Carcinoma,1
44404,Cutaneous Involvement,Telangiectatic Glomangioma,1
44405,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
44406,Duct-Like Structures Present,epithelial-myoepithelial carcinoma of salivary gland,1
44407,Carcinomatous Component Present,Laryngeal Cancer by AJCC v6 Stage,1
44408,Mixed Cellular Population,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
44409,Glandular Pattern,Lung Enteric Adenocarcinoma,1
44410,High Grade Lesion,Pleural Monophasic Synovial Sarcoma,1
44411,Neuroendocrine Differentiation,Sporadic Thyroid Gland Micromedullary Carcinoma,1
44412,Lytic lesion,Malignant Giant Cell Tumor of Bone,1
44413,High Mitotic Activity,Metastatic Bladder Small Cell Carcinoma,1
44414,Carcinomatous Component Present,Gastric Mixed Adenoneuroendocrine Carcinoma,1
44415,Exophytic Polypoid Lesion,Anal polyp,1
44416,Malignant Cellular Infiltrate,Secondary malignant neoplasm of liver,1
44417,Refractory Disease,Refractory Hairy Cell Leukemia,1
44418,Epithelioid Component Present,Cardiac Biphasic Synovial Sarcoma,1
44419,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v7,1
44420,Epithelial Component Present,epithelial-myoepithelial carcinoma of lung,1
44421,Cystic Change,Borderline Ovarian Clear Cell Cystadenofibroma,1
44422,Epithelial Component Present,Sporadic Breast Carcinoma,1
44423,In Situ Lesion,Carcinoma in situ of vagina,1
44424,Malignant Cellular Infiltrate,Grade 3 Endometrial Mucinous Adenocarcinoma,1
44425,Malignant Cellular Infiltrate,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
44426,Mixed Cellular Population,Infiltrating duct and lobular carcinoma,1
44427,Malignant Cellular Infiltrate,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
44428,Malignant Cellular Infiltrate,T-cell lymphoma refractory,1
44429,Childhood Lesion,Childhood Periosteal Osteosarcoma,1
44430,Non-Malignant Cellular Infiltrate,Benign Lymphoproliferative Disorder,1
44431,Malignant Cellular Infiltrate,Recurrent Childhood Liver Cancer,1
44432,Malignant Cellular Infiltrate,AJCC Grade 1 Sarcoma,1
44433,Invasive Lesion,atypical medullary carcinoma of breast,1
44434,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
44435,Intestinal metaplasia,"Adenocarcinoma, intestinal type",1
44436,Epithelial Component Present,Stage 0 Appendix Carcinoma AJCC v7,1
44437,Childhood Lesion,Stage I Childhood Anaplastic Large Cell Lymphoma,1
44438,Malignant Cellular Infiltrate,Classical Burkitt Lymphoma,1
44439,Epithelial Component Present,Stage I Anal Canal Cancer AJCC v6 and v7,1
44440,Epithelial Component Present,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
44441,Carcinomatous Component Present,Anatomic Stage IB Breast Cancer AJCC v8,1
44442,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Uterine Corpus Carcinosarcoma,1
44443,High Grade Lesion,"Liposarcoma, Pleomorphic",1
44444,Epithelial Component Present,Hidroacanthoma simplex,1
44445,Firm mass,Cervical Malignant Peripheral Nerve Sheath Tumor,1
44446,Malignant Cellular Infiltrate,"Transitional cell carcinoma, spindle cell",1
44447,Biphasic Pattern,Myofibromatosis,1
44448,Carcinomatous Component Present,Sporadic Diffuse Gastric Adenocarcinoma,1
44449,Preserved Nuclear Polarity,Ureter Urothelial Papilloma,1
44450,Malignant Cellular Infiltrate,Stage IV Prostate Cancer AJCC v8,1
44451,Carcinomatous Component Present,adenocarcinoma of gallbladder with squamous metaplasia,1
44452,Malignant Cellular Infiltrate,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
44453,Invasive Lesion,Growth Hormone-Producing Pituitary Gland Carcinoma,1
44454,Metastatic Lesion,Metastatic Colorectal Carcinoma,1
44455,Epithelial Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v7,1
44456,Neuroendocrine Differentiation,Gastric Large Cell Neuroendocrine Carcinoma,1
44457,Absence of a Hormonal Syndrome,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
44458,Secondary Lesion,Secondary malignant neoplasm of orbit,1
44459,Carcinomatous Component Present,Stage IIB Pancreatic Cancer AJCC v6 and v7,1
44460,Solitary mass,Clivus Chondroid Chordoma,1
44461,Rapidly Enlarging Mass,keratoacanthoma,1
44462,Malignant Cellular Infiltrate,Salivary Gland Oncocytic Carcinoma,1
44463,Epithelial Component Present,Refractory Endometrial Carcinoma,1
44464,Well-Circumscribed Lesion,Gastric Cronkhite Canada Polyposis,1
44465,Severe cytologic atypia,Gallbladder Neuroendocrine Carcinoma,1
44466,Epithelial Component Present,Bladder Enteric Type Adenocarcinoma,1
44467,Epithelial Component Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
44468,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II,1
44469,Benign Cellular Infiltrate,Papilloma,1
44470,Epithelial Component Present,Refractory Ovarian Carcinoma,1
44471,Metastatic Lesion,Advanced Kaposi Sarcoma,1
44472,Epithelial Component Present,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
44473,Tissue Differentiation Uncertain,Cardiac Monophasic Synovial Sarcoma,1
44474,Perineural spread,Adenoid cystic carcinoma of trachea,1
44475,Carcinomatous Component Present,Refractory Oral Cavity Squamous Cell Carcinoma,1
44476,Malignant Cellular Infiltrate,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
44477,Epithelial Component Present,Fallopian Tube Clear Cell Adenocarcinoma,1
44478,Indolent Clinical Course,Benign lipomatous tumor,1
44479,Neuronal Differentiation,Glioblastoma with Primitive Neuronal Component,1
44480,Epithelial Component Present,Metastatic Carcinoma,1
44481,Malignant Cellular Infiltrate,Cervical carcinoma stage II AJCC v7,1
44482,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of appendix,1
44483,Macule,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7,1
44484,Benign Cellular Infiltrate,Plexiform Schwannoma,1
44485,Carcinomatous Component Present,Stage III Nasopharyngeal Carcinoma AJCC v8,1
44486,Benign Cellular Infiltrate,Lung Squamous Cell Papilloma,1
44487,Benign Cellular Infiltrate,Benign neoplasm of kidney,1
44488,Stromal Invasion,Stage IA Ovarian Cancer,1
44489,Carcinomatous Component Present,Sweat gland adenocarcinoma,1
44490,Fibrotic Stroma Formation,Ovarian Microcystic Stromal Tumor,1
44491,Epithelial Component Present,Stage IIC Appendix Carcinoma AJCC v8,1
44492,Pathologic TNM Finding,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
44493,High Mitotic Activity,"Carcinoma, Small Cell",1
44494,Tissue Differentiation Uncertain,Lung Synovial Sarcoma,1
44495,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
44496,Pushing Tumor Margin,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
44497,Metastatic Lesion,Advanced Malignant Solid Neoplasm,1
44498,Alternative Fascicle (Bundle) Pattern,Appendix Leiomyoma,1
44499,Malignant Cellular Infiltrate,Blastic plasmacytoid dendritic cell neoplasm,1
44500,Carcinomatous Component Present,Parietal cell carcinoma,1
44501,Secondary Lesion,Locally Advanced Urothelial Carcinoma,1
44502,Hypercellular bone marrow,"Polycythemia Vera, Polycythemic Phase",1
44503,Epithelial Component Present,Benign Prostate Phyllodes Tumor,1
44504,Cystic Change,Dermoid Cyst,1
44505,Malignant Cellular Infiltrate,Unresectable Digestive System Neuroendocrine Carcinoma,1
44506,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
44507,Malignant Cellular Infiltrate,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
44508,Osseous Differentiation,Stage IIB Osteosarcoma AJCC v7,1
44509,Mitotic Activity,Anaplastic astrocytoma,1
44510,Epithelial Component Present,Adrenocortical carcinoma,1
44511,Cartilaginous Differentiation,Osteochondromyxoma,1
44512,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,1
44513,Malignant Cellular Infiltrate,Stage II Bone Sarcoma AJCC v7,1
44514,Malignant Cellular Infiltrate,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
44515,Carcinomatous Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
44516,Epithelial Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v8,1
44517,Epithelial Component Present,Carcinoid tumor of rectum,1
44518,Well Differentiated Lesion,Pleural Well Differentiated Papillary Mesothelioma,1
44519,Malignant Cellular Infiltrate,Recurrent Rectal Cancer,1
44520,Malignant Cellular Infiltrate,Grade 2 Colon Adenocarcinoma,1
44521,High Grade Lesion,Adult Synovial Sarcoma,1
44522,Metastatic Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
44523,Malignant Cellular Infiltrate,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
44524,Mixed Cellular Population,Ovarian Seromucinous Adenofibroma,1
44525,Recurrent disease,Recurrent Lip and Oral Cavity Carcinoma,1
44526,Refractory Disease,Refractory Malignant Skin Neoplasm,1
44527,Epithelial Component Present,Prostate Carcinoma Metastatic in the Bone,1
44528,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v7,1
44529,Hyperplastic Tissue Present,Islet Glucagon Cell Hyperplasia,1
44530,Malignant Cellular Infiltrate,Large cell lung cancer stage II,1
44531,High Mitotic Activity,Adult Anaplastic Ependymoma,1
44532,Epithelial Component Present,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
44533,Poorly Differentiated Lesion,Stage IB Lung Large Cell Carcinoma AJCC v7,1
44534,Carcinomatous Component Present,Stage IIA Lung Large Cell Carcinoma AJCC v7,1
44535,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(11;17)(q13;q21),1
44536,Multifocal Lesion,Multiple Endocrine Neoplasia,1
44537,Necrotic changes (finding),Small cell carcinoma of prostate,1
44538,Cutaneous Involvement,Solar Radiation-Related Cutaneous Melanoma,1
44539,Carcinomatous Component Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",1
44540,Villous Pattern,Ampulla of Vater Villous Adenoma,1
44541,Cutaneous Involvement,Refractory Cutaneous Melanoma,1
44542,Mitotic Activity,Recurrent Childhood Glioblastoma,1
44543,Nuclear pleomorphism,Uterine Corpus Bizarre Leiomyoma,1
44544,Benign Cellular Infiltrate,Gardner Fibroma,1
44545,Carcinomatous Component Present,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
44546,Metastatic Lesion,Advanced Cervical Adenocarcinoma,1
44547,Epithelial Component Present,Stage I Pancreatic Cancer AJCC v8,1
44548,Carcinomatous Component Present,Stage IA Lung Squamous Cell Carcinoma AJCC v7,1
44549,Epithelial Component Present,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
44550,Cutaneous Involvement,Dermatofibrosarcoma Protuberans,1
44551,Cystic Change,"Serous cystadenoma, borderline malignancy",1
44552,Well Differentiated Neuroendocrine Lesion,Gastrointestinal Carcinoid Tumor,1
44553,Epithelial Component Present,Locally Advanced Prostate Carcinoma,1
44554,Tissue Differentiation Uncertain,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
44555,Malignant Cellular Infiltrate,Distal Bile Duct Cancer by AJCC v7 Stage,1
44556,Carcinomatous Component Present,Stage III Urethral Cancer AJCC v7,1
44557,Non-Malignant Cellular Infiltrate,Chronic lymphadenitis,1
44558,Collagenous Stroma Formation,Breast Myofibroblastoma,1
44559,Dysplasia,Biliary Intraepithelial Neoplasia-3,1
44560,Epithelial Component Present,Malignant Thymoma,1
44561,Hereditary Lesion,Short Limb Dwarfism-Saddle Nose-Spinal Alterations-Metaphyseal Striation Syndrome,1
44562,Aggressive Clinical Course,Refractory High Risk Myelodysplastic Syndrome,1
44563,Refractory Disease,Waldenstrom's macroglobulinemia refractory,1
44564,Epithelial Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
44565,Carcinomatous Component Present,Stage IV Renal Cell Cancer AJCC v8,1
44566,Benign Cellular Infiltrate,Benign neoplasm of mesothelial tissue of pleura,1
44567,Indolent Clinical Course,lipoma of bone,1
44568,Carcinomatous Component Present,Appendix Carcinoma by AJCC v7 Stage,1
44569,Metastatic Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
44570,Secondary Lesion,Metastatic Cervical Adenosquamous Carcinoma,1
44571,Adnexal Differentiation,Vulvar Nodular Hidradenoma,1
44572,Glomerular Hypertrophy,Primary Focal Segmental Glomerulosclerosis,1
44573,Malignant Cellular Infiltrate,Hereditary Kidney Wilms Tumor,1
44574,Carcinomatous Component Present,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7,1
44575,Chromogranin A Positive Neoplastic Cells Present,Childhood Carcinoid Tumor,1
44576,Malignant Cellular Infiltrate,small cell carcinoma of gallbladder,1
44577,Monomorphic Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,1
44578,Favorable Clinical Outcome,"lymphomatoid papulosis, type C",1
44579,Carcinomatous Component Present,"Adenocarcinoma, metastatic",1
44580,Malignant Cellular Infiltrate,Refractory anemia with excess blasts II,1
44581,Benign Cellular Infiltrate,Inner Ear Lipoma,1
44582,Malignant Cellular Infiltrate,Nodulo-ulcerative basal cell carcinoma,1
44583,Carcinomatous Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
44584,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v8,1
44585,Epithelial Component Present,Common wart,1
44586,Epithelial Component Present,Cervical carcinoma stage II AJCC v7,1
44587,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
44588,Epithelial Component Present,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,1
44589,Non-Invasive Lesion,Ampulla of Vater Tubulovillous Adenoma,1
44590,Monomorphic Cellular Infiltrate,Well Differentiated Oligodendroglioma,1
44591,Malignant Cellular Infiltrate,Clinical Stage IVA Gastric Cancer AJCC v8,1
44592,Low Mitotic Activity,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,1
44593,Carcinomatous Component Present,Cervical Cancer by AJCC v7 Stage,1
44594,Hyperkeratosis,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
44595,Epithelial Component Present,Stage III Bladder Cancer AJCC v6 and v7,1
44596,Malignant Cellular Infiltrate,Stage I Adult Lymphoblastic Lymphoma,1
44597,Malignant Cellular Infiltrate,Stage IIB Prostate Cancer AJCC v7,1
44598,Malignant Primitive Cellular Infiltrate,Endodermal sinus tumor of ovary,1
44599,Tubular Pattern,"Testicular Seminoma, Tubular Variant",1
44600,High Mitotic Activity,Childhood Embryonal Carcinoma,1
44601,Less than 2 Mitoses per 10HPF,Lung Typical Carcinoid Tumor,1
44602,Fibrotic Stroma Formation,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
44603,Nested Pattern,Adult Clear Cell Sarcoma of Soft Parts,1
44604,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
44605,Diffuse Lesion,"Retinoblastoma, diffuse",1
44606,Epithelial Component Present,Eccrine hidrocystoma,1
44607,Diffuse Pattern,Childhood Immunoblastic Lymphoma,1
44608,Cartilaginous Differentiation,Chondrosarcoma recurrent,1
44609,Childhood Lesion,Childhood Subependymal Giant Cell Astrocytoma,1
44610,Absence of Stromal Invasion,Borderline Fallopian Tube Mucinous Tumor,1
44611,Nodular Pattern,Ann Arbor Stage IV Grade 1 Follicular Lymphoma,1
44612,Benign Cellular Infiltrate,Benign neoplasm of neck,1
44613,Neuroendocrine Differentiation,Meckel Diverticulum Neuroendocrine Tumor G1,1
44614,Malignant Cellular Infiltrate,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,1
44615,Mesenchymal Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
44616,Metastatic Lesion,Metastatic Triple-Negative Breast Carcinoma,1
44617,Mesenchymal Component Present,Nephrogenic adenofibroma,1
44618,Neuroendocrine Differentiation,Pituitary Gland Paraganglioma,1
44619,Adulthood Lesion,BCLC Stage D Adult Hepatocellular Carcinoma,1
44620,Fibrotic Stroma Formation,Fallopian Tube Serous Adenofibroma,1
44621,Benign Cellular Infiltrate,Vulvar Angiomyofibroblastoma,1
44622,Refractory Disease,Refractory Malignant Central Nervous System Neoplasm,1
44623,Benign Cellular Infiltrate,Cervical Atypical Polypoid Adenomyoma,1
44624,Epithelial Component Present,"Pheochromocytoma, Extra-Adrenal",1
44625,Secondary Lesion,Locally Advanced Basal Cell Carcinoma,1
44626,Epithelial Component Present,Primary Peritoneal High Grade Serous Adenocarcinoma,1
44627,Necrotic changes (finding),Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
44628,Bone Marrow Involvement,Familial Waldenstrom's Macroglobulinaemia,1
44629,Malignant Cellular Infiltrate,Splenic marginal zone lymphoma refractory,1
44630,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with excess blasts II,1
44631,Infiltrative Growth Pattern,Adult Glioblastoma,1
44632,Carcinomatous Component Present,Small Intestinal Mucinous Adenocarcinoma,1
44633,Two Separate Tumor Masses Present in the Same Organ,Pituitary Gland Double Adenomas,1
44634,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
44635,Papillary Pattern,Sphenoid Sinus Inverted Papilloma,1
44636,Dysplasia,High Grade Esophageal Squamous Intraepithelial Neoplasia,1
44637,Epithelial Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
44638,Diffuse Pattern,Activated B-cell type diffuse large B-cell lymphoma,1
44639,Fibrotic Stroma Formation,Locally Advanced Pancreatic Ductal Adenocarcinoma,1
44640,Malignant Cellular Infiltrate,Metastatic Hypopharyngeal Carcinoma,1
44641,Epithelial Component Present,Stage IV Small Intestinal Adenocarcinoma AJCC v8,1
44642,Epithelial Component Present,Stage IV Laryngeal Carcinoma,1
44643,Metastatic/Recurrent Disease,Adult Clear Cell Sarcoma of Soft Parts,1
44644,Limited Early T-Cell Differentiation,Early T Acute Lymphoblastic Leukemia,1
44645,Malignant Cellular Infiltrate,Malignant tumor of lacrimal gland,1
44646,Epithelial Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",1
44647,Progressive Clinical Course,mu-Chain Disease,1
44648,Exophytic Polypoid Lesion,Small Intestinal Tubulovillous Adenoma,1
44649,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Basophilic Leukemia,1
44650,Vascular Channel Formation,Parotid Gland Hemangioma,1
44651,Papillary Pattern,Stage 0a Bladder Cancer AJCC v8,1
44652,Biphasic Pattern,Borderline Ovarian Clear Cell Adenofibroma,1
44653,Pushing Tumor Margin,"Phyllodes tumor, benign",1
44654,Thick-Walled Hyalinized Vessels Present,Gastric Schwannoma,1
44655,Peripheral Nuclear Palisading,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
44656,Malignant Cellular Infiltrate,Stage IB Distal Bile Duct Cancer AJCC v7,1
44657,Malignant Cellular Infiltrate,Adult Penile Carcinoma,1
44658,Malignant Cellular Infiltrate,Refractory Rhabdomyosarcoma,1
44659,Hyperplastic Tissue Present,Basal cell hyperplasia,1
44660,Refractory Disease,Refractory Malignant Endocrine Neoplasm,1
44661,Local disease,Pleomorphic Lipoma,1
44662,Malignant Cellular Infiltrate,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
44663,Antoni A Pattern,Gastric Schwannoma,1
44664,Epithelial Component Present,Stage I Vulvar Carcinoma,1
44665,Pseudoencapsulated Mass,Low Grade Malignant Peripheral Nerve Sheath Tumor,1
44666,Malignant Cellular Infiltrate,Stage III Oral Cavity Cancer AJCC v6 and v7,1
44667,Dermal Involvement,Vaginal Blue Nevus,1
44668,Benign Cellular Infiltrate,Benign Gastric Granular Cell Tumor,1
44669,Primary Lesion,Brain Stem Intraparenchymal Clear Cell Meningioma,1
44670,Benign Cellular Infiltrate,Myxoma,1
44671,Epithelial Component Present,Preinvasive Neoplasm of the Ampullary Region,1
44672,Carcinomatous Component Present,Stage IIIA Anal Cancer AJCC v8,1
44673,Thyroglobulin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Papillary Carcinoma,1
44674,Monophasic Pattern,Pleural Monophasic Synovial Sarcoma,1
44675,Diffuse Pattern,Adult Grade III Lymphomatoid Granulomatosis,1
44676,Epithelial Component Present,Condylomata Acuminata,1
44677,Angiodestructive Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
44678,Malignant Cellular Infiltrate,Endometrial Stromal Sarcoma,1
44679,Epithelial Component Present,Stage IV Laryngeal Carcinoma,1
44680,Benign Cellular Infiltrate,Benign mixed epithelial and stromal tumor of kidney,1
44681,Biphasic Pattern,Juvenile fibroadenoma of breast,1
44682,Adulthood Lesion,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
44683,Lymphatic Spread,Lymphangitis carcinomatosa,1
44684,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Bone,1
44685,Unfavorable Clinical Outcome,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
44686,Non-Invasive Lesion,Stage 0a Ureter Cancer AJCC v7,1
44687,Mixed Cellular Population,Ovarian Wilms Tumor,1
44688,Carcinomatous Component Present,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
44689,Childhood Lesion,Mixed Hepatoblastoma with Teratoid Features,1
44690,Epithelial Component Present,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
44691,Fibrous Septa Present,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
44692,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v6,1
44693,Antoni A Pattern,Benign Dermal Schwannoma,1
44694,Epithelial Component Present,Stage IV Renal Cell Cancer AJCC v8,1
44695,Epithelial Component Present,Appendix Carcinoma by AJCC v7 Stage,1
44696,High Grade Lesion,Classical Glioblastoma,1
44697,Solitary mass,Metastatic Epithelioid Hemangioendothelioma,1
44698,Benign Cellular Infiltrate,Vulvar Syringoma,1
44699,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v8,1
44700,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v7,1
44701,Well-Circumscribed Lesion,Multiple polyps,1
44702,Malignant Cellular Infiltrate,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8,1
44703,Metastatic Lesion,Meningeal Carcinomatosis,1
44704,Neuroendocrine Differentiation,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
44705,Severe cytologic atypia,Digestive System Neuroendocrine Carcinoma,1
44706,Benign Cellular Infiltrate,Mucinous adenofibroma,1
44707,Epithelial Component Present,Intraductal Non-Comedo Breast Adenocarcinoma,1
44708,Mixed Cellular Population,Malignant Phyllodes Tumor of Prostate,1
44709,Non-Contiguous Disease,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
44710,Carcinomatous Component Present,Sporadic Thyroid Gland Micromedullary Carcinoma,1
44711,Malignant Cellular Infiltrate,Stage IIIA Colon Cancer AJCC v8,1
44712,Metastatic Lesion,Chondrosarcoma metastatic,1
44713,Increased Cellularity Present,olfactory neuroblastoma of nasal cavity,1
44714,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
44715,Epithelial Component Present,Adenocarcinoma of the prostate metastatic,1
44716,Benign Cellular Infiltrate,Pericardial Leiomyoma,1
44717,High Mitotic Activity,Malignant medulloepithelioma of ciliary body,1
44718,Capsular Invasion,"Thymoma, type B2, malignant",1
44719,Malignant Cellular Infiltrate,Recurrent T-Cell Prolymphocytic Leukemia,1
44720,Angiodestructive Pattern,Childhood Grade III Lymphomatoid Granulomatosis,1
44721,Malignant Cellular Infiltrate,Malignant tenosynovial giant cell tumor,1
44722,Malignant Cellular Infiltrate,Recurrent Acute Monoblastic and Monocytic Leukemia,1
44723,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
44724,Necrotic changes (finding),"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
44725,Invasive Lesion,Widely Invasive Thymoma,1
44726,Refractory Disease,Refractory Digestive System Carcinoma,1
44727,Lobular Pattern,Trichilemmocarcinoma,1
44728,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
44729,Epithelial Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
44730,Primary Site Unknown,Carcinoma of unknown primary,1
44731,Benign Cellular Infiltrate,Microcystic/Reticular Schwannoma,1
44732,Embryoid Bodies Present,polyembryoma of testis,1
44733,Malignant Cellular Infiltrate,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
44734,Epithelial Component Present,Stage IIIA Colorectal Cancer AJCC v8,1
44735,Malignant Cellular Infiltrate,Malignant Thymoma,1
44736,Carcinomatous Component Present,Stage IA Ovarian Cancer,1
44737,Malignant Cellular Infiltrate,Barrett's Adenocarcinoma,1
44738,Peripheral Nuclear Palisading,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
44739,Epithelial Component Present,Vaginal Squamous Papilloma,1
44740,Well Differentiated Lesion,Well Differentiated Ovarian Steroid Cell Tumor,1
44741,Clear Perinuclear Halo Present,Cellular Ependymoma,1
44742,Carcinomatous Component Present,Stage IIB Rectal Cancer AJCC v8,1
44743,Osseous Differentiation,Central Nervous System Extraskeletal Osteosarcoma,1
44744,Epithelial Component Present,Platinum-Resistant Urothelial Carcinoma,1
44745,Malignant Cellular Infiltrate,Malignant neoplasm of submandibular gland,1
44746,Cutaneous Involvement,Verrucous epidermal nevus,1
44747,Malignant Cellular Infiltrate,Adenocarcinoma of rectum,1
44748,Malignant Cellular Infiltrate,Recurrent Extranodal Diffuse Large B-cell Lymphoma,1
44749,Carcinomatous Component Present,Gallbladder Carcinoma,1
44750,"Fully Differentiated ""Adult-Type"" Tissues Present",Adult Central Nervous System Mature Teratoma,1
44751,Lymphoplasmacytic Infiltrate,Cervical Lymphoepithelioma-Like Carcinoma,1
44752,Cutaneous Involvement,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
44753,Malignant Cellular Infiltrate,Ann Arbor Stage II Mantle Cell Lymphoma,1
44754,Recurrent disease,Recurrent Childhood Oligoastrocytoma,1
44755,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
44756,Epithelial Component Present,Recurrent Endometrial Mixed Cell Adenocarcinoma,1
44757,Malignant Cellular Infiltrate,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,1
44758,Below the Diaphragm Disease,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb,1
44759,Metastatic Lesion,Squamous Cell Carcinoma of Unknown Primary,1
44760,Cutaneous Involvement,Actinic keratosis,1
44761,Malignant Cellular Infiltrate,signet ring cell carcinoma of breast,1
44762,Childhood Lesion,Childhood Anaplastic Oligoastrocytoma,1
44763,Epithelial Component Present,Sebaceoma,1
44764,Osseous Differentiation,Osteoma of skull,1
44765,Malignant Cellular Infiltrate,Stage I Pancreatic Cancer AJCC v8,1
44766,Carcinomatous Component Present,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
44767,Exophytic Papillary Lesion,Vulvar Warty Carcinoma,1
44768,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma,1
44769,HMB-45-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, benign",1
44770,Cystic Change,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,1
44771,Cystic Change,Seminal Vesicle Cystadenoma,1
44772,Microglandular Pattern,Cervical Microglandular Polyp,1
44773,Epithelial Component Present,Stage IVA Hepatocellular Carcinoma AJCC v7,1
44774,Carcinomatous Component Present,Stage IIIA Eyelid Carcinoma AJCC v8,1
44775,Mild cytologic atypia,Buccal Mucosa Verrucous Carcinoma,1
44776,Secondary Lesion,Stage IV adult soft tissue sarcoma,1
44777,In Situ Lesion,Bladder squamous cell carcinoma stage 0,1
44778,Carcinomatous Component Present,Clear cell squamous cell carcinoma of skin,1
44779,Carcinomatous Component Present,Stage III Esophageal Cancer AJCC v7,1
44780,Increased Cellularity Present,Familial Neuroblastoma,1
44781,Severe cytologic atypia,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
44782,Epithelial Component Present,Gastric Cancer by AJCC v8 Stage,1
44783,Infiltrative Growth Pattern,Recurrent Childhood Gemistocytic Astrocytoma,1
44784,Epithelial Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
44785,Mixed Cellular Population,Fallopian Tube Adenosarcoma,1
44786,Malignant Cellular Infiltrate,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,1
44787,Epithelial Component Present,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
44788,Malignant Cellular Infiltrate,Non-Resectable Malignant Liver Neoplasm,1
44789,Refractory Disease,Refractory Lung Carcinoma,1
44790,Malignant Cellular Infiltrate,Indolent multiple myeloma,1
44791,Diffuse Pattern,Childhood Glioblastoma,1
44792,Infiltrative Growth Pattern,Childhood Cerebellar Anaplastic Astrocytoma,1
44793,Epithelial Component Present,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
44794,Malignant Cellular Infiltrate,Primary Prostate Urothelial Carcinoma,1
44795,Primary Lesion,Recurrent Glioblastoma,1
44796,Ineffective hematopoiesis,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
44797,Malignant Cellular Infiltrate,Kaposi Sarcoma Related to Immunosuppressive Treatment,1
44798,Tissue of Mullerian Origin Present,Cystadenofibroma,1
44799,Stromal Invasion,Stage IV Ovarian Carcinoma,1
44800,Epithelial Component Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
44801,Mixture of Germ Cell Neoplastic Components Present,Teratocarcinoma,1
44802,Epithelial Component Present,Liver carcinoma,1
44803,Neuroendocrine Differentiation,Digestive System Neuroendocrine Neoplasm,1
44804,Epithelial Component Present,Recurrent Merkel Cell Carcinoma,1
44805,Malignant Cellular Infiltrate,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
44806,Secondary Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
44807,Indolent Clinical Course,Ectopic hamartomatous thymoma,1
44808,Primary Lesion,Primary Peritoneal Cancer by AJCC v7 Stage,1
44809,Follicular Cell Differentiation,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
44810,Malignant Cellular Infiltrate,Recurrent Hairy Cell Leukemia,1
44811,Epithelial Component Present,Stage I Major Salivary Gland Cancer AJCC v8,1
44812,Indolent Clinical Course,Leiomyoma of lung,1
44813,Epithelial Component Present,mucinous adenocarcinoma of lung,1
44814,Metaplasia,Metastatic Bladder Squamous Cell Carcinoma,1
44815,Malignant Cellular Infiltrate,Malignant neoplasm of spleen,1
44816,Well-Circumscribed Lesion,Vulvar Cellular Angiofibroma,1
44817,Intraluminal Tumor Growth,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,1
44818,atypia morphology,Malignant Testicular Leydig Cell Tumor,1
44819,Chromogranin A Positive Neoplastic Cells Present,Carcinoid Tumor,1
44820,Malignant Cellular Infiltrate,Squamous cell carcinoma of prostate,1
44821,Neuroendocrine Differentiation,Urinary System Paraganglioma,1
44822,Extraosseous Lesion,Extra-osseous Ewing's sarcoma non-metastatic,1
44823,Malignant Cellular Infiltrate,Metastatic Epithelioid Hemangioendothelioma,1
44824,Carcinomatous Component Present,Ureter Cancer by AJCC v8 Stage,1
44825,Diffuse Pattern,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
44826,Malignant Cellular Infiltrate,Malignant nipple neoplasm male,1
44827,Malignant Cellular Infiltrate,"Perineurioma, malignant",1
44828,Aggressive Clinical Course,undifferentiated sarcoma of ovary,1
44829,Painless Mass,Mediastinal Chondroma,1
44830,Exophytic Polypoid Lesion,tubular adenoma of gallbladder,1
44831,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Squamous Cell Carcinoma,1
44832,Malignant Cellular Infiltrate,rhabdomyosarcoma of mediastinum,1
44833,Malignant Cellular Infiltrate,Gonadal Polyembryoma,1
44834,Malignant Cellular Infiltrate,Stage III Adult Lymphoblastic Lymphoma,1
44835,Mild dysplasia,Low Grade Cervical Squamous Intraepithelial Neoplasia,1
44836,Epithelial Component Present,"Oncocytoma, renal",1
44837,Perivascular Arrangement of Tumor Cells,Solitary Myofibromatosis,1
44838,Malignant Cellular Infiltrate,Central Nervous System Leiomyosarcoma,1
44839,Diffuse Pattern,Lymphohistiocytoid Mesothelioma,1
44840,Absence of Stromal Invasion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
44841,Adulthood Lesion,Adult Diffuse Large B-Cell Lymphoma,1
44842,Locally Aggressive Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,1
44843,Myxoid Stroma Formation,Uterine Corpus Myxoid Leiomyoma,1
44844,Apocrine Differentiation,Apocrine adenoma,1
44845,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myeloid Leukemia with Minimal Differentiation,1
44846,Malignant Cellular Infiltrate,Unresectable Extrahepatic Bile Duct Carcinoma,1
44847,Refractory Disease,Refractory Acute Leukemia,1
44848,Malignant Cellular Infiltrate,Stage II Small Intestinal Adenocarcinoma AJCC v8,1
44849,Secondary Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
44850,Carcinomatous Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7,1
44851,Malignant Cellular Infiltrate,Metastatic Renal Pelvis Urothelial Carcinoma,1
44852,Carcinomatous Component Present,Bladder Urachal Urothelial Carcinoma,1
44853,Borderline Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
44854,Tumor Droplets Present,Adenoameloblastoma,1
44855,Low Mitotic Activity,Gastro-enteropancreatic neuroendocrine tumor,1
44856,Malignant Cellular Infiltrate,B-cell lymphoma stage II,1
44857,Malignant Cellular Infiltrate,Childhood Burkitt Lymphoma,1
44858,Malignant Cellular Infiltrate,Metastatic Rectal Carcinoma,1
44859,Papillary Pattern,Intraductal papillomatosis,1
44860,Malignant Cellular Infiltrate,Stage IVC Pharyngeal Carcinoma,1
44861,Adulthood Lesion,Hodgkin Lymphoma During Pregnancy,1
44862,Epithelial Component Present,Cervical Squamous Intraepithelial Neoplasia,1
44863,Well-Circumscribed Lesion,Giant Fibrovascular Esophageal Polyp,1
44864,Epithelial Component Present,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
44865,Malignant Cellular Infiltrate,Stage 0 Vulvar Carcinoma,1
44866,Vascular Channel Formation,Pyogenic granuloma of skin and subcutaneous tissue,1
44867,Carcinomatous Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
44868,Epithelial Component Present,Recurrent Endometrial Mixed Cell Adenocarcinoma,1
44869,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,1
44870,Epithelial Component Present,Appendix High Grade Intraepithelial Neoplasia,1
44871,Epithelial Component Present,Cervical Cancer by AJCC v7 Stage,1
44872,Low Mitotic Activity,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,1
44873,Above the Diaphragm Disease,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma,1
44874,Malignant Cellular Infiltrate,Stage I Diffuse Large B-Cell Lymphoma,1
44875,Malignant Cellular Infiltrate,Secondary Central Nervous System Lymphoma,1
44876,Malignant Cellular Infiltrate,Childhood Hodgkin Lymphoma by Ann Arbor Stage,1
44877,Malignant Cellular Infiltrate,AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation,1
44878,Tissue Differentiation Uncertain,Follicular Myxoma,1
44879,Malignant Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v7,1
44880,Nuclear Atypia,Giant Cell Glioblastoma,1
44881,Epithelial Component Present,Pathologic Stage III Gastric Cancer AJCC v8,1
44882,Epithelial Component Present,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
44883,Biphasic Pattern,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
44884,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v8,1
44885,Epithelial Component Present,Minor Salivary Gland Small Cell Carcinoma,1
44886,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Tumor G1,1
44887,Epithelial Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,1
44888,Unicystic Lesion,intraductal papilloma of salivary gland,1
44889,Malignant Cellular Infiltrate,Refractory Hepatosplenic T-Cell Lymphoma,1
44890,Secondary Lesion,Squamous Cell Carcinoma of Unknown Primary,1
44891,Epithelial Component Present,Colorectal Low Grade Intraepithelial Neoplasia,1
44892,Metastatic Lesion,Metastatic Lung Carcinoma,1
44893,Stromal Invasion,Recurrent Malignant Ovarian Transitional Cell Tumor,1
44894,Childhood Lesion,Recurrent Childhood Oligodendroglioma,1
44895,Childhood Lesion,Recurrent Childhood Glioblastoma,1
44896,Tissue Differentiation Uncertain,Vulvar Alveolar Soft Part Sarcoma,1
44897,Storiform Growth Pattern,Refractory Undifferentiated Pleomorphic Sarcoma,1
44898,Primary Lesion,Hepatitis C Virus-Related Hepatocellular Carcinoma,1
44899,Non-Hereditary Lesion,Sporadic Retinoblastoma,1
44900,Epithelial Component Present,Oncocytic Schneiderian papilloma,1
44901,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell",1
44902,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pancreas,1
44903,Carcinomatous Component Present,FIGO Stage IIIB Ovarian Cancer,1
44904,Fibrotic Stroma Formation,Fibrolipoma,1
44905,Carcinomatous Component Present,Breast Cancer by AJCC v8 Anatomic Stage,1
44906,Epithelial Component Present,Stage IVC Rectal Cancer AJCC v8,1
44907,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
44908,Primary Lesion,Childhood Brain Stem Gliosarcoma,1
44909,Malignant Cellular Infiltrate,Sellar Chondroid Chordoma,1
44910,Carcinomatous Component Present,Stage IIB Cervical Cancer AJCC v8,1
44911,Epithelial Component Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
44912,Cutaneous Involvement,Atypical Spitz Nevus,1
44913,Carcinomatous Component Present,keratinizing squamous cell carcinoma of lung,1
44914,Well Differentiated Lesion,Vaginal Warty Carcinoma,1
44915,Defective Gamma Heavy Chain Present,gamma-Chain Disease,1
44916,Malignant Cellular Infiltrate,Malignant neoplasm of stomach recurrent,1
44917,Epithelial Component Present,Vestibular Micropapillomatosis,1
44918,Recurrent disease,Testis cancer recurrent,1
44919,Ineffective hematopoiesis,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
44920,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
44921,Malignant Cellular Infiltrate,Unresectable Extrahepatic Bile Duct Carcinoma,1
44922,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
44923,Malignant Cellular Infiltrate,Breast Carcinoma by Gene Expression Profile,1
44924,Childhood Lesion,Recurrent Childhood Astrocytic Tumor,1
44925,Cellular Pleomorphism,Malignant Uterine Corpus PEComa,1
44926,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Seminoma,1
44927,Somatostatin Positive Neoplastic Cells Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
44928,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v8,1
44929,Carcinomatous Component Present,Resectable Renal Cell Carcinoma,1
44930,Primary Lesion,Metastatic Fibrolamellar Carcinoma,1
44931,Epithelial Component Present,Cervical Papillary Squamous Cell Carcinoma,1
44932,Benign Cellular Infiltrate,Capillary hemangioma of retina,1
44933,Diffuse Pattern,Childhood Fibrillary Astrocytoma,1
44934,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8,1
44935,Neuronal Differentiation,Glioblastoma with Primitive Neuronal Component,1
44936,Carcinomatous Component Present,Comedocarcinoma,1
44937,Carcinomatous Component Present,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage,1
44938,Peripheral Nuclear Palisading,Lung Basaloid Squamous Cell Carcinoma,1
44939,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Solid Pattern",1
44940,Malignant Cellular Infiltrate,Recurrent Central Nervous System Lymphoma,1
44941,Well Differentiated Neuroendocrine Lesion,Somatostatinoma,1
44942,Epithelial Component Present,Anal margin basal cell carcinoma,1
44943,Prominent Collagen Rosette Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
44944,Microcystic Change,Sclerosing Polycystic Adenosis,1
44945,White blood cell count increased (lab result),"Leukemia, Myeloid, Chronic-Phase",1
44946,Malignant Cellular Infiltrate,Stage IC Uterine Sarcoma AJCC v7,1
44947,Adnexal Differentiation,Desmoplastic trichoepithelioma,1
44948,Capillary Sized Vascular Channel Formation,Histiocytoid hemangioma,1
44949,Malignant Cellular Infiltrate,Malignant neoplasm of bladder recurrent,1
44950,Tissue of Mullerian Origin Present,Advanced Uterine Corpus Carcinosarcoma,1
44951,Argentaffin Positive Neoplastic Cells Present,Ovarian Insular Carcinoid Tumor,1
44952,Epithelial Component Present,Lip and Oral Cavity Carcinoma,1
44953,Malignant Cellular Infiltrate,Pancreatoblastoma,1
44954,Malignant Cellular Infiltrate,Stage 0 Oropharyngeal Carcinoma,1
44955,Local disease,Infiltrating Intramuscular Lipoma,1
44956,Refractory Disease,Refractory Rhabdomyosarcoma,1
44957,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts,1
44958,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
44959,Malignant Cellular Infiltrate,Gliomatosis Cerebri Type II,1
44960,Malignant Cellular Infiltrate,Gastric lymphoma,1
44961,Cutaneous Involvement,Pre-Malignant Skin Epithelial Lesion,1
44962,High Grade Lesion,Liver Synovial Sarcoma,1
44963,Ground Glass Nuclear Inclusion,Multicentric Thyroid Gland Papillary Carcinoma,1
44964,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1
44965,Epithelial Component Present,Unresectable Paraganglioma,1
44966,Mixed Cellular Population,Eccrine mixed tumor of skin,1
44967,Malignant Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v7,1
44968,Papillary Pattern,intraductal micropapillary carcinoma of breast,1
44969,Secondary Lesion,Metastatic Neoplasm to the Gallbladder,1
44970,Malignant Cellular Infiltrate,Primary Pulmonary Diffuse Large B-Cell Lymphoma,1
44971,Epithelial Component Present,Stage IIC Appendix Carcinoma AJCC v7,1
44972,Hyperchromatism,"Perineurioma, malignant",1
44973,Malignant Cellular Infiltrate,Stage II Vaginal Cancer AJCC v8,1
44974,Cutaneous Involvement,Senile hemangioma of lip,1
44975,Malignant Cellular Infiltrate,Paget's Disease of the Nipple,1
44976,Malignant Cellular Infiltrate,Paget Disease of the Breast without Invasive Carcinoma,1
44977,Increased Cellularity Present,"Anaplastic Astrocytoma, IDH-Wildtype",1
44978,Microcystic Change,Recurrent Childhood Pilocytic Astrocytoma,1
44979,Malignant Cellular Infiltrate,Ann Arbor Stage II Mantle Cell Lymphoma,1
44980,Primary Lesion,Smoldering Systemic Mastocytosis,1
44981,Epithelial Component Present,Pancreatic neuroendocrine tumor metastatic,1
44982,Lymphoplasmacytic Infiltrate,"Castleman Disease, Plasma Cell Type",1
44983,Benign Cellular Infiltrate,Intramuscular lipoma,1
44984,Well-Circumscribed Lesion,Hemangioblastoma,1
44985,Congenital Lesion,Congenital hamartoma,1
44986,Unilineage Dysplasia Present,Refractory Thrombocytopenia,1
44987,Syncytial Pattern,Nasopharyngeal lymphoepithelioma recurrent,1
44988,Malignant Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia,1
44989,Infiltrative Growth Pattern,Dupuytren Contracture,1
44990,Carcinomatous Component Present,"Glandular intraepithelial neoplasia, grade III",1
44991,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of the duodenum,1
44992,Diffuse Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
44993,Carcinomatous Component Present,Stage II Fallopian Tube Cancer,1
44994,Chronic Inflammatory Infiltrate,Childhood Lymphomatoid Granulomatosis,1
44995,Mixed Cellular Population,Adult Mixed Glioma,1
44996,Malignant Cellular Infiltrate,Stage I Superficial Spreading Melanoma AJCC v7,1
44997,Non-Malignant Cellular Infiltrate,Follicular Bronchitis/Bronchiolitis,1
44998,Malignant Cellular Infiltrate,Mantle cell lymphoma stage IV,1
44999,Diffuse Pattern,Recurrent Childhood Anaplastic Astrocytoma,1
45000,Malignant Cellular Infiltrate,Extramedullary Plasmacytoma,1
45001,Epithelial Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
45002,Papillary Pattern,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,1
45003,Benign Cellular Infiltrate,Bizarre leiomyoma,1
45004,Childhood Lesion,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
45005,Epithelial Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
45006,Malignant Cellular Infiltrate,Choriocarcinoma of ovary,1
45007,Carcinomatous Component Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,1
45008,Calcitonin Positive Neoplastic Cells Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
45009,Carcinomatous Component Present,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
45010,Cystic Change,"Cystadenocarcinoma, Serous",1
45011,Benign Cellular Infiltrate,Mature Mediastinal Teratoma,1
45012,Malignant Cellular Infiltrate,Primary Prostate Urothelial Carcinoma,1
45013,Plexiform Vasculature Present,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
45014,High Mitotic Activity,Anaplastic Astroblastoma,1
45015,Neuroendocrine Differentiation,Colon Small Cell Neuroendocrine Carcinoma,1
45016,Epithelial Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
45017,Epithelial Component Present,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8,1
45018,Carcinomatous Component Present,Adenocarcinoma of the prostate stage I,1
45019,Malignant Cellular Infiltrate,Oropharyngeal cancer recurrent,1
45020,Mixed Cellular Population,Soft Palate Pleomorphic Adenoma,1
45021,Metastatic Lesion,Transitional cell cancer of renal pelvis and ureter metastatic,1
45022,Cutaneous Involvement,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
45023,Malignant Cellular Infiltrate,Stage I Merkel Cell Carcinoma AJCC v7,1
45024,Folliculotropic Lymphocytic Infiltrate,Follicular mycosis fungoides,1
45025,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
45026,Carcinomatous Component Present,Stage III Oral Cavity Cancer AJCC v6 and v7,1
45027,Tubular Pattern,Ampulla of Vater Tubulovillous Adenoma,1
45028,Cutaneous Involvement,Regressing nevus,1
45029,Epithelial Component Present,Stage I Rectal Cancer AJCC v8,1
45030,Epithelial Component Present,Stage IIC Appendix Carcinoma AJCC v8,1
45031,Carcinomatous Component Present,Stage IV Colorectal Cancer AJCC v7,1
45032,Pleural effusion disorder,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
45033,Biphasic Pattern,Recurrent Childhood Gliosarcoma,1
45034,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v7,1
45035,Koilocytotic atypia,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,1
45036,Benign Cellular Infiltrate,lipoma of esophagus,1
45037,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of submandibular gland,1
45038,Encapsulated Mass,Thyroid Gland Lipoadenoma,1
45039,Malignant Cellular Infiltrate,Recurrent Anal Mucinous Adenocarcinoma,1
45040,Cystic Change,Syringocystadenoma Papilliferum,1
45041,Malignant Cellular Infiltrate,Recurrent Female Reproductive System Carcinoma,1
45042,Malignant Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v8,1
45043,Slow Growing Mass,Giant Cell Angioblastoma,1
45044,Malignant Cellular Infiltrate,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
45045,Well-Circumscribed Lesion,chondroma of lung,1
45046,Malignant Cellular Infiltrate,Vulvar Adenocarcinoma of Sweat Gland Type,1
45047,Epithelial Component Present,Stage IB Hepatocellular Carcinoma AJCC v8,1
45048,Blasts Under 20 Percent of Peripheral Blood White Cells,Juvenile Myelomonocytic Leukemia,1
45049,Primary Lesion,Hepatoma resectable,1
45050,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1,1
45051,Primary Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v8,1
45052,Epithelial Component Present,Small cell carcinoma of esophagus,1
45053,Benign Cellular Infiltrate,Thyroid Gland Lipoadenoma,1
45054,Neuroendocrine Differentiation,Rectal Neuroendocrine Tumor by AJCC v8 Stage,1
45055,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma,1
45056,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
45057,Slow Growing Mass,Chordoma,1
45058,Secondary Lesion,Colon Carcinoma Metastatic in the Lung,1
45059,Eosinophilic inflammation,Breast Inflammatory Myofibroblastic Tumor,1
45060,Carcinomatous Component Present,Locally Advanced Bile Duct Carcinoma,1
45061,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Signet Ring Variant",1
45062,Malignant Cellular Infiltrate,Laryngeal Squamous Cell Carcinoma,1
45063,Diffuse Pattern,Plasmablastic lymphoma,1
45064,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage I,1
45065,Vascular Channel Formation,Hemangioma of Peripheral Nerve,1
45066,Epithelial Component Present,Stage III Fallopian Tube Cancer AJCC v8,1
45067,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
45068,Epithelial Component Present,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
45069,Malignant Cellular Infiltrate,Anaplastic ganglioglioma,1
45070,Malignant Cellular Infiltrate,Childhood Choroid Plexus Carcinoma,1
45071,Malignant Cellular Infiltrate,Central Nervous System Rhabdomyosarcoma,1
45072,Secondary Lesion,Metastatic Digestive System Neuroendocrine Neoplasm,1
45073,Carcinomatous Component Present,Accessory Urethral Gland Carcinoma,1
45074,Malignant Cellular Infiltrate,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,1
45075,Epithelial Component Present,Stage IVB Lung Cancer AJCC v8,1
45076,Epithelial Component Present,Stage I Cervical Cancer AJCC v6 and v7,1
45077,Cutaneous Involvement,Malignant Eccrine Neoplasm,1
45078,Malignant Cellular Infiltrate,Angiocentric lymphoma recurrent,1
45079,Malignant Cellular Infiltrate,DS Stage III Plasma Cell Myeloma,1
45080,Crystal deposition,Childhood Alveolar Soft Part Sarcoma,1
45081,Cartilaginous Differentiation,mesenchymal chondrosarcoma of bone,1
45082,atypia morphology,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
45083,Carcinomatous Component Present,Stage I Renal Pelvis Cancer AJCC v8,1
45084,Malignant Cellular Infiltrate,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8,1
45085,Primary Lesion,BCLC Stage D Adult Hepatocellular Carcinoma,1
45086,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
45087,Epithelial Component Present,Cervical Cancer by AJCC v7 Stage,1
45088,Malignant Cellular Infiltrate,Malignant Glioma,1
45089,Carcinomatous Component Present,Sebaceous Breast Carcinoma,1
45090,Endophytic Tumor Growth,Ureter Inverted Papilloma,1
45091,Benign Cellular Infiltrate,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,1
45092,Exophytic Polypoid Lesion,"Polyposis, Gastric",1
45093,Low Mitotic Activity,Intestinal Neuroendocrine Tumor G2,1
45094,Epithelial Component Present,"Adenocarcinoma, intestinal type",1
45095,Diffuse Pattern,"Diffuse Astrocytoma, IDH-Wildtype",1
45096,Epithelial Component Present,Vaginal Small Cell Carcinoma,1
45097,Infiltrative Growth Pattern,Fibromatosis colli,1
45098,Well-Circumscribed Lesion,Gastric hyperplastic polyp,1
45099,Malignant Cellular Infiltrate,carcinosarcoma of extrahepatic bile duct,1
45100,Malignant Cellular Infiltrate,"Melanoma, Amelanotic",1
45101,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH,1
45102,Epithelial Component Present,Gastric Cancer by AJCC v8 Pathologic Stage,1
45103,Carcinomatous Component Present,Stage IVC Rectal Cancer AJCC v8,1
45104,No Identifiable Line of Differentiation,Abdominal Undifferentiated Pleomorphic Sarcoma,1
45105,Necrotic changes (finding),small cell carcinoma of kidney,1
45106,Malignant Cellular Infiltrate,Stage II Renal Pelvis and Ureter Cancer AJCC v8,1
45107,Dysplasia,Glandular Cell Intraepithelial Neoplasia,1
45108,EBV-Positive Neoplastic Cells Present,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood,1
45109,Fibrotic Stroma Formation,Sarcomatoid Intrahepatic Cholangiocarcinoma,1
45110,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v7,1
45111,Cutaneous Involvement,basal cell carcinoma of scrotum,1
45112,Carcinomatous Component Present,Recurrent Minor Salivary Gland Adenocarcinoma,1
45113,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
45114,Carcinomatous Component Present,Advanced Carcinoma,1
45115,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
45116,High Grade Lesion,Childhood Glioblastoma,1
45117,Metastatic Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,1
45118,Carcinomatous Component Present,Squamous cell carcinoma of lip,1
45119,Epithelial Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v7,1
45120,Severe dysplasia,Intermediate Grade Ductal Breast Carcinoma In Situ,1
45121,Cutaneous Involvement,"Xeroderma pigmentosum, group B",1
45122,Epithelial Component Present,Stage II Prostate Carcinoma,1
45123,Benign Cellular Infiltrate,Benign epithelial neoplasm of skin,1
45124,Malignant Cellular Infiltrate,Small Intestinal Neuroendocrine Carcinoma,1
45125,Schwannian Stroma Predominant Component of the Tumor Volume,Adrenal Gland Ganglioneuroma,1
45126,Carcinomatous Component Present,Childhood Lung Non-Small Cell Carcinoma,1
45127,Malignant Cellular Infiltrate,Malignant Mixed Tumor,1
45128,Carcinomatous Component Present,"Carcinoma, Endometrioid",1
45129,High Mitotic Activity,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
45130,Carcinomatous Component Present,Stage III Esophageal Cancer AJCC v7,1
45131,Thick-Walled Vessels Present,Angiomyolipoma of kidney,1
45132,Nodular lesions,Thyroid Gland Follicular Adenoma,1
45133,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma,1
45134,Recurrent disease,Recurrent Appendix Mucinous Adenocarcinoma,1
45135,Regional Disease,Locally Advanced Carcinoma,1
45136,Hereditary Lesion,Hereditary Papillary Renal Carcinoma,1
45137,Neuroendocrine Differentiation,Gallbladder Neuroendocrine Tumor G1,1
45138,Epithelial Component Present,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
45139,Serotonin Positive Neoplastic Cells Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
45140,Malignant Cellular Infiltrate,Stage IV Skin Cancer,1
45141,CD30-Positive Neoplastic Cells Present,Recurrent Anaplastic Large Cell Lymphoma,1
45142,Epithelial Component Present,Ampulla of Vater Neuroendocrine Neoplasm,1
45143,Malignant Cellular Infiltrate,Refractory Neuroblastoma,1
45144,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8,1
45145,Malignant Cellular Infiltrate,Carcinoma in Situ,1
45146,Carcinomatous Component Present,Ethmoid Sinus Squamous Cell Carcinoma,1
45147,Primary Lesion,Childhood Gliosarcoma,1
45148,Epithelial Component Present,Resectable Digestive System Carcinoma,1
45149,Cutaneous Involvement,Stage IIIB Cutaneous Melanoma AJCC v7,1
45150,Malignant Cellular Infiltrate,Stage III Renal Pelvis Cancer AJCC v8,1
45151,Peripheral Nuclear Palisading,basaloid squamous cell carcinoma of vulva,1
45152,CD30-Positive Neoplastic Cells Present,Breast implant-associated anaplastic large cell lymphoma,1
45153,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage III,1
45154,Well Differentiated Lesion,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
45155,Low Mitotic Activity,Somatostatinoma,1
45156,Malignant Cellular Infiltrate,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,1
45157,Malignant Cellular Infiltrate,Ovarian cancer stage III,1
45158,Multilayered Rosette Formation,Ependymoblastoma,1
45159,Well-Circumscribed Lesion,Broad Ligament Serous Cystadenoma,1
45160,Anaplasia,Anaplastic large cell lymphoma T- and null-cell types refractory,1
45161,Malignant Cellular Infiltrate,Childhood Lymphoma by AJCC v8 Stage,1
45162,Non-Hereditary Lesion,Gastric Intramucosal Adenocarcinoma,1
45163,Malignant Cellular Infiltrate,Metastatic angiosarcoma,1
45164,High Grade Lesion,Synovial sarcoma non-metastatic,1
45165,Unifocal Disease,Extracutaneous Mastocytoma,1
45166,Pain,Mesenchymal Chondrosarcoma,1
45167,Well Differentiated Neuroendocrine Lesion,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
45168,Anaplasia,Childhood Systemic Anaplastic Large Cell Lymphoma,1
45169,Intraductal Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
45170,Resectable Mass,Pancreatic carcinoma resectable,1
45171,Extensive Stage Lesion,Advanced Sarcoma of the Extremity,1
45172,Carcinomatous Component Present,Stage IV Gallbladder Cancer AJCC v7,1
45173,Serrated Glandular Architecture,Colorectal Serrated Adenocarcinoma,1
45174,Secondary Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
45175,Tissue Differentiation Uncertain,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
45176,Well-Circumscribed Lesion,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
45177,Epithelial Component Present,Stage I Carcinoma of Penis,1
45178,Tissue Differentiation Uncertain,Pulmonary lymphangioleiomyomatosis,1
45179,Carcinomatous Component Present,Stage IIA Penile Cancer AJCC v8,1
45180,Malignant Cellular Infiltrate,Old Burn Scar-Related Skin Squamous Cell Carcinoma,1
45181,Malignant Cellular Infiltrate,Malignant Ovarian Clear Cell Tumor,1
45182,Chromogranin A Positive Neoplastic Cells Present,Small Intestinal Carcinoid Tumor,1
45183,Papillary Pattern,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
45184,Malignant Cellular Infiltrate,sarcoma of oral cavity,1
45185,Epithelial Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
45186,Adulthood Lesion,Adult Alveolar Soft Part Sarcoma,1
45187,atypia morphology,Atypical adenomatous hyperplasia,1
45188,Cystic Change,Childhood Multilocular Cystic Renal Neoplasm,1
45189,Epithelial Component Present,Stage IVC Nasopharyngeal Carcinoma AJCC v7,1
45190,Secondary Lesion,Advanced Head and Neck Carcinoma,1
45191,Serotonin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
45192,Malignant Cellular Infiltrate,childhood nasal type extranodal NK/T-cell lymphoma,1
45193,Fibrosis,Breast Fibrocystic Disease,1
45194,Epithelial Component Present,Bartholin Gland Adenomyoma,1
45195,Adnexal Differentiation,Pilar-Associated Mesenchyme Neoplasm,1
45196,Severe dysplasia,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
45197,Epithelial Component Present,Vulvar Trichoepithelioma,1
45198,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Testicular Choriocarcinoma,1
45199,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(11;17)(q23;q21),1
45200,Childhood Lesion,Childhood Astrocytoma,1
45201,Carcinomatous Component Present,Recurrent Uterine Corpus Carcinosarcoma,1
45202,Secondary Lesion,Lung squamous cell carcinoma stage IV,1
45203,Epithelial Component Present,Foregut Carcinoid Tumor,1
45204,Absence of Invasion,Lobular Neoplasia Type A,1
45205,Carcinomatous Component Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
45206,Osseous Differentiation,Osteoma of skull,1
45207,Epithelial Component Present,Stage II Colorectal Cancer,1
45208,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Leiomyosarcoma,1
45209,Malignant Cellular Infiltrate,Grade 1 Endometrial Endometrioid Adenocarcinoma,1
45210,Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
45211,Carcinomatous Component Present,Localized Gastroesophageal Junction Adenocarcinoma,1
45212,Splenomegaly,"Leukemia, Myeloid, Accelerated Phase",1
45213,Absence of Invasion,Gastrointestinal carcinoma in situ,1
45214,Malignant Cellular Infiltrate,Rhabdoid meningioma,1
45215,Epithelial Component Present,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
45216,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated CEBPA,1
45217,Malignant Cellular Infiltrate,Grade 3 Cutaneous Follicular Lymphoma,1
45218,Refractory Disease,Refractory Urothelial Carcinoma,1
45219,Fibrosis,Lipomatosis of Nerve,1
45220,Malignant Cellular Infiltrate,Recurrent Appendix Mucinous Adenocarcinoma,1
45221,Immunologic Deficiency Syndromes,Lymphoproliferative Disease Associated with Primary Immune Disorder,1
45222,Epithelial Component Present,Stage III Laryngeal Cancer AJCC v6 and v7,1
45223,Hereditary Lesion,Hereditary Male Breast Carcinoma,1
45224,IDH Gene Family Mutation Status Unknown,Diffuse Astrocytoma,1
45225,Calcitonin Positive Neoplastic Cells Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
45226,Pregnancy Complications,"Pregnancy, Tubal",1
45227,Pain,mesenchymal chondrosarcoma of bone,1
45228,Diffuse Pattern,Childhood Gemistocytic Astrocytoma,1
45229,Benign Cellular Infiltrate,Giant Fibrovascular Esophageal Polyp,1
45230,Fibrovascular Septa Present,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
45231,Epithelial Component Present,"Papillary cystadenoma, borderline malignancy",1
45232,CD1a-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis,1
45233,Benign Cellular Infiltrate,Fibroma of prostate,1
45234,Calcitonin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
45235,Low Grade Lesion,Primary Peritoneal Low Grade Serous Adenocarcinoma,1
45236,Malignant Cellular Infiltrate,Anaplastic astrocytoma,1
45237,Epithelial Component Present,Stage III Oropharyngeal Carcinoma AJCC v6,1
45238,Papillary Pattern,Bladder Squamous Papilloma,1
45239,Necrotic changes (finding),Cardiac Malignant Peripheral Nerve Sheath Tumor,1
45240,Secondary Lesion,Metastatic Chordoma,1
45241,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v8,1
45242,Benign Cellular Infiltrate,benign fibrous histiocytoma of bone,1
45243,High Grade Lesion,Temporal Lobe Anaplastic Astrocytoma,1
45244,Malignant Cellular Infiltrate,Metastatic Microsatellite Stable Colorectal Carcinoma,1
45245,Clinical TNM Finding,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
45246,Epithelial Component Present,Mild epithelial dysplasia,1
45247,Confluent Sheets of Anaplastic T-Lymphocytes Present,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
45248,Villous Projections of the Neoplastic Epithelium Present,Colorectal Filiform Serrated Adenoma,1
45249,Malignant Cellular Infiltrate,Cutaneous Angioimmunoblastic T-Cell Lymphoma,1
45250,Benign Cellular Infiltrate,Hidradenoma Papilliferum,1
45251,Cutaneous Involvement,Grade 3 Cutaneous Follicular Lymphoma,1
45252,Malignant Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma,1
45253,Cystic Change,Broad Ligament Serous Cystadenofibroma,1
45254,Carcinomatous Component Present,Refractory Urothelial Carcinoma,1
45255,Epithelial Differentiation,Papillary tumor of the pineal region,1
45256,Benign Cellular Infiltrate,Pleural Schwannoma,1
45257,Malignant Cellular Infiltrate,Submandibular Gland Acinic Cell Carcinoma,1
45258,Malignant Cellular Infiltrate,Malignant neoplasm of kidney,1
45259,Melanin-Pigmented Dendritic Cells Present,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
45260,Secondary Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
45261,Indolent Clinical Course,Deep Lipoma,1
45262,Carcinomatous Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
45263,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
45264,Neuroendocrine Differentiation,Gastrointestinal Carcinoid Tumor,1
45265,Biphasic Pattern,Ovarian serous cystadenofibroma,1
45266,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IIIB,1
45267,Well Differentiated Lesion,Grade I Chondrosarcoma,1
45268,Epithelial Component Present,Stage IVA Lip Cancer AJCC v6 and v7,1
45269,Malignant Cellular Infiltrate,Sarcoma by AJCC Grade,1
45270,Smooth Muscle Component Present,Pulmonary lymphangioleiomyomatosis,1
45271,Benign Cellular Infiltrate,Deep Penetrating Nevus,1
45272,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Tumor,1
45273,Epithelial Component Present,Diffuse Gastric Adenocarcinoma,1
45274,Malignant Cellular Infiltrate,recurrent childhood acute myeloid leukemia,1
45275,Hemorrhagic,Thyroid Angiosarcoma,1
45276,Malignant Cellular Infiltrate,Stage IVB Bone Sarcoma AJCC v7,1
45277,Primary Lesion,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
45278,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v7,1
45279,Hyperkeratosis,Desmoplastic trichilemmoma,1
45280,"Fully Differentiated ""Adult-Type"" Tissues Present",Testicular Dermoid Cyst,1
45281,Eosinophil count raised (finding),Chronic Myelomonocytic Leukemia with Eosinophilia,1
45282,Epithelial Component Present,Metastatic Lung Carcinoma,1
45283,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Cystic Teratoma,1
45284,Epithelial Component Present,Paget Disease of the Scrotum,1
45285,Epithelial Component Present,Small Intestinal Low Grade Intraepithelial Neoplasia,1
45286,"Fully Differentiated ""Adult-Type"" Tissues Present",Adult Central Nervous System Mature Teratoma,1
45287,Malignant Cellular Infiltrate,Stage IIA Bone Sarcoma AJCC v7,1
45288,Non-Hereditary Lesion,Sporadic Diffuse Gastric Adenocarcinoma,1
45289,Stromal Invasion,Stage III Ovarian Cancer AJCC v8,1
45290,Epithelial Component Present,Lung Cancer by AJCC v8 Stage,1
45291,Osseous Differentiation,Stage IIA Osteosarcoma AJCC v7,1
45292,Severe dysplasia,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
45293,Epithelial Component Present,Metastatic Cervical Carcinoma,1
45294,Carcinomatous Component Present,Stage IA Cervical Cancer AJCC v8,1
45295,Malignant Cellular Infiltrate,Metastatic Neoplasm to the Gallbladder,1
45296,Dermal Involvement,Compound nevus of skin,1
45297,Ineffective hematopoiesis,Childhood Myelodysplastic Syndrome,1
45298,Pain,Central Nervous System Mesenchymal Chondrosarcoma,1
45299,Epithelial Component Present,Hormone Receptor Positive Breast Carcinoma,1
45300,Malignant Cellular Infiltrate,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
45301,Malignant Cellular Infiltrate,Secondary malignant neoplasm of parathyroid gland,1
45302,Epithelial Component Present,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
45303,Mixed Cellular Population,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
45304,Malignant Cellular Infiltrate,Transplant-Related Bladder Urothelial Carcinoma,1
45305,Malignant Cellular Infiltrate,Primary Prostate Urothelial Carcinoma,1
45306,Eosinophil count raised (finding),Chronic Myelomonocytic Leukemia with Eosinophilia,1
45307,Benign Cellular Infiltrate,Leiomyomatosis peritonealis disseminata,1
45308,Epithelial Component Present,Low Grade Prostatic Intraepithelial Neoplasia,1
45309,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v6,1
45310,Sebaceous Differentiation,Superficial Epithelioma with Sebaceous Differentiation,1
45311,Exophytic Polypoid Lesion,adenoma of extrahepatic bile duct,1
45312,atypia morphology,Primary ameloblastic carcinoma,1
45313,Carcinomatous Component Present,adenosquamous carcinoma of ovary,1
45314,Severe dysplasia,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
45315,Carcinomatous Component Present,Unresectable Digestive System Neuroendocrine Carcinoma,1
45316,Malignant Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor,1
45317,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage,1
45318,Malignant Cellular Infiltrate,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
45319,Benign Cellular Infiltrate,Classical Poroma,1
45320,Epithelial Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
45321,Refractory Disease,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
45322,Malignant Cellular Infiltrate,Colon Carcinoma Metastatic in the Lung,1
45323,Secondary Lesion,Metastatic Cervical Carcinoma,1
45324,Neuroendocrine Differentiation,"Carcinoid, Goblet Cell",1
45325,Malignant Cellular Infiltrate,Rectosigmoid Mucinous Adenocarcinoma,1
45326,Superficial Lesion,Dupuytren Contracture,1
45327,Infiltrating Tumor Margins Present,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
45328,Storiform Growth Pattern,benign fibrous histiocytoma of bone,1
45329,Malignant Cellular Infiltrate,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
45330,Polymorphic Cellular Infiltrate,"Langerhans Cell Histiocytosis, Disseminated",1
45331,Slow Growing Mass,Dedifferentiated chordoma,1
45332,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
45333,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
45334,Monomorphic Cellular Infiltrate,Ependymoma of spinal cord,1
45335,Stromal Invasion,"Carcinoma, Ovarian Epithelial",1
45336,Malignant Cellular Infiltrate,Childhood Mixed Germ Cell Tumor,1
45337,Benign Cellular Infiltrate,Benign mixed epithelial and stromal tumor of kidney,1
45338,Malignant Cellular Infiltrate,Malignant odontogenic tumor,1
45339,Immunologic Deficiency Syndromes,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
45340,Well-Circumscribed Lesion,"Adenoma, Sweat Gland",1
45341,Dermal Involvement,Eccrine porocarcinoma,1
45342,Extensive Stage Lesion,Advanced Malignant Solid Neoplasm,1
45343,Epithelial Component Present,Recurrent Ampulla of Vater Adenocarcinoma,1
45344,Malignant Cellular Infiltrate,Malignant Intracranial Germ Cell Tumor,1
45345,Systemic disease,Systemic Anaplastic Large Cell Lymphoma,1
45346,Recurrent disease,Recurrent Soft Tissue Sarcoma,1
45347,Stromal Invasion,Recurrent Ovarian Adenocarcinoma,1
45348,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6,1
45349,Carcinomatous Component Present,Barrett's Adenocarcinoma,1
45350,Deep Lesion,Pelvic Fibromatosis,1
45351,Dysplasia,villous adenoma of stomach,1
45352,Tissue Differentiation Uncertain,Peritoneal Desmoplastic Small Round Cell Tumor,1
45353,Epithelial Component Present,Bladder Papillary Urothelial Neoplasm,1
45354,High Grade Lesion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
45355,Carcinomatous Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,1
45356,Glomeruloid Vessels Present,Recurrent Childhood Pilocytic Astrocytoma,1
45357,Nuclear pleomorphism,undifferentiated carcinoma of pancreas,1
45358,Malignant Cellular Infiltrate,Childhood Kidney Wilms Tumor,1
45359,Childhood Lesion,Childhood Bladder Carcinoma,1
45360,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v6 and v7,1
45361,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory High Risk Myelodysplastic Syndrome,1
45362,Malignant Cellular Infiltrate,Aggressive Systemic Mastocytosis,1
45363,Well Differentiated Neuroendocrine Lesion,Stage I Colon Neuroendocrine Tumor AJCC v8,1
45364,Indolent Clinical Course,Odontogenic myxoma,1
45365,Recurrent Genetic Abnormalities Present,Hyperdiploid B Acute Lymphoblastic Leukemia,1
45366,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia T/myeloid,1
45367,Carcinomatous Component Present,Penile Cancer by AJCC v6 Stage,1
45368,Adulthood Lesion,Adult Non-Hodgkin Lymphoma,1
45369,Epithelial Component Present,Stage IIIA Lung Cancer AJCC v8,1
45370,Epithelial Component Present,Pituitary Gland Macroadenoma,1
45371,Adulthood Lesion,Adult Central Nervous System Neoplasm,1
45372,Complete Spontaneous Regression,Type B Lymphomatoid Papulosis,1
45373,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma recurrent,1
45374,Carcinomatous Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
45375,Secondary Lesion,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
45376,CD30-Positive Neoplastic Cells Present,Adult Systemic Anaplastic Large Cell Lymphoma,1
45377,Malignant Cellular Infiltrate,Pericardial mesothelioma malignant recurrent,1
45378,Malignant Cellular Infiltrate,Stage IV Breast Cancer AJCC v6 and v7,1
45379,Borderline Lesion,Grade I Lymphomatoid Granulomatosis,1
45380,Carcinomatous Component Present,Metastatic Parathyroid Gland Carcinoma,1
45381,Dermal Involvement,Neuronevus,1
45382,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor,1
45383,Secondary Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
45384,Necrotic changes (finding),Esophageal Large Cell Neuroendocrine Carcinoma,1
45385,Dysplasia,Low Grade Penile Intraepithelial Neoplasia,1
45386,Malignant Cellular Infiltrate,Stage IIIA Fallopian Tube Cancer AJCC v7,1
45387,Chronic Inflammatory Infiltrate,"lymphomatoid papulosis, type A",1
45388,Osseous Differentiation,Osteogenic Neoplasm,1
45389,Malignant Cellular Infiltrate,"Acute myeloid leukemia, t(8;21) (q22;q22)",1
45390,Benign Cellular Infiltrate,Dermoid cyst of orbit,1
45391,Epithelial Component Present,Endometrial Carcinoma,1
45392,Mitotic Activity,Malignant Ovarian Luteinized Thecoma,1
45393,Non-Invasive Lesion,Bladder Urothelial Carcinoma in Situ,1
45394,Benign Cellular Infiltrate,Sex Hormone-Producing Adrenal Cortex Adenoma,1
45395,Carcinomatous Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
45396,Mesenchymal Differentiation,gliosarcoma,1
45397,Intraductal Lesion,Intraductal papillomatosis,1
45398,Carcinomatous Component Present,Grade 3 Endometrial Mucinous Adenocarcinoma,1
45399,Carcinomatous Component Present,Secretory breast carcinoma,1
45400,Epithelial Component Present,Mucinous carcinoma of breast,1
45401,Ischemia,Acute vascular insufficiency of intestine (disorder),1
45402,Epithelial Component Present,Stage IVA Lip Cancer AJCC v6 and v7,1
45403,Malignant Cellular Infiltrate,Lymphoma stage,1
45404,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation,1
45405,Malignant Cellular Infiltrate,Platinum-Sensitive Lung Small Cell Carcinoma,1
45406,Epithelial Component Present,Unresectable Intrahepatic Cholangiocarcinoma,1
45407,Carcinomatous Component Present,Undifferentiated carcinoma of stomach,1
45408,Indolent Clinical Course,benign neoplasm of lower jaw bone,1
45409,High Grade Lesion,Angiosarcoma NCI Grade 3,1
45410,Cutaneous Involvement,Cutaneous Mantle Cell Lymphoma,1
45411,Cutaneous Involvement,Tufted angioma of skin,1
45412,Epithelial Component Present,Stage IIIB Appendix Carcinoma AJCC v8,1
45413,Carcinomatous Component Present,Cervical Mesonephric Adenocarcinoma,1
45414,Carcinomatous Component Present,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
45415,Resectable Mass,Localized Resectable Adult Hepatocellular Carcinoma,1
45416,Carcinomatous Component Present,Cervical Adenoid Cystic Carcinoma,1
45417,Pregnancy Complications,Morbidly adherent placenta (disorder),1
45418,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Adenocarcinoma, endocervical type",1
45419,Refractory Disease,Refractory Malignant Brain Neoplasm,1
45420,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Corpus Carcinosarcoma,1
45421,Carcinomatous Component Present,Stage IIIC Colorectal Cancer AJCC v8,1
45422,Carcinomatous Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma,1
45423,Malignant Cellular Infiltrate,Unresectable Malignant Neoplasm,1
45424,Cytoplasmic Membrane-Bound Granules Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
45425,Adnexal Differentiation,Hidroacanthoma simplex,1
45426,Poorly Differentiated Lesion,Gingival Spindle Cell Carcinoma,1
45427,Epithelial Component Present,Pancreatic Somatostatinoma,1
45428,Indolent Clinical Course,Cranial Nodular Fasciitis,1
45429,Hereditary Lesion,Hereditary Malignant Neoplasm,1
45430,Clinical TNM Finding,Clinical Stage I Cutaneous Melanoma AJCC v8,1
45431,Primary Lesion,Cerebellar Astrocytoma,1
45432,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
45433,Increased Cellularity Present,Anaplastic Diencephalic Astrocytoma,1
45434,Malignant Cellular Infiltrate,Acute monocytic/monoblastic leukemia,1
45435,Monomorphic Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma,1
45436,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
45437,Childhood Lesion,Infant Acute Undifferentiated Leukemia,1
45438,Malignant Cellular Infiltrate,Adult Mesenchymal Chondrosarcoma,1
45439,Carcinomatous Component Present,Tongue Carcinoma,1
45440,Splenomegaly,"Leukemia, Myeloid, Accelerated Phase",1
45441,Malignant Cellular Infiltrate,Mediastinal seminoma,1
45442,Perineural spread,Adenoid cystic breast carcinoma,1
45443,Carcinomatous Component Present,Recurrent Fallopian Tube Carcinoma,1
45444,Indolent Clinical Course,Bone Leiomyoma,1
45445,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Childhood Myelodysplastic Syndrome,1
45446,Malignant Cellular Infiltrate,Stage 0 Ureter Cancer AJCC v7,1
45447,Carcinomatous Component Present,Stage II Gastric Carcinoma,1
45448,Epithelial Component Present,Unclassified Renal Cell Carcinoma,1
45449,Epithelial Component Present,Stage IIIC Eyelid Carcinoma AJCC v7,1
45450,Exophytic Polypoid Lesion,Appendix Sessile Serrated Adenoma/Polyp,1
45451,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage III,1
45452,Secondary Lesion,Metastatic Carcinoma,1
45453,Mitotic Activity,Adult Glioblastoma,1
45454,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage III,1
45455,Malignant Cellular Infiltrate,Malignant eccrine spiradenoma,1
45456,Carcinomatous Component Present,Stage IIIB Small Intestinal Cancer AJCC v7,1
45457,Mitotic Activity,High Grade Ductal Breast Carcinoma In Situ,1
45458,High Mitotic Activity,Anaplastic Oligodendroglioma,1
45459,Epithelial Component Present,Thoracic Esophagus Squamous Cell Carcinoma,1
45460,atypia morphology,Borderline cystadenoma,1
45461,Deep Lesion,"Liposarcoma, well differentiated",1
45462,"Fully Differentiated ""Adult-Type"" Tissues Present",Extragonadal primary malignant teratoma,1
45463,Malignant Cellular Infiltrate,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
45464,Cystic Change,Ovarian Cystic Teratoma,1
45465,Necrotic changes (finding),Brain Stem Glioblastoma,1
45466,Nodular lesions,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
45467,Carcinomatous Component Present,Stage 0a Renal Pelvis Cancer AJCC v7,1
45468,Carcinomatous Component Present,Childhood Rectal Carcinoma,1
45469,Carcinomatous Component Present,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
45470,Nuclear Pseudoinclusion,Childhood Thyroid Gland Papillary Carcinoma,1
45471,Malignant Cellular Infiltrate,Advanced Gastric Neuroendocrine Carcinoma,1
45472,Benign Cellular Infiltrate,Benign neoplasm of spleen,1
45473,Metastatic Lesion,Secondary malignant neoplasm of urethra,1
45474,Neuroendocrine Differentiation,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
45475,Epithelial Component Present,Recurrent Anal Adenocarcinoma,1
45476,Micropapillary Pattern,"Transitional cell carcinoma, micropapillary",1
45477,Recurrent disease,Breast cancer recurrent,1
45478,Malignant Cellular Infiltrate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
45479,Epithelial Component Present,Adenosquamous cell lung cancer stage II,1
45480,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Central Nervous System Mature Teratoma,1
45481,Carcinomatous Component Present,Ethmoid Sinus Adenocarcinoma,1
45482,Malignant Cellular Infiltrate,Recurrent Minor Salivary Gland Adenocarcinoma,1
45483,Malignant Cellular Infiltrate,Pleural Epithelioid Mesothelioma,1
45484,Systemic disease,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
45485,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage III,1
45486,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage I,1
45487,Intraosseous Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
45488,Malignant Cellular Infiltrate,Childhood Conventional Osteosarcoma,1
45489,Malignant Cellular Infiltrate,Malignant Neoplasm of Lung - Multiple Primary Sites,1
45490,Epithelial Component Present,Gingival Squamous Cell Carcinoma,1
45491,Malignant Cellular Infiltrate,Stage III Breast Cancer AJCC v7,1
45492,Malignant Cellular Infiltrate,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",1
45493,Carcinomatous Component Present,Intraductal carcinoma and lobular carcinoma in situ,1
45494,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,1
45495,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage II,1
45496,Neuroendocrine Differentiation,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
45497,Absence of Invasion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
45498,Malignant Cellular Infiltrate,Locally Advanced Malignant Neoplasm,1
45499,Lepidic Growth Pattern,"Bronchiolo-alveolar carcinoma, non-mucinous",1
45500,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
45501,Slit-Like Stromal Retraction Present,Multifocal superficial basal cell carcinoma,1
45502,Cystic Change,Lung Mucinous Cystadenoma,1
45503,Adulthood Lesion,Adult Burkitt Lymphoma,1
45504,Malignant Cellular Infiltrate,Minor Salivary Gland Small Cell Carcinoma,1
45505,Malignant Cellular Infiltrate,Mixed Cellularity Hodgkin Lymphoma,1
45506,In Situ Lesion,Stage 0is Ureter Cancer AJCC v7,1
45507,Thyroglobulin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Follicular Carcinoma,1
45508,Benign Cellular Infiltrate,Classic Rhabdomyoma,1
45509,Peau d'orange surface of breast,Inflammatory carcinoma of breast stage III,1
45510,Carcinomatous Component Present,Stage IB Lung Adenosquamous Carcinoma AJCC v7,1
45511,Koilocytotic atypia,Cervical Warty Carcinoma,1
45512,Carcinomatous Component Present,Fallopian Tube Squamous Cell Carcinoma,1
45513,Childhood Lesion,Childhood Anaplastic Oligodendroglioma,1
45514,Epithelial Component Present,Stage I Vaginal Cancer AJCC v6 and v7,1
45515,Absence of Invasion,Lobular Neoplasia,1
45516,Epithelial Component Present,Unresectable Carcinoma,1
45517,Epithelial Component Present,Stage IV Renal Cell Cancer,1
45518,Unresectable Mass,Unresectable Liposarcoma,1
45519,Carcinomatous Component Present,BCLC Stage D Hepatocellular Carcinoma,1
45520,Papillary Pattern,Papillary Thyroid Microcarcinoma,1
45521,Well Differentiated Lesion,"Lung Squamous Cell Carcinoma, Papillary Variant",1
45522,Insular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
45523,Chronic Inflammatory Infiltrate,Inflammatory liposarcoma,1
45524,Eosinophilic inflammation,Breast Epithelioid Hemangioma,1
45525,Malignant Cellular Infiltrate,Maxillary Sinus Adenoid Cystic Carcinoma,1
45526,Carcinomatous Component Present,Vaginal Basaloid Carcinoma,1
45527,Infiltrative Growth Pattern,"Glioblastoma, IDH-Wildtype",1
45528,Epithelial Component Present,Malignant phyllodes tumor of breast,1
45529,High Mitotic Activity,Recurrent Salivary Duct Carcinoma,1
45530,Bone Marrow Dysplasia Present,Adult Myelodysplastic Syndrome,1
45531,Benign Cellular Infiltrate,Clear Cell Adrenal Cortical Adenoma,1
45532,Pseudoalveolar Pattern,Alveolar soft part sarcoma recurrent,1
45533,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Unknown Primary,1
45534,Intraductal Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
45535,Ventricular Involvement Only,Fourth Ventricle Ependymal Tumor,1
45536,Malignant Cellular Infiltrate,Posterior Tongue Squamous Cell Carcinoma,1
45537,Indolent Clinical Course,Airway Hemangioma,1
45538,Diffuse Pattern,Brain Glioblastoma,1
45539,Cutaneous Involvement,Pruritus,1
45540,Epithelial Component Present,Stage III Rectal Cancer AJCC v7,1
45541,Deep Lesion,Tendon Sheath Lipoma,1
45542,High Mitotic Activity,Small cell carcinoma of prostate,1
45543,Carcinomatous Component Present,Refractory Endometrial Serous Adenocarcinoma,1
45544,Malignant Cellular Infiltrate,Colorectal Mixed Adenoneuroendocrine Carcinoma,1
45545,Borderline Lesion,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
45546,Benign Cellular Infiltrate,Squamous cell papilloma of skin,1
45547,Epithelial Component Present,Primary hepatic neuroendocrine carcinoma,1
45548,Carcinomatous Component Present,Soft Palate Squamous Cell Carcinoma,1
45549,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage I Plasma Cell Myeloma,1
45550,Epithelial Component Present,Clinical Stage III Gastric Cancer AJCC v8,1
45551,S-100-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
45552,Refractory Disease,Refractory Hepatosplenic T-Cell Lymphoma,1
45553,Well-Circumscribed Lesion,Malignant Vulvar Phyllodes Tumor,1
45554,Epithelial Component Present,Colorectal Adenocarcinoma Metastatic in the Liver,1
45555,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia with Atypia,1
45556,Malignant Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern",1
45557,Lobular Pattern,Pilar tumor,1
45558,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
45559,Epithelial Component Present,endometrioid adenofibroma of ovary,1
45560,Epithelial Component Present,Metastatic Bladder Small Cell Carcinoma,1
45561,Mesenchymal Component Present,Nephrogenic adenofibroma,1
45562,Thrombocytosis,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
45563,Diffuse Lesion,"Diffuse midline glioma, point mutation K27M in histone H3",1
45564,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
45565,Honeycomb Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
45566,Rimming of Adipose Tissue Cells Present,Subcutaneous panniculitis-like T-cell lymphoma,1
45567,High Mitotic Activity,Anaplastic Medulloblastoma,1
45568,Immunologic Deficiency Syndromes,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
45569,Cutaneous Involvement,Vulvar Neoplasm of Skin Appendage Origin,1
45570,Malignant Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v7,1
45571,Metastatic Lesion,Locally Advanced Bile Duct Carcinoma,1
45572,Recurrent disease,Recurrent Adult Immunoblastic Lymphoma,1
45573,Low Mitotic Activity,Gallbladder Neuroendocrine Tumor G2,1
45574,Monomorphic Cellular Infiltrate,Adult Oligodendroglioma,1
45575,atypia morphology,Atypical Adenomatous Lung Hyperplasia,1
45576,Recurrent disease,Recurrent Childhood Cerebral Astrocytoma,1
45577,Benign Cellular Infiltrate,Thyroid Gland Spindle Cell Follicular Adenoma,1
45578,Epithelial Component Present,Stage IV Lung Squamous Cell Carcinoma AJCC v7,1
45579,Carcinomatous Component Present,Cervical Basaloid Carcinoma,1
45580,Epithelioid Component Present,"Synovial sarcoma, epithelioid cell",1
45581,Cutaneous Involvement,Pilosebaceous Hamartoma,1
45582,Malignant Cellular Infiltrate,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,1
45583,Malignant Cellular Infiltrate,Stage 0 Colon Cancer AJCC v8,1
45584,Lymphoplasmacytic Infiltrate,Oropharyngeal lymphoepithelioma stage I,1
45585,Hereditary Lesion,Hereditary Diffuse Gastric Adenocarcinoma,1
45586,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Ann Arbor Stage,1
45587,Carcinomatous Component Present,Refractory Urothelial Carcinoma,1
45588,Mixed Cellular Population,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,1
45589,Ineffective hematopoiesis,Recurrent Myelodysplastic Syndrome,1
45590,Tissue Differentiation Uncertain,Cutaneous myxoma,1
45591,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage III,1
45592,Epithelial Component Present,Non-Functioning Pituitary Gland Microadenoma,1
45593,Monomorphic Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
45594,Carcinomatous Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
45595,Epithelial Component Present,Desmoplastic trichoepithelioma,1
45596,Carcinomatous Component Present,Pancreatic adenocarcinoma metastatic,1
45597,Childhood Lesion,Refractory Childhood Hodgkin Lymphoma,1
45598,Carcinomatous Component Present,signet ring cell carcinoma of appendix,1
45599,Secondary Lesion,Squamous cell carcinoma of head and neck metastatic,1
45600,Vascular Channel Formation,Hemangiosarcoma,1
45601,Well-Circumscribed Lesion,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
45602,Epithelial Component Present,Bronchial adenoma,1
45603,Neuroendocrine Differentiation,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
45604,Recurrent disease,Recurrent Primary Cutaneous Lymphoma,1
45605,Cutaneous Involvement,Benign Eccrine Neoplasm,1
45606,Malignant Cellular Infiltrate,Nephroblastoma,1
45607,Thick-Walled Hyalinized Vessels Present,Cerebellopontine Angle Schwannoma,1
45608,Nuclear Molding,Childhood Lung Small Cell Carcinoma,1
45609,Adulthood Lesion,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
45610,Desmoplastic Stroma Formation,Desmoplastic melanoma,1
45611,Malignant Cellular Infiltrate,Stage III Lip Basal Cell Carcinoma,1
45612,Carcinomatous Component Present,basaloid carcinoma of penis,1
45613,Epithelial Component Present,Maxillary Sinus Adenocarcinoma,1
45614,Neuroendocrine Differentiation,Stage III Appendix Neuroendocrine Tumor AJCC v8,1
45615,Adulthood Lesion,Adult T-cell lymphoma/leukemia refractory,1
45616,Epithelial Component Present,Adult Salivary Gland Carcinoma,1
45617,Epithelial Component Present,Distal Urethral Carcinoma,1
45618,Epithelial Component Present,"Thymoma, type AB, malignant",1
45619,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
45620,S-100-Positive Neoplastic Cells Present,Malignant Lung PEComa,1
45621,Exophytic Polypoid Lesion,Vaginal Villous Adenoma,1
45622,Benign Cellular Infiltrate,Benign neoplasm of pleura,1
45623,Carcinomatous Component Present,Stage IIIA Small Intestinal Cancer AJCC v7,1
45624,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Ganglioneuroblastoma, Intermixed",1
45625,Carcinomatous Component Present,Fallopian Tube Transitional Cell Carcinoma,1
45626,Epithelial Component Present,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
45627,Neonatal Lesion,Neonatal leukemia,1
45628,Well-Circumscribed Lesion,Small Intestinal Villous Adenoma,1
45629,Unresectable Mass,Metastatic Unresectable Sarcoma,1
45630,Pseudoalveolar Pattern,Bladder Alveolar Soft Part Sarcoma,1
45631,S-100-Positive Neoplastic Cells Present,Benign Uterine Corpus PEComa,1
45632,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Apoplectic Leiomyoma,1
45633,Papillary Pattern,Papillary cystic tumor,1
45634,Malignant Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
45635,Carcinomatous Component Present,Familial Nonmedullary Thyroid Gland Carcinoma,1
45636,Hyaline Cartilage Differentiation,Grade I Chondrosarcoma,1
45637,Malignant Cellular Infiltrate,Stage II Pancreatic Cancer AJCC v6 and v7,1
45638,Carcinomatous Component Present,Metastatic Triple-Negative Breast Carcinoma,1
45639,Infiltrative Growth Pattern,Fibromatosis colli,1
45640,Malignant Cellular Infiltrate,"Leukemia, Myelocytic, Acute",1
45641,Fibrotic Stroma Formation,Cervical Adenofibroma,1
45642,Malignant Cellular Infiltrate,Adenocarcinoma in tubular adenoma,1
45643,Necrotic changes (finding),Vulvar Small Cell Carcinoma,1
45644,Childhood Lesion,Stage II Childhood Burkitt Lymphoma,1
45645,Neuroendocrine Differentiation,Stage IV Appendix Neuroendocrine Tumor AJCC v8,1
45646,Malignant Cellular Infiltrate,Post polycythaemia vera myelofibrosis,1
45647,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,1
45648,Moderate dysplasia,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
45649,Epithelial Component Present,Stage II Prostate Carcinoma,1
45650,Malignant Cellular Infiltrate,Laryngeal squamous cell carcinoma recurrent,1
45651,Infantile Lesion,Infant Acute Undifferentiated Leukemia,1
45652,Epithelial Component Present,Resectable Pancreatic Acinar Cell Carcinoma,1
45653,Histiocytosis,T-cell/histiocyte rich large B-cell lymphoma,1
45654,Primary Lesion,Angiosarcoma non-metastatic,1
45655,Absence of Muscle Invasion,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
45656,Immunologic Deficiency Syndromes,Maternally Derived Graft Versus Host Disease,1
45657,Malignant Cellular Infiltrate,Parotid Gland Adenocarcinoma,1
45658,Hereditary Lesion,Hereditary Non-Polyposis Colon Cancer Type 2,1
45659,Local disease,Fibrolipoma,1
45660,Well-Circumscribed Lesion,Colon Hyperplastic Polyp,1
45661,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma,1
45662,Malignant Cellular Infiltrate,Stage III Osteosarcoma AJCC v7,1
45663,Neuroendocrine Differentiation,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
45664,Bone Marrow Dysplasia Present,de novo Myelodysplastic Syndrome,1
45665,Nuclear pleomorphism,Degenerated Schwannoma,1
45666,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Cellular Leiomyoma,1
45667,Cutaneous Involvement,Skin Basaloid Carcinoma,1
45668,Malignant Cellular Infiltrate,"Thymoma, type B3",1
45669,Epithelial Component Present,Stage IIIB Lung Cancer AJCC v8,1
45670,Malignant Cellular Infiltrate,undifferentiated carcinoma of liver,1
45671,Epithelial Component Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,1
45672,Epithelial Component Present,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
45673,Carcinomatous Component Present,Appendix Carcinoma by AJCC v8 Stage,1
45674,Primary Lesion,Recurrent Testicular Lymphoma,1
45675,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
45676,Neuroendocrine Differentiation,Stage 0 Merkel Cell Carcinoma AJCC v7,1
45677,Borderline Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,1
45678,Benign Cellular Infiltrate,Fibromatosis colli,1
45679,Recurrent disease,Recurrent Visual Pathway Glioma,1
45680,Epithelial Component Present,Intraductal papillary breast neoplasm,1
45681,Epithelial Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
45682,Recurrent disease,Recurrent Grade 1 Follicular Lymphoma,1
45683,Papillary Pattern,Vaginal Mullerian Papilloma,1
45684,Glucagon-Like Peptide Positive Neoplastic Cells Present,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
45685,Myxoid Stroma Formation,Unresectable Chordoma,1
45686,Malignant Cellular Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
45687,Chromogranin A Positive Neoplastic Cells Present,Ovarian Carcinoid Tumor,1
45688,Carcinomatous Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
45689,Epithelial Component Present,Stage II Fallopian Tube Cancer AJCC v8,1
45690,Intermediate Grade Neuroendocrine Lesion,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
45691,Metastatic Lesion,Metastatic Neoplasm,1
45692,Intraductal Lesion,Flat Ductal Epithelial Atypia of the Breast,1
45693,Malignant Cellular Infiltrate,Esophageal squamous cell carcinoma recurrent,1
45694,Nodular lesions,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
45695,Malignant Cellular Infiltrate,Stage IB Ampulla of Vater Cancer AJCC v7,1
45696,Childhood Lesion,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
45697,Cystic Change,Seborrheic keratosis,1
45698,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV,1
45699,Malignant Cellular Infiltrate,Human Papillomavirus-Related Verrucous Carcinoma,1
45700,Absence of Stromal Invasion,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
45701,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
45702,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Pathologic Stage,1
45703,Benign Cellular Infiltrate,Leiomyoma of ciliary body,1
45704,Malignant Cellular Infiltrate,Stage 0is Ureter Cancer AJCC v8,1
45705,Malignant Cellular Infiltrate,Mixed Acinar-Ductal Carcinoma of the Pancreas,1
45706,Tubular Structures Present,"Gallbladder Adenocarcinoma, Biliary Type",1
45707,Benign Cellular Infiltrate,Renal Pelvis Urothelial Papilloma,1
45708,Metastatic Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,1
45709,Metastatic Lesion,Secondary malignant neoplasm of pleura,1
45710,Neuropil Present,Differentiating Neuroblastoma,1
45711,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage IV,1
45712,Gyriform Trabecular Pattern,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
45713,Bone Marrow Dysplasia Present,Refractory Thrombocytopenia,1
45714,Papillary Pattern,Laryngeal verrucous carcinoma stage IV,1
45715,Malignant Cellular Infiltrate,Stage IV Ovarian Teratoma AJCC v6 and v7,1
45716,Indolent Clinical Course,Pericardial Adenomatoid Tumor,1
45717,Ineffective hematopoiesis,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
45718,Necrotic changes (finding),small cell carcinoma of ureter,1
45719,Recurrent disease,Recurrent Ovarian Clear Cell Adenocarcinoma,1
45720,Epithelial Component Present,Small intestine carcinoma stage III,1
45721,Primary Lesion,Stage III Hepatocellular Carcinoma AJCC v7,1
45722,Benign Cellular Infiltrate,Benign Pericardial Germ Cell Tumor,1
45723,Epithelial Component Present,Pancreatic Ductal Adenocarcinoma,1
45724,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory High Risk Myelodysplastic Syndrome,1
45725,Malignant Cellular Infiltrate,Stage IIIA Rectal Cancer AJCC v8,1
45726,Epithelial Component Present,Prostate cancer stage A,1
45727,Malignant Cellular Infiltrate,Stage III Ureter Cancer AJCC v8,1
45728,Benign Cellular Infiltrate,Fibromyxolipoma,1
45729,Malignant Cellular Infiltrate,Malignant germ cell neoplasm,1
45730,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of lung,1
45731,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
45732,Secondary Lesion,Stage IV Esophageal Squamous Cell Carcinoma,1
45733,Recurrent disease,Recurrent Retinoblastoma,1
45734,Cavernous Vascular Space Formation,Colon Cavernous Hemangioma,1
45735,Carcinomatous Component Present,BCLC Stage A Hepatocellular Carcinoma,1
45736,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma,1
45737,Neuroendocrine Differentiation,"Neuroendocrine carcinoma, metastatic",1
45738,Cutaneous Involvement,Dermatophytosis,1
45739,Nuclear Molding,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
45740,Firm mass,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
45741,Carcinomatous Component Present,Alcohol-Related Esophageal Squamous Cell Carcinoma,1
45742,Thyroglobulin Positive Neoplastic Cells Present,Nonencapsulated sclerosing tumor,1
45743,Epithelial Component Present,Hindgut Carcinoid Tumor,1
45744,Epithelial Component Present,Endometrial Mucinous Adenocarcinoma,1
45745,Infiltrative Growth Pattern,Metastatic Kidney Medullary Carcinoma,1
45746,Elastin Fibers Present,Trichodiscoma,1
45747,Malignant Cellular Infiltrate,Stage 0 Cervical Cancer AJCC v6,1
45748,Fibrotic Stroma Formation,Laryngeal Mucoepidermoid Carcinoma,1
45749,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid carcinoma ovary,1
45750,Adnexal Differentiation,Sporadic Cylindroma,1
45751,Epithelial Component Present,cystadenocarcinoma of salivary gland,1
45752,Epithelial Component Present,clear cell adenocarcinoma of urethra,1
45753,Epithelial Component Present,Invasive micropapillary carcinoma of breast,1
45754,Carcinomatous Component Present,Stage I Appendix Carcinoma AJCC v7,1
45755,Malignant Cellular Infiltrate,Stage I Ovarian Germ Cell Tumor AJCC v6 and v7,1
45756,Lymphoplasmacytic Infiltrate,Childhood Central Nervous System Germinoma,1
45757,Infiltrative Growth Pattern,Adult Brain Stem Gliosarcoma,1
45758,Malignant Cellular Infiltrate,Refractory Cytopenia of Childhood,1
45759,Epithelial Component Present,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
45760,Ground Glass Nuclear Inclusion,Follicular Variant Thyroid Gland Papillary Carcinoma,1
45761,Malignant Cellular Infiltrate,Resectable Dedifferentiated Liposarcoma,1
45762,Radiation Sickness,Solar Radiation-Related Malignant Neoplasm,1
45763,Dysplasia,Intestinal Intraepithelial Neoplasia,1
45764,Biphasic Pattern,Anal Ectopic Fibroadenoma,1
45765,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
45766,Malignant Cellular Infiltrate,Metastatic Breast Neuroendocrine Neoplasm,1
45767,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v8,1
45768,Well Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor G2,1
45769,Exophytic Polypoid Lesion,Appendix Villous Adenoma,1
45770,Malignant Cellular Infiltrate,Choroid Spindle Cell Type A Melanoma,1
45771,Epithelial Component Present,Stage IVA Hepatocellular Carcinoma AJCC v8,1
45772,Severe cytologic atypia,Small Intestinal Neuroendocrine Carcinoma,1
45773,Epithelial Component Present,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
45774,Carcinomatous Component Present,Carcinoma Arising in Nasal Papillomatosis,1
45775,Malignant Cellular Infiltrate,Carcinoma of subglottis,1
45776,Papillary Pattern,Verrucous carcinoma,1
45777,Metastatic Lesion,Metastatic Ewing's Sarcoma,1
45778,Epithelial Component Present,Tumor of the Thecoma/Fibroma Group,1
45779,Epithelial Component Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12),1
45780,Benign Cellular Infiltrate,Hemangioma of intracranial structure,1
45781,Epithelial Component Present,Metastatic Lung Non-Small Cell Squamous Carcinoma,1
45782,atypia morphology,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
45783,Polymorphic Cellular Infiltrate,Angioimmunoblastic Lymphadenopathy,1
45784,Carcinomatous Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
45785,Malignant Cellular Infiltrate,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8,1
45786,Malignant Cellular Infiltrate,Pharyngeal cancer stage I,1
45787,Malignant Cellular Infiltrate,Retroperitoneal Lymphoma,1
45788,Malignant Cellular Infiltrate,Stage II Burkitt Lymphoma,1
45789,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
45790,Malignant Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
45791,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Minimal Differentiation,1
45792,Bone marrow depression,Hypocellular Myelodysplastic Syndrome,1
45793,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v8,1
45794,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone,1
45795,Childhood Lesion,Recurrent Childhood Pilocytic Astrocytoma,1
45796,Endophytic Tumor Growth,"Transitional cell papilloma, inverted",1
45797,Anaplasia,"Glioblastoma, IDH-Wildtype",1
45798,Epithelial Component Present,Stage I Appendix Neuroendocrine Tumor AJCC v8,1
45799,Epithelial Component Present,Stage 0is Urethral Cancer AJCC v8,1
45800,Mesenchymal Component Present,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
45801,Well-Circumscribed Lesion,Osteoid osteoma,1
45802,Epithelial Component Present,Stage I Merkel Cell Carcinoma AJCC v7,1
45803,Carcinomatous Component Present,Endometrial Clear Cell Adenocarcinoma,1
45804,Well-Circumscribed Lesion,Benign neoplasm of mesothelial tissue of peritoneum,1
45805,Epithelial Component Present,Mesonephric tumor,1
45806,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Mediastinal Teratoma,1
45807,Epithelial Component Present,Pancreatic Medullary Carcinoma,1
45808,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma,1
45809,Epithelial Component Present,Type II Endometrial Adenocarcinoma,1
45810,Breast Microcalcification,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
45811,Primary Lesion,Lentigo maligna recurrent,1
45812,Cutaneous Involvement,Non-Neoplastic Skin Disorder,1
45813,Primary Lesion,Recurrent Childhood Brain Stem Astrocytoma,1
45814,Epithelial Component Present,Hereditary Prostate Carcinoma,1
45815,Epithelial Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
45816,Malignant Cellular Infiltrate,Stage IV Childhood Non-Hodgkin Lymphoma,1
45817,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage IV,1
45818,Malignant Cellular Infiltrate,Activated B-cell type diffuse large B-cell lymphoma,1
45819,Mucoid Stroma Formation,Myxopapillary ependymoma,1
45820,Epithelial Component Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
45821,Recurrent disease,Malignant neoplasm of nasopharynx recurrent,1
45822,Malignant Cellular Infiltrate,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
45823,Malignant Cellular Infiltrate,Malignant neoplasm of meninges,1
45824,Malignant Cellular Infiltrate,"Dendritic Cell Sarcoma, Interdigitating",1
45825,Malignant Cellular Infiltrate,Malignant lymphoma - lymphoplasmacytic,1
45826,Epithelial Component Present,Recurrent Childhood Hepatocellular Carcinoma,1
45827,Malignant Cellular Infiltrate,Minor Salivary Gland Undifferentiated Carcinoma,1
45828,Epithelial Component Present,Colorectal Sarcomatoid Carcinoma,1
45829,Malignant Cellular Infiltrate,Alcohol-Related Laryngeal Carcinoma,1
45830,Childhood Lesion,Stage III Childhood Hodgkin Lymphoma,1
45831,Pregnancy Complications,Gestational Ovarian Choriocarcinoma,1
45832,Carcinomatous Component Present,Gastric Neuroendocrine Carcinoma,1
45833,Recurrent disease,Recurrent Childhood Central Nervous System Neoplasm,1
45834,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
45835,Enterochromaffin Type Granules Present,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
45836,Malignant Cellular Infiltrate,Recurrent Cancer of Gallbladder,1
45837,Malignant Cellular Infiltrate,Recurrent Ovarian Germ Cell Tumor,1
45838,Malignant Cellular Infiltrate,Primary cutaneous gamma-delta T-cell lymphoma,1
45839,Cutaneous Involvement,Clinical Stage IV Cutaneous Melanoma AJCC v8,1
45840,Increased Cellularity Present,Anaplastic Ependymoma,1
45841,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
45842,Cartilaginous Differentiation,Primary chondrosarcoma of bone,1
45843,Epithelial Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,1
45844,Photosensitivity of skin,Rothmund-Thomson syndrome,1
45845,Serum IgM Monoclonal Gammopathy of Less than 30g/L,IgM monoclonal gammopathy of uncertain significance,1
45846,Malignant Cellular Infiltrate,Stage IVC Hypopharyngeal Carcinoma AJCC v7,1
45847,Hyperplastic Tissue Present,Mesonephric Hyperplasia,1
45848,Malignant Cellular Infiltrate,Meningeal Carcinomatosis,1
45849,Polymorphic Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
45850,Biphasic Pattern,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
45851,Carcinomatous Component Present,large cell carcinoma of salivary gland,1
45852,Cutaneous Involvement,Small plaque parapsoriasis,1
45853,Recurrent disease,Testis cancer recurrent,1
45854,Cutaneous Involvement,Cutaneous myxoma,1
45855,Malignant Cellular Infiltrate,Malignant lymphoma - lymphoplasmacytic,1
45856,Cutaneous Involvement,Skin squamous cell carcinoma recurrent,1
45857,Carcinomatous Component Present,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
45858,CD30-Positive Neoplastic Cells Present,"Anaplastic large cell lymphoma, ALK negative",1
45859,Epithelial Component Present,Papillary serous cystadenocarcinoma,1
45860,Concentric Perivascular Arrangement of Tumor Cells,Giant Cell Angioblastoma,1
45861,Childhood Lesion,Rare Childhood Malignant Neoplasm,1
45862,High Mitotic Activity,Combined Lung Large Cell Neuroendocrine Carcinoma,1
45863,Carcinomatous Component Present,Thymic Undifferentiated Carcinoma,1
45864,Generalized Dysplasia,Rectal Traditional Serrated Adenoma,1
45865,Mesenchymal Differentiation,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
45866,Malignant Cellular Infiltrate,Stage IVA Uterine Sarcoma AJCC v7,1
45867,Epithelial Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
45868,Low Grade Neuroendocrine Lesion,Gastric Carcinoid Tumor,1
45869,Malignant Cellular Infiltrate,undifferentiated carcinoma of salivary gland,1
45870,Malignant Cellular Infiltrate,Recurrent Cervical Adenosquamous Carcinoma,1
45871,Malignant Cellular Infiltrate,Secondary malignant neoplasm of prostate,1
45872,Carcinomatous Component Present,Urothelial carcinoma ureter recurrent,1
45873,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,1
45874,Well-Circumscribed Lesion,Malignant phyllodes tumor of breast,1
45875,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Choriocarcinoma,1
45876,Cribriform Pattern,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
45877,Intermediate Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2,1
45878,Nuclear Grooves,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
45879,Metastatic Lesion,CNS metastases,1
45880,Benign Cellular Infiltrate,lipoma of large intestine,1
45881,Multinodular Mass,Adrenal Gland Angiosarcoma,1
45882,Cutaneous Involvement,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
45883,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of trachea,1
45884,Malignant Cellular Infiltrate,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,1
45885,Malignant Cellular Infiltrate,rhabdomyosarcoma of mediastinum,1
45886,Mucoid Stroma Formation,Bile duct mucinous adenocarcinoma,1
45887,Cutaneous Involvement,"Basal cell carcinoma, micronodular",1
45888,Benign Cellular Infiltrate,Ectopic hamartomatous thymoma,1
45889,Malignant Cellular Infiltrate,Endometrioid adenocarcinoma recurrent,1
45890,Erythema,Inflammatory carcinoma of breast stage IV,1
45891,Adulthood Lesion,Adult Lymphoma,1
45892,Carcinomatous Component Present,Adenocarcinoma with osseous metaplasia,1
45893,Carcinomatous Component Present,Colon Cancer by AJCC v8 Stage,1
45894,Carcinomatous Component Present,Hereditary Ovarian Carcinoma,1
45895,Well-Circumscribed Lesion,Colorectal Adenoma with Mild Dysplasia,1
45896,Metastatic Lesion,Metastatic Parathyroid Gland Carcinoma,1
45897,Malignant Cellular Infiltrate,AIDS with Kaposi's sarcoma,1
45898,Necrotic changes (finding),Digestive System Large Cell Neuroendocrine Carcinoma,1
45899,Adulthood Lesion,Adult Mesenchymal Chondrosarcoma,1
45900,Pushing Tumor Margin,Verrucous carcinoma,1
45901,Malignant Cellular Infiltrate,Malignant neoplasm of cerebellum,1
45902,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
45903,Necrotic changes (finding),Recurrent Childhood Giant Cell Glioblastoma,1
45904,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
45905,Secondary Lesion,Secondary Cerebral Hodgkin Lymphoma,1
45906,Epithelial Component Present,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
45907,Hyperplastic Tissue Present,Sebaceous hyperplasia,1
45908,Malignant Cellular Infiltrate,Stage III Vulvar Cancer AJCC v8,1
45909,High Mitotic Activity,Advanced Small Intestinal Neuroendocrine Carcinoma,1
45910,Epithelial Component Present,Palate carcinoma,1
45911,Cutaneous Involvement,Reactive Cutaneous Fibrous Lesion,1
45912,Severe dysplasia,Rectal Adenoma with Severe Dysplasia,1
45913,Adnexal Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
45914,Papillary Pattern,Papillary Thyroid Microcarcinoma,1
45915,Benign Cellular Infiltrate,Benign digestive system neoplasms,1
45916,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Adenocarcinoma,1
45917,Cutaneous Involvement,Cutaneous Melanoma of the Extremity,1
45918,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Liver,1
45919,Malignant Cellular Infiltrate,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
45920,Architectural Distortion,Stage 0a Bladder Cancer AJCC v8,1
45921,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),1
45922,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage II,1
45923,Malignant Cellular Infiltrate,Unresectable Carcinoma,1
45924,Benign Cellular Infiltrate,Benign neurologic neoplasms,1
45925,Malignant Cellular Infiltrate,Solid Alveolar Rhabdomyosarcoma,1
45926,Carcinomatous Component Present,Stage 0 Renal Pelvis Cancer AJCC v7,1
45927,Malignant Cellular Infiltrate,adenocarcinoma of extrahepatic bile duct,1
45928,Epithelial Component Present,Vaginal Mucinous Adenocarcinoma,1
45929,Malignant Cellular Infiltrate,Serous cystadenocarcinoma of pancreas,1
45930,Epithelial Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v8,1
45931,Anaplasia,Intracortical osteosarcoma,1
45932,Malignant Cellular Infiltrate,Recurrent Adult Burkitt Lymphoma,1
45933,Adulthood Lesion,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
45934,Epithelial Component Present,Stage III Adrenal Cortex Carcinoma AJCC v7,1
45935,Edematous Stroma Formation,Superficial angiomyxoma,1
45936,Epithelial Component Present,Adenolymphoma,1
45937,Stromal Invasion,Ovarian epithelial cancer stage II,1
45938,Benign Cellular Infiltrate,Cervical Blue Nevus,1
45939,Recurrent disease,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,1
45940,Epithelial Component Present,Mucinous cystadenocarcinoma of ovary,1
45941,Adulthood Lesion,Stage III Adult Immunoblastic Lymphoma,1
45942,Malignant Cellular Infiltrate,"Pheochromocytoma, malignant",1
45943,Adnexal Differentiation,Vulvar Syringoma,1
45944,Malignant Cellular Infiltrate,Colorectal Small Cell Neuroendocrine Carcinoma,1
45945,Histiocytosis haematophagic,Secondary haemophagocytic lymphohistiocytosis,1
45946,Refractory Disease,Marginal zone lymphoma refractory,1
45947,Malignant Cellular Infiltrate,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
45948,Carcinomatous Component Present,Hard Palate Squamous Cell Carcinoma,1
45949,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of the cecum,1
45950,Malignant Cellular Infiltrate,Grade III Childhood Astrocytoma,1
45951,Malignant Cellular Infiltrate,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,1
45952,Epithelial Component Present,Intestinal Neuroendocrine Tumor G2,1
45953,Cutaneous Involvement,Porphyria Cutanea Tarda,1
45954,Malignant Cellular Infiltrate,"Carcinoma, Signet Ring Cell",1
45955,Carcinomatous Component Present,undifferentiated carcinoma of appendix,1
45956,Well Differentiated Neuroendocrine Lesion,Somatostatinoma,1
45957,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v7,1
45958,Nuclear Atypia,Supratentorial Glioblastoma,1
45959,Carcinomatous Component Present,Stage IIB Ovarian Cancer AJCC v8,1
45960,Malignant Cellular Infiltrate,Bartholin Gland Adenosquamous Carcinoma,1
45961,Epithelial Component Present,Cervical Large Cell Neuroendocrine Carcinoma,1
45962,Refractory Disease,Lymphoplasmacytoid lymphoma/immunocytoma refractory,1
45963,Insular Pattern,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
45964,Indolent Clinical Course,Hemangioma of Peripheral Nerve,1
45965,Carcinomatous Component Present,Stage 0 Distal Bile Duct Cancer AJCC v7,1
45966,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v6,1
45967,Carcinomatous Component Present,Well Differentiated Prostate Adenocarcinoma,1
45968,Well Differentiated Neuroendocrine Lesion,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
45969,Microcystic Change,Childhood Fibrillary Astrocytoma,1
45970,Malignant Cellular Infiltrate,Ganglioneuroblastoma,1
45971,Carcinomatous Component Present,Primary Carcinoma Unspecified Site,1
45972,Malignant Cellular Infiltrate,Ovarian Cancer by FIGO Stage,1
45973,Adulthood Lesion,Stage I Indolent Adult Non-Hodgkin Lymphoma,1
45974,Epithelial Component Present,Low Grade Cervical Squamous Intraepithelial Neoplasia,1
45975,Benign Cellular Infiltrate,Cervical Mullerian Papilloma,1
45976,Poorly Differentiated Lesion,Large cell lung cancer recurrent,1
45977,Malignant Cellular Infiltrate,Recurrent T Acute Lymphoblastic Leukemia,1
45978,Cutaneous Involvement,Post-kala-azar dermal leishmaniasis,1
45979,Epithelial Component Present,Appendix Tubular Adenoma,1
45980,Malignant Cellular Infiltrate,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,1
45981,Malignant Cellular Infiltrate,Stage IV Prostate Cancer AJCC v8,1
45982,Indolent Clinical Course,Squamous odontogenic tumor,1
45983,Malignant Cellular Infiltrate,Burkitt Lymphoma,1
45984,Hyperplastic Tissue Present,Papillary Ductal Breast Hyperplasia,1
45985,Primary Lesion,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,1
45986,Recurrent disease,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent,1
45987,Malignant Cellular Infiltrate,"Carcinoma, Transitional Cell",1
45988,Epithelial Component Present,Stage IIB Eyelid Carcinoma AJCC v8,1
45989,Benign Cellular Infiltrate,Oral Cavity Adenoma,1
45990,Biphasic Pattern,"Transitional cell carcinoma, spindle cell",1
45991,Malignant Cellular Infiltrate,Sarcoma by NCI Grade,1
45992,Cribriform Pattern,Colon Cribriform Comedo-Type Adenocarcinoma,1
45993,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",1
45994,Malignant Cellular Infiltrate,Stage I Ampulla of Vater Cancer AJCC v8,1
45995,Adnexal Differentiation,Neoplasm of skin with adnexal differentiation,1
45996,Clinical TNM Finding,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
45997,Carcinomatous Component Present,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
45998,Increased Cellularity Present,pineoblastoma,1
45999,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
46000,Secondary Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
46001,Melanin Pigment Present,Pigmented Basal Cell Carcinoma,1
46002,Malignant Cellular Infiltrate,Primary Cutaneous Plasmablastic Lymphoma,1
46003,Epithelial Component Present,Stage IV Ovarian Cancer AJCC v6 and v7,1
46004,Malignant Cellular Infiltrate,Waldenstrom's macroglobulinemia refractory,1
46005,Epithelial Component Present,Small Intestinal Signet Ring Cell Carcinoma,1
46006,Carcinomatous Component Present,Lower Gingival Verrucous Carcinoma,1
46007,Carcinomatous Component Present,adenocarcinoma of breast with spindle cell metaplasia,1
46008,Malignant Cellular Infiltrate,Head and Neck Basaloid Carcinoma,1
46009,Immunosuppression-Related Post-Transplant Toxicity,Engraftment syndrome,1
46010,High Mitotic Activity,Small cell carcinoma of esophagus,1
46011,Malignant Cellular Infiltrate,Malignant Mixed Mesodermal (Mullerian) Tumor,1
46012,Carcinomatous Component Present,Carcinoma breast stage I,1
46013,Malignant Cellular Infiltrate,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
46014,Recurrent disease,Recurrent Childhood Protoplasmic Astrocytoma,1
46015,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Neuroendocrine Carcinoma,1
46016,Metaplasia,Lung Enteric Adenocarcinoma,1
46017,Peripheral Nuclear Palisading,Basaloid carcinoma,1
46018,Biphasic Pattern,Carcinosarcoma of cervix uteri,1
46019,Single Cell Necrosis,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
46020,Indolent Clinical Course,Encephalocraniocutaneous lipomatosis,1
46021,Primary Lesion,"Brain Tumor, Primary",1
46022,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
46023,Carcinomatous Component Present,Adenocarcinoma in multiple adenomatous polyps,1
46024,Benign Cellular Infiltrate,lipoma of esophagus,1
46025,Hereditary Lesion,Hereditary spherocytosis,1
46026,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Brain,1
46027,Osseous Differentiation,Periosteal Osteosarcoma,1
46028,Osseous Differentiation,Metastatic osteosarcoma,1
46029,Malignant Cellular Infiltrate,Paget Disease,1
46030,Refractory Disease,Refractory Ependymoma,1
46031,Malignant Cellular Infiltrate,Adenoma of the Colon with Intramucosal Adenocarcinoma,1
46032,Lobulated Growth Pattern,Sellar Chondroid Chordoma,1
46033,Primary Lesion,Childhood Infratentorial Ependymoma,1
46034,Severe cytologic atypia,Neuroendocrine carcinoma of appendix,1
46035,Increased Cellularity Present,Sellar Neuroblastoma,1
46036,Blasts of Mixed Phenotype Present,Acute biphenotypic leukemia,1
46037,Refractory Disease,Refractory Liver Carcinoma,1
46038,Malignant Cellular Infiltrate,Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7,1
46039,Epithelial Component Present,signet ring cell carcinoma of appendix,1
46040,Monophasic Pattern,Lung Monophasic Synovial Sarcoma,1
46041,Papillary Pattern,Papilloma of eyelid,1
46042,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v7,1
46043,Malignant Cellular Infiltrate,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,1
46044,Nuclear Grooves,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
46045,Cystic Change,Clear Cell Papillary Cystadenoma,1
46046,Cutaneous Involvement,Dermatophytosis of groin and perianal area,1
46047,Anaplasia,Thymic Sarcomatoid Carcinoma,1
46048,Microvascular Proliferation,Childhood Pilocytic Astrocytoma,1
46049,Non-Hereditary Lesion,Mucinous adenocarcinoma gastric,1
46050,Myxoid Stroma Formation,Neurothekeoma,1
46051,Epithelial Component Present,Apudoma,1
46052,Epithelial Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
46053,Metastatic Lesion,Carcinomatosis of peritoneal cavity,1
46054,Recurrent disease,Recurrent Thyroid Gland Anaplastic Carcinoma,1
46055,Epithelial Component Present,Appendix High Grade Intraepithelial Neoplasia,1
46056,Epithelial Component Present,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",1
46057,Carcinomatous Component Present,Squamous cell carcinoma with horn formation,1
46058,Benign Cellular Infiltrate,Syringocystadenoma Papilliferum,1
46059,High Grade Lesion,Occult Lung Small Cell Carcinoma,1
46060,Malignant Cellular Infiltrate,Pathologic Stage IIB Gastric Cancer AJCC v8,1
46061,Vascular Channel Formation,Hemangioma of liver,1
46062,Antoni A Pattern,Benign Dermal Schwannoma,1
46063,Malignant Cellular Infiltrate,Small cell carcinoma of lung,1
46064,Carcinomatous Component Present,Recurrent Lobular Breast Carcinoma,1
46065,Carcinomatous Component Present,Metastatic Oropharyngeal Carcinoma,1
46066,Indolent Clinical Course,Parotid Gland Lymphangioma,1
46067,Carcinomatous Component Present,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
46068,Epithelial Component Present,Gastric Carcinoma with Lymphoid Stroma,1
46069,Malignant Cellular Infiltrate,Stage IS Testicular Cancer AJCC v6 and v7,1
46070,Neuroendocrine Differentiation,Pancreatic neuroendocrine tumor metastatic,1
46071,Skin nodule,Skin Nodular Solid Basal Cell Carcinoma,1
46072,Monomorphic Cellular Infiltrate,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,1
46073,Absence of Invasion,Stage 0 Rectal Cancer AJCC v6 and v7,1
46074,Poorly Differentiated Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma,1
46075,Fibrotic Stroma Formation,Sarcomatoid Intrahepatic Cholangiocarcinoma,1
46076,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Teratoma,1
46077,Fibrotic Stroma Formation,Ovarian Microcystic Stromal Tumor,1
46078,Malignant Cellular Infiltrate,Parotid Gland Acinic Cell Carcinoma,1
46079,Malignant Cellular Infiltrate,Nasopharyngeal Papillary Adenocarcinoma,1
46080,Pathologic TNM Finding,Pathologic Stage I Retinoblastoma AJCC v8,1
46081,Hypercellular bone marrow,Philadelphia chromosome negative chronic myelogenous leukemia,1
46082,Geographic Necrosis,Sellar Embryonal Carcinoma,1
46083,In Situ Lesion,Stage 0 Anal Cancer AJCC v8,1
46084,Epithelial Component Present,Adenomatous Polyps,1
46085,Regional Disease,Locally Advanced Unresectable Prostate Carcinoma,1
46086,Malignant Cellular Infiltrate,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
46087,Carcinomatous Component Present,Stage 0 Eyelid Carcinoma AJCC v7,1
46088,Malignant Cellular Infiltrate,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
46089,Adulthood Lesion,Adult Pleomorphic Hepatocellular Carcinoma,1
46090,Erythema,Inflammatory carcinoma of breast stage III,1
46091,Malignant Cellular Infiltrate,Parotid Gland Liposarcoma,1
46092,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage III,1
46093,Severe cytologic atypia,Small Intestinal Neuroendocrine Carcinoma,1
46094,Secondary Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
46095,Malignant Cellular Infiltrate,Myxoinflammatory fibroblastic sarcoma,1
46096,Intermediate Grade Neuroendocrine Lesion,Gastric Neuroendocrine Tumor G2,1
46097,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
46098,Carcinomatous Component Present,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
46099,Malignant Cellular Infiltrate,Ann Arbor Stage IIIA Hodgkin Lymphoma,1
46100,Malignant Cellular Infiltrate,Recurrent Primary Effusion Lymphoma,1
46101,Dysplasia,Stage 0a Renal Pelvis Cancer AJCC v8,1
46102,S-100-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Interdigitating",1
46103,Neuroendocrine Differentiation,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
46104,Well-Circumscribed Lesion,Peutz Jehgers polyp,1
46105,Organoid Pattern,Alveolar Soft Part Sarcoma,1
46106,Malignant Cellular Infiltrate,"Papillary squamous cell carcinoma, non-invasive",1
46107,Neoplastic Plasma Cells Present in Bone Marrow,DS Stage III Plasma Cell Myeloma,1
46108,Carcinomatous Component Present,Ovarian Cancer by FIGO Stage,1
46109,Malignant Cellular Infiltrate,Carcinoma in situ of prostate,1
46110,Multifocal Lesion,"Lipomatosis, Multiple Symmetrical",1
46111,Metaplasia,Urethral Nephrogenic Adenoma,1
46112,Epidermotropic Lymphocytic Infiltrate,Pagetoid reticulosis,1
46113,Tissues Derived from Two or Three Embryonic Layers Present,Mature Ovarian Teratoma,1
46114,Carcinomatous Component Present,Carcinoma of apocrine gland,1
46115,Regional Disease,Ureteric cancer regional,1
46116,Low Mitotic Activity,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
46117,Papillary Pattern,"Papillary cystadenoma, borderline malignancy",1
46118,High Grade Lesion,Langerhans Cell Sarcoma,1
46119,Malignant Cellular Infiltrate,Stage I Oropharyngeal Carcinoma,1
46120,Epithelial Component Present,Breast Carcinoma by Gene Expression Profile,1
46121,Presence of a Hormonal Syndrome,Functioning Pituitary Gland Microadenoma,1
46122,Neuroendocrine Differentiation,Endometrial Small Cell Carcinoma,1
46123,Aggressive Clinical Course,Thoracic NUT Carcinoma,1
46124,Benign Cellular Infiltrate,Desmoplastic trichoepithelioma,1
46125,Malignant Cellular Infiltrate,Childhood Refractory Malignant Solid Neoplasm,1
46126,Primary Lesion,Cerebellar Glioblastoma,1
46127,"Undifferentiated ""Fetal-Type"" Tissues Present",Grade 1 Ovarian Teratoma,1
46128,Carcinomatous Component Present,High Grade Broad Ligament Serous Adenocarcinoma,1
46129,Chronic Inflammatory Infiltrate,Cutaneous Fibrous Histiocytoma,1
46130,Carcinomatous Component Present,Metastatic Kidney Carcinoma,1
46131,Malignant Cellular Infiltrate,Malignant neoplasm of pineal gland,1
46132,Epithelial Component Present,Grade 2 Clear Cell Renal Cell Carcinoma,1
46133,Well-Circumscribed Lesion,Childhood Thyroid Gland Medullary Carcinoma,1
46134,Malignant Cellular Infiltrate,Marginal Zone B-Cell Lymphoma,1
46135,Unfavorable Clinical Outcome,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
46136,Epithelial Component Present,Thyroid stimulating hormone-producing pituitary tumor,1
46137,Intraductal Lesion,Intracystic papillary adenoma,1
46138,Intraocular Lesion,Intraocular Lymphoma,1
46139,Epithelial Component Present,Metastatic Gastric Carcinoma,1
46140,Thick-Walled Hyalinized Vessels Present,Pleural Schwannoma,1
46141,Malignant Cellular Infiltrate,Parotid Gland Undifferentiated Carcinoma,1
46142,Malignant Cellular Infiltrate,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin,1
46143,Tubular Pattern,tubular adenoma of stomach,1
46144,Systemic disease,Aggressive Systemic Mastocytosis,1
46145,Carcinomatous Component Present,Breast Carcinoma with Osteoclastic Giant Cells,1
46146,Exophytic Papillary Lesion,Urethral Condyloma Acuminatum,1
46147,Lesion with Diameter of 10mm or Less,Papillary Thyroid Microcarcinoma,1
46148,Epithelial Component Present,Densely Granulated Corticotroph Adenoma,1
46149,Carcinomatous Component Present,Stage IV Laryngeal Carcinoma,1
46150,Epithelial Component Present,Adrenal Gland Pheochromocytoma,1
46151,Malignant Cellular Infiltrate,bilateral breast cancer,1
46152,Nuclear Grooves,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
46153,Oligodendroglial Component Present,Adult Anaplastic Oligodendroglioma,1
46154,Enamel Formation (finding),"Fibro-odontoma, Ameloblastic",1
46155,Epithelial Component Present,neuroendocrine carcinoma of anal canal,1
46156,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
46157,Pregnancy Complications,Placental Site Nodule or Plaque,1
46158,Refractory Disease,Refractory Small Intestinal Carcinoma,1
46159,Metastatic Lesion,Secondary malignant neoplasm of skin,1
46160,Epithelial Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
46161,Carcinomatous Component Present,Stage II Ureter Cancer AJCC v7,1
46162,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract,1
46163,Invasive Lesion,Squamous cell breast carcinoma,1
46164,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,1
46165,Cytoplasmic Accumulation of Black Pigment,Thyroid Gland Black Follicular Adenoma,1
46166,Malignant Cellular Infiltrate,squamous cell carcinoma of lacrimal gland,1
46167,Carcinomatous Component Present,Stage 0 Vulvar Cancer,1
46168,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage II,1
46169,Bone marrow reticulin fibrosis,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
46170,Epithelial Component Present,adenosquamous carcinoma of ovary,1
46171,Carcinomatous Component Present,Childhood Laryngeal Carcinoma,1
46172,Malignant Cellular Infiltrate,Mantle cell lymphoma refractory,1
46173,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v8,1
46174,Cutaneous Involvement,Stage IVB Basal Cell Lip Carcinoma,1
46175,Cutaneous Involvement,Acral Skin Nevus,1
46176,Malignant Cellular Infiltrate,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",1
46177,Carcinomatous Component Present,Stage II Nasopharyngeal Carcinoma AJCC v8,1
46178,Neuroendocrine Differentiation,Glomus vagale tumor,1
46179,Carcinomatous Component Present,Stage IVB Cervical Cancer AJCC v8,1
46180,Pregnancy Complications,Recurrent Gestational Trophoblastic Tumor,1
46181,Childhood Lesion,Childhood Central Nervous System Mixed Germ Cell Tumor,1
46182,Epithelial Component Present,Adenocarcinoma of the prostate metastatic,1
46183,Painless Mass,Soft tissue chondroma,1
46184,Malignant Cellular Infiltrate,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
46185,Carcinomatous Component Present,Stage I Renal Cell Cancer AJCC v8,1
46186,Malignant Cellular Infiltrate,Malignant retroperitoneal tumor,1
46187,Hypocellular Tissue,Intramuscular Myxoma,1
46188,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
46189,Hemorrhagic,Uterine Angiosarcoma,1
46190,Vascular Channel Formation,Osteoblastic Osteosarcoma,1
46191,Ineffective hematopoiesis,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
46192,Adulthood Lesion,Smoldering Adult T-Cell Leukemia/Lymphoma,1
46193,Splenomegaly,Recurrent B-Cell Prolymphocytic Leukemia,1
46194,Epithelial Component Present,Testicular Carcinoid Tumor,1
46195,High Grade Lesion,Childhood Gliosarcoma,1
46196,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts,1
46197,Carcinomatous Component Present,Choroid Plexus Carcinoma,1
46198,Lepidic Growth Pattern,Lepidic Predominant Adenocarcinoma,1
46199,Curvilinear Thin-Walled Vascular Pattern,Fibromyxosarcoma,1
46200,Epithelial Component Present,Stage IV Laryngeal Cancer AJCC v6,1
46201,Malignant Cellular Infiltrate,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
46202,Capsular Invasion,"Thymoma, type AB, malignant",1
46203,Diffuse Pattern,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
46204,Malignant Cellular Infiltrate,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
46205,Childhood Lesion,Childhood Thyroid Gland Medullary Carcinoma,1
46206,Lymphoplasmacytic Infiltrate,Angiocentric immunoproliferative lesion grade 2,1
46207,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
46208,Cutaneous Involvement,Malignant vascular tumor of skin,1
46209,Epithelial Component Present,Stage II Hypopharyngeal Carcinoma AJCC v8,1
46210,Slow Growing Mass,Central Nervous System Hemangioblastoma,1
46211,Malignant Cellular Infiltrate,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
46212,Malignant Cellular Infiltrate,Skin Clear Cell Basal Cell Carcinoma,1
46213,Malignant Cellular Infiltrate,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
46214,Malignant Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v8,1
46215,High Grade Lesion,Platinum-Sensitive Lung Small Cell Carcinoma,1
46216,Pregnancy Complications,"Placenta, Retained",1
46217,High Grade Lesion,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
46218,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia-1,1
46219,Dysplasia,Esophageal Squamous Intraepithelial Neoplasia,1
46220,Epithelial Component Present,Glomerulosa Cell Adrenal Cortical Adenoma,1
46221,Necrotic changes (finding),Small cell lung cancer recurrent,1
46222,Immunosuppression-Related Post-Transplant Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
46223,Malignant Cellular Infiltrate,Laryngeal Giant Cell Carcinoma,1
46224,Therapy-Related Toxicity,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
46225,Severe dysplasia,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
46226,Malignant Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor,1
46227,Papillary Pattern,Subglottic Verrucous Carcinoma,1
46228,High Mitotic Activity,Small cell carcinoma of the cervix,1
46229,Malignant Cellular Infiltrate,Drop Metastasis in the Spinal Cord,1
46230,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of appendix,1
46231,Malignant Cellular Infiltrate,Stage IIIA Cervical Cancer AJCC v8,1
46232,Cutaneous Involvement,"Dermatofibrosarcoma Protuberans, Myxoid",1
46233,Metaplasia,Bladder squamous cell carcinoma stage 0,1
46234,Mixed Cellular Population,Mixed Salivary Gland Tumor,1
46235,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Choriocarcinoma,1
46236,Malignant Cellular Infiltrate,Stage IVB Cervical Cancer AJCC v8,1
46237,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Neoplasm,1
46238,Malignant Cellular Infiltrate,"Colorectal cancer, hereditary nonpolyposis, type 1",1
46239,Unresectable Mass,Unresectable Melanoma,1
46240,Malignant Cellular Infiltrate,Splenic marginal zone lymphoma refractory,1
46241,Malignant Cellular Infiltrate,Unresectable Skin Basal Cell Carcinoma,1
46242,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of lacrimal gland,1
46243,Refractory Disease,Hodgkin's disease lymphocyte depletion type refractory,1
46244,Tissue of Mullerian Origin Present,Uterine Corpus Adenofibroma,1
46245,Metastatic Lesion,Secondary malignant neoplasm of axilla,1
46246,Malignant Cellular Infiltrate,Secondary Prostate Urothelial Carcinoma,1
46247,Malignant Cellular Infiltrate,"Testicular Seminoma, Pseudoglandular Variant",1
46248,Low Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1,1
46249,Erythema,Multifocal superficial basal cell carcinoma,1
46250,Exophytic Papillary Lesion,Urethral Condyloma Acuminatum,1
46251,Malignant Cellular Infiltrate,Advanced Unresectable Gastric Adenocarcinoma,1
46252,Malignant Cellular Infiltrate,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
46253,Erythroid hyperplasia,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
46254,'Starry-sky' pattern,Burkitt's lymphoma refractory,1
46255,Carcinomatous Component Present,Laryngeal squamous cell carcinoma recurrent,1
46256,Epithelial Component Present,Thymic Papillary Adenocarcinoma,1
46257,Tubular Pattern,tubular adenoma of extrahepatic bile duct,1
46258,Hyalinized Stroma Formation,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
46259,Carcinomatous Component Present,Refractory Female Reproductive System Carcinoma,1
46260,Thin Bands of Collagen Present,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
46261,Carcinomatous Component Present,Adenocarcinoma in Situ,1
46262,Local disease,Transitional cell cancer of the renal pelvis and ureter localized,1
46263,Cutaneous Involvement,Pathologic Stage II Cutaneous Melanoma AJCC v8,1
46264,Epithelial Component Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
46265,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Thrombocytopenia,1
46266,Malignant Cellular Infiltrate,Stage II Bladder Cancer AJCC v8,1
46267,Myxoid Stroma Formation,Refractory Myxoid Liposarcoma,1
46268,Cutaneous Involvement,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
46269,Anaplasia,Recurrent Childhood Anaplastic Large Cell Lymphoma,1
46270,Carcinomatous Component Present,Grade 3 Clear Cell Renal Cell Carcinoma,1
46271,Stromal Invasion,Stage II Ovarian Cancer AJCC v8,1
46272,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma,1
46273,Intermediate Grade Lesion,Malignant carcinoid tumor of lung,1
46274,Alternative Fascicle (Bundle) Pattern,Dartoic myoma,1
46275,Carcinomatous Component Present,Stage IB Vaginal Cancer AJCC v8,1
46276,Malignant Cellular Infiltrate,Prostate Myeloid Sarcoma,1
46277,High Mitotic Activity,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
46278,Epithelial Component Present,Ovarian Sex Cord Tumor with Annular Tubules,1
46279,Severe dysplasia,Stage 0 Vaginal Cancer AJCC v7,1
46280,Carcinomatous Component Present,Gastric Neuroendocrine Carcinoma,1
46281,Malignant Cellular Infiltrate,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
46282,Secondary Lesion,Treatment related acute myeloid leukaemia,1
46283,Vascular Channel Formation,Senile angioma,1
46284,Malignant Cellular Infiltrate,Refractory Aggressive NK-Cell Leukemia,1
46285,Well Differentiated Lesion,Well Differentiated Prostate Adenocarcinoma,1
46286,Single Cell Necrosis,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
46287,Mesenchymal Component Present,Eccrine mixed tumor of skin,1
46288,Malignant Cellular Infiltrate,EBV-Related Carcinoma,1
46289,More than 10 Mitoses per 10HPF,Stage III Lung Small Cell Carcinoma AJCC v7,1
46290,Rosenthal Fibers Present,Rosette-forming glioneuronal neoplasm,1
46291,Chromogranin A Positive Neoplastic Cells Present,Strumal carcinoid,1
46292,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
46293,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma,1
46294,Unresectable Mass,Unresectable Sarcoma,1
46295,Diffuse Pattern,Childhood Gliomatosis Cerebri,1
46296,Malignant Cellular Infiltrate,germinoma of brain,1
46297,Epithelial Component Present,Plantar wart,1
46298,Secondary Lesion,Metastatic Bone Sarcoma,1
46299,Carcinomatous Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
46300,Immunologic Deficiency Syndromes,Hyperacute allograft rejection,1
46301,Borderline Lesion,Borderline cystadenoma,1
46302,Carcinomatous Component Present,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7,1
46303,Carcinomatous Component Present,Stage IIA Primary Peritoneal Cancer AJCC v8,1
46304,Recurrent disease,Pancreatic carcinoma recurrent,1
46305,Malignant Cellular Infiltrate,Mantle cell lymphoma of spleen,1
46306,Painless Mass,Central Nervous System Chondroma,1
46307,Malignant Cellular Infiltrate,Gallbladder Melanoma,1
46308,Papillary Pattern,Parotid Gland Warthin Tumor,1
46309,Malignant Cellular Infiltrate,Metastatic Squamous Cell Breast Carcinoma,1
46310,Mitotic Activity,Adult Brain Stem Gliosarcoma,1
46311,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
46312,Carcinomatous Component Present,Stage IA2 Cervical Cancer AJCC v8,1
46313,Perineural spread,Prostate Adenoid Cystic Carcinoma,1
46314,Metastatic/Recurrent Disease,Adult Synovial Sarcoma,1
46315,Antoni A Pattern,Degenerated Schwannoma,1
46316,Epithelial Component Present,Stage IA1 Lung Cancer AJCC v8,1
46317,Dysplasia,Low Grade Squamous Intraepithelial Neoplasia,1
46318,Indolent Clinical Course,Angiomatosis,1
46319,Acanthosis,Condyloma acuminata of vagina,1
46320,Mixed Cellular Population,Cellular Pleomorphic Adenoma,1
46321,Cystic Change,Eccrine hidrocystoma,1
46322,Thick-Walled Hyalinized Vessels Present,Benign Mediastinal Psammomatous Schwannoma,1
46323,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,1
46324,Malignant Cellular Infiltrate,Broad Ligament Serous Adenocarcinoma,1
46325,Well-Circumscribed Lesion,Vaginal Angiomyofibroblastoma,1
46326,Malignant Cellular Infiltrate,Verrucous carcinoma of penis,1
46327,Epithelial Component Present,Vulvar Warty Carcinoma,1
46328,Dysplasia,tubulovillous adenoma of stomach,1
46329,Dilated Vascular Space Formation,Telangiectatic Glomangioma,1
46330,Epithelial Component Present,Aflatoxins-Related Hepatocellular Carcinoma,1
46331,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v6,1
46332,Epithelial Component Present,Unresectable Bladder Urothelial Carcinoma,1
46333,Epithelial Component Present,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
46334,Single Type of Tissue Derived from One Embryonic Layer Present,Benign Struma Ovarii,1
46335,Childhood Lesion,Childhood Diffuse Astrocytoma,1
46336,Epithelial Component Present,Intestinal Neuroendocrine Carcinoma,1
46337,Benign Cellular Infiltrate,Adenoameloblastoma,1
46338,Mitotic Activity,Brain Stem Glioblastoma,1
46339,Epithelial Component Present,Metastatic Lung Small Cell Carcinoma,1
46340,Refractory Disease,Refractory Carcinoma,1
46341,Biphasic Pattern,Stage IC Uterine Corpus Adenosarcoma AJCC v8,1
46342,Malignant Cellular Infiltrate,Cerebral Glioblastoma,1
46343,Carcinomatous Component Present,Clear Cell Intrahepatic Cholangiocarcinoma,1
46344,Malignant Cellular Infiltrate,Choroid Necrotic Melanoma,1
46345,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
46346,Carcinomatous Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
46347,Hereditary Lesion,Hereditary spherocytosis,1
46348,Malignant Cellular Infiltrate,Refractory Malignant Solid Neoplasm,1
46349,Malignant Cellular Infiltrate,Extrarenal rhabdoid tumor,1
46350,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,1
46351,Carcinomatous Component Present,Stage IIIB Rectal Cancer AJCC v8,1
46352,Benign Cellular Infiltrate,Hard Palate Monomorphic Adenoma,1
46353,Malignant Cellular Infiltrate,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
46354,Malignant Cellular Infiltrate,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
46355,Well-Circumscribed Lesion,Borderline cystadenoma,1
46356,Abundance of Small Lymphocytes,Lymphocyte Rich Classical Hodgkin Lymphoma,1
46357,Mild dysplasia,Mild esophageal dysplasia,1
46358,CD56-Positive Neoplastic Cells Present,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
46359,Malignant Cellular Infiltrate,Stage IIIC Colon Cancer AJCC v8,1
46360,Carcinomatous Component Present,Stage IVB Rectal Cancer AJCC v8,1
46361,Intraductal Lesion,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
46362,Crystal deposition,Alveolar soft part sarcoma non-metastatic,1
46363,Unresectable Mass,Locally Advanced Unresectable Carcinoma,1
46364,Neuroendocrine Differentiation,Atypical carcinoid tumor,1
46365,Presence of a Hormonal Syndrome,Pancreatic Vipoma,1
46366,Papillary Pattern,Vaginal Squamous Papilloma,1
46367,Monomorphic Cellular Infiltrate,Ependymoma,1
46368,Indolent Clinical Course,Peripheral Odontogenic Fibroma,1
46369,Immunologic Deficiency Syndromes,Transplant-Related Disorder,1
46370,Unfavorable Clinical Outcome,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
46371,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
46372,Poorly Differentiated Neuroendocrine Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma,1
46373,Epithelial Component Present,Stage 0 Ureter Cancer AJCC v7,1
46374,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
46375,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Tip Lesion Variant,1
46376,Cutaneous Involvement,Malignant fibrous histiocytoma of skin,1
46377,Monoclonal Cellular Population Present,"Mastocytosis, Diffuse Cutaneous",1
46378,Malignant Cellular Infiltrate,Colon Sarcoma,1
46379,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,1
46380,Borderline Lesion,Borderline Fallopian Tube Endometrioid Tumor,1
46381,Carcinomatous Component Present,Prognostic Stage IA Breast Cancer AJCC v8,1
46382,Carcinomatous Component Present,Stage III Colon Cancer AJCC v7,1
46383,Papillary Pattern,Cervical Squamotransitional Carcinoma,1
46384,Fibromyxoid Stroma Formation,"Ossifying fibromyxoid tumor, malignant",1
46385,Epithelial Component Present,Paraganglioma,1
46386,Lobulated Growth Pattern,Left atrial myxoma,1
46387,Absence of Invasion,Stage 0 Colon Cancer AJCC v8,1
46388,Malignant Cellular Infiltrate,Pathologic Stage IIC Cutaneous Melanoma AJCC v8,1
46389,Epithelial Component Present,Resectable Extrahepatic Bile Duct Adenocarcinoma,1
46390,Carcinomatous Component Present,Uterine Carcinosarcoma,1
46391,Malignant Cellular Infiltrate,Stage III Retroperitoneal Sarcoma AJCC v8,1
46392,Carcinomatous Component Present,Stage IV Gallbladder Cancer AJCC v6,1
